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ABSTRACT 53BP1 AND DOUBLE-STRAND BREAK REPAIR 
PATHWAY CHOICE IN CANCER.  
HARVEER S. DEV. 
The cellular response to DNA double-strand breaks (DSB) is principally the result of two 
competing repair pathways. The Tumour Protein P53 Binding Protein 1 (TP53BP1) gene product 
plays a central role in DSB repair pathway choice, promoting non-homologous end-joining 
(NHEJ) and counteracting homologous recombination (HR). As with all DNA damage response 
(DDR) proteins, cell-cycle regulation of 53BP1 is critical to its function. The inappropriate activity 
of 53BP1 in mitosis, during which most of the DDR is inactivated to preserve genome stability, 
has been shown to have adverse effects on cell division that are characteristic of cancers. We 
explored the consequences of replication stress, associated with oncogene activity, and the 
impact of aberrantly active 53BP1 in mitosis. This work reveals interference with normal mitotic 
mechanisms for detecting and resolving stalled replication intermediates; most evidently 
manifest as reduced mitotic DNA synthesis (MiDAS), and increased accumulation of acentric 
micronuclei and G1 nuclear bodies. We propose that the functional sequestration of TOPBP1 may 
be responsible for these chromosomal mis-segregation defects.  
The mechanism by which 53BP1 (together with RIF1 and MAD2L2) promote NHEJ remains 
elusive. Genome instability in HR-defective cancers, principally those harbouring a mutation in 
BRCA1, can be rescued by the concomitant loss of either 53BP1, RIF1 or MAD2L2. This 
phenomenon has relevance for the development of PARP (Poly(ADP-ribose) polymerase) 
inhibitor resistance, now being used in BRCA1-deficient breast, ovarian and prostate cancers 
based on the principle of ‘synthetic lethality’. As part of a search for other resistance 
mechanisms, we identified the shieldin complex (SHLD1/C20orf196 and SHLD2/FAM35A) that 
when lost suppressed PARP inhibitor sensitivity in BRCA1-deficient cancer cells. We 
demonstrate that SHLD1/2 represent the terminal end-effectors of the 53BP1-RIF1-MAD2L2 
axis, supporting NHEJ activity. We identified three OB-fold domains in SHLD2/FAM35A, that 
bind single-stranded DNA and are necessary for NHEJ. Loss of SHLD1 or SHLD2 (SHLD1/2) 






















caused a hyper-resection phenotype, and which, in the absence of BRCA1 was associated with 
rescuing RAD51 loading. Downregulation in SHLD1/2 expression was also associated with 
intrinsic and acquired resistance across a panel of BRCA1-deficient patient-derived xenograft 
models. Promisingly, this mechanism may impart an acquired vulnerability to cisplatin or 
radiotherapy. Thus, we have characterised a critical component of the 53BP1 axis which is 
deterministic in repair pathway choice and carries implications for the treatment of cancers.  
  





































































 “What can be asserted without evidence can also be dismissed without evidence” 
Christopher Hitchens 





“Science is a bit like the joke about the drunk who is looking under a lamppost for a key that he 
has lost on the other side of the street, because that’s where the light is. It has no other choice.” 
Noam Chomsky 





“We will never know until we try, so go and do the fucking experiment” 
Professor Gerard Evan 
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1. Chapter 1 Introduction 
1.1. The DNA damage response 
Cells are under constant exposure to endogenous and exogenous sources of DNA damage which 
may compromise genome stability. Accurate replication and genome maintenance are essential 
for cellular homeostasis, faithful transmission of genetic material, and organism survival. The 
complex interconnected signal transduction pathways that cells mount in response to DNA 
damage are known as the DNA damage response (DDR). This network of sensors, mediators and 
effectors is necessary for the effective remodelling and repair of DNA, along with checkpoint 
activation to stall cell cycle progression and facilitate these processes. The DDR also involves 
chromatin remodelling, transcriptional changes, and interactions with DNA replication 
machinery, at both a local and global level (Blackford and Jackson, 2017). The recruitment and 
activation of various DDR factors is temporally and spatially regulated in a lesion-specific 
manner. This ensures the safe coordinated action of a plethora of enzymatic activities, which if 
left unchecked could themselves generate cytotoxic DNA damage (Ciccia and Elledge, 2010). 
Furthermore, the dysregulation of these pathways can have a profound impact on human health 
and disease.  
1.1.1. DNA damage 
DNA damage can originate from sources endogenous and exogenous to the cell. Internal sources 
of DNA damage are varied, and can include spontaneous nucleotide misincorporation or 
interconversion leading to abasic or mismatched DNA, or SAM (S-adenosyl methionine)-
induced alkylation (Ciccia and Elledge, 2010). Cellular metabolism can also lead to the generation 
of single-strand breaks via reactive oxygen species (ROS), as well as vis-à-vis gaps formed by 
unligated Okazaki fragments (Hanzlikova et al., 2018). These form an important substrate that is 
relevant to our understanding of the DDR, as are inappropriately embedded genomic 
ribonucleotides which represent one of the most frequent DNA lesions (Zimmermann et al., 
2018). Endogenous stressors including R-loops and transcription collisions can also result in the 






















collapse of replication forks and hence the generation of DNA breaks. Physiological processes 
can also lead to the purposeful generation of double-strand breaks, such as programmed V(D)J 
recombination and immunoglobulin class switching in lymphocytes (see 1.2.2.2 below).  
Exogenous DNA damaging agents encompass the gamut of external physical or chemical 
sources. The former is exemplified by ultraviolet (UV) and ionising irradiation (IR), either from 
environmental or therapeutic sources; UV generates pyrimidine adducts, while IR can induce a 
range of single-strand and double-strand breaks (SSB and DSB respectively), particularly 
generating complex DNA ends, along with oxidative stress and proteomic damage. Clastogenic 
chemicals include traditional pharmacological agents and currently utilised clinical compounds, 
which may alkylate, cross-link or enzymatically inhibit, as typified by methyl methanesulfonate 
(MMS), cisplatin and the topoisomerase I inhibitor camptothecin respectively. The response to 
any of these DNA lesions, begins with their detection for the purposes of activating a specific 
repair pathway to resolve the precise type of abnormal DNA structure which has been generated.  
1.1.2. Damage detection and single-strand break repair 
Three single-stranded DNA damage repair pathways exist. Nucleotide mismatches i.e. A:T or 
T:C, are initially recognised by MSH2-MSH6, which are digested by EXO1 and resynthesised by 
a DNA polymerase, during mismatch repair.  
Small non-distorted base modifications such as alkylation, oxidation or deamination are flipped 
out of the double helix by DNA glycosylases to generate an abasic site, which after cleavage by 
AP endonucleases generates a SSB; the process of base excision repair can subsequently involve 
end-processing, (e.g. PNKP), DNA polymerase for synthesis, before flap endonuclease cleavage 
(e.g. FEN1) and DNA ligation (e.g. LIG1/LIG3 and XRCC1).  
In contrast, bulkier helix-distorting lesions require the nucleotide excision repair pathway, which 
involves various complexes to detect damage in a transcription dependent or independent 
manner, via transcription-coupled or global genomic NER. Dual incision for nucleotide removal 
is followed by the action of DNA polymerases prior to ligation of the remaining nicks. This 
pathway, along with components of homologous recombination, also contribute to interstrand 






















cross-link (ICL) repair that centres around the Fanconi anaemia pathway (see 1.2.1 below). While 
SSBs represent the more abundant of lesions, DSBs represent the most cytotoxic lesions to a 
cell.  
1.2. Double strand break repair pathways 
There are four principal repair pathways for dealing with DSBs. Classical non-homologous end-
joining (cNHEJ), alternative end-joining (or microhomology-mediated end-joining) alt-EJ, 
homologous recombination (HR) and single-strand annealing (SSA). While all of these repair 
pathways employ unique combinations of signal transducers and effectors, they all start with the 
common lesion of a gap across both strands of the DNA duplex.  
The DSB is a competitive substrate, which is initially targeted by at least three proteins with rapid 
binding kinetics; PARP1/PARP2, Ku70/80 (XRCC5/XRCC6) and the MRN (MRE11-RAD50-NBS1) 
complex. PARP1 can detect both SSB and DSBs (Langelier et al., 2012) via its Zn-finger related 
domains, and through a conformational change unfolds the ADP-ribosyl transferase catalytic 
domain leading to auto-PARylation and the establishment of a PARylated platforms on 
surrounding chromatin, which can serve as a docking site for proteins with PAR-binding motifs 
(Lord and Ashworth, 2017, Ray Chaudhuri and Nussenzweig, 2017). PARP1 and the Ku70/80 
heterodimer are likely to be the fastest-acting primary sensors (in part related to their high 
expression levels), which compete directly with each other for mutually exclusive access to the 
DNA ends on which they ‘cap’ or ‘slide’ onto respectively (Yang et al., 2018). Binding of the 
Ku70/80 heterodimer facilitates subsequent activation of DNA-PK, which initiates the NHEJ 
repair pathway (see 1.2.2 below). 
The MRN complex consists of a heterotrimer of MRE11 nuclease (harbouring endo- and exo-
nuclease activities), and structural proteins RAD50 and NBS1. NBS1 appears to initiate the 
binding of the complex to DSBs (Williams et al., 2007). Similar to the actions of Ku on DNA-PKc 
(PRKDC), MRN has an important role in the recruitment and activation of the related kinase ATM 
(Blackford and Jackson, 2017). It is possible for MRN and Ku to simultaneously occupy a single 
DSB site within a cell (Britton et al., 2013), and the net effect of competing sensors on the specific 






















underlying DNA lesion contributes to a cellular commitment to homologous recombination or 
an end-joining repair pathway. 
In the first instance, the ATM activation mediates a signalling cascade on chromatin surrounding 
the break site, which via a series of post-translational modifications and protein recruitments 
serves to amplify the initial damage signal. ATM activation leads to phosphorylation of the 
histone variant H2AX (H2AFX, comprising ~10% histones in human fibroblasts) at Ser139, also 
known as 𝛾H2AX; this provides the docking site for MDC1, which recruits additional MRN and 
ATM, as well as the E3 ubiquitin ligase RNF8. RNF8 mediates widespread chromatin 
decondensation (Luijsterburg et al., 2012), and K-63 linked poly-ubiquitination of L3MBTL2 
(Nowsheen et al., 2018) and/or the histone linker H1 (Thorslund et al., 2015), to recruit the E3 
ligase RNF168, which ubiquitinates H2AK13,15 (Mattiroli et al., 2012), and potentially other 
proteins. This activity may itself be regulated by sumoylations via the SUMO ligases PIAS1/4 
(Galanty et al., 2009). The ubiquitination platform serves to recruit proteins such as 53BP1, 
RAP80 (UIMC1) for the purpose of BRCA1 loading, RAD18 and RNF169, which is auto-
propagated by RNF168’s own ubiquitin binding domain (Schwertman et al., 2016). RNF169 may 
promote resection mediated repair such as SSA, by competing with 53BP1 for H2AK13,15ub 
binding (An et al., 2018, Hu et al., 2017, Kitevski-LeBlanc et al., 2017, Panier et al., 2012). Additional 
chromatin-associated protein modifications in the form of methylations and acetylations also 
play a critical role in establishing a histone code which facilitates the recruitment of individual 
proteins, and tailors the specific DDR that is mounted. The removal of such signals by 
deubiquitinases, demethylases and deacetylases offers further opportunities to regulate the 
cellular response to DNA damage, along with other post-translational modifications including 
sumoylation and ufmylation (Schwertman et al., 2016, Qin et al., 2019). The balance of these 
competing processes can for example, determine 53BP1 or BRCA1 recruitment, and play 
important roles in determining repair pathway choice, as discussed in 1.2.3 below.  
1.2.1. Homologous recombination 
Homologous recombination (HR) describes a form of DNA recombination used to repair DSBs 
in an error-free manner. Its high-fidelity stems from the use of a homology template, which is 






















typically the replicated sister chromatid and hence is restricted to use during S and G2 phases of 
the cell cycle. The failure to utilise the homologous chromosome likely reflects the spatial 
proximity of the sister chromatid, and inhibitory mechanisms which operate on HR components 
outside of these phases.  
After DNA damage detection, DNA end-resection must occur to generate a 3’ overhang for the 
purpose of recombination. Control of DNA end-resection is an obligatory step toward 
commitment to a repair pathway that requires strand annealing, effectively blocking cNHEJ, and 
is therefore an important step in repair pathway choice (see 1.2.3 below). CtIP (RBBP8) and MRN 
are likely to conform to the minimal resection machinery (Anand et al., 2016, Sartori et al., 2007), 
with MRE11’s endonuclease activity beginning the process with an internal nick which facilitates 
its 3’à5’ exonuclease action generating a short 3’ overhang. The HR protein BRCA1 is known to 
form a complex with CtIP and MRN (BRCA1-C complex) (Chen et al., 2008), and likely plays a 
modulatory role in accelerating end-resection (Cruz-Garcia et al., 2014). In contrast, the BRCA1-
A complex (which associates with MERIT40/BRCC3/BABAM1/2/ABRAXAS1 via RAP80) is 
thought to restrict end-resection (Hu et al., 2011), and clearly the interplay between different 
complexes will be important in determining this outcome. BRCA1 is a 1863aa protein with an N-
terminal RING domain required for heterodimerisation with another RING-containing protein, 
BARD1; it contains a central region encoded by exon 11; a coiled-coil domain mediating its 
interaction with PALB2; and C-terminal BRCT repeats that are phosphorylated to enable its 
interaction with phosphorylated CtIP.  
Long-range DNA end-resection by BLM/DNA2 and EXO1 helicase/nucleases generates 
extensive tracts of transiently exposed single-stranded DNA (ssDNA) which are rapidly coated 
by the ssDNA-binding heterotrimer RPA complex (RPA1-RPA2-RPA3). This eliminates 
secondary structures and serves to protect DNA from degradation (Chen et al., 2013), and acts as 
substrate for exchange with the RAD51 recombinase, preventing spontaneous annealing between 
regions of microhomology (Deng et al., 2014). RPA turnover can also be mediated by 
ubiquitination via RFWD3 and PRP19 which can act to activate ATR and HR at stalled replication 
forks (Dubois et al., 2017). The sumoylation of RPA following SENP6 dissociation, can also 






















promote SUMO-targeted ubiquitination and degradation of RPA by RNF4, and/or the 
recruitment of CtIP to facilitate RAD51 exchange (Galanty et al., 2012, Yin et al., 2012). 
RAD51 loading onto DNA is thought to be brought about by the coordinated actions of the 
BRCA1-PALB2-BRCA2 complex. Specifically, BRCA2s C-terminal BRCT repeats disrupt RAD51 
oligomers and facilitates RPA exchange and RAD51-ssDNA loading as monomers, forming a 
nucleofilament for the purposes of strand invasion into the homologous template (Carreira and 
Kowalczykowski, 2011). This invasion step is also likely to be stimulated by the action of BRCA1-
BARD1 binding to RAD51, and the branched DNA D-loop structure which forms during 
recombination (Zhao et al., 2017). This D-loop is generated for synthesis dependent strand 
annealing (SDSA), or can form a double Holliday Junction (HJ) via second-end capture, which 
facilitates branch migration. Dissolution of the latter can also lead to non-crossover products as 
a result of the action of the BLM-TOPOIII-RMI1/2 (BTR complex); in contrast HJ resolution by 
GEN1 or the MUS81-EME1/SLX1-SLX4 nuclease complex generates crossovers. There are 
various anti-recombinases which can act at various stages of this process to reverse these 
processes and favour alternative repair mechanisms, including PARI and the helicases RECQL5 
and RTEL-1 (Ceccaldi et al., 2016a). RADX appears to restrict the recombinogenic function of 
RAD51 by opposing HR and contributes to the cytotoxicity of the PARP inhibitor olaparib and 
the TOP1 poison camptothecin in BRCA2 deficiency (see 1.4.3 below) (Bhat et al., 2018, 
Dungrawala et al., 2017, Schubert et al., 2017). BRCA1 and CtIP are also likely to process the 
second end of a DSB, facilitating its capture in order to achieve SDSA, hence suppressing more 
error-prone long-tract gene conversions; these also suppress small tandem duplications which 
form after aberrant repair of stalled replication forks generating genomic rearrangements 
(Chandramouly et al., 2013, Willis et al., 2017). 
The proteins involved in HR are also employed in the terminal steps of the more complex 
Fanconi anemia pathway for interstrand crosslink (ICL) repair. In brief, the detection of an ICL by 
FANCM-MHF1-MHF2 and UHRF1 recruit the FA core complex and FANCD2-I respectively 
(Rodriguez and D'Andrea, 2017). The core complex serves to ubiquitinate FANCD2-I, which is 
required for recruiting various endonucleases, for the purpose of NER-type DNA incision and 






















unhooking by MUS81-SLX1-SLX4. This generates a DNA adduct which can be bypassed by 
RAD18/PCNA-mediated translesion DNA polymerase ζ (REV3 with REV1 and REV7) recruitment 
and synthesis, and which then serves as a template for HR repair of the remaining DSB (Ceccaldi 
et al., 2016b).  
In contrast to HR, the two alternative lower fidelity homology-based repair pathways are 
alternative end-joining (alt-EJ) and single-strand annealing (SSA) which are discussed in 1.2.2.4 
below.  
1.2.2. Non-homologous end-joining  
1.2.2.1. Classical NHEJ and core NHEJ machinery 
The main DSB repair pathway which can operate throughout the cell cycle, is classical (or 
canonical) NHEJ (Beucher et al., 2009). This involves peripheral factors which promote the 
pathway but are not an absolute requirement for effective repair, and the core end-joining 
machinery which operates in close proximity to the DNA break ends (Ciccia and Elledge, 2010). 
Single molecule fluorescence imaging studies, suggest a two stage model, in which ‘long-range’ 
tethering is mediated by Ku70/80 and DNA-PK bridging the two ends of DNA. This facilitates 
direct ligation by XRCC4-LIG4 and XLF/PAXX co-factors (Ochi et al., 2015) with the formation 
of a short-range complex, sterically blocking access of processing factors in order to prioritise 
rapid direct DNA end-ligation (Graham et al., 2016, Graham et al., 2018). If direct end-joining 
cannot occur, then DNA processing by accessory factors such as Artemis (DCLRE1C) and PNKP 
may be required to generate compatible ends for DNA end-ligation (Ciccia and Elledge, 2010, 
Blackford and Jackson, 2017). It has recently been proposed that the deliberate incorporation of 
ribonucleotides into the DNA ends by DNA Nucleotidylexotransferase (DNTT) and Polµ 
facilitate rapid and effective NHEJ repair (Pryor et al., 2018), albeit ultimately requiring removal 
by RNASEH2A. In this regard, it is noteworthy that while cNHEJ can lead to insertions or 
deletions, it is mostly accurate (Betermier et al., 2014). 






















1.2.2.2. 53BP1 promotes cNHEJ 
We have considered the effects of the DDR in modifying chromatin to create a permissive 
environment for supporting the recruitment of double-strand break repair factors (see 1.2 above). 
Central to promoting NHEJ is the recruitment and retention of p53-binding protein 1 (53BP1; see 
Figure 3.2). 53BP1 is recruited to the chromatin via two principal motifs, a tudor domain that 
facilitates interaction with a dimethylated histone (H4K20me2) and a ubiquitin-dependent 
recruitment (UDR) motif which facilitates interaction with the H2AK13,15ub site (Fradet-
Turcotte et al., 2013, Lee et al., 2014, Orthwein et al., 2014). Constitutive methylation of 
H4K20me2 in the pre-damaged state is bound by the polycomb group proteins L3MBTL1 and 
JMJD2A (KDM4A) which preclude 53BP1 tudor domain binding, in addition to interaction of this 
domain with the TIRR (NUDT16L1) chaperone protein (Her and Bunting, 2018, Drane et al., 2017). 
This interaction is further regulated by the acetylation status of the neighbouring H4K16 residues 
as determined by KAT5 and HDAC1/2 (Hsiao and Mizzen, 2013, Tang et al., 2013). The damage 
dependent re-localisation of 53BP1 from undamaged chromatin, to localise on ~1Mb chromatin 
surrounding a DSB (Clouaire et al., 2018), leads to the formation of microscopically visible 
subnuclear foci, to which the recruitment of downstream partners can be identified. The minimal 
focus-forming region (FFR) of 53BP1 required to facilitate accumulation of 53BP1 foci, 
encompasses the oligomerisation domain, the Gly-Arg-rich (GAR) motif, and the tandem Tudor 
and UDR domains. The N-terminus 28 Ser/Thr-Gln sites are important for downstream 
interactions with RIF1 and PTIP (PAXIP1), while the C-terminus harbours a BRCT domain which 
together with USP28 facilitates p53-mediated transcription independent of its role in DSB repair 
(Panier and Boulton, 2014, Cuella-Martin et al., 2016); see Figure 3.2. 
Central to the function of 53BP1 in promoting NHEJ appears to be its role as a chromatin barrier 
to DNA end-resection which channels repair away from HR. 53BP1 recruits the downstream 
effectors RIF1 to its N-terminal S/T-Q motif in an ATM (and/or ATR) dependent fashion 
(Chapman et al., 2013, Di Virgilio et al., 2013, Escribano-Diaz et al., 2013, Feng et al., 2013, 
Zimmermann et al., 2013), which itself has been shown to be necessary for the recruitment of 
MAD2L2 (or REV7; a subunit of the heterotrimer REV1-REV3-REV7 which has an unrelated 






















function in translesion DNA synthesis as the DNA polymerase ζ) (Boersma et al., 2015, Xu et al., 
2015). The recruitment of the trimeric complex of 53BP1-RIF1-MAD2L2 (Simonetta et al., 2018) 
to sites of damage demonstrates a mutually antagonistic relationship with BRCA1; discussed 
further in 1.2.2.3 below.  
Loss of 53BP1 (Bunting et al., 2010, Bouwman et al., 2010), RIF1 (Chapman et al., 2013, Di Virgilio 
et al., 2013, Escribano-Diaz et al., 2013, Feng et al., 2013, Zimmermann et al., 2013) or MAD2L2 
(Boersma et al., 2015, Xu et al., 2015) is associated with increased DNA end-resection and a failure 
to perform cNHEJ. The latter can be evaluated in physiological contexts, notably for immune cell 
functions. The processing of RAG1-mediated DSBs for V(D)J recombination, necessary for 
antibody diversification, appears to require the core end-joining machinery, but the role of 
53BP1, if relevant, is limited to recombination between RAG cleavage sites that are separated by 
large distances (Difilippantonio et al., 2008, Bothmer et al., 2010, Dimitrova et al., 2008), and may 
be functionally redundant with XLF (Oksenych et al., 2012). In contrast, 53BP1 appears integral 
for the process of class switch recombination (CSR); this involves activation-induced deaminase 
(AID) mediated DSBs at immunoglobulin switch regions to facilitate cNHEJ between the two 
DSBs, resulting in class switching from IgM to different antibody isotypes (Ward et al., 2004, 
Bunting et al., 2010). A similar dependency of CSR on RIF1 (Chapman et al., 2013, Di Virgilio et al., 
2013, Escribano-Diaz et al., 2013, Feng et al., 2013, Zimmermann et al., 2013) or MAD2L2 (Boersma 
et al., 2015, Xu et al., 2015) has also been described. Furthermore, the end-resection that results 
from I-SceI induced CSR in the absence of 53BP1 is ATM and CtIP dependent, suggesting a 
general mechanism in negatively regulating these processes on DNA ends to facilitate end-
joining. 53BP1 has also been suggested to assist with chromatin mobilisation and the formation 
of long range synapses, and may also contribute to these functions, by for example, restricting 
nuclease access (Bothmer et al., 2011, Difilippantonio et al., 2008, Dimitrova et al., 2008); and 
RIF1 has also been shown to repress the chromatin loading of BLM (Feng et al., 2013). 
In a pathological context, the deprotection of linear telomeric ends exposes DSBs which can fuse 
via cNHEJ in a 53BP1-RIF1-MAD2L2 dependent manner. This fusion of deprotected telomeres 
can occur when component(s) of the shelterin complex which normally caps the telomeric ends 






















(preventing damage signalling via ATM activation) are lost e.g. experimentally via TRF2 silencing 
(Zimmermann and de Lange, 2014, Palm and de Lange, 2008). It is important to note that the 
phenotypes described for loss of 53BP1, RIF1 or MAD2L2 do not consistently phenocopy loss of 
core end-joining factors (see (Bunting et al., 2010) and below).  
The 53BP1 effector protein PTIP, may also contribute to some of these processes, possibly via 
its downstream engagement with ABRAXAS. Nussenzweig and colleagues proposed separate 
regions of the 53BP1 N-terminal S/T-Q motif as mediating its recruitment, compared to RIF1; 
although 53BP1-independent recruitment has also been described (Jowsey et al., 2004, Gong et 
al., 2009, Munoz et al., 2007). PTIP does not appear to contribute to CSR, although one study 
suggests its loss can rescue HR in BRCA1 depleted cells, in contrast to the partial rescue of this 
phenotype which they describe for RIF1 depletion (Callen et al., 2013); see below. This partial 
effect may in part reflect the contribution of RIF1 to replication fork stabilisation and origin firing 
(Buonomo et al., 2009, Xu et al., 2010). Hence PTIP’s functions may be complicated by a degree 
of competition with RIF1 for 53BP1 binding, as well cell line differences, exemplified by a HR-
promoting role for PTIP in chicken DT-40 cells (Wang et al., 2010). 
1.2.2.3. Interplay between 53BP1 and BRCA1  
As well as the contribution of the 53BP1-RIF1-MAD2L2 complex to cNHEJ, these components 
also appear to be important in the HR defect that is brought about by BRCA1 deficiency, as seen 
in familial and sporadic cancers (see 1.4 below). This mutual antagonism may operate at several 
levels of BRCA1 function.  
The BRCA1-C complex involving CtIP generates the 3’ DNA overhang which may be countered 
by a cell cycle dependent regulatory circuit of reciprocal inhibition centred around RIF1 
(Escribano-Diaz et al., 2013) and MAD2L2. In keeping with this idea, BRCA1/CtIP depletion 
appears to de-repress RIF1 IRIF in S/G2 phases of the cell cycle (with a minimal effect on 53BP1); 
which may involve ubiquitination via BRCA1-UHRF1 (Zhang et al., 2016). Conversely, 53BP1 and 
RIF1 together prevent the ectopic formation of BRCA1 foci (independently of CtIP) in response 
to damage during G1. The G1 mediated exclusion of BRCA1 from chromatin is likely to be driven 
by the cell cycle (see below), while progress into S phase is associated with the CDK mediated 






















interaction between BRCA1 and CtIP (Sartori et al., 2007, Huertas and Jackson, 2009) which likely 
contributes to the displacement of RIF1 (Escribano-Diaz et al., 2013) and MAD2L2.  
The interplay between BRCA1 and 53BP1 and their associated proteins, appears to be more 
important than direct competition with core components of cNHEJ or DNA end-resection; this 
is reflected by the partial suppression of radial chromosome aberrations in BRCA1ko/LIG4ko cells 
(without rescuing HR) (Bunting et al., 2010), and the partial/minimal defect in end-resection of 
BRCA1 loss compared with say, CtIP (Zhou et al., 2014, Cruz-Garcia et al., 2014, Escribano-Diaz 
et al., 2013, Polato et al., 2014). During S/G2, 53BP1 surrounds a central core focus of BRCA2 
(Chapman et al., 2012), and this might help to promote heterochromatic relaxation, and even 
facilitate HR during G2 (Noon et al., 2010, Kakarougkas et al., 2013), as well as by limiting DNA 
hyper-resection and SSA (see 1.2.2.4 below; (Ochs et al., 2016)). 
BRCA1 also functions with PALB2 and BRCA2 promoting RAD51 loading, an effect which is 
almost entirely abolished in the absence of BRCA1. Concomitant loss of either 53BP1, RIF1 or 
MAD2L2 restores RAD51 IRIF and rescues HR, which can be explained as an indirect effect of 
restoring 3’ ssDNA overhangs (above), or more directly by de-repressing RAD51 loading (e.g. by 
facilitating PALB2 mediated chromatinisation (Zong et al., 2019)). This rescue is evidenced by 
reporter assays, as well as the suppression of PARP-inhibitor (see 1.4.3 below) induced toxic 
chromosome fusions and cell death in BRCA1-deficient cells (Bunting et al., 2010). 
See 1.2.3 below for repair pathway choice. 
1.2.2.4. Alternative end-joining and single-strand annealing 
Alternative end-joining represents a less well-understood subpathway of NHEJ, which can utilise 
small regions (ranging between 2 and 20bp, but typically 4-6nt) of microhomology to facilitate 
DNA annealing between two ends of a DSB, in the absence of classical NHEJ components (which 
instead utilises 0-4nt homology (Chang et al., 2016)). Microhomology mediated end-joining 
describes this same effect and occurs via existing DNA or template-independent nucleotides 
that are added by DNA Polθ (POLQ) (Chang et al., 2017, Wood and Doublie, 2016). DNA Polθ can 
serve to tether DNA ends with minimal microhomology, minimising large deletions, and utilising 






















terminal transferase activity to provide insertions for microhomology (Kent et al., 2016, Yu and 
McVey, 2010). While this pathway can contribute to chromosomal translocations and 
rearrangements, inactivation of factors like DNA Polθ supports its positive contribution to 
genome stability (Yousefzadeh et al., 2014). The DNA damage sensing and/or signalling likely 
involves PARP1 (Robert et al., 2009), followed by MRN/CtIP processing, and potentially flap 
processing and gap filling; concluding with ligation via DNA LIG1/LIG3. A recent study by Markus 
Löbrich and colleagues challenges this model by proposing that slow G1 resection may 
accommodate cNHEJ-mediated repair of resected DNA ends, with Artemis and DNA-PKcs 
engagement for end-processing (Biehs et al., 2017). 
In contrast to cNHEJ which involves DNA end protection by 53BP1 and Ku to minimise DNA 
end-resection, both alt-EJ and SSA (like HR) require some DNA end-resection; this is likely to 
be initiated by MRN/CtIP. Single strand annealing (SSA) requires longer tracts of ssDNA 
resulting from extended lengths of DNA end-resection, typically >20nt of sequence homology 
and larger deletions (but less than the >100bp required for HR) (Bhargava et al., 2016). BLM/DNA2 
and EXO1 appear to contribute to this longer tract resection to facilitate RPA binding and RAD52 
exchange, for the purpose of annealing large regions of homology. It is suggested that the anti-
resection function of 53BP1 may, when limiting, be overcome and favour SSA (Ochs et al., 2016). 
Furthermore, negative regulators of RAD51 nucleofilament formation, are also likely to promote 
these more mutagenic repair pathways; e.g. PARI (PARBP), RECQL5, BLM (Ceccaldi et al., 2016a, 
Grabarz et al., 2013). It is noteworthy that RAD52 loss produces a minimal phenotype but is 
synthetic lethal with BRCA1, PALB2 or BRCA2 loss, suggesting a dependence on this back-up 
pathway upon HR-deficiency (Lok et al., 2013). SSA is also more likely to necessitate the removal 
of large unannealed non-homologous stretches of 3’ ssDNA, utilising components of the NER 
(e.g. XPF-ERCC1) and MMR (MSH2-MSH3) machinery for this flap processing (Bhargava et al., 
2016, Chang et al., 2017). 
1.2.3. DSB repair pathway choice 
The relationship between BRCA1 and 53BP1 represents an important regulatory partnership that 
integrates various cellular signals and helps to determine the correct repair of DNA DSBs. We 






















have discussed how this interplay is likely to be deterministic in the control of DNA end-
resection and RAD51 loading, and as a consequence, repair pathway ‘choice’. The cell cycle plays 
a key role in these processes (Hustedt and Durocher, 2016), including the general suppression of 
DSB repair processes that occurs during mitosis (see 1.3.1 below).  
CDK activity not only acts directly on CtIP to regulate its contribution to resection, but may also 
coordinate its BRCA1 interaction to promote end-resection (Cruz-Garcia et al., 2014, Huertas and 
Jackson, 2009, Huertas et al., 2008) and hence HR; while PLK3 phosphorylations of CtIP at 
overlapping residues may play a role in G1 mediated resection for alt-EJ (Barton et al., 2014, Biehs 
et al., 2017). Both direct effects on mediators of resection such as NBS1 (Falck et al., 2012), and 
indirect effects on expression levels e.g. MRE11 (Kanakkanthara et al., 2016), are required to 
ensure adequate cell cycle control. As previously outlined, the CDK dependent phosphorylation 
of Ser327 on CtIP is important for BRCA1’s antagonism of RIF1 recruitment to sites of damage. 
Clearly there are other regulators of end-resection factors, such as DNA-PK phosphorylations 
reducing Ku-DNA binding during S-phase, and RNF138 facilitating Ku removal and/or promoting 
CtIP’s recruitment to DSB sites (Schmidt et al., 2015, Ismail et al., 2015). The ssDNA translocase 
HELB, interacts with RPA and appears to restrict further end-resection, in a manner which is 
countered by CDK2 activity that reduces its nuclear import during S-phase (Tkac et al., 2016). 
Meanwhile, the S/G2 specific expression of the NHEJ inhibitor CYREN (cell cycle regulator of 
NHEJ) appears to interfere with Ku binding, with loss promoting toxic end-joining at deprotected 
telomeres (Arnoult et al., 2017). 
G1 is also the phase during which BRCA1 and PALB2 are prevented from interacting, by CRL3-
KEAP1 mediated ubiquitination, which is countered in S-phase by its deubiquitination due to 
upregulation of the DUB USP11, facilitating formation of the BRCA1-PALB2-BRCA2 complex for 
HR (Orthwein et al., 2015). ATR mediated phosphorylation of PALB2 in response to resected 
DNA also promotes this BRCA1-PALB2 interaction, favouring RAD51 loading in S-phase 
(Buisson et al., 2017). 
Another important dimension of pathway choice is the chromatin state and its ‘permissiveness’. 
Dynamic chromatin changes via post-translational modifications, constituted histone variants, 






















and DNA methylations can alter flexibility and mobility and hence accessibility of DNA to 
different repair factors. For example a widespread DSB-induced ubiquitination to acetylation 
switch on H2BK120, which ‘cross-talks’ with other chromatin modifications (e.g. H3K79me2 and 
H3K4me3 demethylation) appears to occur specifically at HR-prone sites (Clouaire and Legube, 
2019, Clouaire et al., 2018). The histone code has been shown to have a role in directing DSB 
repair pathway choice toward HR in actively transcribed genes (Aymard et al., 2014). There also 
appears to be complex contributions of nuclear position and the role of F-actin/myosin 
relocalisation of breaks to facilitate specific repair pathways (Caridi et al., 2018, Chiolo et al., 2011, 
Lemaitre et al., 2014). 
A model can be put forward to define the relationship between HR and the onset of S phase, 
whereby HR promoting factors appear behind replication forks resulting in local activation 
(Hustedt and Durocher, 2016). The incorporation of H4K20me0 impairs 53BP1 binding through a 
dilutional effect of methylated histones after replication (Pellegrino et al., 2017). It also results in 
the recruitment of chromatin readers such as MMS22L-TONSL (Saredi et al., 2016) and the 
BRCA1-BARD1 (Nakamura et al., 2019) complex, which likely promote RAD51 loading through 
chromatin remodelling and via BRCA1 localisation at DSBs (in an E3-independent manner but 
necessitating BARD1 binding) respectively. This latter finding suggested that the E3 ligase 
activity of BRCA1-BARD1 complex is dispensable, contradicting other work suggesting a role for 
BRCA1 mediated ubiquitination of H2A at K127 which promotes activity of the chromatin 
remodeller SMARCARD1 and repositioning of 53BP1 to drive long-range end-resection 
(Densham et al., 2016). Regardless, there is clearly a complex interplay between DDR factors 
which regulate pathway choice in a context-specific manner. 
1.3. DDR in mitosis 
1.3.1. DSB repair is attenuated in mitosis 
Mitosis is the shortest stage of the cell cycle, characterised by chromatin condensation and the 
equal segregation of sister chromatids into two separate daughter cells. It has long been 
established that mitotic cells tolerate DNA damage, without activating the complete canonical 






















checkpoint and signaling events that characterise the DDR during interphase (Zirkle and Bloom, 
1953, Rieder and Cole, 1998). As in interphase, γH2AX foci appear following primary detection 
by MRN and MDC1, with concomitant amplification of the ATM signaling cascade (Giunta et al., 
2010). This early phase of the DDR can be mounted in response to damage, but the following 
downstream mediators – RNF8 and RNF168 E3 ligases – are excluded from damaged sites until 
the later stages of mitosis (telophase/cytokinesis) (Giunta and Jackson, 2011, Giunta et al., 2010). 
DSBs are therefore likely to be detected and contained in mitosis, but further processing appears 
to occur in the following G1 phase, when large 2-3µm ‘nuclear bodies’ containing 53BP1 can 
assemble (Lukas et al., 2011). It is tempting to speculate that in mitosis the condensed state of 
the chromatin makes DSB repair difficult, and infer a cost-benefit balance favouring the rapid 
progression through mitosis for cells which have already passed the G2/M and mitotic spindle 
assembly (SAC) checkpoints.  
The Chowdhury and Durocher groups have uncovered how the next layer of the DDR is kept 
inactive during mitosis (Lee et al., 2014, Orthwein et al., 2014): the mitotic kinases (CDK1 and 
PLK1) mediate hyperphosphorylations which inactivate RNF8 (T198) and the ubiquitin-
dependent recruitment motif (UDR) of 53BP1 (T1609/S1618), with these sites being re-‘primed’ 
prior to G1 entry via the phosphatase complex PPP4C/PPP4R3B. The phospho-null mutant 
RNF8T198A can form IRIF in mitosis, and recruits BRCA1, but fails to recruit 53BP1 without it being 
dephosphorylated (Orthwein et al., 2014).  
The 53BP1ED phospho-mimic mutant failed to interact with ubiquitinated H2A K13/15 residues, 
the first of a two-part recognition motif proposed for its recruitment to a DSB (the second 
requires an interaction between 53BP1’s Tudor domain with dimethylated H4K20) (Orthwein et 
al., 2014, Fradet-Turcotte et al., 2013). In contrast, cells expressing the phospho-null mutant 
(53BP1AA) were able to form IRIF and resolve γH2AX to the same extent as the wild-type 
(53BP1WT) during interphase. Expressing 53BP1 and RNF8 phospho-null alanine mutants restores 
their recruitment to sites of damage in mitosis, but paradoxically exacerbates the sensitivity of 
these mitotic cells to radiation (Orthwein et al., 2014).  






















1.3.2. Ectopic recruitment of 53BP1 to chromatin can generate mitotic defects 
The deleterious nature of damage-responsive RNF8T198A/53BP1AA expression in mitosis was 
further demonstrated after 0.5Gy irradiation in nocodazole-arrested cells, which led to anaphase 
bridges, lagging chromosomes and whole-chromosome mis-segregation into (kinetochore-
positive) micronuclei (Lee et al., 2014, Orthwein et al., 2014). These effects could be suppressed 
by inhibiting DNA-PKc, silencing RNF168 (which potentiates 53BP1’s recruitment to chromatin) 
PTIP and RIF1 (53BP1 effector proteins), thus reflecting a deleterious role for activating the NHEJ 
axis in mitosis. Furthermore, stress-induced telomere deprotection following prolonged mitosis 
and genotoxic stress was suggested as one potential mechanism for the observation of telomere 
fusions (Orthwein et al., 2014).  
Hence, the aberrant activation of NHEJ in mitosis interferes with the normal process of 
chromosome segregation and can lead to aneuploidy. It is not understood why ectopic activation 
of the RNF8-53BP1 axis in mitosis should cause this range of defects.  
1.3.3. Replication stress induces mitotic defects in the absence of recombination factors 
The cytologically toxic effect of NHEJ activation is reminiscent of recent work identifying the 
role of HR and HJ mediators in resolving stress-induced replication intermediates, which when 
silenced produced similar mitotic defects. The recruitment of 53BP1AA to damaged DNA was 
induced by low-dose radiation (0.5Gy), and it will be important to establish its relevance to 
endogenous oncogene-induced replication stress. This cellular stress can also generate DSBs as 
well as stalled replication intermediates, and these DNA structures may serve as additional 
substrates for the recruitment of 53BP1 (Halazonetis et al., 2008, Costantino et al., 2014, Lukas 
et al., 2011, Schmidt et al., 2014).  
Low levels of cellular stress can remain undetected allowing cells to enter mitosis in an ‘under-
replicated’ state, particularly at telomeric and centromeric sequences and common fragile sites 
(CFSs). These under-replicated regions may contain stalled or collapsed forks, post-replicative 
gaps or recombination intermediates; and these structures can be fully processed in mitosis by 






















HR-mediated stalled replication fork pathways involving endonucleases and unscheduled DNA 
synthesis (see 1.3.3.4 below).  
1.3.3.1. Common fragile sites  
Chromosomal rearrangements have a predilection for common fragile sites (CFS) (Glover et al., 
1984) which describe over 200 loci within the genome that with replication stress 
(experimentally-induced using low-dose aphidicolin), can be visualised as chromosome gaps or 
breaks on metaphase spreads. These regions are inherently difficult to replicate by virtue of their 
sequence (and structure), dormant replication origins, hypoacetylated chromatin, and/or 
interference with active transcriptional machinery or RNA (Lukas et al., 2011). The inability to 
complete replication of these sites during S-phase can lead to fork stalling and generate 
abnormal intermediates which can persist into mitosis.  
1.3.3.2. Replication fork stalling and restart 
The stalling of a replication fork (RF) in S phase is an important cellular event, that likely occurs 
with frequency in response to a variety of endogenous and exogenous stressors. Replication 
stress (RS) is an important early driver of tumourigenesis and is associated with the activation of 
various oncogenes (Kotsantis et al., 2018). It can be defined as anything which impairs the 
progression of the replisome, and the signalling events that follow are known as the replication 
stress response (RSR). The RSR can result from a variety of DNA structures (e.g. hairpins, G-
quadruplexes, R-loops), nucleotide pool depletion, as well as transcription machinery collisions 
which can interfere with progression of the RF. The RSR begins with a response that results from 
helicase-polymerase uncoupling, which via ssDNA-coated RPA signals to ATR via 
TOPBP1/RHNO1/RAD17/RAD9-RAD1-HUS1 or ETAA1 (Bass et al., 2016, Haahr et al., 2016). This 
leads to 𝛾H2AX formation and downstream activation of CHK1, resulting in cell cycle arrest, 
dormant origin firing (and late origin suppression) for the purpose of stabilising the stalled RF for 
repair (Dungrawala et al., 2015). ATR suppression of late origin firing is also important for 
preventing nuclear RPA exhaustion which if derepressed can lead to replication catastrophe 
(Toledo et al., 2013). These signalling events may be accompanied by fork reversal; regression of 
the fork structure to reanneal parental strands and allow binding of the newly synthesised strands 






















in a ‘chicken foot’ structure, which are likely to play a role in protecting the fork from collapse 
(Kotsantis et al., 2018). Many proteins involved in the DDR have moonlighting functions at 
replication forks, including PARP1 (Ray Chaudhuri et al., 2012), SMARCAL1 (Betous et al., 2013), 
RAD51 (Zellweger et al., 2015) and BRCA1/2 (Schlacher et al., 2011, Schlacher et al., 2012), as well 
as recent reports for 53BP1 itself (Her et al., 2018, Byrum et al., 2019). These work together to 
ensure fork stabilisation and restart, although when this does not happen the concerted actions 
of nucleases can result in the formation of a collapsed RF and single-ended DSBs (seDSB) which 
can only be repaired by HR, and without which leads to toxic end-joining and chromatid fusions 
(Dehe and Gaillard, 2017, Balmus et al., 2019). Fanconi anemia proteins, generally attributed to 
interstrand crosslink repair (as well as alternative lengthening of telomeres), also play a role in 
replication fork stability. This includes the core complex, monoubiquitinated FANCD2-I, with 
FANCD2 specifically limiting ssDNA accumulation by restraining the replication fork (Ceccaldi 
et al., 2016b, Kais et al., 2016). 
The precise contributions of DNA endonucleases and their timing are complex, and not 
universally degradative: CtIP may have an important role in limiting long range resection and the 
collapse of replication forks (Przetocka et al., 2018), as well as MRE11 nuclease activity itself 
which may be necessary to prepare DNA ends for further repair (Mohiuddin et al., 2019). 
BRCA1/BRCA2 appear to have critical roles in countering MRE11-mediated fork degradation, 
which is independent of their effects in HR. Indeed, loss of the proteins PTIP, CHD4 and PARP1 
but not 53BP1, appear to suppress this phenotype, and may play in a role in chemoresistance to 
agents such as PARP inhibitors (see 1.4.3 below) (Ray Chaudhuri et al., 2016). 
Restoration of stalled forks can therefore involve replisome repriming or fork regression, while 
collapsed forks or fork reversions with MUS81-cleavage generate single-ended DSBs for DSB 
repair. The gene conversion process can involves HJ formation, which are eventually 
disassembled by BLM-mediated ‘dissolution’ (in complex with BLM-TopoIIIα-RMI1-RMI2 or the 
BTR complex), or structure-specific endonuclease-mediated ‘resolution’ in G2/M by GEN1 or 
SLX1-SLX4-MUS81-EME1 complexes (Sarbajna and West, 2014, Sarbajna et al., 2014). The failure 
to resolve these intermediates can lead to various mitotic defects.  






















1.3.3.3. Anaphase bridges 
DNA that remains intertwined within an unresolved HJ (catenanes) will impair sister chromatid 
disjunction, and can generate anaphase bridges, which may eventually rupture, and form 
chromosomal breaks. These ‘bulky’ bridges are DAPI- (and BTR complex) positive strands which 
join separating chromatin masses in anaphase and are distinct from thin DAPI-negative ultrafine 
bridges (UFBs) which lack histones and are experimentally visualised by their bound proteins (e.g. 
PICH (ERCC6L) and BLM). UFBs have been identified at the centromeres, telomeres and CFSs 
(Chan and Hickson, 2009). Centromeric UFBs predominate, and are likely to be physiological, 
anchored by kinetochores and the result of intertwined dsDNA catenanes. Alternatively both 
centromeric and telomeric UFBs may arise from recombined DNA due to repetitive satellite 
elements within these regions (Liu et al., 2014). CFS-UFBs are associated with a pair of FANCD2/I 
foci on each sister chromatid, and can bind RPA which may reflect an underlying stress-induced 
gap on the DNA (Chan et al., 2009, Naim and Rosselli, 2009). These sites can develop into 53BP1 
nuclear bodies in G1 if they are not fully resolved in mitosis (Harrigan et al., 2011). 
1.3.3.4. A model for resolving DNA intermediates in mitosis  
A model is emerging in which cell stress can generate interlinked sister chromatids, due to stalled 
replication intermediates (containing HJs), unreplicated regions or post-replicative gaps. 
Chromosome condensation appears to prime some of these structures for processing. This 
enables MUS81-mediated cleavage of HJs and/or the resolution of any under-replicated/post-
replicative gaps (Lai et al., 2017) possibly by break-induced replication (BIR) (see Figure 3.1 taken 
from (Pedersen et al., 2015)). This can prevent the formation of anaphase bridges and hence 
avoids their breakage and potential for fusion (Costantino et al., 2014, Minocherhomji et al., 2015). 
In chicken DT-40 cells, TOPBP1, which co-localises with FANCD2 ‘twin foci’, may recruit SLX4 
and help to facilitate this mitotic DNA synthesis (MiDAS) at CFSs (Pedersen et al., 2015). 
Following replication stress, MiDAS appears to require RAD52 which is necessary for the timely 
recruitment of MUS81 and (non-catalytic subunit Polẟ-3 (POLD3)), but ATR, BRCA2 and RAD51 
appears dispensable for the process of MiDAS (Bhowmick et al., 2016). Defective chromosome 
condensation, silenced MUS81, or inhibited Polẟ-3 all reduce CFS ‘expression’, and produce a 






















familiar pattern of anaphase bridges and chromosome non-disjunctions which also increase 
53BP1 nuclear body formation at CFSs in G1, and can be lethal (Minocherhomji et al., 2015, 
Costantino et al., 2014, Naim et al., 2013).  
1.4. Targeting the DDR in cancer 
1.4.1. DDR dysfunction in disease  
The DNA Damage Response (DDR) is critical for genomic stability and cellular survival, and its 
perturbation contributes to premature ageing, neurodevelopmental disorders, 
immunodeficiencies and cancer (Jackson and Bartek, 2009). Repair pathways can be linked to 
specific biological processes within organisms, that explain the consequences of their 
dysregulation in diseased states. We have already considered some of the physiological roles of 
NHEJ with respect to generating immune cell diversity. Furthermore, meiosis involving SPO11-
mediated DSBs and HR is essential in maintaining genetic diversity for the purpose of gamete 
production. These functions may be relevant to the immune deficiencies and sterility observed 
in patients with defects in DDR genes; indeed mutations in cNHEJ genes can be associated with 
radiosensitive severe combined immunodeficiency disorders (Ciccia and Elledge, 2010). 
HR also has a role in some cancers, in ensuring telomere length is maintained by the process of 
alternative lengthening of telomeres (ALT). While the shelterin complex exists to dampen DDR 
activity at telomeric ends, the dysfunctional recruitment of NHEJ components can result in 
telomere shortening and fusion events, generating chromosomal instability during mitosis. The 
natural attrition of telomeric ends over time is associated with the ageing process and some DDR 
defective mouse models demonstrate hallmarks of accelerated ageing (Niedernhofer et al., 
2006). 
Neurons are particularly sensitive to DNA damage, as these cells generate large amounts of ROS 
in part due to their high mitochondrial activity. Their inability to replicate also limits their 
capacity to utilise template-mediated repair, and this may explain some of the neurodegenerative 






















features observed in diseases defined by DDR gene mutations, e.g. microcephaly associated with 
the RF stabiliser DONSON (Reynolds et al., 2017). 
The predisposition to cancer is generally accepted based on the contribution of genome 
instability to its development (Hanahan and Weinberg, 2011). Gross structural rearrangements 
which characterise cancers, and more subtle effects of mutagenesis result from impairments in 
repair pathways like HR. As one possible mechanistic explanation, HR-deficient cancers often 
upregulate backup alt-EJ pathways such as via Pol𝜃 (Ceccaldi et al., 2015, Mateos-Gomez et al., 
2015). The dependency on these repair pathways is also likely to contribute to the HR-deficient 
genetic mutation signatures (Nik-Zainal et al., 2012). 
The inheritance of mutations in critical repair genes can generate a ‘mutator phenotype’, which 
enables cells to tolerate an accumulation of genome instability, reflecting an inability to detect, 
transduce or repair in response to endogenous DNA damage accumulated over the lifetime of an 
organism (Jackson and Bartek, 2009). In the first instance, the DDR serves as a barrier to 
uncontrolled growth, hence most tumours will evolve some deficiency to overcome this effect 
(Halazonetis et al., 2008). BRCA1 mutations are an exemplar, which when mutated, greatly 
increase the risk of developing breast, ovarian, prostate and pancreatic cancer in particular. The 
penetrance for mutation carriers is variable across tissues, but can be as high as 57% for breast 
cancer by the age of 70 (Chen and Parmigiani, 2007). However, the tissue-specificity of this 
predisposition is very unclear and an area of ongoing investigation. 
1.4.2.Targeting DDR in the clinic 
Not only can mutations in DNA repair genes predispose to cancer development, but the cellular 
response to DNA damage is critical in order to understand how tumours react to treatments such 
as radiotherapy and chemotherapy. These generate DNA damage, and traditional selectivity has 
relied upon the higher proliferation rates (S-phase indices) of tumour cells relative to 
surrounding healthy tissues. In this regard, cancers with deficiencies in critical DNA repair factors 
often have greater sensitivity to such agents.  






















The preferential toxicity toward cancer (relative to normal cells) is being tested with the clinical 
trials of various DDR enzyme inhibitors. This principle of targeting nononcogene addiction is 
premised on cancer cells relying on ‘backup pathways’ which are essential to their survival (Luo 
et al., 2009, Lord and Ashworth, 2017). The exemplar is PARP inhibition described below, but 
other therapies are also being explored which can exploit key differences in cancer DDR, not just 
the loss of specific repair pathways, but also increased levels of endogenous DNA damage, 
including replication stress, that are uniquely exhibited by cancer cells (O'Connor, 2015). 
The latter has driven the targeting of the ATR-CHEK1-WEE1 axis which plays an important role 
in stabilisation and repair of replication forks, preventing the early entry of under-replicated 
genomes in mitosis (O'Connor, 2015). The principle of RPA exhaustion and sensitivity of cancers 
with high replication stress to ATR inhibitors has been described in vitro (Toledo et al., 2017, 
Toledo et al., 2013). Similarly WEE1 inhibition which leads to disinhibition of CDK1 can also 
promote mitotic entry and catastrophe (Aarts et al., 2012). These therapies are being explored in 
clinical trials as monotherapies, and it remains to be seen whether a clinical use can be 
established as a radiosensitiser or other combination regime. As our understanding of DDR and 
RSR pathways and their interconnectivity improves, it will be important to identify the optimal 
patient cohorts in which to use these and other emerging inhibitors including Pol𝜃, and FEN1 
inhibitors currently in development.  
1.4.3.PARP inhibitors and resistance 
PARP inhibitors have been developed based on mimicry of the NAD+ core, with a view to inhibit 
the catalytic site of the PARP enzyme. In doing so, this prevents its PARylation activity, impairing 
chromatin relaxation and PARP dissociation from DNA by competitively inhibiting NAD+ utility 
and hence generating replication fork blockade, which eventually leads to seDSBs (Murai et al., 
2012). 
1.4.3.1. The paradigm of PARP inhibition 
The paradigm for cancer selectivity and pharmacological ‘synthetic lethality’, is represented by 
PARP inhibitors in HR-deficient cancers (e.g. familial BRCA1 mutations) (Lord and Ashworth, 






















2017). Two genes are synthetic lethal when the inactivation of either one is compatible with 
survival, but the combined loss results in cell death (Lord and Ashworth, 2017, Lord and 
Ashworth, 2016). Loss of the second allele as per the ‘two hit hypothesis’ results in the complete 
absence of BRCA1, and the predisposition to cancer. However, such cancer cells are exquisitely 
sensitive to the formation of lesions which can only be repaired by HR; PARP inhibition and 
replication fork collapse generates such a single-ended DSB, which in the absence of HR causes 
cell death. In contrast, surrounding BRCA1 heterozygous cells proficient in HR, tolerate PARP 
inhibition, thus explaining the cancer-selective effect of the drug and limited toxicity to 
surrounding healthy cells, and the clinical efficacy observed in a range of HR defective cancers 
(Moore et al., 2018, Robson et al., 2017, Mateo et al., 2015). 
1.4.3.2. The mode of action of PARP inhibition 
Early models suggested that the inhibition of PARP impairs the capacity of base excision repair, 
leading to single-stranded nicks which are converted into DSBs following RF progression (Farmer 
et al., 2005, Bryant et al., 2005). Since this time, the contribution of PARP trapping has been 
suggested to play a central role, providing a physical obstruction to the progressing replisome, 
and leading to collision, replication fork stalling, and ultimately collapse after processing to 
generate the single-ended DSB which necessitates repair by HR (Murai et al., 2012). In keeping 
with this hypothesis, the potency of PARP inhibitors in terms of their ability to induce trapping 
on DNA (rather than catalytic inhibition per se), appears to correlate strongly with their toxicity 
in HR defective cells (Murai et al., 2012). The utility of lower fidelity repair mechanisms 
accentuates genomic instability and most likely results in a critical accumulation of DSBs which 
is incompatible with cell survival (Patel et al., 2011, Ceccaldi et al., 2015, Balmus et al., 2019). The 
role of PARP1 in alt-EJ may also contribute to the lethality of its inhibition, epistatic to Polθ 
(POLQ) inhibition (Ceccaldi et al., 2015). Furthermore, the generation of seDSBs, and activation 
of NHEJ, may act in concert to promote toxic NHEJ and chromosome fusions, which may 
contribute to the tumouricidal effects in certain contexts (Balmus et al., 2019, D'Andrea, 2018). 
Bartek and colleagues have proposed that inhibition of PARP prevents the detection of 
replication stress and instead increases RF speed rather than collapse, but this in of itself is 






















sufficient to cause DNA damage via an unspecified mechanism (Maya-Mendoza et al., 2018). 
PARP inhibition is known to prevent fork reversal which is necessary for efficient fork restart 
(Ray Chaudhuri et al., 2012). If this fork reversal is necessary to enable the adequate processing 
of unligated Okazaki fragments (a potential endogenous substrate of PARP trapping (Hanzlikova 
et al., 2018)), the increase in RF speed due to PARP inhibition may reflect a failure in RF reversal 
and impaired SSB repair at these sites (Maya-Mendoza et al., 2018, Hanzlikova et al., 2018). 
Persistent SSBs at Okazaki sites are likely to form a replication barrier during the subsequent S-
phase, whereupon they lead to RF stalling (and/or collapse). In addition to this contribution, 
PARP inhibitors are also likely to benefit from the misincorporation of ribonucleotides, which 
appears to require the action of TOP1 as a backup pathway for RNaseH2 based ribonucleotide 
excision repair pathway (Zimmermann et al., 2018). In the absence of RNaseH2, the accumulated 
ribonucleotides are substrates for TOP1-mediated cleavage, and this generates many single-
strand breaks for PARP trapping and subsequent RF blockade (Zimmermann et al., 2018). 
1.4.3.3. Mechanisms of resistance to PARP inhibition 
Since its FDA approval for use in breast and ovarian cancer patients, PARP inhibitors have been 
used as a monotherapy to great effect in patients harbouring BRCA1 and BRCA2 mutations. 
Unfortunately, as with all chemotherapeutic agents, a significant fraction of non-responders or 
transient responders have been identified, reflecting innate or acquired resistance respectively.  
The simplest mechanisms of PARP inhibitor resistance, are those which lead to the re-expression 
of the BRCA1/BRCA2 protein. Genetic reversion of an inherited mutation can restore full length 
wild type protein, while other events can simply cancel a frameshift and restore the open reading 
frame, restoring function by expression of near-full length proteins (Edwards et al., 2008, Sakai 
et al., 2008). Certain truncation mutants can be tolerated, while other mutations will vis-à-vis 
nonsense mediated decay fail to be translated, or else through protein misfolding lead to 
proteasomal degradation e.g. BRCT domain mutations (Johnson et al., 2013). BRCA1 promoter 
methylation is also a well-documented aetiology of HR deficiency, and similarly this can be 
reversed, by active demethylation, or more likely, positive selection from a heterogenous group 
of tumour cells with less promoter methylation. Mutations in PARP1 can also account for PARP 






















inhibitor resistance in patients, due to the inability of PARP1 (the major target) to bind the drug 
(Pettitt et al., 2018) or else decreased/loss of expression of PARP1 itself. Similarly, efflux proteins 
(e.g. P-glycoprotein efflux pump) have been implicated in modifying PARP inhibitor responses 
(D'Andrea, 2018). 
Given the general mechanism of BRCA1 and BRCA2 in terms of promoting HR and RF protection, 
PARP inhibitor resistance can also come about by decreases or loss of protein expression which 
result in restoration of these pathways. We have already outlined the antagonistic relationship 
between BRCA1 and 53BP1, and indeed loss of 53BP1 (Bunting et al., 2010, Bouwman et al., 2010), 
RIF1 (Chapman et al., 2013, Di Virgilio et al., 2013, Escribano-Diaz et al., 2013, Feng et al., 2013, 
Zimmermann et al., 2013) or MAD2L2 (Boersma et al., 2015, Xu et al., 2015) and PTIP (Callen et 
al., 2013) have been shown to restore HR function. In the case of PTIP, its loss has also been 
shown to rescue the RF defect observed in both BRCA1 and BRCA2-deficient cells (Ray 
Chaudhuri et al., 2016). Such a rescue at the level of RF stability appears to be independent of 
restoration of HR, as also demonstrated for PARP1 and CHD4 loss (Ray Chaudhuri et al., 2016), 
which appear to mitigate MRE11 mediated recruitment and RF degradation. Similarly, loss of the 
methyltransferase EZH2, reduces H3K27 methylation and impairs recruitment of the MUS81 
nuclease to the stalled forks due to BRCA2 loss, and indeed EZH2 levels appear to correlate with 
poor outcomes in patients (Rondinelli et al., 2017). 
Recent genetic screens by Elledge and colleagues have revealed synthetic lethal relationships 
between BRCA1 or BRCA2 and FEN1 or APEX2, highlighting the contribution of BER and alt-EJ 
to Okazaki fragment processing, SSB repair, and backup repair of DSBs in cells which are HR-
deficient (Mengwasser et al., 2019). This screen also suggested a dominant negative role involving 
BRCA2 truncation mutants (terminating near BRC repeat 5, compared to those with intact BRC 
repeats) acting in concert with PALB2 and RAD51 paralogues. The expression of hypomorphic 
mutants appears to be a minimum requirement for the restoration of HR function following loss 
of 53BP1 or its related members, and truly null BRCA1 cells may be entirely incapable of restoring 
HR function despite the concomitant loss of an antagonistic protein (Nacson et al., 2018). 






















The loss or chemical inhibition of PARG as a mechanism of PARP inhibitor resistance, suggests 
a degree of catalytic activity is retained even in the presence of the drug. PARG loss/inhibition 
can result in restoring PARP1 signalling and PAR chain stabilisation, reducing PARP1-DNA 
complex formation thus preventing unrestrained RF progression and allowing the recruitment of 
DDR factors to survive the effects of PARP inhibition (Gogola et al., 2018). 
Various strategies are being suggested to target these resistance mechanisms, including 
inhibitors of HSP90 to reduce BRCA1 hypomorph protein stability; PI3K/AKT (Ibrahim et al., 
2012), HDAC (Adimoolam et al., 2007, Kachhap et al., 2010), CDK1 (Johnson et al., 2011) and 
CDK12 (Dubbury et al., 2018) to downregulate HR gene expression; EZH2 to restore MUS81 
recruitment to BRCA2-deficient replication forks (Rondinelli et al., 2017); USP1 which appears to 
have a role in BRCA1-deficient RF stabilization (Lim et al., 2018); Polθ and FEN1 to impair backup 
alt-EJ pathways (Ceccaldi et al., 2015, Mateos-Gomez et al., 2015). There also appears to be a 
reliance in BRCA-deficient cells on ATR signalling, and therefore ATR inhibition may provide an 
additional strategy for overcoming treatment resistance (Yazinski et al., 2017). The G4 quadruplex 
stabilising compound pyridostatin has also been shown to cause DNA damage, potentiating 
replication stress and causing cytotoxicity in olaparib resistant Brca1/53bp1 or Brca1/Mad2l2 
double-deficient cells (Zimmer et al., 2016). Establishing reliable techniques to define HR 
defects clinically, and identifying therapeutic vulnerabilities that may result, will be critical for 
the management of these patient cohorts.  
In this thesis we will seek to explore 53BP1 and its contribution double-strand break repair in 
physiological settings and the pathological context of cancer. Chapter 3 explores the 
contribution of aberrantly active 53BP1 during mitosis, and how this process leads to genomic 
instability due to replication stress, reminiscent of cancer. Chapter 4 reveals insights into novel 
partners of 53BP1, and how these promote NHEJ. We also demonstrate the antagonistic 
relationship between these NHEJ factors and HR, highlighting clinical implications of PARP 
inhibitor utility in BRCA1-deficient cancers, and new therapeutic opportunities which may be 
appropriate in resistant settings. Finally, we consider how our approach for exploring DNA repair 






















networks and treatment resistance may be extended using developments in CRISPR-Cas9 
technology, and translated into clinical settings for future studies.  
  






















2. Chapter 2 Material & Methods 
2.1. Nucleic Acid Methods 
2.1.1. Guide RNA design and cloning methods 
Standardised NEB protocols were used for cloning and site-directed mutagenesis. Cloning for 
guide RNA insertion is exemplified below. For individual primers see appendix 6.3 below. 
Guide RNAs were identified using http://crispr.mit.edu (site now closed) and 
https://chopchop.cbu.uib.no (Labun et al., 2019) webtools for selecting target sites for 
CRISPR/Cas9-directed mutagenesis. Guides receiving highest rankings based on specificity, 
upstream exon targeting and the presence of neighbouring restriction enzyme and primer sites 
for diagnostic digests and PCR were selected. The 3’NGG PAM motif is removed, and 20bp guide 
sequence (along with its reverse complement) are used along with overhangs to enable gRNAs 




An annealing reaction is performed using 1µl of 100µM stock of each forward and reverse oligo, 
along with 98µl of annealing buffer (100µl = 2µl 1M Tris-HCl pH 8.0 (20mM final), 1µl 5M NaCl 
(50mM final), 97µl nuclease-free water). The oligo suspension is placed in a microcentrifuge tube 
and holder allowed to sit in a beaker of boiling water, and allowed to cool down to room 
temperature over several hours. The oligo duplex is then phosphorylated using 5µl of duplexed 
oligo mix (with 5µl 10x PNK buffer (NEB), 5µl 10mM ATP, 1µl T4 PNK (NEB), 34µl water); this 
mixture is incubated for 30min at 37˚C prior to heat inactivation for 20min at 65˚C.  
For cloning of gRNAs into a modified version of the Cas9 containing plasmid pSpCas9(BB)-2A-
GFP (PX458; Addgene plasmid #48138), which contains a BamHI digestion site within the BbsI 
dual sites before the guide scaffold. This protocol involves vector digestion and ligation with the 






















duplexed oligo as follows: 5µl phosphorylated oligos, 100 ng plasmid, 2µl NEB 1.1 (BbsI on pAIO-
WT), 1µl BbsI/BsaI-HF, 1µl ATP 10mM, 0.5µl NEB T4 DNA ligase, made up to 20µl total reaction 
with water. This is followed by T4 ligase heat inactivation (10min at 65˚C) and then plasmid 
digestion with 0.5µl BamHI-HF for 30min at 37˚C to linearise any empty vectors which do not 
contain the guide. Finally, 5µl is transformed in 50µl of chemically competent Xl1-Blue bacteria 
for 30min (thawed from -80˚C on ice for 30min). Heat shock is performed with incubation in a 
42˚C water-bath for 45s before returning the DNA-bacteria mixture to ice for 2min. Cells are then 
allowed to recover by transferring mixture to 1ml of antibiotic-free prewarmed SOC media at 
37˚C with shaking at 225rpm for 1h. After growing the cell-SOB mix is then pelleted by 
centrifugation 5min at 600g, and resuspending in 150µl volume for plating on LB agar with the 
relevant antibiotics, prior to spreading with 4mm autoclaved glass beads. The plate is allowed to 
dry before incubating inverted overnight at 37˚C. Bacterial colonies can then be selected with 
10µl sterile pipette tips for growth in 4ml LB media containing antibiotic at 37˚C with shaking at 
225rpm. The following day, DNA can be extracted isolated for PCR/cloning/sequencing using 
QIAprep Spin Miniprep kit (Qiagen) or transfection purposes via QIAGEN Plasmid Plus Midi or 
Maxi Kits (Qiagen) as per the manufacturer’s protocol.  
A diagnostic restriction digest is then performed using BamHI-HF to exclude empty vector, with 
EcoRI to identify two bands by agarose gel electrophoresis (see 2.1.2 below) of ~9kb and ~0.8kb 
(empty vector demonstrates three bands of ~5,4 and 0.8kb). Vectors identified to have likely 
guide inserts are selected for Sanger sequencing to confirm correct guide insertion using the 
primer CAGAGATTTTGAGACACGGGCC. Sanger sequencing was performed at the Department 
of Biochemistry, University of Cambridge, by preparing 10µl of DNA plasmid samples at 
~100ng/µl, alongside sequencing primers at 10µM. Sequence alignment was performed using 
SnapGene v.3.3.4 (GSL Biotech).  
For other vector/ligase digests, restriction digests were followed by gel band isolation and DNA 
gel extraction via QIAquick Gel Extraction Kit (Qiagen) as per protocol. Digested vectors were 
routinely dephosphorylated (1pmol of DNA ends, 2µl 10X CutSmart buffer (NEB), 1µl quick CIP 
(NEB) made up to 20µl water; incubated 37˚C 10min followed by heat-inactivation at 80˚C for 






















2min. Vector:Insert ligations were performed at 1:3, 1:5 and 1:10 molarity ratios and ligation by 
incubation with 2µl 10X T4 DNA ligase buffer (NEB), 1µl T4 DNA ligase (NEB) made up to 20µl 
water; this was gently mixed by pipetting, incubated at room temperature for 10min (or for blunt 
ends 16˚C overnight), followed by heat inactivation 65˚C 10min and chill on ice prior to 
transformation of 1-5µl of reaction into 50µl chemically-competent cells (see above).  
2.1.2. Polymerase chain reaction (PCR), agarose gel electrophoresis and site-directed 
mutagenesis 
In general polymerase chain reaction (PCR) was performed using Phusion DNA polymerase 
(NEB) as follows:  
Component 20µl reaction 50µl reaction Final 
Concentration Nuclease-free water to 20µl to 50µl  
5X Phusion HF or GC 
Buffer 
4µl 10µl 1X 
10 mM dNTPs 0.4µl 1µl 200µM 
10 µM Forward Primer 1µl 2.5µl 0.5µM 
10 µM Reverse Primer 1µl 2.5µl 0.5µM 
Template DNA Variable Variable <250ng 
DMSO (optional) (0.6µl) (1.5µl) 3% 
Phusion DNA  0.2µl 0.5µl 1.0units/50µl PCR 
 
Step Temperature Time 
Initial Denaturation 98˚C 30s 
25 to 30 cycles 98˚C 5-10s 
 45-72˚C 10-30s 
 72 ˚C 15-30s per kb 
Final Extension 72˚C 5-10 min 






















Hold 4-10 ˚C  
GC buffer is utilised where high GC contents are anticipated, and temperature gradients of 55˚C 
to 80˚C are occasionally used to identify optimal empirical annealing temperatures for PCR.  
Agarose gel electrophoresis is performed using an appropriate concentration of agarose as 
determined by the anticipated product sizes. For 1% gel, 1.5g agarose is added to 150ml 1X TAE 
solution in a 500ml conical flask, which is heated close to boiling prior to the addition of ~17.5µl 
SYBR safe stain (Invitrogen) and pouring into a casting tray containing a gel comb. When set, 
combs are removed, and the gel placed in a gel tank containing TAE solution. A DNA ladder (1kbp 
or 100bp is used (NEB)), for typical run-times of ~80-150V for 1-2h depending on %/voltage. The 
gel can then evaluated using an ultraviolet (UV) transilluminator prior to image capture 
(ChemiDoc MP Imaging System, Bio-rad) and/or fragment isolation.  
For the purposes of site-directed mutagenesis, primers are designed with mutations in the middle 
of primers containing 24-45bp overhangs, and GC content ≥40%. Melting temperatures should 
be ≥78˚C and the 3’ end a C or G. Asymmetric oligonucleotides can be designed to avoid excess 
primer-dimers or hairpin structures. Following PCR using the parental plasmid PCR, clean-up can 
be performed using QIAquick PCR purification kit (Qiagen) as described in their protocol. DpnI 
(NEB) digestion is performed to remove parental vector prior to bacterial transformation and 
DNA extraction as above. 
2.1.3. Reverse transcription – quantitative polymerase chain reaction (RT-qPCR) 
Reverse transcription followed by quantitative polymerase chain reaction was performed as 
follows: 
1x107 cells are harvested by direct lysis using 600µl RLT buffer (add 10µl β-mercaptoethanol to 
1ml RLT buffer). Add 1 vol (approx 600µl) 70% EtOH to lysate and mix by pipetting (do not 
centrifuge). Transfer up to 700µl sample including precipitate to RNeasy mini spin column. 
Centrifuge 15s, discard flowthrough. Add 350µl RW1 buffer, spin 15s, discard flowthrough. Add 
10µl stock DNaseI to 70µl buffer RDD, mix by gentle inversion, brief centrifuge. Add 80µl DNase 
I mix to column, place on benchtop for 15min (20-30˚C). Add 350µl RW1 buffer, spin 15s, discard 






















flowthrough. Add 500µl RPE to column, spin 15s, discard flowthrough. Add 500µl RPE to column, 
spin 2min, discard flowthrough. Spin 1min to dry. Elute into new eppendorf with 30-50µl RNase-
free water, spin 1min. Measure RNA concentration. Using SuperScriptIII reverse transcriptase 
(Invitrogen), 1µl 50µM oligo dT20, 1µg total RNA, 1µl 10mM dNTP, and 10µl RNase free water 
mixture is made, and heated to 65˚C for 5min before transfer to ice for 1min. After a brief 
centrifuge, the following is added to the mixture by gently pipetting up and down: 2µl 10X RT 
buffer, 4µl 25mM MgCl, 2µl 0.1M DTT, 1µl SuperScriptIII Reverse Transcriptase, 1µl RNase Out. 
This is incubated for 50min at 50˚C before heat-inactivation for 5min at 85˚C. Finally, 1µl RNaseH 
is added for 20min at 37˚C. 
Quantitative PCR reaction mixture is obtained with the following: 10µl 2x Fast SYBR Green 
Master Mix (Thermo Fisher), 0.4µl 10µM Fwd primer, 0.4µl 10µM Rev primer, 2µl cDNA template, 
and made up to 20µl with RNase-free water. Serial dilutions of individual cDNA samples are 
obtained (e.g. 10-1, 10-2, 10-3), and individual reactions are performed in technical triplicates per 
cDNA dilution. Finally, primers for house-keeping genes are included in separate reactions in 
order to evaluate normalise changes in transcript levels. The StepOne Plus Real time PCR System 
(ThermoFisher) is used to obtain raw Ct values, in order to quantitate using the comparative Ct 
method 2−ΔΔCT. Melting curves of primers are assessed to help evaluate specificity of primer 
binding. This protocol was used to verify knockout generation prior to Topo-cloning.  
2.2. Protein Methods  
2.2.1. Cell lysis and Immunoblotting 
Adherent cells were washed twice with ice-cold PBS, prior to collection in lysis buffer which 
contained: 50mM Tris-HCl pH 7.5, 2% SDS, serine/threonine phosphatase inhibitor cocktail 
(Sigma-Aldrich), protease inhibitor cocktail (Roche) and 10mM N-ethylmaleimide (Sigma-
Aldrich). Lysates were boiled for 5min at 95˚C, before brief vortex and centrifugation. Protein 
concentration was measured using Pierce™ BCA Protein Assay Kit (ThermoFisher Scientific) 
with absorbance readings measured at 595nm. Samples were equalised in terms of volume and 
concentration with the addition of SDS-PAGE loading buffer. SDS-PAGE was performed using 






















NuPAGE Novex 4-12% Bis/Tris gradient gels (Invitrogen) or 4-20% Tris/glycine gels including 
the PageRuler Plus protein ladder (ThermoFisher), and run in Mini-Cell electrophoresis system 
(ThermoFisher) for 100min at 120V in 1x MOPS SDS (ThermoFisher) or Tris-Glycine/SDS (25mM 
Tris base, 190mM glycine, 0.1% SDS) running buffer respectively. Wet protein transfer onto 
(methanol-activated) PVDF membranes (GE Healthcare) occurred by overnight transfer 
(membrane and gel between Whatman filter papers and sponges) in transfer solution (25mM Tris 
base, 190mM glycine, 20% methanol, 0.1% SDS) at 250mA at 4˚C overnight. Effective transfer 
was confirmed with Ponceau S staining, before being blocked with 5% BSA in TBS-T (TBS 
containing 0.1% Tween-20) for 1h at RT, and then immunoblotting with the indicated primary 
antibodies at 4˚C overnight. The membrane was washed three times with TBS-T. Secondary 
staining was performed with appropriate species of HRP-conjugated antibodies for 1h at RT, prior 
to incubation with chemiluminescent detection regents (GE Healthcare Amersham ECL 
reagents, GE healthcare) and detection by X-ray film (Fuji) in a dark room. Experiments were 
performed at least twice unless otherwise stated. Membrane stripping was performed where 
necessary, by incubating PVDF membranes in 19ml 7M Guanidine HCl and 1ml 1M DTT stripping 
solution at 60˚C on a shaker at 60rpm for 1h. The membrane is washed twice prior to further TBS-
T wash and re-probing with primary antibodies overnight.  
2.2.2. Immunoprecipitation 
Adherent cells were washed twice with ice-cold PBS, prior to collection in lysis buffer which 
contained: 20mM Tris-HCl pH 7.5, 40mM NaCl, 2mM MgCl2, 10% glycerol and 0.5% IGEPAL, N-
ethylmaleimide (NEM, 10mM, Sigma-Aldrich), EDTA-free protease inhibitor cocktail (cOmplete 
Tablets, Roche), EDTA-free serine/threonine phosphatase inhibitor cocktail (PhosSTOP, Roche) 
and Benzonase (10µl/ml lysis buffer, Novagen 70664-3). The NaCl concentration was 
subsequently increased to 250-500mM, before vortexing and incubation on ice for 15min, 
followed by 16,000g centrifugation for 45min at 4°C. For GFP immunoprecipitations, cellular 
extracts were rotated at 4°C overnight with GFP-Trap-A beads (ChromoTek, 10µL per milligram 
of protein). The next day, immunoprecipitation buffer was used to wash the cell-bead mixture 






















five times. This was followed by protein elution from the beads by incubating the mixture at 95°C 
for 5min in 1.5x SDS sample buffer and immunoblotted as in 2.2.1 above. 
2.2.3. In-vitro GST pull-down 
Glutathione sepharose (GE Healthcare) affinity chromatography resin was washed with ice-cold 
PBS and blocked for 30min with 10 % bacterial lysate (non-induced BL21 cells, lysed using PBS 
and lysozyme). The sepharose was then resuspended in binding buffer (10mM Tris pH7.5, 150mM 
NaCl, 0.5% IGEPAL, 0.5mM EDTA, 0.5% BSA). 2pmol of purified GST (bacterial expression) or 
GST-FAM35A (Novus Biologicus) with His-C20orf196 (Creative BioMart) proteins were added 
to the sepharose resin, and incubated for 30min at 4°C. The mixture was then washed five times 
with wash buffer (10mM Tris, pH 7.5, 250mM NaCl, 0.5 % NP40, 0.5mM EDTA) before eluting 
bound proteins with elution buffer (100mM Tris pH 8, 20mM reduced glutathione, 120mM NaCl) 
for 15min at 4°C. The eluates were boiled in lysis buffer prior to immunoblotting with the 
indicated antibodies.  
2.2.4. DNA oligo pull-downs 
HEK293 cells were cultured after transfecting the indicated GFP-tagged products. These were 
prepared for immunoprecipitation as described above. Cell extracts were prepared in 250mM 
NaCl, and after benzonase digestion, EDTA/EGTA added at 10mM to inactivate the nuclease. 
Extracts were pre-cleared by rotation with unconjugated magnetic streptavidin Dyanbeads to 
mitigate non-specific binding, for 1h on slow rotation (Dynal, M-280; 50uL per reaction). Prior to 
the use of Dynabeads, washing was performed with 1x Binding and Washing buffer (1x B&W, 5mM 
Tris-HCl pH 7.5, 0.5mM EDTA, 1M NaCl). Oligo annealing to a separate batch of washed 
Dynabeads was then performed by rotation for 15min at RT in 1x B&W with 10nmol 5’-
biotinylated ssDNA oligo of the sequence: 5’BiosG/ATCGCATTGGCATTGGCAATGCGATACG 
ACTGATCGAGGGTACTCAGCTAGCTGATTCCGATCGGCTTATTCCGTGTACATACATCGGA
T-3’ (IDT), followed by three washes with 1x B&W. Beads conjugated with DNA were then rotated 
with pre-cleared cellular extracts for 1h at RT. Four washes were performed with lysis buffer, prior 






















to protein elution by boiling in 2x SDS sample buffer for 5min, and immunoblotting as per 2.2.1 
above.  
2.2.5. Mass spectrometric analysis 
GFP-Trap pulldown was performed for GFP-FAM35A and GFP-C20orf196 expressing HEK293 
cells, and mass spectrometric analysis performed as detailed in (Dev et al., 2018). For each bait, 
two replicates were performed with label-swap; please refer to appendix 6.6 and 6.7 for enriched 
candidates, which are identified by SILAC H/L ratios in columns 10 and 11 of >2 and <0.5 
respectively.  
2.3. Mammalian cell culture techniques 
2.3.1. Cell culture, propagation and cell stock freezing 
Mammalian cells were cultured at 37°C in a humidified atmosphere containing 5% CO2 in 
Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich; or Nutrient Mixture F-12 (Ham’s 
F-12; Sigma-Aldrich supplemented with 17ml NaHCO3 7.5% per 500ml (Sigma-Aldrich). All 
media was supplemented with 10% (v/v) fetal bovine serum (FBS; BioSera), 100U/ml penicillin 
(Gibco, Life technologies), 100µg/ml streptomycin (Sigma-Aldrich) and 2mM L-glutamine. 
SUM149PT cells were cultured in Ham's F12 supplemented with 5% (v/v) fetal bovine serum, 
10mM HEPES, 1µg/mL hydrocortisone, 5µg/mL insulin, 100U/ml penicillin and 100µg/ml 
streptomycin. For maintenance and selection of cells stably expressing GFP or GFP-tagged 
constructs by G418/Kan resistant plasmids, 0.5mg/ml G418 (Invitrogen) was used. U2OS T-rex 
cells were selected in 200µg/ml hygromycin (Sigma-Aldrich), while U2OS-TLR cells were 
supplemented with 2 µg/ml puromycin (Sigma-Aldrich). Doxycycline induction of RPE-1 p53-null 
FRT-derived cells, U20S Trex/FRT cells stably expressing inducible-constructs occurred 
following co-culture with 1-2µg/ml doxycycline (Sigma-Aldrich) for 24-48 h to induce expression 
of GFP constructs. All cells were originally obtained from the ATCC cell repository and routinely 
tested to be mycoplasma free.  






















Cells were propagated by removing media, washing cells with sterile PBS, prior to the addition of 
warmed 0.025% Trypsin (Gibco, Life technologies) and incubation at 37˚C for ~5min. Cells are 
observed for dissociation under the microscope, prior to harvesting and neutralisation in fresh 
media. For standard propagation, confluent plates of cells can be split and re-seeded in fresh 
media at ratios of 1:4 to 1:10 depending on the cell types. In contrast, where specific numbers of 
cells need to be seeded, cells are pelleted (3min at 400g) prior to resuspension in a smaller 
volume and cell counting. This occurs by mixing an equal volume of cell suspension with 0.4% 
trypan blue dye which is added to a Countess counting chamber (ThermoFisher) and evaluated 
using a Countess Automated Cell Counter (Thermo). An appropriate dilution of cell suspension 
is established for cell propagation.  
Cells are frozen for the purposes of longer-term storage, and to avoid accrual of genome 
instability by continuous culture. Following harvesting and centrifugation, cells are resuspended 
in freezing media which consists of FBS containing 10% dimethylsulfoxide (DMSO) and 
transferred to cryovials (ThermoFisher). Cryovials are immediately placed within a ‘Mr Frosty’ 
Freezing Container (ThermoFisher) in -80˚C freezer for 24-48h prior to transfer to liquid nitrogen 
for long-term storage. In order to thaw cells, cryovials are placed in 37˚C incubator and allowed 
to thaw for ~10min, prior to centrifugation to remove the freezing media and resuspension in 
fresh warm antibiotic-free media. 
2.3.2. Plasmid transfection and electroporation in mammalian cells 
Plasmid transfections were achieved using TransIT-LT1 transfection reagent (Mirus). For 
example, in a 6cm plate, 5µg DNA is added to 500µl Optimem media (Gibco, Life technologies) 
while 15µl TransIT-LT1 is added to 500µl Optimem, and allowed to incubate for 5min at RT. These 
two mixtures are combined to incubate for a further 20-30min prior to dropwise addition on cells.  
In some instances where electroporation was preferred, we utilised the Neon transfection 
system (ThermoFisher). In brief, 1x107 RPE-1 cells were obtained and resuspended in 120µl R-
buffer, mixed with ~8µg DNA dissolved in 30µl water. 100µl of this mixture would be taken up 






















using Neon pipette tips, and inserted into the electroporator with the following settings: 30N, 
1400V, 30ms. Cells were subsequently added dropwise onto warm media in a suitable plate.  
2.3.3. Performing siRNA mediated knockdowns 
The siRNA duplexes were obtained from IDT or MWG biotech; reverse transfection was 
performed using Lipofectamine RNAiMAX (Invitrogen) as per the manufacturer’s instructions. 
For a 6cm plate: 10µl 20µM siRNA duplex was added to 250µl Optimem media (Gibco, Life 
technologies), and 10µl RNAiMAX (Invitrogen) was added to 250µl Optimem, prior to their 
combination and incubation for 15min at RT. The complex is subsequently added to cells that 
have been freshly seeded (at ~150-200% of normal seeding concentrations), prior to dropwise 
addition of siRNA-lipid complex. Media was subsequently changed after 12-16h, and cells treated 
or harvested 48-72h later. Where siRNA depletion is inefficient, dual transfection method is 
adopted whereby forward transfection is repeated ~36h after the first transfection. For siRNA-
plasmid co-transfections, plasmids were transfected 8h after siRNA treatment. In knockdown 
experiments, siRNA targeting firefly luciferase was used as a negative control (see appendix 6.3 
below). 
2.3.4. Generating stable cell lines 
Cells stably expressing inducible proteins were generated in U2OS Trex or RPE-1 p53 null FRT 
(Flip-In) derived cells. The pcDNA5/FRT/TO-neo plasmid containing the GFP-tagged construct 
and pOG44 were transfected in cells in a 1:4 ratio. After 48h, selection was performed with 
0.5mg/ml G418 (Invitrogen) for 7-14 days, in order to generate clones with inducible expression 
of a GFP-tagged protein. This was either facilitated by clonal dilution and manual selection at day 
14 of individual clones using a fluorescence microscope, or bulk sorting by flow cytometry 
(MoFlo cell sorter, Beckman Coulter), into 96-well plate format. Protein expression was 
confirmed by immunoblotting or immunofluorescence.  
2.3.4.1. Generating Cas9-expressing cell lines 
Stable Cas9 expressing cells were generated by lentiviral infection. Lentivirus was generated 
using 293T-LentiX cells grown in 15cm dish at 60% confluency prior to transfection. 18.5µg 






















psPAX2, 4µg pMD2.G and 7.5µg plasmid of interest are added to 800µl Optimem media, and 
800µl Optimem containing 90µl TransIT-LT1, are both left for 5min at RT. These are combined 
for 30min at RT prior to dropwise addition on cells in a 15cm dish. 48h later media is harvested 
and passed through a 0.45µm filter to prevent cell-to-cell contamination. Aliquots are 
subsequently snap frozen on dry ice and stored at -80˚C. Virus packaged with wild-type Cas9 
vector was used to infect parental cell lines, with antibiotic selection of 7-14 days. Individual 
clones were isolated prior to checking the efficiency of Cas9 activity, by transfecting individual 
clones with a plasmid containing: BFP, GFP and a gRNA targeting GFP; in the presence of 
efficient cutting the GFP/BFP ratio fell to <0.1.  
2.3.5. Generating knockout cell lines 
One of two strategies were adopted; either cell lines stably expressing Cas9 were transfected 
with synthetic gRNA or gRNA-expressing plasmids, or plasmids were transfected which encoded 
gRNA as well as Cas9 protein.  
2.3.5.1. Plasmid Cas9-gRNA transfection, sorting, selection and verification 
Knockouts were generated by transfecting the GFP-Cas9 and gRNA containing plasmid into cells 
(as per the method in 2.3.2 above). Cells of moderate GFP expression were isolated and single-
cell sorted into 96 well plate using the MoFlo cell sorter (Beckman Coulter), before being allowed 
to expand over 7-14 days in 15% serum-containing medium. Single clones were isolated for 
duplication across two 96-well plates, followed by genomic DNA extraction using 50µl of 
QuickExtract DNA solution (Illumina) per well of the 96-well plate, and incubation for 5min at 
65˚C then 2min at 98˚C in a PCR plate. The DNA was then used for diagnostic PCR as described 
in 2.1.2 above. Final verification was performed using immunoblotting where antibodies were 
available, and/or TOPO-TA cloning (ThermoFisher): 0.5-4µl fresh PCR product, 1µl salt solution, 
1µl Topo vector made up to 6µl with water; mixture incubated 5-30min at RT prior to 
transformation as above. DNA was extracted as above, and Sanger sequencing with M13 forward 
and reverse standard primers to confirm successful gene-editing.  






















2.3.5.2. YM155 gene knockout strategy 
Synthesised gRNA complexes are purchased (IDT) and transfected alone (in Cas9-expressing 
cells) or in combination with recombinant Cas9 to form ribonucleoproteins. In a 6 well plate 
format, 24pmol total crRNA is used with 24pmol of tracRNA (IDT). If positive selection by co-
transfection with SLC35F2-targeting gRNA is used then this is included in a 3:1 ratio, i.e. 6pmol 
SLC35F2-crRNA + 6pmol tracrRNA complex with 18pmol GOI (gene of interest)-crRNA + 
18pmol tracrRNA complex; these complexes are then mixed with 19.2µl Lipofectamine 
RNAiMAX in 800µL final volume (in OptiMEM) and incubated for 20min at RT to form the RNA-
liposomes. 800µL mix is added to cells in 1600µl of complete medium without antibiotics (final 
volume 2400µl) and incubate at 37˚C overnight. Cells are washed the following day to avoid 
excessive toxicity and complete medium added with antibiotics. 3-6 days can be given to allow 
for gene-editing prior to the addition of the positive selection agent YM155 (Selleck Chemicals; 
at a titrated dose; beginning with final concentration of ~20nM). It is noteworthy that excess 
agent may cause DNA damage so this titrated dose is kept to a minimum. Non-edited cells die 
within 48h, and after clonal expansion, knockout verification was performed by Topo-cloning as 
described in 2.3.5.1 above. 
2.3.6. Cell viability assays 
2.3.6.1. MTT assay 
This assay measure cell viability based on the conversion of MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) compound to an insoluble formazan product, leading to the 
formation of a coloured signal which can be measured in proportion to the number of viable cells. 
Based on plating 150 cells per well in a 96-well format; MTT (Sigma) powder was prepared at 
5mg/ml in PBS solution (vortexed, and filtered at 0.2µm, stored 4˚C in foil). The solution should 
be diluted 1:10 in serum-free media, and 100µl added to each well prior to incubation for 4h (to 
overnight) at 37˚C. A further 100µl of 10% SDS (in PBS) should then be added to each well, and 
left all day in the incubator at 37˚C, prior to measuring absorbance with a microplate reader at 
OD595 with normalisation to background media-only measurements. 






















2.3.6.2. Clonogenic survival assay 
Cells were seeded in 6-well culture dishes (Corning); (1000 cells per well) and 48h later were 
treated with relevant drugs or irradiation. Media and drugs were replenished bi-weekly where 
appropriate. After 14 days, plates were washed with PBS, and colonies were stained with 0.5% 
crystal Violet/20% ethanol followed by washing with water, and air-drying. Quantification was 
performed by manual counting in a blinded fashion.  
2.3.7. DNA damaging agents and laser micro-irradiation 
Camptothecin and cisplatin (Sigma-Aldrich); olaparib (AZD2281), AZD2461 and talazoparib 
(BMN673) were applied at the indicated doses (Stratech Scientific). These were prepared in 
diluents and stored according to the manufacturer’s instructions. Ionising radiation was 
generated using a Faxitron-CellRad (Faxitron Bioptics, LLC) at the stated dose using a 0.5mm 
aluminium filter. Localised tracks of DNA damage were induced by laser micro-irradiation as 
described in (Schmidt et al., 2015). 
2.4. Mammalian cell analysis methods 
2.4.1.Immunofluorescence  
Cells were plated on cover-slips in 6-well plates, in order to achieve a final confluency at fixation 
of 70-80%. Prior to fixation, cells were washed 3x in 0.1% Tween-20/PBS, before pre-extraction 
using ice-cold ‘modified CSK buffer (25mM pH7.4 HEPES, 50mM NaCl, 3mM MgCl2, 0.25% 
Triton X-100, 300mM sucrose). Cells were then gently washed 3x in 0.1% Tween-20/PBS prior to 
fixation in 2% PFA/PBS for 20min at RT. Cells were washed again 3x in 0.1% Tween-20/PBS, prior 
to blocking in 5% BSA/0.1% Tween-20/PBS. Primary antibody solution was prepared in blocking 
buffer, and 50µl is placed on a strip of parafilm in a humidification chamber, before inverting the 
coverslip onto the solution and leaving the chamber at 4˚C overnight. The coverslips are returned 
to 24-well plates, before washing them 3x in 0.1% Tween20/PBS and incubating them in a 
solution containing the appropriate secondary antibody (1:500) and DAPI (Sigma, 1µg/ml) for 1h 
at RT. Finally washing 3x in 0.1% Tween20/PBS occurred before removing excess moisture from 






















each cover slip and inverting it onto a glass slide containing vector shield mounting media and 
sealing the edges with clear nail varnish. 
2.4.1.1. Microscopy and live-cell imaging  
The Olympus confocal microscopy FluoView 1000 was used to acquire fluorescent images of 
fixed and live-cells, acquired using a 40x/60x UPlanSApo/1.35 oil objective lens. Representative 
areas were identified, acquired and quantified as either single-slice confocal images, or multiple 
images across a Z-stack. Representative images shown with scale bar representing 10µm length 
unless otherwise stated. 
2.4.1.2. Super-resolution microscopy 
High resolution microscopy was performed using the Deltavision OMX 3D-SIM system V3 
BLAZE (Applied Precision, GE healthcare), which harboured 3 sCMOS camera, and 
405/499/592.5nm diode laser illumination, and an Olympus PlanApoN 60x 1.52NA oil objective 
lens and standard excitation/emission filter sets. Imaging of each channel occurred sequentially 
via three angles and five phase shifts. Sections were acquired at 0.125µm Z-steps. Raw OMX data 
was reconstructed in SoftWoRx software (v6.5.2., Applied Precision, GE healthcare). Voxelwise 
nearest-neighbour distances were measured between 53BP1 and GFP-FAM35A signals using a 
custom script for Fiji (Richard Bulter, Microscopy Facility, Gurdon Institute; 2017). This enabled 
mapping of signal volumes and measuring of distances using 3D Euclidean distance 
transformation with internal distances set to zero as per the histogram presented in the results 
(see Figure 4.9).  
2.4.1.3. FRAP and association kinetics 
The Olympus confocal microscopy FluoView 1000 setup was used for laser micro-irradiation, and 
subject to a bleach plus (five scans using 488nm argon laser focused via the 60X UPlanSApo/1.35 
oil objective); main scanner, 100% AOTF (acousto–optical tunable filter, slow scanning mode), 
followed by image acquisition at the fastest speed. Average fluorescent intensities of GFP-RPA1 
in the bleached regions were normalised against background intensity of neighbouring 
undamaged area. Mathematical modelling of GFP-RPA1 protein mobility fluorescence changes 






















over time were performed as previously (Schmidt et al., 2015). (It-I0)/Ipre values were plotted as a 
function of time, where I0 is the fluorescence intensity immediately after bleaching, and Ipre is the 
average of the three prebleach measurements. Estimation of mobile protein fraction (A) and 
residence time (t) was performed using Prism 6 software, assuming the existence of one protein 
population using the following equation: y(t) = A[1 exp(-t/ )]. Plotted data are averaged values of a 
minimum of 20 cells accumulated over three independent experiments. To compare between 
different experimental conditions, data were normalised against the fluorescence intensity at the 
time of micro-irradiation. 
2.4.2. Flow cytometry 
Cells are harvested by washing cell pellet with 1mg/ml BSA/PBS, before centrifugation for 4min 
at 400g, aspiration. Cells are either immediately fixed or initially pre-extracted depending on the 
application. Analysis is performed using BD Fortessa, with the following settings: 
Specificity Fluorochrome Excitation laser Filter 
DAPI (4′,6-diamidino-2-phenylindole)  405nm 450/50 
 Alexa-Fluor 488 488nm 530/30 
 Alexa-Fluor 564 594nm 610/20 
EdU (Click-IT) Alexa-Fluor 647 647nm 670/14 
At least 10,000 cells are recorded per event of interest. Data is exported as FACS files for analysis 
using FlowJo (TreeStar) software for analysis.  
2.4.2.1. Cell cycle profiles 
After washing the cell pellet, cells are fixed in 2% PFA/PBS, and incubated for 15min in RT, before 
neutralising the PFA by dilution with 1mg/ml BSA/PBS, and centrifugation for 4min at 400g. 
Samples are subsequently resuspended in BSA buffer containing DAPI (1µg/ml). In addition, 
immunostaining was performed to highlight S-phase populations by EdU incorporation. For 
detecting EdU incorporation, cells are pulsed with 10µM EdU for 30-60min in cell culture prior 
to harvesting and fixation. After fixation and washing, cells are subsequently permeabilised with 






















0.2% Triton X-100/PBS for 15-30min at RT. Washing with BSA/PBS is then followed by 
centrifugation, aspiration, and resuspension with the Click-It cocktail reaction for 1-2h at RT 
(ThermoFisher); 43.75µl PBS, 1µl 100mM CuSO4, 0.25µl 200µM Azide dye, 5µl sodium ascorbate; 
stable for 15min). Cells are washed, centrifuged, aspirated, and resuspended in BSA/PBS buffer 
containing 0.02% sodium azide, DAPI (0.5µg/ml) and 250µg/ml RNase.  
2.4.2.2. Immunostaining  
For cellular staining necessitating pre-extraction, cells were initially washed with BSA/PBS, 
before incubating for 10min on ice with 0.2% Triton X-100/PBS solution. The sample was then 
washed with excess of 1mg/ml BSA/PBS, before centrifugation/aspiration and resuspension in 
2% PFA/PBS for 15min at RT. After a further wash with BSA/PBS, centrifugation/aspiration, the 
cells were resuspended in antibody solution, and the protocol continued as described above.  
2.4.3. Cellular reporter assays  
2.4.3.1. Traffic-light-reporter assay  
The TLR assay has been described previously in detail (Schmidt et al., 2015). In brief, the assay 
involves co-transfection of a plasmid template and I-SceI restriction enzyme, which cuts a 
specific locus within the U2OS-TLR cell line. The template encodes a plasmid which leads to the 
production of a GFP containing plasmid if error-free HR repair is performed following the I-SceI 
induced DSB. Alternatively, if erroneous end-joining is used to repair the break an mCherry signal 
will result. U2OS-TLR cells are depleted with the indicated siRNA for 8h prior to co-transfection 
with the I-SceI expression and HR-Donor plasmids. After 72h the cells are collected and sorted 
using the BD LSR-Fortessa (BD Biosciences), to measure the percentage of positive events. In 
each experiment, 10,000 cells positive for donor (BFP) and I-SceI (IFP) are evaluated for GFP 
(HR) and mCherry (mutagenic end-joining). Analysis is performed as described above. See Figure 
4.19c for schematic of the TLR assay. 
2.4.3.2. Random plasmid integration assay 
Performed as described in (Galanty et al., 2009). Briefly, between two rounds of siRNA 
transfection, U2OS cells were transfected with BamHI–XhoI-linearised pEGFP-C1 (Clontech); 






















this can not be simply self-ligated and NHEJ is required. 24h after DNA transfection, cells were 
collected, counted and plated at low confluency onto a 15cm dish and 6cm dish in complete 
medium, and a 15cm dish in complete medium with 0.5 mg/ml G418 (Gibco, Life technologies). 
The following day, transfection efficiency was calculated by determining the proportion of GFP-
positive cells on the 6cm dish. Cells on the 15cm dishes were incubated at 37 °C for 10-14 days 
until colonies had formed. Colonies were stained with crystal violet and counted, and integration 
events were normalised to transfection and plating efficiencies. Random plasmid integration = 
(plating efficiency of +G418)/[(plating efficiency of -G418) x (transfection efficiency)]. The p-
value was calculated using an unpaired Student’s t-test.  
2.5. CRISPR-Cas9 screen 
A genome-wide CRISPR-Cas9 screen was performed using three different PARP inhibitors in the 
BRCA1-deficient breast cancer cell line SUM149, as outlined in (Dev et al., 2018). The GeCKO 
v2.0 pooled library was utilised at a MOI 0.3 maintaining 250-fold coverage; PARP inhibitor 
treatment commenced at day 7 for a further 14 days, with olaparib/AZD2281 and 
BMN673/talazoparib dose equivalent to IC95, and AZD2461 dose equivalent to IC70. Following 
library preparation and PCR, Illumina Next Generation Sequencing was performed. The 
sequencing was de-multiplexed and number of reads matching each gRNA present in the library 
was determined from the single-read Illumina sequence reads using a custom programming 
script. Genes enriched or depleted in the inhibitor-treated samples were determined by a 
comparison of gRNA counts from these samples with an untreated control using the software 
package MAGeCK version 0.5.5 (Li et al., 2014). 
The MAGeCK commands used were: 
mageck test -k counts.csv  -c DMSO -t WC_2461 -n WC_2461  
mageck test -k counts.csv  -c DMSO -t WC-673 -n WC-673  
mageck test -k counts.csv  -c DMSO -t WC-2281 -n WC-2281  






















2.6. Statistics and analyses.  
Unless stated otherwise Prism 6 (GraphPad Software Inc) was used to calculate p-values based 
on Anova analysis, adjusted for multiple comparisons. Quantifications are based on at least three 
independent experiments unless otherwise specified. Data were considered statistically 
significant for p-values < 0.05. Microscopy image analyses were performed using the open 
software packages ImageJ/FIJI or Volocity 6.3 (Perkin-Elmer). Nuclei were manually segmented 
using the DAPI channel and the resulting regions of interest transferred to the fluorescence 
channel of interest (e.g. GFP, 53BP1, RPA2). Mitotic DNA foci were evaluated with a bespoke Fiji 
script, in condensed Z-stacks; channel intensity was then evaluated after foci detection to 
estimate co-localisations (e.g. EdU channel intensity within a FANCD2 focus). Where 
appropriate all results were normalised to responses in siRNA targeting luciferase (siCTRL) or 
wildtype cells.  
2.6.1.Reproducibility of experiments.  
Excluding screening experiments that were performed only once, and immunoblots which were 
performed twice, all experiments were performed at least three times unless otherwise specified. 
  






















3. Chapter 3 Results: Genome instability and 53BP1 in 
mitosis 
3.1. Introduction  
Non-phosphorylatable mutations in the UDR domain of 53BP1 (53BP1AA) prevent its interaction 
with chromatin in response to damage. We have already outlined previous work which 
demonstrates how the ectopic chromatin recruitment of 53BP1 in response to IR is associated 
with chromosome mis-segregation defects during mitosis (see 1.3.2 above; (Lee et al., 2014)). It 
remains unclear however, whether this applies to the more pathophysiological context of 
replication stress as seen in cancers.  
During interphase, DSB repair pathway choice is determined by the balance of factors which 
favour NHEJ or HR (see 1.2.3 above). By extension, premature activation of NHEJ during mitosis 
may antagonise the mediators involved with recombination and resolution of intermediates that 
form in response to cellular stress. BRCA2 and HR deficiency have been shown to generate 
replication stress, leading to hyper-resected DNA in G2 (potentially for long tract gene 
conversion); this can not only be carried over into mitosis (necessitating mitotic DNA synthesis) 
but also into G1, increasing 53BP1 nuclear body formation (Feng and Jasin, 2017). Intact HR 
pathways may also be required for the subsequent resolution of the G1 nuclear body in the 
following S-phase. This is alongside previously described roles for BRCA2 specific to mitosis 
(Choi et al., 2012, Daniels et al., 2004). 
Inappropriate 53BP1 activity during mitosis may interfere with the processing of stalled 
replication intermediates. Figure 3.1 outlines a current working model of the serial recruitment 
of repair factors, nucleases and DNA synthesis observed during mitosis in response to replication 
stress. We will use this model to explore the impact of 53BP1 recruitment in prometaphase and 
metaphase cells. We hypothesise that the ectopic recruitment of 53BP1AA to sites of DNA 
damage may phenocopy the loss of critical HJ and mitotic replication components in mitosis. If 






















so, 53BP1AA should interfere with this normal DDR during mitosis, and result in genome 
instability.  
 
Figure 3.1 Model of resolving stalled replication intermediates carried over from S-phase during mitosis; taken from 
Pederson et al. 2015 (Pedersen et al., 2015). Recombination intermediates may interlink sister chromatids, or else 
post-replicative gaps may persist. TOPBP1 may be recruited to these sites to facilitate the resolution of HJ by SLX4 
and if necessary complete replication via MiDAS. The persistence of unresolved interlinked intermediates can lead 
to the formation of DAPI-stained chromatin bridges or finer PICH-marked ultrafine bridges. Any or all of these, can 
manifest in the subsequent G1 as 53BP1 nuclear bodies.  
In this chapter, we seek to develop a model system to explore the consequences of short-term 
expression of 53BP1AA. While this protein should mimic wildtype 53BP1 during interphase and in 
response to damage, over-expression of any 53BP1 construct for a sustained period risks being 
deleterious to the cell and could impact the genome instability markers we are looking to 
measure. We will use confocal microscopy to image mitotic cells and identify DDR foci 






















(FANCD2) and DNA synthesis (by EdU incorporation); this will help to establish the effects of 
our 53BP1 mutant cell line on these well-characterised responses (Naim and Rosselli, 2009, Naim 
et al., 2013, Chan et al., 2009, Minocherhomji et al., 2015, Ying et al., 2013, Gallina et al., 2016, 
Pedersen et al., 2015). Finally we will attempt to explore the mechanism by which this leads to 
genome instability.   
3.2. Results 
3.2.1. 53BP1AA induces micronuclei formation with aphidicolin treatment 
In order to study the impact of ectopic 53BP1 activity during mitosis, we generated Flag-tagged 
53BP1 constructs which harbored wild-type or T1609A/S1618A (‘AA’) modifications in the UDR 
domain (Figure 3.2).  
 
Figure 3.2 Schematic of 53BP1, demonstrating the major motifs of 53BP1, as well as the focus forming region (FFR) 
which represents the minimal length of protein necessary for IRIF formation. Importantly, the UDR motif contains 
T1609 and S1618 which are the sites normally phosphorylated during mitosis to prevent chromatinisation.  
This was achieved by sub-cloning 53BP1 from lentiviral constructs into the pcDNA5/FRT-TO 
vector, performing site-directed mutagenesis and transfection to generate doxycycline-
inducible U2OS cells (see materials and methods; 2.3.4); Figure 3.3a,b. By generating ‘flip-in’ 
cells expressing our protein of interest, we sought to minimise any unforeseen toxicity that might 
result from constitutive expression of our constructs. We also employed Flag-tagging for 
downstream purposes as outlined below.  























Figure 3.3 Generation of dox-inducible 53BP1 expressing U2OS cell lines. (a) Immunoblot demonstrating clones 
with dox-inducible expression of Flag-53BP1 harbouring WT or ‘AA’ residues at S1609 and T1618. (b) 
Immunofluorescence demonstrating dox-inducible expression of 53BP1 constructs in U2OS cells. 
In the first instance, we sought to examine the impact of inappropriately active DDR during 
mitosis in cancer, when replication stress is used as a stimulus. There are a range of chromosome 
mis-segregation defects including anaphase bridges and micronuclei resulting from low-dose 
irradiation which can be mediated via NHEJ axis activity (Orthwein et al., 2014). We examined the 
impact of 0.2µM aphidicolin (APH, Sigma-Aldrich) on micronuclei formation; this was achieved 
by 8h of doxycycline-induction in the presence of 0.2µM APH treatment, followed by a further 
16h of APH treatment in the presence of doxycycline and the CDK1 inhibitor R0-3306 (Sigma-
Aldrich); Figure 3.4a. We observed an increase in a proportion of cells harbouring micronuclei 
when 53BP1AA isoforms were expressed which could be ectopically recruited to the chromatin 






















during mitosis (Figure 3.4b). In addition, the majority of these micronuclei appeared acentric, as 
determined by anti-centromere antibody staining within micronuclei (Figure 3.4b).  
 
Figure 3.4 53BP1AA promotes replication-stress induced acentromeric micronuclei formation. (a) Workflow for cell 
treatment prior to fixation, along with representative micrograph demonstrating DAPI-stained micronuclei. (b) 
Quantification showing (top) significant enrichment in APH-induced micronuclei in 53BP1AA (compared to 
53BP1WT) expressing cells; and (bottom) a significant increase in APH-induced centromere negative micronuclei in 
53BP1AA (compared to 53BP1WT) expressing cells.  
3.2.2. Aphidocolin induced G1 nuclear bodies with mitotic 53BP1AA 
The accumulation of replication stress intermediates which remain unresolved during mitosis, 
have been suggested to manifest as large 53BP1 nuclear aggregations known as 53BP1 G1 nuclear 
bodies (Lukas et al., 2011, Harrigan et al., 2011). We performed a similar experiment as per Figure 
3.4; in this instance evaluating Cyclin A negative cells (i.e. cells in G1) for 53BP1 nuclear bodies 
by immunofluorescence and microscopy (Figure 3.5a). Co-staining in the 594 channel with a 
53BP1 antibody was used to functionally confirm anti-Flag accumulation of Flag-53BP1 
constructs in nuclear bodies. This revealed 53BP1AA was associated with a significantly greater 
proportion of G1 nuclear bodies, following replication stress (Figure 3.5b).  























Figure 3.5 53BP1AA promotes formation of G1 nuclear bodies in response to replication stress. (a) Workflow for cell 
treatment prior to fixation, with representative micrograph of 53BP1 nuclear body formation in response to APH. 
(b) Quantification of nuclear body formation in response to APH.  






















3.2.3. 53BP1AA impairs unscheduled DNA synthesis in mitosis 
It has recently been reported that replication stress is associated with DNA repair synthesis in 
mitosis (Minocherhomji et al., 2015). The incorporated nucleoside analogue EdU can be co-
localised with FANCD2 foci, which themselves appear to correlate with Common Fragile Sites 
(CFS) i.e. regions of the genome that are difficult to replicate and may reach mitosis in an under-
replicated state (Chan et al., 2009, Naim and Rosselli, 2009). We sought to evaluate mitotic DNA 
synthesis (Minocherhomji et al., 2015) as a result of replication stress and the expression of our 
53BP1 derivatives. This followed a similar schema as described previously, except that after 16h 
CDK1 inhibition, cells were released into EdU containing media for 45min prior to fixation (see 
Figure 3.6a). In this experiment we examined prometaphase and metaphase spreads, excluding 
any cells at anaphase or beyond. EdU was coupled to Alexa-Fluor 647, and co-localisation of 
signal at FANCD2 foci was examined across 3-D imaging stacks, before utilising FIJI software to 
measure EdU signal intensity at these FANCD2 foci. We saw that despite both cell types 
demonstrating equivalent levels of damage (as indicated by FANCD2 foci per mitotic nucleus), 
each FANCD2 focus was approximately 50% less frequently associated with EdU incorporation 
(Figure 3.6b,c), and similarly each EdU focus was 50% less intense compared to wildtype 
conditions (Figure 3.6d). Arbitrary thresholds for EdU positivity were set in each experiment, but 
then maintained throughout the experiment and across the cell lines. 
  

























Figure 3.6 53BP1AA impairs unscheduled DNA synthesis in mitosis. (a) Workflow for cell treatment prior to fixation, 
with representative micrograph demonstrating FANCD2 co-localisation with EdU signal on condensed 
chromosomes (DAPI) during mitosis. Quantification of (b) number of FANCD2 foci per cell; (c) % EdU positive 
FANCD2 foci; (d) mean EdU intensity per EdU focus (as defined by co-localisation with FANCD2).  
3.2.4. 53BP1AA impairs unscheduled DNA synthesis in mitosis following reduced 
replication origin firing 
A general principle for this model suggests that under-replicated DNA can pass through mitosis 
for resolution in the subsequent daughter cells (Figure 3.1). The failure to complete conventional 
replication during S-G2 phases likely occurs following double fork stalling events. Indeed 53BP1 
appears preferentially bound to larger replicons and its loss has been associated with the 
formation of anaphase UFBs, G1 nuclear bodies, as well as hypersensitivity to replication stress 
when replication origins were experimentally ‘removed’ by MCM5 depletion (Moreno et al., 
2016). We used the reported technique of silencing of the origin licensing factor MCM5 as an 






















alternative source of more ‘physiological’ replication stress (Figure 3.7a), to evaluate the impact 
of 53BP1AA on MiDAS (Moreno et al., 2016). Once again, results suggested that there was a 
significant, albeit smaller, reduction in EdU positive FANCD2 foci, which suggests a more subtle 
but significant reduction in EdU localisation at FANCD2 foci, and a significant reduction in EdU 
intensity per focus, despite equivalent induction of FANCD2 foci per cell; Figure 3.7b-d. We 
observed that MCM5 silencing, appeared to generate more EdU positive FANCD2 foci per cell 
across both conditions, likely reflecting a greater burden and hence carry-over of under-
replicated regions from S-G2 into mitosis.  
 
Figure 3.7 53BP1AA impairs unscheduled DNA synthesis after reduced replication origin firing. (a) Immunoblot 
demonstrating effective MCM5 silencing. Quantification of (b) number of FANCD2 foci per cell; (c) % EdU positive 
FANCD2 foci; (d) mean EdU intensity per EdU focus (as defined by co-localisation with FANCD2). 
3.2.5. 53BP1AA interacts with TOPBP1 in a replication-stress dependent manner in 
mitosis 
In addition to the formation of FANCD2 foci marking sites of replication stress carried into 
mitosis, it has recently been reported that TOPBP1 may also have a role co-localising with sites 
of mitotic DNA synthesis (Figure 3.1). Lisby and colleagues recently described a role for the 
multifunctional protein TOPBP1 in recruiting SLX4 and enabling EdU incorporation during 
mitosis (Pedersen et al., 2015). We performed immunoprecipitation of damaged mitotic U2OS 
cells expressing wildtype or 53BP1AA derivatives.  






















Cells received doxycycline and CDK1 inhibitor as previously described to arrest cells at G2/M. 
Cells were then harvested upon release, this time into 0.1µg/ml nocodazole for 2h to ensure delay 
at mid-mitosis, while avoiding the DNA damaging effects of extended nocodazole treatment. 
This was to accommodate ‘shake-off’ of mitotic cells after 0.5Gy of irradiation (Figure 3.8a) or 
continued 0.2µM APH (Figure 3.8b). In the first instance, IR treatment of 53BP1AA expressing 
U2OS cells appeared to be associated with a TOPBP1 interaction. This interaction was also seen 
to be damage-specific in response to APH; Figure 3.8b. This suggests that 53BP1AA can interact 
with TOPBP1 during mitosis, potentially to the detriment of the normal role of TOPBP1 in 
tethering broken chromosomes until DNA repair can be reactivated in subsequent phases of the 
cell cycle (see discussion).  
 
Figure 3.8 53BP1AA interacts with TOPBP1 in a damage-dependent manner in mitosis. Flag immunoprecipitation in 
response to (a) IR or (b) APH treatment of U2OS cells. 
To further extend this observation, mass spectrometry was performed using HeLa-S3 suspension 
cells expressing a tandem Flag-HA tagged focus forming region (FFR) of 53BP1 harbouring a 
wildtype or phospho-null mutation at the T1608/S1618 residues within the UDR; Figure 3.9a. 
HeLa-S3 cells were double thymidine synchronised and released into nocodazole for 6h prior to 
immunopurification. As would be expected, this 53BP1-FFRAA mutant has been previously 
demonstrated to permit chromatin localization (Lee et al., 2014). These results demonstrate 
various interacting proteins are enriched for in the chromatin-bound fraction of 53BP1AA 
(compared with 53BP1WT), in particular CENPF, NUDT16L1 (the chaperone protein, TIRR (Drane 
et al., 2017)) and MDC1 (Figure 3.9b). 























Figure 3.9 Mass spectrometry identifying differential interacting partners of 53BP1WT and 53BP1 AA recombinants 
(tandem Flag HA tagged). (a) PAGE and silver staining of nuclear soluble and chromatin fractions was followed by 
tryptic digestion and mass spectrometry. (b) Unique interacting peptides identified by proteomic analysis of 
significance p>0.05 (experiment performed by Dipanjan Chowdhury Group; 2016). 
3.3. Discussion 
53BP1 exists in its dephosphorylated form throughout interphase, hence the expression of 
wildtype or phospho-null proteins should be functionally equivalent during S and G2 phases. 
However the expression of 53BP1AA during mitosis is known to be able to facilitate its early 
ectopic recruitment to chromatin, visible as foci by live-cell imaging in metaphase or anaphase 
(Lee et al., 2014, Orthwein et al., 2014). In response to low dose IR of 0.5Gy, 53BP1AA expression 
has been shown to be associated with increased lagging chromosomes and micronuclei 
formation, which appeared to be reversible after inhibition of DNA-PK (Lee et al., 2014). This 
effect was likely dominant negative since 53BP1AA was co-expressed alongside the endogenous 
(phosphorylated) form of 53BP1. The persistent activation of 53BP1AA in mitosis appeared to 
confer hypersensitivity to IR, which could also be reversed by DNA-PK inhibition (Orthwein et 
al., 2014). 
The observed features of genome instability described, are found across various cancer types. It 
will be important to establish the contribution of mechanisms like mitotic 53BP1 activity in 
disease states, and the degree to which this specific aberration contributes to what is likely to be 
a general phenomenon of chromosomal mis-segregation defects. The overexpression of PPP4C 
and the regulatory subunit PPP4R3B in pancreatic, ovarian and gastric cancers (proteinatlas.org), 






















as well as the reduced expression of PLK1 across similar cancer types, may have an impact on the 
phosphorylation status of 53BP1 in mitosis, although this association will need to be verified. 
Our work has demonstrated that the phenomenon of aberrant mitotic DDR activity may be 
relevant in the response to replication stress, a more cancer-relevant phenomenon that is likely 
to contribute to broader features of genome instability (Burrell et al., 2013). We have 
demonstrated that inappropriately ‘active’ 53BP1 during mitosis is sufficient to cause genome 
instability due to replication stress in the preceding S-phase. This was demonstrated in response 
to the DNA polymerase inhibitor APH, as well as MCM5 silencing, which can be used to suppress 
origin firing and reproduce double fork stalling events (Moreno et al., 2016). 53BP1 has been 
shown to associate with large replicons in G1, where the probability of stalling is greater, 
supporting a positive role for 53BP1’s appropriately timed recruitment to chromatin to resolve 
under-replicated DNA during interphase (Moreno et al., 2016). 
53BP1 nuclear bodies are thought to represent the sequestration of entangled/under-replicated 
DNA that persists when first attempts to mediate its repair (involving nucleases, TOPBP1, RAD52 
and Polẟ-3 in MiDAS etc. (Figure 3.1)) fail to resolve the underlying damage (Lukas et al., 2011, 
Harrigan et al., 2011, Pedersen et al., 2015, Bhowmick et al., 2016, Minocherhomji et al., 2015, 
Moreno et al., 2016). Recent work supports the theory that a second chance for repair is available, 
coordinated by 53BP1 in the following cell cycle, which confines the replication and repair of 
these lesions to the latter part of the subsequent S-phase, and utilise its downstream recruitment 
of RIF1 to control late origin firing (Spies et al., 2019). Furthermore, 53BP1’s interaction with 
shieldin (see Chapter 4) appears to play an important role in inhibiting end-resection and in this 
instance, prevents inappropriate RAD51 recruitment in a replicative process that instead requires 
RAD52 for appropriate nuclear body dissolution (Spies et al., 2019). Our work describes the 
consequences of the mistimed utility of 53BP1 during mitosis, which is ordinarily 
dephosphorylated by PPP4C/R3β to permit its normal recruitment in the subsequent G1 (Lee et 
al., 2014). It is interesting to highlight the differences in regulation between first and second 
attempts at repair, whereby 53BP1-independent RAD52 recruitment for MiDAS may be 
appropriate for repair during mitosis, contrasting with the role of 53BP1 in facilitating the 






















mobilisation of RAD52 over RAD51 in the subsequent late S-phase replication-coupled repair. 
This interference with RAD52 loading during the process of MiDAS may explain our observation 
of 53BP1AA reducing EdU incorporation at sites of damage after replication stress.  
We observed an increase in the formation of acentric micronuclei with 53BP1AA expression in 
response to APH, likely reflecting broken chromosome fragments. This contrasts with some 
observations of whole chromosome mis-segregations (lagging chromosomes) seen with 
concomitant IR treatment in mitosis in some studies (Orthwein et al., 2014, Lee et al., 2014), while 
comparable with others (Leimbacher et al., 2019). Our finding of increased acentric chromosome 
fragments within micronuclei fits with a model in which stalled replication intermediates fail to 
be adequately protected, and untethered chromatin fragments become separated from the 
mitotic spindle and undergo random segregation to daughter nuclei.  
A recent study by Stucki, Blackford and colleagues in 2019 has observed that the interaction 
between MDC1 and TOPBP1 plays a critical role in the limited DDR which normally occurs in 
response to damage during mitosis (Leimbacher et al., 2019). The MDC1-TOPBP1 complex was 
suggested to stabilise spontaneous chromosome breaks in mitosis, possibly via a bridging role 
between tethered DNA ends. The finding that some DSBs remain unrepaired and co-localised 
with MDC1 and TOPBP1 up to 24h later, as well as the role for RNF8-RNF168-53BP1 in promoting 
TOPBP1 foci formation during interphase (but not mitosis), suggests a possible explanation for 
our results. The interaction of 53BP1AA with TOPBP1 and possibly MDC1 during mitosis, may 
cause the sequestration of these factors away from the sites of damage. The BRCT0-2 and 
BRCT4/5 domains of TOPBP1 are responsible for its direct binding to phosphorylated MDC1 and 
53BP1 respectively (Cescutti et al., 2010, Blackford et al., 2015, Leimbacher et al., 2019), hence 
there is the potential for sequestration and/or steric competition for binding between these 
proteins. Our findings are also in keeping with Lisby’s work, phenocopying the impact of mitotic 
TOPBP1 depletion in terms of impairing MiDAS and leading to an increase in 53BP1 nuclear body 
formation in the following G1 (Pedersen et al., 2015). 
It was interesting to note a preferential interaction of dephosphorylated 53BP1 FFR with its 
recently identified chaperone NUDT16L1 or TIRR (Drane et al., 2017), see Figure 3.9. The study 






















identifying this protein, posits a role for it in binding the tudor domain of 53BP1, and acting 
competitively with H4K20me2. While the majority of TIRR-bound 53BP1 is thought to be 
nucleoplasmic, it is possible some detergent-resistant fraction exists in dynamic equilibrium.  
In this regard, it is noteworthy that we were unable to visualise 53BP1AA foci at early stages of 
mitosis in response to replication stress, a finding which is consistent with the reported literature 
(Orthwein et al., 2014, Lee et al., 2014). We utilised 0.5% IGEPAL, 0.5M NaCl and benzonase for 
immunoprecipitation experiments (Figure 3.8), suggesting the chromatin-bound 53BP1 (its 
majority) is the fraction interacting with TOPBP1. The failure of 53BP1AA to co-localise with 
FANCD2 foci in response to APH is perhaps not surprising, given the adverse contribution 
53BP1AA appears to play, which is likely spatially separated from sites of repair foci. It will be 
interesting to see whether downstream mediators of 53BP1, such as RIF1 and PTIP, are 
independent of this mitotic interaction, or contribute to this interaction.  
Another notable finding was the mass-spectrometry interaction of the dephosphorylated 53BP1 
FFR interacting specifically with the centromeric protein CENPF. A recent study has revealed a 
mitosis-specific R-loop driven ATR pathway which operates at centromeres to resolve 
catenations and suppress chromosome instability (Kabeche et al., 2018). RNAs have been 
implicated in mediating RNA binding at break sites (Francia et al., 2012) and serving as a trigger 
for 53BP1 transfer from TIRR to damage-associated chromatin (Botuyan et al., 2018). This distinct 
ATR-mediated mitotic signaling pathway centres around an interaction between ATR, Aurora A 
and CENPF to recruit RPA to centromeric R-loops for their dissolution; it is tempting to 
speculate that the preferential interaction of 53BP1AA with CENPF could further contribute to 
the general phenomenon of genome instability which we have documented.  
  






















4. Chapter 4 Results: Shieldin interacts with 53BP1 to 
promote NHEJ and counter HR in BRCA1-deficient cells 
4.1. Introduction 
The discovery of 53BP1 and its two downstream mediators RIF1 and MAD2L2 contributing to the 
HR defect observed in BRCA1 deficiency, reveals an important axis involved in DSB repair 
pathway choice (see 1.2.3). However, it remains unclear whether there are any other members of 
the 53BP1-RIF1-MAD2L2 axis that may contribute to this function. It also remains to be seen how 
the NHEJ-promoting function of this complex is achieved, particularly in regard to any 
interaction between the chromatin and DNA compartments surrounding a DSB, and if there is 
any evidence of direct interaction with core end-joining machinery or whether the supportive 
function of the 53BP1 axis occurs indirectly. 
BRCA1-deficient cancers represent a substantial fraction of germline and acquired genetic 
deficiencies defining various malignancies, including those affecting the breast, ovaries and 
prostate. While these are characterised by their responsiveness to therapies like platinum agents 
and PARP inhibitors, clinical trials also reveal intrinsic and acquired resistance, as discussed in 
1.4.3 above. In order to manage these patients, it will be important to establish an exhaustive list 
of potential mechanisms which may bring about drug resistance.  
One recent technological development which advances this effort is the utility of CRISPR-Cas9, 
in the setting of pooled forward genetic screening. The RNA-guided endonuclease Cas9 has 
emerged from the microbial CRISPR (clustered regular interspaced short palindromic repeat) 
immune system, and represents a transformational gene editing technology for performing 
precise programmable DNA modifications; these are targeted by short RNAs that hybridise with 
target DNA, allowing Cas9 to generate a precise DSB that can be repaired by NHEJ. This leads to 
the generation of indels which can create frameshift mutations and lead to nonsense mediated 
decay of transcripts and/or non-functional protein expression. Libraries of single guide RNAs 
(gRNA) can be generated by pooling together guides targeting any set of genes or non-coding 






















regions, and these can be used with Cas9 to perform high throughput screening of phenotypes of 
interest. For the purposes of identifying markers of drug resistance, genome-wide loss of 
function screens continue to provide valuable insights. We begin by using this method to identify 
suppressors of PARP inhibitor sensitivity in BRCA1-mutant cells.  
4.2. Results 
4.2.1.CRISPR-Cas9 screens identify suppressors of PARP-inhibitor sensitivity in BRCA1-
mutant cells. 
A CRISPR-Cas9 survival screen was used to identify suppressors of PARP-inhibitor sensitivity in 
a BRCA1-mutant cell line (performed by W-T Chiang, PhD student, Steve Jackson Group, 2016). 
In brief, the breast cancer cell line SUM149 (harbouring null and Dexon11 BRCA1 alleles) was 
infected with the whole-genome CRISPR-Cas9 gRNA library (Gecko v.2) at a multiplicity of 
infection of 0.3, prior to seven days of antibiotic selection with puromycin. Library-infected cells 
were then cultured for 14 days in the presence of DMSO or one of three PARP inhibitors 
(olaparib, AZD2461 and talozaporib/BMN673). Genomic DNA extraction, library preparation and 
next-generation sequencing was performed. Read counts were analysed using the MAGeCK 
algorithm and ranked plots of guide abundance were generated (by M Herzog, PhD student, Steve 
Jackson Group, 2016); Figure 4.1a. The screen identified known NHEJ factors which when lost 
restore HR in BRCA1-mutant cells, including TP53BP1, RIF1 and MAD2L2 (Figure 4.1b). The two 
genes which scored highest based on p-value and log-fold change, were two previously 
uncharacterised genes, FAM35A and C20orf196. 






















These gene hits were subsequently validated (Figure 4.2). In the first instance, siRNAs were 
generated which were validated using cells transiently expressing GFP-tagged expression 
constructs of the respective gene products (Figure 4.2a,b,d). The human immortalised epithelial 
cell line RPE-1p53ko were subsequently used as a parental cell line, along with a BRCA1-null 
version (generated by R. Belotserkovskaya, Postdoctoral scientist, Steve Jackson Group, 2015). 
These siRNAs were used to confirm rescue of olaparib-mediated cell death in BRCA1-null but 
not BRCA1-proficient cells (Figure 4.2a,b). Differences in cell survival did not appear to be 
mediated by differences in cell cycle profile (data not shown). CRISPR-Cas9 was used to generate 
FAM35A and C20orf196 de-novo gene knockouts in RPE-1p53ko and RPE-1p53ko/BRCA1ko cell lines. 
This was particularly challenging in the latter, where polyploidy associated with BRCA1 
deficiency reduced the probability of generating complete knockouts (Figure 4.2e). 
Complementations (generated by Flp-In of GFP-tagged constructs) demonstrated the specificity 
of FAM35A and C20orf196 loss to mediate olaparib sensitivity in the setting of BRCA1 deficiency 
(Figure 4.2c-e). It is noteworthy that C20orf196 overexpression caused a dominant-negative 
sensitisation of RPE-1p53ko/BRCA1ko/C20orf196ko cells to olaparib.  
 
Figure 4.1 (a) Schematic of CRISPR-Cas9 screen for PARP-inhibitor resistance factors in BRCA1-mutant cancer cell 
line. (b) MAGeCK analysis of guide enrichments following PARP-inhibitor treatment; False Discovery Rate (FDR) 
of 0.1 shown on each plot.  














































Figure 4.2 (a) siRNA mediated knockdown of FAM35A and C20orf196 rescues BRCA1-null cells, (b) but not BRCA1-
proficient cells, from olaparib sensitivity. Area under curve graphs shown below each survival curve. (c) Validation 






















of FAM35A (left) and C20orf196 (right) knockouts rescuing olaparib sensitivity, and complementations. (d) 
Validation of siRNA efficacy used in (a) by western blot. (e) Validation of CRISPR-Cas9 knockouts by Topo-cloning 
and sequencing. 
4.2.2. FAM35A and C20orf196 domains, interactions and IRIF formation.  
We sought to establish if any structural insights could be gained about FAM35A and C20orf196 
genes, and whether there was any relationship between the two genes. FAM35A and C20orf196 
genes arise relatively late in evolution, with conservation principally among vertebrates (Figure 
4.3a,b). FAM35A encodes for two principle isoforms of 835 and 904 amino acids. Structure 
prediction modelling, by RaptorX, identified an unstructured N-terminal half, and a C-terminal 
half harbouring three highly-conserved oligonucleotide/oligosaccharide-binding (OB)-folds. 
One of these contained a pair of (CXXC) Zn-finger motifs, which were also identifiable in the 
following proteins: 1/ DNA damage-induced apoptosis suppressor protein (Q8IXT1); 2/ Meiosis-
specific with OB domain-containing protein (Q8N635); 3/ DNA repair-scaffolding protein 
(Q14159); 4/ CTC1 and 5/ RPA70. The latter bind to single-stranded DNA, and these OB-folds 
were highly-suggestive of a DNA-interacting module.  
C20orf196 encoded for a shorter protein of 201aa, with potentially one or two wing-helix (WH) 
domains in the C-terminus, similar to those in the yeast CST subunit Stn1 (Sun et al., 2009);Figure 
4.3a. These structural similarities to two components of the CST complex were suggestive of 
functional similarities that will be discussed in 4.3 below.  
 






















Figure 4.3 RaptorX modelling (raptorx.uchicago.edu; bottom), schematic (middle) and per-residue analysis of 
functional changes given a point mutation (predictprotein.org; top) for (a) C20orf196 and (b) FAM35A.  
Given that FAM35A and C20orf196 demonstrate similar phenotypes, we hypothesised that they 
may act in concert. We investigated whether FAM35A and C20orf196 functionally interact, in the 
first instance by utilising a lacR/lacO co-localisation system in U2OS cells. In brief, mCherry-
LacR tagged C20orf196 constructs were generated, and co-transfected in a U2OS cell line 
harbouring a series of lacO repeats, in conjunction with a GFP-tagged expression construct of 
various FAM35A derivatives (U2OS LacSceIII cell line gift from D. Durocher, Toronto). This 
revealed an interaction between FAM35A and C20orf196 mediated via the C-terminus and 
OB3/”FAM”-domain (Figure 4.4a-c). This was confirmed biochemically using cell extracts 
expressing GFP-FAM35A derivatives and HA-C20orf196, as well as by the observation that the 
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Figure 4.4 (a) FAM35A and C20orf196 constructs used in this study, (b) establish an interaction via FAM35A N-
terminus and OB3/FAM-domain with C20orf196, quantified in (c). (d) Co-immunoprecipitation demonstrating both 
FAM35A isoforms interact with C20orf196. (e) Mapping the domains of interaction and (f) non-normalised co-
immunoprecipitation assay showing the effects of co-stabilisation. GFP-tagged constructs used as bait for GFP co-
immunoprecipitation experiments.  
We sought to establish whether the interaction between FAM35A and C20orf196 was direct or 
indirect. In order to assess this, bacterial constructs were designed and synthesised within an 
RSF-duet plasmid vector, encoding for His-tagged C20orf196 in tandem with GST-tagged 
FAM35A for use with Rosetta bacteria and IPTG-mediated expression. We engineered this 
vector to express the proteins in tandem, based on their co-stabilisation. While these could be 
detected with harsh lysis conditions (Figure 4.5a), it was not possible to isolate the proteins with 
milder conditions (Figure 4.5b). Purified products of full-length GST-FAM35A (Novus 
Biologicus) and His-C20orf196 (Creative BioMart) were then commercially obtained, and in-vitro 
GST pulldown confirmed a direct interaction between the two proteins (Figure 4.5c).  























Figure 4.5 (a) Protein purification under (a) harsh (2% SDS) and (b) milder (sonication/1% Triton-X) conditions; (c) 
Recombinant GST-FAM35A and His-C20orf196 interact directly (experiment performed with M. Sczaniecka-Clift, 
Postdoctoral scientist, Steve Jackson Group, 2017)).  
The screen results demonstrate genetic loss of FAM35A or C20orf196 phenocopies the effect 
already established due to loss of 53BP1, RIF1 or MAD2L2 on PARP inhibitor resistance in 
BRCA1-deficient cells. Having established the interaction between FAM35A and C20orf196, we 
speculated whether the interaction extended to these NHEJ accessory factors. Co-
immunoprecipitation experiments were performed with GFP-tagged FAM35A or C20orf196 and 
HA-tagged C20orf196 or FAM35A respectively; Figure 4.6. This confirmed a constitutive 
interaction between our newly identified complex and established components of the 53BP1-
RIF1-MAD2L2 cascade, which was unaffected by the addition of camptothecin. FAM35A was 
consistently more challenging to detect relative to C20orf196, suggestive of its lower 
endogenous abundance, which was subsequently confirmed via mass-spectrometry studies with 
collaborators (Petra Beli Group, Mainz, Germany; see appendix 6.6 and 6.7 for enrichments).  























Figure 4.6 FAM35A and C20orf196 interact with 53BP1, RIF1 and MAD2L2, by GFP co-immunoprecipitation 
experiments in BRCA1-proficient HEK293 cells.  
We next sought to establish whether FAM35A/C20orf196 is recruited to sites of DNA damage, 
and the nature of the relationship with the 53BP1-axis members. In the first instance, U2OS cells 
stably expressing RFP-53BP1 were transfected with GFP-tagged FAM35A or C20orf196 
constructs, prior to live-cell imaging and generating localised DNA damage induced by laser 
micro-irradiation. 53BP1 could be readily detected within five minutes, and both FAM35A and 
C20orf196 localised to sites of damage in similar timeframes (Figure 4.7a). DNA repair factors 
demonstrate localisation to discrete ‘foci’ in response to damage, and we were able to detect 
these in response to camptothecin and irradiation (Figure 4.7b). Figure 4.7c demonstrates the 
ability to detect full-length and N-terminus FAM35A derivatives, but not the C-terminus of 
FAM35A, co-localising with gH2AX in response to irradiation (irradiation-induced foci, IRIF). We 
evaluated the dependence of 53BP1 axis members on the formation of FAM35A and C20orf196 
IRIF. Depletion of 53BP1, RIF1 and MAD2L2 attenuated the formation of foci (relative to control 
conditions) by approximately 80% (Figure 4.7d-g). Notably, FAM35A depletion (and to a lesser 
extent C20orf196) attenuates the ability to detect the other foci, likely reflecting their co-
stabilisation effect noted in Figure 4.4e,f. Hence, 53BP1-RIF1-MAD2L2 act upstream of 






















FAM35A/C20orf196, while depletion of the 53BP1-interacting protein PTIP has no effect (Figure 
4.7h). As a general observation C20orf196 foci were notably smaller than those of FAM35A.  
 













































Figure 4.7 (a) FAM35A and C20orf196 are recruited to localised sites of damage induced by laser micro-irradiation 
(by live-cell imaging) and (b) camptothecin (immunofluorescence micrographs of fixed cells). (c) Full-length and N-
terminus of FAM35A but not its C-terminus form IRIF which can be visualised by IF after pre-extraction. (d) 
FAM35A and C20orf196 expression levels are not affected by BRCA1/53BP1-axis depletion. (e) FAM35A/C20orf196 
do not affect 53BP1 IRIF formation, but 53BP1, RIF1 and MAD2L2 depletions do attenuate (f) FAM35A, and (g) 
C20orf196 IRIF. (h) PTIP depletion did not affect FAM35A/C20orf196 IRIF. Representative micrographs shown 
adjacent to quantifications.  
Since the N-terminus of FAM35A was able to form IRIF, we postulated whether its recruitment 
shared the same dependencies as the full-length FAM35A. We confirmed a similar effect on foci 
number when 53BP1, RIF1 or MAD2L2 were silenced, and further defined the interaction with 
MAD2L2 as occurring via this domain; Figure 4.8a,b.  
 
Figure 4.8 (a) Co-immunoprecipitation showing interaction between N-terminus of FAM35A and MAD2L2, and (b) 
similar dependencies of FAM35A N-terminus IRIF on 53BP1-RIF1-MAD2L2 axis (with representative micrographs 
on the right). 
We performed super-resolution microscopy of both full-length and N-terminus of FAM35A 
(both harbouring an N’ GFP tag), which were co-expressed with RFP-53BP1, in an effort to 
explore the spatial relationship between these proteins. If FAM35A oligomerised via its C-
terminus we might expect larger filamentous complexes more spatially separated from a core of 
53BP1, hence forming larger distances between detectible signals. However, we were able to 
establish that both full-length and N-terminal FAM35A lie within close proximity to 
chromatinised 53BP1, in a conformation that was not distinguishable by these super-resolution 
conditions, potentially supporting an association between the N-terminus of FAM35A and 






















chromatinised 53BP1, and less of an importance of the C-terminus for promoting any 
oligomerisation; Figure 4.9. 













































Figure 4.9 Super-resolution microscopy showing overlap of FAM35A N-terminus and 53BP1 in IRIF. Representative 
micrographs (top), representative approach of algorithm used to quantify spatial overlap (middle); histogram 
showing relative distance of FAM35A pixels from 53BP1 core (bottom).  
4.2.3. FAM35A and C20orf196 promote NHEJ and immunoglobulin class-switch 
recombination. 
Given the dependence of FAM35A/C20orf196 recruitment to sites of damage via the 53BP1-
RIF1-MAD2L2 axis, we wanted to address whether this complex contributes to the process of 
NHEJ. In the first instance, we assessed the impact of depleting FAM35A or C20orf196 on the 
ability to randomly integrate a linearised transfected plasmid. Depletion of both genes 
individually reproduced the random plasmid integration defect observed with silencing 53BP1 or 
core end-joining machinery factors such as XRCC4 and LIG4; Figure 4.10a. This was supported 
by the cellular sensitivity to irradiation observed in FAM35A or C20orf196 knockout cells, 
generated using the parental cell line RPE-1p53ko (Figure 4.10b; experiments performed with 
scientific technician Julia Coates, Steve Jackson group; 2017). 
 
Figure 4.10 FAM35A and C20orf196 contribute to NHEJ as supported by effects of depletion or knockout on (a) 
random plasmid integration and (b) cellular sensitivity to irradiation; right graph shows area under curve. 
We sought to establish whether FAM35A/C20orf196 contributed to the process of physiological 
NHEJ, by the assessment of class switch recombination (Figure 4.11a). We designed guides for 
mouse Fam35a and C20orf196 genes in order to generate knockouts in CH12-Cas9 clones. 
Cytokine stimulation led to comparable AID expression and cellular proliferation (data not 
shown), enabling the measurement of IgM to IgA switching via flow cytometry. Fam35a or 
C20orf196 knockout phenocopied the effect of 53bp1 or Mad2l2 knockout (CSR experiment 






















performed by Ludovic Deriano Group; 2017); Figure 4.11b (complementation experiments 
performed for C20orf196ko; data not shown).  
 
Figure 4.11 (a) Schematic of class switch recombination assay, demonstrating (b) CSR defect due to Fam35a or 
C20orf196 knockout in mouse B-cells (experiment performed by Ludovic Deriano Group; 2017).  
4.2.4. FAM35A and C20orf196 promote telomere-mediated fusions and limit DNA end-
resection. 
In addition to the contribution of Fam35a/C20orf196 to class switch recombination, we also 
examined the impact of their depletion on telomere-mediated fusions after telomere-end 
deprotection. As has been demonstrated for 53bp1 (Martinez et al., 2012), Rif1 (Chapman et al., 
2013) and Mad2l2 (Boersma et al., 2015), depletion of these NHEJ factors leads to telomere fusion 
following deprotection, which is experimentally achieved by TRF2 depletion using a thermo-
sensitive allele system (TRF2ts) in MEF cells (Boersma et al., 2015) (Figure 4.12a). Fam35a and 
C20orf196 depletion phenocopied the effect of Mad2l2 depletion, abrogating telomere fusions 
by ½ to 2/3 (experiment performed by Jacqueline Jacobs Group; 2017), Figure 4.12b.  























Figure 4.12 (a) Schematic of telomere fusion assay in MEFs, demonstrating (b) Fam35a/C20orf196 mediate telomere 
fusion upon deprotection by TRF2 depletion (experiment performed by Jacqueline Jacobs Group; 2017). 
One suggested mechanism for blocking telomere fusion has been the dysregulation of DNA end-
resection which leads to processing of DNA ends that renders the ends incompatible for end-
joining. We tested this hypothesis by visualising ssDNA in FAM35A and C20orf196 knockout 
cells in response to camptothecin. This revealed a disinhibition of end-joining (Figure 4.13a). This 
result was reinforced by the effect of camptothecin-induced RPA2 loading as measured by 
cumulative RPA2 intensity (following pre-extraction; experiments performed with PhD student 
Dominic Pilger; Steve Jackson Group; 2018); Figure 4.13b. In the absence of FAM35A/C20orf196, 
the helicase BLM likely mediated our observation of hyperresection, as measured by RPA 
intensity in BLM depleted cells lacking FAM35A or C20orf196 (Figure 4.13b). This was supported 
by evidence of increased BLM accumulation at sites of laser micro-irradiation in FAM35A or 
C20orf196 knockout cells; Figure 4.13c. This effect of limiting resection did not appear to be a 
by-product of affecting RPA2 residency time at sites of resected double-strand breaks, as 
established by FRAP (Figure 4.13d).  














































Figure 4.13 FAM35A/C20orf196 knockout promotes (a) ssDNA and (b) RPA2 accumulation, likely resulting in 
disinhibition of end-resection mediated by (c) BLM accumulation at sites of damage (performed with PhD student 
D. Pilger, Jackson Group; 2018) (d) FRAP confirms equivalent RPA2 turnover after FAM35A or C20orf196 depletion. 
4.2.5. FAM35A OB folds mediate ssDNA interaction and is required for IR resistance. 
Given the effect of FAM35A/C20orf196 on limiting DNA end-resection, we postulated that the 
OB-folds of the C-terminus of FAM35A may serve a role in competing with resection promoted 
by BLM. Alignment of yeast RPA2 and the C-terminus of FAM35A revealed two tryptophan 
residues which likely played a critical role in DNA binding and could be mapped to within the 
OB1 and OB2 domains (evaluated with Luca Pellegrini, Department of Biochemistry, Cambridge; 
2017); Figure 4.14a,b. We generated FAM35A derivatives harbouring WàA mutations which 
would be predicted to abrogate DNA binding, based on the domain’s shared functional homology 
to the single-stranded DNA binding protein RPA2. Oligo-IP revealed binding to single-stranded 
DNA that appeared to be dependent on these two residues, while binding to dsDNA was less 
consistent and never affected by WàA point mutations (Figure 4.14b).  























Figure 4.14 (a) Schematic structure of FAM35A, and similarity to RPA bound to ssDNA, highlighting two W residues 
predicted to be relevant for DNA binding; as demonstrated by cell lysate co-incubation and pulldown of 
biotinylated oligos, which revealed W489/W640 mediated binding to ssDNA (performed with PhD student 
Jonathan Lam, Steve Jackson Group; 2017). (b) Sequence homology to yRPA2 reveals potential residues critical for 
DNA binding. (c) EMSA confirms binding to ssDNA mediated via W489 and W640 (EMSA performed by 
Postdoctoral scientist Qian Wu, Tom Blundell Group; 2017). 
Bacterial expression constructs were then modified to facilitate purified production of the C-
terminal fragment of FAM35A, and a version harbouring mutations in W489/W640 àAA. EMSA 
on native (non-denaturing) gels confirmed binding specifically mediated by these two residues 
(performed by Postdoctoral scientist Qian Wu, Tom Blundell Group; 2017); Figure 4.14c. 
While GFP-tagged FAM35A harbouring mutations in W489A/W640A were able to form foci in 
response to irradiation, a general observation was made of higher background intensity and lower 
foci intensity relative to a higher background in the mutant derivative cell line (Figure 4.15a). This 
likely reflects a reduced capacity to be able to mobilise from pre-damaged pan-chromatinised 
regions to sites of damage as readily as wild-type FAM35A. This supports a model whereby the 
N-terminus is necessary for damage-dependent localisation, while the C-terminal ssDNA 
binding domain merely assists (but is not an absolute requirement for) IRIF formation/retention.  






















Exploring the phenotypic consequences of abrogating DNA binding, these derivatives were 
unable to rescue FAM35A knockout cells’ sensitivity to irradiation (Figure 4.15b). Notably 
overexpressing the N-terminus of FAM35A mediates a dominant negative effect on the IR 
sensitivity of both FAM35A knockout and wild-type cells, suggesting that interference of 
FAM35A C-terminus to bind to DNA impairs its ability to support end-joining (Figure 4.15b,c). In 
contrast, there was no discernible effect on the olaparib sensitivity of wild-type RPE-1p53ko cells 
upon overexpression of these FAM35A derivatives (Figure 4.15d). Survival experiments were 
performed in conjunction with scientific technician Julia Coates, Steve Jackson Group; 2017).  
 













































Figure 4.15 FAM35A DNA binding mutant impairs (a) IRIF formation, and (b) fails to suppress IR sensitivity in 
FAM35A knockout cells. (c) N-terminus over-expression in wildtype cells also has a dominant negative effect on 
IR sensitivity, but has (d) no effect on response to olaparib. Area under curve shown adjacent to clonogenic survival 
graphs. 
4.2.6. FAM35A or C20orf196 loss restores HR in BRCA1-deficient cells. 
Having defined FAM35A/C20orf196 as terminal end-effectors of the 53BP1-RIF1-MAD2L2 axis 
promoting NHEJ, we next sought to establish any functional relationship with HR factors. It has 
previously been reported that RIF1 recruitment is inhibited by BRCA1-CtIP in S/G2 (Escribano-
Diaz et al., 2013). We also found that FAM35A and C20orf196 IRIF doubled in number when 
BRCA1 but not BRCA2 was depleted; Figure 4.16a.  
 
Figure 4.16 (a) C20orf196 and FAM35A IRIF following BRCA1 or BRCA2 depletion (representative micrographs 
shown for FAM35A). (b) FK2 staining of C20orf196 following BRCA1 depletion. 
We exploited the relative ease of quantifying FAM35A foci to study their temporal dynamics. In 
contrast to 53BP1 IRIF which remained constant, BRCA1 depletion increased baseline formation 
of FAM35A IRIF, which was maintained throughout the response; Figure 4.17a,b. This suggested 






















an increased basal occupancy of 53BP1 on chromatin prior to damage, and a capacity to mobilise 
a similar increase in 53BP1 and FAM35A at the site of a DSB; Figure 4.17a,b. Public datasets 
suggested potential ubiquitination sites which may regulate its accumulation (phosphosite.org). 
We performed IP-immunoblotting which appeared to suggest a damage-independent trend in 
reduced FK2 (conjugated ubiquitin) staining of C20orf196 upon BRCA1 depletion (Figure 4.16b); 
however this could not be confirmed by SILAC mass spectrometry (data not shown; performed 
by Petra Beli Group, Mainz, Germany; 2018).  























Figure 4.17 Temporal kinetics of FAM35A IRIF formation following BRCA1 depletion. (a) IRIF for 53BP1 and 
FAM35A, and (b) time-course of FAM35A IRIF, with representative micrographs of time-course. 
We next tested whether loss of FAM35A or C20orf196 in the context of BRCA1 deficiency was 
sufficient to restore the HR defect, as has been described for 53BP1, RIF1 and MAD2L2 (Boersma 






















et al., 2015, Bothmer et al., 2010, Bouwman et al., 2010, Bunting et al., 2010, Chapman et al., 2013, 
Di Virgilio et al., 2013, Escribano-Diaz et al., 2013, Feng et al., 2013, Xu et al., 2015, Zimmermann 
et al., 2013). We described above that FAM35A/C20orf196 protects DNA ends from unscheduled 
BLM-mediated DNA end-resection, thereby maintaining permissive DNA ends for NHEJ. One 
potential mechanism for 53BP1-RIF1-MAD2L2 loss restoring HR in the absence of BRCA1 is the 
disinhibition of DNA end-resection; permitting additional opportunity for effective RAD51 
loading. We evaluated nuclear RPA2 intensity in response to camptothecin, which revealed DNA 
hyper-resection in BRCA1/FAM35A and BRCA1/C20orf196 double knockout cells that 
phenocopied the effects of depleting the anti-resection factor Abraxas; Figure 4.18. While this 
may contribute to improved kinetics and efficiency of RAD51 loading and therefore HR, it is 
important to note that we were unable to identify a DNA end-resection defect under these 
conditions in RPE-1BRCA1ko cells using this assay (also seen using siRNA depletions in U2OS cells 
and by BrdU staining; personal communication with Yaron Galanty and Rimma Belotserkovskaya, 
Postdoctoral scientists, Steve Jackson Group; 2017); see discussion in 4.3 below.  
 






















Figure 4.18 FAM35A or C20orf196 loss in BRCA1-deficient cells causes hyper-resection phenotype; quantification 
(left) and representative micrographs (right). 
We verified the ability of FAM35A and C20orf196 knockouts to restore RAD51 loading of BRCA1 
knockouts by evaluating S/G2 cells 5.5h after 5Gy irradiation (Figure 4.19a). Both genes 
phenocopied 53BP1 in terms of number of RAD51 foci per cell. Furthermore, BRCA2 recruitment 
to laser lines could also be restored to baseline levels (Figure 4.19b), suggesting the restoration 
of RAD51 loading is occurring at least in part via the canonical BRCA2 (and possibly PALB2) 
pathways. Finally, the traffic-light-reporter assay was used to confirm functional restoration of 
HR defect following double depletion of BRCA1 and FAM35A or C20orf196 (Figure 4.19c). See 
Figure 4.19c (top) for schematic of the traffic-light-reporter assay. 





































































Figure 4.19 FAM35A and C20orf196 loss in BRCA1-deficient cells can restore (a) RAD51, (b) BRCA2 and (c) HR 
reporter assay (top) and effect of FAM35A/C20orf196 depletion (bottom). 
We have described the effect of PARP inhibitor resistance in BRCA1/FAM35A and 
BRCA1/C20orf196 double knockout cells (Figure 4.2). This effect appears to be epistatic with 
53BP1 loss (Figure 4.20a). In the light of FAM35A or C20orf196 loss mediating PARP inhibitor 
resistance in BRCA1-deficient cells, we next sought to establish the impact of complementing 
these proteins and derivatives in the double knockout setting; Figure 4.20b. Complementation 
of full-length FAM35A and C20orf196 was able to re-sensitise cells to olaparib treatment. In the 
case of FAM35A the N-terminus, but not the C-terminus alone, could suppress PARP inhibitor 
resistance in the BRCA1/FAM35A double knockout cell (Figure 4.20b). Without the N-terminus 
to direct the C-terminus to the site of damage, this derivative is unable to partake in damage-
dependent recruitment and essentially has no effect. The effect of the N-terminus suggests its 
chromatinisation as part of the 53BP1-RIF1-MAD2L2/C20orf196 macro-complex is sufficient to 
provide a barrier which impairs effective RAD51 loading. In other words, the C-terminal DNA-
binding domain of FAM35A is necessary for mediating IR sensitivity (and by extension most 
likely NHEJ), while the N-terminus is sufficient to cause olaparib sensitivity (and hence by 
implication antagonise RAD51 loading) (cell survival experiments were performed with scientific 
technician Julia Coates, Steve Jackson Group; 2017). 
Collectively these data demonstrate that C20orf196 and FAM35A operate together to ‘shield’ 
DSBs from inappropriate activities and promote appropriate modes of DSB repair; we therefore 
propose the gene names SHLD1 and SHLD2 and that collectively form the ‘shieldin complex’.  























Figure 4.20 Effects of FAM35A and C20orf196 on cell survival due to olaparib. (a) FAM35A loss is epistatic with 
53BP1 loss in BRCA1-deficient cells in response to olaparib. (b) The N-terminus alone is capable of resensitising 
BRCA1ko/FAM35Ako cells to olaparib.  
4.2.7. FAM35A or C20orf196 loss correlates with PARP inhibitor resistance in cancers. 
Having identified C20orf196/SHLD1 and FAM35A/SHLD2 as mediators of PARP inhibitor 
resistance in BRCA1-deficient cells, we explored whether there was any pathophysiological 
relevance to olaparib-resistance in clinical models. We explored the effect of short-term and 






















sustained PARP inhibitor treatment on BRCA1-deficient patient-derived xenograft models, 
which were either sensitive or had developed resistance to olaparib (Figure 4.21a). In PDX tumour 
models which developed treatment resistance (Figure 4.21a), SHLD1 and SHLD2 transcript levels, 
as well as 53BP1 and PARP1, were found to be downregulated in some tumours; Figure 4.21a 
(experiments performed by Carlos Caldas Group, CRUK Cambridge Institute; 2018). We also 
sought to evaluate intrinsic resistance to PARP inhibitor therapy in a series of BRCA1-deficient 
patient-derived tumour samples from which xenografts were established. In these models, PARP 
inhibitor sensitivity or resistance correlated with high or low SHLD1 and SHLD2 expression 
levels respectively, revealing another association between low shieldin expression levels and 
PARP inhibitor resistance (Figure 4.21b). In two treatment-resistant models with normal shieldin 
transcript levels, deleterious mutations in 53BP1 were observed. We also observed some models 
which independently restored BRCA1 nuclear foci (Cruz et al., 2018), while PDX127 demonstrated 
loss of both FAM35A and C20orf196, suggesting tumours may evolve multiple mechanisms of 
resistance due to tumour heterogeneity or mechanistic cooperation (experiments performed by 
Violetta Serra Group, Vall d'Hebron Institute of Oncology, Barcelona; 2018).  













































Figure 4.21 BRCA1-deficient PDX models (a) subject to olaparib treatment generates PARP inhibitor resistance with 
tumours downregulating shieldin complex components. Schematic of experimental setup (top); relative RNA 
expression levels of tumour specimens from four cohorts of mice for SHLD1, SHLD2, 53BP1, PARP1 (middle); 
growth curves of olaparib sensitive and resistant PDX tumours from cohorts 1-4 (bottom). (b) Intrinsic PARP 
inhibitor resistance correlates with low SHLD1 and SHLD2 expression levels; graphs show SHLD1 and SHLD2 
expression levels and their relationship with intrinsic olaparib sensitivity or resistance. Experiments performed by 
Violeta Serra and Carlos Caldas Groups; 2018. 
It is tempting to speculate that the gain of resistance through the loss of a DNA repair factor or 
complex may generate an alternative therapeutic vulnerability. We tested this hypothesis, by 
examining the sensitivity of BRCA1/FAM35A and BRCA1/C20orf196 knockouts to irradiation and 
cisplatin. This revealed an acquired sensitivity in both cases (Figure 4.22a,b).  























Figure 4.22 Loss of FAM35A or C20orf196 in BRCA1-deficient cells generates therapeutic vulnerabilities to (a) IR 
and (b) cisplatin. Areas under the curve shown for each graph on the right; experiments performed with scientific 
technician Julia Coates, Steve Jackson Group; 2017.  
The additive effects of BRCA1 and SHLD1/2 loss on IR sensitivity may explain this defect, 
particularly given the contribution of SHLD1/2 to NHEJ. The additional sensitivity to the cross-
linking agent cisplatin was surprising, given the effect of restoring HR which is part of the Fanconi 
anemia repair pathway. We examined the effect of FAM35A and C20orf196 on the formation of 






















FANCD2 foci formation in response to cisplatin, and observed an antagonistic relationship which 
appeared to be enhanced (as measured by FANCD2 foci formation) in our knockout cell lines 
(Figure 4.23a), and which was not reciprocal on FAM35A/C20orf196 IRIF (Figure 4.23b). 
 
Figure 4.23 FANCD2 foci are de-repressed in the absence of FAM35A or C20orf196. (a) FANCD2 foci following 
FAM35A, C20orf196 or 53BP1 depletion in response to cisplatin; representative micrograph on right. (b) GFP-
C20orf196 and GFP-FAM35A IRIF are unaffected by FANCD2 silencing; quantification for FAM35A on the right.  























We have identified a new complex of proteins, termed shieldin, which acts as the distal terminal 
end-effector of the established 53BP1-RIF1-MAD2L2 axis in promoting NHEJ, and antagonising 
HR in the absence of BRCA1. Our work suggests a functional equivalence of all members of this 
axis in terms of their capacity to antagonise HR. Structure-function experiments revealed a 
requirement for the C-terminal OB-fold containing domains of FAM35A/SHLD2 to bind DNA, 
and for its role in promoting NHEJ and mediating radioresistance. In contrast, the C-terminus 
appears dispensable for mediating olaparib sensitivity, as complementation of the N-terminus 
alone was sufficient to re-sensitise BRCA1ko/FAM35Ako cells to olaparib. The contributions of 
the various domains of FAM35A to its function that we identified in this study, are summarised 
in the schematic model in Figure 4.24. We have also attempted to correlate expression levels of 
components of the shieldin complex with innate and acquired PARP inhibitor resistance in 
BRCA1-deficient PDX models of breast and ovarian cancer.  
 
Figure 4.24 Schematic of FAM35A/SHLD2, highlighting results from this work attributable to different domains. 
It is tempting to speculate about the two halves of FAM35A and their relevance to its function 
within the two compartments surrounding a DSB. In the break-proximal compartment the C-
terminus may form a stabilising interaction with exposed ssDNA, thereby limiting end-resection. 
Within the chromatin compartment more distal to a DSB, it is possible that the 53BP1 complex 






















sits on histones mediating more long-range effects on the break site; this may involve some DNA 
interaction of FAM35A with e.g. the linker region of DNA, or perhaps simply free exposure of an 
unbound C-terminus. Our super-resolution experiments suggest that FAM35A does not form 
long filamentous structures, and we did not establish any evidence of oligomerisation. One 
possible hypothesis was a role of FAM35A oligomerisation at its C-terminus to stabilise the short 
length of ssDNA generated by the action of CtIP/MRN. It was possible that the oligomerised C-
terminus of FAM35A can cover these short distances, and through a direct interaction with the 
core end-joining machinery, activate the process of NHEJ. Such a model would necessitate a 
dynamic equilibrium between short-range resection and its reversal by fill-in synthesis. This 
model appears to be in part supported by a potential role for the CST (CTC1-STN1-TEN1) 
complex, that interacts with shieldin and mediates Polα-dependent fill-in synthesis (Mirman et 
al., 2018). We did observe an interaction between C20orf196 constructs by co-
immunoprecipitation, suggesting at the very least that this protein multimerises as a dimer 
(Figure 4.4f). The smaller size and relatively insignificant domain architecture makes it 
challenging to predict its precise contribution to this complex. The precise structural interaction 
of FAM35A with chromatin and DNA, and its relationship with C20orf196 and the rest of the 
53BP1 axis members will necessitate further biochemical studies to characterise the structural 
architecture of this complex, for example by in-vitro reconstitution experiments and cryo-
electron microscopy.  
We found that loss of shieldin de-represses DNA end-resection driven by BLM, and it is tempting 
to speculate that the interaction between the OB-folds and ssDNA compete with the 
recruitment and action of nucleases to achieve long-range resection. Our finding of increased 
BLM recruitment in the absence of shieldin is also reminiscent of the increased BLM 
chromatinisation observed with RIF1 silencing (Feng et al., 2013, Xu et al., 2010). 
Recent work has suggested a modest but early impact of BRCA1 on damage-induced DNA end-
resection which is below the level of detection as evidenced by traditional microscopy methods 
(Cruz-Garcia et al., 2014). De-repression of end-resection by loss of 53BP1-RIF1-MAD2L2 is well 
documented, however, evidence for the resection ‘defect’ in BRCA1ko cells which this it is said to 






















rescue, is conflicting. Early data relies on immunoblotting of pRPA signalling in mouse cells in 
response to 30Gy IR, and RPA chip signals at Ig loci during CSR (Chapman et al., 2013, Xu et al., 
2015, Bunting et al., 2010, Boersma et al., 2015), in contrast to RPA IRIF which do not reveal any 
detectible reduction in the absence of BRCA1 (Zhou et al., 2014, Cruz-Garcia et al., 2014). 
While the loss of shieldin may indirectly improve the efficiency of RAD51 loading by generating 
longer lengths of ssDNA than in wildtype cells, the absence of a large detectible DNA end-
resection defect by our methods in BRCA1-deficient cells instead supports the predominant role 
of shieldin in antagonising RAD51 loading directly at the level of competition with PALB2-
BRCA2 recruitment on chromatin surrounding a DSB (Zong et al., 2019). In keeping with this 
theory, the N-terminus of FAM35A could still maintain a complex with C20orf196 and the 53BP1-
RIF1-MAD2L2 components upstream; in this case, the persistence of this larger complex would 
appear to be sufficient to antagonise the loading of RAD51 and hence lead to the olaparib 
sensitivity we observed.  
The contributions of SHLD1/2, both to NHEJ and HR, in the presence and absence of BRCA1, are 
summarised in the model below; Figure 4.25. 























Figure 4.25 Schematic model of SHLD1C20orf196/SHLD2FAM35A function in the presence and absence of BRCA1, as 
revealed by this work. 
We hypothesised that the reciprocal interaction between FAM35A/C20orf196 and BRCA1 may 
be related to BRCA1’s established function as an E3 ubiquitin ligase with its partner BARD1. It 
has recently been suggested that BRCA1 mediates ubiquitination of H2A, for the purposes of 
recruiting the chromatin remodeller SMARCAD1 and repositioning 53BP1; in its absence the 
persistence of 53BP1 maintains the suppression of DNA end-resection (Densham et al., 2016). 
Pull-downs and mass spectrometry was performed and revealed with high-confidence, 
ubiquitination of C20orf196 on K128 and K183 residues, and ubiquitination of FAM35A on K468 
and K483 residues. However further studies including SILAC which were used to evaluate 
damage- and BRCA1- dependency failed to reveal any substantial changes in ubiquitination state 
at these residues. Nevertheless, it is tempting to infer a regulatory role of the K468/K483 
ubiquitination sites of FAM35A, given their proximity to the critical DNA binding residue W489, 
however this modification would have to occur in a camptothecin-independent manner. 






















The direct antagonistic effect of BRCA1 on FAM35A and C20orf196 IRIF was notable, and 
reminiscent of previous reports of RIF1 IRIF upon BRCA1 depletion in S/G2 cells (Chapman et 
al., 2013, Escribano-Diaz et al., 2013, Feng et al., 2013, Zhang et al., 2016); this effect has been 
shown to require the BRCA1-CtIP interaction, but has only a mild effect on 53BP1 IRIF (Chapman 
et al., 2012). The reciprocal interaction between BRCA1 and RIF1 suggested that each was 
responsible for suppressing IRIF in G1 and S/G2 respectively, and suggested that the CDK switch 
mediating the BRCA1-CtIP interaction may play an important role in pathway choice (see 1.2.3). 
These findings support our results which show increased occupancy of chromatinised 53BP1 by 
shieldin in the absence of BRCA1, both in the undamaged state and in response to radiation.  
Our characterisations of shieldin using knockout cells appears to phenocopy that of 53BP1, RIF1 
and MAD2L2. However we could not demonstrate any dependence of shieldin on PTIP, and 
these results appear to be in contradiction to one study which defined PTIP in terms of mediating 
the pathological NHEJ effects (e.g. by telomere fusions) and in opposing BRCA1-dependent HR 
(Callen et al., 2013). We also could not identify any defect in V(D)J recombination due to shieldin 
loss (personal communication with Ludovic Deriano Group; 2019), which again contrasts with the 
role for 53BP1 in ‘long-range’ V(D)J recombination proposed by the same group (Difilippantonio 
et al., 2008). It is possible that some of these differences with PTIP are reflected by assay or cell 
line differences; indeed many of the experiments of the former study were performed in mouse 
cell lines in contrast to our own bias toward the use of human cell model systems. 
We experienced some difficulty with generating knockouts of FAM35A and C20orf196 genes, in 
part reflecting a degree of essentiality in human cell lines and the relative infrequency with which 
these genes could be deleted biallelically. We also observed some subtle differences in the 
phenotypes of the SHLD1 and SHLD2 knockouts, and the character of these IRIF, which may 
reflect separations of function between the two proteins. We are currently generating C20orf196 
knockout mice, however Fam35a itself appears embryonic lethal, again supportive of differences 
in function, at least in early embryological development (ongoing work with former Postdoctoral 
scientist G. Balmus; Steve Jackson Group, 2019). It is noteworthy, that while loss of RIF1 is 
embryonic lethal, 53BP1 deletion can be tolerated, with radiosensitivity and immunodeficiency 






















phenotypes (Buonomo et al., 2009, Ward et al., 2004, Morales et al., 2003), suggesting that there 
are various contributions which 53BP1 axis members make outside of their canonical roles in 
NHEJ and repair pathway choice. 
Our screen also revealed several other candidates that have recently been shown to be important 
in determining repair pathway choice, including TEN1 (part of the CST complex, see above 
(Mirman et al., 2018)), and DYNLL1 (Becker et al., 2018, He et al., 2018). The ATMIN-DYNLL1 
pathway (ATMIN being the transcription factor promoting DYNLL1 expression) has been 
proposed to work either by its impact on the oligomerisation and therefore DSB recruitment of 
53BP1, and/or repressing MRE11 recruitment to directly inhibit DNA end-resection. It is notable 
that not all components of these complexes demonstrated the same fold change enrichment or 
significance across the three different PARP inhibitors, and this likely reflects the strength of 
these suppressors (particularly with respect to the AZD2461 IC70 result), subtle differences in 
their mechanism of action, and the statistical noise of the screen. There are also differences 
observed with other similar screens that have been performed, that can often be attributed to 
differences in screen design, particularly the cell type that has been used. 
Since the presentation and publication of our work (Dev et al., 2018), there have been several 
other studies identifying shieldin as a downstream effector of 53BP1, protecting DNA ends, 
promoting NHEJ and immunoglobulin class switching, and supporting our findings (Ghezraoui et 
al., 2018, Gupta et al., 2018, Mirman et al., 2018, Noordermeer et al., 2018, Findlay et al., 2018, 
Tomida et al., 2018, Gao et al., 2018). Notably, several studies have identified a third component 
of what is being considered a four-component complex, hence SHLD1, SHLD2 interact with 
MAD2L2, which itself interacts with the previously unidentified gene CTC-534A2.2 now termed 
SHLD3. MAD2L2 and SHLD3 are the most proximal elements within the complex localising 
SHLD1/2 to 53BP1-RIF1, with MAD2L2 interacting with SHLD3 via its C-terminal “seatbelt” 
(Ghezraoui et al., 2018). Our inability to detect SHLD3 in our whole genome CRISPR-Cas9 screen 
and mass spectrometry likely reflects the poor annotation of this gene across various datasets. 
Indeed, only 2/6 guides present within the GeCKO v2.0 library assigned to this gene actually 
target exons belonging to the SHLD3 protein, as opposed to an alternatively spliced variant that 






















does not encode for a protein, and these two guides do appear to have some enrichment in the 
presence of PARP inhibition.  
The sequence homology for the OB-folds of SHLD2 to RPA1 and CTC1 held particular relevance, 
due to one group proposing that the CTC1-STN1-TEN1 (CST) complex is recruited downstream 
of shieldin to facilitate the recruitment of Polα in a manner reflecting the recruitment of the 
shelterin complex to a telomeric ends to fill-in excessive overhangs of nascent telomeres 
(Barazas et al., 2018, Mirman et al., 2018). This finding was supported by the suppression of radial 
chromosome formation in PARP inhibitor treated BRCA1-deficient cells after Polα inhibition. 
However, it remains unclear how the DNA binding of SHLD2 cooperates with that of the CST 
complex to regulate fill-in synthesis and determine DNA end-resection. Shieldin mutants which 
fail to interact with CST will assist in assigning more precise functions to each of these 
components (Setiaputra and Durocher, 2019). 
The interaction between the N-terminus of FAM35A/SHLD2 and MAD2L2 was further attributed 
to two prolines (P14, P17) within the highly conserved first 50 residues of SHLD2 (Ghezraoui et 
al., 2018). To test the contribution of the OB-folds, one study artificially forced the recruitment 
of SHLD2 to sites of damage through an FHA-fusion protein. In doing so, this led to the inhibition 
of RAD51 loading in a BRCA1ko/53BP1ko cell line, which required the DNA binding capacity of 
SHLD2’s OB-folds to exhibit this effect. We observed that the DNA binding capacity of SHLD2 
was necessary to mediate radioresistance, but that the C-terminus was dispensable for olaparib 
sensitivity in BRCA1ko cells. The apparent contradiction in conclusions between these two 
reports remains to be resolved, and could be addressed by a knock-in of WàA in the DNA-
binding residues of the endogenous locus of SHLD2, to see whether this would phenocopy 
SHLD2 loss in a BRCA1-deficient background, and hence how much of the function of SHLD2 
can be attributed to its ssDNA binding action. There was an implication in one study of an 
inability to bind <30nt length region, in contrast to typical tandem OB-fold containing proteins, 
and is suggestive of binding to longer lengths of ssDNA than say RPA (Gao et al., 2018). This 
interaction may therefore interfere with RPA binding as a result of the 20-40nt tract length 
generated by MRN/CtIP, and/or sterically hinder the recruitment of BLM/DNA2 or EXO1 






















necessary for switching from short to long range resection (Ciccia and Elledge, 2010). In keeping 
with this theme of negatively antagonising end-resection factors, the 53BP1 interacting protein 
DYNLL1 has been shown to interfere with the MRE11 nuclease activity at DNA ends (He et al., 
2018). It remains to be seen whether this occurs upstream to shieldin activity and whether these 
two anti-resection functions are connected.  
One study explored interacting sites of MAD2L2, and separated residues responsible for its 
interaction with its TLS polymerase partners REV1 and REV3L, compared with the interactions 
for SHLD3 binding. The study went on to ascribe this specific function to cross-linker resistance, 
with mutations abrogating the interaction with REV1/REV3L but preserving the interaction with 
SHLD3 causing cisplatin and MMC sensitivity (Ghezraoui et al., 2018). We observed a sensitivity 
to cisplatin and radiation of double BRCA1ko/SHLD1ko or BRCA1ko/SHLD2ko cells. Our results 
are in keeping with MMC sensitivity observed in HEK293 cells after FAM35A/SHLD2 depletion 
(Tomida et al., 2018), and the finding that FANCD2 recruitment in response to damage was 
enhanced in the absence of SHLD1/2 was suggestive of either a direct or indirect effect on the 
ability to respond to DNA cross-links. One explanation could be that this phenotype reflects an 
accumulation of damage and an inability to complete downstream resolution of a cross-link after 
its detection by the Fanconi anaemia core complex and recruitment and ubiquitination of 
FANCI-D2. The absence of shieldin and the hyper-resection phenotype may interfere with 
classical HR repair, instead favouring RAD52-mediated SSA and leading to an accumulation of 
FANCD2 upstream reflecting unresolved cross-links. Whether these experimental results reflect 
genuine mechanistic differences or else clonal and experimental variation will need to be 
confirmed.  
A broader phenomenon of radiosensitivity conferred by various BRCA1-deficient PARP inhibitor 
resistance mechanisms has been described from in-vitro and in-vivo model systems (Barazas et 
al., 2019). In contrast to HR restoration due to restoring BRCA1 expression, 53BP1-RIF1-
MAD2L2/shieldin/CST losses appear to further increase radiosensitivity despite the equivalent 
restoration of HR (Dev et al., 2018, Barazas et al., 2018, Barazas et al., 2019). Both of these results 
offer a therapeutic opportunity upon the emergence of treatment resistance after PARP 






















inhibition, that may be clinically exploitable. We observed correlations in shieldin expression 
levels and PARP inhibitor resistance, that may support the evaluation of the RNA expression of 
tumour biopsy samples, rather than relying on insights from mutational burden alone. The 
likelihood of bialleic losses in these genes seems a less likely occurrence than the transcriptional 
re-wiring that could produce a similar effect. It is also likely that the mechanisms of HR 
deficiency due to so-called ‘BRCAness’, as well as the mechanisms which may reverse these 
effects and cause resistance, are likely to differ depending on the specific HR-gene in question.  
A recent CRISPR-Cas9 based suppressor screen in ATM-deficient cells, revealed core end-
joining machinery as factors which when individually ‘lost’ can suppress hypersensitivity to 
topotecan or olaparib (Balmus et al., 2019). In contrast, 53BP1 loss was unable to reverse the 
toxicity of topotecan or olaparib in ATM-deficient cells. In the absence of ATM, lethality appears 
to emerge from the toxic end-joining brought about by core end-joining factors acting upon free 
seDSBs, and presumably the mitotic catastrophe that results from breakage of aberrantly fused 
chromosomes. In contrast, core end-joining factors do not appear to be able to rescue the HR 
defect of BRCA1-deficient cells, suggesting that mechanisms remain intact to prevent toxic end-
joining (presumably via ATM activity), and that here cell death arises from accumulation of 
unrepaired free DNA seDSBs. Previous work did suggest that the absence of LIG4 in BRCA1-
deficient cells was sufficient to reduce chromosome rearrangements, but again this was 
insufficient to restore HR, suggesting that this effect may contribute, but was not sufficient to 
cause death in BRCA1-deficient cells, or otherwise chromosome fusions simply represent an 
epiphenomenon (Bunting et al., 2010). 
Regardless of the mechanisms of cytotoxicity, it will be important to continue to identify 
individual factors which contribute to DSB repair pathway choice. In addition, establishing the 
HR status of patients’ tumours, and continuing to define mechanisms of resistance specific to 
individual genetic defects, will be essential to reliably stratify patients to their optimal therapy. 
The techniques explored in this thesis and the DDR pathways that we have defined, should 
support such scientific and translational progress in the future.  
  






















5. Future directions 
CRISPR-Cas9 pooled genetic screening has emerged as an increasingly important experimental 
technique for exploring genetic contributions to specific phenotypes. Our work in chapter 4 
highlights the use of this technique in identifying genetic suppressors of drug sensitivity, and 
alternatively, genetic enhancers of drug sensitivity – so-called dropout candidates – are also 
being explored. The former has the potential to reveal biomarkers of therapeutic resistance (as 
for shieldin and PARP inhibitor resistance in BRCA1-deficient cells), while the latter can identify 
new synthetic lethal interactions, which in the context of drug candidates may reveal therapeutic 
targets for inhibition. It is clear therefore, that the use of whole-genome unbiased cancer cell 
survival screens may help us to identify new mediators of treatment response, as well as 
sensitisers of specific genetic backgrounds.  
The use of isogenic cell lines for the purposes of exploring genetic interactions between a 
specific gene and its synthetic lethal or viable partners, is a useful tool for exploring these 
relationships. However, many genes exhibit functional interactions that can promote or abrogate 
important phenotypes without necessarily manifesting in cell survival or death. As a result we 
necessarily risk missing key players in the DDR by relying upon genetic interactions that cause 
crude changes in the relative fraction of surviving cells in-vitro. One strategy which overcomes 
this limitation is a modification of the genotype to phenotype approach, which I have designed 
and am currently completing. By taking a pooled population of gRNA-infected cells, we can use 
the single-cell based method of fluorescence activated cell sorting (FACS) to isolate cells which 
demonstrate significant deviations in detectible signals, thereby identifying genes which when 
lost, accentuate or attenuate a specific ‘cellular response’. This has the potential to allow us to 
explore a wide variety of signals relevant to the DDR, including changes in the expression level 
of signalling proteins such as p-p53, pCHK1, pKAP1 and 𝛾H2AX. After further optimisation of 
conditions for cellular pre-extraction, we are now able to detect RPA loading onto ssDNA in 
response to DNA damage. Our latest series of experiments will explore factors which increase 
or decrease the amount of RPA loading in cycling cells under control conditions or in response 






















to the topoisomerase I inhibitor camptothecin. I  have optimised a set of conditions, such that at 
1h and 10h recovery post-treatment, low and high RPA signals (respectively) can be associated 
with depletion of CtIP and RAD51 (respectively). In other words, by isolating cells at the ‘tail-
ends’ of each population distribution of RPA intensity, we should be able to identify factors 
which are involved in DNA end-resection, homologous recombination, and in the absence of 
camptothecin, mediators of replication stress. This represents an exciting step forward in the 
ability to explore dynamic cellular responses and identify new genetic determinants of DDR 
pathways. The establishment of FACS-based screening approaches has other potential 
advantages which may make it applicable to a translational setting.  
While pure isogenic cell lines are well-suited to exploring specific genetic relationships, the 
relevance of such model systems to the clinic is more limiting. We need faithful models of patient 
disease in an effort to explore genetic drivers of treatment response in a more representative 
cellular milieu, and which reflects the heterogeneity observed within a mixed population of 
cancer cells. Patient-derived xenografts go some way to modelling disease, but performing 
genetic screens in these systems is costly, time-consuming and not without its own limitations. 
Primary cultures of patient-derived cells may be an option for performing forward genetic 
screens, albeit with the practical challenges associated with isolating sufficient epithelial cells 
from surgical specimens and culturing and expanding them ex-vivo. Fundamentally however, 
their relatively slow growth indices limit the utility of traditional CRISPR-Cas9 ‘survival’ screens 
which would rely on high proliferation rates to outcompete slower growing cells. FACS-based 
CRISPR-Cas9 screening offers an opportunity to explore dynamic cellular signals in response to 
existing and emerging therapies, using these signals as surrogates of treatment sensitivity or 
resistance, and hence identifying new drug targets or biomarkers of response. 
Using the same methodology may enable us to model the cellular responses of cancer cells taken 
from individual patients. It is conceivable that a diagnostic biopsy could, alongside its use for 
routine histopathological assessment, be evaluated by flow cytometry to assess the DDR 
signalling that results from a specific drug treatment. The ex-vivo cells could be used as a 
treatment ‘avatar’ to phenotype the patient’s tumour, enabling the prediction of responsiveness 






















prior to the commencement of therapy. Finally, small hyper-focused libraries of druggable targets 
could be used to predict which drug from a basket of available treatments, would an individual 
patient stand to gain the most benefit. By feeding this information back to the clinic, such a 
strategy could conceivably be used to help deliver personalised medicine. We continue to build 
upon the progress made above, in an effort to help realise this ambition in the coming future.  
  
  






















6. Supplementary information 
6.1. List of figures 
Figure 3.1 Model of resolving stalled replication intermediates carried over from S-phase during 
mitosis; taken from Pederson et al. 2015 (Pedersen et al., 2015). Recombination intermediates 
may interlink sister chromatids, or else post-replicative gaps may persist. TOPBP1 may be 
recruited to these sites to facilitate the resolution of HJ by SLX4 and if necessary complete 
replication via MiDAS. The persistence of unresolved interlinked intermediates can lead to the 
formation of DAPI-stained chromatin bridges or finer PICH-marked ultrafine bridges. Any or all 
of these, can manifest in the subsequent G1 as 53BP1 nuclear bodies. 47 
Figure 3.2 Schematic of 53BP1, demonstrating the major motifs of 53BP1, as well as the focus 
forming region (FFR) which represents the minimal length of protein necessary for IRIF 
formation. Importantly, the UDR motif contains T1609 and S1618 which are the sites normally 
phosphorylated during mitosis to prevent chromatinisation. 48 
Figure 3.3 Generation of dox-inducible 53BP1 expressing U2OS cell lines. (a) Immunoblot 
demonstrating clones with dox-inducible expression of Flag-53BP1 harbouring WT or ‘AA’ 
residues at S1609 and T1618. (b) Immunofluorescence demonstrating dox-inducible expression 
of 53BP1 constructs in U2OS cells. 49 
Figure 3.4 53BP1AA promotes replication-stress induced acentromeric micronuclei formation. (a) 
Workflow for cell treatment prior to fixation, along with representative micrograph 
demonstrating DAPI-stained micronuclei. (b) Quantification showing (top) significant 
enrichment in APH-induced micronuclei in 53BP1AA (compared to 53BP1WT) expressing cells; and 
(bottom) a significant increase in APH-induced centromere negative micronuclei in 53BP1AA 
(compared to 53BP1WT) expressing cells. 50 
Figure 3.5 53BP1AA promotes formation of G1 nuclear bodies in response to replication stress. (a) 
Workflow for cell treatment prior to fixation, with representative micrograph of 53BP1 nuclear 






















body formation in response to APH. (b) Quantification of nuclear body formation in response to 
APH. 51 
Figure 3.6 53BP1AA impairs unscheduled DNA synthesis in mitosis. (a) Workflow for cell 
treatment prior to fixation, with representative micrograph demonstrating FANCD2 co-
localisation with EdU signal on condensed chromosomes (DAPI) during mitosis. Quantification 
of (b) number of FANCD2 foci per cell; (c) % EdU positive FANCD2 foci; (d) mean EdU intensity 
per EdU focus (as defined by co-localisation with FANCD2). 53 
Figure 3.7 53BP1AA impairs unscheduled DNA synthesis after reduced replication origin firing. (a) 
Immunoblot demonstrating effective MCM5 silencing. Quantification of (b) number of FANCD2 
foci per cell; (c) % EdU positive FANCD2 foci; (d) mean EdU intensity per EdU focus (as defined 
by co-localisation with FANCD2). 54 
Figure 3.8 53BP1AA interacts with TOPBP1 in a damage-dependent manner in mitosis. Flag 
immunoprecipitation in response to (a) IR or (b) APH treatment of U2OS cells. 55 
Figure 3.9 Mass spectrometry identifying differential interacting partners of 53BP1WT and 53BP1 
AA recombinants (tandem Flag HA tagged). (a) PAGE and silver staining of nuclear soluble and 
chromatin fractions was followed by tryptic digestion and mass spectrometry. (b) Unique 
interacting peptides identified by proteomic analysis of significance p>0.05 (experiment 
performed by Dipanjan Chowdhury Group; 2016). 56 
Figure 4.1 (a) Schematic of CRISPR-Cas9 screen for PARP-inhibitor resistance factors in BRCA1-
mutant cancer cell line. (b) MAGeCK analysis of guide enrichments following PARP-inhibitor 
treatment; False Discovery Rate (FDR) of 0.1 shown on each plot. 62 
Figure 4.2 (a) siRNA mediated knockdown of FAM35A and C20orf196 rescues BRCA1-null cells, 
(b) but not BRCA1-proficient cells, from olaparib sensitivity. Area under curve graphs shown 
below each survival curve. (c) Validation of FAM35A (left) and C20orf196 (right) knockouts 
rescuing olaparib sensitivity, and complementations. (d) Validation of siRNA efficacy used in (a) 
by western blot. (e) Validation of CRISPR-Cas9 knockouts by Topo-cloning and sequencing. 64 






















Figure 4.3 RaptorX modelling (raptorx.uchicago.edu; bottom), schematic (middle) and per-
residue analysis of functional changes given a point mutation (predictprotein.org; top) for (a) 
C20orf196 and (b) FAM35A. 66 
Figure 4.4 (a) FAM35A and C20orf196 constructs used in this study, (b) establish an interaction 
via FAM35A N-terminus and OB3/FAM-domain with C20orf196, quantified in (c). (d) Co-
immunoprecipitation demonstrating both FAM35A isoforms interact with C20orf196. (e) 
Mapping the domains of interaction and (f) non-normalised co-immunoprecipitation assay 
showing the effects of co-stabilisation. GFP-tagged constructs used as bait for GFP co-
immunoprecipitation experiments. 67 
Figure 4.5 (a) Protein purification under (a) harsh (2% SDS) and (b) milder (sonication/1% Triton-
X) conditions; (c) Recombinant GST-FAM35A and His-C20orf196 interact directly (experiment 
performed with M. Sczaniecka-Clift, Postdoctoral scientist, Steve Jackson Group, 2017)). 68 
Figure 4.6 FAM35A and C20orf196 interact with 53BP1, RIF1 and MAD2L2, by GFP co-
immunoprecipitation experiments in BRCA1-proficient HEK293 cells. 69 
Figure 4.7 (a) FAM35A and C20orf196 are recruited to localised sites of damage induced by laser 
micro-irradiation (by live-cell imaging) and (b) camptothecin (immunofluorescence micrographs 
of fixed cells). (c) Full-length and N-terminus of FAM35A but not its C-terminus form IRIF which 
can be visualised by IF after pre-extraction. (d) FAM35A and C20orf196 expression levels are not 
affected by BRCA1/53BP1-axis depletion. (e) FAM35A/C20orf196 do not affect 53BP1 IRIF 
formation, but 53BP1, RIF1 and MAD2L2 depletions do attenuate (f) FAM35A, and (g) C20orf196 
IRIF. (h) PTIP depletion did not affect FAM35A/C20orf196 IRIF. Representative micrographs 
shown adjacent to quantifications. 72 
Figure 4.8 (a) Co-immunoprecipitation showing interaction between N-terminus of FAM35A and 
MAD2L2, and (b) similar dependencies of FAM35A N-terminus IRIF on 53BP1-RIF1-MAD2L2 
axis (with representative micrographs on the right). 72 
Figure 4.9 Super-resolution microscopy showing overlap of FAM35A N-terminus and 53BP1 in 
IRIF. Representative micrographs (top), representative approach of algorithm used to quantify 






















spatial overlap (middle); histogram showing relative distance of FAM35A pixels from 53BP1 core 
(bottom). 75 
Figure 4.10 FAM35A and C20orf196 contribute to NHEJ as supported by effects of depletion or 
knockout on (a) random plasmid integration and (b) cellular sensitivity to irradiation; right graph 
shows area under curve. 75 
Figure 4.11 (a) Schematic of class switch recombination assay, demonstrating (b) CSR defect due 
to Fam35a or C20orf196 knockout in mouse B-cells (experiment performed by Ludovic Deriano 
Group; 2017). 76 
Figure 4.12 (a) Schematic of telomere fusion assay in MEFs, demonstrating (b) Fam35a/C20orf196 
mediate telomere fusion upon deprotection by TRF2 depletion (experiment performed by 
Jacqueline Jacobs Group; 2017). 77 
Figure 4.13 FAM35A/C20orf196 knockout promotes (a) ssDNA and (b) RPA2 accumulation, likely 
resulting in disinhibition of end-resection mediated by (c) BLM accumulation at sites of damage 
(performed with PhD student D. Pilger, Jackson Group; 2018) (d) FRAP confirms equivalent RPA2 
turnover after FAM35A or C20orf196 depletion. 79 
Figure 4.14 (a) Schematic structure of FAM35A, and similarity to RPA bound to ssDNA, 
highlighting two W residues predicted to be relevant for DNA binding; as demonstrated by cell 
lysate co-incubation and pulldown of biotinylated oligos, which revealed W489/W640 mediated 
binding to ssDNA (performed with PhD student Jonathan Lam, Steve Jackson Group; 2017). (b) 
Sequence homology to yRPA2 reveals potential residues critical for DNA binding. (c) EMSA 
confirms binding to ssDNA mediated via W489 and W640 (EMSA performed by Postdoctoral 
scientist Qian Wu, Tom Blundell Group; 2017). 80 
Figure 4.15 FAM35A DNA binding mutant impairs (a) IRIF formation, and (b) fails to suppress IR 
sensitivity in FAM35A knockout cells. (c) N-terminus over-expression in wildtype cells also has 
a dominant negative effect on IR sensitivity, but has (d) no effect on response to olaparib. Area 
under curve shown adjacent to clonogenic survival graphs. 83 






















Figure 4.16 (a) C20orf196 and FAM35A IRIF following BRCA1 or BRCA2 depletion 
(representative micrographs shown for FAM35A). (b) FK2 staining of C20orf196 following BRCA1 
depletion. 83 
Figure 4.17 Temporal kinetics of FAM35A IRIF formation following BRCA1 depletion. (a) IRIF for 
53BP1 and FAM35A, and (b) time-course of FAM35A IRIF, with representative micrographs of 
time-course. 85 
Figure 4.18 FAM35A or C20orf196 loss in BRCA1-deficient cells causes hyper-resection 
phenotype; quantification (left) and representative micrographs (right). 87 
Figure 4.19 FAM35A and C20orf196 loss in BRCA1-deficient cells can restore (a) RAD51, (b) 
BRCA2 and (c) HR reporter assay (top) and effect of FAM35A/C20orf196 depletion (bottom). 90 
Figure 4.20 Effects of FAM35A and C20orf196 on cell survival due to olaparib. (a) FAM35A loss 
is epistatic with 53BP1 loss in BRCA1-deficient cells in response to olaparib. (b) The N-terminus 
alone is capable of resensitising BRCA1ko/FAM35Ako cells to olaparib. 91 
Figure 4.21 BRCA1-deficient PDX models (a) subject to olaparib treatment generates PARP 
inhibitor resistance with tumours downregulating shieldin complex components. Schematic of 
experimental setup (top); relative RNA expression levels of tumour specimens from four cohorts 
of mice for SHLD1, SHLD2, 53BP1, PARP1 (middle); growth curves of olaparib sensitive and 
resistant PDX tumours from cohorts 1-4 (bottom). (b) Intrinsic PARP inhibitor resistance 
correlates with low SHLD1 and SHLD2 expression levels; graphs show SHLD1 and SHLD2 
expression levels and their relationship with intrinsic olaparib sensitivity or resistance. 
Experiments performed by Violeta Serra and Carlos Caldas Groups; 2018. 94 
Figure 4.22 Loss of FAM35A or C20orf196 in BRCA1-deficient cells generates therapeutic 
vulnerabilities to (a) IR and (b) cisplatin. Areas under the curve shown for each graph on the right; 
experiments performed with scientific technician Julia Coates, Steve Jackson Group; 2017. 95 
Figure 4.23 FANCD2 foci are de-repressed in the absence of FAM35A or C20orf196. (a) FANCD2 
foci following FAM35A, C20orf196 or 53BP1 depletion in response to cisplatin; representative 






















micrograph on right. (b) GFP-C20orf196 and GFP-FAM35A IRIF are unaffected by FANCD2 
silencing; quantification for FAM35A on the right. 96 
Figure 4.24 Schematic of FAM35A/SHLD2, highlighting results from this work attributable to 
different domains. 97 
Figure 4.25 Schematic model of SHLD1C20orf196/SHLD2FAM35A function in the presence and absence 
of BRCA1, as revealed by this work. 100 
 
  






















6.2. Commonly used abbreviations 
53BP1  Tumour Protein P53 Binding Protein 1 
Alt-EJ  alternative end-joining 
ATM  ataxia-telangiectasia mutated 
BLM  BLM RecQ Like Helicase 
BRCA1  breast cancer type 1 susceptibility protein 
BRCA2  breast cancer type 2 susceptibility protein 
CRISPR-Cas9 clustered regularly interspaced short palindromic repeats – CRISPR associated 
protein 9 
DDR  DNA damage response 
DSB  double-strand break 
FACS  Fluorescence Activated Cell Sorting 
FANCD2 Fanconi anaemia complementation group D2 
gRNA  guide-RNA 
HR  homologous recombination  
IR  ionising radiation 
MAD2L2 Mitotic Arrest Deficient 2 Like 2 
MiDAS  mitotic DNA synthesis 
MMEJ  microhomology-mediated end-joining 
NHEJ  non-homologous end-joining 
PARP  poly(ADP-ribose) polymerase 
RIF1  Replication Timing Regulatory Factor 1 
RPA  Replication Protein A 
seDSB  single ended double-strand break 
SHLD1  shieldin 1/C20orf196 
SHLD2  shieldin 2/FAM35A 
SSA  single-strand annealing 
SSB  single-strand break  





































































































6.5. Top 1000 gene enrichments from CRISPR-Cas9 screen 
 
  
RANK Olaparib Talozoparib AZD2461
1 FAM35A C20orf196 C20orf196
2 C20orf196 TP53BP1 SLC44A3 OLAPARIB TALOZAPARIB
3 TP53BP1 FAM35A FAM35A DYNLL1 17 10
4 RIF1 RIF1 IFT80 DYNLL2 20138 18632
5 PAK7 PARP1 FAM122A ATMIN 316 9261
6 C15orf48 MATN1 BBS12
7 RHNO1 TEN1 PCMTD1 PARG 8 5194
8 PARG KCNT1 XKR6
9 MAPK8IP1 MRPS27 ITPKB REV3 17290 6194
10 GNPDA2 DYNLL1 TNFSF15 REV1 17675 12957
11 TPM1 OR5M3 NT5DC3 REV7 102 710
12 RBMY1B AP5Z1 HRC
13 RBMY1A1 HIF3A IL1RAPL2 TEN1 1387 7
14 hsa-mir-4726 MFF TSPAN32 STN1 16261 2568
15 CCNC WDR48 C19orf70 CTC1 16285 1811
16 SLA2 PRR23A NonTargetingControlGuideForHuman_0495
17 DYNLL1 RAD23A C11orf24
18 STK35 SLC29A1 PTPN14
19 ABCC3 IRF2BP1 GPNMB
20 ERN1 YIPF1 SPATS2L
21 ZBTB38 ZNF420 ADCY10
22 STK39 NUDT13 TBC1D29
23 BMPR2 TSPAN12 CCL21
24 MIOX TCTEX1D1 KLHL33
25 ADAM8 CYP11A1 hsa-mir-744
26 SMARCA2 ACER1 FGF2
27 SCD5 hsa-mir-516a-1 LIMS1
28 CRYBB1 ZPLD1 GALR3
29 YBX1 PKP4 TREM2
30 hsa-mir-4469 GP1BB LPCAT3
31 ACAD9 CLCA2 EIF1
32 SCAF1 ANKDD1A DEFB105A
34 UQCC1 TERT DEFB105B
33 UQCC PATE2 GLO1
35 C1orf94 GNB4 TP53BP1
36 CDK8 GPRIN2 RPL37A
37 SLC38A3 ECSIT hsa-mir-378h
38 AKT1 MTRR TROVE2
39 BASP1 RBMY1B CDCA8
40 PIANP RBMY1A1 ASB17
41 PLCXD1_Y TMEM63A CASP3
42 PLCXD1_X RTN4IP1 CDK2
43 TSPAN5 ATP10A DNAJB7
44 FAM180A MICALL2 TUBD1
45 C9orf170 NPBWR2 CENPO
46 HELT hsa-mir-4678 SERPINB3
47 CLDN22 DSC1 RPGR
48 OR52E2 ERO1L hsa-mir-8053
49 FABP4 IQCJ AHRR
50 VSTM4 IQCJ-SCHIP1 NUP188
51 CXCL11 NCAN BABAM1
52 SETDB1 hsa-mir-6759 CARS2
53 FRS2 hsa-mir-3920 TNKS1BP1
54 CTNND2 hsa-mir-1265 B3GALNT2
55 F13B CAMKV ITPK1
56 C5orf24 ATP13A2 KHDRBS1
57 RTN1 CACYBP UBE2G2
58 IMPA1 NonTargetingControlGuideForHuman_0300PRR21
59 TPGS1 EGFL7 RNF19B
60 ACER1 PCDH8 REP15
61 hsa-mir-891b CHST10 KCNH3
62 C13orf45 NonTargetingControlGuideForHuman_0227FAM2 0A
63 RASGRP1 GRM8 SCAF1
64 RBMY1J hsa-mir-4695 CXorf57
65 RBMY1F MEA1 RBP1
66 hsa-mir-3669 RFX3 CCDC74B
67 COX8A MYL2 OR10G4
68 OR7A5 SMIM17 HIAT1
69 SERPINE2 UBN2 CCL8
70 STAU2 NonTargetingControlGuideForHuman_0691HOXD8
71 PDHA1 PRAMEF13 C16orf54
72 JMJD8 AMER3 SMCO3
73 GCHFR GRK6 RRP1
74 GSPT1 NPS MED21
75 CABP1 SHBG CBX3
76 PSMD13 hsa-mir-3196 ZDHHC22
77 CSDE1 LZTS1 BRE
78 INHBA ALDH8A1 PDK2
79 hsa-mir-6514 EXTL3 DEFB124
80 ZMYM2 RARRES2 C13orf45
81 OR2A2 TAS2R39 PER2
82 PHOX2B C6orf58 SMCR7L
83 CAPN12 hsa-mir-3682 GNS
84 SHBG HIST1H2BC HSF2BP
85 N4BP1 FBLN2 PCDHA7
86 SPPL2A FAM72D PINLYP
87 BCL7C CCDC117 SCN5A
88 NSFL1C SLC15A2 MED27
89 PADI3 SERBP1 CSNK1G2
90 REEP4 LOC643037 OPRD1
91 hsa-mir-424 C16orf87 MPI
92 TJP3 ZNF284 WDR24
93 hsa-mir-1248 SPR TSPY8
94 hsa-mir-6886 HOXA9 GRIK1
95 ANKRD54 hsa-mir-4299 UBC
96 hsa-mir-942 ZMAT1 FUT9
97 RAMP3 ZNF878 EXTL3
Genes of interest
Genes below False Discovery Rate (0.1)
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98 TFDP1 PDE12 NIN
99 PROCA1 CT47B1 IL13
100 SMPD2 DPRX PLCG1
101 PGM2L1 CASK WNT8A
102 MAD2L2 CCNB3 CCSER1
103 KIAA1804 hsa-mir-4770 TGIF2-C20orf24
104 ZMAT4 DLL4 DUSP16
105 CENPBD1 FUBP1 UBE2W
106 HTR1F OR56A4 C9orf72
107 ZDHHC20 CIAO1 SLMAP
108 hsa-mir-449b hsa-mir-582 TFPT
109 SPPL2C ABCG4 IL1R1
110 SLC5A2 CPXM2 CDK5R1
111 LAMB1 SFPQ RCAN2
112 CWF19L1 TMEM185A PRRG2
113 REM1 CCNC PCDH15
114 AGO1 hsa-mir-579 TSPY3
115 ENKUR TIMM8A B3GAT1
116 FAM83F NXPH2 BCMO1
117 CACNA1D CHRNA7 RPS11
118 BCCIP POTEE DCTN4
119 NEK6 POTEM ANKRD33
120 CCT8L2 SYT11 CLEC2A
121 TMEM81 hsa-mir-551b OGDHL
122 CCL5 CDK2AP2 NDE1
123 CCDC148 ADRB3 IFNG
124 IMMP1L hsa-mir-548t LILRA1
125 hsa-mir-6852 hsa-mir-548ba hsa-mir-877
126 hsa-mir-7109 CBLN3 PLXNA3
127 URAD hsa-mir-3140 BATF2
128 PRHOXNB M6PR CNPY2
129 NET1 FUK OR5I1
130 P4HB MIOS KLHL28
131 CELSR1 TBC1D8B CDH9
132 MAST4 ARGLU1 TRIP12
133 PCSK1N CDKN2A DPY19L1
134 MN1 ELAVL2 OLR1
135 NonTargetingControlGuideForHuman_0597POPDC2 ATP13A1
136 ABCB10 CAV2 LRP12
137 FAM21C OR2T10 LOC284385
138 LYPD1 SUMO2 C16orf52
139 DDX10 OR2A25 SDC4
140 ERLEC1 hsa-mir-4455 CAMP
141 SIKE1 MRPL15 TMEM89
142 GRPEL2 SLC15A4 AP1G1
143 PSMC2 hsa-mir-1245a ZNF839
144 C18orf32 hsa-mir-1245b HIF3A
145 ELMO3 CCDC171 GPHN
146 NIPA2 OR4Q3 KRT222
147 DHDH LDLRAD2 CCNC
148 MYBPC1 BOLA3 TMEM165
149 C7orf69 TLR8 SIX1
150 KLRK1 MMP13 METTL7A
151 HLA-E GFER OR8K5
152 NonTargetingControlGuideForHuman_0050FBXO34 BNC2
153 MAT1A FBXO24 SOCS7
154 FBXL19 LDHC UNCX
155 GSTO1 OR2AE1 SLC7A4
156 HHLA2 MPPED1 CRYGB
157 REEP3 PPFIBP2 SPDYE3
158 ZC3H10 NonTargetingControlGuideForHuman_0012CHST2
159 CCDC88B NFAT5 NDUFAF2
160 ADPGK SRPK3 CWH43
161 RSPH1 TEF APOBEC4
162 TSPAN11 VAC14 NLGN1
163 CDH20 C1orf204 PAM16
164 CUEDC1 AIM2 KATNB1
165 CNTROB HOXA11 SSBP3
166 FAM169A hsa-mir-4531 SIM2
167 FAM127B RAB4A TNPO1
168 RASSF1 LOC729059 APOL6
169 NonTargetingControlGuideForHuman_0300GUCA1C CXCR2
170 ASB7 MACF1 CTGF
171 PLA2G12B NonTargetingControlGuideForHuman_0594EXOSC7
172 CLDN4 SHC1 ZRANB3
173 hsa-mir-3168 ADCY4 DEFA4
174 GNGT2 DSCR4 PLAA
175 KIAA1324 MLEC PTPRZ1
176 GJA3 ZFP42 KLF14
177 TTC30A RPS6KA5 ZNF496
178 hsa-mir-4639 STK17B DNAJC5G
179 PDZD8 MST1R KRTAP5-10
180 CHST4 MSRB2 ZNF619
181 ZWINT MCM3AP PEX16
182 LOC643037 TAOK2 PPP1R3A
183 SERPIND1 PPP1R9B CXXC1
184 LRRTM3 BDP1 PPIC
185 FAM122A CXCR3 CRHR1
186 SHCBP1L SRRM4 ZNF17
187 RRP1 BRD7 DYNLL1
188 MBLAC1 HHATL CDKN2A
189 THEM6 CADM3 TOMM70A
190 SYT10 UBE4A ARTN
191 SCRN1 RABL2B C2orf71
192 ZG16B ATXN10 SLC4A5
193 OR9A2 MOG hsa-mir-371a
194 TMEM144 ANGPTL6 CYB5A
195 NTN1 ZNF790 ING3
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196 SMPD1 OR6C2 KANSL1L
197 C1QTNF3 COQ5 RRM2B
198 MBD6 TRPV6 RAP1GAP
199 PHF21A CHD1 CCR4
200 PUM1 S1PR4 BET1L
201 MUC6 ZNF580 IRS2
202 KIAA1551 PLK5 CHST14
203 CP DAAM1 ANXA9
204 AP1S1 TAPBP ID3
205 HSD17B14 LIN7A NBAS
206 DEFB125 hsa-mir-628 RGS14
207 FOPNL CANT1 GSK3A
208 KIAA0196 GTF2H1 PRODH
209 BAIAP2 HCLS1 HKR1
210 MAPK3 HSFY1 ZNF497
211 RER1 HSFY2 PBK
212 SKP1 ZHX2 hsa-mir-7849
213 STK4 KBTBD2 ALDH8A1
215 hsa-mir-3926-1 MED26 SUGT1
214 hsa-mir-3926-2 C17orf59 ZBP1
216 KRTAP5-10 ISG15 TSR3
217 CCSAP SUN1 KCNAB3
218 POLE2 FAM133A hsa-mir-19b-1
219 ZBTB21 ZBTB8A hsa-mir-5197
220 ANGPTL4 EXTL2 SLC25A11
221 EDN2 CCDC84 ERGIC2
222 TMEM39B LMBRD1 POLG2
223 YTHDF3 HCAR1 CFHR2
224 CCDC15 hsa-mir-337 P4HB
225 PLD4 OR4C13 TNNI1
226 TRIM44 AP2A1 HNRNPH1
227 QTRTD1 TMCO1 hsa-mir-6884
228 ZNF552 CWC27 RAB8B
229 hsa-mir-4281 NonTargetingControlGuideForHuman_0402CENPQ
230 SPSB2 VWC2L TRAPPC13
231 SCGB2A2 MYOT YIPF1
232 PDE7A BBS10 IRF2BP2
233 TOR1B C1orf189 HEBP1
234 SLC8A1 FAM20B 39508
236 LRP1 CLOCK RAPSN
235 NonTargetingControlGuideForHuman_0958RASL10B SMYD2
237 ATP2C2 TARBP1 TKTL1
238 hsa-mir-5707 KCNJ15 PIGV
239 LYRM9 ZNF93 hsa-mir-940
240 USP27X GCNT4 USP17L10
241 RNF38 C11orf63 GRK7
242 HAS1 NonTargetingControlGuideForHuman_0207DHX58
243 hsa-mir-3692 ONECUT1 FSTL1
244 HERC1 KATNB1 ALS2
245 IFI27L2 GCG HS3ST1
246 HOXC12 GTF3C2 RWDD4
247 FN3KRP CDHR3 hsa-mir-4522
248 AP1S3 JAK2 IFNW1
249 INO80D hsa-mir-3914-2 DMGDH
250 COMMD3 hsa-mir-3914-1 RASGRF2
251 MS4A6E PLXDC1 KRTAP10-5
252 EMC3 CD302 PCDHB9
253 hsa-mir-129-2 MED29 AQP12B
254 MOGAT2 RTN1 UPB1
255 BTN2A1 SNX11 hsa-mir-23b
256 ABCB9 CECR2 STAU1
257 NSRP1 STK40 OR5K1
258 CCDC124 PIANP TWISTNB
259 GRM8 IFRD2 ECT2L
260 CLK4 TMEM8A SIAH1
261 PSMD10 NonTargetingControlGuideForHuman_0128CSMD1
262 TRMT61B PPP4R4 TVP23A
263 MPP3 KLK1 TRIM5
264 NPY4R VENTX POU6F1
265 OR9Q2 KRCC1 CRCT1
266 hsa-mir-636 CENPQ RRS1
267 RHOF MEOX1 DNASE1L3
268 STON2 EFNA3 SYNPR
269 NAV2 FAM216B RNF130
270 SPTA1 RRM2 GJB4
271 IFIT1 CTNNA3 COX8A
272 RCN1 C1orf95 TTC38
273 FBXL17 ALAS2 XIAP
274 FERD3L EID3 PLCH2
275 CDK5R1 PCBD2 NCALD
276 hsa-mir-3118-2 BGLAP PRR25
277 hsa-mir-646 SH3RF2 hsa-mir-582
278 GNPAT ZNF705A LYZ
279 PCYT2 ZNF705D ESR1
280 OR51F2 AMY2A COPS7A
281 POC1B-GALNT4 SLAMF1 SBSN
282 DNAJC10 ODF3L2 PLIN3
283 HTN1 C1orf61 C17orf80
284 ZC3H4 UBE4B HJURP
285 MFF hsa-mir-520f NME5
286 PYCR2 NonTargetingControlGuideForHuman_0731DAPK2
287 TECPR1 CDC20B DNAAF1
288 SENP1 GTF2H2 GRM8
289 TM7SF3 PRELP LTB4R
290 POTED hsa-mir-1305 GSDMA
291 39692 PLGRKT IFNGR1
292 SCARA5 SLC25A13 RETN
293 TFAP4 FAM219A C19orf44
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294 RANBP3L VASP NGF
295 KDM3A BEX2 C15orf26
296 CPNE7 OR8H3 TSPAN4
297 hsa-mir-1293 DEFB114 FBN1
298 CASR GALNTL5 IL19
299 JRK POTEG GLP2R
300 CRISP2 TSSK4 PCOLCE2
301 IL31RA CSF3R ZNF800
302 CAPRIN2 RAB24 SMARCA2
303 RAI14 EXOC6 KRTAP9-3
304 IKBIP FBXO36 TAT
305 ZIK1 TAS2R8 MTMR11
306 PTCH1 CAMK4 C1orf131
307 TET2 MUSTN1 TP53BP2
308 PPP1CA AHNAK hsa-mir-196b
309 NARFL DCAF4 ERLEC1
310 GDF3 SLC25A48 EVC
311 STK38 HDGFRP3 NOX3
312 LHX6 MYEF2 SCAI
313 ZNF641 hsa-mir-4523 TSPAN5
314 JAG2 INTU CANT1
315 WDR25 CASKIN1 TMEM66
316 ATMIN SLC6A12 NARFL
317 NOTCH2 LRRC38 CXorf58
318 LEPREL4 KIRREL2 ZNF215
319 UBFD1 JAKMIP1 TM6SF1
320 PIP5KL1 KRBA2 KIAA0226L
321 NonTargetingControlGuideForHuman_0882ZNF735 SLC6A20
322 MARK4 ACSBG2 PLK3
323 NonTargetingControlGuideForHuman_0990PIN4 CUTA
325 USP17L3 PCDHGB6 SLC48A1
324 USP17L1P PCDHGA8 MFSD11
326 DCAF4L2 GNL2 SDPR
327 IL17REL SOCS3 KIAA1671
328 NSMAF PVALB AFM
329 OR8H3 SOX8 STARD13
330 ARHGAP31 PLD3 CCDC69
331 TMEM156 HDAC8 GALNT11
332 ANKRD6 WNT8A hsa-mir-519a-1
333 C3orf17 CHRNG TAZ
334 TRPM2 TMSB10 ALG10
335 LILRB3 CD81 TAF1D
336 C7orf66 MARCKSL1 hsa-mir-514b
337 SLC6A5 LAMTOR4 CCDC15
338 SFTPC ATP11C MRPL48
339 TM6SF2 WDR45B hsa-mir-7108
340 CDAN1 FAM47C SLC15A4
341 SMIM7 BIRC2 WDR86
342 EZH2 OR2J2 KIAA1328
343 STYX OR8J3 TRPC4
344 HYAL4 CAMK2D NOXO1
345 CPT1B GGA3 MRGPRF
346 IRF2BP1 PLD4 FGFR3
347 MLL LAG3 CMTR1
348 hsa-mir-219a-2 MAPRE1 TSPAN1
349 PGAM2 ADAMTS2 PHF3
350 FGF6 CYBB hsa-mir-933
351 SYT17 ERVMER34-1 TCP10L2
352 PDE1B C11orf16 NXF5
353 OR4D1 ZFYVE28 hsa-mir-509-2
354 CD34 RIPK3 hsa-mir-509-1
355 hsa-mir-3713 ICA1L CENPJ
356 KIF17 FAM3B ZNF835
357 IRF7 BTK TNNI2
358 HDAC2 hsa-mir-4489 PPP1R37
359 TREM1 CDH24 MOCOS
360 ASPM PLG DHX33
361 PGM1 LRIG1 SBF2
362 C8orf82 ARRDC4 PARP1
363 PRMT2 CHAC1 SPIRE1
364 NMB CLDN8 ALG2
365 EEF2K EFNB2 REG3A
366 MMAB UCN3 TRIM23
367 FAM76A NonTargetingControlGuideForHuman_0094MOG
368 MBNL2 hsa-mir-374b CHCHD3
369 MSX2 hsa-mir-374c CLSTN3
370 ANKRD39 PRPSAP2 PRMT10
371 PSG2 CNPY4 EIF4A2
372 ZC3H8 BRCC3 COL4A6
373 CDK19 OLR1 ABCG2
374 EEF1D ZNF341 hsa-mir-6761
375 TOMM40 GJB1 hsa-mir-3065
376 RBP3 NonTargetingControlGuideForHuman_0847hs -mir-338
377 PRRT1 DRG1 HIST1H2BC
378 PMCH DYRK1B CHDH
379 ICAM2 TSPYL5 PIGR
380 FAM117B TXLNB BTN3A2
381 NonTargetingControlGuideForHuman_0752LHX6 C1R
382 EFR3B DCC hsa-mir-4779
383 C8B CD163 SFRP4
384 PLS1 NonTargetingControlGuideForHuman_0316PPM1J
385 SLC2A4RG FAM118B TGFA
386 GOLT1A NonTargetingControlGuideForHuman_0234AQPEP
387 CX3CL1 SCRN3 PRKCE
388 PNPO ANXA2R CORO7-PAM16
389 UTP11L GRN hsa-mir-5090
390 NonTargetingControlGuideForHuman_0753TRIM50 DYRK1B
391 TNIP2 hsa-mir-4253 GPR82
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392 KRTAP25-1 UBL7 TMEM194B
393 ADAM7 PROS1 hsa-mir-6130
394 ART4 C8orf34 FBXL19
395 MAN1C1 OR4L1 SLC3A2
396 GP2 KEL LXN
397 TTLL4 GJC1 ZNF696
399 GCNT7 EREG PCDHB3
398 FAH PAM POP5
400 NonTargetingControlGuideForHuman_0225ZNF668 RPUSD3
401 CUL2 TMEM218 LRRC17
402 hsa-mir-579 PRMT2 HSDL2
403 RNF111 OR6B1 C9orf142
404 CD1C TBC1D19 ZNF142
405 TEKT1 SAC3D1 PTRF
406 PDE4D RHOB TRPC7
407 STAG1 AGPAT1 GRID2
408 GRIK2 ART4 CIR1
409 FAM107A VAV3 KIAA0754
410 C7orf31 DYNLRB2 SLC25A17
411 STK3 RPS15 ST6GAL1
412 CFHR5 XK PPP1R10
413 SLAMF1 EVX2 DOCK9
414 C11orf87 RASL12 DAB1
415 KLK5 ERMARD hsa-mir-6728
416 NonTargetingControlGuideForHuman_0908FOXC2 PRDM16
417 CDK6 PPP2R1B TEX37
418 C6orf163 DMRTC2 RELT
419 ASB13 CLIP4 CRAMP1L
420 RPL39 FAM170A ITPRIP
421 TMEM132D NIPSNAP3B UPK3A
422 LRRN3 USP21 TRIM62
423 JMJD4 KDELC2 GLDC
424 C3orf36 PCSK7 C15orf32
425 KIAA1143 OR52W1 OR6V1
426 P2RX7 LENG1 L3MBTL2
427 hsa-mir-548aa-1 MCFD2 SLC6A13
428 hsa-mir-548d-1 FAM110D RALY
429 AK9 hsa-mir-6894 CBR3
430 MRPS18B RAB19 CXCL11
431 KANSL1L RPS18 COL17A1
432 KDELC1 NonTargetingControlGuideForHuman_0952CD33
433 ALDH1A2 IGFALS ARNT
434 MESP2 MLKL C14orf183
435 LRP6 RBMY1J ACD
436 COMMD5 RBMY1F COL5A3
437 C1orf229 MGAT3 TPGS1
438 IL5 HIST1H3D KIAA1107
439 hsa-mir-5685 ARMC4 KCNK10
440 PSMC5 ATXN3L KAT6A
441 GRHL1 NXPH3 LIMD1
442 ACSL4 hsa-mir-3148 CACYBP
443 SCNN1D NonTargetingControlGuideForHuman_0272RPGRIP1
444 PIGW TCEAL7 ALLC
445 RIC8B DCTD HR
446 NARF TMEM19 UNC50
447 PIGU hsa-mir-486 PSMD6
448 CCL8 hsa-mir-486-2 VIT
449 PIGS ANKRD2 CALCOCO1
450 LRRN1 RNF180 ESRRG
451 SMCO3 YWHAH CWC22
452 PIM2 SCN1B SKP2
453 ME1 PCDH12 C12orf42
454 TMEM151A B4GALNT3 SEC61G
455 HECW1 PTX4 SLC26A9
456 HOXD4 hsa-mir-3122 MALT1
457 SCGB1D2 SCARF2 hsa-mir-371b
458 DNAI2 POMT1 ZNF330
459 POLR2H ASGR1 RNF128
460 MDM1 NonTargetingControlGuideForHuman_0171RIPPLY
461 ACAP1 hsa-mir-4520b PDE3A
462 NonTargetingControlGuideForHuman_0448BPGM PRKAR2B
463 NDUFS1 FAM122A GABRA2
464 CCNB1 CLC PPIAL4D
465 PCBD2 ABCC10 hsa-mir-1184-3
466 ASCC1 HDHD2 hsa-mir-1184-2
467 PREPL CAPN5 hsa-mir-1184-1
468 GAN hsa-mir-132 FURIN
469 MYCL EIF3B FAM169A
470 ZNF286B B4GALT4 TMEM99
471 SRP19 TMEM69 SMOC2
472 PRPS2 CDH9 GGN
473 ADAM11 PGLYRP4 MS4A14
474 SEC61B PLA2G4E PDZRN4
475 GALR2 DENND5B MMD2
476 NonTargetingControlGuideForHuman_0930BRCA2 LOC100129924
477 STAM LCA5 SHE
478 CALML4 DNAH5 TCP11L2
479 LZTR1 FATE1 FRMPD4
480 GNG4 C7orf65 EXOSC9
481 TMEM64 CEP290 NYAP2
482 CCDC59 hsa-mir-3909 SPPL2C
483 SERTAD4 SDHA UMODL1
484 SLC22A18 HIST2H2AC NIPAL3
485 SORBS2 ADRBK2 COL6A6
486 TEAD4 SLC11A1 RNF186
487 TMTC4 NCSTN KCNA7
488 ATP5A1 MIOX CD28
489 HSPB7 hsa-mir-376b E2F2
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490 CMTR1 ZFP64 FUK
491 NT5DC3 WASF2 RARG
492 NHEJ1 MAGEH1 ZNF174
493 RHOB IHH ATRIP
494 RHBDF2 TMEM132B PPP1R35
495 SLC29A1 HERC3 AK8
496 DBP MAP3K14 C6orf7
497 ASMTL_X CXCL13 CHRDL1
498 ASMTL_Y ENKUR NonTargetingControlGuideForHuman_0916
499 GP5 MMAB FCGR3B
500 APOL5 NCAPH DCAF16
501 GRB14 DHX34 RTP3
502 ANAPC7 NonTargetingControlGuideForHuman_0145PNO1
503 OAS2 KRT73 hsa-mir-6129
504 FAM71F1 NonTargetingControlGuideForHuman_0971RANBP1
505 hsa-mir-6837 KTN1 hsa-mir-3679
506 C19orf44 ATG13 CCDC169
507 SLC17A7 CNTLN TSHZ2
508 GOPC PLK1S1 PXMP4
509 PKD1L3 SNRNP25 hsa-mir-4271
510 PCDHA4 hsa-mir-3692 THRAP3
511 HADH AFAP1 MUC16
512 SNX9 hsa-mir-548ag-1 OTX2
513 KLK15 PHLPP2 IL37
514 FHL3 PTN CPLX4
515 SYNE4 PLA2G4B HSP90AA1
516 GLYATL1 NRTN KRTAP6-3
517 APH1A HAPLN2 ACSS2
518 NLGN1 CASP14 OCA2
519 NonTargetingControlGuideForHuman_0515FSD2 TET1
520 DNAAF1 FAM150A KRTAP19-6
521 HSPB1 GPR110 FAM63A
522 CTAG1A COPS4 ACYP1
523 CTAG1B CELSR2 CPNE9
524 NonTargetingControlGuideForHuman_0398TARS2 KLHL1
525 OR4C46 ARHGAP22 OR4C12
526 POLD4 KRTAP19-8 SATB1
527 KLHL7 MTUS1 ZFP91
528 PPM1E GPT EFNA1
529 SPEN PCDH1 IQSEC2
530 RNASEL KAT2B hsa-mir-3168
531 LRRC37A2 ST6GALNAC3 PREP
532 NDNL2 CACNB4 CHPF2
533 RGMA HBS1L DNAH3
534 TM4SF19 hsa-mir-361 BPNT1
535 MGA COL28A1 CHI3L1
536 NonTargetingControlGuideForHuman_0067NonTargetingControlGuideForHuman_0479RNF215
537 CYP21A2 SH2D3A hsa-mir-6806
538 SLMAP KCNJ14 WFIKKN2
539 CLPSL2 PSAP ZNF441
540 NOA1 CACNA1G HTR6
541 SH3GL1 NonTargetingControlGuideForHuman_0105NPPB
542 WBP5 MSRB1 ANKRD37
543 TEKT3 hsa-mir-4781 FSTL3
544 CMTM2 PAM16 KIAA1217
545 TSHZ1 POFUT2 BRAP
546 MGMT TMEM161A GDF1
547 FAM9B SLITRK3 MTHFS
548 XRCC4 NonTargetingControlGuideForHuman_0005DCLRE1C
549 EMILIN1 BORA TRIM28
550 MMAA XRCC4 PGM5
551 NDN UBQLNL ATP1A2
552 S100A4 METRNL BAHCC1
553 NonTargetingControlGuideForHuman_0485GLRA4 hsa-mir-124-1
554 RPGR NDUFS7 SENP1
555 HORMAD1 NonTargetingControlGuideForHuman_0782ANO5
556 COMMD8 PON1 OVGP1
557 PLEKHB2 C5orf34 TXNDC15
558 KRTAP19-4 C16orf13 CTSE
559 OR4N4 GRM1 hsa-mir-3199-2
564 TSPY8 RAD51AP1 hsa-mir-3199-1
561 TSPY4 C2orf72 SNX18
562 TSPY3 EGFR NLRC4
563 TSPY1 SRPK1 NBL1
560 TSPY2 ASTN1 FNDC8
566 RBMY1E hsa-mir-4520a NonTargetingControlGuideForHuman_0380
565 RBMY1D SERINC3 KIAA1467
567 TCEB3C BSG MAGEA11
568 hsa-mir-4533 PRTG STON1
569 JAK2 XXYLT1 hsa-mir-4709
570 LYSMD4 KCNC1 CCL17
571 ATP2B2 LARP7 hsa-mir-3942
572 ACTC1 VSNL1 ANKRD65
573 DUS2 ZSCAN1 PRIMA1
574 MAPK6 GPR158 VDAC2
575 CTPS2 DUSP9 HAX1
576 NonTargetingControlGuideForHuman_0497NonTargetingControlGuideForHuman_0803MTCP1
577 ZZEF1 SMPX SPATC1L
578 RBM39 hsa-mir-4284 VRTN
579 KANK3 GALM C11orf63
580 KDM2A KRTAP21-3 PNPLA2
581 CCP110 DDX58 SAYSD1
582 ZNF721 LAMP5 TMEM60
583 CELSR2 KCNK5 SLURP1
584 NDUFB10 DEPDC7 TFF2
585 SNX20 AP1S3 DMRT3
586 RAP2B STAC2 MOB1A
587 SERPINB13 CNTN1 DECR1
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588 LYSMD3 FAM198A RNF168
589 ZNF75D OR8K3 GPRIN1
590 hsa-mir-302b GPR132 HPD
591 NonTargetingControlGuideForHuman_0933NonTargetingControlGuideForHuman_0567ZNF695
592 UNC13D C1S SENP6
593 RIMBP3 C10orf107 PRAMEF15
594 hsa-mir-933 C1QC PRAMEF9
595 SCRG1 ALG14 ELAC1
596 hsa-let-7f-2 MILR1 CENPA
597 NonTargetingControlGuideForHuman_0969ANKRD35 ZMYND8
598 TMEM86A PTPRZ1 CDH13
599 USP18 CCR4 KLC3
600 CSPG5 CTAGE5 JHDM1D
601 C6orf141 MCCC2 ETFA
602 LRRC1 hsa-mir-4279 AMH
603 C6orf1 FAM19A2 GNAI1
604 FRMD8 hsa-mir-5100 RBKS
605 EHD4 GNG8 TBC1D9
606 PRF1 hsa-mir-411 GTF2A2
607 UBE2U MAFA TUBB
608 LONRF3 NonTargetingControlGuideForHuman_0280ANKS4B
609 GTF2H1 CHST4 TAF3
610 TPCN2 MPP6 FBXO7
611 APOM DUOX1 ZNF7
612 NonTargetingControlGuideForHuman_0019OVOL2 USP3
613 CD46 FAM118A TRAK2
615 ACOT12 ATP5J2-PTCD1 SGTA
614 NonTargetingControlGuideForHuman_0453hs -mir-4670 PIK3R1
616 hsa-mir-629 PLCG1 EMC6
617 UTS2R RGS14 hsa-mir-3652
618 hsa-mir-4418 TRAPPC12 LEPREL2
619 GRB7 RAB11FIP5 P2RY12
620 RASL12 GATSL1 ETV3
621 PTAFR GATSL2 CACNB4
622 RAB8B TBRG1 HOXC12
623 KLHDC10 SGOL2 CASP10
624 CHCHD5 CCDC101 ACVR1B
625 CRADD HBM CT62
626 CLEC4C DLX3 TRPV5
627 NDUFA5 NonTargetingControlGuideForHuman_0906RTP2
628 MYLPF ENO3 NFATC2IP
629 hsa-mir-4740 CLDN15 GNG5
630 ZNF33B TGIF2LY BTBD8
631 NCAPD2 FCRL5 PTRH1
632 hsa-mir-4800 CEBPG ADRBK2
633 CDK17 ZBTB21 KCNN3
634 OTX1 OR52L1 PFKL
635 CEP128 DIEXF PDE6H
636 MAPK12 CYP11B1 NonTargetingControlGuideForHuman_0792
637 NonTargetingControlGuideForHuman_0749GNPDA2 CDCP1
638 CLASP2 MEAF6 CAT
639 OR2T3 LOXL3 TRA2A
640 RTCA CNN3 hsa-mir-4666a
641 GPS1 MYOZ3 CDIP1
642 DHX36 GARS hsa-mir-521-1
643 C8orf86 CEBPZ DPY19L3
644 GABARAPL1 NonTargetingControlGuideForHuman_0508TRNAU1AP
645 TRPV2 MFAP5 COPS7B
647 hsa-mir-513a-1 YME1L1 S100A7
646 hsa-mir-513a-2 ZNF676 ANKRD6
648 HARS2 hsa-mir-548f-3 MYO1G
649 AKR1E2 hsa-mir-6131 SUV420H1
650 RTN4IP1 SPPL2B ZNF85
651 NonTargetingControlGuideForHuman_0886CDX4 RDH5
652 DOPEY2 hsa-mir-8086 ABHD14B
653 CLDN20 GNL3L MAPKBP1
654 OTUB2 CCDC83 ZBTB21
655 CAP2 HIST2H2BF hsa-mir-199a-1
656 hsa-mir-8082 hsa-mir-6878 C18orf63
657 37226 LCORL RNF14
658 OR2AK2 TTLL9 PROK2
659 EIF4EBP2 NonTargetingControlGuideForHuman_0486PRPF8
660 FARSB MIS18BP1 RPN1
661 NonTargetingControlGuideForHuman_0323hs -mir-301a BET3L
662 HAX1 RP2 KIAA1755
663 TMEM206 REP15 C1orf141
664 CHRNA1 NKX2-1 RPH3AL
665 NonTargetingControlGuideForHuman_0537NonTargetingControlGuideForHuman_0978UTP23
666 SULT1C3 MGAM CKLF
667 NonTargetingControlGuideForHuman_0639hs -mir- 611 hsa-mir-4766
668 SLC10A5 UBALD2 CLEC2D
669 DRD1 UCP1 CD8A
670 TMEM65 C20orf166 PLA2G4E
671 GSDMB NonTargetingControlGuideForHuman_0751PIANP
672 CASP3 JAGN1 ICK
673 TEX36 hsa-mir-1277 LAMB2
674 TAS2R13 GDF11 HCAR3
675 ARHGAP40 PCDH20 DDX49
676 MFRP NLGN1 ATE1
677 LYZ CCDC167 NOS1
678 UPP2 NDUFA7 PITPNA
679 CEP63 ZHX1-C8ORF76 DOPEY2
680 E2F7 C8orf76 ENOX2
681 TUBA8 C16orf54 TRIM8
682 RPUSD1 HLA-DOB RAP1GDS1
683 FEN1 CCDC71L hsa-mir-718
684 FLJ45513 FOXC1 hsa-mir-4515
685 C8orf22 hsa-mir-6731 CMTM6
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686 RDH8 SPDYE2B MYT1L
687 hsa-mir-523 SPDYE6 NQO1
688 VGLL4 SPDYE2 NEK11
689 LAMP2 SPDYE2L OR10A2
690 FAM162B SPDYE5 hsa-mir-1277
691 hsa-mir-4636 SCAF1 CD22
692 C17orf99 PLEKHJ1 EBLN2
693 MBD4 NonTargetingControlGuideForHuman_0505MAGEB5
694 SCAMP3 ADCK1 ZNF616
695 NonTargetingControlGuideForHuman_0823SLC30A8 ACIN1
696 SEMA4D CX3CL1 FAM46A
697 PCNXL3 NUDT14 N6AMT1
698 EMCN SH3BGR C15orf41
699 LAPTM4B C11orf31 hsa-mir-3692
700 TCHP SIRT1 MELK
701 APH1B CD40 hsa-mir-6124
702 NonTargetingControlGuideForHuman_0552CEP76 GAB3
703 N4BP2L1 NDUFA2 CASP12
704 KDM5A JDP2 C11orf94
705 C15orf39 RAB27B ARG1
706 CALM3 FOXL1 hsa-mir-7850
707 FRMPD4 hsa-mir-106b DPM1
708 C16orf90 TMEM256 RBM42
709 DPY19L3 VSIG4 BLVRB
710 NonTargetingControlGuideForHuman_0664MAD2L2 PHGDH
711 GPR33 hsa-mir-3689d-1 PPP1CB
712 GMFG GATAD1 ASCL3
713 POLH PSME2 BLMH
714 IL22RA2 CCDC111 ENPP4
715 KLF2 GRWD1 PON2
716 ELL hsa-mir-2467 DCAF12L1
717 TSTD3 CHIC1 LIMCH1
718 CD9 FAM9C SAR1A
719 NFIC NonTargetingControlGuideForHuman_0066C12orf52
720 C11orf80 RAB6C RREB1
721 OR10T2 LRRC23 DLGAP3
722 TTYH1 NonTargetingControlGuideForHuman_0078ST3GAL3
723 hsa-mir-5188 hsa-mir-888 hsa-mir-1297
724 IP6K2 KIAA2022 C5orf28
725 RTBDN SERPING1 OR51B4
726 POMC ARPC3 QARS
727 PXDN GCC2 FLT3LG
728 hsa-mir-151b VMO1 ASF1A
729 HIST1H2BJ C15orf41 IGSF22
730 hsa-mir-7844 MKRN3 ZNF679
731 MYF5 hsa-mir-1258 SYAP1
733 MAB21L1 NonTargetingControlGuideForHuman_0984GANC
732 RCC1 SFTPC PCDH10
734 NUP210L NDUFA9 STK24
735 RAPGEF5 REEP2 hsa-mir-30c-2
736 PARP1 LMO4 UBASH3B
737 SORBS3 PDCD6 ARAP3




742 GRTP1 PITPNM2 hsa-mir-1471
743 FAM175B KRTAP19-3 GPR171
745 AGMAT ANGPT2 hsa-mir-4433b
744 hsa-mir-4499 HS3ST3B1 hsa-mir-4433
746 KIF26B HS3ST3A1 hsa-mir-3115
747 LEP MTX1 hsa-mir-4772
748 CTAGE1 ARHGAP40 C7orf43
749 ANO10 ANKRD44 TCTE3
750 PAOX KSR1 XRCC3
751 hsa-mir-4710 NonTargetingControlGuideForHuman_0708RIC8A
752 hsa-mir-575 DTNBP1 EPPIN
753 PLAG1 LOC100505841 ZNF202
754 GBP3 SSX5 REM1
755 DENND2A SRPX2 INPP4A
756 F9 MEIS2 TOMM40
757 NonTargetingControlGuideForHuman_0585TMEM18 UGT2A3
758 CD81 CDC42SE2 ICAM1
759 TMEM18 PSD APOOL
760 SCARF1 hsa-mir-4251 C1orf194
761 DCDC2 TCEB3 DEFB132
762 GTF2A1L HMX3 TOR3A
763 FTO ABCA1 CLINT1
764 NonTargetingControlGuideForHuman_0200NonTargetingControlGuideForHuman_0647FCGR1A
765 HIST2H2AB FOXR2 GP9
766 DNAH9 ADAMTS13 TIGD7
767 ZNF222 COL24A1 ASTL
768 CMPK1 hsa-mir-4319 GPT
769 FAM157A MESDC1 CTSW
770 VCX3A PRMT10 RBM4
771 LMF2 C4orf27 CLEC4M
772 TLR2 P4HA3 hsa-mir-3649
773 NonTargetingControlGuideForHuman_0439ECHDC2 SHISA6
777 BAGE4 STX17 GIGYF2
774 BAGE5 GPRC5A TNIP3
776 BAGE2 PGAP2 STPG2
775 BAGE3 PRRG2 EED
778 ZSCAN2 ZNF598 CCDC88B
779 CERS4 CLRN2 SLC16A3
781 PSPN NCF1 TSSK2
780 PHB2 SLC5A11 FAM49A
782 AOC1 TACO1 EMD
783 ABP1 MBTPS2 ARAP1
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784 CST7 RET ZSCAN4
785 CEP112 MAP7 VSIG10
786 SWT1 NonTargetingControlGuideForHuman_0385GSTM5
787 MRAP2 MZT2B RTL1
788 hsa-mir-4486 LAMB3 LMTK2
789 MYH10 EMILIN2 SOCS6
790 NonTargetingControlGuideForHuman_0486RSRC1 ZBTB34
791 POU2AF1 ZZEF1 THBD
792 LGMN ENTPD2 PTGES2
793 C16orf45 FAM170B RBL1
794 CX3CR1 CDC42SE1 KIF6
795 HOXC11 hsa-mir-4252 ITGB4
796 TIMD4 GRP KCNU1
797 TMEM59 NonTargetingControlGuideForHuman_0780NR1H4
798 TCP10L2 hsa-mir-8053 EFCAB4B
799 hsa-mir-519a-1 BEND3 SLC10A5
800 AFF3 TNFRSF10C WBP2
801 SUFU CD8A AAMDC
802 hsa-mir-5692c-2 hsa-mir-4267 hsa-mir-6828
803 MDH2 GABPB1 SERTAD3
804 GLDN ZNF205 HLA-DMB
805 hsa-mir-8052 SCT C12orf10
806 TMEM191B hsa-mir-4462 ADORA2A
807 COMMD6 NRL ALX1
808 NonTargetingControlGuideForHuman_0612VTI1A ARL10
809 GINS3 hsa-mir-3164 B3GNTL1
810 FYN AP1M1 TMEM198
811 PARP8 CBLL1 FRMPD1
812 CABLES1 DRAXIN CD9
813 GATM MYH7B PCDHA9
814 PRSS57 NDFIP1 PCDHA2
815 IQCK hsa-mir-186 PCDHA11
816 KRT78 hsa-mir-1281 PCDHA1
817 RFPL1 ZNF705B PCDHA8
818 NonTargetingControlGuideForHuman_0268POLD4 PCDHA13
819 DPEP1 LOC158434 PCDHAC2
821 C1QTNF9B-AS1 hsa-mir-3668 PCDHA5
820 PPP1R12C NonTargetingControlGuideForHuman_0317PCDHA12
822 STK32C KLC4 PCDHA6
823 hsa-mir-325 NonTargetingControlGuideForHuman_0397SETMAR
824 TMEM254 ARHGAP28 FKBP11
825 MED18 LAMP3 GLIS2
826 NonTargetingControlGuideForHuman_0171FAM25C SGK196
827 SMARCA1 FAM25G GAB1
828 NonTargetingControlGuideForHuman_0660COA1 RBP7
829 SMIM1 NonTargetingControlGuideForHuman_0912ABHD17B
830 SMIM8 ID1 EIF2AK2
831 NonTargetingControlGuideForHuman_0549NonTargetingControlGuideForHuman_0868VPS29
832 ERCC1 PEX7 ZSCAN5A
833 NHLH2 IFI6 AFAP1L2
834 TSTA3 OR4A47 MSH3
835 NCR1 hsa-mir-517c SREK1IP1
836 MYEOV2 hsa-mir-6767 FOXRED1
837 ORAI1 SLC38A10 ENTPD1
838 TMEM225 EI24 OR8A1
839 TEX38 CTPS2 FAM187B
840 PRDM7 CD2 ACTL9
841 NTMT1 GAS7 KHDC1L
842 UBE2D1 PI15 C6orf222
843 OR2S2 USP33 HLA-DQB2
844 VPS26A HERC2 SAMD5
845 SLC35C1 MYOM3 PCP2
846 SLC22A14 RNASEL ELOVL3
847 DEPDC1B GAGE5 CLRN1
848 hsa-mir-149 GAGE7 RTEL1
849 FAM26F GAGE6 DNAJA3
851 ATPIF1 GAGE12I SOST
850 IGSF6 GAGE12B LAMB1
852 PITPNC1 GAGE12C NT5C1B-RDH14
853 ABHD17B GAGE12D C20orf96
854 EXOSC4 GAGE12E ERC2
855 TMPRSS15 GAGE12F HEATR6
856 CD151 GAGE12G TRIM50
857 NonTargetingControlGuideForHuman_0558GAGE2C ZNF716
858 HIST1H4F GAGE2B ZNF735
859 GRM6 GAGE2A SPATA33
860 AXIN2 GAGE12H CSF3R
861 ZNF699 hsa-mir-1301 ZNF223
862 NonTargetingControlGuideForHuman_0890PRRC1 TCTN2
863 FAM175A PLSCR4 LCORL
864 MRPL24 ZNF322 CHST3
865 ATF1 ZFAND2A SPTBN4
866 PODXL2 MYL9 ARPC1B
867 LSM6 KIR2DL1 RAPGEF4
868 DCST1 NPEPPS ANKDD1B
869 GRIN2C TPK1 TPST1
870 ZFP30 NonTargetingControlGuideForHuman_0013hs -mir-3689f
871 TRIM16L DOK1 STAP2
872 SLC2A5 DHX36 SLC26A8
873 NonTargetingControlGuideForHuman_0994C15orf5 ZADH2
874 PHF21B VKORC1L1 SLC30A2
875 MERTK STOX1 NBEAL1
876 TMEM11 SLC25A43 AP3B1
877 EVA1B IRF2BPL ARMC12
878 SVEP1 ZFYVE27 DOCK8
879 F3 MSGN1 IGFL1
880 HNRNPH2 C5orf15 GIPC3
881 hsa-mir-5693 KRTAP9-1 FLNB
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882 TMPRSS6 C9orf64 TSPY2
883 MFI2 hsa-mir-548av TSPY1
884 NonTargetingControlGuideForHuman_0387PTK6 TSPY4
885 hsa-mir-3942 TNFRSF6B PDZD4
886 PTPLB GM2A VSIG1
887 AHRR COL4A6 PTPRU
888 DNAJC2 SPATA16 TGFB3
889 UCK2 C1orf186 MIF4GD
890 MRAS SIM2 ANAPC15
891 hsa-mir-508 BLK hsa-mir-581
892 LCN1 NonTargetingControlGuideForHuman_0177ITSN1
893 PCSK6 TADA3 LCA5
894 HOXB1 hsa-mir-516a-2 LRRC47
895 hsa-mir-1255a PDE6A USP47
898 TRIM49 PRDM5 TMEM204
897 TRIM49B FRS2 ARRDC5
899 TRIM49C KRT72 JMJD4
896 TRIM49D1 PRKG1 KDM3A
900 CRELD2 AKAP8L IQSEC3
901 hsa-mir-30a HNRNPK hsa-mir-194-1
902 FOXB2 UCHL3 DENND1A
903 PPP1R2 IDH1 CDKL5
904 MPPED2 hsa-mir-29a hsa-mir-642a
905 NonTargetingControlGuideForHuman_0771SIPA1L1 PTPN7
906 hsa-mir-1204 ULK4 SPG20
907 POLR2B PER2 hsa-mir-4295
908 NonTargetingControlGuideForHuman_0262RANBP1 FUCA1
909 RTN3 MUC22 SIK1
910 ARL5A PIFO hsa-mir-3169
911 HNRNPA3 THOC2 PDGFA
912 REM2 NAV2 TNFAIP8L3
913 TMPRSS4 MCHR2 C1orf192
914 MYL7 ZBTB46 TP53
915 TTC29 SMC1B HERC2
916 GRP PIGW MNDA
917 PRAM1 HIST1H2BM LPP
918 LDOC1 SLC25A12 TMEM201
919 CARD9 FARP1 POU2F3
920 KLF13 hsa-mir-518b FGF9
921 MSLN ADCYAP1R1 CLCN2
922 TMPRSS7 NonTargetingControlGuideForHuman_0730MUM1L1
923 LHFPL3 ZNF564 GBP3
924 NonTargetingControlGuideForHuman_0536DCAF11 PDCL3
925 CD48 KCNJ2 NFIB
926 PRR16 MPDU1 ARMC9
927 PRR23C LOC100127983 PREX1
928 WNT11 ITGAV PNPLA3
929 PRRX2 ZBTB40 PWWP2A
930 PRKCA PF4V1 NEURL2
931 TLR4 LSG1 DTWD1
932 NonTargetingControlGuideForHuman_0912SPEG TIAM1
933 DMRTC1 BCAN hsa-mir-4711
934 DMRTC1B STON2 DIXDC1
935 CCNB3 HPRT1 ZMYND19
936 AHCTF1 SLC45A4 CCDC134
937 KCNRG hsa-mir-493 OTOP1
938 ACTN2 POTEJ MAN2C1
939 RAB40B POTEI CYB5B
940 SZRD1 POTEH SETDB1
941 C16orf13 POTEF GPR21
942 GCC1 NonTargetingControlGuideForHuman_0318FAM180A
943 hsa-mir-16-1 hsa-mir-421 RFX3
944 GULP1 IFT172 CEACAM7
945 DPP8 TRIM25 BRD7
946 SHMT1 TCP11L1 PLG
947 PLEKHF2 HIST1H2AC GNG2
948 FKBP9 APLN EFHC2
949 SIRT1 TRABD2A GRIN3A
950 RAET1E TEX9 XRCC4
951 SLITRK1 FAM3A RAB7L1
952 UQCR11 GLO1 SLIT1
953 GRPR FAT2 GCA
954 ZC3HAV1L NonTargetingControlGuideForHuman_0712ECSCR
955 MEIG1 CCL28 CACNA2D4
956 ANKRD17 LOC100129083 C20orf24
957 CNOT2 CCNO FUCA2
958 ACKR3 SPATA6L NEURL1B
959 PSMD9 H3F3C DEFB127
960 LSP1 DNAJC6 TMEFF2
961 ZNF189 MYLPF LRP2
962 hsa-mir-5698 R3HCC1 COG1
963 EPHX2 SEC23B FEZ1
964 SAMD3 CEP68 NUP160
965 TPSD1 NUMBL BPY2B
966 CCL3L1 ADAM33 BPY2C
967 CCL3L3 EFR3A BPY2
968 LRMP HOXC12 REEP2
969 GADD45G IFIH1 HABP2
970 GNB3 KNG1 DNTT
971 WNT2B hsa-mir-6868 EPPIN-WFDC6
972 NonTargetingControlGuideForHuman_0634EVA1A GCNT3
973 TNNI2 SEMA4B SCML4
974 LIPJ ANXA10 SPSB3
975 ZNF600 OR13C5 PARP3
976 DNAJC28 NSMCE2 hsa-mir-4534
977 DNAJB12 C2orf78 GNB4




981 HS3ST3B1 BMP8A METTL10
982 hsa-mir-642a BMP8B EIF3M
983 hsa-mir-642b TLDC1 FBXO36
984 NFKBIA hsa-mir-7843 PRRC2C
986 IDI2 NonTargetingControlGuideForHuman_0716TSSK3
985 MED25 RBPJL RSU1
987 KERA STK35 KIF11
988 hsa-mir-4487 CLNS1A LAMP3
989 ERP27 GBA SLC9B2
990 AWAT1 H2AFX LHX2
991 CUL7 CORO2B ATAD3B
992 CPSF6 IMPA1 EPG5
993 HIST1H2AG hsa-mir-378d-2 GLS2
994 HNRNPUL2 CHRFAM7A HIST2H2BE
995 NonTargetingControlGuideForHuman_0580PPA1 LYST
996 LYZL6 DICER1 HTR1F
997 NonTargetingControlGuideForHuman_0348PFDN4 HMG20A
998 GLRA3 ACOT2 IVL
999 MICAL2 CUZD1 ITSN2
1000 NDRG3 PARK7 ZNF286A
130































Q86V20-2;Q86V20;U3KQ89Q86V20-2;Q86V20 Protein FAM35A FAM35A 82 82 904 15.952 0.026482 3.85E+11
P13667 P13667 Protein disulfide-isomerase A4PDIA4 12 12 645 7.9634 0.19859 2.52E+08
Q9Y2Z0;Q9Y2Z0-2 Q9Y2Z0;Q9Y2Z0-2 Suppressor of G2 allele of SKP1 homologSUGT1 32 32 365 6.2976 0.11887 1.27E+10
Q9BTT0-3;Q9BTT0;E9PPH5;Q5TB19;E9PLC4;Q9BTT0-2Q9BTT0-3;Q9BTT0;E9PPH5Acidic leucine-rich nuclear phosphoprotein 32 family member EANP32E 5 5 220 5.3043 0.83993 9.06E+08
P30101 P30101 Protein disulfide-isomerase A3PDIA3 15 13 505 3.6903 0.83145 1.20E+09
Q15046;Q15046-2;H3BVA8;J3KRL2;H3BPV7;H3BRC9Q15046;Q15046-2 Lysine--tRNA ligase KARS 37 37 597 3.6655 0.21996 1.95E+10
A0A087X2D5;Q9BRJ2;A0A0G2JMS5;A0A087WU62A0 087X2D5;Q9BRJ2;A0A0G2JMS5;A0A087WU6239S ribosomal protein L45, mitochondrialMRPL45 4 4 306 3.2063 0.56909 5.04E+08
Q9H089;F8WFC6;H7C2X7Q9H089;F8WFC6;H7C2X7Large subunit GTPase 1 homologLSG1 2 2 658 2.8429 0.49519 3.67E+08
Q9ULX6;Q9ULX6-2;V9GZ50;M0R1Y5;M0R010;M0QYT7Q ULX6 Q9ULX6-2;V9GZ50A-kinase anchor protein 8-likeAKAP8L 6 6 646 2.7081 0.35218 1.10E+09
F8VYE8;P36873;P36873-2;F8W0W8;F8VR82;A0A087WYY5;H0Y3Y6;F8WE71;F8W0V8F VYE8;P36873;P36873-2;F8W0W8;F8VR82;A0A087WYY5Serine/threonine-protein phosphatase Serine/threonine-protein phosphatase PP1-gamma catalytic subunitPPP1CC 18 2 304 2.6681 3.2222 2.74E+08
Q9H9J2 Q9H9J2 39S ribosomal protein L44, mitochondrialMRPL 4 7 7 332 2.5446 0.43297 3.94E+08
H0Y6Y8;B1AL05;Q8N983-4;Q8N983-3;Q8N983-2;Q8N983;Q8N983-6;Q8N983-7;M0R051;H0YBU8H0Y6Y8 B1AL05;Q8N983-4;Q8N983-3;Q8N983-2;Q8N983;Q8N983-6;Q8N983-7;M0R051;H0YBU839S ribosomal protein L43, mitochondrialMRPL4 4 4 169 2.5095 NaN 2.91E+08
H7BZJ3 H7BZJ3 PDIA3 3 1 123 2.4947 NaN 4.87E+08
Q13084;A2IDC7;Q4TT37;A2IDC6Q1 084;A2IDC7;Q4TT37;A2IDC639S ribosomal protein L28, mitochondrialMRPL28 7 7 256 2.4929 0.43336 2.77E+08
Q8WXX0 Q8WXX0 Dynein heavy chain 7, axonemalDNAH7 1 1 4024 2.4912 0.48863 1.36E+08
X6RJ73;Q96A35;X6RHI2X6RJ73;Q96A35 39S ribosomal protein L24, mitochondrialMRPL24 4 4 173 2.4115 0.36206 3.24E+08
P46939;P46939-2;P46939-4;Q5T097;P46939-3;Q5JT45;Q5JT44;Q5JT49;H0Y337;P46939-2; 4; T097Utrophin UTRN 16 16 3433 2.3994 0.26881 4.87E+08
A0A075B6T1;Q9C0C7-4;Q9C0C7-2;Q9C0C7-3;Q9C0C7;Q9C0C7-5;Q9C0C7-6;H0YE34A0A075B6T1;Q9C0C7-4;Q9C0C7-2; 3; ;Q9C0C7-5;Q9C0C7-6Activating molecule in BECN1-regulated autophagy protein 1AM RA1 13 13 1179 2.389 0.21254 3.92E+08
C9IY40;Q5T653 C9IY40;Q5T653 39S ribosomal protein L2, mitochondrialMRPL2 3 3 225 2.3816 0.39441 1.73E+08
Q9P015;E5RIZ4;E5RHF4Q9P015;E5RIZ4;E5RHF439S ribosomal protein L15, mitochondrialMRPL15 8 8 296 2.3196 0.45415 3.73E+08
Q9H5H4;H3BS42 Q9H5H4;H3BS42 Zinc finger protein 768ZNF768 3 3 540 2.2879 0.075098 7.13E+07
Q13405;H0YDP7;E9PI78;E9PNF1Q13405;H0YDP7 39S ribosomal protein L49, mitochondrialMRPL49 6 6 166 2.2856 0.42215 8.46E+08
Q99575;E5RK39 Q99575;E5RK39 Ribonucleases P/MRP protein subunit POP1POP1 6 6 1024 2.2727 0.5132 2.97E+08
P49406;S4R3W9;A0A0A0MRF4;S4R455P494 6;S4R3W9;A0A0A0MRF439S ribosomal protein L19, mitochondrialMRPL19 8 8 292 2.2142 0.47026 5.86E+08
A0A0G2JNH5;A0A0G2JP78;A0A0G2JPT5;O75943-3;O75943-4;O75943-2;O75943;H0Y9J8;H0Y9T7;A0A0G2JP31A0A0G2JNH5;A0A0G2JP78;A0A0G2JPT5;O75943- ;O75943-4;O75 43-2;O75943;H0Y9 8Cell cycle checkpoint protein RAD17RAD17 4 4 505 2.2136 0.50627 9.92E+07
P52272-2;P52272;A0A087X0X3;M0R019;M0QZM1;M0R2T0;M0R0N3;M0QYQ7;M0R2I7;M0R0Y6;M0QY96;M0QYL3P52272-2;P52272;A0A087X0X3; 019; 0QZM1Heterogeneous nuclear ribonucleoprotein MHNRNPM 52 52 691 2.2062 0.40004 3.04E+10
E9PKV2;Q9NRX2 E9PKV2;Q9NRX2 39S ribosomal protein L17, mitochondrialMRPL17 2 2 142 2.2009 0.46277 2.96E+08
B4E1Q4;O14730-2;O14730;J3QQL5B4E1Q4;O14730-2;O14730Serine/threonine-protein kinase RIO3RIOK3 5 5 503 2.188 0.58278 1.81E+08
B1AK44;Q9UI95;B1AK45;B1AK43B1AK44;Q9UI95;B1AK45;B1AK43Mitotic spindle assembly checkpoint protein MAD2BMAD2L2 3 3 224 2.1869 0.99297 8.91E+07
Q8TAE8 Q8TAE8 Growth arrest and DNA damage-inducible proteins-interacting protein 1GADD45GIP1 7 7 222 2.1563 0.40556 1.04E+08
P35251-2;P35251;H0Y8U4;H0Y9P8P35251-2;P35251 Replication factor C subunit 1RFC1 15 15 1147 2.1482 0.37156 7.55E+08
O75446 O75446 Histone deacetylase complex subunit SAP30SAP30 2 2 220 2.1312 0.71101 2.13E+08
Q96DV4;Q96DV4-2Q96DV4 39S ribosomal protein L38, mitochondrialMRPL38 4 4 380 2.1193 0.4113 5.66E+08
G3V170;Q9HA47-2;Q9HA47;Q9HA47-3;Q9HA47-4G3V170;Q9HA47-2;Q9HA47;Q9HA47-3;Q9HA47-4Uridine-cytidine kinase 1UCK 2 2 218 2.1086 NaN 1.72E+08
Q7Z2W9;F5H7V8;Q7Z2W9-2;H3BUY0Q7Z2W9;F5H7V8;Q7Z2W9-239S ribosomal protein L21, mitochondrialMRPL21 5 5 205 2.1082 0.38468 1.24E+08
G3V2G1;G3V328;G3V4U9;C9JQV6;D3VVH9;A0A0A0MS38;A0A087X1A8;G3V3R7;F5H211;P54252-3;P54252-4;P54252-2;P54252;G3V2G2;G3V3T6;P54252-5;E9PJN5;A0A087WXY4;G3V526;S4R399;G3V3A6;D3VVP3;G3V3T0;D6R9I5;G3V4B1;G3V390;G3V3S5;G3V4F5;G3V4F4;G3V5H3G3V2G1;G3V328;G3V4U9;C9JQV6;D3VVH9;A0A0 0MS38;A0A087X1A8;G3V3R7;F H 11;P54252-3;P54252-4;P54 5 -2;P54252;G3V2G2;G3V3T6;P54252-5;E9PJN5;A0A087WXY4;G3V526Ataxin-3 TXN3 7 7 223 2.1015 0.43946 4. 4E+
H0Y9G6;E7ETU7;P09001;D6RC14;E9PF06;D6RBQ5H Y9G6;E7ETU7;P09001;D6RC14;E9PF0639S ribosomal protein L3, mitochondrialMRPL3 6 6 363 2.0959 0.34331 2.70E+08
Q9P0M9;D6RAN8;H7C5U8;D6RE11;B3KN43Q9P0M9;D6RAN8;H7C5U839S ribosomal protein L27, mitochondrialMRPL27 6 6 148 2.0873 0.46223 1.38E+08
Q9BYD6;H0Y8N7 Q9BYD6;H0Y8N7 39S ribosomal protein L1, mitochondrialMRPL1 5 5 325 2.0716 0.27676 6.51E+08
P46777;Q5T7N0;R4GNJ2P46777 60S ribosomal protein L5RPL5 22 22 297 2.0616 0.42077 2.00E+09
K7ES61;Q9BYD3;X6RAY8;Q9BYD3-2;K7ELQ0;K7EKI4;K7ELF1;K7EJ73K7ES61;Q9BYD3;X6RAY8;Q9BYD3-2;K7ELQ039S ribosomal protein L4, mitochondrialMRPL4 7 7 300 2.0305 0.41806 1.06E+09
Q9HD33-2;Q9HD33;Q9HD33-3Q9HD3 -2;Q9HD33;Q9HD33-339S ribosomal protein L47, mitochondrialMRPL47 10 10 230 2.0253 0.4178 2.20E+08
Q9BYD2;Q5SZR1 Q9BYD2;Q5SZR1 39S ribosomal protein L9, mitochondrialMRPL9 6 6 267 2.0201 0.47728 1.72E+08
Q9BYD1;E5RJI7;H0YAX3;E5RFI2Q9BYD1;E5RJI7 39S ribosomal protein L13, mitochondrialMRPL13 11 11 178 2.0191 0.53193 5.30E+08
Q8IXM3 Q8IXM3 39S ribosomal protein L41, mitochondrialMRPL41 4 4 137 2.0158 0.48393 5.16E+08
Q9BVP2-2;Q9BVP2;C9JYH9;C9JZT7;B4DMU5Q BVP2-2;Q9BVP2 Guanine nucleotide-binding protein-like 3GNL3 15 15 537 2.0132 0.51048 2.30E+09
A6NJD9;A8MVT4;A8MYK1;Q16540;H7C2P7A6NJD9;A8MVT4;A8MYK1;Q16540;H7C2P739S ribosomal protein L23, mitochondrialMRPL23 2 2 163 2.0129 0.66492 2.15E+08
Q9H8V3-2;Q9H8V3-4;Q9H8V3;Q9H8V3-3;C9JDB4;H7C3G1;C9J0L6;C9JDV9;C9JTI2;C9J1C4;H7C103Q9H8V3-2;Q9H8V3-4;Q9H8V3 Q9H8V3-3Protein ECT2 E T2 10 10 882 2.0053 0.59793 3.75E+08
O95985-3;O95985-2;O95985;H0Y6W0;C9JKE2;C9JT00;F2Z2A5;C9JEI7;C9JF56;C9JTQ7;C9JHR0;C9JEQ1;C9J9X4;H7C4B0O95985-3;O95985-2;O95985;H0Y6W0DNA topoisomerase 3-beta-1;DNA topoisomeraseTOP3B 9 8 707 1.9975 0.50919 2.54E+08
Q9H0U6 Q9H0U6 39S ribosomal protein L18, mitochondrialMRPL18 5 5 180 1.9936 0.50141 6.48E+07
Q9NP92;A0A087WV52Q9NP92 28S ribosomal protein S30, mitochondrialMRPS30 9 9 439 1.9929 0.49675 5.71E+08
Q6UWE0-2;Q6UWE0;Q6UWE0-3Q6UWE0-2;Q6UWE0;Q6UWE0-3E3 ubiquitin-protein ligase LRSAM1LRSAM1 7 7 696 1.9876 0.36352 4.56E+08
Q5W0B1 Q5W0B1 RING finger protein 219RNF219 5 5 726 1.9835 0.39873 3.59E+08
Q08J23-2;Q08J23;Q08J23-3;A0A140T9Y7Q08J23-2;Q08J23;Q08J23-3tRNA (cytosine(34)-C(5))-methyltransferaseNSUN2 38 38 732 1.9769 0.39965 1.24E+10
E9PFK9;Q9UJ41-2;Q9UJ41-4;Q9UJ41-3;Q9UJ41;Q3HKR1;A0A0A0MSJ3;V9GYI8E PFK9;Q9UJ41-2;Q9UJ41-4; 9UJ4 -3;Q9UJ41;Q HKR1;A0A0A0MSJ3Rab5 GDP/GTP exchange factorRABGEF 4 4 504 1.9675 0.49434 2.26E+08
Q9BZE1;S4R369;A6NHR2;H0Y4J2Q9BZE1;S4R369 39S ribosomal protein L37, mitochondrialMRPL37 10 10 423 1.948 0.43364 7.51E+08
Q9BQC6 Q9BQC6 Ribosomal protein 63, mitochondrialMRPL57 2 2 102 1.9398 0.44894 2.75E+08
Q6ZRV2;J3KPS2 Q6ZRV2;J3KPS2 Protein FAM83H FAM83H 12 12 1179 1.9288 0.33055 3.12E+08
P41743;E9PBE1;Q05513-2;Q05513-3;Q05513P4 743 Protein kinase C iota typePRKCI 5 5 596 1.9218 0.61895 7.43E+08
P08579 P08579 U2 small nuclear ribonucleoprotein BSNRPB2 7 5 225 1.9192 0.71091 5.97E+08
Q9NW82;D6RIW8 Q9NW82;D6RIW8 WD repeat-containing protein 70WDR70 4 4 654 1.9106 0.89759 2.81E+08
Q9Y2I7;E9PDH4;Q9Y2I7-4;Q9Y2I7-2;Q9Y2I7-3;C9JL08;F8WEZ0Q9Y2I7;E PDH4; 9Y2I7-4;Q Y2I7-2;Q9Y2I7-31-phosphatidylinositol 3 phosphate 5-kinasePIKFYVE 9 9 2098 1.9076 0.51726 2.73E+08
O15541 O15541 RING finger protein 113ARNF113A 5 5 343 1.9075 0.35745 2.04E+08
H3BLZ8;Q92841;Q92841-1;Q92841-3;Q92841-2;A0A0U1RQJ0H3BLZ8; ;Q92841- ;Q92841-3;Q92841-2Probable ATP-dependent RNA helicase DDX17DDX17 41 33 731 1.9059 0.48052 3.01E+10
Q9Y2X9-2;Q9Y2X9 Q9Y2X9-2;Q9Y2X9 Zinc finger protein 281ZNF281 11 11 859 1.8999 0.35507 5.59E+08
A0A0D9SF60;Q99569-2;Q99569A0A0D SF 0;Q99569-2;Q99569Plakophilin-4 PKP4 3 1 1208 1.8984 NaN 2.28E+07
O15381-5;O15381;O15381-3;O15381-2;O15381-4;E7EWK7;E9PGD8;E9PH71;F8WF01;C9J6P7;C9JP835; ;O15381-3;O15381-2;O15381-4Nuclear valosin-containing protein-likeNVL 22 22 765 1.8962 0.37308 2.44E+09
Q96D46;C9JA08;C9J0B9;C9IZW9;C9K0C2;C9IY70Q96D46;C9JA08 60S ribosomal export protein NMD3NMD3 15 15 503 1.8919 0.55066 1.48E+09
F5H702;Q96GC5-3;Q96GC5;F5H8D0F5H702;Q96GC5-3;Q96GC5;F5H8D039S ribosomal protein L48, mitochondrialMRPL48 5 5 113 1.8908 0.51976 5.09E+08
Q7Z7F7;Q7Z7F7-2;X6R631;X6RIW1Q7Z7F7;Q7Z7F7-2;X6R63139S ribosomal protein L55, mitochondrialMRPL 5 5 5 128 1.8875 0.45571 2.46E+08
O76094;O76094-2;D6RDY6;R4GNC1O76094;O76094-2;D6RDY6Signal recognition particle subunit SRP72SRP72 16 16 671 1.8775 0.51771 2.29E+09
P15924;P15924-2;P15924-3;P15924-2;P15924-3Desmoplakin DSP 42 42 2871 1.8746 0.40733 1.82E+09
Q8IY37;F5H3Y4 Q8IY37;F5H3Y4 Probable ATP-dependent RNA helicase DHX37DHX37 19 19 1157 1.8654 0.46508 8.70E+08
Q9H2W6;A0A087WT51;A0A087WT90Q9H2W6 39S ribosomal protein L46, mitochondrialMRPL46 5 5 279 1.8508 0.45408 3.22E+08
P55795;H0YBK1 P55795 Heterogeneous nuclear ribonucleoprotein H2;Heterogeneous nuclear ribonucleoprotein H2, N-terminally processedHNRNPH2 18 8 449 1.8221 0.50409 3.44E+09
P10412;Q02539;P22492;P16401P10412 Histone H1.4 HIST1H1E 17 5 219 1.8204 0.56378 3.42E+09
Q9UKB1-2;Q9UKB1-3;Q9UKB1;B7Z3H4;Q9Y297-2;Q9Y297Q9UKB1-2;Q9UKB1-3;Q9UKB1;B7Z3H4;Q9Y297-2;Q9Y297F-box/WD repeat-containing protein 11;F-box/WD repeat-containing protein 1AFBXW11;BTRC 3 3 508 1.8179 0.53471 2.41E+07
Q9NVN8 Q9NVN8 Guanine nucleotide-binding protein-like 3-like proteinGNL3L 4 4 582 1.8152 0.30302 3.72E+08
Q6IQ32 Q6IQ32 ADNP homeobox protein 2ADNP 2 2 1131 1.8107 NaN 2.22E+07
Q9NX58 Q9NX58 Cell growth-regulating nucleolar proteinLYAR 7 7 379 1.8097 0.54266 2.52E+08
P43487-2;P43487;F6WQW2;C9JXG8;C9JJ34;C9JGV6;C9JDM3;C9JIC6P43487-2;P43487;F6WQW2;C9JXG8;C9JJ34;C9JGV6Ran-specific GTPase-activating proteinRANBP1 9 9 200 1.8058 0.35542 8.62E+09
O43395;O43395-3 O43395 U4/U6 small nuclear ribonucleoprotein Prp3PRPF3 13 13 683 1.8042 0.62932 5.72E+08
Q96HA7-2;Q96HA7;A0A087X1F6Q96HA -2;Q96HA7Tonsoku-like proteinTONSL 9 9 1378 1.7997 0.51211 3.79E+08
Q5JR08;P08134;E9PQH6Q5JR08;P08134;E9PQH6Rho-related GTP-binding protein RhoCRHOC 5 2 189 1.7977 2.0207 1.06E+08
Q9NQ50 Q9NQ50 39S ribosomal protein L40, mitochondrialMRPL40 5 5 206 1.7854 0.42283 4.62E+08
P16403 P16403 Histone H1.2 HIST1H1C 17 5 213 1.7792 0.48771 2.32E+08
E7EVZ1;Q86UP3-2;Q86UP3-5;Q86UP3;Q86UP3-4;Q86UP3-3;Q15911E7EVZ1;Q86UP3-2;Q86UP3-5;Q86UP3;Q86UP3-4Zinc finger homeobox protein 4ZFHX4 3 3 3590 1.7784 0.57894 5.06E+07
P18124;A8MUD9;C9JIJ5;C9JZ88P18124;A8MUD9 60S ribosomal protein L7RPL7 22 22 248 1.7753 0.53289 1.39E+10
P19338;H7BY16;C9JYW2;C9JLB1;C9J1H7;C9JWL1P19338;H7 Y16 Nucleolin NCL 52 52 710 1.7729 0.46993 4.57E+10
F8WE42;F5H101;Q76FK4-4;Q76FK4;F5GXV1;F5H532;F5H0I5;F5H8B8;A0A0A0MSJ1;F5GWN9;Q76FK4-2F8WE42;F5H101;Q76FK4-4;Q76FK4;F5GXV1;F5H532;F5H I5;F5H8B8;A0A0A0MSJ1;F5GWN9;Q76FK4-2Nucleolar protein 8NOL8 4 4 970 1.772 0.70565 9.54E+07
Q8IWS0;A0A0D9SGE8;Q8IWS0-5;Q8IWS0-3;Q5JRC6;Q8IWS0-4;Q8IWS0-2Q IWS0;A A0D9SGE8;Q8IWS0-5; I 3; 5JRC6;Q8IWS0-4;Q8IWS0-2PHD finger protein 6PHF6 17 17 365 1.7702 0.59399 1.10E+09
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Q9HCK8;Q9HCK8-2;H0YJG4;Q3L8U1-2;Q3L8U1-3;Q3L8U1;H3BTW3;G3V2T9Q9HCK8 9HCK8 Chromodomain-helicase-DNA-binding protein 8CHD8 17 12 2581 1.7682 0.53279 6.36E+08
Q13523;H0YDJ3 Q13523;H0YDJ3 Serine/threonine-protein kinase PRP4 homologPRPF4B 7 7 1007 1.7669 0.77007 2.70E+08
Q8WVD3;J3QLQ3;J3KRU4;J3KSI2;J3QKM8;Q8WVD3-2Q8WVD E3 ubiquitin-protein ligase RNF138RNF138 3 3 245 1.7666 0.44486 1.79E+08
P19525;P19525-2;F8WBH4;C9JZT2P19525;P19525-2 Interferon-induced, double-stranded RNA-activated protein kinaseEIF2AK2 10 10 551 1.7642 0.59442 1.45E+09
A0A0C4DGT3;A0A087WWK8;Q6DN90-2;Q6DN90;Q5JU85-3A0A0C4DGT3;A0A087WWK8;Q6DN90-2;Q6DN90IQ motif and SEC7 domain-containing protein 1IQSEC1 3 2 814 1.7627 0.77423 1.47E+08
A0A0B4J220;E9PLD3;E9PRG8A0A0B4J220 4 4 123 1.7591 0.63531 9.80E+07
Q13823;H0YG10 Q13823 Nucleolar GTP-binding protein 2GNL2 9 9 731 1.7351 0.54163 4.49E+08
O95235-2;O95235;D6R9E4;D6RBN1O95235-2;O95235 Kinesin-like protein KIF20AKIF20 3 3 872 1.7334 0.47964 8.59E+07
K7EJB9;P27797 K7EJB9;P27797 Calreticulin CALR 4 4 247 1.7318 0.474 1.06E+08
O14979-3;O14979-2;A0A087WUK2;O14979;A0A087WU03O14979-3;O14979-2;A0A087WUK2;O14979Heterogeneous nuclear ribonucleoprotein D-likeHNRNPDL 16 14 244 1.7297 0.84168 8.47E+09
J3KTA4;P17844;P17844-2;J3QRQ7;J3QSF1;J3KRZ1;J3KRX8;J3QR02;X6RLV5;J3QRN5;J3QKN9;J3QLG9;J3QR62J3KTA4;P17844;P17844-2Probable ATP-dependent NA helicase DDX5DDX5 45 37 614 1.7282 0.49236 3.85E+10
P16989-3;P16989;A0A0D9SEI8;Q9Y2T7P1698 -3;P16 89 Y-box-binding protein 3YBX3 9 1 342 1.727 0.46008 6.52E+08
P31483-2;C9JTN7;H7BY49P31483-2;C9JTN7;H7BY49Nucleolysin TIA-1 isoform p40TIA1 9 0 375 1.7222 0.65341 9.63E+07
Q8N1G0-2;Q8N1G0;H0Y5I5;F8WCX2Q8N1G0-2;Q8N1G0;H0Y5I5;F8WCX2Zinc finger protein 687ZNF687 3 3 1103 1.7208 NaN 4.98E+07
Q01831;Q01831-2;E7EUB5Q01831;Q01831-2 DNA repair protein complementing XP-C cellsXPC 3 3 940 1.7207 NaN 3.95E+07
Q6NW34-2;Q6NW34;E9PFF8Q6NW34-2;Q6NW34;E9PFF8Uncharacterized protein C3orf17C3orf17 2 2 497 1.7196 NaN 1.90E+07
Q16778;P33778;P23527;P06899;Q96A08;Q6DRA6;Q6DN03Q16778;P33778;P23527;P06899;Q96A08Histone H2B type 2-E;Histone H2B type 1-B;Histone H2B type 1-O;Histone H2B type 1-J;Histone H2B type 1-AHIST2H2BE;HIST1H2B IST1H2BO;HIST1H2BJ;HIST1H2BA10 0 126 1.7187 1.3625 1.28E+09
Q9BYC9;I3L2X1;Q9BYC9-2Q9BYC9 39S ribosomal protein L20, mitochondrialMRPL20 4 4 149 1.7168 0.39169 1.28E+08
Q7Z6Z7-3;Q7Z6Z7;Q7Z6Z7-2;H0Y659;A0A087X146;Q5H963Q7Z6Z7-3;Q7Z6Z7;Q7Z6Z -2E3 ubiquitin-protein ligase HUWE1HUWE1 107 103 4365 1.7155 0.50342 1.32E+10
Q96GA3;A0A075B6Q496GA3 Protein LTV1 homologLTV1 6 6 475 1.7105 0.55668 3.49E+08
P27635;X1WI28;A0A087WV22;H7C123;H7C2C5;Q96L21;B8A6G2;A6QRI9;H7C2U2P27635;X1WI28;A0A087WV22;H7C123;H7C2C560S ribosomal protein L10RPL10 15 2 214 1.7027 0.66466 9.22E+09
P62241;Q5JR95 P62241;Q5JR95 40S ribosomal protein S8RPS8 14 14 208 1.7022 0.58302 1.64E+10
E7ESL0;A0A0C4DGX2;J3KQY1;Q9NWU5;Q9NWU5-2;Q9NWU5-3E7ESL0;A0A0C4DGX2;J3KQY1;Q9NWU5;Q9NWU5-2;Q9NWU5-339S ribosomal protein L22, mitochondrialMRPL 2 6 6 212 1.701 0.55323 3.28E+08
B7WPG3;C9IYN3;D6W592;Q8WVV9-5;Q8WVV9-4;Q8WVV9;Q8WVV9-3;Q8WVV9-2;H7BXH8;C9JJZ7;H7C464B7WPG3;C9IYN3;D6W592;Q8WVV9-5;Q8WVV9-4;Q8WVV9;Q8WVV9-3;Q8WVV9-2Heterogeneous nuclear ribonucleoprotein L-likeHNRPLL;HNRNPLL 14 14 508 1.6912 0.49883 1.71E+09
Q14684;Q14684-2 Q14684;Q14684-2 Ribosomal RNA processing protein 1 homolog BRRP1B 8 8 758 1.6831 0.52971 3.00E+08
Q01968;Q01968-2 Q01968;Q01968-2 Inositol polyphosphate 5-phosphatase OCRL-1OCRL 18 18 901 1.6816 0.42899 1.56E+09
P39019;A0A075B6E2;M0R2L9;M0QXK4;M0QYF7;M0R140P39019;A0A075B6E20S ribosomal protein S19RPS19 19 19 145 1.6797 0.59106 1.81E+09
O15226;O15226-2;A0A087WXT2O15226;O15 26-2 NF-kappa-B-repressing factorNKRF 17 17 690 1.6763 0.61567 5.93E+08
Q96RS0 Q96RS0 Trimethylguanosine synthaseTGS1 2 2 853 1.6746 0.55133 6.12E+07
C9JG87;Q9NYK5;Q9NYK5-2C9JG87;Q9NYK5;Q9NYK5-239S ribosomal protein L39, mitochondrialMRPL39 9 9 297 1.6705 0.56825 8.10E+08
A0A075B6F9;Q9Y314;M0R3B2;M0R1K2;M0QX85;A0A075B797;M0R1T7A0A075B6F9;Q9Y314;M0R3B2Nitric oxide synthase-interacting proteinNOSIP 9 9 304 1.6662 0.48972 1.42E+09
P61927;D6R9X9;D6RG19P61927;D6R9X9;D6RG1960S ribosomal protein L37;Ribosomal protein L37RPL37 3 3 97 1.6662 0.71251 4.22E+07
Q9BU61;Q9BU61-2Q9BU61;Q9BU61-2NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3NDUFAF3 4 4 184 1.6543 1.3267 4.09E+07
Q9P0U3-2;Q9P0U3Q9P0U3-2;Q9P0U3Sentrin-specific protease 1SENP1 4 4 643 1.6536 0.44607 2.39E+08
Q9NV72-2;Q9NV72;G3V1M0;J3KR62;J3KR51;A0A0U1RQK1;A0A087WSW4;A0A087WXT7;A0A087WVZ7;Q9H963;Q8N782;Q8NCK3-2;Q8NCK3;Q5VIY5-2;Q9Y5A6;P0CJ79;A2RRD8;Q5VIY5;Q7L2R6;Q96NL3;Q96N58;Q6ZN06;A6NHJ4;Q0VGE8;P17035-2;Q86XN6-3;Q86XN6-2;P17035;Q86XN6;Q9P0L1;Q9UJW7-2;Q9UJW7;Q8N4W9-2;Q8NB50-3;Q8NB50;Q8N4W9;Q96IR2;Q05481-2;Q05481Q9NV72-2;Q9NV72;G3V M ;J3KR62;J3KR51;A0A0U1RQK1;A0A087WSW4;A0A087WXT7;A0A087WVZ7;Q9H963;Q8N782;Q8NCK3-2; 8NCK3;Q5VIY5-2;Q9Y5A6;P0CJ79;A RD8;Q5VIY5;Q7L2R6;Q96NL3;Q96N58;Q6ZN06;A6NHJ4 0VGE8;P17035-2;Q86XN6-3; -2;P17035;Q86XN6;Q9P0L1;Q9UJW7-2;Q9UJW7;Q8N4W9-2;Q8NB50-3; 8NB50;Q8N4W9; 96IR2;Q05481-2;Q05481Zinc finger protein 701;Putative zinc finger protein 702;Zinc finger protein 525;Zinc finger protein 485;Zinc finger protein 468;Zinc finger and SCAN domain-containing protein 21; inc finger protein 88 Zinc finger protein 320;Zinc finger protein 765;Zinc finger protein 599 Zinc finger protein 578;Zinc finger protein 13;Zinc finger protein 860;Zinc finger protein 816;Zinc finger protein 28;Zinc finger protein 761;Zinc finger protein with KRAB and SCAN domains 7;Zinc finger protein 229;Zinc finger protein 808;Zinc finger protein 62 homolog;Zinc finger protein 845;Zinc finger protein 91ZNF701;ZSCAN21;ZNF525;ZNF 02P; NF485;ZNF468;ZNF 88;ZNF320;ZNF765;ZNF599;ZNF578 ZNF813 ZNF860;ZNF816 ZNF28;ZNF761;ZKSCAN7;ZNF229;ZNF808;ZFP62;ZNF845; F92 465 1.6496 NaN 1.62E+07
P10398;Q96II5;P10398-2P10398;Q96II5 Serine/threonine-protein kinase A-RafARAF 8 5 606 1.6483 0.50818 4.74E+08
Q12965;H0YLE5;O00160Q 2965;H0YLE5;O00160Unconventional myosin-Ie;Unconventional myosin-IfMYO1E;MYO1F 2 2 1108 1.6473 0.5402 1.11E+08
A0A087WYR0;P09132A0A087WYR0;P09132Signal recognition particle 19 kDa proteinSRP19 3 3 120 1.6453 0.68795 3.11E+08
P62081;B5MCP9 P62081;B5MCP9 40S ribosomal protein S7RPS7 17 17 194 1.6417 0.53657 3.93E+09
E7ETB7;E7EQ06;A0A0A0MS31;Q14790-6;Q14790-5;Q14790-8;Q14790-7;Q14790-3;Q14790-2;Q14790;Q14790-4;Q14790-9;C9JB29;H7BZM4;E7EQ01;E7EVN1;H7C0E2E7ETB7;E7E 06;A0A0A0MS31;Q14790-6;Q14790-5;Q14790-8;Q14790-7;Q14790-3; 2; ;Q14790-4;Q14790-9;C9JB29Caspase-8;Caspase-8 subunit p18;Caspase  subunit p10CASP8 3 3 1 8 1.6368 0.59203 2.68E+08
Q5RKV6 Q5RKV6 Exosome complex component MTR3EXOSC6 2 2 272 1.6351 0.81871 4.54E+07
Q9BU76-4;Q9BU76;Q9BU76-3;Q9BU76-2Q9BU76-4;Q9BU76;Q9BU76-3Multiple myeloma tumor-associated protein 2MMTAG2 3 3 189 1.6343 0.43024 5.75E+07
Q5SSJ5;X6RGJ2;Q5SSJ5-2;Q5SSJ5-3;Q5SWC8;B0QZK4;B0QZK9;B0QZK8;Q5SSJ5-5Q5SSJ5;X6RGJ2; 5SSJ5-2 Q5SSJ5-3;Q5SWC8;B0QZK4Heterochromatin protein 1-binding protein 3HP1 P3 12 12 553 1.6341 0.7902 8.46E+08
K7EQ03;K7EP90;Q9BTD8-4;Q9BTD8-2;Q9BTD8-3;Q9BTD8;K7EML2;K7ER08K7EQ03;K7EP90;Q9BTD8-4;Q9BTD8-2;Q9BTD8-3;Q9BTD8RNA-binding protein 42RBM42 3 3 426 1.6336 0.64405 1.07E+08
Q9BTE1;H3BR94;Q9BTE1-2;H3BUD2;H3BS05;Q9BTE1-3;I3L0U8Q9BTE1; R94;Q9 TE1-2;H3BUD2;H3BS05;Q9BTE1-3Dynactin subunit 5 DCTN5 6 6 182 1.6332 0.67147 2.05E+08
Q9BSH4 Q9BSH4 Translational activator of cytochrome c oxidase 1TACO1 12 12 297 1.6325 0.50014 4.51E+09
M0R3F6;M0R2Z9;Q8IX01-4;Q8IX01-3;Q8IX01;M0R065M0R3F6;M0R2Z9;Q8IX01-4;Q8IX01-3;Q8IX01SURP and G-patch domain-containing protein 2SUGP2 6 6 841 1.631 0.53131 2.45E+08
Q02878;F8VZ45;U3KQR5;F8VR69;F8VZA3;F8VWR1;F8VU16Q02878 60S ribosomal protein L6RPL6 21 21 288 1.6309 0.59905 1.37E+10
B4DYP1;O94760-2;O94760;H0Y7N1;A0A140T971;Q5SSV3;Q5SRR8;O95865B4DYP1;O94 60-2;O94760N(G),N(G)-dimethylarginine dimethylaminohydrolase 1DDAH1 3 3 185 1.629 1.0362 2.13E+08
P82914 P82914 28S ribosomal protein S15, mitochondrialMRPS15 8 8 257 1.6276 0.61459 3.02E+08
Q8NB46 Q8NB46 Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit CANKRD52 5 5 1076 1.6258 0.802 8.46E+07
Q92793-2;Q92793;I3L466;I3L3I5Q92793-2;Q92793;I3L466CREB-binding proteinCREBBP 8 4 2404 1.6243 0.48402 3.17E+08
P07992-4;P07992-2;P07992;K7ES46;K7ER60;K7ER89;K7EP14;P07992-3;K7EMT9P07992-4;P07992-2;P07992;K7ES46;K7ER60;K7ER89;K7EP14;P07992-3DNA excision repair protein ERCC-1ERCC1 4 4 225 1.619 0.71909 1.68E+08
Q9UBU9;E9PIN3;Q9UBU9-2;B4E227;E9PQA4;E9PLA7;H0YDU0Q9UBU9;E9PIN3;Q UBU9-2Nuclear RN  export factor 1NXF1 16 16 619 1.6186 0.60454 2.11E+09
Q16822;B4DW73;H0YML5;H0YM31;A0A0A0MS74;Q16822-2;H0YNG4;H0YMA5;H0YMU6;P35558;P35558-2Q16822;B4DW73;H0YML5;H0YM31Phosphoenolpyruvate carboxykinase [GTP], mitochondrialPCK2 22 22 640 1.6153 0.6428 4.33E+09
O14530-2;O14530;B8ZZX4;F8WCJ3;F8WBV5;G3XAJ4O14530-2;O14530;B8ZZX4;F8WCJ3Thioredoxin domain-containing protein 9TXNDC9 7 7 188 1.6141 0.53503 8.54E+08
F8W8I6;P31483;E5RGV5;P31483-3;E5RG67;F8WE16F8W8I6;P3148 ; V5;P31483-3Nucleolysin TIA-1 isoform p40TIA1 9 2 385 1.6116 0.8241 1.64E+08
O95071-2;O95071;E7EMW7;E7ET84;E5RFK7;H0YBB4;H0YAV7O95071-2;O95071;E7EMW73 ubiquitin-protein ligase UBR5UBR5 46 46 2798 1.61 0.55165 2.78E+09
P61353;K7ELC7;K7EQQ9;K7ERY7P61353;K7ELC7;K7EQQ960S ribosomal protein L27RPL27 12 12 136 1.6091 0.63307 6.39E+09
P11766;H0YAG8;D6RAY0;D6R9G2;D6RFE4P11766;H0YAG8 Alcohol dehydrogenase class-3ADH5 4 4 374 1.6078 1.5523 5.62E+08
P62424;Q5T8U3;Q5T8U2P62424;Q5T8U3 60S ribosomal protein L7aRPL7A 19 19 266 1.6057 0.60189 6.52E+09
Q7Z2W4;C9J6P4;Q7Z2W4-2;Q7Z2W4-4;Q7Z2W4-3;H7C5K1;Q7Z2W4-5;G5E9U9;Q9H0J9Q7Z2W4;C9J6P4;Q7Z2W4-2Zinc finger CCCH-type antiviral protein 1ZC3HAV1 27 27 902 1.6054 0.4884 3.70E+09
Q9NXK8;Q9NXK8-2;K7EPN7Q9NXK8;Q9NXK8-2F-box/LRR-repeat protein 12FBXL12 3 3 326 1.6039 0.62093 2.31E+08
A0A0D9SES8;H0YKT5;H0YKN8;H0YL70;Q04726-2;Q04726-7;Q04726-3;Q04726-6;Q04726-5;Q04726-4;Q04726;F5H7D6;H0YNT2;H0YLI3;H0YNI7;H0YKH0;H0YLW9;Q04725-2;H3BUH5;H0YKH5;H7C4P7;K7EJR7A0A D9SES8;H0YKT5;H0YKN8;H YL70;Q04726-2;Q04726-7;Q04726-3;Q04726- ;Q04726-5;Q04 2 -4;Q04726;F5H7D6;H0YNT2;H0YLI3;H0YNI7;H0YKH0;H0YLW9Transducin-like enhancer protein 3LITAF;TLE3 12 6 772 1.6029 0.461 1. 6E+09
P30419-2;P30419;K7EN82;B7Z8J4;Q5VUC6;O60551P30419-2;P30 19;K7EN82;B7Z8J4;Q5VUC6;O60551Glycylpeptide N-tetradecanoyltransferase 1;Glycylpeptide N-tetradecanoyltransferase;Glycylpeptide N-tetradecanoyltransferase 2NMT1;NMT2 2 2 416 1.6 0.68733 2.95E+08
A0A0A0MRF9;P16885;H3BQV5A0A0A0MRF9;P168851-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2PLCG2 6 6 1252 1.5981 0.55379 1.89E+08
Q13643 Q13643 Four and a half LIM domains protein 3FHL3 2 2 280 1.5981 0.76063 1.08E+07
Q8N5N7;Q8N5N7-2Q8N5N7;Q8N5N7-239S ribosomal protein L50, mitochondrialMRPL50 4 4 158 1.5977 0.51725 1.09E+08
Q9NRL2;Q9NRL2-2;A0A087WWN7;H0YJP5Q9NRL2;Q9NRL2-2 Bromodomain adjacent to zinc finger domain protein 1ABAZ1A 23 23 1556 1.596 0.6173 8.00E+08
Q92615;H0Y4V9;H0Y641;A0A087X183;X6RCG6;V9GYI5;B5MCU2Q92615 La-related protein 4BLARP4B 13 13 738 1.5899 0.44044 2.08E+09
Q96FZ2;D6R9T3;E7EMP6;D6RGK7;D6RAZ3;D6RAI0Q96FZ2;D6R9T3;E7EMP6;D6RGK7;D6RAZ3mbryonic stem cell-specific 5-hydroxymethylcytosine-binding proteinHMCES 8 8 354 1.5893 0.46459 5.75E+08
Q08AF3;B4E128;Q08AF3-2Q08AF3 Schlafen family member 5SLFN 3 3 891 1.5886 0.43549 7.31E+07
Q9Y5T5-2;Q9Y5T5;Q9Y5T5-5;Q9Y5T5-3;H9KVB6;Q9Y5T5-4Q9Y5T5-2;Q9Y5T5;Q9Y5T5-5; 3Ubiquitin carboxyl-terminal hydrolase 16USP16 3 3 822 1.5885 NaN 4.02E+07
H0YKX0;Q96EP0-3;Q96EP0;A0A0B4J293;Q96EP0-2;H0YKI4H0YKX ;Q96EP0-3;Q96EP0;A0A0B4J293;Q96EP0-2;H0YKI4E3 ubiquitin-protein ligase RNF31RNF31 4 4 917 1.5882 0.58936 7.92E+07
Q96EB6;B0QZ35;E9PC49;Q96EB6-2Q96EB6;B0QZ35;E9PC49;Q96EB6-2NAD-dependent protein deacetylase sirtuin-1;SirtT1 75 kDa fragmentSIRT1 8 8 747 1.5843 0.48413 4.54E+08
Q9P2D1;A0A087WU44Q9P2D1 Chromodomain-helicase-DNA-binding protein 7CHD7 11 7 2997 1.5817 0.51908 1.05E+08
P61247;E9PFI5;H0Y8L7;D6RG13;D6RAT0;H0Y9Y4;D6RB09;D6RAS7;D6RI02;D6R9B6;D6RED7;D6RGE0P61247;E9PFI5;H0Y8L7;D6RG13;D6RAT0;H0Y9Y4;D6RB094 S ribosomal protein S3aRPS3 28 28 264 1.5757 0.57396 1.29E+10
O75925;O75925-2;H3BS65;H3BSI8;O75925-3O7592 O75925-2 E3 SUMO-protein ligase PIAS1PIAS1 4 3 651 1.5753 0.49141 1.70E+08
P17028;P17028-2;K7EQP8;K7EPZ8;K7EPL1P1702 Zinc finger protein 24ZNF24 8 8 368 1.5745 0.58501 1.23E+08
A0A0D9SFB3;A0A0D9SG12;A0A0D9SF53;O00571;O00571-2;O15523-2;O15523;O15523-3;A0A0J9YVQ7;A0A087WVZ1;B4DLA0;A0A0J9YYH6;C9J081;C9J8G5;A0A087WX09;D6RCM4;Q9NQI0-3;Q9NQI0-2;Q9NQI0-4;Q9NQI0;H0Y960A0A0D9SFB3;A0A0D9SG12;A0A0D9SF53; 00 71;O00571-2; 2;O15523ATP-dependent RNA helicase DDX3X;ATP-dependent RN  helicase DDX3YDDX3X;D X3Y 39 38 640 1.5713 0.617 4 2.05E+10
Q15293;Q15293-2;E9PP27Q15293;Q15293-2 Reticulocalbin-1 RCN1 7 7 331 1.5713 0.69386 1.13E+09
Q8IZH2-2;Q8IZH2;H7C5E4;Q8IZH2-3;F8WDA0;C9JCZ8Q8IZH2-2;Q8IZH2;H7C5E45-3 exoribonuclease 1XRN1 18 18 1694 1.571 0.61704 1.36E+09
Q9H4L7;Q9H4L7-2;Q9H4L7-3;D6RAY8;F8W9M2;Q9H4L7-2 Q9H4L7-3SWI/SNF related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1SMARCAD1 11 11 1026 1.5706 0.68489 5.89E+08
O75717;O75717-2;C9JYB3;H3BSQ1O75717;O75717-2 WD repeat and HMG-box DNA-binding protein 1WDH 1 31 31 1129 1.57 0.51452 1.88E+09
F1T0I1;J3KNL6;O15027-2;O15027-4;O15027-3;O15027;O15027-5;X6RGP5;A0A0C4DH09;Q8N9G1F1T0I1;J3KNL6;O15027-2;O15027-4; 3;O15027;O15 27-5;X6RGP5;A0A0C4DH09Protein transport protein Sec1 ASEC16A 20 20 2334 1.5696 0.3991 7.16E+08
P07305;P07305-2 P07305;P07305-2 Histone H1.0;Histone H1.0, N-terminally processedH1F0 5 5 194 1.5683 0.68287 3.48E+08
Q92522 Q92522 Histone H1x H1FX 6 6 213 1.5658 0.67177 1.40E+09
J3QK89;Q8IWX8 J3QK89;Q8IWX8 Calcium homeostasis endoplasmic reticulum proteinCHERP 4 4 927 1.5643 0.58353 1.82E+08
K7EQJ5;P62841;K7EM56;A0A0B4J2B4;S4R417;K7ELC2;K7EJ78;S4R456K7EQJ5;P62841;K7EM56;A0A0B4J B4;S4R417;K7ELC2;K7EJ78;S4R45640S ribosomal protein S15RPS15 7 7 141 1.5641 0.58148 6.81E+08
P05455;E7ERC4;E9PGX9;E9PFL905455 Lupus La protein SSB 11 11 408 1.5634 0.66991 6.47E+08
Q6P158;H7C109;Q6P158-2;A0A087WZ11;Q6P158-3Q6P158;H7C109 Putative ATP dependent RNA helicase DHX57DHX57 21 19 1386 1.5622 0.52182 7.80E+08
Q9BVQ7-3;Q9BVQ7-2;Q9BVQ7Q9BVQ7-3;Q9BVQ7-2;Q9BVQ7Spermatogenesis-associated protein 5-like protein 1SPATA5L1 2 2 392 1.5619 0.85712 1.70E+08
O00629;H7C4F6 O00629 Importin subunit alpha-3KPNA4 14 10 521 1.5551 0.43691 1.63E+09
133
Q00535;Q00535-2 Q00535;Q00535-2 Cyclin-dependent-like kinase 5CDK5 13 12 292 1.5545 0.6239 2.64E+09
P62753;A2A3R5;A2A3R7P62753;A2A3R5 40S ribosomal protein S6RPS6 15 15 249 1.5541 0.59249 5.93E+09
P67809;A0A087X1S2;H0Y449;C9J5V9P67809;A0A087X1S2;H0Y449Nuclease-sensitive element-binding protein 1YBX1 14 9 324 1.5528 0.46668 3.76E+09
J3QR09;J3KTE4;P84098;J3QL15J3QR09;J3KTE4;P84098Ribosomal protein L19;60S ribosomal protein L19RPL19 11 11 193 1.5524 0.61923 3.62E+09
Q9Y676;A0A0G2JIC6Q9Y676;A0A0G2JIC628S ribosomal protein S18b, mitochondrialMRPS18B 5 5 258 1.5504 0.60378 3.54E+08
Q71RC2-5;Q71RC2;Q71RC2-4;Q71RC2-3;X6RLN4;Q71RC2-7;Q71RC2-2;Q71RC2-6;Q96J85;Q6P4E2;F8W1I4;Q8TBL5;A0A087WTL9;F8VY40;F8W1Z55; ;Q71RC2- 3 X6RLN4;Q71RC2-7;Q71RC2-2; 71RC2-6;Q96J85La-related protein 4LARP4 9 9 653 1.5481 0.40649 8.75E+08
P55036;P55036-2;A6PVX3;H0Y3Y9;H0Y561P55036;P55036-2;A6PVX32 S proteasome non-ATPase regulatory subunit 4PSMD4 12 2 377 1.5474 0.63083 4.25E+09
P18583-2;P18583-7;P18583;P18583-5;P18583-9;P18583-6;P18583-10;P18583-3;P18583-4;P18583-8;H7C1M2;J3QSZ5P18583-2; 7; ;P18583-5;P18583-9;P18583-6;P18583-10;P18583- ;P18583-4;P18583-8Protein SON SON 13 13 2140 1.5472 0.296 3.74E+08
Q9UNQ2;A0A0C4DGB1;D6RCL3Q9UNQ2;A0A0C4DGB1;D6RCL3Probable dimethyladenosine transferaseDIMT1 11 11 313 1.5449 0.6227 1.11E+09
P18077;C9K025;F8WBS5;F8WB72P18077;C9K0 5;F8WBS5;F8WB7260S ribosomal protein L35aRPL35A 15 15 110 1.5409 0.69623 2.30E+09
O00411;K7EMH3 O00411 DNA-directed RNA polymerase, mitochondrialPOLRMT 21 21 1230 1.5397 0.52083 2.47E+09
G5E9A6;P51784 G5E9A6;P51784 Ubiquitin carboxyl-terminal hydrolase;Ubiquitin carboxyl-terminal hydrolase 11USP11 8 6 920 1.5347 0.66403 3.81E+08
O96017;O96017-9;O96017-12;O96017-13;O96017-4;H0Y820;O96017-11;O96017-8;O96017-7;H7C0V7;H0Y4V6;C9JFD7;B7ZBF7;B7ZBF6;O96017-5;O96017-2;B7ZBF2;A0A087X102;O96017-3;O96017-9;O96017-12;O96017-13 4;H0Y820Serine/threonine-protein kinase Chk2CHEK2 7 7 543 1.5331 0.67182 2.27E+08
Q9BRK5;Q9BRK5-6;H0Y3T6;G3V1E2;Q9BRK5-4;Q9BRK5-3;Q9BRK5-2;Q9BRK5-5Q9BRK5;Q9BRK5-6;H0Y3T6 G3V1E2;Q9BRK5-4;Q9BRK5-3;Q9BRK5-245 kDa calcium-binding proteinSDF4 9 9 362 1.5307 0.53997 3.61E+08
P20585 P20585 DNA mismatch repair protein Msh3MSH3 12 12 1137 1.53 0.60498 7.80E+08
Q96FC9-4;Q96FC9-3;Q96FC9-2;Q96FC9;H0YGL4;H0YFY8Q96FC9-4;Q96FC9-3;Q96FC9-2;Q96FC9Probable ATP-dependent RNA helicase DDX11DDX11 6 1 856 1.5292 0.42881 3.05E+08
V9GYM8;Q92974-3;Q92974-2;Q92974;Q5VY93;V9GYF0;V9GZ14;V9GYF5;V9GYG5V9GYM8;Q92974-3; 92974-2;Q92974Rho guanine nucleotide exchange factor 2ARHGEF2 21 21 1031 1.5284 0.55428 1.14E+09
Q9Y3U8;J3QSB5;J3KTD3Q9Y U8;J3QSB5 60S ribosomal protein L36RPL36 8 8 105 1.5258 0.61427 8.53E+08
J3KQN4;P83881;H0Y5B4;H7BZ11;R4GN19;H7BY91;H0Y3V9J3KQN4;P83881;H0Y5B4;H7BZ1160S ribosomal protein L36aRPL36A;RPL36A-HNRNPH2 9 3 142 1.5233 0.63803 9.29E+07
A0A087WYN9;Q7Z478;H0Y8L1A0A087WYN9;Q7Z478ATP-dependent RNA helicase DHX29DHX29 36 35 1370 1.523 0.60233 1.77E+09
Q13472-3;Q13472-2;Q13472;K7ELI7;K7EMT6Q13472-3;Q134 2-2;Q13472DNA topoisomerase 3-alphaTOP3A 3 2 906 1.5226 NaN 6.10E+07
Q9NY93-2;Q9NY93;F8WDT8;G3V0G3;H7C3E9;F8WEI3;H7BZN7Q9NY93-2;Q9NY93;F8WDT8;G3V0G3;H7C3E9Probable ATP-dependent RNA helicase DDX56DDX56 3 3 507 1.5219 0.66161 1.00E+08
Q08211;Q08211-2;REV__H0YA90;REV__Q7Z6J0-3Q08211 ATP-dependent RNA helicase ADHX9 60 60 1270 1.5212 0.6807 3.55E+10
P39023;G5E9G0;H7C422;B5MCW2;H7C3M2;F8WCR1;Q92901P39023;G5E9G0; 7C4260S ribosomal protein L3RPL3 27 27 403 1.5192 0.63909 9.01E+09
J3KQ61;O95696;O95696-2J3KQ61;O95696;O95696-2Bromodomain-containing protein 1BRD1 3 3 509 1.5185 0.5966 6.26E+07
Q92917 Q92917 G patch domain and KOW motifs-containing proteinGPKOW 4 4 476 1.5175 0.81312 2.71E+08
C9J494;Q9H000-2;Q9H000C J494;Q9H000-2;Q9H000Probable E3 ubiquitin-protein ligase makorin-2MKRN2 4 4 414 1.5158 0.52945 4.75E+08
P08621;P08621-2;P08621-3;M0QYR1;P08621-4;M0QX04;P08621-2;P08621-3U1 small nuclear ribonucleoprotein 70 kDaSNRNP70 13 13 437 1.5156 0.72387 6.85E+08
A0A0C4DGA6;Q14527;Q14527-2;H7C5K0A0A0C DGA6;Q14 27;Q14527-2Helicase-like transcription factorHLTF 15 15 1008 1.5155 0.57667 5.30E+08
Q8N142;G3V5D8;Q8N142-2Q8N142;G3V5D8;Q8N142-2Adenylosuccinate synthetase isozyme 1ADSSL1 6 2 457 1.5135 NaN 3.10E+07
O94817 O94817 Ubiquitin-like protein ATG12ATG12 1 1 140 1.5125 0.23331 2.69E+09
Q9P2P6;Q9P2P6-3 Q9P2P6;Q9P2P6-3 StAR-related lipid transfer protein 9STARD9 2 2 4700 1.5124 NaN 1.81E+07
Q9H6S0;D6RA70;D6RF50;D6R9T8Q9H6S0;D6RA70 Probable ATP-dependent RNA helicase YTHDC2YTHDC2 19 19 1430 1.5123 0.66508 7.03E+08
Q9Y4B4;H0Y760 Q9Y4B4;H0Y760 Helicase ARIP4 RAD54L2 6 6 1467 1.5108 0.72582 1.33E+08
P13489;H0YCR7;E9PMJ3;E9PLZ3;E9PIM9;E9PMN0;E9PIK5;E9PMA9;E9PR82;E9PMI113489;H0YCR7 Ribonuclease inhibitorRNH1 16 16 461 1.5107 0.70762 6.80E+09
B7Z879;A0A087WXL6;Q9H270;A0A0G2JS92B7Z879;A0A087WXL6;Q9H270;A0A0G2JS92Vacuolar protein sorting-associated protein 11 homologVPS11 2 2 931 1.5049 NaN 5.41E+07
H3BSK8;Q7Z6E9-2;Q7Z6E9H3BSK8;Q7Z6E9-2;Q7Z6E9E3 ubiquitin-protein ligase RBBP6RBBP6 2 2 1008 1.5048 0.89154 3.08E+07
Q9BXP5-4;Q9BXP5-2;Q9BXP5-3;Q9BXP5;Q9BXP5-5;H7C3A1;H7C1K0;H7C0U8;A0A0A0MSP6;C9JUL9Q9BXP5-4;Q9BXP5-2; 3;Q9BXP5;Q9BXP5-5;H7C3A1Serrate RNA effector molecule homologSRRT 37 37 871 1.5031 0.55242 1.99E+09
O60942-4;O60942;O60942-2;O60942-34; ;O60942-2;O60942-3mRNA-capping enzyme;Polynucleotide 5-triphosphatase;mRNA guanylyltransferaseRNGTT 6 6 541 1.501 0.47791 3.05E+08
P55265-5;P55265;P55265-4;H0YCK3;P55265-3;P55265-25;P55265; 4;H0YCK3;P55265-3;P55265-2Double stranded RNA-specific adenosine deaminaseADAR 48 48 931 1.4976 0.53835 1.14E+10
Q96S55-2;Q96S55;Q96S55-3;Q96S55-42; ;Q96S55-3;Q96S55-4ATPase WRNIP1 WRNIP1 10 10 640 1.4955 0.6643 7.79E+08
Q9BQ39;A0A087WVC1Q9BQ39;A0A087WVC1ATP-dependent RNA helicase DDX50DDX50 8 6 737 1.4952 0.59102 8.66E+08
F8VS10;Q86XZ4 F8VS10;Q86XZ4 Spermatogenesis-associated serine-rich protein 2SPATS2 1 1 295 1.4913 0.84671 7.58E+06
Q9BVJ6-3;Q9BVJ6;Q9BVJ6-2;Q5TAP6;X6RJY0Q9BVJ6-3;Q9BVJ6;Q9BVJ6-2U3 small nucleolar RNA-associated protein 14 homolog AUTP14A 10 10 719 1.4896 0.60531 5.14E+08
P28070 P28070 Proteasome subunit beta type-4PSMB4 2 2 264 1.4894 NaN 5.18E+07
Q9UG63;Q9UG63-2;C9JHK9;C9JZV3Q9UG63;Q UG63-2ATP-binding cassette sub-family F member 2ABCF2 29 29 623 1.4871 0.51634 7.63E+09
Q5VZL5-4;Q5VZL5;Q5VZL5-3;Q5VZL5-2;H7C1I7Q5VZL5-4;Q5VZL5;Q5VZL5-3;Q5VZL5-2;H7C1I7Zinc finger MYM-type protein 4ZMYM4 17 16 1516 1.4857 0.70512 4.73E+08
Q9H7B4;Q9H7B4-3;Q9H7B4-2;B0QZ88;B0QZA0;A8MXR1Q9H7B4;Q9H7B4-3;Q9H7B4-2Histone-lysine N-methyltransferase SMYD3SMYD3 5 5 428 1.4856 0.59343 3.70E+08
Q9UGR2-2;Q9UGR2Q9UGR2-2;Q9UGR2Zinc finger CCCH domain-containing protein 7BZC3H7B 4 4 977 1.4856 0.78846 1.59E+08
M0QZ28;Q9Y4J8-6;Q9Y4J8-10;Q9Y4J8-11;Q9Y4J8-13;Q9Y4J8-2;Q9Y4J8-14;Q9Y4J8-15;Q9Y4J8;M0R0C4M0QZ28;Q9Y4J8-6;Q9Y4J8-10;Q9Y4J8-11;Q9Y4J8-13;Q9Y4J8-2;Q9Y4J8-14 Q9Y4J8-15;Q9Y4J8;M0R0C4Dystrobrevin alpha DTNA 3 1 365 1.483 NaN 7.92E+07
Q8N7H5-3;Q8N7H5;Q8N7H5-2;B4DGJ5Q8N7H5-3;Q8N7H5;Q8N7H5-2RNA polymerase II-associated factor 1 homologPAF1 5 5 485 1.4825 0.62506 8.02E+08
Q96PK6;Q96PK6-2;A0A0A6YYI9;F8WDX3;A0A0A0MSL8;B8ZZ74;Q96PK6-3;Q96PK6-4Q96PK RN -binding protein 14RBM14 24 18 669 1.4823 0.45796 2.76E+09
Q13425;H0YCS0;Q13425-2;H7BY41;A0A140TA73Q13425; 0YCS0 Q13425-2Beta-2-syntrophin SNTB2 5 4 540 1.4816 0.59085 3.30E+08
P62750;H7BY10;K7ERT8;A8MUS3;K7EJV9;K7EMA7P62750;H7BY10;K7ERT8;A8MUS3;K7EJV960S ribosomal protein L23aRPL23A 15 15 156 1.4811 0.59354 5.39E+09
P42766;F2Z388 P42766;F2Z388 60S ribosomal protein L35RPL35 9 9 123 1.4806 0.69633 2.17E+09
Q96PE3-2;Q96PE3-4;Q96PE3-3;Q96PE3;B8ZZB2Q96PE3-2;Q96PE3-4;Q96PE3-3;Q96PE3Type I inositol 3,4-bisphosphate 4-phosphataseINPP4A 5 5 938 1.4802 0.55343 1.02E+08
P26373;P26373-2;J3QSB4;H3BTH3;J3KS98;H3BUK8P26373;P26373-2;J3QSB460S ribosomal protein L13RPL13 13 13 211 1.4799 0.69412 1.01E+10
H0Y2S1;O43824 H0Y2S1;O43824 Putative GTP-binding protein 6GTPBP6 6 6 516 1.4796 0.62119 1.73E+08
E7EXA6;Q8WVB6;Q8WVB6-2;A0A0D9SF58;F8WCC1;Q8WVB6-3;H0Y7D3E7EXA ;Q8WVB6;Q8WVB6-2;A0A0D9SF58;F8WCC1;Q8WVB6-3Chromosome transmission fidelity protein 18 homologCHTF18 12 12 975 1.4795 0.42861 6.53E+08
P20042 P20042 Eukaryotic translation initiation factor 2 subunit 2EIF2S2 23 23 333 1.4788 0.56179 5.99E+09
P47914;F8WF43;C9IYI4P47914 60S ribosomal protein L29RPL29 5 5 159 1.4779 0.61448 2.27E+08
P50914;E7EPB3 P50914;E7EPB3 60S ribosomal protein L14RPL14 10 10 215 1.4767 0.71483 5.04E+09
Q9Y2L1;Q9Y2L1-2;G3V1J5;F2Z2C0Q9Y2L1;Q9Y2L1-2;G3V1J5;F2Z2C0Exosome complex exonuclease RRP44DIS3 51 51 958 1.4758 0.57745 1.56E+10
P62851 P62851 40S ribosomal protein S25RPS25 8 8 125 1.4754 0.71598 4.43E+09
P82933 P82933 28S ribosomal protein S9, mitochondrialMRPS9 9 9 396 1.4753 0.58347 8.91E+08
Q9NY12-2;Q9NY12 Q9NY12-2;Q9NY12 H/ACA ribonucleoprotein complex subunit 1GAR1 3 3 199 1.4752 NaN 5.41E+07
Q04727-2;Q04727-4;Q04727;Q04727-3;Q5T7A9;Q04724;H7C4E4;K7EMK7;Q04725;H7C4W5;H0Y5S0;Q5JSY7;Q04725-3;F8WAY5;A0A0A0MT79;Q5JSZ2;K7EPD4;K7EPF3;K7ESD8;Q5JSY8;Q5JSZ1;Q5T3G3;E7EQH3Q04727-2; 4; 04 27 7-3;Q5T7A9;Q04724Transducin-like enhancer protein ;Transducin-like enhancer protein 1TLE4; LE1 10 7 4 1.4742 0.56657 2.01E+08
O43852;O43852-3;O43852-5;O43852-6;O43852-2;O43852-4;O43852-13;O43852-14;O43852-9;O43852-11;O43852-10;H0Y875;O43852-12;O43852-7;O43852-15;O43852-8;O43852-3;O43852-5;O43852-6;O43852- ;O43852-4;O43852-13;O43852-14;O43852-9;O43852-11;O43852-10Calumenin CALU 8 315 1.4735 0.7 97 3.71E+08
E9PPY3;O43159 E9PPY3;O43159 Ribosomal RNA-processing protein 8RRP8 2 2 306 1.4734 0.75902 1.04E+08
Q5JTH9-2;Q5JTH9-3;Q5JTH9;A0A087X1U8;A0A087X0G0;H7C1M8Q5JTH9-2;Q5JTH9-3;Q5JTH9RRP12-like protein RRP12 24 24 1197 1.4718 0.53388 1.02E+09
Q96EY7;B8ZZQ4;Q96EY7-2;F8WE76Q96EY7 Pentatricopeptide repeat domain-containing protein 3, mitochondrialPTCD3 8 8 689 1.4715 0.73057 1.07E+09
Q8IWR0;I3L2K5;I3L323;I3L2N8;I3L3S2;I3L3F9;I3L1Y3;I3L282;I3L382;Q8IWR0-2Q8IWR0;I3L2K5 Zinc finger CCCH domain-containing protein 7AZC3H7A 11 11 971 1.4714 0.55656 6.18E+08
Q9BZE4;Q9BZE4-2;Q9BZE4-3;Q5T3R7Q9BZE4;Q9BZE4-2;Q9BZE4-3Nucleolar GTP-binding protein 1GTPBP4 23 23 634 1.4712 0.66103 2.37E+09
Q96DT7;Q96DT7-2;Q96DT7-4;Q96DT7-3;Q96DT7-2;Q96DT7-4;Q96DT7-3Zinc finger and BTB domain-containing protein 10ZBTB10 4 4 871 1.471 NaN 1.20E+08
P62857 P62857 40S ribosomal protein S28RPS28 3 3 69 1.4699 0.7491 1.25E+08
P62854;Q5JNZ5 P62854;Q5JNZ5 40S ribosomal protein S26;Putative 40S ribosomal protein S26-like 1RPS26;RPS26P11 4 4 115 1.468 0.69834 2.84E+09
C9JAG1;A0A087WW58;Q9C0D9C9JAG1;A0A087WW58;Q9C0D9Ethanolaminephosphotransferase 1EPT1 2 2 180 1.4673 1.8561 3.58E+08
Q04864-2;Q04864 Q04864-2;Q04864 Proto-oncogene c-RelREL 3 3 587 1.4635 0.72043 8.60E+07
P62917;E9PKU4;E9PKZ0;E9PP36;G3V1A162917;E9PKU4;E9PKZ0;E9PP36;G3V1A160S ribosomal protein L8RPL8 18 18 257 1.4629 0.64086 2.78E+09
Q9H501;A0A087WX71Q9H501;A0A087WX71ESF1 homolog ESF1 3 3 851 1.4624 NaN 8.24E+07
B7ZM99;A0A087WVM4;Q6UB35;H0Y327;Q6UB35-2;Q5JYA8;Q5JYA3;Q4VXM0;Q4VXM1;Q4VXV2B7ZM99;A0A087WVM4;Q6UB35Monofunctional C1-tetrahydrofolate synthase, mitochondrialMTHFD1L 29 28 979 1.4616 0.58629 5.67E+09
J3KNS1;Q9UPW5;Q9UPW5-2;Q9UPW5-3J3KNS1;Q9UPW5;Q9UPW5-2;Q9UPW5-3Cytosolic carboxypeptidase 1AGTPBP1 6 6 1278 1.4612 0.73418 2.53E+08
P62266;D6RD47;D6RDJ2;D6RIX0;D6R9I7P62266;D6RD47;D6RDJ2;D6RIX0;D6R9I740S ribosomal protein S23RPS23 6 6 143 1.4608 0.76151 4.18E+09
Q12756;Q12756-3;Q12756-2;F8W8V9;H7C0K6;H7C3Y8;H7C437;Q12756-3;Q12756-2;F8W8V9Kinesin-like protein KIF1AKIF1 31 25 1690 1.4604 0.55234 1.44E+09
P24468-3;P24468-2;P24468;H3BTC2;P10588P24468-3;P24468-2;P24468COUP transcription factor 2NR2F2 6 2 261 1.4591 0.49619 4.16E+08
Q5VYS8-6;Q5VYS8;X6R3Q3;Q5VYS8-3;Q5VYS8-2;Q5VYS8-4;Q5VYS9;Q5VYS8-5;Q5VYT0;A0A0C4DFW3Q5VYS8-6;Q5VYS8;X6R3Q3;Q5VYS8-3;Q5VYS8-2;Q5VYS8-4Terminal uridylyltransferase 7ZCCHC6 6 6 1457 1.4579 0.52255 1.64E+08
Q8IY17-5;Q8IY17-2;Q8IY17-3;Q8IY17;Q8IY17-4;M0QYF5;M0QZK5;M0R2H4;M0R2K2;M0QYT1;M0R2C28IY17-5; 8IY17-2;Q8IY17-3;Q8I 17;Q8IY17-4Neuropathy target esterasePNPLA6 5 5 1300 1.4566 0.64284 1.83E+08
Q9Y3B9 Q9Y3B9 RRP15-like protein RRP15 5 5 282 1.4563 0.66309 2.90E+08
Q8WTT2 Q8WTT2 Nucleolar complex protein 3 homologNOC3L 17 17 800 1.4561 0.65487 1.81E+09
P82675;P82675-2 P82675 28S ribosomal protein S5, mitochondrialMRPS5 7 7 430 1.4531 0.72468 5.83E+08
Q8N1G4 Q8N1G4 Leucine-rich repeat-containing protein 47LRRC47 26 26 583 1.452 0.57629 8.31E+09
P52597 P52597 Heterogeneous nuclear ribonucleoprotein F;Heterogeneous nuclear ribonucleoprotein F, N-terminally processedHNRNPF 18 16 415 1.4518 0.60524 1.33E+10
Q9UNX3;E5RIT6;E5RHH1Q9UNX3;E5RIT6 60S ribosomal protein L26-like 1RPL26L1 16 2 145 1.4501 0.66387 2.27E+07
134
Q14966-3;Q14966;Q14966-4;A0A096LPH6;Q14966-2;Q14966-53;Q1496 ;Q14966-4Zinc finger protein 638ZNF 38 6 6 1957 1.45 0.7163 1.46E+08
H0Y3N9;Q9UPP1-5;Q9UPP1-4;Q9UPP1-3;Q9UPP1-2;Q9UPP1;E7ET14;A0A087WW48;H0Y589;O75151H0Y3N9;Q9UPP1-5;Q9UPP1-4;Q9UPP1-3;Q9UPP1-2;Q9UPP1Histone lysine demethylase PHF8PHF8 3 3 953 1.449 0.64029 1.41E+08
Q9BUF5;K7ESM5;K7EL29;K7ESQ3;K7EQT3;K7EJ64;K7ERA8;K7EJZ4;K7ES63;K7EN98;K7EPE5Q9BUF5;K7ESM5 Tubulin beta-6 chainTUBB6 24 11 446 1.449 0.68614 1.64E+10
P49754-2;P49754-3;P49754;H7BZX6P49754-2;P49754-3;P49754;H7BZX6Vacuolar protein sorting-associated protein 41 homologVPS41 2 2 802 1.4487 NaN 4.27E+07
B4DJV5;Q13610 B4DJV5;Q13610 Periodic tryptophan protein 1 homologPWP1 5 5 439 1.4475 0.92954 1.83E+08
F8W727;P62910;D3YTB1;D3YTI8F8W727;P62910;D3YTB160S ribosomal protein L32RPL32 16 16 153 1.446 0.57432 6.93E+08
P62899;H7C2W9;C9JU56;B7Z4E3;B7Z4C8;P62899-3;P62899-2;B8ZZK4P62899;H7C2W9;C9JU56;B7Z4E3;B7Z4C8;P62899-3;P62899-2;B8ZZK460S ribosomal protein L31RPL31 12 12 125 1.4458 0.69535 2.91E+09
Q6ZNB6-2;Q6ZNB6 Q6ZNB6-2;Q6ZNB6 NF-X1-type zinc finger protein NFXL1NFXL1 3 3 733 1.4455 0.47885 1.58E+08
Q86V81;E9PB61 Q86V81;E9PB61 THO complex subunit 4ALYREF 5 5 257 1.4425 0.64593 1.60E+09
Q96J01;Q96J01-2;D6RGZ2;D6REC9;H7C0C5Q96J01;Q96J01-2;D6RGZ2THO complex subunit 3THOC3 12 12 351 1.4412 0.62369 1.98E+09
F5H5R8;P18440 F5H5R8;P18440 Arylamine N-acetyltransferase 1NAT1 3 3 352 1.4381 0.58469 3.58E+08
Q5T160;H0Y450 Q5T160 Probable arginine--tRNA ligase, mitochondrialARS2 5 5 578 1.4378 0.80018 3.75E+08
Q9HCE1;Q5JR04;Q9HCE1-2Q9HCE1;Q5JR04;Q9HCE1-2Putative helicase MOV-10MOV10 18 18 1003 1.4371 0.6824 1.43E+09
O00170;E9PMH2;V9GYQ3O00170;E9PMH2 AH receptor-interacting proteinAIP 7 7 330 1.4329 0.63347 4.38E+08
P83731;C9JXB8;C9JNW5P83731;C9JXB8;C9JNW560S ribosomal protein L24RPL24 14 14 157 1.4321 0.74344 7.36E+09
P36578;H3BM89;H3BTP7;H3BU31P365 8;H3BM89 60S ribosomal protein L4RPL4 33 33 427 1.4297 0.65076 1.90E+10
O95433;O95433-2;H0YJG7;G3V438;H0YJ63;G3V3W9;H0YJU2O95433;O95 3-2;H0YJG7;G V438Activator of 90 kDa heat shock protein ATPase homolog 1AHSA1 14 14 338 1.4281 0.67899 9.76E+09
Q96I24;Q96I24-2 Q96I24;Q96I24-2 Far upstream element-binding protein 3FUBP3 23 19 572 1.4261 0.76516 3.65E+09
O15371-3;O15371;O15371-2;B0QYA5;B0QYA4;B0QYA6;B0QYA8;A0A0D9SGB53;O15371 O15371-2;B0QYA5Eukaryotic translation initiation factor 3 subunit DEIF3D 21 21 533 1.4253 0.70216 3.59E+09
P39748;P39748-2;I3L3E9;F5H1Y3;CON__P01030;CON__ENSEMBL:ENSBTAP00000007350P39748;P39748-2;I3L3E9Flap endonuclease 1FEN1 16 16 380 1.4253 0.67351 4.30E+09
P40429;M0QYS1;Q8J015;Q6NVV1;M0QZU1;A0A096LPE0P40429;M0QYS1;Q8J01560S ribosomal protein L13aRPL13A;RPL13a 17 17 203 1.4247 0.65208 3.58E+09
C9JJ19;P82930;A0A087WUZ8C9JJ19;P82930;A0A087WUZ828S ribosomal protein S34, mitochondrialMRPS34 9 9 225 1.4233 0.67496 1.39E+09
E7ETK0;A0A087WUS0;P62847-2;P62847-3;P62847;P62847-4E7ETK0;A0A087WUS0;P62847-2; 3;P62847;P62847-4S ribosomal protein S24RPS24 6 6 131 1.4209 0.71118 2.78E+09
Q9Y3A5;A0A087X020;F8WE72Q9Y3A5;A0A087X020Ribosome maturation protein SBDSSBDS 20 20 250 1.42 0.6762 5.79E+09
O15084;O15084-4;O15084-1;O15084-2;B4DIW9;O15084- ;O15084-1;O15084-2;B4DIW9Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit AANKR 28 13 12 1053 1.4184 0.60323 6.91E+08
Q15366-6;Q15366-3;Q15366;Q15366-2;H3BSS4Q15366- ; 3;Q15366;Q15366-2Poly(rC)-binding protein 2PCBP 19 2 361 1.4163 NaN 3.04E+09
X6R700;Q9Y3Y2-4;Q9Y3Y2;Q9Y3Y2-3;A0A087X1B7;Q5T7Y7X6R700;Q9Y3Y2-4;Q9Y3Y2;Q9Y3Y2-3;A0A087X1B7Chromatin target of PRMT1 proteinCHTOP 3 3 223 1.4155 0.76397 4.78E+07
E9PR30;P62861 E9PR30;P62861 40S ribosomal protein S30FAU 4 4 98 1.4129 0.65661 2.39E+09
Q96JH7 Q96JH7 Deubiquitinating protein VCIP135VCPIP1 9 9 1222 1.4122 0.61296 3.25E+08
Q02543;M0R3D6;M0R1A7;M0R117;M0R0P7Q02543; 0R3D6;M0R1A7;M0R117;M0R0P760S ribosomal protein L18aRPL18A 13 13 176 1.4115 0.75879 1.47E+09
C9J7X6;A4D1U4 C9J7X6;A4D1U4 Protein LCHN KIAA1147;LCHN 3 3 351 1.4107 0.9412 8.30E+07
Q9UG01;Q9UG01-2;F5GZ56;Q9UG01-3;H7C252;H7C186;H7C161;H0YAI8Q9UG01; 2Intraflagellar transport protein 172 homologIFT172 19 19 1749 1.4104 0.52577 5.69E+08
Q9BST8;J3QQH7;J3QLE9;J3QL06;J3KTF1;E9PJ21;A0A087WWI4;K7EQK2;A0A087X054;Q9Y4L1;A0A087X214;A0A087WW13;Q9Y4L1-29BST8;J3QQH7;J3QLE9; 3QL06;J3KTF1;E9PJ21;A0A087WWI4;K7EQK2;A0 87X054;Q9Y4L1;A0A087X214;A0A087WW13Hypoxia up-regulated protein 1HYOU1 3 3 47 1.4091 NaN 3.28E+07
F5H6E2;O00159-2;O00159-3;O00159;I3L204;I3L4D4;I3L501;I3L3Y6;I3L168;I3L3F5F5H6E2;O00159-2;O00159- ;O00159Unconventional myosin-IcMYO1C 23 23 1039 1.4064 0.70148 2.02E+09
D6RID8;Q6P1K8;Q13888;R4GMS9;D6RJD3;D6RIT7;D6RGC9;D6RAW1D6RID8;Q6P1K8;Q13888;R4GMS9;D6RJD3General transcription factor IIH subunit 2-like protein;General transcription factor IIH subunit 2GTF2H2C;GTF2H2 5 5 253 1.404 0.72865 3.25E+08
J3QQ67;Q07020;G3V203;H0YHA7;Q07020-2;F8VYV2;A0A075B7A0;F8VUA6;F8VXR6J3QQ67;Q07020;G3V203;H0YHA7;Q07020-2;F8VY 2; 0A075B7A0;F8VUA660S ribosomal protein L18RPL18 12 12 190 1.4038 0.69306 9.62E+09
Q9NXH9;Q9NXH9-2;K7EQQ8;K7EQU7;K7EQY6;K7EMZ2;K7ENI9;K7EJX9;K7ERR5Q9NXH9;Q9NXH9-2;K7EQQ8tRNA (guanine( 6)-N(2))-dimethyltransferaseTRMT1;SEMA4B 17 17 659 1.4038 0.56654 1.31E+09
Q8N5C6;Q8N5C6-2Q8N5C6;Q8N5C6-2S1 RNA-binding domain-containing protein 1SRBD1 14 14 995 1.4031 0.561 6.22E+08
P04350;M0R278;M0QY85;M0R0X0;M0QY37;M0QX14;M0QZL7;M0QYM7;M0R042;M0R1I1P04350 Tubulin beta-4A chainTUBB4A 31 3 444 1.4003 0.71492 2.40E+09
O76031;H0YM48;H0YK07O76 31 ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrialCLPX 14 14 633 1.4 0.59638 1.61E+09
Q5QPK2;H0Y368;O60762;Q5QPJ9Q5QPK2;H0Y368;O60762;Q5QPJ9Dolichol-phosphate mannosyltransferase subunit 1DPM1 13 13 287 1.3994 0.68471 5.92E+09
P61513;G5E9R3;Q6P4E4;E9PEL3;C9J4Z3;M0R0A1;M0R2L6;A6NKH3P61513;G5E9R3;Q6P4E4;E9PEL3;C9J4Z3;M0R0A1;M0R2L660S ribosomal protein L37aRPL37A 6 6 92 1.397 0.73866 1.46E+09
O15047;C9J2Z9 O15047 Histone-lysine N-methyltransferase SETD1ASETD1A 9 9 1707 1.3969 0.41112 3.76E+08
V9GY48;Q8N5A5-3;Q8N5A5-2;Q8N5A5;A0A0J9YYD9;Q8N5A5-4V9GY48;Q8N5A -3;Q8N5A5-2;Q8N5AZinc finger CCCH-type with G patch domain-containing proteinZGPAT 3 3 417 1.396 0.41924 9.55E+07
P14618-2;H3BTN5;H3BR70P14618-2;H3BTN5;H3BR70Pyruvate kinase PKM;Pyruvate kinasePKM 53 4 531 1.3956 0.62712 1.28E+08
Q6UXN9;C9JBU3 Q6UXN9 WD repeat-containing protein 82WDR82 10 10 313 1.3951 0.61437 1.38E+09
G5E9W7;G5E9V5;P82650;H7C5L9;H7C5F2;H7C5H3;P82650-2;C9J5D8G5E9W7;G5E9V5;P82650;H7C5L928S ribosomal protein S22, mitochondrialMRPS 2 15 15 319 1.3943 0.6445 4.17E+09
Q5VVQ6-2;Q5VVQ6Q5VVQ6-2;Q5VVQ6Ubiquitin thioesterase OTU1YOD1 8 8 304 1.3936 0.53985 1.50E+09
M0R2B7;P28340;M0QZR8;M0QXE6;M0QXQ2;M0QZB4;M0R3H8M0R2B7;P28340;M0QZR8DNA polymerase;DNA polymerase delta catalytic subunitPOLD1 26 26 1133 1.3929 0.60144 2.89E+09
H0Y7P7;Q9UG56;B1AKM8;B1AKM6;Q9UG56-2H0Y7P7;Q9UG56;B1AKM8;B1AKM6;Q9UG56-2Phosphatidylserine decarboxylase proenzyme;Phosphatidylserine decarboxylase alpha chain;Phosphatidylserine decarboxylase beta chainPISD 2 2 362 1.3917 NaN 4.19E+07
A0A0A0MQR1;Q9Y4K4;G3V5C6A0A0A0MQR1;Q9Y4K4Mitogen-activated protein kinase kinase kinase kinase 5MAP4K5 4 4 846 1.3911 0.6729 1.12E+08
E9PDF6;O43795;O43795-2;H7C2Y7;E7EQD9;C9JYW1;Q9UBC5;C9K0I9;C9JUP5;A0A0U1RRI3;G3V342E9PDF6;O43795 O43795-2Unconventional myosin-IbMYO1B 16 16 1107 1.388 0.66492 1.47E+09
Q6R327;Q6R327-3 Q6R327;Q6R327-3 Rapamycin-insensitive companion of mTORRICTOR 7 7 1708 1.388 0.6668 2.44E+08
O60506-4;O60506-3;O60506-2;O60506;B7Z645;O60506-5;F6UXX1;H0YAA0O60506-4;O60506-3;O60506-2;O60506;B7Z645 O60506-5Heterogeneous nuclear ribonucleoprotein QSYNCRIP 23 18 527 1.3878 0.80557 3.05E+09
Q6N069;Q6N069-4;Q6N069-3;Q6N069-2;Q6N069-5Q6N069;Q6N069-4;Q6N069-3;Q6N069-2;Q6N069-5N-alpha-acetyltransferase 16, NatA auxiliary subunitNAA16 10 5 864 1.3876 0.99074 7.65E+07
E7ERS3;Q86VM9;Q86VM9-2;H3BRH3E7ERS3;Q86VM9;Q86VM9-2Zinc finger CCCH domain-containing protein 18ZC3H18 3 3 977 1.3875 0.2708 7.99E+07
P62701;Q8TD47;C9JEH7;P22090P62 01 40S ribosomal protein S4, X isoformRPS4X 24 24 263 1.3861 0.70394 1.93E+10
E7ESC7;Q7L5Y9-3;Q7L5Y9;Q7L5Y9-2;B4DQT1;B4DVN3;D6RE80;D6RIB6;Q7L5Y9-4;D6RDW4;D6REW7;Q7L5Y9-5;D6RA86;D6R8Z3;D6RID6E7ESC7;Q7L5Y9-3;Q7L5Y9;Q7L5Y9-2;B4DQT1;B4DVN3;D6RE80;D6RIB6;Q7L5Y9-4Macrophage erythroblast attacherMAEA 7 7 434 1.3847 0.53258 2.48E+08
O00311;B1AMW7 O00311 Cell division cycle 7-related protein kinaseCDC7 3 3 574 1.3846 0.44167 1.10E+08
G8JLB6;P31943;E9PCY7;D6RBM0;H0YB39;D6RIT2;D6RIU0;D6RAM1;D6R9T0;D6RFM3;E7EN40;D6RDU3;D6RJ04;D6RIH9;H0YBD7;E7EQJ0;E5RGV0;D6RDL0;H0YBG7;D6RF17;E5RGH4;H0YAQ2;D6R9D3;E5RJ94G8JLB6;P31943;E9PCY7;D6RBM0;H0YB39;D6RIT2;D6RIU0Heterogeneous nuclear ribonucleoprotein H;Heterogeneous nuclear ribonucleoprotein H, N-terminally processedHNRNPH 22 11 472 1.3839 0.630 5 4.64E+10
P49643;P49643-2;A0A096LP51P49643 DNA primase large subunitPRIM2 7 7 509 1.3839 0.71333 7.49E+08
Q9C0J8;B9A053;Q9C0J8-3;Q9C0J8-2Q9C0J8 pre-mRNA 3 end processing protein WDR33WDR33 7 7 1336 1.3792 0.34111 2.63E+08
Q9NZI8;Q9NZI8-2;REV__M0QZ54;REV__M0R118;REV__M0R0M7;Q2L6G8;G8JLG2;REV__A0A087WWS7;REV__Q15833;Q15517Q9NZI8; 9NZI8-2 Insulin-like growth factor 2 mRNA-binding protein 1IGF2BP1 31 29 577 1.3766 0.75699 1.38E+10
E9PHA2;Q15003;C9J470;Q15003-2;C9JZP1;H7C415E9PHA2;Q15003;C9J470;Q15003-2Condensin complex subunit 2NCAPH 21 21 730 1.3742 0.56424 3.17E+09
Q13509;A0A0B4J269;Q13509-2;G3V2A3;G3V5W4;G3V2R8;G3V3R4;G3V2N6;G3V542;G3V3J6;G3V3W7Q13509;A0A0B4J 69;Q13 09-2Tubulin beta-3 chainTUBB3 22 6 450 1.3741 0.68103 7.01E+08
Q9Y3Z3;Q9Y3Z3-3;Q9Y3Z3-4;Q9Y3Z3-2Q9Y3Z3;Q9Y3Z3-3;Q9Y3Z3-4;Q9Y3Z3-2Deoxynucleoside triphosphate triphosphohydrolase SAMHD1SAMHD1 20 20 626 1.3731 0.64884 2.86E+09
P43250-2;F8W9W2;P43250-3;P43250;D6RHX8;P34947P43250-2;F8W9W2;P43250-3;P43250G protein coupled receptor kinase 6GRK6 3 3 589 1.373 0.57802 1.28E+08
Q15020;Q15020-4;F8VV04;Q15020-2;F8W667;F8VVK9;H0YHU8;F8VZM2;Q15020-3Q15020; 4; VV04Squamous cell carcinoma antigen recognized by T-cells 3SART3 1 31 963 1.3727 0.70443 2.27E+09
A3KMH1-3;A3KMH1;A3KMH1-2A3KMH1-3;A3KMH1;A3KMH1-2von Willebrand factor A domain-containing protein 8VWA8 15 15 1872 1.3725 0.60217 8.19E+08
F5H562;E7ET55;F5H748;B7ZLR4;P35670-2;P35670-3;P35670-4;P35670;A0A0U1RQY8F5H562;E7ET55;F5H748;B7ZLR4;P35670-2;P35670-3;P35670-4;P35670;A0A0U1RQY8Copper-transporting ATPase 2;WND/14  kDaATP7B 2 2 1035 1.3718 0.81494 1.20E+08
Q9Y5Q8;Q9Y5Q8-3;Q5T7U1;Q9Y5Q8-2;Q5T7U4;Q5T7U0;H7BY84;H0Y5D29Y5Q8; 3; 1; 9Y5Q8-2;Q5T7U4General transcription factor 3C polypeptide 5GTF3C5 10 10 519 1.3686 0.59567 1.49E+09
Q86U86-5;Q86U86-4;Q86U86-7;Q86U86-9;Q86U86-2;Q86U86-8;Q86U86;Q86U86-3;E7EVG2;Q86U86-6;H0Y5B5;C9JPI5;C9J053;C9JQF1;C9J409;C9JCJ2Q86U86-5;Q86U86-4;Q86U86-7;Q86U86-9;Q86U86-2;Q86U86-8;Q86U86 3 E7EVG2;Q86U86-6;H0Y5B5Protein polybromo-1PBRM1 15 15 1582 1.3679 0.61894 4.95E+08
Q9HBD4;A0A0A0MT49;P51532-5;P51532-2;P51532-3;P51532-4;P51532;K7EP28;A0A0U1RRF5;A0A0U1RRD6;A0A0U1RRF8;A0A0A0MSS5;F6UH26;A0A0U1RR09;B1ALG1;F6T8Q0;B1ALG2Q9HBD4;A0A0A0MT49;P51532-5;P51532- ;P51532-3;P51532-4;P51532ranscription activator BRG1SMARCA4 39 25 1679 1.367 0.65614 2.66E+09
Q9UGI8-2;Q9UGI8;F8W7T0;H7BYK1Q9UGI8-2;Q9UGI8 Testin TES 16 16 412 1.3665 0.63467 5.76E+08
B9EGE7;Q8TCN5;Q8TCN5-2B9EGE7;Q8TCN5;Q8TCN5-2Zinc finger protein 507ZNF507 4 4 957 1.364 0.50591 4.09E+07
E9PKT9;O96033 E9PKT9;O96033 Molybdopterin synthase sulfur carrier subunitMOCS2 2 2 83 1.3639 NaN 4.47E+07
Q9H2P0;E9PQK8 Q9H2P0 Activity-dependent neuroprotector homeobox proteinADNP 19 19 1102 1.3636 0.56472 1.07E+09
Q9UNY4;Q9UNY4-2;X6RI15Q9UNY4 Transcription termination factor 2TTF2 5 5 1162 1.3625 0.87553 1.10E+08
Q13126-4;Q13126;Q13126-3;Q13126-2;J3QSB7;B4DUC8;Q13126-7;Q13126-6;Q13126-5;F2Z2F3;F8WES2;J3KRN14; ;Q1 126-3;Q13126-2;J QSB7;B4DUC8;Q13126-7;Q131 6-6;Q13126-5;F2Z2F3S-methyl-5-thioadenosine phosphorylase;Purine nucleoside phosphorylaseMTAP 5 5 280 1.3613 1.432 5.53E+08
P28074;P28074-3;H0YJM8;P28074-2P28074 3 Proteasome subunit beta type-5PSMB5 7 7 263 1.3606 0.6995 1.93E+08
Q9Y6V7;Q9Y6V7-2;M0R1S3;M0QZC0;M0R0K1Q9Y6V7;Q9Y6V7-2 Probable ATP-dependent RNA helicase DDX49DDX49 7 7 483 1.3601 0.60916 3.81E+08
Q13045;Q13045-3;J3QQQ2;K7EQZ7;J3QQU5;J3QLR6;J3KS39;J3KT47;K7EP37;K7EP27Q13045;Q13045-3 Protein flightless-1 homologFLII 25 1 1269 1.3597 0.67551 3.05E+09
Q9Y291;C9JBY7 Q9Y291;C9JBY7 28S ribosomal protein S33, mitochondrialMRPS 3 3 3 106 1.3577 0.74063 1.57E+08
A0A0A0MRI0;P42771-2;K7ES20;K7ENC6;Q8N726;Q8N726-2;P42772A0A0A0MRI0;P42771-2;K7ES20;K7ENC6Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3CDKN A 6 2 170 1.3566 0.34907 2.80E+07
Q09472;I3L0Q1 Q09472 Histone acetyltransferase p300EP300 8 4 2414 1.356 0.48235 4.65E+07
P46776;E9PJD9;E9PLL6;E9PLX746776;E9PJD9;E9PLL6;E9PLX760S ribosomal protein L27aRPL27A 8 8 148 1.3541 0.7847 2.30E+09
H7BXH2;E9PKF6;Q5H9R7-6;Q5H9R7-2;Q5H9R7;Q5H9R7-5;Q5H9R7-3;Q5H9R7-4;E9PQP7;E9PNN8;H0YEN2;E9PK08;E9PKG4;E9PJD8;H0YEV0;H0YDW1H7BXH2;E9PKF6;Q5H9R7-6;Q5H9R7-2;Q5H9R7;Q5H9R7-5;Q5H9R7-3;Q5H9R7-4;E9PQP7Serine/threonine protein phosphatase 6 regulatory subunit 3PPP6R3 20 20 27 1.3536 0.63762 1.68E+09
P46779;H0YKD8;P46779-2;P46779-3;H0YMF4;P46779-4;P46779-5;H0YLP6P46779 H0YKD8;P46779-2; 3;H0YMF4;P46779-4;P46779-5;H0YLP66 S ribosomal protein L28RPL28 15 15 137 1.3527 0.70496 2.69E+09
M0R0F0;M0R0R2;P46782;M0QZN2M0R0F0;M0R0R2;P46782;M0QZN20S ribosomal protein S5;40S ribosomal protein S5, N-terminally processedRPS5 10 10 200 1.3525 0.66789 1.07E+09
J3QS41;P42694;P42694-2;A0A075B6R3;J3KT20;J3QRR8;J3KS59J3QS41;P42694;P42694-2Probable helicase with zinc finger domainHELZ 15 15 1943 1.3522 0.67096 5.86E+08
P53621;P53621-2 P53621;P53621-2 Coatomer subunit alpha;Xenin;ProxeninCOPA 72 72 1224 1.3521 0.66011 2.50E+10
D6RIC3;A0A0C4DGU5;A0A087X2G6;Q9Y3C1;Q9Y3C1-3;Q9Y3C1-2;A0A087X1T1;D6RC60D6RIC3;A0A0C4DGU5;A0A087X2G6; ;Q9Y3C1-3;Q9Y3C1-2;A A087X1T1Nucleolar protein 16NOP 6 4 4 150 1.3513 0.75967 2.00E+08
A0A087X0M4;Q9BWU0;A0A087WWF4;H7C256A0A087X M4;Q9BWU0Kanadaptin SLC4A1AP 5 5 742 1.3502 0.95007 2.15E+08
135
O60716-5;O60716-3;C9JZR2;O60716-13;O60716-11;O60716-8;O60716-7;O60716-2;O60716;O60716-21;O60716-19;O60716-16;O60716-15;O60716-10;O60716-9;O60716-6;O60716-4;O60716-24;O60716-23;O60716-18;O60716-17;O60716-14;O60716-12;O60716-22;O60716-20;O60716-29;O60716-27;O60716-32;O60716-31;O60716-26;O60716-25;O60716-30;O60716-28;E9PRE2;H0YC95;E9PKY0;E9PKL1;D6R9A8O60716-5;O60716-3;C9JZR2;O60716-13;O60716- 1;O60716-8;O60716-7; ;O60716;O60716-2 ;O60716-19;O60716-16;O6 716-15;O60716- 0;O60716-9;O60716- ;O60716-4;O60716-24;O60716-23;O60716-18;O60716-17;O60716-14;O60716-12;O6 716-22;O60716-20;O60716-29;O60716-27;O60716-32;O60716-3 ;O60716-26;O6 716-25;O60716-30;O60716-28Catenin delta-1 CTNND1 23 22 933 1.3474 0.60349 1.61E+09
A0A0D9SFM0;Q149N8-2;Q149N8-4;Q149N8;H0YBI0;H7C2W2;K4DI94;Q149N8-5A0A0D9SFM0;Q149N8-2;Q149N8-4;Q149N8;H0YBI0;H7C2W2;K4DI94;Q149N8-5E3 ubiquitin-protein ligase SHPRHSHPRH 2 2 1687 1.3473 0.6079 3.79E+07
Q9NZB2;Q9NZB2-6;Q9NZB2-4;Q9NZB2-5;A0A0C4DG79;Q9NZB2-2;A0A0C4DH52;Q5T035;Q9NZB2-6;Q9NZB2- ;Q9NZB2-5Constitutive coactivator of PP R-gamma-like protein 1FAM120 27 27 1118 1.3466 0.57013 2.65E+09
Q96GD0;B1AHD3 Q96GD0 Pyridoxal phosphate phosphatasePDXP 13 13 296 1.3447 0.56485 3.04E+09
H3BM14;H3BM74;Q9Y5A7-2;Q9Y5A7;C9JRT6;F8WDB6;C9J7X7;F8WDL9;H7C5N1H3BM14;H3BM74;Q9Y5A7-2;Q9Y5A7;C9JRT6;F8WDB6NEDD8 ultimate buster 1NUB1 9 9 625 1.344 0.75361 5.61E+08
O75600;O75600-2;H7BZ75;F2Z340;C9IZC9O 5600 O75600-2 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrialGCAT 6 6 419 1.3435 0.55343 4.82E+08
Q9NVH0-2;Q9NVH0;C9JLF4Q9NVH0-2;Q9NVH0Exonuclease 3-5 domain-containing protein 2EXD2 8 8 496 1.3425 0.62358 4.56E+08
Q96RP9;C9IZ01;F8WAU4Q96RP9;C9IZ01;F8WAU4Elongation factor G, mitochondrialGFM1 20 1 751 1.3421 0.79366 3.33E+09
P49207 P49207 60S ribosomal protein L34RPL34 7 7 117 1.3405 0.85933 7.13E+08
Q96G46;Q96G46-2;Q96G46-3;K7EPA4;K7ER20;K7EQU9;K7EJX8Q96G46;Q96G46-2tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-likeDUS3L 13 13 650 1.3404 0.48281 1.06E+09
Q9P2I0;H0YJF4;G3V3T7Q9P2I0 Cleavage and polyadenylation specificity factor subunit 2CPSF2 16 16 782 1.3392 0.66326 1.30E+09
A0A075B746;P82921A0A075B746;P829218S ribosomal protein S21, mitochondrialMRPS21 2 2 87 1.3386 0.82279 2.98E+08
P31689;P31689-2 P31689;P31689-2 DnaJ homolog subfamily A member 1DNAJ 1 19 19 397 1.3374 0.56648 4.52E+09
Q14257;Q14257-2;H0YL43;A8MXP8Q14257;Q14257-2;H0YL43;A8MXP8Reticulocalbin-2 RCN2 14 14 317 1.3371 0.58802 4.22E+09
P82673;H0YG82;P82673-2P82673;H0YG82;P82673-228S ribosomal protein S35, mitochondrialMRPS35 6 6 323 1.3368 0.61889 3.88E+08
O95801 O95801 Tetratricopeptide repeat protein 4TTC4 2 2 387 1.3367 NaN 1.37E+08
A0A087WXM6;J3QQT2;J3KRX5;A0A0A6YYL6;P18621;P18621-3;J3KRB3;A0A087WWH0;J3QS96;J3QLC8;A0A0A0MRF8;P18621-2;A0A087WY81;J3KSJ0A0A087WXM6;J3QQT2;J3KRX5;A0A0A YYL6;P18621;P18621-3;J3KRB3;A0A087WWH ;J3QS96;J3QLC8;A0A0 MRF8;P1 621-2;A0A087WY810S ribosomal protein 17RPL17 14 14 169 1.3366 0.80541 3.14E+09
P41214;P41214-2;Q5SY38;A0A087X1L6P41214;P41214-2 Eukaryotic translation initiation factor 2DEIF2D 14 14 584 1.3363 0.57893 1.81E+09
P33981-2;P33981;D6RF82;D6REX1;D6RIC6;D6RFY1P339 1-2;P33981 Dual specificity protein kinase TTKTTK 11 11 856 1.336 0.59361 5.92E+08
A0A0A6YYI3;A0A0B4J1V8;Q9NQ55-2;Q9NQ55;Q9NQ55-3;A8MV53;H7C446;C9JHF7;C9J3W3A0A0A6YYI3;A0A0B4J1V8;Q9NQ5 -2;Q9NQ5 ;Q9NQ55-3;A8MV53;H7C446Suppressor of SWI4 1 homologPPAN 4 4 520 1.3353 0.79868 2.56E+08
P53597;H7C233 P53597 Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrialSUCLG1 11 11 346 1.3351 0.70518 2.14E+09
Q9Y5V3;Q9Y5V3-2 Q9Y5V3;Q9Y5V3-2 Melanoma-associated antigen D1MAGED1 4 3 778 1.335 0.44055 1.51E+08
O43719;Q5H918;Q5H919O43719;Q5H918 HIV Tat-specific factor 1HTATSF1 16 16 755 1.3331 0.53653 1.15E+09
P54198;P54198-2 P54198;P54198-2 Protein HIRA HIRA 4 4 1017 1.3316 0.53369 1.08E+08
A0A0A0MSK4;A0A0A0MRC4;Q86YR5-4;Q86YR5;A0A087WVF5;Q86YR5-3;Q86YR5-2A0A0MSK4;A0A0A0MRC4;Q86YR5-4;Q86YR5;A0A087WVF ;Q86YR5-3G-protein-signaling modulator 1GPSM1 11 11 675 1.3309 0.71665 4.24E+08
P62277;J3KMX5;E9PS50P62277;J3KMX5 40S ribosomal protein S13RPS13 13 13 151 1.3309 0.75597 7.11E+09
P61313;E7EQV9;E7ENU7;E7EX53;P61313-2;E7ERA2P61313; 7EQV9;E7ENU760S ribosomal protein L15;Ribosomal protein L15RPL15 13 13 204 1.3303 0.6774 3.37E+09
G3XAG1;Q96ME7-2;Q96ME7-3;Q96ME7G3XAG1;Q96ME7-2;Q96ME7-3;Q96ME7Zinc finger protein 512ZNF512 2 2 566 1.3302 0.68681 9.28E+07
Q9BRX2 Q9BRX2 Protein pelota homologPELO 14 14 385 1.3299 0.75365 1.53E+09
Q14147;H7C504 Q14147 Probable ATP-dependent RNA helicase DHX34DHX34 9 9 1143 1.3298 0.51015 4.62E+08
P61254;J3QRI7;J3QQQ9;J3QQV1;J3QRC4;J3KTJ8;J3KSS0;J3KS10;H7C1F9;Q2PPJ7-3;Q2PPJ7-2;Q2PPJ7P61254;J3QRI7;J3QQQ9;J3QQV1;J3QRC4;J3KTJ860S ribosomal protein L26RPL26 KRBA2 20 6 145 1.329 0.69324 2.74E+09
A2RTX5-2;A2RTX5;B7ZLP8A2RTX5-2;A2RTX5;B7ZLP8Probable threonine--tRNA ligase 2, cytoplasmicTA SL2 8 4 707 1.3287 0.84347 1.66E+08
Q9NQW6-2;Q9NQW6;C9JJT6;H7C1K5Q9NQW -2;Q9NQW6Actin-binding protein anillinANLN 6 6 1087 1.328 0.49559 1.73E+08
P14866;M0QXS5;P14866-2;M0QYT0;M0R076;M0R1W6;B4DVF8;M0QYL7P148 6; 0 XS5;P14866-2Heterogeneous nuclear ribonucleoprotein LHNRNPL 30 30 589 1.3275 0.65432 2.57E+10
Q05086-2;Q05086-3;Q05086;A0A0D9SG77;A0A0D9SG63;A0A0D9SES7;A0A0D9SF91;S4R306;A0A0D9SGI3Q05086-2;Q 5 86-3;Q05086;A0A0D9SG77Ubiquitin-protein ligase E3AUBE3A 11 11 852 1.3274 0.76953 6.26E+08
Q9BYN8 Q9BYN8 28S ribosomal protein S26, mitochondrialMRPS26 7 7 205 1.3271 0.71193 1.77E+08
Q9BVA1 Q9BVA1 Tubulin beta-2B chainTUBB2B 32 2 445 1.327 0.80741 1.49E+10
Q3SY69;Q3SY69-3;Q3SY69-2;H0YHN9;REV__Q14005-4;REV__H0YLH9;REV__Q14005-3Q3SY69 Mitochondrial 10-formyltetrahydrofolate dehydrogenaseALDH1 2 24 20 923 1.3269 0.84702 2.28E+09
Q9BXW6;Q9BXW6-2;Q9BXW6-4;J3QLA2;J3KTA6;J3KSG6;E7ER58;J3QSB8Q9BXW6;Q9BXW6-2;Q9BXW6-4Oxysterol-binding protein-related protein 1OSBPL1A 4 4 950 1.3269 0.81089 9.93E+07
H3BRU6;F8VZX2 H3BRU6;F8VZX2 PCBP2 18 2 301 1.3266 0.45074 1.02E+09
A0A087WSW7;F6XU50;A0A0B4J1V9;Q9NRZ9-3;Q9NRZ9-2;Q9NRZ9;Q9NRZ9-6;Q9NRZ9-5;Q9NRZ9-4;Q9NW36;B1ALG6;Q9NRZ9-8;Q9NRZ9-7A0A087WSW7;F6XU50;A0A0B4J1V ;Q9NRZ9-3; 2; ;Q9NRZ9-6;Q9NRZ9-5;Q9NRZ9-4Lymphoid-specific helicaseHELLS 11 11 700 1.3249 0.63385 7.05E+08
B7Z6D5;Q96GQ7;A0A087X059;A0A087WYH5B7Z6D5;Q 6GQ7 Probable ATP-dependent RNA helicase DDX27DDX27 12 12 765 1.3243 0.65186 1.09E+09
Q13123;E7EQZ7;Q9H4P6;D6REL4;D6RAY9;D6RCQ4Q13123;E7EQZ7;Q9H4P6;D6REL4Protein Red IK 10 10 557 1.3242 0.63558 8.89E+08
Q9UHB9;Q9UHB9-4;Q9UHB9-2;Q9UHB9-3;K7EN53;K7EQC2Q9UHB9;Q9UHB9-4;Q9UHB9-2Signal recognition particle subunit SRP68SRP68 33 33 627 1.324 0.71893 5.36E+09
Q96CB9-4;Q96CB9;M0R1K5;Q96CB9-2;Q96CB9-3Q96CB9-4;Q96CB9 5-methylcytosine rRNA methyltransferase NSUN4NSUN4 3 3 335 1.3235 0.60505 1.49E+08
A0A087WY54;Q15649A0A087WY54;Q15649Zinc finger HIT domain-containing protein 3ZNHIT3 2 2 90 1.3233 NaN 1.50E+07
Q9UDY8;Q9UDY8-2Q9UDY8;Q9UDY8-2Mucosa-associated lymphoid tissue lymphoma translocation protein 1MALT1 5 5 824 1.323 0.5435 1.39E+08
Q9NYP9 Q9NYP9 Protein Mis18-alphaMIS18A 2 2 233 1.3223 0.87401 1.61E+08
Q12789;Q12789-3;H3BRD0;H3BU37;I3L1Z3;H3BU55Q12789;Q12789-3 General transcription factor 3C polypeptide 1GTF3C1 38 38 2109 1.322 0.78762 1.78E+09
P25786;P25786-2;F5GX11;B4DEV8;F5H112P25786;P25786-2;F5GX11;B4DEV8Proteasome subunit alpha type-1;Proteasome subunit alpha typePSMA1 12 12 263 1.321 0.61862 2.14E+09
Q9NRY4;A2RRE5 Q9NRY4;A2RRE5 Rho GTPase-activating protein 35ARHGAP35;GRLF1 10 10 1499 1.32 0.60745 4.06E+08
C9JP00;A0A0A0MQX8;Q9NR56;Q9NR56-3;Q9NR56-4;Q9NR56-7;Q9NR56-6;Q9NR56-2;Q9NR56-5;H7C4T5;Q86VM6;O95205;Q5VZF2-3;Q5VZF2-2;Q5VZF2;C9J4T8;Q9NUK0-4;Q9NUK0-3;C9JCX1;H7C4Y1C9JP00;A0A0A0MQX8;Q9NR56;Q9NR56-3;Q9NR56-4;Q9NR56-7;Q9NR56-6;Q9NR56-2; 9NR56-5;H7C4T5;Q86VM6;O95205;Q5VZF2-3;Q5VZF2-2;Q5VZF2Muscleblind like protein 1;Muscleblind-like protein 2MBNL1; BLL;MBNL2 8 5 348 1.3197 0.70858 6.62E+08
Q13247-3;Q13247;Q13247-2;A0A0D9SGD2;B4DJK0;B4DUA43;Q13247;Q13247-2erine/arginine-rich splicing factor 6SRSF6 6 4 335 1.3197 0.67323 1.31E+08
Q96A33;Q96A33-2;A0A087WYW6;J3QR89Q96A33;Q96A33-2 Coiled-coil domain-containing protein 47CCDC47 8 8 483 1.3178 0.79815 8.02E+08
Q96D53-2;Q96D53;M0R001;M0R011Q96D53-2;Q96D53;M0R001;M0R011AarF domain-containing protein kinase 4ADCK4 2 2 503 1.3176 0.57656 1.06E+08
Q8NEC7;D6R9W2;Q8NEC7-3;D6RCC4;D6RCC9Q8NEC7;D6R9W2;Q8NE 7-3Glutathione S-transferase C-terminal domain-containing proteinGSTCD 3 3 633 1.3173 0.6237 1.20E+08
Q8TER5-2;Q8TER5-4;Q8TER5-3;Q8TER5Q8TER5-2;Q8TER5-4;Q8TER5-3;Q8TER5Rho guanine nucleotide exchange factor 40ARHGEF40 3 3 805 1.3167 NaN 3.97E+07
Q15398-3;Q15398;G3V543;G3V4E5;Q15398-1Q15398-3;Q15398;G3V543;G3V4E5;Q15398-1Disks large-associated protein 5DLGAP5 2 2 842 1.3165 NaN 3.28E+07
O75891;O75891-3;O75891-4;O75891-2;C9IZ36;C9JY00;C9JYZ6;O75891-3;O75891-4;O75891-2Cytosolic 10-formyltetrahydrofolate dehydrogenaseALDH1L1 5 2 902 1.3158 0.51931 7.86E+07
Q9BVS4-2;Q9BVS4 Q9BVS4-2;Q9BVS4 Serine/threonine-protein kinase RIO2RIOK2 2 2 474 1.3155 0.47398 1.01E+08
Q9Y3B7;Q9Y3B7-2;Q9Y3B7-3;E9PQB6;H0YCD5;Q9Y3B7-2;Q9 3B7-33 S ribosomal protein L11, mitochondrialMRPL 1 11 11 192 1.3155 0.47995 4.66E+08
Q9H0S4;Q9H0S4-2;F5H1N9Q9 0S4;Q9H0S4-2;F5H1N9Probable ATP-dependent RNA helicase DDX47DDX47 12 12 455 1.3147 0.71176 1.86E+09
Q9Y2U8 Q9Y2U8 Inner nuclear membrane protein Man1LEMD3 3 3 911 1.3143 0.36995 5.38E+07
Q9NYV4-2;Q9NYV4;J3QSD7;Q9NYV4-3;H0YAZ9;Q9BVE2;E7EUK8;E5RGN0;A0A087X209;A0A087WZU2;F5H6Z0;Q00534;Q96Q40-2;Q96Q40-4;Q96Q40-3;O94921-3;Q96Q40-5;Q96Q40;O94921-2;O94921;Q07002;Q07002-2;Q00536;Q00536-3;Q07002-3;Q00537-2;Q00537;Q00536-2;Q14004-2;Q14004Q9NYV4-2;Q9NYV4;J3QSD7; NYV4-3Cyclin-dependent kinase 12CD 12 5 4 1481 1.3141 0.39798 1.72E+08
O14647-2;O14647 O14647-2;O14647 Chromodomain-helicase-DNA-binding protein 2CHD2 8 4 1739 1.3139 NaN 4.55E+07
Q5T1Z4;Q5T1Z8;Q14671-2;Q14671-3;H0YEH2;Q14671;E9PR38;Q14671-4;H0YDK8;H0YC97;E9PMX1;H0YDC5;E9PM68;E9PL65Q5T Z4; 5T1Z8;Q14671- -3;H0YEH2;Q14671;E9PR3 ;Q14671-4;H0YDK8Pumilio homolog 1 UM1 12 12 1189 1.3138 0.72529 5.95E+08
A0A0R4J2E8;A8MXP9;P43243;D6REM6;D6R991;H0Y8T4;B3KM87;P43243-2;D6R8Z5;D6RCM3;D6REK4;D6RBI2;D6RBK5;D6RE02;D6RIA2;Q68E03;D6RB45;D6R9F3;D6RAM9;D6RAY2;D6RBS2A0A0R4J2E8;A8MXP9;P43243;D6REM6;D6R991Matrin-3 MAT 3 9 39 847 1.3136 0.70073 1.89E+10
P26358;P26358-2;P26358-3;K7ENW7;K7EJL0;K7EIZ6;K7EMU8;K7ERQ1;K7ELB1;K7ENQ6;P26358-2;P26358-3DNA (cytosine-5)-methyltransferase 1DNMT1 31 31 1616 1.3134 0.65073 1.84E+09
Q06787-6;Q06787-4;Q06787-5;Q06787-7;Q06787-3;Q06787;G8JLE9;R9WNI0;A8MQB8;G3V0J0;Q06787-10;Q06787-8;Q06787-2;Q06787-9;A0A087WXI3;Q06787-11;Q8IXW7;A0A087WWR6;A0A087WY29Q06787-6;Q06787-4;Q06787-5;Q06787- ;Q06787-3;Q06787;G8JLE9;R9WNI0;A8MQB8;G3V0J0;Q06787-10;Q06787-8;Q06787-2;Q06787-9;A0A087W I3;Q06787-11Fragile X mental retardation protein 1FMR1 5 4 590 1.3133 0.78713 1.92E+08
Q99766;Q8WXQ4 Q99766 ATP synthase subunit s, mitochondrialATP5S 3 3 215 1.3127 0.88039 6.29E+07
Q5VZE5;Q5VZE5-2 Q5VZE5 N-alpha-acetyltransferase 35, NatC auxiliary subunitNAA35 7 7 725 1.3124 0.74943 5.74E+08
E9PMP7;E9PMS6;F8WD26;J3KP06;Q8WWI1-3;Q8WWI1-4;Q8WWI1-2;Q8WWI1;E9PLU6;E9PK58;E9PJ10;H0Y424;A0A0A0MTE2;E9PMT2;Q8WWI1-5E9PMP7;E9 MS6;F8WD26;J3KP06;Q8WWI1-3;Q8WWI1-4;Q8WWI1-2;Q8WWI1;E9PLU6;E9PK58;E9PJ10;H0Y424;A0A0A0MTE2;E9PMT2;Q8WWI1-5LIM domain only protein 7LMO7 2 2 10 6 1.3097 0.78232 4.79E+07
Q86XP3;A0A0A0MSJ0;Q86XP3-2;J3QRI2;J3KTK9;J3KRE3Q86XP3;A0A0A0MSJ0;Q86XP3-2ATP-dependent RNA helicase DDX42DDX42 16 16 938 1.3095 0.86754 9.67E+08
M0QY97;Q9UPT8 M0QY97;Q9UPT8 Zinc finger CCCH domain-containing protein 4ZC3H4 4 4 910 1.3086 0.50943 6.72E+07
P82663;E7EPW2;P82663-2;P82663-3P82663;E7EPW2;P82663-2;P82663-328S ribosomal protein S25, mitochondrialMRPS25 11 11 173 1.3072 0.74849 2.49E+08
Q14999;Q14999-2;E9PEZ1;Q8IWT3-3;Q8IWT3Q14999;Q14999-2 Cullin-7 CUL7 7 7 1698 1.3071 0.71273 2.43E+08
Q16543;K7EQA9;K7EKQ2;K7EL68;K7EIU0;REV__B4DFN3;REV__Q13563-3;REV__Q13563Q16543;K7EQA9;K7EKQ2Hsp90 co-chaperone Cdc37;Hsp90 co-chaperone Cdc37, N-terminally processedCDC37 21 21 378 1.3067 0.7107 4.40E+09
Q9UL03-3;Q9UL03;C9JVX2;C9JXP6;C9J885;C9K0V7;F8WAV7;G5E9X1;B3KQH5;Q9UL03-2Q UL03-3;Q9UL03;C9JVX2;C9JXP6;C9J885;C9K0V7;F8WAV7Integrator complex subunit 6INTS6 4 3 874 1.3067 0.5829 1.37E+08
Q6P5Z2 Q6P5Z2 Serine/threonine-protein kinase N3PKN3 5 4 889 1.3058 0.52095 2.88E+07
Q13885 Q13885 Tubulin beta-2A chainTUBB2A 32 2 445 1.3051 NaN 1.78E+08
O15305;H3BRM0;H3BV55;H3BPH4;O15305-2;H3BR08;H3BM92;H3BV34;H3BT06;H3BNY9;Q92871O15305;H3BRM0;H3BV 5Phosphomannomutase 2;PhosphomannomutaseP M 7 7 246 1.3046 0.83908 6.05E+08
Q9UPY3;Q9UPY3-2;Q9UPY3-3;H0YJZ6;Q9UPY3-2 Endoribonuclease DicerDICER1 21 21 1922 1.3019 0.67576 9.68E+08
O14646-2;O14646;H0Y8V4;A0A087WVF4O14646-2;O14646 Chromodomain-helicase-DNA-binding protein 1CHD1 14 10 1709 1.3005 0.73212 5.52E+08
C9J5N1;Q9BTE6;Q9BTE6-2;Q9BTE6-3;K7EQ85;L7N2F4;H7C054C9J5N1;Q9BTE6;Q9BTE6-2;Q9BTE6-3Alanyl-tRNA editing protein Aarsd1PTGES3L-AARSD1;AARSD1 10 10 495 1.3003 0.82106 9.07E+08
Q9H267;F5H008;Q9H267-2;G3V3F9Q9H267;F5H008;Q9H267-2Vacuolar protein sorting-associated protein 33BVPS33B 15 15 617 1.2995 0.56304 1.06E+09
Q03164-2;Q03164;Q03164-32;Q03164;Q03164-3Histone-lysine N-methyltransferase 2A;MLL cleavage product N320;MLL cleavage product C180KMT2A 3 3 3931 1.2991 0.66686 5.70E+07
Q7L8L6 Q7L8L6 FAST kinase domain-containing protein 5FASTKD5 2 2 764 1.2988 NaN 1.06E+08
P40938;P40938-2;A0A087X270P40938;P40938-2 Replication factor C subunit 3RFC3 10 10 356 1.2985 0.79403 1.48E+09
Q9GZS1-2;Q9GZS1;E7EX70Q9GZS1-2;Q9GZS1;E7EX70DNA-directed RNA polymerase I subunit RPA49POLR1E 8 8 419 1.2985 0.67551 4.57E+08
P43897;P43897-2;C9JT21;C9JG32;F8VPA7;F8VS27;P43897-3;P43897-4P43897;P43897-2 Elongation factor Ts, mitochondrialTSFM 11 11 325 1.2975 0.71037 3.00E+09
P53618;E9PP73;E9PP63;E9PKQ153618;E9PP73 Coatomer subunit betaCOPB1 52 52 953 1.297 0.65471 1.96E+10
G3V5Z7;P60900;G3V3I1;G3V295;G3V3U4;P60900-2;G3V4S5;G3V2S7;H0YJC4;P60900-3G3V5Z7;P60900;G V3I1;G3V295; 3U4;P60900-2Proteasome subunit alpha type;Proteasome subunit alpha type-6P MA 6 6 252 1.2969 0.72565 8.44E+08
Q9Y263;E5RIM3;H0YBW4;H0YC16;H0YAU9Q9Y263;E5RIM3 Phospholipase A-2-activating proteinPLAA 28 28 795 1.2969 0.61552 3.61E+09
136
Q9Y4K3 Q9Y4K3 TNF receptor-associated factor 6TRAF6 5 5 522 1.2967 0.62074 3.66E+08
P62191;P62191-2;G3V4X1P6219 ;P62191-2 26S protease regulatory subunit 4PSMC1 24 24 440 1.2964 0.72889 6.08E+09
Q6PJI9;Q6PJI9-3;H3BMH3;Q6PJI9-4;Q6PJI9-2;H3BR95;H3BNY4;B7Z7V6;H3BV71Q6PJI9 3 H3BMH3 Q6PJI -4;Q6PJI9-2WD repeat-containing protein 59WDR59 6 6 974 1.2961 0.54164 1.47E+08
Q9C0C9;K7ES11;K7EQ12Q9C0C9;K7ES11 E2/E3 hybrid ubiquitin-protein ligase UBE2OUBE2O 22 22 1292 1.2955 0.87308 1.51E+09
Q14166;V9GY16 Q14166 Tubulin--tyrosine ligase-like protein 12TTLL12 15 15 644 1.2945 0.92585 2.67E+09
O60566;O60566-3;O60566-2;H3BTB9;O60566-3;O60566-2Mitotic checkpoint serine/threonine-protein kinase BUB1 betaBUB1B 6 6 1050 1.2937 0.61309 1.12E+08
Q9UPT9-2;Q9UPT9;A6NNY8;J3QS30;K7ESK0;K7ERX6Q9UPT9-2; 9UPT9;A6NNY8Ubiquitin carboxyl-terminal hydrolase 22;Ubiquitin carboxyl-terminal hydrolase 27USP22;USP27X 3 3 513 1.2937 0.66036 1.54E+08
O43776;K7EIU7;O43776-2;K7EJ19;K7EQ35;K7EPK2;K7EMQ6;REV__H7BZ55O43776 Asparagine--tRNA ligase, cytoplasmicNARS 29 29 548 1.2928 0.67781 1.04E+10
J3KMX2;B9EGA3;Q92925-3;Q92925-2;Q92925;J3QWB6;Q6STE5-2;Q6STE5;F8VW95;C9JYI7;F8VZ70;F8VUB0;Q96GM5-2;Q96GM5J3KMX2 B EGA3;Q92925-3;Q92925-2;Q92925 J3QWB6SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2SMARCD2 5 5 456 1.2921 0.77615 1.91E+08
Q12972;A0A0A0MT09;Q12972-2;Q12972-3Q1297 Nuclear inhibitor of protein phosphatase 1;Activator of RNA decayPPP1R8 15 15 351 1.2914 0.65509 2.50E+09
Q8TDD1;Q8TDD1-2;F8VRX4Q TDD1;Q8TDD1-2ATP-dependent RNA helicase DDX54DDX54 10 10 881 1.2913 0.7371 3.80E+08
P78344;D3DQV9;P78344-2;H0Y3P2;H0YCH5;H0YD77;H0YEC5;E9PKF8;H0YE22;H0YCF8;H0YEN8;H0YDC0;H0YD99;H0YE44;H0YEI7P783 4;D3DQV9;P78344-2;H0Y3P2Eukaryotic translation initiation factor 4 gamma 2EIF4G2 46 46 907 1.2905 0.59628 8.84E+09
A0A087WY00;G3V394;F8WE88;F8W6H6;Q9Y4I1-2;Q9Y4I1;Q9Y4I1-3;E7ERV5A0A0 7WY00;G3V394;F8WE88 F8W6H6;Q9Y4I1-2;Q9Y4I1;Q9Y4I1-3;E7ERV5Unconventional myosin-VaMYO5A 2 2 1828 1.2901 NaN 2.19E+07
C9JYQ9;H0Y8C2;Q6P5R6C9JYQ9;H0Y8C2;Q6P5R660S ribosomal protein L22-like 1RPL22L1 4 2 121 1.2889 0.77489 1.39E+08
O95983-2;O95983;K7EIE8;A0A087WT34;A0A087X1H1;A0A0A0MTS6O959 3-2;O95983;K7EIE8Methyl-CpG-binding domain protein 3MBD3 4 4 259 1.2884 0.64544 5.08E+08
G3V529;Q9GZR7;Q9GZR7-2;F5GYL3;A0A087WXU8G3V529;Q9 ZR7;Q9GZR7-2;F5GYL3;A0A087WXU8TP-dependent RNA helicase DDX24DDX24 14 14 816 1.2881 0.58105 4.23E+08
F2Z2W7;Q8IZ69-2;Q8IZ69;H7C100;C9K041F2Z2W7;Q8IZ69-2;Q8IZ69tRNA (uracil-5-)-methyltransferase homolog ATRMT2A 8 8 643 1.288 0.40883 1.98E+08
Q92665 Q92665 28S ribosomal protein S31, mitochondrialMRPS31 7 7 395 1.2874 0.67647 7.87E+08
Q96EL2;F8VYR5 Q96EL2 28S ribosomal protein S24, mitochondrialMRPS24 6 6 167 1.2869 0.75644 4.12E+08
P0DN76;Q01081;Q01081-2;Q01081-4;Q8WU68-3;Q8WU68;K7EJH3;K7EJM7;M0QYK5;M0R2N4;Q01081-3;Q8WU68-2P0DN76; ;Q01081-2;Q01081-4Splicing factor U2AF 35 kDa subunitU2AF1 9 9 240 1.2868 0.79799 2.58E+09
O43379;O43379-4 O43379;O43379-4 WD repeat-containing protein 62WDR62 3 3 1518 1.2847 0.79404 3.23E+07
A0A087WXC5;E7ESZ7;O95299;O95299-2;H7C2W5;H7C1Y7;H7C2X4;Q8N1B9;C9J6X0A0A087WXC5;E7ESZ7;O95 99;O95299-2NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrialNDUFA10 8 8 355 1.2846 0.69761 3.97E+09
Q92995-2;Q92995;H7C5J3Q92995-2;Q92995;H7C5J3Ubiquitin carboxyl-terminal hydrolase 13USP13 4 3 798 1.2831 0.7537 1.63E+08
C9JXR7;A8MVM1;P42574;A0A087WU32C9JXR7;A8MVM1;P42574;A0A087WU32Caspase-3;Caspase-  subunit p17;Caspase-3 subunit p12CASP3 3 3 117 1.2826 0.84478 1.01E+08
C9JNE2;Q9Y530;C9JXC3;C9J5P1;H7C5Q1;C9JA90;C9IZY1C9JNE2;Q9Y530; 9JXC3;C9J5P1O-acetyl-ADP-ribose deacetylase 1OARD1 5 5 131 1.2812 0.74167 2.44E+08
Q9UBW7;A0A087X151;Q9UBW7-2Q9UBW7 Zinc finger MYM-type protein 2ZMYM2 8 8 1377 1.2812 0.6481 1.18E+08
Q12923-3;Q12923;Q12923-4;Q12923-23; ;Q12923-4;Q12923-2Tyrosine protein phosphatase non-receptor type 13PTPN13 14 14 2466 1.2809 0.94572 3.57E+08
J3KNN5;Q9UJV9;H0Y8L8J3KNN5;Q9UJV9 Probable ATP-dependent RNA helicase DDX41DDX41 5 5 640 1.2798 0.83659 3.73E+08
A0A087WYU1;Q9Y5X1A0A087WYU1;Q9Y5X1Sorting nexin-9 SNX9 7 7 594 1.2784 1.0984 3.38E+08
Q15386;Q15386-2;Q15386-3 Ubiquitin-protein ligase E3CUBE3C 25 25 1083 1.278 0.62615 2.47E+09
Q9Y5Y2;H3BNF0;H3BNS4;H3BRK5;H3BMW1;H3BQR2;B7Z6P0;H3BRE1Q9Y5Y2;H3BNF0;H3BNS4Cytosolic Fe-S cluster assembly factor NUBP2NUBP2 9 9 271 1.2775 0.70226 2.10E+09
Q5QPR4;J3QR29;A0A0D9SEI3;Q5QPR3;B7ZVY7;A0A0D9SER5;A0A0D9SEN2;J3QR44;Q9UQ88-5;Q9UQ88-10;P21127-12;P21127-4;P21127-5;P21127-10;P21127-6;P21127-9;Q9UQ88-4;P21127-8;Q9UQ88-3;Q9UQ88-2;P21127-3;P21127-2;Q9UQ88;P21127;Q9UQ88-8;Q9UQ88-9Q5QPR4;J3 R29;A0A0D9SEI3;Q5QPR3;B7ZVY7;A0A0D9SER5;A0A0D9SEN2;J3QR44;Q9UQ88-5;Q9UQ88- 0;P21127-12;P21127-4;P21127-5;P21127-10;P21127-6;P21127-9;Q9UQ88-4;P21127- ;Q9UQ88-3;Q9UQ88-2;P21127-3;P21127-2;Q9UQ 8;P21127;Q9UQ88-8;Q9UQ88-9Cyclin-dependent kinase 11A;Cyclin-dependent kinase 11BCDK1 A CDK11B;CDC2L1 2 2 746 1.2767 0.86187 1.63E+08
A0A0C4DFX4;Q6ZRS2-3;Q6ZRS2-2;Q6ZRS2;A0A0A0MS59;A0A087X0E3A0A0C4DFX4;Q6ZRS2-3;Q6ZRS2-2;Q6ZRS2;A0A A0MS59;A0A087X0E3Helicase SRCAP SRC P 11 10 3053 1.2766 0.83417 4.48E+08
Q05655;Q05655-2;C9JZU8;C9J9P1;C9K0E3Q05655;Q05655-2 Protein kinase C delta type;Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunitPRKCD 6 6 676 1.2756 0.72948 5.91E+08
C9JJN9;Q8N3P4-2;Q8N3P4-3;Q8N3P4C9JJN9;Q8N3P4-2;Q8N3P4-3;Q8N3P4Vacuolar protein sorting-associated protein 8 homologVPS8 4 4 1428 1.2751 0.61811 9.35E+07
Q9P2R3;Q9P2R3-2;Q9P2R3-4;I3L3P8;K7EPT2;I3L1Z9;Q9P2R3-2;Q9 2R3-4Ankyrin repeat and FYVE domain-containing protein 1ANKFY1 22 22 1169 1.2744 0.78294 2.07E+09
B4DZS0;O76075;J3KT26;O76075-2B4DZS0;O76075;J3KT26DNA fragmentation factor subunit betaDFFB 4 4 362 1.2736 0.87305 2.14E+08
P37108;H0YLA2 P37108;H0YLA2 Signal recognition particle 14 kDa proteinSRP14 9 9 136 1.2727 0.92125 3.05E+09
P61978;P61978-2;S4R359;S4R457P61978;P61978-2 Heterogeneous nuclear ribonucleoprotein KHNRNPK 34 2 463 1.2715 0.7461 5.11E+10
P62280;M0QZC5;M0R1H6;M0R1H5P62280; 0QZC5 40S ribosomal protein S11RPS11 22 22 158 1.2705 0.86732 3.70E+09
H7C2Q8;Q99848 H7C2Q8;Q99848 Probable rRNA-processing protein EBP2EBNA1BP2 4 4 361 1.2701 0.48927 2.05E+08
P26368-2;P26368;K7ENG2;K7ELP8P26368-2;P26368;K7ENG2Splicing factor U2AF 65 kDa subunitU2AF2 15 15 471 1.2695 0.7648 6.29E+09
Q86YP4-2;Q86YP4;Q86YP4-3;C9JVY3;V9GY85;H7C3H1;C9JMI3;C9JGN4;C9JHD7;C9JJK9;V9GYX52;Q86YP4;Q86YP4-3Transcriptional repressor p66-alphaGATAD2A 12 11 608 1.268 0.63315 3.49E+08
Q99459 Q99459 Cell division cycle 5-like proteinCDC5L 22 22 802 1.2661 0.60975 1.21E+09
H0YF29;Q6P1X6-2;Q6P1X6H0YF29;Q6P1X6-2;Q6P1X6UPF0598 protein C8orf82C8orf82 3 3 261 1.2651 NaN 4.95E+07
P15880;H0YEN5;E9PQD7;E9PMM9;I3L404;E9PPT0;E9PM36;H3BNG3;H0YE2715880;H0YEN5;E9PQD7;E9PMM9;I3L404;E9PPT0;E9PM36S ribosomal protein S2RPS2 17 17 293 1.2646 0.73609 2.07E+10
O76021;J3QSV6;I3L3C4;I3L3U9;O76021-2;I3L234;J3KPU7;I3L2F2;I3L4T8;I3L1Y4O76021;J3QSV6 Ribosomal L1 domain-containing protein 1RSL1D1 20 20 490 1.264 0.81819 3.14E+09
A0A0A0MTH3;Q13418;Q13418-2;Q13418-3;A0A087WWY6;E9PQ52;A0A087WW45A0A0A0MTH3; ;Q13418-2;Q13418-3Integrin-linked protein kinaseILK 10 10 483 1.2639 0.69537 1.04E+09
Q15366-4;Q15366-7;Q15366-5;Q15366-8;F8W0G4;F8VRH0;F8VXH9;F8W1G6;E9PFP8;P57721-5;P57721-4;P57721;J3QT27;P57721-2;P57721-3;F8VTZ0;H3BND9Q15366-4;Q15366-7;Q15366-5;Q15366-8Poly(rC)-binding protein 2PCBP 20 3 331 1.2637 0.72654 2.00E+10
Q8WUM0 Q8WUM0 Nuclear pore complex protein Nup133NUP133 29 29 1156 1.2634 0.66192 4.93E+09
Q9UK61-3;Q9UK61-4;Q9UK61;Q9UK61-2;A0A087X0F1Q9UK61-3;Q9UK61-4;Q9UK61;Q9UK61-2Protein FAM208A FAM208A 12 12 1512 1.2634 0.7429 4.20E+08
Q13049;Q5JVY0 Q13049;Q5JVY0 E3 ubiquitin-protein ligase TRIM32TRIM32 3 3 653 1.2632 0.56334 1.53E+08
K7EIL6;K7EJ58;K7EQU8;K7EMF1;H0UID0;K7EN92;K7EN88;O75771-3;O75771-4;O75771-5;O75771;O75771-8K7EIL6;K7EJ58;K7EQU8;K7EMF1;H0UID0;K7EN92 K EN88;O75771-3;O75771-4; 5;O75771;O75771-8DNA repair protein RAD51 homolog 4D;hCG_19 9222;hCG_2039 182 2 204 1.2626 0.87613 2.73E+07
Q15185-3;Q15185-4;Q15185;A0A087WYT3;B4DDC6;Q15185-2Q15185-3;Q151 5-4;Q15185;A0A087WYT3;B4DDC6;Q15185-2Prostaglandin E synthase 3PTGES3 8 8 130 1.2617 0.63257 1.96E+08
Q5HYI8;C9JXM3;F8WF50;F8WDC7Q5HYI8;C9JXM3 Rab-like protein 3 RABL3 7 7 236 1.2615 0.71446 2.70E+08
O43390;O43390-3;B4DT28O 3390;O43390-3;B4DT28Heterogeneous nuclear ribonucleoprotein RHNRNPR 24 3 633 1.2612 0.85843 5.68E+09
H7BXY3;Q7L2E3-3;Q7L2E3;Q7L2E3-2H7BXY3;Q7L2E3-3;Q7L2E3;Q7L2E3-2Putative ATP-dependent RNA helicase DHX30DHX30 43 43 1166 1.2611 0.74056 4.51E+09
P62195;P62195-2;J3QQM1;J3QSA9;J3KRP2;J3QLH6;J3QSE0;J3QRW1;J3QRR3;J3KTQ9P62195;P62195-2;J3QQM1;J3QSA9;J3KRP226S protease regulatory subunit 8PSMC5 28 27 406 1.2608 0.80118 1.19E+10
O14733;O14733-4;O14733-2;O14733-3;O14733-4;O14733-2;O14733-3Dual specificity mitogen-activated protein kinase kinase 7MAP2K7 8 8 419 1.2607 0.68689 5.11E+08
P17252;J3KRN5;H3BV73;P05771P17252 Protein kinase C alpha typePRKCA 7 5 672 1.2607 1.098 5.40E+08
Q96KR1;H0Y8W1 Q96KR1 Zinc finger RNA-binding proteinZFR 18 18 1074 1.2607 0.56668 1.19E+09
P09543-2;P09543;K7EN66;C9K0L8;K7ERZ0;K7ERC4P09543-2;P09543 2,3-cyclic-nucleotide 3-phosphodiesteraseCNP 17 17 401 1.2606 0.76632 1.48E+09
F6UYG0;F5GWT4;Q9H4A3-2;Q9H4A3;Q9H4A3-5;Q9H4A3-6;Q9H4A3-7F6UYG0;F5GWT4;Q9H4A3-2;Q9H4A3;Q9H4A3-5;Q9H4A3-6;Q9H4A3-7Serine/threonine-protein kinase WNK1WNK1 1 1 393 1.2603 NaN 1.06E+07
P50579-3;P50579;G3V1U3;F8VRR3;F8VQZ7;P50579-2;F8VSC4P50579-3;P50579;G3V1U3;F8VRR3;F8 QZ7;P50579-2Methionine aminopeptidase 2METAP2 5 5 455 1.26 0.65977 8.02E+07
O14964-2;O14964;I3L1P5;I3L1E3O14964-2;O14964 Hepatocyte growth factor-regulated tyrosine kinase substrateHGS 3 3 690 1.2582 1.2512 3.04E+08
Q01085;E7ETJ9;E7ETC0;A6NKZ9Q01085;E7ETJ9;E7ETC0;A6NKZ9Nucleolysin TIAR TIAL1 12 1 375 1.2581 0.91616 2.13E+09
Q86W42;Q86W42-2;Q86W42-3Q86W42;Q86W42-2;Q86W42-3THO complex subunit 6 homologTHOC6 11 11 341 1.2581 0.68655 3.01E+09
Q9BQG0;Q9BQG0-2;I3L1L3;I3L2H8;I3L311Q9BQG0;Q9BQG0-2;I3L1L3Myb-binding protein 1AMYBBP1A 29 29 1328 1.2578 0.69241 3.53E+09
Q9UMY1;H7C2B1;Q9UMY1-2Q9UMY1;H7C2B1;Q9UMY1-2Nucleolar protein 7NOL7 5 5 257 1.2577 0.82919 2.15E+08
O00267-2;O00267;M0QYL9O00267-2;O00267 Transcription elongation factor SPT5SUPT5H 18 18 1083 1.2575 0.91643 1.50E+09
Q96P11;Q96P11-2;Q96P11-4;Q96P11-5;Q63ZY6-5;Q63ZY6;Q96P11-3;Q63ZY6-4;Q63ZY6-2;Q63ZY6-6;Q3KNT7-2;Q3KNT7-3;Q3KNT7;Q96P11-2;Q96P11-4;Q96P11-5Probable 28S rRNA (cytosine-C(5))-methyltransferaseNSUN5 12 12 429 1.2573 0.67506 9.40E+08
Q9UBN7;Q9UBN7-2;A6NDI8;E7EPS2;C9J172;E9PEH1;E7EP63;E7ER52Q9UBN7;Q9UBN7-2;A6NDI8;E7EPS2Histone deacetylase 6HDAC6 4 4 1215 1.2571 0.63089 3.64E+08
G5E933;O95248;O95248-4;H0Y5W8G5E933;O95248;O95248-4Myotubularin-related protein 5SBF1 19 18 1868 1.2567 0.58699 5.42E+08
P28072;A0A087X2I4;I3L3X7P28072;A0A087X2I4;I3L3X7Proteasome subunit beta type-6PSMB6 4 4 239 1.2566 0.73756 5.87E+07
Q9Y399;Q5T8A0 Q9Y399;Q5T8A0 28S ribosomal protein S2, mitochondrialMRPS2 10 10 296 1.2558 0.78062 9.89E+08
Q8WUA2 Q8WUA2 Peptidyl-prolyl cis-trans isomerase-like 4PPIL4 8 8 492 1.2552 0.79391 2.99E+08
O94832;J3QRN6;K7EIG7;J3KRL0;J3QRR2O94832;J3QRN6;K7EIG7Unconventional myosin-IdMYO1D 21 21 1006 1.2539 0.68789 1.34E+09
Q9H307;Q9H307-2;G3V5F0;G3V579Q9H307;Q9H307-2Pinin PNN 6 6 717 1.2526 0.94117 3.07E+08
Q8IX18-4;Q8IX18-3;Q8IX18-2;Q8IX18;J3KTK0;J3KSW6;F5H625Q8IX18-4;Q8IX18-3;Q8IX18-2;Q8IX18;J3KTK0;J3KSW6Probable ATP-dependent RNA helicase DHX40DHX4 8 8 702 1.252 0.65774 6.74E+08
B1ALB4;E9PD50;Q92540-2;Q92540;Q92540-5;Q92540-4;D6RAD0;E9PEK3B1ALB4 E9PD5 ; 2; ;Q92540-5;Q 2540-4Protein SMG7 SMG7 4 4 757 1.2519 0.78512 3.48E+07
Q5VTR2;C9J0A5;C9JXC9;C9JWJ4Q5VTR2 E3 ubiquitin-protein ligase BRE1ARNF20 23 21 975 1.25 0.58678 1.16E+09
Q86U44;H0YFV6;Q86U44-2;F5H6D8;B4DTN4Q86U44 H0YFV6;Q86U4 -2N6-adenosine-methyltransferase 70 kDa subunitMETTL3 6 6 580 1.2497 0.98607 3.33E+08
P84022;H0YMP2;H0YL71;H3BP09;H3BVD1;K7EJX0;B7Z5N5;P84022-3;P84022-2;O15198-2;Q15796-2;Q15796;O15198P84022;H0YMP2;H0YL71;H3BP09;H3BVD1;K7EJX0;B7Z5N5;P84022-3;P84022-2;O15198-2;Q 7 6-2;Q15796;O15198Mothers against decapentaplegic homolog 3;Mothers against decapentaplegic homolog 9;Mothers against decapentaplegic homolog 2SMAD3;SMAD2;SMAD9 2 2 425 1.2496 0.51481 1.41E+08
Q13625-2;Q13625;Q13625-3;Q96KQ42; 13625;Q13625-3Apoptosis-stimulating of p53 protein 2TP53BP2 4 4 1005 1.2492 0.57225 1.57E+08
Q96SI9-2;Q96SI9 Q96SI9-2;Q96SI9 Spermatid perinuclear RNA-binding proteinSTRBP 9 5 658 1.2492 0.59875 1.41E+08
P61962;A0A087WWI6;P61962-2P619 2;A0A087WWI6DDB1- and CUL4-associated factor 7DCAF7 8 8 342 1.248 0.66211 1.47E+09
A6NHN7;A6NHB5;Q14202-2;Q14202A6NHN7;A6NHB5;Q14202-2;Q14202Zinc finger MYM-type protein 3ZMYM3 6 5 1280 1.2479 0.82704 1.85E+08
Q86WX3;F8WFE7 Q86WX3;F8WFE7 Active regulator of SIRT1RPS 9BP1 2 2 136 1.2475 0.49955 2.70E+08
A0A0A0MR09;P43378;H3BQT6A0A0A0MR09;P43378Tyrosine-protein phosphatase non-receptor type 9PTPN9 5 5 583 1.2466 0.82777 2.13E+08
P46778;M0R181;G3V1B3;M0R3I5P46778;M0R181;G3V1B360S ribosomal protein L21RPL21 15 15 160 1.2464 0.7505 4.90E+09
Q9H2U1;Q9H2U1-3;Q9H2U1-2;E7EWK3;A0A0G2JQU7;H7C5F5;A0A0G2JRP3;H7C514Q9H2U1;Q9H2U1-3;Q9H2U1-2;E7EWK3ATP-dependent RNA helicase DHX36DHX36 27 26 1008 1.2461 0.7876 3.12E+09
Q9H6T3;Q9H6T3-3;Q9H6T3-2;Q9H6T3-3;Q9H6T3-2RNA polymerase II-associated protein 3RPAP3 8 8 665 1.2454 0.67938 7.01E+08
E9PPJ1;Q8NG31-3;Q8NG31-4;Q8NG31-2;Q8NG31;H0YCZ2E9PPJ1;Q8NG31- ;Q8NG31-4;Q8NG31-2;Q8NG31Protein CASC5 CASC5 3 3 1746 1.245 NaN 5.50E+07
137
O15344;C9J453;O15344-2;A0A087X255;A0A087X0X0;C9JZJ7;Q9UJV3-2;Q9UJV3;A6PVI4O15344;C9J453;O15344-2;A0A 87X255;A0A087X0X0E3 ubiquitin-protein ligase Midline-1MID1 10 10 667 1.244 0.96302 6.16E+08
Q8NB90;Q8NB90-2;Q8NB90-3Q8NB90;Q8NB90-2;Q8NB90-3Spermatogenesis-associated protein 5SPATA5 12 11 893 1.2433 0.55846 4.89E+08
P06748;P06748-3;P06748-2;E5RI98;E5RGW4;P06748-3;P06748-2Nucleophosmin NPM1 16 16 294 1.2432 0.92843 2.33E+10
P38159;H3BT71;P38159-2;H0Y6E7;Q96E39;H3BR27;H3BUY5;P38159-3;H3BNC1;O75526;Q8N7X1P38159; 3BT71;P38159-2;H0Y6E7;Q96E39RNA-binding motif protein, X chromosome RNA-binding motif protein, X chromosome, N-terminally processed;RNA binding motif protein, X-linked-like-1RBMX;RBMXL1 13 13 391 1.2426 0.69169 2.49E+09
P43686;P43686-2 P43686;P43686-2 26S protease regulatory subunit 6BPSMC4 32 32 418 1.2418 0.74428 1.15E+10
Q9Y3D3;A6ND22;Q9Y3D3-2Q9Y3D3;A6ND22;Q9Y3D3-228S ribosomal protein S16, mitochondrialMRPS16 2 2 137 1.2417 0.85435 2.85E+08
Q9NWK9-2;Q9NWK9Q9NWK9-2;Q9NWK9Box C/D snoRNA protein 1ZNHIT6 3 3 431 1.2406 0.51337 8.66E+07
Q86XL3;Q86XL3-2;F5H6J0;F5H1D4;Q86XL3-3Q86XL3;Q86XL3-2 Ankyrin repeat and LEM domain-containing protein 2ANKLE2 4 4 938 1.2403 0.6394 8.04E+07
O15111 O15111 Inhibitor of nuclear factor kappa-B kinase subunit alphaCHUK 5 5 745 1.2398 0.74055 2.15E+08
A0A087X0R7;Q9H4L4;J3QL36A0A087X0R7;Q9H4L4Sentrin-specific protease 3SENP3 3 3 540 1.2389 0.63232 1.04E+08
O75150;H3BP71;O75150-4;O75150-3;H3BS50;A0A087WTK2;H3BQ99;H3BUL6;I3L332O75150;H3BP71;O75150-4 O75150-3E3 ubiquitin-protein ligase BRE1BRNF40 17 15 1001 1.2389 0.64596 4.40E+08
Q4G0F5 Q4G0F5 Vacuolar protein sorting-associated protein 26BVPS26B 3 2 336 1.238 NaN 1.04E+08
Q9H1Y0;L7UQJ2;Q9H1Y0-2;Q7Z3H3Q9H1Y0;L UQJ2;Q9H1Y0-2Autophagy protein 5ATG5 4 4 275 1.2379 0.86604 2.40E+08
A0A024R4M0;P46781;B5MCT8;C9JM19;F2Z3C0;A8MXK4A0A024R4M0;P46781;B5MCT8;C9JM1940S ribosomal protein S9RPS9 20 20 194 1.2375 0.7606 8.62E+09
O14802;Q7Z755;R4GMX2O14802 DNA-directed RNA polymerase III subunit RPC1POLR3A 39 38 1390 1.2369 0.71485 2.37E+09
Q9BY77;F6VRR5;Q9BY77-2;F8WCX5;Q8WUT1;Q6R954;F8WEE2Q9BY77;F6VRR5; 9BY77-2;F8WCX5Polymerase delta-interacting protein 3POLDIP3 13 13 421 1.2362 0.72129 2.00E+09
P60891;P60891-2;B1ALA9;B7ZB02;A0A0B4J207;P21108;B1ALA7P60891;P60891-2;B1ALA9;B7ZB02Ribose-phosphate pyrophosphokinase 1PRPS1 22 10 318 1.2348 0.83329 1.10E+10
Q8TF05-2;Q8TF05;J3KRU1;J3QL26;J3KSB0;J3QLA6;J3QQV0;J3QRV2;F8WAJ9;J3KSS1Q8TF05-2; 8TF05;J3KRU1;J3QL26;J3KSB0;J3QLA6;J3QQV0erine/threonine-protein phosphatase 4 regulatory subunit 1PPP4 1 6 6 933 1.2344 0.71298 1.44E+08
C9JE12;C9JCW7;Q9BVT8C9JE12;C9JCW7;Q9BVT8Transmembrane and ubiquitin-like domain-containing protein 1TMUB1 1 1 152 1.2342 1.213 2.38E+07
O94808;E5RJP4 O94808;E5RJP4 Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2GFPT2 5 3 682 1.2342 0.92441 1.98E+08
P78362;P78362-2;H7C2I2;C9J2M4;H7C521;C9JWF7;H7C5L6;A8MPP7;A8MPY5;E7ETV6;Q9UPE1-2;Q9UPE1-3;Q9UPE1-4;Q9UPE1P 8362;P78362-2;H7C2I2;C9J2M4;H7C521;C9JWF7;H7C5L6;A8MPP7;A8MPY5;E7ETV6;Q9UPE1-2;Q9UPE1-3;Q9UPE1-4;Q9UPE1SRSF protein kinase 2;SRSF protein kinase 2 N-terminal;SRSF protein kinase 2 C terminal;SRSF protein kinase 3SRPK2;SRPK3 2 1 688 1.2336 NaN 1.63E+07
Q96RY7;Q96RY7-2 Q96RY7;Q96RY7-2 Intraflagellar transport protein 140 homologIFT140 3 3 1462 1.2336 0.69402 1.28E+08
Q8N2K0-3;Q8N2K0;Q8N2K0-2;Q5T712;I3L440;I3L294Q8N2K0-3;Q8N2K0;Q8N2K0-2;Q5T712Monoacylglycerol lipase ABHD12ABHD12 4 4 360 1.2335 1.0103 1.91E+08
O43172-2;O43172 O43172-2;O43172 U4/U6 small nuclear ribonucleoprotein Prp4PRPF4 15 15 521 1.2333 0.93803 2.04E+09
A0A087WY71;Q96CW1-2;Q96CW1;E9PFW3;C9JJ47;C9JGT8;C9JJD3;C9JTK4;C9JPV8;H7C4C3A0A087WY71;Q96CW1-2;Q96CW1;E9PFW3;C9JJ47;C9JGT8;C9JJD3;C9JTK4AP-2 complex subunit muAP2M1 10 10 434 1.233 0.7364 8.07E+08
Q8NI60-3;Q8NI60;Q8NI60-4;Q8NI60-2Q8NI60-3;Q8NI60;Q8NI60-4Chaperone activity of bc1 complex-like, mitochondrialADCK3 10 10 595 1.2327 0.64821 1.17E+09
Q9NRF8 Q9NRF8 CTP synthase 2 CTPS2 18 14 586 1.2326 0.75778 1.93E+09
P35250;P35250-2;A0A087WVY3;H7C5P4;H7C5P1;H7C5Q7;F8WC37;H7C5A0;H7C5G4;H7C596;H7C5S7P35250;P35250-2;A0A087WVY3Replication factor C subunit 2RFC2 13 13 354 1.2324 0.77704 1.94E+09
Q9H0D6;Q9H0D6-2Q9H0D6;Q9H0D6-25-3 exoribonuclease 2XRN2 21 21 950 1.2324 0.73085 2.37E+09
P49915;P49915-2 P49915;P49915-2 GMP synthase [glutamine-hydrolyzing]GMPS 41 41 693 1.2323 0.65738 1.91E+10
P36954;K7EK49;K7EKS1P36954;K7EK49;K7EKS1DNA-directed RNA polymerase II subunit RPB9POLR2I 2 2 125 1.232 0.7887 1.93E+08
Q9H9Y6;Q9H9Y6-3;Q9H9Y6-2;Q9H9Y6-5;Q9H9Y6-4;H7C0D9;C9JJG2;C9JS83;F8WDS4;F8WAK7;F8WBB9;F8WCS3;Q9H9Y6-3;Q9H9Y6-2;Q9H9Y6-5;Q H9Y6-4DNA-directed RNA polymerase I subunit RPA2POLR1B 16 16 1135 1.2319 0.82249 1.22E+09
Q6P1J9 Q6P1J9 Parafibromin CDC73 14 14 531 1.2318 0.75678 1.35E+09
E9PN76;Q8ND24-2;Q8ND24E9P 76;Q8ND24-2;Q8ND24RING finger protein 214RNF214 2 2 513 1.231 NaN 1.96E+07
P31327;P31327-3;P31327-2;Q5R211;P31327-3;P31327-2Carbamoyl-phosphate synthase [ammonia], mitochondrialCPS1 22 19 1500 1.2296 0.76878 1.76E+09
P49411;H3BNU3 P49411 Elongation factor Tu, mitochondrialTUFM 29 29 452 1.2296 0.75076 3.69E+10
P63173;J3KT73;J3QL01;J3KSP2P63173;J3KT73;J3QL0160S ribosomal protein L38RPL38 8 8 70 1.2294 0.76241 7.27E+09
F8W7U8;P49959;P49959-2;P49959-3;F5GXT0;F5H742;F5H256F8W7U8; ;P49959-2;P49959-3Double-strand break repair protein MRE11AMRE11A 11 11 707 1.228 0.82777 1.67E+09
Q9BXS5;Q9BXS5-2;K7EJL1;E7ENJ6;K7EQX3;K7EPJ8;A0A087WZX7;K7ENA7;Q9Y6Q5;Q9Y6Q5-2;K7ER75;K7EPR4;K7EJJ1;K7EK69;K7EQ90;K7ERH5;K7EL08;K7EMG5Q9BXS5;Q9BXS5-2;K7EJL1; 7ENJ6AP-1 complex subunit mu-1AP1M1 17 17 423 1.2276 0.71103 1.96E+09
Q16531;F5GY55;Q16531-2;F5GWI0;F5GZY8;F5H2L3;F5GYG8;F5H198Q16531; Y55 DNA damage-binding protein 1DDB1 23 23 1140 1.2272 0.6076 2.20E+09
P05387;H0YDD8 P05387 60S acidic ribosomal protein P2RPLP2 11 11 115 1.2271 0.54259 4.88E+09
P23258;Q9NRH3;K7EIS0;K7EKE5P23258;Q9NRH3 Tubulin gamma-1 chain;Tubulin gamma-2 chainTUBG1;TUBG2 26 26 451 1.2269 0.62444 4.81E+09
P07900;P07900-2;G3V2J8;Q14568;Q58FG0;Q58FG1P07900;P07900-2 Heat shock protein HSP 90-alphaAA1 54 35 732 1.2268 0.91579 3.85E+10
F8W020;F8VY35;F8W0J6;F5H4R6;H0YIV4;P55209-2;P55209;H0YHC3;F8W118;F8VV59;B7Z9C2;H0YH88;F8VXI6;F8VUX1;F8W543;F8VRJ2;F8VVB5;P55209-3F8W020;F8VY35;F8W0J6;F5H4R6;H0YIV4;P55209-2;P55209;H0YHC3;F8W118;F8VV59;B7Z9C2;H0YH8 ;F8VXI6;F8VUX1;F8W543;F8VRJ2;F8VVB5;P55209-3Nucleosome assembly protein 1 like 1NAP1L1 9 7 207 1.2248 1.0 7 5.44E+09
Q5QPM7;Q92530;Q5QPM9;H0Y555;F5H4Z3Q5QPM7;Q92 30;Q5QPM9Proteasome inhibitor PI31 subunitPSMF 4 4 263 1.2231 0.72298 6.06E+08
Q96QG7;E9PR67;Q96QG7-2Q96QG7;E9PR67;Q96QG7-2Myotubularin-related protein 9MTMR9 2 2 549 1.2217 0.7495 1.85E+08
A0A0D9SEJ5;F5GY05;Q96EK7;Q96EK7-2;Q96EK7-3A0A0D9SEJ5;F5GY05; ;Q96EK7-2Constitutive coactivator of peroxisome proliferator-activated receptor gammaFAM120B 7 7 922 1.2206 0.72194 3.21E+08
Q6PKG0;Q6PKG0-3;A0A0B4J210;E5RH50;H0YC33;H0YBW1;Q659C4-7;Q659C4-6;Q659C4-5;Q659C4-9;Q659C4-2;Q659C4;H0YC73Q6PKG0;Q6PKG0-3;A0A B4J210;E5RH50La-related protein 1LARP1 8 8 1096 1.2206 0.82231 4.85E+08
Q9NW13;Q9NW13-2;C9JE21;C9JAA9;H7C5G8Q9NW13;Q NW13-2RNA-binding protein 28RBM28 13 13 759 1.2196 0.71197 8.02E+08
J3QLS3;Q9Y2R9;J3KSI8;J3QQS1;J3QKW2J3QLS3; 9Y2R9;J3KSI8;J3QQS1;J3QKW228S ribosomal protein S7, mitochondrialMRPS7 10 10 271 1.2195 0.70598 1.59E+09
A0A087WZZ5;Q13435;E9PPJ0;E9PJT3;H0YEX5;E9PJ04;H0YCG1;E9PIL8A0A087WZZ5;Q1 435; 9PPJ0Splicing factor 3B subunit 2SF3B2 13 13 871 1.2184 0.67673 3.85E+08
Q99956 Q99956 Dual specificity protein phosphatase 9DUSP9 5 5 384 1.2183 0.70541 8.38E+08
Q92878;Q92878-2;Q92878-3;E7ESD9;E7EN38;H7C0V2;C9JNH8;H7C0P8;E9PM98;Q92878-2;Q92878-3DNA repair protein RAD50 42 42 1312 1.2178 0.68094 3.51E+09
R4GNH3;E9PKD5;E9PMD8;E9PN50;E9PLG2R4GNH3;E9PKD5;E9PMD8;E9PN50 PSMC3 30 1 423 1.2175 0.87218 9.15E+09
Q7Z6M1;Q7Z6M1-2;Q5T1S5;Q5T1S4Q7Z6M1; 7Z6M1-2;Q5T1S5Rab9 effector protein with kelch motifsRABEPK 7 7 372 1.2173 1.226 3.87E+08
O60678;A0A0A0MSN7;O60678-2O60678;A0A0A0MSN7;O60678-2Protein arginine N-methyltransferase 3PRMT3 14 14 531 1.2172 0.76605 1.78E+09
Q9H9A6 Q9H9A6 Leucine-rich repeat-containing protein 40LRRC40 32 32 602 1.217 0.81026 8.20E+09
Q8N3C0;Q8N3C0-4;E5RFZ0;Q8N3C0-3Q8N3C0 Activating signal cointegrator 1 complex subunit 3ASCC3 38 38 2202 1.2155 0.85178 2.50E+09
Q5T9A4;Q5T9A4-3 Q5T9A4;Q5T9A4-3 ATPase family AAA domain-containing protein 3BATAD3B 26 5 648 1.2151 0.90891 3.75E+08
Q12765;Q12765-2;B8ZZP4;C9J7U9;C9K052;Q12765-3Q12765;Q12765-2;B8ZZP4;C9J7U9;C9K052;Q12765-3Secernin-1 SCRN1 4 4 414 1.2148 1.1688 3.44E+08
Q7LBC6;Q7LBC6-2;H0Y9V5;Q7LBC6-3Q7LBC6; 2 Lysine-specific demethylase 3BKDM3B 8 8 1761 1.2144 0.65233 1.73E+08
Q07666-2;Q07666;Q07666-3;E5RG12;H0YAQ1;H0YAQ3;E5RJZ9;O75525-2;O75525;Q5VWX12;Q07666 KH domain-containing, RNA-binding, signal transduction-associated protein 1KHD BS1 5 5 418 1.2141 1.0542 2.68E+08
P35249;C9JZI1;P35249-2;C9J8M3;C9JTT7;C9JXZ7;C9JGY5;F8WE44;C9JW34;H7C1P0P35249;C9JZI1 P35249-2;C9J8M3;C9JTT7;C9JXZ7Replication factor C subunit 4RFC4 17 17 363 1.2134 0.70935 2.21E+09
Q96JC1-2;Q96JC1 Q96JC1-2;Q96JC1 Vam6/Vps39-like proteinVPS39 4 4 875 1.2127 0.63344 1.87E+08
Q9NZL9-4;Q9NZL9-2;Q9NZL9;H7C0X7;Q9NZL9-3;E5RJR3;Q9NZL9-5Q9NZL9-4;Q9NZL9-2;Q9NZL9 H7C0X7;Q9NZL9-3Methionine adenosyltransferase 2 subunit betaMAT2B 6 6 306 1.2114 1.0614 5.71E+08
O95487-2;O95487;O95487-32;O95487;O95487-3Protein transport protein Sec24BSEC24B 16 16 1233 1.2102 0.74197 8.47E+08
A0A0A6YYL4;P57737-3;P57737-4;P57737;P57737-2;I3L167;E7EP81;I3L1U7;I3L0X9;I3L3T0;I3L212;Q9Y3D7;I3L0X8;I3L442;I3L426A0A0A6YYL4;P57737-3; 4;P57737;P57737-2Coronin-7 CORO7 15 15 1048 1.209 0.8499 8.92E+08
P58557;P58557-2;P58557-4;P58557-3;P58557-2 Putative ribonucleaseYBEY 4 4 167 1.2079 0.68676 9.37E+07
P52701;P52701-3;P52701-2;A0A087WWJ1;P52701-4;A0A087WYT6;F8WAX8;C9JH55;C9J8Y8;C9J7Y7;F8W7G9;U3KQ72;P52701-3;P52701-2;A A087WWJ1;P52701-4DNA mismatch repair protein Msh6MSH6 38 38 1360 1.2078 0.79879 5.59E+09
Q9Y2W1 Q9Y2W1 Thyroid hormone receptor-associated protein 3THRAP3 1 1 955 1.2078 NaN 2.52E+07
J3QLR8 J3QLR8 MRPS23 9 1 152 1.2076 0.6061 6.38E+08
Q92547 Q92547 DNA topoisomerase 2-binding protein 1TOPBP1 10 10 1522 1.2071 0.51711 1.19E+08
F8W9X7;Q567U6;H7C050F8W9X7;Q567U6 Coiled-coil domain-containing protein 93CCDC93 6 6 630 1.2069 0.87386 2.48E+08
Q9NW08;Q9NW08-2;F8VRU2Q9NW08;Q9NW08-2DNA-directed RNA polymerase III subunit RPC2POLR3B 15 15 1133 1.205 0.74894 1.12E+09
P62699 P62699 Protein yippee-like 5YPEL5 3 3 121 1.2044 0.80412 5.23E+07
O60884;I3L320;A0A087WT48O60884 DnaJ homolog subfamily A member 2DNAJ 2 14 14 412 1.2041 0.7123 3.18E+09
P35658-2;P35658-4;P35658;P35658-3;P35658-5;A0A0A0MSW3;H0YF36;H0Y837;E9PKD2;B7ZAV2P35658-2; 4; ;P35658-3;P35658-5;A0A0A0MSW3Nuclear pore complex protein Nup214NUP214 18 18 2079 1.2037 0.59807 1.04E+09
E9PC69;Q7KZI7-12;Q7KZI7-14;Q7KZI7-3;Q7KZI7-6;Q7KZI7-11;Q7KZI7-8;Q7KZI7;E7ETY4;Q7KZI7-10;Q7KZI7-13;Q7KZI7-7;Q7KZI7-2;Q7KZI7-15;Q7KZI7-5;Q7KZI7-16;Q7KZI7-4;Q7KZI7-9;F5H6N2;F5H4F6;K7EK17;K7EKG8;Q96L34-2;Q96L34E9PC69;Q7KZI7-12;Q7KZI7-14; 7KZI7-3;Q7KZI7-6;Q7KZI7-11;Q7KZI7-8;Q7KZI7;E ETY4;Q7KZI7-10;Q7KZI7-13; 7KZI7-7;Q7KZI7-2;Q7KZI7-15;Q7KZI7-5;Q7KZI7-16;Q7KZI7-4;Q7KZI7-9Serine/threonine-protein kinase MARK2MAR 2 9 6 78 1.2033 0.5833 1.50E+08
Q7Z5K2;Q7Z5K2-2;Q7Z5K2-3;Q8WVX6;Q7Z5K2-2;Q7Z5K2-3Wings apart-like protein homologWAPAL 19 19 1190 1.2025 0.60493 1.28E+09
P23378 P23378 Glycine dehydrogenase (decarboxylating), mitochondrialGLDC 2 2 1020 1.2016 NaN 6.88E+07
Q9NX20;E9PI14 Q9NX20 39S ribosomal protein L16, mitochondrialMRPL16 9 9 251 1.2012 0.79718 2.71E+08
A0A024R4N9;Q9BSV6;E7EQB3;B0V3J0;A9C4B9;A0A0G2JNK5A0A024R4N9;Q9BSV6;E7EQB3;B V3 0;A9C4B9;A0A0G2JNK5tRNA-splicing endonuclease subunit Sen34TSEN34 4 4 310 1.2009 0.8036 2.38E+08
Q7L3T8 Q7L3T8 Probable proline--tRNA ligase, mitochondrialPARS2 4 4 475 1.1995 1.2078 2.07E+08
P24666;G5E9R5;P24666-4;F2Z2Q9;P24666-3;P24666-2;D3YTI2P24666;G5E9R5;P24666-4;F Z2Q9;P24666-3;P24666-2Low molecular weight phosphotyrosine protein phosphataseACP1 8 8 158 1.1994 0.68467 4.93E+09
Q9Y619;Q5VZD9;F2Z354Q9Y619;Q5VZD9 Mitochondrial ornithine transporter 1SLC25A15 6 6 301 1.1994 0.75601 2.71E+08
P22830;P22830-2;K7ELX4;K7EPN2;K7EJX5;K7EKP7;K7EJM8P22830;P22830-2;K7ELX4Ferrochelatase, mitochondrialFECH 12 12 423 1.1992 0.66309 7.22E+08
P40937;P40937-2;F5H5S0;E9PEP3;C9JH72;F5H304;F5H0U6P40937;P40937-2 Replication factor C subunit 5RFC5 15 15 340 1.1991 0.70932 3.70E+09
P21964-2;P21964;E7EMS6;E7EUU8;H7BZ45;F8WBW9P21964-2;P21964;E7EMS6;E7EUU8Catechol O-methyltransferaseCOMT 13 13 221 1.1985 0.66854 1.21E+09
Q92620;Q92620-2;J3KTG2;H3BQT9;H3BV01;J3KRT1;J3KSA8;H3BMS7Q92620 Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16DHX 8 14 14 1227 1.1984 0.8055 6.63E+08
O75616;J3QSB2;J3QRV9;O75616-2;K7EQJ8;J3QT61O75616;J3QSB ;J3QRV9;O75 6-2GTPase Era, mitochondrialERAL1 7 7 437 1.1983 0.72437 5.25E+08
Q9BU02;G3V5B9;G3V5Q5;Q9BU02-2Q9BU02;G3V5B9;G3V5Q5;Q9BU02-2Thiamine-triphosphataseTHTPA 2 2 230 1.1981 0.96477 1.64E+08
Q9C0D5-2;Q9C0D5;A0A0A0MSM4Q9C0D5-2;Q9C0D5Protein TANC1 TANC1 8 8 1755 1.1978 0.80227 2.50E+08
Q969S9-3;Q969S9;Q969S9-4;Q969S9-2;Q969S9-5;D6RAL1;D6RF753; ;Q969S9-4;Q969S9-2;Q969S9-5Ribosome-releasing factor 2, mitochondrialGFM2 6 6 777 1.1972 0.80651 1.70E+08
138
A0A087WWP4;Q96T37-4;Q96T37-2;Q96T37-3;Q96T37A0A087WWP4;Q96T37-4;Q96T37-2;Q96T37-3;Q96T37Putative RNA-binding protein 15RBM15 11 11 933 1.1968 0.72648 4.70E+08
P49720;A0A087WXQ8;A0A087WY10;A0A087WUL2P49720;A0A087WXQ8;A0A087WY10;A0A087WUL2Proteasome subunit beta type-3PSMB3 6 6 205 1.1968 0.80489 3.17E+08
P49914;A0A0A6YYL1;A0A0U1RQM3;P49914-2;A0A0U1RR23P49914;A0A0A6YYL1;A0A0U1RQM3;P49914-25-formyltetrahydrofolate cyclo-ligaseMTHFS 4 4 203 1.1968 NaN 8.98E+07
O60783 O60783 28S ribosomal protein S14, mitochondrialMRPS14 3 3 128 1.1967 0.90129 4.50E+08
H3BPE1;H3BQK9;Q9UPN3;E9PLY5;E9PNZ4;Q9UPN3-4;Q9UPN3-3;Q9UPN3-2;E9PLY0;H0Y390H3BPE1;H3BQK9;Q9UPN3;E9PLY5;E9PNZ4;Q9UPN3-4;Q9UPN3-3;Q9UPN3-2Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5MACF1 3 2 7555 1.1961 NaN 2.53E+07
Q9NVV4-2;Q9NVV4;Q5T852;A0A087WYC0;A0A0C4DGS5;Q08379-2;Q08379Q9NVV4-2;Q9NVV4Poly(A) RNA polymerase, mitochondrialMTPAP 8 8 712 1.1949 0.69573 5.22E+08
Q13263;Q13263-2;M0R0K9;M0R3C0;M0R2I3Q13263;Q13263-2 Transcription intermediary factor 1-betaTRIM28 32 32 835 1.1936 0.63889 1.43E+10
Q9NX24;D6RC52;D6RCB9;J3QSY4;H0YC83Q9NX24;D6RC52;D6RCB9;J3QSY4H/ACA ribonucleoprotein complex subunit 2NHP2 5 5 153 1.1935 0.75664 2.72E+08
Q9NZC9;H7BYI2;H7C1I3;H7C051Q9NZC9;H7BYI2 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1SMARCAL1 4 4 954 1.1935 0.59847 6.60E+07
Q9UNE7;Q9UNE7-2;H3BTA3;H3BUD0;H3BS86Q9UNE7;Q9UNE7-2;H3BTA3;H3BUD0;H3BS86E3 ubiquitin-protein ligase CHIPSTUB1 14 14 303 1.1934 0.92427 1.84E+09
P51398-2;P51398-3;P51398;V9GZ03;V9GYJ9;V9GYL9;V9GYA7;V9GZ61;V9GYC9;V9GYW1;V9GY11;V9GYJ3;V9GYF7P51398-2;P51398-3;P51398;V9GZ03;V9GYJ9;V9GYL9;V9GYA728S ribosomal protein S2 , mitochondrialD P3 10 10 357 1.1932 0.77789 1.51E+09
O15067;H0YGH1;J3QSG0;J3QSH6;J3KT98;J3KTQ5;J3KTL4O15067 Phosphoribosylformylglycinamidine synthasePFAS 46 46 1338 1.1931 0.72663 1.39E+10
Q9NYU2-2;Q9NYU2Q9NYU2-2;Q9NYU2UDP-glucose:glycoprotein glucosyltransferase 1UGGT1 8 8 1531 1.1928 0.82512 2.22E+08
O14617;O14617-5;O14617-4;O14617-2;O14617-3;A0A087WYN6;K7ELX8;K7ERW8;O14617-5;O14617-4;O14617-2;O14 17-3AP-3 complex subunit delta-1AP3D1 30 30 1153 1.1923 0.66333 2.72E+09
Q9NUU7;I3L0H8;Q9UMR2-4;I3L352;Q9NUU7-2;H3BTB3;J3QRH0;H3BSL8;H3BP36;H3BP50;H0YD26;E9PR46;J3QL17;Q9UHL0-2;Q9UHL0Q9NUU7;I 0H8 UMR2 4;I3L352;Q9NUU7-2ATP-dependent RNA helicase DDX19A;ATP-dependent RNA helicase DDX19BDDX19A; B 23 3 478 1.1913 0.78525 5.17E+09
Q96MX6-2;Q96MX6Q96MX6-2;Q96MX6WD repeat-containing protein 92WDR92 3 3 288 1.1907 0.9029 1.33E+08
O75419-2;O75419;O75419-3;H7BZ91;C9K087;C9J9112;O 5419 O75419-3ell division control protein 45 homologCDC45 14 14 520 1.1898 0.72592 7.91E+08
Q96ST3 Q96ST3 Paired amphipathic helix protein Sin3aSIN3A 6 6 1273 1.1897 0.94304 1.84E+08
E7EVX8;Q8WWY3;Q8WWY3-4;Q8WWY3-3;Q8WWY3-2;E7EU94;E7ESX0;E7EN72E7EVX8;Q8WWY3;Q8WWY3-4;Q8WWY3-3;Q8WWY3-2U4/U6 small nuclear ribonucleoprotein Prp31PRPF31 11 11 493 1.1886 0.7721 1.07E+09
P11908;P11908-2;H7C540;A6NMS2;D3YTJ7P11908 P11908-2 Ribose-phosphate pyrophosphokinase 2PRPS2 19 7 318 1.1886 0.74406 2.26E+09
Q9Y224;G3V4C6;G3V4E7;H0YJB9Q9Y224;G3V4C6 UPF0568 protein C14orf166C14orf166 4 4 244 1.1879 0.91089 4.49E+08
P31749-2;P31749;G3V2I6;A0A087WY56;G3V3X1;Q9Y243-2;Q9Y243P 1749-2;P31 49;G3V2I6RAC-alpha serine/threonine-protein kinaseAKT1 4 4 418 1.1877 0.8113 1.62E+08
O00443;A0A0C4DGF9;O00443-2;E9PPP3O00443 hosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alphaPIK3C2A 24 24 1686 1.1872 0.94118 9.54E+08
E9PC74;Q13144;C9JRD9E9PC74;Q13144 Translation initiation factor eIF-2B subunit epsilonEIF2B5 4 4 705 1.1871 0.69959 4.76E+08
Q9H6R0;I3L1L6;Q9H6R0-2Q9H6R0;I3L1L6;Q9H6R0-2Putative ATP-dependent RNA helicase DHX33DHX33 4 4 707 1.1867 0.87973 2.19E+08
O00425;O00425-2;F8WD15O00425 Insulin-like growth factor 2 mRNA-binding protein 3IGF2BP3 24 20 579 1.1866 0.89545 2.57E+09
P49137;P49137-2 P49137;P49137-2 MAP kinase-activated protein kinase 2MAPKAPK2 4 4 400 1.1866 0.85757 9.33E+07
Q6L8Q7;Q6L8Q7-2;F6T1Q0Q L8 7;Q6L8Q7-2;F6T1Q02,5-phosphodiesterase 12PDE 13 13 609 1.1859 0.77675 2.63E+09
Q9BW92;U3KQG0;F6S7Q7;Q9BW92-2;U3KQ50Q9BW92;U3KQG0;F6S7 7;Q9BW92-2Threonine--tRNA ligase, mitochondrialTARS2 13 13 718 1.1859 0.76331 9.03E+08
Q99683;Q99683-2 Q99683;Q99683-2 Mitogen-activated protein kinase kinase kinase 5MAP3K5 2 2 1374 1.1858 NaN 4.95E+07
F5GYN4;J3KR44;Q96FW1;F5H6Q1;F5GYJ8;F5H3F0;Q96FW1-2F5GYN4;J3KR44;Q96FW1;F5H6 1;F5GYJ8Ubiquitin thioesterase OTUB1OTUB1 10 10 241 1.1857 0.92016 1.33E+10
Q9Y4E8-2;Q9Y4E8-3;Q9Y4E8Q9Y4E8-2;Q9Y4E8-3;Q9Y4E8Ubiquitin carboxyl-terminal hydrolase 15USP15 4 3 952 1.1856 0.86631 1.52E+08
Q5SQP8;P56545;P56545-2;A0A087WYL1Q5SQP8;P56545;P56545-2C-terminal-binding protein 2CTBP2 16 11 513 1.1853 0.75269 4.23E+09
Q8WXE1-5;Q8WXE1-3;Q8WXE1-2;Q8WXE1;A0A0U1RQR9;A0A0U1RRM7;A0A0U1RQW3Q8WXE1-5;Q8WXE1-3;Q8WXE1-2; 8WXE1;A0A0U1RQR9;A0A0U1RRM7;A0A0U1RQW3ATR-interacting proteinTRIP 2 2 664 1.1847 NaN 7.38E+08
Q15424-2;Q15424;Q15424-4;Q15424-3;K7ES422; ;Q1542 -4;Q15424-3;K7ES42Scaffold attachment factor B1SAFB 2 2 848 1.1843 0.88539 3.88E+07
M0QXB5;O95571;M0QY80M0QXB5;O95571;M0QY80Persulfide dioxygenase ETHE1, mitochondrialETH 1 2 2 260 1.1842 NaN 1.47E+08
O00273-2;O00273;K7ERT1O00273-2;O00273 DNA fragmentation factor subunit alphaDFFA 4 4 268 1.1836 0.84546 4.14E+08
P35998;P35998-2;C9JLS9P359 8;P35998-2 26S protease regulatory subunit 7PSMC2 30 30 433 1.1833 0.76668 1.28E+10
Q8NE71-2;Q8NE71;H0YGW7;Q5STZ8;A0A0G2JIC2;F5GYK6Q8NE71-2;Q8NE71;H0Y W7ATP-binding cassette sub-family F member 1ABCF1 18 18 807 1.183 1.0517 1.12E+09
Q14181;E9PIQ6;Q14181-2;H0YDR7Q 4 81;E9PIQ6;Q14181-2DNA polymerase alpha subunit BPOLA2 4 4 598 1.1814 0.81666 2.65E+08
Q99613-2;Q99613;B5ME19;H3BPE4;H3BPE3;H3BTY8Q99613-2;Q99613;B5ME19Eukaryotic translation initiation factor 3 subunit C;Eukaryotic translation initiation factor 3 subunit C-like proteinEIF3C;EIF3CL 34 34 903 1.1813 0.82404 9.33E+09
P12004 P12004 Proliferating cell nuclear antigenPCNA 17 17 261 1.1811 0.80929 2.51E+10
Q14315-2;Q14315 Q14315-2;Q14315 Filamin-C FLNC 59 53 2692 1.1809 0.88798 3.48E+09
Q15365;H3BSP4;C9K0A2;F8WC71;C9IZV9;C9J7A9;C9JSA6;C9J5V4;C9JTY5;C9JZY3;C9J0A4;F6TJN8;P57723-2;P57723Q15365 Poly(rC)-binding protein 1PCBP 17 12 356 1.1808 0.74598 7.64E+09
P15104;A0A087WYJ1P 5104 Glutamine synthetaseGLUL 4 4 373 1.1795 1.2786 6.15E+07
O75592-2;O75592;H7C3U4;A0A0C4DGY7O 5592-2;O75592 E3 ubiquitin-protein ligase MYCBP2MYCBP2 29 29 4637 1.1793 0.74346 9.05E+08
P68371;M0R2D3;M0R2T4;A0A075B724P68371 Tubulin beta-4B chainTUBB4B 34 1 445 1.1789 0.84383 2.61E+11
P29372-5;P29372-4;P29372-2;P29372;A2IDA3P29372-5;P29372-4;P 9372-2;P29372;A2IDA3DNA-3-methyladenine glycosylaseMPG 7 7 281 1.1787 0.67654 1.73E+09
F5GX99;H0YGM0;Q9H078-4;Q9H078-2;Q9H078;Q9H078-5;Q9H078-3;F5H392;F5H7A5F5GX99;H0YGM0;Q9H078-4;Q9H078-2;Q9H078;Q9H078-5;Q9 078-3;F5H392;F5H7A5Caseinolytic peptidase B protein homologCLPB 4 4 501 1.1786 0.85017 2.36E+08
Q9BY44-3;Q9BY44;F8WAE5;Q9BY44-4;C9IZE1;Q9BY44-2;H7C5Q3;H7C5R5;F8WF18;F8WAT3Q9BY44-3;Q9BY4 ;F8WAE5;Q9BY 4-4;C9IZE1Eukaryotic translation initiation factor 2A;Eukaryotic translation initiation factor 2A, N-terminally processedEIF2A 17 17 560 1.1786 0.71555 2.87E+09
Q01780;Q01780-2;K7EJ37Q01780;Q01780-2 Exosome component 10EXOSC10 23 23 885 1.1784 0.8036 2.09E+09
Q13217;X6R9L0 Q13217;X6R9L0 DnaJ homolog subfamily C member 3DNAJ 3 6 6 504 1.1782 0.74396 6.68E+08
Q9GZT3-2;Q9GZT3;A0A087WUN7;H0YJ40;G3V4X6;G3V2S9;H0YJW7;H0YJI1;H0YJ07;H0YJU7;J3KPY6Q9GZT3-2;Q9GZT3;A0A087WUN7;H0YJ40;G3V4X6;G3V2S9;H0YJW7SR  stem-loop-interacting RNA-binding protein, mitochondrialSLIRP 10 10 107 1.1776 0.75551 8.25E+08
P05198;G3V4T5;H0YJS4P05198;G3V4T5;H0YJS4Eukaryotic translation initiation factor 2 subunit 1EIF2S1 28 28 315 1.1775 0.7821 1.12E+10
A0A0U1RRM1;Q8WXI9;A0A0U1RR30A0A0U1RRM1;Q8WXI9Transcriptional repressor p66-betaGATAD2B 7 6 577 1.1773 0.61387 5.20E+08
B4DHE8;Q96DH6-2;Q96DH6;J3KTC1;J3QKT5;B4DM51;Q96DH6-3B4DHE8;Q96DH6-2; 96DH6;J3KTC1;J3QKT5RNA-binding protein Musashi homolog 2IGSF9B;MSI2 8 7 324 1.1765 0.80028 1.46E+09
G5E9S8;G3V2E7;F8W6L3;G3V3H3;G3V5R9;E7EVH7;Q07866-8;Q07866-2;Q07866-3;Q07866;Q07866-7;Q07866-5;Q07866-10;Q07866-6;Q07866-4;Q07866-9G5E9S8;G3V2E7;F8W6L3;G3V3H3;G3V5R9;E7EVH7;Q07866-8;Q07866-2; 3; ;Q07866-7;Q 7866-5;Q07866-10;Q07866- ;Q07866-4;Q07866-9Kinesin light chain 1KLC1 2 2 549 1.174 0.86704 6.79E+07
P31323 P31323 cAMP-dependent protein kinase type II-beta regulatory subunitPRKAR2B 6 4 418 1.1747 1.0266 1.63E+08
Q8NFW8;Q8NFW8-2;F5H296;F5GYM0Q8NFW8;Q8NFW8-2N-acylneuraminate cytidylyltransferaseCMAS 11 11 434 1.1744 0.69464 1.37E+09
Q86WA6-2;Q86WA6;H7C0M3Q86WA6-2;Q86WA6;H7C0M3Valacyclovir hydrolaseBPHL 2 2 274 1.1737 0.60001 1.33E+08
O60488-2;O60488;D6RF95;D6RFW9;D6RDA8;D6RD96;H0Y9A0O 0488-2;O60488 Long-chain-fatty-acid--CoA ligase 4ACSL4 16 14 670 1.1736 0.70016 9.52E+08
Q96I25;Q5W011;Q5W010;H0Y6J6;Q5W012Q96I25 Q5W011;Q5W010Splicing factor 45 RBM17 6 6 401 1.1733 0.53966 1.05E+08
Q2TAL8 Q2TAL8 Glutamine-rich protein 1QRICH1 7 7 776 1.173 0.94494 2.85E+08
P13807-2;P13807;M0QYU1P13807-2;P13807 Glycogen [starch] synthase, muscleGYS1 12 12 673 1.1728 0.7714 1.91E+09
S4R468;Q8NE86-3;Q8NE86S4R468;Q8NE86-3;Q8NE86Calcium uniporter protein, mitochondrialMCU 1 1 167 1.1712 NaN 4.82E+07
Q8TDX7;F5H3U7;F8WAG2;Q5TBH0;Q5TBG1;Q5TBG7;Q5TBH2;Q5TBH1;Q8TDX7-2;Q9HC98;Q9HC98-3;Q9HC98-4;Q9HC98-2Q8TDX7 Serine/threonine-protein kinase Nek7NEK7 3 3 302 1.1711 0.74115 2.56E+08
A0A087X2I1;P62333;H0YJC0;H0YJS8;H0YJX2;H0YJE9;H0YJT1;H0YJD2;H0YJY8A0A 87X2I1;P62333;H0YJC26S protease regulatory subunit 10BPSMC6 24 24 403 1.1706 0.85199 7.83E+09
Q86VV8-4;Q86VV8-3;Q86VV8;J3KTD2;J3KT00;Q86VV8-2Q86VV8-4;Q86VV8-3;Q86VV ;J3KTD2;J3KT00;Q86VV8-2Rotatin RTTN 4 4 879 1.1703 1.1811 3.33E+08
Q8IVS2;Q8IVS2-2 Q8IVS2;Q8IVS2-2 Malonyl-CoA-acyl carrier protein transacylase, mitochondrialMCAT 5 5 390 1.1701 0.63362 2.13E+08
Q9UKG1;C9JAB0;C9K0C4Q9UKG1 DCC-interacting protein 13-alphaAPPL 11 11 709 1.17 0.86033 7.83E+08
Q5SY16 Q5SY16 Polynucleotide 5-hydroxyl-kinase NOL9NOL9 10 10 702 1.1698 0.85185 9.44E+08
Q00577 Q00577 Transcriptional activator protein Pur-alphaPURA 3 3 322 1.1697 0.89773 8.23E+08
Q8IU81 Q8IU81 Interferon regulatory factor 2-binding protein 1IRF2BP1 3 3 584 1.1694 1.2547 3.05E+08
A0A0G2JIS2;Q96KQ7-2;Q96KQ7;A2ABF8;A0A0G2JIR1;A2ABF9;A0A0G2JK64;Q96KQ7-3;A0A0G2JRR0;A0A0G2JRN8A0A0G2JIS2;Q96KQ7-2;Q96KQ7;A2ABF8;A0A0G2JIR1;A2ABF9;A0A0G2JK64;Q96KQ7-3Histone-lysine N-methyltransferase EHMT2EHMT2 3 3 1176 1.1691 NaN 1.21E+08
F5GWX5;A0A0C4DGG9;Q14839;Q14839-2;Q8TDI0;K7EMY3;F2Z2R5;I3L229;H7C3H7;H7C0J3;K7EPV1;K7ESA5;F5H6N4F5GWX5;A0A0C DGG9; 14839;Q14839-2Chromodomain-helicase-DNA-binding protein 4CHD4 47 40 1905 1.1678 0.81295 4.90E+09
P14174 P14174 Macrophage migration inhibitory factorMIF 4 4 115 1.1677 0.54733 3.29E+09
Q8TD30;H3BU54;Q8TD30-2;P24298Q8TD30 Alanine aminotransferase 2GPT2 3 3 523 1.1662 NaN 7.90E+07
O95163;F5H2T0;H0YDF3O95163;F5H2T0 Elongator complex protein 1IKBKAP 34 34 1332 1.1661 0.91135 4.95E+09
P25205;P25205-2;J3KQ69;Q7Z6P5P25205;P25205-2;J3KQ69DNA replication licensing factor MCM3MCM3 49 49 808 1.1659 0.77266 1.20E+10
A0A0D9SF63;Q9BZK7;Q9BQ87;O60907-2;O60907;C9JLJ1;C9JCK0;C9JBN1;A0A0D9SF25;F8W9D8;C9IYU9A0A0D9SF63;Q9BZK7;Q9BQ8 ;O60907-2;O6 907F-box-like/WD repeat-containing protein TBL1XR1;F-box-like/WD repeat-containing protein TBL1Y;F-box-like/WD repeat-containing protein TBL1XTBL1XR1;TBL1Y;TBL1X 6 6 474 1.1655 0.81284 2.46E+08
E9PIF2;Q13206 E9PIF2;Q13206 Probable ATP-dependent RNA helicase DDX10DDX10 10 10 835 1.165 0.91445 3.66E+08
H7C441;C9JXG5;F8WCP5;Q13769;C9JXU6;F5GZF3;C9JCL9;H7C072H7C441;C9JXG5;F8WCP5;Q13769;C9JXU6;F5GZF3;C9JCL9;H7C072THO complex subunit 5 homologT O 5 4 4 176 1.1646 1.0512 9.58E+07
P62269;A0A0G2JQH2;Q5GGW2;J3JS69P62269 40S ribosomal protein S18RPS18 22 22 152 1.1645 0.93051 6.91E+09
A8MQ02;F8W9I4;E9PFY5A8MQ02 MLLT4 14 1 1781 1.1636 0.57867 4.85E+08
Q969Y2-3;Q969Y2;Q969Y2-4;Q969Y2-23; ;Q969Y2-4;Q969Y2-2tRNA modification GTPase GTPBP3, mitochondrialTPBP3 2 2 471 1.1635 1.0644 8.99E+07
Q9NQW7-3;Q5T6H7;Q9NQW7;Q9NQW7-4;Q9NQW7-2;Q5T6H3;Q5T6H2Q9NQW7-3; 5T6H7;Q9NQW7;Q9N W7-4;Q9NQW7-2Xaa-Pro aminopeptidase 1XPNPEP1 4 4 666 1.1631 1.4389 3.83E+08
P60983;G3V4P8;G3V3X4;M0QYG8;M0R1D2;M0R0C1;M0QYJ8;O60234P60983;G3V4P8 Glia maturation factor betaGMFB 7 7 142 1.1625 1.6763 2.44E+08
O75400-2;O75400;O75400-3;H7C2N3;F5H5782;O 5400;O75400-3Pre-mRNA-processing factor 40 homolog APRPF40A 5 5 930 1.1624 0.51665 2.77E+08
P56937-3;P56937-2;P56937;V9GYN3P56937-3;P56937-2;P569373-keto-steroid reductaseHSD17B7 3 3 306 1.1622 0.79093 2.30E+08
A0A0C4DG89;Q7L014;D6RJA6;H0Y9U3A0A0C4DG89;Q7L014Probable ATP-dependent RNA helicase DDX46DDX46 33 33 1032 1.1621 0.77626 2.60E+09
B1AK87;B1AK88;P47756-2;P47756;B1AK85B1AK87;B1AK88;P47756-2;P47756;B1AK85F-actin-capping protein subunit betaCAPZB 6 6 260 1.162 1.3815 6.18E+08
Q8TD19;G3V459;G3V5V0;G3V2Z5Q8TD19 Serine/threonine-protein kinase Nek9NEK9 17 17 979 1.1616 0.81979 1.82E+09
Q14980-2;Q14980;A0A087WY61;Q14980-4;Q14980-3;H0YFY6;Q14980-5;K4DIE0;F5H4J1;F5H6Y5Q149 0-2;Q14980;A0A087WY61;Q14980-4; 14980-3;H0YFY6Nuclear mitotic apparatus protein 1NUMA1 8 8 2101 1.1614 1.2365 1.57E+08
139
Q7Z4H3-2;Q7Z4H3;V9GYS5;V9GZ04;Q7Z4H3-3Q7Z4H3-2;Q7Z4H3 HD domain-containing protein 2HDDC2 10 10 170 1.1607 0.84884 1.06E+09
Q9Y266;A0A0A0MSU9;A0A0A0MSS4Q Y266 Nuclear migration protein nudCNUDC 21 21 331 1.1605 0.94783 2.06E+09
Q5SNT2;H0Y4R5;Q5SNT2-2;H0Y994Q5SNT ; 4R5;Q5SNT2-2Transmembrane protein 201TMEM201 3 3 666 1.1604 1.0704 1.05E+08
P36542;P36542-2 P36542;P36542-2 ATP synthase subunit gamma, mitochondrialATP5C1 12 12 298 1.1596 0.81723 4.20E+09
Q9NP77;Q9NP77-2Q9NP77;Q9NP77-2RNA polymerase II subunit A C-terminal domain phosphatase SSU72SSU72 7 7 194 1.1587 0.73928 4.26E+08
P58107;A0A075B730;A0A087X1U6P58107;A0A075B730;A0A087X1U6Epiplakin EPPK1 35 29 5090 1.1586 0.86789 1.01E+09
K7EQL6;Q8NFA0;K7EL53;K7EKZ1;P35125-2;P35125K7EQL6;Q8NFA0 Ubiquitin carboxyl-terminal hydrolase;Ubiquitin carboxyl-terminal hydrolase 32USP32 4 4 1274 1.1585 0.87881 4.22E+07
K7EM18;P41567;O60739K7EM18;P41567;O60739Eukaryotic translation initiation factor 1;Eukaryotic translation initiation factor 1bEIF1;EIF1B 4 4 121 1.1584 0.80967 9.78E+07
O15235 O15235 28S ribosomal protein S12, mitochondrialMRPS12 3 3 138 1.1582 0.52995 3.83E+07
Q14103-3;Q14103;H0Y8G5;H0YA96;D6RAF8;D6RF44;D6RD83Q14103-3;Q14103;H0Y8G5;H0YA96;D6RAF8;D6RF44eterogeneous nuclear ribonucleoprotein D0HNRNP 21 4 306 1.1564 0.97817 2.48E+10
Q9Y5Q9;Q9Y5Q9-2;H7C0C0;F8WC64;H0YFI7;H7C143Q9Y5Q9 General transcription factor 3C polypeptide 3GTF3C3 12 12 886 1.156 0.70412 1.17E+09
P33992;B1AHB1;B1AHB2;B1AHA9P33992;B1AHB1 DNA replication licensing factor MCM5MCM5 46 46 734 1.155 0.73472 1.44E+10
O00458;O00458-2;C9JA65;C9JLG5;C9JFH1;H0YEE3;E9PMY4;C9JNM6O00458;O004 8-2;C9JA65Interferon-related developmental regulator 1IFRD1 4 4 451 1.1549 0.84164 2.74E+08
F8W925;Q8NFI3-2;Q8NFI3-3;Q8NFI3;J3QLG5F8W925;Q8NFI3-2;Q8NFI3-3;Q8NFI3;J3QLG5Cytosolic endo-beta-N-acetylglucosaminidaseE GASE 2 2 365 1.1547 0.9139 8.70E+07
P24534;C9JZW3;F2Z2G2;F8WF65P 4534 Elongation factor 1-betaEEF1B2 13 11 225 1.1545 0.95917 1.10E+10
O94966-4;O94966-3;O94966;O94966-7;O94966-6;O94966-5;E7ESU0;E7EST9;B5MEG5;A0A0A0MR08;O94966-2O94966-4; 3; ;O94966-7;O94966-6;O94966- ;E7ESU0;E7EST9;B5MEG5Ubiquitin carboxyl-terminal hydrolase 19;Ubiquitin carboxyl-terminal hydrolaseUSP19 1 10 1268 1.1542 0.58238 5.17E+08
P12956;B1AHC9;P12956-2P12956;B1AHC9;P12956-2X-ray repair cross-complementing protein 6XRCC6 47 47 609 1.154 0.99072 3.44E+10
Q6PD62;H0YCE8 Q6PD62 RNA polymerase-associated protein CTR9 homologCTR9 12 12 1173 1.1536 0.66678 9.60E+08
Q9BVC3 Q9BVC3 Sister chromatid cohesion protein DCC1DSCC1 2 2 393 1.1527 0.8211 9.05E+07
P62273;A0A087WTT6;P62273-2P 2273;A0A087WTT6;P62273-240S ribosomal protein S29RPS29 3 3 56 1.1522 1.1212 1.05E+09
Q9Y4W6;K7EP56 Q9Y4W6 AFG3-like protein 2 AFG3L2 19 18 797 1.1519 0.77218 1.87E+09
Q8IWV8-4;Q8IWV8;Q8IWV8-2;Q8IWV8-3Q8I V8-4;Q8I V8E  ubiquitin-protein ligase UBR2UBR2 16 16 1755 1.1515 0.68761 4.35E+08
Q71U36-2;Q71U36;Q13748;Q13748-2;Q6PEY2;F8VQQ4;V9GZ17Q71U36-2;Q71U36; 13748;Q13748-2Tubulin alpha-1A chain;Tubulin alpha-3C/D chainTUBA1A;TUBA3C 34 1 416 1.1512 0.8769 8.75E+08
Q5T9B7;P00568;H0YID2;H0Y4J6;Q9Y6K8-2;Q9Y6K8-3;Q9Y6K8Q5T9B7;P00568;H0YID2;H0Y4J6Adenylate kinase isoenzyme 1AK1 6 6 210 1.1499 0.89545 2.70E+08
P62263;H0YB22;E5RH77P62263;H0YB22;E5RH7740S ribosomal protein S14RPS14 11 11 151 1.1494 0.7611 8.72E+09
P47813;O14602;X6RAC9;A6NJH9P47813;O14602;X6RAC9;A6NJH9Eukaryotic translation initiation factor 1A, X-chromosomal;Eukaryotic translation initiation factor 1A, Y-chromosomalEIF1AX;EIF1AY 6 6 144 1.1487 0.83885 5.72E+08
Q5TG40;Q9NPF5;Q5TG37;Q5TG38;Q5TG39Q5TG40;Q9NPF5;Q5TG37;Q5TG38;Q5TG39DNA methyltransferase 1-associated protein 1DMAP1 4 4 302 1.1483 0.81915 1.74E+08
O43347;H0YHB7 O43347 RNA-binding protein Musashi homolog 1MSI1 9 8 362 1.1482 0.81688 1.59E+09
Q9Y5A9;A0A087WXZ3;Q9Y5A9-2;S4R3J8;S4R3V3Q9Y5A9; 0A087WXZ3;Q9Y5A9-2YTH domain containing family protein 2YTHDF2 13 10 579 1.1475 0.68947 1.76E+09
Q12906;Q12906-7;Q12906-5;Q12906-4;Q12906-2;Q12906-6;Q12906-3;K7EKJ9;K7EQR9;K7ER69;K7ERM6;K7ENK6;K7EM82;K7EJ09;K7EKY0;K7EPG3;K7EQ75;K7ELV3;Q12906-7;Q12906-5;Q12906-4;Q12906-2;Q12906-6;Q12906-3Interleukin enhancer-binding factor 3ILF3 29 25 894 1.147 0.79997 7.30E+09
O60318;O60318-2 O60318 Germinal-center associated nuclear proteinMCM3AP 18 18 1980 1.1464 0.47686 8.49E+08
O75190;A0A0J9YX62;O75190-3;C9J2C4;O75190-2;E9PH18;C9JB42;C9JDR7;C9JDX6;F8WCZ4;C9J2P2;O75190-4;C9JN01;Q8WWF6;Q8NHS0;Q7Z6W7O75190;A0A0J YX62; 75190-3;C9J2C4 O75190-2;E9PH18;C9JB42;C9JDR7;C9JDX6;F8WCZ4;C9J2P2;O75190-4DnaJ homolog subfamily  member 6DNAJ 6 10 9 326 1.1464 0.65855 8.88E+08
P17655;P17655-2 P17655;P17655-2 Calpain-2 catalytic subunitCAPN2 12 12 700 1.1463 0.92544 6.60E+08
P33993;P33993-3;P33993-2;C9J8M6;P33993-3 DNA replication licensing factor MCM7MCM7 43 43 719 1.146 0.70821 2.11E+10
Q13242;H0YIB4;S4R3G0Q13242;H0YIB4;S4R3G0Serine/arginine-rich splicing factor 9SRSF9 5 5 221 1.1456 0.87907 6.20E+08
Q8NHU6-2;Q8NHU6;Q8NHU6-3Q8NHU6-2;Q8NHU6;Q8NHU6-3Tudor domain-containing protein 7TDRD7 4 4 1024 1.1452 NaN 3.11E+07
Q9P253;H0YMC9;H0YLM6Q9P253 Vacuolar protein sorting-associated protein 18 homologVPS18 4 4 973 1.145 0.68916 1.32E+08
O60231;A0A140T947;Q5SQH5;A0A140T8Y5;A0A140T9T4;A2AB15O60231;A0A140T947;Q5SQH5Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16DHX16 18 17 1041 1.1448 1.001 6.87E+08
O15379;O15379-2 O15379;O15379-2 Histone deacetylase 3HDAC3 4 3 428 1.1447 0.71763 1.42E+08
O75934 O75934 Pre-mRNA-splicing factor SPF27BCAS2 3 3 225 1.1443 1.1713 2.88E+08
Q13642-1;Q13642-5;Q13642-4;Q5JXI8;Q13642;A0A0D9SFI6;A0A0D9SFB0;Q5JXH9;A0A0D9SFZ9;Q5JXH8;Q5JXH7;Q5JXI3;Q5JXI2;Q13642-3;A0A0D9SG53;A0A0D9SGB2;Q5JXI0;A0A0D9SGD1;A0A0D9SGC5;A0A0D9SEY7Q13642-1;Q13642-5;Q13642-4;Q5JXI8;Q13642;A0A0D9SFI6;A0 D9SFB0;Q5JXH9;A0A0D9SFZ9;Q5JXH8;Q5JXH7;Q5JXI3;Q5JXI2;Q13642-3;A0A0D9SG53;A0 D9SGB2;Q5JXI0Four and a half LIM domains protein 1HL1 8 8 280 1.144 0.84199 1.06E+09
Q96I59;H0YEL9;E9PRK2;Q96I59-2;H0YE96Q96I59;H0YEL9;E9PRK2Probable asparagine--tRNA ligase, mitochondrialNA S2 8 8 477 1.1434 0.81327 1.15E+09
A0A087WV66;P46013;P46013-2A0A087WV66;P46013;P46013-2Antigen KI-67 MKI67 4 4 3255 1.1417 1.0244 9.64E+07
Q9BTY7;E9PIX0 Q9BTY7 Protein HGH1 homologHGH1 6 6 390 1.1416 0.86214 3.91E+08
Q9NR45;Q5TBR0;Q5TBR1Q9NR45 Sialic acid synthase NANS 13 13 359 1.1416 0.9697 3.80E+09
Q14258 Q14258 E3 ubiquitin/ISG15 ligase TRIM25TRIM25 12 12 630 1.1415 0.7631 1.10E+09
O60684;Q5TFJ7;S4R3E5;H0Y3K0O60684;Q5TFJ7 Importin subunit alpha-7KPNA6 12 4 536 1.1413 0.75153 9.58E+08
G5E9C8;Q07889;A0A087X277;Q07889-2;Q07890-2;Q07890G5E9C8;Q07889 Son of sevenless homolog 1SOS1 3 3 1318 1.1412 0.82991 4.47E+07
Q9Y316-2;Q9Y316;Q9Y316-3;B5MCI62;Q9Y31 ;Q9Y316-3Protein MEMO1 MEMO1 8 8 274 1.141 0.77156 1.62E+09
P51114-2;P51114;B4DXZ6;E9PFF5;E7EU85;P51114-3;C9JZE0;C9JY20;C9JAJ4;C9IZ22;C9JYQ6;C9J5B4;H7C4S4P51114-2; 51114;B4DXZ6;E9PFF5;E7EU85;P51114-3Fragile X mental retardation syndrome-related protein 1FXR1 6 14 539 1.1407 0.87255 1.87E+09
A6NHR9;A6NHR9-2;J3KTL8;A6NHR9-3;J3QSH1;J3KRK8A6NHR9;A6NHR9-2;J3KTL8Structural maintenance of chromosomes flexible hinge domain-containing protein 1SMCHD1 34 34 2005 1.1403 0.88446 2.17E+09
E9PDQ5;B1ALK7;Q14155-6;Q14155-1;Q14155-5;Q14155-2;Q14155-3;Q14155;E7EUY6;Q15052-2;Q15052E9PDQ5;B ALK7;Q14155-6;Q14155-1;Q14155- ;Q14155-2;Q14155-3;Q14155;E7EUY6;Q15052-2;Q15052Rho guanine nucleotide exchange factor 7;Rho guanine nucleotide exchange factor 6ARHGEF7;ARHGEF6 2 2 547 1.1403 0.93215 1.23E+08
P61011;P61011-2;G3V4F7;G3V480;G3V346;A0A0D9SFN7;G3V3L9P61011;P61011-2;G3V4F7Signal recognition particle 54 kDa proteinSRP54 24 24 504 1.1403 0.93996 3.02E+09
P14618;P14618-3;B4DNK4;H3BQ34;H3BUW1;H3BTJ2;H3BT25;H3BU13;H3BN34;H3BQZ3;P30613-2;P30613P14618;P14618-3;B4DNK4; 3 Q34Pyruvate kinase PKM;Pyruvate kinasePKM 54 5 531 1.1401 0.84363 1.38E+11
Q9BRA2;I3L2R6;I3L0K2;I3L3M7Q9BRA2;I3L2R6 Thioredoxin domain-containing protein 17TXNDC17 6 6 123 1.1383 0.89345 2.04E+09
Q9HBH5 Q9HBH5 Retinol dehydrogenase 14RDH14 4 4 336 1.1374 0.86261 2.29E+08
P17812;P17812-2 P17812;P17812-2 CTP synthase 1 CTPS1 33 29 591 1.1369 0.77619 1.05E+10
Q9HC35;B5MBZ0;Q9HC35-2Q9HC35;B5MBZ0;Q9HC35-2Echinoderm microtubule-associated protein-like 4EML4 23 23 981 1.1367 0.78837 9.90E+08
Q9UPR3 Q9UPR3 Protein SMG5 SMG5 3 3 1016 1.1365 NaN 5.94E+07
Q14690;S4R3Q4 Q14690 Protein RRP5 homologPDCD11 56 56 1871 1.1361 0.90697 6.21E+09
Q02978;I3L1P8;Q02978-2Q02978;I3L1P8;Q02978-2Mitochondrial 2-oxoglutarate/malate carrier proteinSLC25A11 18 18 314 1.1352 0.77131 1.61E+10
A0A140T962;A0A140T9J9;A0A140T9B3;Q29963;A0A140T937;O19617;A0A140T921;A2AEA2;A0A140T9H5;A0A140T912;A0A140T9U8;A0A140T930;P30480;P30460;P01889;P01893;Q29865;P10321;Q07000;P30508;P30505;P30501;A0A140TA21;A0A140TA05;A0A140T951;F6U0H7;A0A140T9D4;A0A140T9L3;A0A140T9E1;A0A140T942;Q5SRN7;A0A0G2JI36;A0A140T9W2;Q6DU44;A0A140T9U0;A0A0G2JIF0;Q5SRN5;A0A0G2JIF2;A0A140T9M0;A0A0G2JH50;A0A0G2JL56;A2BF26;Q29960-2;P13747;Q95365;Q29836;Q29718;P30475;P30462;P18463;Q04826;P30479;Q31612;P30455;P30447;P30443;P16188;P13746;P05534;P04439;P30510;P30504;P04222;P30499;Q9TNN7;Q29960;P13746-2;F8W9Z8;A0A140TA12;A0A140T9Z7;A0A140T9X6;A0A140T9W7;A0A140T9W3;A0A140T9D9;A0A140T9C2;A0A140T939;A0A140T9S9;A0A140T9H3;A0A140T9G0;A0A140T9A9;Q31611;A0A0G2JNX1;A0A140T9T1;A0A140T9M5;A0A140T975;A0A140T955;A0A140T941;A0A140T933;A0A140T8W8;Q9GJ45;A0A140T9V0;A0A140T8X0;Q8MH48;A0A0G2JNF2;A0A0G2JNY4;A0A140T9Z6;Q5RJ85;A0A0G2JPQ3;D0EV57;A0A0G2JPA3;B0UXQ0;A0A140T9I0;A0A140T9X5;A0A140T913;A0A140T8Y4;A0A0G2JPD3;A0A140T9B7;A0A0G2JH66;P17693;Q29940;P30685;P30498;P304A0A140T962;A0A140T9J9;A0 140T9B3;Q29963;A0 140T937;O19617;A0 140T921;A2 E 2;A A140T9H5;A0A140T912;A A140T9U8;A0A140T930;P30480;P30460;P01889;P01893;Q29865;P10321;Q07000;P30508;P30505;P3050 ;A0A140TA2 ;A0A140TA05;A0 140T951;F6U0H7;A A140T9D4;A0A140T9L3;A0A140T9E1;A0 140T942;Q5SRN7;A0A0G2JI36;A0A140T9W2;Q6DU44;A0A140T9U0;A0 0G2JIF0;Q5SRN5;A0A0G2JIF2;A0A14 T9M0;A0A0G2JH50;A0A0G2JL56;A2BF26 299 0-2;P13747;Q95365;Q29836;Q29718;P30475;P30462;P18463;Q04826;P30479;Q31612;P30455;P30447;P30443;P16188;P13746;P05534;P04439;P30510;P30504;P04222;P30499;Q9TNN7 Q29960;P137 6-2HLA class I histocompatibility antigen, Cw-6 alpha chain;HLA class I histocompatibility antigen, B-42 alpha chain;HLA class I histocompatibility antigen, B-  alpha chain;HLA class I histocompatibility antigen, B-7 alpha chain;Putative HLA class I histocompatibility antigen, alpha chain H;HLA class I histocompatibility antigen, Cw-18 alpha chain;HLA class I histocompatibility antigen, Cw-7 alpha chain;HL  class I histocompatibility antigen, Cw-15 alpha chain;HLA class I histocompatibility antigen, Cw-12 alpha chain;HLA class I histocompatibility antigen, Cw-8 alpha chain;HLA class I histocompatibility antigen, Cw-2 alpha chain;HLA class I histocompatibility antigen, Cw-16 alpha chain;HLA class I histocompatibility antigen, alpha chain E HL  class I histocompatibility antigen, B-38 alpha chain HL  class I histocompatibility antigen, B-67 alpha chain;HLA class I histocompatibility antigen, B-82 alpha chain;HLA class I histocompatibility antigen, B-39 alpha chain;HLA class I histocompatibility antigen, B-14 alphaHLA-C;HLA-B;HL -H;HLA-A;HLA- 4 4 36 1.1 45 0.86429 4.23E+08
P46199;H7C213 P46199;H7C213 Translation initiation factor IF-2, mitochondrialMTIF2 4 4 727 1.1341 0.8482 3.08E+08
E7EX90;Q14203-3;Q14203-4;Q14203-6;Q14203;Q14203-5;Q14203-2;Q6AWB1;E7EWF7;C9JJD0;C9JKG6;E9PCY0;C9J1B7;C9JZA4;C9JTE5;C9JJN7E7EX90;Q14203- ;Q14203-4; 6; ;Q14203-5;Q14203-2;Q6AWB1Dynactin subunit 1 DCTN1;DKFZp686E0752 47 47 1256 1.1335 0.76888 4.50E+09
Q9Y4W2-2;Q9Y4W2;Q9Y4W2-3;Q9Y4W2-4Q9Y4W2-2;Q9Y4W2;Q9Y4W2-3;Q9Y4W2-4Ribosomal biogenesis protein LAS1LLAS1L 10 10 717 1.1328 0.92928 1.68E+09
H7C1N3;O15155;C9JTT8;Q68DU7;O15155-2H7C1N3;O15155;C9JTT8;Q68DU7;O15155-2BET1 homolog BET1;DKFZp781C0425 2 2 133 1.1324 0.9774 2.50E+07
Q9BZX2;Q9BZX2-2 Q9BZX2 Uridine-cytidine kinase 2UCK 7 7 261 1.1324 0.79847 1.74E+09
Q9BQC3;E9PLL2;E9PMH7;H0YCR5;Q9BQC3-2;Q9BQC3-3Q9BQC3;E9PLL2;E9PMH7;H0YCR5;Q9BQC3-2;Q9BQC3-3Diphthamide biosynthesis protein 2DPH2 2 2 489 1.1323 0.85452 1.92E+08
Q9Y2X0-2;Q9Y2X0-3;Q9Y2X0;K7EKS6;B9TWZ6;U3KQ43;Q9Y2X0-5;Q9Y2X0-4;B9TX03;B9TX12;B9TX11;A0A0J9YYC6;A0A0J9YXE6;A0A0J9YXA0;U3KQB4Q9Y2X0-2;Q9Y2X0-3;Q9Y2X0;K7EKS6;B9TWZ6;U3KQ43;Q9Y2 -5;Q9Y2X0-4Mediator of RNA polymerase II transcription subunit 16MED1 3 3 841 1.1314 0.85249 2.81E+08
Q9Y285;K7ER00;Q9Y285-2;K7EPH2;K7ER16;K7EK06;K7ERS0Q9Y285;K7ER00;Q9Y285-2;K7EPH2;K7ER16Phenylalanine--tRNA ligase alpha subunitFARSA 21 21 508 1.1313 0.84587 4.27E+09
P35659;D6R9L5;B4DFG0;P35659-2;D6RDA2;H0Y993P35659;D6R9L5 B4DFG0;P35659-2Protein DEK DEK 3 3 375 1.1304 1.2923 1.84E+08
Q96C36;A0A087WTV6;A0A087WZR9;J3KR12;A0A087WX69;A0A087WZF0Q96C36;A0A087WTV6;A0A087WZR9;J3KR12Pyrroline-5-carboxylate reductase 2PYCR 17 16 320 1.1303 0.75089 5.51E+09
P46821;D6RA40;D6RA32;E9PGC8;P78559;P78559-2P46821 Microtubule associated protein 1B;MAP1B heavy chain;MAP1 light chain LC1MAP1B 9 9 2468 1.1294 1.0815 8.65E+08
Q9BUK6-3;Q9BUK6-2;Q9BUK6;Q9BUK6-7;Q9BUK6-4;Q9BUK6-5;Q9BUK6-6Q9BUK6-3;Q9BUK6-2;Q9BUK6;Q9BUK6-7Protein misato homolog 1MSTO1 9 8 558 1.1294 0.72418 5.32E+08
Q9UKN8;F2Z356 Q9UKN8 General transcription factor 3C polypeptide 4GTF3C4 16 16 822 1.1287 0.77245 1.41E+09
R4GNB1;Q4L235-3;Q4L235-4;Q4L235-2;Q4L235R4GNB1;Q4L235-3;Q4L235-4;Q4L235-2;Q4L235Acyl-CoA synthetase family member 4AASDH 2 2 945 1.1282 0.64311 7.54E+07
P07384;E9PL37;E9PIA9;E9PLX0;E9PJJ3;E9PLC9;E9PMC6;E9PJA6;E9PSA6;E9PQB3;E9PRM107384 Calpain-1 catalytic subunitCAPN1 7 7 714 1.1273 1.0121 4.32E+08
Q13572;G3V4M9;Q13572-2;G3V588;G3V3C0;G3V5A3Q13572;G3V4M9;Q13572-2Inositol-tetrakisphosphate 1-kinaseITPK1 3 3 414 1.1273 1.0559 1.82E+08
H0YM23;O75179-7;O75179-2;O75179;O75179-6;H0YLQ3;O75179-3;O75179-4;O75179-5H0YM23;O75179-7; 2;O75179 6 H0YLQ3;O75179-3;O75179-4Ankyrin repeat domain-containing protein 17ANKRD17 22 11 2487 1.1266 0.8468 7.74E+08
I3L2Z9;I3L100;I3L2W2;Q96JN8-2;Q96JN8;K7EPS7I3L2Z9;I3L100 I3L2W2 Q96JN8-2;Q96JN8;K7EPS7Neuralized-like protein 4NEURL4 2 2 1017 1.1266 0.59663 4.43E+07
Q9NVP1;H7C452 Q9NVP1 ATP-dependent RNA helicase DDX18DDX18 12 12 670 1.1257 0.89523 7.78E+08
D3YTB5;P51617-2;P51617-3;P51617;P51617-4;H7C224;H7C2I6;F8WAB6;H7C3C1;H7C1F0;H7C3G8D3YTB5;P51617-2; 3;P51617 P51617-4;H7C224Interleukin-1 receptor-associated kinase 1IRAK 10 10 708 1.1253 0.78971 1.34E+09
P50402;Q5HY57;F8WEQ1P50402;Q5HY57 Emerin EMD 15 15 254 1.1251 0.71696 2.04E+09
Q9UDY2-5;Q9UDY2-4;Q9UDY2-2;Q9UDY2-6;Q9UDY2-3;Q9UDY2;Q9UDY2-7Q9UDY2-5;Q9UDY2-4;Q9UDY2-2;Q9UDY2-6;Q9UDY2-3;Q9UDY2;Q9UDY2-7Tight junction protein ZO-2TJP2 2 2 993 1.1248 NaN 4.89E+07
Q14558-2;Q14558;B4DP31;C9J168;C9JUN4;C9JNQ3;C9JKT9Q14558-2;Q 4558;B4DP31;C9J168Phosphoribosyl pyrophosphate synthase-associated protein 1PRPSAP1 11 9 385 1.1244 0.92292 4.15E+09
Q5VUJ6-2;Q5VUJ6 Q5VUJ6-2;Q5VUJ6 Leucine-rich repeat and calponin homology domain-containing protein 2LRCH2 6 6 748 1.1244 0.72925 1.96E+08
E9PGC0;P20936-2;P20936-4;P20936;P20936-3E9PGC0;P20936-2; 4;P20936Ras GTPase-activating protein 1RASA1 6 6 881 1.1239 0.87944 1.74E+08
A0A0C4DFR8;Q9UBK9;S4R2Z4A0A0C4DFR8;Q9UBK9;S4R2Z4Protein UXT UXT 2 2 169 1.1231 1.2429 6.70E+07
Q9NQT5;Q9NQT5-2Q9NQT5;Q9NQT5-2Exosome complex component RRP40EXOSC3 9 9 275 1.1229 0.87342 2.94E+09
Q9BUQ8;H0YI52;F8VVA2Q9BUQ8 Probable ATP-dependent RNA helicase DDX23DDX23 18 18 820 1.1226 0.82218 1.26E+09
Q13148;B1AKP7;G3V162;A0A087X260;A0A087WYY0;A0A087WX29;K7EN94;K7EJM5;A0A087WXQ5;A0A087WV68;Q13148-4;A0A087WW61;A0A087WX67;A0A087WXV3;A0A087WZC9;K7EJ99;A0A0A0MSV7;A0A087WTZ4;K7EL26;A0A087WZM1;A0A087WYE7Q13148;B1AKP7;G3V162;A0A087X260;A0A087WYY0;A0A087WX29;K7EN94;K7EJM5;A0A087WXQ5;A0A087WV68T R DN -binding protein 43T RDBP 12 12 414 1.1225 0.82701 4.38E+0
H0Y8R1;F5H5I6;H0YAK1;Q12849-5;Q12849;H0YAM1H0Y8R1;F5H5I6 H0YAK1;Q12849-5;Q12849G-rich sequence factor 1GRSF1 13 13 417 1.1219 0.82337 9.22E+08
Q5JP53;P07437;Q5ST81;A6NNZ2;CON__ENSEMBL:ENSBTAP00000025008;Q9H4B7Q5JP53;P07437;Q5ST81Tubulin beta chain TUBB 32 5 426 1.1219 0.91827 1.03E+11
140
P42166 P42166 Lamina-associated polypeptide 2, isoform alpha;Thymopoietin;ThymopentinTMPO 3 3 694 1.1217 0.88374 2.07E+08
P49721;A0A087WVV1P49721 Proteasome subunit beta type-2PSMB2 7 7 201 1.1214 0.82187 2.80E+08
H3BTB7;Q5JPH6;Q5JPH6-2H3BTB7;Q5JPH6;Q5JPH6-2Probable glutamate--tRNA ligase, mitochondrialEA S2 5 5 506 1.1213 0.47041 5.26E+08
P53350;I3L387;I3L2H5P53350 Serine/threonine-protein kinase PLK1PLK1 10 10 603 1.1212 0.44932 4.70E+08
J3QRV5;Q6P1M3-2;Q6P1M3J3QRV5;Q6P1M3-2;Q6P1M3Lethal(2) giant larvae protein homolog 2SPATS2;LLGL2 2 2 1019 1.1209 NaN 9.60E+06
O75569;O75569-3;O75569-2;G5E9Q4;F8WEG8;C9JMM3;O75569-3;O75569-2;G5E9Q4Interferon-inducible double-stranded RNA-dependent protein kinase activator APRKRA 9 9 313 1.1208 0.9462 9.03E+08
A6NDG6;H3BV17 A6NDG6 Phosphoglycolate phosphatasePGP 10 10 321 1.12 0.75287 2.26E+09
P78417;Q5TA02;P78417-3;P78417-2;Q5TA01P78417;Q5TA02;P78417-3;P78417-2Glutathione S-transferase omega-1GSTO1 10 10 241 1.1199 0.966 2.54E+09
O76071 O76071 Probable cytosolic iron-sulfur protein assembly protein CIAO1CIAO1 6 6 339 1.1189 0.78588 3.65E+08
P62829;C9JD32;J3KT29;J3KTJ3;B9ZVP7;J3QQT9P62829;C9JD32;J3KT29;J3KTJ3;B9ZVP760S ribosomal protein L23RPL23 14 14 140 1.1187 0.87132 1.43E+10
E9PER6;O15530-4;O15530-2;O15530-3;O15530;H3BQ10;Q6A1A2;O15530-5E9PER6;O15530-4;O15530-2;O15530-3;O15530;H3BQ10;Q6A1A2;O15530-5-phosphoinositide-dependent protein kinase 1 Putative 3-phosphoinositide-dependent protein kinase 2PDPK1;PDPK2 2 2 529 1.1185 0.87377 1.99E+08
O95714;A0A0J9YVP0;H3BUQ1;A0A0G2JPS8;A0A0J9YXQ8;Q9BVR0O95714;A0 0J9YVP0E3 ubiquitin-protein ligase HERC2HERC2 11 11 4834 1.1183 0.86958 1.54E+08
P78346;P78346-2;Q5VU11;Q5VU10P78346;P78346-2;Q5VU11Ribonuclease P protein subunit p30RPP30 11 11 268 1.1176 0.82452 3.25E+09
Q9H9T3-2;Q9H9T3;B4DKA4;Q9H9T3-4;Q9H9T3-5;E5RHY2;E5RIC0;E5RIZ7;H0YAP7;E5RHR2Q9H9T3-2;Q9H9T3;B4DKA4;Q9H9T3-4;Q9H9T3-Elongator complex protein 3LP3 7 7 533 1.117 1.0559 4.48E+08
M0R300;M0R0P8;Q13459-2;Q13459;M0R2J3M0R300;M0R0P8 Q13459-2;Q13459Unconventional myosin-IXbMYO9B 10 10 2072 1.1169 0.83226 1.85E+08
O60244;H7C3E5;H7C017O60244 Mediator of RNA polymerase II transcription subunit 14MED14 12 12 1454 1.1157 0.78935 3.51E+08
Q8IY81 Q8IY81 pre-rRNA processing protein FTSJ3FTSJ3 11 11 847 1.1154 0.72904 1.06E+09
K7EJE8;K7EKE6;P36776-2;P36776;P36776-3;K7ER27;K7ERR6;K7ER56;K7EQF8K7EJE8;K7EKE ; 2;P36776;P36776-3Lon protease homolog, mitochondrialLONP1 32 32 829 1.1142 0.8746 6.20E+09
P49792;F8VYC4;P0DJD0;P0DJD1;C9J1W9;C9JF75;C9J6W1;Q7Z3J3-2;F8WBP7;H0YBN8P49792 E3 SUMO-protein ligase RanBP2RANBP2 76 55 3224 1.1133 0.79293 7.03E+09
P11940;P11940-2;A0A087WTT1;E7EQV3;E7ERJ7;H0YAR2;H0YBN4;Q9H361;E5RJB9;E5RGH3;E5RH24;H0YAP2;E5RHG7;H0YB86;H0YAS6;H0YB75;Q4VXU2;H0YAS7;Q4VXU2-2;E5RGC4;E5RFD8;H0YEQ8;E5RJM8;H0YC10;Q5JQF8;Q96DU9-2;Q96DU9P11940;P11940-2;A0A087WTT1;E7EQV3;E7ERJ7Polyadenylate-binding protein 1PABPC1 22 14 636 1.1131 0.8538 7.50E+09
A0A087WW77;Q15334A0A087WW77;Q15334Lethal(2) giant larvae protein homolog 1LLGL1 16 16 1056 1.1122 0.79315 1.28E+09
P15170-2;P15170-3;P15170;H3BR35;Q8IYD1;H3BSV8P15170-2;P15170-3;P15 70;H3BR35Eukaryotic peptide chain release factor GTP-binding subunit ERF3AGSPT1 18 18 636 1.1121 0.83325 2.35E+09
Q93074-3;Q93074;Q93074-2;Q7Z3Z53; 93074;Q93074-2;Q7Z3Z5Mediator of RNA polymerase II transcription subunit 12MED12;TNRC11 6 6 2176 1.1121 0.76385 1.33E+08
Q6PHR2-3;Q6PHR2;Q6PHR2-4;Q6PHR2-2;H3BPN6;H3BT78Q6PHR2-3;Q6PHR2;Q6PHR2-4Serine/threonine-protein kinase ULK3ULK3 6 6 470 1.1118 0.56844 2.90E+08
Q8WXX5 Q8WXX5 DnaJ homolog subfamily C member 9DNAJ 9 3 3 260 1.1116 0.58026 2.43E+08
P11498;E9PRE7;P11498-2;E9PS68P11498;E9PRE7;P11498-2Pyruvate carboxylase, mitochondrialPC 12 12 1178 1.1113 0.74706 6.06E+08
Q96L92-3;Q96L92;A0A0C4DFU6;Q96L92-2;Q96L92-4;H7C603Q96L92-3;Q96L92;A0A0C4DFU6;Q96L92-2Sorting nexin 27 SNX27 13 13 528 1.1111 0.80433 1.55E+09
P49711;P49711-2;V9GY73;Q8NI51-11;Q8NI51-6;Q8NI51-5;Q8NI51-10;Q8NI51-2;Q8NI51-8;Q8NI51;Q8NI51-3;Q8NI51-7P49711;P49711-2 Transcriptional repressor CTCFCTCF 4 4 727 1.1108 1.0473 2.06E+08
Q99717;Q15797 Q99717;Q15797 Mothers against decapentaplegic homolog 5;Mothers against decapentaplegic homolog 1SMAD5;SMAD1 2 2 465 1.1108 0.54798 1.37E+08
B4DP61;E7EQZ4;Q16637-4;Q16637-2;Q16637-3;Q16637;H0YBZ9;A0A0G2JRX5;A0A0G2JRY6B4DP61;E7EQZ4;Q16637-4;Q16637-2;Q16637-3;Q16637;H0YBZ9;A0A0G2JRX5;A0A0G2JRY6Survival motor neuron proteinSMN1 2 2 227 1.1105 1.0926 4.33E+08
Q01813;Q01813-2;B1APP6;B1APP8;V9GY25;Q5VSR5;H0Y757;V9GYV7;H0Y3Y3Q01813 Q01813-2 ATP-dependent 6-phosphofructokinase, platelet typePFKP 30 25 784 1.1104 0.83311 1.42E+10
P62995-3;P62995;H7C2L4;H7BXF3P62995-3;P62995;H7C2L4;H7BXF3Transformer-2 protein homolog betaTRA2B 5 5 188 1.1096 1.0788 5.60E+08
P78316;E9PFK5;P78316-2P78316;E9PFK5;P78316-2Nucleolar protein 14NOP14 13 13 857 1.1096 0.71025 4.41E+08
Q96DG6 Q96DG6 Carboxymethylenebutenolidase homologCMBL 3 3 245 1.1091 0.88142 1.14E+08
P52948-5;P52948;P52948-6;P52948-2;H7C3P6;H0YDF4;P52948-4;P52948-3;H0YDA1;H0YCT1;H0YEN45; ;P52948- P52948-2;H7C3P6Nuclear pore complex protein Nup98-Nup96;Nuclear pore complex protein Nup98;Nuclear pore complex protein Nup96NUP98 18 18 1800 1.109 0.94086 1.41E+09
P68363;P68363-2 P68363;P68363-2 Tubulin alpha-1B chainTUBA1B 34 0 451 1.1088 0.86795 2.61E+11
Q5JRI1;O75494-5;O75494-4;O75494-6;O75494-3;O75494-2;O75494;Q6IQ42;Q8WXF0;R4GMP8Q5JRI1;O75494-5;O75494- ;O75494-6;O75494-3;O75494-2;O75494Serine/arginine-rich splicing factor 10SRSF10 8 8 172 1.1084 0.83499 7.18E+08
F8WAS3;Q16718;C9IZN5;A0A087X1G1;H7BYD0;Q16718-2F8WAS3;Q16 18;C9IZN5;A A087X G1;H7BYD0;Q16718-2NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5NDUFA5 3 3 70 1.1078 NaN 1.69E+08
O95602;B9ZVN9 O95602;B9ZVN9 DNA-directed RNA polymerase I subunit RPA1;DNA-directed RNA polymerasePOLR1A 52 51 1720 1.1076 0.79364 3.63E+09
P17152 P17152 Transmembrane protein 11, mitochondrialTMEM 1 3 3 192 1.1076 0.63023 3.14E+08
Q9H974-2;Q9H974-3;Q9H974;Q9H974-4Q9H 74-2;Q9H974-3;Q9H974;Q9H974-4Queuine tRNA-ribosyltransferase subunit QTRTD1QTRTD1 3 3 292 1.1076 1.1684 1.55E+08
P62873-2;P62873;B1AKQ8;F6X3N5;F6UT28;E7EP32;F5H8J8;F5H100;F5H0S8;E9PCP0;P16520-2;P16520;B3KVK2;P62879-2P62873-2;P62873;B1AKQ8;F6X3N ;F6UT28;E7EP32Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1GNB1;GNB2 7 2 332 1.107 0.96826 1.26E+09
E9PK01;P29692;E9PQ49;E9PI39;P29692-4;E9PPR1;E9PL12;E9PQZ1;E9PMW7;E9PIZ1;H0YCK7;E9PK06;E9PK72;H0YE58;H0YE72;E9PKK3;E9PNW6;E9PJD0;E9PQC9E9PK01; 2969 ;E9PQ 9;E9 I39;P29692-4;E9PPR1;E9PL12;E9PQZ1;E9PMW7;E9PIZ1;H0YCK7Elongation factor 1-deltaEEF1D 12 0 261 1.1055 0.9371 1.90E+09
Q15072 Q15072 Zinc finger protein OZFZNF146 3 3 292 1.1055 0.62597 3.57E+07
Q9Y2Q9;H0YAT2;H7C5V3;E5RGC7;E5RK86;E5RFH3;H0YC42;U3KQQ8;E5RFT8Q9Y2Q9;H0YAT2;H7C5V3;E5RGC728S ribosomal protein S28, mitochondrialMRPS28 5 5 187 1.1054 0.89158 5.39E+08
Q15233;Q15233-2;H7C367;C9JYS8;C9IZL7;C9J4X2;A0A0U1RQF9Q15233;Q15233-2;H7C367Non-POU domain-containing octamer-binding proteinNONO 39 33 471 1.1053 0.9814 1.32E+10
K7ERI7;P35268;K7EMH1;K7ELC4;K7EP65;K7EKS7;K7EJT5K7ERI7;P35268;K7EMH1;K7ELC4;K7EP65;K7EKS70S ribosomal protein L22RPL22 9 7 95 1.1052 0.84238 5.93E+09
Q9Y5B9;G3V5A4;G3V401;G3V2X0Q9Y5B9 FACT complex subunit SPT16SUPT16H 44 44 1047 1.1049 0.97432 1.34E+10
G5EA06;Q92552;Q92552-2;D6RH20;D6RJC7;E5RJ73G5EA06;Q92552;Q92552-2;D6RH2028S ribosomal protein S27, mitochondrialMRPS27 14 14 358 1.1048 0.91219 1.29E+09
Q9Y4B6-2;Q9Y4B6;Q9Y4B6-32;Q9Y4B6;Q9Y4B6-3Protein VPRBP VPRBP 17 17 1506 1.1047 0.94974 6.68E+08
Q5R3I4;H7C089;A9UJP8Q5R3I4;H7C089 Tetratricopeptide repeat protein 38TTC38 3 3 469 1.1043 0.52939 8.71E+07
Q9BXJ9;A0A0B4J1W3;Q9BXJ9-4Q9BXJ9;A0A0B4J1W3;Q9BXJ9-4N-alpha-acetyltransferase 15, NatA auxiliary subunitNAA15 35 30 866 1.1042 0.91 4.12E+09
Q9NVI7-2;Q9NVI7;H0Y2W2;Q9NVI7-3;Q5SV16;Q5T9A4-2Q9NVI7-2;Q9NVI7;H0Y2W2; 9NVI7 3ATPase family AA domain-containing protein 3AATAD3A 33 11 586 1.1041 0.74732 8.23E+09
O43542;G3V3Q2;G3V3H9;G3V399O4 542;G3V3Q2 DNA repair protein XRCC3 3 3 346 1.1039 0.51474 1.69E+08
O00483 O00483 Cytochrome c oxidase subunit NDUFA4NDUFA4 4 4 81 1.1035 0.90694 4.79E+08
Q15056-2;Q15056 Q15056-2;Q15056 Eukaryotic translation initiation factor 4HEIF4H 9 9 228 1.1031 0.99763 1.74E+09
P13674-3;P13674-2;P13674P13674-3;P13674-2;P13674Prolyl 4-hydroxylase subunit alpha-1P4HA1 1 1 516 1.1029 NaN 4.07E+07
Q92990-2;Q92990;M0QX84;M0QXG8Q92990-2;Q92990;M0QX84;M0QXG8Glomulin GLMN 2 2 417 1.1028 1.097 7.51E+07
Q9NTX5-6;Q9NTX5-2;Q9NTX5;Q9NTX5-3;H0Y5L2;E9PIU8;H0YCS9;J3KP84;E9PPG7;E9PRU6;F2Z2D6;E9PJS8;E9PLY6;Q9NTX5-5Q9NTX5-6; 2;Q9NTX5;Q9NTX5-3Ethylmalonyl-CoA decarboxylaseECHDC1 9 9 284 1.1028 0.88109 1.95E+09
Q8NBM4;X6R5E5;Q8NBM4-4;Q8NBM4-3;Q8NBM4-2;Q5JUH4;Q8NBM4-5Q8NBM4;X6R5E5;Q8NBM4-4;Q8NBM4-3;Q8NBM4-2Ubiquitin-associated domain-containing protein 2UBAC2 4 4 344 1.1022 0.74111 1.99E+08
Q6NZY4;Q6NZY4-2;F5H6J5;F5GX80Q6NZY4;Q6NZY4-2;F5H6J5;F5GX80Zinc finger CCHC domain-containing protein 8ZCCHC8 6 6 707 1.1021 0.68482 4.80E+08
P46060;B0QYT5;B0QYT4;H0Y4Q3P46060 Ran GTPase-activating protein 1RANGAP1 9 9 587 1.1016 1.0464 9.38E+08
Q8NEN9 Q8NEN9 PDZ domain-containing protein 8PDZD8 5 5 1154 1.1011 0.6068 1.88E+08
Q8N122;Q8N122-3;I3L436;Q8N122-2Q8N122;Q8N122-3Regulatory-associated protein of mTORRPTOR 22 22 1335 1.1007 0.80248 1.68E+09
E7EMB1;Q9UH65;E9PJK8E7EMB1;Q9UH65 Switch-associated protein 70SWAP70 4 4 527 1.1004 1.0484 2.15E+08
Q86UV5;Q86UV5-8;Q86UV5-2;Q86UV5-3;Q86UV5-4;Q86UV5-7;A0A0A0MRS6;Q86UV5-5;H3BLX5;E9PRY5;E9PJH5;Q86UV5-6Q86UV5;Q86UV5-8;Q86UV5-2;Q86UV5-3;Q86UV5-4;Q86UV5-7Ubiquitin carboxyl-terminal hydrolase 48USP48 12 12 1035 1.1003 0.87908 6.88E+08
Q9BUJ2-2;Q9BUJ2;A0A0A0MRA5;B7Z4B8;Q9BUJ2-3;Q9BUJ2-4;M0R3F1;M0QYZ0;M0R203;M0QZV6;M0R0K8;M0QYI8;M0QYM5;M0R247;A0A087X1I2;Q9BUJ2-5Q9BUJ2-2;Q9BUJ2;A0A0A0MRA5;B7Z4B8;Q9BUJ2-3;Q9BUJ2-4;M0R3F1;M0QYZ0Heterogeneous nuclear ribonucleoprotein U-like protein 1HNRNP L1 18 18 80 1.09 8 0.78572 1.75E+09
Q13310-2;Q13310-3;B1ANR0;Q13310;H0Y5F5;B1ANR1;H0YCC8;H0YEU6;H0Y6X6;H0YER0Q13310-2; -3;B1ANR0;Q13310;H0Y5F5Polyadenylate-binding protein 4PABPC4 15 7 631 1.0993 0.78757 6.17E+08
F5H658;Q14562 F5H658;Q14562 ATP-dependent RNA helicase DHX8DHX8 6 5 1181 1.0989 1.0274 4.23E+08
P07737;K7EJ44;CON__P02584;I3L3D5P07737;K7EJ44 Profilin-1 PFN1 17 17 140 1.098 0.85064 3.86E+10
A2A274;Q99798 A2A274;Q99798 Aconitate hydratase, mitochondrialACO2 6 6 805 1.0974 1.3117 6.14E+08
O94906;O94906-2 O94906;O94906-2 Pre-mRNA-processing factor 6PRPF6 32 32 941 1.0971 0.86023 1.91E+09
Q8N9T8;H0YFD2;F8WFC1Q8N9T8;H0YFD2;F8WFC1Protein KRI1 homologKRI1 4 4 703 1.0971 0.50039 7.74E+07
Q14240;Q14240-2;E7EQG2Q14240;Q14240-2;E7EQG2ukaryotic initiation factor 4A-IIEIF4A2 19 3 407 1.0963 1.0056 1.27E+08
O60293-2;O60293 O60293-2;O60293 Zinc finger C3H1 domain-containing proteinZFC3H1 5 5 1910 1.096 0.64198 9.33E+07
Q504Q3-2;Q504Q3-3;Q504Q3;F8VXK8Q504Q3-2;Q504Q3-3;Q504Q3PAB-dependent poly(A)-specific ribonuclease subunit PAN2P N2 6 6 1198 1.0958 0.6268 1.83E+08
F5H5N1;A0A087WXF6;A0A087WTI3;F5GXJ1;O75251-2;O75251F5H5N1;A0A087WXF6;A0A087WTI3;F5GXJ ;O75251-2;O75251NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrialNDUFS7 2 2 182 1.0953 1.1811 1.78E+08
Q9NV88-3;Q9NV88-2;Q9NV88;G3XAN1;H0YBK3;E5RK47;E5RG70Q9NV88-3;Q9NV88-2;Q9NV88;G3XAN1Integrator complex subunit 9INTS9 4 4 634 1.0952 0.8611 2.24E+08
Q86W56-3;Q86W56-2;Q86W56;Q86W56-5;Q86W56-4Q86W56-3;Q86W56-2;Q86W56;Q86W56-5;Q86W56-4Poly(ADP-ribose) glycohydrolasePARG 4 4 868 1.0946 0.96474 1.19E+08
P62244;I3L3P7;I3L246;H3BN98;H3BV27;H3BT37;I3L303;H3BVC7P62244;I3L3P7;I3L 46;H3BN9840S ribosomal protein S15aRPS15A 11 11 130 1.0945 0.86683 6.79E+09
Q6P1N0;Q6P1N0-2;K7EMP1;K7EJY5Q6P1N0;Q6P1N0-2Coiled-coil and C2 domain-containing protein 1ACC2D1A 11 11 951 1.0939 0.65351 3.73E+08
Q9Y2R4;A0A087X1P7;A0A087WTD6;A0A087X069;A0A087X121Q9Y2R4 Probable ATP-dependent RNA helicase DDX52DDX52 8 8 599 1.0938 0.91256 8.55E+08
Q9HBG6-11;Q9HBG6-10;Q9HBG6-4;Q9HBG6-3;Q9HBG6-6;Q9HBG6;Q9HBG6-5;Q9HBG6-7;Q9HBG6-8;Q9HBG6-9;H0YAG9;H0YAG6;D6RAF7;H0Y9E5;H0Y8I2;H0Y9E1;D6RIB5;H0Y9I6;H0Y978;H0Y9Q2Q9HBG6-11;Q9HBG6-10;Q9HBG6-4;Q9HBG6-3;Q9HBG6-6;Q9HBG6;Q9HBG6-5;Q9HBG6-7;Q9 BG6-8;Q9HB -9Intraflagellar transport protein 122 homologIFT122 5 5 93 1.0935 0.6355 6.85E+ 7
Q9NVE7;A0A0G2JR38;E9PHT6;H0YA26;H0Y9E4;H0YA31Q9NVE7;A0A G2JR38;E9PHT6;H0YA26Pantothenate kinase 4PANK4 14 14 773 1.0928 0.92308 8.34E+08
P62906 P62906 60S ribosomal protein L10aRPL10A 16 16 217 1.0925 0.84001 9.00E+09
Q96J02-2;Q96J02;Q96J02-3;H0YBA4;Q9H0M0-6;Q9H0M0-3;Q9H0M0Q96J02-2;Q96J02; 96J02-3E3 ubiquitin-protein ligase Itchy homologITCH 12 12 862 1.0923 0.79036 4.83E+08
Q96ME1-4;Q96ME1-2;Q96ME1;H0Y6I6;Q96ME1-3Q96ME1-4;Q96ME1-2;Q96ME1;H0Y6I6;Q96ME1-3F-box/LRR-repeat protein 18FBXL18 10 10 718 1.0922 0.91112 6.02E+08
Q6NVU6 Q6NVU6 Inactive Ufm1-specific protease 1UFSP1 2 2 142 1.0921 0.79526 2.67E+07
Q93009-3;Q93009;H3BND8;F5H2X1;H3BUV0;H3BTM1;H3BRA2;H3BQD1;H3BMF6Q93009-3;Q93009;H3BND8Ubiquitin carboxyl-terminal hydrolase 7;Ubiquitin carboxyl-terminal hydrolaseUSP7 26 26 1086 1.092 1.0191 2.34E+09
O95251-2;O95251-4;O95251;E7EUP3;O95251-3;O95251-5O95251-2;O95251-4;O95251;E7EUP3;O95251-3;O95251-5Histone acetyltransferase KAT7KAT7 4 4 501 1.0918 0.77905 1.83E+08
P67775-2;P67775;P62714;H0YBN9;E7ESG8;E5RFI3;E5RHP4;E5RHC1;H0YC237 75-2;P67775;P62714Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform;Serine/threonine-protein phosphatase 2A catalytic subunit beta isoformPPP2CA;PPP2CB 7 5 255 1.0915 0.88011 5.08E+08
A0A087WU64;A6NMQ1;P09884A0A087WU64;A6NMQ1;P09884DNA polymerase;DNA polymerase alpha catalytic subunitPOLA1 23 23 1461 1.0913 0.80934 1.62E+09
P24752;H0YEL7;P24752-2;E9PRQ6;E9PKF3P24752 Acetyl-CoA acetyltransferase, mitochondrialACAT1 22 22 427 1.0913 0.81658 7.59E+09
141
O60701;O60701-2;O60701-3;E7ER95;E7ER83;E7ETF4;E7EV97;D6RHF4;E9PBD2;O60701-2;O60701-3UDP-glucose 6-dehydrogenaseUGDH 14 14 494 1.0904 0.89309 2.46E+09
Q9UII4;E9PBL0 Q9UII4;E9PBL0 E3 ISG15--protein ligase HERC5HERC5 4 4 1024 1.0904 0.75753 1.71E+08
A0A0A0MRJ0;Q5VT25-3;Q5VT25-4;Q5VT25-5;Q5VT25;Q5VT25-2;Q5VT25-6;H0Y6R0;H0Y7V8;A0A0A0MRJ1;H0Y5V1;H0Y6V3A0A0A0MRJ0;Q5VT25-3;Q5VT25-4; 5; ;Q5VT25-2;Q5VT25-6Serine/threonine-protein kinase MRCK alphaCDC42BPA 6 5 1699 1.0903 0.67561 1.32E+08
Q8TCD5;J3KRC4;J3KSY6;J3KSX6;Q8TCD5-2Q8TCD5;J3KRC4;J3KSY65(3)-deoxyribonucleotidase, cytosolic typeNT5C 7 7 201 1.0901 0.80155 1.80E+08
A0A087WUQ6;P07203A A087WUQ6;P07203Glutathione peroxidase 1GPX 2 2 202 1.0898 0.79777 5.30E+07
P43246;P43246-2;E9PHA6;V9H019;A0A087X078;A0A087X1E7;V9H0B2;V9H015;C9J809P4324 ;P43246-2;E9PHA6;V9H019;A0A087X078;A0A087X1E7DNA mismatch repair protein Msh2MSH2 32 32 934 1.0893 0.82234 4.08E+09
A0A0A0MQR2;Q9BY42;A2A2L5;A2A2L6A0A0A0MQR2;Q9BY42;A2A2L5Protein RTF2 homologRTFDC1 3 3 336 1.0892 0.52267 9.43E+07
Q14697;Q14697-2;F5H6X6;E9PKU7;E9PNH1Q14 97 Q1469 -2;F5H6X6;E9PKU7Neutral alpha-glucosidase ABGANAB 28 28 944 1.0886 0.96977 2.31E+09
Q00059;H7BYN3;Q00059-2Q00059;H7BYN3;Q00059-2Transcription factor A, mitochondrialTFAM 3 3 246 1.0885 NaN 1.88E+07
P32322;E2QRB3;P32322-3;P32322-2;J3KQ22;J3QL24;J3QKT4;J3QLK9;J3QL23;J3QR88;J3KTA8;J3QKT3;J3QRZ0;J3KSA9P32322;E2QRB3;P3232 -3;P32322-2;J3KQ22Pyrroline-5-carboxylate reductase 1, mitochondrial;Pyrroline-5-carboxylate reductasePYCR1 20 11 319 1.0884 0.79262 4.26E+09
P06730;P06730-2;D6RBW1;P06730-3;H0Y8J7;D6RFJ3;D6RHE2;H0Y8X3;A6NMX2P06730;P06730-2;D6RBW1;P067 0-3Eukaryotic translation initiation factor 4EEIF4E 7 7 217 1.0875 0.85689 3.24E+09
Q9BWF3;E9PB51;Q9BWF3-4;E9PLB0;E9PM61;D6R9K7;U3KQD5;J3QRR5;Q9BWF3-3;Q9BWF3-2Q9BWF3;E9PB51;Q BWF3-4RNA-binding protein 4RBM4 14 0 364 1.0874 1.0138 1.61E+09
Q7Z3K3-5;Q7Z3K3-2;Q7Z3K3-3;Q7Z3K3;Q7Z3K3-7;Q7Z3K3-6;Q7Z3K3-4;H7C238;M0R2X2;H0YCT3Q7Z3K3-5;Q7Z3K3-2; 3; ;Q7Z3K3-7;Q7Z3K3-6Pogo transposable element with ZNF domainPOG 13 13 1315 1.0871 0.79695 8.15E+08
I6L894;Q01484;A0A0U1RQN6;E9PHW9;Q01484-5;Q01484-2;B7Z651;D6RHE1;E9PCH6;D6RIY9;D6R9U4I6L894;Q01484;A0A0U1RQN6;E9PHW9;Q01484-5 Q01484-2;B7Z651;D6RHE1nkyrin-2 ANK2 5 3 3924 1.0869 1.2173 6.50E+07
P60228;E5RGA2;H0YBR5;E5RIT4;E5RHS5;H0YAW4;H0YBP5;E5RII3;E5RIP5;E5RJ25P60228;E5RGA2; 0YBR5Eukaryotic translation initiation factor 3 subunit EEIF3E 18 18 445 1.0868 0.95803 1.99E+09
Q96H79;Q96H79-2Q96H79 Zinc finger CCCH-type antiviral protein 1-likeZC3HAV1L 8 8 300 1.0859 0.785 1.50E+09
P08238;Q58FF7 P08238 Heat shock protein HSP 90-betaAB1 56 30 724 1.0858 1.0417 1.77E+11
P49756;P49756-2;P49756-3;E9PQU5;H0YE46;P4 756-2 P4975 -3RNA-binding protein 25RBM25 8 8 843 1.0857 0.80819 4.24E+08
P55809;E9PDW2;P55809-2;Q9BYC2P 5809;E9PDW ;P55809-2Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrialOXCT1 10 10 520 1.0856 0.78455 5.57E+08
Q2TAY7;Q2TAY7-2 Q2TAY7;Q2TAY7-2 WD40 repeat-containing protein SMU1;WD40 repeat-containing protein SMU1, N-terminally processedSMU1 17 17 513 1.0856 0.81827 5.56E+09
F8W930;Q9Y6M1-1;Q9Y6M1;Q9Y6M1-5;Q9Y6M1-6;Q9Y6M1-3;Q9Y6M1-4F8W930;Q9Y6M1-1;Q9Y6M1;Q9Y6M1-5;Q9Y6M1-6;Q9Y6M1-3;Q9Y6M1-4Insulin-like growth factor 2 mRNA binding protein 2IGF2BP2 9 6 605 1.0852 1.1933 2.90E+08
Q9P2R7-2;Q9P2R7;Q5T9Q5;A0A0U1RQF8;A0A0U1RQL1;Q5T9Q8;A0A0U1RRI1;A0A0U1RQU79P2R7-2;Q9P2R7;Q5T9Q5Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrialSUCLA2 15 15 441 1.0848 0.83602 1.76E+09
P49368;P49368-2;B4DUR8;E9PRC8;Q5SZX6;Q5SZW8;E9PQ35;E9PM09;Q5SZX9P 936 ;P4936 -2;B4DUR8T-complex protein 1 subunit gammaCCT3 43 43 545 1.0847 0.84586 5.10E+10
P19174;P19174-2;V9GY71;V9GYH5;V9GY63;M0QX77;A0A0D9SEK2P191 4;P19174-2 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1PLCG1 18 18 1290 1.0839 0.89605 9.40E+08
H3BLV9;Q5R363;Q96SB4-4;Q96SB4;Q96SB4-3;H0Y932;D6RBF8;D6RBM8H3 LV9 5R363; 4;Q96SB4;Q96SB4-3SRSF protein kinase 1SRPK1 8 7 671 1.0833 0.85835 6.77E+08
O43865;O43865-2;H0Y8B3;Q96HN2-4;Q96HN2-3;C9K0S0O43 65 O43865-2 Putative adenosylhomocysteinase 2AHCYL1 7 5 530 1.083 0.95717 5.01E+08
O94806;H0Y5M6;F8WBA3;O94806-2;Q15139O94806;H0Y5M6;F8WBA3;O94806-2;Q15139Serine/threonine-protein kinase D3;Serine/threonine-protein kinase D;Serine/threonine-protein kinase D1PRKD3;PRKD1 2 2 890 1.083 NaN 6.38E+07
A0A096LNJ4;A0A087WX43;D6RE84;A0A096LP10;A0A087WTT9;Q9NP73-2;Q9NP73;A0A096LNL2;Q9NP73-3A0A096LNJ4;A0A087WX43;D6RE84;A0A096LP10;A0A087WTT9;Q9NP73-2;Q9NP73;A0A096LNL2;Q9NP73-3Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13ALG13 2 2 132 1.0828 NaN 2.41E+08
F5GYT8;E9PHF7;Q96RQ3;G5E9X5;E9PG35F5GYT8;E9PHF7;Q96RQ3;G5E9X5;E9PG35Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrialMCCC1 5 5 575 1.0823 0.60947 2.75E+08
Q96EE3;Q96EE3-1;K7ELV2;K7EP88;K7ENI5;K7EPZ5Q96EE3;Q96EE3-1;K7ELV2;K7EP88ucleoporin SEH1 SEH1L 10 10 360 1.0814 0.83097 2.24E+09
P46783;F6U211;S4R435;Q9NQ39P 6783;F6U211;S4R435;Q9NQ3940S ribosomal protein S10;Putative 40S ribosomal protein S10-likeRPS10;RPS10-NUDT3;RPS10P5 9 9 165 1.0813 0.89513 3.38E+09
A0A087WW06;Q96AY4;B0QYP50A087WW06;Q96AY4Tetratricopeptide repeat protein 28TTC28 22 22 2354 1.0805 0.88504 7.22E+08
O43396;K7ER96;K7EML9;K7EME7;K7EKG2;K7EPB7O43396;K7ER96 Thioredoxin-like protein 1TXNL 13 13 289 1.0802 0.87468 2.48E+09
E9PS17;E9PK59;Q96KG9-3;Q96KG9-4;Q96KG9-2;Q96KG9;Q96KG9-5;Q96KG9-6;E9PPN3;H0YCI6;A0A0A0MQX4;H0YDH0E9PS17 E9PK59;Q96KG9-3;Q96KG9-4;Q96KG9-2;Q96KG9;Q96KG9-5;Q96KG9-6;E9PPN3N-terminal kinase-like proteinSCYL1 13 13 775 1.0801 0.86066 4.62E+08
Q15126 Q15126 Phosphomevalonate kinasePMVK 5 5 192 1.0801 1.2495 1.23E+08
Q96AC1-2;Q96AC1;Q96AC1-3;H0YJ34;A0A0U1RRM8;G3V3J0;H0YJB6;G3V5R2;G3V281;G3V1L6;Q9BQL6-4;Q9BQL6-2;Q9BQL62;Q96AC1;Q96AC1-3;H0YJ 4;A0A0U1RRM8Fermitin family homolog 2FERMT2 9 9 633 1.0799 1.0439 7.33E+08
Q13601;Q13601-2;A0A087WZC7Q13601;Q13601-2;A0A087WZC7KRR1 small subunit processome component homologKRR1 8 8 381 1.0793 0.90722 4.51E+08
Q9BQ67;M0QX71 Q9BQ67;M0QX71 Glutamate-rich WD repeat-containing protein 1GRWD1 12 12 446 1.0793 1.0094 5.36E+09
Q8NFH4;F8VTY2 Q8NFH4;F8VTY2 Nucleoporin Nup37NUP37 8 8 326 1.0786 0.90766 1.25E+09
Q9NUD5;Q9NUD5-2Q9NUD5;Q9NUD5-2Zinc finger CCHC domain-containing protein 3ZCCHC3 5 5 404 1.0784 1.1774 3.93E+08
Q86WJ1;Q86WJ1-2;A0A087WTM4;A0A087WWW4Q86WJ1;Q86WJ1-2Chromodomain-helicase-DNA-binding protein 1-likeCHD1L 21 2 897 1.0782 0.83151 1.04E+09
P61081;M0QX69;M0QYI6P61081 NEDD8-conjugating enzyme Ubc12UBE2M 13 13 183 1.0772 0.83355 3.61E+09
Q9Y613;J3KTH7 Q9Y613 FH1/FH2 domain-containing protein 1FHOD1 4 4 1164 1.0771 0.87564 6.68E+07
P51553;P51553-2;E9PF84;G5E9Q7;E7EQB8;H7C1W2;H0Y5Q7P51553;P51553-2; 9PF84;G5E9Q7;E7E B8;H7C1W2Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrialIDH3G 11 11 393 1.0767 1.0035 1.65E+09
P82664 P82664 28S ribosomal protein S10, mitochondrialMRPS10 6 6 201 1.0767 0.75927 2.62E+08
P27694;I3L4R8;I3L2M5;I3L524P27694 Replication protein A 70 kDa DNA-binding subunit;Replication protein A 70 kDa DNA-binding subunit, N-terminally processedRPA1 26 26 616 1.0766 0.90379 8.78E+09
Q7Z392;D6RHE5;Q7Z392-4;Q7Z392-3Q7Z392 D6RHE5;Q7Z392-4;Q7Z392-3Trafficking protein particle complex subunit 11TRAPPC11 5 5 1133 1.076 1.2475 1.39E+08
E9PD68;Q14194;Q14194-2;H0YBT4;Q14195;Q14195-2E9PD68;Q1419 ; 4-2Dihydropyrimidinase-related protein 1CRMP1 5 3 570 1.0758 1.4544 2.04E+08
O43143 O43143 Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15DHX15 27 26 795 1.0757 1.135 6.55E+09
Q9NRG9;Q9NRG9-2;F8VZ44;H3BU82;F8VUB6Q9NRG9 Q9NRG9-2;F8VZ44;H3BU82Aladin AAAS 11 11 546 1.0757 0.86137 1.35E+09
Q9BTZ2;Q9BTZ2-8;Q9BTZ2-4;F5GWZ1;Q9BTZ2-7;Q9BTZ2-2;Q9BTZ2-5;Q9BTZ2-3;H0YN69;D3YTE6;Q6PKH6;Q6PKH6-2;P0CG22;H0YLE1;H0YKN3;A0A087WSZ6;F6TD35;E9PFL3;A0A087WXI8Q9BTZ2;Q9BTZ2-8; 4;F5GWZ1;Q9BTZ2-7;Q9BTZ2-2;Q9BTZ2-5;Q9BTZ2-3Dehydrogenase/reductase SDR family member 4DHRS4 8 8 278 1.0752 0.87005 4.03E+08
H9KV28;A0A140T8Z0;A0A0G2JH68;O60610-2;O60610-3;O60610;E5RJ79;B4E2I7H9KV28;A0A140T8Z0;A A0G2JH68;O60610-2;O60610-3;O60610Protein diaphanous homolog 1DIAPH1 25 25 1228 1.0742 0.68358 1.12E+09
J3KMZ8;Q92785-2;Q92785;E9PN04J3KMZ8;Q 2785-2;Q92785;E9PN04Zinc finger protein ubi-d4DPF2 4 4 405 1.0741 0.85036 4.07E+08
P61764;P61764-2;A0A0D9SEH5;A0A0D9SG72;A0A0D9SFQ7;A0A0D9SFW6;A0A0D9SEP9;A0A096LP52P61764;P61764-2 Syntaxin-binding protein 1STXBP 9 594 1.074 0.94439 3.44E+08
Q13363-2;Q13363;D6RAX2;E7ESU7;E7EPF8;E9PGB1;H0Y8W7;H0Y9M9;E7EUB3;H0Y8U5Q13363-2;Q13363;D6RAX2;E7ESU7;E7EPF8C-terminal-binding protein 1CTBP1 14 9 429 1.074 1.0483 3.13E+09
Q8WXF1-2;Q8WXF1;X6RDA4Q8WXF1-2;Q8WXF1;X6RDA4Paraspeckle component 1PSPC 14 10 393 1.074 0.9889 1.55E+09
O14531;Q5T0Q6 O14531;Q5T0Q6 Dihydropyrimidinase-related protein 4DPYSL4 3 3 572 1.0737 1.2784 8.18E+07
P62136;P62136-2;E9PMD7;P62136-3;F5H1L6;F5H037P62136;P62136-2;E9PMD7;P62136-3Serine/threonine protein phosphatase PP1-alpha catalytic subunit;Serine/threonine-protein phosphatasePPP1CA 21 5 330 1.0735 0.77692 1.40E+10
P62140;E7ETD8;C9JP48;C9J9S3P62140;E7ETD8;C9JP48Serine/threonine-protein phosphatase PP1-beta catalytic subunit;Serine/threonine-protein phosphatasePPP1CB 18 6 327 1.0735 1.0184 1.27E+09
P41227;P41227-2;F8W808;A8MWP7;C9JN83;C9JW55;Q9BSU3;H0Y8T0P41227;P41227-2 F8W808;A8MWP7N-alpha-acetyltransferase 10NAA10 9 9 235 1.0731 0.93443 7.95E+08
Q9NPD3;E9PI41;E9PPI9Q9NPD3;E9PI41 Exosome complex component RRP41EXOSC4 3 3 245 1.0729 0.98093 1.92E+08
I3L397;I3L504;P63241;P63241-2;Q6IS14;F8WCJ1;C9J7B5;C9J4W5;Q9GZV4I3L397;I3L504 P 3241;P63241-2;Q6IS14;F8 CJ1;C9J7B5;C9J4W5;Q9GZV4Eukaryotic translation initiation factor 5A-1;Eukaryotic translation initiation factor 5A-1-like;Eukaryotic translation initiation factor 5A-2EIF5A;EIF5AL1;EIF5A2 13 13 147 1.0725 1.0225 5.43E+09
Q96F86;H3BSQ0;H3BPN4;H3BPW9;H3BQ37;H3BQP5;H3BU87;H3BNJ7;H3BTD6;H3BMB8;H3BTH0Q96F86 Enhancer of mRNA-decapping protein 3EDC3 13 13 508 1.0721 0.79509 8.65E+08
O75828 O75828 Carbonyl reductase [NADPH] 3CBR3 6 4 277 1.072 0.78638 2.28E+08
K7ESN3;Q8N2G8-2;Q8N2G8-3;Q8N2G8;K7EJT7;K7EQ41;K7EL54K7ESN3;Q8N2G8-2;Q8N2G8-3;Q8N2G8GH3 domain-containing proteinGHDC 3 3 479 1.0716 NaN 7.41E+07
Q9UET6-2;Q9UET6;B7Z4K4Q9UET6-2;Q9UET6;B7Z4K4Putative tRNA (cytidine(32)/guanosine(34)-2-O)-methyltransferaseFTSJ1 2 2 327 1.0713 1.0775 1.51E+08
P42696;A2A2V2;P42696-2;Q5TCT4;H7C5M1P42696;A2A2V2;P42696-2RNA-binding protein 34RBM34 7 7 430 1.07 0.88953 6.53E+08
A0A087WUB9;Q8WYA6-4;Q8WYA6;Q8WYA6-3;Q8WYA6-2;A2A2P1A0A087WUB9;Q8WYA6-4;Q8WYA6;Q8WY 6-3;Q8WYA6-2Beta catenin-like protein 1CTNNBL1 9 9 568 1.0693 0.99223 5.90E+08
O43251-6;O43251-8;B0QYV1;A0A0G2JRA5;O43251-5;O43251-10;O43251-2;O43251;S4R469;F8VR27;F8VZY7;B0QYY4;A0A087X2B1;J3KNW3;B7Z1U7;F8VZG9;O43251-3;O43251-9;Q9NWB1-3;O43251-4;Q9NWB1-4;Q9NWB1-5;Q9NWB1;O43251-7;Q9NWB1-2;A0A0G2JSB3;I3L1D4;B0QYY7;A0A0G2JRD1;S4R3K7;J3QRF4;F8VRS4;A6NFN3;A6NFN3-2;B0QYY6;J3QQZ2O43251-6 O43251-8;B0QYV1;A0A0G2JRA5;O43251- ;O43251-10;O 3251-2;O43251;S4R469;F8VR27;F8VZY7;B0QYY4;A0A087X2B1;J3KNW3;B7Z1U7;F8VZG9;O43251-3;O43251-9;Q9NWB1-3;O 3251-4;Q9NWB1-4;Q9NWB1-5;Q9NWB1;O43251-7;Q9NWB1-2NA binding protein fox  homolog 2;RNA binding protein fox-1 homolog;RNA binding protein fox-1 homolog 1BFOX2 RBFOX 7 7 450 1.0693 0.7 579 4. 7E+08
A0A0C4DFL7;Q16850;Q16850-2;C9IYR8;H7C0D0A A0C4DFL7;Q16850;Q16850-2Lanosterol 14-alpha demethylaseCYP51A1 4 4 509 1.0691 0.97727 2.75E+08
Q5VY60;Q7Z4H7-3;Q7Z4H7;Q7Z4H7-2;Q5SYF95VY60; 3; 7Z4H7;Q7Z4H7-2HAUS augmin-like complex subunit 6HAUS6 7 7 802 1.0673 0.80145 3.59E+08
Q96JM3;S4R3K0 Q96JM3 Chromosome alignment-maintaining phosphoprotein 1CHAMP1 5 5 812 1.0671 0.68474 2.58E+08
O15354 O15354 Prosaposin receptor GPR37GPR37 1 1 613 1.0668 NaN 1.47E+07
Q02790;F5H1U3;F5H120;H0YFG2Q02790 Peptidyl-prolyl cis-trans isomerase FKBP4;Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processedFKBP4 24 24 459 1.0663 1.2138 4.47E+09
E7ENQ1;G3XAA2;H7C360;G5E948;E7EN19;E7ESS2;A0A0D9SEY1;O95819-4;O95819-2;O95819;O95819-5;O95819-3;Q9UKE5-8;Q8N4C8-5;Q9UKE5-5;Q8N4C8-2;Q9UKE5-7;Q8N4C8-3;Q9UKE5-3;Q8N4C8-4;Q9UKE5-6;Q9UKE5-2;Q8N4C8;Q9UKE5-4;Q9UKE5;C9J338;I3L2I2;C9J840;E7EX83;A0A0D9SG62;H7C0P6;E7ETN6;I3L1U1E7ENQ1;G3XAA2;H7C360;G5E948;E7EN19;E7ESS2;A0A0D9SEY1;O95819-4; 2; ;O95819- ;O95819-3;Q9UKE5-8;Q8N4C8-5;Q9UKE5-5;Q8N4C8-2;Q9UKE5-7;Q8N4C8-3;Q9UKE5-3;Q8N4C8-4;Q9UKE5-6; 9 KE5-2; 8N4C8;Q UKE5-4;Q9UKE5;C9J338;I3L2I2;C9J840;E7EX83;A0A0D9SG62Mitogen-activated protein kinase kinase kinase kinase 4;TRAF2 and NCK-interacting protein kinase Misshapen like kinase 1MAP4K4;TNIK;MINK1 8 8 1 54 1.066 0.88723 3.98E+0
Q3B7T1-5;Q3B7T1;H0YCQ0;H0Y353;Q3B7T1-3Q3B7T1-5;Q3B7T1 Erythroid differentiation-related factor 1EDRF1 6 6 1204 1.066 0.94012 8.39E+07
Q7Z406-6;Q7Z406-2;Q7Z406;Q7Z406-4;Q7Z406-5;M0QY43;A0A0C4DFM8;A1L2Z2Q7Z406- ; 2; ;Q7Z406-4;Q7Z406-5; 0QY43Myosin-14 MYH14 22 14 2003 1.0659 1.2077 1.37E+09
O00139-2;O00139-1;O00139-5;O00139;O00139-4;D6R9M0;H0Y5Z9;H0Y8H2O00139-2;O00139-1; 5;O00139;O00139-4Kinesin-like protein KIF2AKIF2 13 12 660 1.0658 0.89219 9.12E+08
P11021 P11021 78 kDa glucose-regulated proteinHSPA5 42 40 654 1.0654 0.76857 2.37E+10
Q13155;A8MU58;F8W950Q13155;A8MU58;F8W950Aminoacyl tRNA synthase complex-interacting multifunctional protein 2AIMP2 11 11 320 1.0654 0.99735 4.04E+09
Q15149-7;Q15149-8;Q15149-9;Q15149-5;Q15149-4;Q15149-6;Q15149-3;Q15149-2;Q15149;H0YDN1;E9PMV1;Q9UPN3-5Q15149-7;Q15149-8;Q15149- ;Q15149-5;Q15149-4;Q15149-6;Q15149-3;Q15149-2;Q15149Plectin PLEC 58 51 4515 1.0654 0.80505 3.18E+09
Q8WVM0 Q8WVM0 Dimethyladenosine transferase 1, mitochondrialTFB1M 5 5 346 1.0654 0.74599 3.18E+08
Q9P2J5;Q9P2J5-2;Q9P2J5-3;A0A087WXY1Q9P2J5;Q9P2J5-2 Leucine--tRNA ligase, cytoplasmicLARS 50 50 1176 1.0652 0.97017 2.03E+10
O95376;C9JZ71;C9JCL4;F8WCS4;C9JBC5O95376 E3 ubiquitin-protein ligase ARIH2ARIH2 9 9 493 1.0651 0.79192 7.42E+08
Q9BXB4;H7C487;Q9BXB5-2;Q9BXB5Q9BXB4 Oxysterol-binding protein-related protein 11OSBPL11 5 5 747 1.0647 1.3492 3.09E+08
Q7Z2T5;X6RK96;Q7Z2T5-2Q7Z2T5;X6RK96 TRMT1-like protein TRMT1L 8 8 733 1.0643 0.83462 6.21E+08
Q9BYB4;Q9BYB4-2;C9JPQ6Q9BYB4 Guanine nucleotide-binding protein subunit beta-like protein 1GNB1L 6 6 327 1.0643 0.62282 5.13E+08
Q96QK1;I3L4S0;I3L4P4Q96QK1 Vacuolar protein sorting-associated protein 35VPS35 31 31 796 1.064 0.94374 6.46E+09
Q9ULX3;H3BUR4 Q9ULX3;H3BUR4 RNA-binding protein NOB1NOB1 10 10 412 1.0638 0.77286 1.58E+09
Q96S44;Q5JZ02 Q96S44;Q5JZ02 TP53-regulating kinaseTP53RK 4 4 253 1.0634 0.95717 9.54E+08
P49916-3;P49916;P49916-4;P49916-2;K7ERZ5;K7EQB6;K7ENR9;K7EJR43; ;P49916-4;P49916-2;K7ERZ5DNA ligase 3 LIG3 28 28 922 1.0631 0.77227 2.25E+09
Q6IN85-2;Q6IN85;G3V5Z3;Q6IN85-4;H0YIY8;Q6IN85-5;G3V5A2;G3V4R3;G3V231;H0YJN6;Q5MIZ7-5Q6IN85-2;Q6IN85;G3V5Z3;Q6IN85-4;H0YIY8;Q6IN85-5Serine/threonine-protein phosphatase 4 regulatory subunit 3ASMEK1 14 12 820 1.0625 0.88108 7.40E+08
Q8IWV7;A0A087WTJ9;H3BUC4;Q8IWV7-2Q8IWV7 E3 ubiquitin-protein ligase UBR1UBR1 8 8 1749 1.0621 0.96828 4.33E+08
142
Q9HAD4;H0YAA3;Q9HAD4-2;H0Y9Z3;D6RE66;A0A0C4DG28;H0YAI6;D6RA22;D6RJA5;D6RH33;D6R9E7;D6RB94;B4DK73;B4DHS8;D6RBY6;D6RIX6;D6R9M1Q9HAD4; 0YAA ;Q9HAD4-2;H Y9Z3;D6RE66;A0A0C4DG28WD repeat-containing protein 41WDR41 6 6 459 1.062 0.95972 6.74E+08
A0A087WZN1;O43837;A0A087X2E5;O43837-2;O43837-3;A0A0D9SG66A0A087WZN1;O43837;A0A087X2E5;O43837-2;O43837-3Isocitrate dehydrogenase [NAD] subunit beta, mitochondrialIDH B 15 15 387 1.0618 0.91674 2.26E+09
O60343-2;O60343-3;O60343;O60343-5;O60343-4;Q5JU47;A0JNU9;C9JIE2O60343-2; 3;TBC1 domain family member 4TBC1D4 23 21 1235 1.0617 0.98086 2.61E+09
P49761-1;P49761;H3BRE4;H3BNQ5;H3BUL5;H3BVF8;H3BQG1;P49761-3P49761-1;P49761;H3BRE4;H3BNQ5;H3BUL5;H3BVF8;H3BQG1;P49761-3Dual specificity protein kinase CLK3CLK3 2 2 490 1.0613 NaN 1.07E+08
Q16513;Q16513-3;Q16513-2;Q16513-4;Q16513-5;B1AL79;A0A0A0MRN8;H0Y5V5;H0Y429;Q16513- ;Q16513-2;Q16513-4;Q16513-5;B1AL79Serine/threonine-protein kinase N2PKN2 37 36 984 1.0608 0.76002 4.14E+09
O94874-2;O94874;O94874-32;O94874;O94874-3E3 UFM1-protein ligase 1UFL 18 18 729 1.0607 1.0364 1.02E+09
F8W8R3;P49005;A0A087WWF6;C9JLE1;C9IZD2;C9J8Z7;C9JHC7;H7C1B3F8W8R3;P49005;A0A087WWF6;C9JLE1;C9IZD2; 9J8Z7;C9JHC7DNA polymerase delta subunit 2POLD2 9 9 455 1.0594 0.75702 1.53E+09
O14545;F8VNX8;F8VWK2;F8VVF3;O14545-2O14545;F8 NX8 TRAF-type zinc finger domain-containing protein 1TRAFD1 3 3 582 1.0586 0.67488 8.97E+07
C9JKF1;Q5K651 C9JKF1;Q5K651 Sterile alpha motif domain-containing protein 9SAMD9 3 3 1283 1.0585 1.1389 4.98E+07
Q13043-2;Q13043;A0A087WVN8;F5H5B4;Q13188;Q13188-2Q13 43-2;Q13043;A0A087WVN8;F5H5B4;Q13188;Q13188-2Serine/threonine-protein kinase 4;Serine/threonine-protein kinase 4 37kDa subunit;Serine/threonine-protein kinase 4 18kDa subunit;Serine/threonine-protein kinase 3;Serine/threonine-protein kinase 3 36kDa subunit;Serine/threonine-protein kinase 3 20kDa subunitSTK4;STK3 2 2 462 1.0584 NaN 7.49E+07
Q52LJ0;Q52LJ0-2;H0YNA1Q52LJ0;Q52LJ0-2 Protein FAM98B FAM98B 5 4 330 1.0584 1.0109 4.67E+08
Q9NSD9;Q9NSD9-2Q9NSD9;Q9NSD9-2Phenylalanine--tRNA ligase beta subunitFARSB 20 20 589 1.0583 0.96061 3.56E+09
A0A087WX08;Q9UEY8-2;Q9UEY8A0A087WX0 ;Q9UEY8-2;Q9UEY8Gamma-adducin ADD3 5 5 672 1.0579 0.98737 5.10E+08
Q15050 Q15050 Ribosome biogenesis regulatory protein homologRRS1 2 2 365 1.0578 NaN 1.16E+08
Q5TDH0;Q5TDH0-3;Q5TDH0-2;H0YII4;H0YI90Q5TDH0;Q5TDH0-3;Q5TDH0-2Protein DDI1 homolog 2DDI 9 9 399 1.0575 0.82104 2.17E+09
E9PF10;O75694;O75694-2;D6RA13E9PF10;O75694;O75694-2Nuclear pore complex protein Nup155NUP155 40 40 1327 1.0573 0.93972 5.74E+09
O75131;A0A087WYQ3;H0YB26;E5RHZ0;A0A087WXR6;A0A087WUS8;E5RFT7;E7ENV7;Q86YQ8-2;Q9HCH3-2;Q96FN4-2;Q96FN4;Q8IYJ1;Q96A23;O95741;Q9UBL6-2;Q86YQ8;Q96A23-2;Q9HCH3;O95741-2;Q9UBL6O75131;A0A087WYQ3Copine-3 CPNE3 21 21 537 1.0573 1.0401 5.64E+09
Q92889;Q92889-2 Q92889 DNA repair endonuclease XPFERCC4 5 5 916 1.0572 0.89618 8.96E+07
Q96TA2-3;Q96TA2-2;Q96TA2;Q96I63;Q5T8D2;Q5T8D1Q96TA2-3; TA2-2;Q96TA2;Q96I63ATP-dependent zinc metalloprotease YME1L1YME1L1 7 7 683 1.057 0.88268 6.40E+08
Q8TEM1;Q8TEM1-2Q8TEM1;Q8TEM1-2Nuclear pore membrane glycoprotein 210NUP210 30 30 1887 1.0569 1.0229 2.60E+09
Q9Y4X5;H3BNB9;A0A087WT96;H3BSK4Q9Y4X5;H3BNB9 E3 ubiquitin-protein ligase ARIH1ARIH1 6 6 557 1.0566 0.71533 4.27E+08
Q07864;F5H1D6;F5H7E4Q07864;F5H1D6 DNA polymerase epsilon catalytic subunit A;DNA polymerasePOLE 33 33 2286 1.0564 0.80587 1.69E+09
Q9BZE9;Q9BZE9-2;Q9BZE9-3;J3QL04;J3KRY8;J3QR12;Q9BZE9-4;J3KRF7;C9JAL9;J3QR50;J3QRW3;J3KRG1Q9BZE9;Q9BZE9-2;Q9BZE9-3;J3QL04;J3KRY8;J3QR12;Q9BZE9-4Tether containing UBX domain for GLUT4ASPSCR1 6 6 553 1.0564 0.78465 4.87E+08
Q7RTV0 Q7RTV0 PHD finger-like domain-containing protein 5APHF5A 5 5 110 1.0562 0.93813 1.08E+08
F5H5D3;Q9BQE3;F8VVB9;F8VRZ4;F8VS66;F8VWV9;F8VX09;C9K0S6;F8VRK0;F8VXZ7;F8W0F6;Q9H853F5H5D3;Q9BQE3 Tubulin alpha-1C chainTUBA1C 34 4 519 1.0558 NaN 4.11E+08
Q8N1G2;H0YCQ1 Q8N1G2 Cap-specific mRNA (nucleoside-2-O-)-methyltransferase 1CMTR1 4 4 835 1.0556 1.123 1.68E+08
Q9UQE7 Q9UQE7 Structural maintenance of chromosomes protein 3SMC3 66 66 1217 1.0549 0.90073 9.31E+09
Q96BY7 Q96BY7 Autophagy-related protein 2 homolog BATG2B 2 2 2078 1.0547 1.5189 4.34E+07
Q8WYQ5-3;Q8WYQ5Q8WYQ5-3;Q8WYQ5Microprocessor complex subunit DGCR8DGCR8 2 2 740 1.0545 NaN 1.38E+07
O94822;O94822-3;S4R3T2;O94822-2O94822; 94822-3 E3 ubiquitin-protein ligase listerinLTN1 11 7 1766 1.0539 1.0168 4.57E+08
Q8IWZ3;Q8IWZ3-4;Q8IWZ3-6;E9PDP5;H7C2F5;H3BLS9;H0Y4P6;Q8IWZ3-5;Q8IWZ3-2;D6RHC4;Q8IWZ3-3;H0Y785;H0Y472;A0A0A0MQZ8;H0Y7Y3;H7C0V5I ;Q8IWZ3-4 Q8IWZ3-6;E9PDP5;H7C2F5;H3BLS9Ankyrin repeat and KH domain-containing protein 1ANKHD1 25 14 2542 1.0536 0.73442 1.98E+09
O76003 O76003 Glutaredoxin-3 GLRX3 11 11 335 1.0531 1.0358 3.31E+09
G3V4K3;Q9H9C1-2;Q9H9C1G3V4K3;Q9H9C1-2;Q9H9C1Spermatogenesis-defective protein 39 homologVIPAS39 7 7 519 1.0528 0.57497 1.99E+08
O14654 O14654 Insulin receptor substrate 4IRS4 47 47 1257 1.0525 0.69061 6.92E+09
F5H5P2;P12694;P12694-2;F5GXU9;M0R0C8;H0YH31F5H5P ;P12694 P12694-2;F5GXU9;M0R0C82-oxoisovalerate dehydrogenase subunit alpha, mitochondrialBCKDHA 4 4 479 1.0519 0.56334 2.09E+08
Q02880-2;Q02880;E9PCY5;H7BZ82Q02880-2;Q02880;E9PCY5DNA topoisomerase 2-beta;DNA topoisomerase 2TOP2B 23 13 1621 1.0513 1.2102 8.55E+08
Q12955-7;Q12955-5;Q12955-4;Q12955;A0A087WZ65;A0A087WTF3;Q12955-6;A0A087WUY3;H0Y3A4;A0A087WWI5;H0Y951;A0A087WX55;A0A087WY90;H0YA66;H0YAH5;A0A087WTE8;A0A087WVC2;H0Y931Q12955-7;Q12955- ;Q12955-4;Q12955;A0A087WZ65;A0A087WTF3;Q12955-6;A0A087WUY3Ankyrin-3 NK3 9 8 1465 1.0513 0.9772 2.07E+ 8
O95782-2;O95782 O95782-2;O95782 AP-2 complex subunit alpha-1AP2A1 26 17 955 1.0511 0.71583 1.19E+09
Q9BY32;Q9BY32-3;Q9BY32-2;Q9BY32-3 Inosine triphosphate pyrophosphataseITPA 5 5 194 1.0508 1.0219 5.58E+08
P18031;B4DSN5 P18031;B4DSN5 Tyrosine-protein phosphatase non-receptor type 1;Tyrosine-protein phosphatase non-receptor typePTPN1 9 9 435 1.0506 1.1181 8.75E+08
Q8NCN5;A8MT40;H3BQG3;B7ZAR9;Q8NCN5-2Q8NCN5;A8MT40;H3BQG3Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrialPDPR 6 6 879 1.0506 0.6686 2.29E+08
Q3ZCQ8;Q3ZCQ8-2;Q3ZCQ8-3;M0R2F8;M0R0C3;M0R003;M0R1Y4;M0R047;M0R2Q2;M0QXC3;M0R2Z3;M0R303;M0R2D2;Q3ZCQ8-2;Q3ZCQ8-3;M0R2F8;M0R0C3itochondrial import inner membrane translocase subunit TIM50TIMM50 11 11 353 1.0504 0.76266 2.57E+09
Q9NPF4;G3V445;G3V249Q9NPF4 Probable tRNA N6-adenosine threonylcarbamoyltransferaseOSGEP 8 8 335 1.0503 0.90505 1.07E+09
Q8TED1;E7ETY7;J3KNB5Q8TED1;E7ETY7;J3KNB5Probable glutathione peroxidase 8;Glutathione peroxidaseGPX8 4 4 209 1.0502 0.77601 1.61E+08
O15294;O15294-3;O15294-4;O15294-2;C9JZL3;O15294-3;O15294-4;O15294-2UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitOGT 10 10 1046 1.0494 0.90158 6.02E+08
Q6PL18;Q6PL18-2;A0A0B4J211Q6PL18;Q6PL18-2 ATPase family AAA domain-containing protein 2ATAD2 4 4 1390 1.0491 0.74758 1.13E+08
E9PJH7;Q9H936;A0A0D9SFE1;A0A0D9SEI9;K4DIA8;K4DIB8;E9PS95;K4DIB6;K4DIB3;Q9H1K4;A0A0D9SFA8;K4DIB0;K4DIA2;A0A0D9SG84;E9PI74;E9PQ36;E9PJY0;A0A0A6YYN8E9PJH7;Q9H936;A0A0D9SFE1;A0A0D9SEI ;K4DIA8;K4DIB8;E9PS95Mitochondrial glutamate carrier 1LC25A22 9 9 313 1.0489 0.9254 2.52E+09
O75436;S4R3Q6;O75436-2;S4R2Y3O75436 3Q6;O75436-2Vacuolar protein sorting-associated protein 26AVPS26A 11 10 327 1.0487 0.8202 1.97E+09
Q7L0Y3;C9JVB6 Q7L0Y3;C9JVB6 Mitochondrial ribonuclease P protein 1TRMT10C 8 8 403 1.0483 0.81531 2.67E+08
Q96EK4 Q96EK4 THAP domain-containing protein 11THAP11 3 3 314 1.0481 0.84166 1.89E+08
M0QXB4;O14579;A0A087X0I4;O14579-3;O14579-2;M0R061M0QXB4;O14579;A0A087X0I4;O14579-3;O14579-2;M0R061Coatomer subunit epsilonCOPE 16 16 331 1.048 0.87978 6.15E+09
P78347-2;P78347-4;P78347-3;P78347;P78347-5;C9J6M0;A0A087WW90;A0A0D9SF80;A0A0A0MSY2;Q86UP8-3;Q86UP8;Q6EKJ0P78347-2;P78347-4; 3;P78347General transcription factor II-IGTF2I 39 39 957 1.0479 0.81094 6.07E+09
C9JVN9;Q9H9P8-2;Q9H9P8;G3V5S1;G3V272C JVN9;Q9H9P8-2;Q9H9P8L-2-hydroxyglutarate dehydrogenase, mitochondrialL2HGDH 9 9 441 1.0473 0.77973 1.31E+09
P62879;C9JZN1;C9JIS1;C9JXA5;Q9HAV0;C9JD14P62879;C9JZN1;C9JIS1;C9JXA5;Q9HAV0Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2;Guanine nucleotide-binding protein subunit beta-4GNB2;GNB4 7 2 340 1.0468 0.9548 1.38E+09
Q8WWM7-6;Q8WWM7-8;Q8WWM7-5;Q8WWM7-4;Q8WWM7-9;Q8WWM7-2;Q8WWM7;Q8WWM7-3;H3BUF6;H3BSK9;Q8WWM7-7;H3BSQ5;H3BUE3Q8WWM7-6;Q8WWM7-8;Q8WWM7-5;Q8WWM7-4;Q8WWM7-9;Q8WWM7-2;Q8WWM7;Q8WWM7-3;H3BUF6;H3BSK9;Q8WWM7-7Ataxin-2-like proteinATXN2L 8 8 968 1.0468 0.69617 2.83E+08
Q9H5Q4 Q9H5Q4 Dimethyladenosine transferase 2, mitochondrialTFB2M 7 7 396 1.0468 0.73483 3.46E+08
Q9Y4P1-6;Q9Y4P1;Q9Y4P1-2;C9JQ72;C9JIK8;Q9Y4P1-4;F2Z2K8;Q9Y4P1-3;H0Y2Y0;C9JVD5;C9J3C0;H7C2A6;C9J1C16;Q9Y4P1;Q9Y4P1-2;C9JQ72;C9JIK8;Q9Y4P1-4Cysteine protease ATG4BATG4B 9 9 380 1.0463 1.0367 1.03E+09
P62913 P62913 60S ribosomal protein L11RPL11 12 2 178 1.0453 1.0677 1.32E+10
Q8TAT6;Q8TAT6-2;I3L4U9;A0A0D9SFI9;I3L283;I3L3I1Q8TAT6;Q8TAT6-2 Nuclear protein localization protein 4 homologNPLOC4 12 12 608 1.0453 1.1609 9.71E+08
Q9UHD2 Q9UHD2 Serine/threonine-protein kinase TBK1TBK1 5 5 729 1.0446 0.94737 3.19E+08
Q8WWH5 Q8WWH5 Probable tRNA pseudouridine synthase 1TRUB1 8 8 349 1.0443 0.8796 6.41E+08
P46063;F8WA66;F8WD97;F5H2L2;F5H4P4;F5H3W0P46063 AT -dependent DNA helicase Q1RECQL 22 22 649 1.0442 0.88161 4.39E+09
M0QZR4;Q92888;Q92888-3;Q92888-2;Q92888-4;M0QYC1;M0R2C7;M0QZH8;M0R3H5;M0QYS3M0QZR4 ;Q92888-3;Q92888-2;Q92888-4;M0QYC1Rho guanine nucleotide exchange factor 1ARHGEF1 11 11 968 1.0441 0.85372 3.37E+08
P50995-2;P50995;H0Y6E1P50995-2;P50995 Annexin A11 ANXA11 16 16 472 1.044 1.0672 1.66E+09
P57740;P57740-2;P57740-3;H0YG15;G3V1T4;P57740-2 P57740-3Nuclear pore complex protein Nup107NUP107 28 28 925 1.0438 0.72406 3.28E+09
Q9Y450-4;Q9Y450;B7Z524;H0YDX7;J3QT46;H0YES5;E9PHZ9;E9PJ90;E9PN23;E9PS53;G5E991;E9PMN1;E9PLR4;Q9Y450-2Q9Y450-4;Q9Y450;B7Z524;H0YDX7;J3QT46HBS1-like protein HBS1L 17 17 642 1.0435 0.87155 1.99E+09
O75191-2;O75191 O75191-2;O75191 Xylulose kinase XYLB 2 2 399 1.0433 NaN 5.83E+07
Q08945;E9PMD4;A0A0U1RRK2;E9PPZ7Q08945 FACT complex subunit SSRP1SSRP1 27 27 709 1.0433 0.94402 1.09E+10
P32929-2;P32929-3;P32929P32929-2;P32929-3;P32929Cystathionine gamma-lyaseCTH 4 4 361 1.0431 NaN 1.27E+08
Q9NWT1 Q9NWT1 p21-activated protein kinase-interacting protein 1PAK1IP1 3 3 392 1.0431 1.0732 1.51E+08
P25685;P25685-2;M0R080;M0QYT3;M0QXK0;M0R128;M0R1D6;M0QZD0P25685;P25685-2 DnaJ homolog subfamily B member 1DNAJ 1 9 9 340 1.043 1.2393 4.03E+08
Q8TC12;Q8TC12-2;G3V2G6;H0YIZ8;G3V234;H0YJ10;H0YJ46;Q8TC12-3Q8TC12;Q8TC12-2;G3V2G6;H0YIZ8;G3V234Retinol dehydrogenase 11RDH11 8 8 318 1.0423 0.90935 1.79E+09
Q99426;Q99426-2;K7EP07;K7EK42;K7EL99;K7EQH0;K7ER04Q99426;Q99426-2;K7EP07;K7EK42Tubulin-folding cofactor BTBCB 12 12 244 1.042 1.0412 1.06E+09
J3QRS3;P19105;O14950;P24844;J3KTJ1;P24844-2J3QRS3;P19105;O14950;P24844Myosin regulatory light chain 12A;Myosin regulatory light chain 12B;Myosin regulatory light polypeptide 9MYL12A;MYL12B;MYL9 8 8 177 1.0411 1.1509 1.11E+09
Q9UER7-3;Q9UER7-5;Q9UER7-4;Q9UER7-2;Q9UER7Q9UER7-3;Q9UER7-5;Q9UER7-4;Q9UER7-2;Q9UER7Death domain-associated protein 6DAXX 1 1 665 1.0411 NaN 7.72E+07
P35573;P35573-2;P35573-3;P35573-2;P35573-3Glycogen debranching enzyme;4-alpha-glucanotransferase;Amylo-alpha-1,6-glucosidaseAGL 63 3 1532 1.0407 0.8649 8.28E+09
P63010;P63010-2;P63010-3;A0A087X253;A0A087WU93;A0A087WZQ6;A0A087WYD1;K7ERB2;K7EJ01;K7EN71;K7EJX1;A0A087WXS3;K7EKZ5;P63010-2;P6301 -3;A0A087X253;A0A087WU93;A0A087WZQ6;A0A087WYD1AP-2 complex subunit betaP2B1 27 14 937 1.0407 0.8404 1.76E+09
Q9NXC5;Q9NXC5-2Q9NXC5;Q9NXC5-2WD repeat-containing protein mioMIOS 7 7 875 1.0407 0.72433 3.06E+08
Q9BZH6;S4R3Z0;S4R451;S4R3P9Q9BZH6 WD repeat-containing protein 11WDR11 15 15 1224 1.0405 0.73163 1.08E+09
Q9UQR0;H0Y6S1;Q9UQR0-2Q9UQR0 Sex comb on midleg-like protein 2SCML2 5 5 700 1.0403 0.85748 3.98E+08
A0A087X1N2;Q03701;C9J9W7A0A087X1N2;Q03701CCAAT/enhancer-binding protein zetaCEBPZ 13 13 998 1.0392 0.91842 4.78E+08
A2RRP1-2;A2RRP1;H0Y5G7;H7C007;H7BZR3;C9JCM7;H7BZU5A2RRP1-2;A2RRP1;H0Y5G7Neuroblastoma-amplified sequenceNBAS 17 17 2251 1.039 0.88952 8.29E+08
Q99623;J3KPX7;F5GY37;Q99623-2;F5GWA7;F5H3X6;F5H0C5;F5H2D2;U3KPZ5Q99623;J3KPX7; Y37;Q99623-2;F5GWA7;F5H3X6Prohibitin-2 PHB2 23 23 299 1.0388 1.1757 1.87E+10
P68366-2;P68366;C9JEV8;C9JDS9;C9JQ00;C9JJQ8;C9JDL2P68366-2;P68366 Tubulin alpha-4A chainTUBA4A 27 3 433 1.0386 0.81794 5.40E+08
Q7KZ85;Q7KZ85-2;Q7KZ85-3 Transcription elongation factor SPT6SUPT6H 33 33 1726 1.0386 1.0378 2.20E+09
H0YNU5;P54132;H0YLV8H0YNU5;P54132 Bloom syndrome proteinBLM 5 5 1286 1.0382 0.56047 1.25E+08
Q9NSV4-7;Q9NSV4-6;Q9NSV4-5;Q9NSV4-4;Q9NSV4;Q9NSV4-2;Q9NSV4-1Q9NSV4-7;Q9NSV4-6;Q9NSV4-5; 4; ;Q9NSV4-2;Q9NSV4-1Protein diaphanous homolog 3DIAPH3 7 7 1112 1.038 0.8661 6.09E+07
Q8TF46-2;Q8TF46-4;Q8TF46;Q8TF46-3Q8TF46-2;Q8TF46-4;Q8TF46DIS3-like exonuclease 1DIS3L 3 3 920 1.0379 0.50523 9.59E+07
A8K968;A0A0A0MRA8;Q9Y2J2-2;Q9Y2J2-4;Q9Y2J2;A0A0J9YY18;A0A0J9YW31;B2RB02;Q9Y2J2-3;A0A0J9YW26;J3QS83;J3KT37;A0A0J9YWN0;A0A0J9YWE1;A0A0J9YWS48K968;A0A0A0MRA8;Q9Y2J2-2;Q9Y2J2-4;Q9Y2J2;A0A0J9YY18Band 4.1-like protein 3;Band 4.1-like protein 3, N-terminally processedEPB41L3 17 17 756 1.0377 0.76753 1.01E+09
D6RH30;P19838;P19838-2D6RH30;P19838;P19838-2Nuclear factor NF-kappa-B p105 subunit;Nuclear factor NF-kappa-B p50 subunitNFKB1 2 2 198 1.0376 1.029 1.25E+08
Q13547;Q5TEE2;E5RFI6;E5RJ04;E5RGV4;E5RHE7;E5RH52;E5RG37;E5RFP9;H3BM24;E5RK19;E7ESJ6Q13547;Q5T E2 Histone deacetylase 1HDAC1 11 7 482 1.0375 1.0541 2.93E+09
Q15054;Q15054-3;Q15054-2;E9PM91;E9PNC0;E9PRK3;Q15054-3;Q15054-2DNA polymerase delta subunit 3POLD3 5 5 466 1.0375 0.72871 2.70E+08
O75116;Q14DU5;E9PF63;C9JFJ0;D6REE7;A0A0U1RQV4;Q13464O75116;Q14DU5;E9PF63Rho-associated protein kinase 2ROCK2 4 4 1388 1.0373 1.161 6.26E+07
143
Q86UK7-2;Q86UK7-3;Q86UK7;H3BQQ2Q86UK7-2;Q86UK7-3;Q86UK7;H3BQQ2Zinc finger protein 598ZNF598 7 7 896 1.0368 0.52414 4.15E+08
O00165;O00165-2;O00165-5;O00165-3;E9PIQ7;Q5VYD6;O00165-4;O00165-6;O00165-2;O00165-5;O00165-3;E9PIQ7HCLS1-associated protein X 1HAX 9 9 279 1.0356 0.78289 1.48E+09
A0A087WZ13;E9PAU2;Q8IY67-2;Q8IY67;K7EKR9;Q8IY67-3;K7EQG2A0A0 7WZ13;E9PAU2;Q8IY67-2;Q8IY67Ribonucleoprotein PTB-binding 1RAV R1 13 13 739 1.0348 0.88991 8.24E+08
Q5QJE6;J3KP30 Q5QJE6 Deoxynucleotidyltransferase terminal-interacting protein 2DNTTIP2 4 4 756 1.0348 1.2481 6.26E+07
Q9H3P7 Q9H3P7 Golgi resident protein GCP60ACBD3 11 11 528 1.0348 0.99351 4.62E+08
A0A087WWS7;Q15833-2;Q15833;Q15833-3;M0R1A1;M0R0M7;M0QZ54;M0R376;M0R0D4;M0R118A0A087WWS7; 2;Q15833;Q15833-3; R1A1; 0M7Syntaxin-binding protein 2STXBP ;ZNF 4 4 4 579 1.0347 0.88571 1.01E+08
P49327;A0A0U1RQF0;A0A0U1RRG3;J3KTF0P49327;A0A0U1RQF0atty acid synthase;[Acyl-carrier-protein] S-acetyltransferase;[Acyl-carrier-protein] S-malonyltransferase;3-oxoacyl-[acyl-carrier-protein] synthase;3-oxoacyl-[acyl-carrier-protein] reductase;3-hydroxyacyl-[acyl-carrier-protein] dehydratase;Enoyl-[acyl-carrier-protein] reductase;Oleoyl-[acyl-carrier-protein] hydrolaseF SN 130 130 2511 1.0339 0.82683 1.33E+11
Q9Y4G6;H0YMT1;H0YN01Q9Y4G6;H0YMT1 Talin-2 TLN2 3 2 2542 1.0339 0.82936 1.13E+08
E9PF19;Q9Y4P3;Q96E41;A0A087WXC6;F8WCR3;F8WDI9E9PF19;Q9Y4P3;Q96E41Transducin beta-like protein 2TBL2 9 9 411 1.0338 1.0799 3.64E+08
E9PKP7;P17480-2;P17480;E9PMM2;E9PLT2E9PKP7;P17480-2;P17480Nucleolar transcription factor 1UBTF 8 8 745 1.0337 0.79397 6.50E+08
Q96EY1;Q96EY1-2;Q96EY1-3Q96EY1;Q96EY1-2 DnaJ homolog subfamily A member 3, mitochondrialDNAJ 3 8 8 480 1.0337 0.98662 1.64E+09
F5H8D7;P18887;M0QZ96;M0R0D2;M0R1U8;M0QYS5F5H8D7;P18887 DNA repair protein XRCC1FOXH1;XRCC1 5 5 602 1.0326 0.78912 1.31E+08
Q6ZN17;Q6ZN17-2 Q6ZN17 Protein lin-28 homolog BLIN28B 5 5 250 1.0326 1.1613 2.89E+08
P52564;P52564-2;A0A0A0MRF7;K7EIW3P52564;P52564-2 Dual specificity mitogen-activated protein kinase kinase 6MAP2K6 5 3 334 1.0325 0.96932 3.22E+08
D6RF48;Q9P2W9;D6RC71D6RF48;Q9P2W9 Syntaxin-18 STX18 7 7 308 1.0318 1.2631 3.25E+08
Q9BV44;H7C3J3;H7C0R6Q9BV44;H7C3J3;H7C0R6THUMP domain-containing protein 3THUMPD3 8 8 507 1.0306 0.99012 5.92E+08
A0A0A0MTL5;Q13309;Q13309-2;D6R9R7;D6RAG5;Q13309-4A0A0A0MTL5;Q13309;Q13309-2S-phase kinase-associated protein 2SKP2 7 7 435 1.0294 0.53315 4.18E+08
P38117;P38117-2;M0QY67P38117;P38117-2;M0QY67Electron transfer flavoprotein subunit betaETFB 6 6 255 1.0294 1.1031 4.35E+08
Q9NVM9;Q9NVM9-2;F5H5W1;F5H457;H0YH12Q9NVM9;Q9NVM9-2Protein asunder homologASUN 3 3 706 1.0294 1.2535 2.24E+08
O43929;O43929-2;O43929-3;C9JGH7;C9J2X8;Q53SE3;CON__Q2YDI2;O43929-2 O43929-3rigin recognition complex subunit 4ORC4 7 7 436 1.029 0.93171 3.39E+08
O14976-2;O14976;D6RF16;D6RAQ7;D6RE78;D6RAW3;A0A087X1U9O1497 -2;O14976 Cyclin-G-associated kinaseGAK 6 6 1232 1.0288 0.8633 5.20E+08
P08243-2;P08243;P08243-3;F8WEJ5;C9J057;C9JT45;C9JM09;C9JLN62;P08243;P08243-3;F8WEJ5Asparagine synthetase [glutamine-hydrolyzing]ASNS 24 24 540 1.0283 1.2634 9.14E+09
Q9Y265;Q9Y265-2;E7ETR0;H7C4G5;H7C4I3;J3QLR1Q9Y265;Q9Y265-2;E7ETR0RuvB-like 1 RUVBL1 28 28 456 1.0271 0.9426 1.08E+10
P11586;F5H2F4;V9GYY3P11586;F5H2F4 C-1-tetrahydrofolate synthase, cytoplasmic;Methylenetetrahydrofolate dehydrogenase;Methenyltetrahydrofolate cyclohydrolase;Formyltetrahydrofolate synthetase;C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processedMTHFD1 61 60 935 1.0264 0.90422 2.78E+10
Q9NSE4 Q9NSE4 Isoleucine--tRNA ligase, mitochondrialIARS2 27 27 1012 1.0261 0.96102 2.55E+09
C4B7M2;Q96JI7-2;Q96JI7-3;Q96JI7;H0YN34C4B7M2 -2;Q96JI7-3;Q96JI7;H0YN34Spatacsin SPG11 2 2 2265 1.026 1.1873 1.31E+07
P06132;H0Y5R6;Q5T446P06132;H0Y5R6;Q5T446Uroporphyrinogen decarboxylaseUROD 8 8 367 1.0259 0.908 1.43E+09
K7EQ02;K7EQ55;K7EK33;Q96EP5-2;Q96EP5K7EQ02;K7EQ55;K7EK33;Q96EP5-2;Q96EP5DAZ-associated protein 1DAZAP1 8 8 327 1.0247 0.8792 5.87E+08
P53992;G5EA31;P53992-2;A0A0U1RR49P5399 ;G5EA3 Protein transport protein Sec24CSEC24C 22 22 1094 1.0247 0.74204 3.20E+09
A0A087X295;Q9NNW5;E9PDU5;E9PBK6;Q6PKC6;C9K020;V9GZ65;C9JFP6;V9GYU1;E5RFX3;F8WE36A0A087X295;Q9NNW5;E9PDU5;E9PBK6D repeat-containing protein 6WDR6 16 16 1151 1.0246 0.8043 1.14E+09
Q9Y283-2;Q9Y283 Q9Y283-2;Q9Y283 Inversin INVS 1 1 895 1.0246 1.2668 1.93E+07
P08708;H0YN88;A0A075B716;H0YN73;H3BNC9P08708;H0YN88;A0A075B71640S ribosomal protein S17RPS17 13 13 135 1.0244 0.94747 2.35E+09
Q13951-2;J3KTD8 Q13951-2 Core-binding factor subunit betaCBFB 8 2 187 1.024 1.1572 5.77E+08
J3QRD1;P51648;P51648-2;J3QS00;I3L1M4;J3KTD9;I3L2W1J3QRD1;P51648;P5 648-2;J3QS00;I3L1M4Fatty aldehyde dehydrogenaseALDH3A2 3 3 393 1.0232 1.1786 2.59E+08
Q16512;Q16512-2;Q16512-3;K7EL10;K7EM57;K7EKY9;K7EN76;Q16512-2 Serine/threonine-protein kinase N1PKN1 15 14 942 1.0231 0.74304 8.44E+08
Q15751;H0YNB1 Q15751;H0YNB1 Probable E3 ubiquitin-protein ligase HERC1HERC1 4 4 4861 1.023 NaN 2.16E+07
O43175;Q5SZU1 O43175;Q5SZU1 D-3-phosphoglycerate dehydrogenasePHGDH 24 24 533 1.0226 1.1985 3.03E+10
F5H269;Q9Y485 F5H269;Q9Y485 DmX-like protein 1 DMXL1 2 2 3048 1.0222 NaN 1.64E+07
Q9UIM3 Q9UIM3 FK506-binding protein-likeFKBPL 3 3 349 1.0222 NaN 1.36E+08
A0A087WVQ6;Q00610-2;Q00610;J3KS13;K7EJJ5;J3KSQ2;J3KRF5;J3QL20;A0A087WV74;A0A087WXH4;F5H5N6A0A087WVQ6;Q00610-2;Q00610Clathrin heavy chain 1CLTC 94 73 1679 1.0219 1.0234 9.15E+10
O75746;O75746-2;F8W9J0;H0YFB2;B4DGK6O75746;O75746-2 Calcium-binding mitochondrial carrier protein Aralar1SLC25A12 16 11 678 1.0213 0.9196 1.93E+09
E7EU96;Q5U5J2;P68400;Q8NEV1;P68400-2;V9GYA2;V9GY80;A0A087WY74E7EU96;Q5U5J2;P68400 Q8NEV1;P6840 -2Casein kinase II subunit alpha;Casein kinase II subunit alpha 3CSNK2 1 SNK2A3 14 14 385 1.021 1.0258 4.39E+09
Q96HW7;Q96HW7-2;Q96HW7-4;Q96HW7-3;F8WAA7;E9PIM3Q96HW7;Q96HW7-2Integrator complex subunit 4INTS4 11 11 963 1.0195 0.84889 4.85E+08
Q96K76-4;Q96K76;Q96K76-2;Q96K76-34; ;Q96K76-2Ubiquitin carboxyl-terminal hydrolase 47USP47 11 11 1355 1.0195 1.0551 4.65E+08
P78527;P78527-2;F5GX40;H0YG84P78527;P78527-2 DNA-dependent protein kinase catalytic subunitPRKDC 206 206 4128 1.0192 1.0843 4.81E+10
Q15717;Q15717-2;M0QZR9;M0R055;B1APY9;B1APY8;A0A0A0MRX1;A0A0R4J2E6;Q12926-2;Q12926;P26378-4;P26378-2;P26378-5;P26378;P26378-3;B1AM48Q15717;Q15717-2;M0QZR9EL V-like protein 1 EL VL1 20 20 326 1.019 1.0562 1.24E+10
A0A0A0MTH9;O14981;O14981-2A0A0A0MTH9;O14981TATA-binding protein-associated factor 172BTAF1 28 28 1849 1.0186 0.8773 1.93E+09
S4R3H4;E7EQT4;Q9UKV3-5;Q9UKV3;G3V3B0;Q9UKV3-3;Q9UKV3-2S4R3H4;E7EQT4;Q9UKV3-5;Q9UKV3;G3V3B0;Q9UKV3-3;Q9UKV3-2Apoptotic chromatin condensation inducer in the nucleusACIN1 2 2 1283 1.0186 1.2116 7.51E+07
Q58FF8 Q58FF8 Putative heat shock protein HSP 90-beta 2HSP90AB2P 13 2 381 1.0186 1.0807 4.39E+09
P84090;G3V279 P84090;G3V279 Enhancer of rudimentary homologERH 4 4 104 1.0185 1.2569 3.99E+08
A8MYT4;Q8NEB9;K7ENH3;K7EIV6;M0R308;K7EKH3A8MYT4;Q8NEB9 Phosphatidylinositol 3-kinase;Phosphatidylinositol 3-kinase catalytic subunit type 3PIK3C3 3 3 824 1.0183 NaN 8.41E+07
Q9Y383;A0A0A6YYC3;Q96HJ9-2;A0A0A6YYJ8;Q9Y383-3;Q9Y383-2;V9GZ75;F8WEU3;B8ZZ09;B8ZZ10;A8MYV2;Q9NQ29-2;Q9NQ29-3;Q9NQ29Q9Y383;A0A0A6YYC3;Q96HJ9-2;A0A0A6YYJ8;Q9Y383-3;Q9Y383-2Putative RNA-binding protein Luc -like 2LUC7L 6 6 92 1.0183 1.2141 2.52E+08
Q9Y3A4 Q9Y3A4 Ribosomal RNA-processing protein 7 homolog ARRP7A 2 2 280 1.0182 NaN 3.42E+07
P23246;P23246-2;H0Y9K7;C9JHW1;E7ESB6P23246;P23246-2 Splicing factor, proline- and glutamine-richSFPQ 21 18 707 1.018 1.224 5.86E+09
O00505;H0Y4S9 O00505 Importin subunit alpha-4KPNA3 14 10 521 1.0176 0.92458 1.28E+09
P11172;P11172-3;E9PFD2;P11172-2;P11172-4;F2Z3P2;F2Z303;F8WDG4P11172;P11172-3;E9PFD ;P11172-2;P11172-4Uridine 5-monophosphate synthase;Orotate phosphoribosyltransferase;Orotidine 5-phosphate decarboxylaseUMPS 22 22 480 1.0175 1.1428 3.36E+09
A0PJW6 A0PJW6 Transmembrane protein 223TMEM 23 2 2 202 1.0173 NaN 8.17E+07
Q9NXG2;H3BNW0 Q9NXG2 THUMP domain-containing protein 1THUMPD1 9 9 353 1.0173 0.84764 4.90E+08
Q8N163-2;Q8N163;G3V119;H0YB24;E5RFJ3;E5RHJ4;H0YC69;E5RGU7;H0YC58;A0A087X2B6;E5RHH8Q8N163-2;Q8N163;G3V119;H0YB24Cell cycle and apoptosis regulator protein 2CCAR2 23 23 923 1.0172 0.96063 2.95E+09
Q66K14-2;Q66K14;G3V133;E5RIN2Q66K14-2;Q66K14 TBC1 domain family member 9BTBC1D9B 10 10 1233 1.0169 0.69145 4.63E+08
Q8ND04;Q8ND04-2;Q8ND04-3;J3QRE1;J3KTD7Q8ND04;Q8ND04-2 Q8N 04-3Protein SMG8 SMG8 8 8 991 1.0167 0.69169 2.03E+08
P08559-3;P08559;P08559-2;P08559-4;Q5JPU3;Q5JPU0;Q5JPT9;Q5JPU1;P29803;Q5JPU23; ;P08559-2;P08559-4yruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrialPDHA1 22 22 359 1.0165 0.87667 9.99E+09
P40939;H0YFD6;P40939-2P40939 Trifunctional enzyme subunit alpha, mitochondrial;Long-chain enoyl-CoA hydratase;Long chain 3-hydroxyacyl-CoA dehydrogenaseHADHA 33 33 763 1.0163 0.97636 1.33E+10
A6PW57;Q99755-2;Q99755-4;Q99755-3;Q99755;A6PW58;A2A5X0;O14986-3;O14986;O14986-2;O60331-4;O60331;O60331-2;O60331-3A6PW 7;Q99755-2;Q99755-4;Q99755-3;Q99755Phosphatidylinositol 4-phosphate 5-kinase type-1 alphaPIP5K1A 5 4 550 1.0162 0.75435 5.71E+08
P52294;C9JYI4;C9J352;C9JWD9;F2Z3G4;C9J4U1P 294;C9JYI4 Importin subunit alpha-5;Importin subunit alpha-5, N-terminally processedKPNA1 13 6 538 1.0162 0.89304 1.83E+09
Q9Y4E6-2;Q9Y4E6;A2RRE0;K7EMB8Q9Y4E6-2;Q9Y4E6;A2RRE0WD repeat-containing protein 7WDR7 6 6 1457 1.0158 0.68778 2.04E+08
P40227;P40227-2 P40227;P40227-2 T-complex protein 1 subunit zetaCCT6A 34 29 531 1.0156 0.94945 3.78E+10
Q5T5C7;P49591 Q5T5C7;P49591 Serine--tRNA ligase, cytoplasmicSARS 12 12 536 1.0155 1.393 2.38E+09
P23381;P23381-2;G3V3H8;G3V3Y5;G3V277;G3V423;G3V5U1;G3V456;G3V3P2;G3V227;H0YJP3;G3V2Y7;G3V3X0;G3V5W1;G3V3S7;G3V2F2;G3V3R3;G3V4S4;G3V313;G3V339;G3V2C0;G3V4C7;G3V4N8P23 81;P23381-2 Tryptophan--tRNA ligase, cytoplasmic;T1-TrpRS;T2-TrpRSWARS 29 29 4 1 1.014 0.97123 1.33E+10
Q15120;Q15120-2 Q15120;Q15120-2 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialPDK3 4 4 406 1.0143 0.87137 1.65E+08
P51570;P51570-2;K7EII7;K7ERJ9;K7ERN9P51570;P51570-2 Galactokinase GALK1 22 22 392 1.014 0.77815 5.78E+09
Q9Y223;Q9Y223-2;Q9Y223-3;Q9Y223-5;Q9Y223-4;Q9Y223-2;Q9Y223- ;Q9Y223-5;Q9Y223-4Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase;UDP-N-acetylglucosamine 2-epimerase (hydrolyzing);N-acetylmannosamine kinaseGNE 12 12 722 1.0139 0.95608 1.37E+09
Q69YN4-3;Q69YN4;Q69YN4-2;Q69YN4-4;H0YBN5;H0YB683; ;Q69YN4-2;Q69YN4-4Protein virilizer homologKIAA1429 10 10 1797 1.0133 0.98004 3.98E+08
Q05048;A0A0A0MSZ9;A3KFI9Q05048;A0A0A0MSZ9Cleavage stimulation factor subunit 1CSTF1 14 14 431 1.0131 0.97137 1.13E+09
Q5SRQ6;P67870;Q5SRQ3;N0E472;A0A0G2JM12;N0E644;A0A0G2JM58Q5SRQ6;P67870;Q5SRQ3;N0E472;A0A0G2JM12Casein kinase II subunit betaCSNK2B;CSNK2B-LY6G5B-1181;CSNK2B-LY6G5B--9916 6 234 1.013 0.81289 3.88E+08
Q9UIG0-2;Q9UIG0 Q9UIG0-2;Q9UIG0 Tyrosine-protein kinase BAZ1BBAZ1B 17 17 1479 1.0129 0.93557 8.91E+08
O43318-2;O43318;Q9UG54;O43318-4;O43318-3O43318-2;O4 318;Q9UG54;O43318-4;O43318-3Mitogen-activated protein kinase kinase kinase 7MAP3K7;DKFZp586F0420 3 3 579 1.0117 0.93592 1.18E+08
E9PRF4;Q15047-3;Q15047;E9PQM8;E9PAP1;X6RHV1;B0QZE6;E9PS59;X6R732;Q15047-2E9PRF4;Q15047-3;Q15047;E9PQM8Histone-lysine N-methyltransferase SETDB1S TDB1 6 6 1259 1.0114 0.77783 2.02E+08
Q15048;E9PP40;E9PNL0;E9PRP5Q15 48;E9 P40 Leucine-rich repeat-containing protein 14LRRC14 6 6 493 1.0114 0.75814 2.43E+08
Q5JTZ9 Q5JTZ9 Alanine--tRNA ligase, mitochondrialAARS2 20 20 985 1.0112 0.78177 1.60E+09
Q9UI43;E9PGN6 Q9UI43;E9PGN6 Putative ribosomal RNA methyltransferase 2FTSJ2 2 2 246 1.0111 NaN 3.47E+06
H0Y4Z8;Q3YEC7;Q3YEC7-2;A0A0X1KG72;Q8WYT4;G3V154;F2Z2T0;Q3YEC7-3H0Y4Z8;Q3YEC7;Q3YEC7-2;A0A0X1KG72Rab-like protein 6 RABL6 3 3 730 1.011 0.94171 6.90E+07
O60563;O60563-2 O60563 Cyclin-T1 CCNT1 6 6 726 1.0108 0.76558 1.09E+08
P62380;Q7Z6T9;Q7Z6U0;Q7Z6U1;Q7Z6U2P 2380;Q7Z6T9;Q7Z6U0;Q7Z6U1;Q7Z6U2TATA box-binding protein-like protein 1TBPL1 3 3 186 1.0108 0.84778 2.59E+08
A0A087WV73;P46087;P46087-4;P46087-2;P46087-3;F5GWB7;F5H709;F5H5X6;F5GYR3;F5H359;F5H8G6A0A087WV73; ;P46087-4;P46087-2;P46087-3Probable 2 S rRNA (cytosine(4447)-C(5))-methyltransferaseNOP2 20 20 855 1.0104 1.0587 2.97E+09
H7C5A7;E9PJN0;O14734;H0Y698;Q9BR14;E9PMC4;E9PIS4;E9PRD4H C5A7;E9PJN0;O14734Acyl-coenzyme A thioesterase 8ACOT8 3 3 209 1.0104 0.86457 3.62E+08
P43490;A0A0C4DFS8;C9JG65;C9JF35P43490;A0A0C4DFS8Nicotinamide phosphoribosyltransferaseNAMPT 25 25 491 1.0104 0.90811 1.06E+10
I3L0N3;P46459;P46459-2;I3L2G1;I3L0L3;K7EQD6;I3L338;I3L4Q9I3L0N3 P46459;P46459-2Vesicle-fusing ATPaseNSF 36 36 739 1.0103 0.9249 4.94E+09
P48643;E7ENZ3;B7ZAR1;E9PCA1;P48643-2;D6RIZ7;H0Y914P48643;E7ENZ3;B7ZAR1;E9PCA1;P48643-2T-complex protein  subunit epsilonCCT5 42 42 541 1.0102 0.95101 2.32E+10
Q96CW5;Q96CW5-2;A0A087WWB5;A0A087WU06;Q96CW5-3;A0A0J9YX63;A0A0J9YX56;A0A087WZV5Q96CW5;Q96CW5-2Gamma-tubulin complex component 3TUBGCP3 13 13 907 1.0097 0.93126 8.80E+08
Q9Y2L5;J3QQJ5;Q9Y2L5-2;J3KSL8;J3QSA1;J3QR00;J3QQS5Q9Y2L5;J3QQJ5;Q9Y2L5-2;J3KSL8;J3QSA1Trafficking protein particle complex subunit 8TRAPPC8 27 27 1435 1.0097 0.88408 1.56E+09
P43034;I3L3N5;I3L495;P43034-2P43034 Platelet-activating factor acetylhydrolase IB subunit alphaPAFAH1B1 14 14 410 1.0096 1.0019 1.40E+09
Q9NSI2-2;Q9NSI2;C9JJU7Q9NSI2-2;Q9NSI2 Protein FAM207A FAM207A 3 3 215 1.0094 1.0807 2.06E+08
144
Q8N335;C9K0P5;C9JFA7;C9JM46;P21695-2;P21695Q8N335 Glycerol-3-phosphate dehydrogenase 1-like proteinGPD1L 4 4 351 1.009 1.2093 1.13E+08
Q6P4A7;Q6P4A7-2;Q6P4A7-3;B1AMV7;Q6P4A7-2 Sideroflexin-4 SFXN4 9 9 337 1.0089 0.68529 1.78E+09
Q99666;J3KQ37;O14715;F8W705;Q99666-2;H7BZ48Q99666;J3KQ37;O14715RANBP2-like and GRIP domain-containing protein 5/6;RANBP2-like and GRIP domain-containing protein 8RGPD5;RGPD8 21 4 1765 1.0081 0.7954 9.19E+07
Q9Y230;Q9Y230-2;M0R0Y3;X6R2L4;M0QXI6;M0R0Z0;M0QXZ7Q9Y230;Q9Y 30-2;M0R0Y3RuvB-like 2 RUVBL2 31 31 463 1.0081 0.9458 1.63E+10
Q8TDN6 Q8TDN6 Ribosome biogenesis protein BRX1 homologBRIX1 9 9 353 1.0076 1.0131 8.53E+08
E9PM35;P49407-2;P49407E9PM35;P49407-2;P49407Beta-arrestin-1 ARRB1 3 2 258 1.0075 0.89747 1.77E+08
O75643;O75643-2;B4E0P5O75643 U5 small nuclear ribonucleoprotein 200 kDa helicaseSNRNP200 91 91 2136 1.0075 1.0089 1.63E+10
O00178;F5H716 O00178 GTP-binding protein 1GTPBP1 3 3 669 1.0071 1.3951 4.78E+08
E7EN20;Q9UPN9;H0Y612;Q9UPN9-2E7EN 0;Q9UPN9;H0Y612;Q9UPN9-2E3 ubiquitin-protein ligase TRIM33TRIM33 8 8 1119 1.0069 0.93602 4.54E+08
Q9UJW0;Q9UJW0-3;Q9UJW0-2;E5RI97;E5RK21;E5RGG1;H9KVE0Q9UJW0;Q9UJW0-3;Q9UJW0-2Dynactin subunit 4 DCTN4 9 9 460 1.0069 0.7752 1.04E+09
P41252;A0A0A0MSX9;J3KR24;Q5TCD1;Q5TCC6;Q5TCC9P41252;A0A0A0MSX9;J3KR24Isoleucine--tRNA ligase, cytoplasmicIARS 69 69 1262 1.0066 1.0628 3.08E+10
O60832;O60832-2;C9IYT0;H7C0M1;H7C2Q9;H7BZF2;H7C2Q2O60832;O6 832-2;C9IYT0;H7C0M1H/ACA ribonucleoprotein complex subunit 4DKC1 16 16 514 1.0057 0.99192 1.52E+09
A1L0T0;E9PJS0;M0R026;M0R1B5;E9PL44;M0QZX5A1L0T0;E9PJS0;M0R026;M0R1B5;E9PL44Acetolactate synthase-like proteinILVBL 4 4 632 1.0053 1.0133 2.66E+08
Q9GZT9-2;Q9GZT9;Q9GZT9-32;Q9GZT9;Q9GZT9-3Egl nine homolog 1 EGLN1 3 3 404 1.0052 0.68971 1.01E+08
F8WA39;Q13613;H7BZJ1;H7C406;E9PPP8;Q8NEC6;Q13613-2;F8W764;F8W8S8;E9PIH9;H0YDX3F8WA39;Q13 13;H7BZJ1;H7C406;E9PPP8;Q NEC6;Q13613-2Myotubularin-related protein 1MTMR1 3 3 673 1.0051 0.73991 2.14E+08
K7ERG2;Q9NYR9-2;Q9NYR9;H7BXP1;Q9NYR9-3K7ERG2;Q9NYR9-2;Q9NYR9;H7BXP1;Q9NYR9-3NF-kappa-B inhibitor-interacting Ras-like protein 2NKI AS2 4 4 141 1.0051 0.65302 2.59E+08
H7BZ14;Q9H2H8;B8ZZ77;Q9H2H8-2;C9K058H7BZ14;Q9H2H8 B8ZZ77;Q9H2H8-2Peptidyl-prolyl cis-trans isomerase;Peptidyl-prolyl cis-trans isomerase-like 3PPIL3 3 3 180 1.005 NaN 3.15E+07
P50213;H0YL72;P50213-2;H0YMU3;H0YLI6;H0YKD0;H0YNF5;H0YM64P50213; 0YL72;P50213-2;H0YMU3;H0YLI6Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrialIDH3A 10 10 366 1.0046 1.0046 4.48E+09
P55039;A8MZF9;J3QKW7;J3KRL5;J3QR71;J3QRI9;J3QL90;J3QKV7;J3QQI1;J3QLF3P55039;A8MZF9 Developmentally-regulated GTP-binding protein 2DRG2 9 9 364 1.0044 1.2913 1.39E+09
Q01469 Q01469 Fatty acid-binding protein, epidermalFABP5 7 7 135 1.0041 0.89274 5.56E+08
O95486;O95486-2;H0Y9J6O95486 Protein transport protein Sec24ASEC24A 5 5 1093 1.004 0.97914 3.81E+08
P62249;M0R210;A0A087WZ27;M0R3H0;M0R1M5;Q6IPX4;M0QX76P62249;M0R210;A0A087WZ27 M0R3H0;M0R1M5;Q6IPX44 S ribosomal protein S16RPS16 20 20 146 1.0039 1.0185 1.61E+10
P35244;B5MC59 P35244;B5MC59 Replication protein A 14 kDa subunitRPA3 4 4 121 1.0038 1.1138 3.07E+08
Q9UJS0;Q9UJS0-2;R4GN64Q9UJS0;Q9UJS0-2 Calcium-binding mitochondrial carrier protein Aralar2SLC25A13 29 24 675 1.0034 0.9335 1.29E+10
Q9Y697-2;Q9Y697;Q9Y697-3;F2Z2E7;H7C0I5;H0YGN52;Q9Y697;Q9Y697-3;F2Z2E7Cysteine desulfurase, mitochondrialNFS1 4 4 397 1.003 0.97179 2.25E+08
Q9BS26 Q9BS26 Endoplasmic reticulum resident protein 44ERP44 4 4 406 1.0029 1.2658 4.40E+08
C9J9K3;A0A0C4DG17;P08865;F8WD59C9J9K3;A0A0C4 G17;P08865;F8WD5940S ribosomal protein SARPSA 13 13 264 1.0028 1.3343 3.71E+09
Q7Z4S6-6;Q7Z4S6-3;Q7Z4S6-5;Q7Z4S6-2;Q7Z4S6;Q7Z4S6-4;H0YHT2;H0YIM7;H0YIM6;H0YHG9;H0YI78;Q86VH2-3;Q86VH2-2;Q86VH2;O75037-3;O75037-4;O75037-2;O75037Q7Z4S6-6;Q7Z4S6-3;Q7Z4S6-5;Q7Z4S6-2;Q7Z4S6;Q7Z4S6-4Kinesin-like protein KIF21AKIF21 7 6 16 1 1. 019 0.90278 2.51E+08
Q9UHI6;E9PJ60;Q9UHI6-2Q9UHI6 Probable ATP-dependent RNA helicase DDX20DDX20 21 21 824 1.0019 0.78007 1.65E+09
P62888;E5RI99;A0A0C4DH44;A0A0B4J213;E5RJH3P62888;E5RI99;A0A0C4DH4460S ribosomal protein L30RPL30 8 8 115 1.0014 0.97971 3.01E+09
Q9UN37;I3L4J1 Q9UN37;I3L4J1 Vacuolar protein sorting-associated protein 4AVPS4A 10 7 437 1.0014 0.97401 1.61E+09
Q709C8-4;Q709C8-2;Q709C8-3;Q709C8Q709C8-4;Q709C8-2;Q709C8-3;Q709C8Vacuolar protein sorting-associated protein 13CVPS13C 10 10 3585 1.0003 1.3978 3.18E+08
P22307-4;P22307-7;P22307-8;P22307;H0YF61;H0YCB0;E9PLD1;P22307-2;P22307-3;H0YD06;P22307-5;P22307-6P22307-4;P22307- ;P22307-8;P22307;H0YF61;H0YCB0;E9PLD1;P22307-2 3Non-specific lipid-transfer proteinSCP2 4 4 466 1 0.99774 2.81E+08
Q969Z3;X1WI34;Q969Z3-2Q969Z3;X1WI34;Q969Z3-2Mitochondrial amidoxime reducing component 202-Mar 2 2 335 0.99982 1.2463 1.08E+08
P10586-2;P10586;H0Y380;H0Y4H1;H0Y7Z9;H0Y6Z7;Q3KPI9;F5GWR7;P23468-3;P23468-7;P23468-5;P23468-4;P23468-6;P23468-2;P23468;G8JL96;A0A0A0MR60;Q13332-7;Q13332-5;Q13332-6;Q13332-3;Q13332-4;Q13332-2;Q13332P105 6-2;P10586;H0Y380;H0Y4H1;H0Y7Z9;H0Y6Z7Receptor-type tyrosine-protein phosphatase FPTPRF 7 7 1 98 0.99981 1.0419 1.90E+08
H7C2Z6;H7BXD5;P28676H7C2Z6;H7BXD5;P28676Grancalcin GCA 2 2 146 0.99905 NaN 3.91E+07
P20618 P20618 Proteasome subunit beta type-1PSMB1 7 7 241 0.99868 0.7979 4.32E+08
O60256;O60256-3;O60256-4;O60256-2;E7EPA1;C9JJS3;C9K0K7;I3L0S1;C9JDU5;C9JDH0;E7EW35;I3L331;I3L164;I3L4G9;O60256-3;O60256-4;O60256-2;E7EPA1;C9JJS3;C9K0K7;I3L S1Phosphoribosyl pyrophosphate synthase-associated protein 2PRPSAP2 16 14 369 0.99842 0.94287 5.33E+09
Q14318;Q14318-2;U3KQ64;A0A0A0MTJ1;Q14318-3;M0R2K9;U3KQI1;M0R1Q0;M0R1S6;M0R2Q6Q14318;Q14318-2;U3KQ64;A0A0A0MTJ1;Q14318-3Peptidyl-prolyl cis-trans isomerase FKBP8F BP8 10 10 412 0.99841 1.1175 9.44E+08
P53004;C9J1E1 P53004 Biliverdin reductase ABLVRA 19 19 296 0.99833 0.8863 6.21E+09
F8W6I7;P09651-3;P09651-2;P09651;F8VZ49;Q32P51;F8VTQ5;F8W646;F8VYN5;H0YH80F8W6I7;P09651-3;P09651-2;P09651;F8VZ49;Q32P51;F8VTQ5Heterogeneous nuclear ribonucleoprotein A1;Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed;Heterogeneous nuclear ribonucleoprotein A1-like 2HNRNPA1;HNRNPA1L2 23 21 307 0.99828 0.97832 2.10E+10
Q5TA45-2;Q5TA45-3;Q5TA45;C9IYS7;A0A087WYI0;Q5TA45-4;Q5TA45-5;J3QRY6;C9J979;Q96HV7;E9PNS4;E9PMA2;A0A0D9SGA8;H0YE15;E9PJG0;E9PKA4;E9PNH9;E9PI75;E9PIG1;A0A087WXT8Q5TA45-2;Q5TA45-3;Q5TA45;C9IYS7;A0A087WYI0;Q5TA45-4;Q5TA45-5;J3QRY6Integrator complex subunit 11CPSF3L 8 8 499 0.99787 0.8 507 3.01E+08
J3KTL2;Q07955;Q07955-3;Q07955-2;J3QQV5;J3KSW7;J3KSR8J3KTL2; ;Q07955-3 Q07955-2Serine/arginine-rich splicing factor 1SRSF1 3 3 253 0.99776 0.70444 1.93E+08
H7BYN4;Q02241-3;Q02241-2;Q02241;H0YKQ5H7BYN4;Q02241-3;Q 2241-2;Q02241Kinesin-like protein KIF23KIF23 6 6 952 0.99774 0.91507 3.63E+08
Q9NYY8-2;Q9NYY8 Q9NYY8-2;Q9NYY8 FAST kinase domain-containing protein 2FASTKD2 9 9 648 0.99773 0.90773 5.52E+08
P23396;P23396-2;E9PL09;E9PPU1;F2Z2S8;H0YCJ7;E9PQ96;E9PJH4;E9PK82;H0YEU2;H0YF32;E9PSF4;E9PQX2;H0YES8P23396;P23396-2;E9PL09;E9PPU1;F2Z2S8;H0YCJ7;E9PQ96;E9PJH4;E9PK82;H0YEU240S ribosomal protein S3RPS3 28 27 243 0.99759 0.9414 5.37E+10
B7ZAX5;Q01415-2;Q01415;H0YLL3;H0YLL8;H0YK10B7ZAX ;Q 1415-2;Q01415N-acetylgalactosamine kinaseGALK2 3 3 434 0.99755 0.84758 1.88E+08
Q13451;Q13451-2 Q13451 Peptidyl-prolyl cis-trans isomerase FKBP5FKBP5 13 13 457 0.99742 1.0294 8.87E+08
P50750;P50750-2;X6RE90P50750;P50750-2 Cyclin-dependent kinase 9CDK9 10 9 372 0.99712 0.91682 7.55E+08
O00743;O00743-2;O00743-3;Q5T1S7;O00743-2;O00743-3Serine/threonine-protein phosphatase 6 catalytic subunit;Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processedPPP6C 10 10 305 0.99705 0.8484 1.29E+09
O60934;A0A0C4DG07;E5RGU1;E5RGR7;E2QRP0;A0A087X1V5O60934;A0A0C4DG07Nibrin NBN 5 5 754 0.99683 NaN 1.16E+08
K7EIG1;I3L4B5;I3L318;Q9Y5I4-2;Q9Y5I4K7EIG1 CLUH 41 0 1251 0.99676 0.94666 4.13E+09
Q6P3X3;F8WCH1 Q6P3X3 Tetratricopeptide repeat protein 27TTC27 8 8 843 0.99675 1.0491 3.91E+09
C9J2P0;P51965;H7C061;B7Z306;P51965-2;P51965-3;A0A087X283;R4GND1;Q96LR5;Q969T4;R4GN77;C9J1809J2P0;P51965;H7C061;B7Z306;P51965-2;P51965-3;A0A087X283;R4GND1;Q96LR5;Q969T4Ubiquitin-conjugating enzyme E2 E1;Ubiquitin-conjugating enzyme E2 E2;Ubiquitin-conjugating enzyme E2 E3UBE E1;UB E3; BE2E2 4 4 147 0.99654 0.87147 1.78E+08
Q06124-3;Q06124-2;Q06124Q06124-3;Q06124-2;Q06124Tyrosine-protein phosphatase non-receptor type 11PTPN11 2 2 460 0.99588 1.3704 2.43E+08
P12236;Q9H0C2 P12236 ADP/ATP translocase 3;ADP/ATP translocase 3, N-terminally processedSLC25A6 29 10 298 0.99535 1.0598 5.42E+10
Q9BR61 Q9BR61 Acyl-CoA-binding domain-containing protein 6ACBD6 2 2 282 0.99515 0.8308 1.03E+08
A0A0A0MRI2;Q9UNH7-2;Q9UNH7;G3V5X9A0A0A0MRI2;Q9UNH7-2;Q9UNH7;G3V5X9Sorting nexin-6;Sorting nexin-6, N-terminally processedSNX6 2 2 418 0.99513 0.98045 5.08E+07
P32121;P32121-3;P32121-4;P32121-5;P32121-2;Q68DZ5;K7ENA6;I3L412;I3L0V6;K7EL17;P32121-3;P32121-4;P32121- P32121-2;Q68DZ5;K7ENA6Beta-arrestin-2 ARRB2;DKFZp 6L0365 6 5 409 0.99497 0.64738 3.40E+08
O00186 O00186 Syntaxin-binding protein 3STXBP 10 10 592 0.99467 1.1538 8.44E+08
Q12800-2;Q12800-3;Q12800-4;Q12800;C9JWL3;F8VWL0;F8VX55;Q9NZI7-4;Q9NZI7Q12800-2;Q12800-3;Q12800-4;Q128 0;C9JWL3;F8VWL0;F8VX55;Q9NZI7-4;Q9NZI7Alpha-globin transcription factor CP2;Upstream-binding protein 1T P2;UBP1 2 2 450 0.9943 NaN 2.08E+08
Q9BQ52;G5E9D5;Q9BQ52-4;E7ES68;Q9BQ52-3;Q9BQ52-2;H7C2I4;V9GYS7;J3QRS2;V9GYU5;J3QL08;V9GZ72;J3QLK4Q9BQ52;G5 9D5; 9B 52-4;E7ES68;Q9BQ5 -3Zinc phosphodiesterase ELAC protein 2ELA 18 18 826 0.99374 0.88583 2.95E+09
Q96L91-4;Q96L91-3;Q96L91-5;Q96L91-2;Q96L91;A0A0A0MR80Q96L91-4;Q96L91-3;Q96L91-5;Q96L91-2;Q96L91E1A-binding protein p40EP 12 12 3042 0.9936 0.69373 1.88E+08
Q13257;Q13257-2 Q13257 Mitotic spindle assembly checkpoint protein MAD2AMAD2L1 7 7 205 0.99306 0.91024 1.37E+09
O95336;M0R261;M0R0U3;M0R1L2O95336; 0R261;M0R0U3;M0R1L26-phosphogluconolactonasePGLS 11 11 258 0.993 1.1103 4.13E+09
P55884;P55884-2;C9JZG1;C9JQN7P55884;P55884-2 Eukaryotic translation initiation factor 3 subunit BEIF3B 26 26 814 0.99284 1.0946 5.60E+09
Q7KZJ0;J3QKK3;O43502-2;O43502;J3QLB5;E9PI66Q7KZJ0;J3QKK3;O43502-2;O43502;J3QLB5;E9PI66DNA repair protein RAD51 homolog 3C 3 3 134 0.99213 0.8709 2.52E+08
Q96A65;Q96A65-2 Q96A65;Q96A65-2 Exocyst complex component 4EXOC4 15 15 974 0.99192 0.89359 8.76E+08
Q9GZS3;H0YL19;H0YN81;H0YMF9;H3BQA8;H0YLA1;H0YM76Q9GZS3;H0YL19;H0YN 1;H0YMF9;H3BQA8WD repeat-containing protein 61;WD repeat-containing protein 61, N-terminally processedWDR61 9 9 305 0.99191 1.0128 2.21E+09
O75792 O75792 Ribonuclease H2 subunit ARNASEH2A 9 9 299 0.99171 1.0039 1.19E+09
H7BXI1;A0FGR8-2;A0A087WXU3;A0FGR8;A0FGR8-6;A0FGR8-4;A0FGR8-5H7BXI1;A0FGR8-2;A0A087WXU3; ;A0FGR8-6;A0FGR8-4Extended synaptotagmin-2ESYT2 8 8 884 0.99131 0.85175 8.14E+08
Q9BZF1-3;Q9BZF1-2;Q9BZF1;F8VQX7;F8VUA7;F8VVD3;F8VVE7;F8VZ43;Q9H0X9-3;Q9H0X9-2;Q9H0X9Q9BZF1-3;Q9BZF1-2;Q9BZF1;F8VQX7;F8VUA7Oxysterol-binding protein-related protein 8;Oxysterol-binding proteinOSBPL8 9 847 0.99123 1.0327 3.21E+08
Q9BQS8;Q9BQS8-4;C9J2W6;H7BZ74;Q9BQS8-3;Q9BQS8-2Q BQS8;Q9 QS8-4;C9J2W6 H7 Z74;Q9BQS8-3;Q9BQS8-2FYVE and coiled-coil domain-containing protein 1FYCO1 2 2 1478 0.99115 0.92963 8.66E+07
O00442;O00442-2;A6NIC1O00442;O00442-2 RNA 3-terminal phosphate cyclaseRTCA 12 12 366 0.99081 0.91046 2.97E+09
P28288;P28288-2;P28288-3;P28288-2 ATP-binding cassette sub-family D member 3ABCD3 24 24 659 0.99038 0.91234 4.20E+09
I3L0E3;Q9Y2R5;E9PE17I3L0E3;Q9Y2R5;E9PE1728S ribosomal protein S17, mitochondrialMRPS17 5 5 225 0.99026 0.93315 6.13E+08
P06400 P06400 Retinoblastoma-associated proteinRB1 7 7 928 0.99 0.8447 7.50E+08
Q86UA1;Q86UA1-2Q86UA1;Q86UA1-2Pre-mRNA-processing factor 39PRPF39 4 4 669 0.98968 1.1999 2.85E+08
F8VYY9;P54619-2;P54619;P54619-3;H0YIC9;H0YHF8;F8VZX1;F8VPF5;F8VVA3;F8VSL2;E9PGP6;Q9UGJ0-2;Q9UGJ0-3;Q9UGJ0F8VYY ; 2;P54619;P54619-3;H0YIC9;H0YH ;F8VZX15-AMP-activated protein kinase subunit gamma-1PRKAG1 8 8 280 0.98863 1.3388 5.37E+08
Q15650;H0YL91 Q15650 Activating signal cointegrator 1TRIP4 3 3 581 0.98843 NaN 3.72E+07
Q9H2C0 Q9H2C0 Gigaxonin GAN 4 4 597 0.98833 0.95615 2.35E+08
P19623;K7ESL0;K7EQ47;K7EL89;K7EKM4P19623 Spermidine synthaseSRM 17 17 302 0.98818 1.1397 6.90E+09
P14923;C9JTX4;C9J826;C9JK18;C9JKY1P14923;C9JTX4;C9J826;C9JK18;C9JKY1unction plakoglobinJUP 7 5 745 0.98812 1.1524 4.63E+08
P63167;F8VXL2;F8VRV5;F8VXI7P63167;F8VXL2;F8VRV5Dynein light chain 1, cytoplasmicDYNLL1 5 4 89 0.98761 0.85249 1.52E+08
Q7Z3B4-2;Q7Z3B4-3;Q7Z3B4Q7Z3B4-2;Q7Z3B4-3;Q7Z3B4Nucleoporin p54 NUP54 2 2 291 0.98761 1.2388 1.94E+08
A0A0G2JNZ2;A0A0G2JPP5;Q14160;Q14160-3;A0A0G2JMS7;Q14160-2;H0YDF9;Q5T0G3;H0YCG0;Q9BTT6-2A0A0G2JNZ2;A A0G2JPP5;Q14160;Q14160-3;A A0G2JMS7 14160-2Protein scribble homologCRIB 7 6 1630 0.98726 0.79768 4.88E+08
A0A0A0MRM8;Q9UM54-6;A0A0D9SGC1;E7EW20;Q9UM54-5;Q9UM54-2;Q9UM54-4;Q9UM54-1;Q9UM54;Q5JVM0A0A0A0MRM8;Q9UM54-6;A0A0D9SGC1;E7EW20;Q9UM54-5;Q9UM54-2;Q9UM54-4;Q9UM54-1;Q9UM54Unconventional myosin-VIMYO6 35 35 1253 0.98721 0.96832 2.15E+09
Q14677;Q14677-3;Q14677-2;Q14677-3;Q14677-2Clathrin interactor 1CLINT1 5 5 625 0.98668 1.1289 2.58E+08
Q86TP1;Q86TP1-2;Q5SZG1;Q86TP1-5;Q86TP1-4;Q86TP1-3;Q5SZF2;Q86TP1-6;Q86TP1-786TP ; 2 Protein prune homologPRUNE 7 7 453 0.98625 1.0063 4.84E+08
B4DJ81;P28331-3;P28331-4;P28331-5;P28331;P28331-2B4DJ8 ;P28331-3;P28331-4; 5;P28331;P28331-2NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrialNDUFS1 7 7 611 0.98602 1.2 9.67E+08
Q15118;C9JKT3;Q15118-2;C9IYB4;F8WC75;F8WEJ6Q 5118;C9JKT3;Q15118-2;C9IYB4[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialPDK1 4 4 436 0.98556 1.0175 1.86E+08
P78345;Q5VUC9;Q5VUC3P78345 Ribonuclease P protein subunit p38RPP38 3 3 283 0.98554 0.93616 1.23E+08
Q5JRX3;Q5JRX3-2;Q5JRX3-3;A0A0A0MRX9;H0Y7L7;B1APQ0;H0Y4F7;B1APQ1Q5JRX3;Q5JRX3-2;Q5JRX3-3;A0A0A0MRX9Presequence protease, mitochondrialPITRM1 34 34 1037 0.9852 0.88856 4.57E+09
145
Q66K74-2;Q66K74;M0QXQ9;M0QY41;M0QZ50;M0R1M7;M0R1J2Q66K74-2;Q66K74 icrotubule-associated protein 1S;MAP1S heavy chain;MAP1S light chainAP1S 8 8 1033 0.98504 0.82961 6.20E+08
Q9Y2S0;A0A0R4J2F3;Q7Z776;A0A087X0U2;Q9Y2S0-2Q9Y2S0;A0 R4J2F3DNA-directed RNA polymerases I and III subunit RPAC2POLR1D 6 6 133 0.98477 0.95432 3.00E+08
P48651-3;P48651-2;P48651P48651-3;P48651-2;P48651Phosphatidylserine synthase 1PTDSS1 2 2 301 0.98459 0.92205 4.81E+08
O43684-2;O43684;J3QT28;J3QSX4O43684-2;O43684;J3QT28Mitotic checkpoint protein BUB3BUB3 15 15 326 0.98307 0.97419 4.76E+09
Q5H928;Q99714-2;Q997145H928;Q99714-2;Q997143-hydroxyacyl-CoA dehydrogenase type-2HSD17B10 2 2 169 0.98273 NaN 6.24E+07
Q15477;H7C5N0;H7C4L3;B4E0B4;F8WDE8Q15477 Helicase SKI2W SKIV2L 28 28 1246 0.98268 1.0099 1.44E+09
Q8N684-2;Q8N684;Q8N684-3;F5H669;J3QT54;F5H6M0;F5H047;C9J286;C9J323;C9JM38;F5H5B7;F5H1W4;F5H2K8;F5H6P5;F5H6A8;F5GXA3Q8N684-2;Q8N 84;Q8N684-3;F5H669;J3QT54;F5H6M0;F5H047Cleavage and polyadenylation specificity factor subunit 7CPSF7 8 8 462 0.98261 1.2119 1.03E+09
P55735;A0A0C4DFR6;P55735-2;P55735-3;A8MXL6;E7ERC8P55735;A0A0C4DFR6;P55735-2;P55735-3;A8MXL6Protein SEC13 homologSEC13 8 8 322 0.98256 1.181 2.78E+09
P42677;Q5T4L4;C9J1C5P42677;Q5T4L4 40S ribosomal protein S27RPS27 7 3 84 0.98173 0.84438 3.21E+09
P55010;H0YK29;H0YK11;H0YMJ8;H0YM54;H0YLZ1;H0YN40P55010 Eukaryotic translation initiation factor 5EIF5 5 5 431 0.98173 1.1018 3.23E+08
O60341;O60341-2;R4GMP9;R4GMQ1O60341;O60341-2;R4GMP9Lysine-specific histone demethylase 1AKDM1A 10 10 852 0.98165 1.2354 8.00E+08
Q9UBB9;F6SQZ1;F6XM96;F6UKU9;H0Y4U8;Q9UBB9-2Q9UBB9 Tuftelin-interacting protein 11TFIP11 7 7 837 0.98097 0.73338 2.08E+08
Q6P1L8 Q6P1L8 39S ribosomal protein L14, mitochondrialMRPL14 4 4 145 0.98048 1.0951 1.54E+08
Q5JVF3-3;Q5JVF3;Q5JVF3-2;Q5JVF3-4Q5JVF3-3;Q5JVF3;Q5JVF3-2;Q5JVF3-4PCI domain-containing protein 2PCID2 13 13 376 0.98016 0.80238 5.94E+08
Q8TB36-2;Q8TB36 Q8TB36-2;Q8TB36 Ganglioside-induced differentiation-associated protein 1GDAP1 3 3 290 0.98003 0.78235 7.41E+07
Q9UKF6;G5E9W3;C9JZH6Q9UKF6;G5E9W3 Cleavage and polyadenylation specificity factor subunit 3CPSF3 13 13 684 0.9798 0.94824 1.45E+09
M0R0N4;M0QYZ2;P53680;X6R390;P53680-2;M0QZ21;M0R1S0M0R0N4;M0QYZ2;P53680;X6R390;P53680-2;M0QZ21AP-2 complex subunit sigmaAP2S1 6 6 144 0.97937 0.86883 2.38E+08
Q9Y2H6-2;Q9Y2H6;H7C507;G5E9X3Q9Y2H6-2;Q9Y2H6;H7C507Fibronectin type-III domain-containing protein 3AFNDC3A 3 3 1142 0.97917 1.8365 1.17E+08
Q96HS1;Q96HS1-2;F5GXG4Q96HS1;Q96HS1-2 Serine/threonine-protein phosphatase PGAM5, mitochondrialPGAM5 16 16 289 0.97899 0.90897 1.26E+09
Q06203;D6RE15;D6RCC8Q06203 AmidophosphoribosyltransferasePPAT 3 3 517 0.97852 1.7085 2.63E+08
O60502-4;O60502;O60502-2;O60502-3;H7C3X04; ;O60502-2;O60502-3Bifunctional protein NCOAT;Protein O-GlcNAcase;Histone acetyltransferaseMGEA5 14 14 863 0.97815 0.87325 1.39E+09
Q6P1X5;H0YB55 Q6P1X5;H0YB55 Transcription initiation factor TFIID subunit 2TAF2 2 2 1199 0.97802 1.049 7.97E+07
H3BSB3;H3BNT4;Q99547H3BSB3;H3BNT4;Q99547M-phase phosphoprotein 6MPHOSPH6 5 5 131 0.97759 0.63123 8.51E+07
P05141 P05141 ADP/ATP translocase 2;ADP/ATP translocase 2, N-terminally processedSLC25A5 28 12 298 0.97754 1.0827 2.77E+10
Q86UT6-2;Q86UT6;C9JLK8;C9JQE9;C9J0R6Q86UT6-2;Q86UT6 NLR family member X1NLRX1 7 7 921 0.97751 0.92085 2.30E+08
O60826 O60826 Coiled-coil domain-containing protein 22CCDC22 6 6 627 0.97722 1.0865 1.14E+08
P61201;P61201-2;B4DIH5;H0YKU5;H0YM03;H0YMC2P61201;P61201-2;B4DIH5;H0YKU5COP9 signalosome complex subunit 2COPS2 12 12 443 0.97711 1.2559 1.65E+09
Q7Z4Q2;Q7Z4Q2-2;Q7Z4Q2-3;Q7Z4Q2-2 HEAT repeat-containing protein 3HEATR3 10 10 680 0.97693 0.89338 7.76E+08
Q8WVM8;Q8WVM8-2;Q8WVM8-3;J3KNG4;G3V2M8;G3V4I1;G3V363;H0YJS6;G3V5F3;G3V3K9;G3V5E2;H0YJY1Q8WVM8;Q WVM8-2;Q8WV 8-3Sec1 family domain-containing protein 1SCFD1 17 17 642 0.97668 1.0045 2.08E+09
K7EMQ8;J3QKS7;B4DGM3;Q969G3-6;Q969G3-5;Q969G3-3;Q969G3-2;Q969G3-4;Q969G3;H7C048K7E Q8;J3QKS7;B4DGM3;Q96 G3-6;Q96 G3-5;Q96 G3-3;Q96 G3-2;Q969G3-4;Q969G3;H7C048SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1SMARCE1 3 3 177 0.97546 1.0537 1.09E+08
O15269;O15269-2 O15269 Serine palmitoyltransferase 1SPTLC1 7 7 473 0.97523 0.94955 1.45E+09
B1AHD1;P55769 B1AHD1;P55769 NHP2-like protein 1;NHP2-like protein 1, N-terminally processedNHP2L1 4 4 132 0.9752 1.0214 1.10E+08
A0A087WTP3;Q92945;M0R0I5;M0R3J3;M0QYH3A0A087WTP3;Q92945;M0R0I5Far upstream element-binding protein 2KHSRP 6 4 711 0.97494 1.0461 2.63E+08
Q92696;H0YLH3;H0YKZ8;H0YMG5;H0YLG7;H0YKP6Q92696;H0YLH3;H0YKZ8;H0YMG5;H0YLG7Geranylgeranyl transferase type-2 subunit alphaRABGGTA 4 4 567 0.97456 1.1773 6.32E+08
P50991;P50991-2 P50991;P50991-2 T-complex protein 1 subunit deltaCCT4 36 36 539 0.97454 0.95324 5.48E+10
P35606-2;P35606;D6RBT6;D6R997;D6RBZ7;D6RCL6;D6RBG7;H0Y938;H0YAC7P3560 -2;P35606 Coatomer subunit betaCOPB2 33 33 877 0.97441 1.0503 5.77E+09
Q14571 Q14571 Inositol 1,4,5-trisphosphate receptor type 2ITPR2 10 7 2701 0.97404 1.0766 1.70E+08
P19784;H3BSA1;H3BV19;H3BNI9P19784;H3BSA1;H3BV19Casein kinase II subunit alphaCSNK2A2 7 7 350 0.97268 0.94895 4.10E+08
O94925-3;B8ZZA8;O94925-2;B8ZZC5;H7BZD194925-3 Glutaminase kidney isoform, mitochondrialGLS 13 2 598 0.97252 1.1738 1.91E+09
O15160;O15160-2;E7EQB9;D6RDJ3;H0Y723O15160;O15160-2;E7EQB9DNA-directed RNA polymerases I and III subunit RPAC1POLR1C 13 13 346 0.9723 0.98886 3.07E+09
P27348;E9PG15 P27348 14-3-3 protein thetaYWHAQ 8 3 245 0.97214 1.0989 2.49E+08
Q9Y333 Q9Y333 U6 snRNA-associated Sm-like protein LSm2LSM2 1 1 95 0.97145 1.2419 7.48E+07
H0YDU8;P53041;A8MU39;M0R196;A0A087WY80;E7EU14H0YDU8;P53041;A8MU39Serine/threonine-protein phosphatase;Serine/threonine-protein phosphatase 5PPP5C 4 4 485 0.97134 1.3127 9.83E+07
P13010;C9JZ81;H7C0H9P13010 X-ray repair cross-complementing protein 5XRCC5 46 46 732 0.97069 1.1983 3.12E+10
Q9HC21-2;Q9HC21;J3KRY6;J3KSI7;J3QL84;J3KS44;J3QLV3;J3KSB1Q9HC21-2;Q9HC21;J3KRY6;J3KSI7;J3QL84;J3KS44;J3QLV3Mitochondrial thiamine pyrophosphate carrierSLC25A 9 6 6 263 0.97038 1.081 4.03E+08
Q2TAM5;E9PKH5;A0A087X0W8;Q04206-2;Q04206-3;Q04206;Q04206-4;E9PI38;E9PQS6;E9PKV4;A0A087WVP0;E9PJR1;E9PRX2;E9PNV4;E9PMD5;E9PJZ9;E9PM47;E9PNK5;E9PN69Q2TAM5;E9PKH5;A0A087X0W8;Q04206-2; 3;Q04206;Q04206-4;E9PI38;E9PQS6;E9PKV4;A0A087WVP0Transcription factor p65RELA 7 7 377 0.97002 0.86696 3.97E+08
Q8N8A6 Q8N8A6 ATP-dependent RNA helicase DDX51DDX51 5 5 666 0.96997 0.81866 3.29E+08
Q8WUK0;Q8WUK0-2;E9PQM0;Q8WUK0-3Q8WUK0;Q8WUK0-2Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1PTPMT1 6 6 201 0.9699 0.81699 4.88E+08
P13639 P13639 Elongation factor 2 EEF2 56 55 858 0.96989 1.1564 2.99E+10
Q99832;Q99832-3;Q99832-4;Q99832-2;F8WAM2;F8WBP8;A0A0D9SG95;Q99832-3;Q99832-4;Q99832-2T-complex protein 1 subunit etaCCT7 41 41 543 0.96942 0.99349 2.86E+10
Q16555-2;Q16555;E5RFU4Q16555-2;Q16555 Dihydropyrimidinase-related protein 2DPYSL2 6 4 536 0.96921 1.2868 4.50E+08
Q8N6R0-3;Q8N6R0;Q8N6R0-4;Q8N6R0-1;Q8N6R0-2Q8N6R0-3;Q8N6R0;Q8N6R0-4;Q8N6R0-1Methyltransferase-like protein 13METTL13 13 13 613 0.96898 0.99868 6.58E+08
P22033 P22033 Methylmalonyl-CoA mutase, mitochondrialMUT 6 6 750 0.96872 0.73904 2.10E+08
P31146;H3BTU6;H3BRJ0;H3BRY3P31146;H3BTU6;H3BRJ0;H3BRY3Coronin-1A;CoroninCORO1A 2 2 461 0.96865 1.0326 7.01E+07
O75489;E9PS48;O75489-2;E9PKL8;G3V194O75489 NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrialNDUFS3 12 12 264 0.96856 1.2545 1.68E+09
F5H365;Q15436;Q15436-2;G3V5X8;G3V4Q2;G3V4V1;G3V1W4;G3V3G5;G3V2R6;G3V5K1F H365;Q15436;Q15 36-2Protein transport protein Sec23ASEC23A 14 12 736 0.96847 1.0368 1.98E+09
P15927;P15927-2;P15927-3;Q5TEJ7;Q5TEJ0;P15927-2;P15927-3;Q5TEJ7Replication protein A 32 kDa subunitRPA2 8 8 270 0.96833 0.94141 1.57E+09
P41240;H3BUM9;H3BN15;H3BU69;K7ENL8;K7ES68;K7EQY5;A0A087WUR1;P42679-3;P42679;P42679-2P41240 Tyrosine-protein kinase CSKCSK 14 14 450 0.96819 1.1839 1.77E+09
A0A0B4J1S8;Q9UBF8-2;Q9UBF8;Q9UBF8-3;E9PL47;F8W860;H0YCW3;A0A0A0MSL0A0A0B4J1S ; 2;Q UBF8;Q9UBF8-3;E9PL47;F8W860Phosphatidylinositol 4-kinase betaPI KB 6 6 828 0.96802 1.0019 2.57E+08
Q13085;Q13085-4;Q13085-3;Q13085-2;Q59FY4;O00763-3;O00763-2;O00763;A0A0C4DGT1;A0A087X2F8;A0A087X0W4;A0A087X126;S4R3S7;F8W8T8;H0YGH5;A0A087WVR6;A0A087WYK6;Q13085-4;Q13085-3;Q13085 2;Q59FY4Acetyl-CoA carboxylase 1;Biotin carboxylaseACACA 48 48 2346 0.967 8 1.1415 3.69E+09
P49189;P49189-2 P49189;P49189-2 4-trimethylaminobutyraldehyde dehydrogenaseALDH9A1 19 19 494 0.96774 1.0497 7.56E+09
D6RAN4;P32969;E7ESE0;H0Y9V9;H0Y9R4D6RAN4;P32969;E7ESE0;H0Y9V960S ribosomal protein L9RPL9 11 11 182 0.9677 1.159 6.66E+09
Q86U42-2;Q86U42;H0YJH9;B4DEH8;G3V4T2;Q92843-2Q86U42-2;Q86U42;H0YJH9;B4DEH8;G3V4T2;Q92843-2Polyadenylate-binding protein 2PABPN1 2 2 296 0.96689 1.139 3.91E+08
Q1KMD3;H3BQZ7 Q1KMD3;H3BQZ7 Heterogeneous nuclear ribonucleoprotein U-like protein 2HNRNPUL2;HNRNPUL2-BSCL2 7 7 747 0.96673 0.92057 4.24E+08
A0A0U1RQC9;P04637-4;P04637;A0A087WZU8;J3KP33;P04637-5;P04637-6;P04637-2;P04637-3;A0A087X1Q1;P04637-7;A0A087WXZ1;A0A087WT22;E7ESS1;E7EQX7;P04637-8;P04637-9;E9PFT5;E7EMR6;E9PCY9;S4R334A0A0U1RQC9;P 463 -4;P04637;A0A087WZU8;J3KP 3;P04637-5;P04637-6;P04637-2;P04637-3;A0A087X1Q1;P04637-7;A0A087WXZ1;A0A087WT22;E7ESS1;E7EQX ;P04637-8;P04637-9Cellular tumor antigen p53TP5 15 15 41 0.96636 0.93811 1.52E+09
P05388;F8VWS0;P05388-2;F8VU65;F8VW21;F8VPE8;G3V210;F8VQY6;F8VRK7;F8VZS0;Q8NHW5;F8VWV4;F8VS58;F8W1K8P05388; WS0;P05388-2;F8VU65;F8VW21;F8VPE8;G3V210;F8VQY6;F8VRK7;F8VZS0 Q8NHW5;F8VWV460S acidic ribosomal protein P0;60S acidic ribosomal protein P0-likeRPLP0;RPL 0P6 21 21 317 0.96594 1.015 4.53E+10
Q9UN86-2;Q9UN86;D6RAC7;D6RB17;D6RGJ4;D6RBM9;D6REX8;D6RBR0;D6RE13;D6RBW8;D6R9X5;D6R9A4Q9UN86-2;Q9UN86;D6RAC7;D6RB17;D6RGJ4Ras TPase-activating protein-binding protein 2G3BP2 9 8 449 0.96577 1.0181 1.44E+09
Q9NVH2-3;Q9NVH2;Q9NVH2-2;Q9NVH2-4;A0A087WXK3Q9NVH2-3;Q9NVH2;Q9NVH2-2;Q9NVH2-4Integrator complex subunit 7INTS7 16 16 942 0.96554 0.84227 7.02E+08
P09110;H7C131;C9JDE9;P09110-2;B4DVF4;F2Z2Q6;F2Z3P7;H0Y4D4P09110;H7C131;C9JDE9;P09110-23-ketoacyl-CoA thiolase, peroxisomalACAA1 5 5 424 0.96541 1.0097 5.69E+08
Q12797-10;Q12797;E5RHK2;A0A087WW51Q12797-10;Q12797Aspartyl/asparaginyl beta-hydroxylaseASPH 5 5 729 0.96498 0.72386 5.56E+08
H0Y7A7;P62158;E7ETZ0;E7EMB3;F8WBR5;M0QZ52;G3V479;G3V361;Q96HY3;G3V226;C9J7T9;P27482;P02585H0Y7A ;P6215 ;E7ETZ0;E7EMB3;F8WBR5;M0QZ52;G3V479;G3V361;Q96HY3Calmodulin CAL 2;CALM1;CALM3 6 6 187 0.9648 0.66445 3.88E+08
Q3MHD2;Q3MHD2-2;K7ELG9Q3MHD2;Q3MHD2-2;K7ELG9Protein LSM12 homologLSM12 8 8 195 0.96477 0.84531 1.75E+09
E9PIR7;F8W809;A0A087WSW9;A0A087WSY9;Q16881-5;Q16881-2;Q16881-4;Q16881-3;Q16881-6;Q16881;E9PKD3;E2QRB9;Q16881-7;E9PQI3;E9PLT3;E9PKI4;A0A0B4J225;E9PIZ5E9PIR7;F8W809;A0A087WSW9;A0A087WSY9;Q16881-5;Q16881-2;Q16881-4;Q16881-3;Q16881-6; 16881;E9PKD3 2QRB9;Q16881-7Thioredoxin reductase 1, cytoplasmicGML;TXNRD1 5 5 4 2 0.9643 1.4904 4.80E+08
O94973;O94973-2;A0A0G2JS82;O94973-3;A0A0G2JQM1;E9PR62;A0A0G2JRF9;A0A0G2JQA4;A0A0G2JQT9;H0YEG0;A0A0G2JS17;H0YDE9;E9PQP4;E9PPY8;A0A0G2JRS3;M0R2D9;E9PPZ3;E9PS94;E9PNC4O94973;O94973-2;A0A0G2JS8 ;O94973-3;A0A0G2JQM1P 2 complex subunit alpha-2AP2A2 27 18 939 0.96407 0.883 3.17E+09
O95831-3;O95831;O95831-2;E9PMA0;O95831-5;O95831-6;O95831-43;O 5831; 95831-2;E9PMA0Apoptosis-inducing factor 1, mitochondrialAIFM1 27 27 609 0.96362 1.0244 7.17E+09
H7C0Q6;Q9C037-3;Q9C037-2;Q9C037H7C0Q6;Q9C037-3;Q9C037-2;Q9C037Tripartite motif-containing protein 4TRIM4 2 2 202 0.96341 2.0449 3.08E+09
P33176 P33176 Kinesin-1 heavy chainKIF5B 33 24 963 0.96309 0.92068 2.56E+09
Q9Y3B2;R4GMQ7;B1AMU4;R4GNH9;B1AMU7;B1AMU3Q9Y3B2; MQ7;B1A U4;R4GNH9;B1AMU7;B1AMU3Exosome complex component CSL4EXOSC1 8 8 195 0.96262 0.88967 4.10E+08
O95340;O95340-2 O95340;O95340-2 Bifunctional 3-phosphoadenosine 5-phosphosulfate synthase 2;Sulfate adenylyltransferase;Adenylyl-sulfate kinasePAPSS2 6 6 614 0.96249 0.88553 2.83E+08
Q9H0C8;F8SNU7;H7C2I8;E9PC05;F8SNU6Q9H0C8;F8SNU7;H7C2I8Integrin-linked kinase-associated serine/threonine phosphatase 2CILKAP;ILKAP3 15 15 392 0.96239 0.87566 1.26E+09
B4DTS2;Q9BZL6;Q9BZL6-2;M0QXC6;M0R2Z84DTS2;Q9BZL6;Q9BZL6-2Serine/threonine-protein kinase D;Serine/threonine-protein kinase D2PRKD2 4 4 888 0.96176 0.91441 2.99E+08
G3V5T9;P24941-2;P24941;E7ESI2;Q00526;K7EJ83G3V5T9;P24941-2;P24941;E7ESI2Cyclin-dependent kinase 2CDK2 7 5 346 0.9614 0.91718 1.11E+09
O15143;C9JBJ7;C9K057;C9J4Z7;F8VXW2;C9JEY1;C9JQM8;C9JFG9;C9J6C8;C9JTT6O15143 Actin-related protein 2/3 complex subunit 1BARPC1B 5 5 372 0.96138 1.2518 4.22E+08
A0A024RA52;P25787;C9JCK5;H3BT36A0A024RA52;P25787;C9JCK5Proteasome subunit alpha type;Proteasome subunit alpha type-2PSMA2 6 6 234 0.96129 0.94866 3.86E+08
U3KQC1;A0A0A0MQU0;Q9BV38;K7EIR0;K7EML4;A0A087X237;K7EKX5U3K C1;A0A0A0MQU0;Q9BV38;K7EIR0WD repeat-containing protein 18WDR18 10 10 394 0.96113 1.0311 6.50E+08
Q5TH30;Q9UGV2-2;Q9UGV2;Q9UGV2-3;Q5TH29;F8WBF9Q5TH30;Q9UGV2-2;Q9UGV2;Q9UGV2-3Protein NDRG3 NDRG3 3 3 388 0.96084 1.2525 2.80E+08
Q9UKX7-2;Q9UKX7;B0QY21Q9UKX7-2;Q9UKX7;B0QY21Nuclear pore complex protein Nup50NUP50 3 3 440 0.96071 0.74677 1.16E+08
P22059;H0YCV6 P22059;H0YCV6 Oxysterol-binding protein 1OSBP 2 2 807 0.95992 NaN 1.19E+08
O43491;E9PHY5;O43491-4;E9PK52;O43491-3;E9PII3;O43491-2;I6L9B1;H0Y5B0;Q6R5J7;E9PMV8;E9PQD2;Q6ZSX4;E9PJP4;E9PQN0;E9PRG1;E9PIG0;E9PPC9;E9PMG5;E9PN54O43491; HY5; 4; K52;O43491-3;E9PII3;O43491-2;I6L9B1Band 4.1-like protein 2EPB41L2 30 30 1 05 0.95 69 0.93819 3.26E+09
A0A0X1KG71;Q8WX92A0A0X1KG71;Q8WX92Negative elongation factor BNELFB 7 7 628 0.95944 1.1159 4.76E+08
Q9UNS2;Q9UNS2-2;H7C3P9;J3QL22;J3QS85;J3KTQ1;J3QKR0;C9JLV5Q9UNS2;Q9UNS2-2;H7C3P9COP9 signalosome complex subunit 3COPS3 4 4 423 0.95867 1.2745 1.49E+08
H0YH69;Q9HBU6;H0YFP7;Q9HBU6-2H0YH69;Q9HBU6;H0YFP7;Q9HBU6-2Ethanolamine kinase 1ETNK1 2 2 425 0.95859 0.79258 5.50E+07
O14874-2;O14874-3;O14874;H3BNP3;H3BUV3;H3BTL2;H3BS02O14874-2;O14874-3;O14874;H3BNP3;H3BUV3;H3BTL2;H3BS02[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrialBCKDK 2 2 335 0.95816 0.76157 2.24E+08
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A3KFL1;A3KFL5;A3KFL2;Q13868-3;Q13868-2;Q13868A3KFL1;A3KFL5;A3KFL2;Q13868-3;Q13868-2;Q13868Exosome complex component RRP4EXOSC2 2 2 200 0.95691 1.1498 1.22E+08
Q13546;Q13546-2 Q13546;Q13546-2 Receptor-interacting serine/threonine-protein kinase 1RIPK1 7 7 671 0.95677 1.2647 1.77E+08
Q15042;Q15042-3;Q15042-4;Q15042-3;Q15042-4Rab3 GTPase-activating protein catalytic subunitRAB3GAP1 16 16 981 0.95642 1.0709 7.64E+08
C9J0I9;Q86WB0;Q86WB0-3;Q86WB0-2;F8WAU5C9J0I9;Q86WB0;Q86WB0-3;Q86WB0-2Nuclear-interacting partner of ALKZC3HC1 3 3 459 0.9559 0.99262 4.40E+08
O15357;O15357-2;F5GY16;H7BXR2;A0A0A0MTP6O15357;O15357-2 Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2INPPL1 3 3 1258 0.95556 0.76967 1.40E+08
Q9Y678;H0Y8X7;D6RG17Q9Y678 Coatomer subunit gamma-1COPG1 40 36 874 0.955 0.91432 9.12E+09
Q9UID3-2;Q9UID3;E9PJ36;E9PMB6;H0YEE1;E9PRV0;E9PKX7;H0YDX9;H0YCB7Q9UID3-2;Q9UID3 Vacuolar protein sorting-associated protein 51 homologVPS51 7 7 658 0.95494 0.88483 3.90E+08
Q9H7B2;Q5VXN0 Q9H7B2;Q5VXN0 Ribosome production factor 2 homologRPF2 4 4 306 0.95436 1.1682 2.11E+08
B4DGU4;P35222 B4DGU4;P35222 Catenin beta-1 CTNNB1 6 4 774 0.95434 1.0089 2.10E+08
Q92597;Q92597-3;Q92597-2;E5RJY1;E7ESM1;E5RIR1;E5RGM5;E5RIV1;E5RIM2;E5RI76;E5RH82;E5RK17;E5RJ98;E5RG99;Q92597-3;Q92597-2Protein NDRG NDRG1 8 8 394 0.95402 0.8806 7.87E+08
Q147X3;Q147X3-2;J3KNC2;B4DK34Q147X3;Q147X3-2 N-alpha-acetyltransferase 30NAA30 7 7 362 0.95389 0.91702 5.60E+08
Q92900-2;Q92900 Q92900-2;Q92900 Regulator of nonsense transcripts 1UPF1 47 47 1118 0.95388 1.1442 9.40E+09
P25788-2;P25788;G3V4X5;G3V3W4;G3V5N4;H0YJ03P25788-2;P25788 Proteasome subunit alpha type-3PSMA3 9 9 248 0.95379 0.94585 1.19E+09
Q06587;Q06587-2 Q06587;Q06587-2 E3 ubiquitin-protein ligase RING1RING1 4 3 406 0.95377 1.1408 5.91E+08
Q99615;Q99615-2;K7EIH8;K7EPP7;K7ESP1;K7EJL5;K7EN19;K7EJV7;K7ER44;K7ELJ8;K7EJE9;K7EK03;K7EJ24Q99615;Q99615-2;K7EIH8;K7EPP ;K7ESP1DnaJ homolog subfamily C member 7DNAJ 7 18 18 494 0.95343 1.1256 5.68E+08
O43660;O43660-2;D6RA26;H0YA24;B7Z982;H0YAA2O43660;O43660-2;D6RA26Pleiotropic regulator 1PLRG1 8 8 514 0.95306 1.1893 5.72E+08
P49841;P49841-2 P49841;P49841-2 Glycogen synthase kinase-3 betaGSK3B 3 2 420 0.95303 0.90579 2.52E+08
C9JP03;Q5T6P2;C9JD09;C9JUW9;X6RDJ2;Q5T6P1;X6RGK9;A0A0C4DFN6;A0A0A0MSS3;Q8ND83-2;Q8ND83-4;Q8ND83;Q8ND83-3C9JP03;Q5T6P2;C9JD09;C9JUW9;X6RDJ2;Q5T6P1;X RGK9; A0C4DFN6;A0A0A0MSS3;Q8ND83-2;Q8ND83-4;Q8ND83SLAIN motif-containing protein 1SL IN1 3 3 99 0.95285 NaN 8.31E+07
Q86YS7;Q86YS7-2;Q86YS7-3;Q86YS7-4;Q86YS7-5;H0YFC4Q86YS7;Q86YS7-2;Q86YS7-3;Q86 S7-4;Q86YS7-5;H0YFC4C2 domain-containing protein 5C2CD5 2 2 1000 0.95238 1.1395 1.34E+08
Q5RIB5;Q5JTY2;A0A087WTC0;Q6NVZ8;F8WEG4;A0A0B4J2E3;A0A087WZQ3;F8WEU0;E7EUZ7;A0A087WYD2;F2Z2T4;A0A087X140;A0A087WWG3;A0A0A6YYH9;Q5RIB0;H0Y5V3;C9J3G2;A0A0A0MRU4;Q9BRT8-4;Q5RIA9-3;Q5JTY5-2;Q9BRT8-3;Q9BRT8;Q8IUF1;Q5RIA9;Q5JTY5;Q4V339;A0A0B4J1T6;A0A087X1C0;A0A0B4J2F1;Q9BRT8-2Q5RIB5;Q5JTY2;A0A0 7WTC0;Q6NVZ8;F8WEG4;A0A0B4J2E3;A0A087WZQ3;F8WEU0;E7EUZ7;A0A087WYD2;F2Z2T4;A0A087X14 ;A0A087WWG3;A0A A6YYH9;Q5RIB0;H Y5V3;C9J3G2;A0A0A0MRU4;Q9BRT8-4;Q5RIA9-3;Q5JTY5-2; 9BRT8-3;Q9BRT8;Q8IUF1;Q5RIA9;Q5JTY5;Q4V339;A0A0B4J1T6;A0A087X1C0;A0A0B4J2F1;Q9BRT8-2COB  domain-containing protein 1;COB  domain-containing protein 5;COBW domain-containing protein 3;COBW domain-containing protein 2;COBW domain-containing protein 6CB D5;CB D3 BWD2;CBWD1;CBWD7;CB 62 2 113 0.952 7 1.1347 1.71E+08
A2ABE9;H7C2J4;A0A0G2JK42;A0A140T9J3;A0A140T982;A0A0G2JK88;A0A024RCV8;O43196-4;O43196;O43196-2;O43196-32ABE9;H7C2J4;A0A0G2JK42;A0A140T9J3;A0A140T982;A0A0G2JK88;A0A02 RCV8; 4; ;O43196-2;O43196-3MutS protein homolog 5MSH5 2 2 333 0.95205 0.95809 1.43E+08
Q96GK7;C9JGM0;Q6P2I3;C9J5B6Q96GK7;C9JGM0;Q6P2I3Fumarylacetoacetate hydrolase domain-containing protein 2A;Fumarylacetoacetate hydrolase domain-containing protein 2BFAHD2A;FAHD2B 4 4 314 0.95144 1.0237 2.31E+08
Q13526;K7EN45;K7EMU7;O15428Q13526;K7EN45;K7EMU7Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1PIN1 8 8 163 0.95141 1.2501 1.56E+09
P30050;P30050-2 P30050;P30050-2 60S ribosomal protein L12RPL12 10 10 165 0.95122 1.1514 4.35E+09
A0A087WUZ3;Q01082;Q01082-3;Q01082-2;F8W6C1A0A087WUZ ; ;Q01082-3;Q01082-2Spectrin beta chain, non-erythrocytic 1SPTBN1 9 9 2366 0.95049 1.3516 3.76E+08
C9JP16;O75718 C9JP16;O75718 Cartilage-associated proteinCRTAP 3 3 358 0.94944 1.416 1.34E+08
Q02252-2;Q02252;G3V4Z4Q02252-2;Q02252 Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrialALDH6A1 7 7 522 0.94936 0.8187 3.64E+08
Q96KP1 Q96KP1 Exocyst complex component 2EXOC2 9 9 924 0.94903 0.91267 4.75E+08
P62495;B7Z7P8;P62495-2;D6RCB3;D6RJE8;I3L492P62495;B7Z7P8 P 2495-2Eukaryotic peptide chain release factor subunit 1ETF1 5 5 437 0.9481 1.6214 4.72E+08
Q9HCS7 Q9HCS7 Pre-mRNA-splicing factor SYF1XAB2 11 11 855 0.94795 0.89631 3.34E+08
A0A087WVD7;Q9Y3D8;Q9Y3D8-2;A0A087WY94;D6RDH4A0A087WVD7;Q9Y3D8;Q9Y3D8-2;A0A087WY94;D6RDH4Adenylate kinase isoenzyme 6AK6;TAF9 4 4 109 0.94779 1.0372 6.66E+08
P27707;D6RFG8;D6RCP9P27707;D6RFG8 Deoxycytidine kinaseDCK 5 5 260 0.94744 1.1901 4.70E+08
Q13158 Q13158 FAS-associated death domain proteinFADD 1 1 208 0.94728 0.98328 6.73E+07
Q9NTJ3;E9PD53;Q9NTJ3-2;C9JR83;C9J9E4;C9JVD8;C9J578;C9JWF0;C9IYK2;C9JJ64Q9NTJ3;E PD53;Q9NTJ3-2Structural maintenance of chromosomes protein 4;Structural maintenance of chromosomes proteinSMC4 63 63 1288 0.94707 1.0428 5.28E+09
Q5HYK3;F8VVX6;B4DP72;F8VP53;F8VVW7;Q5HYK3-2Q5HYK3;F8VVX6;B4DP722-methoxy-6 polyprenyl-1,4-benzoquinol methylase, mitochondrialCOQ5 6 6 327 0.947 1.0594 2.03E+08
Q86T03;Q86T03-2;H0YJ90Q86T03;Q86T03-2;H0YJ90Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphataseTMEM55B 2 2 277 0.94694 0.74947 3.29E+08
P60604;F8WCB9;F8WDB1;P60604-2P60604;F8WCB9;F8WDB1;P60604-2Ubiquitin-conjugating enzyme E2 G2UBE2G2 2 2 165 0.94651 0.97927 1.44E+08
Q86X55-1;Q86X55;Q86X55-2;K7EQA8;K7EK20;K7EPK1;K7EQB91;Q86X55 Q86X55-2;K7EQA8Histone-arginine methyltransferase CARM1CARM1 14 14 585 0.94642 1.06 2.19E+09
Q16658;C9JFC0;A0A0A0MSB2;C9JPH9Q16658 Fascin FSCN1 14 14 493 0.94614 1.0664 2.64E+09
P55210;P55210-3;Q5SVL2;A0A0A0MRL7;P55210-4P 5210;P55210-3;Q5SVL2;A A0A0MRL7;P55210-4Caspase-7;Caspase-7 subunit p20;Caspase-7 subunit p11CASP7 6 4 303 0.94599 1.006 5.58E+08
A0A0U1RR46;A0A0X1KG69;A0A087WUZ6;Q8NI35-4;Q8NI35-3;Q8NI35-2;Q8NI35A0A0U1RR46;A0A0X1KG69;A0A087WUZ6;Q8NI35-4;Q8NI35-3;Q8NI35-2;Q8NI35InaD-like protein INADL 1 1 683 0.94561 NaN 9.91E+06
P42704;A0A0C4DG06;B8ZZ38;C9JCA9;H7C3W8P42704 Leucine-rich PPR motif-containing protein, mitochondrialLRPPRC 77 77 1394 0.94539 1.0889 2.12E+10
P19367;P19367-4;P19367-2;P19367-3;B1AR63;B1AR62;B1AR61;Q2TB90;Q2TB90-3;Q2TB90-2;P19367-4;P19367-2;P 93 7-3Hexokinase-1 HK1 43 39 917 0.94534 0.97991 7.76E+09
E9PEB5;Q96AE4;Q96AE4-2;C9JSZ1E9PEB5;Q96AE4;Q96AE4-2Far upstream element-binding protein 1FUBP1 9 5 655 0.94533 0.89679 3.00E+08
P48444;B0YIW6;P48444-2;Q6P1Q5;E9PK34P48444;B0YIW6;P4844 -2Coatomer subunit deltaARCN1 27 27 511 0.94502 0.97507 7.17E+09
Q6P1M0;Q6P1M0-2Q6P1M0 Long-chain fatty acid transport protein 4SLC27A4 8 8 643 0.94491 1.0553 6.62E+08
Q96P48-3;Q96P48;E7EU13;Q96P48-7;Q96P48-2;Q96P48-4;Q96P48-1;A0A0A0MSJ2;Q96P48-5;F5GWQ2;F5GWN4;F8WBT0;H0YGD1Q96P48-3;Q96P48;E7EU13;Q96P48-7;Q96P48-2;Q96P48-4;Q96P48-1;A0A0A0MSJ2;Q96P48-5Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1RA 1 9 9 1439 0.94474 0.85649 3.20E+08
Q5JY65;Q9BZJ0-2;Q9BZJ0-3;Q9BZJ0Q5JY65;Q9BZJ0-2;Q9BZJ0-3;Q9BZJ0Crooked neck-like protein 1CRNKL 8 8 836 0.94468 1.0322 5.80E+08
Q70CQ2-3;Q70CQ2-2;Q70CQ2;H7C150;A0A0C4DG73;H7C183Q70CQ2-3;Q70CQ2-2;Q70CQ2Ubiquitin carboxyl-terminal hydrolase 34USP34 7 7 3312 0.94424 1.1548 1.55E+08
O75534-2;O75534;O75534-3;O75534-4;E9PLT0;E9PLD4;E9PKN4;E9PNG32; ;O75534-3;O75534-4;E9PLT0Cold shock domain containing protein E1CSDE1 28 28 767 0.94405 1.1527 3.78E+09
Q9H7Z7;A6NHH0;X6RJ95Q9H7Z7 Prostaglandin E synthase 2;Prostaglandin E synthase 2 truncated formPTGES2 7 7 377 0.94388 1.2409 6.14E+08
Q3B726 Q3B726 DNA-directed RNA polymerase I subunit RPA43TWISTNB 3 3 338 0.94382 NaN 1.14E+08
Q9Y3I0 Q9Y3I0 tRNA-splicing ligase RtcB homologRTC 24 24 505 0.94345 1.1693 1.05E+10
C9JG97;C9JEH3;Q13685;H7C0R2;C9JTS3C9JG97;C9JEH3;Q13685;H7C0R2Angio-associated migratory cell proteinAAMP 5 5 415 0.94237 1.0511 9.56E+08
Q9P265 Q9P265 Disco-interacting protein 2 homolog BDIP2B 2 2 1576 0.94172 1.0365 1.80E+07
Q9HD47-4;Q9HD47-2;Q9HD47-3;Q9HD47Q9HD47- ;Q9HD47-2;Q9HD47-3;Q9HD47Ran guanine nucleotide release factorRANGRF 2 2 118 0.94156 NaN 3.96E+07
O95202;O95202-2;O95202-3 LETM1 and EF-hand domain-containing protein 1, mitochondrialLETM1 7 7 739 0.94149 0.97872 3.68E+08
Q9NYJ8;Q9NYJ8-2;U3KQ62;U3KQR0Q9NYJ8 Q9NYJ8-2 TGF-beta-activated kinase 1 and MAP3K7-binding protein 2TAB2 5 5 693 0.94088 0.8716 1.78E+08
O14925;Q5SRD1;B4DDK6O14925;Q5SRD1;B4DDK6Mitochondrial import inner membrane translocase subunit Tim23;Putative mitochondrial import inner membrane translocase subunit Tim23BTIMM23;TIMM23B 4 4 209 0.94068 0.99595 1.01E+09
P31040;D6RFM5;P31040-2;A0A087X1I3;P31040-3;H0Y8X1P31040;D6RFM5;P31040-2;A0A087X1I3;P31040-3Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrialSDHA 13 13 664 0.94052 1.3927 6.42E+08
P42285;H0YAC4;H0Y8U3;D6REC7P42285 Superkiller viralicidic activity 2-like 2SKIV2L2 35 35 1042 0.94007 0.97944 5.22E+09
P11388;P11388-2;P11388-3;P11388-4;J3KTB7;P11388-2;P11388-3;P11388-4DNA topoisomerase 2-alphaTOP2A 51 41 1531 0.93985 1.1234 6.61E+09
F8VPD4;P27708;H7C3Z5;H7BZB3;H7C2E4F8VPD4;P27708 CAD protein;Glutamine-dependent carbamoyl-phosphate synthase;Aspartate carbamoyltransferase;DihydroorotaseCAD 85 82 2162 0.93971 0.96669 3.50E+10
P10768;X6RA14;H7BZT7;U3KQT1P10 68;X6RA14;H7BZT7;U3KQT1S-formylglutathione hydrolaseESD 8 8 282 0.93941 1.2307 3.40E+09
Q9Y679-2;Q9Y679;Q9Y679-32;Q9Y679;Q9Y679-3Ancient ubiquitous protein 1AUP1 9 9 410 0.93939 0.91899 6.29E+08
Q8IVD9 Q8IVD9 NudC domain-containing protein 3NUDCD3 4 4 361 0.93932 1.1281 1.23E+08
Q15058 Q15058 Kinesin-like protein KIF14KIF14 4 4 1648 0.93915 NaN 5.28E+07
Q9UBE0;B3KNJ4;Q9UBE0-2;Q9UBE0-3;M0QZS6;M0QX65;M0R054;M0QYM8;M0R375;M0R286;M0QYP2Q9UBE0;B3KNJ4;Q9UBE0-2;Q9UBE0-3;M0QZS6; 0QX65S MO activating enzyme subunit 1;SU O-activating enzyme subunit 1, N-terminally processedSAE1 27 27 346 0.93875 0.92526 6.57E+09
P13804-2;P13804;H0YK49;H0YL12;H0YNX6;H0YLU7;H0YKF0;H0YL83P13804-2;P13804;H0YK49;H0YL12;H0YNX6;H0YLU7;H0YKF0Electron transfer flavoprotein subunit alpha, mitochondrialETFA 12 12 284 0.93838 1.1851 5.26E+09
Q5TDF0;Q9BSD7 Q5TDF0;Q9BSD7 Cancer-related nucleoside-triphosphataseNTPCR 7 7 228 0.93828 0.94929 1.98E+09
P14625;Q96GW1;F8W026;Q58FF3;H0YIV0P146 5 Endoplasmin HSP90B1 33 31 803 0.93728 1.3513 7.44E+09
B2R4S9;U3KQK0;Q99879;Q99877;Q93079;Q5QNW6;P62807;P58876;O60814;Q5QNW6-2;Q99880B2R4S9;U3KQK0;Q99879;Q99877;Q93079;Q5QNW6;P62807;P58876;O60814;Q5QNW6-2;Q99880Histone H2B;Histone H2B type 1-M;Histone H2B type 1-N;Histone H2B type 1-H;Histone H2B type 2-F;Histone H2B type 1-C/E/F/G/I;Histone H2B type 1-D;Histone H2B type 1-K;Histone H2B type 1-LHIST1H2BC;HIST1H2BN IST1H2BM;HIST1H2BH;HIST2H2BF;HIST1H2BD;HIST1H2BK;HIST1H2BL11 0 126 0.93662 1.3767 1.04E+08
A0A087X1A5;O95793-2;O95793;Q5JW30;O95793-3;Q5JW28;F6UDC6;G5EA18;Q9NUL3-4A0A087X1A5;O95793-2;O95793;Q5J 30;O95793-3Double-stranded RNA-binding protein Staufen homolog 1STAU1 12 11 493 0.9366 0.85522 1.25E+09
O43252 O43252 Bifunctional 3-phosphoadenosine 5-phosphosulfate synthase 1;Sulfate adenylyltransferase;Adenylyl-sulfate kinasePAPSS1 11 11 624 0.93653 1.0517 1.65E+09
Q9Y2Z4;H0YHS6 Q9Y2Z4;H0YHS6 Tyrosine--tRNA ligase, mitochondrialYARS2 8 8 477 0.9365 1.1694 9.55E+08
O95573;F5GWH2;C9JC11;F5H062O95573 Long-chain-fatty-acid--CoA ligase 3ACSL3 21 19 720 0.93638 0.95259 2.83E+09
Q9BTE7;E9PM04;H0YCN4;E9PQV9;E9PLH8;E9PM78;H0YD80;E9PLS2Q9BTE7;E9PM04;H0YCN4;E9PQV9DC 1-like protein 5;DCN1-like proteinDCUN1D5 4 4 237 0.936 0.99137 7.90E+07
P22626;P22626-2;A0A087WUI2P22626;P22626-2;A0A087WUI2Heterogeneous nuclear ribonucleoproteins A2/B1HNRNPA2B1 25 24 353 0.93564 1.0194 1.54E+10
E9PEX6;P09622;P09622-3;P09622-2;F8WDM5;F2Z2E3E9PEX6; ;P09622-3;P09622-2Dihydrolipoyl dehydrogenase, mitochondrialDLD 12 12 486 0.93552 0.89604 1.66E+09
P07814;V9GYZ6;V9GZ76P0 814;V9GYZ6 Bifunctional glutamate/proline--tRNA ligase;Glutamate--tRNA ligase;Proline--tRNA ligaseEPRS 70 70 1512 0.93548 1.0741 1.93E+10
O15144;H7C3F9 O15144;H7C3F9 Actin-related protein 2/3 complex subunit 2ARPC2 6 6 300 0.93525 1.5635 3.43E+08
F8VZJ2;F8W0W4;H0YHX9;Q13765;E9PAV3-2;E9PAV3;F8W1N5;F8VNW4;F8VZ58;Q9BZK3F8VZJ2;F8W0W4;H0YHX9;Q13765;E9PAV3-2;E9PAV3;F8W1N5;F8VNW4Nascent polypeptide-associated complex subunit alpha;Nascent polypeptide-associated complex subunit alpha, muscle-specific formNACA 5 5 136 0.93449 1.2181 4.34E+09
O95394;O95394-3;O95394-4;A0A087WT27;J3KN95;H0Y8I3;D6RCQ8;H0Y987;D6RCD1;D6RF77;D6RC77;D6RIS6;O95394-3;O95394-4;A0A087WT27;J3KN95Phosphoacetylglucosamine mutasePGM3 14 14 542 0.93442 1.1527 7.60E+08
Q8WUM4;Q8WUM4-2;Q8WUM4-3;C9IZF9;F8WEQ7;F8WBR8;F8WDK9Q8WUM4;Q8WUM4-2Programmed cell death 6-interacting proteinPDCD6IP 43 43 868 0.9341 1.0085 5.97E+09
G3V5T0;A0A0C4DFM0;A0A0A0MR33;G3V267;G3V4T6;O43708;O43708-3;O43708-2;G3V3B9;H0YJN8G3V5T0; 0A0C4DFM0;A0A0A0MR33;G3V267;G3V4T6; ;O43708-3;O4370 -2aleylacetoacetate isomeraseGSTZ1 6 6 202 0.93378 1.0461 5.40E+08
Q9P035;H3BS72;H3BPZ1;Q9P035-2;H3BRL8;H3BMZ1Q9P035;H3BS7 PZ1 Q9P035-2Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3PTPLAD1 14 14 362 0.93364 1.0824 4.34E+09
Q14683;G8JLG1;H0Y7K8;V9GY57;V9GYN9Q14683; 8JLG1 Structural maintenance of chromosomes protein 1ASMC1A 69 69 1233 0.93335 0.94949 7.44E+09
A8MX75;P18074;E7EVE9;P18074-2;K7EKF3;K7EIT8A8MX75;P18074;E7EVE9;P18074-2TFIIH basal transcription factor complex helicase XPD subunitERCC2 5 5 706 0.93333 0.96854 3.90E+08
P57053 P57053 Histone H2B type F-SH2BFS 11 1 126 0.93309 1.2814 1.65E+10
P52732 P52732 Kinesin-like protein KIF11KIF11 18 18 1056 0.9324 0.77763 6.70E+08
Q6PJ69;H0YGS7;H0YG27;K7EM44;K7EJ59Q6PJ69;H0YGS7;H0YG27Tripartite motif-containing protein 65TRIM65 3 3 517 0.93228 0.93572 1.51E+08
P33991;E5RG31;E5RFJ8;E5RFR3;Q9UJA3-2;Q9UJA3-3;Q9UJA3;Q9UJA3-4P33991 DNA replication licensing factor MCM4MCM4 41 41 863 0.93197 0.8552 1.30E+10
Q6P6C2;Q6P6C2-1;Q6P6C2-3;Q6P6C2-1;Q6P6C2-3RNA demethylase ALKBH5ALKBH5 2 2 394 0.93196 NaN 1.61E+08
147
O00148;O00148-2;K7EQN7;O00148-3;K7EPJ3;A0A0D9SEM9;K7EN69;K7ENP6;K7EL56;K7EIL8;F6SXL5O00148; 2; QN7;O00148-3ATP-dependent RNA helicase DDX39ADDX39A 25 10 427 0.93157 1.0724 1.59E+10
P50416-2;P50416;H3BMD2;H3BUJ0;H3BP22;H3BUV7P50416-2;P50416 Carnitine O-palmitoyltransferase 1, liver isoformCPT1A 7 7 756 0.93088 1.3853 5.31E+08
Q13409-3;Q13409-7;Q13409-2;Q13409;Q13409-6;Q13409-5;E7EQL5;E7EV09;E7EQU2;E7ESD3;E7EMU4;E9PGG1;E7EUM4;E7ERR6;E7ERH4;E7ET01;E7ETL8;E7EU01;E5RFE1;C9J3E7;E5RJ75;O14576-4;O14576-3;O14576-5;O14576-2;O14576Q13409-3;Q13409-7; 2; ;Q13409-6;Q13409-5;E7EQL5; 7EV09; 7EQU2;E7ESD3;E7E U4Cytoplasmic dynein 1 intermediate chain 2DYNC1I2 11 11 612 0.93064 1.0781 4.78E+08
Q7Z3C6;Q7Z3C6-2;Q7Z3C6-3;H7C1G6;C9JD65;H7C152;C9JS65;C9JFV2;F2Z3I6;C9JX27;C9IYZ9;C9JKV7;C9JDK4;C9JXG2;Q7Z3C6-2;Q7Z3C6-3Autophagy-related protein 9AATG9A 10 10 839 0.93058 0.85551 4.22E+08
J3KN36;Q5JPE7-2;P69849;Q5JPE7;Q5JPE7-3;A0A087WTD5J3KN36;Q5JPE7-2;P69849;Q5JPE7;Q5JPE7-3Nodal modulator 2;Nodal modulator 3OMO3;NOMO2 9 1 1267 0.93016 1.013 4.50E+08
Q13616;A0A0C4DGX4Q13616;A0A0C4DGX4Cullin-1 CUL1 15 15 776 0.92998 1.1654 1.48E+09
Q9Y5S2;H0YLY0 Q9Y5S2;H0YLY0 Serine/threonine-protein kinase MRCK betaCDC42BPB 7 6 1711 0.92971 0.8416 1.79E+08
A0A0A0MTR7;A0A0A0MTC1;Q63HN8;Q63HN8-4;Q63HN8-6;Q63HN8-5A0A0MTR7;A0A0A0MTC1;Q63HN8;Q63HN8-4E3 ubiquitin-protein ligase RNF213RNF213 38 38 5207 0.92962 1.0732 1.20E+09
Q9UBT2;K7EPL2;Q9UBT2-2;U3KQ93;U3KQ55;K7ES38;K7ESK7Q9UBT2;K7EPL2;Q9UBT2-2SUMO-activating enzyme subunit 2UBA2 7 7 640 0.92939 1.4687 2.71E+08
B1AJY5;B1AJY7;O75832;B1AJY6;O75832-2B1AJY5;B1AJY7;O7583226S proteasome non-ATPase regulatory subunit 10PSMD10 14 14 185 0.92925 1.0164 2.12E+09
P55072;C9JUP7;C9IZA5P55072 Transitional endoplasmic reticulum ATPaseVCP 47 47 806 0.92898 0.79715 1.62E+10
Q93077;Q7L7L0;P04908Q 3077;Q7L7L0;P04908Histone H2A type 1-C;Histone H2A type 3;Histone H2A type 1-B/EHIST1H2AC;HIST3H2A;HIST1H2AB 6 1 130 0.92874 1.3999 8.76E+08
Q16763;K7EPJ1 Q16763;K7EPJ1 Ubiquitin-conjugating enzyme E2 SUBE2S 4 4 222 0.92852 1.0079 1.69E+08
Q9BTE3-2;Q9BTE3;Q9BTE3-3Q9BTE3-2;Q9BTE3;Q9BTE3-3Mini-chromosome maintenance complex-binding proteinMCMBP 8 8 640 0.92829 1.0348 2.78E+08
H0Y645;B0QY35;B0QY34;H7BYT1;P48730-2;P48730;P49674;J3QQI9;B0QY36;H0Y2N6H0Y645;B0QY35;B0QY34;H7BYT1; 8730-2;P48730;P49 74;J3QQI9;B0QY36Casein kinase I isoform delta;Casein kinase I isoform epsilonCSNK1E;CSNK1D 3 270 0.92824 1.1656 1.23E+08
P50502;H7C3I1;F6VDH7;Q3KNR6;A0A087X1H6;Q8IZP2;Q8NFI4P50502;H7C3I1;F6VDH7;Q3KNR6;A0A087X1H6;Q8IZP2;Q8NFI4Hsc70-interacting protein;Putative protein FAM10A4;Putative protein FAM10A5ST13;ST13P4;ST13P5 6 6 369 0.92819 1.148 1.28E+09
P09960-4;P09960;P09960-3;P09960-24; ;P09960-3;P09960-2Leukotriene A-4 hydrolaseLTA4H 11 11 587 0.92818 1.2776 8.08E+08
O94776;O94776-2 O94776;O94776-2 Metastasis-associated protein MTA2MTA2 16 11 668 0.92803 1.2009 1.21E+09
O75306-2;O75306 O75306-2;O75306 NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrialNDUFS2 12 12 457 0.92797 1.0301 1.27E+09
F8VQX6;H0YI09;Q9H8H3F8VQX6;H0YI09;Q9H8H3Methyltransferase-like protein 7AMETTL7A 2 2 180 0.92773 1.5027 8.62E+07
P45974-2;P45974;F5H571P459 4-2;P45974 Ubiquitin carboxyl-terminal hydrolase 5USP5 23 22 835 0.92747 1.0653 1.81E+09
Q9BUP3-3;Q9BUP3;E9PI87;Q9BUP3-2Q BUP3-3;Q9BUP3Oxidoreductase HTATIP2HTATIP2 7 7 276 0.92617 0.73112 3.44E+08
Q9NVX2;A0A0A0MRH0;K7EN33;Q9NVX2-2;K7ERN7Q9NVX2;A0A0A0MRH0; N33Notchless protein homolog 1NLE1 9 9 485 0.92617 0.91348 1.26E+09
O43913;O43913-2;G3V0H0O43913;O43913-2 Origin recognition complex subunit 5ORC5 9 9 435 0.92612 1.2184 7.40E+08
P56537;A0A0U1RQV5;P56537-2;B7ZBH1P 6537;A0A0U1RQV5;P56537-2Eukaryotic translation initiation factor 6EIF6 3 3 245 0.9261 1.2671 2.87E+08
Q92572;F5H459 Q92572;F5H459 AP-3 complex subunit sigma-1AP3S1 7 7 193 0.92608 1.0425 2.52E+08
Q99733;Q99733-2;C9J6D1;C9JZI7;E9PNW0;E9PJJ2;E9PS34;E9PNJ7;A8MXH2;E9PKT8;E9PKI2;E9PP22;C9J1B1;H0YCI4Q 9733;Q99733-2;C9J6D1;C9JZI7;E9PNW0;E9PJJ2;E9PS34;E9PNJ7;A8MXH2;E9PKT8ucleosome assembly protein 1-like 4AP1L4 9 7 375 0.9258 1.2856 2.45E+08
G3V4F2;A0A087X0W7;A0A087WT95;Q86TX2;P49753;P49753-2G3V4F2;A0A087X0W7;A0A087WT95;Q86TX ;P49753Acyl-coenzyme A thioesterase 1;Acyl-coenzyme A thioesterase 2, mitochondrialACOT1;ACOT2 11 11 395 0.92539 0.85463 1.12E+09
E9PH64;E7EWZ0;E9PF49;Q9Y6M9E9PH64;E7EWZ0;E9PF49;Q9Y6M9NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9NDUFB9 2 2 168 0.92509 NaN 7.52E+07
H0YBS1;Q75QN2-2;Q75QN2;J3KNV5;H0YC12;E5RIN8;E5RG48H0YBS1;Q75QN2-2;Q75QN2;J3KNVIntegrator complex subunit 8INTS8 6 6 800 0.92506 0.87451 2.31E+08
Q6P2Q9;I3L0J9;I3L3Z8;I3L1T8Q6P2Q9 Pre-mRNA-processing-splicing factor 8PRPF8 92 92 2335 0.92493 1.0796 1.41E+10
Q96I99;E9PDQ8;Q96I99-2;H0Y852Q96I99;E9PDQ8;Q96I99-2;H0Y852Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrialSUCLG2 12 12 432 0.92493 1.0917 1.78E+09
P30153;B3KQV6;C9J9C1;P30154-4;P30154;P30154-2;E9PH38;P30154-5;E9PPI5;E9PNM7;E9PHZ6;P30154-3;M0QXG4;M0R0K6;H0YDG7P30 53;B3KQV6;C9J9C1Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoformPPP2R1A 16 16 589 0.92459 0.98502 1.92E+09
O95400 O95400 CD2 antigen cytoplasmic tail-binding protein 2CD2BP2 5 5 341 0.92435 1.1686 4.52E+08
Q6GMV2;E2QRN5;F8WEJ9;C9IYN9Q6GMV2;E2QRN5;F8WEJ9;C9IYN9SET and MYND domain-containing protein 5SMYD5 2 2 418 0.92394 1.5931 2.00E+08
J3KRR7;Q9NQC7-2;Q9NQC7J3KRR7;Q9NQC7-2;Q9NQC7Ubiquitin carboxyl-terminal hydrolase CYLDFAM134C;CYLD 1 1 910 0.92389 NaN 5.55E+07
P13984 P13984 General transcription factor IIF subunit 2GTF2F2 3 3 249 0.92372 1.1426 9.95E+07
P36404;V9GYD0;P36404-2P36404;V9GYD0;P36404-2ADP-ribosylation factor-like protein 2ARL2;ARL2-SNX15 10 10 184 0.92355 1.0829 1.18E+09
D6REX3;O94979-6;O94979-3;O94979-10;O94979-4;O94979-9;O94979-2;O94979;O94979-8;D6RHZ5;H7BXG7;O94979-7;O94979-5;H0YAB3;H0Y8V7;H0Y9K1;H0Y9T9;H0Y8W8;H0YAF5;D6RE64;D6RCQ9;D6RBT0;D6RHE8;H0Y9V3D6REX3;O94979-6;O94979-3;O94979-10;O94979-4;O94979- ; 2;O94979;O94979-8;D6RHZ5;H7BXG7;O94979-7 O94979-5;H0YAB3Protein transport protein Sec31ASEC31A 25 25 12 1 0.92326 1.1526 2.98E+09
O75155-2;O75155;F8WBB8O75155-2;O75155 Cullin-associated NEDD8-dissociated protein 2CAND2 13 10 1119 0.92279 0.89572 6.47E+08
D6R9P3;D6RD18;D6RBZ0;A0A087WZV1;Q99729-3;Q99729-2;Q99729-4;Q99729D6R9P3;D6RD18;D6RBZ0;A0A087WZV1;Q99729-3;Q99729-2;Q99729-4;Q99729Heterogeneous nuclear ribonucleoprotein A/BHNRNPAB 12 12 280 0.92257 1.1807 4.78E+09
P17987;E7EQR6;E7ERF2;F5H282;F5GZ03;F5H136;F5H676;F5GZI8;F5H726;F5GYL4;F5H7Y1P17987;E7EQR6;E7ERF2;F5H282T-complex protein 1 subunit alphaTCP1 35 35 556 0.92242 1.0278 4.39E+10
Q969X5-2;Q969X5 Q969X5-2;Q969X5 Endoplasmic reticulum-Golgi intermediate compartment protein 1ERGIC1 3 3 198 0.92241 1.1206 1.74E+08
D6RIY6;Q06265;Q06265-2;Q06265-3;Q06265-4;D6R905;D6RA17;D6RAP4;H0Y9L5D6RIY6; ;Q06265-2;Q06265-3;Q06265-4;D6R905;D6RA17Exosome complex component RP45EXOSC9 4 4 423 0.92235 1.3797 7.18E+08
Q01518;Q01518-2;Q5T0R7;Q5T0R6;Q5T0R5;Q5T0R4;Q5T0R3;Q5T0R2;Q5T0R1;Q5T0R9;Q5T0R8;Q5T0S301518 01518-2;Q5T0R7;Q5T0R6;Q5T0R5;Q5T0R4;Q5T0R3;Q5T0R2;Q5T0R1;Q5T0R9Adenylyl cyclase-associated protein 1;Adenylyl cyclase-associated proteinCAP1 13 13 475 0.92205 1.4511 1.38E+09
Q9NXE4-2;Q9NXE4;Q9NXE4-4;H7BXF4;B1PBA3;Q9NXE4-3;H7C1Q6;Q9NXE4-6;Q9NXE4-9;Q9NXE4-10;Q9NXE4-7;Q9NXE4-8;C9J647;H7C0W5;Q9NXE4-5;H7C2E2;H7C2J2;F8WF03;F2Z2I0;F2Z2W5;H7C2352;Q9N E Q9NXE4-4;H7BXF4 B1PBA3; 9 XE4-3;H7C1Q6;Q9NXE4-6;Q9NXE4-9;Q9NXE4-10;Q9NXE -7;Q9NXE4-8Sphingomyelin phosphodiesterase 4SM D4 8 8 798 0.92191 0.92 68 6.35E+08
Q13200;Q13200-3;Q13200-2;H7C1H2;C9JPC0;H7C2Q3;F8WBS8;Q13200-3;Q1320 -226S proteasome non-ATPase regulatory subunit 2PSMD2 41 41 908 0.92171 0.95999 8.41E+09
Q14152-2;Q14152 Q14152-2;Q14152 Eukaryotic translation initiation factor 3 subunit AEIF3A 32 32 1348 0.92151 1.1318 5.16E+09
Q9UJU6;Q9UJU6-2;Q9UJU6-3;B4DDD6;H0Y5J4;Q9UJU6-5;Q9UJU6-6;Q9UJU6-4;F8WBG8;F8WC20;F8WBB2;F8WFE1;H7C111;Q9UJU6-2;Q9UJU6-3;B4DDD6;H0Y5J4;Q9UJ 6-5;Q9UJU6-6;Q9UJU6-4Drebrin-like proteinDBNL 8 8 430 0.92127 1.2642 3.50E+08
Q5VWZ2-2;Q5VWZ2Q5VWZ2-2;Q5VWZ2Lysophospholipase-like protein 1LYPLAL1 6 6 221 0.92078 1.4849 4.59E+08
Q92890;Q92890-1;Q92890-3;C9J6N9;C9JNP9;Q92890-1;Q92890-3Ubiquitin fusion degradation protein 1 homologUFD1L 4 4 307 0.92073 1.2857 8.89E+08
Q9BXW9-3;Q9BXW9;Q9BXW9-1;H7BZJ7;Q9BXW9-4Q9BXW9-3;Q9BXW9; 9 X 9-1;H7BZJ7Fanconi anemia group D2 proteinFANCD2 8 8 1249 0.92063 1.0309 2.62E+08
E9PF18;A0A0A0MSE2;Q16836;Q16836-3;Q16836-29PF18;A0A0A0MSE2; ;Q16836-3;Q16836-2Hydroxyacyl-coenzyme A dehydrogenase, mitochondrialHADH 4 4 318 0.92011 NaN 2.46E+08
O75153 O75153 Clustered mitochondria protein homologCLUH 41 2 1309 0.92002 0.68664 5.28E+07
Q9UHR6 Q9UHR6 Zinc finger HIT domain-containing protein 2ZNHIT2 3 3 403 0.91947 0.93591 1.50E+08
H3BND4;Q6P996-3;Q6P996-4;Q6P996-5;Q6P996;Q86XE2;Q6P996-2;Q6P474;H3BNL6;J3KNK7;Q6XYB5H3BND4;Q6P996-3;Q6P996-4; 6P996-5;Q6P996Pyridoxal-dependent decarboxylase domain-containing protein 1PDXDC1 11 11 806 0.91937 1.1782 6.61E+08
A0A088AWN3;A0A0A0MSY4;A0A0A0MRA7;Q9BZ29-3;Q9BZ29-5;Q9BZ29;Q9BZ29-4;Q5JUD3;H7BZ79;Q5JUD8;H0Y3S1;A0A0A0MT38;Q9BZ29-6A0A088AWN3; A0A0MSY4;A0A0A0MRA7;Q9BZ29-3; 5; 9BZ29 Q9 2 -4;Q5JUD3;H7BZ79;Q5JUD8;H0Y3S1;A0A0A0MT38;Q9BZ29-6Dedicator of cytokinesis protein 9DOCK9 2 2 2079 0.91929 1.181 5.71E+07
A0A0C4DFM7;Q5TAX3;E9PKX1;E9PKY2;H0YDJ1;H0YEE8;Q5TAX3-2A0A0C4DFM7;Q5TAX3;E9PKX1;E9PKY2Terminal uridylyltransferase 4ZCCHC11 3 3 1645 0.91867 0.77757 9.40E+07
Q96EK6;G3V5E4;G3V4W4Q96EK6;G3V5E4;G3V4W4Glucosamine 6-phosphate N-acetyltransferaseGNPNAT1 7 7 184 0.91866 1.2111 8.40E+08
Q00325-2;Q00325;F8VVM2;F8VZL5;F8VWR4;F8VWQ0Q00325-2;Q00325;F8VVM2Phosphate carrier protein, mitochondrialSLC25A3 18 18 361 0.91863 0.90878 1.21E+10
Q13112 Q13112 Chromatin assembly factor 1 subunit BCHAF1B 3 3 559 0.91816 1.022 3.09E+08
Q96HR8-2;Q96HR8Q96HR8-2;Q96HR8H/ACA ribonucleoprotein complex non-core subunit NAF1NAF1 1 1 389 0.91787 0.90776 1.01E+08
Q96EY5-2;Q96EY5;E9PLL0;E9PLZ8;E9PQA6;Q96EY5-3Q96EY5-2;Q96EY5;E9PLL0;E9PLZ8;E9PQA6;Q96EY5-3Multivesicular body subunit 12AMVB12A 2 2 233 0.91783 NaN 1.58E+08
D6RAX7;D6RFN0;Q9BT78;Q9BT78-2;D6RD63D6RAX7;D6RFN0;Q9BT78;Q9BT78-2;D6RD63COP9 signalosome complex subunit 4COPS4 9 9 420 0.91775 1.1913 5.20E+08
Q9BQA1;Q9BQA1-2;H0Y711Q9BQA ;Q9BQA1-2;H0Y711Methylosome protein 50WDR77 7 7 342 0.91748 1.4588 1.02E+09
O95239;O95239-2;Q2VIQ3;Q5JRK0O95239;O95239-2 Chromosome-associated kinesin KIF4AKIF4A 9 8 1232 0.91718 0.93823 2.67E+08
Q15084-3;Q15084;Q15084-4;Q15084-5;Q15084-23; ;Q15084- ;Q15084-5;Q15084-2Protein disulfide-isomerase A6PDIA6 14 14 437 0.91693 0.99681 5.73E+09
Q15648-3;Q15648 Q15648-3;Q15648 Mediator of RNA polymerase II transcription subunit 1MED1 1 1 556 0.91627 1.1362 6.03E+07
Q8WUA4;H0Y4Q6;A0A087WZD8;Q8WUA4-2;H7C318;H7C1A9Q8WUA4;H0Y4Q6;A0A087WZD8;Q8WU 4-2General transcription factor 3C polypeptide 2GTF3C2 6 6 911 0.91611 0.71799 1.41E+08
Q9H3U1-2;Q9H3U1;Q9H3U1-3Q9H3U1-2;Q9H3U1Protein unc-45 homolog AUNC45A 33 33 929 0.916 1.033 3.71E+09
P15374;A0A087WTB8;Q5TBK7P15374;A0A087WTB8Ubiquitin carboxyl-terminal hydrolase isozyme L3UCHL3 4 4 230 0.91577 1.4523 1.37E+08
A0A087X1F4;Q9H944;B7ZBQ1;A6PVP4;B7ZBQ3;Q9H944-2A0A087X1F4;Q9H944;B7ZBQ1;A6PVP4;B7ZBQ3;Q9H944-2Mediator of RNA polymerase II transcription subunit 20MED20 2 2 211 0.9157 1.1434 1.34E+08
P53007;B4DP62 P53007;B4DP62 Tricarboxylate transport protein, mitochondrialSLC25A1 11 11 311 0.91454 0.82511 2.81E+09
A0A0U1RR32;A0A0U1RRH7;Q99878;Q96KK5;Q9BTM1;Q16777;Q6FI13;P20671;P0C0S8;H0YFX9;Q9BTM1-2;Q96QV6;P16104;REV__H0Y672;REV__E7EQ67;REV__H7BY63;REV__Q8NB25-4;REV__Q8NB25-2;REV__A0A087X2A7;REV__Q8NB25-3;REV__Q8NB25;Q71UI9-5A0A0U1RR32;A0A0U1RRH7;Q99878;Q96KK5;Q9BTM1;Q16777;Q6FI13;P20671;P0C0S8;H0YFX9;Q9BTM1-2;Q96QV6;P16104Histone H2A type 1-J;Histone H2A type 1-H;Histone H2A.J;Histone H2A type 2-C Histone H2A type 2-A;Histone H2A type 1-D; istone H2A type 1;Histone H2A;Histone H2A type 1-A;Histone H2AXHIST1H2AJ;HIST1H2A 2AFJ; IST H2AC;HIST2H2AA3;HIST1H2AD; IST1H2AG;HIST1H2AA;H2AFX6 1 169 0.914 5 1.2117 1.64 +10
P49588;P49588-2;H3BPK7P49588;P49588-2 Alanine--tRNA ligase, cytoplasmicAARS 37 37 968 0.91414 1.2464 4.28E+09
G5E975;Q12824-2;A0A0U1RQQ2G5E975;Q12824-2;A0A0U1RQQ2SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1SMARCB1 6 1 394 0.914 1.0441 9.38E+08
Q99570;D6RJ98;D6RAC3;D6RBB7Q99570 Phosphoinositide 3-kinase regulatory subunit 4PIK3R4 16 16 1358 0.91379 0.96865 2.81E+09
Q5SWX3;A0A0A0MS52;A0A0A0MT11;Q13555-10;Q13555-3;Q13555-5;Q13555-4;Q13555-7;Q13555-9;Q13555-2;Q13555-8;Q13555;Q13555-6;Q8WU40;H0Y6G2Q5SWX3; A0A0MS52;A0A0A0MT11;Q13555-10;Q13555-3;Q13555- ;Q13555-4;Q13555-7;Q13555-9;Q13555-2; 8; 13555;Q13555-6;Q8WU40;H0Y6G2Calcium/calmodulin-dependent protein kinase type II subunit gammaCAMK2G 8 3 16 0.91361 1.0155 5.90E+08
O75083;O75083-3;D6RD66O75083;O75083-3;D6RD66WD repeat-containing protein 1WDR1 21 21 606 0.91356 1.2696 6.68E+09
Q92769-3;Q92769 Q92769-3;Q92769 Histone deacetylase 2HDAC2 8 4 458 0.913 0.90967 5.05E+08
Q9UMS4;F5GY56;F5H2I0;H0YGF3;H0YGZ5Q9UMS4;F5GY56 Pre-mRNA-processing factor 19PRPF19 13 13 504 0.91226 1.2214 3.90E+09
Q9BW27;J3KT10;Q9BW27-3;J3QL54;Q9BW27-2;F5H0W7;J3KRC0;J3QLD4;J3QLH0;J3KSH3;J3QLV0;J3KS87;J3QL91;J3QS63Q9BW27; KT10; 9 27-3;J3QL54;Q9BW27-2Nuclear pore complex protein Nup85NUP85 12 12 656 0.91223 1.1831 1.47E+09
F8VSA6;E9PS38;S4R3E9;E9PL57;Q15843F8VSA6;E9PS38;S4R E9;E9PL57;Q15843NEDD8 NEDD8;NEDD8-MDP1 2 2 50 0.91208 0.91358 7.93E+08
Q9C0B7 Q9C0B7 Transport and Golgi organization protein 6 homologTANGO6 8 8 1094 0.91202 0.79889 2.64E+08
Q96EK5;A0A0D9SFK7Q96EK5 KIF1-binding proteinKIAA1279 10 10 621 0.91156 1.1707 1.51E+09
A8MTY9;O14972-2;O14972;A8MY26A8MTY9;O14972-2;O14972;A8MY26Down syndrome critical region protein 3DSCR3 4 4 249 0.91087 0.94278 4.09E+08
P52789;E9PB90;P52790P52789;E9PB90 Hexokinase-2 HK2 29 25 917 0.9104 1.0747 2.17E+09
O00399;E5RK00 O00399 Dynactin subunit 6 DCTN6 4 4 190 0.90996 0.90333 1.05E+08
Q8WYP5;Q8WYP5-3;Q8WYP5-2Q8WYP5;Q8WYP5-3;Q8WYP5-2Protein ELYS AHCTF1 11 11 2266 0.90965 1.381 3.71E+08
P05165-3;P05165-2;P05165P05165-3;P05165-2;P05165Propionyl-CoA carboxylase alpha chain, mitochondrialPCCA 1 1 681 0.90939 1.2929 3.60E+07
B7Z9I1;Q5T4U5;P11310;P11310-2;E9PJM9;H0YDT5;E9PRX4B7Z9I1;Q5T4U5;P11310;P11310-2Medium-chain specific acyl-CoA dehydrogenase, mitochondrialACADM 10 10 385 0.90925 1.0865 1.64E+09
Q9H2M9;F8WDJ2;Q9H2M9-2Q9H2 9 Rab3 GTPase-activating protein non-catalytic subunitRAB3GAP2 21 21 1393 0.90878 1.198 2.14E+09
Q7Z417 Q7Z417 Nuclear fragile X mental retardation-interacting protein 2NUFIP2 2 695 0.90871 0.96427 8.52E+07
148
J3KMX1;Q99567 J3KMX1;Q99567 Nuclear pore complex protein Nup88NUP88 5 5 696 0.90868 1.1593 3.72E+08
Q96FX7;H0Y2Q1 Q96FX7;H0Y2Q1 tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61ATRMT61A 5 5 289 0.90826 1.2243 4.66E+08
F5H7K1;E7EWW0;Q7Z3J2;C9J7I2;Q7Z3J2-2;H3BVG8;H3BV68;I3L1U5;H3BNX2;F6S1J4F5H7K1;E7EWW0;Q7Z3J2;C9J7I2;Q7Z3J2-2;H3BVG8;H3BV68UPF0505 protein C1 orf62C16orf62 7 7 959 0.9079 1.1919 2.45E+08
P54886-2;P54886 P54886-2;P54886 Delta-1-pyrroline-5-carboxylate synthase;Glutamate 5-kinase;Gamma-glutamyl phosphate reductaseALDH18A1 32 32 793 0.90767 1.2331 8.09E+09
Q13907;Q13907-2;C9JD53;C9JKM8Q13907;Q13907-2 Isopentenyl-diphosphate Delta-isomerase 1IDI1 8 8 227 0.90757 0.96475 1.45E+09
Q9Y2T2;E5RJ52;P53677;H0YBM0;H0YBA0;E7ER80;P53677-2Q9Y2T2 AP-3 complex subunit mu-1AP3M1 8 8 418 0.9075 0.98646 7.02E+08
P46736-2;P46736-3;P46736;P46736-5;X6RJS7;A0A087WZR3;H9KVA9;A0A0D9SF50;A0A0A0MS96;P46736-4P46736-2; 3;P46736;P46736-5;X6RJS7;A0A087WZR3;H9KV 9; 0A0D9SF50Lys-63-specific deubiquitinase BRCC36B CC3 9 9 291 0.90734 1.1263 9.58E+08
Q5T760;Q05519-2;Q05519;B4DWT1;S4R3C45T760;Q05519-2;Q05519;B4DWT1Serine/arginine-rich splicing factor 11SRSF11 3 3 389 0.9067 1.3598 4.06E+08
P02545-2;P02545-6;P02545;Q3BDU5;P02545-3;Q5TCI8;P02545-5;P02545-4;H0YAB0;A0A0C4DGC5P02545-2;P02545-6;P02545; 3BDU5;P02545-3;Q5TCI8;P02545-5;P 2545-4relamin-A/C;Lamin-A/CLMNA 11 10 572 0.90634 1.2278 2.12E+08
P18754;P18754-2;C9JW69;C9JRH2;C9JMJ4;C9J3R0;C9JQZ4P18754;P18754-2;C9JW69;C9JRH2;C9JMJ4;C9J3R0;C9JQZ4Regulator of chromosome condensationRCC1 12 12 421 0.90632 1.4388 4.40E+09
G3V582;F5H039;Q9NQX3;Q9NQX3-2;G3V4D2;G3V4R0;G3V355;H0YJ30G3V582;F5H039;Q9NQX3;Q9NQX3-2Gephyrin;Molybdopterin adenylyltransferase;Molybdopterin molybdenumtransferaseGPHN 3 3 380 0.90622 1.1344 1.79E+08
P31153;P31153-2;Q00266P31153;P31153-2 S-adenosylmethionine synthase isoform type-2MAT2A 12 12 395 0.9062 1.2618 2.60E+09
A3KN83-4;A3KN83-3;A3KN83-2;A3KN83A3KN83-4;A3KN83- ;A3KN83-2;A3KN83Protein strawberry notch homolog 1SBNO1 3 3 732 0.90618 1.2927 3.93E+07
K7EMT0;Q15428 K7EMT0;Q15428 Splicing factor 3A subunit 2SF3A2 2 2 135 0.90601 1.0992 1.07E+08
P35579;P35579-2;Q5BKV1;B1AH99;REV__S4R3H4;REV__E7EQT4;REV__Q9UKV3-5;REV__Q9UKV3P35579 P3557 -2 Myosin-9 MYH9 107 89 1960 0.906 1.1298 2.46E+10
A0A087WTA5;E7ERK9;Q9UI10-3;Q9UI10;Q9UI10-2;A0A087WW69;F8W8L6;H7C2L8A0A087WTA5;E7ERK9;Q9UI10-3;Q9UI10;Q9UI10-2;A0A08 WW69Translation initiation factor eIF-2B subunit deltaEIF2B4 9 9 520 0.90597 0.86137 8.63E+08
O75340-2;O75340;A0A024QZ42;H0Y9X3;A0A087WZ38O75340-2;O75340;A0 024QZ42Programmed cell death protein 6PDCD6;hCG_1985580 5 5 189 0.90591 1.2719 3.20E+08
P42765;A0A0B4J2A4;K7EME0;K7ER88;K7EJB1;K7EJ68P42 65;A0A0B4J2A4;K7EME03-ketoacyl-CoA thiolase, mitochondrialACAA2 19 19 397 0.9057 0.90945 2.68E+09
Q12769;G3V198;E9PR16;Q12769-3;Q12769-2;E9PSI3Q12769;G3V198;E9PR16Nuclear pore complex protein Nup160NUP160 31 31 1436 0.90552 1.1248 3.44E+09
P13995;B9A062;P13995-2;B8ZZU9P13995; 9A062;P13995-2Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial;NAD-dependent methylenetetrahydrofolate dehydrogenase;Methenyltetrahydrofolate cyclohydrolaseMTHFD2 6 6 350 0.90542 1.3117 7.26E+08
Q13151 Q13151 Heterogeneous nuclear ribonucleoprotein A0HNRNPA0 18 18 305 0.90516 1.2027 4.84E+09
P23919-2;P23919;H7BZ20;H7C312;G5E9E9;H7C3A4P23919-2;P23919;H7BZ20;H7C312Thymidylate kinase DTYMK 10 10 188 0.90478 0.98157 5.60E+08
O95347;O95347-2;Q5T821;A0A0C4DGE5O95347 O95347-2 Structural maintenance of chromosomes protein 2SMC2 34 34 1197 0.90452 1.0439 3.47E+09
Q96NB2;R4GMW0;A0A0C4DGR6;R4GMR9;R4GN74;R4GNC2;R4GN63Q96NB2 Sideroflexin-2 SFXN2 6 6 322 0.90424 0.72763 2.60E+08
Q99707;Q99707-2;B1ANE3Q99707;Q99707-2 Methionine synthaseMTR 15 15 1265 0.90412 1.2276 7.72E+08
Q13356;Q13356-2 Q13356;Q13356-2 Peptidyl-prolyl cis-trans isomerase-like 2PPIL2 5 5 520 0.90402 0.84815 1.75E+08
P11274-2;P11274;H0Y554;A9UF01;I3L1U8;I3L2P5P1127 -2;P11274;H0Y554Breakpoint cluster region proteinBCR 7 6 1227 0.90389 1.0188 4.02E+08
O60573;C9JEL3;B9A044;B8ZZ50;O60573-2;B8ZZL3;B4E1E4;B9A023O60573;C9JEL3;B9A044;B8ZZ50;O60573-2;B8ZZL3Eukaryotic translation initiation factor 4E type 2EIF4E2 4 4 245 0.90384 1.3559 2.06E+08
Q96EK9 Q96EK9 Protein KTI12 homologKTI12 3 3 354 0.90376 0.95197 8.80E+07
D6RFI1;Q16643;Q16643-3;D6R9W4;Q16643-2D RFI1;Q16643;Q16 43-3;D6R9W4;Q16643-2Drebrin DBN1 2 2 124 0.90343 1.4162 2.32E+08
K7EMM8;Q49A26-5;Q49A26-4;Q49A26-2;Q49A26-3;Q49A26K7EMM8;Q49A26-5;Q49A26-4;Q49A26-2;Q49A26-3;Q49A26Putative oxidoreductase GLYR1GLYR1 1 1 524 0.90318 0.85783 1.22E+08
P26639;P26639-2;D6RCA5;D6R9F8;D6RDJ6;D6RBR8;D6RJ97;D6RHV7;D6RCS6P26639 P26639-2 Threonine--t NA ligase, cytoplasmicTARS 41 37 723 0.90316 1.1797 1.11E+10
A6NIW2;Q5JSL3;A0A0J9YW646NIW2;Q5JSL3;A0A0J9YW64Dedicator of cytokinesis protein 11DOCK11 21 21 2077 0.90307 1.2213 9.45E+08
Q6YP21-3;Q6YP21;A0A0A0MRN7;A0A0A0MRN6;Q6YP21-2Q6YP21-3;Q6YP21;A0A0A0MRN7Kynurenine--oxoglutarate transaminase 3CCBL2 7 7 420 0.90306 1.2773 6.57E+08
Q8N1F7;H3BVG0;Q8N1F7-2;H3BPA9;H3BM93;H3BRI8;H3BVE2;H3BNN5;H3BV11;H3BRD9;H3BP95;H3BMX0;H3BV15;H3BNG7Q8N1F7; 3 VG0;Q8N1F7-2Nuclear pore complex protein up9NUP93 45 45 819 0.90258 1.0417 6.90E+09
F5GZ28;P18858-3;P18858;M0R0Q7;P18858-2;B4E135F5GZ2 ;P18858-3;P1 858;M0R0Q7;P18858-2DNA ligase;DNA ligase 1LIG1 10 10 851 0.90256 0.98653 4.57E+08
P62314;J3QLI9;J3QLR7P62314;J3QLI9 Small nuclear ribonucleoprotein Sm D1SNRPD1 4 4 119 0.90176 1.1728 2.65E+09
Q9NZ32;V9GYX7;G3V2Q5;G3V5Y4;F6S9Y6;G3V524;H0YJD9Q9NZ32;V9GYX7;G3V2Q5;G3V5Y4;F6S Y6Actin-related protein 10ACTR10 6 6 417 0.90166 0.90972 2.56E+08
Q9H0A0;Q9H0A0-2;A0A087WV29;E9PMU0;E9PJN6Q9H A0;Q9H0A0-2;A0A087WV29N-acetyltransferase 10NAT10 30 30 1025 0.90136 1.0125 2.04E+09
P55084;P55084-2;F5GZQ3;B5MD38;C9JEY0;C9JE81;C9K0M0P55084;P 5084-2;F5GZQ3;B5MD38Trifunctional enzyme subunit beta, mitochondrial;3-ketoacyl-CoA thiolaseHADHB 24 24 474 0.90075 1.1305 4.73E+09
Q5VWN6;Q5VWN6-2Q5VWN6;Q5VWN6-2Protein FAM208B FAM208B 2 2 2430 0.90072 NaN 2.35E+07
P00558;P00558-2;P072050558;P00558-2 Phosphoglycerate kinase 1PGK1 35 35 417 0.9004 1.11 2.42E+10
O00116;B8ZZ81 O00116 Alkyldihydroxyacetonephosphate synthase, peroxisomalAGPS 17 17 658 0.90011 1.1078 2.92E+09
Q9UI30-2;Q9UI30;F5GX77;F5GYQ2Q9UI30-2;Q9UI30;F5GX77Multifunctional methyltransferase subunit TRM112-like proteinTRMT112 6 6 120 0.90007 1.0459 6.37E+08
C9J2Y9;P30876;C9J4M6C9J2Y9;P30876;C9J4M6DNA-directed RNA polymerase;DNA-directed RNA polymerase II subunit RPB2POLR2B 36 36 1167 0.8997 0.9731 6.48E+09
Q96SK2-3;Q96SK2-2;Q96SK2;C9JYX1;Q96SK2-4;C9J5K4Q96SK2-3;Q96SK2-2;Q96SK2;C9JYX1;Q96SK2-4Transmembrane protein 209TMEM209 3 3 519 0.89953 0.8049 1.92E+08
H0YCM7;Q5JVZ5;Q96JJ3-3;Q96JJ3;Q5JW01;H7C0N5;H7C0S6;H7C3P3;Q5JVZ8;Q5JVZ4;Q92556H0YCM7;Q5 VZ5;Q96JJ3-3;Q96JJ3;Q5JW01Engulfment and cell motility protein 2ELMO2 3 3 441 0.89927 1.1666 2.29E+08
O95104-3;O95104;A0A0A0MT33;O95104-2;Q9UPN6;Q9UPN6-2O95104-3;O95104;A0A0A0MT33;O95104-2;Q9UPN6;Q9UPN6-2Splicing factor, arginine/serine-rich 15; rotein SCAF8SCAF4;SCAF8 2 2 1132 0.89915 NaN 5.15E+07
P16152;E9PQ63;A8MTM1;P16152-2P16152;E9PQ63;A8MTM1;P16152-2Carbonyl reductase [NADPH] 1CBR1 17 15 277 0.89898 1.2581 1.66E+10
Q9NW64-2;Q9NW64;E5RJW4;E5RHA8Q9NW64-2;Q9NW64Pre-mRNA-splicing factor RBM22RBM22 9 9 371 0.89885 1.0385 6.63E+08
A0A087WU65;Q9NRW7;Q5T4Q0;Q9NRW7-2A0A087WU65;Q9NR 7;Q5T4Q0;Q9NRW7-2Vacuolar protein sorting-associated protein 45VPS45 2 2 447 0.8988 0.95511 3.10E+07
P08237;P08237-3;P08237-2;F8VP00;F8VX13;F8VNX2;F8VZQ1;F8VSL1;F8W1J8;F8VSF7;F8VW30;F8VUB8;F8VTQ3;F8VYK8;F8VZI0;F8VVE3;F8VZ53;F8VSF5;P0 237-3;P08237-2ATP-dependent 6-phosphofructokinase, muscle typePFKM 23 19 780 0. 9823 1.0827 4.79E+09
Q9H7Z3;G3V338 Q9H7Z3 Protein NRDE2 homologNRDE2 3 3 1164 0.8982 NaN 1.99E+07
F5H8F7;Q9UBL3-3;Q9UBL3;Q9UBL3-2;H0YBF6;H0YAQ0F5H8F7; 3;Q9U L3;Q9UBL3-2;H0YBF6Set1/Ash2 histone methyltransferase complex subunit ASH2ASH2L 4 4 489 0.89711 1.2381 3.02E+08
Q9NPQ8-4;Q9NPQ8;Q9NPQ8-3;Q9NPQ8-2;E9PSI0;H0YEN0;E9PI04;H0YE35;E9PLE5;H0YC88;B7WPL0;Q9NVN3-4;Q9NVN3-3;Q9NVN3;Q9NVN3-1Q9NPQ8-4;Q9NPQ8;Q9NPQ8-3;Q9NPQ8-2Synembryn-A RIC8A 11 11 530 0.89681 1.0497 1.39E+09
Q709F0;F8WEV0;D6RDI8;Q709F0-3;Q709F0-2Q709F0;F8WEV0;D6RDI8;Q709F0-3;Q709F0-2Acyl-CoA dehydrogenase family member 11ACAD11 6 6 780 0.8966 0.98485 7.10E+08
Q15031;E9PHM2;C9JYR8Q15031;E9PHM2 Probable leucine--tRNA ligase, mitochondrialLARS2 4 4 903 0.89634 1.2414 4.39E+07
Q9NXR7-4;Q9NXR7-3;Q9NXR7;Q9NXR7-1;F8W733;C9J2G0Q9NXR7-4;Q9NXR7-3;Q9NXR7;Q9NXR7-1;F8W733BRCA1-A complex subunit BREBRE 6 6 376 0.896 1.0326 1.35E+09
P60842;J3KT12;P60842-2;J3QS69;J3KTB5;J3KSZ0;J3QL43;J3KTN0;J3QR64;J3QLN6;J3KS25;J3QKZ9;J3QL52;J3KT04;J3KS93;J3KSN7;J3QQP0;E7EMV8;E9PBH4;F8WE11;C9JUF0P60842;J3KT12;P60842-2;J3QS69;J3KTB5;J3KSZ0;J3QL4Eukaryotic initiation factor 4A-IEIF4A1 33 17 406 0. 9571 1.1088 6.02E+10
A0A0C4DGQ8;Q6IAN0;J3KRS1;J3QKT1;J3QLK1;J3QLJ8A A0C4DGQ8;Q6IAN0;J3KRS1Dehydrogenase/reductase SDR family member 7BDHRS7B 10 10 310 0.89561 1.1665 1.20E+09
Q29RF7;Q29RF7-3;H0Y9L6Q29RF7 Sister chromatid cohesion protein PDS5 homolog APDS5A 15 14 1337 0.89524 1.2326 7.77E+08
P27144;D3DQ64 P27144;D3DQ64 Adenylate kinase 4, mitochondrialAK4 5 5 223 0.89523 1.011 7.60E+08
Q15654;A0A0D9SFS2Q15654;A0A0D9SFS2Thyroid receptor-interacting protein 6TRIP6 4 4 476 0.89481 0.77277 3.02E+08
R4GN43;A0A0C4DGS0;P56556R4GN43;A0A0C4DGS0;P56556NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6NDUFA6 3 3 71 0.89454 1.1611 1.69E+08
Q92922;F8WE13;F8VXC8;Q8TAQ2-2;Q8TAQ2-3;Q8TAQ2Q92922 SWI/SNF complex subunit SMARCC1SMARCC1 6 6 1105 0.89434 0.69436 1.65E+08
O15355 O15355 Protein phosphatase 1GPPM1G 9 9 546 0.89363 1.1449 9.29E+08
H0YN26;P39687;H7BZ09;Q92688-2;O43423;Q92688H0YN26;P39687 H7BZ09; -2;O43423;Q92688Acidic leucine-rich nuclear phosphoprotein 32 family member A;Acidic leucine-rich nuclear phosphoprotein 32 family member B;Acidic leucine-rich nuclear phosphoprotein 32 family member CANP32A;ANP32B;ANP32C 2 2 177 0.89293 1.3523 7.59E+07
Q9P260-2;A0A075B785;Q9P260Q9P260-2;A A075B785;Q9P260LisH domain and HEAT repeat-containing protein KIAA1468KIAA1468 3 3 1250 0.8925 0.59969 8.56E+07
H0YCY8;P53634;P53634-2;P53634-3H0YCY8; ;P53634-2;P53634-3Dipeptidyl peptidase 1;Dipeptidyl peptidase 1 exclusion domain chain;Dipeptidyl peptidase 1 heavy chain;Dipeptidyl peptidase 1 light chainCTSC 2 2 245 0.89185 1.2609 5.57E+07
Q7Z2Z2-2;Q7Z2Z2 Q7Z2Z2-2;Q7Z2Z2 Elongation factor Tu GTP-binding domain-containing protein 1EFTUD1 10 10 1069 0.89153 1.0337 2.76E+08
O43615;M0QXU7;M0R301;M0QXM9;M0R124O43615; 0 XU7 Mitochondrial import inner membrane translocase subunit TIM44TIMM44 21 21 452 0.89139 1.312 3.75E+09
Q6PI48 Q6PI48 Aspartate--tRNA ligase, mitochondrialDARS2 22 22 645 0.89137 1.2444 5.28E+09
B4DLN1;F6QW41 B4DLN1 MRPL12 12 0 442 0.89096 1.1126 4.05E+09
Q6IA86-4;Q6IA86-2;Q6IA86-3;Q6IA86-5;Q6IA86;Q6IA86-6;Q6IA86-7;F5GX79Q6IA86-4;Q6IA86-2;Q6IA86-3;Q6IA86-5;Q6IA86;Q6IA86-6;Q6IA86-7Elongator complex protein 2ELP2 4 4 705 0.89094 0.88027 1.05E+08
I3L2B0 I3L2B0 CLUH 36 2 1236 0.89071 0.84018 1.47E+07
O75152;E9PQ61;E9PBY7O75152;E9PQ61;E9PBY7Zinc finger CCCH domain-containing protein 11AZC3H11A 15 15 810 0.89069 0.89583 7.60E+08
O15164-2;O15164;A0A087X1V3O15164-2;O15164;A0A087X1V3Transcription intermediary factor 1-alphaTRIM24 3 3 1016 0.89014 0.71302 9.47E+07
Q5VZU9;P29144 Q5VZU9;P29144 Tripeptidyl-peptidase 2TPP2 22 22 1262 0.89012 1.0261 1.36E+09
Q9NR50;Q9NR50-3;Q9NR50-2;H0Y580;A0A0D9SEN0Q9NR50;Q9NR50-3;Q9NR50-2Translation initiation factor eIF-2B subunit gammaEIF2B3 7 7 452 0.88987 1.2679 5.87E+08
Q8NAV1 Q8NAV1 Pre-mRNA-splicing factor 38APRPF38A 4 4 312 0.88962 1.5511 2.28E+08
A0A0J9YXM6;Q562E7-4;Q562E7;E9PDG3;Q562E7-2;Q562E7-6;Q562E7-5;Q562E7-3A0A0J9YXM6;Q562E7-4;Q562E7WD repeat-containing protein 81WDR81 4 4 1940 0.88909 0.87488 6.99E+07
Q00796;H0YLA4;H0YKB3;Q00796-2Q00796;H0YLA4 Sorbitol dehydrogenaseSORD 9 9 357 0.88902 1.1798 2.08E+09
Q9H2G2-2;Q9H2G2;O94804Q9H2G2-2;Q9H2G2STE20-like serine/threonine-protein kinaseSLK 18 18 1204 0.88889 0.93361 4.02E+08
Q9Y490 Q9Y490 Talin-1 TLN1 21 20 2541 0.88845 0.91266 1.66E+09
Q9H832-2;Q9H832;I3L4C5Q9H832-2;Q9H832Ubiquitin-conjugating enzyme E2 ZUBE2Z 4 4 246 0.88839 1.1893 1.91E+08
Q9UI12-2;Q9UI12;G3V126;E5RK31;E5RJG1;A0A0D9SG68;E5RG49;E5RHH0Q9UI12-2;Q9UI12;G3V 26V-type proton ATPase subunit HATP6V1H 8 8 465 0.8882 1.1184 6.15E+08
A0A0A0MTN0;Q13617;Q13617-2;Q5T2B5;Q5T2B7A0A0A0MTN0; 13617 1361 -2;Q5T2B5Cullin-2 CUL2 8 8 758 0.88794 1.3815 4.43E+08
Q13136-2;Q13136;E9PJZ7;H0YEF9;H0YDW2Q13136-2;Q13136;E9PJZ7Liprin-alpha-1 PPFIA1 7 7 1185 0.88729 0.96213 3.17E+08
Q16186;A0A087WX59;A0A087WUX6Q16186;A0A087WX59Proteasomal ubiquitin receptor ADRM1ADRM1 3 3 407 0.88728 1.2252 3.17E+08
B3KS98;O15372;A0A087WZK9;E5RJT0;E5RFW7;E5RFH0;E5RGU4B3KS98;O15372;A0A087 ZK9Eukaryotic translation initiation factor 3 subunit HEIF3S3;EIF3H 6 6 366 0.88724 1.4434 1.64E+08
P14868;P14868-2;H7BZ35;C9J7S3;C9JLC1;H7C278;C9JQM9P14868;P14868-2 Aspartate--tRNA ligase, cytoplasmicDARS 24 24 501 0.88718 1.1269 3.94E+09
A0A0D9SFR6;Q86XP1-5;Q86XP1-3;Q86XP1-2;Q86XP1A0A0D9SFR6;Q86XP1-5;Q86XP1-3;Q86XP1-2;Q86XP1Diacylglycerol kinase etaDGKH 5 5 1028 0.88675 1.2868 1.11E+08
Q96GA7;F8VYZ3;F8VZ97;H0YIA2;H0YID3Q96GA7;F8VYZ3 Serine dehydratase-likeSDSL 4 4 329 0.88669 1.3182 1.67E+08
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G8JLB3;Q9Y606-2;Q9Y606;F5H1S9;F5H168;F5GY32;F8W9U5;F5H1B2;F5GXL3G8JLB3;Q9Y606-2;Q9Y606;F5H1S9tRNA pseudouridine synthase;tRNA pseudouridine synthase A, mitochondrialPUS1 8 8 384 0.88613 1.1727 9.17E+08
P62318-2;P62318;H3BT13P623 8-2;P62318 Small nuclear ribonucleoprotein Sm D3SNRPD3 3 3 120 0.88611 1.2959 7.42E+09
H3BMZ9;H3BPP3;H3BP57;H3BT48;H3BUZ9;F5GX71;H3BPB8;P34949;H3BPM5;H3BNY8;H3BPU7;H3BU66;H3BN01;H3BQX0;H3BT46;B4DYB8;P34949-2H3BMZ9;H3BPP3;H3BP57;H3BT48;H3BUZ9;F5GX71;H3BPB8;P34949;H3BPM5;H3BNY8Mannose-6-phosphate isomeraseMPI 4 4 264 0.88607 1.3546 2.96E+08
Q53H96-2;Q53H96;A0A0A0MQS1;B5MD87;F8WEI0Q53H96-2; 53H96;A0A0A0MQS1;B5MD87Pyrroline-5-carboxylate reductase 3PYCRL 8 8 254 0.88601 0.78351 2.73E+08
Q9UQ80;Q9UQ80-2;F8VR77;F8W0A3;H0YIN7;F8VZ69Q9UQ80;Q9UQ80-2;F8VR77Proliferation-associated protein 2G4PA2G4 29 29 394 0.88598 1.1234 1.87E+10
F8W1R7;G3V1V0;P60660-2;P60660;J3KND3;G8JLA2;B7Z6Z4;G3V1Y7;F8VPF3;F8VZU9;F8W180;H0YI43;F8W1I5;P14649;F8VXL3F8W1R7 G3V1V ;P60660-2;P60660;J3KND3;G8JLA2;B7Z6Z4;G3V1Y7;F8VPF3;F8VZU9;F8W180Myosin light polypeptide 6PDE6H;M 6 8 8 145 0.88588 1.2975 1.03E+09
P30044-2;P30044;P30044-3;P30044-42; ;P30044-3;P30044-4eroxiredoxin-5, mitochondrialPRDX5 4 4 162 0.88588 0.96544 1.44E+08
C9JFE4;A0A096LP07;A0A096LPJ3;A8K070;Q13098-5;Q13098;Q13098-7;Q13098-6;J3QQX0;J3QS84;J3QS88;J3KTB0;J3QLE8;J3QLT0;J3QL53;J3KRE8;J3KSA5;J3KRJ4C9JFE4;A0A096LP07;A0A096LPJ3 A8K 70; 5; ;Q1 098-7 Q13098-6COP9 signalosome complex subunit 1GPS1 4 4 471 0. 8558 1.0266 3.60E+08
A8MT37;P49840;M0QYV0A8MT37;P49840;M0QYV0Glycogen synthase kinase-3 alphaGSK3A 5 4 401 0.885 0.97 3.87E+08
F2Z2U4;Q9Y4A5-2;Q9Y4A5;H0Y4W2;C9K0N1F2Z2U4;Q9 A5-2;Q9Y4A5;H0Y4W2Transformation/transcription domain-associated proteinTRRAP 28 28 3848 0.88492 1.0537 1.45E+09
A0A087WXI1;Q6NVY1;Q6NVY1-2;B9A058;F8W8A6;B8ZZZ0;H7C126;H7C400;H7BYI7;H7C1A5A0A087WXI1;Q6NVY1 Q6NVY1-2;B9A0583-hydroxyisobutyryl-CoA hydrolase, mitochondrialHIBCH 10 10 380 0.88475 1.0001 7.51E+08
P23528;E9PP50;E9PK25;G3V1A4;E9PQB7;E9PS23;E9PLJ323 28;E9PP50;E9PK25;G3V1A4;E9PQB7;E9PS23;E9PLJ3Cofilin-1 CFL1 17 13 166 0.88472 1.1873 1.28E+10
Q15018 Q15018 BRISC complex subunit Abro1FAM175B 9 9 415 0.88456 0.93608 6.92E+08
Q9NU22;Q5T795;REV__P21359-3;REV__P21359-5;REV__P21359-4;REV__J3KSB5;REV__P21359-2;REV__P21359-6;REV__P21359Q9NU 2 Midasin MDN1 76 76 5596 0.88425 1.1738 4.64E+09
O14744;O14744-5;O14744-2;O14744-3;G3V580;H0YJX6;G3V5L5;G3V2X6;O14744-4;G3V2L6;C9JSX3;G3V507;G3V2F5;H0YJ77;G3V5T6;H0YJD3;H7BZ44;O14744-5;O14744-2;O14744-3;G3V 80;H0YJX6Protein arginine N-methyltransferase 5;Protein arginine N-methyltransferase 5, N-terminally processedPRMT5 12 12 637 0.88404 1.321 1.21E+09
A6NIT2;A6NMN0;P46020-3;P46020-2;P46020A6NIT2;A6NMN ;P46020-3;P46020-2;P46020hosphorylase b kinase regulatory subunit alpha, skeletal muscle isoformHKA1 4 3 1181 0.88375 1.2538 2.35E+08
P10155;P10155-3;P10155-5;P10155-4;P10155-2;H0Y9N5;G5E9R9;D6RDN1;D6RE09;P10155-3;P10155- ;P10155-460 kDa SS A/Ro ribonucleoproteinTROVE2 16 16 538 0.88375 1.2793 2.34E+09
Q96CS3;D6RBG6 Q96CS3 FAS-associated factor 2FAF2 19 19 445 0.88368 0.99466 4.79E+09
P78371;F5GWF6;P78371-2;F8VQ14P78371;F5GWF6;P78371-2;F8VQ14T-complex protein 1 subunit betaCCT2 35 35 535 0.88335 1.1368 1.65E+10
Q96CU9-3;Q96CU9;Q96CU9-2Q96CU9-3;Q96CU9;Q96CU9-2FAD-dependent oxidoreductase domain-containing protein 1FOXRED1 2 2 472 0.88297 NaN 1.40E+08
P20700;E9PBF6;A0A0D9SFE5;A0A0D9SFY5P20700;E9PBF6;A0A0D9SFE5Lamin-B1 LMNB1 32 28 586 0.88285 1.3002 3.21E+09
Q5T6V5;Q5T6V7;Q5T6V6Q5T6V5 UPF0553 protein C9orf64C9orf64 14 14 341 0.88259 1.0487 1.56E+10
D6RE77;B7Z7Y1;A0A0A6YYB7;E9PCH4;Q8TEU7-2;Q8TEU7-5;Q8TEU7-3;Q8TEU7;Q8TEU7-4;A0A0A6YYJ1;Q8TEU7-6;Q9Y4G8D6RE77;B7Z7Y1;A0A0A6YYB7;E9PCH4;Q8TEU7-2;Q8TEU7-5; 3;Q8TEU7;Q8TEU7-4;A0A0A6YYJ1;Q8TEU7-6Rap guanine nucleotide exchange factor 6RAPG F6 6 6 1114 0.88214 1.1711 3.35E+08
H0YBP1;E7ESA6;Q05397-7;Q05397;E9PEI4;H0YB16;H0YBZ1;Q05397-2;Q05397-5;B4DWJ1;Q05397-6;E5RHD8;E5RI03;E5RJQ2;E5RG80;H0YB99;Q05397-4;Q05397-3H0YBP1;E7ESA6;Q05397-7;Q05397;E9PEI4;H0YB16;H YBZ1;Q05397-2;Q05397-5;B4DWJ1;Q05397-6Focal adhesion kinase 1TK2 7 7 1017 0.8821 0.70735 2.75E+08
F6RFD5;P60981;P60981-2F6RFD5;P60981;P60981-2Destrin DSTN 5 4 135 0.88209 1.1457 9.88E+08
Q93008-1;Q93008;O00507;O00507-2;H7C2M9Q930 8-1;Q93008 Probable ubiquitin carboxyl-terminal hydrolase FAF-XUSP9X 44 44 2554 0.88198 1.1613 4.12E+09
Q92499;Q92499-2;F1T0B3;A0A087X2G1;Q92499-3Q92499;Q92499- ;F T0B3;A0A087X2G1;Q92499-3ATP-dependent RNA helicase DDX1DDX1 24 24 740 0.88169 1.3517 3.24E+09
Q96P47;Q96P47-2;Q96P47-4;C9J975;Q96P47-3;Q96P47-6;H0Y873;Q96P47-5;C9J8Z2;H7C4F1;A0A087X044;E7ESL9;A0A087X1U1;F5GXM9;E7EUN2;Q9UPQ3-3;Q9UPQ3-2;Q9UPQ3;Q96P4 -2; 96P47-4;C J975;Q96P47- 6Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3AGA 3 5 5 875 0.88167 0.94491 3.38E+08
Q0VDF9;H7C2A1;B0YIZ1Q0VDF9 Heat shock 70 kDa protein 14HSPA14 10 10 509 0.8814 1.1853 1.43E+09
Q00839;Q00839-2;Q5RI1800839;Q00839-2 Heterogeneous nuclear ribonucleoprotein UHNRNPU 36 36 825 0.88089 1.0431 3.81E+10
Q15773;F5H0Y3;F5H7L5;F5H800Q15773 Myeloid leukemia factor 2MLF2 7 7 248 0.88056 0.92346 3.67E+08
Q9HCN8 Q9HCN8 Stromal cell-derived factor 2-like protein 1SDF2L1 3 3 221 0.87902 0.93293 2.80E+08
Q9H553;Q9H553-2;A0A0A0MTE0Q9H553;Q9H553-2Alpha-1,3/1,6-mannosyltransferase ALG2ALG2 6 6 416 0.87899 1.0057 3.13E+08
Q8NI27;A0A0C4DG98;H0Y815;F2Z2V2;H7C477;H0Y7U4;Q8NI27-2Q NI27;A0A0C4DG98T O complex subunit 2THOC2 23 23 1593 0.87844 1.168 2.07E+09
J3KN10;P42356;P42356-2;A8MTF1;A4QPH2-4;A4QPH2;Q8N8J0;A4QPH2-2J3KN10;P42356 Phosphatidylinositol 4-kinase alphaPI KA 24 24 2102 0.87801 1.0393 9.79E+08
A0A0G2JQK5;Q6DKJ4A0A0G2JQK5;Q6DKJ4Nucleoredoxin NXN 3 3 120 0.87785 1.2686 9.44E+07
A0A087WVR3;A0A087WTW0;Q96T88;Q96T88-2;A0A087WWG9A0A087WVR3;A0A087WTW0;Q96T 8;Q96T88-2E3 ubiquitin-protein ligase UHRF1UHRF1 4 4 806 0.87756 0.90771 1.66E+08
Q9UJZ1;A0A087WYB4;Q9UJZ1-2;F2Z2I8Q9UJZ1;A0A087WYB4;Q9UJZ1-2Stomatin-like protein 2, mitochondrialSTOML2 19 19 356 0.87741 1.1901 8.16E+09
V9GZ56;Q9Y4Z0;M0QXB0;U3KQK1V9GZ56;Q9Y4Z0;M0QXB0U6 snRNA-associated Sm-like protein LSm4LSM4 3 3 238 0.87712 0.95691 2.25E+08
Q7LGA3-3;Q7LGA3-2;Q7LGA3;K7EP71Q7LGA3- ;Q LGA3-2;Q7LGA3;K7EP71Heparan sulfate 2-O-sulfotransferase 1HS2ST1 2 2 229 0.87697 1.289 1.76E+08
Q13838;Q13838-2;Q5STU3;A0A0G2JJZ9;F6WLT2;A0A140T9X3;A0A0A0MT12;F6TRA5;F6S4E6;A0A140T9X9;A0A140T996;F6UJC5;A0A140TA18;F6R6M7;A0A140T973;A0A140T9K1;A0A140T9L4;F6QYI9;A0A0G2JJL7;H0Y400;A0A140T9K2;A0A140T9N3;A0A0G2JHN7;F6U6E2;F6S2B7;H0YCC613838 Q13838-2;Q5STU3;A0 G2JJZ9;F6WLT2; 0A140T9X3; 0A0A0MT12;F6TRA5;F6S4E6;A0A140T9X9;A0 140T996;F6UJC5;A0A140TA18Spliceosome RNA helicase DDX39BDDX39B 24 9 428 0.87687 1.351 5.33E+09
Q9Y696;A6PVS0;Q9NZA1-3;O15247;Q9NZA1-2;Q9NZA1;Q96NY7-2;Q96NY7Q9Y696 Chloride intracellular channel protein 4CLIC4 12 12 253 0.87632 1.0913 1.81E+09
Q969U7-2;Q969U7;K7ENR6;V9GZ55Q969U7-2;Q969U7;K7ENR6;V9GZ55Proteasome assembly chaperone 2PSMG2 7 7 233 0.87631 1.2022 2.63E+08
Q12931-2;Q12931;I3L0K7;I3L239;I3L253;I3L2D5Q12931-2;Q129 1;I3L0K7Heat shock protein 75 kDa, mitochondrialTRAP1 19 19 651 0.87624 1.447 3.76E+09
P35270 P35270 Sepiapterin reductaseSPR 7 7 261 0.87619 1.3228 2.73E+09
Q9NQE9 Q9NQE9 Histidine triad nucleotide-binding protein 3HINT3 3 3 182 0.87609 1.1264 1.29E+08
P26641;P26641-2 P26641;P26641-2 Elongation factor 1-gammaEEF1G 27 27 437 0.87575 1.3643 3.41E+10
Q13595-4;Q13595-3;Q13595;Q13595-2Q13595-4; 3;Q13595;Q13595-2Transformer-2 protein homolog alphaTRA2A 5 5 180 0.87572 1.0483 2.26E+08
Q99797 Q99797 Mitochondrial intermediate peptidaseMIPEP 2 2 713 0.87561 1.0444 4.59E+07
P00966;Q5T6L6;Q5T6L5P00966;Q5T6L6 Argininosuccinate synthaseASS1 16 16 412 0.87551 1.2151 1.70E+09
Q8NF37;A0A0G2JQ62;A0A0G2JRI7Q8NF37;A0A0G2JQ62;A0A0G2JRI7Lysophosphatidylcholine acyltransferase 1LPCAT1 7 7 534 0.87537 1.0812 4.23E+08
Q8IYB8;B1AR60 Q8IYB8 ATP-dependent RNA helicase SUPV3L1, mitochondrialSUPV3L1 14 14 786 0.87531 1.0491 1.59E+09
P30084 P30084 Enoyl-CoA hydratase, mitochondrialECHS1 11 11 290 0.87521 1.2406 1.80E+09
Q9Y6Y8;Q9Y6Y8-2;A0A0C4DH82;H7C0V8;H7C4C4;REV__H7BYP9;REV__O15068-5;REV__O15068-4;REV__O15068-3;REV__O15068-2;REV__O15068-6;REV__O15068-8;REV__O15068-10;REV__O15068-9;REV__O15068Q9Y6Y8;Q9Y6Y8-2 SEC23-interacting proteinSEC23IP 22 22 1000 0.87515 1.0956 1.33E+09
Q7KZF4;H7C597 Q7KZF4 Staphylococcal nuclease domain-containing protein 1SND1 46 46 910 0.87475 1.2544 1.23E+10
H7BYC8;Q8TCX1-3;Q8TCX1;Q8TCX1-2;E5RJK4;E5RFM8;Q8TCX1-5;Q8TCX1-4H7BYC8; 3;Q8TCX1;Q8TCX1-2Cytoplasmic dynein 2 light intermediate chain 1DYNC2LI1 3 3 318 0.87422 1.1596 1.36E+08
Q9UKD2 Q9UKD2 mRNA turnover protein 4 homologMRTO4 11 11 239 0.87415 0.93758 1.56E+09
Q96GM8;Q96GM8-2Q96GM8;Q96GM8-2Target of EGR1 protein 1TOE1 6 6 510 0.87414 1.0621 7.02E+08
P48047;H7C0C1;H7C068;H7C086P48047;H7C0C1 ATP synthase subunit O, mitochondrialATP5O 9 9 213 0.87405 1.2495 1.99E+09
Q9BST9;Q9BST9-3;Q9BST9-2Q9BST9;Q9BST9-3;Q9BST9-2Rhotekin RTKN 2 2 563 0.87385 NaN 1.00E+08
O75439;G3V0E4;F8WAZ6;F8WEA6;F8WBE1O75439;G3V0E4 Mitochondrial-processing peptidase subunit betaPMPCB 13 12 489 0.87355 1.1507 2.75E+09
P49736;H0Y8E6;F8WDM3P49736;H0Y8E6 DNA replication licensing factor MCM2MCM2 31 31 904 0.87351 1.1745 4.82E+09
Q9HB71;Q9HB71-3;B2ZWH1;Q9HB71-2Q9HB71;Q9HB71-3Calcyclin-binding proteinCACYBP 16 16 228 0.87346 1.491 7.60E+09
P35232;C9JW96;C9JZ20;E7ESE2;E9PCW0;P35232-2;D6RBK0P35232;C9JW96; 9JZ20;E7ESE2;E9PCWProhibitin PHB 15 15 272 0.87335 1.4822 1.47E+10
Q96BW9-3;Q96BW9;Q96BW9-2;A0A0G2JQ92;H7C1A2;B4E101;G3V0F3Q96BW9-3;Q96BW9;Q96BW9-2; 0A0G2JQ92Phosphatidate cytidylyltransferase, mitochondrialTAMM41 8 8 337 0.87331 1.0676 1.14E+09
P56962;E9PJW1;E9PQU9;E9PJV6;E9PIC2P56962;E9PJW1;E9PQU9;E9PJV6;E9PIC2Syntaxin-17 STX17 2 2 302 0.87263 1.0614 1.13E+08
D6R938;E9PBG7;E9PF82;Q13557-8;Q13557-12;Q13557-10;Q13557;Q13557-6;Q13557-11;Q13557-9;Q13557-5;Q13557-3;Q13557-4;H0Y9J2;H0Y9C2D6R938;E9PBG7;E9PF82;Q13557-8;Q 3557-12;Q135 7-10; ;Q 3557-6;Q13557-11;Q13557-9;Q13557-5;Q13557-3;Q13557-4Calcium/calmodulin-dependent protein kinase type II subunit deltaCAMK2D 13 9 498 .87 27 1.1237 1.51E+09
Q8WVI0 Q8WVI0 Small integral membrane protein 4SMIM4 2 2 70 0.87164 NaN 4.31E+07
Q16795;F5H0J3;H3BRM9;F5GY40Q16795 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrialNDUFA9 9 9 377 0.87159 1.3712 1.48E+09
A0A0D9SF54;A0A0D9SGF6;Q13813-3;Q13813;Q13813-2A0A0D9SF54;A0A0D9SGF6; 3;Q13813;Q13813-2Spectrin alpha chain, non-erythrocytic 1SPTAN1 6 6 2457 0.87143 1.2796 1.74E+08
O75170-6;O75170-2;O75170-4;O75170-3;O75170-5;O75170;T1ECW5;A0A0A0MSJ8O75170-6;O75170-2;O75170-4;O75170-3;O75170-5;O75170;T1ECW5Serine/threonine-protein phosphatase 6 regulatory subunit 2PPP6R2 3 3 905 0.87135 1.5156 9.22E+07
P50748;E7ES84;P50748-2;F5H5V0;H0YFL5P50748;E7ES84 Kinetochore-associated protein 1KNTC1 25 25 2209 0.87108 1.1861 1.19E+09
Q9H5X1;H0YKV4;Q9H5X1-2;H0YLH6Q9H5X1; KV4;Q9H5X1-2MIP18 family protein FAM96AFAM96A 4 4 160 0.87053 1.1261 7.54E+07
Q04656-5;Q04656;Q04656-2;Q04656-35; ;Q04656-2;Q04656-3Copper-transporting ATPase 1ATP7A 2 2 1422 0.87001 NaN 4.62E+07
A0A024RCR6;A0A0G2JK23;P46379-2;P46379;P46379-3;A0A0G2JL47;P46379-4;P46379-5;X6REW1;A0A0G2JJM1;F6S6P2;F6UR09;F6U1F2;F6XTU0;A0A0G2JJR8;F6WML8;F6VEM6;F6X9W3;F6U341;F6TC96;H0Y4L1;H0Y710;H0Y7K4;H0Y759;A0A0G2JJ92;A0A0G2JIB3;A0A0G2JIA9A0A024RCR6;A0A0G2JK23; 2;P46379;P 6379- ;A0A0G2JL47;P46379-4;P46379-5;X6REW1;A0A0G2JJM1;F6S6P2Large proline-rich protein BAGB T3;BAG6 22 22 1126 .8697 0.69301 2.82E+09
Q9NRX4;Q9NRX4-2Q9NRX4 14 kDa phosphohistidine phosphatasePHPT1 3 3 125 0.86926 1.2143 1.32E+08
J3KN66;Q5JTV8-3;A0A0A0MSK5;Q5JTV8-2;Q5JTV8;H0YD16;H0Y4R4J3KN66;Q5JTV8-3;A0A0A0MSK5;Q5JTV8-2;Q5JTV8Torsin-1A-interacting protein 1TOR1AIP1 3 3 599 0.86894 1.0862 3.40E+08
Q9Y5S9-2;Q9Y5S9;A0A0J9YW13Q9Y5S9-2;Q9Y5S9 RNA-binding protein 8ARBM8A 3 3 173 0.86859 1.095 1.65E+08
O43324;D6RBD7;C9J1V9;O43324-2;H0YAL7;D6RCQ0O43324;D6RBD7;C9J1V9;O43324-2;H0YAL7Eukaryotic translation elongation factor 1 epsilon-1EEF1E1;EEF1E1-BLOC S5 5 5 174 0.86858 1.5746 5.85E+08
P11171-2;P11171;Q4VB86;P11171-3;P11171-4;P11171-5;P11171-6;P11171-7P11171-2;P11171 Q4VB86;P11171-3;P11171-4;P11171-5;P11171-6;P11171-7rotein 4. EPB41 15 15 831 0.86812 0.99663 8.21E+08
Q9P287-2;Q9P287-4;Q9P287-3Q9P287-2;Q9P287-4;Q9P287-3BRCA2 and CDKN1A-interacting proteinBCCIP 4 1 322 0.86796 1.2408 1.61E+09
H0YH87;V9GY86;Q99700-2;Q99700-4;Q99700;F8WB06;F8VQP2;Q99700-5;F8VVY6;F8VRK6;F8W0B5H0YH87 V GY86;Q99700-2;Q99700-4;Q99700;F8WB06 QP2;Q99700-5Ataxin ATXN 9 9 916 0.86775 0.69619 2.66E+08
Q9UFC0;H7C5S6;F8WDB4;H7C5N7Q9UFC0;H7C5S6 Leucine-rich repeat and WD repeat-containing protein 1LRWD1 5 5 647 0.86772 1.0719 4.00E+08
P84095;F8WET9;B1AH79;G3V4H1;G3V476;A0A0C4DH03;Q9H4E5-2;P17081;Q9H4E5P84095 Rho-related GTP-binding protein RhoGRHOG 8 7 191 0.86761 1.1028 1.99E+08
O43149;I3L141;O43149-2;O43149-3O43149 Zinc finger ZZ-type and EF-hand domain-containing protein 1ZZEF1 7 7 2961 0.86757 1.0313 2.92E+08
Q9UBS4;H7C2Y5 Q9UBS4 DnaJ homolog subfamily B member 11DNAJ 11 9 9 358 0.86732 1.1772 1.45E+09
A0A087X256;Q2M389;Q2M389-2;F8VYH7;F8W1W1A0A087X256;Q2M389;Q2M389-2WASH complex subunit 7KIAA1033 11 11 1174 0.86704 1.2928 5.13E+08
Q04837;A0A0G2JLD8;E7EUY5;C9K0U8Q04837;A0A0G2JLD8;E7EUY5;C9K0U8Single-stranded DNA-binding protein, mitochondrialSSBP1 8 8 148 0.86694 1.0518 7.06E+08
Q9BSJ2;Q9BSJ2-4;F2Z2B9;Q9BSJ2-3;B3KTU7;R4GMM4Q9BSJ2;Q9BSJ2-4;F2Z2B9;Q9BSJ2-3Gamma-tubulin complex component 2TUBGCP2 20 20 902 0.86668 1.0609 1.90E+09
Q9BT22;Q9BT22-2;K7EID2;K7EPU3;K7EQK1;A0A087WZJ8;Q6GMV1;C9J202Q9BT22;Q9BT22-2 Chitobiosyldiphosphodolichol beta-mannosyltransferaseALG1 6 6 464 0.86648 1.3001 1.26E+09
E9PH82;Q8NCA5-2;Q8NCA5E9PH82;Q8NCA5-2;Q8NCA5Protein FAM98A FAM98A 4 3 312 0.86647 1.2499 4.72E+08
P16435;H0Y4R2;E7EMD0;E7EWU0P16435;H0Y4R2;E7EMD0NA PH--cytochrome P450 reductasePOR 6 6 677 0.86639 1.8181 2.29E+08
Q8IY18 Q8IY18 Structural maintenance of chromosomes protein 5SMC5 10 10 1101 0.86628 1.0739 2.62E+08
150
Q9NUQ9;E5RI16;E5RK61;E5RFS4;E5RHU5;E5RGI7;E5RJE1;E5RIR8;E5RJL8;Q9NUQ9-2Q9NUQ9;E5RI16 Protein FAM49B FAM49B 3 3 324 0.86618 1.4009 2.16E+08
F5H345;P08397-2;P08397;P08397-4;P08397-3;F5GY90;F5H226;F5H0P4F5H 45; 2; ;P08397-4;P08397-3;F5GY90;F5H226Porphobilinogen deaminaseHMBS 5 5 330 0.86546 0.959 5.12E+08
Q8IUF8-4;Q8IUF8;Q8IUF8-3;Q8IUF8-2;H0Y9L8;D6RCB6Q8IUF8-4;Q8IUF8;Q8IUF8-3;Q8IUF8-2Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINAMINA 6 6 464 0.86546 1.1229 6.02E+08
Q96GW9 Q96GW9 Methionine--tRNA ligase, mitochondrialMARS2 6 6 593 0.86497 0.71018 2.36E+08
P35580;P35580-5;P35580-2;P35580-3;P35580-4;E7ERA5;A0A087X0T3;P12883;P13535;Q9Y623;P13533;P12882;P11055;Q9UKX2;A7E2Y1;P35580-5;P35580-2;P35580-3;P35580-4Myosin-10 MYH10 66 47 1976 0.86489 1.3927 6.75E+09
Q9P0J7;C9J3I2 Q9P0J7 E3 ubiquitin-protein ligase KCMF1KCMF1 3 3 381 0.86459 1.1542 2.52E+08
Q16527;F8VQR7;F8VW96Q16527;F8VQR7;F8VW96Cysteine and glycine-rich protein 2CSRP2 8 8 193 0.86448 0.81259 3.96E+07
P63104;E7EX29;B0AZS6;P63104-2;B7Z2E6;H0YB80;E7ESK7;E5RIR4;E9PD24;E7EVZ2;E5RGE1P63104;E7EX29;B0AZS6;P63104-2;B7Z2 6;H0YB80;E7ESK14-3-3 protein zeta/deltaYWHAZ 15 9 245 0.86444 1.1961 2.02E+09
Q9UBD5-3;Q9UBD5;Q9UBD5-2Q9UBD5-3;Q9UBD5;Q9UBD5-2Origin recognition complex subunit 3ORC3 4 4 568 0.86432 1.4917 2.71E+08
Q9H6K4;Q9H6K4-2Q9H6K4;Q9H6K4-2Optic atrophy 3 proteinOPA3 2 2 179 0.86425 0.99774 8.88E+07
Q8NEZ5;Q8NEZ5-3;H3BTH6;H3BRE0;H3BVA4;H3BUC1;Q8NEZ5-2;H3BTR7Q8NEZ5 Q8NEZ5-3;H3BTH6F-box only protein 22FBXO22 6 6 403 0.86412 1.2748 6.96E+08
G8JLP4;Q9Y4F3-3;Q9Y4F3-4;Q9Y4F3-5;Q9Y4F3;F8VRS5;F8VVB8;Q9Y4F3-6;Q86UP2-2;Q86UP2-3;Q86UP2-4;Q86UP2G8JLP4;Q9Y4F3-3;Q9Y4F3-4;Q9Y4F3-5;Q9Y4F3;F8VRS5;F VVB8;Q9Y4F3-6;Q86UP2-2;Q86UP2-3;Q86UP2-4;Q86UP2Meiosis arrest female protein 1;KinectinKIAA0430;KTN1 2 2 1577 0.86377 NaN 6.68E+07
Q8WWC4;H7C0V0 Q8WWC4 Uncharacterized protein C2orf47, mitochondrialC2orf47 5 5 291 0.86334 0.94207 1.57E+08
Q14498-3;Q14498-2;Q14498;G3XAC6;A0A0U1RQH7;H0Y4X3;A0A0U1RQW2;Q5QP23;Q5QP22;F8WF24;F2Z3E6;F2Z2Z5;F8WF73;A8MYG5;G3V5Z6;H0YJJ3;A0A087X122Q14498-3;Q14498-2;Q14498;G3XAC6;A0A0U1RQH7;H0Y4X3RN -binding protein 39RBM39 18 16 508 0.86295 1.2616 5.15E+09
P62316;P62316-2;K7ERG4;K7EJB5P62316;P62316-2;K7ERG4Small nuclear ribonucleoprotein Sm D2SNRPD2 12 12 118 0.86273 1.1649 1.31E+09
Q99661-2;Q99661;Q5JR89;Q5JR91;Q8N4N899661-2;Q9 661 Kinesin-like protein KIF2CKIF2C 5 4 671 0.86262 1.2528 9.29E+07
Q9HAU5;Q9HAU5-2Q9HAU5 Regulator of nonsense transcripts 2UPF2 11 11 1272 0.86262 1.0577 5.87E+08
Q15437;Q5QPE2;Q5QPE1Q15437;Q5QPE2 Protein transport protein Sec23BSEC23B 12 10 767 0.86229 1.0354 8.48E+08
Q9GZT4;I3L3N0;V9GYE8;I3L4B4;Q3ZK31;I3L4W4Q9GZT4;I3L3N0;V9GYE8;I3L4B4Serine racemase SRR 4 4 340 0.86217 1.1595 4.52E+08
P49458;E9PE20;P49458-2P 9458;E9PE20;P49458-2Signal recognition particle 9 kDa proteinSRP9 5 5 86 0.86138 1.2185 1.40E+08
Q15370;Q15370-2;A0A0B4J296;B8ZZU8;I3L0M9Q15370;Q15370-2;A0A0B4J296;B8ZZU8;I3L0M9Transcription elongation factor B polypeptide 2TCEB2 4 4 118 0.86057 0.91878 1.21E+08
P61978-3;Q5T6W2P61978-3;Q5T6W2Heterogeneous nuclear ribonucleoprotein KHNRNPK 33 1 440 0.8602 1.3393 1.01E+09
J3QRU1;P06241-3;P06241-2;P12931;P06241;P12931-2;P07947;Q573B4;H0Y3C5;J3KPD6;P07948-2;P08631-3;P08631-2;P06239;P07948;P08631-4;P08631;P06239-3J3QRU ;P06241-3; -2;P12931; 62 1;P12931-2;P07947;Q573B4;H0Y3C5;J3KPD6;P07948-2;P08631-3; 8631-2;P06239; 7948; 86 1 4;P08631;P06239-3Tyrosine-protein kinase Fyn roto-oncogene tyrosine-protein kinase Src;Tyrosine-protein kinase Yes;Tyrosine-protein kinase Lyn;Tyrosine-protein kinase HCK;Tyrosine-protein kinase LckYES1;FYN;SRC;LCK;HCK;LYN 2 2 548 0.86019 1.3278 9.47E+07
E5RJR5;P63208;E7ERH2;F8W8N3;P63208-2E5RJR5;P63208;E7ERH2;F8W8N3;P63208-2S-phase kinase-associated protein 1SKP1 4 2 163 0.85988 0.50683 3.78E+07
Q15029-2;Q15029-3;Q15029;K7EP67;K7EJ74;K7EIV5;K7EIT3Q15029-2;Q15029-3;Q15029116 kDa U5 small nuclear ribonucleoprotein componentEFTUD2 39 38 937 0.85965 1.0161 6.79E+09
Q14566 Q14566 DNA replication licensing factor MCM6MCM6 39 39 821 0.85904 1.0453 1.15E+10
A0A087X0B7;H7C3C7;Q5SQN1-2;Q5SQN1;U3KPT7;A0A087X2J6;H0Y627;Q5SQN1-3;Q5SQN1-4A0A087X0B7;H7C3C7;Q5SQN1-2;Q5SQN1;U3KPT7;A0A087X2J6;H0Y627;Q5SQN1-3;Q5SQN1-4Synaptosomal-associated protein 47SNAP47 2 2 419 0.85875 NaN 7.92E+07
Q9NXF1-2;Q9NXF1;A0A0A0MSR3Q9NXF1-2;Q9NXF1 Testis-expressed sequence 10 proteinTEX10 9 9 913 0.85872 1.0448 4.03E+08
G5EA36;P30260;P30260-2;I3L394;I3L328;F6QPS0;I3L2Z8;I3L3H6G5EA36;P30260;P30260-2Cell division cycle protein 27 homologCDC27 11 11 823 0.85869 1.028 9.35E+08
P30837;A0A0U1RQK9P30837 Aldehyde dehydrogenase X, mitochondrialALDH1B1 20 20 517 0.85779 1.228 3.50E+09
P14324-2;P14324;A0A087X1D8;A0A087WVN4;A0A087X090;A0A087WTP2P14324-2;P14324;A0A087X1D8;A0A087WVN4Farnesyl pyrophosphate synthaseFDPS 8 8 353 0.85768 1.0353 5.91E+09
P21359-2;P21359-6;P21359;H0Y465;J3KSB5;P21359-4;J3QSG6;J3KRT8;J3QQN8;P21359-3;P21359-5;K7EID4;J3KSX8P21359-2;P21359-6;P21359;H0Y465;J3KSB5;P21359-4Neurofibromin;Neurofibromin truncatedNF1 18 18 2818 0.85654 1.0661 9.21E+08
P57772;P57772-2;C9J8T0P57772;P57772-2;C9J8T0Selenocysteine-specific elongation factorEEFSEC 6 6 596 0.85603 0.92454 3.01E+08
E9PHH9;Q9BUI4 E9PHH9;Q9BUI4 DNA-directed RNA polymerase III subunit RPC3POLR3C 3 3 411 0.85574 1.3958 2.55E+08
Q5SRN1;O60508 Q5SRN1;O60508 Pre-mRNA-processing factor 17CDC40 3 3 539 0.85565 1.4187 2.76E+08
O95140;Q5JXC5 O95140 Mitofusin-2 MFN2 5 5 757 0.85564 1.0603 2.26E+08
P30520;G3V232 P30520 Adenylosuccinate synthetase isozyme 2ADSS 21 17 456 0.85557 1.0455 8.83E+09
C9JYM0;O75817 C9JYM0;O75817 Ribonuclease P protein subunit p20POP7 2 2 137 0.85554 0.95866 1.10E+08
Q13895;H7BY94;F8WBL2Q13895 Bystin BYSL 4 4 437 0.85553 NaN 7.03E+07
H0Y9R3;Q9H7D7-2;Q9H7D7H0Y9R3;Q9H7D7-2;Q9H7D7WD repeat-containing protein 26WDR26 5 5 295 0.85546 1.1346 2.25E+08
B3KT28;Q9UNN5;B1ANM7;Q9UNN5-2B3KT28; 9 5;B1ANM7;Q9UNN5-2F S-associated factor 1FAF1 3 3 464 0.85533 1.3874 1.16E+08
P62330 P62330 ADP-ribosylation factor 6ARF6 4 4 175 0.85456 1.4202 5.52E+08
Q00005-6;Q00005;Q00005-2;P63151;Q00005-3;Q66LE6;P63151-2;Q00005-4;Q00005-5;Q00005-7;E5RIY1;H0YB06;E5RFR96;Q00005 2 P 3151;Q00005-3; 66LE6;P63151-2;Q00005-4;Q00005-5;Q00 05-7;E5RIY1;H0YB06;E5RFR9Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform;Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform;Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoformPP2R2B;PPP2R2A;PPP2R2D 2 2 432 0.8544 N N 1.09E+08
P48735;P48735-2;H0YL11;C9J4N6P48735;P48735-2 Isocitrate dehydrogenase [NADP], mitochondrialIDH2 19 18 452 0.85391 1.1558 4.33E+09
H7C3X5;E9PNU4;Q13190-3;Q13190-2;Q13190-4;Q13190H7C3X5;E9PNU4;Q13190-3;Q13190-2;Q13190-4;Q13190Syntaxin 5 STX5 1 1 158 0.85335 NaN 1.24E+07
O43264;O43264-2;F5H3C1O43264;O43264-2 Centromere/kinetochore protein zw10 homologZW10 4 4 779 0.85295 1.3849 3.79E+08
Q96IU4;B4DQI4;F8W9U3;Q96IU4-2Q96IU4;B4DQI4;F8W9U3Alpha/beta hydrolase domain-containing protein 14BABHD14B 9 9 210 0.8525 1.1388 1.17E+09
P25098;E9PRV7;P35626;Q8N433P25098;E9PRV7;P35626Beta-adrenergic receptor kinase 1;Beta-adrenergic receptor kinase 2ADRBK1;ADRBK2 3 3 689 0.85232 1.133 8.62E+07
Q14573;B7ZMI3 Q14573 Inositol 1,4,5-trisphosphate receptor type 3ITPR3 9 6 2671 0.8523 1.1156 1.89E+08
Q08752;H0Y8J0 Q08752 Peptidyl-prolyl cis-trans isomerase DPPID 7 7 370 0.85121 1.635 2.86E+08
O75475 O75475 PC4 and SFRS1-interacting proteinPSIP1 1 1 530 0.85077 1.3187 4.93E+07
P50990;P50990-2;P50990-3;H7C4C8;H7C2U0;P50990-2 P50990-3T-complex protein 1 subunit thetaCCT8 44 44 548 0.85041 1.1863 3.43E+10
Q99961-3;Q99961-2;Q99961;M0R2K6;M0QYE0;M0R0I3Q99961-3;Q99961-2;Q99961;M0R2K6;M0QYE0;M0R0I3Endophilin-A2 SH3GL1 2 2 304 0.84988 NaN 6.77E+07
P62487;E9PIU7;H0YEE4;E9PKH3P62487 DNA-directed RNA polymerase II subunit RPB7POLR2G 3 3 172 0.84978 1.0017 7.59E+07
O00303;H0YDT6;E9PQV8;A0A0D9SEZ9O00303 Eukaryotic translation initiation factor 3 subunit FEIF3F 14 14 357 0.8495 1.4837 1.09E+10
B1AHR1;Q9UH03-2;Q9UH03;B1AHR2B1AHR1;Q9UH03-2;Q9UH03;B1AHR2Neuronal-specific septin-3 03-Sep 3 3 294 0.84947 1.2521 1.19E+08
Q04917;A2IDB2;F8WEB6;A2IDB1Q04917;A2IDB2 14-3-3 protein eta YWHAH 9 5 246 0.84929 0.9794 8.24E+07
Q00587-2;Q00587 Q00587-2;Q00587 Cdc42 effector protein 1CDC42EP1 2 2 384 0.8491 NaN 9.38E+07
Q6KC79-2;Q6KC79 Q6KC79-2;Q6KC79 Nipped-B-like proteinNIPBL 6 6 2697 0.84885 0.98052 2.13E+08
Q13347;Q5TFK1 Q13347 Eukaryotic translation initiation factor 3 subunit IEIF3I 15 15 325 0.8488 1.273 3.82E+09
O75369-2;O75369-9;O75369;O75369-8;O75369-6;O75369-3;E7EN95;O75369-7;O75369-5;O75369-4;A0A0C4DGA1;H7C5L4;A0A0A0MT44O75369-2; 9; ;O75369-8;O75369-6; 3;E EN95;O75369-7;O75369-5;O75369-4Filamin-B FLNB 60 54 2578 0.84849 1.1957 5.10E+09
Q7L576;Q7L576-2;A0A0G2JR96;A0A0G2JQT1;Q7L576-3;H0YL50;A0A0G2JRX2;A0A087WU52;A0A0G2JRV9;A0A087WWL1;A0A0G2JQH3;A0A087WVZ5;A0A087X0D6;A0A087WV63;A0A0G2JRF5;A0A087WWY5;A0A087WZL7Q7L576;Q7L576-2;A0A0G2JR96;A0A0G2JQT1Cytoplasmic FMR1-interacting protein 1CYFIP 32 19 1253 0.84806 1.1738 3.40E+09
Q9H3N1;G3V448 Q9H3N1 Thioredoxin-related transmembrane protein 1TMX1 6 6 280 0.8476 1.0134 1.40E+08
Q93100-4;Q93100-3;Q93100-2;Q93100;I3L213;I3L3F2;I3L0Z1;H3BV13;I3NHZ9;H3BQ89Q93100-4;Q93100-3;Q93100-2;Q93100Phosphorylase b kinase regulatory subunit betaPHKB 5 5 1086 0.84706 1.0737 2.56E+08
P51116;I3L1Z2 P51116 Fragile X mental retardation syndrome-related protein 2FXR2 6 4 673 0.84689 1.6507 1.24E+08
Q8TEQ6 Q8TEQ6 Gem-associated protein 5GEMIN5 33 33 1508 0.84688 1.1408 3.10E+09
P52298-3;P52298;F8WE41;C9JQX9;B3KSB0;P52298-2P52298-3;P52298;F8WE41;C9JQX9;B3KSB0;P52298-2Nuclear cap-binding protein subunit 2NC P2 4 4 103 0.84662 1.2646 2.77E+08
H0YME5;Q9P2K8-2;Q9P2K8;Q9P2K8-3H0YME5; 2;Q9P2K8Eukaryotic translation initiation factor 2-alpha kinase 4EIF2AK4 8 8 1427 0.84627 1.3298 4.55E+08
Q8IYQ7 Q8IYQ7 Threonine synthase-like 1THNSL1 4 4 743 0.84558 0.85538 1.26E+08
Q14019;H3BT58 Q14019;H3BT58 Coactosin-like proteinCOTL1 7 7 142 0.84557 1.1095 2.49E+08
P34896-2;P34896;P34896-4;P34896-3;J3KRK5;J3KRZ52; ;P34896-4;P34896-3Serine hydroxymethyltransferase, cytosolicSHMT1 8 7 444 0.8453 1.0647 7.96E+08
Q9UBF2;Q9UBF2-2 Q9UBF2;Q9UBF2-2 Coatomer subunit gamma-2COPG2 18 14 871 0.84478 1.1587 1.47E+09
O95352-3;O95352;O95352-2;H7C2R3;H7BZ92;C9JE55;H7C2J8;C9J415;C9JFF43;O95352;O9535 -2Ubiquitin-like modifier-activating enzyme ATG7ATG7 3 3 623 0.8444 1.2929 3.43E+08
A0A087X0S7;A0A087WTU1;A0A0B4J2G4;Q15345-3;Q15345A0A087X0S7;A0A087WTU1;A0A0B4J2G4;Q15345-3;Q15345Leucine-rich repeat-containing protein 1LRRC41 2 2 521 0.84433 NaN 1.41E+08
O75165;H0Y8Q2;H0YA63O75165 DnaJ homolog subfamily C member 13DNAJ 13 32 32 2243 0.84396 1.2132 1.50E+09
P51665;H3BNT7;H3BTM8;H3BQV2P51665;H3BNT7;H3BTM826S proteasome non-ATPase regulatory subunit 7PSMD7 7 7 324 0.84385 1.2516 4.14E+08
Q12904;Q12904-2;D6R937Q12 04;Q12904-2 Aminoacyl tRNA synthase complex-interacting multifunctional protein 1;Endothelial monocyte-activating polypeptide 2AIMP1 12 12 312 0.8436 1.1526 5.95E+09
O60547-2;O60547 O60547-2;O60547 GDP-mannose 4,6 dehydrataseGMDS 6 6 342 0.84354 1.4044 2.65E+08
P11413;P11413-3;P11413-2;E9PD92;E7EM57;E7EUI8;P11413-3;P11413-2;E9PD92;E7EM57;E7EUI8Glucose 6-phosphate 1-dehydrogenaseG6PD 9 9 515 0.84346 1.4121 9.18E+08
O60306;H0YH15;H0YLN9O60306 Intron-binding protein aquariusAQR 22 22 1485 0.84331 1.3508 9.12E+08
P20290-2;P20290;H0Y9Y1;D6RDG3P20290-2;P20290 Transcription factor BTF3BTF3 3 3 162 0.84327 1.2734 2.37E+08
Q9NZ01;M0R3C3;Q9NZ01-2;M0QXM3;M0R329;B4DR74Q9NZ01 Very-long-chain enoyl-CoA reductaseTECR 12 12 308 0.84317 0.97278 1.70E+09
O75794;X6RKY7;X6RF82;X6RA30;H7BZW7O75794;X6RKY7;X6RF82;X6RA30Cell division cycle protein 123 homologCDC123 4 4 336 0.84314 1.1492 3.08E+08
P07237;H7BZ94;I3L398;H0Y3Z3;I3L312;I3L4M2;I3NI03;I3L3U6;I3L0S0;I3L514;I3L3P5;I3L1Y5P07237;H7BZ94;I3L398;H0Y3Z3Protein disulfide-isomeraseP4HB 16 16 508 0.84256 1.5029 1.95E+09
M0QXN5;P37198 M0QXN5;P37198 Nuclear pore glycoprotein p62NUP62 3 3 446 0.84235 NaN 1.04E+08
P31939-2;P31939;F8WEF0;C9JLK0;H7C1S2P31939-2;P31939 Bifunctional purine biosynthesis protein PURH;Phosphoribosylaminoimidazolecarboxamide formyltransferase;IMP cyclohydrolaseATIC 9 9 591 0.84226 0.97441 5.76E+08
B0QY89;Q9Y262-2;Q9Y262;B0QY90;H7C3A0;C9JHP4;C9K0Q7;H0Y7E6B0QY89;Q9Y262-2;Q9Y262;B0QY90Eukaryotic translation initiation factor 3 subunit LEIF3L 12 12 607 0.84145 1.418 1.24E+09
Q9NXX6;Q9NXX6-2;Q8N140Q9NXX6 Non-structural maintenance of chromosomes element 4 homolog ANSMCE4A 3 3 385 0.84135 0.98245 1.37E+08
J3KMZ7;Q9H0H0 J3KMZ7;Q9H0H0 Integrator complex subunit 2INTS2 6 6 1196 0.84106 1.3001 2.38E+08
Q9NWH9;H0YLW7;H0YMW8;H0YNF3;H0YMR6;H0YLE6;H0YL55;H7BXE3;H7C3F4;Q9NWH9-3Q9NWH9 LW7;H0Y W8;H0YNF3;H0YMR6;H0YLE6;H0YL55;H7BXE3SAFB-like transcription modulatorS T 3 3 1034 0.84097 1.2559 2.82E+07
E7ET15;O15042-3;O15042-2;O15042;H7C4V2E7ET15;O15042-3;O1504 -2;O15042U2 snRNP-associated SURP motif-containing proteinU2SURP 4 4 1028 0.84096 1.0382 1.09E+08
P41091;Q2VIR3;F8W810;Q2VIR3-2;H7BZU1P41091;Q2VIR3 F8W810;Q2VIR3-2Eukaryotic translation initiation factor 2 subunit 3;Putative eukaryotic translation initiation factor 2 subunit 3-like proteinEIF2S3;EIF2S3L 17 17 472 0.8408 1.0803 6.69E+09
Q5T0A6;Q86SQ9-3;Q86SQ9-4;Q86SQ9;Q86SQ9-2;H0Y4T1;Q5T0A35T0A6;Q86SQ9-3; 4;Q86SQ9; 86SQ9-2Dehydrodolichyl diphosphate synthaseDHDDS 3 3 169 0.84034 1.034 5.96E+07
151
F8W9T3;O95219;O95219-2F8W9T3;O95219 Sorting nexin-4 SNX4 3 3 155 0.84029 NaN 1.65E+07
H7BXZ6;Q8IXI2-4;Q8IXI2;Q8IXI2-5;Q8IXI2-2;Q8IXI2-7;Q8IXI2-3;Q8IXI2-6;K7EIQ7H7BXZ6;Q8IXI2-4;Q8IXI2; 8IXI2-5; 8IXI2-2; 8IXI2-7;Q8IXI2-3;Q8IXI2-6Mitochondrial Rho GTPase;Mitochondrial Rho GTPase 1TMEM91;RHOT1 3 2 597 0.83994 1.2141 1.77E+08
P26374;P24386 P26374;P24386 Rab proteins geranylgeranyltransferase component A 2;Rab proteins geranylgeranyltransferase component A 1CHML;CHM 2 2 656 0.8398 NaN 3.26E+07
Q6P587;Q6P587-2;Q6P587-3;Q6P587-2;Q6P587-3Acylpyruvase FAHD1, mitochondrialFAHD1 3 3 224 0.83914 0.87254 4.55E+08
G5EA30;Q92879-2;Q92879-3;Q92879-6;Q92879;Q92879-4;Q92879-5;E9PQK4;E9PSH0;E9PKU1;E9PKA1;F5H4Y5;F5H0D8;V9GYD9;Q5VZZ6;A0A0J9YX66;E9PC62;A0A0J9YXJ0;O95319-5;O95319-2;O95319;O95319-4;O95319-3G5EA30;Q92879-2;Q92879-3; 6; ;Q92879- Q92879-5;E9PQK4;E9PSH0;E9PKU1CUGBP Elav-like family member 1CELF1 7 7 514 0.83901 1.1977 8.71E+07
Q8NBU5;Q8NBU5-2Q8NBU5 ATPase family AAA domain-containing protein 1ATAD1 3 3 361 0.83863 0.90143 1.65E+08
Q9NRX1;F8WBJ6 Q9NRX1;F8WBJ6 RNA-binding protein PNO1PNO1 5 5 252 0.83852 1.0823 5.07E+08
O95470;H0Y3V8;H7BXL7O95470;H0Y3V8;H7BXL7Sphingosine-1-phosphate lyase 1SGPL1 6 6 568 0.83849 1.1707 1.43E+08
Q7L523;Q5VZM2-2;Q5VZM0;Q5VZM27L523;Q5VZM2-2;Q5VZM0;Q5VZM2Ras-related GTP-binding protein A;Ras-related GTP-binding protein BRRAGA;RRAGB 4 4 313 0.83763 1.2036 2.75E+08
A0A087WVZ9;P19388;A0A087WWX0;A0A0A0MQR7;A0A087WVN5A0A087WVZ9;P19388;A0A087WWX0;A0A0A0MQR7DN -directed RNA polymerases I, II, and III subunit RPABC1POLR2E 5 5 184 0.83759 0.87213 1.69E+08
H0YDT0;Q96D71-2;Q96D71-4;Q96D71-3;Q96D71;H0YCR2;E9PMG1;H0YE89;H0YCF0;H7C1V2H0Y T0;Q96D71-2;Q96D71-4;Q96D71-3;Q96D71;H0YCR2;E9PMG1RalBP1-associated Eps domain-containing protein 1R PS1 3 3 754 0.83723 0.78944 1.01E+08
Q9HCN4;Q9HCN4-3;Q9HCN4-2;Q9HCN4-4;Q9HCN4-5;F8WD09Q9HCN4;Q9HCN4-3;Q9HCN4-2;Q9HCN4-4;Q9HCN4-5GPN-loop GTPase 1 GPN1 3 3 374 0.837 NaN 1.42E+08
Q8N201 Q8N201 Integrator complex subunit 1INTS1 16 16 2190 0.83687 1.736 7.00E+08
P57088;D6RAA6;H0Y8N0;J3KN43;D6RBY2P57088;D6RAA6 Transmembrane protein 33TMEM 3 8 8 247 0.83685 1.1192 3.24E+09
Q96HC4;Q96HC4-7;Q96HC4-4;Q96HC4-6;A0A0D9SFR4;H0YBI4;H0Y8Y3;Q96HC4-3;Q96HC4-2;H0Y929;A0A0A0MSP3Q96HC4;Q96HC4-7;Q96HC4-4;Q96HC4-6;A0A D9SFR4;H0YBI4 H0Y8Y3;Q96HC4-3;Q96HC4-2PDZ and LIM domain protein 5PDLIM5 6 596 0.83669 1.1898 3.03E+08
P09936;D6RE83;D6R956;D6R974;D6RF53P09936;D6RE83;D6R956;D6R974Ubiquitin carboxyl-terminal hydrolase isozyme L1UCHL1 12 12 223 0.8364 1.4304 9.12E+08
Q96RG2;Q96RG2-2;Q96RG2-4Q96RG2;Q96RG2-2;Q96RG2-4PAS domain-containing serine/threonine-protein kinasePASK 4 4 1323 0.83631 0.99476 1.53E+08
F5H4B6;Q8IZ83-3;Q8IZ83;M0QY06F5H4B6;Q8IZ83-3;Q8IZ83Aldehyde dehydrogenase family 16 member A1ALDH16A1 6 6 639 0.83623 0.98689 4.31E+08
P56134-3;P56134 P56134-3;P56134 ATP synthase subunit f, mitochondrialATP5J2 4 2 55 0.83606 1.5272 5.77E+08
P61586;C9JNR4;C9JX21;Q5JR06;Q5JR07;E9PN11;Q5JR05;U3KQA9;U3KQV3;E9PLA2;C9JRM1;P62745P61586;C9JNR4;C9JX21Transforming protein RhoRHOA 6 3 193 0.83567 1.5501 3.71E+08
Q14694;Q14694-3;Q14694-2;J3KT19;H3BQP1;H3BNS8;H3BNA1;Q14694-3;Q14694-2Ubiquitin carboxyl-terminal hydrolase 10USP10 8 8 798 0.83566 1.0681 5.79E+08
B7Z7F3;Q9H6Z4-3;Q9H6Z4-2;Q9H6Z4;K7EMH9;K7ENJ2;K7EID7;K7ENB9;K7EPW1;K7ESQ0;K7EN31B7Z7F3;Q9H6Z4-3;Q9H6Z4-2;Q9H6Z4Ran-binding protein 3ZNF8 RANBP3 3 3 494 0.83522 NaN 5.74E+07
A0A0A0MQU1;Q27J81-2;Q27J81A0A0A0MQU1;Q27J81-2;Q27J81Inverted formin-2 INF2 6 6 717 0.83512 0.9522 1.09E+08
P48507;P48507-2 P48507;P48507-2 Glutamate--cysteine ligase regulatory subunitGCLM 6 6 274 0.83489 1.2472 9.85E+08
A0A0C4DGY8;D6RA00;A0A087WTH0;Q9UHY7-2;Q9UHY7A A0C4DGY8;D6RA00;A0A087WT 0;Q9UHY7-2;Q9UHY7Enolase phosphatase E1ENOPH1 2 2 149 0.83469 1.3467 3.61E+08
Q9Y241;Q9Y241-2;C9JAW5;C9JNU6;A8MV81Q9Y241;Q Y241-2;C9JAW5;C9JNU6HIG1 domain family member 1A, mitochondrialHIGD1A 4 4 93 0.83463 1.2461 7.61E+08
P61981 P61981 14-3-3 protein gamma;14-3-3 protein gamma, N-terminally processedYWHAG 11 6 247 0.83457 1.3019 1.48E+08
Q68EM7-2;Q68EM7;Q68EM7-6;Q68EM7-5;Q68EM7-3;Q68EM7-4;I3L4P6;C9IZD3;Q68EM7-7;I3L4P0;I3L3P1;I3L1S9;I3L4Y5;I3L460Q68EM7-2;Q68EM7;Q68EM7-6;Q68EM7-5Rho GTPase-activating protein 17ARHGAP17 9 9 803 0.8345 0.76044 3.49E+08
P54136;P54136-2;E5RJM9;E5RH09P54136;P54136-2 Arginine--tRNA ligase, cytoplasmicRARS 32 32 660 0.83423 1.2326 9.66E+09
E7ESY4;Q13330-3;Q13330;Q13330-2;H0Y4T7;H7C3F3;H0YIT0;E9PF88;F8W9Y9E7ESY4; 3;Q13330;Q13 30-2Metastasis-associated protein MTA1MTA1 9 4 703 0.83415 1.4323 4.70E+08
A6NJA2;P54578-2;P54578-3;P54578;J3QQT6;J3KS55;H0YA47A6NJA2;P54578-2;P54578-3;P54578Ubiquitin carboxyl-terminal hydrolase;Ubiquitin carboxyl-terminal hydrolase 14USP14 13 13 448 0.83411 1.1558 2.23E+09
P11717;S4R328 P11717 Cation-independent mannose-6-phosphate receptorIGF2R 5 5 2491 0.834 3.1924 7.31E+08
F5H442;Q99816;Q99816-2F5H44 ;Q99816 Tumor susceptibility gene 101 proteinTSG10 5 5 365 0.83364 1.5372 4.92E+08
P35813-2;P35813;P35813-3;E9PKB5;B8ZZF0;C9JIR6;O75688-5;O75688-4;O75688-2;O756882;P35813;P35813-3rotein phosphatase 1APPM1A 3 3 324 0.83351 1.3824 4.22E+07
P17858;P17858-2 P17858;P17858-2 ATP-dependent 6-phosphofructokinase, liver typePFKL 22 17 780 0.83332 1.2032 4.12E+09
A0A0C4DG33;O43933;O43933-2;H7BZH3A0A0C4DG33;O4393 ;O43933-2Peroxisome biogenesis factor 1PEX1 9 9 1226 0.83309 0.9617 2.75E+08
J9JIC5;Q9HAS0;J3KRR1;K7ERX0;K7EIQ2;K7EII1J9JIC5;Q9HAS0;J3KRR1Protein Njmu-R1 C17orf75 4 4 396 0.83296 1.2162 2.48E+08
C9J2I0;B8ZZY2;P52594-2;P52594-3;P52594;P52594-4C J2I0;B8ZZY2;P52594-2; 3;P52594;P52594-4Arf-GA  domain and FG repeat-containing protein 1AGFG1 2 2 238 0.8327 0.95626 1.03E+08
P45954-2;P45954 P45954-2;P45954 Short/branched chain specific acyl-CoA dehydrogenase, mitochondrialACADSB 7 7 330 0.8326 1.2329 6.08E+08
Q9BV20;Q9BV20-2 Q9BV20;Q9BV20-2 Methylthioribose-1-phosphate isomeraseMRI1 13 13 369 0.83207 1.0291 4.59E+09
Q9Y6A9;C9JBL1;X6R2S6Q9Y6A9;C9JBL1;X6R2S6Signal peptidase complex subunit 1SPCS1 2 2 102 0.83188 1.0705 6.51E+07
Q14669-4;Q14669-2;Q14669;Q14669-3;H7C2Y1Q14669-4; 2;Q14669;Q14669-3E3 ubiquitin-protein ligase TRIP12TRIP12 20 20 1722 0.83181 0.825 9.82E+08
Q7Z4L5;Q7Z4L5-2;H9KV93Q7Z4L5 Tetratricopeptide repeat protein 21BTTC21B 6 6 1316 0.83148 1.0301 2.38E+08
O43447;C9JQD4;O43447-2;H0YEL5;A6NM32O43447 C9JQD4;O43447-2;H0YEL5Peptidyl-prolyl cis-trans isomerase H;Peptidyl-prolyl cis-trans isomerasePPIH 12 12 177 0.83127 1.1363 2.09E+09
E9PFN5;Q9Y2Q3-4;Q9Y2Q3;Q9Y2Q3-3;Q9Y2Q3-2;C9JNT3E PFN5; 4; ;Q9Y2Q3-3;Q9Y2Q3-2Glutathione S-transferase kappa 1GSTK1 3 3 190 0.83097 1.2309 1.96E+08
P05976-2;P05976;P085905976-2;P05976;P08590Myosin light chain 1/3, skeletal muscle isoform;Myosin light chain 3MYL1;MYL3 1 1 150 0.83082 1.39 7.70E+07
P82912-2;P82912;H0YL99;P82912-3P82912-2;P82912;H0YL99;P82912-328S ribosomal protein S11, mitochondrialMRPS 1 4 4 193 0.83081 1.1851 1.68E+08
Q969F9-2;Q969F9;G5E9V4;H7C5G2Q969F9-2;Q969F9;G5E9V4Hermansky-Pudlak syndrome 3 proteinHPS3 3 3 890 0.83049 1.3118 1.02E+08
O00154-4;O00154-6;O00154-7;O00154;O00154-5;K7EKP8;O00154-2;O00154-3;Q6ZUV0O00154- ;O00154-6; 7;O00154; 5;K7EKP8;O00154-2;O00154-3Cytosolic acyl coenzyme A thioester hydrolaseAC T7 17 17 338 0.82988 1.3514 7.00E+09
Q13395 Q13395 Probable methyltransferase TARBP1TARBP1 11 11 1621 0.8297 1.2219 5.15E+08
C9J3L8;C9J5W0;E9PAL7;C9IZQ1;P43307-2;P43307C9J3L8;C9J5W0;E9PAL7;C9IZQ1;P43307-2;P43307Translocon-associated protein subunit alphaSSR1 2 2 265 0.8292 1.3586 1.35E+09
P62805 P62805 Histone H4 HIST1H4A 15 15 103 0.8292 1.541 3.38E+10
Q8N1B4-2;Q8N1B4;A0A0G2JIG2Q8N1B4-2;Q8N1B4Vacuolar protein sorting-associated protein 52 homologVPS52 4 4 598 0.82916 0.96434 2.60E+08
Q15555-4;Q15555-5;Q15555-3;Q15555;K7EL66;K7ERD8;Q15555-2;M0QX52;K7ENB3;C9JB30;Q9UPY8-2;Q9UPY8Q15555-4;Q15555- ;Q15555-3;Q15555;K7EL66 K7ERD8;Q15555-2Microtubule-associated protein RP/EB family member 2MAPRE2 7 7 274 0.82909 1.112 1.70E+09
O00487;C9JW37 O00487 26S proteasome non-ATPase regulatory subunit 14PSMD14 9 9 310 0.82862 1.3974 1.77E+09
Q5VYK3;J3KN16;R4GMY1;F6XAQ5;R4GMY3Q5VYK3;J3KN16 Proteasome-associated protein ECM29 homologECM29;KIAA0368 35 35 1845 0.82843 1.1332 2.55E+09
Q8WU90;F8WB26;H7C466;F8WF67Q8WU90;F8WB26 Zinc finger CCCH domain-containing protein 15ZC3H15 3 3 426 0.82807 1.102 2.40E+08
Q9BYG3;C9J808;C9J6C5;H7BZL0Q9BYG3;C9J808;C9J6C5MKI67 FHA domain-interacting nucleolar phosphoproteinNIFK 7 7 293 0.82807 1.1211 6.78E+08
O94925;C9JIJ6;B7Z509;H7C201O94925 Glutaminase kidney isoform, mitochondrialGLS 13 2 669 0.82787 1.3774 5.05E+07
A0A087WUC6;Q15005;E9PI68;E9PL01;E9PRB9;H0YE04A A087WUC6;Q15005;E9PI68;E9PL01;E9PRB9Signal peptidase complex subunit 2SPCS2 16 16 227 0.82702 1.1933 7.57E+08
O43242;O43242-2;H0YGV8O43242;O43242-2 26S proteasome non-ATPase regulatory subunit 3PSMD3 32 32 534 0.82692 1.3281 9.02E+09
O75607 O75607 Nucleoplasmin-3 NPM3 4 4 178 0.8268 1.1064 6.89E+09
P06737-2;P06737;E9PK47;P11217-2;P11217P06737-2;P06 37;E9PK4Glycogen phosphorylase, liver form;PhosphorylasePYGL 37 32 813 0.8267 1.1606 6.91E+09
A0A0B4J1Z1;C9JAB2;Q16629-3;Q16629-2;Q16629-4;Q16629A0A0B4J1Z1;C9JAB2;Q16629-3;Q16629-2;Q16629-4;Q16629Serine/arginine-rich splicing factor 7SRSF7 2 2 137 0.82655 1.1966 2.23E+08
P11142;E9PKE3;E9PNE6;P11142-2;A8K7Q2;E9PN89;E9PS65;E9PLF4;E9PQQ4;E9PQK7;E9PM13;E9PN25;E9PI6511142;E9PKE3;E9PNE6 P11142-2;A8K7Q2Heat shock cognate 71 kDa proteinHSPA8 46 19 646 0.82654 1.1627 1.03E+11
Q2NKX8;B5MDQ0 Q2NKX8;B5MDQ0 DNA excision repair protein ERCC-6-likeERCC6L 11 11 1250 0.82533 1.1813 3.53E+08
P49441;C9J128;C9J2Z6;C9J173;B8ZZF6;E7ET59;E7EUX4;E7ENF2P49441 Inositol polyphosphate 1-phosphataseINPP1 3 3 399 0.82505 1.2572 3.15E+08
Q8N3U4;Q8N3U4-2;B1AMT4;Q68DW7;Q8WVM7-2;Q8WVM7Q8N3U4;Q8N3U4-2Cohesin subunit SA-2STAG2 3 3 1231 0.8249 1.4622 4.79E+07
P84103-2;P84103;A0A087X2D0P84103-2;P84103;A0A087X2D0Serine/arginine-rich splicing factor 3SRSF3 5 5 124 0.82481 0.97329 9.96E+08
P42224;J3KPM9;P42224-2;E7EPD2;D2KFR9;E7ENM1;E9PH66;H7BZ88;H7BZB5P42224 J3K M9;P42224-2Signal transducer and activator of transcription 1-alpha/beta;Signal transducer and activator of transcriptionSTAT1 16 16 750 0.82467 1.4739 1.41E+09
P09874;Q5VX84;Q5VX85P09874 Poly [ADP-ribose] polymerase 1PARP1 53 53 1014 0.82449 1.375 3.36E+10
Q9UIC8-3;Q9UIC8;Q9UIC8-2;I3L2Q8;I3L4A2;I3L2E3;H3BUP7;I3L537Q9UIC8-3;Q9UIC8;Q9UIC8-2;I3L2Q8;I3L4A2eucine carboxyl methyltransferase 1CMT1 4 4 279 0.8242 1.074 3.45E+08
J3KRA9;Q96Q15-2;Q96Q15;Q96Q15-3;I3L400;I3L0W2;H3BQN7;Q96Q15-4J3KRA9;Q96Q15-2;Q96Q15;Q96Q15-3Serine/threonine protein kinase SMG1SMG1 3 3 3551 0.82406 1.0948 7.07E+07
Q13283;E5RIZ6;E5RH00;E5RI46;E5RIF8;E5RH42;E5RJU8;Q13283-2Q13283 Ras GTPase-activating protein-binding protein 1G BP1 11 10 466 0.824 1.2329 2.32E+09
F8VYN9;P40616-2;P40616;B4DZG7;F8VP99;F8VP63F8VYN9;P 0616-2;P40616;B4DZG7ADP-ribosylation factor-like protein 1ARL1 5 5 194 0.8236 1.2039 1.23E+09
P06493;A0A024QZP7;A0A087WZZ9;P06493-2;E5RIU6;K7ELV5;G3V31706493;A0A024QZP7;A0A087WZZ9;P06493-2;E5RIU6Cyclin dependent kinase 1CDK1;CDC2 18 16 297 0.82344 1.0767 5.58E+09
E7ESP9;P07197;E7EMV2;P07197-2;P12036-2;P12036E7ESP9;P07197 E7EMV2;P07197-2Neurofilament medium polypeptideNEFM 9 7 877 0.82313 1.7049 7.01E+08
Q9NVH1-3;Q9NVH1-2;Q9NVH1;B1AK20;Q5TH61Q9NVH1-3;Q9NVH1-2;Q9NVH1DnaJ homolog subfamily C member 11DNAJ 11 7 7 507 0.82313 1.1737 5.22E+08
Q14126;J3KSI6 Q14126 Desmoglein-2 DSG2 4 4 1118 0.82308 0.94301 1.30E+08
Q96E14;I3L2E0 Q96E14 RecQ-mediated genome instability protein 2RMI2 3 3 147 0.82281 1.1936 1.09E+08
P62875 P62875 DNA-directed RNA polymerases I, II, and III subunit RPABC5POLR2L 2 2 67 0.8218 1.2131 4.86E+08
O14776-2;O14776;G3V220O14776-2;O14776 Transcription elongation regulator 1TCERG1 5 5 1077 0.82159 0.69998 1.30E+08
Q9Y277;Q9Y277-2;E5RFP6;E5RJN6;E5RHZ6;E5RK27;E5RFL1;E5RHE1Q9Y277;Q9Y277-2 Voltage-dependent anion-selective channel protein 3VDAC3 8 8 283 0.82149 1.4916 5.05E+09
O43809;H3BND3;H3BV41O43809;H3BND3 Cleavage and polyadenylation specificity factor subunit 5NUDT21 4 4 227 0.82116 1.3831 7.72E+07
B1AHQ7;B1AHQ6;Q9NSP4-4;Q9NSP4-2;Q9NSP4B1AHQ7;B1AHQ6;Q9NSP4- ;Q9NSP4-2;Q9NSP4Centromere protein MCENPM 2 2 73 0.82086 1.7516 1.02E+08
Q8N584-2;Q8N584;G3V1P2Q8N584-2;Q8N584;G3V1P2Tetratricopeptide repeat protein 39CTTC39C 3 3 522 0.82073 0.8524 1.47E+08
P11177-2;P11177;P11177-3;C9J634;F8WF022;P11177;P11177-3;C9J634yruvate dehydrogenase E1 component subunit beta, mitochondrialPDHB 14 14 341 0.82037 1.1583 7.29E+09
H0YNG3;P67812-4;P67812;P67812-3;H0YNX5;P67812-2;H0YKT4;H0YNA5;P0C7V7H0YNG3; 4;P67812 3 NX5;P67812-2;H0YKT4Signal peptidase complex catalytic subunit SEC11ASEC11A 7 7 163 0.8202 1.2979 8.13E+08
Q9H845;H0Y8Z9;D6RCD8Q9H845;H0Y8Z9 Acyl-CoA dehydrogenase family member 9, mitochondrialACAD9 6 6 621 0.81962 1.5408 4.39E+08
O95456-2;O95456;F8WBH7O95456-2;O95456 Proteasome assembly chaperone 1PSMG1 6 6 267 0.81933 1.0317 1.87E+09
Q9NVI1;Q9NVI1-1;Q9NVI1-2;F8W7R3;H3BP78;H3BMG4;Q9NVI1-4;H3BT54;H3BQE2;H3BS60;H3BN35Q9NVI1;Q9NVI1-1;Q9NVI1-2;F8W7R3;H3BP78Fanconi anemia group I proteinFANCI 40 40 1328 0.81926 1.1961 3.21E+09
R4GNB2;R4GN35;Q5VZ89-6;Q5VZ89;X6RAE7;Q5VZ89-2;Q5VZ89-5;X6R5W5;Q5VZ89-4;Q5VZ89-3R4GNB2;R4GN35;Q5VZ89-6;Q5VZ89;X6RAE7;Q5VZ89-2;Q5VZ89-5DENN domain-containing protein 4CDENND4C 6 6 1909 0.81914 1.4974 1.91E+08
H7C0C7;Q9UKZ1 H7C0C7;Q9UKZ1 CCR4-NOT transcription complex subunit 11CNOT11 2 2 127 0.81865 NaN 1.35E+08
152
P22102;P22102-2;F8WD69;C9JBJ1;C9JTV6;C9JZG2;C9JKQ7;A0A140TA71;H7C366P22102 Trifunctional purine biosynthetic protein adenosine-3;Phosphoribosylamine--glycine ligase;Phosphoribosylformylglycinamidine cyclo-ligase;Phosphoribosylglycinamide formyltransferaseGART 46 46 1010 0.81766 1.19 1.30E+10
Q60FE5;P21333-2;P21333;Q5HY54;A0A087WWY3;F8WE98;H0Y5C6;H0Y5F3;H7C2E7Q60FE5;P21333-2;P21333;Q5HY54;A0A087WWY3Filamin-A FLNA 67 62 2620 0.81727 1.2522 6.74E+09
O00203-3;O00203;H0YBD0;F5GWU4;F5GYB0O 0203-3;O00203 AP-3 complex subunit beta-1AP3B1 11 8 1045 0.81693 1.6322 4.90E+08
Q6YN16;Q6YN16-2 Q6YN16;Q6YN16-2 Hydroxysteroid dehydrogenase-like protein 2HSDL2 9 9 418 0.81691 0.86075 1.06E+09
A0A0A0MRK6;Q13505-3;Q13505;A0A0C4DFQ1;Q13505-2A0A0A0MRK6;Q13505-3; 3505Metaxin-1 MTX1 3 3 466 0.81671 1.3289 2.90E+08
E9PKG1;H7C2I1;Q99873-3;Q99873-2;Q99873-4;Q99873;E9PIX6;E9PQ98;E9PNR9;H0YDE4;A0A087X1W2;E9PMW9;Q9NR22-2;Q9NR22E9PKG1;H7C2I1;Q99873- ;Q99873-2;Q 9873-4;Q99873;E9PIX6;E9PQ98;E9PNR9;H0YDE4;A0A087X1W2Protein arginine N-methyltransferase 1PRMT1 14 14 325 0.81655 1.511 3.18E+09
A0A087X2H1;Q9ULT8;H0YJP0;G3V4V5;H0YJD4;A0A087WVU6;H0YJ72;H0YJV8A0A087X2H1;Q9ULT8;H0YJP0E3 ubiquitin-protein ligase HECTD1HECTD1 33 33 2614 0.81626 0.97721 2.01E+09
B4DXW1;P61158;F8WDR7;Q9P1U1-2;Q9P1U1;Q9P1U1-3;A0A0A0MTI9;H7C4J1;C9IZN3;Q9C0K3B4DXW1;P6 158 Actin-related protein 3ACTR3 18 18 367 0.81626 1.333 3.51E+09
P12814;P12814-3;H9KV75;P12814-2;P12814-4;G3V2W4;G3V2N5;H0YJ11;H0YJW3;H7C5W8;P35609-2;P35609;G3V2X9;G3V2E8;G3V5M4P12814 3 H9KV75;P12814-2;P12814-4Alpha-actinin- ACTN 28 15 892 0.81596 1.2639 9.31E+08
Q9H1A4;H0Y564;F8WAS1Q9H1A4;H0Y564 Anaphase-promoting complex subunit 1ANAPC1 19 19 1944 0.81549 1.1673 1.01E+09
Q71DI3;Q16695;P68431;K7EMV3;B4DEB1;K7EK07;K7ES00;P84243;K7EP01;Q6NXT2Q71DI3;Q16695;P68431;K7EMV3;B4DEB1;K7EK07;K7ES00;P84243;K7EP01;Q6NXT2Histone H3.2;Histone H3.1t;Histone H3.1;Histone H3;Histone H3.3;Histone H3.3CHIST2H3A;HIST3H3;HIST1H3A; F3B;H3F3A;H3F3C6 2 136 0.81532 1.5729 2.87E+09
Q96SB8;Q96SB8-2;C9JMN1;A0A0A0MRY1Q96SB8;Q96SB8-2;C9JMN1Structural maintenance of chromosomes protein 6SMC6 9 9 1091 0.81466 1.1748 3.91E+08
Q9HB90;Q9NQL2;Q9NQL2-2Q9HB90;Q9NQL2 Ras-related GTP-binding protein C;Ras-related GTP-binding protein DRRAGC;RRAGD 7 7 399 0.81427 1.123 3.10E+08
Q14232;Q14232-2;F5H0D0;H0YGG4Q14232;Q14232-2;F5H0D0Translation initiation factor eIF-2B subunit alphaEIF2B1 12 12 305 0.81424 1.1239 1.81E+09
O15270 O15270 Serine palmitoyltransferase 2SPTLC2 2 2 562 0.81387 0.94233 1.85E+08
Q6ZW49;Q6ZW49-2;Q6ZW49-1;F8WC23;H7BZI8Q6ZW49;Q6ZW49- ;Q6ZW49-1PAX-interacting protein 1PAXIP1 5 5 1069 0.81386 0.8834 2.79E+08
P30566;A0A0A6YY92;P30566-2;A0A096LNY6;A0A096LNY5;A0A096LPA2;A0A096LNY4;B4DEP1;A0A096LP72;A0A096LP92;A0A096LNT4;V9GY96;A0A096LP76P30566;A0A0A6YY 2;P30566-2;A0A096LNY6;A0A096LNY5Adenylosuccinate lyaseADSL 16 16 484 0.81375 1.1751 5.03E+09
P62258;P62258-2;B4DJF2;I3L3T1;K7EIT4;K7EM20;I3L0W5P62258;P62258-2;B4DJF2;I3L3T11 -3-3 protein epsilonYWHAE 15 12 255 0.81301 1.0041 9.26E+08
P31946-2;P31946;Q4VY20;Q4VY19;A0A0J9YWE8;A0A0J9YWZ2P31946-2;P31946 14-3-3 protein beta/alpha;14-3-3 protein beta/alpha, N-terminally processedY HAB 10 4 244 0.81292 1.0874 1.73E+08
P31942-2;P31942;P31942-3;P31942-4;P31942-6;P31942-52; ;P31942-3;P31942-4Heterogeneous nuclear ribonucleoprotein H3HNRNPH3 7 6 331 0.81278 1.4263 1.37E+09
Q9NXV6;J3KNE1;D6RGD2Q9NXV6 CDKN2A-interacting proteinCDKN2AIP 3 3 580 0.81275 1.3036 6.71E+07
P00367;P49448;P00367-3;P00367-2P00367; 49448;P00367-3Glutamate dehydrogenase 1, mitochondrial;Glutamate dehydrogenase 2, mitochondrialGLUD1;GLUD2 9 9 558 0.81261 0.94078 5.54E+08
P21912;A0A087WXX8;A0A087WWT1P21912;A0A087WXX8;A0A087WWT1Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrialSDHB 3 3 280 0.8126 1.2365 4.03E+08
P53582;H0Y955;H0Y903P53582;H0Y955 Methionine aminopeptidase 1METAP1 4 4 386 0.81245 1.1895 1.80E+08
F8W6G1;Q9UHY1;C9JHZ6F8W6G1;Q9UHY1 Nuclear receptor-binding proteinNRBP1 3 3 543 0.81233 1.7013 3.28E+08
P62913-2;Q5VVC8;Q5VVC9P62913-2;Q5VVC8;Q5VVC960S ribosomal protein L11RPL11 11 1 177 0.81229 NaN 4.28E+06
J3QL14;R4GN72;F5GYQ1;P61421;H3BQJ1J3QL14;R4GN72;F5GYQ1;P61421;H3BQJ1V-type proton ATPase subunit d 1ATP6V0D1 2 2 232 0.81214 NaN 1.20E+08
Q5JWT2;Q9ULK4-4;Q9ULK4-5;Q9ULK4-3;Q9ULK4;Q9ULK4-2;Q9ULK4-65JWT2;Q9ULK4- ;Q9ULK4-5; 3; ;Q9ULK4-2Mediator of RNA polymerase II transcription subunit 23MED23 19 19 1374 0.81212 1.1625 1.18E+09
P49593;P49593-2;B5MCT7;A8MX49;C9J2F3;C9JL74P49593;P49593-2;B5MCT7;A8MX49Protein phosphatase 1FPPM1F 11 11 454 0.8118 0.98413 1.71E+09
P51812;B1AXG1;E9PMM7;D6R910;B1AXG2;B7Z3B5;E9PGT3;F2Z2J1;Q15418-3;Q15418-4;Q15349;Q15418;Q15349-3;Q15418-2;Q9UK32-2;Q9UK32;Q15349-2P51812;B1AXG1 Ribosomal protein S6 kinase alpha-3RPS6KA3 3 3 740 0.81154 2.0048 1.80E+08
Q9Y2A7;Q9Y2A7-2 Q9Y2A7;Q9Y2A7-2 Nck-associated protein 1NCKAP1 23 23 1128 0.81102 1.2599 2.23E+09
Q6P2E9;Q6P2E9-2;I3L2F4;I3L0V0;I3L3M2Q6P2E9;Q6P2E9-2 Enhancer of mRNA-decapping protein 4EDC4 17 17 1401 0.81098 1.005 7.97E+08
P22087;M0R299;M0QXL5;M0R0P1;M0R2Q4;M0R2U2;M0R1H0;M0R2B0P22087;M0R299;M0QXL5; 0R0P1; 0 2Q4; 0 2U2;M0R1H0;M0R2B0r NA 2-O-methyltransferase fibrillarinFBL 12 11 321 0.8109 1.1849 5.59E+09
Q8NB37;Q8NB37-2;E9PQD8;H0YF25;E9PLI5;Q8NB37-3;H0YER3;H0YE25;Q8NB37-4Q8NB37;Q8NB37-2;E9PQD ;H0YF25;E9PLI5 Q8NB37-3Parkinson disease 7 domain-containing protein 1PDDC1 3 3 220 0.81045 0.88639 1.15E+08
Q9HA77;H0YFV1;F5H623Q9HA77;H0YFV1;F5H623Probable cysteine--tRNA ligase, mitochondrialCARS2 2 2 564 0.80997 0.93566 1.44E+08
O95168;O95168-2;C9JXQ9;F2Z3P9O 5168;O95168-2;C9JXQ9;F2Z3P9NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4NDUFB4 6 6 129 0.80993 1.3247 3.75E+08
Q9P258 Q9P258 Protein RCC2 RCC2 4 4 522 0.80927 1.4843 1.33E+08
Q9UM13;D6R9Q5;D6RD74;D6RA92Q9UM13;D6R Q5;D6RD74;D6RA92Anaphase-promoting complex subunit 10ANAPC10 2 2 185 0.80924 0.89733 6.79E+07
A0A0A0MRP6;B7ZLQ5;P28370-2;P28370A0A0A0MRP6;B7ZLQ5;P28370-2;P28370Probable global transcription activator SNF2L1SMARCA1 20 7 1058 0.80911 1.5165 1.83E+08
Q71UI9;P0C0S5;C9J0D1;Q71UI9-3;Q71UI9-4;Q71UI9-2;C9J386Q71UI9;P0C0S5;C9J0D1;Q71UI9-3;Q71UI9-4;Q71UI9-2;C9J386Histone H2A.V;Histone H2A.Z;Histone H2AH2AFV;H2AFZ 5 3 128 0.80861 1.4134 5.32E+08
Q9Y315;E9PPM8;G3V158;E9PML7;E9PJ44;E9PJB9;E9PMH9Q9Y315;E9PPM8;G3V158Putative deoxyribose-phosphate aldolaseDERA 7 7 318 0.80857 1.2939 3.83E+08
Q9NTJ5;F8WCQ2;E9PGZ4;Q9NTJ5-2;C9JV50;F8WDN7Q9NTJ5;F8WCQ2;E9PGZ4;Q9NTJ5-2Phosphatidylinositide phosphatase SAC1SACM1L 4 4 587 0.80845 1.4593 1.13E+08
Q9UEW8-2;Q9UEW8Q9UEW8-2;Q9UEW8STE20/SPS1-related proline-alanine-rich protein kinaseSTK39 11 8 526 0.80826 1.0003 3.94E+08
P04843;B7Z4L4;F8WF32P04843;B7Z4L4 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1RPN1 29 29 607 0.80731 1.7769 7.28E+09
Q9Y4C2;Q9Y4C2-2;C9K0E7;C9J9F4;C9JD13Q9Y4C2;Q9Y4C2-2 Protein FAM115A FAM115A 13 13 921 0.80661 0.7864 6.80E+08
O15397;O15397-2;F5H2I3;H0YH64;F5H244O15397;O15397-2 Importin-8 IPO8 11 10 1037 0.80631 1.2456 4.83E+08
A0A0C4DGS9;Q9Y6K0A A0C4DGS9;Q9Y6K0Choline/ethanolaminephosphotransferase 1CEPT1 1 1 280 0.80598 NaN 2.13E+08
A0A0C4DGZ0;P24928;A0A087WWE2;P24928-2A0A0C4DGZ0;P24928;A0A087WWE2DN -directed RNA polymerase II subunit RPB1POLR2A 47 47 1970 0.80577 1.0969 3.08E+09
Q9NUQ8-2;Q9NUQ8Q9NUQ8-2;Q9NUQ8ATP-binding cassette sub-family F member 3ABCF3 6 6 703 0.80569 1.106 3.19E+08
A0A087WY12;Q9BQT8-2;Q9BQT8A0A087WY12;Q9BQT8-2;Q9BQT8Mitochondrial 2-oxodicarboxylate carrierSLC25A21 2 2 234 0.80565 0.9496 8.31E+07
P11441;Q5HY81 P11441;Q5HY81 Ubiquitin-like protein 4AUBL4A 3 3 157 0.80543 0.56833 3.91E+07
O75821;K7EL20;K7ER90;K7ENA8;K7EP16;K7EL60O75821;K7EL20;K7ER90;K7ENA8ukaryotic translation initiation factor 3 subunit GEIF3G 12 12 320 0.80534 1.2954 2.24E+09
P23921;E9PL69;E9PP77;H0YCY723921;E9PL69 Ribonucleoside-diphosphate reductase large subunitRRM1 20 20 792 0.80528 1.0304 1.80E+09
Q5LJA5;Q5LJA9;Q9Y5K5-2;Q9Y5K5-4;Q9Y5K5-3;Q9Y5K5;Q5LJB0;H0Y6Y4;H0Y4E0;H0Y4K0;H0Y636Q5LJA5;Q5LJA9;Q9Y5K5-2;Q9Y5K5-4; 9Y5K5-3;Q9 5K5;Q5LJB0;H0Y6Y4Ubiquitin carboxyl-terminal hydrolase isozyme L5UCHL 12 12 355 0.80516 1.4108 3.94E+09
E7EM64;Q7L5N1;H7C3T0E7EM64;Q7L5N1 COP9 signalosome complex subunit 6COPS6 4 4 326 0.80441 1.2783 3.98E+08
J3KPT4;Q9H4I3-2;Q9H4I3J3KPT4;Q9H4I3-2;Q9H4I3TraB domain-containing proteinTRABD 4 4 379 0.80438 1.0782 2.68E+08
P61163;R4GMT0 P61163;R4GMT0 Alpha-centractin ACTR1A 14 9 376 0.80407 1.3377 5.58E+09
Q969V3-2;Q969V3;K7EMW4;A0A0C4DGP7;K7ELZ9;K7ENM2;K7EQ66;K7EN96Q969V3-2;Q969V3;K7EMW4;A0A0C4DGP7;K7ELZ9Nicalin NCLN 16 16 562 0.80406 1.3898 1.07E+09
Q9UBX3;Q9UBX3-2;F6RGN5;I3L1E8Q9UBX3;Q9UBX3-2;F6RGN5Mitochondrial dicarboxylate carrierSLC25A10 8 1 287 0.80395 1.2272 1.04E+08
P53396;P53396-2;P53396-3;K7ESG8;K7EIE7;P53396-2;P53396-3ATP-citrate synthaseACLY 60 60 1101 0.80387 1.1536 3.16E+10
Q53GQ0;E9PI21;Q53GQ0-2Q53GQ0 Estradiol 17-beta-dehydrogenase 12HSD17B12 14 14 312 0.80382 1.3475 5.53E+09
Q10469 Q10469 Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferaseMGAT2 2 2 447 0.80366 0.81482 7.97E+07
O43592;F8WDU6;F5GYW6;F5GZM3O43592 Exportin-T XPOT 23 23 962 0.80338 1.2356 3.99E+09
Q8N4Q0;Q8N4Q0-2Q8N4Q0;Q8N4Q0-2Zinc-binding alcohol dehydrogenase domain-containing protein 2ZADH2 2 2 377 0.80306 1.0024 3.77E+08
Q9UBB6-2;Q9UBB6;Q9UBB6-3;C9J5H8Q9UBB6-2;Q9UBB6;Q9UBB6-3;C9J5H8Neurochondrin NCDN 3 3 712 0.80246 2.1405 5.66E+07
A0A087X0Q1;Q7Z739;A0A024R7W5;A0A087WY31;A0A087X0C3;S4R373A0A087X0Q1;Q7Z739;A0A024R7W5;A0A087WY31YTH domain-containing family protein 3YTHDF3 6 2 583 0.80195 1.4488 2.36E+08
Q86X76-2;Q86X76-4;Q86X76;Q86X76-3;Q86X76-5Q86X76-2; 4; ;Q86X76-3;Q86X76-5Nitrilase homolog 1NIT1 3 3 291 0.8019 1.3433 2.17E+08
P62308;A8MWD9;Q49AN9;F5H013;C9JVQ0P62308 A8MWD9;Q49AN9;F5H013;C9JVQ0Small nuclear ribonucleoprotein G;Putative small nuclear ribonucleoprotein G-like protein 15SNRPG;SNRPGP15 4 4 76 0.8015 1.3238 8.04E+08
O94855;O94855-2;E9PDM8;E9PC44O 4855;O 4855-2;E9PDM8;E9PC44Protein transport protein Sec24DSEC24D 5 5 1032 0.80146 1.6684 3.68E+08
Q8NBY1;B4E0Y9;Q9P289;Q9P289-2;Q9P289-3;C9JDH9;C9J6L2;C9JCC0;C9J232;H7C279;O00506-3;O00506-2;O00506;C9JJV0Q8NBY1;B4E0Y9; ;Q9P289-2 Q P289-3;C9JDH ;C9J6L2; 9JCC0;C9J232;H7C279;O00506-3;O00506-2;O00506Serine/threonine-protein kinase MST4;Serine/threonine-protein kinase 25RBM4B;MST4;STK 5 7 3 392 0.80112 1.3352 6.32E+08
E9PN81;Q8TDP1-2;Q8TDP1;H0YEF3;E9PKP0;H0YE52;H0YCP5E9PN8 ;Q8TDP1-2;Q8TDP1;H0YEF3Ribonuclease H2 subunit CRNASEH2C 5 5 247 0.80001 0.88641 1.05E+08
Q13185;C9JMM0;B8ZZ43;S4R2Y4Q13185 Chromobox protein homolog 3CBX3 5 4 183 0.7999 1.2982 6.38E+08
P55263-3;P55263-4;P55263-2;P55263P55263- ;P55263-4;P55263-2;P55263Adenosine kinase ADK 2 2 305 0.79987 1.5632 4.06E+07
P36405 P36405 ADP-ribosylation factor-like protein 3ARL3 3 3 182 0.79986 1.6157 6.63E+07
K7ERF1;Q9UBQ5;K7ES31;Q9UBQ5-2;A0A087WVB9;K7EQM4;K7EK53K7ERF1;Q9UBQ5 K7ES31;Q9UBQ5-2;A0A087WVB9;K7EQM4Eukaryotic translation initiation factor 3 subunit KEIF3K 6 6 192 0.79982 1.1964 1.86E+08
H0YJV7;P25490;H0YJU4;O15391;Q96MM3H0YJV7;P25490 Transcriptional repressor protein YY1YY1 6 6 190 0.7996 1.1187 9.89E+07
Q9P0J0;Q9P0J0-2;B4DEZ3;K7EJE1;E7ENQ6;U3KQP3;K7EP87Q9P0J0;Q9P0J0-2;B4DEZ3; 7EJE1;E7ENQ6ADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13DUFA13 7 7 144 0.7993 1.2263 5.72E+08
P0CG13;J3KSJ7;H3BPP1;H0YAV5;E5RGY5;E5RHL4;H3BQB7P0CG13;J3KSJ7;H3BPP1;H0YAV5Chromosome transmission fidelity protein 8 homologCHTF8 3 3 121 0.79908 1.1174 2.79E+07
Q14676-3;Q14676-2;Q14676;Q14676-4Q14676-3; 2;Q14676;Q14676-4Mediator of DNA damage checkpoint protein 1MDC1 9 9 1802 0.79871 1.4532 2.75E+08
O14929;O14929-2;F8W9G7O14929;O14929-2 Histone acetyltransferase type B catalytic subunitHAT1 9 9 419 0.79816 1.4413 1.31E+09
Q86XI2;Q86XI2-2;H0Y6U5;F8WE06Q8 XI2;Q86XI2-2;H0Y6U5Condensin-2 complex subunit G2NCAPG2 17 17 1143 0.79809 0.98549 9.46E+08
Q8IX12-2;Q8IX12;A0A0C4DGG8;F5H1H2;F5H2E6;F5H3E1;H0YFJ7Q8IX12-2;Q IX12;A0A0C4DGG8Cell division cycle and apoptosis regulator protein 1CCAR1 17 17 1135 0.79768 1.3033 1.42E+09
B4E1G1;Q9BUN8-2;Q9BUN8;E5RGY0B4E1G1;Q9BUN8-2;Q9BUN8Derlin-1 DERL1 3 3 151 0.79728 1.4745 2.26E+08
Q9NP97;B1AKR6;Q8TF09;H3BNG9;H3BPA0;Q7Z4M1;H3BQI1;Q9NP97-2Q9NP97; 1AKR6;Q8TF 9Dynein light chain roadblock-type 1;Dynein light chain roadblock-type 2DYNLRB1;DYNLRB2 4 4 96 0.79687 1.1879 3.65E+08
A0A087WUA5;Q9H223A0A087WUA5;Q9H223EH domain-containing protein 4EHD4 8 7 540 0.79661 1.5321 8.26E+08
E7EQR4;P26038;P35241;P15311;P35241-5;P35241-4;V9GZ54;E9PQ82;E9PNV3;P35241-3E7EQR4;P26038;P35241; 1 31 ;P35241-5;P35241-4Moesin;Radixin;EzrinE R;MSN;RDX 3 3 586 0.79658 1.5617 9.17E+07
P10809;E7ESH4;E7EXB4;P10809-2;C9JL25;C9JL19;C9JCQ4;C9J0S9P10809 60 kDa heat shock protein, mitochondrialHSPD1 40 40 573 0.79613 1.2451 1.49E+10
Q9H900-2;Q9H900Q9H900-2;Q9H900Protein zwilch homologZWILCH 2 2 477 0.79606 1.3291 3.59E+08
Q12792;F8VS81;Q12792-4;Q12792-3;F8VRG3Q12792;F8VS81;Q12792-4;Q12792-3Twinfilin-1 TWF1 3 3 350 0.79589 1.6715 1.04E+08
Q8IZ07;H0YIN8;F8W150;S4R3U2;S4R3D2Q8IZ07;H0YIN8 Ankyrin repeat domain-containing protein 13AANKRD13A 4 3 590 0.79451 0.81921 5.32E+07
P19387;H3BRR2 P19387 DNA-directed RNA polymerase II subunit RPB3POLR2C 5 5 275 0.79449 1.3449 7.61E+08
P55060-3;P55060;P55060-4;P55060-23; ;P55060-4Exportin-2 CSE1L 34 34 945 0.79387 1.176 2.08E+10
Q96DI7;Q96DI7-2;Q9NSS8Q96DI7;Q96DI7-2;Q9NSS8U5 small nuclear ribonucleoprotein 40 kDa proteinSNRNP40;DKFZp 34 199 7 7 357 0.79384 1.3487 1.53E+09
153
P51571;A6NLM8 P51571;A6NLM8 Translocon-associated protein subunit deltaSSR4 7 7 173 0.79366 1.3531 1.58E+09
Q9NWX5;F6TX30 Q9NWX5;F6TX30 Ankyrin repeat and SOCS box protein 6ASB6 3 3 421 0.7936 0.82675 1.70E+08
O75874 O75874 Isocitrate dehydrogenase [NADP] cytoplasmicIDH1 4 3 414 0.79356 NaN 4.12E+07
Q9BSF4;K7ENF5 Q9BSF4 Uncharacterized protein C19orf52C19orf52 4 4 260 0.79305 1.283 4.75E+08
C9JRZ6;F8WAR4;Q9NX63;F8WD73C9JRZ6;F8WAR4;Q9NX63MICOS complex subunit MIC19CHCHD3 4 4 232 0.79298 0.97274 8.80E+07
Q9BX68 Q9BX68 Histidine triad nucleotide-binding protein 2, mitochondrialHINT2 3 3 163 0.79286 1.403 1.59E+08
Q01167-3;Q01167-2;Q01167Q01167-3;Q01167-2;Q01167Forkhead box protein K2FOXK2 1 1 328 0.79275 NaN 2.08E+07
P08047-3;P08047;H3BUU5;P08047-2P08047-3;P08047;H3BUU5;P08047-2Transcription factor Sp1SP1 2 2 737 0.79243 0.96543 1.91E+08
E9PS41;Q6RFH5-2;Q6RFH5E9PS41;Q6RFH5-2;Q6RFH5WD repeat-containing protein 74WDR74 2 2 328 0.79211 0.98843 4.85E+07
P47897;P47897-2;B4DDN1;C9J165;A0A0U1RQT0;A0A0U1RQE9;H7C0R3;A0A0U1RQM8;A0A0U1RRI9;A0A0U1RQL2;A0A0U1RQU2;A0A0U1RR66;A0A0U1RQQ5;A0A0U1RRC8;A0A0U1RQX5;A0A0U1RRJ7;A0A0U1RQJ6;F2Z2V6;A0A0U1RQC3;A0A0U1RQX9P 7897;P47897-2;B4DDN1Glutamine--tRNA ligaseQARS 33 33 775 0.79151 .2443 5.72E+09
P23526;P23526-2 P23526;P23526-2 AdenosylhomocysteinaseAHCY 25 25 432 0.7913 1.1872 1.46E+10
Q7L2H7;Q7L2H7-2;J3KNJ2;H0YCQ8;E9PRY0;E9PN86;E7ESM3;E9PRI2Q7L2H7;Q7L2H7-2;J3KNJ2;H0YCQ8Eukaryotic translation initiation factor 3 subunit MEIF3M 17 17 374 0.79118 1.5464 4.50E+09
Q8TCE6-2;Q8TCE6;Q6NSW5;F6TM29Q8TCE6-2;Q8TCE6;Q6NSW5;F6TM29Protein FAM45A;Protein FAM45BFAM45 ;FAM45B 6 6 349 0.79106 0.99555 4.21E+08
Q16576;E9PC52;Q16576-2;Q5JP01;Q5JP02;Q5JNZ6;C9JAJ9;C9J7L0Q16576;E9PC52; 16576-2Histone-binding protein RBBP7RBBP7 13 6 425 0.79099 1.215 3.27E+09
Q9NTI5-2;Q9NTI5;Q9NTI5-3;A9IYQ1Q9NTI5-2;Q9NTI5 Sister chromatid cohesion protein PDS5 homolog BPDS5B 17 16 1391 0.7909 1.1397 1.39E+09
Q6PML9;D6R9M6 Q6PML9 Zinc transporter 9 SLC30A9 5 5 568 0.79054 1.2632 1.65E+08
Q5T4S7-3;Q5T4S7-4;Q5T4S7;Q5T4S7-2;Q5T4S7-5;A0A0A0MSW0;X6R960;X6RE05;Q5TBN9;Q5T4S7-6Q5T4S7-3;Q5T4S7-4;Q5T4S7;Q5T4S7-2E3 ubiquitin-protein ligase UBR4UBR4 77 77 5159 0.79047 1.2727 5.61E+09
Q9NR12;D6RH06;Q9NR12-5;Q9NR12-6;Q9NR12-4;Q9NR12-2;D6RF83;H7BYK4;Q9NR12-3;D6RAN1Q9NR12;D6RH06;Q9NR12-5;Q9NR12-6;Q9NR12-4;Q9NR12-2;D6RF8 ;H7BYK4;Q9NR12-3;D6RAN1PDZ and LIM domain protein 7PDLIM7 6 6 457 0.78956 1.0026 6.26E+08
P61009 P61009 Signal peptidase complex subunit 3SPCS3 6 6 180 0.78951 1.3508 1.89E+08
P68104;Q5VTE0;A0A087WVQ9;P68104-2;A0A087WV01;A6PW80;Q5JR01P6 104; 5VTE0;A0A087WVQ9;P68 04-2;A0A087WV01Elongation factor 1-alpha 1;Putative elongation factor 1-alpha-like 3EEF1A EEF1A1P5 25 13 462 0.78927 1.6357 6.80E+10
Q9Y3F4;Q9Y3F4-2;H0YH33Q9Y3F4;Q9Y3F4-2 Serine-threonine kinase receptor-associated proteinSTRAP 12 12 350 0.78914 1.3888 1.96E+09
O14818;O14818-2;H0Y586;O14818-4;Q8TAA3-2;Q8TAA3-5;Q8TAA3;A0A087WYS6;F5GY34O14818 2 H0Y586Proteasome subunit alpha type-7PSMA7 12 12 248 0.78899 1.2135 2.99E+09
Q02809;Q02809-2;Q5JXB7;Q5JXB802809; 02809-2 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1PLOD1 7 7 727 0.78873 1.4139 4.57E+08
Q9H6R4-4;Q9H6R4;A0A0A0MRW6;Q9H6R4-2;Q9H6R4-3;A0A0C4DFX0Q9H6R4-4;Q9H6R4;A0A0A0MRW6;Q9H6R4-2;Q9H6R4-3Nucleolar protein 6NOL6 18 18 1143 0.78847 1.3151 8.76E+08
O95372;Q5QPQ1;Q5QPQ0;Q5QPQ3;Q5QPQ2;Q5QPN9;Q5QPN5O95372;Q5QPQ1;Q5QPQ0;Q5QPQ3;Q5QPQ2Acyl-protein thioesterase 2LY LA 5 5 231 0.78813 1.0152 6.86E+07
P42345;B1AKP8;B1AKQ2P42345 Serine/threonine-protein kinase mTORMTOR 13 13 2549 0.78783 1.0526 7.53E+08
G8JLD5;O00429-4;O00429-5;O00429-3;O00429-2;O00429;O00429-8;O00429-6;F8VZ52;O00429-7;H0YHY4;F8VR28;F8VYL3;B4DPZ9;F8W1W3;F8VUJ9;B4DDQ3G8JLD5;O00429-4;O00429-5;O00429-3; 2; ;O00429-8; 00429-6;F8VZ52 O00429-7Dynamin-1-like proteinDNM1L 3 3 712 0.78772 1.7465 1.76E+08
Q07021;I3L3Q7;I3L3B0Q07021;I3L3Q7;I3L3B0Complement component 1 Q subcomponent-binding protein, mitochondrialC1QBP 8 8 282 0.7877 1.3972 6.33E+09
E7ESC6;Q9UIA9;E5RIW1E7ESC6;Q9UIA9;E5RIW1Exportin-7 XPO7 2 2 1088 0.78757 1.4087 4.02E+07
H0YLI7;P59780;Q7Z6K5-2;A0A0A6YYH1;H0YLX6;H0YN38;P59780-2;H0YNI6;H0YKM3;A0A087WY05H0YLI7;P59780;Q7Z6K5-2;A0A A6YYH1AP-3 complex subunit sigma-2AP3S2 5 5 205 0.78742 0.99963 6.17E+07
A0A0A0MRN4;Q5BKZ1-3;Q5BKZ1A0A0A0MRN4;Q5BKZ1-3;Q5BKZ1DBIRD complex subunit ZNF326ZNF326 2 2 493 0.78739 0.9725 2.73E+08
Q9BTV4 Q9BTV4 Transmembrane protein 43TMEM43 2 2 400 0.78726 NaN 6.51E+07
O00299 O00299 Chloride intracellular channel protein 1CLIC1 11 11 241 0.78722 1.2927 4.20E+09
Q96GJ1-3;Q96GJ1-2;Q96GJ1Q96GJ1-3;Q96GJ1-2;Q96GJ1tRNA (uracil(54)-C(5))-methyltransferase homologTRMT2B 2 2 459 0.78695 NaN 2.81E+07
F8WDV0;Q9UI26;Q9UI26-2;H0Y8M5;D6RJB1F8WDV0;Q9UI26;Q9UI26-2Importin-11 IPO11 4 4 863 0.78688 1.6323 1.81E+08
P36957;P36957-2;Q86SW4;H0YJF9;G3V5M3;G3V3F0P3 957;P36957-2;Q86SW4Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrialDLST 5 5 453 0.78682 1.7288 5.90E+08
P16615-5;P16615-2;P16615-3;P16615;P16615-4;H7C5W9;O14983-2;O14983;O14983-3;Q93084-4;Q93084-2;Q93084-3;Q93084-7;Q93084;Q93084-6;Q93084-5;J3QSY6;A0A0C4DH86;H3BVB2P16615- ;P16615-2; 3;P16615;P16615-4;H7C5W9Sarcoplasmic/endoplasmic reticulum calcium ATPase 2ATP2A2 37 37 997 0.7 653 1.1411 1.21E+10
B3KQ25;K7ESG5;P61289;P61289-3;P61289-2;K9J957;K7EMD0;K7EPX6;K7EKR3;A0A087WTV2;K7ENH2B3KQ25;K7ESG5; ;P61289-3;P61289-2;K9J957;K7EMD0;K7EPX6;K7E R3;A0A087WTV2;K7ENH2Proteasome activator complex subunit 3PSME3 4 4 193 0.7857 0.83027 2.47E+08
P25398 P25398 40S ribosomal protein S12RPS12 8 8 132 0.78526 1.3641 2.34E+09
Q15397;S4R3K8 Q15397;S4R3K8 Pumilio domain-containing protein KIAA0020KIAA0020 2 2 648 0.78497 NaN 9.48E+07
Q04323;E9PRQ7;E9PJ81;Q04323-2;A0A087WTZ5;E9PS08Q04323;E9PRQ7;E9PJ 1;Q04323-2;A0A087WTZ5UBX domain-containing protein 1UBXN1 14 14 297 0.78479 1.0288 2.50E+09
Q13162;H7C3T4;A6NJJ0;A6NG45Q13162;H7C3T4 Peroxiredoxin-4 PRDX4 7 4 271 0.78465 1.523 8.58E+08
P52907 P52907 F-actin-capping protein subunit alpha-1CAPZA1 8 6 286 0.78413 1.284 2.31E+09
Q8NCM8;Q8NCM8-2;H0YDE0;Q8NCM8-3Q8NCM8;Q8NCM8-2Cytoplasmic dynein 2 heavy chain 1DYNC2H1 23 23 4307 0.78366 1.4653 9.03E+08
Q8NAT1 Q8NAT1 Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2POMGNT2 2 2 580 0.78355 1.3015 8.55E+07
P86791;P86790 P86791;P86790 Vacuolar fusion protein CCZ1 homolog;Vacuolar fusion protein CCZ1 homolog BCCZ1; CZ1B 3 3 482 0.78334 0.90381 1.50E+08
P50851 P50851 Lipopolysaccharide-responsive and beige-like anchor proteinLRBA 22 0 2863 0.78309 1.1299 1.17E+09
Q9NVA1-2;Q9NVA1;B1AKV4;B1AKV2;F6UTR7;B1AKV6;B1AKV3;Q9NVA1-5;Q9NVA1-4;F8WCR2;Q9NVA1-3Q9NVA1-2;Q9NVA1;B1AKV4;B1AKV2;F6UTR7;B1AKV6;B1AKV3;Q9NVA1-5;Q9NVA1-4Ubiquinol-cytochrome-c reductase complex assembly factor 1UQCC1 3 3 273 0.78299 2.0789 7.67E+07
Q8IYB7;H7C440;Q8IYB7-3;Q8IYB7-2;C9JGP4;Q8IYB7-4;Q8IYB7-5;H7C036;H7C1Q8Q8IYB7;H7C440;Q8IYB7-3;Q8IYB7-2DIS3 like exonuclease 2DIS3L2 8 8 885 0.78283 0.97908 2.52E+08
Q8TED0-3;Q8TED0;H0Y8P4;Q8TED0-2;D6RF65Q8TED0-3;Q8TED0;H0Y8P4;Q8TED0-2U3 small nucleolar RNA-associated protein 15 homologUTP15 7 7 499 0.78265 1.1179 6.86E+08
E9PN51;F8W9K7;E9PPW7;O00217;E9PKH6E9 N51;F8W9K7;E9PPW7;O00217;E9PKH6NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrialNDUFS8 4 4 110 0.78197 1.1401 9.39E+07
Q9HCJ3-2;Q9HCJ3;E9PE10Q9HCJ3-2;Q9HCJ3 Ribonucleoprotein PTB-binding 2RAVER2 3 3 678 0.78167 NaN 9.95E+07
P63244;H0YAF8;J3KPE3;D6R9Z1;H0Y8W2;D6R9L0;D6RFX4;D6RHH4;H0YAM7;D6RAC2;D6RFZ9;D6REE5;D6RAU2;E9PD14;D6RF23;D6RBD0;H0Y8R5;D6RGK8;H0Y9P0;D6R909;D6RHJ5P63244;H0YAF8;J3KPE3;D6R9Z1;H0Y8W2;D6R9L0;D6RFX4;D6RHH4;H0YAM7;D6RAC2;D6RFZ9;D6REE5Guanine nucleotide-binding protein subunit beta-2-like 1;Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processedGNB2L1 1 11 317 0.78166 1.3544 2.81E+09
H0Y6T7;Q92542-2;Q92542;Q5T205;H0Y3Z4H0Y6T7; 92542-2;Q92542Nicastrin NCSTN 3 3 275 0.78153 1.5125 9.93E+07
Q6PGP7;D6RCE2;H0Y964Q6PGP7 Tetratricopeptide repeat protein 37TTC37 22 22 1564 0.78123 1.1842 1.40E+09
Q9UBI1;R4GMW6;H0Y4W0;R4GMX3;R4GN54;H0Y6Z9;R4GN06;R4GNF2;H0Y4E5;Q5T8Z1Q9UBI1;R4 W6;H0Y4W0;R4GMX3;R4GN54;H0Y6Z9COMM domain-containing protein 3COMMD3;COMMD3-BMI1 7 7 195 0.7812 1.3552 1.77E+08
O00258;B7Z1T1;O00258-2;A0A096LNT6;H7BYE5O00258;B7Z1T1;O00258-2Tail-anchored protein insertion receptor WRBWRB 3 3 174 0.78094 1.4975 9.46E+07
Q92621;U3KPX2;U3KQ97Q92621 Nuclear pore complex protein Nup205NUP205 56 56 2012 0.78028 1.1636 7.58E+09
Q9UI09;F8VXI1;F8VRD8;Q9UI09-2;H0YID5Q9UI09;F8VXI1;F8VRD8;Q9UI09-2NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12NDUFA12 4 4 145 0.77997 1.8853 1.46E+08
B9A018;Q53GS9;A0A087X1B2;Q53GS9-2;Q53GS9-3;A0A087WW31;F8WC91B9A018;Q53GS9;A0A087X1B2;Q53GS9-2;Q53GS9-3U4/U6.U5 tri-snRNP associated protein 2USP39 8 8 536 0.77981 1.4466 1.05E+09
Q6PD74;Q6PD74-2;H0YL49Q6PD74;Q6PD74-2Alpha- and gamma-adaptin-binding protein p34AAGAB 3 3 315 0.77951 0.98278 2.12E+08
E7EWC2;F5H7S7;Q13576;Q13576-3;Q13576-2;D6R939E7EWC2;F5H7S7; ;Q13576-3;Q13576-2Ras GTPase-activating-like protein IQGAP2IQGAP2 7 5 1402 0.77909 1.3636 1.47E+08
Q5VIR6-4;F6VX93;Q5VIR6-2;Q5VIR6-3;Q5VIR6;I3L184;E7EVT8;I3L0S6Q5VIR6-4;F6 X93;Q5VIR6-2;Q5VIR6-3;Q5VIR6Vacuolar protein sorting-associated protein 53 homologPS5 5 5 832 0.77906 1.0505 1.87E+08
P38919;I3L3H2 P38919 Eukaryotic initiation factor 4A-III;Eukaryotic initiation factor 4A-III, N-terminally processedEIF4A3 26 21 411 0.7784 1.2292 8.86E+09
P11387;Q969P6-2;Q969P6;E5RIC7;E5RJ95;E5RFS0;E5RJ33;H0YBR3;H0YAR3;H0YC03;E5RGE7;E5RGR4;E5RFE3;E5RGR2P11387 DNA topoisomerase 1TOP1 25 25 765 0.77836 1.2144 3.26E+09
M0QYT9;Q14653;M0R0X9;M0QXC8;M0R205;M0QZB8;M0QZB7;Q14653-3;Q14653-2;Q14653-4M0QYT9;Q14653; 0R0X9; 0QXC8;M0R205;M0QZB8;M0QZB7;Q14653- ;Q14653-2;Q14653-4Interferon regulatory factor 3I F3 2 2 281 0.77799 NaN 1.31E+08
I3L2C7;P57678;I3L399;I3L4A4;I3L4M4;E7EN12;I3L1J7I3L2C7;P57678 Gem-associated protein 4GEMIN4 22 22 1047 0.77782 1.1915 1.97E+09
E9PC15;Q53H12;E9PG39;A0A0G2JLG5;A0A0G2JLD0E9PC15;Q53H12;E9PG39;A0A0G2JLG5Acylglycerol kinase, mitochondrialAGK 10 10 394 0.77764 1.2756 1.38E+09
O60287 O60287 Nucleolar pre-ribosomal-associated protein 1URB1 22 22 2271 0.77756 1.2524 1.18E+09
Q15813;Q15813-2 Q15813;Q15813-2 Tubulin-specific chaperone ETBCE 8 8 527 0.77756 1.3485 1.26E+09
Q9Y295;H0YI06;F8WEE0Q9Y295 Developmentally-regulated GTP-binding protein 1DRG1 7 7 367 0.77741 1.3168 1.06E+09
Q5SRE5;Q5SRE5-2;H7C4K7Q5SRE5;Q5SRE5-2 Nucleoporin NUP188 homologNUP188 34 34 1749 0.77727 1.1274 2.32E+09
Q9BPX3;D6RA93;H0Y9Z8Q9BPX3 Condensin complex subunit 3NCAPG 25 25 1015 0.77723 1.2223 1.56E+09
A0A087X1K9;O75608-2;O75608;B4DP64;E5RGR0;E5RJ48;E5RI35A0A08 X1K9;O75608-2;O75608;B4DP64;E5RGR0Acyl-protein thioesterase 1LYPLA 4 4 166 0.77629 1.0942 7.80E+08
O75351 O75351 Vacuolar protein sorting-associated protein 4BVPS4B 8 5 444 0.77625 1.1568 7.04E+08
Q14692 Q14692 Ribosome biogenesis protein BMS1 homologBMS1 19 19 1282 0.77617 1.1449 1.21E+09
P51970 P51970 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8NDUFA8 3 3 172 0.77573 0.77786 5.10E+07
Q9HCU5;H7C2N7;B5MC98;F8WCS5;H7C0W3Q9HCU5;H7C2N7;B5MC98Prolactin regulatory element-binding proteinPREB 4 4 417 0.77515 NaN 1.97E+08
J3QLE5;A8MT02;P14678-2;P63162;P14678;P63162-2;P14678-3;J3KRY3;S4R3P3J3QLE5;A8MT0 ; -2;P6316 ; ;P6 162-2;P14678-3Small nuclear ribonucleoprotein-associated proteins B and B;Small nuclear ribonucleoprotein-associated protein NSNRPN;SNRPB 7 7 169 0.77503 1.1835 3.61E+09
P13861-2;P13861;H7C1L0;H7C330;H7C4A9P13861-2;P13861;H7C1L0cAMP-dependent protein kinase type II-alpha regulatory subunitPRKAR2A 8 6 382 0.77423 1.4112 6.67E+08
Q14739;C9JXK0;C9JES9Q14739;C9JXK0 Lamin-B receptor LBR 12 12 615 0.77421 1.4247 2.90E+09
A2A2Q9;Q9Y312 A2A2Q9;Q9Y312 Protein AAR2 homologAAR2 9 9 398 0.77417 0.90214 5.90E+08
E7EV99;E7ENY0;P35611-2;P35611-6;P35611;P35611-3;P35611-4;A0A0A0MSR2;P35611-5;H0Y9H2;D6RF25;D6RJE2;D6RAH3E7EV99;E7ENY0;P35611-2; 6; ;P35611-3;P35611-4;A0A0A0MSR P35611-5;H0Y9H2Alpha-adducin ADD1 8 7 632 0.77315 1.123 1.06E+09
P00403 P00403 Cytochrome c oxidase subunit 2MT-CO2 6 6 227 0.77266 1.4578 7.60E+08
P62304;A6NHK2 P62304;A6NHK2 Small nuclear ribonucleoprotein ESNRPE 4 4 92 0.77201 1.3802 1.94E+09
Q9C0D3;A8DPD7;Q9C0D3-2Q9C0D3;A8DPD7 Protein zyg-11 homolog BZYG11B 3 3 744 0.7719 1.409 1.45E+08
P50453;H7BXK7;C9J7N5;A0A0C4DGW9;P30740-2;P50452-2;P50452;P30740;O75830P50453 Serpin B9 SERPINB9 4 4 376 0.77188 1.5033 1.48E+08
O95298;E9PM14;A0A087WUM3;O95298-3;E9PQ53;O95298-2O95298;E9PM14;A0A087WUM 3;E9PQ53N DH dehydrogenase [ubiquinone] 1 subunit C2;NADH dehydrogenase [ubiquinone] 1 subunit C2, isoform 2NDUFC2;NDUFC2-KCTD14 3 3 119 0.77146 1.246 1.30E+07
Q15750-2;Q15750 Q15750-2;Q15750 TGF-beta-activated kinase 1 and MAP3K7-binding protein 1TAB1 5 5 462 0.77126 1.0653 5.96E+08
K7EP06;O43148;O43148-2K7EP06;O43148;O43148-2mRNA cap guanine-N7 methyltransferaseRNMT 2 2 298 0.77119 1.66 1.50E+08
Q6VY07;Q6VY07-2;H0YF56;E9PPK2;B4DF77Q6VY07;Q6VY07-2;H0YF56;E9PPK2;B4DF77Phosphofurin acidic cluster sorting protein 1PACS1 2 2 963 0.77084 NaN 2.10E+07
Q6P9B6;H3BM75;H3BUB0Q6P9B6;H3BM75 TLD domain-containing protein 1TLDC1 3 3 456 0.77065 1.8354 5.09E+08
P30085;Q5T0D2;P30085-2P30085;Q5T0D2 UMP-CMP kinase CMPK1 7 7 196 0.77049 1.1514 1.28E+08
154
P45880-2;P45880;P45880-1;A0A0A0MR02;Q5JSD2;Q5JSD1;A2A3S12;P4588 ;P45880-1;A0A0A0MR02Voltage dependent anion-selective channel protein 2VD C2 9 9 283 0.77045 1.5994 6.90E+09
P56192;P56192-2;H0YIP0;H0YHV5;F5H2V6;F8VS26;F8W0M7;F8W0S4;F8VZZ9;H0YI94;H0YIC2;F8VPL7;H0YHL6;H0YI27P56192;P56192-2 Methionine--tRNA ligase, cytoplasmicARS 38 38 900 0.77041 1.179 1.26E+10
A0A0U1RQQ9;Q6P3W7;F8VSC5;F8VPW3;H0YIK6A0A0U1RQQ9;Q6P3W7;F8VSC5SCY1-like protein 2 SCYL2 12 12 933 0.76981 1.0194 6.20E+08
Q9UPU5;A0A0U1RQI9Q UPU5 Ubiquitin carboxyl-terminal hydrolase 24USP24 26 26 2620 0.76966 1.2693 1.54E+09
F8VVA7;P61923;F8W651;P61923-4;F8VXB1;F8VUC5;F8W156;F8VYZ4;P61923-5;F8VXR1;F8VYK5;P61923-2;P61923-3F8VVA7;P61923;F8W651;P61923-4;F8VXB1;F8VUC5;F8W156;F8VYZ4;P61923-5;F8VXR1Coatomer subunit zeta-1COPZ1 6 6 198 0.76944 1.4594 1.48E+09
P04844-2;P04844;Q5JYR4;Q5JYR7;F2Z3K5;Q5JYR3;H0Y5M1P04844-2;P04844 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2RPN2 14 14 615 0.76942 1.7524 2.91E+09
Q9H061;E9PI90;Q9H061-2;E9PIH8Q9H061;E9PI90;Q9H061-2Transmembrane protein 126ATMEM126A 4 4 195 0.76905 1.1877 2.12E+08
P04406;P04406-2;E7EUT5;O14556P04406;P04406-2;E7EUT5Glyceraldehyde-3-phosphate dehydrogenaseGAPDH 21 21 335 0.76885 1.3819 1.25E+10
P56589;Q7Z6V3 P56589;Q7Z6V3 Peroxisomal biogenesis factor 3PEX3 3 3 373 0.7685 0.95395 3.81E+07
Q9BR76;A0A087WW53;F5H390;F5H0D2Q9BR76 Coronin-1B CORO1B 5 5 489 0.76824 1.155 3.01E+08
Q9Y320-2;Q9Y320;E9PSF0;E9PRL5;H3BSU7;E9PLR1;G3V155Q9Y320-2;Q9Y320 Thioredoxin-related transmembrane protein 2TMX2 3 3 258 0.76815 1.0784 5.58E+08
A0A096LPI6;A0A0B4J2H4;H7C1F6;A0A0B4J2D5;P30042-2;P30042;A0A096LNH5;H7C2G3;A0A096LNJ1;A0A096LP73;F2Z2Q0;A0A096LP12A0A096LPI6;A0 B4J2H4;H7C1F6;A0A0B4J2D5;P30 42-2;P30042;A0A096LNH5;H7C2G3ES1 protein homolog, mitochondrialC21orf33 11 8 279 0.76795 1.0398 8.13E+08
Q15036;Q15036-2;F8WAZ0Q15036;Q15036-2 Sorting nexin-17 SNX17 5 5 470 0.76768 1.0954 2.32E+08
Q5TFE4;Q5TFE4-2;Q5QPD0;H0YDA5Q5TFE4 Q5TFE4-2;Q5QPD05-nucleotidase domain-containing protein 1NT5DC1 11 11 455 0.76755 1.2894 1.42E+09
P20073-2;P20073 P20073-2;P20073 Annexin A7 ANXA7 6 6 466 0.76733 1.6907 3.65E+08
Q3SXM5;Q3SXM5-2;H3BQI7;H3BT52;H3BNH5Q3SXM5;Q SXM5-2Inactive hydroxysteroid dehydrogenase-like protein 1HSDL1 9 9 330 0.76665 1.4914 8.05E+08
E5RHG8;Q15369;R4GMY8;Q15369-2E5RHG8;Q15369;R4GMY8;Q15369-2Transcription elongation factor B polypeptide 1TCEB1 7 7 89 0.76636 1.2339 8.08E+08
Q96KP4-2;Q96KP4;J3KSS4;J3QRP4;J3QQN6;J3QR27;J3QLU1;J3QKQ0;J3QRD0;J3QRA8;J3QL02;J3KSV5;A0A087WYZ1;J3QKT2Q96KP4-2;Q96KP4 Cytosolic non-specific dipeptidaseCNDP2 3 3 391 0.76635 1.5339 2.68E+08
Q86VP6;Q86VP6-2;A0A0C4DGH5;H0YH27;Q86VP6-3;F5H6I6Q86VP6;Q86VP6-2;A0A0C4DGH5Cullin-associated NEDD8-dissociated protein 1CAND1 37 34 1230 0.76604 1.1045 7.56E+09
F6SS63;Q8N5C8-2;Q8N5C8F6SS63;Q8N5C8-2;Q8N5C8TGF-beta-activated kinase 1 and MAP3K7-binding protein 3TAB3 1 1 608 0.76601 1.1445 8.31E+07
Q9UHV9 Q9UHV9 Prefoldin subunit 2 PFDN2 3 3 154 0.76591 1.0228 1.26E+08
P10606 P10606 Cytochrome c oxidase subunit 5B, mitochondrialCOX5B 6 6 129 0.76576 1.0219 2.22E+08
Q05639 Q05639 Elongation factor 1-alpha 2EEF1A 14 2 463 0.76576 1.5732 2.12E+08
P62979;J3QS39;J3QTR3;F5H6Q2;F5GYU3;F5H2Z3;F5H265;B4DV12;F5H388;F5H747;F5GXK7;J3QKN0;Q5PY61;Q96C32;P62987;P0CG47;P0CG48;M0R1V7;M0R1M6;F5GZ39;J3QSA3P62979;J3 S39;J3QTR3;F5H6Q2;F5GYU3;F5H2Z3;F5H265;B4DV12;F5H388;F5H747;F5GXK7;J3QKN0;Q5PY61;Q96C32;P62987;P0CG47;P0CG48;M0R1V7;M0R1M6;F5GZ39biquitin-40S ribosomal protein S27a;Ubiquitin 40S ribosomal protein S27a;Ubiquitin-60S ribosomal protein L40;Ubiquitin; 0S ribosomal protein L40;Polyubiquitin-B;Ubiquitin;Polyubiquitin-C;UbiquitinRPS27A;UBB;UBC;UBA52 14 15 0.76569 1.3286 1.46E+11
E3W994;J3KR49;A0A0U1RQI6;E7ERI8;E7EW49;O75122;O75122-3;H0Y5T1;F8WA11;Q7Z460-2;Q7Z460-4;Q7Z460-5;Q7Z460-3;Q7Z460E3W994;J3KR49;A0A0U1RQI6;E7ERI8;E7EW49;O75122;O75122-3CLIP-associating protein CLASP2 5 5 1273 0.76568 0.98964 1.39E+08
P15121;E9PEF9;E9PCX2;C9JRZ8;C9JRZ8-2P15121;E9PEF ;E9PCX2Aldose reductase AKR1B1 3 3 316 0.76552 1.5183 9.33E+07
J9JID7;Q03252 J9JID7;Q03252 Lamin-B2 LMNB2 8 4 620 0.76547 1.388 1.28E+08
Q9NZJ7-2;Q9NZJ7;H0Y8C3;F6WFU6;H7C196;Q9NZJ7-3Q9NZJ7-2;Q9NZJ7;H0Y8C3;F6WFU6Mitochondrial carrier homolog 1MTCH1 9 9 372 0.76479 1.5254 3.17E+08
Q14008-2;Q14008;Q14008-3;H0YDX52;Q14008;Q14008-3Cytoskeleton-associated protein 5CKAP5 7 7 1972 0.76444 0.80003 2.91E+08
Q14964;C9JB90 Q14964 Ras-related protein Rab-39AAB39 6 5 217 0.7639 0.98872 3.41E+08
Q9BWH6;Q9BWH6-2;H3BRE8;Q9BWH6-3;H3BPM3;H3BPY8;H3BTJ6Q9BWH6;Q9BWH6-2;H3BRE8RNA polymerase II-associated protein 1RPAP1 15 15 1393 0.76359 1.1738 7.12E+08
Q9Y5M8;H7C4H2;C9J5Z8Q9Y5M8 Signal recognition particle receptor subunit betaSRPRB 7 7 271 0.76302 1.4732 6.83E+08
P49257 P49257 Protein ERGIC-53 LMAN1 5 5 510 0.76273 1.5612 2.58E+08
P05091;P05091-2;F8VP50;S4R3S4P05091;P05091-2;F8VP50Aldehyde dehydrogenase, mitochondrialALDH2 7 7 517 0.76262 1.573 4.71E+08
O95396 O95396 Adenylyltransferase and sulfurtransferase MOCS3;Molybdopterin-synthase adenylyltransferase;Molybdopterin-synthase sulfurtransferaseMOCS3 8 8 460 0.76255 0.99462 4.26E+08
Q96I51-3;Q96I51;A0A087WT38;Q96I51-2Q96I51-3;Q96I51;A0A087WT38;Q96I51-2Williams-Beuren syndrome chromosomal region 16 proteinWBSCR16 4 4 454 0.76235 0.87067 1.76E+08
O15145;F8VR50;C9JZD1O15 45;F8VR50;C9JZD1Actin-related protein 2/3 complex subunit 3ARPC3 5 5 178 0.76227 1.5706 5.56E+08
P35914;P35914-3;P35914-2 Hydroxymethylglutaryl-CoA lyase, mitochondrialHMGCL 3 3 325 0.76215 1.2873 9.22E+07
P52788-2;P52788;H7C2R7P52788-2;P52788 Spermine synthase SMS 5 5 313 0.76208 1.2576 7.53E+08
P51649;P51649-2;C9J8Q5P51649;P51649-2;C9J8Q5Succinate-semialdehyde dehydrogenase, mitochondrialALDH5A1 11 11 535 0.76206 1.0509 5.73E+08
B5MCF9;O00541-2;O00541;B3KXD6;H7C267;H7BYY8B5MCF9;O00541-2;O00541;B3KXD6Pescadillo homologPES1 15 15 571 0.76184 1.3936 6.66E+08
Q86Y56;Q86Y56-2;H0Y650;E9PGY2;Q86Y56-3;H7C3B1Q86Y 6;Q86Y56-2;H0Y 50EAT repeat-containing protein 2HEATR2 10 10 855 0.76156 1.3436 7.96E+08
Q14204;H0YJ21 Q14204 Cytoplasmic dynein 1 heavy chain 1DYNC1H1 201 200 4646 0.76143 1.4503 3.02E+10
F5H619;Q86XA9-2;Q86XA9;H7C5W6F5H61 ;Q86XA9-2;Q86XA9;H7C5W6HEAT repeat-containing protein 5AHEATR5A 5 5 2046 0.76048 1.8886 2.36E+08
C9JA28;Q9UNL2;Q9UNL2-2;C9J365C9JA 8;Q9UNL2;Q9UNL2-2;C9J365Translocon-associated protein subunit gammaSSR3 2 2 174 0.76018 1.6126 6.12E+08
A0A087X0Q9;Q9BVL4A0A087X0Q9;Q9BVL4Selenoprotein O SELO 1 1 668 0.75999 NaN 1.36E+08
Q9Y5J1;J3KSR7;J3QR85;J3QLD6;J3QRG0Q9Y5 1 U3 small nucleolar RNA-associated protein 18 homologUTP18 7 7 556 0.75896 1.1853 3.63E+08
P41250;H7C443;F8WCK4P41250 Glycine--tRNA ligaseGARS 33 33 739 0.75894 1.1996 1.03E+10
A0A087WXP7;Q9H2P9-3;Q9H2P9-2;Q9H2P9-6;Q9H2P9-4;Q9H2P9;Q9H2P9-5A0A087WXP7;Q9H2P9-3;Q9H2P9-2;Q9H2P9-6;Q9H2P9-4;Q9H2P9;Q9H2P9-5Diphthine synthaseDPH5 7 7 243 0.75887 1.1875 9.47E+08
O43747;O43747-2;H3BNR4;H3BN75;H3BS13;H3BV30;H3BRM7;H3BN71;B4DGE1;H3BR36;H3BUN9;B3KNW1O43747;O43747-2 AP-1 complex subunit gamma-1AP1G1 14 14 822 0.75852 1.6254 1.60E+09
H7C1E4;P61966;P61966-2H7C1E4;P61966;P61966-2AP-1 complex subunit sigma-1AAP1S1 3 3 191 0.75817 1.8069 1.60E+08
A6NF51;O95861-4;O95861;O95861-2;F8W1J0;F8VVW8;F8VZG4;O95861-3A6NF5 ; 4;O95861;O95861-2;F8W1J0;F8VVW8;F8VZG43(2),5-bisphosphate nucleotidase BPNT1 5 5 291 0.75797 1.6766 2.45E+08
B4DKY1;P49589-2;P49589;P49589-3B DKY1; 2;P49589;P49589-3Cysteine--tRNA ligase, cytoplasmicCARS 5 5 739 0.75783 1.6657 1.19E+08
P46019 P46019 Phosphorylase b kinase regulatory subunit alpha, liver isoformPHKA2 3 2 1235 0.75762 1.0521 6.06E+07
Q16698-2;Q16698;E5RJD2;E5RJG7;E5RFV2;H0YAW3;E5RID6Q16698-2;Q16698;E5RJD2;E5RJG7;E5RFV22,4-dienoyl-CoA reductase, mitochondrialECR1 4 4 326 0.75739 1.5617 2.97E+08
P27824;P27824-2;P27824-3;D6RGY2;D6RFL1;H0Y9Q7;D6RAU8;D6RB85;D6RDP7;H0Y9H1;D6RAQ8;D6RHJ3;D6RD16;P27824- P27824-3Calnexin C NX 14 14 592 0.757 1.3208 2.97E+09
P62310 P62310 U6 snRNA-associated Sm-like protein LSm3LSM3 3 3 102 0.75688 0.99923 6.94E+07
O00231;O00231-2;J3QRY4;J3QS13;J3KSW3O00231;O002 1-2;J3QRY426S proteasome non-ATPase regulatory subunit 11PSMD11 22 22 422 0.75667 1.7272 3.37E+09
O75396;A0A087X1A9O75396 Vesicle-trafficking protein SEC22bSEC22B 5 5 215 0.75646 1.2244 5.75E+08
P50570-3;P50570-4;P50570-2;P50570-5;P50570;K7EMQ3;E5RHK8;Q9UQ16-5;Q9UQ16-2;Q9UQ16-3;Q9UQ16;Q9UQ16-4;E5RIK2;K7EPK9;H7C5U0P50570-3;P50570-4;P50570-2;P50570-5;P50570Dynamin-2 DNM2 21 15 866 0.75611 1.2481 1.57E+09
Q96TC7;H0YNE5;H0YLG5;H0YMB1;Q96TC7-2Q96TC7;H0YNE5;H0YLG5Regulator of microtubule dynamics protein 3RMDN3 3 3 470 0.7559 1.2846 3.76E+08
Q9UNM6;A0A087WUL9;Q9UNM6-2;J3KNQ3;H0YD73;E9PL38;E9PPD2;E9PQG3Q9UNM6;A0A087WUL9;Q9UNM6-2;J3KNQ3;H0YD73;E9PL3826S proteasome non-ATPase regulatory subunit 13PSMD13 12 12 376 0.75543 1.6168 7.95E+08
P26196;Q8IV96 P26196 Probable ATP-dependent RNA helicase DDX6DDX6 15 15 483 0.75517 1.3714 5.50E+09
P09382 P09382 Galectin-1 LGALS1 3 3 135 0.75516 1.9146 3.62E+08
P22314-2;P22314;Q5JRR6;Q5JRR9;Q5JRS0;Q5JRS1;Q5JRS3;Q5JRS2P22314-2;P22314 Ubiquitin-like modifier-activating enzyme 1UBA1 23 23 1018 0.75479 1.5545 3.96E+09
Q9UDR5;F8WAH1;F8WE53Q9UDR5;F8WAH1 Alpha-aminoadipic semialdehyde synthase, mitochondrial;Lysine ketoglutarate reductase;Saccharopine dehydrogenaseAASS 4 4 926 0.75471 1.2111 7.71E+07
P26640;A0A140T936;A0A140T954;P26640-2;A2ABF4;A0A0G2JJT9;H0Y426;A0A140T904P26640;A0A140T93Valine--tRNA ligase VARS 42 42 1264 0.75423 1.1463 9.54E+09
Q9Y6G9;E9PHI6 Q9Y6G9;E9PHI6 Cytoplasmic dynein 1 light intermediate chain 1DYNC1LI1 5 5 523 0.75305 1.7409 4.12E+08
H3BMQ0;P49815-6;P49815-5;P49815-3;P49815-2;P49815-4;P49815;P49815-7;H3BQK4;I3L3B1;Q5HYF7;P49815-8H3BMQ0;P49815-6;P49815- ;P49815-3;P49815-2; 4;P49815;P49815-7Tuberin TSC2 14 4 1751 0.75279 1.1963 8.86E+08
P51991;H7C1J8 P51991 Heterogeneous nuclear ribonucleoprotein A3HNRNPA3 21 4 378 0.7527 1.2066 6.52E+09
P08574 P08574 Cytochrome c1, heme protein, mitochondrialCYC1 6 6 325 0.75223 1.2875 1.34E+09
Q15291-2;Q15291 Q15291-2;Q15291 Retinoblastoma-binding protein 5RBBP5 4 4 500 0.75205 1.1865 3.32E+08
Q96T76;Q96T76-8;Q96T76-9;Q96T76-5;Q5T454;Q96T76-7;H0Y746;B0QZ77;F8WCH8;H0Y7V3;H7C1W5;H7C0A9;Q96T76-8;Q96T76-9; 5MMS19 nucleotide excision repair protein homologMMS19 24 24 1030 0.75197 1.2307 3.21E+09
O00567;H0YDU4;H0Y653;Q5JXT2O00567 Nucleolar protein 56NOP56 26 26 594 0.75192 1.4301 5.38E+09
Q15645;H0YAL2;Q15645-2Q15645 Pachytene checkpoint protein 2 homologTRIP13 12 12 432 0.75176 1.2837 2.54E+09
A0A0C4DG54;Q5R372-2;Q5R372-4;Q5R372;Q5R372-3;A0A0U1RQY6;A0A0U1RRM5A0A0C4DG54;Q5R372- ; 4;Q5R372;Q5R372-3;A0A0U1RQY6;A0A0U1RRM5ab GTPase-activating protein 1-likeABGAP1L 2 2 582 0.75158 1.6886 8.26E+07
Q06210-2;Q06210 Q06210-2;Q06210 Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1GFPT1 24 22 681 0.75156 1.3725 4.89E+09
P21796;C9JI87 P21796;C9JI87 Voltage-dependent anion-selective channel protein 1VDAC1 15 15 283 0.75071 1.5595 5.42E+09
Q9Y3D0;J3KS95;H3BNV7;J3QLT9Q9Y3D0;J3KS95 Mitotic spindle-associated MMXD complex subunit MIP18FAM96B 7 7 163 0.75005 1.3748 7.62E+08
Q15459;Q15459-2;F8WB66Q15459;Q15459-2 Splicing factor 3A subunit 1SF3A1 4 4 793 0.74998 1.1369 1.26E+08
P36871;P36871-2;P36871-3;P36871-2;P36871-3hosphoglucomutase-1PGM1 13 13 562 0.74944 1.3991 9.76E+08
Q9Y281;Q9Y281-3;F8WDN3;G3V2U0Q9Y281;Q9Y281-3 Cofilin-2 CFL2 6 2 166 0.74941 1.3159 1.48E+08
O14735;B3KY94;O14735-3;H3BUR9;O14735-2O14735;B KY94; 14735-3;H3BUR9CDP-diacylglycerol--inositol 3-phosphatidyltransferaseCDIPT 6 6 213 0.74916 1.2401 1.13E+09
Q9UDW1;Q9NZY4;Q9UDW1-2Q9UD 1;Q9NZY4;Q9UDW1-2Cytochrome b-c1 complex subunit 9UQCR10 3 3 63 0.74811 1.4246 2.93E+08
I3L3S0;Q9Y5R8;I3L3V5;I3L1R8I3L3S0;Q9Y5R8;I3L3V5Trafficking protein particle complex subunit 1TRAPPC1 3 3 95 0.74746 1.4313 1.11E+08
P42025 P42025 Beta-centractin ACTR1B 6 1 376 0.74721 1.1866 1.27E+09
Q8WTW3;A0A087WVI0;E9PBL8;J3QKY9;J3QLT5;J3KRP4;J3KSY3Q8WTW3;A0A087WVI0;E9PBL8Conserved oligomeric Golgi complex subunit 1CO 1;ADCK1 18 18 980 0.74711 0.93595 9.62E+08
Q9NUQ7;D6RGX2;H0YA18;D6RB53;D6RA67;D6R9J7;H0Y9B0Q9NUQ7;D6RGX2;H0YA18Ufm -specific protease 2UFSP2 11 11 469 0.74669 1.0301 1.05E+09
Q32MN6;P20226-2;P20226;H0Y6D8;Q7Z6S5;Q6SJ96Q32MN ;P20226-2;P20226;H0Y D8;Q7Z6S5;Q6SJ96TATA-box-binding protein;TATA box-binding protein-like protein 2TBP;TBPL2 2 2 288 0.74666 NaN 1.74E+08
P25705;P25705-2;P25705-3;K7EK77;K7ENJ4;K7ERX7;K7EJP1;K7EQH4;K7ESA0;K7EKV9;K7EM08;A0A0A0MTS3;P25705-2;P25705-3ATP synthase subunit alpha, mitochondrialATP5A1 37 37 553 0.74654 1.5618 1.93E+10
E9PMY3;E9PML8;E9PJC0;E9PRR9;Q12974-2;Q12974-3;Q12974-4;Q12974;E9PL34;A0A0D9SGK2;Q93096E9PMY3;E9PML8;E PJC0;E9PRR9;Q12974-2;Q12974-3;Q12974-4;Q12 74;E9PL34;A0A0D9SGK2;Q93096Protein tyrosine phosphatase type IVA 2;Protein tyrosine phosphatase type IVA 1PTP4A2;PTP4A1 2 2 63 0.74651 1.2167 4.49E+07
C9J5D1;E7EQ69;Q9GZZ1;A0A087WWJ2;Q9GZZ1-2;B0AZT5;C9JZU6;C9J5J3;A0A0D9SF32;F8WCK0C9J5D1;E7EQ69;Q9GZZ1;A0A087WWJ2;Q9GZZ1-2;B0AZT5N-alpha-acetyltransferase 50NAA50 12 12 129 0.74649 1.3848 8.55E+08
Q86YV9 Q86YV9 Hermansky-Pudlak syndrome 6 proteinHPS6 3 3 775 0.74599 1.0617 1.38E+08
155
Q9Y2S7;B4DEM9 Q9Y2S7;B4DEM9 Polymerase delta-interacting protein 2POLDIP2 3 3 368 0.74553 1.3501 2.57E+08
Q658Y4;E7ER68 Q658Y4;E7ER68 Protein FAM91A1 FAM91A1 4 4 838 0.74527 NaN 9.51E+07
Q9NR30;Q9NR30-2Q9NR30;Q9NR30-2Nucleolar RNA helicase 2DDX21 49 47 783 0.74513 1.1757 2.02E+10
A0A0A0MSK6;Q13017-2;Q13017A0A0A0MSK6;Q13017-2;Q13017Rho GTPase-activating protein 5ARHGAP5 2 2 1498 0.74509 NaN 2.26E+07
O95630;C9JK83;O95630-2O95630;C9JK83;O95630-2STAM binding proteinSTAMBP 2 2 424 0.74454 NaN 8.81E+07
Q96SI1-2;Q96SI1;K7EN63;V9GYY8;K7EIF1;K7EPF0;K7EQS3;K7EM48;REV__Q14999;REV__Q14999-2Q96SI1-2;Q96SI1;K7EN63;V9GYY8BTB/POZ domain-containing protein KCTD15KCTD15 3 3 234 0.74409 1.1651 1.38E+08
O95155-2;O95155;O95155-4;O95155-3;B1AQ61;K7EP752; ;O95155-4;O9515 -3Ubiquitin conjugation factor E4 BUBE4B 9 9 1173 0.74311 1.1068 2.77E+08
F5H0C4;Q9BRP4-2;Q9BRP4;F5H5D4;F5H103;F5H3I1;Q9BRP4-3F5H0C ;Q9BRP -2;Q9BRP4;F5H5D4;F5H103;F5H3I1;Q9BRP4-3Proteasomal ATPase-associated factor 1PAAF1 2 2 393 0.743 NaN 7.46E+07
Q9UL25 Q9UL25 Ras-related protein Rab-21AB21 8 8 225 0.74274 1.4381 1.11E+09
O14949 O14949 Cytochrome b-c1 complex subunit 8UQCRQ 5 5 82 0.74225 1.2805 5.66E+08
P62306;A0A0B4J254;F8W0W6P62306 Small nuclear ribonucleoprotein FSNRPF 3 3 86 0.74225 1.2377 2.18E+08
P34932;A0A087WYC1;A0A087WTS8;P34932-2P34932;A0A087WYC1;A0A087WTS8Heat shock 70 kDa protein 4HSPA4 21 19 840 0.74182 1.2529 2.77E+09
E5RIF2;Q9Y6D6;E5RHL7E5RIF2;Q9Y6D6;E5RHL7Brefeldin A-inhibited guanine nucleotide-exchange protein 1ARFGEF1 3 3 1279 0.74129 1.434 7.24E+07
Q96P70 Q96P70 Importin-9 IPO9 16 16 1041 0.74117 1.2551 2.34E+09
H0Y8C6;O00410;O00410-3;O00410-2;C9JMV5;E7ETV3;C9JZD8;C9J875;C9JQT6;E7ESA1;E7ESZ1;E7EWK4;E7EX05;E7EQT5;E7ETV8;E7EV12;H0Y3V4H0Y8C6; ;O00410-3;O00410-2Importin-5 IPO5 12 12 1099 0.74087 0.99118 5.87E+08
Q8N0U8 Q8N0U8 Vitamin K epoxide reductase complex subunit 1-like protein 1VKORC1L1 2 2 176 0.74076 NaN 2.79E+07
P34897-3;P34897;P34897-2;G3V2Y4;H0YIZ0;G3V5L0;G3V4W5;G3V2D2;G3V5403;P 4897;P34897-2;G3V2Y4;H0YIZ0Serine hydroxymethyltransferase, mitochondrial;Serine hydroxymethyltransferaseSHMT2 10 9 483 0.74059 1.3649 1.03E+09
O00330-3;O00330;H0YD97;O00330-2O 0330-3;O00330;H0YD97;O00330-2Pyruvate dehydrogenase protein X component, mitochondrialPDHX 7 7 486 0.73982 1.2185 2.84E+08
O60271-4;A0A087X2D8;O60271-2;O60271;O60271-9;O60271-5;O60271-3;H0YBE9;E9PFH7;A0A087WYG2;Q9UPT6;D6RHI8;H0YBS5;Q9UPT6-2O60271-4;A0A087X2D8; 2; ;O60271-9;O60271-5;O60271-3C-Jun-amino-terminal kinase-interacting protein 4SPAG9 26 26 1307 0.73932 1.274 7.87E+08
Q6NUK1;Q6NUK1-2;J3KN42Q6NUK1;Q6NUK1-2Calcium-binding mitochondrial carrier protein SCaMC-1SLC25A24 9 9 477 0.73841 1.3227 8.18E+08
Q9BWJ5 Q9BWJ5 Splicing factor 3B subunit 5SF3B5 3 3 86 0.73828 1.5474 1.45E+08
Q8IUI8-2;Q8IUI8 Q8IUI8-2;Q8IUI8 Cytokine receptor-like factor 3CRLF3 1 1 438 0.73825 1.1188 1.73E+08
O75955;A0A140T9R1;O75955-2;A0A140T9W4;A0A140T9X0;A2AB09;A2AB13;A2AB11;A0A0G2JJQ6;A2AB12;A2AB10;A0A140T907;A0A140T9B1;A0A140T957;A0A140T910;A0A140T9C3;A0A140T959;A0A140T974O75955;A0A14 T9R1;O75955-2;A0A14 T9W4;A0 140T9X0; 2AB09Flotillin-1 FLOT1 8 8 427 0.73824 1.3 44 3.58E+08
P08240;P08240-2 P08240;P08240-2 Signal recognition particle receptor subunit alphaSRPR 9 9 638 0.73807 1.362 7.53E+08
Q9BSJ8;Q9BSJ8-2;F8VZB1Q9BSJ8;Q9BSJ8-2 Extended synaptotagmin-1ESYT1 16 16 1104 0.73791 1.5402 1.30E+09
P0DMV9;P0DMV8;A0A0G2JIW1;P0DMV8-2;V9GZ37P0DMV9;P0DMV8;A0A0G2JIW1;P0DMV8-2;V9GZ37HSPA1A 49 26 641 0.73742 1.2021 1.65E+11
A0A096LP25;Q6ZSR9A0A096LP25;Q6ZSR9Uncharacterized protein FLJ45252 2 2 511 0.73697 NaN 4.32E+07
A0AVF1-2;A0AVF1-3;A0AVF1;Q96CU4;B7Z2T3;B7Z6R6;F8WEZ4A0AVF1-2;A0AVF1-3;A0AVF1;Q96CU4;B7 2T3;B7Z6R6Tetratricopeptide repeat protein 26TTC26 3 3 487 0.73623 1.326 3.09E+07
Q5TEC6 Q5TEC6 Histone H3 HIST2H3PS2 5 1 136 0.73602 1.6181 7.99E+08
F5H895;A0A0B4J239;F5GXX5;P61803F5H895;A0A0B4J239;F5GXX5;P61803Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1DAD1 2 2 65 0.73596 1.7492 1.99E+08
Q9UHD8-5;Q9UHD8-7;Q9UHD8-2;Q9UHD8;Q9UHD8-3;Q9UHD8-4;Q9UHD8-9;Q9UHD8-8;K7ENL0;K7EL40;K7EK18;K7ER52;K7EPY1;K7EIE4;K7EQD7;K7EJV0;K7EJ51;K7ELJ9;K7ER14;K7EIR4;K7EKN4;K7EN52;K7ENQ5;K7EJZ2;K7EJL9;K7ER34;K7EQ08;K7ERG1Q9UHD8-5;Q9UHD8-7;Q9UHD8-2;Q9UHD8;Q9UHD8-3Septin-9 09 Sep 27 27 579 0.73577 1.216 3.00E+09
Q9BXW7-2;Q9BXW7;A8MYZ9Q9BXW7-2;Q9BXW7Cat eye syndrome critical region protein 5CECR5 11 11 393 0.73574 1.1938 2.43E+09
Q13561;Q13561-3;Q13561-2;H0YI98;F8W1I6;F8VW18;H0YHL1;F8VRV7;F8VX93;Q13561-3;Q13561-2;H0YI98;F8W1I6;F8VW18Dynactin subunit 2 DCTN2 7 7 401 0.73508 0.59225 3.79E+08
Q6UWP7-3;Q6UWP7;C9K0C3;Q6UWP7-2;C9J5S5;C9JA02;C9JMW2;C9JUV9;C9JXY8;C9J6F4Q6UWP7-3;Q6UWP7;C9K0C3;Q6UWP7-2Lysocardiolipin acyltransferase 1LCLAT1 4 4 376 0.73474 1.8804 1.68E+08
Q9UBQ7;U3KQ56;Q9UBQ7-2Q9UBQ7;U3KQ56 Glyoxylate reductase/hydroxypyruvate reductaseGRHPR 13 13 328 0.73448 1.2315 4.80E+09
Q9UNX4;Q6PDA5 Q9UNX4 WD repeat-containing protein 3WDR3 29 29 943 0.73433 1.1892 1.94E+09
O43301;K7ELE6 O43301 Heat shock 70 kDa protein 12AHSPA12A 4 4 675 0.73408 1.307 2.05E+08
Q15393;Q15393-2;Q15393-3;J3QL37;I3L4G7;J3QRB2;H3BMB0;J3QKV4Splicing factor 3B subunit 3SF3B3 38 38 1217 0.734 1.268 9.27E+09
P10620;F5GX73;F5H613;F5H7F6;F5H6X2;F5H760;P10620-2P10620;F5GX73;F5H613;F5H7F6;F5H6X ;F5H760;P10620-2Microsomal glutathione S-transferase 1MGST1 2 2 155 0.73331 1.2952 5.46E+07
A0A087X0Z7;H0YJ66;Q9Y394-2;Q9Y394;H0YJE4;H0YJR8A0A087X0Z7;H0YJ66;Q9 394-2;Q9Y394;H0YJE4;H0YJR8Dehydrogenase/reductase SDR family member 7DHRS7 5 5 376 0.73326 1.9328 1.38E+08
Q8WVC2;P63220;Q9BYK1;Q9BYK2Q8WVC2;P63220;Q9BYK140S ribosomal protein S21RPS21 6 6 81 0.73276 1.3394 4.18E+08
P29218;P29218-3;E5RIP7;H0YBL1;E5RG13;E5RG94;E5RHE9;E5RI82;E5RGY4;P29218-2P29218;P292 8-3;E5RIP7;H0YBL1;E5RG13Inositol monophosphatase 1IMPA1 4 4 277 0.73232 1.8185 3.68E+08
J3KPS0;Q9NXW2;Q9NXW2-2;V9GYN7;V9GY70J3KPS0;Q9NXW2;Q9NXW2-2;V9GYN7DnaJ homolog subfamily B member 12DNAJ 12 3 3 409 0.73222 0.71213 3.39E+08
K7EM02;K7EIJ8;Q8IYT4-2;Q8IYT4K7EM02;K7EIJ8;Q8IYT4-2;Q8IYT4Katanin p60 ATPase-containing subunit A-like 2KATNAL2 1 1 128 0.73217 NaN 1.29E+09
A0A0C4DGU2;Q9Y4U1A0A0C4DGU2;Q9Y4U1Methylmalonic aciduria and homocystinuria type C proteinMMACHC 2 2 225 0.73208 0.84419 1.10E+08
Q10567-3;Q10567-2;Q10567;Q10567-4;C9J1E7;H7C034Q10567-3; 2;Q10567;Q10567-4;C9J1E7AP-1 complex subunit beta-1AP1B1 21 8 939 0.7319 1.3211 3.42E+08
P30040;F8VY02;P30040-2P30 40;F8VY02;P30040-2Endoplasmic reticulum resident protein 29ERP29 2 2 261 0.73159 1.1815 8.80E+07
P09661;H0YKK0;H0YMA0;H0YLR3P09661;H0YKK0 U2 small nuclear ribonucleoprotein ASNRPA1 24 24 255 0.73142 1.2813 3.02E+10
Q68DK2-2;Q68DK2;G3V2D8Q68DK2-2;Q68DK2;G3V2D8Zinc finger FYVE domain-containing protein 26ZFYVE26 2 2 2518 0.73101 NaN 7.00E+06
F8W726;Q14157-4;Q14157-1;Q14157-3;Q14157;Q14157-5;Q5VU77;Q5VU81;Q5VU80;Q5VU79;Q5VU78;H0Y5H6;H7C2T8F8W726;Q14157-4;Q14157-1; 3; 14157; 14157-5;Q5VU77Ubiquitin-associated protein 2-likeUBAP2L 4 4 1079 0.7309 1.3566 2.06E+08
K7EMY7;K7ER15;Q9H0R4;K7EQD2;Q9H0R4-2;K7EJQ8K7EMY7;K7ER15;Q9H0R4;K7EQD2;Q9H0R4-2Haloacid dehalogenase-like hydrolase domain-containing protein 2HDHD2 3 3 146 0.73084 1.2385 1.43E+08
C9J0J7;G5E9Q6;P35080-2;C9JQ45;C9J2N0C9J J7 G5E9Q6;P35080-2;C9JQ45;C9J2N0Profilin;Profilin-2 PFN2 6 3 91 0.73077 1.3243 1.19E+08
Q15021;E7EN77;F5GZK7;F5H431Q15021;E7EN77 Condensin complex subunit 1NCAPD2 27 27 1401 0.73061 1.3966 2.57E+09
P38646;D6RJI2;H0YBG6;D6RA73;H0Y8S0P38 46 Stress-70 protein, mitochondrialHSPA9 40 39 679 0.73004 1.5507 1.43E+10
P00338;P00338-3;P00338-4;P00338-5;P00338-2;F5GYU2;F5GXY2;F5GXH2;F5H5J4;F5H6W8;F5GZQ4;F5H8H6;F5GXC7;F5GWW2;F5GXU1;P00338-3;P00338-4;P00338-5;P00338-2;F5GYU2;F5GXY2;F5GXH2L-lactate dehydrogenase A chainLDHA 15 15 332 0.73003 1.3879 2.76E+09
P49903;P49903-2;P49903-3;P49903-4;Q5T5U6;P49903-2;P49903-3;P49903-4Selenide, water dikinase 1SEPHS1 4 4 392 0.72973 1.6062 2.93E+08
Q14674;Q14674-2;H3BRX7Q14674;Q14674-2 Separin ESPL1 4 4 2120 0.72968 1.2921 9.63E+07
P56377;H7BZG6;H0Y673;F6SFB5;A6NH01;P56377-2P56377;H7 ZG6;H0Y673;F6SFB5;A6NH01;P56377-2AP-1 complex subunit sigma-2AP1S2 2 2 157 0.72936 1.3808 2.80E+08
Q9ULC4-2;Q9ULC4;Q9ULC4-32;Q9ULC4;Q9ULC4-3Malignant T-cell-amplified sequence 1MCTS1 6 6 169 0.72934 1.4169 7.37E+08
Q99497;K7ELW0;K7EN27Q99497;K7ELW0 Protein DJ-1 PARK7 7 7 189 0.72928 1.432 7.29E+08
P30041 P30041 Peroxiredoxin-6 PRDX6 13 13 224 0.72902 1.4963 6.45E+08
P08133-2;P08133;E5RK69;E7EMC6;E5RI05;E5RJF5;E5RK63;E5RFF0;H0YC77;E5RIU8;E5RJR0P08133-2;P08133;E5RK69;E7EMC6Annexin A6;AnnexinANXA6 5 5 641 0.72899 1.6662 2.40E+08
Q14657 Q14657 EKC/KEOPS complex subunit LAGE3LAGE3 2 2 143 0.72881 NaN 2.56E+07
Q9NPE3;H0YM60 Q9NPE3 H/ACA ribonucleoprotein complex subunit 3NOP10 5 5 64 0.72851 1.209 1.62E+08
A0A0C4DGS1;P39656-3;P39656;P39656-2;U3KQ84A0A0C4DGS1; 3;P 9656;P39656-2Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunitDDOST 13 13 439 0.72762 1.818 3.11E+09
Q9Y5P6;Q9Y5P6-2 Q9Y5P6;Q9Y5P6-2 Mannose-1-phosphate guanyltransferase betaGMPPB 6 6 360 0.72696 1.1238 5.43E+08
Q6NXE6-2;Q6NXE6;B4E1N1;F5GWV0;F5H4P3;F5H2X2;F5H2K4;F5H3X1;F5H052;H0YGQ5;H0YH65;F5H6J3;F5GZP0;F5H7V0;H0YGL0Q6NXE6-2;Q6NXE6;B4E1N1;F5GWV0;F5H4P3Armadillo repeat-containing protein 6ARMC6 11 11 476 0.72679 1.3999 1.49E+09
H0Y7L2;Q96N67-4;Q96N67-2;Q96N67-3;Q96N67-5;Q96N67-6;Q96N67;A0A0C4DGY6;Q96N67-7;A0A0U1RQT6;A0A0U1RRC1;A0A0U1RQJ5;A0A0U1RQG7;A0A0U1RR97;K7EP51H0Y7L2;Q96N 7-4;Q96N 7-2;Q96N 7-3;Q96N 7-5;Q96N67-6;Q96N67Dedicator of cytokinesis protein 7DOCK7 52 47 2129 0.72659 1.429 2.48E+09
J9JIE6;Q9UM00-2;Q9UM00;J3QQY2;J3KS45;J3KTQ7J JIE6;Q9UM00-2;Q9UM00;J3QQY2;J3KS45Transmembrane and coiled-coil domain-containing protein 1TMCO1 4 4 239 0.72654 1.1791 1.61E+08
B8ZZN6;P63165;B8ZZJ0;B8ZZ67;B9A032;P63165-2B8ZZN6;P63165;B8ZZJ0;B8ZZ67;B9A032;P63165-2Small ubiquitin-related modifier 1SUMO1 2 2 146 0.72605 1.428 8.09E+07
Q9ULE6 Q9ULE6 Paladin PALD1 7 7 856 0.72603 0.94232 2.72E+08
O60725 O60725 Protein-S-isoprenylcysteine O-methyltransferaseICMT 3 3 284 0.72596 1.0977 3.50E+08
F2Z2V0;B0QZ18;Q99829;A6PVH9;E7ENH5;Q5JX56;Q5JX58;Q5JX59;Q5JX60;Q5JX44;Q5JX55;H0Y524;Q5JX45;Q5JX54;Q5JX61;Q5JX52;Q5JX57;E7EV27F2Z2V0;B0QZ18;Q99829;A6PVH9;E7ENH5;Q5JX56;Q5JX58;Q5JX59;Q5JX60;Q JX44Copine-1 CPNE1 9 9 533 0.7 527 1.2896 1.19E+09
J3KTF4;J3QRG5;J3KSJ5;Q9BQA9-2;Q9BQA9;J3QQQ4;H0Y2X1;J3QRZ2;J3QLB7;J3QKS6J3KTF4;J3QRG5;J3KSJ5;Q9B A9-2;Q9BQA9;J3QQQ4;H0Y2X1;J3QRZ2;J3QLB7;J3QKS6Uncharacterized protein C17orf62C 7orf62 2 2 88 0.72488 NaN 2.67E+07
A0A0A0MRJ6;H7BY58;P22061;P22061-2;F6S8N6;F8WDT3;F8WAV5;F8WAX2;C9J0F2;H7C4X2A0A0A0MRJ6;H7BY58;P22061;P22061-2;F6S8N6Protein-L-isoaspartate O-methyltransferase;Protein-L-isoaspartate(D-aspartate) O-methyltransferasePCMT1 12 12 285 0.7248 1.4107 7.86E+08
Q9Y512 Q9Y512 Sorting and assembly machinery component 50 homologSAMM50 5 5 469 0.72461 NaN 3.41E+08
Q9Y276;C9J8G3;C9J1S9;H7C492;C9JAS4Q9Y276; 9J8G3;C9J1S9Mitochondrial chaperone BCS1BCS1L 6 6 419 0.72399 1.4627 1.38E+08
Q96IX5 Q96IX5 Up-regulated during skeletal muscle growth protein 5USMG5 4 4 58 0.72302 1.0519 3.91E+08
Q09028-3;Q09028;Q09028-2;Q09028-4;H0YF10;H0YCT5;H0YDK2;H0YEU5;E9PNS6;E9PNS2;E9PIC4;E9PND5;C9JPP33; ;Q09028-2;Q 9028-4;H0YF10Histone-binding protein RBBP4RBBP4 11 4 410 0.72301 1.5631 2.89E+09
P60174-1;P60174;P60174-4;U3KPZ0;U3KQF3;U3KPS51;P60174;P60174-4Triosephosphate isomeraseTPI1 11 11 249 0.72279 1.5828 1.69E+09
P0DN79;P35520;P35520-2;C9JMA6;H7C2H4;H7C1W6;H7C2W0P0DN79;P35520 P35520-2;C9JMA6Cystathionine beta-synthaseCBS 18 18 551 0.72277 1.0599 1.95E+09
Q68CQ4 Q68CQ4 Digestive organ expansion factor homologDIEXF 2 2 756 0.72182 1.0118 7.23E+07
P63096;P63096-2;C9JPP4;C9JL77P63096;P63096-2;C9JPP4Guanine nucleotide-binding protein G(i) subunit alpha-1GNAI1 6 2 354 0.7212 1.6284 3.50E+08
V9GY93;Q9HC07-2;Q9HC07V9GY93;Q9HC07-2;Q9HC07Transmembrane protein 165TMEM165 3 3 158 0.72055 1.8216 1.49E+08
Q8NFF5-3;Q8NFF5-2;Q8NFF5;Q5T196;Q8NFF5-4;Q8NFF5-5;Q5T190;Q5T191Q8NFF5-3; 8NFF5-2;Q8NFF5; 5T196;Q8NFF5-4; 8NFF5-5FAD synthase;Molybdenum cofactor biosynthesis protein-like region;FAD synthase regionFLAD 7 7 446 0.72044 1.2965 6.59E+08
H3BSW3;H3BQF1;H3BQZ9;P07741-2;P07741;H3BQB1H3BSW3;H3BQF1 H3BQZ9;P0774 -2;P07741;H3BQB1Adenine phosphoribosyltransferaseAPRT 4 4 63 0.72024 1.605 2.23E+08
Q7L5D6;Q7L5D6-2;C9JPA8;C9JHN8;C9JY46Q7L5D6;Q7L5D6-2;C9JPA8;C9JHN8Golgi to ER traffic protein 4 homologGET4 6 6 327 0.71933 1.3308 9.21E+08
P04792;F8WE04;C9J3N8P04792 Heat shock protein beta-1HSPB1 16 16 205 0.71918 1.0985 3.15E+09
Q13535-2;Q13535-3;Q13535Q13535-2;Q13535-3;Q13535Serine/threonine-protein kinase ATRATR 4 4 2580 0.71863 1.4207 1.75E+08
Q8NFH3;Q8NFH3-2Q8NFH3 Nucleoporin Nup43NUP43 3 3 380 0.71801 1.565 3.55E+08
Q5QNZ2;P24539 Q5QNZ2;P24539 ATP synthase F(0) complex subunit B1, mitochondrialATP5F1 10 10 195 0.71794 1.8826 3.08E+08
F8VZY9;P05783;CON__H-INV:HIT000015463F8VZY9;P05783 Keratin, type I cytoskeletal 18KRT18 13 7 391 0.71734 1.2573 8.97E+08
P12532;P12532-2;F8WCN3;C9JSQ1;C9J8F6;C9J6W7;C9JT96;C9J995;D6RHV3;D6R998;P17540P12532;P12532-2;F8WCN3;C9JSQ1Creatine kinase U-type, mitochondrialCKMT1A;CKMT1B 6 6 417 0.71667 1.4648 5.02E+08
156
Q9NWV8;M0R3F4;M0R2A4;M0R2K3;M0R193;M0R0I0;J3KQS6;M0QXG9;M0R2I2;Q9NWV8-3;M0R3H9;M0QYV1;Q9NWV8-2Q9NWV8;M0R3F4;M0R2A4;M0R2K3;M0R193;M0R0I0;J3KQS6;M0QXG9;M0R2I2;Q9NWV8-3BRISC and BRCA1-A complex member 1BABA 1 5 5 329 0.71633 0.9253 1.28E+08
P08754;P04899;P04899-4;P04899-6;P04899-3;P04899-5;P04899-2;P11488;P09471-2;P09471;P19087;A8MTJ3;A0A087WTB6;A2A2R6;Q5JWD1;H0Y7E8;H3BTM2;A0A087WZE5;F8WE78;Q5JWE9;H0Y7F4;P38405-3;P38405;P38405-2P0875 ; ;P04899-4Guanine nucleotide-binding protein G(k) subunit alpha;Guanine nucleotide-binding protein G(i) subunit alpha-2GNAI3;GNAI2 8 4 354 0.71613 1.4853 1.63E+09
Q96G61;Q8NFP7 Q96G61;Q8NFP7 Diphosphoinositol polyphosphate phosphohydrolase 3-beta;Diphosphoinositol polyphosphate phosphohydrolase 3-alphaNUDT11;NUDT10 3 3 164 0.71598 0.80334 9.04E+07
Q96RL7-4;Q96RL7-2;Q96RL7-3;Q96RL7;H0Y7P8Q96RL7-4;Q96RL7-2;Q96RL7-3;Q96RL7Vacuolar protein sorting-associated protein 13AVPS13A 4 4 3069 0.71588 1.1379 9.54E+07
Q9H9A5-4;Q9H9A5-3;Q9H9A5-2;Q9H9A5;Q9H9A5-6;H7C1X9;E9PCN5Q9H A5-4;Q9H A5-3;Q9H9A5-2;Q9H9A5;Q H9A -6;H7C1X9;E9PCN5CCR4-NOT transcription complex subunit 10CNOT10 2 2 695 0.71524 1.3755 2.22E+08
P62877 P62877 E3 ubiquitin-protein ligase RBX1;E3 ubiquitin-protein ligase RBX1, N-terminally processedRBX1 2 2 108 0.7151 NaN 1.49E+07
Q9UBM7;E9PM00;E9PJ54;H0YE57;E9PRL8;E9PQ71;E9PIP9Q9UBM7;E9PM00 7-dehydrocholesterol reductaseDHCR7 6 6 475 0.71486 1.2694 1.22E+09
P18085;C9JPM4;C9JAK5;U3KQF2P18085;C9JPM4;C9JAK5;U3KQF2ADP-ribosylation factor 4ARF4 8 5 180 0.71473 1.124 3.51E+08
Q99653;H0YKE7;F5GX29;H0YNG9;H0YLY7;H0YLX1Q99653;H0YKE7;F5GX29;H0YNG9;H0YLY7Calcineurin B homologous protein 1CHP1 8 8 195 0.71466 1.3251 3.29E+08
P51149;C9J592;C9J8S3;C9J4S4;C9IZZ0;C9J4V0;C9J7D1P5114 ;C9J592;C9J8S3;C9J4S4;C9IZZ0;C9J4V0Ras-related protein Rab-7aAB7A 5 5 207 0.7145 1.6227 3.15E+08
X6RJP6;P37802;P37802-2X6RJP6;P37802;P37802-2Transgelin-2 TAGLN2 3 3 187 0.71399 1.599 1.63E+08
P22695;H3BRG4;H3BSJ9;H3BP04;H3BUE4;H3BUI9;A0A087WVZ4P22695;H3BRG4;H3BSJ9Cytochrome b-c1 complex subunit 2, mitochondrialUQCRC2 20 20 453 0.71393 1.5103 1.08E+10
E9PGT6;Q99627-2;Q99627;H7C3S9E PGT6;Q99627-2;Q99627;H7C3S9COP9 signalosome complex subunit 8COPS8 4 4 173 0.71378 1.0122 2.11E+08
C9JQV3;Q8N1F8;Q8N1F8-2C9JQV3;Q8N1F8;Q8N1F8-2Serine/threonine-protein kinase 11-interacting proteinSTK11IP 5 5 1088 0.7134 1.2368 1.87E+08
P60866;P60866-2;E5RJX2;E5RIP1;G3XAN0P60866;P60866-2;E5RJX2;E5RIP140S ribosomal protein S20RPS20 9 9 119 0.71301 1.3654 1.06E+10
Q9UNZ2;Q9UNZ2-5;F2Z2K0;Q9UNZ2-4;Q9UNZ2-6;R4GNE6;G3V4V8;R4GMY2Q9UNZ2; 5;F2Z2K0;Q9UNZ2-4;Q9UNZ2-6NSFL1 cofactor p47NSFL1C 7 7 370 0.71243 1.0407 3.10E+08
Q8IXI1;H3BST5;I3L2C6;Q8IXI1-2;H3BUX4;H3BMP9;H3BVI5Q8IXI1;H3BST5;I3L2C6;Q8IXI1-2Mitochondrial Rho GTPase 2RHOT2 6 5 618 0.71192 1.1489 1.21E+09
Q14139;Q14139-2;B7Z7P0Q14139;Q14139-2 Ubiquitin conjugation factor E4 AUBE4A 3 3 1066 0.7119 1.2301 1.08E+08
Q15019;Q15019-3;Q15019-2;B5MCX3;C9J2Q4;C9J938;C9JB25;H7C2Y0;C9IY94;C9IZU3;H7C310;C9JQJ4;B5MD47;C9JZI2;C9JFT1;F8WB65;H7C1T1;C9JT15;C9JSE7;Q15019-3;Q15019-2;B5MCX3;C9J2Q4Septin-2 02-Sep 14 14 361 0.71185 1.9749 1.52E+09
Q9NY61;A0A087WWS8Q9NY61;A0A087WWS8Protein AATF AATF 3 3 560 0.71169 NaN 2.71E+08
P49773;D6RC06;D6REP8;D6RE99;D6RD60P49773 Histidine triad nucleotide-binding protein 1HINT1 3 3 126 0.71121 1.9964 1.62E+08
P42695;G3V1A9;E9PKK4;E9PQA3;E9PLE0P42695;G3V1A9;E9PKK4Condensin-2 complex subunit D3NCAPD3 17 17 1498 0.71109 1.1565 9.28E+08
P09496-2;P09496-4;P09496-3;P09496;F8WF69;C9J8P9;P09496-5P09496-2;P09496-4;P09496-3;P09496;F8WF69Clathrin light chain ACLTA 3 3 218 0.71073 1.0869 2.75E+07
Q8N766-4;Q8N766-3;Q8N766-2;Q8N766;H7C4E3Q8N766-4;Q8N766-3;Q8N766-2;Q8N766ER membrane protein complex subunit 1EMC1 6 6 971 0.71056 1.3549 2.21E+08
Q6NSI4;Q6NSI4-2;Q6NSI4-4Q6NSI4;Q6NSI4-2;Q6NSI4-4Uncharacterized protein CXorf57CXorf57 4 4 855 0.71053 0.9121 7.41E+07
Q9NRK6;A0A0G2JLV0;A0A087WYD6;X5CMH5;Q9NUT2-5;Q9NUT2-4;Q03519;Q9NUT2-2;Q9NUT2Q9NRK6;A0A0G2JLV0;A0A087WYD6;X5CMH5;Q9NUT2-5; 9 T2-4; 03519;Q9NUT2-2;Q9NUT2ATP-binding cassette sub-family B member 10, mitochondrial;ATP-binding cassette sub-family B member 8, mitochondrial;Antigen peptide transporter 2ABCB10;TAP2;ABCB8 2 2 738 0.70962 1.3037 4.68E+07
P14735;P14735-2;Q5T5N3P14735 Insulin-degrading enzymeIDE 13 13 1019 0.70883 1.4 7.95E+08
A0A0U1RRM4;P26599;P26599-2;P26599-3;A6NLN1;A0A0D9SF20;K7EKJ7;K7EK45;A0A087WUW5;K7ELW5;K7ES59;O95758-1;O95758-6;O95758-2;O95758;O95758-5;O95758-4;A0A087WU68;O95758-7;X6R242A0A0U1RRM4; ;P26599-2 P2659 -3;A6NLN1;A0A0D9SF2 ;K7EKJ7Polypyrimidine tract-binding protein 1PTBP1 12 12 588 0.70815 1.7383 3.64E+09
Q9NRZ5;H0Y5R3;Q9NRZ5-2Q9NRZ5;H0Y5R3;Q9NRZ5-21-acyl sn-glycerol-3-phosphate acyltransferase deltaAGPAT4 2 2 378 0.70712 NaN 4.04E+06
Q16891-2;Q16891;B9A067;Q16891-4;Q16891-3;C9J406;H7C463;A0A087WYS0;D6RAW4Q16891-2;Q16891 B9A067;Q16891-4;Q16891-3;C9J406;H7C4 3MICOS complex subunit MIC6IMMT 25 25 747 0.70647 1.2172 2.46E+09
P36507;G5E9C7;M0R1B6P36507 Dual specificity mitogen-activated protein kinase kinase 2MAP2K2 14 9 400 0.70644 1.322 1.11E+09
Q8N4V1;Q8N4V1-2Q8N4V1;Q8N4V1-2Membrane magnesium transporter 1MMGT1 2 2 131 0.70631 1.3754 1.13E+08
F5H6I7;Q6DD88;F5GWF8F5H6I7;Q6DD88;F5GWF8Atlastin-3 ATL3 2 2 523 0.7063 1.3912 1.59E+08
G3V1A0;G5EA23;E9PKS9;E9PQE8;J3KP27;E9PN70;Q9Y296-2;Q9Y296G3V1A0;G5 A2 ;E9PKS ;E9PQE8;J3KP27;E PN70;Q9Y296-2;Q9Y296Trafficking protein particle complex subunit 4TRAPPC4 2 2 117 0.70614 1.155 3.18E+07
Q9NZ45 Q9NZ45 CDGSH iron-sulfur domain-containing protein 1CISD1 3 3 108 0.70589 1.2805 1.12E+08
P51659;E7ER27;E7EWE5;P51659-3;P51659-2;G5E9S2;E7ET17;E7EPL9P51659;E7ER27 E7EWE5;P51659-3;P51659-2Peroxisomal multifunctional enzyme type 2;(3R)-hydroxyacyl-CoA dehydrogenase;Enoyl-CoA hydratase 2HSD17B4 15 15 736 0.70552 1.5463 2.54E+09
J3QQW9;Q15022 J3QQW9;Q15022 Polycomb protein SUZ12SUZ12 2 2 716 0.70525 1.4826 1.69E+08
Q14C86-3;Q14C86-2;Q14C86-6;F8W9S7;Q14C86-4;Q14C86-5;Q14C86;C9IZ08;B4DGD8;B0QZ65;H0Y7I9;A0A0A0MQV8;H0Y4E7;C9IZX9Q14C86-3;Q14C86-2; 14C86-6;F8W9S7;Q14C86-4;Q14C86-5;Q14C86;C9IZ08GTPase-activating protein and VPS9 domain-containing protein 1GAPVD1 24 24 1433 0.70524 0.98475 1.83E+09
Q10570;A0A087X101;E9PIM1;A0A087WTV4Q 0570 Cleavage and polyadenylation specificity factor subunit 1CPSF1 32 32 1443 0.70516 1.3415 3.47E+09
F8VQE1;Q9UHB6-2;Q9UHB6-5;Q9UHB6;Q9UHB6-4;F8VS07;Q9UHB6-3;F8VRN8F8VQE1;Q9UHB6-2;Q9UHB6-5;Q9UHB6 4 S07;Q9UHB6-3LIM domain and actin-binding protein 1TRMT1;LIMA1 8 8 598 0.70481 1.6271 3.45E+08
P61077;P61077-2;D6R9F6;D6R933;D6RGD0;D6R980;D6RAW0;D6RIZ3;D6RA11;D6RFM0;D6RAH7;H9KV45;A0A0A0MQU3;A0A087WY85;P62837-2;P62837;P61077-3P 1077;P 1077-2;D6R9F6;D6R933;D6RGD0;D6R980;D6RAW0;D6RIZ3;D6RA11;D6RFM0;D6R H7;H9KV45;A0A0A0MQU3;A0A087WY85; 283 2;P62837;P61077-3Ubiquitin-conjugating enzyme E2 3;Ubiquitin-conjugating enzyme E2 2UBE2D3;UBE2 2 2 2 147 0.70477 1.4208 2.40E+08
P51809-3;P51809;P51809-2;E5RH063;P518 9;P51809-2Vesicle-associated membrane protein 7VAMP7 4 4 179 0.70464 1.5854 1.75E+08
Q9Y3P9;Q9Y3P9-3;Q9Y3P9-2;Q9Y3P9-4Rab GTPase-activating protein 1RABGAP1 5 3 1069 0.70434 1.5624 1.55E+08
A0A140T9L0;A0A0G2JJL1A0A140T9L0;A0A0G2JJL1 4 1 322 0.70427 1.1928 2.48E+08
H7C1S7;C9JNL5;H7C3V9;H7C277;A0A0A0MQU4;Q96I15-2;Q96I15H7C1S7;C9JNL5;H7C3V9;H7C277;A0A0A0MQU4;Q96I15-2;Q96I15Selenocysteine lyaseSCLY 2 2 168 0.70358 1.0667 9.59E+07
Q9BT73 Q9BT73 Proteasome assembly chaperone 3PSMG3 1 1 122 0.70283 NaN 2.95E+07
Q9BT25-2;Q9BT25-3;Q9BT25Q9BT25-2;Q9BT25-3;Q9BT25HAUS augmin-like complex subunit 8HAUS8 1 1 349 0.70183 NaN 8.61E+07
P04181-2;P04181 P04181-2;P04181 Ornithine aminotransferase, mitochondrial;Ornithine aminotransferase, hepatic form;Ornithine aminotransferase, renal formOAT 3 3 301 0.70157 1.4086 8.20E+07
E7EVJ5;Q96F07-2;Q96F07;H7C229;E7EW33;A0A087WVE1;A0A087WTQ3;A0A087WWZ1E7EVJ5;Q96F07-2;Q96F07;H7C229;E7EW33Cytoplasmic FMR1-interacting protein 2CYFIP2 21 8 1227 0.70134 0.9427 1.88E+08
E7ES33;E7EPK1;Q16181-2;Q16181;G3V1Q4;A0A0U1RRH9;A0A0U1RRE1;Q5JXL7;A0A0U1RRM2;A0A0U1RQK0;A0A0U1RRD1;Q6ZU15E7ES33;E7EPK ;Q16 81-2;Q16181;G3V1Q4Septin-7 07-Sep 8 8 417 0.7012 1.7931 7.52E+08
A0A087WY55;Q9NP79;Q5TGM0;Q9NP79-2A0A087WY55;Q9NP79;Q5TGM0;Q9NP79-2Vacuolar protein sorting-associated protein VTA1 homologVTA1 7 7 280 0.70096 1.2127 1.24E+09
Q9ULV4;Q9ULV4-2;Q9ULV4-3;B4E3S0;H0YHL7;F8VV53;F8W1H8;F8VUX3;F8VSA4;F8VRE9;F8VTT6;F8VVB7;Q9ULV4-2;Q9ULV4-3;B4E S0;H0Y L7Coronin 1C;CoroninCORO1C 12 12 474 0.70078 1.356 1.58E+09
O00232;O00232-2;J3KTJ5;J3KSK1O00232;O00232-2 26S proteasome non-ATPase regulatory subunit 12PSMD12 17 17 456 0.70036 1.8214 1.78E+09
H0Y2Y8;Q15942;H7C3D3;Q15942-2;C9IZ41H0Y2Y8;Q15942;H7C3D3;Q15942-2Zyxin ZYX 7 7 540 0.69953 1.2805 1.26E+08
A0A140TA86;Q5XKP0;K7EIR2;A0A140TA84A A140TA86;Q5XKP0;K7EIR2;A0A140TA84rotein QIL1 QIL1;C19orf70 2 2 140 0.69876 NaN 7.03E+07
P61026 P61026 Ras-related protein Rab-10AB10 5 3 200 0.69661 1.7659 1.02E+08
P62937;P62937-2;F8WE65;C9J5S7;P0DN26;A0A0H2UH34;A0A0B4J2A2;A0A075B767;A0A075B759;Q9Y536;F5H284;E5RIZ5;P0DN37P62937;P62937-2;F8WE65;C9J5S7Peptidyl-prolyl cis-trans isomerase ;Peptidyl-prolyl cis-trans isomerase A, N-terminally processed;Peptidyl-prolyl cis-trans isomerasePPIA 13 13 165 0.6952 1.5848 5.63E+09
H0YMV8;Q71UM5;C9JLI6H0YMV8;Q71UM5;C9JLI640S ribosomal protein S27;40S ribosomal protein S27-likeRPS27L 6 2 100 0.69504 0.63454 1.69E+08
Q96A72;F5H6N1;F5H124Q96A72;F5H6N1 Protein mago nashi homolog 2MAGOHB 6 1 148 0.6937 1.3401 2.77E+08
Q8WVX9;E9PNW8;E9PPB8Q8WVX9;E9PNW8 Fatty acyl-CoA reductase 1FAR1 8 8 515 0.69362 1.0838 8.57E+08
Q9HD20-2;Q9HD20;H7C3H2;Q9HD20-3Q9HD20-2;Q9HD20Manganese-transporting ATPase 13A1ATP13A1 7 7 1086 0.69205 1.0368 2.02E+08
Q9NRP0;A0A087WUD3;Q9NRP0-2Q9NRP0;A0A087WUD3;Q9NRP0-2Oligosaccharyltransferase complex subunit OSTCOSTC 2 2 149 0.69196 1.4255 1.01E+08
P20020-6;P20020-3;P20020-4;P20020;P20020-5;P20020-2;E7ERY9;P23634-5;P23634-4;P23634-3;P23634-2;P23634-7;P23634-6;P23634-8;P23634;Q16720-8;Q16720-7;Q16720-6;Q16720-3;Q16720-5;Q16720-2;Q16720-4;Q16720;H0Y7S3;Q01814-4;Q01814-7;Q01814-3;Q01814-6;Q01814-2;Q01814-8;Q01814-5;Q01814;A0A0U1RQU3P20020-6;P20020-3; 4; ;P20020-5;P20020-2;E7ERY9;P23634-5;P23634- ;P23634-3;P23634-2;P23634-7;P23634-6;P23634 P23634Plasma membrane calcium-transporting ATPase 1;Calcium transporting ATPase;Plasma membrane calcium-transporting ATPase 4ATP2B1;ATP2B4 8 8 1184 0. 9156 1.1136 4.66E+08
O95816;O95816-2 O95816;O95816-2 BAG family molecular chaperone regulator 2BAG2 4 4 211 0.6902 1.559 1.28E+08
Q9GZL7 Q9GZL7 Ribosome biogenesis protein WDR12WDR12 9 9 423 0.6899 1.4064 9.11E+08
Q9BVG4;A6NDF3 Q9BVG4 Protein PBDC1 PBDC1 5 5 233 0.68986 1.8139 2.78E+08
A0A096LNH6;Q14185A0A096LNH6;Q14185Dedicator of cytokinesis protein 1DOCK1 3 3 1886 0.68965 1.2856 5.70E+07
D6RGE2;Q96CN7 D6RGE2;Q96CN7 Isochorismatase domain-containing protein 1ISOC1 2 2 188 0.68895 1.0639 2.49E+08
Q9Y3B4 Q9Y3B4 Splicing factor 3B subunit 6SF3B6 3 3 125 0.68852 1.5299 2.57E+08
Q9Y3T9 Q9Y3T9 Nucleolar complex protein 2 homologNOC2L 16 16 749 0.68703 1.4124 1.91E+09
A0A0J9YWJ4;K7EJD2;A0A0J9YWB6;A0A0A0MR03;Q9Y5B0-4;Q9Y5B0A0 J9YWJ4;K7EJD2; A0J9YWB6;A0A0A0MR03;Q9Y5B0-4;Q9Y5B0RN  polymerase II subunit A C-terminal domain phosphataseCTDP1 4 4 737 0.68677 1.046 9.73E+07
A0A0C4DGP2;A0A0C4DGP5;Q86Y91-2;Q86Y91-3;Q86Y91;Q86Y91-4A0A0C4DGP2;A0A0C4DGP5;Q86Y91-2; 3;Q86Y91;Q86Y91-4Kinesin-like protein KIF18BKIF18 3 3 833 0.68641 NaN 2.47E+07
Q13315;E9PIN0 Q13315;E9PIN0 Serine-protein kinase ATMATM 9 9 3056 0.68617 1.3609 1.29E+08
Q14146;Q5VYD0 Q14146 Unhealthy ribosome biogenesis protein 2 homologURB2 21 21 1524 0.68594 1.3787 1.31E+09
P31930 P31930 Cytochrome b-c1 complex subunit 1, mitochondrialUQCRC1 20 19 480 0.68586 1.6263 6.56E+09
B1AMS2;Q14141-2;Q14141-4;Q14141;Q14141-3B1AMS2;Q14141-2; 4;Q14141;Q14141-3Septin-6 06-Sep 3 2 431 0.68575 1.9478 2.37E+08
O60264 O60264 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5SMARCA5 36 23 1052 0.68434 1.3631 3.68E+09
P61221;D6R9I9;D6RGF4;H0Y990P61221;D6R9I9 ATP-binding cassette sub-family E member 1ABCE1 16 16 599 0.68319 1.6903 1.73E+09
C9JLU1;P52434-3;P52434;P52434-4C9JLU1; 3;P52434;P52434-4DNA-directed RNA polymerases I, II, and III subunit RPABC3POLR2H 5 5 149 0.68283 1.576 2.91E+08
G3V0I5;P49821-2;P49821;E9PPS5;E9PPR0;E9PQP1;E9PMX3;B4DE93G3V0I5;P49821-2; 49821;E9 PS5;E9PPR0;E9PQP1;E9PMX3;B4DE93NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrialNDUFV1 2 2 457 0.68188 1.2148 6.31E+07
P52292;J3QLL0;J3KS65;J3QL07P52292;J3QLL0;J3KS65Importin subunit alpha-1KPNA2;POU2F2 17 17 529 0.68167 1.3997 4.03E+09
J3KPS3;P04075;P04075-2;H3BQN4;H3BPS8;H3BUH7;H3BR04;H3BMQ8;H3BU78;H3BR68;A0A087WXX2;P05062J3KPS3;P04075;P04075-2;H3BQN4;H3BPS8;H3BUH7;H3BR04Fructose-bisphosphate aldolase AALDOA 22 21 368 0.68129 2.1453 4.26E+09
K4DI93;Q13620-3;Q13620-1;Q13620;A6NE76;A0A087WWN2K4DI93;Q13620-3;Q13620-1;Q13620Cullin-4B CUL4B 11 6 900 0.68072 1.4863 6.79E+08
E9PHG5;Q6UW02-2;Q6UW02;Q8WZ13;F8WBE2;C9J8K7E9PHG5;Q6UW02-2 Q6UW02;Q8WZ13;F8WBE2;C9J8K7Cytochrome P450 20A1CYP20A1 2 2 470 0.6798 NaN 9.04E+07
A0A087X207;A0A087X2J1;Q9H6U6-2;Q9H6U6-7;Q9H6U6;Q9H6U6-3;Q9H6U6-8;K7EKB0;K7EJH7;K7EML5;K7ESE9;Q9H6U6-6A0A087X207;A0A087X2J1;Q9H6U -2;Q9H6U6-7;Q9H6U6;Q9H6U6-3;Q9H6U6-8;K7EKB0;K7 JH7;K7EML5;K7ESE9;Q9H6U6-6Breast carcinoma-amplified sequence 3BCAS3 2 2 650 0.67935 1.2959 1.82E+08
O95373;E9PLB2;E9PLJ0O95373 Importin-7 IPO7 20 19 1038 0.67906 1.3159 1.89E+09
P31948;P31948-3;P31948-2;F5H783;F5GXD8;P31948- ;P3194 -2;F5H783Stress-induced-phosphoprotein 1STIP1 10 10 543 0.67848 1.2652 6.37E+08
P47985;P0C7P4 P47985;P0C7P4 Cytochrome b-c1 complex subunit Rieske, mitochondrial;Cytochrome b-c1 complex subunit 11;Putative cytochrome b-c1 complex subunit Rieske-like protein 1UQCRFS1;UQCRFS1P1 5 5 274 0.67809 1.4646 5.36E+08
Q9BTX1-6;Q9BTX1-5;Q9BTX1-2;Q9BTX1;Q9BTX1-3;Q9BTX1-4Q9BTX1-6;Q9BTX1-5; 2; ;Q9BTX1-3;Q9BTX1-4Nucleoporin NDC1 NDC1 5 5 559 0.6772 1.4381 2.19E+08
P40926;P40926-2;G3XAL0P40926;P40926-2;G3XAL0Malate dehydrogenase, mitochondrial;Malate dehydrogenaseMDH2 5 5 338 0.67629 1.6244 7.36E+08
O14980;C9JKM9;C9J673;H7BZC5;C9IZS4;C9JQ02;C9JV99;F8WF71;C9JF49;C9IYM2O14980 Exportin-1 XPO1 27 27 1071 0.67602 1.4464 6.15E+09
Q6DKI1;R4GMU7;Q6DKI1-2Q6DKI1;R4GMU7;Q6DKI1-20S ribosomal protein L7-like 1RPL7L1 6 6 246 0.67582 1.4415 1.15E+09
J3KNE0;A6NKT7 J3KNE0;A6NKT7 RanBP2-like and GRIP domain-containing protein 3RGPD3 23 0 1760 0.6757 0.7399 1.58E+08
157
P22234;E9PBS1;P22234-2;D6RF62P 2234;E9PBS1;P22234-2;D6RF62Multifunctional protein ADE2;Phosphoribosylaminoimidazole-succinocarboxamide synthase;Phosphoribosylaminoimidazole carboxylasePAICS 21 21 425 0.67556 2.1108 5.96E+09
A0A0J9YYL3;A0A0J9YXJ8;A0A0J9YVP6;A0A0J9YXX5;Q9UHX1-4;Q9UHX1-6;Q9UHX1-3;Q9UHX1-5;Q9UHX1-2;Q9UHX1;A0A0J9YVR6;E9PQ56;A0A0J9YWM1;H0YEM1;E9PN18;H0YCP8;E9PL19;E9PMU7A0A0J9YYL3;A0A0J9YXJ8;A0A0J9YVP6;A0A0J9YXX5;Q9UHX1-4;Q9UHX1-6;Q9UHX1-3;Q9UHX1-5;Q9UHX1-2;Q9UHX1;A0 J9YVR6;E9PQ56;A0A0J9YWM1;H0YEM1;E9PN18;H0YCP8Poly(U)-binding-splicing factor PUF60PUF60 0 0 505 0.67542 1.7611 1. 8E+09
B1AH87;P30536 B1AH87;P30536 Translocator proteinTSPO 1 1 107 0.67441 1.3315 3.81E+07
Q96CX2;Q68DU8 Q96CX2 BTB/POZ domain-containing protein KCTD12KCTD12 9 9 325 0.67371 1.3865 1.31E+09
Q9H8Y8-2;Q9H8Y8;Q9H8Y8-32;Q9H8Y8;Q9H8Y8-3Golgi reassembly-stacking protein 2GORASP2 2 2 384 0.67334 NaN 3.62E+07
Q9HAV4;H0Y9I3;E2QRM39HAV4 Exportin-5 XPO5 12 12 1204 0.67312 1.5142 9.22E+08
Q9H9B4;D6RFI0;S4R2X2;D6RDG7;D6RAE9;H0Y9J5Q9H9B4;D6RFI0;S4R2X2Sideroflexin-1 SFXN1 16 15 322 0.67232 1.4372 1.10E+10
G3XAN4;Q15629-2;Q15629G3XAN4;Q15629-2;Q15629Translocating chain-associated membrane protein 1TRAM1 2 2 288 0.67219 NaN 1.57E+08
P10515;H0YDD4;E9PEJ4P10515;H0YDD4;E9PEJ4Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial;Acetyltransferase component of pyruvate dehydrogenase complexDLAT 10 10 647 0.67198 1.6987 1.82E+09
C9JTK6;J3KQ32;Q9NTK5-3;Q9NTK5C9JTK6;J3KQ32;Q9NTK5-3;Q9NTK5Obg-like ATPase 1 OLA1 1 1 116 0.6714 NaN 6.59E+07
P12235;V9GYG0 P12235;V9GYG0 ADP/ATP translocase 1SLC25A4 21 5 298 0.67111 0.8012 1.39E+09
Q96JG6;Q96JG6-3;Q96JG6-2;C9JA29;H0Y7Q2;F8WDT1;F2Z3F0;Q96 G6-3;Q96JG6-2Coiled-coil domain-containing protein 132CCDC132 6 6 964 0.67077 1.1748 1.47E+08
P32119;A6NIW5;P32119-2P32119;A6NIW5 Peroxiredoxin-2 PRDX2 15 14 198 0.67052 2.007 5.97E+09
O43818 O43818 U3 small nucleolar RNA-interacting protein 2RRP9 2 2 475 0.66999 1.0459 6.07E+07
H3BUV4;Q9NWW5;H3BNF1;H3BUT1;Q9NWW5-2;H3BRN7;H3BTY43BUV4;Q9NWW5;H3BNF1;H3BUT1;Q9NWW5-2Ceroid-lipofuscinosis neuronal protein 6CLN6 3 3 213 0.66989 NaN 2.57E+08
P07195;C9J7H8;A8MW50;F5H793P07195;C9J7H8;A8MW50L-lactate dehydrogenase B chain;L-lactate dehydrogenaseLDHB 10 10 334 0.66871 1.6525 3.40E+09
O60763;O60763-2;REV__R4GMN2;REV__Q5VZ89-5;REV__Q5VZ89-6;REV__Q5VZ89;REV__R4GNB2;REV__R4GN35O60763;O60763-2 General vesicular transport factor p115USO1 24 24 962 0.66866 1.3489 2.02E+09
G3XAH6;P51003;P51003-2;Q9NRJ5;A0A0C4DGK1;G3V3I9;H0YJ00;G3V457;G3V2A0;H7C3W0;F8WAT4;Q9BWT3-2;Q9BWT3G3XAH6;P51003;P51 03-2;Q9NRJ5;A0A0C4DGK1Poly(A) polymerase alpha;Poly(A) polymerase betaPAPOLA;PAPOLB 8 8 724 0.66672 1.2858 5.79E+08
P51153;A0A087WWB9;H0YMN7;H0YNE9;Q92930;H0YLJ8;H0YL94;M0R257;P59190-2;P59190;P20337;O95716;P20336;Q96E17P51153;A0A087WWB9Ras-related protein Rab-13AB13 5 2 203 0.66572 1.3218 1.21E+08
Q15008;Q15008-4;Q15008-3;Q15008-2;C9J0E9;C9J7B7;H7C531;Q15008-4;Q150 8-3;Q15008-2;C9J0E926S proteasome non-ATPase regulatory subunit 6PSMD6 14 14 389 0.66479 1.1436 1.84E+09
Q9UBB4-2;Q9UBB4;B1AHE4;B1AHE3Q9UBB -2;Q9UBB4Ataxin-10 ATXN10 10 10 411 0.66343 1.3143 1.01E+09
Q68E01-2;Q68E01;Q68E01-3;A0A096LNW8;Q68E01-42;Q68E01;Q68E01-3Integrator complex subunit 3INTS3 12 12 1042 0.66337 1.0585 3.73E+08
E9PLK3;P55786;P55786-2;A6NEC2;H0YDG0;E9PP11;A6NEC2-2;H0YCQ5;E9PJY4;E9PPD4;A6NEC2-3E9PLK3;P55786;P55786-2Puromycin-sensitive aminopeptidaseNPEPPS 28 28 915 0.66313 1.4432 3.23E+09
P61160;P61160-2;F5H6T1P61160;P61160-2;F5H6T1Actin-related protein 2ACTR2 6 6 394 0.66305 1.4323 8.71E+08
Q9UBQ0;F8VXU5;Q9UBQ0-2Q9UBQ0;F8VXU5;Q9UBQ0-2Vacuolar protein sorting-associated protein 29VPS29 4 4 182 0.66287 1.3646 3.67E+08
Q9NVQ4;Q9NVQ4-3;Q9NVQ4-2;C9JDZ2Q9NVQ4;Q9NVQ4-3;Q9NVQ4-2;C9JDZ2Fas apoptotic inhibitory molecule 1FAIM 6 6 179 0.66255 1.7027 3.62E+08
P00505;P00505-2 P00505;P00505-2 Aspartate aminotransferase, mitochondrialGOT2 5 5 430 0.66221 1.7554 4.17E+08
Q8N138-4;Q8N138;J3KTF9;J3QRM9Q8N138-4; 8N138;J3KTF9;J3QRM9ORM1-like protein 3ORMDL3 2 2 137 0.66068 1.0965 4.90E+06
P21266;A0A0A0MTN3;E9PLF1;E9PHN7;E9PHN6;Q5T8Q9;Q5T8R1;F6XZQ7;P28161-2;P46439;P28161P21266;A0A0A0MTN3Glutathione S-transferase Mu 3GSTM3 9 9 225 0.65928 1.5685 9.76E+08
Q9NZJ4;Q9NZJ4-2;H0Y6M8Q9NZJ4;Q9NZJ4-2 Sacsin SACS 3 3 4579 0.65878 NaN 1.84E+07
Q9Y221;Q9Y221-2;J3QRD6;J3QRR4;J3QLW7Q9Y221;Q9Y221-2;J3QRD6;J3QRR4;J3QLW760S ribosome subunit biogenesis protein NIP7 homologNIP7 4 4 180 0.65856 1.3277 1.86E+08
P06576;H0YH81;F8W079;F8W0P7;H0YI37P06576;H0YH81 ATP synthase subunit beta, mitochondrial;ATP synthase subunit betaATP5B 22 22 529 0.65763 1.6798 7.07E+09
Q9H3K6-2;Q9H3K6;H3BV85;H3BTW0;A0A0B4J295;A0A087WZT3;H3BVE0Q9H3K6-2;Q9H3K6;H3BV85;H3BTW ;A0A0B4J295;A A087WZT3;H3BVE0BolA-like protein 2 BOLA2;BOLA2B 3 3 58 0.65756 1.3067 3.22E+08
Q8N0X7 Q8N0X7 Spartin SPG20 9 9 666 0.65739 1.3648 7.93E+08
P12277;H0YJG0;G3V4N7;G3V461;H0YJK0P12277;H0YJG0 Creatine kinase B-typeCKB 11 11 381 0.65634 1.6624 1.10E+09
E9PFH4;Q9Y5L0-3;Q9Y5L0;C9J7E5;Q9Y5L0-1;Q9Y5L0-5E PFH4;Q9Y5L0-3;Q9Y5L0;C9J7E5;Q9Y5L0-1;Q9Y5L0-5Transportin-3 TNPO3 7 7 857 0.65409 1.5779 5.83E+08
A6NEM2;P51610-2;P51610;P51610-4;P51610-3;H7C1C4A6NEM2; 2; ;P51610-Host cell factor 1;HCF N-terminal chain 1;HCF N-terminal chain 2;HCF N-terminal chain 3;HCF N-terminal chain 4;HCF N-terminal chain 5;HCF N-terminal chain 6;HCF C-terminal chain 1;HCF C-terminal chain 2;HCF C-terminal chain 3;HCF C-terminal chain 4;HCF C-terminal chain 5;HCF C-terminal chain 6HCFC1 10 10 2080 0.65318 1.4457 1.07E+09
P61956-2;P61956;A8MUA9;A8MU27;Q6EEV6;P55854;P55854-2P61956-2;P61956 Small ubiquitin-related modifier 2SUMO2 3 3 71 0.65257 1.3964 2.35E+08
Q8IWA0 Q8IWA0 WD repeat-containing protein 75WDR75 9 9 830 0.65248 1.3767 1.02E+09
Q9Y570;Q9Y570-4;Q9Y570-2;Q9Y570-3;Q9Y570-4;Q9Y570-2Protein phosphatase methylesterase 1PPME1 8 8 386 0.65209 1.3625 8.99E+08
G8JLH9;P40763-3;P40763-2;P40763G8JLH9;P40763- ;P40763-2;P40763Signal transducer and activator of transcription;Signal transducer and activator of transcription 3STAT3 2 2 672 0.65186 1.8651 1.21E+08
A0A0A0MSI0;Q06830;A0A0A0MRQ5A 0 0MSI0;Q06830Peroxiredoxin-1 PRDX1 13 9 171 0.65109 1.6958 2.51E+09
A0A0A0MRB5;Q8WXG6-6;Q8WXG6-8;Q8WXG6-5;Q8WXG6-4;Q8WXG6-7;Q8WXG6-3;Q8WXG6-2;Q8WXG6;C9JM97;C9JLZ9;C9K0L0A0A0A0MRB5;Q8WXG6-6;Q8WXG6-8;Q8WXG6-5;Q8WXG6-4;Q8WXG6-7;Q8WXG6-3;Q8WXG6-2;Q8WXG6;C9JM97;C9JLZ9;C9K0L0MAP kinase-activating death domain proteinMADD 2 2 1588 0.65 59 2.3232 1.68E+07
Q9HCC0-2;Q9HCC0;D6RD67Q9HCC0-2;Q9HCC0;D6RD67Methylcrotonoyl-CoA carboxylase beta chain, mitochondrialMCCC2 2 2 525 0.64976 1.0225 1.07E+08
Q09161;X6R941 Q09161 Nuclear cap-binding protein subunit 1NCBP1 11 11 790 0.64975 1.6546 1.15E+09
Q92616 Q92616 Translational activator GCN1GCN1L1 84 84 2671 0.64954 1.6932 7.03E+09
P11216;H0Y4Z6 P11216 Glycogen phosphorylase, brain formPYGB 11 6 843 0.64895 1.4799 3.40E+08
J3KTF8;J3QQX2;P52565;J3KRE2;J3KRY1;P52565-2;J3KS60J3KTF8;J3QQX2;P5256 ;J3KRE2;J3KRY1;P52565-2;J3KS60Rho GDP-dissociation inhibitor 1ARHGDIA 6 6 194 0.64716 2.0454 1.53E+09
B5MDF5;P62826;F5H018;J3KQE5;H0YFC6;B4DV51;A0A087X0W0B5MDF5;P62826;F5H018;J3KQE5;H YFC6GTP-binding nuclear protein RanRAN 10 10 233 0.64673 1.9402 2.91E+09
Q96IJ6;Q96IJ6-2;A0A087WUI8;A0A0U1RRC2;C9JAH0;F8WD54;C9J255Q96IJ6;Q96IJ6-2;A0A087WUI8Mannose-1-phosphate guanyltransferase alphaGMPPA 5 5 420 0.64553 1.2973 5.15E+08
Q9BWD1;Q9BWD1-2Q9BWD1;Q9BWD1-2Acetyl-CoA acetyltransferase, cytosolicACAT2 12 12 397 0.64509 1.2942 2.38E+09
P49755;G3V2K7 P49755;G3V2K7 Transmembrane emp24 domain-containing protein 10TMED10 6 6 219 0.64489 2.0031 4.84E+08
Q86V85 Q86V85 Integral membrane protein GPR180GPR180 2 2 440 0.64423 1.5922 7.81E+06
P25789;H0YN18;P25789-2;H0YMZ1;H0YL69;H0YMI6;H0YMA1;H0YLC2;H0YKT8;H0YKS0;H0YMV3;H0YLS6P25789 N18;P2578 -2;H0YMZ1;H0YL69;H0YMI6;H0YMA1Proteasome subunit alpha type-4;Proteasome subunit alpha typePSMA4 10 10 261 0.64397 1.184 1.02E+09
P09972;K7EKH5;C9J8F3;J3KSV6;J3QKP5;A8MVZ9P09972;K7EKH5;C9J8F3;J3KSV6;J3QKP5;A8MVZ9Fructose-bisphosphate aldolase CALDOC 3 2 364 0.64369 2.1853 1.28E+09
V9GYG2;V9GYP9;Q5T621;P14550V9GYG2;V9GYP9;Q5T621;P14550Alcohol dehydrogenase [NADP(+)]AKR1A1 1 1 119 0.64347 NaN 7.62E+07
Q6RW13;Q6RW13-2Q6RW13;Q6RW13-2Type-1 angiotensin II receptor-associated proteinAGTRAP 2 2 159 0.64263 NaN 5.50E+07
P28066;P28066-2 P28066;P28066-2 Proteasome subunit alpha type-5PSMA5 6 6 241 0.64161 1.2416 6.08E+08
Q5SWX8-4;Q5SWX8;Q5SWX8-3;Q5SWX8-2Q5SWX8-4;Q5SWX8;Q5SWX8-3;Q5SWX8-2Protein odr-4 homologODR4 4 4 422 0.64069 1.2018 3.11E+08
A6NFX8;Q9UKK9;A6NJU6;C9JYY9;A6NCQ0A6NFX8;Q9UKK9 ADP-sugar pyrophosphataseNUDT5 5 5 232 0.64066 1.0143 2.81E+08
O75947;O75947-2;F5H608O75947;O75947-2 ATP synthase subunit d, mitochondrialATP5H 3 3 161 0.63982 1.1453 6.51E+07
P49642;F8VNY2 P49642;F8VNY2 DNA primase small subunit;DNA primasePRIM1 3 3 420 0.63928 1.2152 1.80E+08
Q5VW36 Q5VW36 Focadhesin FOCAD 12 4 1801 0.63913 1.3396 4.73E+08
A0A067XG54;Q8NB49-2;Q8NB49-3;Q8NB49-4;Q8NB49A0A067XG54;Q8NB49-2;Q8NB49-3;Q8NB49-4;Q8NB49Phospholipid-transporting ATPase IGATP11C 2 2 1113 0.63896 1.0599 8.11E+07
E7EQ61;Q9GZZ9;E7EWE1;Q9GZZ9-27EQ61;Q9GZZ9;E7EWE1;Q9GZZ9-2Ubiquitin-like modifier-activating enzyme 5UBA5 2 2 377 0.63597 NaN 1.22E+08
E2QRD4;Q6ZRQ5 E2QRD4;Q6ZRQ5 Protein MMS22-likeMMS22L 2 2 1203 0.63562 NaN 5.73E+07
A0A0B4J1R6;P29401;P29401-2;E9PFF2A0A0B J1R6;P29401;P29401-2Transketolase TKT 7 7 457 0.63554 1.2438 5.03E+08
Q9Y2V2;H3BTK3;I3L3X8;H3BSW7;H3BUY4;H3BPY5;H3BNU9Q9Y2V2;H3BTK3;I3L3X8;H3BSW7;H3B Y4;H3BPY5;H3BNU9Calcium-regulated heat stable protein 1CAR SP1 2 2 147 0.63548 1.511 7.08E+07
B8ZZ47;H0Y714;Q96G21;F8WCN0;B9A008;E7ENR5B8ZZ47;H0Y714;Q96G21;F8WCN0;B9A008;E7ENR5U3 small nucleolar ribonucleoprotein protein IMP4IMP4 2 2 248 0.63535 1.2056 3.32E+08
O60216;E5RFZ5;E5RG18;E5RI01;Q9H4I0O60216;E5RFZ5 Double-strand-break repair protein rad21 homologRAD21 8 8 631 0.6349 1.2146 3.81E+08
Q5QJ74;E9PP54 Q5QJ74;E9PP54 Tubulin-specific chaperone cofactor E-like proteinTBCEL 2 2 424 0.63434 0.9218 1.36E+08
P56385 P56385 ATP synthase subunit e, mitochondrialATP5I 2 2 69 0.63356 1.6979 1.40E+08
Q9H773;H3BSA6 Q9H773;H3BSA6 dCTP pyrophosphatase 1DCTPP1 4 4 170 0.63341 1.0915 6.31E+07
O43808;B0QYW5;F6RTR7;F8WE74;B1AHN4;F8WEC6O43808;B0QYW5;F6RTR7;F8WE74Peroxisomal membrane protein PMP34SLC25A17 3 3 307 0.63285 1.5569 2.22E+08
E9PN17;O75964;Q7Z4Y8E9PN17;O75964 ATP synthase subunit g, mitochondrialATP5L 6 6 76 0.63227 1.8322 6.30E+08
B4DR61;P61619;F8W776;Q8TC24;P61619-3;Q9H9S3-2;Q9H9S3-3;Q9H9S3;H7C1Q9;C9JXC6;H7C069;A6NK38;F2Z2C7;A6NIF9;C9JJV4B4DR 1;P61619;F8W776; 8TC24;P6161 - ;Q9H9S3-2;Q9H9S3-3;Q9H9S3Protein transport protein Sec61 subunit alpha isoform 1;Protein transport protein Sec61 subunit alpha isoform 2SEC61A1;SEC61A2 8 8 482 0.63184 1.3566 2.15E+08
Q8TB61-5;Q8TB61-4;Q8TB61-3;Q8TB61-2;Q8TB61Q8TB61-5;Q8TB61-4;Q8TB61-3;Q8TB61-2;Q8TB61Adenosine 3-phospho 5-phosphosulfate transporter 1SLC35B2 2 2 299 0.6312 1.6432 1.34E+08
P31350;P31350-2;C9JXC1;A0A0C4DGZ6;H0YAV1;Q7LG56-2;Q7LG56;Q7LG56-6P31350;P31350-2;C9JXC1Ribonucleoside-diphosphate reductase subunit M2RRM2 6 6 389 0.63045 1.6862 4.23E+08
C9JS59;C9J266;Q5XPI4;Q5XPI4-2C9JS59;C9J266;Q5XPI4;Q5XPI4-2E3 ubiquitin protein ligase RNF123RNF123 3 3 721 0.63033 0.84487 9.09E+07
Q92973-2;Q92973;Q92973-3;O14787-2;O14787;S4R398;A0A075B780;K7ENW1;K7ESC1;E7EW372;Q92973;Q92973-3;O14787-2Transportin- ;Transportin-2TNPO1;TNPO2 7 7 890 0.62929 1.2744 3.24E+08
Q14974;Q14974-2;J3KTM9;J3QR48;J3QKQ5;J3QRG4Q14974 Q14974-2;J3KTM9Importin subunit beta-1KPNB1 29 29 876 0.62893 1.5822 1.09E+10
P50395-2;P50395;Q5SX87;Q5SX86;Q5SX91;P31150P 0395-2;P50395;Q5SX87Rab GDP dissociation inhibitor betaGDI2 4 4 400 0.62787 1.9369 3.54E+08
P84077;P61204;F5H423;P61204-2;F5H0C7;H0YGG7P84077;P61204; 423;P61204-2ADP-ribosylation factor 1;ADP-ribosylation factor 3ARF1;ARF3 10 6 181 0.62745 1.7094 2.74E+09
P20674;H3BRM5;H3BV69;H3BNX8P20 74;H3BRM5;H3BV69;H3BNX8Cytochrome c oxidase subunit 5A, mitochondrialCOX5A 3 3 150 0.62743 1.3265 4.43E+07
P52209-2;P52209;K7EM49;K7EPF6;K7EMN2;K7ELN9P5220 -2;P52209 6-phosphogluconate dehydrogenase, decarboxylatingPGD 23 23 470 0.62688 1.9836 6.63E+09
P30048-2;P30048 P30048-2;P30048 Thioredoxin-dependent peroxide reductase, mitochondrialPRDX3 5 5 238 0.6262 1.943 3.80E+08
P62942;Q1JUQ3;Q1JUQ5;A0A087WTS4;Q5W0X3;A0A087WV48;A0A087WZM5P62942;Q1JUQ3;Q1JUQ5;A0A087WTS4;Q5W0X3;A0A087WV48;A0A087WZM5Peptidyl-prolyl cis-trans isomerase FKBP1A;Peptidyl-prolyl cis-trans isomeraseFKBP1 ;FKBP12-Exin;FKBP12-Exi 2 2 2 108 0.62491 1.501 4.63E+07
Q96GD4-4;Q96GD4-2;Q96GD4;Q96GD4-5;J3QR41;J3KTD6;J3QLN8;J3KT86;J3KRJ2;J3KRF8;Q96GD4-3Q96GD4-4;Q96GD4-2;Q96GD4;Q96GD4-5;J3QR41;J3KTD6;J3QLN8;J3KT86Aurora kinase B AURKB 5 5 303 0.62482 1.1354 3.02E+08
P49419-2;P49419;F8VS02;A0A140T9V3;P49419-4;A0A0J9YWF7;H0YHM6;F8VVF2P49419-2;P4941 ;F8VS02;A0A140T9V3;P49419-4;A0A0J9YWF7Alpha-aminoadipic semialdehyde dehydrogenaseALDH A1 12 12 511 0.62439 1.8937 1.75E+09
D6RG15;Q6IBS0;H0Y858D6RG15;Q6IBS0 Twinfilin-2 TWF2 3 3 254 0.62419 2.0336 2.29E+08
P00492 P00492 Hypoxanthine-guanine phosphoribosyltransferaseHPRT1 7 6 218 0.62398 1.844 1.39E+09
Q6Y1H2 Q6Y1H2 Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2PTPLB 2 2 254 0.62296 1.4981 1.21E+07
Q9UIV1-2;Q9UIV1;H0YBT3;H0YAV9Q9UIV1-2;Q9UIV1;H0YBT3;H0YAV9CCR4-NOT transcription complex subunit 7CNOT7 3 3 244 0.62197 1.6232 1.55E+08
158
Q6SZW1;Q6SZW1-2Q6SZW1;Q6SZW1-2Sterile alpha and TIR motif-containing protein 1SARM1 5 5 724 0.61981 1.4996 2.70E+08
F8WCF6;P59998;F8WDD7;A0A0A6YYG9;P59998-3;P59998-2;H7C0A3;R4GN08;P59998-4;F8WDW3;F8WE39F8WCF6;P59998;F8WDD7;A0A0A6YYG9;P59998- P59998-2;H7C0A3Actin-related protein /3 complex subunit 4ARPC4-TTLL3;ARPC4 5 5 181 0.61929 1.7531 1.59E+09
E9PNN3;Q03393 E9PNN3;Q03393 6-pyruvoyl tetrahydrobiopterin synthasePTS 2 2 77 0.61921 0.96098 2.17E+07
Q9BPU6;E7EWB4;E9PHT0;E7ESV0Q9BPU6 Dihydropyrimidinase-related protein 5DPYSL5 10 10 564 0.61878 1.7026 1.05E+09
Q969X6;H3BSH7;Q969X6-2;A0A0J9YWM9;Q969X6-3;H3BPD7;H3BRM8;A0A0J9YXV4;I3L4T9;A0A0J9YWK2;J3KSE6;J3KTR0;J3KSI1Q969X6;H3BSH7;Q96 X6-2;A0A0J9YWM9;Q969X6-3Cirhin CIRH1A 8 8 686 0.61754 1.5124 1.34E+09
P03886 P03886 NADH-ubiquinone oxidoreductase chain 1MT-ND1 4 4 318 0.61739 1.564 8.81E+07
P46940;H0YLE8;A0A0J9YXZ5;A0A087WWP1;F2Z2E2;Q86VI3;E9PDT6P46940;H0YLE8;A0A0J9YXZ5Ras GTPase-activating-like protein IQGAP1IQGAP1 40 38 1657 0.61677 1.6084 4.82E+09
Q9H7E9;Q9H7E9-2 Q9H7E9;Q9H7E9-2 UPF0488 protein C8orf33C8orf33 2 2 229 0.61521 NaN 1.26E+07
P38432 P38432 Coilin COIL 2 2 576 0.61464 1.7663 3.29E+08
P05023-4;P05023;P05023-3;P05023-2;B1AKY9;P50993;H0Y7C1;Q13733;Q5TC01;P20648;Q5TC02;E9PRA5;Q5TC05;M0QXF24; ;P05023-3;P05023-2Sodium/potassium-transporting ATPase subunit alpha-1ATP1A1 45 27 1023 0.61408 1.6054 1.08E+10
Q5BJF2;Q86XC5;J3KT68;J3KTD1Q5BJF2;Q86XC5;J3KT68;J3KTD1Transmembrane protein 97TMEM97 2 2 176 0.6137 1.3054 1.99E+08
Q9UNF1;Q5H909;Q9UNF1-2;Q5H907;A0A087X070;G5E9N2;Q12816-5;Q12816-2;Q12816-3;Q12816-4;Q12816Q9UNF1;Q5H909;Q9UNF1-2;Q5H907Melanoma-associated antigen D2MAGED2 17 16 606 0.61113 1.4569 1.47E+09
C9J1Z8;P84085;F5H1V1;F5H6T5;F8WDB3C9J Z8;P84085 ADP-ribosylation factor 5ARF5 7 3 150 0.61092 1.1992 2.79E+07
Q9UJA5;Q9UJA5-4;Q9UJA5-3;Q9UJA5-2;Q9UJA5-4;Q9UJA5-3;Q9UJA5-2tRNA (adenine(58) N(1))-methyltransferase non-catalytic subunit TRM6TRMT6 3 3 497 0.61054 1.1801 7.43E+07
O00264;O00264-2 O00264;O00264-2 Membrane-associated progesterone receptor component 1PGRMC1 7 7 195 0.61045 1.2315 2.29E+08
K7ES52;K7ERJ1;K7ERV3;P04183;K7ENW5K7ES52;K7ERJ1;K7ERV3;P04183Thymidine kinase;Thymidine kinase, cytosolicTK1 3 3 180 0.61009 NaN 1.36E+08
Q5VTU3;P63172 Q5VTU3;P63172 Dynein light chain Tctex-type 1DYNLT1 3 3 92 0.60964 1.4198 1.09E+08
H0YNW5;H0YKC5;P33316-2;P33316;H0YMM5;A0A0C4DGL3;H0YNJ9;H0YKI0;H0YMP1H0YNW5;H0YKC5;P33316-2;P33316;H0YMM5;A0A0C4DGL3;H0YNJ9;H0YKI0Deoxyuridine 5-triphosphate nucleotidohydrolase, mitochondrialDUT 3 3 167 0.60947 1.2927 3.31E+07
A6NLH6;Q9P003 A6NLH6;Q9P003 Protein cornichon homolog 4CNIH4 1 1 137 0.60817 1.6674 1.71E+09
P51148;P51148-2;K7ERI8;K7ERQ8;F8VVK3;K7ENY4;F8VWU4;F8VVZ0;F8VUA5;P61020-2;P20339-2;P61020;P20339;K7EIP6;F8WCY6;F8WD79;F8VPW9;F8VSF8;F8VWZ7P51148;P51148-2;K7ERI8;K7ERQ8;F8VVK3;K7ENY4Ras-related protein Rab-5CAB5C 6 6 216 0.60799 1.5888 2.48E+08
P46977;P46977-2;A0A0C4DH80;E9PN73;E9PI32;H0YET6P46977;P46977-2 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3ASTT3A 10 10 705 0.60771 2.2213 1.21E+09
Q7LC14;A0A087WVX9;O00221;H3BNC2Q7LC14;A0A087WVX9;O00221;H3BNC2NF-kappa-B inhibitor epsilonNFKBIE 2 2 361 0.60699 NaN 5.82E+07
Q7Z3U7-2;Q7Z3U7-6;Q7Z3U7-5;Q7Z3U7;Q7Z3U7-3;F8VZV1;F8VZV6;F8VQS2Q7Z3U7-2;Q7Z3U7-6; 5;Q7Z3U7Protein MON2 homologMON2 9 9 1675 0.60685 1.5671 3.85E+08
Q6P9B9 Q6P9B9 Integrator complex subunit 5INTS5 4 4 1019 0.60614 1.4847 2.32E+08
Q9H8M7;X6R9S5;X6RC97;X6RC30Q9H8M7;X6R9S5;X6RC97;X6RC30Protein FAM188A FAM188A 2 2 445 0.60572 NaN 6.25E+07
Q8TEX9;Q8TEX9-2;H0YN14;H0YN07;H0YMR4;H0YLV0;H0YL92;H0YKG5;H0YK93Q8TEX9;Q8TEX9-2;H0YN14Importin-4 IPO4 19 19 1081 0.60452 1.4238 1.95E+09
Q15738;C9JDR0 Q15738;C9JDR0 Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylatingNSDHL 4 4 373 0.60441 1.412 2.73E+08
Q9H583;Q5T3Q7;Q6P664Q9H583;Q5T3Q7 HEAT repeat-containing protein 1;HEAT repeat-containing protein 1, N-terminally processedHEATR1 43 43 2144 0.60401 1.4422 4.99E+09
G3V4W0;B4DY08;B2R5W2;G3V4C1;P07910-2;P07910-4;G3V2D6;P07910-3;G3V251;G3V5X6;G3V3K6;P0DMR1;B7ZW38;A0A0G2JPF8;A0A0G2JNQ3;O60812;B2RXH8;G3V5V7;B4DSU6;G3V4M8;G3V2H6G3V4W0;B4DY08;B2R5W G3V4C1;P07910-2; 4; D6 P07910-3;G3V251;G3V5X6;G3V3K6;P0DMR1;B7ZW38;A0A0G2JPF8;A0A0G2JNQ3;O60812;B2RXH8Heterogeneous nuclear ribonucleoproteins C1/C2;Heterogeneous nuclear ribonucleoprotein C-like 1;Heterogeneous nuclear ribonucleoprotein C-like 2HNRNPC;LOC649 30;HNRN CL1;HNRNPCL222 3 262 0.60318 1.507 2.18E+10
A0A0A0MSQ0;P13797-3;P13797-2;P13797;H7C4N2;U3KQI3;C9JAM8;P13796;Q5TBN3A0A0A0MSQ0;P13797-3;P13797-2;P13797Plastin-3 PLS3 10 8 617 0.60274 2.382 6.98E+08
P28838-2;P28838 P28838-2;P28838 Cytosol aminopeptidaseLAP3 2 2 488 0.60235 NaN 3.92E+07
D6RCD0;Q8NBQ5 D6RCD0;Q8NBQ5 Estradiol 17-beta-dehydrogenase 11HSD17B11 3 3 256 0.6023 1.1561 2.88E+08
P54709;H7C547;F8WBY4;C9JA36;P54709-2;H7C4L9;C9JXZ1P54709;H7C547;F8WBY4;C9JA36;P54709-2Sodium/potassium-transporting ATPase subunit beta-3ATP1B3 4 4 279 0.60152 2.1359 4.61E+08
H3BMH2;H3BSC1;P62491-2;Q15907-2;P62491;Q15907;B4DQU5H3BMH ;H3BSC1;P62491-2 -2;P62491;Q15907Ras-related protein Rab-11A;Ras-related protein Rab-11BAB11 ; AB11B 5 5 155 0.60076 2.0192 1.73E+08
P23284 P23284 Peptidyl-prolyl cis-trans isomerase BPPIB 5 5 216 0.59931 1.4143 1.68E+08
Q86Y39;K7EQ77;K7EK78;K7EP35;K7EMT4;Q86Y39-2Q86Y39;K7EQ77;K7EK78;K7EP35;K7EMT4;Q86Y39-2NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11NDUFA11 3 3 141 0.59894 1.3252 6.61E+07
Q92538-3;Q92538-2;Q92538Q92538-3;Q92538-2;Q92538Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1GBF1 21 21 1855 0.5971 1.581 9.85E+08
O75533;B4DGZ4;H7C341;O75533-2;F8WC19O75533 Splicing factor 3B subunit 1SF3B1 36 36 1304 0.59692 1.2783 2.80E+09
Q8NC51-4;Q8NC51-3;Q8NC51-2;Q8NC51Q8NC51-4;Q8NC51-3;Q8NC51-2;Q8NC51Plasminogen activator inhibitor 1 RNA-binding proteinSERBP1 5 5 387 0.59657 1.5169 3.49E+08
Q96B26;H7C581 Q96B26 Exosome complex component RRP43EXOSC8 4 4 276 0.59555 1.8027 8.46E+08
A0A024QZX5;A0A087X1N8;P35237A0A024QZX5;A0A087X1N8;P35237Serpin B6 SERPINB6 4 4 380 0.59479 1.5834 3.64E+08
A5YKK6-2;A5YKK6;A5YKK6-3;A5YKK6-4;H3BMZ2;H3BVC9;B5MDN3;H3BT18;H3BU44;H3BR89;H3BNB1;H3BMH0A5YKK6-2;A5YKK6;A5YKK6-3;A5YKK6-4CCR4-NOT transcription complex subunit 1CNOT1 32 32 2371 0.59466 1.5551 1.79E+09
G3V2I3;A6NED2 G3V2I3;A6NED2 RCC1 domain-containing protein 1RCCD1 3 3 374 0.59303 1.191 1.22E+08
O96008;O96008-2;K7EKG4;K7EJ57O96008 O96008-2;K7EKG4;K7EJ57Mitochondrial import receptor subunit TOM40 homologTOMM40 8 8 361 0.59299 1.9665 1.50E+09
Q15417-3;Q15417;E9PDU6;Q15417-2;K7ES69;A0A087X271;B4DDF4;B4DUT8;Q99439-2;Q99439Q15417-3;Q15417;E9PDU6;Q15417-Calponin-3 CNN3 3 3 283 0.5922 NaN 4.60E+07
O95757;E9PDE8;D6RJ96O95757;E9PDE8;D6RJ96Heat shock 70 kDa protein 4LHSPA4L 15 13 839 0.59048 1.1589 7.41E+08
B8ZZG1;Q9NZW5 B8ZZG1;Q9NZW5 MAGUK p55 subfamily member 6MPP6 2 1 428 0.58936 NaN 7.74E+07
P09211;A8MX94;A0A087X243;A0A087X2E9P09211;A8MX94 Glutathione S-transferase PGSTP1 6 6 210 0.58908 1.8473 9.77E+08
O43707;O43707-2;F5GXS2;O43707-3;H7C144;K7EJH8;F6THM6;A0A087WSZ2;Q08043;K7EP19;M0QZQ3;C9JY79;Q9H254-2;Q9H254-4;Q9H254O43707; 2 Alpha-actinin-4 ACTN4 47 34 911 0.58891 1.6374 8.70E+09
H0YGS2;H0YG62;J3KP52;H0YEJ9;A0A0A0MRF3;H0YE88;Q53GI4;P28347-2;Q15561-3;P28347;Q15561;Q99594;Q15562;Q15562-2;Q15562-4H0YGS2;H0YG62;J3KP52;H0YEJ9;A0A0A0MRF3;H0YE88; 53GI4;P28347-2 -3;P28347;Q15561;Q99594; ;Q15562-2;Q15562-4Transcriptional enhancer factor TEF-1;Transcriptional enhancer factor TEF-3;Transcriptional enhancer factor TEF-5;Transcriptional enhancer factor TEF-4TEAD4;TEAD1;TEAD3;TEAD2 2 2 175 0.58758 NaN 5.02E+06
A0A087X2B5;P35613-2;P35613;I3L192;A0A087WUV8;P35613-3;P35613-4;R4GMX5;R4GN83A0A087X2B5;P35613-2;P35613;I3L192;A0A087WUV8;P35613-3;P35613-4;R4GMX5Basigin BSG 4 221 0.58683 1.851 3.15E+08
Q9P0M6;Q5SQT3 Q9P0M6 Core histone macro-H2A.2H2AFY2 8 7 372 0.58312 1.5206 1.05E+09
O75844 O75844 CAAX prenyl protease 1 homologZMPSTE24 10 10 475 0.58245 1.9268 6.14E+08
Q5T092;A0A0A0MR06;Q5T091;Q9P0H9;O15258;Q5T093Q5T092;A0A0A0MR06;Q5T091;Q9P0H9;O15258Protein RER1 RER 3 3 158 0.58088 1.455 9.45E+07
Q12788;J3KNP2;A0A087WYP7;H3BN88Q12 88;J3KNP2 Transducin beta-like protein 3TBL3 15 15 808 0.57877 1.3674 1.46E+09
K7EJR3;R4GMR5;P48556;K7EJC1;K7ERW6;K7ENY6K7EJR3;R4GMR5;P48556;K7EJC126S proteasome non-ATPase regulatory subunit 8PSMD8 3 3 251 0.57876 1.6714 2.66E+08
B3KPJ4;A0A0A0MSI2;Q8IXK0-2;Q8IXK0-4;Q8IXK0;Q8IXK0-5;H7C528;Q8IXK0-3;Q8NDX5-2;Q8NDX5;Q8NDX5-7B3KPJ4;A0A0A0MSI2;Q8IXK0-2;Q8IXK0-4;Q8IXK0; 8IXK0-5;H7C528;Q8IXK0-3;Q8NDX5-2;Q8NDX5;Q8NDX5-7Polyhomeotic-like protein 2;Polyhomeotic-like protein 3PHC2;PHC3 2 2 464 0.57825 NaN 7.73E+07
C9J315;P48449-2;P48449-3;P48449C9J315;P48449-2;P48449-3;P48449Lanosterol synthaseLSS 2 2 262 0.57708 1.3196 1.17E+08
O75691 O75691 Small subunit processome component 20 homologUTP20 23 23 2785 0.57639 1.6096 1.13E+09
P52306-6;P52306-2;P52306-3;P52306;P52306-5;H0Y8M2;P52306-4P52306- ;P52306-2; 3;P52306;P52306-5;H0Y8M2;P52306-4Rap1 GTPase-GDP dissociation stimulator 1RAP1GDS1 3 3 516 0.5758 1.4536 1.31E+08
O75367-2;O75367-3;O75367;B4DJC3;D6RCF2O75367-2;O75367-3;O75367Core histone macro-H2A.1H2AFY 7 6 369 0.57494 1.4633 2.13E+09
P00491;G3V393;G3V5M2P00491 Purine nucleoside phosphorylasePNP 3 3 289 0.57454 1.6847 1.34E+08
Q9Y2X3;H7BZ72;F8WED0Q9Y2X3 Nucleolar protein 58NOP58 21 21 529 0.57348 1.739 6.84E+09
A0A087WUT6;O60841A0A087WUT6;O60841Eukaryotic translation initiation factor 5BEIF5B 10 10 1220 0.57326 1.6687 7.91E+08
O96007 O96007 Molybdopterin synthase catalytic subunitMOCS2 3 3 188 0.57295 1.489 8.24E+07
Q96BM9 Q96BM9 ADP-ribosylation factor-like protein 8AARL8A 1 1 186 0.57158 1.4685 1.04E+08
Q9NUQ2;H0YC22 Q9NUQ2;H0YC22 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilonAGPAT5 2 2 364 0.57112 1.7355 4.25E+07
Q3LIE7;Q15392-2;Q15392Q3LIE7;Q15392-2;Q15392Delta( 4)-sterol reductaseNbl 03646;DHCR24 6 6 427 0.57053 0.87658 1.05E+08
Q7KZN9-2;Q7KZN9 Q7KZN9-2;Q7KZN9 Cytochrome c oxidase assembly protein COX15 homologCOX15 8 8 388 0.57022 1.4944 7.31E+08
B4DY09;Q12905;X6R6Z1;A0A0A0MRL0B4DY09;Q12905 Interleukin enhancer-binding factor 2ILF2 16 16 352 0.5694 1.9111 1.09E+10
Q15125;C9J719;C9JJ78Q15125;C9J719;C9JJ783-beta-hydroxysteroid-Delta(8),Delta(7)-isomeraseEBP 3 3 230 0.5687 1.6209 6.78E+07
Q9NS69 Q9NS69 Mitochondrial import receptor subunit TOM22 homologTOMM22 6 6 142 0.56843 1.7543 1.39E+09
E7EN32;O00255-2;O00255;E7ENS2;E7EPR4;E7ET29;O00255-3;Q9GZQ5E7EN32;O00255-2;O00255;E7ENS2;E7EPR4;E7ET29;O00255-3Menin MEN1 3 3 555 0.56828 0.91282 6.06E+07
P42858;H0YA07 P42858 Huntingtin HTT 26 26 3142 0.56619 1.8313 1.38E+09
Q9NV31 Q9NV31 U3 small nucleolar ribonucleoprotein protein IMP3IMP3 5 5 184 0.56567 1.3173 3.71E+08
P06733;K7EM90;P06733-2;F5H1C3;E5RI09;E5RG95;K7EPM1;K7EKN2;E5RGZ4;F5H0C8;P13929-3;P09104-2;P13929-2;P13929;P09104P06733;K7EM90;P06733-2Alpha-enolase;EnolaseENO1 1 19 434 0.56342 1.513 2.98E+09
P17066;P48741 P17066 Heat shock 70 kDa protein 6HSPA6 23 11 643 0.56257 1.3041 1.91E+09
K7EM73;K7ELJ7;A0A0C4DGQ5;P04632;K7ES78;K7EMQ1;U3KQE2;K7EIV0;A0A075B7C0;K7EKD8K7EM73;K7ELJ7;A0A0C4DGQ5;P04632;K7ES78;K7EMQ1;U3KQE2;K7EIV0;A0A075B7C0;K7EKD8Calpain small subunit 1CAPNS1 2 2 163 0.56225 1.3855 1.15E+08
P52435;A0A0B4J2F8;F6S314;E2QRJ6;A6NFM0;Q9H1A7;Q9GZM3;F8WF84P52435;A0A0B4J2F8;F6S314;E2QRJ6;A6NFM0;Q9H1A7;Q9GZM3D A-directed RNA polymerase II subunit RPB11-a;DNA-directed RNA polymerase II subunit RPB11-b2;DNA-directed RNA polymerase II subunit RPB11-b1POLR2J;POLR2J3 POLR2J2 4 4 1 7 0.56205 1.4456 7.17E+07
H0Y4R1;P12268;E7ETK5;C9K0R9;C9J381;P20839-2;P20839-4;P20839;P20839-3;P20839-7;P20839-5;P20839-6H0Y4R1;P12268;E7ETK5Inosine-5-monophosphate dehydrogenase 2IMPDH2 10 10 470 0.56087 1.3245 4.37E+08
P61019-2;P61019;E9PKL7;Q5HYI5;Q8WUD1;H7C125;Q6PIK3;Q8WUD1-2P61019-2;P61019;E9PKL7;Q5HYI5; 8WUD1Ras-related protein Rab-2A;Ras-related protein Rab-2BAB2 ;DKFZp313C1541;RAB2B 3 3 188 0.55987 1.7582 1.09E+08
A0A087WT20;Q9NV06;B3KME9;E5RHM4;Q9NV06-2A0A087WT20;Q9NV06;B3KME9DDB1- and CUL4-associated factor 13DCAF13 5 5 597 0.55784 1.4761 2.63E+08
E7EPM6;P33121-2;P33121-3;P33121;D6RER0;B7Z3Z9;H0Y9Z9;D6RG07;H0Y9U7E7EPM6;P33121-2;P33121-3;P 3121;D6RER0;B7Z3Z9Long-chain-fatty-acid--CoA ligase 1ACSL1 3 3 664 0.55752 1.0783 2.10E+08
P50454;E9PR70;E9PPV6;E9PKH2;E9PK86;E9PMI5;E9PNX1;E9PJH8;E9PIG2;E9PRS3;H0YEP8;E9PLA6;E9PQ3450454;E9PR70;E9PPV6;E9PKH2Serpin H1 S R INH1 15 15 418 0.55542 1.9479 5.53E+09
Q15181;Q5SQT6 Q15181;Q5SQT6 Inorganic pyrophosphatasePPA1 12 12 289 0.55358 2.0602 3.71E+09
Q9P2D3-3;Q9P2D3;Q9P2D3-2;H7C2X3Q9P2D3-3;Q9P2D3;Q9P2D3-2HEAT repeat-containing protein 5BHEATR5B 7 7 1982 0.55289 1.5567 1.43E+08
P30086 P30086 Phosphatidylethanolamine-binding protein 1;Hippocampal cholinergic neurostimulating peptidePEBP1 2 2 187 0.54959 1.3529 5.03E+07
Q5T7C4;P09429;B2RPK0Q5T7C4;P09429;B2RPK0High mobility group protein B1;Putative high mobility group protein B1-like 1HMGB1;HMGB1P1 2 2 158 0.54838 NaN 3.41E+07
Q32Q12;P22392-2;J3KPD9;E7ERL0;P22392;E5RHP0;O60361;F6XY72;C9K028Q32Q12;P22392- ;J KPD9;E7ERL0;P22392;E5RHP0Nucleoside diphosphate kinase Nucleoside diphosphate kinase BNME1-NME2;NME2;NME1 11 3 292 0.54669 1.6151 1.07E+09
P54577;A0A0C4DGZ5P 4577 Tyrosine--tRNA ligase, cytoplasmic;Tyrosine--tRNA ligase, cytoplasmic, N-terminally processedYARS 3 3 528 0.54497 2.3855 1.80E+08
Q9H8H0;J3QR28;J3QLQ6;Q9H8H0-2;J3QKV19H8H0;J3QR28 Nucleolar protein 11NOL11 11 11 719 0.54496 1.7243 1.24E+09
Q14137-2;Q14137;A0A075B729Q14137-2;Q14137 Ribosome biogenesis protein BOP1BOP1 10 10 634 0.53941 1.1836 8.88E+08
O95747;C9JIG9;F8WBK9O95747;C9JIG9 Serine/threonine-protein kinase OSR1OXSR1 12 9 527 0.53867 1.6954 1.64E+09
159
Q9Y6C9;E9PIE4 Q9Y6C9;E9PIE4 Mitochondrial carrier homolog 2MTCH2 8 8 303 0.53845 1.9913 2.81E+09
Q9BPX5 Q9BPX5 Actin-related protein 2/3 complex subunit 5-like proteinARPC5L 2 2 153 0.53813 1.3955 5.05E+07
Q5VV89;O14880;Q5VV87Q5 V89;O14880 Microsomal glutathione S-transferase 3MGST3 4 4 166 0.53812 2.0039 3.13E+08
Q86X10;Q86X10-3;A2A2F0;Q86X10-4;Q86X10-2;A0A0J9YW54Q86X1 ; 3;A2A2F ;Q86X10-4;Q86X10-2Ral GTPase-activating protein subunit betaRALGAPB 9 9 1494 0.5367 1.1911 8.90E+08
Q8N6L1;Q8N6L1-2 Q8N6L1;Q8N6L1-2 Keratinocyte-associated protein 2KRTCAP2 1 1 136 0.5366 1.7247 1.15E+08
Q9HD45;Q5TB53 Q9HD45;Q5TB53 Transmembrane 9 superfamily member 3TM9SF3 7 7 589 0.53571 1.759 4.27E+08
B5MC22;Q9UDX5;H7C417;F8WEN7;Q9UDX5-2B5MC22;Q9UDX5;H7C417Mitochondrial fission process protein 1MTFP1 3 3 143 0.53491 2.5712 1.34E+08
P00918;E5RID5;E5RK37P00918;E5RID5;E5RK37Carbonic anhydrase 2CA2 3 3 260 0.53449 NaN 3.86E+08
Q04760-2;Q04760 Q04760-2;Q04760 Lactoylglutathione lyaseGLO1 4 4 169 0.53382 1.922 1.38E+08
G3V144;A1X283 G3V144;A1X283 SH3 and PX domain-containing protein 2BSH3PXD2B 2 2 430 0.53297 0.9046 2.33E+07
S4R350;A2A2G4;Q9Y672S4R350;A2A2G4;Q9Y672Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferaseALG6 1 1 281 0.52993 NaN 1.42E+08
Q562R1 Q562R1 Beta-actin-like protein 2ACTBL2 7 1 376 0.52981 NaN 8.26E+07
Q9Y3C6 Q9Y3C6 Peptidyl-prolyl cis-trans isomerase-like 1PPIL1 2 2 166 0.529 1.7746 4.80E+07
Q6AI08;K7EIX2;A0A087WXZ7;K7ELR8;K7EKW7;K7ESP5Q6AI08;K7EIX2;A0A087 XZ7HEAT repeat-containing protein 6HEATR6 7 7 1181 0.52892 1.4855 3.95E+08
O60493-2;O60493-4;O60493;O60493-3O60493-2; 4;O60493Sorting nexin-3 SNX3 3 3 130 0.52887 3.0872 2.15E+07
P27105-2;P27105 P27105-2;P27105 Erythrocyte band 7 integral membrane proteinSTOM 1 1 123 0.52789 1.5941 2.38E+07
Q9Y3D6 Q9Y3D6 Mitochondrial fission 1 proteinFIS1 2 2 152 0.52789 1.9306 4.68E+07
K7ESP4;Q8WVC6;Q8WVC6-2K7ESP4;Q8WVC6;Q8WVC6-2Dephospho-CoA kinase domain-containing proteinDCAKD 7 7 209 0.52627 1.6716 2.14E+08
E9PJ42;Q5BJD5-3;Q5BJD5-2;Q5BJD5E9PJ42;Q5BJD5-3;Q5BJD5-2;Q5BJD5Transmembrane protein 41BTMEM41B 1 1 196 0.52619 1.3837 9.47E+06
F5GZS6;J3KPF3;P08195-3;P08195;P08195-4;P08195-2;F5H0E2;H0YFS2;F5H867;F5GZI0;F5GZR9;H0YFX4F5GZS6;J3KPF3; 3; ;P08195-4;P 8195-24F2 cell-surface antigen heavy chainSLC3A2 22 22 599 0.52613 2.0154 7.67E+09
Q8TDZ2;Q8TDZ2-4;Q8TDZ2-2;Q5TED7;Q8TDZ2-4;Q8TDZ2-2Protein methionine sulfoxide oxidase MICAL1MICAL1 4 4 1067 0.52472 1.7262 9.44E+07
P45985;P45985-2;R4GN37P 5985;P45985-2 Dual specificity mitogen-activated protein kinase kinase 4MAP2K4 4 399 0.52438 1.2998 1.55E+08
E9PHS0;O43813;F8WDS9E9PHS0;O43813;F8WDS9LanC-like protein 1 LANCL1 3 3 196 0.52435 0.63042 3.47E+09
A0A024R4E5;Q00341;Q00341-2;H0Y394;H7C0A4;C9JIZ1;H7C2D1;H7BZC3;C9J5E5;C9JZI8;C9JHZ8;C9JES8;C9JT62;C9JHS7;C9JK79;C9JHS9;C9J739;C9JMQ6;C9JQ82;C9JBS3;C9JEJ8;A0A0U1RVI6;C9JHN6A0A024R4E5;Q 0 41 Q00341-2;H0Y394Vigilin DLBP 29 9 1268 0.52383 1.9729 2.16E+09
Q9NPI6-2;Q9NPI6;A0A087WT55;A0A087WXD0Q9NPI6-2;Q9NPI6 mRNA-decapping enzyme 1ADCP1A 6 6 544 0.52119 1.6237 5.13E+08
Q9NR09;H7C094;H7C3P0;REV__Q96C03;REV__Q96C03-3;REV__Q9NR09Q9NR09 Baculoviral IAP repeat-containing protein 6BIRC6 38 38 4857 0.52025 1.7166 1.68E+09
P00387-2;P00387;P00387-3;B1AHF32;P00387;P00387-3;B1AHF3NADH-cytochrome b5 reductase 3;NADH-cytochrome b5 reductase 3 membrane-bound form;NADH-cytochrome b5 reductase 3 soluble formCYB5R3 10 10 278 0.51866 1.2063 2.06E+09
P61006;P61006-2 P61006;P61006-2 Ras-related protein Rab-8AAB8 4 2 207 0.51855 1.5769 2.33E+07
Q12768;E7EQI7;E5RFU6Q12768;E7EQI7 WASH complex subunit strumpellinKIAA0196 9 9 1159 0.51683 1.7772 3.99E+08
S4R329;H0YK61;H0YNK0;H0YNK8;Q5J8M3-3;Q5J8M3-2;Q5J8M3;H0YMH5;H0YLP8S4R329;H0YK61;H0YNK0;H0YNK8;Q5J8M3-3;Q5J8 3-2;Q5J8M3;H0YMH5;H0YLP8ER membrane protein complex subunit 4E C4 2 2 72 0.51601 NaN 5.62E+07
Q96K37;H7C1I0;Q96K37-2Q96K37;H7C1I0 Solute carrier family 35 member E1SLC35E1 3 3 410 0.51499 1.1781 1.61E+08
E7ES96;P49768-2;P49768;P49768-3;P49768-5;P49768-6;P49768-7E7ES96; 2; ;P49768-3;P49768-5;P49768-6;P49768-7Presenilin;Presenilin-1;Presenilin-1 NTF subunit;Presenilin-1 CTF subunit;Presenilin-1 CTF12PSEN1 2 2 375 0.51347 1.4359 6.36E+07
Q969Z0;C9J7P5;C9IZN7;Q969Z0-2;C9J5A2;C9J347;H7C4R5Q969Z0;C9J7P5;C9IZN7;Q969Z0-2Protein TBRG4 TBRG4 8 8 631 0.5132 2.1556 2.10E+08
P32189-1;P32189-4;Q14409;P32189-2;P32189;F8WDA9;F8WBI8;F8WC39;A6NP46P32189-1 4 Q1440 ;P32189-2;P321 9;F8WDA9;F8WBI8;F8WC39;A6NP46Glycerol kinase;Putative glycerol kinase 3GK;GK3P 2 2 524 0.5125 NaN 1.94E+07
P18669;P15259 P18669;P15259 Phosphoglycerate mutase 1;Phosphoglycerate mutase 2PGAM1;PGAM2 2 2 254 0.51169 NaN 6.42E+07
Q69YN2;Q69YN2-3;X6R7M0;Q69YN2-2Q 9YN2;Q69YN2-3 CWF19-like protein 1CWF19L1 9 9 538 0.51112 2.0935 6.46E+08
E9PLD0;Q9H0U4;A0A087WTI1;Q92928E9PLD0;Q9H0U4;A0A087WTI1;Q92928Ras-related protein Rab-1B;Putative Ras-related protein Rab-1CAB1 ;RAB1C 6 3 169 0.51108 1.6677 4.30E+08
Q5R3B4;O95563 Q5R3B4;O95563 Mitochondrial pyruvate carrier 2MPC2 3 3 105 0.50899 1.9872 5.52E+07
B0QZ43;O75477 B0QZ43;O75477 Erlin-1 ERLIN1 6 2 275 0.50738 NaN 1.72E+08
Q96DA2 Q96DA2 Ras-related protein Rab-39BAB39 3 3 213 0.50562 NaN 2.65E+07
E9PF16;Q96CM8-4;Q96CM8-3;Q96CM8;Q96CM8-2E9PF16;Q96CM8-4;Q96CM8-3;Q96CM8;Q96CM8-2Acyl-CoA synthetase family member 2, mitochondrialACSF2 2 2 572 0.49788 1.0849 2.02E+08
O94905;E5RHW4;E5RJ09;O94905-2;O94905-3O94905;E5RHW4 Erlin-2 ERLIN2 17 13 339 0.49579 1.7554 3.09E+09
Q8IYI0;A0A0A0MSQ5;Q5TGB0;Q8IYI0-2;Q5TGA6Q8IYI0 Uncharacterized protein C20orf196C20orf196 5 5 205 0.4921 0.9693 2.28E+09
Q8TCT9-5;Q8TCT9;A0A075B6F6;Q8TCT9-4;Q8TCT9-2;A0A0C4DGU3Q8TCT9-5;Q8TC 9;A0A075B6F6;Q8TCT9-4;Q8TCT9-2Minor histocompatibility antigen H13HM13 3 3 335 0.49063 1.9174 4.61E+08
Q04637-5;Q04637-4;Q04637-3;Q04637;Q04637-9;E7EX73;E9PGM1;E7EUU4;Q04637-8;Q04637-6;Q04637-7;A0A0A0MR52;C9JF13;C9J6B6;C9K073;C9J2Z7;H7C044;H7C0V6;A0A0A0MSA7;A0A0U1RQK7;O43432-4;O43432;O43432-3;F8WCF2;C9JHW9Q04637-5;Q04637-4; 3;Q04637;Q04637-9;E7EX73;E9PGM1 E7EUU4;Q04637-8;Q04637-6;Q04637-7;A0A0A0MR52;C9JF13Eukaryotic translation initiation factor 4 gamma EIF4G1 2 2 435 0.48629 1.5224 1.41E+09
A0A0B4J2E5;Q15269;C9J544;A0A0J9YX21A0A0B4J2E5;Q15269Periodic tryptophan protein 2 homologPWP2 20 17 919 0.48622 1.5704 3.01E+09
P51572;P51572-2;C9JSP1;C9JQ75;C9J0M4P51572;P51572-2 B-cell receptor-associated protein 31BCAP31 4 4 246 0.4842 2.1243 1.13E+08
Q92598-2;Q92598;Q92598-3;Q92598-4;A0A0A0MSM0;R4GN69;Q5TBM32; ;Q92598-3;Q92598-4;A0A0A0MSM0Heat shock protein 105 kDaHSPH1 32 30 814 0.48373 1.6975 5.33E+09
Q7Z494;Q7Z494-2;A0A0J9YXS1;Q7Z494-3;Q7Z494-6;H0YAM4;F2Z3A8;Q7Z494-7;Q7Z494-4;Q7Z494-5Q7Z494;Q7Z494-2 Nephrocystin-3 NPHP3 7 7 1330 0.48186 1.7056 1.96E+08
P63261;I3L3I0;I3L1U9;K7EM38;I3L3R2;J3KT65;I3L4N8;C9JUM1;P63267-2;F8WCH0;Q9BYX7P63261;I3L3I0;I L1U9Actin, cytoplasmic 2;Actin, cytoplasmic 2, N-terminally processedACTG 21 1 375 0.4814 1.9435 3.92E+10
Q8IZD4;F5GZK9;Q8IZD4-2;F5H4R4;B4DVJ6Q8IZD4;F5GZK9;Q8IZD4-2mRNA-decapping enzyme 1BDCP1B 3 3 617 0.48056 NaN 8.03E+07
Q5QPL9;Q9UKM9-2;Q9UKM9;Q5QPM0;Q5QPM1;Q5QPM2Q5QPL9;Q9UKM9-2 9UK 9 0;Q5QPM1RNA-binding protein RalyRALY 9 9 237 0.4759 1.9664 1.02E+09
P62820;E7END7;P62820-3;P62820-2P62820;E7END7;P62820-3;P62820-2Ras-related protein Rab-1AAB1 5 2 205 0.4751 1.5403 9.68E+07
Q9GZN8;Q9GZN8-2;H7BYU9Q9GZN8;Q9GZN8-2;H7BYU9UPF0687 protein C20orf27C20orf27 3 3 174 0.47423 1.838 1.57E+08
Q9H3G5;H7C0X5;A0A087WVP6;A0A087WXJ9;C9JLV0;C9J6L4;H7C218;C9JI22Q9H3G5;H7C0X5;A0A087WVP6Probable serine carboxypeptidase CPVLCPVL 5 5 476 0.47348 2.2955 3.27E+08
P33527-5;P33527-2;P33527-3;P33527;A0A0A0MS99;I3L4X2;P33527-8;P33527-6;P33527-7;P33527-4;P33527-9;O15438;O15438-4P33527-5;P33527-2;P33527-3;P33527;A0A0A0MS99;I3L4X2;P33527-8;P33527-6;P33527- ;P33527-4 P33527 9Multidrug resistance-associated protein 1ABCC1 13 13 1416 0.47323 1.8133 4.11E+08
O15511;O15511-2;B1ALC0O 5511;O15511-2;B1ALC0Actin-related protein 2/3 complex subunit 5ARPC5 3 3 151 0.46938 2.4997 1.21E+08
Q9NZJ9-2;Q9NZJ9-3;Q9NZJ9Q9NZJ9-2;Q9NZJ9-3;Q9NZJ9Diphosphoinositol polyphosphate phosphohydrolase 2NUDT4 2 2 181 0.46748 3.4367 1.59E+10
Q13232;H3BPR2;H3BPD9;H3BMQ7;H3BRA8Q13232;H3BPR2 Nucleoside diphosphate kinase 3;Nucleoside diphosphate kinaseNME3 9 9 169 0.46247 1.7131 4.04E+08
Q01650;A0A0C4DGL4;H0YJ95;G3V4Z6;Q9UM01;Q92536Q01650 Large neutral amino acids transporter small subunit 1SLC7A5 6 6 507 0.46124 2.2516 4.12E+08
Q6YHU6;Q6YHU6-3;H0Y3V5;Q6YHU6-2;Q6YHU6-4;Q6YHU6-6;Q6YHU6-5;B6ZDE5;F5H3M9;B5MC89;H7BYZ4Q6YHU6; 3;H0 3V5;Q6YHU6-2Thyroid adenoma associated proteinTHADA 11 11 1953 0.46122 1.4853 4.29E+08
P07196;A0A087X0W2P07196 Neurofilament light polypeptideNEFL 5 3 543 0.45369 1.9041 2.49E+08
J3QLD9;E7EMK3;Q14254;K7EKW9J3QLD9;E7EMK3;Q14254Flotillin-2 FLOT2 7 7 428 0.4533 1.3113 2.82E+08
P68133;P68032;P63267;P62736;A6NL76;F8WB63;B8ZZJ2;C9JFL5;F6UVQ4;F6QUT6P68133;P68032;P63267;P627 6;A6NL76;F8WB63;B8ZZJ2;C9JFL5;F6UVQ4;F6QUT6Actin, alpha skeletal muscle;Actin, alpha cardiac muscle 1;Actin, gamma-enteric smooth muscle;Actin, aortic smooth muscleACTA1;ACTC1;ACTG ;AC A2 14 1 377 0.45088 2.1851 1.34E+09
A0A087WVD4;Q9HBK9-2;Q9HBK9A0A087WVD4;Q9HBK9-2;Q9HBK9Arsenite methyltransferaseAS3MT 4 4 338 0.44338 2.6605 5.72E+08
P08670;B0YJC4;B0YJC5;Q5JVS8;H7C5W5;P41219;P17661;P41219-2;P14136-3;P14136;P14136-2;K7EKH6;F8W835P08670;B0YJC4 Vimentin VIM 47 43 466 0.44287 2.2218 2.49E+10
C9JC03;A0A024R571;Q9H4M9;C9J2Z4;C9JIJ3;C9IZH1;A0A0C4DH83;Q9NZN3;C9JDQ8;Q9NZN3-2;Q9NZN4C9JC03;A0A024R571;Q9H4M9;C9J2Z4EH domain-containing protein 1EHD1 7 6 374 0.44249 2.7177 2.50E+08
Q5T8U5;O15260-2;O15260;O15260-3;B7Z1G8Q5T8U5; 2;O15260;O15260-3Surfeit locus protein 4SURF4 3 3 186 0.44218 1.8736 3.92E+07
A6NEM5;Q92643;B1AK81;Q92643-2A6NEM5;Q92643;B1AK81;Q92643-2GPI-anchor transamidasePIGK 2 2 332 0.44162 0.66374 7.86E+07
P04080 P04080 Cystatin-B CSTB 2 2 98 0.43902 1.5144 1.09E+08
V9GYR2;P05026-2;P05026V9GYR2;P05026-2;P05026Sodium/potassium-transporting ATPase subunit beta-1ATP1B1 2 2 130 0.43506 2.145 1.80E+08
Q02750;Q02750-2 Q02750;Q02750-2 Dual specificity mitogen-activated protein kinase kinase 1MAP2K1 8 3 393 0.42916 NaN 7.00E+07
P63000;P63000-2 P63000;P63000-2 Ras-related C3 botulinum toxin substrate 1RAC1 3 1 192 0.42839 1.2766 6.74E+07
Q9NRW1;P20340-2;P20340;C9JU14;J3KR73;P20340-4;Q9NRW1-2;F5H3K7;C9J0I2;F5GX61;P20340-3Q9NRW1;P20340-2;P20 40;C9JU14;J3K 73;P 0340-4;Q9NRW1-2Ras-related protein Rab-6B;Ras-related protein Rab- AAB6 ; AB6A 3 2 208 0.42592 1.1993 1.31E+08
Q9UHD1-2;Q9UHD1;E9PHZ2;E9PPQ5;E9PIZ4;E9PSD5;E9PL00Q9UHD1-2;Q9UHD1;E9PHZ2;E9PPQ5Cysteine and histidine-rich domain-containing protein 1CHORDC1 6 6 313 0.42317 2.3312 5.06E+08
P10599-2;P10599 P10599-2;P10599 Thioredoxin TXN 4 4 85 0.42312 NaN 4.92E+07
P63092-3;P63092-2;P63092;P63092-4;Q5JWF2-2;Q5JWF2;A0A0A0MR13;S4R3E3P63092-3; 2;P6309 ;P63092-4;Q5JWF2-2;Q5JWF2Guanine nucleotide-binding protein G(s) subunit alpha isoforms short;Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLasGNAS 7 6 379 0.42151 1.8829 9.26E+08
C9J880;Q68CQ7-2;Q68CQ7;C9JA13C9J880;Q68CQ7-2;Q68CQ7;C9JA13Glycosyltransferase 8 domain-containing protein 1GLT8D1 2 2 174 0.42116 NaN 6.43E+07
Q13423;E9PCX7;D6RAI5;D6RHU2;D6RCR6Q13423;E9PCX7 NAD(P) transhydrogenase, mitochondrialNNT 11 11 1086 0.4211 2.3287 3.71E+08
J3KR97;Q9BTW9;Q9BTW9-4;Q9BTW9-5;I3L0V3;I3L439;I3L3H4;I3L131;I3L143;I3L163;I3L4D2;I3L500;I3L1S3;A0A0J9YWI5;A0A0J9YVR1;Q9BTW9-3;I3L120;A0A0J9YXU4;A0A0J9YVU1J3KR97;Q9BTW9;Q9BTW9-4;Q9BTW9-5Tubulin-specific chaperone DTBCD 17 17 1230 0.4193 2.3193 1.27E+09
O43924;B8ZZK5;C9IZ52O43924;B8ZZK5;C9IZ52Retinal rod rhodopsin-sensitive cGMP 3,5-cyclic phosphodiesterase subunit deltaPDE6D 3 3 150 0.41435 0.6219 9.00E+07
O14828-2;O14828 O14828-2;O14828 Secretory carrier-associated membrane protein 3SCAMP3 4 4 321 0.41409 2.1623 1.04E+08
P60953;Q5JYX0;P60953-1P60953;Q5JYX0;P60953-1Cell division control protein 42 homologCDC42 3 2 191 0.41197 1.9722 1.79E+08
Q99460-2;Q99460;A0A087WW66;H7C378;H7BZR6;C9J9M4;F8WCE3Q99460-2;Q99460;A0A08 WW6626S proteasome non-ATPase regulatory subunit 1PSMD1 40 40 922 0.41063 2.337 6.59E+09
P53985;Q5T8R3;Q5T8R5;P53985-2;Q5T8R4P53985;Q5T8R3; 5;P53985-2Monocarboxylate transporter 1SLC16A1 8 8 500 0.40746 2.145 5.59E+08
B4DWR3;P61758 B4DWR3;P61758 Prefoldin subunit 3 VBP1 4 4 192 0.4051 2.1883 6.46E+07
A0A0B4J2A0;Q9UHJ6A0A0B4J2A0;Q9UHJ6Sedoheptulokinase SHPK 3 3 478 0.40103 2.1532 1.92E+08
Q7Z7K6-3;Q7Z7K6;Q7Z7K6-2;A0A0M3HER23;Q7Z7K6;Q7Z7K6-2Centromere protein VCENPV 3 3 272 0.39937 2.2163 4.34E+08
Q9NYH9;J3KRR8 Q9NYH9 U3 small nucleolar RNA-associated protein 6 homologUTP6 7 7 597 0.3967 1.6227 2.72E+08
K7ELQ9;Q6UW68;K7EM09;K7EPR0;K7ER05;K7EJQ9K7ELQ9;Q6UW68;K7EM09;K7EPR0Transmembrane protein 205TMEM205 3 3 170 0.39321 2.4352 5.10E+07
K7ENI6;K7ERE1;Q8N2U0K7ENI6;K7ERE1;Q8N2U0Transmembrane protein 256TMEM256 3 3 41 0.38916 2.0002 6.79E+07
P02786;G3V0E5;H7C3V5;F8WBE5P02786;G3V0E5 Transferrin receptor protein 1;Transferrin receptor protein 1, serum formTFRC 15 15 760 0.38238 3.3026 1.40E+09
Q9Y2P8;Q5VZU3;Q9Y2P8-2;Q5VZU2;Q5VYW8Q9Y2P8 RNA 3-terminal phosphate cyclase-like proteinRCL1 7 7 373 0.37975 2.5764 1.07E+09
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Q9NR31;X1WI22;D6RAA2;Q5SQT8;D6RDB2;D6RD69;Q9Y6B6;H0Y5E8;Q9NR31-2Q9NR31;X1WI22;D6RAA2;Q5SQT8;D6RDB2;D6RD69;Q9Y6B6GTP-binding protein SAR1a;GTP-binding protein SAR1bSAR1A;SAR1B 3 3 198 0.37183 2.8518 5.83E+08
A0A0A0MTB8;Q8NI36A0A0A0MTB8;Q8NI36WD repeat-containing protein 36WDR36 6 6 895 0.36887 1.5737 3.29E+08
J3QS48;I3L295;J3KT75;J3QW43;J3QRD5;Q9H3L2;Q1HDL3;A0A087WV81;O75352-2;O75352;J3KSI4;I3L1D2;I3L4E0;J3KTK8;J3QQZ4;I3L405;I3L261J3QS48;I3L295;J3KT75;J3QW43;J3QRD5;Q9H3L2;Q1HDL3;A0A087WV81;O75352-2;O75352;J3KSI4;I3L1D2;I3L4E0;J3KTK8;J3QQZ4Mannose-P-dolichol utilization defect 1 proteinMPDU1;HBEBP2BPA 101 0.36672 2.3419 7.34E+07
Q15061;C9JEE7;C9IZK7Q15061 WD repeat-containing protein 43WDR43 10 10 677 0.33831 2.0942 6.09E+08
P00374-2;P00374;C9JJ68;B4DM58;Q86XF0P00374-2;P00374 Dihydrofolate reductaseDHFR 3 3 135 0.33516 4.1108 1.04E+08
Q9Y289 Q9Y289 Sodium-dependent multivitamin transporterSLC5A6 2 2 635 0.32059 2.0846 1.00E+08
X6RCC3;A0A087WV97;Q8WU79-3;Q8WU79-2;Q8WU79X6RCC3;A0A087WV97;Q8WU79-3;Q8WU79-2;Q8WU79Stromal membrane-associated protein 2SMAP2 2 2 174 0.31628 NaN 1.70E+08
P11166 P11166 Solute carrier family 2, facilitated glucose transporter member 1SLC2A1 2 2 492 0.31546 NaN 3.68E+07
Q99536;K7ESA3;Q99536-2;Q99536-3;K7ERT7;K7ENX2;K7EM19Q99536;K7ESA3;Q99536-2;Q99536-3Synaptic vesicle membrane protein VAT-1 homologVAT1 3 3 393 0.30754 NaN 1.46E+08
Q15758;M0QXM4;Q15758-3;Q15758-2;M0QX44;M0R14415758;M0QXM4;Q15758-3;Q15758-2Neutral amino acid transporter B(0)SLC1A5 10 10 541 0.2956 3.0599 1.99E+09
P42771;J3QRG6;P42771-4;G3XAG3;P42771-3P42771;J3QR 6; 4Cyclin dependent kinase inhibitor 2A, isoforms 1/2/3CDKN2A 7 3 156 0.24369 3.7259 7.53E+08
P07355;H0YKS4;H0YMD0;H0YMU9;H0YN42;A6NMY6;P07355-2;H0YMM1;H0YKZ7;H0YLV6;H0YMT9;H0YKX9;H0YNP5;H0YKL9;H0YMW4;H0YM50;H0YMD9;H0YKV8;H0YNB8;H0YN52;H0YKN4;H0YNA0;H0YN28;H0YL33;H0YLE2P07355;H0YKS4; 0YMD0;H0YMU9;H0YN42;A6N Y6;P07355-2;H0YMM1;H0YKZ7;H0YLV6;H0YMT9;H0YKX9;H0YNP5;H0YKL9 W4;H0YM50Annexin A2;Annexin;Putative annexin A2-like proteinA XA2;A XA2P2 10 10 339 0.242 3.4018 9.41E+08
F6R5I9;B4DZ60;P17707F6R5I9;B4DZ60;P17707S-adenosylmethionine decarboxylase proenzyme;S-adenosylmethionine decarboxylase alpha chain;S-adenosylmethionine decarboxylase beta chainAMD1 1 1 48 0.22681 NaN 3.22E+07
X6RFL8;P61106 X6RFL8;P61106 Ras-related protein Rab-14AB14 3 3 181 0.22551 1.6937 7.07E+07
J3KR58;Q99611 J3KR58;Q99611 Selenide, water dikinase 2SEPHS2 1 1 448 0.19453 NaN 5.36E+07
A0A087WTM7;P04114A0A087WTM7;P04114Apolipoprotein B-100;Apolipoprotein B-48APOB 6 3 4344 0.062725 NaN 1.17E+08
K7ELU5;Q7Z3V5 K7ELU5;Q7Z3V5 Zinc finger protein 571ZNF571 1 1 84 0.039252 NaN 1.85E+10
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6.7. C20orf196 SILAC interactomes 
 
Protein IDs Majority protein IDsProtein names Gene names Peptides Unique peptides Sequence length Q-value Score Ratio H/L normalized 1Ratio H/L normalized 2Intensity
Q8TDX7;F8WAG2;F5H3U7;Q5TBH0;Q8TDX7-2Q8TDX7 Serine/threonine-protein kinase Nek7NEK7 5 4 302 0 18.891 9.8112 0.17384 7.99E+08
A0A087WVC4;A0A0A0MS54;P22694-4;P22694-3;P22694;P22694-5;P22694-7;P22694-6;P22694-9;P22694-2;B1APG1;B1APG0;B1APG2;B1APF8;B1APF9;B1APG3;P22694-8;P22694-10;B1APF7;P17612-2;P176120 087WVC4;A0A0A0MS54;P22694-4;P2 694-3;P2 694;P22694-5;P22694-7;P22694-6;P 2694-9;P22694-2; 1; G0;B1APG2;B1APF8;B1APF9;B1APG3;P22694-8;P22694-10;B1APF7cAMP-dependent protein kinase catalytic subunit betaPRKACB 338 0 51.985 7. 972 0.2157 4.76E+08
P11766;H0YAG8;D6RAY0;D6R9G2;D6RFE4P11766;H0YA 8 Alcohol dehydrogenase class-3ADH5 4 4 374 0 55.901 6.594 0.13017 7.07E+08
H3BPB8;P34949;H3BMZ9;H3BPP3;H3BP57;H3BT48;H3BUZ9;F5GX71;H3BPM5;P34949-2;H3BPU7;H3BU66;H3BQX0;H3BNY8;H3BT46;H3BUG1;H3BN01;B4DYB83BPB8 P 4949; MZ9; PP3; 3BP57;H3BT48; 3BUZ9;F5GX71;H3BPM5;P34949-2Mannose-6-phosphate isomeraseMPI 5 5 403 0 31.786 6.5408 0.60263 4.37E+08
F5H7K1;E7EWW0;Q7Z3J2;C9J7I2;Q7Z3J2-2;H3BVG8;H3BV68;H3BRV8;H3BUS7;H3BNX2;F6S1J4F5H7K1;E7EWW0;Q7Z3J ;C9J7I2;Q7Z3J2-2 VG ; V68UPF0505 protein C16orf62 13 13 959 0 68.34 6.1668 0.7711 1.50E+09
Q8IYI0;Q5TGB0;Q8IYI0-2;Q5TGA6Q8 YI0 B0 Uncharacterized protein C20orf196C20orf196 21 16 205 0 323.31 6.0396 0.013471 4.27E+11
Q9H8Y8;Q9H8Y8-3;Q9H8Y8-2;F8WEG2;C9J9V9;H7C0J2;C9J0V5;G3V0G1;Q9BQQ3-2;Q9BQQ3Q9H8Y8;Q9H8Y8-3;Q9H8Y8-2olgi reassembly-stacking protein 2GORASP2 11 11 452 0 111.3 5.4436 0.18291 1.60E+09
Q9Y535-2;Q9Y535;E7ERZ2;F8WDV1;F8WDS5Q9Y535-2;Q9Y535;E7ERZ2;F8WDV1;F8WDS5DNA-directed RNA polymerase III subunit RPC8POLR3H 3 3 175 0 55.178 4.8326 0.18942 3.42E+08
O95983-2;O95983;K7EIE8;A0A087WT34;A0A087X1H1;A0A0A0MTS6O95983-2;O95983;K7EIE8Methyl-CpG-binding domain protein 3MBD3 5 5 259 0 38.158 4.732 0.4654 7.64E+08
B1AK45;B1AK43;B1AK44;Q9UI95B1AK45;B1AK43;B1AK44;Q9UI95Mitotic spindle assembly checkpoint protein MAD2BMAD2L2 2 2 167 0 9.038 4.6463 0.20681 4.10E+08
Q9H7Z6;Q9H7Z6-2;H3BMX5Q9H7Z6;Q9H7Z6-2Histone acetyltransferase KAT8KAT8 3 3 458 0 8.8365 4.5107 NaN 4.72E+07
H0YH87;V9GY86;Q99700-2;Q99700-4;Q99700;F8WB06;F8VQP2;Q99700-5;F8VRK6;F8W0B5;F8VVY6H0YH87;V9GY86;Q99700-2;Q99700-4;Q99700 F8WB06;F8VQP2;Q99700-Ataxin-2 ATXN2 10 10 916 0 63.022 4.4873 0.62468 4.56E+08
Q9NVJ2;Q9NVJ2-2Q9NVJ2;Q9NVJ2-2ADP-ribosylation factor-like protein 8BARL8B 4 3 186 0 10.522 4.229 0.69566 9.22E+07
Q96FK6;G3V4B8 Q96FK6;G3V4B8 WD repeat-containing protein 89WDR89 5 5 387 0 52.646 3.9262 1.1788 3.48E+08
Q7L273;K7ENB5;K7EQN1Q7L273;K7ENB5;K7EQN1BTB/POZ domain-containing protein KCTD9KCTD9 2 2 389 0 6.6722 3.8941 NaN 8.44E+07
Q8TCT9-5;Q8TCT9;A0A075B6F6;Q8TCT9-4;Q8TCT9-2;A0A0C4DGU3Q8TCT9-5;Q8TCT9;A0A075B6F6;Q8TCT9-4;Q8TCT9-2Minor histocompatibility antigen H13HM13 3 3 335 0 21.284 3.7788 NaN 5.96E+08
O94760;B4DYP1;O94760-2;H0Y7N1;A0A140T971;Q5SSV3;Q5SRR8;O9586594760;B4D P1;O94760-2N(G),N(G)-dimethylarginine dimethylaminohydrolase 1DDAH1 7 7 285 0 30.106 3.7151 0.58237 2.96E+08
M0QY97;Q9UPT8 M0QY97;Q9UPT8 Zinc finger CCCH domain-containing protein 4ZC3H4 4 4 910 0 38.764 3.614 0.20506 1.56E+08
Q8WWH5 Q8WWH5 Probable tRNA pseudouridine synthase 1TRUB1 13 13 349 0 60.421 3.3743 0.52817 1.30E+09
Q3B726 Q3B726 DNA-directed RNA polymerase I subunit RPA43TWISTNB 3 3 338 0 30.471 3.2574 0.85254 7.15E+07
P0C7P0 P0C7P0 CDGSH iron-sulfur domain-containing protein 3, mitochondrialCISD3 1 1 127 0 4.6985 3.0902 NaN 1.16E+08
Q96BM9 Q96BM9 ADP-ribosylation factor-like protein 8AARL8A 2 1 186 0 4.3574 2.972 0.15729 2.86E+08
Q6P1R4;H0YGW8;J3KT57;F5H0Q0;J3QQZ0;J3QLE4;J3QQL9;J3QKP9Q6P1R4;H0YGW8;J3KT57;F5H0Q0;J3 QZ0;J3QLE4tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-likeDUS1L 4 4 473 0 14.277 2.8904 NaN 9.58E+07
Q92905;E5RHH5;E5RHF2Q92905;E5RHH5 COP9 signalosome complex subunit 5COPS5 3 3 334 0 12.707 2.8807 1.0056 2.42E+08
Q70Z53-2;Q70Z53-4;Q70Z53-5;Q70Z53-3;Q70Z53Q70Z53-2;Q70Z53-4;Q70Z53- ;Q70Z53-3;Q70Z53Protein FRA10AC1FRA10AC1 2 2 276 0 11.44 2.8576 0.083071 2.90E+08
P47813;X6RAC9;O14602;A6NJH9P47813;X6RAC9;O14602;A6NJH9Eukaryotic translation initiation factor 1A, X-chromosomal;Eukaryotic translation initiation factor 1A, Y-chromosomalEIF1AX;EIF1AY 7 7 144 0 102.88 2.8432 0.29041 2.47E+09
Q9NQT5;Q9NQT5-2Q9NQT5;Q9NQT5-2Exosome complex component RRP40EXOSC3 11 11 275 0 120.06 2.7359 0.36167 2.89E+09
A0A0A0MRB5;Q8WXG6-6;Q8WXG6-8;Q8WXG6-5;Q8WXG6-4;Q8WXG6-3;Q8WXG6-2;Q8WXG6-7;Q8WXG6;C9JM97;C9JLZ9;C9K0L0A0A0A0MRB5;Q8WXG6-6;Q8WXG6-8;Q8WXG6-5;Q8WXG6-4;Q8WXG6-3;Q8WXG6-2;Q8WXG6-7;Q8WXG6MAP kinase-activating death domain proteinMADD 4 4 1588 0 14.729 2.7195 1.5158 6.91E+07
Q7KZJ0;J3QKK3;O43502-2;O43502;J3QLB5;E9PI66Q7KZJ0;J3QKK3;O4 502-2;O43502;J3QLB5;E9PI66DNA repair protein RAD51 homolog 3RAD51C 3 3 134 0 31.856 2.7194 0.89126 3.72E+08
G3V1N5;B4E3L3;Q96RU2-2;Q96RU2;H0YG96;Q96RU2-3G3V1N5;B4E3L3;Q96RU2-2 ;H0YG96;Q96RU2-3Ubiquitin carboxyl terminal hydrolase;Ubiquitin carboxyl-terminal hydrolase 28USP28 2 2 753 0.0047524 2.4381 2.654 NaN 2.93E+07
Q8N6Q8;H0YIN2;F8VZA8Q8N6Q8;H0YIN2;F8VZA8Methyltransferase-like protein 25METTL25 2 2 603 0 3.8923 2.6374 NaN 3.06E+07
F8W9B8;A0A0A0MSI8;O00471F8W9B8;A0A0A0MSI8;O00471Exocyst complex component 5EXOC5 3 3 643 0 7.0314 2.5969 NaN 6.94E+07
A0A087X2D5;Q9BRJ2;A0A0G2JMS5;A0A087WU62A0A087X2D5;Q9BRJ2;A0A0G2JMS5;A0A087WU6239S ribosomal protein L45, mitochondrialMRP 3 3 306 0 15.5 2.5616 0.1163 3.97E+08
H0Y7A7;P62158;F8WBR5;M0QZ52;G3V479;E7ETZ0;E7EMB3;G3V361;Q96HY3;G3V226;C9J7T9;P27482;P02585H0Y7A7 P62158;F8WBR5;M0Q 52;G3V479;E7ETZ0;E7EMBCalmodulin CALM2;CALM1;CALM3 6 6 187 0 152 2.5085 0.52873 9.57E+08
P12236 P12236 ADP/ATP translocase 3;ADP/ATP translocase 3, N-terminally processedSLC25A6 32 11 298 0 270.47 2.477 0.33654 3.35E+10
A6NHG8;Q13114-2;Q13114A6NHG8;Q13114-2;Q13114TNF receptor-associated factor 3TRAF3 2 2 543 0.0020688 2.962 2.4536 NaN 9.08E+07
O60645-2;O60645-3;O60645;D6RB59;D6RBR9;H0Y995O60645-2;O60645-3;O 0645;D6RB59Exocyst complex component 3EXOC3 7 7 641 0 23.893 2.4526 0.88073 4.51E+08
Q15785 Q15785 Mitochondrial import receptor subunit TOM34TOMM34 5 5 309 0 92.838 2.4434 0.90012 3.54E+08
P11182;Q5VVL7 P11182;Q5VVL7 Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrialDBT 4 4 482 0 22.041 2.4356 0.79635 1.22E+08
Q96SI1-2;Q96SI1;V9GYY8;K7EN63;K7EIF1;K7EPF0;K7EQS3;K7EM48;REV__Q14999;REV__Q14999-2Q 6SI1-2;Q96SI1;V9GYY8;K7EN63BTB/POZ domain-containing protein KCTD15KCTD15 4 4 234 0 23.732 2.4181 0.92958 2.50E+08
Q2NKJ3;Q2NKJ3-2Q2NKJ3;Q2NKJ3-2CST complex subunit CTC1CTC1 3 3 1217 0 17.311 2.3908 NaN 1.50E+08
Q9UBW7;A0A087X151;Q9UBW7-2Q9UBW7 Zinc finger MYM-type protein 2ZMYM2 7 6 1377 0 21.612 2.3873 0.85472 1.46E+08
Q9BTV4 Q9BTV4 Transmembrane protein 43TMEM43 4 4 400 0 17.964 2.3771 0.41173 1.73E+08
Q9BR61 Q9BR61 Acyl-CoA-binding domain-containing protein 6ACBD6 5 5 282 0 27.274 2.3748 0.279 1.60E+08
K7ERV3;P04183;K7ES52;K7ERJ1;K7ENW5K7ERV3;P04183;K7ES52;K7ERJ1Thymidine kinase;Thymidine kinase, cytosolicK1 4 4 267 0 21.566 2.3712 0.24466 4.82E+08
Q16778;P33778;P23527;P06899;Q6DRA6;Q6DN03Q16778;P33778;P23527;P06899Histone H2B type 2-E;Histone H2B type 1-B;Histone H2B type 1-O;Histone H2B type 1-JHIST2H2BE; IST1H2BB;HIST1H2BO;HIST1H2BJ9 0 126 0 13.58 2.3574 0.31781 3.58E+09
Q96GD4-4;Q96GD4-2;Q96GD4;Q96GD4-5;J3QR41;J3KTD6;J3QLN8;J3KT86;J3KRJ2;J3KRF8;Q96GD4-3Q96GD4-4;Q96GD4-2;Q96GD4;Q96GD4-5;J3QR41;J3KTD6;J3QLN8;J3KT86Aurora kinase B AURKB 5 5 303 0 31.922 2.3242 0.23341 6.33E+08
P63167;F8VXL2;F8VRV5;F8VXI7P63167;F8VXL2;F8VRV5Dynein light chain 1, cytoplasmicDYNLL1 7 5 89 0 36.971 2.3226 0.37144 6.25E+08
P82664 P82664 28S ribosomal protein S10, mitochondrialMRP 6 6 201 0 50.713 2.3223 0.66378 1.03E+09
A0A087WT67;O14628-4;O14628-7;O14628-5;O14628-6;O14628;E9PIY8;I3L4C4;E9PQ92;E9PJ50;R4GMT1;B4DI05;E7EX64;A0A087X2B0;A0A0A0MRU8;A0A0M3HEQ9;F8W6Y9;C9J2N8;F5H032;A0A0A6YYI6;A0A087WVT1;B9EG95;A0A087WUV0;A0A087WYZ0;B2ZWH0;F8WEL6;A0A0A0MS50;A0A0C4DFQ3;F8W7T7;A0A087WXA8;H0Y892;H9KV89;A0A087X254;Q15973-2;Q6ZT77;P52743;O75840-2;O75840-4;Q15973-4;Q15973-1;O75840;Q13887-2;Q8IZC7-2;Q13360-2;Q96N95;P57682;Q9H4T2;Q15973;Q9UJN7;Q13887-4;Q96BR6-2;Q9Y4X4;Q6U7Q0;O95780-2;O75346-2;O95125-2;P16415-2;Q8N859;Q8IZC7;Q8N8L2;Q9UC06;Q13887;Q96H40;Q96BR6;O95780-3;Q13360;A6NP11;Q15937;O95780;O75346;Q9NPC7-3;Q9HBT8-2;P36508-2;Q9HBT8;P0CG31;Q7Z3I7;C9JN71;Q6ZMS4;Q14584;Q9H7R0-2;Q9UC07;Q96RE9-4;P36508;Q86YE8-2;Q86YE8-4;Q8NDW4;Q9NPC7-2;P15621-2;Q96RE9;Q86YE8-3;Q9NPC7;P16415;Q7Z7L9;Q8N184-1;Q96MX3;Q96RE9-2;Q96RE9-3;P17025-2;Q9H7R0;P15621-3;Q8N7K0-2;P17025;Q8N972;Q32M78;P17017;Q2M218-2;Q8N184;O95125;Q2M218;P15621;Q86YE8;Q9Y2A4;Q8N7K0;O14978;P51814-4;Q6ZMW2;Q8N8J6;Q8N8J6-3;Q8N8J6-2;P51814-8;P51814-7;Q86WZ6-2;Q99676;Q9HBT7;P51814-6;P51814-2;P51814A0A087WT67;O14628-4;O14628-7;O14628-5;O14628-6;O14628;E9PIY8Zinc finger protein 195ZNF195 4 3 633 0 1 .649 2.3143 Na 4.90E+07
O75190;A0A0J9YX62;O75190-3;C9J2C4;E9PH18;O75190-4;C9JDX6;F8WCZ4;C9J2P2;C9JDR7;C9JB42;Q8NHS0;C9JN01;Q8WWF6;Q7Z6W7O75190;A0A0J9YX62;O75190-3;C9J2C4;E9PH18;O75190-4;C9JDX6;F8WCZ4;C9J2P2DnaJ homolog subfamily B member 6DNAJB6 14 2 326 0 122.28 2.3006 0.37276 5.42E+09
Q96FJ2 Q96FJ2 Dynein light chain 2, cytoplasmicDYNLL2 5 3 89 0 14.104 2.266 0.19323 1.30E+08
A0A075B6F9;Q9Y314;M0R3B2;M0R1K2;M0QX85;A0A075B797;M0R1T7A0A075B6F9 Q9Y314; 0R3B2Nitric oxide synthase-interacting proteinNOSIP 9 9 304 0 82.776 2.2523 0.4305 1.34E+09
Q15366-2;Q15366Q15366-2;Q15366Poly(rC)-binding protein 2PCBP2 19 0 366 0 10.808 2.1826 0.12461 4.09E+09
Q9C037-2;Q9C037;H7C0Q6;Q9C037-3Q9C037-2 ;H7C0Q6;Q9C037-3Tripartite motif-containing protein 4TRIM4 3 3 474 0 7.9096 2.1751 1.1298 6.16E+09
K7EQH1;A0A087WVF1;Q5BIX2;Q96B23-2;Q96B23K7EQH1;A0A087WVF1;Q5BIX2;Q96B23-2;Q96B23Uncharacterized protein C18orf25C18orf25;ARKL1 1 1 146 0 18.909 2.1621 NaN 1.17E+07
K7ELA4;B5MD17;J3KS05;P83916;C9JWS9K7ELA4;B5MD17;J3KS05;P83916;C9JWS9Chromobox protein homolog 1CBX1 3 2 138 0 40.847 2.1582 0.52991 2.32E+08
Q9NR45;Q5TBR0;Q5TBR19NR45 Sialic acid synthaseNANS 16 16 359 0 199.54 2.1342 0.4655 7.28E+09
Q15554;J3KSZ6;U3KQ35;H3BR06;H3BR37;H3BTA7;Q15554-4Q155 4;J3KSZ U KQ 5; R06Telomeric repeat-binding factor 2TERF2 3 3 542 0 6.5662 2.1107 NaN 3.55E+07
Q9Y697-2;Q9Y697;Q9Y697-3;H7C0I5;H0YGN5;F2Z2E7Q9Y697-2;Q9Y697;Q9Y697-3Cysteine desulfurase, mitochondrialNFS1 7 7 397 0 25.26 2.1061 0.83717 1.91E+08
Q96NW4;K7ELM1Q96NW4;K7ELM1Ankyrin repeat domain-containing protein 27ANKRD27 2 2 1050 0 6.7286 2.0849 NaN 6.26E+07
H7BY83;Q5JSH3-2;Q5JSH3;Q5JSH3-4;Q5JSH3-3H7BY83;Q5JSH3-2;Q5JSH3;Q5JSH3-4;Q5JSH3-3WD repeat-containing protein 44WDR44 5 5 806 0 16.786 2.0737 0.89028 6.36E+07
Q86XZ4;F8VS10 Q86XZ4;F8VS10 Spermatogenesis-associated serine-rich protein 2SPATS2 6 6 545 0 29.965 2.0649 NaN 6.46E+07
Q9BPZ7-5;Q9BPZ7-6;Q9BPZ7-3;Q9BPZ7-2;Q9BPZ7;B1AMB1;B1AMA6;B1AMB2;E9PGB8;B1AMA5;Q9BPZ7-4Q9BPZ7-5;Q9BPZ7-6;Q9BPZ7-3;Q9BPZ7-2 Q9BPZ7;B1A B1;B1AMA6 B2 E9PGB8;B1AMA5;Q9BPZ7-4Target of rapamycin complex 2 subunit MAPK P1MAPKAP1 2 2 323 0 16.258 2.0487 NaN 1.86E+08
Q8NAV1 Q8NAV1 Pre-mRNA-splicing factor 38APRPF38A 6 6 312 0 31.665 2.0465 0.42664 1.63E+08
Q13642-1;Q13642-5;Q13642-4;Q5JXI8;Q13642;A0A0D9SFZ9;Q5JXH8;Q5JXH7;Q5JXI3;Q5JXI2;Q13642-3;A0A0D9SFI6;A0A0D9SFB0;Q5JXH9;A0A0D9SG53;A0A0D9SGB2;Q5JXI0;A0A0D9SGD1;A0A0D9SEY7;A0A0D9SGC5Q13642-1;Q13642-5;Q13642-4;Q5JXI8;Q13642;A0A0D9SFZ9;Q5JXH8;Q5JXH7;Q5JXI3;Q5JXI2;Q13 42-3;A0A0D9SFI6;A0A0D9SFB0;Q JXH9;A0A0D9SG53;A0A0D9SGB2;Q5JXIFour and a half LIM domains protein 1FHL1 13 13 8 93.83 2.0196 0.10659 3.28E+0
O15541 O15541 RING finger protein 113ARNF113A 3 3 343 0 8.3916 2.0161 NaN 6.52E+06
A0A0A0MQR8;A0A0A0MSZ1;A0A0A0MT23;J3KNR0;P27448-6;P27448-3;P27448-4;P27448-2;P27448;P27448-7;A0A0A0MST9;P27448-8;H0YIY6;H0YNV4;H0YKJ3;H0YKP9;A2SY060 0A0MQR8;A0A0A0MSZ1;A0A0A0MT23;J3KNR0;P27448-6;P27448-3;P 7448- ;P274 8-2;P27448;P27448-7;A0A0A0MST9;P27448-8M P/microtubule affinity-regulating kinase 3MARK3 11 3 713 0 17. 47 2.0081 0.58561 1.15E+08
F5H562;E7ET55;F5H748;B7ZLR4;P35670-2;P35670-3;P35670-4;P35670;A0A0U1RQY8F5H562;E7ET55;F5H 48;B7ZLR4;P 5670-2;P35670-3;P35670-4;P35670Copper-transporting ATPase 2;WND/14  kDaATP7B 5 5 1035 0 22.607 1.9834 0.70432 2.98E+08
Q6ZRV2;J3KPS2 Q6ZRV2;J3KPS2 Protein FAM83H FAM83H 16 16 1179 0 154.88 1.9697 0.59051 7.81E+08
P52435;A0A0B4J2F8;F6S314;E2QRJ6;A6NFM0;Q9H1A7;Q9GZM3;F8WF84;D6RAG0;E7EP90;A0A0B4J1Z8;E7EWC6;Q9GZM3-2P52435;A0A0B4J2F8;F6S314;E2QRJ6;A6NF 0;Q9H1A7;Q9GZM3;F8WF84DNA-directed RNA polymerase II subunit RPB11-a;DNA-directed RNA polymerase II subunit RPB11-b2;DNA-directed RNA polymerase II subunit RPB11-b1POLR2J;POLR2J3;POLR2J2 4 4 117 0 13.279 1.9688 0.27943 2.50E+08
Q9UJY1;H0YG30 Q9UJY1 Heat shock protein beta-8HSPB8 4 4 196 0 7.4407 1.9651 0.82032 1.95E+08
Q9H3N1;G3V448 Q9H3N1 Thioredoxin-related transmembrane protein 1TMX1 5 5 280 0 22.717 1.9528 1.2118 1.10E+08
F6QDS0 F6QDS0 24 0 479 0 64.507 1.9441 NaN 3.63E+08
O95219;O95219-2;F8W9T3O95219;O95219-2;F8W9T3Sorting nexin-4 SNX4 6 6 450 0 58.047 1.9354 0.84938 2.41E+08
O43852;O43852-3;O43852-2;O43852-4;O43852-5;O43852-6;O43852-15;H0Y875;O43852-9;O43852-10;O43852-13;O43852-14;O43852-11;O43852-8;O43852-12;O43852-7O43852;O43852-3;O 3852-2;O43852-4;O43852-5;O43852-6;O43852-15;H0Y875;O43852-9;O43852-10Calumenin CALU 10 3 5 0 16 .14 1.9302 0.23335 9.74E+08
Q9ULX6;Q9ULX6-2;V9GZ50;M0R1Y5;M0R010;M0QYT7Q9ULX6;Q9ULX6-2A-kinase anchor protein 8-likeAKAP8L 9 9 646 0 105.45 1.9203 0.57224 2.23E+09
H7C5F9;B4E2D5;R4GND2;F6S7C4;Q8NEM7-2;Q8NEM7;Q8NEM7-3H7C5F9 B4E2D5;R4GND2;F6S7C4;Q8NEM7-2;Q8NEM7;Q8NEM7-3Transcription factor SPT20 homologSUPT20H 1 1 378 0 32.623 1.9085 NaN 1.27E+08
Q14687-2;Q14687-3;Q14687;H7C3B5;H0Y613;C9JLW9Q14687-2;Q14687-3;Q14687;H7C3B5;H0Y613Genetic suppressor element 1GSE1 6 6 1113 0 34.066 1.899 0.64689 1.36E+08
Q9UGR2-2;Q9UGR2Q9UGR2-2;Q9UGR2Zinc finger CCCH domain-containing protein 7BZC3H7B 8 8 977 0 54.039 1.8946 1.1298 7.17E+08
O00443;A0A0C4DGF9;O00443-2;E9PPP3O00443 Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alphaPIK3C2A 27 27 1686 0 235.74 1.8942 0.66923 1.25E+09
Q9UGP4;C9JRJ5 Q9UGP4;C9JRJ5 LIM domain-containing protein 1LIMD1 5 5 676 0 20.905 1.8924 1.2032 1.67E+08
Q9HB71;Q9HB71-3;B2ZWH1;Q9HB71-2Q9HB71;Q9HB71-3Calcyclin-binding proteinCACYBP 20 20 228 0 307.88 1.8859 0.60158 1.13E+10
Q7L8W6;H0YND7;H0YNH5;Q7L8W6-2Q7L8W6;H0YND7;H0YNH5Diphthine--ammonia ligaseDPH6 4 4 267 0 38.415 1.8808 4.0816 2.78E+08
Q13136-2;Q13136;E9PJZ7;R4GNF1;E9PPF6;H0YEF9;H0YDW2;R4GN36;O75145-2;O75145Q13136-2;Q13136;E9 JZ7Liprin-alpha-1 PPFIA1 6 6 1185 0 46.365 1.8805 0.25433 3.18E+08
H3BNT4;Q99547;H3BSB3;H3BNK8;H3BU96NT4;Q99547; SB3M-phase phosphoprotein 6MPHOSPH6 9 9 142 0 36.253 1.8762 0.52481 4.99E+08
Q92540-2;Q92540;E9PD50;Q92540-5;Q92540-4;B1ALB4;E9PEK3;E9PBK2;D6RAD0Q92540-2; 92540;E9PD50;Q92540-5;Q92540-4;B1ALB4Protein SMG7 SMG7 10 10 1091 0 30.263 1.8762 0.76246 2.14E+08
A0A0G2JH68;O60610;H9KV28;A0A140T8Z0;O60610-2;O60610-3;B4E2I7;E5RJ79;H7C2W8A0A0G2JH6 ;O60610;H9KV28;A0A140T8Z0;O60610-2;O60610-3Protein diaphanous homolog 1DIAPH1 41 41 1272 0 323.31 1.8685 0.44794 4.32E+09
Q9BXY0 Q9BXY0 Protein MAK16 homologMAK16 2 2 300 0 15.857 1.8678 0.50965 2.19E+08
Q09666;E9PQE3;E9PJZ0;E9PKR9;E9PJC6;E9PLK4;Q09666-2Q09666;E9PQE3;E9PJZ0;E9PKR9;E PJC6;E9PLK4;Q09666-2Neuroblast differentiation-associated protein AHNAKAHNAK 2 2 5890 0 5.8365 1.8644 NaN 2.13E+08
O75446 O75446 Histone deacetylase complex subunit SAP30SAP30 4 4 220 0 20.198 1.8626 0.23987 4.33E+08
Q6ZW49;Q6ZW49-2;Q6ZW49-1;F8WC23;H7BZI8Q6ZW49;Q6ZW49-2;Q6ZW49-1PAX-interacting protein 1PAXIP 6 6 1069 0 24.231 1.8612 1.3341 4.19E+08
K7ENL4;J3QL63;J3QL47;Q96ET8-3;J3KS67;C9JYS5;Q9NYZ1K7ENL4;J3QL63;J3QL47;Q 6ET8-3;J3KS67;C9JYS5;Q9NYZ1Golgi apparatus membrane protein TVP23 homolog BTVP23B;TVP23C 2 2 132 0 12.669 1.8515 NaN 4.51E+07
P49914;A0A0A6YYL1;A0A0U1RQM3;P49914-2;A0A0U1RR23P49914;A0A0A6YYL1;A0A0U1RQM3;P49914-25-formyltetrahydrofolate cyclo-ligaseMTHFS 7 7 203 0 51.449 1.85 0.62285 4.84E+08
Q9NVX0-3;Q9NVX0;Q9NVX0-2Q9NVX0-3;Q9NVX0;Q9NVX0-2HAUS augmin-like complex subunit 2HAUS2 4 4 204 0 6.581 1.8442 NaN 7.02E+07
Q9NWH9;H7BXE3;H0YLW7;H0YMW8;H0YNF3;H0YMR6;H0YLE6;H0YL55;H7C3F4;Q9NWH9-3Q9NWH9 7BXE3;H0YLW7;H0YMW8 NF3; 0YMR6;H0YLE6;H0YL55;H7C3F4;Q9NWH9-3SAFB-like transcription modulatorSLTM 4 4 1034 0 47.386 1.8365 0.88745 9.27E+07
Q5T7C4;P09429;B2RPK0Q5T7C4;P09429 High mobility group protein B1HMGB1 3 3 158 0 9.1165 1.8295 NaN 1.80E+08
Q9Y6D5 Q9Y6D5 Brefeldin A-inhibited guanine nucleotide-exchange protein 2ARFGEF2 10 8 1785 0 44.792 1.8189 0.70601 1.87E+08
Q6P6B7;Q6P6B7-2Q6P6B7;Q6P6B7-2Ankyrin repeat domain-containing protein 16ANKRD16 3 3 361 0 13.255 1.814 1.0292 8.94E+07
Q14289-2;Q14289;E9PBI4Q14289-2;Q14289;E9PBI4Protein-tyrosine kinase 2-betaPTK2B 2 2 967 0.0063882 2.1936 1.8077 0.44513 1.11E+07
A0A087WTX2;Q92504A0A087WTX2;Q92504Zinc transporter SLC39A7SLC39A7 1 1 429 0 4.9764 1.8072 NaN 9.72E+06
Q09472;I3L0Q1 Q09472 Histone acetyltransferase p300EP300 13 5 2414 0 25.08 1.8069 0.81878 1.62E+08
A6NML8;K4DI95;C9J6U3;O60879-2;O60879-3;O60879A6NML8;K4DI95;C9J6U3;O60879-2;O60879-3;O60879Protein diaphanous homolog 2DIAPH2 7 7 1096 0 30.85 1.8035 0.77487 2.24E+08
163
Q12765;Q12765-2;Q12765-3;C9K052;B8ZZP4;C9J7U9Q12765;Q12765-2;Q12765-3;C9K052Secernin-1 SCRN1 7 7 414 0 35.999 1.8035 0.90208 5.61E+08
Q7Z7H8;Q7Z7H8-2Q7Z7H8;Q7Z7H8-239S ribosomal protein L10, mitochondrialMRP 4 4 261 0 27.585 1.7978 0.60536 4.62E+08
Q15020;Q15020-4;Q15020-2;F8W667;F8VVK9;F8VZM2;H0YHU8;Q15020-3Q15020;Q15020-4Squamous cell carcinoma antigen recognized by T-cells 3SART3 33 7 963 0 323.31 1.7922 0.53142 4.48E+09
Q96JM3;S4R3K0 Q96JM3 Chromosome alignment-maintaining phosphoprotein 1CHAMP1 14 14 812 0 164.85 1.7921 0.40329 9.17E+08
A0A0U1RR32;A0A0U1RRH7;Q99878;Q96KK5;Q9BTM1;Q16777;Q6FI13;P20671;P0C0S8;H0YFX9;Q9BTM1-2;Q96QV6;P16104;REV__H0Y672;REV__E7EQ67;REV__H7BY63;REV__Q8NB25-4;REV__Q8NB25-2;REV__A0A087X2A7;REV__Q8NB25-3;REV__Q8NB25;Q71UI9-5A0A0U1RR32;A0A0U1RRH7; 9878; 9 KK5; 9BTM1;Q1 77;Q6FI13;P20671;P0C0S8;H0YFX9;Q9BTM1-2;Q96QV6;P16104Histone H2A type -J;Histone H2A type -H;Histone H2A.J;Histone H2A type 2-C;Histone H A type 2-A;Histone H2A type 1-D;Histone H2A type 1;Histone H2A;Histone H2A type 1-A;Histone H2AXHIST1H2AJ; IS 1H2AH;H2AFJ;HI T H AC;HIST2 A3;HIST1 2AD;HIST1H2AG;HIST1H2AA;H2AFX7 2 169 0 6 .065 1.7918 0.42253 5.85E+09
Q9Y673-2;Q9Y673Q9Y673-2;Q9Y673Dolichyl-phosphate beta-glucosyltransferaseALG5 2 2 294 0 8.1759 1.7898 NaN 5.63E+07
Q9BTE1;H3BR94;Q9BTE1-2;H3BUD2;H3BS05;Q9BTE1-3;I3L0U8Q9BTE1;H3BR94;Q9BTE1-2 H3 UD2;H BS05;Q9BTE1-3Dynactin subunit 5DCTN5 6 6 182 0 47.367 1.7815 0.48545 5.30E+08
Q9Y383;A0A0A6YYC3;Q96HJ9-2;A0A0A6YYJ8;Q9Y383-3;Q9Y383-2;V9GZ75;F8WEU3Q9Y383;A0A0A6YYC3;Q96HJ9-2;A0A0A6YYJ ;Q9Y383-3;Q9Y383-2Putative RNA-binding protein Luc7-like 2LUC7L2 9 7 392 0 60.83 1.7793 0.73242 8.41E+08
H3BPE1;H3BQK9;Q9UPN3;Q9UPN3-4;Q9UPN3-3;Q9UPN3-2;E9PLY5;E9PNZ4;H0Y390;E9PLY0;Q9UPN3-5;E9PS75;H0YD69H3B E1;H3BQK9;Q9UPN3;Q9UPN3-4;Q9UPN3-3;Q9UPN3-2;E9PLY5;E9PNZ4;H0Y390Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5MACF1 3 12 7555 0 43.353 1.7766 0.60833 3.51E+08
H0YMV8;Q71UM5;C9JLI6H0YMV8;Q71UM5;C9JLI640S ribosomal protein S27;40S ribosomal protein S27-likeRPS27L 6 2 100 0 22.586 1.7748 NaN 4.91E+08
H7BYN4;Q02241-2;Q02241;Q02241-3;H0YKQ5;H0YME6;H0YMJ4H7BYN4;Q02241-2;Q02241;Q02241-3Kinesin-like protein KIF23KIF23 16 16 952 0 125.13 1.771 0.63539 1.25E+09
Q5SZR1;Q9BYD2 Q5SZR1;Q9BYD2 39S ribosomal protein L9, mitochondrialMRP 3 3 233 0 30.794 1.7689 NaN 8.14E+07
P15880;H0YEN5;E9PQD7;I3L404;E9PMM9;E9PPT0;E9PM36;H3BNG3;H0YE27P15880;H0YEN5;E9PQD7;I3L404 M9;E9PPT0;E9PM3640S ribosomal protein S2RPS2 19 19 293 0 214.1 1.764 0.6309 2.39E+10
Q9NQW6-2;Q9NQW6;H7C3S1;C9JJT6;H7C1C2;H7C1K5Q9NQW6-2;Q9NQW6Actin-binding protein anillinANLN 6 6 1087 0 82.235 1.7567 2.0077 2.16E+08
Q9UBI9 Q9UBI9 Headcase protein homologHECA 3 3 543 0 9.7163 1.7543 NaN 5.88E+07
Q12824-2;G5E975;Q12824;B5MCL5;C9JTA6;A0A0G2JSE9;A0A0U1RQQ2;A0A0U1RRB8Q12824-2;G5E97 Q12824;B5MCL5SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1SMARCB1 9 9 376 0 171.41 1.754 0.83057 2.19E+09
Q16527;F8VQR7;F8VW96Q16527;F8VQR7;F8VW96Cysteine and glycine-rich protein 2CSRP2 10 10 193 0 85.194 1.7465 0.56288 3.29E+08
Q16720-8;Q16720-7;Q16720-6;Q16720-3;Q16720-5;Q16720-2;Q16720-4;Q16720Q16720-8;Q16720-7;Q16720-6;Q16720-3;Q16720-5;Q16720-2;Q16720-4;Q16720Plasma membrane calcium transporting ATPase 3ATP2B3 11 2 1115 0.00026638 3.4969 1.7417 NaN 4.24E+06
Q9Y283-2;Q9Y283Q9Y283-2;Q9Y283Inversin INVS 1 1 895 0.0013082 3.1286 1.7404 0.47671 4.65E+07
Q86TJ2-3;Q86TJ2-2;Q86TJ2;D6RC20;D6RJ05Q86TJ2-3;Q86TJ -2;Q86TJ2Transcriptional adapter 2-betaTADA2B 5 5 328 0 20.292 1.7325 0.73152 1.70E+08
Q6R327;Q6R327-3;D6R9S6;Q6R327-4Q6R327;Q6R327-3Rapamycin-insensitive companion of mTORRICTOR 14 14 1708 0 79.801 1.7293 0.76288 5.78E+08
C9JP00;A0A0A0MQX8;Q9NR56;Q9NR56-7;Q86VM6;O95205;Q5VZF2-3;Q5VZF2-2;Q5VZF2;B1AKI6;Q9NUK0-2;Q9NUK0;C9J4T8;C9JCX1;H7C4Y1;Q9NUK0-4;Q9NUK0-3C9JP00;A0A0A0MQX8;Q9NR56;Q9NR 6-7; 86VM6Muscleblind-like protein 1MBNL1 9 2 348 0 71.646 1.7263 0.48953 1.62E+09
P24534;C9JZW3;F2Z2G2;F8WF65P24534 Elongation factor 1-betaEEF1B2 14 12 225 0 164.82 1.7256 0.3244 1.90E+10
Q9HD26-2;Q9HD26;F5H1Y4;Q9HD26-3;A0A0J9YVX5Q9HD26-2; ;F5H1Y4;Q9HD26-3Golgi-associated PDZ and coiled-coil motif-containing proteinGOPC 11 11 454 0 110.41 1.7206 0.89681 4.16E+08
Q6Y1H2;C9JWG1;H7C4K8Q6Y1H2 Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2PTPLB 5 5 254 0 11.942 1.717 0.86575 1.28E+08
P35249;C9JZI1;P35249-2;C9J8M3;C9JTT7;C9JXZ7;C9JGY5;F8WE44;H7C1P0;C9JW34P35249 ZI1;P35249-2;C9J8M3;C9JTT7Replication factor C subunit 4RFC4 19 19 363 0 311.23 1.7133 0.5929 3.52E+09
Q9BT25-2;Q9BT25-3;Q9BT25Q9BT25- ;Q9BT25-3;Q9BT25HAUS augmin-like complex subunit 8HAUS8 7 7 349 0 183.73 1.7122 0.46742 1.40E+09
Q9BTT0-3;Q9BTT0;E9PPH5;Q5TB19;E9PLC4;Q9BTT0-2Q9BTT0-3;Q9 TT0;E9PPH5Acidic leucine-rich nuclear phosphoprotein 32 family member EANP32E 5 5 220 0 109.18 1.7121 0.38943 1.35E+09
Q5T280;R4GNG4;A0A087WYA7Q5T2 0 Uncharacterized protein C9orf114C9orf114 3 3 376 0 13.798 1.7077 0.6212 1.03E+08
A0A0C4DFM7;Q5TAX3;E9PKY2;E9PKX1;H0YDJ1;H0YEE8;Q5TAX3-2A0A0C4DFM7;Q5TAX3;E9PKY2;E9PKX1Terminal uridylyltransferase 4ZCCHC11 5 5 1645 0 59.325 1.7049 0.69429 1.58E+08
Q9Y5V3;Q9Y5V3-2;Q96JG8-2;Q96JG8;Q96JG8-4Q9Y5V3;Q9Y5V3-2Melanoma associated antigen D1MAGED1 13 12 778 0 256.2 1.6982 0.39423 1.02E+09
P42166;P42167-3P42166 Lamina-associated polypeptide 2, isoform alpha;Thymopoietin;ThymopentinTMPO 15 11 694 0 158.15 1.6947 0.51763 1.51E+09
Q6IQ49-2;Q6IQ49Q6IQ49-2;Q6IQ49Protein SDE2 homologSDE2 1 1 439 0.0087634 2.0635 1.6882 NaN 9.66E+06
E9PQG4;A0A0A0MRL8;A0A0A0MRL9;E9PL24;A0A0C4DFQ0;A0A087WVF8;A0A0A0MRM0;A0A0A0MRM1;A0A087WX83;A0A075B749;Q5VU43-6;Q5VU43-7;Q5VU43-2;Q5VU43-3;Q5VU43;Q5VU43-4E9PQG4;A0A0A0MRL8;A0A0A0MRL9;E9PL24;A0A0C4DFQ ;A0A087WVF8; A0 RM0; A0A0MRM1; 0A087WX83;A0A075B749;Q5VU43-6;Q5VU43-7;Q5VU43-2;Q5VU43- ;Q5VU43;Q5VU43-4Myomegalin PDE4DIP 3 3 740 0 16.128 1.68 6 NaN 4.11E+07
P82914 P82914 28S ribosomal protein S15, mitochondrialMRP 7 7 257 0 14.749 1.6855 0.48324 1.19E+09
Q3MHD2;Q3MHD2-2;K7ELG9Q3MHD2;Q3MHD2-2;K7ELG9Protein SM12 homologLSM12 8 8 195 0 57.201 1.6829 0.56269 3.51E+09
E9PH99;Q9Y4E5-2;Q9Y4E5;D6RIA1E9PH99;Q9Y4E5-2;Q9Y4E5Zinc finger protein 451ZNF451 6 6 1041 0 21.352 1.6742 0.89122 7.03E+07
P53621;P53621-2P53621;P53621-2Coatomer subunit alpha;Xenin;ProxeninCOPA 87 87 1224 0 323.31 1.6738 0.54565 5.52E+10
P53350;I3L2H5;I3L387;I3L309P53350 Serine/threonine-protein kinase PLK1PLK1 8 8 603 0 56.668 1.6693 NaN 4.25E+08
P53985;Q5T8R5;P53985-2;Q5T8R3;Q5T8R4P53985;Q5T8R5;P539 5-2Monocarboxylate transporter 1SLC16A1 9 9 500 0 97.127 1.6685 0.96056 1.15E+09
P39748;P39748-2;I3L3E9;F5H1Y3;CON__P01030;CON__ENSEMBL:ENSBTAP00000007350P39748;P39748-2Flap endonuclease 1FEN1 22 22 380 0 323.31 1.6611 0.56668 1.10E+10
K7EP32;Q9BZV1;Q9BZV1-2;K7ELN1;K7EJ02K7EP32;Q9BZV1;Q9BZV1-2UBX domain-containing protein 6UBXN6 5 5 371 0 15.799 1.6606 0.75819 2.55E+08
Q9UKX7-2;Q9UKX7Q9UKX7-2;Q9UKX7Nuclear pore complex protein Nup50NUP50 2 2 440 0 6.1075 1.6579 NaN 3.41E+07
F8VR31;P51530-3;P51530-4;P51530;P51530-2;H0Y455F8VR31;P51530- ;P51530-4;P51530;P51530-2DNA replication ATP-dependent helicase/nuclease DNA2;DNA replication nuclease DNA2;DNA replication ATP-dependent helicase DNA2DNA2 4 4 867 0 8.0722 1.6563 0.6016 1.00E+08
Q9UI43;E9PGN6 Q9UI43;E9PGN6 Putative ribosomal RNA methyltransferase 2FTSJ2 3 3 246 0 6.289 1.6503 NaN 5.09E+07
E7EN20;Q9UPN9;H0Y612E7EN20;Q9UPN9;H0Y612E3 ubiquitin-protein ligase TRIM33TRIM33 12 2 1119 0 114.67 1.6471 0.51758 1.55E+09
E7EPP6;J3KN87;O14757-2;O14757-3;O14757;A0A087WT52;E9PRU7;E9PJI4;E9PPA5;E9PKQ3E7EPP6;J3KN87;O14757-2;O14757-3;O14757Serine/threonine-protein kinase Chk1CHEK1 5 5 492 0 27.944 1.6464 1.0474 3.65E+08
Q96KP1;Q2MDF5 Q96KP1 Exocyst complex component 2EXOC2 17 17 924 0 106.57 1.6424 0.5155 1.65E+09
Q9H2P0;E9PQK8 Q9H2P0 Activity-dependent neuroprotector homeobox proteinADNP 25 25 1102 0 176.85 1.6393 0.60649 2.60E+09
Q9NQE9 Q9NQE9 Histidine triad nucleotide-binding protein 3HINT3 3 3 182 0 16.423 1.6375 5.3158 4.39E+08
A0A0A0MRN5;Q9NZT2-2;Q9NZT2;A0A087X028A0A0A0MRN5;Q9NZT2-2;Q9NZT2;A0A087X028Opioid growth factor receptorOGFR 4 4 625 0 29.893 1.6357 0.74122 2.27E+08
A0A075B6T1;Q9C0C7-4;Q9C0C7-2;Q9C0C7-3;Q9C0C7;Q9C0C7-5;Q9C0C7-6;H0YE34A0A075B6T1;Q9C0C7-4;Q9C0C7-2;Q9C0C7-3;Q9C0C7;Q9C0C7-5;Q9C0C7-6Activating molecule in BECN1-regulated autophagy protein 1AMBRA1 9 9 1179 0 67.728 1.6335 0.70103 4.19E+08
Q7Z4H7-3;Q7Z4H7;Q5VY60;Q7Z4H7-2;Q5SYF9Q7Z4H7-3; 7Z4 7;Q5VY60;Q7Z4H7-2HAUS augmin-like complex subunit 6HAUS6 16 16 920 0 68.246 1.6321 0.42936 1.26E+09
Q8TER5-2;Q8TER5-4;Q8TER5-3;Q8TER5Q8TER5-2;Q8TER5-4;Q8TER5-3;Q8TER5ho guanine nucleotide exchange factor 40ARHGEF40 2 2 805 0 4.7199 1.6312 NaN 4.46E+07
Q8N5C6;Q8N5C6-2Q8N5C6;Q8N5C6-2S1 RNA-binding domain-containing protein 1SRBD1 20 20 995 0 168.09 1.6302 0.70671 2.22E+09
P13804;P13804-2;H0YK49;H0YLU7;H0YNX6;H0YL12;H0YL83;H0YM12;J3KN60P1380 ;P13804-2;H0YK49; 0YLU7;H0YNX6;H0YLElectron transfer flavoprotein subunit alpha, mitochondrialETFA 17 8 333 0 266.33 1.6284 0.57361 1.13E+10
Q9UHR4 Q9UHR4 Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1BAIAP2L1 4 4 511 0 15.565 1.6234 NaN 1.11E+08
P35251-2;P35251;H0Y8U4;H0Y9P8P35251-2;P35251Replication factor C subunit 1RFC1 9 9 1147 0 58.565 1.6228 0.59615 8.64E+08
O15164-2;O15164;A0A087X1V3O15164-2;O15164;A0A087X1V3Transcription intermediary factor 1-alphaTRIM24 11 11 1016 0 35.363 1.6159 0.67124 4.98E+08
D6W601;Q96EY9 D6W601;Q96EY9 Probable inactive tRNA-specific adenosine deaminase-like protein 3hCG_22695;ADAT3 2 2 367 0.0023018 2.7901 1.6106 NaN 1.88E+07
O15371-3;O15371;O15371-2;B0QYA5;B0QYA6;B0QYA4;B0QYA8;A0A0D9SGB5O15371-3;O15371;O15371-2;B0QYA5Eukaryotic translation initiation factor 3 subunit DEIF3D 22 22 533 0 309.02 1.6096 0.83668 4.48E+09
Q9H0H5;F8VRD2;F8VWX0;F8W0L1;F8VZ66;F8VV47;F8VWY4;F8VVE5;F8VYH6;F8VUW9;F8VV39;F8VQZ5;F8VS54;F8VV37;F8W1E5;F8VVY0;F8VXH1;F8VQF5;F8W1T4Q9H0H5 VRD2;F8 WX0;F8W0L1;F8VZ66;F8 47;F8VWY4;F8VVE5Rac GTPase-activating protein 1RACGAP1 5 5 632 0 11.849 1.6035 NaN 6.40E+07
A0A0A0MRM8;Q9UM54-5;Q9UM54-2;Q9UM54-6;E7EW20;Q9UM54-4;Q9UM54-1;Q9UM54;A0A0D9SGC1;Q5JVM0A0A0A0MRM8;Q9UM54-5;Q9UM54-2;Q9UM54-6;E7EW20;Q9UM54-4;Q9UM54-1;Q9UM54;A0A0D9SGC1nconventional myosin-VIMYO6 48 48 1253 0 323.31 1.5916 0.67775 6.51E+09
M0QZR4;Q92888;Q92888-3;Q92888-2;Q92888-4;M0QYC1;M0R2C7;M0QYS3;M0QZH8;M0R3H5;M0QXV6M0QZR4;Q92888;Q92888-3;Q92888-2;Q92888-4; 0QYC1Rho guanine nucleotide exchange factor ARHGEF1 21 21 968 0 232.71 1.5913 0.60962 1.30E+09
A0A087X1F4;Q9H944;A6PVP4;B7ZBQ3;Q9H944-2;B7ZBQ1A0A087X1F ;Q9H944;A6PVP ;B7ZBQ3;Q9H944-2Mediator of RNA polymerase II transcription subunit 20MED20 3 3 211 0 9.5897 1.5887 NaN 1.10E+08
P37108;H0YLA2;H0YLW0P37108;H0YLA2 Signal recognition particle 14 kDa proteinSRP14 10 10 136 0 75.295 1.5887 0.5867 6.43E+09
J3KNB8;F5H538;Q9Y6R4-2;Q9Y6R4;F5H4R1;F5H1X6J3KNB8;F5H538;Q9Y6R4-2;Q9Y6R4;F5H4R1Mitogen-activated protein kinase kinase kinase 4MAP3K4 6 6 1554 0 22.858 1.5821 0.75042 2.50E+08
O43719;Q5H918;Q5H919O437 HIV Tat-specific factor 1HTATSF1 27 27 755 0 323.31 1.5806 0.60411 2.61E+09
V9GYM8;Q92974-3;Q92974-2;Q92974;V9GYF0;Q5VY93;V9GZ14;V9GYF5;V9GYG5;REV__J3KQ37;REV__P0DJD0;REV__P0DJD1;REV__F8VYC4;REV__A6NKT7;REV__J3KNE0;REV__Q99666;REV__O14715V9GYM8;Q92974-3;Q92974-2;Q92974Rho guanine nucleotide exchange factor 2ARHGEF2 31 31 1031 0 323.31 1.5804 0.60652 3.75E+09
Q9UGN5-2;Q9UGN5;G3V167;H0YH02Q9UGN5-2;Q9UGN5;G3V167;H0YH02Poly [ADP-ribose] polymerase 2PARP2 4 4 570 0 10.17 1.5801 NaN 2.02E+07
P43034;I3L3N5;I3L495;P43034-2P43034 Platelet-activating factor acetylhydrolase IB subunit alphaPAFAH1B1 20 20 410 0 186.91 1.5787 0.53467 5.17E+09
Q13409-3;Q13409-7;Q13409-2;Q13409;Q13409-6;Q13409-5;E7EQL5;E7EV09;E9PGG1;E7EUM4;E7ERR6;E7ERH4;E7ET01;E7ETL8;E7EQU2;E7ESD3;E7EMU4;E7EU01Q13409-3;Q13409-7;Q13409-2;Q13409;Q13409-6;Q13409-5;E7EQL5;E7EV09Cytoplasmic dynein 1 intermediate chain 2DYNC1I2 7 7 612 0 56.639 1.5764 0.86979 8.65E+08
Q8NFW8;Q8NFW8-2;F5GYM0;F5H296Q8NFW8;Q8NFW8-2N-acylneuraminate cytidylyltransferaseCMAS 19 19 434 0 98.956 1.5763 0.54575 5.74E+09
Q8IWS0-5;Q8IWS0;A0A0D9SGE8;Q8IWS0-3;Q5JRC6;Q8IWS0-4;Q8IWS0-2Q8IWS0-5;Q8IWS0;A0A0D9SGE8;Q8IWS0-3;Q5JRC6;Q8IWS0-4;Q8IWS0-2PHD finger protein 6PHF6 13 13 331 0 98.176 1.5744 0.72394 2.40E+09
Q86YP4-2;Q86YP4;Q86YP4-3;C9JHD7;C9JJK9;C9JVY3;V9GY85;H7C3H1;C9JMI3;C9JGN4;V9GYX5Q86YP4-2;Q86YP4;Q86YP4-3Transcriptional repressor p66-alphaGATAD2A 16 15 608 0 97.688 1.5739 0.76588 6.82E+08
I3VM54;Q9Y2K7-5;Q9Y2K7-2;Q9Y2K7;Q9Y2K7-4;Q9Y2K7-3I3VM54;Q9Y2K7-5;Q9Y2K7-2;Q9Y2K7;Q9Y2K7-4Lysine-specific demethylase 2AKDM2A 6 6 1145 0 15.625 1.5716 0.79155 2.40E+08
H0Y3N9;Q9UPP1-2;Q9UPP1;Q9UPP1-5;Q9UPP1-4;Q9UPP1-3;H0Y589;H0Y7M8;H7BZB7H0Y3N9;Q9UPP1-2;Q9UPP1;Q9UPP1-5;Q9UPP1-4;Q9UPP1-3 0Y589Histone lysine demethylase PHFPHF8 6 5 953 0 32.188 1.5671 0.60446 3.00E+08
Q9NSV4;Q9NSV4-6;Q9NSV4-5;Q9NSV4-4;Q9NSV4-7;Q9NSV4-1;Q9NSV4-2Q9NSV4;Q9NSV4-6;Q9NSV4-5;Q9NSV4-4;Q9NSV4-7;Q9NSV4-1;Q9NSV4-2Protein diaphanous homolog 3DIAPH3 24 24 1193 0 180.46 1.5668 0.76986 7.51E+08
P52732 P52732 Kinesin-like protein KIF11KIF11 33 33 1056 0 262.99 1.5658 0.56616 3.42E+09
Q9UNI6;V9GYV5;V9GY92Q9UNI6 Dual specificity protein phosphatase 12DUSP12 4 4 340 0 13.051 1.5644 0.69765 2.70E+08
M0QXA7;O95785-3;B9EGQ5;O95785-4;O95785;O95785-2M0QXA7;O95785-3;B9EGQ5;O95785-4;O95785;O95785-2Protein Wiz WIZ 4 4 968 0 79.117 1.5643 NaN 7.56E+07
Q9NP77;Q9NP77-2Q9NP77;Q9NP77-2RNA polymerase II subunit A C-terminal domain phosphatase SSU72SSU72 7 7 194 0 34.406 1.5639 0.59556 1.05E+09
A6NKD9;G3V5D5;G3V2D7;H0YJE0A6NK 9 Coiled-coil domain-containing protein 85CCCDC85C 3 3 419 0 20.795 1.5576 0.70474 3.31E+07
Q14149 Q14149 MORC family CW-type zinc finger protein 3MORC3 4 4 939 0 21.086 1.5541 0.95962 9.73E+07
P35658-2;P35658-4;P35658;P35658-3;P35658-5;A0A0A0MSW3;H0Y837;H0YF36;B7ZAV2;E9PKD2P35658-2;P35658-4;P35658;P35658-3;P35658-5;A0A0A0MSW3Nuclear pore complex protein Nup214NUP214 22 22 2079 0 323.31 1.5528 0.58982 1.93E+09
Q9ULV4;Q9ULV4-2;Q9ULV4-3;B4E3S0;H0YHL7;F8VV53;F8W1H8;F8VUX3;F8VSA4;F8VRE9;F8VTT6;F8VVB7Q9ULV4;Q9ULV4-2;Q9ULV4-3;B4E3S0;H0YHL7Coronin-1C;CoroninCORO1C 19 19 474 0 205.19 1.5509 0.86896 3.40E+09
Q15293;Q15293-2;E9PP27Q15293;Q15293-2Reticulocalbin-1 RCN1 11 11 331 0 145.49 1.55 0.65809 2.03E+09
E9PDR5;E7EPI0;Q9P2D0-2;Q9P2D0;D6R9F4E9P R5;E7E I0;Q9P2D0-2;Q9P2D0Inhibitor of Bruton tyrosine kinaseIBTK 3 3 1152 0 5.4257 1.5498 0.98936 7.72E+07
O94927;U3KQJ5;U3KQG4;O94927-2O94927 U3KQJ5;U3KQG4;O94927-2HAUS augmin-like complex subunit 5HAUS5 2 2 633 0.0023077 2.817 1.5492 NaN 6.02E+06
G5E9A6;P51784 G5E9A6;P51784 Ubiquitin carboxyl-terminal hydrolase;Ubiquitin carboxyl-terminal hydrolase 11USP11 8 6 920 0 21.987 1.5479 0.80164 4.70E+08
P52272-2;P52272;A0A087X0X3;M0QZM1;M0R019;M0R2T0;M0R0N3;M0QYQ7;M0R2I7;M0R0Y6;M0QY96;M0QYL3P52272-2;P52272;A0A087X0X3;M0QZM1Heterogeneous nuclear ribonucleoprotein MHNRNP 51 51 691 0 323.31 1.5461 0.70408 3.80E+10
P53803 P53803 DNA-directed RNA polymerases I, II, and III subunit RPABC4POLR2K 2 2 58 0.0070818 2.1267 1.546 0.54193 6.49E+08
P49841-2;P49841P49841-2;P49841Glycogen synthase kinase-3 betaGSK3B 4 3 433 0 22.838 1.5451 0.81898 3.82E+08
B4DZS0;O76075;J3KT26;O76075-2B4DZS0;O76075 DNA fragmentation factor subunit betaDFFB 5 5 362 0 39.012 1.543 0.67019 6.40E+08
O75146-2;O75146O75146-2;O75146Huntingtin-interacting protein 1-related proteinHIP1R 2 2 615 0 24.411 1.5425 NaN 2.17E+07
P15924;P15924-3;P15924-2P15924;P15924-3;P15924-2Desmoplakin DSP 45 45 2871 0 323.31 1.5409 0.50328 1.92E+09
F5H5V4;F5GX23;J3KN29;O00233-2;O00233;F5H7X1;F5H169;O00233-3F5H5V4;F5GX23;J3KN29;O00233-2;O00233;F5H7X126S proteasome non-ATPase regulatory subunit 9PSMD9 5 5 153 0 18.956 1.5396 NaN 9.95E+07
Q14258 Q14258 E3 ubiquitin/ISG15 ligase TRIM25TRIM25 20 20 630 0 108.22 1.5395 NaN 2.30E+09
Q96A65;Q96A65-2Q96A65 Exocyst complex component 4EXOC4 32 32 974 0 197.34 1.5376 0.55734 3.70E+09
O43683-2;O43683-3;O43683;C9JRC7;C9JQA4O4368 -2;O43683-3;O43683Mitotic checkpoint serine/threonine-protein kinase BUB1BUB1 9 9 1028 0 46.761 1.5346 0.40607 3.71E+08
I6L9J0;F8W8M9;B1AM27;O14795;O14795-2;F8VZH8;F8W0P6;H7BXE5;F8W059;Q9UPW8;Q8NB66I6L9J0;F8W8M9;B1AM27;O14795;O14795-2 F8VZH8 P6 H7BXE5;F8W059;Q9UPW8;Q8NB66Protein unc-13 homolog B;Protein unc-13 homolog A;Protein unc-13 homolog CUNC13 UNC13A;UNC13C 2 2 1197 0 10.098 1.5322 NaN 2.88E+07
A0A0A0MQR2;Q9BY42;A2A2L5;A2A2L6A0A0 0MQR2;Q9BY42;A2A2L5Protein RTF2 homologRTFDC1 7 7 336 0 30.349 1.5312 0.50829 1.97E+08
Q8N3F8;B0QY91;H0Y6J8Q8N3F8;B0QY91;H0Y6J8MICAL-like protein 1MICALL1 3 3 863 0 4.4802 1.5304 NaN 7.60E+07
A0A087WTZ0;Q8NCE2-3;Q8NCE2-2;Q8NCE2;C9JR61;B4DJ23;C9JSR1A0A087WTZ0;Q8NCE2-3;Q8NCE2-2;Q8NCE2;C9J 61;B4DJ23;C9JSR1Myotubularin-related protein 14MTMR14 2 2 520 0 3.8221 1.5303 NaN 3.84E+07
164
Q93034;H0YCA0 Q93034 Cullin-5 CUL5 17 17 780 0 158.23 1.5294 0.69971 1.43E+09
Q9P0U4;Q9P0U4-2;K7EQ21;K7EKZ6Q9P0U4;Q9P0U4-2;K7EQ21CXXC-type zinc finger protein 1CXXC1 4 4 656 0 25.374 1.5293 0.41679 5.13E+07
P33981-2;P33981;D6RF82;D6REX1;D6RIC6;D6RFY1P33981-2;P33981Dual specificity protein kinase TTKTTK 16 16 856 0 143.08 1.5282 0.82929 1.67E+09
A0A087WXM6;J3QQT2;J3KRX5;A0A0A6YYL6;P18621;P18621-3;J3QLC8;A0A0A0MRF8;P18621-2;J3KRB3;A0A087WWH0;J3QS96;A0A087WY81;J3KSJ0A0A087WXM6;J3QQT2;J3KRX5;A0A0A6YYL6;P18621;P18621-3;J3QLC8;A0A0A0MRF8;P18621-2;J3KRB3;A0A087WWH0;J3QS9660S ribosomal protein L17RPL17 15 15 169 0 137.61 1.5273 0.28844 1.03E+10
C9JRD2;C9JXB9;P25686-2;P25686;C9J1G2;E7ETU0;C9JX00C9JRD2;C9JXB9;P25686-2;P25686;C9J1G2;E7ETU0;C9JX00DnaJ homolog subfamily B member 2DNAJB 4 3 228 0 6.9573 1.5263 NaN 6.91E+07
Q96BT7;Q96BT7-4;C9JQN2;Q96BT7-3;Q96BT7-2Q96BT7;Q96BT7-4Alkylated DNA repair protein alkB homolog 8ALKBH8 3 3 664 0 9.091 1.5261 NaN 7.66E+07
Q15773;F5H0Y3;F5H7L5;F5H800Q15773 Myeloid leukemia factor 2MLF2 10 10 248 0 120.75 1.5246 0.45449 2.11E+09
O14530;O14530-2;B8ZZX4;F8WCJ3;F8WBV5;G3XAJ4O14530;O14530-2;B8ZZX4;F8WC 3Thioredoxin domain-containing protein 9TXNDC9 9 9 226 0 70.935 1.5243 0.61319 1.87E+09
Q6P1N0;Q6P1N0-2;K7EJY5;K7EMP1Q6P1N0;Q6P1N0-2Coiled-coil and C2 domain-containing protein 1ACC2D1A 14 14 951 0 66.52 1.5234 0.53084 9.87E+08
P41223;P41223-2;C9JNV2;F8WCN7;C9JCD9P41223;P41223-2 NV2Protein BUD31 homologBUD31 3 3 144 0 8.9576 1.5219 0.71204 1.68E+08
Q96HS1;Q96HS1-2;F5GXG4Q96HS1;Q96HS1-2Serine/threonine-protein phosphatase PGAM5, mitochondrialPGAM5 21 21 289 0 105.02 1.5217 0.75478 2.61E+09
Q9H089;H7C2X7;F8WFC6Q9H089 Large subunit GTPase 1 homologLSG 5 5 658 0 22.744 1.5206 0.81826 4.74E+08
Q96JC1-2;Q96JC1Q96JC1-2;Q96JC1Vam6/Vps39-like proteinVPS39 6 6 875 0 19.967 1.5201 0.60725 3.99E+08
O00165;O00165-2;O00165-5;O00165-3;E9PIQ7;Q5VYD6;O00165-4;O00165-6O00165;O00165-2;O00165-5;O00165-3;E9PIQ7;Q5VYD6HCLS1-associated protein X-1HAX1 14 14 279 0 147.91 1.518 0.57667 3.05E+09
P61247;E9PFI5;D6RG13;D6RAT0;H0Y8L7;H0Y9Y4;D6RB09;D6RAS7;D6R9B6;D6RI02;D6RED7;D6RGE0P61247;E9PFI5;D6RG13;D6RAT0;H0Y8L7;H0Y9Y4; 6RB0940S ribosomal protein S3aPS3A 27 27 264 0 323.31 1.518 0.68046 1.47E+10
Q9C0J8;C9J8B4 Q9C0J8 pre-mRNA 3 end processing protein WDR33WDR33 4 4 1336 0 27.863 1.5175 0.90258 2.40E+08
P62877 P62877 E3 ubiquitin-protein ligase RBX1;E3 ubiquitin-protein ligase RBX1, N-terminally processedRBX1 3 3 108 0 20.762 1.5173 0.22496 5.97E+07
Q6PHR2-3;Q6PHR2;Q6PHR2-4;Q6PHR2-2;H3BPN6;H3BT78;H3BP85Q6PHR2-3;Q6PHR2;Q6P R2-4Serine/threonine-protein kinase ULK3ULK3 14 14 470 0 54.277 1.5169 0.62633 1.03E+09
E9PFK9;Q9UJ41-2;Q9UJ41-4;Q9UJ41-3;Q9UJ41;Q3HKR1;A0A0A0MSJ3;V9GYI8;E9PHB8E9PFK9;Q9UJ41-2;Q9UJ41- ;Q9UJ41-3;Q9UJ41;Q3HKR1Rab5 GDP/GTP exchange factorRABGEF1 5 5 504 0 14.042 1.5159 NaN 2.12E+08
O76041-2 O76041-2 2 2 270 0 5.4112 1.5146 NaN 3.18E+07
Q9BUH6 Q9BUH6 Uncharacterized protein C9orf142C9orf142 6 6 204 0 21.983 1.5112 0.47218 1.96E+08
O76031;H0YM48;H0YK07O76031 ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrialCLPX 24 24 633 0 283.17 1.5068 NaN 2.37E+09
Q96QF0-8;Q96QF0-2;Q96QF0;H3BNG1;F8VTR6;H0YI02;J3KPG1;Q96QF0-5;Q96QF0-7;Q96QF0-6;Q96QF0-3;Q96QF0-4Q96 F0-8;Q96QF0-2;Q96QF0; 3BNG1;F8VTR6;H0YI02;J3KPG1;Q96 F0-5;Q96 F0-7;Q96 F0-6;Q96QF0-3;Q96QF0-4Rab-3A-interacting proteinRAB3I 2 2 254 0 3.8302 1.504 NaN 3.22E+07
P46939-4;P46939;P46939-2;Q5T097;P46939-3;H0Y337P46939-4;P4693 ;P46939-2;Q5T097;P46939-3Utrophin UTRN 10 10 1347 0 55.923 1.5027 0.70067 3.62E+08
P20585 P20585 DNA mismatch repair protein Msh3MSH3 21 21 1137 0 278.01 1.4986 0.56253 2.16E+09
O14733;O14733-4;O14733-3;O14733-2O14733;O14733-4;O14733-3;O14733-2Dual specificity mitogen-activated protein kinase kinase 7MAP2K7 8 8 419 0 27.443 1.4971 0.6288 1.12E+09
P17028;P17028-2;K7EQP8;K7EPZ8;K7EPL1P1 028;P1 028-2;K7EQP8;K7EPZ8;K7EPL1Zinc finger protein 24ZNF24 8 8 368 0 31.609 1.4965 0.57749 3.91E+08
Q15185-4;Q15185;A0A087WYT3;Q15185-3;B4DDC6;Q15185-2Q15185-4;Q15185;A0A087WYT3;Q15185-3;B4DDC6Prostaglandin E synthase PTGES3 9 9 139 0 182.45 1.4942 0.59716 6.52E+08
O00411;K7EMH3;K7ESD1O0041 DNA-directed RNA polymerase, mitochondrialPOLRMT 34 34 1230 0 284.9 1.4903 0.63451 5.81E+09
O60870-2;O60870O60870-2;O60870DNA/RNA-binding protein KIN17KIN 2 2 374 0 4.5718 1.4894 NaN 3.35E+07
O15305;H3BV55;H3BRM0;H3BPH4;O15305-2;H3BR08;H3BM92;H3BV34;H3BT06;H3BNY9;Q92871O15305; 3 V55;H3BRM0;H3BPH4Phosphomannomutase 2;PhosphomannomutasePMM2 14 14 246 0 65.687 1.4885 0.45691 1.96E+09
Q5THJ4-2;Q5THJ4;H3BLS7Q5THJ4-2;Q5THJ4;H3BLS7Vacuolar protein sorting-associated protein 13DVPS13D 7 7 4363 0 35.266 1.4877 1.366 1.94E+08
Q9NVV4-2;Q9NVV4;Q5T851;Q5T852;A0A087WYC0;A0A0C4DGS5;Q08379-2;Q08379Q9NVV4-2; 9NVV4Poly(A) RNA polymerase, mitochondrialMTPAP 9 9 712 0 56.376 1.4857 NaN 6.91E+08
Q9H8V3-2;Q9H8V3-4;Q9H8V3;Q9H8V3-3;H7C3G1;C9JDB4Q9H8V3-2;Q9H8V3-4;Q9H8V3;Q9H8V3-3Protein E T2 ECT2 5 5 882 0 19.798 1.4845 0.59608 2.04E+08
Q9BTE7;H0YCN4;E9PM04;E9PQV9;H0Y9C5;E9PLH8;E9PM78;H0YD80;E9PLS2;H0Y907;Q92564-2;Q92564;Q92564-3Q9BTE7 H0YCN4;E9PM04;E9PQV9DCN1-like protein 5;DCN1-like proteinDCUN1D5 6 6 237 0 22.438 1.48 0.6848 4.62E+08
Q6UWE0;Q6UWE0-2;Q6UWE0-3Q6UWE0;Q6UWE0-2;Q6UWE0-3E3 ubiquitin protein ligase LRSAM1LRSAM1 12 12 723 0 93.265 1.4798 0.96575 1.07E+09
Q9H3S7 Q9H3S7 Tyrosine-protein phosphatase non-receptor type 23PTPN23 4 4 1636 0 8.329 1.4749 0.78398 1.01E+08
P20042 P20042 Eukaryotic translation initiation factor 2 subunit 2EIF2S2 22 22 333 0 258.88 1.4734 0.5746 8.40E+09
K7ERD7;O95707;K7ESH8;K7EK50;A0A0A0MQS4;K7EQV2K7ERD7;O957 7 Ribonuclease P protein subunit p29POP4 3 3 181 0 8.5684 1.4731 NaN 1.41E+08
A0A087WV66;P46013;P46013-2A0A087WV66;P46013;P46013-2Antigen KI-67 MKI67 10 10 3255 0 65.028 1.4726 0.98144 2.10E+08
Q8WVM0 Q8WVM0 Dimethyladenosine transferase 1, mitochondrialTFB1M 9 9 346 0 32.576 1.4711 0.64272 1.65E+09
O94817 O94817 Ubiquitin-like protein ATG12ATG12 2 2 140 0 3.7102 1.4707 1.2225 4.26E+09
Q6IQ32 Q6IQ32 ADNP homeobox protein 2ADNP2 2 2 1131 0 10.535 1.4703 0.59168 8.95E+07
Q96G61;Q8NFP7 Q96G61;Q8NFP7 Diphosphoinositol polyphosphate phosphohydrolase 3-beta;Diphosphoinositol polyphosphate phosphohydrolase 3-alphaNUDT11;NUDT10 7 6 164 0 24.066 1.47 0.53491 6.26E+08
G3V5T9;P24941;P24941-2;E7ESI2;G3V317;Q00526;K7EJ83G3V5T9;P24941 P24941-2;E7ESI2Cyclin-dependent kinase 2CDK2 15 13 346 0 89.871 1.4654 0.30548 3.31E+09
P62269;A0A0G2JQH2;Q5GGW2;J3JS69P6 269 40S ribosomal protein S18RPS18 23 23 152 0 91.464 1.4639 0.55371 2.70E+10
P24468-3;P24468-2;P24468;H3BTC2P 4468-3;P24468-2;P24468COUP transcription factor 2NR2F2 9 4 261 0 88.642 1.4629 0.67886 1.46E+09
Q7L2H7;Q7L2H7-2;J3KNJ2;H0YCQ8;E9PN86;E9PRY0;E7ESM3;E9PRI2Q7L2H7;Q7L2H7-2;J3KNJ2Eukaryotic translation initiation factor 3 subunit MEIF3 22 22 374 0 300.31 1.4613 0.75614 1.37E+10
Q96BW9-3;Q96BW9;Q96BW9-2;A0A0G2JQ92;H7C1A2;B4E101Q 6BW9-3;Q96BW9;Q96BW9-2Phosphatidate cytidylyltransferase, mitochondrialTAMM41 9 9 337 0 82.782 1.4608 0.60754 1.15E+09
O95235-2;O95235;D6R9E4;D6RBN1O95235-2;O95235Kinesin-like protein KIF20AKIF20A 3 3 872 0 37.884 1.46 0.93022 1.84E+08
Q68EM7-5;Q68EM7-2;Q68EM7-6;Q68EM7;Q68EM7-4;C9IZD3;Q68EM7-3;I3L4P0;I3L4P6;I3L1S9;J3KRS3;I3L460;F5H6L3;E7ERK8;Q68EM7-7;Q17R89-2;Q17R89-3;Q17R89Q68EM7-5;Q68EM7-2;Q68EM7-6;Q68EM7Rho GTPase-activating protein 17ARHGAP17 13 1 867 0 50.86 1.4581 0.71397 9.79E+08
Q9P2R7-2;Q9P2R7;Q5T9Q5;A0A0U1RQF8;A0A0U1RQL1;Q5T9Q8;A0A0U1RRI1;A0A0U1RQU7Q9P2R7-2;Q9P2R7; 5T9Q5Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrialSUCLA2 9 19 441 0 87.607 1.4569 0.66104 3.11E+09
Q96FC9-4;Q96FC9-3;Q96FC9-2;A8MPP1;Q92771;Q96FC9;H0YFY8;H0YGL4;F5GXJ8;F6WZM0;F5H235;C9K0E8;B4DMS8;R4GNE1;F5GYY1;F5GXL6;Q96FC9-5Q96FC9-4;Q96FC9-3;Q96FC9-2;A8MPP1;Q92771;Q96FC9Probable ATP-dependent RNA helicase DDX11;Putative ATP-dependent RNA helicase DDX11-like protein 8;Putative ATP-dependent RNA helicase DDX12DDX11;DDX 1L8;DDX12P 10 10 856 0 50.816 1.4563 0.749 8.54E+08
O94826 O94826 Mitochondrial import receptor subunit TOM70TOMM70A 5 5 608 0 16.987 1.4562 NaN 3.59E+08
O43663-3;O43663-2;O43663-4;O43663;H0YLA0;H0YM42;H0YL53O4366 -3;O 366 -2;O43663-4;O43663Protein regulator of cytokinesis 1PRC1 3 3 525 0 10.924 1.4547 NaN 2.76E+08
H0Y360;Q01433-5;Q01433-2;Q01433;Q01433-3;Q01433-4;E9PIJ1;E9PJF6;H0YCL9;H0YF16H0Y360;Q01433-5;Q01433-2;Q01433;Q01433-3 Q01433-4AMP deaminase 2 AMPD2 14 14 861 0 59.249 1.4543 0.62215 7.04E+08
Q9BY77;F6VRR5;F8WCX5;Q6R954Q9BY77;F VRR5;F8WCX5Polymerase delta-interacting protein 3POLDIP3 17 3 421 0 97.779 1.4539 0.66049 3.82E+09
P08708;H0YN88;A0A075B716;H0YN73;H3BNC9P08708;H0YN88;A0A075 71640S ribosomal protein S17RPS17 14 14 135 0 314.41 1.4518 0.47724 8.19E+09
Q15047-3;Q15047;E9PRF4;E9PQM8;Q15047-2;X6R732Q15047-3;Q15047;E9PRF4;E9PQM8Histone-lysine N-methyltransferase SETDB1SETDB1 8 8 1290 0 48.726 1.4517 0.75893 2.90E+08
Q9BVC3 Q9BVC3 Sister chromatid cohesion protein DCC1DSCC1 2 2 393 0 9.2087 1.4516 0.6573 2.09E+08
P40939;H0YFD6;P40939-2P40939 Trifunctional enzyme subunit alpha, mitochondrial;Long-chain enoyl-CoA hydratase;Long chain 3-hydroxyacyl-CoA dehydrogenaseHADHA 46 46 763 0 323.31 1.4509 0.6709 4.18E+10
P04792;F8WE04;C9J3N8P04792 Heat shock protein beta-1HSPB1 20 20 205 0 256.68 1.4504 0.39273 1.84E+10
A0A0G2JNH5;A0A0G2JP78;A0A0G2JPT5;O75943-3;O75943-4;O75943-2;O75943;H0Y9J8A0A0G2JNH5;A0A0G2JP78;A0A0G2JPT5;O75943-3;O75943-4;O75943-2;O75943;H0Y9J8Cell cycle checkpoint protein RAD17RAD17 4 4 505 0 22.032 1.4499 2.318 2.68E+08
D4Q8H0;Q9NYL2-2D4Q8H0;Q9NYL2-2Mitogen-activated protein kinase kinase kinase MLTpk;ZAK 7 3 455 0 50.76 1.4499 0.80914 3.91E+08
Q16543;K7EKQ2;K7EQA9;K7EL68;K7EIU0;REV__B4DFN3;REV__Q13563-3;REV__Q13563Q16543;K7EKQ2;K7EQA9Hsp90 co-chaperone Cdc37;Hsp90 co-chaperone Cdc37, N-terminally processedCD 37 28 28 378 0 188.43 1.4497 0.66564 8.81E+09
Q9H4L7;Q9H4L7-2;Q9H4L7-3;D6RAY8;F8W9M2Q9H4L7;Q9H4L7-2;Q9H4L7-3SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1SMARCAD1 14 14 1026 0 52.465 1.4491 0.70252 7.14E+08
P33992;B1AHB1;B1AHB2;B1AHA9;F8WFD7P3399 ; B1 DNA replication licensing factor MCM5MCM5 56 56 734 0 323.31 1.4473 0.68464 3.92E+10
O00487;C9JW37 O00487 26S proteasome non-ATPase regulatory subunit 14PSMD14 8 8 310 0 164.04 1.4465 0.6838 3.66E+09
O95059 O95059 Ribonuclease P protein subunit p14RPP14 6 6 124 0 36.91 1.4464 1.024 6.41E+08
E9PHI4;O94901-6;O94901-5;O94901-8;O94901;O94901-9;C9K051;H7C019;C9JK55;H7C2K3;H0Y6N5;H0Y742;O94901-2;O94901-7;O94901-3E9PHI4;O94901-6;O94901-5;O94901-8;O949 1;O949 -9;C9K051;H7C019;C9JK5 ; 7C2K3;H0Y6N5;H0Y742;O94901-2;O94901-7;O94901-3SUN domain-containing protein 1SUN1 2 2 822 0 6.9 44 1.4455 0.82485 1.23E+08
Q5T1C6;F6XC58;E9PLJ7Q5T1C6;F6XC58;E9PLJ7Acyl-coenzyme A thioesterase THEM4THEM4 4 4 240 0 24.506 1.4434 0.73028 3.93E+08
P38117;P38117-2;M0QY67P38117;P38117-2;M0QY67Electron transfer flavoprotein subunit betaETFB 15 15 255 0 60.216 1.4407 0.4159 1.56E+09
P62306;A0A0B4J254;F8W0W6P62306;A0A0B4J254;F8W0W6Small nuclear ribonucleoprotein FSNRPF 4 4 86 0 39.726 1.4406 1.0013 6.07E+08
Q01780;Q01780-2;K7EJ37Q01780;Q01780-2Exosome component 10EXOSC10 39 39 885 0 264.37 1.4393 0.74862 6.50E+09
Q6ZT12;Q6ZT12-4Q6ZT12;Q6ZT12-4E3 ubiquitin-protein ligase UBR3UBR3 3 3 1888 0 9.6061 1.4391 NaN 3.91E+07
E7ESC7;Q7L5Y9;Q7L5Y9-3;B4DQT1;B4DVN3;Q7L5Y9-2;D6RE80;D6REW7;D6RIB6;Q7L5Y9-4;D6RDW4;Q7L5Y9-5;D6RA86;D6RID6;D6R8Z3E7ESC7;Q7L5Y9;Q7L5Y9- B4DQT1;B4DVN3;Q7L5Y9-2; E80;D6REW7;D6RIB6;Q7L5Y9-4Macrophage erythroblast attacherMAEA 9 9 434 0 33.348 1.4388 0.77233 4.11E+08
P51970 P51970 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8NDUFA8 2 2 172 0 9.0935 1.4385 NaN 2.71E+07
Q8IY17-5;Q8IY17-2;Q8IY17-3;Q8IY17;Q8IY17-4;M0QYF5;M0QZK5;M0R2H4;M0R2K2Q8IY17-5;Q8IY17-2 3 Q8IY17;Q8IY17-4Neuropathy target esterasePNPLA6 4 4 1300 0 18.085 1.4356 0.4261 8.56E+07
P49407-2;P49407;E9PM35;H0YET9P4 407-2;P49407;E9PM35Beta-arrestin-1 ARRB1 7 7 410 0 30.212 1.4342 0.85418 3.58E+08
E9PHA2;Q15003;C9J470;Q15003-2;C9JZP1;H7C415E PHA2;Q15003;C9J470;Q15003-2Condensin complex subunit 2NCAPH 28 28 730 0 279.6 1.4337 0.59457 7.09E+09
B8ZZY2;P52594-2;P52594-3;P52594;P52594-4;C9J2I0B8ZZY2;P52594-2;P52594-3;P52594;P52594-4;C9J2I0Arf-GAP domain and FG repeat-containing protein 1AG 1 8 7 541 0 78.495 1.4336 0.24087 3.58E+08
Q8TC07-2;Q8TC07-3;Q8TC07;C9JA93;F8VV61Q8TC07-2;Q8TC07-3;Q8TC07TBC1 domain family member 15TBC1D15 9 9 674 0 22.314 1.4315 NaN 6.16E+08
Q01469;I6L8B7;A8MUU1Q01469 Fatty acid-binding protein, epidermalFABP5 9 9 135 0 84.572 1.4308 0.50437 2.32E+09
O15145;F8VR50;C9JZD1O15145 Actin-related protein 2/3 complex subunit 3ARPC3 7 7 178 0 96.766 1.4307 0.9386 2.76E+09
A0A087X1X7;E9PRY8;P29692-2;E9PIZ1;H0YCK7;H0YE58;H0YE72;E9PQR8;E9PQC9;E9PKH7;E9PNC8;E9PPY1;E9PJV8;E9PN56;E9PN71;E9PRL0A0A087X1X7;E9PRY8;P29692-2;E9PIZ1;H0YCK7Elongation factor 1-deltaEEF1D 18 3 631 0 193.61 1.4297 0.62168 6.39E+09
Q01518;Q5T0R5;Q5T0R4;Q5T0R3;Q5T0R2;Q5T0R1;Q5T0R7;Q5T0R601518 Adenylyl cyclase-associated protein 1CAP1 28 1 475 0 320.8 1.4277 0.55136 1.29E+10
A0A0A0MTN0;Q13617;Q13617-2;Q5T2B5;Q5T2B7A0A0A0MTN0;Q13617;Q13617-2;Q5T2B5Cullin-2 CUL2 24 24 758 0 157.12 1.4271 0.64206 3.63E+09
O15091-4;O15091-2;O15091;O15091-3O15091-4;O15091-2;O15091Mitochondrial ribonuclease P protein 3KIAA0391 4 4 488 0 14.143 1.427 NaN 1.67E+08
Q96CB9-4;Q96CB9;Q96CB9-3Q96CB9-4;Q96CB95-methylcytosine rRNA methyltransferase NSUN4NSUN4 3 3 335 0 13.814 1.4266 0.86547 1.82E+08
F8W727;P62910;D3YTB1;D3YTI8F8W727;P62910;D3YTB160S ribosomal protein L32RPL32 14 14 153 0 50.845 1.4244 0.6805 9.02E+08
P22695;H3BRG4;H3BSJ9;H3BP04;H3BUE4;H3BUI9;A0A087WVZ4P22695;H3BRG4;H3BSJ9Cytochrome b-c1 complex subunit 2, mitochondrialUQCRC2 24 24 453 0 323.31 1.4243 0.63128 3.10E+10
Q9NXV6 Q9NXV6 CDKN2A-interacting proteinCDKN2AIP 6 6 580 0 57.537 1.424 NaN 1.33E+08
Q96JH7 Q96JH7 Deubiquitinating protein VCIP135VCPIP1 10 10 1222 0 55.55 1.4235 0.80646 3.41E+08
Q8NEW0 Q8NEW0 Zinc transporter 7SLC30A7 2 2 376 0 5.7707 1.4202 1.2681 2.51E+08
B3KPJ4;A0A0A0MSI2;Q8IXK0-2;Q8IXK0-4;Q8IXK0;Q8IXK0-5;Q8IXK0-3;H7C528;Q8NDX5-2;Q8NDX5;Q8NDX5-7B3KPJ4;A0A0A0MSI2;Q8IXK0-2; 8IXK0-4; 8IXK0;Q8IXK0-5;Q8IXK0-3Polyhomeotic-like protein 2PHC2 3 3 464 0 7.9566 1.4201 1.0581 1.38E+08
P62280;M0QZC5;M0R1H5;M0R1H6P62280;M0QZC5 40S ribosomal protein S11RPS11 23 23 158 0 119.42 1.4198 0.23149 1.43E+10
Q8N7H5-3;Q8N7H5;Q8N7H5-2;B4DGJ5Q8N7H5-3;Q8N7H5;Q8N7H5-2;B4DGJ5RNA polymerase II-associated factor 1 homologPAF1 10 10 485 0 91.537 1.4197 NaN 8.08E+08
O43572;E7EMD6;J3QRM7O43572;E7EMD6 A-kinase anchor protein 10, mitochondrialAKAP10 5 5 662 0 24.44 1.4171 NaN 1.45E+08
Q9H078-2;Q9H078;H0YGM0;Q9H078-5;Q9H078-3;Q9H078-4;F5GX99;F5H7A5;F5H392Q9H078-2;Q9H078;H0YGM0;Q9H078-5;Q9H078-3;Q9H0 8-4;F5GX99Caseinolytic peptidase B protein homologCLPB 12 12 677 0 78.937 1.4165 NaN 5.77E+08
Q9BSH4 Q9BSH4 Translational activator of cytochrome c oxidase 1TACO1 14 14 297 0 158.69 1.4162 0.34228 6.35E+09
C9JNK6;O75431-2;O75431;C9JAZ1C9JNK6;O75431-2;O75431;C9JAZ1Metaxin-2 MTX2 3 3 207 0 26.201 1.4157 0.30945 1.38E+08
E7EVJ5;Q96F07-2;Q96F07;H7C229;E7EW33;A0A087WWZ1;A0A087WVE1;A0A087WTQ3;A0A087WZL7E7EVJ5;Q96F07-2;Q96F07 H7C229;E7EW33Cytoplasmic FMR1-interacting protein 2CYFIP2 35 14 1227 0 60.475 1.4156 0.5697 9.33E+08
A6NHB5;Q14202-2;Q14202;A6NHN7A6NHB5;Q14202-2;Q14202;A6NHN7Zinc finger MYM-type protein 3ZMYM3 10 8 1372 0 54.073 1.4143 0.41162 3.96E+08
Q5W0B1 Q5W0B1 RING finger protein 219RNF219 8 8 726 0 109.67 1.4142 1.0493 6.18E+08
165
Q9Y266;A0A0A0MSU9;A0A0A0MSS4Q9Y266 Nuclear migration protein nudCNUDC 27 27 331 0 178.92 1.4136 0.59776 4.03E+09
A0A087WZN1;O43837;A0A087X2E5;O43837-2;O43837-3;A0A0D9SG66A0A087WZN1;O43837;A0A087X2E5;O43837-2Isocitrate dehydrogenase [NA ] subunit beta, mitochondrialIDH3B 24 24 387 0 193.69 1.4135 0.54351 9.53E+09
A0A075B746;P82921A0A075B746;P8292128S ribosomal protein S21, mitochondrialMRP 4 4 87 0 32.243 1.4131 0.67803 1.00E+09
Q99567;J3KMX1;I3L245;I3L4K7;I3L2W3Q99567;J3KMX1 Nuclear pore complex protein Nup88NUP88 11 11 741 0 76.073 1.4127 1.1032 6.27E+08
Q9NUP7 Q9NUP7 tRNA:m(4)X modification enzyme TRM13 homologTRMT13 2 2 481 0 7.6775 1.4123 NaN 1.46E+08
Q9UNY4;Q9UNY4-2;X6RI15Q9UNY4;Q9UNY4-2Transcription termination factor 2TTF2 17 17 1162 0 127.08 1.4119 0.74271 7.17E+08
Q96G46;Q96G46-2;Q96G46-3;K7EM42;K7EJX8;K7EPA4;K7EMI3;K7ER20;K7EQU9Q96G46;Q96G46-2;Q96G46-3tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-likeDUS3L 22 22 650 0 311.07 1.4104 0.57355 4.43E+09
C9JEL3;B9A044;B8ZZ50;O60573-2;O60573;B4E1E4;B9A023;B8ZZL3C9JEL3;B9A044;B8ZZ50;O60573-2;O6 573Eukaryotic translation initiation factor 4E type 2EIF4E2 6 6 213 0 24.557 1.41 0.5031 2.29E+08
Q8IXW5-2;Q8IXW5Q8IXW5-2;Q8IXW5Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2RPAP2 3 3 584 0 8.8754 1.4081 0.38216 1.82E+08
A0A0D9SFB3;A0A0D9SG12;A0A0D9SF53;O00571;O00571-2;O15523-2;O15523;O15523-3;B4DLA0;A0A0J9YVQ7;A0A0J9YYH6;C9J081;A0A087WX09;A0A087WVZ1;C9J8G5;D6RCM4;Q9NQI0-3;Q9NQI0-2;Q9NQI0-4;Q9NQI0;H0Y960A0A0D9SFB3;A0A0D9SG12;A0A0D9SF53;O00571;O00571-2;O15523-2;O15523ATP-dependent RNA helicase DDX3X ATP-dependent RNA helicase DDX3YDDX3X;DDX3Y 41 40 640 0 323.31 1.407 0.86593 2.17E+10
P36542;P36542-2P36542;P36542-2ATP synthase subunit gamma, mitochondrialATP5C1 15 15 298 0 89.025 1.4067 0.70952 8.03E+09
A0A0A0MSK4;A0A0A0MRC4;Q86YR5-4;Q86YR5;A0A087WVF5;Q86YR5-3;Q86YR5-2A0A0A0MSK4;A0A0A0MRC4;Q86YR5-4;Q86YR5;A0A087WVF5;Q86YR5-3G-protein-signaling modulator 1GPSM1 12 12 675 0 62.757 1.4051 0.7376 8.38E+08
Q9P253 Q9P253 Vacuolar protein sorting-associated protein 18 homologVPS18 8 8 973 0 34.349 1.403 0.88425 7.32E+08
Q8IVD9 Q8IVD9 NudC domain-containing protein 3NUDCD3 5 5 361 0 21.192 1.4025 0.61913 3.89E+08
O15020-2;O15020;A4QPE4O15020-2;O15020;A4QPE4Spectrin beta chain, non-erythrocytic 2SPTBN2 8 7 2365 0 29.218 1.4022 0.7284 1.32E+08
P05198;G3V4T5;H0YJS4P05198;G3V4T5;H0YJS4Eukaryotic translation initiation factor 2 subunit 1EIF2S1 28 28 315 0 323.31 1.3997 0.7258 1.52E+10
Q8IWR0;I3L2K5;I3L323;I3L2N8;Q8IWR0-2;I3L3S2;I3L3F9;I3L1Y3;I3L282;I3L382Q8IWR0;I3L2K5 Zinc finger CCCH domain-containing protein 7AZC3H7A 17 17 971 0 71.814 1.3987 0.33291 9.19E+08
O15460-2;O15460;C9JN43;C9JIG4;C9JCP0;C9JX45;A8MXE0;E7ERI1;E7ENX0;E7EPI9O15460-2;O15460Prolyl 4-hydroxylase subunit alpha-2P4HA2 3 3 533 0 10.784 1.3984 3.3856 1.27E+08
Q99797 Q99797 Mitochondrial intermediate peptidaseMIPEP 7 7 713 0 14.81 1.3974 NaN 1.78E+08
P27540-2;P27540-3;P27540-4;P27540;A6NGV6P27540-2;P27540-3;P27540-4;P27540;A6NGV6Aryl hydrocarbon receptor nuclear translocatorARNT 4 4 774 0 25.67 1.3968 1.2609 1.39E+08
Q13625-2;Q13625;Q13625-3;Q96KQ4Q13625-2;Q13625;Q13625-3Apoptosis stimulating of p53 protein 2TP53BP2 8 8 1005 0 79.429 1.3952 0.68624 3.15E+08
Q86UK7-2;Q86UK7-3;Q86UK7;H3BQQ2Q86UK7-2;Q86UK7-3;Q86UK7;H3BQQ2Zinc finger protein 598ZNF598 10 10 896 0 47.988 1.3943 0.5833 2.10E+08
Q7RTV0 Q7RTV0 PHD finger-like domain-containing protein 5APHF5A 7 7 110 0 25.493 1.394 0.5892 8.93E+08
P18583-6;P18583-10;P18583-3;P18583-4;P18583-7;P18583;P18583-5;P18583-9;P18583-2;H7C1M2;P18583-8;J3QSZ5P 8583-6;P18583-10;P18583-3;P18583-4;P18583-7;P18583;P18583-5;P18583-9;P18583-2Protein SON SON 2 2 2108 0 50.951 1.3932 0.69792 3.65E+08
Q9Y2X9-2;Q9Y2X9Q9Y2X9-2;Q9Y2X9Zinc finger protein 281ZNF281 13 13 859 0 206.95 1.3931 0.56444 1.12E+09
C9JGR9;E7EQ49;A0A087WTQ2;Q9Y2I8-3;Q9Y2I8;Q9Y2I8-2C9JGR9;E7EQ49;A0A087WTQ2 3;Q9Y2I8;Q9Y2I8-2WD repeat-containing protein 37WDR37 3 3 209 0 24.238 1.3928 NaN 1.93E+08
Q9UBX3;Q9UBX3-2;F6RGN5;I3L1E8Q9UBX3;Q9UBX3-2;F6RGN5Mitochondrial dicarboxylate carrierSLC25A10 15 1 287 0 10.751 1.3923 0.81005 7.44E+07
P62136;P62136-2;P62136-3;E9PMD7;F5H1L6;F5H037P62136;P62136-2;P62136-3;E9PMD7Serine/threonine-protein phosphatase PP1-alpha catalytic subunit;Serine/threonine-protein phosphatasePPP1CA 24 6 330 0 320.86 1.3921 0.6755 2.36E+10
Q9UGJ1-2;Q9UGJ1;H3BPU4;H3BS59;H3BNL9Q9UGJ1-2 Q9UGJ1; PU4Gamma-tubulin complex component 4TUBGCP4 3 3 666 0 6.4184 1.3899 NaN 4.63E+07
Q9P0U3-2;Q9P0U3;F8VRZ8Q9P0U3-2;Q9P0U3Sentrin-specific protease 1SENP1 7 7 643 0 56.719 1.3886 NaN 2.81E+08
P05771-2;P05771;I3L148P05771-2;P05771Protein kinase C beta typePRKCB 5 2 673 0 26.407 1.3866 0.7741 3.57E+08
P62140;E7ETD8;C9JP48;C9J9S3P62140;E7ETD8;C9JP48Serine/threonine-protein phosphatase PP1-beta catalytic subunit;Serine/threonine-protein phosphatasePPP1CB 20 6 327 0 35.086 1.3863 0.7475 2.76E+09
C9JJN9;Q8N3P4-2;Q8N3P4-3;Q8N3P4;H7C058C9JJ 9;Q8N3P4-2;Q8N3P4-3;Q8N3P4Vacuolar protein sorting-associated protein 8 homologVPS8 6 6 1428 0 29.232 1.3854 0.61391 3.17E+08
Q3SY69;Q3SY69-3;Q3SY69-2;H0YHN9;REV__Q14005-4;REV__H0YLH9;REV__Q14005-3;REV__Q14005-2;REV__Q14005Q3SY69 Mitochondrial 10-formyltetrahydrofolate dehydrogenaseALDH1L2 32 28 923 0 248.06 1.3854 0.68776 4.39E+09
A0A0G2JKR7;P28702;P28702-3;A0A0G2JHI1A A0G2JKR7;P287 2;P28702-3Retinoic acid receptor RXR-betaRXRB 7 4 347 0 30.949 1.3852 NaN 4.08E+08
Q9H1Z4-2;Q9H1Z4;A0A087X091Q9H1Z4-2;Q H1Z4;A0A087X091WD repeat-containing protein 13WDR13 3 3 393 0 10.932 1.3838 0.9606 7.62E+07
Q7Z5K2;Q7Z5K2-2;Q7Z5K2-3;Q8WVX6Q7Z5K2;Q7Z5K2-2;Q7Z5K2-3Wings apart-like protein homologWAPAL 28 28 1190 0 246.28 1.3837 0.56345 2.33E+09
H3BM14;H3BM74;Q9Y5A7-2;Q9Y5A7;C9JRT6;F8WDB6;C9J7X7;H7C5N1;F8WDL9H3BM14;H3BM74;Q9Y5A7-2;Q9Y5A7;C9JRT6;F8WDB6NEDD8 ultimate buster 1NUB1 10 10 625 0 61.273 1.3836 0.71841 7.18E+08
Q8NBT2;Q8NBT2-2Q8NBT2;Q8NBT2-2Kinetochore protein Spc24SPC24 8 1 197 0 99.164 1.3832 0.65331 6.07E+08
Q15072 Q15072 Zinc finger protein OZFZNF146 4 4 292 0 10.029 1.3827 0.67167 1.43E+08
Q9UBE0;B3KNJ4;Q9UBE0-2;Q9UBE0-3;M0QZS6;M0QX65;M0R054;M0QYM8;M0R286;M0R375;M0QYP2Q9UBE0;B3KNJ4;Q9UBE0-2;Q9UBE0-3; 0QZS6;M0QX65SU O-activating enzyme subunit 1;SUMO-activating enzyme subunit 1, N-terminally processedSAE1 29 29 346 0 323.31 1.3819 0.67516 2.04E+10
P05783;F8VZY9;CON__H-INV:HIT000015463P05783;F8VZY9 Keratin, type I cytoskeletal 18KRT18 18 12 430 0 114.6 1.3818 0.88225 1.90E+09
Q15650;H0YLN7;H0YL91Q15650 Activating signal cointegrator 1TRIP4 6 6 581 0 53.913 1.3814 NaN 2.02E+08
J3QRS3;P19105;O14950;P24844;J3KTJ1;P24844-2J3QRS3;P19105;O14950;P24844Myosin regulatory light chain 12A;Myosin regulatory light chain 12B;Myosin regulatory light polypeptide 9MYL12A;MYL12B;MYL9 9 9 177 0 176.05 1.3797 0.73751 3.34E+09
Q6ZNB6-2;Q6ZNB6Q6ZNB6-2;Q6ZNB6NF-X1-type zinc finger protein NFXL1NFXL1 5 5 733 0 123.76 1.3762 0.67411 6.09E+08
Q9Y3A5;A0A087X020;F8WE72Q9Y3A5;A0A087X020Ribosome maturation protein SBDSSBDS 24 24 250 0 323.31 1.376 0.52916 1.39E+10
Q9BRZ2;C9JI91;Q15834;Q9BRZ2-2Q9BRZ2 E3 ubiquitin-protein ligase TRIM56TRIM56 4 4 755 0 27.081 1.3754 0.76714 7.94E+07
Q12972;Q12972-2;A0A0A0MT09;Q12972-3Q12972 Nuclear inhibitor of protein phosphatase 1;Activator of RNA decayPPP1R8 16 16 351 0 244.68 1.3727 0.66776 4.34E+09
E9PJN5;G3V2G1;G3V328;G3V4U9;A0A087WXY4;C9JQV6;D3VVH9;A0A0A0MS38;A0A087X1A8;G3V3R7;F5H211;P54252-3;P54252-4;P54252-2;P54252;G3V2G2;G3V526;G3V3T6;P54252-5;G3V3A6;D3VVP3;G3V3T0;D6R9I5;G3V4B1;G3V390;G3V3S5;G3V4F5;G3V4F4;G3V5H3;S4R399E9PJN5 2G1 G3V328;G3V4U ;A0A087WXY4;C9JQV6;D3VVH9;A0A0A0MS38;A0A087X1A8;G3V3R7;F5H211;P54252-3;P54252-4;P54252- ;P54252 2G2;G3V526;G3V3T6;P54252-5Ataxin-3 ATXN3 3 3 205 0 7. 87 1. 7 4 0.87296 .13E+08
P61201;P61201-2;B4DIH5;H0YKU5;H0YM03;H0YMC2P61201;P61201-2;B4DIH5; KU5COP9 signalosome complex subunit 2COPS2 21 21 443 0 246.07 1.3724 0.6916 5.13E+09
P53597;H7C233 P53597 Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrialSUCLG1 14 14 346 0 288.59 1.3722 0.71118 3.34E+09
B7ZAX5;Q01415-2;Q01415;H0YLL3;H0YLL8;H0YK10B7ZAX5;Q01415-2;Q01415N-acetylgalactosamine kinaseGALK2 6 6 434 0 29.107 1.3717 0.76116 4.42E+08
E7EQ01;E7EVN1;E7ETB7;E7EQ06;A0A0A0MS31;Q14790-6;Q14790-5;Q14790-8;Q14790-7;Q14790-3;Q14790-2;Q14790;Q14790-4;Q14790-9E7EQ01;E7EVN1;E7ETB7;E7EQ06;A0A0A0MS31;Q14790-6;Q14790-5;Q14790-8;Q14790-7;Q14790-3;Q14790-2;Q14790;Q14790-4;Q14790-9Caspase-8;Caspase-8 subunit p18 Caspase-8 subunit p 0CASP8 3 3 116 0 38.924 1.3716 2.7411 2.46E+08
P41091;Q2VIR3;F8W810;Q2VIR3-2;H7BZU1P41091; 2 IR3;F8W810;Q2VIR3-2Eukaryotic translation initiation factor 2 subunit 3;Putative eukaryotic translation initiation factor 2 subunit 3-like proteinEIF2S3;EIF2S3L 26 26 472 0 323.31 1.3713 0.639 2.41E+10
Q7LBC6;Q7LBC6-2;Q7LBC6-3;H0Y9V5Q7LBC6;Q7LBC6-2Lysine-specific demethylase 3BKDM3B 10 10 1761 0 150.78 1.3713 0.59294 3.68E+08
Q8NDV3-2;Q8NDV3-3;Q8NDV3Q8NDV3-2;Q8NDV3-3;Q8NDV3Structural maintenance of chromosomes protein 1BSMC1B 3 3 1161 0 4.5391 1.3708 0.78791 2.29E+07
A0A087X0R7;Q9H4L4;J3QL36;J3QRE4;A0A087WV50A0A087X0R7;Q9H4L4;J3QL36Sentrin-specific protease 3SENP3 6 6 540 0 29.119 1.3699 NaN 2.75E+08
Q86UA1;Q86UA1-2;H0YJY9Q86UA1 Pre-mRNA-processing factor 39PRPF39 12 12 669 0 48.611 1.3697 0.75048 1.01E+09
Q96HP0;K7ESB7;K7EP20Q96HP0;K7ESB7 Dedicator of cytokinesis protein 6DOCK6 7 3 2047 0 9.7591 1.3697 NaN 6.61E+07
C9JG87;Q9NYK5;Q9NYK5-2C9JG87;Q9NYK5;Q9NYK5-239S ribosomal protein L39, mitochondrialMRP 5 5 297 0 30.705 1.369 1.0722 5.17E+08
Q8IXQ5-5;Q8IXQ5-2;Q8IXQ5;H7C259Q8IXQ5-5;Q8IXQ -2;Q8IXQ5;H7C259Kelch-like protein 7KLHL7 2 2 538 0.0065966 2.1392 1.369 NaN 5.29E+07
P40937;P40937-2;C9JH72;F5H5S0;E9PEP3;F5H0U6;F5H304P4093 ;P40937-2Replication factor C subunit 5RFC5 17 17 340 0 304.03 1.368 0.68131 8.52E+09
Q9BXP5-4;Q9BXP5-2;Q9BXP5-3;Q9BXP5;Q9BXP5-5;H7C3A1;H7C1K0;H7C0U8;C9JUL9;A0A0A0MSP6Q9BXP5-4;Q9BXP5-2;Q9BXP5-3;Q9BXP5;Q9BXP5-5; 3A1Serrate RNA effector molecule homologSRRT 37 37 871 0 219.43 1.3678 0.70308 3.99E+09
A0A0D9SFK2;Q92614-3;Q92614-4;Q92614;Q92614-2;Q92614-5;H0YEV9A0A0D9SFK2;Q92614-3;Q92614- ;Q92614;Q92614-2;Q92614-5Unconventional myosin-XVIIIaMYO18A 9 9 2038 0 57.185 1.3675 2.6989 2.26E+08
Q6P587;Q6P587-2;Q6P587-3Q6P587;Q6P587-2;Q6P587-3Acylpyruvase FAHD1, mitochondrialFAHD1 8 8 224 0 101.12 1.3674 0.80348 2.09E+09
O95817;C9JFK9 O95817;C9JFK9 BAG family molecular chaperone regulator 3BAG3 4 4 575 0 14.581 1.367 1.8317 1.18E+08
O14964;O14964-2;I3L1P5;I3L1E3;I3L165;I3L2H4O14964;O14964-2Hepatocyte growth factor-regulated tyrosine kinase substrateHGS 13 13 777 0 32.628 1.3668 0.56511 4.31E+08
P56377;F6SFB5;A6NH01;H7BZG6;H0Y673;P56377-2P56377;F6SFB5 A6NH01AP-1 complex subunit sigma-2AP1S2 3 3 157 0 56.059 1.3666 0.98518 4.62E+08
E7ERS3;Q86VM9-2;Q86VM9;H3BRH3;H3BP01E7ERS3;Q86VM9-2;Q86VM9Zinc finger CCCH domain-containing protein 18ZC3H18 7 7 977 0 16.488 1.3664 2.045 7.54E+07
Q86U86-5;Q86U86-4;Q86U86-7;Q86U86-9;Q86U86-2;Q86U86-8;Q86U86;Q86U86-3;E7EVG2;H0Y5B5;Q86U86-6;C9JPI5Q86U -5;Q86U -4;Q86U -7;Q86U -9;Q86U -2;Q86U86-8;Q86U86;Q86U86-3;E7EVG2;H0Y5B5;Q86U86-6Protein polybromo-1PBRM1 14 14 1 82 0 140.61 1.3657 1.1158 5.98E+08
B4E1Q4;O14730-2;O14730;J3QQL5B4E1Q4;O14730-2;O14730Serine/threonine-protein kinase RIO3RIOK3 5 5 503 0 20.988 1.3653 NaN 2.59E+08
P41227;P41227-2;F8W808;A8MWP7;C9JN83;C9JW55;Q9BSU3;H0Y8T0P41227;P41227-2;F8W808;A8M P7N-alpha-acetyltransferase 10NAA10 12 12 235 0 188.1 1.3646 0.67754 1.19E+09
J3KNL6;O15027;O15027-5;F1T0I1;O15027-2;O15027-4;O15027-3;X6RGP5;A0A0C4DH09;Q8N9G1J3KNL6;O15027; 15027-5;F1T0I1;O15027-2;O15027-4;O15027-3;X6RGP5;A0A0C4DH09Protein transport protein Sec16ASEC16A 15 15 2357 0 106.84 1.3644 0.75442 1.03E+09
Q9HB21;Q5RGS4;Q9HB21-2;Q5RGS4;Q9HB21-2Pleckstrin homology domain-containing family A member 1PLEKHA1 3 3 404 0 9.3434 1.3644 0.49427 5.72E+07
P50402;Q5HY57;F8WEQ1P50402;Q5HY57 Emerin EMD 17 17 254 0 144.01 1.3639 0.637 4.06E+09
Q8WUH6 Q8WUH6 Transmembrane protein 263TMEM263 2 2 116 0 9.9273 1.3632 0.7242 2.39E+08
Q9NV70-2;Q9NV70Q9NV70-2;Q9NV70Exocyst complex component 1EXOC1 4 4 879 0 9.1863 1.3624 0.85467 8.55E+07
P40938;P40938-2;A0A087X270P4 93 ;P40938-2Replication factor C subunit 3RFC3 14 14 356 0 145.79 1.3621 0.4821 2.28E+09
Q15056-2;Q15056Q15056-2;Q15056Eukaryotic translation initiation factor 4HEIF4H 10 10 228 0 197.31 1.3591 0.53263 4.50E+09
Q96IZ6;F8WAS9;A0A087WW35;Q96IZ6-2;H7C552Q96IZ6 Methyltransferase-like protein 2AMETTL2A 6 1 378 0 45.433 1.3587 1.0131 3.37E+08
Q92783-2;Q92783;A6NMU3Q92783-2;Q92783Signal transducing adapter molecule 1STAM 5 4 403 0 32.814 1.3584 NaN 1.34E+08
Q13616;A0A0C4DGX4Q13616;A0A0C4DGX4Cullin-1 CUL1 41 41 776 0 323.31 1.3577 0.59821 7.35E+09
Q08J23;Q08J23-2;Q08J23-3;A0A140T9Y7Q08J23;Q08J23-2;Q08J23-3tRNA (cytosine(34)-C(5))-methyltransferaseNSUN2 44 44 767 0 323.31 1.3573 0.73763 1.97E+10
Q96I99;Q96I99-2;E9PDQ8;H0Y852Q 6I99;Q96I99-2;E9PDQ8;H0Y852Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrialSUCLG2 16 16 432 0 126.06 1.357 0.75202 3.01E+09
P19525;P19525-2;C9JZT2;F8WBH4P1 525;P19525-2Interferon-induced, double-stranded RNA-activated protein kinaseEIF2AK2 18 18 551 0 108.62 1.3551 NaN 1.71E+09
Q9NPL8;C9JU35;G3XA94;H7C5U1;F8WAU6;F8WB00;F8WC42;C9JR82Q9NPL8;C9JU35 G3X 94Complex I assembly factor TIMMDC1, mitochondrialTIMMDC1 8 8 285 0 46.829 1.3548 1.1188 4.71E+08
Q92917 Q92917 G patch domain and KOW motifs-containing proteinGP 7 7 476 0 31.909 1.3541 0.24031 3.11E+08
A0A0A0MR05;Q9BVC4;H3BM50;H3BPU5;H3BPT1;H3BN58;H3BSZ4;Q9BVC4-5;H3BR25;Q9BVC4-4;H3BR38;Q9BVC4-3;H3BQ74;I3L2E7A0A0A0MR05;Q9BVC4;H3BM50; PU5; PT1;H3BN58;H3BSZ4;Q9BVC4-5;H3BR25;Q9BVC4-Target of rapamycin complex subunit LST8MLST8 5 5 327 0 35.72 1.354 0.55318 2.39E+08
H3BLZ8;Q92841;Q92841-1;Q92841-3;Q92841-2;A0A0U1RQJ0H3BLZ8;Q92841;Q92841-1;Q92841-3;Q92841-2Probable ATP-dependent RNA helicase DDX17DDX17 41 33 731 0 323.31 1.3535 0.70289 3.57E+10
Q32P41 Q32P41 tRNA (guanine(37)-N1)-methyltransferaseTRMT5 7 7 509 0 56.991 1.3522 1.8566 2.34E+08
Q9NW08;Q9NW08-2;F8VRU2Q9NW08;Q9NW08-2DNA-directed RNA polymerase III subunit RPC2POLR3B 24 24 1133 0 99.987 1.3512 0.82959 1.98E+09
P46779;H0YKD8;P46779-2;P46779-3;H0YMF4;P46779-4;P46779-5;H0YLP6P46779;H0YKD8;P46779-2;P46779-3;H0YMF4;P46779-4;P46779-560S ribosomal protein L28RPL28 15 15 137 0 45.712 1.3502 0.60895 3.57E+09
Q8NG08;F5H1I4;Q8NG08-2Q8NG08;F5H1I4 DNA helicase B HELB 3 3 1087 0 6.9167 1.3489 NaN 7.03E+07
A6NFX8;Q9UKK9;A6NJU6;A6NCQ0;C9JYY9;H0YEY4FX8;Q9UKK9;A6NJU6;A6NCQ0DP-sugar pyrophosphataseNUDT5 11 11 232 0 49.944 1.3487 0.53877 1.80E+09
Q9UHD1;Q9UHD1-2;E9PPQ5;E9PIZ4;E9PSD5;E9PHZ2;E9PL00;E9PIF7Q9UHD1;Q9UHD1-2;E9PPQ5Cysteine and histidine-rich domain-containing protein 1CHORDC1 12 12 332 0 80.474 1.3485 0.16602 1.56E+09
Q9Y2S0;A0A0R4J2F3;Q7Z776;A0A087X0U2;Q9Y2S0-2Q9Y2S0;A0A0R4J2F3DNA-directed RNA polymerases I and III subunit RPAC2POLR1D 5 5 133 0 55.293 1.3483 0.69463 1.18E+09
P22059;H0YCV6;H7C1R2;H7C368;H7C428;A0A0A0MSB4;Q6ZN50;Q969R2-5;Q969R2-4;Q969R2-6;Q969R2-3;Q969R2-2;Q969R2P22059 Oxysterol-binding protein 1OSBP 14 14 807 0 111.85 1.3474 0.92621 1.10E+09
P78344;D3DQV9;P78344-2;H0Y3P2;H0YCH5;H0YD77;E9PKF8;H0YEC5;H0YE22;H0YCF8;H0YD99;H0YEN8;H0YDC0;H0YEI7;H0YE44;D3DQV9;P78344-2; 0Y3P2Eukaryotic translation initiation factor 4 gamma 2EIF4G2 45 45 907 0 323.31 1.3471 0.64377 1.93E+10
S4R3N1;Q9Y3A3-2;Q9Y3A3-3;Q9Y3A3;B4DM50S4R3N1;Q9Y3A3-2;Q9Y3A3-3;Q9Y3A3;B4DM50MOB-like protein phoceinHSPE1- OB4;MOB4 4 4 261 0 21.717 1.3471 NaN 7.52E+07
A0A087WY55;Q9NP79;Q5TGM0;Q9NP79-2A0A087WY55;Q9NP79;Q5TGM0;Q9NP79-2Vacuolar protein sorting-associated protein VTA1 homologVTA1 8 8 280 0 203.06 1.347 0.69491 2.63E+09
P62841;K7EM56;A0A0B4J2B4;S4R417;K7EQJ5;K7ELC2;K7EJ78;S4R456P62841;K7EM56;A0A0B4J2B4;S4R417;K7EQJ5;K7ELC2;K7EJ78;S4R4564 S ribosomal protein S15RPS15 7 7 145 0 60.13 1.3463 0.55263 7.09E+08
Q9NX20;E9PI14 Q9NX20 39S ribosomal protein L16, mitochondrialMRP 9 9 251 0 74.227 1.3463 0.34512 1.28E+09
Q6NUQ1;C9J5S3 Q6NUQ1 RAD50-interacting protein 1RINT1 6 6 792 0 31.189 1.346 0.74842 3.48E+08
O00139-2;O00139-1;O00139-5;O00139;O00139-4;D6R9M0;H0Y8H2;H0Y5Z9O00139-2;O00139-1;O00139-5;O00139;O00139-4Kinesin-like protein KIF2AKIF2A 23 22 660 0 115.12 1.345 0.65706 3.40E+09
166
G3V4S6;G3V433;G3V3R1;P49757-8;P49757-7;P49757-6;P49757-5;P49757-4;P49757-2;P49757-3;P497573 4S6;G3V433;G3V3R1;P49757-8;P49757-7;P49757-6;P 9757- ;P49757-4;P49757-2;P49757-3;P49757Protein numb homologNUMB 1 1 67 0 4.0785 1.3447 NaN 1.20E+07
Q9H7Z3;H0YJT0;G3V338Q9H7Z3 Protein NRDE2 homologNRDE2 10 10 1164 0 50.259 1.3443 0.8217 2.19E+08
H0YM23;O75179-7;O75179-2;O75179;O75179-6;H0YLQ3;O75179-3;O75179-4;O75179-5H0YM23;O751 9-7;O75179-2;O75179;O75179-6;H0YLQ3Ankyrin repeat domain-containing protein 17ANKRD17 25 14 2487 0 143.44 1.3437 0.76194 1.23E+09
P84095 P84095 Rho-related GTP-binding protein RhoGRHOG 5 4 191 0 39.684 1.3434 0.91812 8.52E+08
O75436;S4R3Q6;O75436-2;S4R2Y375436;S4R3Q6;O75436-2Vacuolar protein sorting-associated protein 26AVPS26A 14 13 327 0 140.71 1.3433 0.77576 5.31E+09
Q96S44;Q5JZ02 Q96S44 TP53-regulating kinaseTP53RK 7 7 253 0 78.724 1.3433 0.5819 2.49E+09
Q86V81;E9PB61 Q86V81;E9PB61 THO complex subunit 4ALYREF 6 6 257 0 162.63 1.3427 0.29044 1.80E+09
Q9H5Q4 Q9H5Q4 Dimethyladenosine transferase 2, mitochondrialTFB2M 8 8 396 0 23.026 1.3422 0.75328 3.45E+08
O00267-2;O00267;M0QYL9O00267-2;O00267Transcription elongation factor SPT5SUPT5H 36 36 1083 0 298.26 1.3421 0.82591 5.34E+09
Q8TBE9 Q8TBE9 N-acylneuraminate-9-phosphataseNANP 5 5 248 0 55.712 1.3421 0.76326 4.40E+08
Q9NVN8 Q9NVN8 Guanine nucleotide-binding protein-like 3-like proteinGNL3L 8 8 582 0 57.77 1.3394 NaN 4.56E+08
P51553;P51553-2;G5E9Q7;E7EQB8;E9PF84;H7C1W2;H0Y5Q7P51553;P51553-2;G5E9Q7;E7EQB8 E9PF84;H7C1W2Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrialIDH3G 18 18 393 0 307.48 1.3388 0.77921 4.40E+09
O75190-2 O75190-2 DnaJ homolog subfamily B member 6DNAJB6 13 1 241 0 4.4815 1.3387 NaN 7.65E+07
Q5BKZ1;A0A0A0MRN4;Q5BKZ1-3Q5BKZ1;A0A0A0MRN4;Q5BKZ1-3DBIRD complex subunit ZNF326ZNF326 7 7 582 0 30.38 1.3381 NaN 2.33E+08
Q9H832-2;Q9H832;I3L4C5;H0Y9X8;I3L3V3;I3L286Q9H832-2;Q9H832;I3L4C5Ubiquitin-conjugating enzyme E2 ZUBE2Z 7 7 246 0 22.103 1.3378 0.99658 5.90E+08
Q5VZL5-4;Q5VZL5;Q5VZL5-3;Q5VZL5-2;H7C1I7;Q5SVZ7;A6NL54;H0YH25;Q9UJ78-1;Q9UJ78-5;Q14202-3;Q9UJ78Q5VZL5-4;Q5VZL5;Q5VZL5-3;Q5VZL5-2;H7C1I7Zinc finger MYM-type protein 4ZMYM4 18 16 1516 0 150.72 1.3376 0.75883 8.73E+08
P55809;E9PDW2;P55809-2;Q9BYC2;E9PDW2 Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrialOXCT1 17 17 520 0 211.69 1.3375 0.64706 3.56E+09
P30039-2;P30039;A0A0C4DFS0;V9GY00P3 039-2;P3 039;A A0C4DFS0;V9GY00Phenazine biosynthesis-like domain-containing proteinPBLD 5 5 280 0 44.313 1.337 0.62732 2.95E+08
P17987;E7EQR6;F5H282;E7ERF2;F5GZ03;F5H136;F5H676;F5GZI8;F5H726;F5GYL4;F5H7Y1P17987;E7EQR6;F5H282;E7ERF2T-complex protein 1 subunit alphaTCP1 44 44 556 0 323.31 1.3365 0.67172 5.74E+10
E9PGT1;Q15631;H7C1D4;Q15631-2;A0A0J9YVW2E9PGT1 ;H7C1D4;Q15631-2Translin TSN 4 4 223 0 20.615 1.3364 0.77466 2.32E+08
Q5BJF2;Q86XC5;J3KT68;J3KTD1Q5BJF2;Q86XC5;J3KT68;J3KTD1Transmembrane protein 97TMEM97 2 2 176 0 8.3912 1.3356 NaN 3.54E+07
A0A0B4J1W3;Q9BXJ9;Q9BXJ9-4A0A0B4J1W3;Q9BXJ9;Q9BXJ9-4N-alpha-acetyltransferase 15, NatA auxiliary subunitNAA15 48 41 865 0 251.37 1.3347 0.67145 1.14E+10
Q12756;Q12756-3;Q12756-2;F8W8V9;H7C0K6;H7C3Y8;H7C437Q12756;Q12756-3;Q12756-2;F8W8V9Kinesin-like protein KIF1AKIF1A 31 25 1690 0 221.38 1.3343 0.66747 1.93E+09
Q9BY32;Q9BY32-3;Q9BY32-2Q9BY32;Q9BY32-3;Q9BY32-2Inosine triphosphate pyrophosphataseITPA 8 8 194 0 80.118 1.3342 0.20616 2.17E+09
Q9UG63;Q9UG63-2;C9JHK9;C9JZV3Q9UG63;Q9UG63-2ATP-binding cassette sub-family F member 2ABCF2 32 32 623 0 150.7 1.3338 0.7407 6.22E+09
Q8WXI9;A0A0U1RRM1;A0A0U1RR30;A0A0U1RRK3;A0A0U1RR34Q8WXI9; 0A0U1RRM1Transcriptional repressor p66-betaG TAD2B 16 15 593 0 94.147 1.3335 NaN 1.10E+09
P32121;P32121-3;P32121-4;P32121-5;P32121-2;I3L412;K7ENA6;Q68DZ5;K7EL17P32121;P32121-3;P32121-4;P32121-5;P32121-2;I3L412;K7ENA6Beta-arrestin ARRB2 7 7 409 0 23.213 1.3334 1.027 3.89E+08
V9GY48;Q8N5A5-3;Q8N5A5-2;Q8N5A5;Q8N5A5-4;A0A087WT57;A0A0J9YYD9V9GY48;Q8N5A5-3;Q8N5A5-2;Q8N5A5;Q8N A5-4Zinc finger CCCH-type with G patch domain-containing proteinZGPAT 6 6 417 0 53.03 1.333 NaN 1.04E+08
O60678;A0A0A0MSN7;O60678-2O60678;A0A0A0MSN7;O60678-2Protein arginine N-methyltransferase 3PRMT3 17 17 531 0 77.485 1.3329 NaN 2.37E+09
Q9NXH9-2;Q9NXH9;K7EQQ8;K7EQU7;K7EQY6;K7EMZ2;K7ENI9;K7ERR5;K7EJX9Q9NXH9-2;Q9NXH9; Q8tRNA (guanine(26)-N(2))-dimethyltransferaseTRMT1;SEMA4B 18 18 630 0 138.18 1.3325 1.6879 1.11E+09
Q9UNM6;Q9UNM6-2;J3KNQ3;A0A087WUL9;E9PL38;H0YD73;E9PQG3;E9PPD2Q9UNM6;Q9UNM6-2;J3KNQ3;A0A087WUL9;E9PL38;H0YD7326S proteasome non-ATPase regulatory subunit 13PSMD13 19 19 376 0 135.23 1.3323 0.81089 3.70E+09
Q13045;Q13045-3;K7EQZ7;J3QQQ2;J3QLR6;J3QQU5;J3KT47Q13045;Q13045-3Protein flightless-1 homologFLII 37 2 1269 0 323.31 1.3321 0.72454 5.06E+09
Q7Z4L5;Q7Z4L5-2;H9KV93;Q8NDW8-3Q7Z4L5 Tetratricopeptide repeat protein 21BTTC21B 12 11 1316 0 146.19 1.3318 0.77174 6.93E+08
A0A0R4J2E8;A8MXP9;P43243;D6REM6;D6R991;H0Y8T4;B3KM87;P43243-2;D6RBK5;D6R8Z5;D6RCM3;D6REK4;D6RBI2;D6RE02;D6RIA2;Q68E03;D6RB45;D6R9F3;D6RAM9;D6RAY2;D6RBS2A0A0R4J E8 A8MXP9 P43243;D6REM6;D6R991atrin- ATR3 43 43 847 0 323.31 1.331 0.69992 4.71E+10
P67775;P62714;P67775-2;H0YC23;E7ESG8;E5RHC1;H0YBN9;E5RFI3;E5RHP4;E5RI56P67775;P62714;P6 775-2Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform;Serine/threonine-protein phosphatase 2A catalytic subunit beta isoformPPP2CA;PPP2CB 12 11 309 0 110.29 1.3308 0.88689 2.09E+09
Q14257;Q14257-2;H0YL43;A8MXP8Q14257;Q14257-2;H0YL43Reticulocalbin-2 RCN2 13 13 317 0 280.3 1.3308 0.62246 3.21E+09
A0A0C4DFZ9;Q58A45-2;Q58A45-3;Q58A45;Q58A45-40A0C4DFZ9;Q58A45-2;Q58A45-3;Q58A45PAB dependent poly(A)-specific ribonuclease subunit PAN3PAN3 7 7 687 0 27.637 1.3299 NaN 1.74E+08
Q96GX5-2;Q96GX5-3;Q96GX5;A0A087WUU7Q96GX5-2;Q96GX5-3;Q96GX5;A0A087WUU7Serine/threonine-protein kinase greatwallMASTL 4 4 840 0 13.804 1.3286 0.50122 3.97E+08
E7ESL0;A0A0C4DGX2;J3KQY1;Q9NWU5;Q9NWU5-2;Q9NWU5-3E7ESL0;A0A0C4DGX2;J3KQY1;Q9NWU5;Q9NWU5-2;Q9NWU5-339S ribosomal protein L22, mitochondrialMRP 6 6 212 0 30.278 1.3282 0.75217 3.07E+08
Q16186;A0A087WX59;A0A087WUX6Q16186; 0A087WX59Proteasomal ubiquitin receptor ADRM1ADRM1 9 9 407 0 38.548 1.3282 0.62678 5.12E+08
P15056;H7C5K3;H7C560P15056 Serine/threonine-protein kinase B-rafBRAF 3 3 766 0 10.725 1.328 0.9613 1.06E+08
Q96RS0 Q96RS0 Trimethylguanosine synthaseTGS1 3 3 853 0 7.5902 1.3277 0.64608 8.13E+07
Q15233;Q15233-2;H7C367;C9JYS8;C9IZL7;C9J4X2;A0A0U1RQF9Q15233;Q15233-2;H7C367Non-POU domain-containing octamer-binding proteinNONO 37 33 471 0 323.31 1.3274 0.73625 2.15E+10
Q14677;Q14677-3;Q14677-2Q14677;Q14677-3;Q14677-2Clathrin interactor 1CLINT1 11 11 625 0 125.68 1.3264 NaN 9.16E+08
Q96IX5 Q96IX5 Up-regulated during skeletal muscle growth protein 5USMG5 4 4 58 0 71.892 1.3252 1.0522 1.23E+09
Q9Y224;G3V4C6;H0YJB9;G3V4E7Q9Y224;G3V4C6;H0YJB9UPF0568 protein C14orf166 8 8 244 0 36.043 1.325 0.63205 4.59E+08
J3KRA9;Q96Q15-2;Q96Q15;Q96Q15-3;Q96Q15-4;H3BQN7;I3L144;I3L400;I3L0W2J3KRA9;Q96Q15-2;Q96Q15;Q96Q15-3;Q96Q 5-4Serine/threonine-protein kinase SMG1SMG1 14 14 3551 0 89.72 1.3245 1.1428 3.32E+08
Q8IVS2;Q8IVS2-2 Q8IVS2 Malonyl-CoA-acyl carrier protein transacylase, mitochondrialMCAT 9 9 390 0 44.104 1.3245 0.85125 8.03E+08
Q01968-2;Q01968Q01968-2;Q01968Inositol polyphosphate 5-phosphatase OCRL-1OCRL 21 21 893 0 126.78 1.3237 0.63839 3.08E+09
Q9NRY4;A2RRE5 Q9NRY4;A2RRE5 Rho GTPase-activating protein 35ARHGAP35;GRLF1 14 14 1499 0 52.625 1.3231 0.67517 5.53E+08
Q96JG6-3;Q96JG6;H7BZP1;H0Y7Q2;Q96JG6-2;C9JA29Q96JG6-3;Q96JG6;H7BZP1Coiled-coil domain-containing protein 132CCDC132 10 10 934 0 35.769 1.3224 0.82838 3.00E+08
Q9NV35 Q9NV35 Probable 8-oxo-dGTP diphosphatase NUDT15NUDT15 3 3 164 0 8.6961 1.3216 0.72232 2.15E+08
P43250-2;D6RHX8;F8W9W2;P43250-3;P43250;D6RDA3;D6RHC7;P34947P43250-2;D6RHX8;F8W9W2;P43250- ;P43250G protein-coupled receptor kinase 6GRK6 7 7 589 0 49.57 1.3214 NaN 3.20E+08
P43405-2;P43405P43405-2;P43405Tyrosine-protein kinase SYKSYK 6 6 612 0 41.331 1.3209 NaN 2.48E+08
P82933;H7BZC4 P82933 28S ribosomal protein S9, mitochondrialMRP 16 16 396 0 98.029 1.3207 0.8507 1.69E+09
P45973;F8VNY3 P45973 Chromobox protein homolog 5CBX5 13 13 191 0 88.021 1.3194 0.2031 8.21E+08
F5H345;P08397-2;P08397;P08397-4;P08397-3;F5GY90;F5H0P4;F5H226;F5H4W5;F5H4X2F5H345;P08397-2;P08397;P08397-4;P08397-3;F5GY90;F5H0P4; 226Porphobilinogen deaminaseHMBS 8 8 330 0 137.33 1.3191 0.80513 1.18E+09
Q9UL03-3;Q9UL03;B3KQH5;C9JVX2;G5E9X1Q9UL03-3 Q UL03;B3KQH5Integrator complex subunit 6INTS6 3 1 874 0 7.4391 1.3191 0.84009 1.67E+08
E7EWM3;A0A087X127;Q8NF64-3;Q8NF64-2;Q8NF64;F6WR09;Q9ULJ6-2;Q9ULJ6E7EWM3;A0A087X127;Q8NF64-3;Q8NF64-2; 8NF64;F6WR09;Q9ULJ6-2;Q9ULJ6Zinc finger MIZ domain-containing protein 2;Zinc finger MIZ domain-containing protein 1ZMIZ2;ZMIZ1 2 2 888 0 29.629 1.3185 NaN 1.76E+08
P09936;D6RE83;D6R956;D6R974;D6RF53P09936; 6RE83; 956;D6R974Ubiquitin carboxyl-terminal hydrolase isozyme L1UCHL1 12 12 223 0 151.85 1.3182 0.46032 2.79E+09
P62913 P62913 60S ribosomal protein L11RPL11 13 2 178 0 80.568 1.3179 0.66051 1.88E+10
Q7Z4H3;Q7Z4H3-2;V9GYS5;V9GZ04;Q7Z4H3-3Q7Z4H3;Q7Z4H3-2HD domain-containing protein 2HDDC2 14 14 204 0 179.17 1.3173 0.54749 4.51E+09
Q9H269;Q9H269-2;Q5JUB0;Q5JUA9Q9H269;Q9H269-2Vacuolar protein sorting-associated protein 16 homologVPS16 9 9 839 0 45.88 1.317 1.2031 8.32E+08
P17252;J3KRN5;H3BV73;M0R0I9;P05129-2;P05129P17252;J3KRN5 Protein kinase C alpha typePRKCA 10 7 672 0 50.288 1.3169 0.83516 1.47E+09
Q9UPU7-2;Q9UPU7;C9JW56;Q9UPU7-3Q9UPU7-2; 9 P 7;C9JW56TB 1 domain family member 2BTBC1D2B 8 8 914 0 61.455 1.3152 1.0921 2.84E+08
P61981 P61981 14-3-3 protein gamma;14-3-3 protein gamma, N-terminally processedYWHAG 13 8 247 0 42.848 1.3144 0.57778 9.24E+08
Q9UNQ2;A0A0C4DGB1;D6RCL3Q9UNQ2;A0A0C4DGB1;D6RCL3Probable dimethyladenosine transferaseDIMT1 14 14 313 0 76.428 1.3144 0.73764 2.07E+09
C9J494;Q9H000-2;Q9H000C9J494;Q9H000-2;Q9H000Probable E3 ubiquitin-protein ligase makorin-2MKRN2 7 7 414 0 26.671 1.314 0.55333 1.22E+09
D3DTZ5;J3QSB9;P63272D DTZ5;J3QSB9;P63272Transcription elongation factor SPT4SUPT4H1 2 2 76 0 9.8856 1.314 0.71237 5.11E+08
O75569-3;O75569-2;O75569;F8WEG8;G5E9Q4;C9JMM3O75569-3;O75569-2;O75569;F8WEG8;G5E9Q4;C9JMM3Interferon-inducible double-stranded RNA-dependent protein kinase activator APRKRA 7 7 288 0 58.382 1.3139 0.87771 2.08E+09
O75828 O75828 Carbonyl reductase [NADPH] 3CBR3 12 8 277 0 35.17 1.3138 0.67537 7.31E+08
Q9UEY8-2;A0A087WX08;Q9UEY8Q9UEY8-2;A0A087WX08;Q9UEY8Gamma-adducin ADD3 13 12 674 0 106.21 1.3138 0.7798 1.50E+09
E9PGE5;Q9NUY8-2;Q9NUY8;C9IZ32;C9JAM5E9PGE5;Q9NUY8-2;Q9NUY8;C9IZ32;C9JAM5TBC1 domain family member 23TBC1D23 2 2 562 0 5.6229 1.3132 NaN 4.76E+07
Q9NVE7;A0A0G2JR38;E9PHT6;H0YA26;H0Y9E4;H0YA31;A0A0G2JQS7;D6RJF3;H0YA02Q9NVE7;A0A0G2JR38;E9PHT6;H0YA26Pantothenate kinase 4PANK4 23 23 773 0 131.74 1.3124 0.78376 1.92E+09
Q5VUJ6-2;Q5VUJ6Q5VUJ6-2;Q5VUJ6Leucine-rich repeat and calponin homology domain-containing protein 2LRCH2 10 10 748 0 57.914 1.3123 0.85522 8.11E+08
Q9BVA0;H3BPK1;H3BT67;H3BPD8;H3BTU7;H3BTV8Q9 VA0 Katanin p80 WD40 repeat-containing subunit B1KATNB1 7 7 655 0 41.859 1.3116 NaN 1.41E+08
O43823;M0QYL4 O43823 A-kinase anchor protein 8AKAP8 7 7 692 0 42.074 1.3104 1.0996 3.02E+08
Q99661;Q99661-2;Q5JR91;Q5JR89Q99661;Q99661-2;Q5JR91Kinesin-like protein KIF2CKIF2C 12 11 725 0 131.82 1.3102 0.78635 8.58E+08
E9PK01;P29692;E9PQ49;E9PI39;P29692-4;E9PQZ1;E9PPR1;E9PL12;E9PMW7;E9PK06;E9PK72;E9PKK3;E9PNW6;E9PJD0E9PK01;P296 2;E PQ49;E9PI39;P29692-4;E9PQZ1;E9PPR1; L12;E9PMW7;E9P 06Elongation factor 1-deltaEEF1D 16 0 261 0.0018172 3.0255 1.3093 NaN 5.75E+08
Q96H79;Q96H79-2Q96H79 Zinc finger CCCH-type antiviral protein 1-likeZC3HAV1L 11 11 300 0 201.13 1.3083 0.68575 3.52E+09
Q9Y6D9-3;Q9Y6D9;C9JP81;C9JKI7;C9JPS1;C9JTA2;C9K086Q9Y6D9-3;Q9Y6D9;C9JP81Mitotic spindle assembly checkpoint protein MAD1MAD1L1 4 4 626 0 10.168 1.308 0.75103 1.35E+08
Q6P5Z2 Q6P5Z2 Serine/threonine-protein kinase N3PKN3 9 8 889 0 32.896 1.3079 0.77162 3.43E+08
Q14019;H3BT58 Q14019;H3BT58 Coactosin-like proteinCOTL1 12 12 142 0 47.484 1.3078 0.66572 4.32E+08
O95155-2;O95155;O95155-4;O95155-3;K7EP75;K7ERA7;B1AQ61O95155-2;O95155;O95155-4;O95155-3Ubiquitin conjugation factor E4 BUBE4B 17 17 1173 0 89.579 1.3076 0.63336 1.07E+09
Q9BUP3-3;Q9BUP3;E9PI87;Q9BUP3-2Q9BUP3-3;Q9BUP3;E9PI87Oxidoreductase HTATIP2HTATIP2 10 10 276 0 62.721 1.3072 0.61477 2.19E+09
J3QK89;Q8IWX8 J3QK89;Q8IWX8 Calcium homeostasis endoplasmic reticulum proteinCHERP 6 6 927 0 21.478 1.3069 0.92396 3.89E+08
G3V4K3;Q9H9C1;Q9H9C1-2G3V4K3;Q9H9C1;Q9H9C1-2Spermatogenesis-defective protein 39 homologVIPAS39 15 15 519 0 57.515 1.3058 0.80757 3.65E+08
A0A087WZZ5;Q13435;E9PPJ0;E9PJT3;E9PJ04;H0YCG1;H0YEX5;E9PIL8A0A087WZZ5;Q13435;E9PPJ0Splicing factor 3B subunit 2SF3B2 7 7 871 0 25.705 1.3053 0.94476 2.65E+08
P48735;P48735-2;H0YL11P48735;P48735-2;H0YL11Isocitrate dehydrogenase [NADP], mitochondrialIDH2 26 24 452 0 306.11 1.305 0.6082 1.22E+10
O95071-2;O95071;E7EMW7;E7ET84;H0YBB4;H0YAV7;E5RFK7O95071-2;O95071;E7EMW7E3 ubiquitin-protein ligase UBR5UB 5 44 44 2798 0 242.74 1.3031 0.7894 3.21E+09
A0A0A0MRF3;Q53GI4;Q15561-3;Q15561;H0YGS2;H0YEJ9;H0YE88;P28347-2;P28347;Q99594;Q15562;Q15562-2;Q15562-4;H0YG62;J3KP52;H0Y7B0;H0YCZ6;Q15561-2A0A0A0MRF3;Q53GI4;Q15561-3;Q15561;H0YGS2;H0YEJ9;H0YE88;P28347-2;P28347; 99 94;Q15562;Q15562-2;Q15562-4;H0YG62;J3KP52Transcriptional enhancer factor TEF- ;Transcriptional enhancer factor TEF-1;Transcriptional enhancer factor TEF-5;Transcriptional enhancer factor TEF-4T AD4;TEAD1; AD3;TEAD2 4 4 391 0 11.123 1.3028 1.2055 7.93E+07
Q8NBU5;Q8NBU5-2Q8NBU5;Q8NBU5-2ATPase family AAA domain-containing protein 1ATAD1 8 8 361 0 38.175 1.3027 0.9544 6.20E+08
E3W994;J3KR49;A0A0U1RQI6;E7ERI8;E7EW49;O75122;O75122-3;B3KR06;E7ENG2;O75122-2;C9J668;H7C4X8;H7C4I5;H7C5M8;D6RBU8;H0Y5T1;F8WA11;Q7Z460-2;Q7Z460-4;Q7Z460-5;Q7Z460-3;Q7Z460E3W994;J3KR49;A0A0U1RQI6;E7ERI8 E7EW49;O75122;O75122-3CLIP-associating protein 2CLASP2 10 10 1273 38.003 1.3 26 2.1783 3.88E+08
Q86US8 Q86US8 Telomerase-binding protein EST1ASMG6 2 2 1419 0 8.2325 1.3026 NaN 3.63E+07
C9J0I9;Q86WB0;Q86WB0-3;Q86WB0-2;F8WAU5C9J0I9;Q86WB0;Q86WB0-3;Q86WB0-2Nuclear-interacting partner of ALKZC3HC1 5 5 459 0 22.049 1.302 NaN 7.01E+08
O94874-2;O94874;O94874-3O94874-2;O94874;O94874-3E3 UFM1-protein ligase 1UFL1 21 20 729 0 215.72 1.3014 0.76667 3.79E+09
Q5T6V5;Q5T6V7;Q5T6V6Q5T6V5;Q5T6V7 UPF0553 protein C9orf64 17 17 341 0 85.215 1.3013 0.89282 6.92E+09
Q9NX74;E7EUN9;J3QLD5;H3BQX4;H3BM64;I3L4H0;I3L4Y9;H3BRI6;H3BSF3;I3L0K0;H3BMK6;H3BTR3;I3L1K5Q9NX74;E7EUN9 tRNA-dihydrouridine(20) synthase [NAD(P)+]-likeDUS2 11 11 493 0 34.923 1.3013 0.97581 4.29E+08
Q7Z2W4;C9J6P4;Q7Z2W4-2;Q7Z2W4-3;Q7Z2W4-4;H7C5K1;Q7Z2W4-5;G5E9U9;Q9H0J9;C9J6P4;Q7Z2W4-2;Q7Z2W4-3Zinc finger CCCH-type antiviral protein 1Z 3HAV1 34 34 902 0 297.89 1.3009 0.78511 5.73E+09
O00231;O00231-2;J3QRY4;J3QS13;J3KSW3O00231;O00231-2 6S proteasome non-ATPase regulatory subunit 11PSMD11 26 26 422 0 242.82 1.3008 0.71747 1.00E+10
Q9UKU7;Q9UKU7-2;Q9UKU7-3;E9PLS3Q9UK 7;Q9UKU7-2;Q9UKU7-3Isobutyryl-CoA dehydrogenase, mitochondrialACAD8 4 4 415 0 13.593 1.3007 1.0092 1.06E+08
Q5T5C7;P49591 Q5T5C7;P49591 Serine--tRNA ligase, cytoplasmicSARS 19 19 536 0 183.46 1.3006 0.83982 3.54E+09
Q9Y6D6;E5RIF2;E5RHL7Q9Y6D6;E5RIF2 Brefeldin A-inhibited guanine nucleotide-exchange protein 1ARFGEF1 7 5 1849 0 42.563 1.3002 0.83889 1.99E+08
Q9Y285;K7ER00;Q9Y285-2;K7ER16;K7EPH2;K7EK06;K7ERS0Q9Y285;K7ER00;Q9Y285-2;K7ER16;K7EPH2Phenylalanine--tRNA ligase alpha subunitF RSA 22 22 508 0 277.51 1.2996 NaN 4.84E+09
167
O75170-6;O75170-2;O75170-4;O75170-3;O75170-5;O75170O751 0-6;O751 0-2;O751 0-4;O751 0-3;O75170-5;O75170Serine/threonine-protein phosphatase 6 regulatory subunit 2PPP6R2 1 1 905 0 7.7846 1.2991 0.85333 2.73E+08
P61927;D6R9X9;D6RG19P 1927;D6R9X9;D6RG1960S ribosomal protein L37;Ribosomal protein L37RPL37 2 2 97 0 3.8026 1.2991 0.86977 2.23E+07
P62750;H7BY10;K7EJV9;K7ERT8;A8MUS3;K7EMA7P62750;H7BY10;K7EJV9;K7ERT8;A8MUS360S ribosomal protein L23aRPL2 A 13 13 156 0 45.891 1.2978 0.54714 5.55E+09
Q96EE3;Q96EE3-1;K7ELV2;K7EP88;K7ENI5;K7EPZ5Q96EE3;Q96EE3-1;K7ELV2;K7EP88Nucleoporin SEH1SEH1L 18 18 360 0 171.41 1.2977 0.78793 5.55E+09
Q96RE7;K7ENW4 Q96RE7 Nucleus accumbens-associated protein 1NACC1 3 3 527 0 13.472 1.2953 NaN 2.15E+08
H0Y6H0;Q8NB78-2;Q8NB78H0Y6H0;Q8NB78-2;Q8NB78Lysine-specific histone demethylase 1BKDM1B 2 2 640 0 9.0564 1.295 0.59173 1.41E+08
P42285;H0YAC4;D6REC7;H0Y8U3P42285 Superkiller viralicidic activity 2-like 2SKIV2L2 53 53 1042 0 323.31 1.2948 0.67184 1.44E+10
H0YN26;P39687;H7BZ09;Q92688-2;O43423;Q926880YN26;P39687;H7BZ09;Q92688-2;O43423;Q92688Acidic leucine-rich nuclear phosphoprotein 32 family member A;Acidic leucine-rich nuclear phosphoprotein 32 family member B;Acidic leucine-rich nuclear phosphoprotein 32 family member CANP 2A;ANP32B;ANP32C 2 2 177 0 5.9188 1.2941 0.85227 1.14E+08
Q92665 Q92665 28S ribosomal protein S31, mitochondrialMRP 10 10 395 0 121.91 1.2941 0.84416 1.47E+09
Q8NCN5;A8MT40;H3BQG3;B7ZAR9;Q8NCN5-2;H3BV59;H3BUH3Q8NCN5;A8MT40;H3BQG3Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrialPDPR 12 12 879 0 42.522 1.2939 0.79857 1.09E+09
Q14571;Q14571-2Q14571 Inositol 1,4,5-trisphosphate receptor type 2ITPR2 8 6 2701 0 17.622 1.2921 1.1714 1.66E+08
Q13523;H0YDJ3 Q13523;H0YDJ3 Serine/threonine-protein kinase PRP4 homologPRPF4B 9 9 1007 0 38.032 1.2903 1.0934 3.96E+08
Q14573 Q14573 Inositol 1,4,5-trisphosphate receptor type 3ITPR3 15 13 2671 0 74.002 1.2902 0.34842 4.23E+08
O00429-3;O00429;O00429-6;G8JLD5;O00429-4;O00429-5;O00429-2;O00429-8;O00429-7;F8VZ52;B4DPZ9;F8W1W3;F8VUJ9;B4DDQ3;H0YHY4;F8VR28;F8VYL3O00429-3;O00429;O0 429-6;G8JLD5;O00429-4;O00429-5;O00429-2;O00429-8;O00429-7ynamin-1 like proteinNM1L 16 16 710 0 289.11 1.2897 0.84327 9.98E+08
Q13217;X6R9L0 Q13217;X6R9L0 DnaJ homolog subfamily C member 3DNAJC3 16 16 504 0 133.14 1.2895 0.82662 2.48E+09
P78347-2;P78347-4;P78347-3;P78347;P78347-5;C9J6M0;A0A087WW90;A0A0D9SF80;A0A0A0MSY2;Q86UP8-3;Q86UP8;Q6EKJ0P78347-2;P78347- ;P78347-3;P78347General transcription factor II-IGTF2I 48 4 957 0 323.31 1.2889 0.65034 1.57E+10
Q9NXG2;H3BNW0Q9NXG2 THUMP domain-containing protein 1THUMPD1 17 17 353 0 70.096 1.2879 0.80052 1.87E+09
P55084;P55084-2;F5GZQ3;B5MD38;C9JEY0;C9JE81;C9K0M0P5 084;P5 084-2;F5GZQ3;B5MD38Trifunctional enzyme subunit beta, mitochondrial;3-ketoacyl-CoA thiolaseHADHB 28 28 474 0 323.31 1.2878 0.72066 2.68E+10
O00170;E9PMH2;V9GYQ3O00170;E9PMH2 AH receptor-interacting proteinAIP 4 4 330 0 46.193 1.2875 0.69893 1.19E+09
P52735-3;P52735-2;P52735P52735- ;P52735-2;P52735Guanine nucleotide exchange factor VAV2VAV2 8 8 839 0 39.121 1.2874 0.77795 4.53E+08
F5H6E2;O00159-2;O00159-3;O00159;I3L204;I3L4D4;I3L501;I3L3Y6;I3L168;I3L3F5F5H6E2;O00159-2;O00159-3;O00159Unconventional myosin-IcMYO1C 31 31 1039 0 203.89 1.2871 0.79327 4.46E+09
Q52LJ0;Q52LJ0-2;H0YNA1Q52LJ0;Q52LJ0-2 Protein FAM98B FAM98B 5 5 330 0 65.416 1.2869 0.80045 8.52E+08
Q13263;Q13263-2;M0R0K9;M0R3C0;M0R2I3Q13263;Q1326 -2Transcription intermediary factor 1-betaTRIM28 38 38 835 0 323.31 1.2866 0.64335 2.62E+10
P02545;P02545-3;P02545-5;P02545-4;A0A0C4DGC5P02545;P02545-3;P02545-5;P02545-4Prelamin A/C;Lamin A/CLMNA 20 2 664 0 159.18 1.2863 1.0009 8.42E+08
Q9H0R6;X6R772;Q9H0R6-2;X6R772;Q9H0R6-2Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrialQRSL1 4 4 528 0 23.878 1.2855 NaN 9.64E+07
A6NDG6;H3BV17 A6NDG6 Phosphoglycolate phosphatasePGP 11 11 321 0 102.9 1.2851 0.63327 3.98E+09
Q9UKN8;F2Z356 Q9UKN8 General transcription factor 3C polypeptide 4GTF3C4 32 32 822 0 323.31 1.2851 0.66199 4.08E+09
Q9UKG1;C9JAB0;C9K0C4;H0YH86;Q8NEU8-2;Q8NEU8;Q8NEU8-3Q9UKG1 DCC-interacting protein 13-alphaAPPL1 17 17 709 0 180.79 1.285 0.7723 1.94E+09
Q9P287;Q9P287-3Q9P287;Q9P287-3BRCA2 and CDKN1A-interacting proteinBCCIP 9 2 314 0 123.05 1.2848 0.9306 5.44E+09
O15269;O15269-2O15269 Serine palmitoyltransferase 1SPTLC1 16 16 473 0 143.68 1.2847 0.74349 2.82E+09
Q9UQE7 Q9UQE7 Structural maintenance of chromosomes protein 3SMC3 76 76 1217 0 323.31 1.2847 0.80635 1.41E+10
A0A087WYU1;Q9Y5X1A0A087WYU1;Q9Y5X1Sorting nexin-9 SNX9 13 13 594 0 167.76 1.2845 NaN 7.77E+08
A6NMQ1;P09884;A0A087WU646NMQ1;P09884;A0A087WU64DN  polymerase;DNA polymerase alpha catalytic subunitPOLA1 25 25 1468 0 237.04 1.2844 0.71547 3.34E+09
Q5T9B7;P00568;H0YID2;H0Y4J6;Q9Y6K8-2;Q9Y6K8-3;Q9Y6K8Q5T9B7;P005 8;H0YID2;H0Y4J6Adenylate kinase isoenzyme 1AK1 7 7 210 0 22.81 1.2841 0.5703 8.11E+08
A0A087WYN9;Q7Z478;H0Y8L1A0A087WYN9;Q7Z478ATP-dependent RNA helicase DHX29DHX29 41 41 1370 0 323.31 1.2826 0.75786 3.04E+09
E7EMB1;Q9UH65;E9PJK8;E9PJM77EMB1;Q9UH65 Switch-associated protein 70SWAP70 5 5 527 0 16.484 1.2824 NaN 1.53E+08
A0A087WUB9;Q8WYA6-4;Q8WYA6;Q8WYA6-3;Q8WYA6-2;A2A2P1A0A087WUB9;Q8WYA6-4;Q8WYA6;Q8WYA6-3;Q8WYA6-2Beta-catenin-like protein 1CTNNBL1 13 13 568 0 42.558 1.2818 NaN 7.10E+08
Q9NTI5-2;Q9NTI5;Q9NTI5-3;A9IYQ1;Q9NTI5-5;Q9NTI5-49 TI5-2;Q NTI5 Sister chromatid cohesion protein PDS5 homolog BPDS5B 33 31 1391 0 279.83 1.2815 0.76624 3.91E+09
P27707;D6RFG8;D6RCP9P27707;D6RFG8;D6RCP9eoxycytidine kinaseDCK 8 8 260 0 49.595 1.2812 0.61008 9.36E+08
P06400 P06400 Retinoblastoma-associated proteinRB1 14 14 928 0 117.65 1.2808 0.8892 1.84E+09
E9PKG1;H7C2I1;Q99873-3;Q99873-2;Q99873-4;Q99873;E9PIX6;E9PQ98;H0YDE4;A0A087X1W2;E9PNR9;E9PMW9;Q9NR22-2;Q9NR22;E9PMZ2E9PKG1;H7C2I1;Q99873-3;Q99873-2;Q9 873-4;Q99873;E9PIX6;E9PQ98;H0YD 4;A0A087X1 2;E9P 9Protein arginine N methyltransferase 1PRMT1 15 15 325 0 114.27 1.2805 0.70086 5.86E+09
P49321-4;P49321;P49321-3;E9PRH9;H0YF33;Q5T624;P49321-2;H0YDS9;E9PI86P49321-4;P4 321;P49321-3;E9PRH9;H0YF33;Q5T624;P4 321-2;H0YDS9Nuclear autoantigenic sperm proteinNASP 4 4 724 0 26.628 1.2795 NaN 1.06E+08
O00399;E5RK00 O00399 Dynactin subunit 6DCTN6 5 5 190 0 29.536 1.2786 0.47028 7.33E+08
P30084 P30084 Enoyl-CoA hydratase, mitochondrialECHS1 19 19 290 0 209.17 1.2784 0.5552 6.43E+09
P55039;A8MZF9;J3QKW7;J3QRI9;J3KRL5;J3QR71;J3QL90;J3QKV7;J3QLF3;J3QQI1P55039;A8MZF9;J3QKW7Developmentally-regulated GTP-binding protein 2DRG2 15 14 364 0 121.25 1.278 0.87833 3.34E+09
Q8IYB8;B1AR60 Q8IYB8 ATP-dependent RNA helicase SUPV3L1, mitochondrialSUPV3L1 24 24 786 0 186.12 1.2776 0.7602 6.31E+09
Q9HAU5;Q9HAU5-2Q9HAU5 Regulator of nonsense transcripts 2UPF2 21 21 1272 0 104.29 1.2775 0.67588 1.52E+09
Q9BRX2 Q9BRX2 Protein pelota homologPELO 15 15 385 0 175.95 1.277 0.82332 2.67E+09
O60716-5;O60716-3;C9JZR2;O60716-8;O60716-7;O60716-2;O60716;O60716-13;O60716-11;O60716-6;O60716-4;O60716-21;O60716-19;O60716-16;O60716-15;O60716-10;O60716-9;O60716-24;O60716-23;O60716-18;O60716-17;O60716-14;O60716-12;O60716-22;O60716-20;O60716-29;O60716-27;O60716-32;O60716-31;O60716-26;O60716-25;O60716-30;O60716-28;E9PRE2;H0YC95;E9PKY0;E9PKL1O60716-5;O60716-3;C9JZR2;O60716-8;O60716-7;O60716-2;O60716;O60716-13;O6071 -11;O60716-6;O6071 -4;O60716-21;O60716-19;O60716-16;O60716-15;O6071 -10;O6071 -9;O60716-24;O60716-23;O60 16-18;O60716-17;O60716-14;O60716-12;O60716-22;O60716-20;O60 16-29;O60716-27;O60716-32;O60716-31;O60716-26;O60716-25;O60716-30;O60716-28Catenin delta-1 CTNND1 30 30 933 0 251.67 .2768 0.75316 3.82E+09
Q9UK58-4;Q9UK58-6;Q9UK58;Q9UK58-5Q9UK58-4;Q9UK58-6;Q9UK58;Q9UK58-5Cyclin-L1 CCNL1 2 2 232 0 30.631 1.2766 NaN 8.65E+07
Q8N1G2;H0YCQ1;H0Y4T0Q8N1G2 Cap-specific mRNA (nucleoside-2-O-)-methyltransferase 1CMTR1 8 8 835 0 27.548 1.276 0.95542 6.94E+08
Q9NTX5-6;Q9NTX5-2;Q9NTX5;Q9NTX5-3;H0Y5L2;J3KP84;E9PPG7;E9PRU6;F2Z2D6;E9PJS8;E9PLY6;Q9NTX5-5;E9PIU8;H0YCS9;H0Y525;Q9NTX5-4Q9NTX5-6;Q9NTX5-2;Q9NTX5;Q9NTX5-3;H0Y5L2Ethylmalonyl-CoA decarboxylaseECHDC1 12 12 284 0 164.28 1.2758 0.79601 2.18E+09
Q96D71-3;Q96D71;E9PMG1;H0YDT0;Q96D71-2;Q96D71-4;H0YE89;H0YCF0;H0YE73;H7C1V2;H0YCR2Q96D71-3;Q96 71 E9PMG ;H0YDT0;Q96D71-2;Q96D71-4RalB 1-associated Eps domain-containing protein 1REPS1 5 5 795 0 71.29 1.2751 0.69755 4.21E+08
A0A024RAC6;Q14241A0A024RAC6;Q14241Transcription elongation factor B polypeptide 3TCEB3 4 4 772 0 41.604 1.2749 0.99746 2.00E+08
P78527;P78527-2;F5GX40;H0YG84P78527;P78527-2DNA-dependent protein kinase catalytic subunitPRKDC 233 233 4128 0 323.31 1.2729 0.8353 1.02E+11
Q00535;Q00535-2Q00535;Q00535-2Cyclin-dependent-like kinase 5CDK5 16 15 292 0 81.432 1.2727 0.73099 4.32E+09
P45985;P45985-2P45985;P45985-2Dual specificity mitogen-activated protein kinase kinase 4MAP2K4 3 3 399 0 9.015 1.2726 0.8212 4.56E+08
H0YCE7;O43427-2;O43427;E9PSD3H0YCE7;O43427-2;O43427;E9PSD3Acidic fibroblast growth factor intracellular-binding proteinFIBP 4 4 137 0 8.9649 1.2722 0.63182 4.19E+08
H3BPJ9;O96000;H3BV16;O96000-2H3BPJ9; ;H3BV16;O96000-2NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10NDUFB10 2 2 161 0 7.4692 1.2722 NaN 1.22E+08
Q9UJF2;Q9UJF2-2;H0Y638;H0Y3A3;A0A0A0MQZ2;B7ZCA0;Q5VWQ8-3;Q5VWQ8-4;Q5VWQ8-2;Q5VWQ8-5;Q5VWQ8;Q96PV0-3;Q96PV0-2;Q96PV0-4;Q96PV0Q9UJF2;Q9UJF2-2;H0Y638Ras GTPase-activating protein nGAPRASAL2 4 4 1139 0 19.145 1.2713 3.8943 1.30E+08
Q96G03;Q96G03-2;E9PD70;E7ENQ8Q96G03;Q96G03-2Phosphoglucomutase-2PGM2 3 3 612 0 33.462 1.2711 NaN 1.51E+08
Q14562;F5H658;K7EJH9;K7END7Q14562;F5H658 ATP-dependent RNA helicase DHX8DHX8 11 10 1220 0 74.753 1.2703 0.77657 6.64E+08
Q6IN85;Q6IN85-2;G3V5Z3;Q6IN85-4;H0YIY8;Q6IN85-5;G3V5A2;H0YJN6;Q5MIZ7-3;Q5MIZ7-2;Q5MIZ7;G3V4R3;G3V231;Q5MIZ7-5Q6IN85;Q6IN85-2;G3V5Z3 I 4 H0YIY8;Q6IN85-5Serine/threonine-protein phosphatase 4 regulatory subunit 3ASMEK1 16 16 833 0 90.388 1.2703 0.77426 1.95E+09
P20020-6;P20020-3;P20020-4;P20020;P20020-5;P20020-2;E7ERY9;H0Y7S3;Q01814-6;Q01814-8;Q01814-5;Q01814;Q01814-4;Q01814-7;Q01814-3;Q01814-2;A0A0U1RQU3;H0YHH6;F8W1V5;H0YDG5;H7BZS8;H7BY13P20020-6;P20020-3;P20 20-4;P20 20;P 0020-5;P20020-2;E7ERY9Plasma membrane calcium-transporting ATPase ;Calcium-transporting ATPaseATP2B1 25 14 1184 0 129.75 1.2691 0.79549 1.59E+09
Q9BUI4;E9PHH9 Q9BUI4;E9PHH9 DNA-directed RNA polymerase III subunit RPC3POLR3C 10 10 534 0 129.8 1.2687 NaN 4.32E+08
Q3B7T1;Q3B7T1-5;Q3B7T1-3;Q3B7T1-4;E9PJ07;H0YCQ0;H0YCS2;H0Y353Q3B7T1;Q B7T1-5;Q3B7T1-3Erythroid differentiation-related factor 1EDRF1 11 11 1238 0 52.839 1.2686 0.61978 4.34E+08
A0A0A0MQV2;O75582;O75582-3;O75582-2;G3V2D1A0A0A0MQV ;O75582;O75582-3;O75582-2Ribosomal protein S6 kinase alpha-5RPS6KA5 8 6 807 0 31.604 1.2684 0.71224 3.41E+08
Q7L1Q6-2;Q7L1Q6;Q7L1Q6-4;Q7L1Q6-3;C9IZ80;C9J188;C9JWF5;C9JFN4;C9JV57;H0Y503;E9PFD4Q7L1Q6-2;Q7L1Q6;Q7L1Q6-4;Q7L Q6-3;C9IZ80Basic leucine zipper and W2 domain-containing protein 1BZW1 9 8 353 0 17.896 1.268 1.1209 3.65E+08
P30837;A0A0U1RQK9;H0Y2X5;H0YMG7;O94788-4;O94788-2;O94788-3;P00352;P47895;O94788P30837 Aldehyde dehydrogenase X, mitochondrialALDH1B1 24 22 517 0 306.51 1.2677 0.77274 1.03E+10
A0A087WW58;Q9C0D9;C9JAG1A0A087WW58;Q9C0D9;C9JAG1Ethanolaminephosphotransferase 1EPT1 2 2 396 0 38.867 1.2673 0.5312 4.37E+08
Q9HB90;Q9NQL2;Q9NQL2-2HB90 Ras-related GTP-binding protein CRRAGC 9 9 399 0 28.668 1.2673 0.93936 7.02E+08
Q14315;Q14315-2Q14315;Q14315-2Filamin-C FLNC 67 60 2725 0 323.31 1.267 0.95114 7.09E+09
A0A096LNV3;A0A096LP02;Q9Y508-2;Q9Y508A0A096LNV3;A A096LP02;Q9Y508-2;Q9Y508E3 ubiquitin-protein ligase RNF114RNF114 4 4 188 0 10.134 1.2662 0.39001 1.31E+08
P42677;Q5T4L4;C9J1C5P42677;Q5T4L4 40S ribosomal protein S27RPS27 7 3 84 0 56.313 1.266 0.65838 1.73E+10
P13674-3;P13674-2;P13674P13674-3;P13674-2;P13674Prolyl 4-hydroxylase subunit alpha-1P4HA1 2 2 516 0 16.194 1.2648 NaN 1.20E+08
P55263-3;P55263-4;P55263-2;P55263P55263-3;P55263-4;P55263-2;P55263Adenosine kinase ADK 3 3 305 0 18.928 1.2639 0.65094 1.48E+08
Q15120;Q15120-2Q15120;Q15120-2[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrialPDK3 7 7 406 0 18.902 1.2637 0.91479 5.24E+08
P78417;Q5TA02;P78417-3;P78417-2;Q5TA01P78417;Q5TA02;P78417-3;P78417-2;Q5TA01Glutathione S-transferase omega-1GSTO1 18 18 241 0 89.435 1.2632 0.48777 8.52E+09
R4GN43;A0A0C4DGS0;P56556R4GN43;A0A0C4DGS0;P56556NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6NDUFA6 4 4 71 0 12.436 1.2627 0.33362 3.65E+08
Q58EX7-2;Q58EX7Q58EX7-2;Q58EX7Puratrophin-1 PLEKHG4 2 2 1110 0 9.6349 1.2626 2.5328 8.29E+07
Q7Z4S6-6;Q7Z4S6-3;Q7Z4S6-5;Q7Z4S6-2;Q7Z4S6;Q7Z4S6-4;H0YIM7;H0YHT2;H0YIM6;O75037-3;O75037-4;O75037-2;O75037;H0YHG9;H0YI78Q7Z4S6-6;Q7Z4S6-3;Q7Z4S6-5;Q7Z4S6-2;Q7Z4S6;Q7Z4S6-4Kinesin-like protein KIF21AKIF21A 8 7 1621 0 128.94 1.2613 0.64084 4.42E+08
Q9NR12;Q9NR12-2;D6RH06;Q9NR12-5;Q9NR12-6;Q9NR12-4;D6RF83;H7BYK4;Q9NR12-3;D6RAN1;H0Y8W6Q9NR12;Q9NR12- ;D6RH06;Q9NR12-5;Q9NR12-6;Q9NR12-4PDZ and LIM domain protein 7PDLIM7 10 10 457 0 118.95 1.2608 0.87806 1.08E+09
Q12830-4;Q12830-2;Q12830;E7ETD6;F5GXF5;A0A0A0MR81;J3QQQ8;J3KSK9;E9PE19Q12830-4;Q12830-2;Q12830;E7ETD6;F5GXF5Nucleosome-remodeling factor subunit BPTFBPTF 19 19 2903 0 98.334 1.2603 0.61876 5.05E+08
C9J9W2;Q14847;Q14847-2;Q14847-3C9J9W2;Q14847;Q14847-2;Q14847-3LIM and SH3 domain protein 1LASP1 3 3 166 0 18.102 1.2591 0.58357 8.40E+07
Q9Y619;Q5VZD9;F2Z354Q9Y619 Mitochondrial ornithine transporter 1SLC25A15 8 8 301 0 22.952 1.2591 0.62056 4.75E+08
H7BXH2;E9PKF6;Q5H9R7-6;Q5H9R7-2;Q5H9R7;Q5H9R7-5;Q5H9R7-3;Q5H9R7-4;E9PQP7;H0YEN2;E9PNN8;E9PK08;E9PKG4;E9PJD8;H0YEV0;H0YDW1H7BXH2;E9PKF6;Q5H9R7-6;Q5H9R7-2;Q5H9R7;Q5H9R7-5;Q5H9R7-3;Q5H9R7-4;E9PQP7Serine/threonine-protein phosphatase 6 regulatory subunit 3PPP6R3 21 21 827 0 225.64 1.2589 0.58966 4.05E+09
H3BSM7;Q96GQ5;H3BR29;I3L2V0;H3BTA0;H3BS97;Q96GQ5-2H3BSM7;Q96GQ5;H3BR29UPF0420 protein C16orf58 4 4 466 0 13.176 1.2581 0.68061 1.73E+08
Q93009;Q93009-3;H3BND8;F5H2X1;H3BUV0;H3BTM1;H3BRA2;H3BQD1;H3BMF6Q93009;Q93009-3 ND8Ubiquitin carboxyl-terminal hydrolase 7;Ubiquitin carboxyl-terminal hydrolaseUSP7 43 43 1102 0 312.82 1.2579 0.70364 5.15E+09
B4DFG0;P35659-2;P35659;D6RDA2;H0Y993;D6R9L5;H0Y8X0B4DFG0;P35659- ;P35659; DA2;H0Y993Protein DEK DEK 4 4 347 0 17.437 1.2576 0.89795 5.39E+08
O60547-2;O60547O60547-2;O60547GDP-mannose 4,6 dehydrataseGMDS 8 8 342 0 50.045 1.2574 0.80595 1.14E+09
Q8NEN9 Q8NEN9 PDZ domain-containing protein 8PDZD8 7 7 1154 0 45.616 1.2565 0.95607 4.15E+08
P49792;F8WBP7 P49792 E3 SUMO-protein ligase RanBP2RANBP2 95 65 3224 0 323.31 1.2561 0.74393 1.23E+10
Q9Y315;E9PPM8;G3V158;E9PML7;E9PMH9;E9PJ44;E9PJB9;E9PPK3Q9Y315 PM8;G3V158Putative deoxyribose-phosphate aldolaseDERA 12 12 318 0 124.16 1.256 0.83612 7.41E+08
R4GMQ5;P07858 R4GMQ5;P07858 Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chainCTSB 1 1 76 0 7.6677 1.2559 NaN 1.38E+07
Q8NCA5-2;Q8NCA5;E9PH82;C9J3G8Q8NCA5- ;Q8NCA5;E9PH82Protein FAM98A FAM98A 5 5 518 0 106.26 1.2543 NaN 4.86E+08
P42224;J3KPM9;P42224-2;E7EPD2;D2KFR9;E7ENM1;E9PH66;H7BZ88;H7BZB5P42224;J3KPM9;P4 224-2Signal transducer and activator of transcription 1-alpha/beta;Signal transducer and activator of transcriptionSTAT1 27 27 750 0 236.72 1.2542 0.8724 4.89E+09
Q8IWZ3;Q8IWZ3-4;Q8IWZ3-6;E9PDP5;H7C2F5;H3BLS9;H0Y4P6;Q8IWZ3-5;Q8IWZ3-2;H0Y785;H0Y472;Q8IWZ3-3;D6RHC4;A0A0A0MQZ8;H0Y7Y3;H7C0V5Q8IWZ3;Q8IWZ3-4;Q8IWZ3-6;E9PDP5;H7C2F5;H3BLS9Ankyrin repeat and K  domain-containing protein 1ANKHD1 27 16 25 2 0 265.74 1.254 0.6637 2.81E+09
A0A087X0M4;Q9BWU0;A0A087WWF4;H7C256A0A087X0M4;Q9BWU0;A0A087WWF4Kanadaptin SLC4A1AP 6 6 742 0 65.271 1.2537 0.58012 4.31E+08
Q9HC21-2;Q9HC21;J3KRY6;J3KSI7;J3QL84;J3KS44;J3QLV3;J3KSB1Q9HC21-2;Q9HC21;J3KRY6;J3KSI7;J3QL84;J3KS44;J3QLV3Mitochondrial thiamine pyrophosphate carrierSLC25A19 6 5 263 0 24.398 1.2536 0.79401 6.30E+08
Q02252-2;Q02252;G3V4Z4Q02252-2;Q02252;G3V4Z4Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrialALDH6A1 8 8 522 0 83.235 1.253 0.79767 1.14E+09
P50750;P50750-2;X6RE90P50750;P50750-2Cyclin-dependent kinase 9CDK9 11 10 372 0 51.138 1.2528 0.73886 9.75E+08
P00966;Q5T6L6;Q5T6L5P00966;Q5T6L6 Argininosuccinate synthaseASS1 24 24 412 0 234.55 1.2526 0.73653 5.30E+09
P67809;A0A087X1S2;H0Y449;C9J5V9;Q9Y2T7;A0A0D9SEI8P67809;A0A087X1S2;H0Y449Nuclease-sensitive element-binding protein 1YBX1 11 6 324 0 274.77 1.2525 0.64838 2.32E+09
Q9Y2Z0-2;Q9Y2Z0Q9Y2Z0-2;Q9Y2Z0Suppressor of G2 allele of SKP1 homologSUGT1 23 23 333 0 266.72 1.2525 0.79672 4.05E+09
168
Q96EK6;G3V5E4;G3V4W4Q96EK6;G3V5E4;G3V4W4Glucosamine 6-phosphate N-acetyltransferaseGNPNAT1 8 8 184 0 75.348 1.252 0.67007 2.41E+09
C9J384;Q9BQ75-2;Q9BQ75;H7C515C9J384;Q9BQ75-2;Q9BQ75Protein CMSS1 CMSS1 3 3 225 0 13.227 1.2518 1.0589 2.25E+08
O43929;O43929-2;O43929-3;CON__Q2YDI2;C9JGH7;C9J2X8;Q53SE3O43929;O43929-2;O439 9-3Origin recognition complex subunit 4ORC4 9 9 436 0 75 1.2518 0.64752 8.99E+08
P07737;K7EJ44;CON__P02584;I3L3D5P07737;K7EJ44 Profilin-1 PFN1 20 20 140 0 285.87 1.2518 0.74413 9.18E+10
P63104;E7EX29;E7ESK7;B0AZS6;P63104-2;E5RIR4;E9PD24;E7EVZ2;B7Z2E6;H0YB80;E5RGE1P63104;E7EX29;E7ESK7;B0AZS6;P63104-214-3-3 protein zeta/deltaYWHAZ 16 11 245 0 280.89 1.2518 0.20507 3.43E+09
Q9NZJ7-2;Q9NZJ7;H0Y8C3;F6WFU6;Q9NZJ7-3;H7C196Q9NZJ7-2;Q9NZJ7 H0Y8C3;F6WFU6Mitochondrial carrier homolog 1MTCH1 13 13 372 0 51.766 1.2512 0.55746 8.90E+08
B4DHE8;Q96DH6-2;Q96DH6;J3KTC1;J3QKT5;B4DM51;Q96DH6-3B4DHE8;Q96DH6-2;Q96DH6;J3KTC ;J3QKT5RNA-binding protein Musashi homolog 2IGSF9B;MSI2 9 8 324 0 85.71 1.2501 0.88692 2.00E+09
A0A0J9YWJ4;K7EJD2;A0A0J9YWB6;A0A0A0MR03;Q9Y5B0-4;Q9Y5B0A0A0J9YWJ4;K7EJD2;A0A0J9YWB6;A0A0A0MR03;Q9Y5B0-4;Q9Y5B0RN  polymerase II subunit A C-terminal domain phosphataseCTDP1 3 3 737 0 7.4779 1.2495 1.1079 1.17E+08
O60488-2;O60488;D6RF95;D6RD96;D6RFW9;D6RDA8;H0Y9A0O60488-2;O60488Long-chain-fatty-acid--Co  ligase 4ACSL4 20 18 670 0 124.08 1.2491 1.0057 1.84E+09
E9PP76;J3KNF4;O14618E9PP76;J3KNF4;O14618Superoxide dismutase [Cu-Zn];Copper chaperone for superoxide dismutaseCCS 2 2 68 0 5.9071 1.2489 NaN 9.86E+07
Q14103-3;Q14103;H0Y8G5;H0YA96;Q14103-4;Q14103-2;D6RAF8;D6RF44;D6RD83;D6RBQ9Q14103-3;Q14103;H0Y8G5;H0YA96;Q14103-4;Q14103-2;D6RAF8Heterogeneous nuclear ribonucleoprotein D0HNRNPD 23 20 306 0 323.31 1.2487 0.71201 3.49E+10
Q8WUK0;Q8WUK0-2;E9PQM0;Q8WUK0-3Q8WUK0;Q8WUK0-2Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1PTPMT1 6 6 201 0 42.787 1.2483 0.49435 1.05E+09
Q04727-4;Q04727;Q04727-3;Q04727-2;H7C4E4;H7C4W5;H0Y5S0;Q5JSY7;H7C4P7Q04727-4;Q04727;Q04727-3;Q04727-2Transducin-like enhancer protein 4TLE4 11 3 748 0 29.143 1.2481 0.90476 6.83E+08
Q9Y2Z2-2;Q9Y2Z2-5;Q9Y2Z2-4;Q9Y2Z2;Q9Y2Z2-6Q9Y2Z2-2;Q9Y2Z2-5;Q9Y2Z2-4;Q9Y2Z2;Q9Y2Z2-6Protein MTO1 homolog, mitochondrialMTO1 1 1 595 0 4.7376 1.248 NaN 9.46E+07
Q13526;K7EMU7;K7EN45;O15428Q13526 K7EMU7;K7EN45Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1PIN1 10 10 163 0 153 1.2479 0.80044 3.43E+09
P50995-2;P50995;H0Y6E1;E5RIN3;P27216;P27216-2P5 995-2;P50995Annexin A11 ANXA11 20 20 472 0 166.72 1.2474 0.65002 5.85E+09
Q8TAV0;Q8TAV0-3;Q8TAV0-5;Q8TAV0-2;Q8TAV0-4;E9PQL1;B1AJQ5Q8TAV0;Q8TAV0-3;Q8TAV0-5;Q8TAV0-2;Q8T V0-4;E9PQL1Protein F M76A FAM76A 5 5 307 0 24.367 1.2474 0.30357 8.22E+07
Q14194;E9PD68;Q14194-214194;E9PD68;Q14194-2Dihydropyrimidinase-related protein 1CRMP1 10 9 572 0 90.555 1.2469 NaN 7.95E+08
A0A087X256;Q2M389;Q2M389-2;F8VYH7;F8W1W1A0A087X256;Q2M389;Q2M389-2WASH complex subunit 7KIAA1033 25 25 1174 0 211.82 1.2466 0.85445 2.10E+09
Q9NZC9;H7BYI2;H7C1I3;H7C051Q9NZC9;H7BYI2 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1SMARCAL1 7 7 954 0 20.944 1.2466 1.2095 3.65E+08
H0Y2S1;O43824 H0Y2S1;O43824 Putative GTP-binding protein 6GTPBP6 5 5 516 0 15.909 1.2461 0.9966 1.15E+08
Q71U36-2;Q71U36;Q13748;Q13748-2;F8VQQ4;Q6PEY2;F8VRZ4;F8VS66;V9GZ17;F8VWV9;F8VX09;F8VRK0;F8W0F6;F8VXZ7Q71U36-2 71U36;Q13748Tubulin alpha-1A chain;Tubulin alpha-3C/D chainTUBA1A;TUBA3C 41 1 416 0 31.996 1.2458 0.84965 2.54E+09
O43491;Q6R5J7;E9PMV8;Q6ZSX4;E9PPC9;E9PN54O43491 Band 4.1-like protein 2EPB41L2 42 1 1005 0 323.31 1.2455 0.71457 5.54E+09
P32322;E2QRB3;P32322-3;P32322-2;J3KQ22;J3QL24;J3QLK9;J3QL32;J3QKT4;J3QR88;J3QL23;J3KTA8;J3QKT3;J3QRZ0;J3KSA9P32322;E2QRB3;P32 22-3;P32322-2;J3KQ22;J3QL 4Pyrroline-5-carboxylate reductase 1, mitochondrial;Pyrroline-5-carboxylate reductasePYCR1 20 19 319 0 317.77 1.2453 0.72367 6.57E+09
F8W9X7;Q567U6;H7C050F8W9X7;Q567U6 Coiled-coil domain-containing protein 93CCDC93 6 6 630 0 47.391 1.2452 NaN 1.67E+08
O60934;A0A0C4DG07;E5RGU1;A0A087X1V5;E5RGR7;E2QRP0;E5RGN7O60934;A0A0C4DG07Nibrin NBN 19 19 754 0 133.59 1.2448 0.62191 1.33E+09
X6RLT1;H0UI80;Q8IXH7-4;Q8IXH7X6RLT1;H0UI80;Q8IXH7-4;Q8IXH7Negative elongation factor C/DNELFCD;TH1L 2 2 593 0 4.2964 1.2446 NaN 3.73E+07
P41214;P41214-2;Q5SY38;A0A087X1L6P41214;P41214-2Eukaryotic translation initiation factor 2DEIF2D 21 21 584 0 148.87 1.2446 NaN 2.32E+09
M0R300;M0R0P8;Q13459-2;Q13459;M0R2J3;M0QZY4M0R300;M0R0P8;Q13459-2;Q13459Unconventional myosin-IXbMYO9B 14 12 2072 0 51.052 1.2444 1.0067 4.62E+08
Q96D09;Q5JY77 Q96D09 G-protein coupled receptor-associated sorting protein 2GPRASP2 8 8 838 0 153.39 1.2442 0.60632 2.82E+08
Q9Y399;Q5T8A0 Q9Y399;Q5T8A0 28S ribosomal protein S2, mitochondrialMRP 14 14 296 0 58.096 1.2438 0.85659 2.42E+09
C9J5N1;Q9BTE6;Q9BTE6-2;Q9BTE6-3;K7EQ85;L7N2F4;K7N799;H7C054C9J5N1;Q9BTE6;Q9BT 6-2;Q9BTE6-3Alanyl-tRNA editing protein Aarsd1PTGES3L-AARSD1;AARSD1 14 14 495 0 139.24 1.2435 0.61667 2.23E+09
Q93074-3;Q93074;Q93074-2;Q7Z3Z5;F8WAE6;Q86YW9-4;Q86YW9Q93074-3;Q93074;Q93074-2; 7Z3Z5Mediator of RNA polymerase II transcription subunit 12MED12;TNRC11 8 8 2176 0 26.983 1.2431 0.88072 3.30E+08
Q9Y2J2-2;A8K968;A0A0A0MRA8;Q9Y2J2-4;Q9Y2J2;Q9Y2J2-3;B2RB02;A0A0J9YY18;A0A0J9YW31;J3KT37;A0A0J9YW26;J3QS55;A0A0J9YWN0;A0A0J9YWE1;A0A0J9YWS4;J3QRQ6;J3KS70;J3QLU5;J3QS83;J3QKY2;J3KRD1;J3QKK4;J3QR33Q9Y2J2-2;A8K968;A0A0A0MRA8; 9Y2J2-4;Q9Y2J2;Q9Y2J2-3;B2RB 2Band .1-like protein 3;Band 4.1-like protein 3, N-terminally processedEPB41L3 33 28 865 0 323.31 1.2431 0.6998 .69E+09
P31153;P31153-2;Q00266P31153;P31153-2S-adenosylmethionine synthase isoform type-2MAT2A 13 13 395 0 137.62 1.243 1.1268 4.07E+09
O00458;O00458-2;C9JA65;E9PMY4;C9JNM6;C9JLG5;C9JFH1;H0YEE3O00458;O00458-2;C9JA65Interferon-related developmental regulator 1IFRD1 6 6 451 0 48.808 1.2429 0.84406 5.85E+08
P62081;B5MCP9 P62081;B5MCP9 40S ribosomal protein S7RPS7 18 18 194 0 273.06 1.2422 0.72843 6.75E+09
H7C0E5;H7BZM7;O75312H C0E5;H7BZM7;O75312Zinc finger protein ZPR1ZPR1 2 2 386 0 10.869 1.2418 NaN 8.33E+07
F5H101;Q76FK4-4;Q76FK4;F8WE42;F5GWN9;Q76FK4-2;F5GXV1;F5H532;F5H0I5;F5H8B8;A0A0A0MSJ1F5H101;Q76FK4-4;Q76FK4;F8WE42;F5GWN9;Q76FK4-2Nucleolar protein 8NOL8 6 6 1085 0 150.73 1.2415 1.1124 1.73E+08
Q92878;Q92878-2;Q92878-3;E7EN38;E7ESD9;C9JNH8;E9PM98;H7C0V2;H7C0P8Q92878;Q92878-2;Q92878-3DNA repair protein RAD50RAD50 58 58 1312 0 323.31 1.2414 0.77253 3.74E+09
E7EXA6;Q8WVB6;Q8WVB6-2;A0A0D9SF58;F8WCC1;Q8WVB6-3;H0Y7D3E7EXA6;Q8WVB6;Q8WVB6-2;A0A0D9SF58;F8WCC1Chromosome transmission fidelity protein 18 homologCHTF18 11 10 975 0 34.322 1.2411 0.7769 4.91E+08
Q13572;G3V4M9;Q13572-2;G3V588;G3V3C0;G3V5A313572;G3V4M9;Q13572-2Inositol-tetrakisphosphate 1-kinaseITPK1 3 3 414 0 26.106 1.2407 0.80032 5.11E+08
Q15149;Q15149-7;Q15149-8;Q15149-9;Q15149-5;Q15149-4;Q15149-6;Q15149-3;Q15149-2;H0YDN1;E9PMV1;E9PKG0Q15149;Q15149-7;Q15149-8;Q15149-9;Q15149-5;Q15149-4;Q15149-6;Q15149-3;Q15149-2Plectin PLEC 67 57 4684 0 323.31 1.2405 0.88944 4.49E+09
P62829;J3KT29;C9JD32;J3KTJ3;B9ZVP7;J3QQT9P628 9;J3KT29;C9JD32;J3K J3;B9ZVP760S ribosomal protein L23RPL23 18 18 140 0 116.98 1.2401 0.76748 3.04E+10
Q96HC4;Q96HC4-4;Q96HC4-6;Q96HC4-7;Q96HC4-3;Q96HC4-2;H0Y8Y3;A0A0D9SFR4;H0YBI4;A0A0A0MSP3;H0Y929;D6RAA1;A0A0D9SFW3;D6RGG6;Q96HC4-5Q96HC4;Q96HC4-4;Q96HC4-6;Q96HC4-7;Q96 C4-3;Q96HC4-2PDZ and LIM domain protein 5PDLIM5 18 18 596 0 90.15 1.2401 0.76463 1.04E+09
Q15126 Q15126 Phosphomevalonate kinasePMVK 11 11 192 0 53.642 1.2397 0.70588 7.33E+08
Q96B26;H7C581 Q96B26 Exosome complex component RRP43EXOSC8 6 6 276 0 49.755 1.2396 1.0874 1.04E+09
Q96D46;C9JA08;C9J0B9;C9IZW9;C9K0C2;C9IY70Q96D46;C9JA08;C9J0B960S ribosomal export protein NMD3NMD3 18 18 503 0 183.12 1.2393 NaN 1.51E+09
A2A2Q9;Q9Y312 A2A2Q9;Q9Y312 Protein AAR2 homologAAR2 8 8 398 0 52.8 1.2391 0.94142 7.88E+08
Q5T1Z4;Q5T1Z8;Q14671-2;Q14671-3;H0YDK8;H0YC97;H0YDC5;A0A0C4DG68;A0A0A0MR59;Q8TB72-2;Q8TB72-4;Q8TB72-3;Q8TB72;E9PMX1Q5T1Z4;Q5T1Z8;Q14671-2;Q14671-3; 0Y K8Pumilio homolog 1PUM1 14 1 1189 0 86.31 1.2391 0.93776 9.16E+08
Q9Y490 Q9Y490 Talin-1 TLN1 45 41 2541 0 323.31 1.2391 0.70625 5.23E+09
J3QLS3;Q9Y2R9;J3KSI8;J3QQS1;J3QKW2J3QLS3; 9Y2R9;J3KSI8;J3QQS1;J3QKW228S ribosomal protein S7, mitochondrialMRP 10 10 271 0 49.392 1.238 0.89277 1.73E+09
K4DI93;Q13620-1;Q13620;Q13620-3;A6NE76K4DI93;Q13620-1;Q13620;Q13620-3Cullin-4B CUL4B 34 22 900 0 280.22 1.2379 0.77215 4.99E+09
O76071 O76071 Probable cytosolic iron-sulfur protein assembly protein CIAO1CIAO1 9 9 339 0 153.3 1.2371 0.749 1.81E+09
Q8NHV4;Q8NHV4-3;Q8NHV4-2;G3V2M9;G3V4L2;G3V2V3Q8NHV4;Q8NHV4-3;Q8NH -Protein NEDD1 NEDD1 4 4 660 0 75.287 1.2371 NaN 7.67E+07
P13010;C9JZ81;H7C0H9P13010 X-ray repair cross-complementing protein 5XRCC5 55 55 732 0 323.31 1.236 0.71207 9.50E+10
P22033 P22033 Methylmalonyl-CoA mutase, mitochondrialMUT 13 13 750 0 60.655 1.2355 0.72632 1.05E+09
Q96RL7-4;Q96RL7-2;Q96RL7-3;Q96RL7;H0Y7P8Q96RL7-4;Q96RL7-2;Q96RL7-3;Q96RL7Vacuolar protein sorting-associated protein 13AVPS13A 11 11 3069 0 35.796 1.2342 1.1046 2.58E+08
Q8NI27;A0A0C4DG98;H0Y815;F2Z2V2;H7C477;H0Y7U4;Q8NI27-2;H0Y594Q8NI27;A0A0C4DG98THO complex subunit 2THOC2 38 38 1593 0 199.29 1.2339 0.81819 5.61E+09
Q9BRK5-6;Q9BRK5;G3V1E2;Q9BRK5-4;Q9BRK5-3;H0Y3T6;Q9BRK5-2Q9BRK5-6; 9BRK5;G3V1E2;Q9BRK5-4;Q9BRK5-3;H0Y3T6;Q9BRK5-245 kDa calcium-binding proteinSDF4 7 7 348 0 47.245 1.2339 0.62051 7.14E+08
Q9NZB2;Q9NZB2-6;Q9NZB2-4;Q9NZB2-2;Q9NZB2-5;A0A0C4DG79;A0A0C4DH52;Q5T035Q9NZB2;Q9NZB2-6;Q9NZB2-4;Q9NZB2-2;Q9NZB2-5Constitutive coactivator of PPAR-gamma-like protein 1F M120A 31 31 1118 0 188.6 1.2332 0.78982 3.23E+09
P14618-2;H3BTN5;H3BR70;H3BQ34;H3BUW1;H3BTJ2;H3BT25;H3BU13;H3BN34;H3BQZ3;P30613-2;P30613P14618-2; TN5 R70;H3BQ34Pyruvate kinase PKM;Pyruvate kinasePKM 56 5 531 0 29.931 1.2328 NaN 2.22E+08
Q9Y2R4;A0A087X1P7;A0A087WTD6;A0A087X069;A0A087X121Q9Y2R4 Probable ATP-dependent RNA helicase DDX52DDX52 13 13 599 0 95.547 1.2328 NaN 9.21E+08
Q6UXN9;C9JBU3 Q6UXN9 WD repeat-containing protein 82WDR82 13 13 313 0 127.36 1.2323 0.83163 2.09E+09
P62888;E5RI99;A0A0C4DH44;A0A0B4J213;E5RJH3P62888;E5RI99;A0A0C4DH4460S ribosomal protein L30RPL30 8 8 115 0 65.784 1.2321 0.68462 6.09E+09
P60228;E5RGA2;H0YBR5;E5RHS5;E5RIT4;H0YAW4;E5RII3;E5RIP5;E5RJ25;H0YBP5P60228;E5RGA2 Eukaryotic translation initiation factor 3 subunit EEIF E 21 21 445 0 105.81 1.2317 0.75586 3.96E+09
O43592;F8WDU6;F5GYW6;F5GZM3O43592 Exportin-T XPOT 37 37 962 0 323.31 1.2308 0.82341 1.11E+10
Q5T4U5;P11310;P11310-2;B7Z9I1;E9PJM9;E9PRX4;H0YDT5Q5T4U5;P11310;P11310-2;B7Z9I1Medium-chain specific acyl-CoA dehydrogenase, mitochondrialACADM 13 13 454 0 111.68 1.2307 0.75391 3.98E+09
E9PC74;Q13144;C9JRD9;H7C2X0E9PC74;Q13144 Translation initiation factor eIF-2B subunit epsilonEIF2B5 15 15 705 0 78.203 1.2305 0.88035 1.67E+09
Q92733 Q92733 Proline-rich protein PRCCPRCC 2 2 491 0 11.396 1.2305 NaN 4.86E+07
Q96C36;A0A087WTV6;A0A087WZR9;J3KR12;A0A087WX69;A0A087WZF0Q96C36;A0A087WTV6;A0A087WZR9;J3KR12Pyrroline-5-carboxylate reductase 2PYCR2 20 19 320 0 141.88 1.2305 0.70039 1.05E+10
O15111;Q9UPZ9-2;Q9UPZ9O15111 Inhibitor of nuclear factor kappa-B kinase subunit alphaCHUK 19 18 745 0 215.51 1.2293 0.64765 1.60E+09
O60749-2;O60749;D6RC15;H0YK42;Q13596-2;Q13596O60749-2;O60749Sorting nexin-2 SNX2 8 8 402 0 51.066 1.2288 NaN 3.91E+08
P43246;E9PHA6;P43246-2;V9H019;A0A087X078;A0A087X1E7;V9H0B2;V9H015;C9J809P43246;E9P A6;P43246-2;V9H019;A0A087X078;A0A087X1E7DN  mismatch repair protein Msh2MSH2 4 40 934 0 323.31 1.2284 0.78987 1.05E+10
Q96RY7;Q96RY7-2;I3L0Y8Q96R 7;Q96RY7-2Intraflagellar transport protein 140 homologIFT140 7 7 1462 0 33.554 1.2272 0.84686 2.44E+08
P08559-3;P08559;P08559-2;P08559-4;Q5JPU3;Q5JPU0;Q5JPT9;Q5JPU1;P29803;Q5JPU2P085 9-3;P085 9;P08559-2;P08559-4Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrialPDHA1 25 25 359 0 312.13 1.2259 0.72729 1.59E+10
Q9H6Q4-3;Q9H6Q4;Q9H6Q4-2;J3QRB0;H3BSH2;J3KS48;J3KT43;E9PH27;E7EP87;A0A088AWN8;Q9UHQ1-4;Q9UHQ1-3;Q9UHQ1;Q9UHQ1-2Q9H6Q4-3;Q9H6Q4;Q9H6Q4-2Cytosolic Fe-S cluster assembly factor NARFLNARFL 3 3 374 0 16.293 1.2256 0.83763 5.37E+07
Q6P1K8;Q13888;D6RID8;D6RIT7;D6RGC9;R4GMS9;D6RJD3;D6RAW1Q P1K8;Q13888;D6RID8;D6RIT7; 6 GC9 R4GMS9;D6RJD3General transcription factor IIH subunit 2-like protein;General transcription factor IIH subunit 2GTF2H2C; TF2H2 6 6 395 0 19.592 1.2255 0.7672 5.40E+08
Q7L8L6 Q7L8L6 FAST kinase domain-containing protein 5FASTKD5 9 9 764 0 97.106 1.225 NaN 3.87E+08
O14979-3;O14979-2;A0A087WU03O14979-3;O14979-2Heterogeneous nuclear ribonucleoprotein D-likeHNRNPDL 14 1 244 0 263.32 1.2248 0.41218 1.09E+10
Q96AC1;Q96AC1-3;H0YJ34;Q96AC1-2;A0A0U1RRM8;H0YJB6;G3V281;G3V3J0;G3V5R2;G3V1L6;Q9BQL6-4;Q9BQL6-2;Q9BQL6Q96AC1;Q96AC1-3;H0YJ34;Q96AC1-2;A0A0U1RRM8Fermitin family homolog 2FERMT2 3 22 680 0 264.96 1.2248 0.69674 4.24E+09
P50570-4;P50570-3;K7EMQ3;K7EPK9P50570-4;P50570-3Dynamin-2 DNM2 33 2 870 0 301.63 1.2242 0.78447 5.97E+09
O15344;O15344-2;C9J453;A0A087X255;A0A087X0X0;C9JZJ7;Q9UJV3-2;Q9UJV3;A6PVI4O153 4;O15344-2;C9J453;A0A087X255E3 ubiquitin-protein ligase Midline-1MID1 16 16 667 0 52.467 1.2239 NaN 4.44E+08
Q9NYV4-2;Q9NYV4;J3QSD7;Q9NYV4-3;Q9BVE2;A0A087X209;H0YAZ9;E7EUK8;E5RGN0;A0A087WZU2;F5H6Z0;Q00534;Q96Q40-2;Q96Q40-4;Q96Q40-3;O94921-3;Q96Q40-5;Q96Q40;O94921-2;O94921;Q07002;Q07002-2;Q00536;Q00536-3;Q07002-3;Q00537-2;Q00537;Q00536-2Q9NYV4-2;Q9NYV4;J3QSD7;Q9NYV4-3Cyclin-dependent kinase 12CDK12 5 3 1481 0 12.742 1.2237 0.82765 3.83E+08
M0QXB5;O95571;M0QY80;M0QX800 XB5 O95571;M0QY80Persulfide dioxygenase ETHE1, mitochondrialETHE1 3 3 260 0 30.02 1.2234 0.70426 6.06E+08
Q9UI09;F8VXI1;F8VRD8;Q9UI09-2;H0YID5Q9UI09;F8VXI1;F8VRD8;Q9UI09-2NA H dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12NDUFA12 5 5 145 0 26.818 1.2233 1.012 3.07E+08
O60566;O60566-3;O60566-2O60566;O60566-3;O60566-2Mitotic checkpoint serine/threonine-protein kinase BUB1 betaBUB1B 5 5 1050 0 29.811 1.2232 0.99255 1.69E+08
P21266;A0A0A0MTN3;E9PLF1;E9PHN7;E9PHN6;Q5T8Q9;Q5T8R1;F6XZQ7;P28161-2;P46439;P28161P21266;A0A0A0MTN3Glutathione S-transferase Mu 3GSTM3 12 12 225 0 66.223 1.2231 0.76575 5.17E+09
P50336;H0YFP3;F5H825;H0YFE1;F5GZT7P50336;H0YFP3 Protoporphyrinogen oxidasePPOX 3 3 477 0 7.7912 1.223 NaN 6.63E+07
P62273;P62273-2;A0A087WTT6P62273;P62273-2;A0A087WTT640S ribosomal protein S29RPS29 5 5 56 0 25.355 1.223 0.86847 3.85E+09
Q9UBU9;E9PIN3;Q9UBU9-2;B4E227;E9PQA4;E9PLA7;H0YDU0;E9PMV7Q9UBU9;E9PIN3;Q9UBU9-2Nuclear RNA export factor 1NXF1 24 24 619 0 162.95 1.2229 NaN 2.45E+09
P49368;P49368-2;B4DUR8;E9PRC8;Q5SZX6;Q5SZW8;E9PQ35;E9PM09;Q5SZX9P49368;P4 368-2;B4DUR8T-complex protein 1 subunit gammaCCT3 43 43 545 0 323.31 1.2227 0.67906 5.38E+10
P20700;E9PBF6;A0A0D9SFE5;A0A0D9SFY5P2 700;E9PBF6;A0A0D9SFE5Lamin-B1 LMNB1 46 42 586 0 323.31 1.2225 0.98847 6.12E+09
Q15637-4;Q15637-6;Q15637-7;Q15637-3;Q15637-2;Q15637;Q15637-5;C9J792;F8WEV5;A0A0J9YY76;H0Y7L4;A0A0J9YWQ8;A0A0A0MSQ4;H7C561;B1AK53-2;B1AK53Q15637-4;Q15637-6;Q15637-7;Q15637-3;Q15637-2;Q15637;Q15637-5Splicing factor 1 SF 5 5 548 0 17.274 1.2222 NaN 1.35E+08
Q5SVZ6 Q5SVZ6 Zinc finger MYM-type protein 1ZMYM1 7 6 1142 0 22.328 1.2217 0.91455 2.88E+08
Q8NI60-3;Q8NI60;Q8NI60-4;Q8NI60-2Q8NI60-3;Q8NI60;Q8NI60-4Chaperone activity of bc1 complex-like, mitochondrialADCK3 8 8 595 0 112.38 1.2217 0.77824 1.89E+09
J3QKS7;B4DGM3;Q969G3-6;Q969G3-5;Q969G3-3;Q969G3-2;Q969G3-4;Q969G3;J3KT85;J3QR61;K7EMQ8;H7C048J3QKS7;B4DGM3;Q969G3-6;Q969G3-5;Q969G3-3;Q969G3-2;Q969G3-4;Q969G3;J3KT85 J3QR61;K7EMQ8SWI/SNF related matrix associated actin-dependent regulator of chromatin subfamily E member 1SMARCE1 4 4 288 0 20.073 1.2213 1.0044 2.91E+08
V9GZ56;Q9Y4Z0;M0QXB0;U3KQS7;U3KQK1V9GZ56 Q9Y4Z0;M0QXB06 snRNA-associated Sm-like protein LSm4LSM4 4 4 238 0 21.178 1.2211 0.13263 9.63E+08
J3KTA4;P17844;P17844-2;J3QRQ7;J3QSF1;J3KRX8;J3KRZ1;J3QR02;X6RLV5;J3QKN9;J3QRN5;J3QLG9;J3QR62J3KTA4;P17844;P17844-2Probable ATP-dependent RNA helicase DDX5DDX5 44 36 614 0 323.31 1.2209 0.74791 3.79E+10
Q9NPF4;G3V445;G3V249Q9NPF4 Probable tRNA N6-adenosine threonylcarbamoyltransferaseOSGEP 12 12 335 0 104.25 1.2209 0.77992 3.26E+09
Q9P0K7-4;Q9P0K7-3;Q9P0K7;Q9P0K7-2Q9P0K7-4;Q9P0K7-3;Q9P0K7;Q9P0K7-2Ankycorbin RAI14 5 5 951 0 32.378 1.2209 0.9038 7.38E+08
P00558;P00558-2;P07205P0 558;P00558-2Phosphoglycerate kinase 1PGK1 40 40 417 0 323.31 1.2208 0.47212 5.00E+10
O95985-3;O95985-2;O95985;H0Y6W0;C9JKE2;C9JT00;F2Z2A5;H7C4B0;C9JEI7O9598 -3;O95985-2;O 5985;H0Y6W0DNA topoisomerase 3-beta-1;DNA topoisomeraseTOP3B 7 7 707 0 15.087 1.2203 1.0131 3.59E+08
Q8TCD5;J3KRC4;J3KSY6;J3KSX6;Q8TCD5-2Q8TCD5;J3KRC4;J3KSY6;J3KSX65(3)-deoxyribonucleotidase, cytosolic typeNT5C 8 8 201 0 87.908 1.2199 0.84214 1.68E+09
169
B5MBZ8;C9JD73;C9J177;H7C003;Q15435-5;Q15435-4;Q15435-3;Q15435-2;Q15435B5MBZ8;C9JD73;C9J177;H7C003;Q1543 -5;Q1543 -4;Q1543 -3;Q15435-2;Q15435Protein phosphatase 1 regulatory subunit 7PPP R7 2 2 274 0 3.9932 1.2193 NaN 4.16E+07
P52298;P52298-3;C9JQX9;B3KSB0;P52298-2;F8WE41;A6PVI3P52298;P52298-3;C9JQX9;B3KSB0;P52298-2Nuclear cap-binding protein subunit 2NCBP2 5 5 156 0 20.733 1.2193 0.61696 1.04E+09
Q8WYQ5-3;Q8WYQ58WYQ5-3;Q8WYQ5Microprocessor complex subunit DGCR8DGCR8 3 3 740 0 8.873 1.2186 0.67482 3.07E+08
J3QRN6;O94832;K7EIG7;J3KRL0;J3QRR2J3QRN6;O94832;K7EIG7Unconventional myosin-IdMYO1D 22 22 961 0 182.69 1.2183 0.77702 2.90E+09
P46063;F8WA66;F8WD97;F5H2L2;F5H4P4;F5H3W0;F5GYB7P46063 ATP-dependent DNA helicase Q1RECQL 30 30 649 0 323.31 1.2176 NaN 5.08E+09
Q7Z406;Q7Z406-6;Q7Z406-2;Q7Z406-5;Q7Z406-4;M0QY43;A0A0C4DFM8;A1L2Z2Q7Z406;Q7Z406-6;Q7Z406-2;Q7Z4 6-5;Q7Z406- ;M0QY43Myosin-14 M H14 27 18 1995 0 123.74 1.2176 0.88841 2.56E+09
A0A0A0MTH9;O14981;O14981-2A0A0A0MTH9;O14981TATA-binding protein-associated factor 172BTAF1 36 36 1849 0 196.34 1.2171 0.83819 3.19E+09
Q12923-3;Q12923;Q12923-4;Q12923-2Q12923- ;Q12923;Q12923-4;Q12923-2Tyrosine-protein phosphatase non-receptor type 13PTPN13 9 9 2466 0 50.161 1.2165 1.0536 3.82E+08
Q96GD0;B1AHD3 Q96GD0 Pyridoxal phosphate phosphatasePDXP 15 15 296 0 77.89 1.2165 0.79577 3.88E+09
Q9Y5P6;Q9Y5P6-2Q9Y5P6;Q9Y5P6-2Mannose-1-phosphate guanyltransferase betaGMPPB 8 8 360 0 53.815 1.2165 0.8857 1.29E+09
E7EX90;Q14203-3;Q14203-4;Q14203-6;Q14203;Q14203-5;Q14203-2;Q6AWB1;E7EWF7;C9JJD0;C9JKG6;E9PCY0;C9J1B7;C9JZA4;C9JTE5;C9JJN7E7EX90;Q14203-3;Q14203-4;Q14203-6;Q14203;Q14203-5;Q14203-2;Q6AWB1Dynactin subunit 1DCTN1;DKFZp686E 752 43 43 1256 0 323.31 1.2154 0.77991 6.89E+09
P52701;P52701-3;P52701-2;A0A087WWJ1;P52701-4;A0A087WYT6;F8WAX8;C9JH55;F8W7G9;C9J8Y8;C9J7Y7;U3KQ72P52701;P52701-3;P52701-2;A0A087WWJ1;P52701-4DNA mismatch repair protein Msh6MSH6 47 47 1360 0 323.31 1.2149 0.7771 1.01E+10
Q16555-2;Q16555;E5RFU4;H0YBT4;Q14195;Q14195-2Q16555-2;Q16555Dihydropyrimidinase-related protein 2DPYSL2 9 8 536 0 57.367 1.2149 NaN 4.45E+08
O75340-2;O75340;A0A024QZ42;H0Y9X3;A0A087WZ38O75340-2;O75340;A0A024QZ42Programmed cell death protein 6PDCD6;hCG_1985580 7 7 189 0 25.196 1.2147 0.88004 8.66E+08
Q16878 Q16878 Cysteine dioxygenase type 1CDO1 1 1 200 0.0090024 2.0627 1.2143 NaN 3.74E+08
J3QLR8;Q9Y3D9 J3QLR8;Q9Y3D9 28S ribosomal protein S23, mitochondrialMRP 8 8 152 0 39.568 1.2138 0.85695 2.09E+09
O15067;H0YGH1;J3QSG0;J3QSH6;J3KT98;J3KTL4;J3KTQ5;J3QL39O15067 Phosphoribosylformylglycinamidine synthasePFAS 57 57 1338 0 323.31 1.2135 0.7884 2.40E+10
P23381;P23381-2;G3V3H8;G3V3Y5;G3V277;G3V423;G3V5U1;G3V456;H0YJP3;G3V3P2;G3V227;G3V2Y7;G3V3X0;G3V5W1;G3V3S7;G3V2F2;G3V3R3;G3V4S4;G3V313;G3V339;G3V2C0;G3V4C7;G3V4N8P2 381;P23381-2Tryptophan--tRNA ligase, cytoplasmic;T1-TrpRS;T2-TrpRSWARS 34 34 471 0 323.31 1.2134 0.75402 3.43E+10
J3KMX2;B9EGA3;Q92925-3;Q92925-2;Q92925;J3QWB6;Q6STE5-2;Q6STE5;F8VW95;C9JYI7J3KMX2;B9EGA3;Q92925-3;Q92925-2; 92925;J3QWB6SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2SMARCD 10 8 456 0 66.94 1.2133 NaN 4.31E+08
J3KNN5;Q9UJV9;H0Y8L8;H0YA06;D6RGI7J3KNN5;Q9UJV9 Probable ATP-dependent RNA helicase DDX41DDX41 12 12 640 0 35.534 1.2132 NaN 6.29E+08
O15226;O15226-2;A0A087WXT2O15226;O152 6-2NF-kappa-B-repressing factorNKRF 20 20 690 0 86.036 1.2128 0.92709 1.33E+09
P47756-2;B1AK87;B1AK88;P47756;B1AK85P47756-2;B1AK87;B1AK88;P47756;B1AK85F-actin-capping protein subunit betaCAPZB 11 11 272 0 90.988 1.2128 0.89173 3.34E+09
D6REA0;O75879;D6RDU9;H0Y9W6;H0Y8G7;H0Y9F2;B4E0P26REA0;O75879 Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrialPET11 7 7 516 0 20.149 1.2127 0.76084 2.70E+08
P60660-2;F8W1R7;G8JLA2;G3V1V0;P60660;J3KND3;B7Z6Z4;F8VPF3;G3V1Y7;F8VZU9;F8W180;F8VXL3;F8W1I5;P14649;H0YI43P60660-2;F8W1R7;G8JLA2;G3V1V0;P60660;J3KND3;B7Z6Z4;F8VPF3;G3V1Y7Myosin light polypeptide 6MYL ;PDE6H 9 9 151 0 153.76 1.2117 0.87671 4.82E+09
D6RAX7;Q9BT78;D6RFN0;Q9BT78-2;D6RD636RAX7; 9BT78;D6RFN0;Q9BT78-2;D6RD63COP9 signalosome complex subunit 4COPS4 11 11 420 0 66.268 1.2115 0.78228 1.22E+09
P13489;H0YCR7;E9PMJ3;E9PLZ3;E9PIM9;E9PMN0;E9PIK5;E9PMA9;E9PR82;E9PMI1P13489;H0YCR7 Ribonuclease inhibitorRNH1 20 20 461 0 241.85 1.2107 0.81719 1.30E+10
Q99832;Q99832-3;Q99832-4;Q99832-2;F8WAM2;F8WBP8;A0A0D9SG95Q99832;Q99832-3;Q99832-4;Q99 32-2T-complex protein 1 subunit etaCCT7 46 46 543 0 323.31 1.2104 0.58546 3.38E+10
M0R2Z9;Q8IX01-4;Q8IX01;M0R3F6;Q8IX01-3;M0R216;M0R065M0R2Z9;Q8IX01-4;Q8IX01;M0R3F6;Q8IX01-3SURP and G-patch domain containing protein 2SUGP2 19 19 1096 0 251.68 1.2102 0.92714 1.46E+09
Q08211;Q08211-2;REV__H0YA90;REV__Q7Z6J0-3Q08211 ATP-dependent RNA helicase ADHX9 69 69 1270 0 323.31 1.2092 1.0215 4.80E+10
Q9NR50-3;Q9NR50-2;Q9NR50;H0Y580;A0A0D9SEN0Q9NR50-3;Q9NR50-2;Q9NR50;H0Y580Translation initiation factor eIF-2B subunit gammaEIF2B3 11 11 401 0 77.419 1.2088 1.0329 1.65E+09
Q96PE3-2;Q96PE3-4;Q96PE3-3;Q96PE3;B8ZZB2Q96PE3-2;Q96PE3-4;Q96PE3-3;Q96PE3Type I inositol 3,4-bisphosphate 4-phosphataseINPP4A 8 8 938 0 29.611 1.2087 0.77801 5.15E+08
Q3KQV9;Q3KQV9-2Q3KQV9;Q3KQV9-2UDP-N-acetylhexosamine pyrophosphorylase-like protein 1UAP1L1 2 1 507 0.00053036 3.4117 1.2081 NaN 9.40E+07
P43897;P43897-2;C9JT21;C9JG32;F8VPA7;F8VS27;P43897-4;P43897-3P43897;P43897-2;C9JT21Elongation factor Ts, mitochondrial;Elongation factor TsSFM 10 10 325 0 256.07 1.2079 0.61664 7.24E+09
O96011-2;O96011;H7C3V6O96011-2;O96011;H7C3V6Peroxisomal membrane protein 11BPEX11B 4 4 245 0 8.5391 1.2077 0.49243 1.54E+08
P27635;X1WI28;F8W7C6;A0A087WV22;H7C123;H7C2C5;B8A6G2;A6QRI9;Q96L21;H7C2U2P27635;X1WI28;F8W7C6;A0A087WV22;H7C123;H7C2C560S ribosomal protein L10RPL10 16 16 214 0 217.92 1.2072 0.94757 1.65E+10
Q96DT7-2;Q96DT7;Q96DT7-4;Q96DT7-3Q96DT7-2;Q96DT7;Q96DT7-4;Q96DT7-3Zinc finger and BTB domain-containing protein 10ZBTB10 7 7 847 0 63.777 1.2071 1.1429 3.17E+08
O00154-6;O00154-4;O00154-7;O00154;O00154-5;K7EKP8;O00154-2;O00154-3;Q6ZUV0O00154-6;O00154-4;O00154-7;O00154;O0 154-5;K7EKP8;O00154-2;O00154-3Cytosolic acyl coenzyme A thioester hydrolaseACOT7 19 19 329 0 159.24 1.2068 0.81728 1.23E+10
G3V5T0;A0A0C4DFM0;A0A0A0MR33;G3V4T6;G3V267;O43708;O43708-3;O43708-2;G3V3B9;H0YJN8G3V5T ;A0A0C4DFM0;A0A0A0MR33;G3V4T6;G3V267;O43708;O43708-3Maleylacetoacetate isomeraseGSTZ1 7 7 202 0 82.389 1.2066 0.55193 1.82E+09
Q9NZI8;Q9NZI8-2;REV__M0QZ54;REV__M0R118;REV__M0R0M7;Q2L6G8;G8JLG2;REV__A0A087WWS7;REV__Q15833;Q15517Q9NZI8;Q9NZI8-2 Insulin-like growth factor 2 mRNA-binding protein 1IGF2BP1 29 27 577 0 282.61 1.2063 0.9239 1.59E+10
P62701;Q8TD47 P62701 40S ribosomal protein S4, X isoformRPS4X 32 19 263 0 305.3 1.2059 0.80967 3.49E+10
Q9NWT6;E9PNR8;E9PL41Q NWT6 Hypoxia-inducible factor 1-alpha inhibitorHIF1AN 3 3 349 0 19.387 1.2059 0.50624 2.57E+08
Q9NW82;D6RIW8Q9NW82;D6RIW8WD repeat-containing protein 70WDR70 12 12 654 0 120.59 1.2055 0.96747 7.17E+08
Q15042;Q15042-3;Q15042-4;C9J1R5Q15042;Q15042-3;Q15042-4Rab3 GTPase-activating protein catalytic subunitRAB3GAP1 22 22 981 0 205.58 1.2054 0.82394 3.06E+09
G5E933;O95248;O95248-4;H0Y5W8G5E933;O95248;O95248-4Myotubularin-related protein 5SBF1 19 19 1868 0 89.31 1.2042 0.73563 6.53E+08
Q969U7-2;Q969U7;K7ENR6;V9GZ55;K7ER45Q969U7-2;Q969U7;K7ENR6;V9GZ55Proteasome assembly chaperone 2PSMG2 9 9 233 0 34.212 1.2042 0.77985 8.64E+08
P23396;P23396-2;E9PL09;E9PPU1;F2Z2S8;H0YCJ7;H0YF32;E9PQ96;E9PJH4;E9PK82;H0YEU2;E9PSF4;E9PQX2;H0YES8P23396;P23396-2;E9PL09;E9PPU1;F2Z2S8;H0YCJ7;H0YF3240S ribosomal protein 3RPS 34 33 243 0 299.93 1.2039 0.82258 9.63E+10
Q96HA7-2;Q96HA7;A0A087X1F6Q96HA7-2;Q9 HA7;A0A087X1F6Tonsoku-like proteinTONSL 11 11 1378 0 91.903 1.2038 0.90273 3.04E+08
Q92615;A0A087X183;X6RCG6;V9GYI5;B5MCU2Q92615 La-related protein 4BLARP4B 13 9 738 0 100.8 1.2033 0.82122 2.46E+09
B4DK25;H0Y5C2;O95260;B4E107;F5GXE4;O95260-2;Q5SQQ1B4DK25;H0Y5C2;O95260;B4E107;F5GXE4;O95260-2Arginyl-tRNA--protein transferase 1ATE1 3 3 403 0 22.341 1.2027 NaN 6.19E+07
Q9NVI1;Q9NVI1-1;Q9NVI1-2;F8W7R3;H3BP78;H3BMG4;Q9NVI1-4;H3BT54;H3BQE2;H3BN35;H3BS60Q9NVI1;Q9NVI1-1;Q9NVI1-2;F8W7R3;H3BP78Fanconi anemia group I proteinFANCI 50 50 1328 0 323.31 1.2027 0.74028 7.24E+09
Q6N069;Q6N069-4;Q6N069-3;Q6N069-2;Q6N069-5Q6N069;Q6N0 9-4;Q6N0 9-3;Q6N069-2;Q6N069-5N-alpha-acetyltransferase 16, NatA auxiliary subunitNAA16 12 5 864 0 16.818 1.2024 0.53258 2.39E+08
J3KNS1;Q9UPW5;Q9UPW5-2;Q9UPW5-3J3KNS1;Q9UPW5;Q9UPW5-2;Q9UPW5-3Cytosolic carboxypeptidase 1AGTPBP1 8 8 1278 0 71.859 1.202 0.80619 5.10E+08
Q9HBD4;A0A0A0MT49;P51532-5;P51532-2;P51532-3;P51532-4;P51532;A0A0U1RRG6;A0A0U1RRF5;K7EP28;A0A0U1RRD6;A0A0U1RRF8;A0A0A0MSS5;F6UH26;A0A0U1RQU0;A0A0U1RR09;F6XE55;A0A0U1RQW7;A0A0U1RRN2;B1ALG1;A0A0U1RR83;A0A0U1RQX3;F6T8Q0;B1ALG2;A0A0U1RR26;B4DNT1;B1ALF6Q9HBD4;A0A0A0MT49;P51532-5;P51532-2;P51532- ;P51532-4;P51532Transcription activator BRG1SMARCA4 37 22 1679 323.31 1.2018 0.78455 3.58E+09
H7C1A0;Q9HC62-2;Q9HC62H7C1A0;Q9HC62-2;Q9HC62Sentrin-specific protease 2SENP2 1 1 203 0 10.627 1.2016 NaN 5.04E+07
Q13769;F8WCP5;C9JXG5;H7C441;C9JXU6;F5GZF3;C9JCL9;H7C072Q13769;F8WCP5;C9JXG5;H7C441THO complex subunit 5 homologTHOC5 19 19 683 0 136.22 1.2016 0.87 1.51E+09
P62263;H0YB22;E5RH77P62263;H0YB22;E5RH7740S ribosomal protein S14RPS14 11 11 151 0 169.39 1.2009 0.57744 2.80E+10
A8MT37;P49840;M0QYV0A8MT37;P49840;M0QYV0Glycogen synthase kinase-3 alphaGSK3A 8 7 401 0 30.138 1.2008 0.72043 8.25E+08
Q9Y5S2;H0YLY0;A0A0U1RRC3Q9Y5S2;H0YLY0 Serine/threonine-protein kinase MRCK betaCDC42BPB 10 7 1711 0 43.974 1.2007 0.83321 1.92E+08
P85037;P85037-2;U3KQ26P85037;P85037-2Forkhead box protein K1FOX 4 4 733 0 41.069 1.2006 0.93286 6.80E+08
O95487-2;O95487;O95487-3O95487-2;O95487;O95487-3Protein transport protein Sec24BSEC24B 20 20 1233 0 147.88 1.2004 0.80635 2.04E+09
Q8WUY1;H0YAR9 Q8WUY1;H0YAR9 Protein THEM6 THEM6 2 2 208 0 5.6237 1.2 NaN 5.37E+07
P61978;P61978-2P61978;P61978-2Heterogeneous nuclear ribonucleoprotein KHNRNPK 34 2 463 0 323.31 1.1996 0.89435 5.43E+10
Q16795;F5H0J3;H3BRM9;F5GY40Q16795 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrialNDUFA9 9 9 377 0 40.921 1.1995 0.92852 2.55E+09
P35250;P35250-2;A0A087WVY3;H7C5P4;H7C5P1;H7C5Q7;F8WC37;H7C5A0;H7C5G4;H7C596;H7C5S7P35250;P35250-2;A0A087WVY3Replication factor  subunit 2RFC2 17 17 354 0 233.04 1.1994 0.76385 3.39E+09
P41743 P41743 Protein kinase C iota typePRKCI 11 9 596 0 112.91 1.1993 NaN 4.42E+08
A0A0D9SES8;H0YKT5;H0YKN8;H0YL70;Q04726-2;Q04726-7;Q04726-3;Q04726-6;Q04726-5;Q04726-4;Q04726;F5H7D6;H0YNT2;H0YNI7;H0YLI3;H0YKH0;H0YLW9;Q04725-2;H3BUH5;H0YKH5;K7EJR7A0A0D9SES8;H0YKT5;H0YKN8;H0YL70;Q04726-2;Q04726-7;Q04726-3;Q04726-6;Q04726-5;Q04726-4;Q 4726;F5H7D6;H0YNT2;H0YNI7;H0YLI3Transducin-like enhancer protein 3LITAF;TLE3 14 9 772 0 94.81 1.199 0.88372 2.64E+09
Q99613;Q99613-2;B5ME19;H3BPE4;H3BPE3;H3BTY8Q99613;Q99613-2;B5ME19Eukaryotic translation initiation factor 3 subunit C;Eukaryotic translation initiation factor 3 subunit C-like proteinEIF3C;EIF3CL 41 41 913 0 323.31 1.1984 0.83362 1.85E+10
K7ERI7;P35268;K7EMH1;K7ELC4;K7EP65;K7EKS7;K7EJT5K7ERI7 P35268;K7EMH1;K7ELC4;K7EP65;K7EKS760S ribosomal protein L22RPL22 9 7 95 0 104.12 1.1983 0.60319 1.33E+10
Q9Y6Y8;Q9Y6Y8-2;A0A0C4DH82;H7C0V8;H7C4C4;REV__H7BYP9;REV__O15068-5;REV__O15068-4;REV__O15068-3;REV__O15068-2;REV__O15068-6;REV__O15068-8;REV__O15068-10;REV__O15068-9;REV__O15068Q9Y6Y8;Q9Y6Y8-2SEC23-interacting proteinSEC23IP 27 27 1000 0 190.61 1.1979 0.95341 3.92E+ 9
B1AJY7;O75832;B1AJY5;O75832-2;B1AJY6B1AJY7;O75832;B1AJY526S proteasome non-ATPase regulatory subunit 10PSMD10 15 15 193 0 258.16 1.1972 0.50269 1.13E+10
G3V0G5;Q8IV38 G3V0G5;Q8IV38 Ankyrin repeat and MYND domain-containing protein 2ANKMY2 2 2 341 0 20.765 1.1971 0.95347 1.34E+08
Q9Y3A2-2;Q9Y3A2Q9Y3A2-2;Q9Y3A2Probable U3 small nucleolar RNA-associated protein 11UTP11L 2 2 148 0.0049517 2.3198 1.197 NaN 3.65E+06
Q96QK1;I3L4S0;I3L4P4Q96QK1 Vacuolar protein sorting-associated protein 35VPS35 45 45 796 0 323.31 1.196 0.85061 1.66E+10
O75891;O75891-3;O75891-2;O75891-4;C9IZ36;C9JY00;C9JYZ6O75891;O75891-3;O75891-2;O75891-4Cytosolic 10-formyltetrahydrofolate dehydrogenaseALDH1L1 6 2 902 0 20.955 1.1959 0.67364 3.06E+08
Q99623;J3KPX7;F5GY37;Q99623-2;F5GWA7;F5H3X6;F5H0C5;F5H2D2;U3KPZ5Q99623;J3KPX7;F5GY37;Q99623-2; GWA7;F5H3X6Prohibitin-2 PHB2 26 26 299 0 269.51 1.195 0.8146 4.28E+10
P47755;C9JUG7;F8W9N7;P47755-2;A0A0D9SET8P47755;C9JUG7;F8W9N7;P47755-2F-actin-capping protein subunit alpha-2CAPZA2 6 4 286 0 68.764 1.1949 0.96331 1.36E+09
Q2TAY7;Q2TAY7-2Q2TAY7;Q2TAY7-2WD40 repeat-containing protein SMU1;WD40 repeat-containing protein SMU1, N-terminally processedSMU1 22 22 513 0 323.31 1.1949 0.86095 1.22E+10
Q9C0B7 Q9C0B7 Transport and Golgi organization protein 6 homologTANGO6 6 6 1094 0 67.446 1.1949 0.65647 4.15E+08
P61764;P61764-2;A0A0D9SEP9;A0A0D9SG72;A0A0D9SFQ7;A0A0D9SFW6;A0A0D9SEH5;A0A096LP52P61764;P61764-2Syntaxin-binding protein 1STXBP1 10 10 594 0 63.422 1.1944 NaN 4.16E+08
Q9NZ45 Q9NZ45 CDGSH iron-sulfur domain-containing protein 1CISD1 2 2 108 0 16.242 1.1941 0.85513 3.58E+08
A0A087X1H5;Q15057;A0A0U1RQT1;H7C3Q8;H7C3K3;C9J8L1A0A087X1H5; 1505 ;A0A0U1RQT1Arf-G P with coiled-coil, ANK repeat and PH domain-containing protein 2A AP2 10 10 777 0 71.874 1.1934 1.3303 6.20E+08
Q96ST3;H3BNZ3;H3BP90Q96ST3 Paired amphipathic helix protein Sin3aSIN3A 15 15 1273 0 137.92 1.1931 0.78135 9.28E+08
O60942;O60942-4;O60942-2;O60942-3O60942;O60942-4;O60942-2;O60942-3mRNA-capping enzyme;Polynucleotide 5-triphosphatase;mRNA guanylyltransferaseRNGTT 8 8 597 0 43.763 1.1929 NaN 4.03E+08
Q6P3W7;F8VSC5;A0A0U1RQQ9;H0YIK6;F8VPW3Q6P3W7;F8VSC5;A0A0U1RQQ9SCY1-like protein 2SCYL2 14 14 929 0 119.34 1.1924 0.81404 1.54E+09
Q504Q3-2;Q504Q3-3;Q504Q3;F8VXK8Q504Q3-2;Q504Q3-3;Q504Q3PAB-dependent poly(A)-specific ribonuclease subunit PAN2PAN2 11 11 1198 0 56.91 1.1908 0.48051 4.91E+08
A6NJ78;A0A0U1RR76;A6NJ78-2;A0A0U1RRF2;B5MC64;A0A0U1RR64;A0A0U1RRD2;F8WD83;A6NJ78-3;A6NJ78-4A6NJ78 Probable methyltransferase-like protein 15METTL15 5 5 407 0 18.482 1.1906 1.0456 3.29E+08
K7EQ02;K7EQ55;K7EK33;Q96EP5-2;Q96EP5K7EQ02;K7EQ55;K7EK33;Q96EP5-2;Q96EP5DAZ-associated protein 1DAZAP1 7 7 327 0 110.3 1.1906 0.85683 2.72E+09
P30154-4;P30154;P30154-2;P30154-5;P30154-3;H0YDG7;E9PPI5;E9PNM7;E9PHZ6P30154-4;P30154;P30154-2;P 0154-5;P30154-3Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoformPPP2R1B 7 2 556 0 9.6035 1.1906 NaN 1.15E+08
A0A0D9SFR6;Q86XP1-5;Q86XP1-3;Q86XP1-2;Q86XP1A0A0D9SFR6;Q86XP1-5;Q86XP1-3;Q86XP1-2;Q86XP1Diacylglycerol kinase etaDGKH 3 3 1028 0 11.191 1.1903 1.4132 1.09E+08
O15357;O15357-2;A0A0A0MTP6;F5GY16;H7BXR2;H0YFZ4O15357;O15357-2;A0A0A0MTP6Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2INPPL1 6 6 1258 0 19.477 1.1903 0.68833 2.02E+08
J3KNQ4;Q9NVD7;E9PS97;A0A087WZB5;Q9HBI1-3;Q9HBI1;Q9HBI1-2J3KNQ4;Q9NVD7;E9PS97;A0A087WZ 5;Q9HBI1-3;Q9HBI1;Q9HBI1-2Alpha-parvin;Beta-parvinPARVA;PARVB 2 2 412 0 33.582 1.1902 NaN 1.07E+08
P55795 P55795 Heterogeneous nuclear ribonucleoprotein H2;Heterogeneous nuclear ribonucleoprotein H2, N-terminally processedHNRNPH2 17 8 449 0 143.77 1.19 0.85432 5.08E+09
A0A087WX71;Q9H501A0A087WX71;Q9H501ESF1 homolog ESF1 2 2 456 0 10.195 1.1895 0.30625 1.73E+08
A6NHR9;A6NHR9-2;J3KTL8;A6NHR9-3;J3QSH1;J3KRK8A6NHR9;A6NHR9-2;J3KTL8Structural maintenance of chromosomes flexible hinge domain-containing protein 1SMCHD1 50 50 2005 0 323.31 1.1892 0.78657 4.09E+09
Q99598;Q5VVQ1;C4P0D6;C4P0D8Q99598 Q5VVQ1;C4P0D6;C4P0D8Translin-associated protein XTSNAX;DISC1 2 2 290 0 23.413 1.1886 0.97193 4.69E+08
D6RAN4;P32969;E7ESE0;H0Y9V9;H0Y9R4D6RAN4;P32969;E7ESE0;H0Y9V960S ribosomal protein L9RPL9 16 16 182 0 173.14 1.1884 0.95908 2.33E+10
Q2NKX8;B5MDQ0Q2NKX8;B5MDQ0DNA excision repair protein ERCC-6-likeERCC6L 20 20 1250 0 219.96 1.1883 0.96344 1.16E+09
Q13151 Q13151 Heterogeneous nuclear ribonucleoprotein A0HNRNPA0 18 18 305 0 323.31 1.188 1.1209 7.87E+09
Q9Y277;Q9Y277-2;E5RFP6;E5RJN6;E5RHZ6;E5RK27;E5RFL1;E5RHE1Q9Y277;Q9Y277-2Voltage-dependent anion-selective channel protein 3VDAC3 9 9 283 0 190.49 1.1878 0.85882 8.33E+09
Q27J81-2;Q27J81;A0A0A0MQU1;Q27J81-3Q27J81-2; 27J81;A0A0A0MQU1Inverted formin-2 INF2 10 10 1240 0 78.757 1.1875 0.84224 2.39E+08
E9PF18;A0A0A0MSE2;Q16836;Q16836-3;Q16836-2E9PF18;A0A0A0MSE2;Q16836;Q16836-3;Q16836-2Hydroxyacyl-coenzyme A dehydrogenase, mitochondrialHADH 7 7 318 0 75.273 1.1871 1.1762 1.83E+09
Q9NTJ5;F8WCQ2;E9PGZ4;Q9NTJ5-2;C9JV50;F8WDN7Q9NTJ5 F8WCQ2;E9PGZ4;Q9NTJ5-2Phosphatidylinositide phosphatase SAC1SACM1L 6 6 587 0 12.963 1.1871 NaN 8.71E+07
J3KR44;Q96FW1;F5H6Q1;F5GYN4;F5GYJ8;F5H3F0;Q96FW1-2J3KR44;Q96FW1;F5H6Q1;F5GYN4;F5GYJ8;F5H3F0Ubiquitin thioesterase OTUB1OTUB 13 13 272 0 180.99 1.1869 0.92573 1.56E+10
P63096;P63096-2;C9JPP4;C9JL77P63096;P63096-2;C9JPP4Guanine nucleotide-binding protein G(i) subunit alpha-1GNAI1 8 3 354 0 22.158 1.1869 0.8371 7.85E+08
170
D6RBD7;C9J1V9;O43324-2;O43324;H0YAL7;D6RCQ0D6RBD7;C9J1V9;O43324-2;O43324;H0YAL7Eukaryotic translation elongation factor 1 epsilon-1EEF1E1;EEF1E1-BLOC1S5 6 6 150 0 75.989 1.1865 1.1216 1.32E+09
Q9Y450-4;Q9Y450;B7Z524;H0YDX7;J3QT46;E9PHZ9;H0YES5;E9PJ90;E9PN23;E9PS53;G5E991;E9PMN1;E9PLR4;Q9Y450-2Q9Y4 0-4;Q9Y450;B7Z524;H0YDX7;J3QT46H S1-like protein HBS1L 27 27 642 0 181.05 1.1864 0.8498 3.61E+09
E9PEX6;P09622;P09622-3;P09622-2;F8WDM5;F2Z2E3E9PEX6;P0962 ;P09622-3;P0962 -2Dihydrolipoyl dehydrogenase, mitochondrialDLD 15 15 486 0 98.151 1.1863 0.72755 3.64E+09
O14617;O14617-5;O14617-4;O14617-2;O14617-3;A0A087WYN6;K7ELX8;K7ERW8O14617;O146 7-5;O146 7-4;O14617-2;O14617-3AP 3 complex subunit delta-1AP3D1 38 38 1153 0 323.31 1.1863 0.77233 5.91E+09
A0A087X0B7;Q5SQN1;H7C3C7;Q5SQN1-2;U3KPT7;A0A087X2J6;Q5SQN1-4;H0Y627;Q5SQN1-3A0A08 X0B ;H7C3C7;Q5SQN1-2Synaptosomal-associated protein 47S AP47 7 7 419 0 43.64 1.1859 0.86905 5.90E+08
Q9GZL7 Q9GZL7 Ribosome biogenesis protein WDR12WDR12 15 15 423 0 134.94 1.1846 0.95104 4.75E+09
P49916-3;P49916;P49916-4;P49916-2;K7ERZ5;K7EQB6;K7ENR9;K7EJR4P49 16-3;P49 16;P49916-4;P49916-2DNA ligase 3 LIG3 33 33 922 0 323.31 1.1845 0.81502 5.59E+09
Q96SB8;Q96SB8-2;C9JMN1;A0A0A0MRY1Q96SB8;Q96SB8-2;C9JMN1Structural maintenance of chromosomes protein 6SMC6 15 15 1091 0 128.75 1.1845 0.86238 7.91E+08
Q8N5M1;C9J2Q2 Q8N5M1 ATP synthase mitochondrial F1 complex assembly factor 2ATPAF2 3 3 289 0 15.672 1.1843 0.50662 1.98E+08
Q05086-2;Q05086-3;Q05086;A0A0D9SG77;A0A0D9SGI3;A0A0D9SF91;A0A0D9SG63;A0A0D9SES7;S4R306Q05086-2;Q05086-3;Q05086;A0A0D9SG77Ubiquitin-protein ligase E3AUBE3A 16 16 852 0 176.81 1.1841 0.81843 1.20E+09
P11171-2;P11171;Q4VB86;P11171-4;P11171-3;P11171-5;P11171-7;P11171-6;Q4VXN1P11171-2;P11171;Q4VB86;P11171-4;P11171-3;P11171-5;P11171-7;P11171-6Protein 4.1 EPB41 23 20 831 0 121.88 1.1834 0.73098 2.17E+09
O60826 O60826 Coiled-coil domain-containing protein 22CCDC22 12 12 627 0 121.53 1.1833 NaN 5.52E+08
P78316;E9PFK5;P78316-2P78316;E9PFK5;P78316-2Nucleolar protein 14NOP14 9 9 857 0 57.245 1.1833 1.0887 6.39E+08
Q9NTJ3;E9PD53;Q9NTJ3-2;C9JR83;C9J9E4;C9J578;C9JWF0;C9IYK2;C9JJ64;C9JVD8Q9NTJ3;E9PD53;Q9NTJ3-2Structural maintenance of chromosomes protein 4;Structural maintenance of chromosomes proteinSMC4 69 69 1288 0 323.31 1.1833 0.81489 9.87E+09
P08047-3;P08047;H3BUU5;P08047-2P08047-3 ;H3BUU5;P08047-2Transcription factor Sp1SP1 2 2 737 0 94.611 1.1822 0.83304 3.81E+08
A0A087WU53;Q9H0U3;Q9H0U3-2A A087WU53;Q9H0U3;Q9H0U3-2Magnesium transporter protein 1MAGT1 4 4 367 0 33.575 1.1821 1.3445 1.70E+08
P61254;J3KTJ8;J3QRI7;J3QQQ9;J3QQV1;J3QRC4;J3KSS0;J3KS10;H7C1F9;Q2PPJ7-3;Q2PPJ7-2;Q2PPJ7P61254;J3KTJ8;J3 RI7;J3 QQ9;J3QQV1;J3QRC460S ribosomal protein L26RPL26;KRBA2 16 5 145 0 44.027 1.1821 1.5824 3.95E+09
P11498;P11498-2;E9PRE7;E9PS68P11498 Pyruvate carboxylase, mitochondrialPC 27 27 1178 0 206.75 1.1815 0.86015 1.74E+09
P23526;P23526-2P23526;P23526-2AdenosylhomocysteinaseAHCY 31 31 432 0 323.31 1.1811 0.70548 4.33E+10
E9PKP7;P17480-2;P17480;E9PMM2;E9PLT2E9PKP7;P17480-2;P17480Nucleolar transcription factor 1UBTF 11 11 745 0 46.444 1.181 0.98193 1.60E+09
G3V325;O75127;C9JJT5;P56134-4;P56134-2;C9JU26;C9JGL8;C9JWL7;C9JQN9G3V325;O75127 entatricopeptide repeat-containing protein 1, mitochondrialATP5J2 PTCD1;PT D1 10 8 749 0 33.111 1.1807 0.93624 1.66E+09
Q13395 Q13395 Probable methyltransferase TARBP1TARBP1 23 23 1621 0 142.78 1.1806 0.80954 1.49E+09
Q70CQ2-3;Q70CQ2-2;Q70CQ2;A0A0C4DG73;H7C150;H7C183Q70CQ2-3;Q70CQ2-2;Q70CQ2Ubiquitin carboxyl-terminal hydrolase 34USP34 10 10 3312 0 66.112 1.1805 0.95065 2.99E+08
Q9GZS1-2;Q9GZS1;E7EX70Q9GZS1-2;Q9GZS1DNA-directed RNA polymerase I subunit RPA49POLR1E 14 14 419 0 67.51 1.1803 0.72076 1.17E+09
Q9NSI2-2;Q9NSI2;C9JJU7Q NSI2-2;Q9NSI2;C9JJU7Protein FAM207AFAM207A 8 8 215 0 36.225 1.1801 0.80396 5.94E+08
P50851;H0YA17 P50851 Lipopolysaccharide-responsive and beige-like anchor proteinLRBA 35 0 2863 0 182.54 1.1799 0.88894 2.40E+09
O75306-2;O75306O75306-2;O75306NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrialNDUFS2 13 13 457 0 106.17 1.1797 0.83019 3.39E+09
P41252;A0A0A0MSX9;J3KR24;Q5TCD1;Q5TCC6;Q5TCC9P41252;A0A0A0MSX9;J3KR24Isoleucine--tRNA ligase, cytoplasmicIARS 79 79 1262 0 323.31 1.1796 0.88716 5.54E+10
P11274-2;P11274;H0Y554;A9UF01;I3L2P5P11274-2;P11274Breakpoint cluster region proteinBCR 9 8 1227 0 32.431 1.1794 0.88282 6.20E+08
C9JPE1;O43772;F8WEF6C9JPE1;O43772 Mitochondrial carnitine/acylcarnitine carrier proteinSLC25A20 6 6 228 0 15.951 1.1788 0.7375 2.99E+08
Q6NVY1;A0A087WXI1;Q6NVY1-2;B9A058;F8W8A6;B8ZZZ0;H7C1A5;H7C126;H7C400;H7BYI7Q6NVY1;A0A087WXI1;Q6NVY1-2 9A0583-hydroxyisobutyryl-CoA hydrolase, mitochondrialHIBCH 16 16 386 0 128.7 1.1788 0.67614 2.23E+09
H0YFS7;E7EW59;Q9Y467;A9JR48;A0A087WXW6;H3BSM9;A0A140TA74;A0A140TA70;Q9BXA9-3;Q9BXA9-4;Q9NSC2-2;Q9BXA9-2;Q9BXA9;Q9NSC2H0YFS ;E7EW59;Q9Y467Sal-like protein 2 ALL2 3 3 02 0 15.335 1.1786 0.83598 1.46E+08
P11177-2;P11177;P11177-3;C9J634;F8WF02P1 7 -2;P11177;P11177-3;C9J634Pyruvate dehydrogenase E1 component subunit beta, mitochondrialPDHB 16 16 341 0 199.73 1.1785 0.85341 1.76E+10
P24666;G5E9R5;P24666-4;P24666-3;F2Z2Q9P24666;G5E9R5;P24666-4;P24666-3Low molecular weight phosphotyrosine protein phosphataseACP1 9 4 158 0 122.25 1.1785 0.66782 9.26E+09
H3BRM5;H3BV69;H3BNX8;P206743 RM5 H3BV69;H3BNX8;P20674Cytochrome c oxidase subunit 5A, mitochondrialCOX5A 2 2 69 0.0015633 3.0676 1.1784 1.3153 3.90E+07
P40227;P40227-2P40227;P40227-2T-complex protein 1 subunit zetaCCT6A 36 29 531 0 323.31 1.178 0.70252 4.10E+10
O43252 O43252 Bifunctional 3-phosphoadenosine 5-phosphosulfate synthase 1;Sulfate adenylyltransferase;Adenylyl-sulfate kinasePAPSS1 15 15 624 0 165.95 1.1777 NaN 2.44E+09
Q7Z6Z7-2;Q7Z6Z7-3;Q7Z6Z7;H0Y659;A0A087X1S3;Q5H963;A0A087X146;A5YM72-2;A5YM72;A5YM72-4;A5YM72-5;A5YM72-3Q7Z6Z7-2;Q7Z6Z7-3;Q7Z6Z7E  ubiquitin-protein ligase HUWE1HUWE1 107 107 4358 0 323.31 1.1776 0.84913 1.90E+10
J3KN16;Q5VYK3;R4GMY1;R4GMY3;F6XAQ5J3KN16 Q5VYK3 Proteasome-associated protein ECM29 homologKIAA0368;ECM29 46 46 2017 0 323.31 1.1768 0.83296 4.86E+09
Q99459 Q99459 Cell division cycle 5-like proteinCDC5L 20 20 802 0 228.82 1.1761 0.647 2.12E+09
P61224-2;P61224-3;P62834;P61224;F5H823;B7ZB78;F5GZG1;A0A075B6Q0;F5GX62;E7ESV4;A0A0J9YXB3;F5H7Y6;P61224-4;A6NIZ1;F5H4H0;F5GYH7;F5H077;F5GWU8;F5H491;F5H0B7;F5H500;F5H6R7;F5H004;F5GYB5P61224-2;P612 4-3;P62834;P61224;F5H823;B7ZB78;F5GZG1;A0A075B6Q0;F5GX62;E7ESV4;A0A0J9YXB3;F5H7Y6;P61224-4;A6NIZ1Ras-related protein Rap-1b;Ras-related protein Rap-1A;Ras-related protein Rap-1b-like proteinRAP1B;RAP1 3 3 137 0 8.7938 1.176 NaN 7.02E+07
M0R2B7;P28340;M0QZR8;M0QXE6;M0QXQ2;M0QZB4;M0R3H8;M0R2I8R2B7 P28340; 0QZR8DNA polymerase;DNA polymerase delta catalytic subunitPOLD1 43 43 1133 0 323.31 1.1755 0.69587 5.86E+09
P25398 P25398 40S ribosomal protein S12RPS12 10 10 132 0 93.415 1.1745 0.63778 5.21E+09
Q16513;Q16513-3;Q16513-2;Q16513-4;Q16513-5;B1AL79;A0A0A0MRN8;H0Y5V5;H0Y429Q16513;Q165 3-3;Q165 3-2;Q16513-4;Q16513-5;B1AL79Serine/threonine-protein kinase N2PKN2 38 37 984 0 323.31 1.1744 0.76317 7.55E+09
P23528;G3V1A4;E9PK25;E9PP50;E9PQB7;E9PLJ3;E9PS23P23528;G3V1A4;E9PK25;E9PP50;E9PQB7;E9PLJ3;E9PS23Cofilin-1 CFL1 23 19 166 0 323.31 1.1742 0.37148 3.76E+10
A0A0X1KG71;Q8WX92A0A0X1KG71;Q8WX92Negative elongation factor BNELFB 13 13 628 0 45.329 1.1735 NaN 8.20E+08
O95470;H0Y3V8;H7BXL7O95470 Sphingosine-1-phosphate lyase 1SGPL1 9 9 568 0 35.251 1.1735 NaN 2.82E+08
Q9NVM9;Q9NVM9-2;H0YH12;H0YIA9;F5H457;F8VRX9;F5H5W1Q9NVM9;Q9NVM9-2Protein asunder homologASUN 11 11 706 0 50.174 1.173 0.68721 9.77E+08
P15927;P15927-2;P15927-3;Q5TEJ7;Q5TEJ0P15927;P15927-2;P15927-3;Q5TEJ7Replication protein A 32 kDa subunitRPA2 10 10 270 0 126.89 1.1721 0.97308 1.47E+09
Q13425;H7BY41;H0YCS0;A0A140TA73;Q13425-2Q13425;H7BY41;H0YCS0;A0A140TA73;Q13425-2Beta-2-syntrophinSNTB2 2 2 540 0 4.9822 1.1721 NaN 8.98E+07
Q9UGI8-2;Q9UGI8;F8W7T0;H7BYK1Q9UGI8-2;Q9UGI8Testin TES 20 20 412 0 120.07 1.172 0.75445 1.45E+09
Q86VP6;Q86VP6-2;A0A0C4DGH5;H0YH27;Q86VP6-3;F5H6I6Q86VP6;Q86VP6-2;A0A0C4DGH5Cullin-associated NEDD8-dissociated protein 1CAN 1 52 46 1230 0 323.31 1.1717 0.8352 1.90E+10
E7EWP2;E7EPJ7;O75962-5;O75962-2;O75962-4;O75962;F5H228E7EWP2;E7EPJ7;O75962-5;O75962-2;O7 96 -4;O75962;F5H228Triple functional domain proteinTRI 3 3 2309 0 11.437 1.1715 1.209 6.64E+07
Q9NW64-2;Q9NW64;E5RJW4;E5RHA8Q9NW64-2;Q9NW64;E5RJW4Pre-mRNA-splicing factor RBM22RBM22 10 10 371 0 89.62 1.1714 0.97869 1.28E+09
C9J9K3;A0A0C4DG17;P08865;F8WD59C9J9K3;A0A0C4DG17;P08865;F8WD5940S ribosomal protein SARPSA 15 15 264 0 216.08 1.1713 1.1391 6.98E+09
P36954;K7EKS1;K7EK49P36954;K7EKS1 DNA-directed RNA polymerase II subunit RPB9POLR2I 4 4 125 0 36.248 1.1713 0.7308 1.08E+09
J3KQ48;Q9Y3E5 J3KQ48;Q9Y3E5 Peptidyl-tRNA hydrolase 2, mitochondrialPTRH2 4 4 180 0 102.28 1.1711 0.34988 4.88E+08
B4DJ81;P28331-3;P28331-4;P28331-5;P28331;P28331-2B4DJ81;P28331- ;P28331-4;P283 1-5;P28331;P28331-2NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrialNDUFS1 15 15 611 0 99.614 1.171 0.74031 1.21E+09
A3KN83-3;A3KN83-2;A3KN83;A3KN83-4;K7ES28;Q9Y2G9-3;Q9Y2G9A3KN83-3;A3KN83-2;A3KN83;A3KN83-4Protein strawberry notch homolog 1SBNO1 8 8 1391 0 45.634 1.1704 0.90895 3.13E+08
Q9NXC5;Q9NXC5-2;C9JUE6;C9JTV2;C9JAQ1Q9NXC5;Q9NXC5-2WD repeat-containing protein mioMIOS 9 9 875 0 47.303 1.1701 1.1388 5.43E+08
Q9Y4E8-2;Q9Y4E8-3;Q9Y4E8;H0YI31;Q9Y4E8-4;H0YHM4;F8VVY7;F8VZG8;F8W0H4Q9Y4E8-2;Q9Y4E8-3;Q9Y4E8Ubiquitin carboxyl-terminal hydrolase 15USP15 10 9 952 0 200.94 1.1701 0.93951 8.84E+08
Q96I51-2;Q96I51-3;Q96I51;A0A087WT38Q96I51-2;Q96I51-3;Q96I51;A0A087WT38illiams-Beuren syndrome chromosomal region 16 proteinBSCR16 5 5 358 0 20.23 1.17 1.3019 5.53E+07
Q96P11-2;Q96P11;Q96P11-4;Q96P11-5;Q96P11-3;Q63ZY6-5;Q63ZY6;Q63ZY6-6;Q63ZY6-4;Q3KNT7-2;Q63ZY6-2;Q3KNT7-3;Q3KNT7Q96P11-2;Q96P11;Q96P11-4;Q96P11-5Probable 28S rRNA (cytosine-C(5))-methyltransferaseNSUN5 16 16 466 0 63.148 1.1698 0.83402 1.17E+09
Q9Y5M8;H7C4H2;C9J5Z8Q Y M8;H7C4H2 Signal recognition particle receptor subunit betaSRPRB 12 12 271 0 148.93 1.1696 0.7379 3.00E+09
O95202;O95202-2;O95202-3O95202 LETM1 and EF-hand domain-containing protein 1, mitochondrialLETM1 11 11 739 0 64.345 1.1691 0.86379 7.61E+08
P49643;A0A096LP51;P49643-249643 DNA primase large subunitPRIM2 7 7 509 0 35.059 1.169 NaN 6.34E+08
Q8ND04;Q8ND04-2;Q8ND04-3;J3KTD7;J3QRE1Q8ND04;Q8ND04-2;Q8ND04-3Protein SMG8 SMG8 14 14 991 0 249.23 1.1689 0.73745 1.17E+09
P21964-2;P21964;E7EMS6;E7EUU8;H7BZ45;F8WBW9P21964-2;P21964;E EMS6;E7EUU8;H7BZ45Catechol O-methyltransferaseCOMT 19 19 221 0 203.7 1.1688 0.53465 2.66E+09
Q6P1J9 Q6P1J9 Parafibromin CDC73 21 21 531 0 64.512 1.1686 NaN 1.35E+09
Q9Y3Z3;Q9Y3Z3-4;Q9Y3Z3-2;Q9Y3Z3-3Q9Y3Z3;Q9Y3Z3-4;Q9Y3Z3-2;Q9Y3Z3-3Deoxynucleoside triphosphate triphosphohydrolase SAMHD1SAMHD1 25 25 626 0 165.58 1.1686 1.7579 3.83E+09
E9PC66;P17029;B3KRF7E9PC66;P17029;B3KRF7Zinc finger protein with KRAB and SCAN domains 1ZKSCAN1 2 2 527 0 37.08 1.1684 NaN 6.33E+07
O43865;O43865-2;H0Y8B3;Q96HN2-4;Q96HN2-3;C9K0S0O43865;O43865-Putative adenosylhomocysteinase 2AHCYL1 11 7 530 0 42.55 1.1674 NaN 9.27E+08
Q13045-2;J3KS39;K7EP37;K7EP27Q13045-2 Protein flightless-1 homologFLII 36 0 1214 0 12.662 1.1673 NaN 1.10E+08
Q14008-2;Q14008;Q14008-3;E9PQH5;H0YDX5Q14008-2;Q14008;Q14008-3Cytoskeleton-associated protein 5CKAP5 16 16 1972 0 71.282 1.1673 0.58292 1.03E+09
Q9Y316;Q9Y316-2;Q9Y316-3;B5MCI6Q9Y316;Q9Y316-2;Q9Y316-3Protein MEMO1 MEMO1 10 10 297 0 161.17 1.1673 0.8524 1.56E+09
Q96QG7;Q96QG7-2;E9PR67Q96QG7;Q96QG7-2Myotubularin-related protein 9MTMR9 8 8 549 0 17.189 1.1668 0.81265 6.42E+08
Q5VYS8-6;Q5VYS8;X6R3Q3;Q5VYS8-4;Q5VYS8-3;Q5VYS8-2;Q5VYT0;Q5VYS9;A0A0C4DFW3;Q5VYS8-5Q5VYS8-6;Q5VYS8;X6R3Q3;Q5VYS8-4Terminal uridylyltransferase 7ZCCHC6 6 6 1457 0 16.425 1.1667 0.41013 1.97E+08
Q6P3X3;F8WCH1 Q6P3X3 Tetratricopeptide repeat protein 27TTC27 15 15 843 0 125.14 1.1666 0.87148 3.88E+09
P31946-2;A0A0J9YWZ2P31946-2 14-3-3 protein beta/alpha;14-3-3 protein beta/alpha, N-terminally processedYWHAB 14 1 244 0 240.76 1.1661 0.75376 8.13E+08
O60563;O60563-2O60563 Cyclin-T1 CCNT1 13 13 726 0 145.73 1.1659 0.69522 1.72E+09
P53004;C9J1E1 P53004 Biliverdin reductase ABLVRA 21 21 296 0 255.84 1.1658 0.77421 9.17E+09
B0QZ35;E9PC49;Q96EB6;Q96EB6-2B0QZ35;E9PC49;Q96EB6;Q96EB6-2NAD-dependent protein deacetylase sirtuin-1;SirtT1 75 kDa fragmentSIRT1 7 7 444 0 182.68 1.1654 1.0167 5.47E+08
P08754;P11488;P19087;A8MTJ3;A0A087WTB6;A2A2R6;Q5JWD1;H0Y7E8;A0A087WZE5;P38405-3;P38405;P38405-2P08754 Guanine nucleotide-binding protein G(k) subunit alphaGNAI3 12 8 354 0 159.06 1.1652 1.0752 3.16E+09
P55196-1;J3KN01;P55196-2;P55196-3;P55196;P55196-5;Q5TIG5;P55196-6;H0Y7R8;H0Y948;H0Y8L4P5 196-1;J3KN01;P55196-2;P5 196-3;P5 196;P55196-5;Q5TIG5;P551 6-6Afadin MLLT4 19 2 1816 0 129.84 1.1652 0.90783 1.06E+09
Q02790;F5H1U3;F5H120;H0YFG2Q02790 Peptidyl-prolyl cis-trans isomerase FKBP4;Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processedFKBP4 29 29 459 0 323.31 1.1652 0.77231 2.05E+10
Q8TEU7;B7Z7Y1;E9PCH4;Q8TEU7-2;Q8TEU7-4;A0A0A6YYB7;Q8TEU7-5;Q8TEU7-3;D6RE77;A0A0A6YYJ1;Q8TEU7-6Q8TEU7;B7Z7Y1;E9PCH4;Q8TEU7-2;Q8TEU7-4;A0A0A6YYB7;Q8TEU7-5;Q8TEU7-3;D6RE77;A0A0A6YYJ1;Q8TEU7-6Rap guanine nucleotide exchange factor 6RAPGEF6 11 10 601 0 101.94 1.1644 0.58739 6.28E+08
F5GWX5;A0A0C4DGG9;Q14839;Q14839-2;Q8TDI0;K7EMY3;Q12873-2;Q12873;Q12873-3;F5H6N4;F2Z2R5;I3L229;H7C3H7;H7C0J3;K7EPV1;K7ESA5F5 WX5;A0A0C4DGG ;Q14839;Q14839-2Chromodomain-helicase-DNA-binding protein 4CHD4 58 58 1905 0 323.31 1.1636 0.84123 7.73E+09
X6RCC3;A0A087WV97;Q8WU79-2;Q8WU79;Q8WU79-3X6RCC3;A0A087WV97;Q8WU79-2;Q8WU79;Q8WU79-3Stromal membrane-associated protein 2SMAP2 3 2 174 0 7.6907 1.1634 0.88561 2.73E+08
P14625;Q96GW1;H0YIV0;Q58FF3;F8W026P14625 Endoplasmin HSP90B1 45 43 803 0 323.31 1.1629 0.84678 1.60E+10
Q8IWV7;A0A087WTJ9;Q8IWV7-2;A0A0C4DGM0;H3BUC4;H3BS20;H3BNQ6;H3BUZ4;H3BQF8Q8IWV7;A0A087WTJ9E3 ubiquitin-protein ligase UBR1BR1 19 19 1749 0 87.337 1.1628 0.76536 1.08E+09
P48729-3;P48729;P48729-2;D6REM4;Q8N752;E7ETM0;E5RG27;D6RGE5;H0Y9X2;U3KQK7;U3KQ83;U3KPX3P48729-3;P48729;P48729-2;D6RE 4;Q8N752;E7ETM0Casein kinase I isoform alpha;Casein kinase I isoform alpha-likeCSNK1A1;CSNK1A1L 6 6 325 0 14.841 1.1626 0.85627 1.69E+08
Q7L576;A0A0G2JR96;A0A0G2JQT1;Q7L576-2;Q7L576-3;A0A0G2JQH3;A0A087WVZ5;H0YL50;A0A0G2JRX2;A0A087WU52;A0A0G2JRV9;A0A087WWL1;A0A087X0D6;A0A087WV63;A0A0G2JRF5;A0A087WWY5Q7L576;A0A0G2JR96;A0A0G2JQT1;Q7L576-2Cytoplasmic FMR1 interacting protein 1CYFIP1 53 32 1253 286.01 1.1623 0.80876 9.26E+09
Q96RP9;C9IZ01;F8WAU4;C9JA25;H7C5M4Q96RP9;C9IZ01;F8WAUElongation factor G, mitochondrialFM1 30 1 751 0 149.13 1.1621 0.86894 7.53E+09
P55265-5;P55265;P55265-4P5 265-5;P55265;P55265-4Double-stranded RNA-specific adenosine deaminaseADAR 52 3 931 0 316.68 1.1618 0.75619 1.50E+10
Q9Y6V7;Q9Y6V7-2;M0R1S3;M0QZC0;M0R0K1Q9Y6V7 Probable ATP-dependent RNA helicase DDX49DDX49 7 7 483 0 22.698 1.1618 0.7442 6.82E+08
Q9Y547;A6NIR2;X6R7Y7Q9Y547;A6NIR2;X6R7Y7Intraflagellar transport protein 25 homologHSPB11 2 2 144 0 72.463 1.1615 1.2883 7.51E+08
J3KMZ8;Q92785;Q92785-2;E9PN04J3KMZ8;Q92785;Q92785-2Zinc finger protein ubi-d4DPF2 8 8 405 0 53.561 1.1614 0.63867 1.07E+09
P36404;V9GYD0;P36404-2P36404;V9GYD0;P36404-2ADP-ribosylation factor-like protein 2ARL2;ARL2-SNX15 11 11 184 0 129.7 1.1611 0.77725 2.35E+09
O43747;O43747-2;H3BNR4;H3BR36;H3BUN9;B4DGE1;H3BN71;B3KNW1;H3BRM7;H3BN75;H3BNN2;H3BS13;H3BV30O43747;O43747-2AP-1 complex subunit gamma-1AP1G1 29 29 822 0 323.31 1.1609 0.8122 7.78E+09
Q8N1G4 Q8N1G4 Leucine-rich repeat-containing protein 47LRRC47 25 25 583 0 201.38 1.1602 1.1373 6.40E+09
E9PDF6;O43795;O43795-2;H7C2Y7;E7EQD9;C9JYW1;A0A0U1RRI3;C9JUP5;Q9UBC5;C9K0I9;G3V342E9PDF6;O43795;O43795-2Unconventional myosin-IbMYO1B 23 23 1107 0 185.24 1.1601 0.73008 2.87E+09
P68363;P68363-2P68363;P68363-2Tubulin alpha-1B chainTUBA1B 41 0 451 0 323.31 1.1601 0.90292 4.61E+11
A0A087WY12;Q9BQT8-2;Q9BQT8A0A087WY12;Q9BQT8-2;Q9BQT8Mitochondrial 2-oxodicarboxylate carrierSLC25A21 3 3 234 0 15.294 1.1598 0.57643 7.06E+07
O75934 O75934 Pre-mRNA-splicing factor SPF27BCAS2 9 9 225 0 84.368 1.1595 0.647 1.13E+09
171
A3KMH1-3;A3KMH1;A3KMH1-2A3KMH1-3;A3KMH1;A3KMH1-2von Willebrand factor A domain-containing protein 8VWA8 21 21 1872 0 112.44 1.1593 0.68449 8.92E+08
E7EU96;Q5U5J2;P68400;Q8NEV1;P68400-2;V9GYA2;V9GY80;A0A087WY74E7EU96;Q5U5J2;P68400;Q8NEV1;P68400-2Casein kinase II subunit alpha;Casein kinase II subunit alpha 3CSNK2A1;CSNK2A3 16 16 385 0 323.31 1.1591 0.80607 8.86E+09
Q9H2G2-2;Q9H2G2;O94804;H0YB71Q9H2G2-2;Q9H2G2STE20-like serine/threonine-protein kinaseSLK 20 20 1204 0 151.56 1.1587 0.832 5.39E+08
Q9NVV0;H7C3B3;A0A0A0MRS4;H7C4C1Q9NVV0;H7C3B3;A0A0A0MRS4Trimeric intracellular cation channel type BTMEM38B 3 3 291 0 31.134 1.1586 0.40328 1.20E+08
P25786;P25786-2;F5GX11;B4DEV8;F5H112P2 786;P25786-2;F5GX11;B4DEV8Proteasome subunit alpha type-1;Proteasome subunit alpha typePSMA1 16 16 263 0 95.639 1.1581 0.71591 3.45E+09
P26374 P26374 Rab proteins geranylgeranyltransferase component A 2CHML 4 4 656 0 11.649 1.1581 1.0793 7.35E+08
Q13315;E9PIN0;E9PRG7;Q6P7P1;M0QXY8;E9PIQ5;H0YDU7;A0A087X0E9Q13315 Serine-protein kinase ATMATM 21 21 3056 0 117.54 1.1578 0.82164 6.68E+08
Q8N3C0;Q8N3C0-4;E5RFZ0;Q8N3C0-3;J3KNJ4Q8N3C0 Activating signal cointegrator 1 complex subunit 3ASCC3 55 55 2202 0 323.31 1.1568 0.83251 3.96E+09
P43490;A0A0C4DFS8;C9JG65;C9JF35P43490;A0A0C4DFS8Nicotinamide phosphoribosyltransferaseNAMPT 30 30 491 0 323.31 1.1562 0.7229 3.10E+10
Q96KR1;H0Y8W1 Q96KR1 Zinc finger RNA-binding proteinZFR 29 29 1074 0 323.31 1.1557 0.70227 2.19E+09
E9PKT9;O96033 E9PKT9;O96033 Molybdopterin synthase sulfur carrier subunitMOCS2 2 2 83 0.0030449 2.6564 1.1553 NaN 2.99E+08
Q9BXW9;Q9BXW9-1;Q9BXW9-3;H7BZJ7;Q9BXW9-4Q9BXW9;Q BXW9-1;Q9BXW9-3Fanconi anemia group D2 proteinFANCD2 18 18 1451 0 110.56 1.1546 0.89831 8.60E+08
Q13123;E7EQZ7;D6REL4;Q9H4P6;A0A0C4DGW5Q13123;E7EQZ7 Protein Red IK 10 10 557 0 76.217 1.1544 NaN 6.45E+08
O95347;O95347-2;Q5T821;A0A0C4DGE5O95347;O95347-2Structural maintenance of chromosomes protein 2SMC2 53 53 1197 0 323.31 1.1539 0.88634 7.76E+09
Q9Y2I7;E9PDH4;Q9Y2I7-2;Q9Y2I7-3;Q9Y2I7-4;F8WEZ0;C9JL08Q9Y2I7;E9PDH4 1-phosphatidylinositol 3-phosphate 5-kinasePIKFYVE 12 12 2098 0 36.008 1.1537 0.71416 3.82E+08
P62249;M0R210;A0A087WZ27;M0R3H0;M0R1M5;Q6IPX4;M0QX76P62249;M0R210;A0A 87WZ27;M0R3H04 S ribosomal protein S16PS16 23 23 146 0 83.554 1.1536 0.9049 3.58E+10
Q7L0Y3;C9JVB6 Q7L0Y3;C9JVB6 Mitochondrial ribonuclease P protein 1TRMT10C 13 13 403 0 140.29 1.1535 0.91256 1.93E+09
A0A087WTU3;Q9Y6I9A0A087WTU3;Q9Y6I9Testis-expressed sequence 264 proteinTEX264 2 2 239 0 4.8707 1.1532 0.76052 8.37E+07
Q8N1G0-2;Q8N1G0;H0Y5I5;F8WCX2Q8N1G0-2;Q8N1G0;H0Y5I5;F8WCX2Zinc finger protein 687ZNF687 4 4 1103 0 10.965 1.153 1.1965 1.39E+08
Q0PNE2;C9IYN7;Q0PNE2-2;C9J9N8;C9JEX8;C9JLH5;C9JA82;C9J2D6;F8WE64;H7BZM9Q0PNE2;C9IYN7;Q0PNE2-2;C9J9N8;C9JEX8;C9JLH5;C9JA82;C9J2D6Elongator complex protein 6ELP6 7 7 266 0 50.403 1.1529 0.84318 3.98E+08
Q92499;F1T0B3;A0A087X2G1;Q92499-2;Q92499-3Q92499;F1T0B3;A0A087X2G1;Q92499-2;Q92499-3ATP dependent RNA helicase DDX1DDX1 37 37 740 0 323.31 1.1526 0.93866 1.17E+10
Q92541;H0YKX1 Q92541 RNA polymerase-associated protein RTF1 homologRTF1 11 11 710 0 61.965 1.1519 0.82259 7.85E+08
Q2TAM5;E9PKH5;A0A087X0W8;Q04206-2;Q04206-3;Q04206;Q04206-4;E9PI38;E9PQS6;E9PKV4;A0A087WVP0;E9PMD5;E9PJR1;E9PRX2;E9PNV4Q2TAM5;E9PKH5;A0A087X W8;Q042 6-2;Q04206-3;Q04206;Q0420 -4;E9PI38;E9PQS6;E9PKV4;A0A087WVP0Transcription factor p 5RELA 8 8 37 0 28.457 1.1518 NaN 7.72E+08
Q9BSJ2;Q9BSJ2-4;F2Z2B9;Q9BSJ2-3;B3KTU7;R4GMM4Q9BSJ2; 9 SJ2-4;F2Z2B9;Q9BSJ2-3Gamma-tubulin complex component 2TUBGCP2 32 32 902 0 323.31 1.1517 0.79808 5.36E+09
F2Z2U4;Q9Y4A5-2;Q9Y4A5;H0Y4W2F2Z2U4;Q9Y4A5- ;Q9Y4A5;H0Y4W2Transformation/transcription domain-associated proteinTRRAP 48 48 3848 0 176.1 1.1514 0.7615 1.80E+09
Q5JVZ5;Q96JJ3;Q96JJ3-3;H0YCM7;Q5JVZ8;Q5JW01;Q5JVZ4;H7C0S6;H7C3P3;H7C0N5;Q92556-3Q5JVZ5 Q96JJ3;Q96 J3-3;H0YCM7Engulfment and cell motility protein 2ELMO2 9 7 718 0 45.373 1.1512 0.79673 4.34E+08
P42766;F2Z388 P42766;F2Z388 60S ribosomal protein L35RPL35 8 8 123 0 57.376 1.1508 0.69406 2.56E+09
A0A0A0MTH3;Q13418;Q13418-3;Q13418-2;A0A087WWY6;E9PQ52;A0A087WW45A0A0A0MTH3;Q13418;Q13418-3;Q13418-2Integrin-linked protein kinaseILK 16 16 483 0 76.87 1.1507 0.80133 2.44E+09
E9PGT6;Q99627-2;Q99627;H7C3S9E9PGT6;Q99627-2;Q99627;H7C3S9COP  signalosome complex subunit 8COPS8 3 3 173 0 48.505 1.1506 0.9071 3.83E+08
Q86U44;F5H6D8;B4DTN4;H0YFV6;B4E349;Q86U44-2Q86U4 ;F5H6D8;B4DTN4;H0YFV6N6-adenosine-methyltransferase 70 kDa subunitMETTL3 7 7 580 0 31.304 1.1504 NaN 4.46E+08
P45880;A0A0A0MR02;P45880-2;P45880-1;Q5JSD2;Q5JSD1;A2A3S1P45880;A0A0A0MR02;P45880-2;P4 880-1;Q5JSD2;Q5JSD1Voltage-dependent anion-selective channel protein 2VDAC2 13 13 294 0 323.31 1.1503 1.0763 1.15E+10
E7ESY4;Q13330-3;Q13330;H0Y4T7;Q13330-2;F8W9Y9;H7C3F3E7ESY4;Q13330-3;Q13330;H0Y4T7;Q13330-2Metastasis-associated protein MTA1MTA1 13 8 703 0 82.875 1.1502 1.1242 1.31E+09
Q7Z3B4-3;Q7Z3B4;Q7Z3B4-2Q7Z3B4-3;Q7Z3B4;Q7Z3B4-2Nucleoporin p54 NUP54 10 10 459 0 103.86 1.1498 NaN 3.68E+08
Q9HBH5;C9J2C7 Q9HBH5 Retinol dehydrogenase 14RDH14 5 5 336 0 35.776 1.1497 1.0478 4.96E+08
P26639;P26639-2;D6R9F8;D6RCA5;D6RDJ6;D6RBR8;D6RJ97;D6RHV7;D6RCS6P2 639;P2 639-2Threonine--t NA ligase, cytoplasmicTARS 50 46 723 0 323.31 1.1496 0.7993 2.95E+10
P62873;P62873-2;B1AKQ8;F6UT28;F6X3N5;B3KVK2;F5H8J8;F5H100;F5H0S8;E9PCP0;P16520-2;P16520P62873;P62873-2;B1AKQ8;F6UT28;F6X3N5Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-GNB1 10 4 340 0 129.79 1.1496 0.7225 2.25E+09
Q9NUQ8-2;Q9NUQ89NUQ8-2;Q9NUQ8ATP-binding cassette sub-family F member 3ABCF3 14 14 703 0 87.796 1.1495 0.90992 1.10E+09
Q5TFE4;Q5TFE4-2;Q5QPD0;H0YDA55TFE4;Q5TFE4-2 5-nucleotidase domain-containing protein 1NT5DC1 19 19 455 0 187.57 1.1489 0.66672 4.34E+09
P21359-2;P21359-6;P21359;H0Y465;J3KSB5;P21359-4;P21359-3;P21359-5;J3QSG6;J3KRT8;J3QQN8;K7EID4;K7EP94;J3QLS2;J3KSX8P21359-2;P21359-6;P213 9;H0Y465;J3KSB ;P21359-4Neurofibromin;Neurofibromin truncatedNF1 36 36 2818 0 189.95 1.1486 0.86806 2.52E+09
P49411;H3BNU3 P49411 Elongation factor Tu, mitochondrialUFM 32 32 452 0 323.31 1.1486 0.6881 5.04E+10
P02545-2;Q3BDU5;P02545-6;Q5TCI8;H0YAB0P02545-2;Q3BDU5;P02545-6;Q5TCI8Prelamin-A/C;Lamin-A/CLMNA 19 1 572 0 28.075 1.1485 NaN 4.93E+07
O43615;M0QXU7;M0R301;M0QXM9;M0R124O43615;M0QXU7Mitochondrial import inner membrane translocase subunit TIM44TIMM44 23 23 452 0 148.67 1.1484 0.84441 5.34E+09
O95456-2;O95456;F8WBH7O95456-2;O95456Proteasome assembly chaperone 1PSMG1 8 8 267 0 33.78 1.1482 0.81024 2.99E+09
P62195;P62195-2;J3QQM1;J3QSA9;J3KRP2;J3QLH6;J3QSE0;J3QRW1;J3QRR3;J3KTQ9P62195;P62195-2;J3QQM1;J3QSA9;J3KRP2;J3QLH626S protease regulatory subunit 8PSMC5 29 28 406 0 323.31 1.1481 0.78921 1.79E+10
Q9Y2L1;Q9Y2L1-2;G3V1J5;F2Z2C0Q9Y2L1;Q9Y2L1-2;G3V1J5;F2Z2C0Exosome complex exonuclease RRP44DIS3 58 58 958 0 323.31 1.1481 0.78147 2.99E+10
Q02978;I3L1P8;Q02978-2Q02978;I3L1P8;Q02978-2Mitochondrial 2-oxoglutarate/malate carrier proteinSLC25A11 21 21 314 0 312.26 1.1476 0.81288 2.36E+10
Q96DG6 Q96DG6 Carboxymethylenebutenolidase homologCMBL 8 8 245 0 17.735 1.1474 0.63826 3.20E+08
P23919;P23919-2;H7BZ20;H7C312;G5E9E9;H7C3A4P23919;P23919-2;H7BZ20;H7C312Thymidylate kinaseDTYMK 15 15 212 0 47.668 1.1471 0.59714 2.20E+09
Q16822;B4DW73;H0YML5;H0YM31;A0A0A0MS74;Q16822-2;H0YNG4;H0YMA5;H0YMU6;P35558;P35558-2Q16822;B4DW73;H YML5;H0YM3Phosphoenolpyruvate carboxykinase [GTP], mitochondrialPCK2 26 26 640 0 150.17 1.1469 1.2215 5.25E+09
E5KLK1;E5KLJ6;E5KLJ9;E5KLJ5;O60313;O60313-2;H7C141;H7C3G2;H7C321E5KLK1;E5KLJ6;E5KLJ9;E5KLJ5;O60313;O60313-Dynamin-like 12  kDa protein, mitochondrial;Dynamin-like 120 kDa protein, form S1OPA 13 13 961 0 48.882 1.1467 0.67062 7.43E+08
O15160;O15160-2;E7EQB9;D6RDJ3;H0Y723O15160;O15160-2;E7EQB9DNA-directed RNA polymerases I and III subunit RPAC1POLR1C 9 9 346 0 64.569 1.1467 1.0219 3.50E+09
Q9Y2U8 Q9Y2U8 Inner nuclear membrane protein Man1LEMD3 3 3 911 0 13.995 1.1467 0.94867 1.30E+08
P14923;C9JTX4;C9J826;C9JK18;C9JKY1;C9JPI2;K7ERP3P14923 unction plakoglobinJUP 21 19 745 0 156.35 1.1465 0.86971 2.33E+09
Q05655;Q05655-2;C9J9P1;C9K0E3;C9JZU8Q05655;Q05655-2Protein kinase C delta type;Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunitPRKCD 9 9 676 0 46.335 1.1462 0.78701 7.19E+08
Q9Y4U1;A0A0C4DGU2Q9Y4U1;A0A0C4DGU2Methylmalonic aciduria and homocystinuria type C proteinMMACHC 3 3 282 0 14.168 1.1462 0.4135 8.61E+07
P41250;H7C443;F8WCK4P41250 Glycine--tRNA ligaseGARS 40 40 739 0 323.31 1.1461 0.79187 2.64E+10
Q7Z2T5;Q7Z2T5-2;X6RK96Q7Z2T5;Q7Z2T5-2TRMT1-like proteinTRMT1L 23 23 733 0 318.25 1.1453 0.84762 3.23E+09
P53618;E9PP73;E9PP63;E9PKQ1P53 18;E9PP73 Coatomer subunit betaCOPB1 54 54 953 0 323.31 1.145 0.85521 3.86E+10
A0A0B4J1V9;Q9NRZ9-2;Q9NRZ9;Q9NRZ9-5;Q9NRZ9-4;Q9NRZ9-3;F6XU50;Q9NRZ9-6;A0A087WSW7;Q9NRZ9-7;Q9NRZ9-8;Q9NW36;B1ALG6;Q9NRZ9-9;Q76H82A0A0B4J1V9;Q9NRZ9-2;Q9NRZ9;Q9NRZ9-5;Q9NRZ9-4;Q9NRZ9-3;F6XU50;Q9NRZ9-6;A0A08 WSW7Lymphoid-specific helicaseHELLS 18 18 84 0 51.2 7 1.1446 0.79323 1.05E+09
P35579;P35579-2;Q5BKV1;B1AH99;REV__S4R3H4;REV__E7EQT4;REV__Q9UKV3-5;REV__Q9UKV3;A0A087X0T3;P13535;Q9UKX3;Q9Y623;P13533;P12882;P11055;Q9UKX2;A7E2Y1P3 579;P35579-2Myosin-9 MYH9 123 100 1960 0 323.31 1.1444 0.89427 5.68E+10
A0A0C4DGT3;A0A087WWK8;Q6DN90-2;Q6DN90A0A0C4DGT3;A0A087WWK8;Q6DN90-2;Q6DN90IQ motif and SEC7 domain-containing protein 1IQSEC1 3 3 814 0 34.018 1.1443 NaN 8.51E+07
P62316;P62316-2;K7ERG4;K7EJB5P62316;P62316-2;K7ERG4Small nuclear ribonucleoprotein Sm D2SNRPD2 14 14 118 0 159.96 1.1442 0.80387 4.58E+09
Q9HBD1-6;Q9HBD1-4;Q9HBD1;A6NHN2;Q9HBD1-2;Q9HBD1-3;Q5TC82-2;Q5TC82;H0Y5D9Q9HBD1-6;Q9HBD1-4;Q9HBD1;A6NHN2;Q9HBD1-2;Q9HBD1-3;Q5TC82-2;Q5TC82Roquin-2;Roquin-1RC3H2;RC3H1 3 3 869 0 11.979 1.1439 NaN 7.94E+07
Q96PK6;Q96PK6-2;A0A0A6YYI9;F8WDX3;A0A0A0MSL8;B8ZZ74;Q96PK6-3;Q96PK6-4Q96PK6 RNA-binding protein 14RBM14 27 21 669 0 160.69 1.1437 0.72858 3.12E+09
Q13618-2;Q13618;Q13618-3;A0A087WTG3;H7C1L6;H7C399;A0A087X1R9Q13618-2;Q1361 ;Q13618-3Cullin-3 CUL3 16 16 744 0 140.54 1.1435 1.0507 9.16E+08
Q8WUM4;Q8WUM4-2;Q8WUM4-3;C9IZF9;F8WEQ7;F8WBR8;F8WDK9Q8WUM4;Q8WUM4-2Programmed cell death 6-interacting proteinPDCD IP 56 56 868 0 323.31 1.1435 0.76722 1.87E+10
P30153;B3KQV6;C9J9C1;E9PH38;M0QXG4;M0R0K6P30153;B3KQV6 Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoformPPP2R1A 23 18 589 0 185.54 1.1431 0.51146 2.07E+09
Q12955-5;Q12955-4;Q12955;Q12955-7;A0A087WZ65;A0A087WTF3;Q12955-6;A0A087WUY3;H0Y3A4;A0A087WWI5;H0YA66;H0YAH5;A0A087WTE8;A0A087WVC2;H0Y951;A0A087WX55;A0A087WY90;D6RHY3;A0A087X0B4Q12955-5;Q12955-4;Q12955;Q129 5-7;A0A087WZ65;A0A087WTF3;Q12955-6;A0 087WUY3Ankyrin-3 ANK3 15 14 1861 132.45 1. 431 0.72906 1.14E+09
O95340;O95340-2O95340;O95340-2Bifunctional 3-phosphoadenosine 5-phosphosulfate synthase 2;Sulfate adenylyltransferase;Adenylyl-sulfate kinasePAPSS2 8 8 614 0 45.371 1.143 NaN 8.98E+08
K7ENF0 K7ENF0 NARS 2 2 47 0 8.1512 1.1429 NaN 2.08E+08
O60684;Q5TFJ7;S4R3E5;H0Y3K0O60684;Q5TFJ7 Importin subunit alpha-7KPNA6 16 8 536 0 156.08 1.1429 NaN 2.33E+09
Q9UKB1-2;Q9UKB1-3;Q9UKB1Q9UKB1-2;Q9UKB1-3;Q9UKB1F-box/WD repeat-containing protein 11FBXW11 4 1 508 0 10.686 1.1428 0.55371 9.07E+07
O14920-4;O14920-2;O14920;G3V105;E5RGW5;O14920-3O14920-4;O14920-2;O14920;G3V105;E5RGW5Inhibitor of nuclear factor kappa-B kinase subunit betaIKBKB 6 5 697 0 14.681 1.1414 0.78614 2.75E+08
P53582;H0Y955;H0Y903;H0YAI3P53582;H0Y955 Methionine aminopeptidase 1METAP1 7 7 386 0 49.167 1.141 0.71648 5.77E+08
Q9Y3D8;A0A087WVD7;Q9Y3D8-2;D6RDH4;A0A087WY94Q9Y3D8;A0A087WVD7;Q9Y3D8-2;D6RDH4Adenylate kinase isoenzyme 6AK6;TAF9 5 5 172 0 20.934 1.1409 1.0656 1.65E+09
P28288;P28288-2;P28288-3P2828 ;P28288-2ATP-binding cassette sub-family D member 3ABCD3 31 31 659 0 211.81 1.1408 NaN 6.26E+09
P35244;B5MC59 P35244;B5MC59 Replication protein A 14 kDa subunitRPA3 5 5 121 0 216.03 1.1408 0.8221 8.42E+08
Q9H1D9 Q9H1D9 DNA-directed RNA polymerase III subunit RPC6POLR3F 6 6 316 0 22.599 1.1407 0.78856 7.14E+08
F5GWT4;Q9H4A3-2;Q9H4A3;Q9H4A3-5;Q9H4A3-6;Q9H4A3-7;F6UYG0;A6PVV2;F8W9F9;H0Y7T5;Q9Y3S1-3;Q9Y3S1-2;Q9Y3S1-4;Q9Y3S1;K7ENT7;A0A087WYK2;Q96J92-2;Q96J92-3;Q96J92;Q9BYP7-3;Q9BYP7-4;Q9BYP7-2;Q9BYP7;Q9H4A3-4F5GWT4;Q9H4A3-2;Q9H4A3;Q9H4A3-5;Q9H4A3-6;Q9H4A3-7;F6UYG0Serine/threonine-protein kinase WNK1WNK1 7 7 2134 0 17.207 1.1404 0.7936 1.98E+08
Q6YN16;Q6YN16-2Q6YN16;Q6YN16-2Hydroxysteroid dehydrogenase-like protein 2HSDL2 15 15 418 0 88.34 1.14 0.66983 2.41E+09
G5E9X5;E9PG35;E9PHF7;Q96RQ3;F5GYT8G5E9X5;E9PG35;E9PHF7;Q96RQ3;F5GYT8Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrialMCCC1 8 8 434 0 82.604 1.1396 0.67199 6.68E+08
Q5SNT2-2;Q5SNT2;H0Y4R5Q5SNT2-2;Q5SNT2;H0Y4R5Transmembrane protein 201TMEM201 3 3 392 0 19.534 1.1396 1.2176 2.40E+08
Q9Y3B2;R4GMQ7;B1AMU7;B1AMU3;B1AMU4;R4GNH9Q9Y3B2;R4GMQ7;B1AMU7;B1AMU3;B1AMU4;R4GNH9Exosome complex component CSL4EXOSC1 7 7 195 0 48.146 1.1391 0.84333 1.54E+09
Q86TP1;Q86TP1-2;Q86TP1-4;Q86TP1-3;Q86TP1-5;Q5SZG1;Q86TP1-7;Q5SZF2;Q86TP1-6Q86TP1;Q86TP1-2;Q86TP1-4;Q86TP1-3;Q86TP1-5Protein prune homologPRUNE 13 13 453 0 87.937 1.1389 0.70083 1.16E+09
P46783;F6U211;S4R435;Q9NQ39P46783;F6U211;S4R435;Q9NQ3940S ribosomal protein S10;Putative 40S ribosomal protein S10-likeRPS10;RPS10-NUDT3;RPS10P5 13 12 165 0 92.838 1.1387 0.73519 6.38E+09
P07992-2;P07992;P07992-4;K7ER60;K7ER89;K7EP14;P07992-3;K7ES46;K7EMT9;K7EK97P079 2-2;P0 992;P0 992-4;K7ER60;K ER89;K7EP14;P07992-3DNA excision repair protein ERCC-ERCC1 5 5 273 0 18.229 1.1385 0.97107 2.46E+08
Q92597;Q92597-3;Q92597-2;E5RJY1;E7ESM1;E5RIR1;E5RGM5;E5RIV1;E5RIM2;E5RI76;E5RH82;E5RK17;E5RJ98;E5RG99Q92597;Q92597-3;Q92597-2Protein NDRG1 ND 1 7 7 394 0 66.801 1.1381 0.78057 8.79E+08
Q9BTY7;E9PIX0 Q9BTY7 Protein HGH1 homologHGH1 5 5 390 0 25.948 1.1381 0.88688 6.52E+08
P51157-3;P51157-2;P51157;H0Y9G4;Q8WVF3;H0Y9S6P51157-3;P51157-2;P51157; 0Y9G4;Q8WVF3;H0Y9S6Ras-related protein Rab-28RAB28 2 2 204 0 25.311 1.138 NaN 4.63E+07
Q9Y6J9;E9PP94 Q9Y6J9 TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6LTAF6L 4 4 622 0 23.596 1.1379 NaN 1.78E+08
O00311;B1AMW7O00311 Cell division cycle 7-related protein kinaseCDC7 9 9 574 0 20.875 1.1378 NaN 1.96E+08
Q9H9A6 Q9H9A6 Leucine-rich repeat-containing protein 40LRRC40 31 31 602 0 323.31 1.1378 0.54137 8.92E+09
E7EQR4;P15311;P26038;P35241;P35241-5;P35241-4;V9GZ54;E9PQ82;E9PNV3;P35241-3E7EQR4;P15311;P26038;P35241;P35241- ;P35241-4Ezrin;Moesin;RadixinEZR;MSN;RDX 4 4 586 0 12.187 1.1375 NaN 2.36E+08
Q9C0D5-2;Q9C0D5;A0A0A0MSM4Q9C0D5-2;Q9C0D5Protein TANC1 TANC1 5 5 1755 0 11.423 1.1372 0.676 2.09E+08
A0A087X2I1;P62333;H0YJC0;H0YJS8;H0YJX2;H0YJE9;H0YJT1;H0YJD2;H0YJY8A0A087X2I1;P62333;H0YJC0;H0YJS826S protease regulatory subunit 10BPSMC6 22 22 403 0 224.7 1.137 0.88245 1.51E+10
Q9UPT9-2;Q9UPT9;A6NNY8;K7ESK0;K7ERX6;J3QS30Q9UPT9-2;Q9UPT9;A6NNY8Ubiquitin carboxyl-terminal hydrolase 22;Ubiquitin carboxyl-terminal hydrolase 27USP22;USP27X 10 10 513 0 117 1.137 NaN 9.29E+08
A0A087WY00;G3V394;F8WE88;F8W6H6;Q9Y4I1-2;Q9Y4I1;Q9Y4I1-3;H0YMK3;Q9NQX4-2;H0YM93;H0YM96;Q9UES5;O95317;E7ERV5;Q7Z7A5;Q9ULV0A0A087 Y00 G3V394;F8WE88;F8W6H6 2 Q9 4I1;Q9Y4I1-3Unconventional myosin-VaMYO5A 7 5 1828 0 49.24 1.1369 1.1256 1.33E+08
C9JK83;O95630-2;O95630;F5H5B9;C9JZ93;C9JEK5C9JK83;O9 630-2;O956 0;F5H5B9;C9JZ93;C9JEK5STAM-binding proteinSTAMBP 5 5 318 0 11.038 1.1369 0.84586 2.13E+08
Q92616 Q92616 Translational activator GCN1GCN1L1 122 122 2671 0 323.31 1.1369 0.88109 2.08E+10
Q99575;E5RK39 Q99575 Ribonucleases P/MRP protein subunit POP1POP1 5 5 1024 0 14.344 1.1369 0.8689 2.38E+08
Q9NUD5;Q9NUD5-2Q9NUD5;Q9NUD5-2Zinc finger CCHC domain-containing protein 3ZCCHC3 8 8 404 0 53.233 1.1367 0.78873 7.27E+08
K7ERG2;Q9NYR9-2;Q9NYR9;H7BXP1;Q9NYR9-3K7ERG2;Q9NYR9-2; ;H7BXP1;Q9NYR9-3NF-kappa B inhibitor-interacting Ras-like protein 2NKIRAS2 4 4 141 0 11.663 1.1365 0.60564 3.99E+08
Q8WY54-2;Q8WY54;Q8WY54-3Q8WY54-2;Q8WY54;Q8WY54-3Protein phosphatase 1EPPM1E 5 5 755 0 35.83 1.1362 0.87534 3.16E+08
Q9UQR0;H0Y6S1;Q9UQR0-2 Sex comb on midleg-like protein 2SCML2 9 9 700 0 40.649 1.1362 0.67046 8.40E+08
172
Q96FZ2;D6R9T3;E7EMP6;D6RGK7;D6RAZ3;D6RAI0Q96FZ2; 6R9T3 E7EMP6; GK7Embryonic stem cell-specific 5-hydroxymethylcytosine-binding proteinHMCES 7 7 354 0 31.806 1.136 0.61103 4.39E+08
G5EA30;Q92879-2;Q92879-3;Q92879;Q92879-5;Q92879-6;Q92879-4;E9PQK4;E9PSH0;E9PKU1;V9GYD9;Q5VZZ6;A0A0J9YX66;E9PC62;A0A0J9YXJ0;O95319-5;O95319-2;O95319;O95319-4;O95319-3;E9PKA1;F5H4Y5;F5H0D8G5EA30;Q92879-2;Q92879-3;Q92879;Q92879-5;Q92879-6;Q92879-4CUGBP Elav like family member 1CELF1 13 13 514 0 69.389 1.1358 0.82808 8.16E+08
O14531;Q5T0Q6 O14531;Q5T0Q6 Dihydropyrimidinase-related protein 4DPYSL4 9 9 572 0 42.603 1.1348 NaN 2.81E+08
Q13356;Q13356-2Q13356;Q13356-2Peptidyl-prolyl cis-trans isomerase-like 2PPIL2 6 6 520 0 75.843 1.1348 NaN 3.48E+08
Q96HW7;Q96HW7-2;Q96HW7-4;Q96HW7-3;F8WAA7;E9PIM3Q96HW7 Integrator complex subunit 4INTS4 15 15 963 0 84.84 1.1347 0.6504 9.69E+08
Q9UID3-2;Q9UID3;H0YEE1;E9PJ36;E9PKX7;E9PMB6;E9PRV0;H0YCB7;H0YDX9Q9UID3-2;Q9UID3Vacuolar protein sorting-associated protein 51 homologV S51 19 19 658 0 102.38 1.1347 0.73496 1.81E+09
Q9NVH1-3;Q9NVH1-2;Q9NVH1;B1AK20;Q5TH61Q9NVH1-3;Q9NVH1-2 9NVH1;B1AK20DnaJ homolog subfamily C member 11DNAJC11 9 9 507 0 127.61 1.1343 NaN 7.41E+08
Q04917;A2IDB2;F8WEB6;A2IDB1Q04917;A2IDB2 14-3-3 protein etaYWHAH 16 13 246 0 184.67 1.134 0.65337 1.80E+09
Q8TD19;G3V459;G3V5V0;G3V2Z5Q8TD19 Serine/threonine-protein kinase Nek9NEK9 21 21 979 0 190.11 1.1337 0.82392 3.75E+09
Q7Z4Q2;Q7Z4Q2-2;Q7Z4Q2-3Q7Z4Q2;Q7Z4Q2-2HEAT repeat-containing protein 3HEATR3 10 10 680 0 46.424 1.1334 NaN 7.09E+08
Q8NG31-2;Q8NG31;E9PPJ1;Q8NG31-3;Q8NG31-4;H0YCZ2;H0YEY7Q8NG31-2;Q8NG31;E9PPJ1;Q8NG31-3;Q8NG31-4Protein CASC5 CASC5 6 6 2316 0 22.008 1.1329 0.71616 1.08E+08
Q2TAL8;C9JAL2;C9JIA8Q2TAL8 Glutamine-rich protein 1QRICH1 13 13 776 0 180.78 1.1328 0.85144 1.23E+09
P62424;Q5T8U3;Q5T8U2P62424;Q5T8U3 60S ribosomal protein L7aRPL7A 16 16 266 0 70.867 1.1326 1.6626 3.63E+09
P46734-2;P46734;P46734-3;E9PRZ0;K7ELM6;K7EIW3;J3KRV4;J3QR49P46734-2;P46734;P46734-3Dual specificity mitogen-activated protein kinase kinase 3MAP2K3 9 6 318 0 45.855 1.1322 0.71404 6.31E+08
Q8WTW3;A0A087WVI0;E9PBL8;J3QKY9;J3QLT5;J3KRP4;J3KSY3Q8WTW3;A0A087WVI0;E9PBL8Conserved oligomeric Golgi complex subunit 1COG1;ADCK1 22 22 980 0 323.31 1.1321 0.773 2.24E+09
Q9BW83-2;Q9BW83;F5GZ09;B1AH58;H0Y6C7Q9BW83-2;Q9BW83;F5GZ09Intraflagellar transport protein 27 homologIFT27 3 3 185 0 7.706 1.132 0.67556 1.32E+08
P23378 P23378 Glycine dehydrogenase (decarboxylating), mitochondrialGLDC 2 2 1020 0 10.717 1.1317 NaN 1.01E+08
E9PLA9;G3V153;A0A087X082;Q14444-2;Q14444E9PLA9;G3V153;A0A087X082;Q14444-2;Q14444Caprin- CAPRIN 2 2 186 0 4.4281 1.1315 NaN 1.08E+08
Q06124-2;Q06124;Q06124-3;A0A0U1RRI0;H0YF12Q06124-2;Q06124;Q06124-3Tyrosine-protein phosphatase non-receptor type 11PTPN11 8 18 593 0 96.27 1.1313 NaN 6.33E+08
Q9BZK7;A0A0D9SF63;Q9BQ87;O60907-2;O60907;C9JLJ1;A0A0D9SFI2;C9JCK0;C9JBN1;A0A0D9SF25;F8W9D8;C9IYU9Q9BZK7;A0A0D9SF63-box-like/WD repeat-containing protein TBL1XR1TBL1XR1 7 7 514 0 98.044 1.1302 0.98814 5.45E+08
P05423;E5RHT4;E7EQ68P05423 DNA-directed RNA polymerase III subunit RPC4POLR3D 5 5 398 0 28.774 1.13 0.81255 3.57E+08
Q15019;Q15019-3;Q15019-2;B5MCX3;C9J938;H7C310;C9JB25;C9J2Q4;C9IY94;H7C2Y0;C9IZU3;C9JQJ4;H7C1T1;C9JT15;C9JSE7;C9JFT1;F8WB65;B5MD47;C9JZI2Q15019;Q15019-3;Q15019-2;B5MCX3Septin-2 02-Sep 11 11 361 0 111.07 1.1296 1.1444 1.98E+09
Q00325-2;Q00325;F8VVM2;F8VWQ0;F8VZL5;F8VWR4Q00325- Q00325;F8VVM2Phosphate carrier protein, mitochondrialSLC25A3 18 18 361 0 143.77 1.1295 0.74948 2.07E+10
Q86Y39;K7EQ77;K7EK78;K7EP35;K7EMT4;Q86Y39-2Q86Y39;K7EQ77;K7EK78;K7EP35;K7EMT4;Q86Y39-2NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11NDUFA11 3 3 141 0 12.51 1.1286 0.27701 1.75E+08
P53992;G5EA31;P53992-2;A0A0U1RR49P53992;G5E 31 Protein transport protein Sec24CSEC24C 26 25 1094 0 205.63 1.1284 0.78109 7.27E+09
P27348;E9PG15 P27348;E9PG15 14-3-3 protein thetaYWHAQ 16 11 245 0 213.66 1.1278 0.4471 7.84E+08
Q9Y2A7;Q9Y2A7-2;F8W050;P55160Q9Y2A7;Q9Y2A7-2Nck-associated protein 1NCKAP1 35 35 1128 0 192.68 1.1275 1.0134 5.14E+09
Q66K14-2;Q66K14;G3V133;Q6ZT07;E5RIN2;H0YB08Q66K14-2; 6K14TBC1 domain family member 9BTBC1D9B 14 14 1233 0 83.365 1.1273 0.86604 8.77E+08
P38935 P38935 DNA-binding protein SMUBP-2IGH BP2 3 3 993 0 22.298 1.127 0.9549 2.03E+08
Q9Y263;E5RIM3;H0YBW4;H0YC16;H0YAU9Q9Y263 E5RIM3 Phospholipase A-2-activating proteinPLAA 33 33 795 0 323.31 1.127 0.92662 6.80E+09
F5H452;Q5JSB6;Q5JSB5;Q14186F5H4 2;Q5JSB6;Q5JSB5;Q14186Transcription factor Dp-1TF P1 1 1 119 0 18.008 1.1269 NaN 2.28E+08
P58107 P58107 Epiplakin EPPK1 38 2 5090 0 323.31 1.1269 0.79171 1.48E+09
P31323 P31323 cAMP-dependent protein kinase type II-beta regulatory subunitPRKAR2B 6 3 418 0 20.603 1.1266 0.83316 3.28E+08
Q5SRQ6;P67870;Q5SRQ3;N0E472;A0A0G2JM12;N0E644;A0A0G2JM585SR 6;P67870;Q5SRQ3Casein kinase II subunit betaCSNK2B;CSNK2B-LY6G5B-1181 7 7 234 0 45.25 1.1263 0.62915 1.09E+09
Q8N684-2;Q8N684;Q8N684-3;F5H669;J3QT54;F5H6M0;F5H047;C9J286;C9J323;C9JM38;F5H5B7;F5H1W4;F5H2K8;F5H6P5;F5H6A8;F5GXA3Q8N684-2;Q8N684;Q8N684-3;F5H669;J3QT54 F5H6M0;F5H047Cleavage and polyadenylation specificity factor subunit 7CPS 7 15 5 4 2 0 137.33 1.1263 0.903 4.05E+09
Q709C8-4;Q709C8-2;Q709C8-3;Q709C8Q709C8-4;Q709C8-2;Q709C8-3;Q709C8Vacuolar protein sorting-associated protein 13CVPS13C 18 18 3585 0 111.92 1.126 0.92634 9.71E+08
H0Y7L2;Q96N67-2;Q96N67-4;Q96N67-6;Q96N67;Q96N67-3;Q96N67-5;A0A0C4DGY6;Q96N67-7;A0A0U1RRC1;A0A0U1RQJ5;A0A0U1RQT6;A0A0U1RR97;A0A0U1RQG7;K7EP51H0Y7L2;Q96N67-2;Q96N67-4;Q96N67-6;Q96N67;Q96N67-3;Q96N67-5Dedicator of cytokinesis protein 7DOCK7 68 62 2129 0 323.31 1.1257 0.95103 4.46E+09
O96017;O96017-9;O96017-13;O96017-4;H0Y820;O96017-12;O96017-11;H0Y4V6;B7ZBF6;O96017-3;O96017-8;O96017-7;H7C0V7;B7ZBF2;A0A087X102;C9JFD7;B7ZBF7;O96017-5;O96017-2O96017;O96017-9;O96017-13;O96017-4;H0Y820;O96017-12;O96017-11Serine/threonine-protein kinase Chk2CHEK2 10 10 543 0 48.672 1.1257 NaN 4.01E+08
Q9GZT3-2;Q9GZT3;A0A087WUN7;H0YJ40;G3V4X6;G3V2S9;H0YJW7;H0YJI1;H0YJ07;H0YJU7;J3KPY6Q9GZT3-2;Q9GZT3;A0A087WUN7;H0YJ40;G3V4X6;G3V2S9;H0YJW7SRA stem-loop-interacting RNA-binding protein, mitochondrialSLIRP 10 10 107 0 58.573 1.1248 0.9183 3.06E+09
Q9NXR7-4;Q9NXR7-3;Q9NXR7;Q9NXR7-1;F8W733;C9J2G0;A0A075B7D2Q9NXR7-4;Q9NXR7-3;Q9NXR ;Q9NXR7-1;F8W733;C9J2G0B CA1-A complex subunit BREB E 6 6 376 0 48.203 1.1246 0.90529 2.39E+09
Q15843;F8VSA6;E9PS38;S4R3E9;E9PL57Q15843;F8VSA6;E9PS38;S4R3E9;E9PL57NEDD8 NEDD8;NEDD8-MDP1 3 3 81 0 44.66 1.1242 0.63858 2.41E+09
P06730;P06730-2;D6RBW1;P06730-3;H0Y8J7;D6RFJ3;D6RHE2;H0Y8X3;A6NMX2P0 730;P06730-2;D6RBW1;P0 730-3;H0Y8J7Eukaryotic translation initiation factor 4EEIF4E 9 9 217 0 71.73 1.1241 0.75933 4.74E+09
Q9H0C8;F8SNU7;H7C2I8;E9PC05;F8SNU6Q9H0C8;F8SNU7;H7C2I8;E9PC05Integrin-linked kinase-associated serine/threonine phosphatase 2CILKAP;ILKAP3 14 14 392 0 71.191 1.1239 0.91079 2.56E+09
Q6PJG6;Q6PJG6-3;Q6PJG6-2Q6PJG6 BRCA1-associated ATM activator 1BRAT1 5 5 821 0 64.48 1.1238 1.15 3.40E+08
Q9H6T3;Q9H6T3-2;Q9H6T3-3Q9H6T3;Q9H6T3-2;Q9H6T3-3RNA polymerase II-associated protein 3RPAP3 12 12 665 0 99.226 1.1238 0.79505 1.03E+09
P61586;C9JNR4;C9JX21;Q5JR07;Q5JR05;C9JRM1;Q5JR06;E9PN11;U3KQA9;U3KQV3;E9PLA2;P62745P61586;C9JNR4;C9JX21Transforming protein RhoARHOA 10 5 193 0 115.27 1.1237 1.0169 1.71E+09
O95905-2;O95905;O95905-3;F2Z2R1;C9J316O95905-2;O95905;O95905-3Protein SGT1 ECD 3 3 601 0 18.119 1.1236 NaN 4.05E+07
Q86XP3;A0A0A0MSJ0;Q86XP3-2;J3QRI2;J3KTK9;J3KRE3Q86XP3;A0A0A0MSJ0;Q86XP3-2ATP-dependent RNA helicase DDX42DDX42 25 25 938 0 140.28 1.1235 0.78948 3.26E+09
Q9UBD5;Q9UBD5-2;Q9UBD5-3Q9UBD5;Q9UBD5-2;Q9UBD5-3Origin recognition complex subunit 3ORC3 9 9 711 0 61.964 1.1235 0.99223 6.35E+08
Q8WUM0 Q8WUM0 Nuclear pore complex protein Nup133NUP133 43 43 1156 0 323.31 1.123 0.80506 8.75E+09
Q5HYI8;C9JXM3;F8WF50;F8WDC7;H7C533;F8WAX9Q5HYI8 C9JXM3;F8WF50;F8 DC7Rab-like protein 3 RABL3 8 8 236 0 105.4 1.1229 0.72913 6.18E+08
Q9H267;F5H008;Q9H267-2;G3V3F9;F5H008;Q9H267-2Vacuolar protein sorting-associated protein 33BVPS33B 14 14 617 0 56.696 1.1229 NaN 1.14E+09
Q9P2D1;Q9P2D1-2Q9P2D1 Chromodomain-helicase-DNA-binding protein 7CHD7 9 5 2997 0 14.332 1.1229 0.82196 1.60E+08
Q658Y4;E7ER68;G3V120;H0YC80;H0YBR6Q658Y4;E7ER68 Protein FAM91A1 FAM91A1 9 9 838 0 39.389 1.1228 0.84332 6.47E+08
Q14166;V9GY16 Q14166 Tubulin--tyrosine ligase-like protein 12TTLL12 20 20 644 0 153.27 1.1224 0.66492 2.29E+09
Q05048;A0A0A0MSZ9;A3KFI9Q05048;A0A0A0MSZ9Cleavage stimulation factor subunit 1CSTF1 14 14 431 0 323.31 1.1222 0.71899 5.58E+09
Q13049;Q5JVY0 Q13049;Q5JVY0 E3 ubiquitin-protein ligase TRIM32TRIM32 2 2 653 0 10.945 1.122 NaN 6.13E+07
Q9H1P3-2;Q9H1P3;A0A087WTV1;E7ET92Q9H1P3-2;Q9H1P3;A0A087WTV1;E7ET92Oxysterol-binding protein-related protein 2;Oxysterol-binding proteinOSBPL2 6 6 468 0 13.303 1.1213 4.4752 3.50E+08
P0DN76;Q01081;Q01081-2;Q01081-4;Q8WU68-3;Q8WU68;M0QYK5;M0R2N4;Q01081-3;Q8WU68-2;K7EJH3;K7EJM7P DN76;Q01081;Q010 1-2;Q01081-4Splicing factor U2AF 35 kDa subunitU2AF1 9 9 240 0 101.24 1.1206 0.72232 3.17E+09
P26641;P26641-2P26641;P26641-2Elongation factor 1-gammaEEF1G 34 34 437 0 323.31 1.1198 0.84475 1.06E+11
Q5QPK2;H0Y368;O60762;Q5QPJ9Q5QPK2;H0Y368;O60762;Q5QPJ9Dolichol-phosphate mannosyltransferase subunit 1DPM1 13 13 287 0 122.45 1.119 0.89987 4.95E+09
P40616-2;P40616;F8VYN9;B4DZG7;F8VP99;F8W1Z8;F8VP63P40616-2;P40616;F8VYN9;B4DZG7ADP-ribosylation factor-like protein 1ARL1 9 9 164 0 83.711 1.1189 0.84573 2.81E+09
Q9Y4W6;K7EP56 Q9Y4W6 AFG3-like protein 2AFG3L2 28 27 797 0 273.98 1.1187 0.72911 3.87E+09
Q9Y5Y2;H3BNF0;H3BQR2;H3BNS4;H3BRK5;B7Z6P0;H3BMW1;H3BRE1Q9Y5Y F0 QR2;H3BNS4Cytosolic Fe-S cluster assembly factor NUBP2NUBP2 9 9 271 0 82.349 1.1184 0.8722 2.50E+09
P49207 P49207 60S ribosomal protein L34RPL34 5 5 117 0 14.861 1.1181 0.82416 2.03E+09
P62318-2;P62318;H3BT13P62318-2;P62318;H3BT13Small nuclear ribonucleoprotein Sm D3SNRPD3 5 5 120 0 161.15 1.118 0.9455 1.41E+10
Q13451;Q13451-2Q13451 Peptidyl-prolyl cis-trans isomerase FKBP5FKBP5 23 23 457 0 289.29 1.1179 0.63055 3.38E+09
F5H5P2;P12694;F5GXU9;P12694-2;H0YH31;M0R0C8F5H5P2;P12694;F5GXU9;P12694-22-oxoisovalerate dehydrogenase subunit alpha, mitochondrialBCKDHA 4 4 479 0 41.55 1.1176 0.81144 3.44E+08
Q86WA6;Q86WA6-2;B4DML3;H7C0M3;F2Z2Q1;Q49AI2Q86WA6;Q86WA6-2Valacyclovir hydrolaseBPHL 6 6 291 0 17.63 1.1172 0.69224 5.31E+08
P19784;H3BSA1;H3BNI9;H3BV19P19784;H3BSA1 Casein kinase II subunit alphaCSNK2A2 10 10 350 0 80.933 1.1171 0.84849 1.60E+09
P46821;D6RA32;D6RA40;D6RCL2;D6RGJ3P46821 Microtubule-associated protein 1B;MAP1B heavy chain;MAP1 light chain LC1MAP1B 18 17 2468 0 177.18 1.1169 0.83171 1.60E+09
Q8WWY3;E7EVX8;Q8WWY3-4;Q8WWY3-2;Q8WWY3-3;E7EU94;E7ESX0;E7EN72Q8 Y3;E7EVX8;Q8WWY3-4;Q8WWY3-2;Q8WWY3-3U4/U6 small nuclear ribonucleoprotein Prp31PRPF31 13 13 499 0 102.82 1.1167 NaN 1.50E+09
B4DXW1;P61158;F8WDR7;Q9P1U1-2;Q9P1U1;Q9P1U1-3;A0A0A0MTI9;H7C4J1;C9IZN3;Q9C0K3B4DXW1;P61158 Actin-related protein ACTR3 17 17 367 0 151.97 1.1165 0.80466 6.78E+09
H7C147;H7C3W1;O60443-3;O60443H7C147;H7C3W1;O60443-3;O60443Non-syndromic hearing impairment protein 5DFNA5 1 1 192 0 4.7876 1.1162 NaN 1.50E+07
Q9UBN7;Q9UBN7-2;A6NDI8;E7EPS2;C9J172;E9PEH1;E7EP63;E7ER52Q9UB 7;Q9UBN7-2Histone deacetylase 6HDAC6 5 5 1215 0 47.414 1.1162 0.70276 3.28E+08
Q6ZN17 Q6ZN17 Protein lin-28 homolog BLIN28 3 3 250 0 17.116 1.1161 1.1748 4.72E+08
Q13185;S4R2Y4;C9JMM0;B8ZZ43Q13185;S4R2Y4 Chromobox protein homolog 3CBX3 5 4 183 0 42.814 1.116 0.82108 2.01E+09
O43264;O43264-2;F5H3C1O43264;O43264-2Centromere/kinetochore protein zw10 homologZW10 9 9 779 0 97.594 1.1154 0.90923 8.10E+08
A0A0D9SF70;G5E9L0;Q8N6H7;E9PQP3;Q8N6H7-3;Q8N6H7-2;E9PMU9;H0YDN9;E9PIY6;E9PMR9;E9PM63;E9PNY8;E9PJT7;E9PK28;E9PN48;E9PM18A0A0D9SF70;G5E9L0 ;E9PQP3;Q8N6H7-3;Q8N6H7-2;E9PMU9;H0YDN9;E9PIY6ADP-ribosylation factor GTPase activating protein 2ARFGAP2 6 5 385 0 30.071 1.1153 NaN 3.01E+08
P23921;E9PL69;E9PP77;H0YCY7P23921;E9PL69 Ribonucleoside-diphosphate reductase large subunitRRM1 26 26 792 0 275.28 1.1151 0.8449 6.73E+09
E9PGC0;P20936-2;P20936-4;P20936;P20936-3E9PGC0;P20936-2;P20936-4;P20936Ras GTPase activating protein 1RASA1 7 7 881 0 35.782 1.115 0.71637 3.50E+08
P35573;P35573-2;P35573-3P35 73;P 5573-2;P35573-3Glycogen debranching enzyme;4-alpha-glucanotransferase;Amylo-alpha-1,6-glucosidaseAGL 68 68 1532 0 323.31 1.115 0.83849 1.14E+10
A0A0R4J2F6;Q12894;Q12894-2;H7C2Z4;H7C444A0A0R4J2F6;Q12894;Q1289 -2;H7C2Z4Interferon-related developmental regulator 2IFRD2 6 6 442 0 20.928 1.1144 0.84952 4.09E+08
A0A024QZX5;A0A087X1N8;P35237A0A024QZX5;A0A087X1N8;P35237Serpin B6 SERPINB6 8 8 380 0 39.819 1.1142 0.93044 7.69E+08
C9JRZ6;F8WAR4;Q9NX63C9JRZ6;F8WAR4;Q9NX63MICOS complex subunit MIC19CHCHD3 8 8 232 0 39.995 1.1141 0.38642 2.95E+08
Q9NX08 Q9NX08 COMM domain-containing protein 8COMMD8 3 3 183 0 29.618 1.114 0.66606 1.09E+09
P18031;B4DSN5 P18031;B4DSN5 Tyrosine-protein phosphatase non-receptor type 1;Tyrosine-protein phosphatase non-receptor typePTPN1 13 13 435 0 56.476 1.1139 1.2984 2.47E+09
H0Y4Z8;Q3YEC7;Q3YEC7-2;A0A0X1KG72;Q8WYT4;G3V154;F2Z2T0;Q3YEC7-3H0Y4Z8;Q3YEC7;Q3YEC7-2;A0A0X1KG72Rab-like protein 6 RABL6 3 3 730 0 19.997 1.1137 0.96804 2.65E+08
O15047;C9J2Z9 O15047 Histone-lysine N-methyltransferase SETD1ASETD1A 12 11 1707 0 51.97 1.1137 0.73537 5.05E+08
Q9P2J5;Q9P2J5-2;Q9P2J5-3;A0A087WXY1Q9P2J5;Q9P2J5-2Leucine--tRNA ligase, cytoplasmicLARS 62 62 1176 0 323.31 1.1131 0.94137 3.58E+10
P21796;C9JI87 P21796;C9JI87 Voltage-dependent anion-selective channel protein 1VDAC1 18 18 283 0 323.31 1.113 0.95191 1.25E+10
P49915;P49915-2P49915;P49915-2GMP synthase [glutamine-hydrolyzing]GMPS 46 46 693 0 323.31 1.1126 0.60898 1.51E+10
Q8WWM7-6;Q8WWM7-8;Q8WWM7-5;Q8WWM7-4;Q8WWM7-9;Q8WWM7-2;Q8WWM7;Q8WWM7-3;H3BUF6;Q8WWM7-7;H3BSK9;H3BSQ5;H3BUE3Q8WWM7-6;Q8WWM7-8;Q8WWM7-5;Q8WWM7-4;Q8WWM7-9;Q8WWM7-2;Q8WWM7;Q8WWM7-3;H3BUF6;Q8WWM7-7; 3BSK9Ataxin-2-like proteinATXN2L 13 13 968 0 81.915 1.1122 1.5503 5.10E+08
P52948-5;P52948;P52948-6;P52948-2;H7C3P6;H0YDF4;P52948-4;P52948-3;H0YCT1;H0YDA1;H0YEN4P52948-5;P52948;P52948-6;P52948-2;H7C3P6Nuclear pore complex protein Nup98-Nup96;Nuclear pore complex protein Nup98;Nuclear pore complex protein Nup96NUP98 29 29 1800 0 287.9 1.1121 0.86924 4.16E+09
P31749-2;P31749;G3V2I6;G3V4I6;A0A087WY56;G3V3X1P31749-2;P31749RAC-alpha serine/threonine-protein kinaseAKT1 5 5 418 0 20.893 1.1112 NaN 1.80E+08
Q5VTR2;C9JWJ4;C9J0A5;C9JXC9Q5VTR2 E3 ubiquitin-protein ligase BRE1ARNF20 19 16 975 0 181.05 1.111 0.80254 9.48E+08
Q9BTZ2-8;Q9BTZ2-4;Q9BTZ2;F5GWZ1;Q9BTZ2-3;Q9BTZ2-7;Q9BTZ2-2;Q9BTZ2-5;D3YTE6;P0CG22;H0YNP7;A0A087WSZ6;F6TD35;E9PFL3;A0A087WXI8;H0YN69;Q6PKH6;Q6PKH6-2Q9BTZ2-8;Q9BTZ2-4; ;F5GWZ1;Q9BTZ2-3;Q9BTZ2-7;Q9BTZ2-2;Q9BTZ -5Dehydrogenase/reductase SDR family member 4DHRS4 7 7 226 21.531 1.1109 0.76086 1.21E+09
Q9H2U1;Q9H2U1-3;Q9H2U1-2;E7EWK3;A0A0G2JQU7;A0A0G2JRP3;H7C5F5;H7C514Q9H2U1;Q9H2U1-3;Q9H2U1- ;E7EWK3ATP-dependent RNA helicase DHX36DHX36 29 28 1008 0 215.14 1.1109 0.98592 4.23E+09
Q9C0C9;K7ES11;K7EQ12Q9C0C9;K7ES11 E2/E3 hybrid ubiquitin-protein ligase UBE2OUBE2O 23 23 1292 0 167.97 1.1107 0.90397 2.47E+09
Q12933-4;Q12933-3;Q12933;Q12933-2;B1AMY1;B1AMX7;B1AMX8Q12933-4;Q12933- ;Q12933;Q12933-2TNF receptor-associated factor 2TRAF2 5 5 476 0 21.572 1.1106 NaN 2.30E+08
Q15555-5;Q15555-3;Q15555;Q15555-4;K7ERD8;Q15555-2;K7EL66;M0QX52;K7ENB3;C9JB30;Q9UPY8-2;Q9UPY8Q1555 -5;Q15555-3;Q15555;Q15 -4;K7ERD8;Q15555- ; L66Microtubule-associated protein RP/EB family member 2MAPRE2 14 14 284 0 283.39 1.1106 0.74931 4.37E+09
P09543-2;P09543;K7ERC4;K7EN66;C9K0L8;K7ERZ0P09543-2;P095432,3-cyclic-nucleotide 3-phosphodiesteraseCNP 20 20 401 0 118.86 1.1104 0.95569 1.99E+09
A6PW57;Q99755-2;Q99755-4;Q99755-3;Q99755;O60331-4;O60331;O60331-2;O60331-3;O14986-3;O14986;O14986-2;A0A0A0MT25;A0A0A0MSP5A6PW57;Q99755-2;Q99755-4;Q99755-3;Q99755Phosphatidylinositol 4-phosphate 5-kinase type-1 alphaPIP5K1A 7 3 550 20.658 1.1102 NaN 1.99E+08
Q4G0F5;H0YCI7 Q4G0F5 Vacuolar protein sorting-associated protein 26BVPS26B 5 4 336 0 13.425 1.1096 1.2969 3.00E+08
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Q8NEC7;D6R9W2;Q8NEC7-3;D6RCC4;D6RCC9Q8NEC7;D6R9W2;Q8NEC7-3Glutathione S-transferase C-terminal domain-containing proteinGSTCD 7 7 633 0 17.503 1.1096 NaN 1.52E+08
Q9H553;Q9H553-2;A0A0A0MTE0Q9H553;Q9H553-2Alpha-1,3/1,6-mannosyltransferase ALG2ALG2 7 7 416 0 22.286 1.1091 0.97289 3.21E+08
Q9NSD9;Q9NSD9-2Q9NSD9;Q9NSD9-2Phenylalanine--tRNA ligase beta subunitF RSB 19 19 589 0 202.17 1.1091 0.61221 3.97E+09
Q6KCM7;Q6KCM7-4;Q6KCM7-5;Q6KCM7-2;Q6KCM7-3;Q6KCM7-6;H7C4Z4Q6KCM7;Q6KCM7-4;Q6KCM7-5;Q6KCM7-2;Q6KCM7-3;Q6KCM7-6Calcium-binding mitochondrial carrier protein SCaMC-2SLC25A25 3 3 469 0 9.041 1.109 0.76956 5.66E+07
P19174;P19174-2;V9GY71;V9GYH5;V9GY63;M0QX77;A0A0D9SEK2P1 174;P1 174-21-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1PLCG1 22 22 1290 0 229.36 1.1088 0.78864 1.21E+09
O75717;O75717-2;C9JYB3;H3BSQ1O75717;O75717-2WD repeat and HMG-box DNA-binding protein 1WDHD1 28 28 1129 0 323.31 1.1087 0.88306 1.73E+09
Q08752 Q08752 Peptidyl-prolyl cis-trans isomerase DPPID 3 3 370 0 8.3734 1.1085 0.59996 1.41E+08
Q99959-2;Q99959;B8QGS9;A0A087WXY2Q99959-2;Q99959;B8QGS9Plakophilin-2 PKP2 4 4 837 0 7.7318 1.1078 1.665 3.59E+07
A0A087WXC5;E7ESZ7;O95299;O95299-2;H7C2W5;H7C1Y7;H7C2X4;Q8N1B9;C9J6X0A0A087WXC5;E7ESZ7;O95299;O95299-2NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrialNDUFA10 12 12 355 0 112.08 1.1077 0.83522 6.55E+09
Q14232;F5H0D0;Q14232-2;H0YGG4;F5H0D0;Q14232-2Translation initiation factor eIF-2B subunit alphaEIF2B1 15 15 305 0 118.4 1.1069 0.73135 4.70E+09
Q8N584-2;Q8N584;G3V1P2Q8N584- ;Q8N584;G3V1P2Tetratricopeptide repeat protein 39CTTC39C 7 7 522 0 35.448 1.1069 NaN 1.91E+08
Q96L91-3;Q96L91-5;Q96L91-2;Q96L91;Q96L91-4;A0A0A0MR80Q96L91-3;Q96L91-5;Q96L91-2;Q96L91;Q96L91-4E1A-binding protein p400EP4 14 14 3086 0 59.434 1.1067 0.74827 7.56E+08
P62380;Q7Z6U2;Q7Z6T9;Q7Z6U0;Q7Z6U1P62380;Q7Z6U2 TATA box-binding protein-like protein 1TBPL1 3 3 186 0 51.751 1.1065 0.7882 4.60E+08
P47985;P0C7P4 P47985;P0C7P4 Cytochrome b-c1 complex subunit Rieske, mitochondrial;Cytochrome b-c1 complex subunit 11;Putative cytochrome b-c1 complex subunit Rieske-like protein 1UQCRFS1;UQCRFS1P1 11 11 274 0 166.81 1.1064 0.69216 3.48E+09
Q9NXW2;J3KPS0;Q9NXW2-2;V9GYN7;V9GY70;J3KPS0;Q9NXW2-2;V9GYN7DnaJ homolog subfamily B member 12DNAJB12 8 8 375 0 27.062 1.1063 0.57434 2.71E+08
G3V0I5;P49821-2;P49821;B4DE93;E9PPR0;E9PQP1;E9PMX3;E9PJL9;E9PLC6;E9PPD6;E9PPS5G3V0I5;P49821-2;P49821;B4DE93;E9PPR0; QP1;E9PMX3NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrialNDUFV1 6 6 457 0 16.566 1.1062 NaN 1.78E+08
A2RTX5;A2RTX5-2;B7ZLP8;H0YKB9A2RTX5;A2RTX5-2;B7ZLP8Probable threonine--tRNA ligase 2, cytoplasmicTARSL2 13 9 802 0 30.16 1.1061 1.0291 4.36E+08
O95376;C9JZ71;C9JCL4;F8WCS4;C9JBC5O95376 E3 ubiquitin-protein ligase ARIH2ARIH2 11 11 493 0 165.29 1.1057 NaN 9.38E+08
Q13363;Q13363-2;D6RAX2;E7ESU7;E7EPF8;E9PGB1;H0Y8W7;H0Y9M9;E7EUB3;H0Y8U5Q13363;Q13363-2;D6RAX2;E7ESU7;E7EPF8C-terminal-binding protein 1CTBP1 16 11 440 0 142.83 1.1056 0.91589 4.61E+09
P52597 P52597 Heterogeneous nuclear ribonucleoprotein F;Heterogeneous nuclear ribonucleoprotein F, N-terminally processedHNRNPF 16 14 415 0 323.31 1.1049 0.91734 1.93E+10
B3KS98;O15372;A0A087WZK9;E5RJT0;E5RGU4;E5RFH0;E5RFW7;E5RHC7;E5RH59B3KS98;O15372;A0A087WZK9;E5RJT0Eukaryotic translation initiation factor 3 subunit HEIF3S3;EIF3H 12 12 366 0 110.84 1.1047 0.84824 3.11E+09
Q5JVF3-3;Q5JVF3;Q5JVF3-4;Q5JVF3-25J F3-3; 5J F3;Q5JVF3-4;Q5JVF3-2PCI domain-containing protein 2PCID2 15 15 376 0 180.76 1.1039 0.80382 1.57E+09
Q5VVQ6-2;Q5VVQ6Q5VVQ6-2;Q5VVQ6Ubiquitin thioesterase OTU1YOD1 9 9 304 0 57.946 1.1037 0.83657 9.19E+08
P26373;P26373-2;J3QSB4;H3BTH3;J3KS98;H3BUK8P26373;P26373-2;J3QSB460S ribosomal protein L13RPL13 19 19 211 0 114.51 1.1036 1.0058 1.12E+10
Q01813;Q01813-2;B1APP6;B1APP8;Q5VSR5;H0Y757;V9GY25;V9GYV7;H0Y3Y3Q0 813;Q0 813-2ATP-dependent 6-phosphofructokinase, platelet typePFKP 37 32 784 0 323.31 1.1034 0.86713 2.88E+10
Q8IZH2-2;Q8IZH2;H7C5E4;Q8IZH2-3;H7C583;F8WDA0;C9JCZ8Q8IZH2-2;Q8IZH2;H7C5E45-3 exoribonuclease 1XRN1 23 23 1694 0 105.66 1.1032 0.77621 1.77E+09
O75925;O75925-2;O75925-3;H3BS65;H3BSI8;B4DGW0O75925;O75925-2;O75925-3E3 SUMO-protein ligase PIAS1PIAS1 4 3 651 0 69.49 1.103 NaN 2.19E+08
Q8N5X7-2;Q8N5X7;C9JUY2;C9J6E5;C9J7Z6Q8N5X7-2;Q8N5X7;C9JUY2;C9J6E5;C9J7Z6Eukaryotic translation initiation factor 4E type 3EIF4E3 2 2 118 0 6.7361 1.1028 NaN 1.66E+07
Q14690;S4R3Q4 Q14690 Protein RRP5 homologPDCD11 67 67 1871 0 323.31 1.1027 0.97928 9.65E+09
F5H702;Q96GC5-3;Q96GC5;F5H8D0F5H702;Q96GC5-3;Q96GC5;F5H8D09S ribosomal protein L48, mitochondrialMRP 5 5 113 0 32.718 1.1023 0.36086 3.05E+08
Q9UPU5 Q9UPU5 Ubiquitin carboxyl-terminal hydrolase 24USP24 35 35 2620 0 323.31 1.1023 0.8234 3.47E+09
Q9UQ80;Q9UQ80-2;F8VR77;F8W0A3;H0YIN7;F8VZ69Q9UQ80;Q9UQ80-2;F8VR77Proliferation-associated protein 2G4PA2G4 31 31 394 0 323.31 1.1023 0.86033 3.01E+10
Q5VV42-2;Q5VV42Q5VV42-2;Q5VV42Threonylcarbamoyladenosine tRNA methylthiotransferaseCDKAL1 3 3 488 0 18.197 1.1021 NaN 1.36E+08
Q9UBB9;Q9UBB9-2;F6SQZ1;F6XM96;H0Y4U8;F6UKU9Q9UBB9 Tuftelin-interacting protein 11TFIP11 16 16 837 0 86.748 1.1008 0.87693 1.28E+09
H0YBR0;Q96Q05-3;Q96Q05;Q96Q05-2H0YBR0;Q96Q05-3;Q96Q05;Q96Q05-2Trafficking protein particle complex subunit 9TRAPPC9 3 3 992 0 6.4994 1.1007 5.7822 1.88E+08
Q9BZE2;E9PNY6;E9PRI9;A0A087WY59Q9BZE2 tRNA pseudouridine(38/39) synthasePUS3 3 3 481 0 6.6982 1.0999 0.86085 1.37E+08
H7C1E4;P61966;P61966-2H7C1E4;P61966;P61966-2AP-1 complex subunit sigma-1AAP1S1 2 2 191 0 52.586 1.0998 0.84615 4.78E+08
O75150;H3BP71;O75150-4;O75150-3;A0A087WTK2;H3BS50;H3BQ99;H3BUL6;I3L332;H3BP71;O75150-4;O75150-E3 ubiquitin-protein ligase BRE1BRNF40 25 22 1001 0 166.63 1.0996 0.78992 1.02E+09
Q9GZT9-2;Q9GZT9;Q9GZT9-3;G3V3M1;F8W1G2;Q9H6Z9Q9GZT9-2;Q9GZT9;Q9GZT9-3Egl nine homolog 1EGLN1 7 7 404 0 39 1.0995 0.69495 3.77E+08
Q5SY16 Q5SY16 Polynucleotide 5-hydroxyl-kinase NOL9NOL9 15 15 702 0 133.45 1.0993 1.0531 2.31E+09
Q9Y5A9;A0A087WXZ3;Q9Y5A9-2;S4R3J8;S4R3V3;Q9BYJ9-2Q9Y5A ;A0A087WXZ3;Q9Y5A9-2YTH domain-containing family protein 2YTHDF2 15 11 579 0 183.97 1.0992 0.96554 1.86E+09
Q14156-2;Q14156;Q14156-3;E5RJS1;H7BXG9;E7ESK9;Q9Y2G0-3;Q9Y2G0Q14156-2;Q14156;Q14156-3Protein EFR3 homolog AEFR3 5 5 785 0 60.103 1.0987 1.0898 3.16E+08
Q14689-6;Q14689;Q14689-3;Q14689-2;Q14689-4;Q14689-5;E7EPU2;A0A0U1RQW6;Q9Y2E4Q14689-6;Q14689;Q14689-3;Q14689-2;Q14689-4;Q14689-5Disco-interacting protein 2 homolog ADIP A 3 2 1567 0 7.8892 1.0985 1.2429 7.69E+07
J9JIC5;Q9HAS0;J3KRR1;K7ERX0;K7EIQ2;K7EII1J9JIC5;Q9HAS0;J3KRR1Protein Njmu-R1 C17orf75 5 5 396 0 12.584 1.0984 1.093 4.37E+08
P25205;P25205-2;J3KQ69;Q7Z6P5P25205;P25205-2;J3KQ69DNA replication licensing factor MCM3MCM3 52 52 808 0 323.31 1.098 0.91541 2.36E+10
Q8NAF0 Q8NAF0 Zinc finger protein 579ZNF579 3 3 562 0 35.395 1.0975 NaN 2.46E+07
Q14CX7-2;Q14CX7Q14CX7-2;Q14CX7N-alpha-acetyltransferase 25, NatB auxiliary subunitNAA25 3 3 859 0 9.019 1.0973 NaN 1.22E+08
Q9NVQ4;Q9NVQ4-3;Q9NVQ4-2;C9JDZ2Q9NVQ4;Q9NVQ4-3;Q9NVQ4-2;C9JDZ2Fas apoptotic inhibitory molecule 1FAIM 9 9 179 0 52.424 1.0971 0.80777 1.04E+09
Q5VIR6-4;Q5VIR6-2;Q5VIR6-3;Q5VIR6;F6VX93;I3L184;E7EVT8;I3L0S6;I3L1W6Q5VIR6-4;Q5VIR6-2;Q5 IR6-3;Q5VIR6;F6VX93Vacuolar protein sorting-associated protein 53 homologVPS53 11 11 832 0 38 1.097 0.93359 7.26E+08
Q9UI12-2;Q9UI12;G3V126;E5RK31;E5RJG1;A0A0D9SG68;H0YB41;E5RG49;E5RHH0Q9UI -2;Q9UI12;G3V126V-type proton ATPase subunit HATP6V1H 12 12 465 0 114.85 1.0969 0.91737 1.78E+09
I3L397;I3L504;P63241;P63241-2;Q6IS14;F8WCJ1;C9J7B5I3L397;I3L504;P63241;P63241-2;Q6IS14;F8WCJ1;C9J7B5Eukaryotic translation initiation factor 5A-1;Eukaryotic translation initiation factor 5A-1-likeEIF5A;EIF5AL1;EIF5A2 15 7 147 0 323.31 1.0967 0.76415 1.81E+10
C9JP03;Q5T6P2;C9JD09;C9JUW9;X6RDJ2;Q5T6P1;X6RGK9;A0A0C4DFN6;A0A0A0MSS3;Q8ND83-2;Q8ND83-4;Q8ND83;B7Z326C9JP03;Q5T6P2;C9J 09;C9JUW9;X6RDJ2;Q5T6P1;X6RGK9;A0A0C4DFN6;A0A0A0MSS3;Q8ND 3-2;Q8ND83-4;Q8ND83;B7Z326SLAIN motif-containing protein SLAIN1 2 2 99 0 9.063 1.0963 NaN 9.86E+06
Q13325-2;Q13325Q13325-2;Q13325Interferon-induced protein with tetratricopeptide repeats 5IFIT5 3 3 434 0 20.402 1.0956 0.82935 3.07E+08
Q9H7Z7;X6RJ95;A6NHH0Q9 7Z7 Prostaglandin E synthase 2;Prostaglandin E synthase 2 truncated formPTGES2 7 7 377 0 72.999 1.0955 0.87653 7.24E+08
A0A096LNH6;Q14185A0A096LNH6;Q14185Dedicator of cytokinesis protein 1DOCK1 5 5 1886 0 23.521 1.095 1.2765 1.46E+08
Q96I24;Q96I24-2 Q96I24 Far upstream element-binding protein 3FUBP3 25 21 572 0 300.11 1.0949 1.0502 3.11E+09
Q9Y3F4;Q9Y3F4-2;H0YH33Q9Y3F4;Q9Y3F4-2Serine-threonine kinase receptor-associated proteinSTRAP 17 17 350 0 121.45 1.0946 1.1082 3.31E+09
Q6GMV2;E2QRN5;F8WEJ9;C9IYN9Q6GMV2 SET and MYND domain-containing protein 5SMYD5 4 4 418 0 44.08 1.094 0.83454 6.93E+08
Q59GN2;P62891 Q59GN2;P62891 Putative 60S ribosomal protein L39-like 5;60S ribosomal protein L39RPL39P5;RPL39 2 2 51 0 5.4106 1.0939 NaN 3.12E+08
Q9H6S0;D6RA70;D6RF50;D6R9T8Q9H6S0; 6RA70 Probable ATP-dependent RNA helicase YTHDC2YTHDC2 18 18 1430 0 93.498 1.0939 1.1909 9.45E+08
P29144;Q5VZU9 P29144;Q5VZU9 Tripeptidyl-peptidase 2TPP 31 31 1249 0 323.31 1.0938 0.85239 3.22E+09
O75694-2;O75694;E9PF10O75694-2;O75694;E9PF10Nuclear pore complex protein Nup155NUP155 44 44 1332 0 323.31 1.0937 0.86957 1.03E+10
Q9HCE5;A0A0D9SF88;A0A0D9SFW0;D6RBL4Q9HCE5 N6-adenosine-methyltransferase subunit METTL14METTL14 5 5 456 0 47.856 1.0934 NaN 2.49E+08
Q92845-2;Q92845-3;Q92845;Q92845-4Q92845-2;Q92845-3;Q92845;Q92845-4Kinesin-associated protein 3KIFAP3 5 4 748 0 153.47 1.0933 0.57407 4.00E+08
Q9NUU7;I3L0H8;I3L352;Q9NUU7-2;H3BTB3;J3QRH0;H3BSL8;H3BP36;H3BP50;H0YD26;E9PR46;J3QL17;Q9UHL0-2;Q9UHL0Q9NUU7;I3L0H8;I3L 52;Q9NUU7-2ATP-dependent RNA helicase DDX19ADDX19A 4 478 0 275.45 1.0932 0.83782 8.24E+09
Q86Y56;Q86Y56-2;H0Y650;E9PGY2;Q86Y56-3;H7C3B1Q86 56;Q86Y56-2;H0Y650HEAT repeat-containing protein 2HEATR2 19 19 855 0 262.36 1.0928 1.0414 2.89E+09
O95714;A0A0J9YVP0;A0A0J9YXQ8;H3BUQ1O95714;A0A0J9YVP0E  ubiquitin-protein ligase HERC2HERC2 11 11 4834 0 35.362 1.0927 2.1181 2.73E+08
P49790-2;P49790;P49790-3P49790-2;P49790;P49790-3Nuclear pore complex protein Nup153NUP153 4 4 1433 0 8.5446 1.0921 0.68987 1.07E+08
O00273;O00273-2;K7ERT1O00273;O00273-2DNA fragmentation factor subunit alphaDFFA 7 7 331 0 45.046 1.0919 0.65738 9.28E+08
Q8NC60 Q8NC60 Nitric oxide-associated protein 1NOA1 2 2 698 0 16.988 1.0917 NaN 6.91E+07
P61081;M0QX69;M0QYI6P61081 NEDD8-conjugating enzyme Ubc12UBE2M 12 12 183 0 73.213 1.0916 0.71985 6.71E+09
Q9UJW0;Q9UJW0-3;Q9UJW0-2;H9KVE0;E5RK21;E5RGG1;E5RI97Q9UJW0;Q9UJW0-3;Q9UJW0-2Dynactin subunit 4DCTN4 13 13 460 0 85.725 1.0912 NaN 1.38E+09
P42574;C9JXR7;A8MVM1;A0A087WU32P42574;C9JXR7;A8MVM1Caspase-3;Caspase-3 subunit p17;Caspase-3 subunit p12CASP3 7 7 277 0 28.837 1.0909 1.8737 4.84E+08
P48444;B0YIW6;P48444-2;Q6P1Q5;E9PK34P48444;B0YIW6;P48444-2Coatomer subunit deltaARCN1 33 33 511 0 229.22 1.0907 0.66823 7.96E+09
P22830;P22830-2;K7ELX4;K7EPN2;K7EKP7;K7EJX5;K7EJM8P22830;P22830-2;K7ELX4Ferrochelatase, mitochondrialF CH 13 13 423 0 66.029 1.0905 0.84641 1.71E+09
Q86W56-3;Q86W56-2;Q86W56;Q86W56-5;Q86W56-4Q86W56-3;Q86W56-2;Q86W56;Q86W56-5;Q86W56-4Poly(ADP-ribose) glycohydrolasePARG 5 5 868 0 24.301 1.0899 1.0344 4.00E+08
Q13158 Q13158 FAS-associated death domain proteinFADD 3 3 208 0 10.428 1.0897 0.98026 2.19E+08
B0QYK0;Q01844-6;Q01844-3;Q01844;Q01844-5;F8WC90;H7BY36;A0A0D9SFL3;C9JGE3;Q01844-4;Q01844-2B0QYK0;Q01844-6;Q01844-3;Q01844;Q01844-5 F8WC90;H7BY36;A0A0D9SFL3;C9JGE3;Q01844-4;Q01844-2RNA-binding protein EWSEWSR1 2 2 618 0 37.32 1.0892 1.0534 1.55E+08
P48047;H7C0C1;H7C086;H7C068P48 47; C1 ATP synthase subunit O, mitochondrialATP5O 12 12 213 0 132.81 1.0889 0.7087 6.33E+09
O00186 O00186 Syntaxin-binding protein 3STXBP3 12 12 592 0 102.05 1.0887 NaN 9.34E+08
Q9BXS5;Q9BXS5-2;K7EJL1;E7ENJ6;K7EQX3;K7EPJ8;A0A087WZX7;K7ENA7;K7ER75;Q9Y6Q5;Q9Y6Q5-2;K7EK69;K7EQ90;K7ERH5;K7EL08;K7EPR4;K7EJJ1;K7EMG5Q9BXS5;Q9BXS5-2;K7EJL1;E7ENJ6AP-1 complex subunit mu-1P1M1 14 14 423 0 100.12 1.0885 0.80517 3.63E+09
I3L112;P52429 I3L112;P52429 Diacylglycerol kinase;Diacylglycerol kinase epsilonDGKE 3 3 456 0 7.9998 1.0883 NaN 9.46E+07
E7ESP9;P07197;E7EMV2;P07197-2;P12036-2;P12036E7ESP9;P07197;E7EMV2Neurofilament medium polypeptideNEFM 23 21 877 0 228.09 1.0879 1.1815 2.36E+09
K7EM73;K7ELJ7;A0A0C4DGQ5;P04632;U3KQE2;K7EIV0;A0A075B7C0;K7EKD8;K7ES78;K7EMQ1;U3KPR7K7EM73;K7ELJ7;A0A0C4DGQ5;P04632;U3KQE2;K7EIV0;A0A075B C0;K7EKD8Calpain small subunit 1CAPNS1 3 3 163 0 23.21 1.0876 0.6146 2.06E+08
Q9H974-2;Q9H974-3;Q9H974;Q9H974-4;C9K0B6Q9H974-2;Q9H974-3;Q9H974;Q9H974-4Queuine tRNA-ribosyltransferase subunit QTRTD1QTRTD1 6 6 292 0 39.035 1.0876 1.1143 9.95E+08
Q6IBS0;D6RG15;H0Y858;H7C5I2;Q9NR96-4Q6IBS0;D6RG15 Twinfilin-2 TWF2 7 6 349 0 85.832 1.0873 0.40249 1.02E+09
O15084;O15084-4;O15084-1;B4DIW9;O15084-2;H7C4A0;H7C209;Q8N8A2-5;Q8N8A2-3;Q8N8A2-4;Q8N8A2;Q8N8A2-2O15084;O 5084-4;O15084-1;B4DIW9;O15084-2Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit AANKRD28 10 10 1053 0 41.967 1.0872 0.95558 4.91E+08
M0QXB4;O14579;A0A087X0I4;O14579-3;O14579-2;M0R061M QXB4;O14579;A0A087X0I4;O14579-3;O14579-2Coatomer subunit epsilonCOPE 17 17 331 0 323.31 1.0866 0.77879 1.34E+10
Q9Y2Q9;H0YAT2;H7C5V3;E5RGC7;E5RK86;E5RFH3;E5RFT8;H0YC42Q9Y2Q9;H0YAT2;H7C5V3;E5RGC7;E5RK 6;E5RFH328S ribosomal protein S28, mitochondrialMRP 4 4 187 0 12.414 1.0864 1.044 1.20E+09
Q9Y4K3 Q9Y4K3 TNF receptor-associated factor 6TRAF6 7 7 522 0 30.918 1.0862 NaN 4.27E+08
Q7L2E3-2;H7BXY3;Q7L2E3-3;Q7L2E3Q7L2E3-2;H7BXY3;Q7L2E3-3;Q7L2E3Putative ATP-dependent RNA helicase DHX30DHX30 54 54 1222 0 323.31 1.0858 1.0008 8.62E+09
Q01085-2 Q01085-2 Nucleolysin TIAR TIAL1 13 3 392 0 93.687 1.0851 1.3944 2.29E+09
Q96EK5;A0A0D9SFK7Q96EK5 KIF1-binding proteinKIAA1279 16 16 621 0 168.91 1.085 1.9668 2.26E+09
P54098;A0A0D9SFM1;H0YCD2;H0YDF1;H0YD36;H0YCV2P54098 NA polymerase subunit gamma-1POLG 6 6 1239 0 51.719 1.0847 1.0487 1.53E+08
Q8TF05-2;Q8TF05;J3QL26;J3KSB0;J3QLA6;J3QQV0;J3KRU1Q8TF05-2;Q8TF05Serine/threonine-protein phosphatase 4 regulatory subunit 1PPP4R1 7 7 933 0 19.553 1.0845 0.60176 3.46E+08
H3BPK3;H3BPQ4;Q16775-2;Q16775;H3BQW8;Q16775-3H3BPK3;H3BPQ4;Q16775-2;Q16775;H3BQW8;Q16775-3Hydroxyacylglutathione hydrolase, mitochondrialHAGH 2 2 239 0 9.9643 1.0839 0.88782 8.33E+07
Q9NPF5;Q5TG40;Q5TG39;Q5TG389NPF5; 40 DNA methyltransferase 1-associated protein 1DMAP1 5 5 467 0 60.124 1.0839 NaN 1.82E+08
E7EPM6;P33121-2;P33121-3;P33121;B7Z3Z9;D6RER0;H0Y9Z9;H0Y9U7;D6RG07;E7ERD7;Q9UKU0-7;Q9UKU0-2;Q9UKU0-5;Q9UKU0-3;Q9UKU0;Q9UKU0-9;Q9UKU0-6;Q9UKU0-8;Q9UKU0-1E7EPM6;P 3121- ;P33121-3;P33121;B7Z3Z9;D6RER0Long-chain-fatty-acid--CoA ligase 1ACSL1 6 6 664 0 14.016 1.0837 NaN 3.04E+08
Q969S9-3;Q969S9;Q969S9-2;Q969S9-4;Q969S9-5;D6RAL1;D6RF75Q969S9-3;Q969S9;Q969S9-2;Q969S9-4;Q9 9S9-5Ribosome-releasing factor 2, mitochondrialGFM2 15 15 777 0 84.475 1.0833 0.69161 9.47E+08
Q8N1F7;H3BVG0;Q8N1F7-2;H3BPA9;H3BM93;H3BRI8;H3BV11;H3BNN5;H3BVE2;H3BP95;H3BMX0;H3BRD9;H3BV15;H3BNG7;H3BVG0;Q8N1F7-2Nuclear pore complex protein Nup93NUP93 52 52 819 0 323.31 1.0831 0.86049 1.48E+10
B8ZZG1;Q9NZW5 B8ZZG1;Q9NZW5 MAGUK p55 subfamily member 6MPP6 3 2 428 0 11.094 1.0828 NaN 1.55E+08
P57740;P57740-2;P57740-3;H0YG15;G3V1T4;F5GY77P57 40;P57740-2;P57740-3Nuclear pore complex protein Nup107NUP107 32 32 925 0 299.5 1.0828 0.86331 6.36E+09
Q9Y5L0-3;Q9Y5L0;C9J7E5;Q9Y5L0-1;Q9Y5L0-5;E9PFH4Q9Y5L0-3;Q9Y5L0;C9J7E5;Q9Y5L0-1;Q9Y5L0-5;E9PFH4Transportin-3 TNPO3 13 13 909 0 169.44 1.0824 0.85656 1.75E+09
E9PF19;Q9Y4P3;Q96E41;F8WCR3;F8WDI9;A0A087WXC6E9PF19;Q9Y4P Q96E41Transducin beta-like protein 2TBL2 11 11 411 0 81.933 1.0821 0.82837 8.20E+08
174
A8MX75;P18074;E7EVE9;P18074-2;K7EKF3;K7EIT8A8MX75;P18074;E7EVE9;P18074-2TFIIH basal transcription factor complex helicase XPD subunitERCC2 9 9 706 0 55.262 1.0819 0.81805 9.78E+08
P06132;Q5T446;H0Y5R6P06132;Q5T446;H0Y5R6Uroporphyrinogen decarboxylaseUROD 13 13 367 0 195.09 1.0819 0.76635 4.70E+09
Q9BVG4;A6NDF3 Q9BVG4;A6NDF3 Protein PBDC1 PBDC1 6 6 233 0 20.086 1.0819 1.084 6.48E+08
A6NIW2;Q5JSL3;A0A0J9YW64;A0A0J9YXQ7;Q96BY6-3;Q96BY6A6NIW2;Q5JSL3;A0A0J9YW64Dedicator of cytokinesis protein 11DOCK11 32 31 2077 0 214.98 1.0815 0.83919 1.81E+09
A2ABE9;H7C2J4;A0A0G2JK42;A0A140T9J3;A0A140T982;A0A0G2JK88;A0A024RCV8;O43196-4;O43196;O43196-2;O43196-3A2ABE9;H7C2J4;A0A0G2JK42;A0A140T9J3;A0A140T982;A0A0G2JK88;A0A024RCV8;O43196-4;O43196;O43196-2;O43196-3MutS protein homolog 5MSH5 2 2 333 0.0047405 2.4123 1.0814 0.74998 3.96E+08
P06493;A0A024QZP7;A0A087WZZ9;P06493-2;E5RIU6;K7ELV5P06493;A0A024QZ 7;A0A087WZZ9;P06493-2;E5RIU6Cyclin-dependent kinase 1CDK1;CDC2 20 18 297 0 205.41 1.0809 0.71204 9.03E+09
Q9Y4W2-2;Q9Y4W2;Q9Y4W2-3;Q9Y4W2-4Q9Y4W2-2;Q9Y4W2;Q9Y4W2-3Ribosomal biogenesis protein LAS1LLAS1L 17 17 717 0 133.32 1.0808 1.055 3.95E+09
Q9NV31 Q9NV31 U3 small nucleolar ribonucleoprotein protein IMP3IMP3 7 7 184 0 56.617 1.0803 1.3187 1.14E+09
A0A0D9SF60;Q99569-2;Q99569A0A0D9SF60;Q99569-2;Q99569Plakophilin-4 PKP4 2 2 1208 0 7.1673 1.0801 NaN 3.61E+07
P14618;P14618-3;B4DNK4P1 618;P14618-3;B4DNK4Pyruvate kinase PKM;Pyruvate kinasePKM 56 5 531 0 323.31 1.08 0.83229 1.17E+11
Q6PD62;H0YCE8 Q6PD62 RNA polymerase-associated protein CTR9 homologCTR9 17 17 1173 0 159.29 1.079 1.0499 1.65E+09
Q9Y613;J3KTH7 Q9Y613 FH1/FH2 domain-containing protein 1FHOD1 9 9 1164 0 40.004 1.0789 1.1111 3.35E+08
A0A087WWP4;Q96T37-4;Q96T37-2;Q96T37-3;Q96T37A0A087WWP4;Q96T37-4;Q96T37-2;Q96T37-3;Q96T37Putative RNA-binding protein 15RBM15 16 15 933 0 92.743 1.0783 0.60495 1.45E+09
Q9BWF3;E9PB51;Q9BWF3-4;E9PLB0;E9PM61;D6R9K7;U3KQD5;J3QRR5;Q9BWF3-3;Q9BWF3-2;E9PB51 RNA-binding protein 4RBM4 12 0 364 0 147.7 1.0782 0.8713 3.57E+09
Q12931-2;Q12931;I3L0K7;I3L239;I3L253;I3L2D5Q12931-2;Q12 31;I3L0K7Heat shock protein 75 kDa, mitochondrialTRAP1 25 25 651 0 267.54 1.0775 2.4093 4.94E+09
Q9NRL2-2;Q9NRL2;A0A087WWN7;H0YJP5Q9NRL2-2;Q9 RL2Bromodomain adjacent to zinc finger domain protein 1ABAZ1A 24 24 1524 0 187.88 1.0775 0.84782 9.65E+08
A0A067XG54;Q8NB49-3;Q8NB49-2;Q8NB49-4;Q8NB49A0A067XG54;Q8NB49-3;Q8NB49-2;Q8NB49-4;Q8NB49Phospholipid-transporting ATPase IGATP11C 6 6 1113 0 30.622 1.0772 0.76738 2.96E+08
Q15366-5;Q15366-8Q15366-5;Q15366-8Poly(rC)-binding protein 2PCBP2 20 0 335 0 323.31 1.0772 0.90877 3.06E+10
O75792 O75792 Ribonuclease H2 subunit ARNASEH2A 10 10 299 0 67.828 1.0771 0.98422 1.67E+09
P31327;P31327-3;P31327-2;Q5R211;E7EWJ3;C9JTA4P31327;P31327-3;P31327-2Carbamoyl-phosphate synthase [ammonia], mitochondrialCPS1 30 26 1500 0 208.3 1.0763 0.76301 2.60E+09
P04150-13;P04150-12;P04150-11;P04150-9;P04150-2;P04150-6;P04150-8;P04150-10;P04150;P04150-3;D6RDA9;Q3MSN4;P04150-16;P04150-15;P04150-14;P04150-7;P04150-5P04150-13;P04 50-12;P04150- 1;P04150-9;P04150-2;P04150-6;P04150-8;P04150-10;P04150;P04150-3;D6RDA9;Q3MSN4;P04150-16;P04150-15;P04150- 4;P04150-7;P04150-5Glucocorticoid receptorNR3C1 2 2 680 0.0028047 2.741 1.07 4 NaN 8.17E+07
J3KTF8;J3QQX2;P52565;J3KRY1;P52565-2;J3KRE2;J3KS60J3KTF8;J3QQX2;P52565;J3KRY1;P525 5-2;J3KRE2Rho GDP-dissociation inhibitor 1ARHGDIA 9 9 194 0 120.15 1.0749 0.91975 3.51E+09
O00743;O00743-2;O00743-3;Q5T1S7O00743;O00743-2;O00743-3erine/threonine-protein phosphatase 6 catalytic subunit;Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processedPPP6C 11 11 305 0 85.866 1.0749 0.85457 2.93E+09
Q6NZY4;Q6NZY4-2;F5H6J5;F5GX80Q6NZY4;Q6NZY4-2Zinc finger CCHC domain-containing protein 8ZCCHC8 8 8 707 0 74.45 1.0744 0.62726 1.08E+09
P11908;P11908-2;H7C540;A6NMS2;D3YTJ7P11908;P11908- Ribose-phosphate pyrophosphokinase 2PRPS2 21 9 318 0 103.38 1.0739 0.97226 2.54E+09
P49137;P49137-2P49137;P49137-2MAP kinase-activated protein kinase 2MAPKAPK2 4 3 400 0 9.6068 1.0737 1.0101 2.23E+08
C9J6A7;Q96AT9-5;Q96AT9-3;Q96AT9-2;Q96AT9;C9IYE8;E7ESZ6;C9J8S0;C9J9T0;C9IZU8;Q96AT9-4;Q2QD12;C9JCL8C9J 7;Q96AT9-5;Q96AT9-3;Q96AT9-2;Q96AT9;C9IYE8;E7ESZ6;C9J8S0;C9J9T0;C9IZU8;Q96AT9-4;Q2QD12Ribulose phosphate 3-epimerase;Ribulose-phosphate 3-epimerase-like protein 1RP ;RPEL1 3 3 159 0 13.921 1.0736 0.75397 5.96E+08
Q9BQ52;Q9BQ52-4;G5E9D5;E7ES68;Q9BQ52-3;Q9BQ52-2;H7C2I4;V9GYS7;V9GZ72;J3QRS2;V9GYU5;J3QL08;J3QLK4;J3QQT1Q9BQ52;Q9BQ52-4;G5E9D5;E7ES68;Q9BQ52-3Zinc phosphodiesterase ELAC protein 2ELAC2 35 35 826 0 323.31 1.0725 0.76365 7.28E+09
Q9UL25 Q9UL25 Ras-related protein Rab-21RAB21 11 11 225 0 99.716 1.0717 0.8584 3.68E+09
H3BTB7;Q5JPH6;Q5JPH6-2H3BTB7;Q5JPH6;Q5JPH6-2Probable glutamate--tRNA ligase, mitochondrialEARS2 14 14 506 0 41.249 1.0709 0.7007 1.78E+09
O00232;O00232-2;J3KTJ5;J3KSK1O00232;O00232-2 6S proteasome non-ATPase regulatory subunit 12PSMD12 23 23 456 0 209.38 1.0709 0.96149 7.11E+09
Q5JTZ9;A0A087WTZ2;Q9H2T7Q5JTZ Alanine--tRNA ligase, mitochondrialAARS2 29 29 985 0 229.69 1.0706 0.80085 2.84E+09
Q9UHB6;Q9UHB6-4;F8VQE1;Q9UHB6-2;Q9UHB6-5;F8VS07;Q9UHB6-3;F8VRN8;F8VTU2;F8VVQ7Q9UHB6;Q9UHB6-4;F8VQE1;Q9UHB6-2;Q9UHB6-5;F8VS07;Q9UHB6-3;F8 RN8LIM domain and actin-binding protein 1LIMA1;TRMT1 23 759 0 215.78 1.0706 0.79149 1.59E+09
Q8IY18 Q8IY18 Structural maintenance of chromosomes protein 5SMC5 10 10 1101 0 47.355 1.0705 0.89538 6.07E+08
A0A0B4J1W0;O75448-2;O75448;B4DDR8;F5H5K2;F5GY88;B9TX62;E9PFL1A0A0B4J1W0;O75448-2 O75448;B4DDR8;F5H5K2;F5GY88Mediator of RNA polymerase II transcription subunit 24MED24 4 4 1014 0 17.08 1.0704 1.2299 1.72E+08
E9PMP7;E9PMS6;F8WD26;J3KP06;Q8WWI1-3;Q8WWI1-4;Q8WWI1-2;Q8WWI1;H0Y424;A0A0A0MTE2;E9PMT2;Q8WWI1-5;E9PLU6;E9PK58;H0YE95;E9PJ10;H0YDQ3;H0YDG6E9PMP7;E9PMS ;F D26;J3KP06;Q8WWI1-3;Q8WWI1-4;Q8WWI1-2;Q8WWI1;H0Y424;A0A0A0MTE2;E9PMT2;Q8WWI1-5LIM domain only protein 7LMO7 5 5 1046 0 22.991 1.0702 0.62818 1.54E+08
P82912-2;P82912;H0YL99;P82912-3P82912-2;P82912;H0YL99;P82912-328S ribosomal protein S11, mitochondrialMRP 4 4 193 0 18.648 1.0702 0.76914 4.18E+08
Q8ND24;Q8ND24-2;E9PN76;E9PRE9Q8ND24;Q8ND24-2;E9PN76RING finger protein 214RNF214 5 5 703 0 15.234 1.0701 NaN 2.16E+08
Q9UI26;F8WDV0;Q9UI26-2;D6RJB1;D6RCN7;H0Y8M5;D6RCQ2;F8WDV0;Q9UI26-2Importin-11 IPO11 14 14 975 0 223.86 1.0701 0.92683 1.73E+09
P49458;E9PE20;P49458-2P49458 Signal recognition particle 9 kDa proteinSRP9 6 6 86 0 13.978 1.07 0.88891 1.04E+08
P19623;K7EKM4;K7EQ47;K7EL89;K7ESL0P19623 Spermidine synthaseSRM 14 14 302 0 260.46 1.0699 0.83547 1.23E+10
P04350;M0R278;M0QY85;M0R0X0;M0QY37;M0QX14;M0QZL7;M0QYM7;M0R042;M0R1I1P04350 Tubulin beta-4A chainTUBB4A 34 4 444 0 222.42 1.0691 0.97182 6.43E+09
Q9BSD7;Q5TDF0 Q9BSD7;Q5TDF0 Cancer-related nucleoside-triphosphataseNTPCR 7 7 190 0 34.969 1.0691 0.90354 3.65E+09
D6REX3;O94979-6;O94979-3;O94979-10;O94979-4;O94979-9;O94979-2;O94979;O94979-8;D6RHZ5;H7BXG7;O94979-7;O94979-5;H0YAB3;H0Y8V7;H0Y9T9;H0Y9K1;H0Y8W8;D6RE64;D6RCQ9;H0YAF5;D6RBT0;D6RHE8;H0Y9V3D6REX3;O94979-6;O9497 -3;O9 97 -10;O 4979-4;O94979-9;O94979-2;O94979;O94979-8 D6RHZ5;H7BXG7;O94979-7;O94979-5Protein transport protein Sec31ASEC31A 36 36 1251 0 283.86 1.069 0.88831 5.69E+09
O75600;O75600-2;H7BZ75;F2Z340;C9IZC9O75600;O75600-2 -amino-3-ketobutyrate coenzyme A ligase, mitochondrialGCAT 7 7 419 0 55.214 1.0687 1.1817 1.09E+09
Q13619;A0A0A0MR50;Q13619-2;A0A087WWN2Q13619;A0A0A0MR50;Q13619-2Cullin-4A CUL4A 16 4 759 0 18.952 1.0684 4.9467 2.00E+08
O95298;O95298-2;E9PM14;A0A087WUM3;E9PQ53;E9PRJ5;O95298-3;E9PRQ4;A0A087WY27O95298;O95298-2;E9PM14;A0A087WUM3;E9PQ53NADH dehydrogenase [ubiquinone] 1 subunit C2;NADH dehydrogenase [ubiquinone] 1 subunit C2, isoform 2ND FC2;NDUFC2-KCTD1 6 6 119 0 21.93 1.0683 0.48155 1.41E+08
Q9BXW6;Q9BXW6-2;Q9BXW6-4;J3QLA2;J3KTA6;J3KSG6;E7ER58;J3QSB8Q9BXW6 Oxysterol-binding protein-related protein 1OSBPL1A 6 6 950 0 19.461 1.0683 0.71218 1.44E+08
O14925;Q5SRD1;B4DDK6O14925;Q5SRD1 Mitochondrial import inner membrane translocase subunit Tim23;Putative mitochondrial import inner membrane translocase subunit Tim23BTIMM23;TIMM23B 7 7 209 0 69.59 1.0677 0.91341 2.05E+09
Q9BRA2;I3L2R6;I3L0K2;I3L3M7Q9BRA2;I L2R6;I3L0K2;I3L3M7Thioredoxin domain-containing protein 17TXNDC17 6 6 123 0 41.623 1.0676 0.79478 5.48E+09
Q14683;G8JLG1;H0Y7K8;V9GY57;V9GYN9Q14683;G8JLG1 Structural maintenance of chromosomes protein 1ASMC1A 71 71 1233 0 323.31 1.0674 0.91587 9.22E+09
Q9P260-2;Q9P260;A0A075B785Q9P260-2;Q9P260;A0A075B785LisH domain and HEAT repeat-containing protein KIAA1468KI A1468 5 5 1250 0 17.338 1.0674 0.93347 4.22E+08
P46060;B0QYT5;B0QYT4;H0Y4Q3;B0QYT6P46060 Ran GTPase-activating protein 1RANGAP1 15 15 587 0 105.75 1.0673 0.87321 2.09E+09
A0A087WW06;Q96AY4;B0QYP4;B0QYP5A0A087WW06;Q96AY4Tetratricopeptide repeat protein 28TTC28 24 24 2354 0 128.04 1.0672 1.054 9.38E+08
P11216;H0Y4Z6 P11216 Glycogen phosphorylase, brain formPYGB 16 9 843 0 59.556 1.067 1.3815 1.13E+09
Q29RF7;Q29RF7-3;H0Y9L6;H0Y9L9Q29RF7 Sister chromatid cohesion protein PDS5 homolog APDS5A 28 26 1337 0 323.31 1.067 0.90929 2.09E+09
Q9UHY1;F8W6G1;C9JHZ6Q9U Y1;F8W6G1Nuclear receptor-binding proteinNRBP1 6 6 535 0 55.667 1.0667 NaN 9.88E+08
Q8N4Q0;Q8N4Q0-2Q8N4Q0 Zinc-binding alcohol dehydrogenase domain-containing protein 2ZADH2 7 7 377 0 47.43 1.0664 0.81486 1.22E+09
A0A0C4DG02;F8WE91;Q9Y6K1-2;Q9Y6K1A0A0C4DG02;F8WE91;Q9Y6K1-2;Q9Y6K1DNA (cytosine-5)-methyltransferase 3ADNMT3A 2 2 689 0 6.4915 1.0663 NaN 2.75E+07
E5RHG8;Q15369;Q15369-2;R4GMY8E5RHG8;Q15369;Q15369-2;R4GMY8Transcription elongation factor B polypeptide 1TCEB1 6 6 89 0 99.623 1.0659 1.0151 1.59E+09
D3YTB5;P51617-4;P51617-2;P51617-3;P51617;H7C224;H7C2I6;F8WAB6;H7C3C1;H7C1F0D3YTB5;P51617-4;P51617-2;P51617-3;P51617;H7C224; 7C2I6Interleukin-1 receptor-associated kinase 1IRAK1 10 10 708 0 148.94 1.0658 0.84475 2.91E+09
P31930 P31930 Cytochrome b-c1 complex subunit 1, mitochondrialUQCRC1 24 23 480 0 323.31 1.0655 0.92721 1.92E+10
Q96EK9 Q96EK9 Protein KTI12 homologKTI12 5 5 354 0 11.532 1.0647 0.85733 2.49E+08
Q9H3U1;Q9H3U1-3Q9H3U1 Protein unc-45 homolog AUNC45 41 2 944 0 323.31 1.0647 0.85637 8.02E+09
B3KQ25;K7ESG5;P61289;P61289-3;P61289-2;K9J957;K7EMD0;K7EPX6;K7EKR3;A0A087WTV2;K7ENH2B3KQ25;K7ESG5;P61289;P6128 -3;P61289-2;K9J957; MD0;K7EPX6;K7EKR3;A0A087WTV2;K7ENH2Proteasome activator complex subunit 3PSM 3 4 4 193 0 32.77 1.0644 1.4899 3.94E+08
Q9P2R3;Q9P2R3-2;Q9P2R3-4;I3L3P8;K7EPT2;I3L1Z9Q9P2R3;Q9P2R -2;Q9P2R3-4Ankyrin repeat and FYVE domain-containing protein 1ANKFY1 27 27 1169 0 323.31 1.0641 0.96117 3.12E+09
Q9H0D6;Q9H0D6-2Q9H0D6;Q9H0D6-25-3 exoribonuclease 2XRN2 26 26 950 0 195.9 1.064 0.95404 3.52E+09
O14802;Q7Z755;R4GMX2O1480 DNA-directed RNA polymerase III subunit RPC1POLR3A 42 41 1390 0 257.87 1.0635 0.77725 3.86E+09
B4E3T4;Q93062-4;Q93062-5;Q93062;Q93062-2;Q93062-3B4E T4;Q93062-4;Q93062-5;Q93062;Q93062-2;Q93062-3RNA-binding protein with multiple splicingRBPMS 3 2 224 0 26.81 1.0633 NaN 1.00E+08
E9PC69;Q7KZI7-14;Q7KZI7-11;Q7KZI7-8;Q7KZI7;Q7KZI7-15;Q7KZI7-16;Q7KZI7-12;Q7KZI7-3;Q7KZI7-6;E7ETY4;Q7KZI7-13;Q7KZI7-5;Q7KZI7-4;Q7KZI7-9;Q7KZI7-10;Q7KZI7-7;Q7KZI7-2;F5H4F6;F5H6N2;Q96L34-2;Q96L34;K7EN95;K7EK17;K7EKG8;F5H4J8;Q6IPE9E9PC69;Q7KZI -14;Q7KZI7-11 8;Q7KZI7;Q7KZI -15;Q7KZI -16;Q7KZI7-12;Q7KZI7-3; I 6;E7ETY4;Q7KZI7-13;Q7KZI7-5;Q7KZI7-4;Q7KZI7-9;Q KZI7-10;Q7KZI7-7;Q7KZI7-2Serine/threonine-protein kinase MARK2MARK2 21 15 7 8 0 104.8 1.0623 0. 4008 9.07E+08
O60524-4;O60524-3;O60524;G3V5V3;O60524-5;O60524-2;G3V547;G3V4D9O60524-4;O60524- ; ;G3V5V3;O60524-5Nuclear export mediator factor NEMFNEMF 9 9 1034 0 20.5 1.0623 0.63524 3.33E+08
O75821;K7EL20;K7ER90;K7ENA8;K7EP16;K7EL60O75821;K7EL20;K7ER90;K7ENA8Eukaryotic translation initiation factor 3 subunit GEIF3G 15 15 320 0 140.61 1.0621 0.21599 4.20E+09
Q9BXB4;H7C487;Q9BXB5-2;Q9BXB54 Oxysterol-binding protein-related protein 11OSBPL11 10 10 747 0 122.22 1.0618 0.79738 1.22E+09
Q86XL3;Q86XL3-2;F5H1D4;Q86XL3-3Q86XL3 Ankyrin repeat and LEM domain-containing protein 2ANKLE2 5 5 938 0 58.157 1.0616 0.73759 9.77E+07
Q9Y5Q9;Q9Y5Q9-2;H7C0C0;F8WC64;H7C143;H0YFI7;H7BZV8Q9Y5Q9 General transcription factor 3C polypeptide 3GTF3C3 19 19 886 0 144.78 1.0616 1.0438 2.52E+09
P05165-3;P05165-2;P05165;H0Y5U0;Q5JTW6P05165-3;P05165-2;P05165Propionyl-CoA carboxylase alpha chain, mitochondrialPCCA 8 8 681 0 36.938 1.0615 NaN 2.73E+08
A0A087X1K9;O75608-2;O75608;E5RGR0;B4DP64;E5RJ48;E5RI35A A087X1K9;O7 608-2;O75608;E5RGR0;B4DP64;E5RJ48Acyl protein thioesterase 1LYPLA1 6 6 166 0 21.385 1.0614 0.69854 1.97E+09
Q7Z3C6;Q7Z3C6-2;Q7Z3C6-3;H7C152;H7C1G6;C9JS65;C9JFV2;C9JX27;C9JD65;C9IYZ9;C9JKV7;C9JDK4;C9JXG2;F2Z3I6Q7Z3C6;Q7Z3C6-2;Q7Z3C6-3Autophagy-related protein 9AATG9A 13 13 839 0 66.235 1.061 0.97874 1.09E+09
Q9Y5K5-2;Q9Y5K5-4;Q9Y5K5-3;Q9Y5K5;Q5LJA5;Q5LJA9;H0Y6Y4;Q5LJB0;H0Y4E0;H0Y636;H0Y4K0Q9Y5K5-2;Q9Y5K5-4;Q9Y5K5-3;Q9Y5K5;Q5LJA5;Q5LJA9;H0Y6Y4;Q5LJB0;H0Y4E0Ubiquitin carboxyl-terminal hydrolase isozyme L5UC L5 19 19 316 0 147.05 1.0608 0.96166 5.50E+09
Q15365;H3BSP4;C9K0A2;F8WC71;C9IZV9;C9J7A9;C9JSA6;C9J5V4;C9JTY5;C9JZY3;C9J0A4;F6TJN8;P57723-2;P57723Q15365 Poly(rC)-binding protein 1PCBP1 17 12 356 0 323.31 1.0607 0.87374 1.65E+10
Q6PJI9;Q6PJI9-2;B7Z7V6;H3BR95;H3BMH3;Q6PJI9-3;Q6PJI9-4;H3BV71;H3BNY4Q6PJI9 Q6PJI -2;B7Z7V6WD repeat-containing protein 59WDR5 8 8 974 0 45.323 1.0607 1.526 3.78E+08
P61006;P61006-2;H0YMN7;H0YNE9;Q92930;M0R257;P20337;O95716;P20336;Q96E17P61006;P61 06-2;H0YMN7;H YNE9;Q929 0Ras-related protein Rab-8A;Ras-related protein Rab-8BRAB8A;RAB8B 4 2 207 0 13.452 1.0605 1.0473 8.24E+07
P23258;Q9NRH3;K7EIS0;K7EKE5P23258;Q9NRH3 Tubulin gamma-1 chain;Tubulin gamma-2 chainTUBG1;TUBG2 25 25 451 0 323.31 1.0594 0.83216 1.34E+10
P51531-2;P51531;F6VDE0;A0A0U1RQZ9;A0A0U1RQE1;A0A0U1RRJ8;F6RS74;A0A0A0MT03P51531-2;P51531;F6VDE0;A0A0U1RQZ9Probable global transcription activator SNF2L2SMARCA2 18 3 1572 0 14.318 1.0589 NaN 9.67E+07
Q15386;Q15386-2;Q15386-3Q15386 Ubiquitin-protein ligase E3CUBE3C 27 27 1083 0 166.17 1.0589 0.98406 4.04E+09
E7EN19;E7ESS2;E7ENQ1;G3XAA2;H7C360;G5E948;A0A0D9SEY1;O95819-4;O95819-2;O95819;O95819-5;O95819-3;E7EX83;A0A0D9SG62;C9J840;H7C0P6;H7C3Z6E7EN 9;E7ESS2;E ENQ1; 3XAA2;H7C360;G5E948;A0A0D9SEY1;O95819-4;O95819-2;O95819;O95819-5;O95819-3;E7EX83;A0A0D9SG62;C9J840Mitogen-activated protein kinase kinase kinase kinase 4MAP4K4 11 4 1272 0 30.827 1.0588 0.87129 3.86E+08
O15381;O15381-5;O15381-2;O15381-3;O15381-4;E7EWK7;E9PH71;E9PGD8;C9J6P7;F8WF01;C9JP83O15381;O15381-5;O15381-2;O15381-3;O15381-4Nuclear valosin-containing protein-likeNVL 17 17 856 0 91.561 1.0588 0.73675 2.01E+09
C9JYQ9;H0Y8C2;Q6P5R6C9JYQ9;H0Y8C2;Q6P5R660S ribosomal protein L22-like 1RPL22L1 5 3 121 0 19.623 1.0587 0.58084 9.24E+08
O00203-3;O00203;Q13367;Q13367-4;F5GWU4;F5GYB0;H0YBD0;Q13367-3O00203-3;O00203AP-3 complex subunit beta-1AP3B1 17 17 1045 0 113.45 1.0584 0.94473 1.56E+09
F8WA39;Q13613;Q13613-2;Q8NEC6;H0YDX3;E9PIH9;H7BZJ1;H7C406;E9PPP8;F8W764;F8W8S8F8WA39;Q13613;Q13613-2;Q8NEC6;H0YDX3Myotubularin-related protein 1MTMR1 8 8 673 0 42.543 1.0582 NaN 3.64E+08
C9JLV4;O14727-5;O14727-4;O14727;O14727-3;O14727-2;O14727-6C9JLV4;O14727-5;O14727-4;O14727;O14727-3;O14727-2;O14727-6Apoptotic protease-activating factor 1APAF1 5 5 1163 0 31.504 1.0579 1.1467 1.97E+08
O75439;G3V0E4;F8WAZ6;F8WEA6;F8WBE1O75439;G3V0E4 Mitochondrial-processing peptidase subunit betaPMPCB 17 16 489 0 243.81 1.0576 0.88714 6.05E+09
P36507;G5E9C7;M0R1B6P36507;G5E9C7 Dual specificity mitogen-activated protein kinase kinase 2MAP2K2 16 10 400 0 119.31 1.0569 0.75503 2.59E+09
O60231;A0A140T947;Q5SQH5;A0A140T8Y5;A0A140T9T4;A2AB15O60231;A0A140T9 7;Q5SQH5Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16DHX16 18 17 1041 0 85.256 1.0567 1.1381 8.96E+08
Q7Z6M1;Q5T1S5;Q7Z6M1-2;Q5T1S4;Q5T1S5;Q7Z6M1-2Rab9 effector protein with kelch motifsRABEPK 4 4 372 0 26.422 1.0567 0.85229 4.09E+08
Q5VZE5;Q5VZE5-2Q5VZE5 N-alpha-acetyltransferase 35, NatC auxiliary subunitNAA35 12 12 725 0 56.193 1.0566 0.75275 1.40E+09
Q96CW5;Q96CW5-2;A0A087WWB5;A0A087WU06;Q96CW5-3;A0A0J9YX63;A0A0J9YX56;A0A087WZV5Q96CW5;Q96CW -2Gamma-tubulin complex component 3TUBGCP 20 20 907 0 280.66 1.0566 1.0247 2.37E+09
Q9BV20;Q9BV20-2Q9BV20;Q9BV20-2Methylthioribose-1-phosphate isomeraseMRI1 18 18 369 0 131.95 1.0564 0.91046 7.85E+09
B4DGU4;P35222;E7EMJ5;C9IZ65;E9PDF9;E7EV28;P35222-2B4DGU4;P35222 Catenin beta-1 CTNNB1 18 16 774 0 110.61 1.0561 0.83277 1.09E+09
Q9H2M9;Q9H2M9-2;F8WDJ2Q9H2M9 Rab3 GTPase-activating protein non-catalytic subunitRAB3GAP2 33 33 1393 0 281.43 1.0561 0.82579 3.92E+09
O95628-8;O95628-4;O95628-9;O95628-10;O95628-5;O95628-3;O95628-2;O95628;O95628-7;O95628-6O95628-8;O 5628-4;O95628-9;O9 628-10;O95628-5;O95628-3;O95628-2;O95628;O95628-7;O95628-6CCR4-NOT transcription complex subunit 4CNOT4 2 2 639 0 37.879 1.0559 NaN 1.05E+08
Q92747;E9PF58;Q92747-2Q92747;E9PF58;Q92747-2Actin-related protein 2/3 complex subunit 1AARPC1A 10 9 370 0 50.688 1.0551 0.80919 5.89E+08
Q9BS26 Q9BS26 Endoplasmic reticulum resident protein 44ERP44 4 4 406 0 10.656 1.055 0.85579 6.13E+08
O94822;O94822-3;H7BYG8;S4R3T2;O94822-2O94822;O9 822-3E3 ubiquitin-protein ligase listerinLTN1 18 18 1766 0 124.26 1.0549 0.92969 1.52E+09
175
P12004 P12004 Proliferating cell nuclear antigenPCNA 16 16 261 0 312.05 1.0549 0.91019 3.08E+10
Q9BUJ2-2;Q9BUJ2;A0A0A0MRA5;B7Z4B8;Q9BUJ2-3;Q9BUJ2-4;M0R3F1;M0QYZ0;M0R0K8;M0QZV6;M0QYI8;M0R203;M0QYM5;M0R247;A0A087X1I2;Q9BUJ2-5Q9BUJ2-2;Q9BUJ2;A0A0A0MRA5;B7Z4B8;Q9BUJ2-3;Q9BUJ2-4; 3F1; 0 YZ0Heterogeneous nuclear ribonucleoprotein U-like protein 1HNRNPUL1 23 23 804 0 170.84 1.0547 0.96301 2.55E+09
Q15370;Q15370-2;B8ZZU8;I3L0M9;A0A0B4J296Q15370;Q15370-2;B8ZZU8;I3L0M9;A0A0B4J296Transcription elongation factor B polypeptide 2TCEB2 9 9 118 0 27.85 1.0545 0.6364 1.92E+09
O75165;H0Y8Q2;H0YA63O75165 DnaJ homolog subfamily C member 13DNAJC13 41 41 2243 0 192.59 1.0544 0.89105 3.04E+09
Q96J01;Q96J01-2;D6RGZ2;D6REC9;H7C0C5Q96J01;Q9 J01-2;D6RGZ2THO complex subunit 3THOC3 13 13 351 0 123.26 1.0543 0.90974 2.42E+09
P58557;P58557-2;P58557-4;P58557-3P585 7;P58557-2Putative ribonucleaseYBEY 4 4 167 0 12.433 1.0542 0.53424 3.86E+08
G5EA06;Q92552;Q92552-2;D6RH20;D6RJC7;E5RJ73G5EA06;Q92552;Q92552-2;D6RH2028S ribosomal protein S27, mitochondrialMRP 14 14 358 0 90.629 1.0539 1.0833 2.40E+09
O14646-2;O14646O14646-2;O14646Chromodomain-helicase-DNA-binding protein 1CHD1 11 8 1709 0 35.672 1.0535 0.83349 5.06E+08
O15143;C9J4Z7;F8VXW2;C9JEY1;C9JQM8;C9JFG9;C9J6C8;C9JBJ7;C9K057;C9JTT6;C9JM51;F8WEB3O15143 Actin-related protein 2/3 complex subunit 1BARPC1B 10 9 372 0 79.089 1.0533 1.0844 5.58E+08
P48643;E7ENZ3;B7ZAR1;E9PCA1;P48643-2;D6RIZ7;H0Y914P48643;E7ENZ3;B7ZAR1;E9PCA1;P48643-2T-complex protein 1 subunit epsilonCCT5 44 44 541 0 323.31 1.0532 0.75934 2.32E+10
Q8IY37;F5H3Y4 Q8IY37;F5H3Y4 Probable ATP-dependent RNA helicase DHX37DHX37 12 12 1157 0 50.183 1.0532 0.73736 6.43E+08
Q14147;H7C504 Q14147 Probable ATP-dependent RNA helicase DHX34DHX34 12 12 1143 0 127.07 1.0529 0.83139 9.88E+08
A0A087WVS8;Q70IA6-2;Q70IA6;Q70IA6-3A0A087WVS8; 70I 6-2;Q70IA6;Q70IA6-3MOB kinase activator 2MOB2 2 2 236 0 4.0426 1.0528 NaN 1.49E+08
Q9NXF1-2;Q9NXF1;A0A0A0MSR3Q9NXF1-2;Q9NXF1Testis-expressed sequence 10 proteinTEX10 12 12 913 0 85.679 1.0528 1.0963 9.69E+08
Q9UHB9;Q9UHB9-4;Q9UHB9-2;Q9UHB9-3;K7EN53;K7EQC2Q9UHB9;Q9UHB9-4;Q9UHB9-2Signal recognition particle subunit SRP68SRP68 39 39 627 0 285.26 1.0528 0.98911 5.19E+09
A2A2G4;Q9Y672;S4R350A2A2G4;Q9Y672;S4R350Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferaseALG6 2 2 509 0 5.5501 1.0527 4.7786 2.14E+08
Q12789;Q12789-3;H3BRD0;H3BU55;H3BU37;I3L1Z3Q12789;Q12789-3General transcription factor 3C polypeptide 1GTF3C1 48 48 2109 0 286.18 1.0525 0.83398 3.11E+09
A0A0B4J1S8;Q9UBF8-2;Q9UBF8;Q9UBF8-3;E9PL47;F8W860;A0A0A0MSL0;H0YCW3A0A0B4J1S8;Q9UBF8-2;Q9UBF8;Q9UBF8-3Phosphatidylinositol 4-kinase betaPI4KB 9 9 828 0 46.693 1.0523 0.82183 9.11E+08
B4DY09;Q12905;X6R6Z1;A0A0A0MRL0B4DY09;Q12905 Interleukin enhancer-binding factor 2ILF2 24 24 352 0 323.31 1.0523 0.78129 2.47E+10
P54886;P54886-2P54886;P54886-2Delta-1-pyrroline-5-carboxylate synthase;Glutamate 5-kinase;Gamma-glutamyl phosphate reductaseALDH18A1 43 43 795 0 323.31 1.0522 0.92142 2.00E+10
Q8WUA2 Q8WUA2 Peptidyl-prolyl cis-trans isomerase-like 4PPIL4 7 7 492 0 45.715 1.0517 NaN 4.88E+08
A0A087X140;A0A087WWG3;A0A0A6YYH9;Q5RIB0;H0Y5V3;C9J3G2;A0A0A0MRU4;Q5RIA9-3;Q5JTY5-2;Q9BRT8-3;Q9BRT8;Q8IUF1;Q5RIA9;Q5JTY5;Q4V339;A0A0B4J2F1;Q9BRT8-2;Q5RIB5;Q5JTY2;A0A087WTC0;Q5RIB3;H0Y857;Q6NVZ8;F8WEG4;A0A0B4J2E3;A0A087WZQ3;F8WEU0;E7EUZ7;A0A087WYD2;F2Z2T4;Q5RIA9-2;Q9BRT8-4;A6NM15;A0A0B4J1T6;A0A087X1C0A0A087X140;A0A087WWG3;A0A0A6YYH9;Q5RIB0;H0Y5V3;C9J3G2;A0A0A0MRU4;Q5RIA9-3;Q5JTY5-2;Q9BRT8-3;Q9BRT8;Q8IUF1;Q5RIA9;Q5JTY5;Q4V339;A0A0B4J2F1;Q9BRT8-2;Q5RIB5;Q5JTY2;A0A087WTC0;Q5RIB3;H0Y857;Q6NVZ8;F8WEG4;A0A0B4J2E3;A0A 87WZQ3;F8WEU0;E7EUZ7;A0A087WYD ;F2Z2T4;Q5RIA9-2;Q9BRT8- ;A6NM15COB  domain-containing protein 5;COBW domain-containing protein 3;COBW domain-containing protein 1;COBW domain-containing protein 2;CO W domain-containing protein 6;Putative COBW domain-containing protein 7CBWD5;CBWD7;CBWD2;CBWD3;CBWD1;CBWD64 4 347 0 28.417 1.0511 0.73155 4.29E+08
Q9HCK8;Q9HCK8-2;H0YJG4;Q8TD26;Q3L8U1-2;Q3L8U1-3;Q3L8U1;H3BTW3;G3V2T9;C9JFU2;H7C294;A0A087WU44;Q8TD26-3Q9HCK8;Q9HCK8-2Chromodomain-helicase-DNA-binding protein 8CHD8 14 10 2581 0 96.596 1.0511 1.0293 7.89E+08
Q9Y320-2;Q9Y320;E9PSF0;E9PRL5;H3BSU7;E9PLR1;G3V155Q9Y320-2;Q9Y320Thioredoxin-related transmembrane protein 2TMX2 5 5 258 0 18.732 1.0511 0.75875 1.09E+09
O95394;O95394-3;O95394-4;J3KN95;A0A087WT27;H0Y987;H0Y8I3;D6RCQ8;D6RIS6;D6RF77;D6RCD1;D6RC77O95394;O95394-3;O95394-4;J3KN95;A0A087WT27Phosphoacetylglucosamine mutasePGM3 17 17 542 0 91.797 1.051 NaN 9.67E+08
E7EQZ4;Q16637-4;Q16637-2;Q16637-3;Q16637;B4DP61;H0YBZ9;A0A0G2JRX5;A0A0G2JRY6E7EQZ4;Q16637-4;Q16637-2;Q16637-3;Q16637;B4DP61Survival motor neuron proteinSMN1 6 6 294 0 78.179 1.0506 0.88192 8.37E+08
P20073-2;P20073P20073-2;P20073Annexin A7 ANXA7 12 12 466 0 60.134 1.0502 0.76457 1.38E+09
G8JLB3;Q9Y606-2;Q9Y606;F5H1S9;F5GY32;F5GXL3;F5H168;F8W9U5;F5H1B2G8JLB3;Q9Y606-2;Q9 606;F5H1S9tRNA pseudouridine synthase;tRNA pseudouridine synthase A, mitochondrialPUS1 14 14 384 0 72.025 1.0501 0.81292 1.60E+09
P07384;E9PL37;E9PRM1;E9PLX0;E9PJJ3;E9PLC9;E9PMC6;E9PJA6;E9PSA6;E9PQB3;E9PIA9P07384 Calpain-1 catalytic subunitCAPN1 23 23 714 0 106.02 1.0501 0.61613 3.23E+09
P34932;A0A087WYC1;A0A087WTS8;P34932-2P34932;A0A087WYC1;A0A087WTS8Heat shock 70 kDa protein 4HSPA4 29 27 840 0 276.84 1.05 1.1315 4.78E+09
B9EGE7;Q8TCN5;Q8TCN5-2B9EGE7;Q8TCN5;Q8TCN5-2Zinc finger protein 507ZNF507 2 2 957 0 3.8165 1.0498 0.7769 1.13E+07
P55060-3;P55060;P55060-4;P55060-2P5 060-3;P5 060;P55060-4Exportin-2 CSE1L 39 39 945 0 323.31 1.0496 0.93974 3.18E+10
O60306;H0YH15;H0YLN9O60306 Intron-binding protein aquariusAQR 30 30 1485 0 323.31 1.0495 0.85408 2.14E+09
P31350;P31350-2;C9JXC1;A0A0C4DGZ6;H0YAV1;Q7LG56-3;Q7LG56-2;Q7LG56;Q7LG56-6P31350;P31350-2;C9JXC1Ribonucleoside-diphosphate reductase subunit M2RRM2 8 8 389 0 40.493 1.0495 1.0725 1.13E+09
Q53GQ0;E9PI21;Q53GQ0-2Q53GQ0 Estradiol 17-beta-dehydrogenase 12HSD17B12 16 16 312 0 199.65 1.0489 1.0009 7.38E+09
Q13148;B1AKP7;G3V162;A0A087X260;A0A087WYY0;A0A087WX29;K7EN94;K7EJM5;A0A087WXQ5;A0A087WV68;Q13148-4;A0A087WW61;A0A087WX67;A0A087WXV3;A0A087WZC9;A0A087WTZ4;K7EL26;A0A087WZM1;K7EJ99;A0A0A0MSV7;A0A087WYE7Q13148;B1 KP7;G3V162;A0A087X26 ;A0A087WYY0;A0A08 WX29;K7EN94;K7EJM5; A087WX 5;A0A087WV6 ;Q13148-4TAR DN -binding protein 43T RDBP 10 10 414 0 289.34 1.0485 0.97813 1.33E+10
Q9BQA9-2;Q9BQA9;H0Y2X1;J3KTF4;J3QRZ2;J3QLB7;J3QKS6;J3QRG5;J3KSJ5Q9BQA9-2;Q9BQA9;H0Y2X1;J3KTF4;J3QRZ2;J3QLB7;J3QKS6;J3QRG5;J3KSJ5Uncharacterized protein C17orf62C17orf62 2 2 173 0 5.2781 1.0485 NaN 1.25E+08
O95602;B9ZVN9 O95602;B9ZVN9 DNA-directed RNA polymerase I subunit RPA1;DNA-directed RNA polymerasePOLR1A 55 54 1720 0 323.31 1.0481 0.91632 5.10E+09
G3XAH6;P51003;P51003-2;A0A0C4DGK1;G3V2A0;G3V3I9;H0YJ00;Q9NRJ5;G3V457;H0YJL4G3XAH6;P510 3;P51003-2oly(A) polymerase alphaPAPOLA 2 18 724 0 157.86 1.0477 0.80588 2.72E+09
C9JFE4;Q13098-5;Q13098;Q13098-7;A0A096LP07;A0A096LPJ3;A8K070;Q13098-6;J3KSA5;J3QLT0;J3KRJ4;J3QS88;J3KTB0;J3QS84;J3QLE8;J3QL53;J3KRE8;J3QQX0C9JFE4;Q13098-5;Q13098;Q13098-7;A0A096LP07;A0A096LPJ3;A8K070;Q13098-6COP9 signalosome complex subunit 1GPS1 14 14 471 0 53.764 1.0474 0.7932 1.20E+09
Q86UV5;Q86UV5-8;Q86UV5-2;Q86UV5-3;Q86UV5-4;Q86UV5-7;A0A0A0MRS6;Q86UV5-5;H3BLX5;E9PRY5;E9PJH5;Q86UV5-6Q86UV5;Q86UV5-8;Q86UV5-2;Q86UV5-3;Q86UV5-4;Q86UV5-7biquitin carboxyl-terminal hydrolase 48SP48 13 13 1035 0 152.94 1.0474 0.70197 1.34E+09
Q8TAT6;Q8TAT6-2;I3L4U9;I3L283;A0A0D9SFI9;I3L3I1;I3L281Q8TAT6;Q8TAT6-2Nuclear protein localization protein 4 homologNP OC4 14 14 608 0 218.94 1.0467 NaN 1.26E+09
Q9H1Y0;Q9H1Y0-2;L7UQJ2Q9H1Y0;Q9H1Y0-2;L7UQJ2Autophagy protein 5ATG5 6 6 275 0 32.757 1.0461 0.81875 8.85E+08
Q9ULC3 Q9ULC3 Ras-related protein Rab-23RAB23 4 4 237 0 36.216 1.0459 0.84919 2.99E+08
A0A0A0MRF9;P16885A0A0A0MRF9;P168851-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2PLCG2 4 4 1252 0 38.068 1.0458 1.2114 2.16E+08
P42704;A0A0C4DG06;B8ZZ38;C9JCA9;H7C3W8;A0A0C4DG51;Q9NP80-3;Q9NP80-2;Q9NP80P42704 Leucine-rich PPR motif-containing protein, mitochondrialLRPPRC 96 96 1394 0 323.31 1.0458 0.99342 4.08E+10
O75884;A0A087WYQ5;O75884-2O75884;A0A087WYQ5;O75884-2Putative hydrolase RBBP9RB P9 4 4 186 0 18.091 1.0455 0.73525 4.02E+08
Q969H6;Q969H6-2Q969H6;Q969H6-2Ribonuclease P/MRP protein subunit POP5POP5 4 4 163 0 14.226 1.0451 0.79802 1.23E+08
Q9Y4X5;A0A087WT96;H3BNB9;H3BSK4Q9Y4X5 E3 ubiquitin-protein ligase ARIH1ARIH1 10 10 557 0 54.202 1.0451 NaN 1.18E+09
A2RRP1-2;A2RRP1;H0Y5G7;H7C007;H7BZR3;C9JCM7;H7C1Y9A2RRP1-2;A2RRP1; 0Y5G7Neuroblastoma-amplified sequenceNBAS 23 23 2251 0 168.74 1.0448 0.98754 1.27E+09
P30044-2;P30044;P30044-3;P30044-4P30 4 -2;P30 4 ;P30044-3Peroxiredoxin-5, mitochondrialPRDX5 5 5 162 0 28.628 1.0448 1.2243 5.35E+08
F5H4V9;Q16342-3;Q16342;F5GWT2;J3QK82;A0A087WYJ3;Q16342-5;Q16342-2;Q16342-4F5H4V9;Q16342-3;Q1634Programmed cell death protein 2PDCD2 3 3 298 0 22.282 1.0447 0.57532 2.71E+08
Q96K76-4;Q96K76;Q96K76-2;Q96K76-3Q96K76-4;Q96K76;Q96K76-2Ubiquitin carboxyl-terminal hydrolase 47USP47 14 14 1355 0 86.755 1.0447 0.80454 6.87E+08
O43776;K7EIU7;K7EQ35;O43776-2;K7EJ19;K7EPK2;K7EMQ6;REV__H7BZ55O43776 Asparagine--tRNA ligase, cytoplasmicNARS 26 26 548 0 323.31 1.0446 0.84469 9.81E+09
Q9Y2T2;E5RJ52;P53677;H0YBM0;H0YBA0;E7ER80;P53677-2Q9Y2T2 AP-3 complex subunit mu-1AP3M1 13 13 418 0 151.05 1.0443 0.83218 1.75E+09
P26358;P26358-2;P26358-3;K7ENW7;K7EJL0;K7EMU8;K7EIZ6;K7EP77;K7ERQ1;K7ELB1;K7ENQ6P26358;P26358-2;P26358-3DNA (cytosine-5)-methyltransferase 1DNMT1 32 32 1616 0 203.45 1.0428 0.78426 2.33E+09
Q9Y241;Q9Y241-2;C9JAW5;C9JNU6;A8MV81Q9Y241;Q9Y241-2;C9JAW5;C9JNU6HIG1 domain family member 1A, mitochondrialHIGD1A 4 4 93 0 46.086 1.0428 0.8578 9.92E+08
F2Z2I2;Q5W015;Q5VX20;Q16875-3;Q16875-2;Q16875;Q16875-4;O60825-2;O60825;F6XNB3;F6RAZ1;H0Y483;I1Z9G3;Q4VBA9;Q66S35;P16118-2;Q16877-2;Q16877-3;Q16877;P16118F2Z2I2;Q5W01 ;Q5VX20;Q16875-3;Q16875-2;Q16875;Q16875-4;O60825-2;O608256-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3;6-phosphofructo-2-kinase;Fructose-2, -bisphosphatase;6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2;6-phosphofructo-2-kinase;Fructose-2,6-bisphosphatasePFKFB3;PFKFB2 4 4 455 0 6.0419 1.0427 NaN 5.19E+07
C9J5D1;E7EQ69;Q9GZZ1;A0A087WWJ2;Q9GZZ1-2;B0AZT5;C9JZU6;C9J5J3;A0A0D9SF32;F8WCK0C9J5D1;E7EQ69;Q9GZZ1;A0A087WWJ2;Q9G Z1-2;B0AZT5N-alpha-acetyltransferase 50NAA50 14 14 129 0 73.838 1.0426 0.50105 3.18E+09
O60671-2;O60671O60671-2;O60671Cell cycle checkpoint protein RAD1RAD1 2 2 246 0 7.1835 1.0426 NaN 1.58E+08
P50213;H0YL72;P50213-2;H0YMU3;H0YLI6;H0YNF5;H0YM46;H0YKD0;H0YM64P50213;H0YL72;P50213-2;H0YMU3Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrialIDH3A 14 14 366 0 209.71 1.0424 0.77422 9.36E+09
P49756;P49756-2;P49756-3;E9PQU5;H0YE46;E9PSE8P49756;P49756-2;P49756-3;E9PQU5RNA-binding protein 25RBM25 8 8 843 0 24.75 1.042 0.78984 6.75E+08
A2A274;Q99798 A2A274;Q99798 Aconitate hydratase, mitochondrialACO2 14 14 805 0 90.685 1.0419 0.99258 1.73E+09
Q9GZS3;H0YN81;H0YL19;H0YMF9;H3BQA8;H0YM76;H0YLA1Q9GZS3;H0YN81; 0YL19; F9WD repeat-containing protein 61;WD repeat-containing protein 61, N-terminally processedWDR61 11 11 305 0 160.28 1.0417 0.97578 2.55E+09
F5GZ28;P18858;P18858-3;M0R0Q7;P18858-2;B4E135;M0R1S4;M0QY71;M0R1G7F5GZ28;P18858;P18858-3;M0R0Q7;P18858-2DNA ligase;DNA ligase 1LIG1 14 14 851 0 93.943 1.0414 0.80533 1.95E+09
A0A087WUC6;Q15005;E9PL01;E9PI68;E9PRB9;H0YE04A A087WUC6;Q15005;E9PL01;E9PI68;E9PRB9Signal peptidase complex subunit 2SPCS2 18 18 227 0 245.55 1.0413 0.7756 5.75E+09
Q07864;F5H1D6;F5H7E4Q07864;F5H1D6 DNA polymerase epsilon catalytic subunit A;DNA polymerasePOLE 33 33 2286 0 239.79 1.0413 0.79908 2.35E+09
A0A0A0MR09;P43378;H3BQT6A0A0A0MR09;P43378Tyrosine-protein phosphatase non-receptor type 9PTPN9 9 9 583 0 41.434 1.0411 NaN 3.83E+08
P25098;E9PRV7;P35626;Q8N433P25098;E9PRV7 Beta-adrenergic receptor kinase 1ADRBK1 8 8 689 0 26.82 1.0411 0.92133 3.78E+08
Q9Y570;Q9Y570-4;Q9Y570-2;Q9Y570-3Q9Y570;Q9Y570-4;Q9Y570-2Protein phosphatase methylesterase 1PPME1 9 9 386 0 32.836 1.041 1.4253 9.17E+08
O94973;O94973-2;A0A0G2JS82;O94973-3;A0A0G2JQM1;E9PR62;A0A0G2JRF9;A0A0G2JQA4;A0A0G2JQT9;H0YEG0;A0A0G2JS17;H0YDE9;E9PPY8;A0A0G2JRS3;M0R2D9;E9PQP4;E9PNC4;E9PPZ3;E9PS94O94973;O94973-2;A0A0G2JS82;O94973-3;A0A0G2JQM1AP-2 complex subunit alpha-2AP2A2 36 24 939 0 316.65 1.0406 0.8527 9.35E+09
D6RCD0;Q8NBQ5 D6RCD0;Q8NBQ5 Estradiol 17-beta-dehydrogenase 11HSD17B11 5 5 256 0 53.273 1.0405 1.0459 3.63E+08
Q66K74-2;Q66K74;M0QXQ9;M0QY41;M0QZ50;M0R1M7;M0R1J2Q66K74-2;Q66K7 Microtubule-associated protein 1S;MAP1S heavy chain;MAP1S light chainAP1S 9 9 1033 0 47.826 1.0405 0.99435 9.34E+08
Q96EL2;F8VYR5 Q96EL2 28S ribosomal protein S24, mitochondrialMRP 6 6 167 0 66.322 1.0404 0.82895 7.31E+08
O75400-2;O75400-3;O75400O75400-2;O75400-3;O75400Pre-mRNA-processing factor 40 homolog APRPF40A 3 3 930 0 12.995 1.0403 1.6759 3.41E+08
O43347;H0YHB7 O43347;H0YHB7 RNA-binding protein Musashi homolog 1MSI1 11 10 362 0 93.968 1.0397 0.90825 2.86E+09
P06737-2;P06737;E9PK47P06737-2;P06737;E9PK47Glycogen phosphorylase, liver form;PhosphorylasePYGL 46 38 813 0 323.31 1.0397 1.0392 1.90E+10
Q96L92;Q96L92-3;Q96L92-2;A0A0C4DFU6;Q96L92-4;H7C603Q96L92;Q96L92-3;Q96L92-2;A0A0C4DFU6Sorting nexin-27 SNX27 18 18 541 0 92.671 1.0394 NaN 1.77E+09
K7EKE6;K7EJE8;P36776-2;P36776;P36776-3;K7ER27;K7ERR6;K7EQF8;K7ER56K7EKE6;K7EJE8;P367 6-2;P36776;P36776-3Lon protease homolog, mitochondrialLONP1 40 40 845 0 323.31 1.0393 0.878 1.23E+10
P49959;F8W7U8;P49959-3;P49959-2;F5GXT0;F5H742;F5H256;F8W7U8;P49959-3;P49959-2Double-strand break repair protein MRE11AMRE11A 21 21 708 0 153.74 1.0392 0.96891 2.80E+09
A0A0G2JQX1;A0A0G2JPW5;A0A0G2JSA7;A0A087X1Z1;Q96RT8-2;Q96RT8;A0A0G2JR45;A0A0G2JRG1;A0A0G2JQK7;A0A0G2JQK2;A0A087WVL9A0A0G2JQX1;A0A0G2JPW5;A0A0G2JSA7;A0A087X1Z1;Q96RT8-2;Q96RT8;A0A0G2JR45;A0A0G2JRG1Gamma-tubulin complex component 5TUBGCP5 3 3 1 24 0 41.515 1.0383 0.6476 1.65E+08
Q9Y2H6-2;Q9Y2H6;G5E9X3;H7C507;A0A087X1M6Q9Y2H6-2;Q9Y2H6;G5E9X3Fibronectin type-III domain-containing protein 3AFNDC3A 6 6 1142 0 57.938 1.0382 2.1094 2.65E+08
Q9NVI7-2;Q9NVI7;H0Y2W2;Q9NVI7-3;Q5SV16Q9NVI7- ;H0Y2W2;Q9NVI7-3ATPase family AAA domain-containing protein 3AATAD3A 36 9 586 0 312.51 1.0381 0.86759 8.22E+09
Q5T9A4;Q5T9A4-3;Q5T9A4-2Q5T9A4;Q5T9A4-3ATPase family AAA domain-containing protein 3BATAD3B 31 6 648 0 153.35 1.0378 1.1021 5.45E+08
J3QS41;P42694;P42694-2;A0A075B6R3;J3QRR8;J3KT20J3QS41;P42694;P42694-2Probable helicase with zinc finger domainHELZ 18 18 1943 0 99.083 1.0376 0.78673 8.43E+08
Q5JQP3;Q5JQP4;Q5JQP2;Q5JQP8;Q9UGP5-2;Q9UGP5;Q9HBN3;Q5JQN9Q5JQP3;Q5JQP4;Q5JQ 2;Q5JQP8;Q9UGP5-2;Q9UGP5;Q9HBN3;Q5JQN9DNA polymerase lambdaPOLL 2 2 218 0 9.9537 1.0375 NaN 3.53E+07
O14949 O14949 Cytochrome b-c1 complex subunit 8UQCRQ 9 9 82 0 34.619 1.0363 0.63836 3.00E+09
Q14643-4;Q14643-3;Q14643-8;Q14643-7;Q14643-5;Q14643-6;Q14643-2;Q14643Q14643-4;Q14643-3;Q14643-8;Q14643-7;Q14643-5;Q14643-6;Q14643-2;Q14643Inositol 1, ,5-trisphosphate receptor type 1ITPR1 4 2 2695 0 7.6089 1.0361 0.67736 5.12E+07
O43684-2;O43684;J3QT28;J3QSX4O4 684-2;O43684;J3QT28Mitotic checkpoint protein BUB3BUB3 15 15 326 0 196.82 1.0352 0.91656 1.05E+10
P51116;I3L1Z2 P51116 Fragile X mental retardation syndrome-related protein 2FXR2 6 4 673 0 31.67 1.0346 0.75254 3.33E+08
P82675;P82675-2P82675 28S ribosomal protein S5, mitochondrialMRP 5 5 430 0 22.023 1.0346 1.262 4.29E+08
Q9UMS4;F5GY56;F5H2I0;H0YGF3;H0YGZ5Q9UMS4;F5 Y56 Pre-mRNA-processing factor 19PRPF19 16 16 504 0 298.9 1.0346 1.0175 6.05E+09
W0S4B9;P16591-3;P16591-2;P16591W0S4B ;P16591-3;P16591-2;P16591Tyrosine-protein kinase FerPe1Fe10;FER 4 4 411 0 5.0797 1.0341 3.6303 1.96E+08
Q96P47;Q96P47-2;Q96P47-4;Q96P47-5;C9J975;H0Y873;Q96P47-3;Q96P47-6;H7C4F1;E7ESL9;C9J8Z2;A0A087X044;A0A087X1U1;F5GXM9;E7EUN2;Q9UPQ3-3;Q9UPQ3-2;Q9UPQ3Q96P47;Q96P47-2;Q96P47-4;Q96P47-5Arf GAP with GTPase, ANK repeat and H domain-containing protein 3AGAP3 11 11 875 0 112.01 1.034 0.7876 1.65E+09
Q8NCW5-2;Q8NCW5;Q5T3I4Q8NCW5-2;Q8NCW5NAD(P)H-hydrate epimeraseAPOA1BP 5 5 185 0 16.7 1.0339 1.1199 2.94E+08
Q6P9B6;H3BM75;H3BUB0;H3BTC5Q6P9B6;H3BM7 ;H3BUB0TLD domain-containing protein 1TLDC1 6 6 456 0 87.366 1.0338 1.237 1.04E+09
Q96EY1;Q96EY1-2;Q96EY1-3Q96EY1;Q96EY1-2;Q96EY1-3DnaJ homolog subfamily A member 3, mitochondrialDNAJA3 8 8 480 0 51.072 1.0332 1.2336 2.24E+09
P12956;B1AHC9;P12956-2P12956;B1AHC9;P12956-2X-ray repair cross-complementing protein 6XRCC6 42 42 609 0 323.31 1.0331 0.94035 3.28E+10
I3L0N3;P46459;P46459-2;I3L2G1;K7EQD6;I3L0L3;I3L338;I3L4Q9I3L0N3;P46459;P46459-2Vesicle fusing ATPaseNSF 47 47 739 0 323.31 1.0329 0.9601 1.33E+10
O95140;O95140-2;Q5JXC5O95140 Mitofusin-2 MFN2 12 12 757 0 75.405 1.0328 0.74371 1.00E+09
Q86W42;Q86W42-2;Q86W42-3Q86W42;Q86W42-2;Q86W42-3THO complex subunit 6 homologTHOC6 13 13 341 0 240.7 1.0326 0.96578 3.61E+09
Q92526;Q92526-2;Q92526-3;J3KRI6Q92526;Q92526-2;Q92526-3T-complex protein 1 subunit zeta-2CCT6B 9 2 530 0 14.485 1.0324 NaN 1.40E+08
P08133;P08133-2;E5RK69;E7EMC6;E5RI05;E5RFF0;E5RIU8;E5RJR0;E5RJF5;E5RK63;H0YC77P08133;P08133-2;E5RK69;E7EMC6Annexin A6;AnnexinANXA6 9 9 673 0 67.143 1.032 NaN 5.89E+08
P60891;P60891-2;B1ALA9;A0A0B4J207;P21108;B1ALA7P60891;P6 891-2;B1ALA9Ribose-phosphate pyrophosphokinase 1PRPS1 23 9 318 0 302.77 1.032 0.92137 1.52E+10
176
Q9UNS2;Q9UNS2-2;H7C3P9;J3KTQ1;J3QKR0;C9JLV5;J3QL22;J3QS85Q9UNS2;Q9UNS2-2;H7C3P9COP9 signalosome complex subunit 3COPS3 5 5 423 0 36.873 1.032 1.1291 9.40E+08
A0A0C4DFX4;Q6ZRS2-3;Q6ZRS2-2;Q6ZRS2;A0A0A0MS59;A0A087X0E3A0A0C4DFX4;Q6ZRS2-3;Q6ZRS2-2;Q6ZRS2;A0A0A0MS59;A0A087X0E3Helicase SRC P SRC P 12 11 3053 0 57.489 1.0317 0.80992 4.19E+08
Q9UPR3 Q9UPR3 Protein SMG5 SMG5 5 5 1016 0 14.646 1.0315 1.7129 1.36E+08
A0A087WVF7;Q9NZM3-2;Q9NZM3;H0Y3G5;Q15811-4;Q15811-9;Q15811-8;Q15811A0A087WVF7;Q9NZM3-2; 9NZM3;H0Y3G5;Q158 1-4;Q158 1-9;Q15811-8;Q15811Intersectin-2;Intersectin-ITSN2;ITSN1 2 2 1680 0 4.1708 1.0312 0.70352 6.85E+07
A0A0D9SEJ5;F5GY05;Q96EK7;Q96EK7-2;Q96EK7-3A0A0D9SEJ5;F5GY05;Q96EK7;Q96EK7-2Constitutive coactivator of peroxisome proliferator-activated receptor gammaFAM120B 7 7 922 0 51.779 1.0312 1.1205 6.31E+08
Q9BW92;U3KQG0;Q9BW92-2;F6S7Q7;U3KQ50;Q5T5E9Q9BW92;U3KQG0;Q9BW92-2;F6S7Q7Threonine -tRNA ligase, mitochondrialTARS2 21 21 718 0 166.4 1.0311 0.82946 2.30E+09
Q5SQP8;P56545;P56545-2;A0A087WYL1Q5SQP8;P56545;P56545-2C-terminal-binding protein 2CTBP2 16 11 513 0 156.57 1.0308 0.8645 6.90E+09
O60725 O60725 Protein-S-isoprenylcysteine O-methyltransferaseICMT 4 4 284 0 15.726 1.0306 0.8535 8.02E+08
F8VY35;F5H4R6;P55209-2;P55209;F8W0J6;H0YIV4;F8W020;F8W118;F8VV59;H0YH88;H0YHC3;F8VUX1;F8W543;B7Z9C2;F8VXI6;F8VRJ2;F8VVB5;P55209-3;B7Z4K9F8VY35;F5H4R6;P55209-2;P55209;F8W0J6;H0YIV4;F8W020;F8W118;F8VV59;H0YH88;H0YHC F8VUX1; W543;B7Z9C2;F8VXI6;F8VRJ2;F8VVB5;P55209-3Nucleosome assembly protein 1-like 1NAP1L1 3 11 264 0 323.31 1.0304 1.0586 9.27E+09
P49588;P49588-2;H3BPK7P49588;P49588-2Alanine--tRNA ligase, cytoplasmicAARS 45 45 968 0 323.31 1.0303 0.94672 9.59E+09
Q8NCM8;Q8NCM8-2;H0YDE0Q8NCM8;Q8NCM8-2Cytoplasmic dynein 2 heavy chain 1DYNC2H1 34 34 4307 0 131.85 1.0303 1.0588 1.50E+09
O43660;O43660-2;H0YA24;D6RA26;H0YAA2;B7Z982O43660;O43660-2; 0Y 24Pleiotropic regulator 1PLRG1 14 14 514 0 165.03 1.0301 1.109 8.52E+08
Q9Y6A9 Q9Y6A9 Signal peptidase complex subunit 1SPCS1 1 1 102 0 5.5555 1.0299 NaN 1.08E+08
O00178;F5H716;F5H257O00178;F5H716 GTP-binding protein 1GTPBP1 5 5 669 0 24.161 1.0298 1.1378 7.45E+08
P24752;H0YEL7;E9PRQ6;P24752-2P24752 Acetyl-CoA acetyltransferase, mitochondrialACAT1 22 22 427 0 237.45 1.0292 0.87075 1.83E+10
Q8N2K0-3;Q8N2K0;Q8N2K0-2;Q5T712;I3L440;I3L294Q8N2K0-3;Q8N2K0;Q8N2K0-2;Q5T712Monoacylglycerol lipase ABHD12ABHD12 5 5 360 0 10.873 1.0291 0.99554 2.80E+08
Q9UM13;D6RA92;D6R9Q5;D6RD74Q9UM13 A92Anaphase-promoting complex subunit 10ANAPC10 3 3 185 0 23.798 1.0291 0.92889 2.55E+08
O95861-4;O95861;O95861-2;A6NF51;O95861-3;F8W1J0;F8VZG4;F8VVW8;F8VRY7O95861-4;O95861;O95861-2;A6NF51;O95861-3;F8W1J03(2), -bisphosphate nucleotidase 1BPNT1 9 9 272 0 72.231 1.0287 1.1145 7.98E+08
P07814;V9GYZ6;V9GZ76P07814;V9GYZ6 Bifunctional glutamate/proline--tRNA ligase;Glutamate--tRNA ligase;Proline--tRNA ligaseEPRS 96 96 1512 0 323.31 1.0287 0.90462 3.54E+10
Q9NPD3;E9PPI9;E9PI41Q9NPD3;E9PPI9;E9PI41Exosome complex component RRP41EXOSC4 4 4 245 0 15.129 1.0285 1.0873 3.40E+08
Q93008-1;Q93008;O00507;O00507-2;H7C2M9Q93008-1;Q930 8Probable ubiquitin carboxyl-terminal hydrolase FAF-XUSP9X 58 58 2554 0 323.31 1.0278 1.0044 7.08E+09
Q7KZ85;Q7KZ85-3;Q7KZ85-2Q7KZ85 Transcription elongation factor SPT6SUPT6H 38 38 1726 0 323.31 1.0276 0.90241 2.97E+09
Q16352;A0A087WYG8Q16352;A0A087WYG8Alpha-internexin INA 9 7 499 0 64.013 1.0275 NaN 3.88E+08
P78346;P78346-2;Q5VU11;Q5VU10P78346;P78346-2;Q5VU11;Q5VU10Ribonuclease P protein subunit p30RPP30 17 17 268 0 238.74 1.0271 0.4419 3.60E+09
O00629;H7C4F6 O00629 Importin subunit alpha-3KPNA4 15 8 521 0 111.6 1.026 NaN 3.57E+08
P55735;A0A0C4DFR6;P55735-2;P55735-3;A8MXL6;E7ERC8P55735;A0A0C4DFR6;P55735-2;P55735-3;A8MXL6Protein SEC13 homologSEC13 12 12 322 0 182.39 1.0256 0.79645 4.53E+09
O43172-2;O43172O43172-2;O43172U4/U6 small nuclear ribonucleoprotein Prp4PRPF4 16 16 521 0 184.4 1.0255 NaN 2.14E+09
Q7Z3K3-5;Q7Z3K3-2;Q7Z3K3-3;Q7Z3K3;Q7Z3K3-7;Q7Z3K3-6;Q7Z3K3-4;M0R2X2;H7C238;A6PW30;E9PJY9;E9PIR8;H0YCT3Q7Z3K3-5;Q7Z3K3-2;Q7Z3K3-3;Q7Z3K3;Q7Z3K3-7;Q7Z3K3-6Pogo transposable element with ZNF domainPOGZ 19 19 1315 0 147.37 1.0255 0.80484 2.10E+09
P23246;P23246-2;H0Y9K7;H0Y9U2P23246;P23246-2Splicing factor, proline- and glutamine-richSFPQ 30 28 707 0 323.31 1.0254 0.94944 1.50E+10
P11142;E9PKE3;E9PNE6;P11142-2;A8K7Q2;E9PN89;E9PS65;E9PLF4;E9PQQ4;E9PQK7;E9PK54;E9PPY6;E9PM13;E9PN25;E9PI65P11142;E9PKE3;E9PNE6;P11142-2;A8K7Q2Heat shock cognate 71 kDa proteinHSPA8 48 32 646 0 323.31 1.0252 1.2019 9.83E+10
P48507;P48507-2P48507;P48507-2Glutamate--cysteine ligase regulatory subunitGCLM 8 8 274 0 92.687 1.0246 0.95272 1.86E+09
P08238;Q58FF7 P08238 Heat shock protein HSP 90-betaHSP90AB1 58 29 724 0 323.31 1.0242 0.98648 2.51E+11
G8JLB6;P31943;E9PCY7;D6RBM0;D6RIU0;D6RFM3;D6RIT2;H0YB39;D6RAM1;D6R9T0;E7EN40;D6RDU3;D6RJ04;D6RIH9;E7EQJ0;E5RGV0;H0YBD7;D6RDL0;H0YBG7;E5RGH4;D6RF17;H0YAQ2;D6R9D3;E5RJ94G8JLB6;P31943;E9PCY7 B 0; IU0;D6RFM3;D6RIT2;H0YB39Heterogeneous nuclear ribonucleoprotein ;Heterogeneous nuclear ribonucleoprotein H, N-terminally processedHNRNPH1 22 12 472 0 323.31 1.0241 0.97115 6.45E+10
P05388;F8VWS0;F8VU65;P05388-2;F8VW21;F8VZS0;F8VPE8;G3V210;F8VQY6;F8VRK7;F8VWV4;F8VS58;Q8NHW5;F8W1K8P05388;F8VWS0;F8VU65;P05388-2;F8VW21;F8VZS0;F8VPE8;G3V210;F8VQY6; RK7;F VWV460S acidic ribosomal protein P0RPLP0 23 23 317 0 323.31 1.0241 0.92063 4.97E+10
O60502;O60502-4;O60502-2;O60502-3;H7C3X0O60502;O60502-4;O60502-2;O60502-3Bifunctional protein NCOAT;Protein O-GlcNAcase;Histone acetyltransferaseMGEA5 16 16 916 0 186.51 1.0239 0.96992 2.82E+09
Q15018 Q15018 BRISC complex subunit Abro1FAM175B 14 14 415 0 92.294 1.0239 0.88079 1.72E+09
Q8NBM4;X6R5E5;Q8NBM4-4;Q8NBM4-3;Q8NBM4-2;Q5JUH4;Q8NBM4-5;X6R5E5;Q8NBM4-4;Q8NBM4-3;Q8NBM4-2Ubiquitin-associated domain-containing protein 2UBAC2 4 4 344 0 37.133 1.0237 0.65007 2.17E+08
H0YF29;Q6P1X6-2;Q6P1X6H0YF29;Q6P1X6-2;Q6P1X6UPF0598 protein C8orf82 5 5 261 0 36.993 1.0236 0.73812 1.34E+08
P51649;P51649-2;C9J8Q5P51649;P51649-2;C9J8Q5Succinate-semialdehyde dehydrogenase, mitochondrialALDH5A1 17 17 535 0 138.35 1.0234 0.83902 1.70E+09
P16152;E9PQ63;A8MTM1;P16152-2P16152;E9PQ63;A8MTM1;P16152-2Carbonyl reductase [NADPH] 1CBR1 20 16 277 0 294.52 1.0231 1.0504 2.29E+10
P62906 P62906 60S ribosomal protein L10aRPL10A 18 18 217 0 188.65 1.0231 0.51793 1.70E+10
Q9UIA9;E7ESC6;E5RIW1;H0YBE1Q9UIA9;E7ESC6 Exportin-7 XPO7 12 12 1087 0 51.304 1.0229 0.67841 4.56E+08
Q15654;A0A0D9SFS2;H7BZE2Q15654;A0A0D9SFS2Thyroid receptor-interacting protein 6TRIP6 6 6 476 0 86.414 1.0228 0.46934 6.64E+08
Q13131;Q13131-2;Q96E92Q13131;Q13131-2;Q96E925-AMP-activated protein kinase catalytic subunit alpha-1PRKAA1 4 3 559 0 14.398 1.0225 NaN 2.18E+08
P60842;J3KT12;P60842-2;J3QS69;J3KTB5;J3KSZ0;J3QL43;J3KTN0;J3QR64;J3QLN6;J3KS25;J3QKZ9;J3QL52;J3KT04;J3KS93;J3QQP0P60842;J3KT12;P60842-2;J3QS69;J3KTB5;J3KSZ0;J3QL 3Eukaryotic initiation factor 4A-IEIF4A1 36 18 406 0 323.31 1.0224 1.0464 1.17E+11
Q8IWV8-4;Q8IWV8;Q8IWV8-3;Q8IWV8-2Q8IWV8-4;Q8IWV8;Q8IWV8-3E3 ubiquitin-protein ligase UBR2UBR2 12 12 1755 0 34.043 1.0224 0.96937 3.78E+08
Q9BUF5;K7ESM5;K7EL29;K7ES63;K7EN98;K7ESQ3;K7EQT3;K7EJ64;K7ERA8;K7EJZ4;K7EPE5;K7EK43Q9BUF5;K7ESM5 Tubulin beta-6 chainTUBB6 25 11 446 0 289.64 1.022 1.0055 1.63E+10
Q9HAV4;H0Y9I3;E2QRM3;H0Y3W3;H0YA57Q9HAV4 Exportin-5 XPO5 23 23 1204 0 244.72 1.022 0.90148 3.12E+09
P37802;P37802-2;X6RJP6;C9J5W6;Q9UI15P37802;P37802-2;X6RJP6Transgelin-2 TAGLN2 7 7 199 0 38.558 1.0217 0.99813 3.54E+08
P83731;C9JXB8;C9JNW5P83731;C9JXB8;C9JNW560S ribosomal protein L24RPL24 12 12 157 0 42.322 1.0217 0.536 7.96E+09
Q5VWZ2;Q5VWZ2-2Q5VWZ2;Q5VWZ2-2Lysophospholipase-like protein 1LYPLAL1 10 10 237 0 121.93 1.0217 0.94677 2.21E+09
O94925-3;H7BZD1;B8ZZA8;B8ZZC5;O94925-2O94925-3 Glutaminase kidney isoform, mitochondrialGLS 18 3 598 0 49.36 1.0216 1.376 5.24E+08
P29218;P29218-3;E5RIP7;H0YBL1;E5RG94;E5RIF4;E5RHE9;E5RG13;E5RI82;E5RGY4;P29218-2P29218;P29218-3;E5RIP7;H0YBL1;E5RG94;E5RIF4;E5RHE9;E5RG13;E5RI82;E5RGY4;P29218-2Inositol monophosphatase 1IMPA1 6 6 277 0 68.48 1.0215 0.69861 9.05E+08
Q12797-10;Q12797;E5RHK2;A0A087WW51;A0A087WUJ2Q12797-10;Q12797Aspartyl/asparaginyl beta-hydroxylaseASPH 8 8 729 0 43.906 1.0215 1.3064 6.56E+08
Q6NUK1;Q6NUK1-2;J3KN42;H3BMI3Q6NUK1;Q6NUK1-2Calcium-binding mitochondrial carrier protein SCaMC-1SLC25A24 23 23 477 0 102.17 1.0207 0.84356 3.38E+09
Q8N122;Q8N122-3;Q8N122-2;I3L436;I3L2I3Q8N122;Q8N122-3Regulatory-associated protein of mTORRPTOR 25 25 1335 0 190.04 1.0205 0.9351 2.45E+09
P46736-2;P46736-3;P46736;A0A087WZR3;H9KVA9;A0A0D9SF50;X6RJS7;P46736-5;P46736-4;A0A0A0MS96P46736-2;P46736-3;P46736;A0 087WZR3;H9KVA9;A0A0D9SF50;X6RJS7;P 6736-5;P46736-4Lys-63-specific deubiquitinase BRCC36BRCC3 10 10 291 0 75.702 1.0203 0.92331 1.79E+09
Q9BYE7-3;Q9BYE7Q9BYE7-3;Q9BYE7Polycomb group RING finger protein 6PC F6 1 1 275 0 9.6945 1.0202 1.3892 1.98E+07
O75534-2;O75534;O75534-3;O75534-4;E9PLT0;E9PLD4;E9PNG3;E9PKN4O75534-2;O75534;O75534-3;O75534-4;E9PLT0Cold shock domain-containing protein E1CSD 1 38 38 767 0 323.31 1.0201 0.92501 8.72E+09
P25788-2;P25788;G3V4X5;G3V3W4;G3V5N4P25788-2;P25788Proteasome subunit alpha type-3PSMA3 9 9 248 0 63.957 1.02 1.0468 2.59E+09
P50991;P50991-2P50991;P50991-2T-complex protein 1 subunit deltaCCT4 39 39 539 0 323.31 1.02 0.86044 5.06E+10
Q9Y4R8;H3BRS3;H3BU45Q9Y4R8 Telomere length regulation protein TEL2 homologTELO2 13 13 837 0 42.082 1.0197 0.92513 6.14E+08
Q8NHH9-3;Q8NHH9-5;Q8NHH9;B5MCN0;Q8NHH9-4;Q8NHH9-2;C9JQQ5Q8NHH9-3;Q8NHH9-5;Q8NH 9;B5MC 0;Q8NHH9-4;Q8NHH9-2;C9JQQ5Atlastin-2 ATL2 4 4 412 0 33.156 1.0196 NaN 3.00E+08
Q6NXE6-2;Q6NXE6;F5GWV0;F5H4P3;B4E1N1;F5H2X2;F5H2K4;F5H052;F5H3X1;H0YH65;F5GZP0;H0YGQ5;F5H6J3;F5H7V0;H0YGL0Q6NXE6-2;Q6NXE6;F5GWV0;F5H4P3;B4E1N1Armadillo repeat-containing protein 6ARMC6 16 16 476 0 169.45 1.0195 1.0475 3.57E+09
P26196;Q8IV96 P26196 Probable ATP-dependent RNA helicase DDX6DDX6 19 19 483 0 323.31 1.0194 0.8444 1.47E+10
Q96TA2-3;Q96TA2-2;Q96TA2;Q96I63;R4GNA5;Q5T8D1;Q5T8D2Q96TA2-3;Q96TA2-2;Q96TA2;Q96I63ATP-dependent zinc metalloprotease YME1L1YME1L1 8 8 683 0 127.39 1.0193 NaN 7.83E+08
Q92890;Q92890-1;Q92890-3;C9IZG3;C9J6N9;C9JNP9Q92890;Q92890-1;Q92890-3Ubiquitin fusion degradation protein 1 homologUFD1L 11 11 307 0 114.94 1.0192 0.93526 1.87E+09
Q8IYI6 Q8IYI6 Exocyst complex component 8EXOC8 8 8 725 0 57.377 1.0191 1.4806 4.88E+08
O15379;O15379-2O15379;O15379-2Histone deacetylase 3HDAC3 4 3 428 0 9.5631 1.0188 0.85472 2.48E+08
Q9UBT2;Q9UBT2-2;K7EPL2;K7ESK7;U3KQ93;U3KQ55;K7ES38Q9UBT2;Q9UBT2-2;K7EPL2SUMO-activating enzyme subunit 2UBA2 17 17 640 0 231.17 1.0188 0.99418 1.12E+09
Q8IX18-3;Q8IX18;Q8IX18-2;Q8IX18-4;J3KSW6;J3KTK0;F5H625;J3KSX98IX18-3; 8IX18;Q8IX18-2;Q8IX18-4;J3KSW6Probable ATP-dependent RNA helicase DHX40DHX40 16 16 722 0 66.694 1.0187 0.88893 1.71E+09
P27144;D3DQ64 P27144;D3DQ64 Adenylate kinase 4, mitochondrialAK4 9 9 223 0 70.442 1.0185 0.85763 2.19E+09
Q58FF8 Q58FF8 Putative heat shock protein HSP 90-beta 2HSP90AB2P 14 2 381 0 41.333 1.0183 1.0051 7.82E+09
F8WBE2;C9J8K7;E9PHG5;Q6UW02-2;Q6UW02F8WBE2;C9J8K7;E9PHG5;Q6UW02-2;Q6UW02Cytochrome P450 20A1CYP20A1 3 3 208 0 8.0377 1.0182 1.1157 7.23E+07
Q0VDF9;H7C2A1;B0YIZ1Q0VDF9 Heat shock 70 kDa protein 14HSPA14 16 16 509 0 78.866 1.0181 0.92148 2.65E+09
Q68CZ2-2;Q68CZ2;Q68CZ2-4;Q68CZ2-3;C9JWN9;C9JTD0;C9JHU5;E9PCX8Q68CZ2-2;Q68CZ2;Q68CZ2-4;Q68CZ2-3;C9JWN9;C9JTD0;C9JHU5;E9PCX8Tensin-3 TNS3 4 4 1205 0 23.264 1.018 0.87115 2.02E+08
P12081-3;P12081-2;P12081-4;P12081;B3KWE1;E7ETE2;B4E1C5;B4DDD8;D6RJE6;D6RF05P12081-3;P12081-2;P12081-4 P12081;B3KWE1;E7ETE2;B4E1C5;B4DDD8Histidine--tRNA ligase, cytoplasmicHARS 5 2 449 0 33.135 1.0179 1.4424 6.62E+08
Q5JY65;Q9BZJ0-2;Q9BZJ0-3;Q9BZJ05JY65;Q9BZJ0-2;Q9BZJ0-3;Q9BZJ0Crooked neck-like protein 1CRNKL1 13 13 836 0 66.892 1.0177 0.87249 9.01E+08
O75844 O75844 CAAX prenyl protease 1 homologZMPSTE24 13 13 475 0 103.24 1.0173 1.0007 2.14E+09
P27694;I3L4R8;I3L524;I3L2M5P27694;I3L4R8 Replication protein A 70 kDa DNA-binding subunit;Replication protein A 70 kDa DNA-binding subunit, N-terminally processedRPA1 29 29 616 0 323.31 1.0173 0.62261 1.21E+10
P36551;H0YA22;P36551-2P36551 Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrialCPOX 4 4 454 0 13.136 1.0173 1.2028 3.10E+08
J3QRV5;Q6P1M3-2;Q6P1M3;J3QLV4;J3QRZ8;C9JUZ7;J3QL58;J3QSA6;J3QS20;C9JPK3;C9K0E4;C9JCY1;C9JQS3;E9PFI2;Q6P1M3-3;Q9Y2K9J3 RV5;Q6P1M3-2 Q6P1M3;J3QLV4;J3QRZ8;C9JUZ7;J3QL58;J3QSA6;J3QS20;C9JPK3;C9K0E4;C9JCY1;C9JQS3;E9PFI2;Q6P1M3-3;Q9Y2K9Lethal(2) giant larvae protein homolog 2;Syntaxin-binding protein 5-likeSPATS2;LLGL2;STXBP5L 2 2 019 0.003786 2.5725 1.0172 NaN 1.76E+07
Q7L3T8 Q7L3T8 Probable proline--tRNA ligase, mitochondrialPARS2 6 6 475 0 52.92 1.0172 0.92581 4.28E+08
A0A0C4DG89;Q7L014;D6RJA6;H0Y9U3A0A0C4DG89;Q7L014Probable ATP-dependent RNA helicase DDX46DDX46 33 33 1032 0 186.1 1.0166 0.95573 3.60E+09
Q07065 Q07065 Cytoskeleton-associated protein 4CKAP4 6 6 602 0 83.71 1.0165 NaN 2.08E+08
Q9BZH6;S4R3Z0;S4R451;S4R3P9Q9BZH6 WD repeat-containing protein 11WDR11 22 22 1224 0 232.18 1.0164 0.80409 2.42E+09
Q6PKG0;A0A0B4J210;Q6PKG0-3;E5RH50;H0YC33;H0YBW1;H0YC73;H0YAN4;Q659C4-7;Q659C4-6;Q659C4-5;Q659C4-9;Q659C4-2;Q659C4Q6PKG0;A0A0B4J210;Q6PKG0-3;E5RH50La-related protein 1LARP1 9 9 109 0 47.085 1.0162 1.0502 5.28E+08
Q9UI30;F5GX77;Q9UI30-2;F5GYQ2Q9UI30;F5GX77;Q9UI30-2Multifunctional methyltransferase subunit TRM112-like proteinTRMT112 7 7 125 0 56.692 1.0157 0.95461 2.02E+09
A0A0A0MRP6;B7ZLQ5;P28370-2;P28370A0A0A0MRP6;B7ZLQ5;P28370-2;P28370Probable global transcription activator SNF2L1SMARCA1 23 8 1058 0 55.149 1.0156 1.193 3.20E+08
Q71RC2-5;Q71RC2;Q71RC2-4;Q71RC2-3;Q71RC2-7;Q71RC2-2;Q71RC2-6;Q96J85;Q6P4E2;X6RLN4;Q8TBL5;A0A087WTL9;F8VY40;F8W1I4;F8W1Z5;F8VNV1Q71RC2-5;Q71RC2;Q71RC2-4;Q 1RC2-3;Q71RC2-7;Q71RC2-2;Q71RC2-6;Q96J85;Q6P4E2;X6RLN4La-related protein 4LA P4 11 10 653 0 70.139 1.0156 0.90263 2.61E+09
P50748;E7ES84;P50748-2;F5H5V0;H0YFL5;J3KQF2P50748;E7ES84 Kinetochore-associated protein 1KNTC1 40 40 2209 0 202.28 1.0154 1.1045 2.06E+09
Q8IZQ1-2;Q8IZQ1 Q8IZQ1-2;Q8IZQ1 WD repeat and FYVE domain-containing protein 3WDFY3 4 4 3509 0 7.9155 1.0153 NaN 4.23E+07
P08243-2;P08243;P08243-3;F8WEJ5;C9J057;C9JT45;C9JM09;C9JLN6P08243-2;P0 243;P08243-3;F8WEJ5Asparagine synthetase [glutamine-hydrolyzing]ASNS 29 29 540 0 249.27 1.015 1.1312 1.07E+10
Q8IU60-2;Q8IU60;H0Y9T5Q8IU60-2;Q8IU60;H0Y9T5m7GpppN-mRNA hydrolaseDCP2 3 3 385 0 8.8488 1.015 1.0559 1.78E+08
A0A0C4DGQ8;Q6IAN0;J3KRS1;J3QKT1;J3QLK1;J3QLJ80A0C4DGQ8;Q6IAN0;J3KRS1Dehydrogenase/reductase SDR family member 7BDHRS7B 11 11 310 0 62.485 1.0147 0.74462 1.50E+09
O94806;C9JKP8;H0Y5M6;F8WBA3;O94806-2;Q15139O94806;C9JKP8;H0Y5M ;F8WBA3;O94806-2;Q15139Serine/threonine-protein kinase D ;Serine/threonine-protein kinase D;Serine/threonine-protein kinase D1PRKD3;PRKD1 2 2 890 0 5.6444 1.0144 0.68248 1.13E+08
H3BLV9;Q5R363;Q96SB4-4;Q96SB4;Q96SB4-3;D6RBF8;H0Y932;H7C2I2;D6RBM8;H7C521;H7C5L6;A8MPP7;A8MPY5;E7ETV6;Q9UPE1-2;Q9UPE1-3;Q9UPE1-4;Q9UPE1H3BLV9;Q5R363;Q96SB4-4;Q9 S 4;Q96SB4-3SRSF protein kinase 1SRPK1 12 11 671 0 158 1.014 0.99055 1.90E+09
Q9NRX1;F8WBJ6 Q9NRX1;F8WBJ6 RNA-binding protein PNO1PNO1 10 10 252 0 35.598 1.014 0.92719 1.20E+09
C9JJ19;P82930;A0A087WUZ8C9JJ19;P82930;A0A087WUZ828S ribosomal protein S34, mitochondrialMRP 8 8 225 0 49.106 1.0136 1.0949 1.58E+09
Q9GZZ9;E7EQ61;Q9GZZ9-2;E7EWE1;C9J5W5;C9JRV9;C9J0F6Q9G Z9;E7EQ61;Q9GZZ9-2 E7EWE1Ubiquitin-like modifier-activating enzyme 5UBA5 5 5 404 0 61.233 1.0136 1.2734 9.08E+08
Q99426;Q99426-2;K7EP07;K7EK42;K7EL99;K7EQH0;K7ER04Q99426;Q99426-2;K7EP07;K7EK42Tubulin-folding cofactor BTBCB 13 13 244 0 185.02 1.0135 0.76061 1.42E+09
Q8TB61-5;Q8TB61-4;Q8TB61-3;Q8TB61-2;Q8TB61Q8TB61-5;Q8TB61-4;Q8TB61-3;Q8TB61-2;Q8TB61Adenosine 3-phospho 5-phosphosulfate transporter 1SLC35B2 2 2 299 0 5.1265 1.0134 NaN 2.46E+08
Q13509;A0A0B4J269;Q13509-2;G3V5W4;G3V2R8;G3V3R4;G3V2N6;G3V542;G3V3J6;G3V3W7Q13509;A A0B4J269;Q13509-2Tubulin beta 3 chainTUBB3 23 3 450 0 104 1.0133 1.1028 2.03E+09
O43395;O43395-3O43395 U4/U6 small nuclear ribonucleoprotein Prp3PRPF3 9 9 683 0 161.33 1.0132 1.0415 6.26E+08
177
Q14152;Q14152-2Q14152;Q14152-2Eukaryotic translation initiation factor 3 subunit AEIF3A 43 43 1382 0 237.83 1.0129 0.92458 1.02E+10
Q9UG01;Q9UG01-2;F5GZ56;Q9UG01-3;H0YAI8;H7C252Q9UG01;Q9UG01-2Intraflagellar transport protein 172 homologIFT172 14 14 1749 0 64.019 1.0129 0.96111 4.51E+08
O75874;C9J4N6;C9JLU6;C9JJE5O75874;C9J4N6 Isocitrate dehydrogenase [NADP] cytoplasmicIDH1 8 6 414 0 23.534 1.0128 0.78255 2.59E+08
O95163;F5H2T0;H0YDF3O95163;F5H2T0 Elongator complex protein 1IKBKAP 40 40 1332 0 323.31 1.0126 0.96044 6.44E+09
Q9UIG0-2;Q9UIG0Q9UIG0-2;Q9UIG0Tyrosine-protein kinase BAZ1BBAZ1B 25 25 1479 0 127.39 1.0125 1.3717 1.29E+09
Q9Y5B9;G3V5A4;G3V401;G3V2X0Q9Y5B9 FACT complex subunit SPT16SUPT16H 56 56 1047 0 323.31 1.0124 0.99788 2.18E+10
P51570;P51570-2;K7ERJ9;K7EII7;K7ERN9P51570;P51570-2Galactokinase GALK1 20 20 392 0 210.26 1.0123 0.88215 7.71E+09
F6SS63;Q8N5C8-2;Q8N5C8F6SS63;Q8N5C8-2;Q8N5C8TGF-beta-activated kinase 1 and MAP3K7-binding protein 3TAB3 1 1 608 0.0061501 2.2092 1.0122 NaN 5.35E+07
O75152;E9PQ61;E9PBY7O75152;E9PQ61;E9PBY7Zinc finger CCCH domain-containing protein 11AZC3H11A 16 16 810 0 71.525 1.012 0.86737 1.41E+09
Q15648-3;Q15648Q15648-3;Q15648Mediator of RNA polymerase II transcription subunit 1MED1 1 1 556 0.0027954 2.6934 1.012 0.91679 7.55E+07
O15144;C9JTV5;G5E9J0;H7C3F9;G5E9S7O15144 Actin-related protein 2/3 complex subunit 2ARPC2 8 8 300 0 71.799 1.0118 1.0086 7.42E+08
A8DPD7;Q9C0D3 A8DPD7;Q9C0D3 Protein zyg-11 homolog BZYG11 4 4 566 0 15.985 1.0114 NaN 2.26E+08
Q9H900;Q9H900-2;H3BQ07Q9H900;Q9H900-2Protein zwilch homologZWILCH 6 6 591 0 55.915 1.0114 NaN 2.19E+08
Q92620;Q92620-2;J3KTG2;H3BQT9;H3BV01;J3KRT1;J3KSA8;H3BMS7Q92620 Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16DHX3 11 11 1227 0 41.977 1.0112 0.98456 5.06E+08
Q8WXF1-2;Q8WXF1;X6RDA4Q8WXF1-2;Q8WXF1;X6RDA4Paraspeckle component 1PSPC1 15 13 393 0 203.76 1.011 1.0272 2.35E+09
E9PN51;F8W9K7;E9PPW7;O00217;E9PKH6N51;F8W9K ; PW7;O00217;E9PKH6NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrialNDUFS8 4 4 110 0 15.342 1.0106 0.82252 3.45E+08
P26368-2;P26368;K7ENG2;K7ELP8P26368-2;P26368;K7ENG2Splicing factor U2AF 65 kDa subunitU2AF2 17 17 471 0 231.14 1.0102 1.0732 3.96E+09
P42765;A0A0B4J2A4;K7EME0;K7EJ68P42765;A0A0B4 2A4;K7EME03-ketoacyl-CoA thiolase, mitochondrialACAA2 20 20 397 0 323.31 1.0101 0.81288 4.29E+09
P78371;F5GWF6;P78371-2;F8VQ14;F5GWF6;P78371-2;F8VQ14T-complex protein 1 subunit betaCCT2 35 35 535 0 323.31 1.01 0.99585 1.79E+10
Q14966-4;Q14966-3;Q14966;A0A096LPH6;Q14966-2;Q14966-5;A0A096LPI0Q14966-4;Q14966-3;Q14966;A0A096LPH6;Q14966-2Zinc finger protein 638ZNF638 8 8 1139 0 32.463 1.01 1.0353 2.75E+08
Q53H96;A0A0A0MQS1;Q53H96-2;B5MD87;F8WEI0Q53H96;A0A0A0MQS1;Q53H96-2Pyrroline-5-carboxylate reductase 3PYCRL 10 10 274 0 56.424 1.0099 0.73648 9.61E+08
Q13907;Q13907-2;C9JKM8;C9JD53;Q9BXS1Q13907;Q13907-2Isopentenyl-diphosphate Delta-isomerase 1IDI1 12 12 227 0 83.758 1.0092 0.75045 2.59E+09
D6RF48;Q9P2W9;D6RC716 F48;Q9P2W9 Syntaxin-18 STX18 7 7 308 0 39.164 1.009 0.98007 5.97E+08
M0R0F0;P46782;M0R0R2;M0QZN2F0 P46782;M0R0R2;M0QZN240S ribosomal protein S5;40S ribosomal protein S5, N-terminally processedRPS5 10 10 200 0 109.52 1.009 0.95362 3.84E+08
A0A0C4DFP4;Q96IV0-2;Q96IV0;Q96IV0-3;Q96IV0-5;H0Y2P2;C9JU75;Q96IV0-4A0A0C4DFP4; 96I 0-2; 96I 0;Q96IV0-3;Q96IV0-5;H0Y2P2Peptide-N(4)-(N-acetyl beta-glucosaminyl)asparagine amidaseNGLY1 5 5 633 0 16.17 1.0086 NaN 1.03E+08
P42695;G3V1A9;E9PKK4;E9PLE0;E9PQA3P42695;G3V1A9;E9PKK4Condensin-2 complex subunit D3NCAPD3 30 30 1498 0 194.65 1.0084 0.94336 2.14E+09
F5H8F7;Q9UBL3-3;Q9UBL3;Q9UBL3-2;H0YBF6;H0YAQ0F5H8F7;Q9UBL3- ;Q9UBL3;Q9UBL3-2;H0YBF6Set1/Ash2 histone methyltransferase complex subunit ASH2ASH2L 10 10 489 0 101.94 1.0081 0.38741 1.01E+09
O43678;O43678-2O43678;O43678-2NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2NDUFA2 2 2 99 0 38.056 1.0078 0.73552 1.08E+08
Q13322-3;Q13322-2;Q13322-4;Q13322;C9JTW6Q13322-3;Q13322-2;Q13322-4;Q13322Growth factor receptor-bound protein 10GRB10 5 5 536 0 8.1965 1.0078 NaN 1.53E+08
P53007;B4DP62 P53007;B4DP62 Tricarboxylate transport protein, mitochondrialSLC25A1 12 12 311 0 91.87 1.0076 0.84311 5.89E+09
P50502;A0A087X1H6;H7C3I1;Q3KNR6;Q8IZP2;Q8NFI4;F6VDH7;F8WAQ7P50502;A0A087X1H6;H7C3I1;Q3KNR6;Q8IZP2;Q8NFI4;F6VDH7Hsc70-interacting protein; utative protein FAM10A4;Putative protein FAM10A5ST13;ST13P4;ST13P5 8 8 369 0 64.758 1.0074 1.0812 2.48E+09
Q5T160;H0Y450 Q5T160 Probable arginine--tRNA ligase, mitochondrialRARS2 6 6 578 0 36.191 1.0072 NaN 4.20E+08
B4DLN1;P52815;F6QW41B4DLN MRPL12 18 4 442 0 315.23 1.0068 0.7316 5.81E+09
Q9NWK9-2;Q9NWK9Q9NWK9-2;Q9NWK9Box C/D snoRNA protein 1ZNHIT6 5 5 431 0 29.05 1.0068 NaN 2.16E+08
A0A087WY71;Q96CW1-2;Q96CW1;E9PFW3;C9JJ47;C9JJD3;C9JGT8;C9JPV8;C9JTK4;H7C4C3A0A087WY71;Q96CW1-2;Q96CW1;E9PFW3;C9JJ47;C9JJD3;C9JGT8;C9JPV8;C9JTK4AP-2 complex subunit muAP2M1 19 19 434 0 94.93 1.0067 0.80766 2.12E+09
G5EA36;I3L394;F6QPS0;I3L328;I3L225;I3L3H6;K7EMA6;I3L2Z8;E9PRZ6G5EA36 CDC27 20 1 823 0 164.63 1.0067 0.91994 3.32E+09
Q9BSF4;K7ENF5 Q9BSF4 Uncharacterized protein C19orf52C19orf52 6 6 260 0 65.087 1.0067 0.95007 1.43E+09
P18754;P18754-2;C9JW69;C9JRH2;C9JMJ4;C9J3R0;C9JQZ4P18754;P18754-2;C9JW69;C9J H2;C9JMJ4;C9J3R0;C9JQZ4Regulator of chromosome condensationRCC1 13 13 421 0 267.46 1.0065 0.91097 8.87E+09
P62258;P62258-2;B4DJF2;I3L3T1;K7EIT4;K7EM20;I3L0W5P62258;P62258-2;B4DJF2;I3L3T114-3-3 protein epsilonYWHAE 22 19 255 0 168.29 1.0059 0.82956 7.19E+09
P08574 P08574 Cytochrome c1, heme protein, mitochondrialCYC1 10 10 325 0 91.454 1.0056 0.88389 2.90E+09
X6R6D0;P29353-5;P29353-3;P29353-2;P29353-7;P29353;P29353-6;H0Y539;Q5T188;P98077X6R6D0;P29353- ;P 9353-3;P29353-2;P29353-7;P293 ;P29353-6;H0Y539SHC-transforming protein 1SHC1 4 4 354 0 21.19 1.0055 1.1498 3.10E+08
A0A096LPI6;A0A0B4J2D5;P30042;A0A096LNH5;A0A0B4J2H4;H7C1F6;P30042-2;H7C2G3;A0A096LP73;F2Z2Q0;A0A096LP12;A0A096LNJ1A0A096L I6;A0A0B4J2D5;P30042;A0A096LNH5;A0A0B4J2H4;H7C1F6;P30042-2;H C2G3ES1 protein homolog, mitochondrialC21orf33 13 9 279 0 216.83 1.0052 0.29638 4.41E+09
O75155-2;O75155;F8WBB8O75155-2;O75155Cullin-associated NEDD8-dissociated protein 2CAN 2 16 10 1119 0 63.763 1.0051 0.88392 1.17E+09
Q9H0A8;A0A0B4J287;H3BM91;H3BPG2;H3BQF2;Q9H0A8-3;Q9H0A8-2;H3BRX0Q9H0A8;A0A0B4J287;H3BM91 H3BPG2;H3BQF2;Q9H0A8-3;Q9H0A8-2COMM domain-containing protein 4COMMD4 6 6 199 0 108.46 1.0051 0.46208 1.12E+09
Q5JWT2;Q9ULK4-4;Q9ULK4-5;Q9ULK4-3;Q9ULK4;Q9ULK4-2;Q9ULK4-6Q5JWT2;Q9ULK4-4;Q9ULK4-5;Q9ULK4-3;Q9ULK4;Q9ULK4-2Mediator of RNA polymerase II transcription subunit 23MED23 22 22 1374 0 126.44 1.0047 0.94815 2.16E+09
G3XAG1;Q96ME7-2;Q96ME7-3;Q96ME7G3XAG1;Q96ME7-2;Q96ME7-3;Q96ME7Zinc finger protein 512ZNF512 3 3 566 0 13.033 1.0046 0.33615 8.52E+07
J3QL56;O75880 J3QL56;O75880 Protein SCO1 homolog, mitochondrialSCO1 3 3 270 0 27.144 1.0046 1.0277 8.48E+08
P61077;P61077-2;D6R9F6;D6R933;D6RGD0;D6R980;D6RAW0;D6RIZ3;D6RA11;D6RFM0;D6RAH7;H9KV45;A0A0A0MQU3;A0A087WY85;P62837-2;P62837;P61077-3P61077;P61077-2; 6R9F6; 33; GD0;D6R980; W0;D6RIZ3; 11;D6RFM0 D6RAH7;H9KV45; A0A0MQU3;A0A087WY 5;P6283 -2;P62837;P61077-3Ubiquitin-conjugating enzyme E2 D3 Ubiquitin-conjugating enzyme E2 D2UBE2D3;UBE2D2 2 147 0 6.584 1.004 NaN 4.09E+08
H3BSW6;Q2VPK5-3;Q2VPK5;Q2VPK5-5;H3BPG4H3BSW6;Q2VPK5-3;Q2VPK5;Q2VPK5-5Cytoplasmic tRNA 2 thiolation protein 2CTU2 4 4 586 0 21.102 1.0039 NaN 2.43E+08
P42345;B1AKP8;B1AKQ2P42345 Serine/threonine-protein kinase mTORMTOR 19 19 2549 0 146.76 1.0039 0.97016 1.16E+09
Q8TD30;Q8TD30-2;H3BU54;P24298Q8TD30;Q8TD30-2Alanine aminotransferase 2GPT2 4 4 523 0 17.471 1.0037 1.1689 1.96E+08
B1ANM7;Q9UNN5-2;Q9UNN5;B3KT28B1ANM7;Q9UNN5-2;Q9UNN5;B3KT28FAS-associated factor 1FAF 2 2 490 0 6.2151 1.0036 NaN 3.43E+07
Q9BYB4;Q9BYB4-2;C9JPQ6Q9BYB4;Q9BYB4-2Guanine nucleotide-binding protein subunit beta-like protein 1GNB1L 10 10 327 0 51.515 1.0036 0.81224 1.05E+09
Q9Y223;Q9Y223-2;Q9Y223-3;Q9Y223-5;Q9Y223-4Q9Y2 3;Q9Y223- ;Q9Y223-3;Q9Y223-5;Q9Y223-4Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase;UDP-N-acetylglucosamine 2-epimerase (hydrolyzing);N-acetylmannosamine kinaseGNE 12 12 722 0 57.675 1.0033 1.5398 1.32E+09
Q13951-2;J3KRT0;H3BSC0;J3KTD8Q13951-2 Core-binding factor subunit betaCBFB 9 3 187 0 90.962 1.0029 1.0141 1.07E+09
Q14318;Q14318-2;U3KQ64;A0A0A0MTJ1;M0R2K9;Q14318-3;M0R1Q0;M0R1S6;M0R2Q6;U3KQI1Q14318;Q14318-2;U3KQ64Peptidyl-prolyl cis-trans isomerase FKBP8FKBP 11 11 412 0 75.241 1.0029 0.92508 1.17E+09
O60343-2;O60343-3;O60343;O60343-5;O60343-4;Q5JU47;A0JNU9O60343-2;O60343- ;O60343TBC1 domain family member 4TBC1D4 23 21 1235 0 172.4 1.0028 1.137 2.20E+09
Q8NE71-2;Q8NE71;H0YGW7;A0A0G2JIC2;Q5STZ8;F5GYK6Q8NE71-2;Q8NE71;H0YGW7ATP-binding cassette sub-family F member 1ABCF1 20 20 807 0 188.18 1.0028 1.0526 2.38E+09
Q9Y6X3;V9GYS3;V9GZ52;Q9Y6X3-3;Q9Y6X3-2Q9Y6X3;V9GYS3;V9GZ52MAU2 chromatid cohesion factor homologMAU2 5 5 613 0 16.39 1.0027 NaN 1.54E+08
P45974-2;P45974;F5H571P4 974-2;P45974Ubiquitin carboxyl-terminal hydrolase 5USP5 26 24 835 0 218.06 1.0023 0.99075 5.20E+09
Q15208 Q15208 Serine/threonine-protein kinase 38STK38 3 3 465 0 11.071 1.0023 NaN 9.11E+07
Q15291;Q15291-2Q15291;Q15291-2Retinoblastoma-binding protein 5RBBP5 9 9 538 0 85.179 1.0022 NaN 7.25E+08
P31146;H3BRY3;H3BTU6;H3BRJ0;H3BNA2;H3BU76;H3BSL1P31146; 3BRY3 Coronin-1A;CoroninCORO1A 5 5 461 0 11.085 1.002 0.55672 1.94E+07
Q00587-2;Q00587;B0QYC6;B0QYC7;B0QYC8Q0 587-2;Q00587Cdc42 effector protein 1CDC42EP1 7 7 384 0 29.951 1.0016 0.81066 4.10E+08
A0A087X0Q1;Q7Z739;A0A024R7W5;A0A087WY31;A0A087X0C3;S4R373A0A087X0Q1;Q7Z739; 0A024R7W5;A0A087WY31YTH domain-containing family protein 3YTHDF3 9 4 583 0 35.513 1.0012 NaN 3.62E+08
A0A087X211;Q8TCG1;Q8TCG1-2;F8WAX6;F8WF26A0A087X21 ;Q8TCG1;Q8TCG1-2Protein CIP2A KIAA1524 6 6 906 0 26.806 1.0007 0.78483 2.74E+08
Q9H9Y6;Q9H9Y6-3;Q9H9Y6-2;Q9H9Y6-5;Q9H9Y6-4;H7C0D9;C9JJG2;C9JS83;F8WDS4;F8WAK7;F8WBB9;F8WCS3Q9H9Y6;Q9H9Y6-3;Q9H9Y6-2;Q9H9Y6-5;Q9H9Y6-4DNA-directed RNA polymerase I subunit RPA2POLR1B 21 21 1135 0 106.47 1.0003 0.89529 1.65E+09
E9PMS3;E9PQW0;E9PMM3;Q9Y5Y5;Q9Y5Y5-2E9P S3;E9PQW0;E9PMM3;Q9Y5Y5;Q9Y5Y5-2Peroxisomal membrane protein PEX16PEX16 1 1 52 0.00079386 3.3462 1.0001 1.3104 3.02E+07
P33991;E5RG31;E5RFJ8;E5RFR3;E5RG53;Q9UJA3-2;Q9UJA3-3;Q9UJA3;Q9UJA3-4P33991 DNA replication licensing factor MCM4MCM4 46 46 863 0 323.31 0.99979 0.94487 2.71E+10
Q9NZL9-4;Q9NZL9-2;Q9NZL9;H7C0X7;Q9NZL9-3;E5RJR3;Q9NZL9-5Q9NZL9-4;Q9NZL9-2; 9 ZL9;H7C0X7;Q9NZL9-3Methionine adenosyltransferase 2 subunit betaMAT2B 5 5 306 0 32.692 0.99926 1.0307 6.36E+08
Q92882 Q92882 Osteoclast-stimulating factor 1OSTF1 2 2 214 0 6.5629 0.99897 NaN 9.79E+07
P25685;P25685-2;M0R080;M0QYT3;M0QXK0;M0R128;M0R1D6;M0QZD0P25685;P25685-2; 0R080DnaJ homolog subfamily B member 1DNAJB1 9 9 340 0 27.741 0.99879 1.027 2.99E+08
O94966-7;O94966-6;E7EST9;O94966-4;O94966-3;O94966-5;E7ESU0;B5MEG5;O94966;A0A0A0MR08;O94966-2O94966-7;O94966-6;E7EST9;O94966-4;O94966-3;O94966-5;E7ESU0;B5MEG5;O94966Ubiquitin carboxyl-terminal hydrolase 19;Ubiquitin carboxyl-terminal hydrolaseUSP19 14 14 1372 0 86.847 0.99875 0.8233 8.26E+08
Q8TAG9;E7EW84;Q8TAG9-2;F2Z3K0;B1AP46;E7EW84;Q8T G9-2;F2Z3K0Exocyst complex component 6EXOC6 8 8 804 0 36.705 0.99857 0.69147 2.67E+08
Q5HYK3;F8VVX6;F8VP53;F8VVW7;B4DP72;Q5HYK3-2Q5HYK3;F8 VX6;F8V 53;F8VVW7;B4DP722-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrialCOQ5 6 6 327 0 79.207 0.9985 1.0036 6.78E+08
Q16891-2;Q16891;B9A067;Q16891-4;Q16891-3;C9J406;H7C463;A0A087WYS0;D6RAW4Q16891-2; 16891;B9A067;Q16891-4;Q16891-3;C9J406;H7C463MICOS complex subunit MIC60IMMT 38 38 747 0 323.31 0.99819 0.91914 5.21E+09
O14654;H3BTC1 O14654 Insulin receptor substrate 4IRS4 51 51 1257 0 323.31 0.99734 0.87848 1.11E+10
P07196;A0A087X0W2P07196;A0A087X0W2Neurofilament light polypeptideNEFL 10 8 543 0 54.279 0.99722 NaN 5.08E+08
Q6PJ69;H0YG27;H0YGS7Q6PJ69;H0YG27;H0YGS7Tripartite motif-containing protein 65TRIM65 4 4 517 0 31.07 0.99709 NaN 1.23E+08
O94776;O94776-2O94776;O94776-2Metastasis-associated protein MTA2MTA2 14 10 668 0 88.301 0.99707 0.76787 1.19E+09
P56937-3;P56937-2;P56937;V9GYN3P56937- ;P56937-2;P569373-keto-steroid reductaseHSD17B7 4 4 306 0 15.634 0.99705 NaN 2.30E+08
P68366-2;P68366;C9JDS9;C9JEV8;C9JQ00;C9JJQ8;C9JDL2;C9K0S6;Q9H853P68366-2;P68366Tubulin alpha-4A chainTUBA4A 32 3 433 0 10.84 0.99691 0.81809 5.99E+08
Q15717;Q15717-2;M0QZR9;M0R055Q15717;Q15717-2;M0QZR9ELAV-like protein 1ELAVL1 19 17 326 0 223.65 0.99627 1.2931 1.85E+10
Q99570;D6RJ98;D6RAC3;D6RBB7Q99570 Phosphoinositide 3-kinase regulatory subunit 4PIK3R4 23 23 1358 0 145.05 0.99621 0.9365 2.13E+09
Q96I59;Q96I59-2;H0YEL9;E9PRK2;H0YE96Q96I59;Q 6I59-2 Probable asparagine--tRNA ligase, mitochondrialNARS2 13 13 477 0 177.01 0.99591 0.81292 2.59E+09
O75419-2;O75419;O75419-3;C9K087;H7BZ91;C9J911O75419-2;O75419;O7541 -3Cell division control protein 45 homologCDC45 13 13 520 0 78.402 0.99565 NaN 6.76E+08
Q9P035;H3BS72;H3BPZ1;Q9P035-2;H3BRL8;H3BMZ1Q9P035;H3BS72;H3BPZ1;Q9P035-2Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3PTPLAD1 14 14 362 0 201.26 0.99495 0.98949 8.30E+09
P49189;P49189-2P49189;P49189-24-trimethylaminobutyraldehyde dehydrogenaseALDH9A1 23 23 494 0 199.12 0.99461 0.90398 1.62E+10
Q5T8C6;Q13042-4;Q13042-3;Q13042-2;Q13042Q5T8C6;Q13042-4;Q13042-3;Q13042-2;Q13042Cell division cycle protein 16 homologCDC16 6 6 475 0 22.423 0.99446 NaN 2.10E+08
E9PHH8;Q9Y6X2 E9PHH8;Q9Y6X2 E3 SUMO-protein ligase PIAS3PIAS3 2 2 593 0 8.3705 0.99419 NaN 4.90E+07
E9PC15;Q53H12;E9PG39;A0A0G2JLG5;A0A0G2JLD0E9PC15;Q53H12;E9PG39;A0A0G2JLG5Acylglycerol kinase, mitochondrialAGK 12 12 394 0 191.19 0.99414 0.79539 5.92E+09
M0R0N4;M0QYZ2;P53680;X6R390;P53680-2;M0QZ21;M0R1S0M0R0N4;M0QYZ2;P53680;X6R390;P53680-2;M0QZ21AP-2 complex subunit sigmaAP2S1 6 6 144 0 36.665 0.99393 0.9625 1.85E+09
Q9BPX3;D6RA93;H0Y9Z8Q9BPX3 Condensin complex subunit 3NCAPG 26 26 1015 0 198.34 0.99373 0.96203 3.89E+09
Q6P4A7;Q6P4A7-2;Q6P4A7-3;B1AMV7Q6P4A7;Q6P4A7-2;Q6P4A7-3Sideroflexin-4 SFXN4 9 9 337 0 99.361 0.99291 0.96159 7.18E+08
Q75QN2-2;Q75QN2;J3KNV5;H0YBS1;E5RIN8;E5RG48;H0YC12;E5RJF0;H0YBQ1;E5RJL5Q75Q 2-2;Q75QN2;J3K V5;H0YBS1Integrator complex subunit 8INTS8 8 7 978 0 162.72 0.99269 0.73116 7.40E+08
A0A087X1N2;Q03701;C9J9W7A0A087X1N2;Q03701CCAAT/enhancer-binding protein zetaCEBPZ 20 20 998 0 180.01 0.99219 1.1233 1.04E+09
Q96GW9 Q96GW9 Methionine--tRNA ligase, mitochondrialMARS2 4 4 593 0 19.81 0.99205 NaN 2.66E+08
O60783 O60783 28S ribosomal protein S14, mitochondrialMRP 3 3 128 0 21.797 0.99149 0.99362 1.02E+09
Q9UBI1;R4GMW6;H0Y4W0;H0Y6Z9;R4GMX3;R4GN54;H0Y4E5;R4GNF2;R4GN06;Q5T8Z1Q9UBI1;R4GMW6 H0Y4W0 H0Y6Z9;R4GMX3;R4 54;H0Y4E5COM  domain-containing protein 3COM D COMMD3-BMI1 6 6 195 0 41.286 0.99148 1 4.94E+08
P15170-2;P15170-3;P15170;H3BR35;Q8IYD1;H3BSV8P15170-2;P15170-3;P15170;H3BR35Eukaryotic peptide chain release factor GTP-binding subunit ERF3AGSPT1 26 26 636 0 217.99 0.99131 0.9199 3.95E+09
Q8WUA4;H0Y4Q6;A0A087WZD8;Q8WUA4-2;H7C318;H7C1A9;C9JNH7;H7C3X9Q8WUA4;H0Y4 6;A0A087WZD8;Q8WUA4-2General transcription factor 3C polypeptide 2GTF3C2 8 8 911 0 58.637 0.99125 0.71823 3.39E+08
Q5T447;Q5T447-2Q5T447 E3 ubiquitin-protein ligase HECTD3HECTD3 8 8 861 0 48.682 0.99119 0.46503 5.59E+08
Q9NQT4;M0R050;M0R102Q9NQT4;M0R050 Exosome complex component RRP46EXOSC5 3 3 235 0 5.081 0.99104 0.53706 2.45E+08
A8MU39;H0YDU8;P53041;M0R196;A0A087WY80;E7EU14A8MU39;H YDU8 P53 41Serine/threonine-protein phosphatase;Serine/threonine-protein phosphatase 5PPP5C 3 3 371 0 10.546 0.9897 NaN 1.56E+06
178
Q9Y678;H0Y8X7;D6RG17Q9Y678 Coatomer subunit gamma-1COPG1 46 42 874 0 323.31 0.98956 0.95314 1.86E+10
P29590-4;P29590-2;P29590-5;P29590-9;P29590-3;P29590-8;P29590;H3BVD2;H3BT57;P29590-14;P29590-10;P29590-12;P29590-13;P29590-11P 9590-4;P29590-2;P29590-5;P29590- ;P29590-3;P29590-8;P29590;H3BVD2;H3BT57;P29590-14;P29590-10;P29590-12;P29590-13;P29590-11Protein PML PML 2 2 560 0 18.365 0.98955 NaN 7.52E+07
P05141 P05141 ADP/ATP translocase 2;ADP/ATP translocase 2, N-terminally processedSLC25A5 37 18 298 0 274.99 0.9888 0.831 9.33E+10
Q9Y5R8;I3L3S0;I3L1R8;I3L3V5Q9Y5R8;I L3S0 Trafficking protein particle complex subunit 1TRAPPC1 3 3 145 0 9.5087 0.98879 0.92056 4.41E+08
O60216;E5RJW1;E5RJK5;E5RFZ5;E5RFV8;E5RIN7;E5RI01;E5RG18;Q9H4I0;A0A140T8W2;Q9H4I0-2O60216 Double-strand-break repair protein rad21 homologRAD21 16 16 631 0 69.126 0.98855 1.0557 1.04E+09
Q92621;U3KPX2;U3KQ97;U3KQ47Q92621 Nuclear pore complex protein Nup205NUP205 68 68 2012 0 323.31 0.98851 0.94173 1.54E+10
Q92696;H0YLH3;H0YMG5;H0YLG7;H0YKZ8;H0YKP6Q92696; H3 Geranylgeranyl transferase type-2 subunit alphaRABGGTA 13 13 567 0 84.818 0.98842 NaN 7.81E+08
Q6P2E9;Q6P2E9-2;I3L2F4;I3L0V0Q6P E9 Q6P2E9-2Enhancer of mRNA-decapping protein 4EDC4 26 26 1401 0 161.6 0.98829 0.75847 3.13E+09
F5H365;Q15436;Q15436-2;G3V4V1;G3V1W4;G3V3G5;G3V2R6;G3V5X8;G3V4Q2;G3V5K1F5H365;Q15436;Q15436-2Protein transport protein Sec2 ASEC23A 17 14 736 0 228.04 0.98811 1.0157 4.00E+09
Q96I25;Q5W012;Q5W011;Q5W010;H0Y6J696I25;Q5W012 Splicing factor 45 RBM17 7 7 401 0 38.346 0.98811 0.66007 2.34E+08
F8VWT9;J3KPF0;Q9Y4D8-4;Q9Y4D8;Q9Y4D8-2;Q9Y4D8-5F8VWT9;J3KPF0;Q9Y4D8-4;Q9Y4D8;Q9Y4D8-2Probable E3 ubiquitin-protein ligase HECTD4HECTD4 4 4 4284 0 23 0.98773 0.97997 1.14E+08
U3KQC1;A0A0A0MQU0;Q9BV38;K7EIR0;K7EML4;A0A087X237;K7EKX5;U3KQK3U3KQC1;A0A0A0MQU0;Q9BV38;K7EIR0WD repeat-containing protein 18WDR18 11 11 394 0 73.322 0.98754 0.95095 2.69E+09
P50579-3;P50579;G3V1U3;F8VSC4;F8VRR3;F8VQZ7;P50579-2;F8VY03P50579- ;P50579;G3V1U3;F8VSC4;F8VRR3;F8VQZ7;P50579-2Methionine aminopeptidase 2METAP2 5 5 455 0 56.835 0.98752 NaN 1.37E+08
Q9H871 Q9H871 Protein RMD5 homolog ARMND5A 2 2 391 0 8.3353 0.987 0.89549 2.41E+08
Q9Y265;Q9Y265-2;E7ETR0;H7C4G5;H7C4I3;J3QLR1Q9Y265;Q9Y265-2;E7ETR0RuvB-like 1 RUVBL1 31 31 456 0 323.31 0.98699 0.94791 1.86E+10
Q9Y3I0 Q9Y3I0 tRNA-splicing ligase RtcB homologRTCB 34 34 505 0 323.31 0.98695 1.0449 3.36E+10
P37198;M0QXN5;M0QX10;A0A0U1RVK9;M0QYY0;M0QX13;M0QZL5;M0R1S1;M0QX64;M0R302P37198;M0QXN5 Nuclear pore glycoprotein p62NUP62 5 5 522 0 57.28 0.98603 NaN 1.60E+08
Q15645;H0YAL2;Q15645-2Q15645 Pachytene checkpoint protein 2 homologTRIP13 18 18 432 0 184.49 0.98599 0.87133 5.92E+09
Q86VV8;Q86VV8-4;Q86VV8-3;J3KTD2;J3KT00;Q86VV8-2Q86V 8;Q86VV8-4;Q86VV8-3;J3KTD2;J3KT00;Q86VV8-2Rotatin RTTN 4 4 2226 0 11.809 0.98592 0.88198 7.05E+08
A0PJW6 A0PJW6 Transmembrane protein 223TMEM223 2 2 202 0 18.181 0.98571 NaN 7.89E+07
Q15477;H7C5N0;H7C4L3;B4E0B4;F8WDE8Q15 77 Helicase SKI2W SKIV2L 28 28 1246 0 200.59 0.9857 1.0893 2.15E+09
P63244;J3KPE3;H0YAF8;D6RHH4;D6R9Z1;D6RAC2;H0Y8W2;D6R9L0;D6RFX4;H0YAM7;D6REE5;D6RFZ9;D6RAU2;E9PD14;D6RBD0;H0Y8R5;D6RGK8;D6R909;D6RHJ5;D6RDI0P63244;J3KPE3;H0YAF8 HH4;D6R9Z1; 6RAC2;H0Y8W2;D6R9L0 FX4;H0YAM7;D6REE5;D6RFZ9Guanine nucleotide-binding protein subunit beta-2-like 1;Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processedGNB2L1 13 9 317 0 101.75 0.98559 1.3149 2.65E+09
P33993;P33993-3;P33993-2;C9J8M6P3 9 3;P33993-3;P33993-2DNA replication licensing factor MCM7MCM7 45 45 719 0 323.31 0.98533 0.96054 3.79E+10
A0A0A0MRJ0;Q5VT25-3;Q5VT25-4;Q5VT25-5;Q5VT25;Q5VT25-2;Q5VT25-6;H0Y7V8;A0A0A0MRJ1;H0Y5V1;H0Y6V3;H0Y6R0A0A0A0MRJ0;Q5VT25-3;Q VT25-4;Q5VT25-5;Q5VT25;Q5VT25-2;Q5VT25-6;H0Y7V8;A0A0A MRJ1;H0Y5V1Serine/threonine-protein kinase MRCK alphaCDC42BPA 13 10 1699 0 54.617 0.98532 1.0961 2.92E+08
Q9UBB6-2;Q9UBB6;Q9UBB6-3;C9J5H8Q9UBB6-2;Q9UBB6;Q9UBB6-3;C9J5H8Neurochondrin NCDN 4 4 712 0 11.633 0.98528 NaN 1.13E+08
O43318-2;O43318;Q9UG54;O43318-4;O43318-3O43318-2; ;Q9UG54;O43318-4;O43318-3Mitogen-activated protein kinase kinase kinase 7MAP3K7;DKFZp586F0420 5 5 579 0 92.337 0.98517 NaN 1.47E+08
Q12792;Q12792-3;F8VS81;Q12792-4;F8VRG3;F8W1Q9Q12792;Q12792-3;F8VS81;Q12792-4Twinfilin-1 TWF1 7 6 350 0 75.793 0.98517 0.97516 1.24E+09
O95168;C9JXQ9;O95168-2;F2Z3P9O95168;C9JXQ9;O95168-2;F2Z3P9NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4NDUFB4 4 4 129 0 29.87 0.98505 0.76938 3.02E+08
P62308;A8MWD9;Q49AN9;F5H013;C9JVQ0P62308;A8MWD9;Q49AN9;F5H013;C9JVQ0Small nuclear ribonucleoprotein G;Putative small nuclear ribonucleoprotein G-like protein 15SNRPG;SNRPGP15 5 5 76 0 26.8 0.98462 0.83118 3.07E+09
A2A3N6 A2A3N6 Putative PIP5K1A and PSMD4-like proteinPIPSL 8 0 862 0 34.439 0.984 NaN 1.40E+08
Q96P70 Q96P70 Importin-9 IPO9 21 21 1041 0 292.57 0.98363 0.90783 5.35E+09
O00257-3;O00257;F8WCW6;I3L4F1O00257-3;O00257;F8WCW6;I3L4F1E3 SUMO-protein ligase CBX4CBX4 2 2 290 0 5.6341 0.98354 NaN 5.67E+07
P14324-2;P14324;A0A087X1D8;A0A087WVN4;A0A087X090;A0A087WTP2P14324-2;P14324;A0A087X1D8; A087WVN4Farnesyl pyrophosphate synthaseFDPS 9 9 353 0 139.84 0.98336 0.97063 9.99E+09
E9PS17;Q96KG9-3;Q96KG9-2;Q96KG9;E9PK59;Q96KG9-4;Q96KG9-5;Q96KG9-6;E9PPN3;H0YCI6;A0A0A0MQX4;H0YDH0E9PS17;Q96KG9-3;Q96KG9-2; 96K 9;E9PK59;Q96KG9-4;Q96KG9-5;Q96KG9-6;E9PPN3N-terminal kinase-like proteinSCYL1 16 16 775 0 199.03 0.98314 0.71296 1.27E+09
Q96S55-2;Q96S55;Q96S55-3;Q96S55-4Q96S5 -2;Q96S5 ;Q96S55-3;Q96S55-4ATPase WRNIP1 WRNIP1 10 10 640 0 44.618 0.98307 1.1261 9.89E+08
Q04837;A0A0G2JLD8;E7EUY5;C9K0U8Q04837;A0A0G2JLD8;E7EUY5;C9K0U8Single-stranded DNA-binding protein, mitochondrialSSBP1 9 9 148 0 98.293 0.98305 0.91817 1.81E+09
P61026;H0YLJ8;H0YL94;P59190-2;P59190P61026 Ras-related protein Rab-10RAB10 6 4 200 0 17.257 0.98272 1.131 3.32E+08
Q9UHD2 Q9UHD2 Serine/threonine-protein kinase TBK1TBK1 11 11 729 0 120.1 0.98243 0.72226 9.44E+08
J3QLE5;A8MT02;P14678-2;P63162;P14678;P63162-2;P14678-3;J3KRY3;S4R3P3J3QLE5;A8MT02;P14678-2;P63162;P14678;P63162-2;P14678-3;J3KRY3;S4R3P3Small nuclear ribonucleoprotein-associated proteins B and B;Small nuclear ribonucleoprotein-associated protein NSNRPN;SNRPB 9 9 169 0 50.169 0.98231 1.0318 7.87E+09
P61221;D6R9I9;D6RGF4;H0Y990P61221;D6R I9 ATP-binding cassette sub-family E member 1ABCE1 21 21 599 0 196.7 0.9823 0.36921 3.88E+09
P09874;Q5VX84;Q5VX85P09874 Poly [ADP-ribose] polymerase 1PARP1 68 68 1014 0 323.31 0.98215 1.1324 6.45E+10
Q9UBF2;Q9UBF2-2;H3BS45;F5H1S1;Q92521Q9U F2;Q9UBF2-2Coatomer subunit gamma-2COPG2 32 28 871 0 323.31 0.98209 1.0568 5.98E+09
A8MTY9;O14972-2;O14972;A8MY26A8MTY9;O14972-2;O14972;A8MY26Down syndrome critical region protein 3DSCR3 4 4 249 0 23.958 0.98189 0.9397 5.12E+08
P10768;X6RA14;H7BZT7;U3KQT1P10768;X6RA14;H7BZT7S-formylglutathione hydrolaseESD 11 11 282 0 214.64 0.98172 0.90887 5.72E+09
Q14204;H0YJ21 Q14204 Cytoplasmic dynein 1 heavy chain 1DYNC1H1 244 244 4646 0 323.31 0.98123 1.0274 6.22E+10
I3L0E3;Q9Y2R5;E9PE17I3L0E3;Q9Y2R5;E9PE1728S ribosomal protein S17, mitochondrialMRP 6 6 225 0 45.277 0.98083 1.102 1.07E+09
P40763-3;P40763-2;P40763;G8JLH9;K7EP08P40763-3;P40763-2;P40763;G8JLH9Signal transducer and activator of transcription 3;Signal transducer and activator of transcriptionSTAT3 9 9 722 0 99.448 0.98068 0.8993 9.39E+08
Q14999;Q14999-2;E9PEZ1;Q8IWT3-3;Q8IWT3Q14999;Q14999-2Cullin-7 CUL7 6 6 1698 0 50.242 0.98051 1.9422 2.61E+08
H0Y760;Q9Y4B4 H0Y760;Q9Y4B4 Helicase ARIP4 RAD54L2 6 6 1296 0 45.026 0.98047 1.103 2.64E+08
Q9UJS0;Q9UJS0-2;R4GN64Q9UJS0;Q9UJS0-2Calcium-binding mitochondrial carrier protein Aralar2SLC25A13 29 22 675 0 303.81 0.98024 0.94891 1.17E+10
Q15910-3;Q15910;Q15910-2;Q15910-5;Q15910-4;E9PDH6;G3XAL2Q15910-3;Q15910;Q159 0-2;Q15910-5;Q15910-4Histone-lysine N-methyltransferase EZH2EZH2 4 4 707 0 28.379 0.98006 1.0855 3.51E+08
Q9NVH0-2;Q9NVH0;C9JLF4Q9NVH0-2;Q9NVH0Exonuclease 3-5 domain-containing protein 2EXD2 8 8 496 0 24.429 0.97989 NaN 4.17E+08
P55010;H0YLZ1;H0YN40P55010 Eukaryotic translation initiation factor 5EIF5 6 6 431 0 13.902 0.97948 1.0467 4.25E+08
P46199;H7C213 P46199 Translation initiation factor IF-2, mitochondrialMTIF2 5 5 727 0 14.78 0.97909 0.94595 3.28E+08
Q13043-2;Q13043;A0A087WVN8;F5H5B4Q13043-2;Q13043;A0A087WVN8;F5H5B4Serine/threonine-protein kinase 4;Serine/threonine-protein kinase 4 37kDa subunit;Serine/threonine-protein kinase 4 18kDa subunitSTK4 4 3 462 0 11.886 0.97875 NaN 1.22E+08
B4DTS2;Q9BZL6;Q9BZL6-2;M0QXC6;M0R2Z8B4DTS2;Q9BZL6;Q9BZL6-2Serine/threonine-protein kinase D;Serine/threonine-protein kinase D2PRKD2 3 3 888 0 43.644 0.97857 0.96859 2.89E+08
Q9NUQ9;E5RI16;Q9NUQ9-2;E5RK61;E5RFS4;E5RHU5;E5RGI7;E5RJE1;E5RIR8;E5RJL8;A0A087X178;Q9H0Q0Q9NUQ9;E5RI16;Q9NUQ9-2Protein FAM49B FAM49B 4 4 324 0 21.773 0.97856 0.95424 3.65E+08
O00116;B8ZZ81 O00116 Alkyldihydroxyacetonephosphate synthase, peroxisomalAGPS 25 25 658 0 261.19 0.97827 1.3266 3.56E+09
Q92547;H0Y8I7 Q92547 DNA topoisomerase 2-binding protein 1TOPBP1 9 9 1522 0 24.726 0.97802 0.87814 1.53E+08
Q14566 Q14566 DNA replication licensing factor MCM6MCM6 49 49 821 0 323.31 0.9778 0.95364 2.25E+10
O95782-2;O95782O95782-2;O95782AP-2 complex subunit alpha-1AP2A1 28 16 955 0 156.62 0.97767 0.89121 2.45E+09
K7ENL9;Q96DM3;A0A087WZD4K7ENL9;Q96DM3;A0A087WZD4Uncharacterized protein C18orf8C18orf8 2 2 609 0 10.79 0.97694 NaN 8.27E+07
P12235;V9GYG0;Q9H0C2P12235;V9GYG0 ADP/ATP translocase 1SLC25A4 26 8 298 0 57.011 0.9767 1.1235 2.34E+09
Q8IUF8;Q8IUF8-4;Q8IUF8-3;Q8IUF8-2;D6RCB6;H0Y9L88I F8;Q8IUF8-4;Q8IUF8-3;Q8IUF8-2Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINAMINA 14 14 465 0 230.4 0.97653 0.82536 2.60E+09
Q8WVM8;Q8WVM8-2;Q8WVM8-3;J3KNG4;G3V4I1;G3V5F3;G3V2M8;G3V3K9;G3V363;H0YJS6;G3V5E2;H0YJY1Q8WVM8;Q8WVM8-2;Q8WVM8-3Sec1 family domain-containing protein 1SCFD1 24 24 642 0 314.9 0.97643 NaN 2.58E+09
H3BSW3;H3BQF1;H3BQZ9;P07741-2;P07741;H3BQB13 SW3;H3BQF1;H3BQZ9;P07741-2;P07741;H3BQB1Adenine phosphoribosyltransferaseAPRT 4 4 63 0 19.564 0.97633 1.0366 4.87E+08
C9JVN9;Q9H9P8-2;Q9H9P8;G3V5S1;G3V272C9JVN9;Q9H9P8-2;Q9H9P8L-2-hydroxyglutarate dehydrogenase, mitochondrialL2HGDH 9 9 441 0 48.95 0.97618 0.91975 1.60E+09
Q9UBV2;G3V3B3;Q9UBV2-2;G3V3B3;Q9UBV2-2Protein sel-1 homolog 1SEL1L 2 2 794 0 10.52 0.97579 0.85972 7.07E+07
Q9HAV7 Q9HAV7 GrpE protein homolog 1, mitochondrialGRPEL1 4 4 217 0 15.337 0.97574 0.43318 2.25E+08
E7EM64;Q7L5N1;H7C3T0E EM64;Q7L5N1 COP9 signalosome complex subunit 6COPS6 6 6 326 0 57.857 0.97509 0.8616 1.20E+09
Q9P2I0;H0YJF4;G3V3T7Q9P2I0 Cleavage and polyadenylation specificity factor subunit 2CPSF2 17 17 782 0 199.42 0.97488 0.99532 1.55E+09
O14776-2;O14776;G3V220O14776-2;O14776;G3V220Transcription elongation regulator 1TCERG1 5 5 1077 0 19.358 0.97445 0.78759 2.09E+08
F5H7S7;Q13576;E7EWC2;Q13576-3;Q13576-2;D6R939;E9PDT6;D6R999;H0YA28;D6RGC6;D6RDK8F5H7S7 ;E7EWC2;Q13576-3;Q13576-2Ras GTPase-activating-like protein IQGAP2IQGAP2 24 22 1525 0 204.28 0.97336 0.95786 1.17E+09
H0Y7P7;Q9UG56-2;Q9UG56;B1AKM8;B1AKM6H0Y7P7;Q9UG56-2;Q9UG56;B1AKM8;B1AKM6Phosphatidylserine decarboxylase proenzyme;Phosphatidylserine decarboxylase alpha chain;Phosphatidylserine decarboxylase beta chainPISD 3 3 362 0 11.716 0.9732 1.3932 2.29E+08
F5H170;Q8WW22-3;Q8WW22;Q8WW22-2F5H170;Q8WW22-3;Q8WW22;Q8WW22-2DnaJ homolog subfamily A member 4DNAJA4 1 1 219 0.0063694 2.1619 0.9731 0.94918 6.98E+07
O43242;O43242-2;H0YGV8O43242;O43242-2 6S proteasome non-ATPase regulatory subunit 3PSMD3 37 37 534 0 248.78 0.97292 0.84113 1.22E+10
P05091;P05091-2;F8VP50;S4R3S4P05091;P05091-2Aldehyde dehydrogenase, mitochondrialALDH2 14 12 517 0 47.231 0.97292 1.0008 9.96E+08
Q6P2P2;Q6P2P2-2Q6P2P2;Q6P2P2-2Putative protein arginine N-methyltransferase 9PRMT9 9 9 845 0 25.065 0.97256 1.2708 4.14E+08
O00303;H0YDT6;A0A0D9SEZ9;E9PQV8O00303 Eukaryotic translation initiation factor 3 subunit FEIF3F 16 16 357 0 230.98 0.97251 1.0015 2.72E+10
P50990;P50990-2;P50990-3;H7C4C8;H7C2U0P509 0;P50990-2;P50990-3T-complex protein 1 subunit thetaCCT8 46 46 548 0 323.31 0.97207 0.8608 3.82E+10
C9JKF1;Q5K651 C9JKF1;Q5K651 Sterile alpha motif domain-containing protein 9SAMD9 3 3 1283 0 9.6446 0.97195 1.54 7.65E+07
Q9BYN8 Q9BYN8 28S ribosomal protein S26, mitochondrialMRP 10 10 205 0 25.72 0.9717 0.9764 4.53E+08
B4E2Q0;P98194-4;P98194;H0Y9V7;P98194-2;P98194-3;P98194-5;P98194-8;P98194-9;P98194-6;P98194-7;H0Y8X9;H0Y9S7B4E2Q0;P981 4-4;P98194;H0Y9V7;P98194-2;P98194-3;P98194-5;P 8194-8;P98194- ;P98194-6;P981 4-7Calcium-transporting ATPase Calcium-transporting AT ase type 2C member ATP2C1 5 5 953 0 32.773 0.97165 1.0705 2.36E+08
D6RGI3;D6RER5;Q9NVA2;Q9NVA2-2;D6RDU5;H0Y961;H0Y9G8;D6RDP1;D6R9Y6D6RGI3;D6RER5;Q9NVA2;Q9NVA2-2 D6RDU5;H0Y96Septin-11 11-Sep 6 3 425 0 17.986 0.97164 1.2276 1.65E+08
A0A0U1RQC9;P04637-4;P04637;A0A087WZU8;J3KP33;P04637-7;P04637-5;P04637-6;P04637-2;P04637-3;A0A087X1Q1;E7ESS1;P04637-8;P04637-9;E7EQX7;A0A087WXZ1;A0A087WT22;E7EMR6;E9PFT5;E9PCY9;S4R334A0A0U1RQC9;P04637-4;P04637;A0A087WZU8;J3KP3 ;P04637-7;P04637-5;P04637-6;P04637-2;P04637-3;A0A087X1Q1;E7ESS1;P04637-8;P04637-9;E7EQX7Cellular tumor antigen p53TP53 18 18 4 0 0 98.041 0.97 63 1.2122 2.60E+09
Q9UNE7;Q9UNE7-2;H3BTA3;H3BUD0;H3BS86Q9UNE7;Q9UNE7-2 TA3;H3BUD0;H3BS86E3 ubiquitin-protein ligase CHIPSTUB1 15 15 303 0 111.29 0.97163 0.93283 3.06E+09
P23368;P23368-2P23368;P23368-2NAD-dependent malic enzyme, mitochondrialME2 2 2 584 0 26.952 0.97151 NaN 6.68E+07
Q99653;H0YNG9;H0YKE7;F5GX29;H0YLY7;H0YLX1Q99653;H0YNG9;H0YKE7;F5G 29;H0YLY7Calcineurin B homologous protein 1CHP1 8 8 195 0 80.578 0.97125 0.67656 4.54E+08
Q99497;K7ELW0;K7EN27Q9949 ;K7ELW0;K7EN27Protein DJ-1 PARK7 11 11 189 0 48.098 0.97111 0.783 1.49E+09
P55210;P55210-3;A0A0A0MRL7;P55210-4;Q5SVL2P55210;P55210-3;A0A0A0MRL7;P55210-4;Q5SVL2Caspase-7;Caspase-7 subunit p20;Caspase-7 subunit p11CASP7 9 5 303 0 144.79 0.97103 0.85424 1.05E+09
P19447;H7C309 P19447 TFIIH basal transcription factor complex helicase XPB subunitERCC3 8 8 782 0 114.91 0.97088 1.0828 1.15E+09
P25705;P25705-2;P25705-3;K7EK77;K7ENJ4;K7ERX7;K7EJP1;K7EQH4;K7ESA0P25705;P25705-2;P25705-3;K7EK 7ATP synthase subunit alpha, mitochondrialATP5A1 37 37 553 0 323.31 0.9705 0.91854 5.01E+10
O95757;E9PDE8;D6RJ96O95757;E9PDE8;D6RJ96Heat shock 70 kDa protein 4LHSPA4L 12 9 839 0 58.239 0.97019 1.1857 1.04E+09
C9JQ72;Q9Y4P1-6;Q9Y4P1;Q9Y4P1-2;C9JIK8;F2Z2K8;C9JVD5;C9J3C0;Q9Y4P1-3;Q9Y4P1-4;H0Y2Y0;C9J1C1C9JQ72;Q9Y4P1-6;Q9Y4P1;Q9Y4P1-2;C9JIK8;F2Z2K8;C9JVD5;C9J3C0;Q9Y4P1-3;Q9Y4P1-4Cysteine protease ATG4B 8 8 266 0 84.143 0.97007 1.0018 1.54E+09
Q13535-2;Q13535-3;Q13535;D6RFJ6;D6RIG7Q13535-2;Q13535-3;Q13535Serine/threonine-protein kinase ATRATR 12 12 2580 0 41.72 0.96985 0.70681 2.54E+08
P35580;P35580-5;P35580-2;P35580-3;P35580-4;E7ERA5P35 80;P35580-5;P 5580-2;P35580-3;P35580-4Myosin-10 MYH10 91 66 1976 0 323.31 0.96974 1.127 1.54E+10
Q86X10;Q86X10-3;A2A2F0;Q86X10-4;Q86X10-2;A0A0J9YW54Q86X10;Q86X10-3;A2A2F0;Q86X10-4;Q86X10-2;A0A0J9YW54Ral GTPase-activating protein subunit betaRALGAPB 10 10 1494 0 105.28 0.96962 1.073 8.80E+08
E9PJN0;O14734;E9PRD4;H7C5A7;Q9BR14;E9PMC4;E9PIS4;H0Y698;F6VBM3E9PJN0;O14734;E P D ;H7C5A7 Q9BR14;E9PMC4;E9PIS4Acyl-coenzyme A thioesterase 8ACOT8 4 4 226 0 42.353 0.96945 0.97169 4.50E+08
P13984 P13984 General transcription factor IIF subunit 2GTF2F2 7 7 249 0 84.769 0.96919 0.79433 9.70E+08
R4GNB2;R4GN35;Q5VZ89-6;Q5VZ89;X6RAE7;Q5VZ89-3;Q5VZ89-2;Q5VZ89-5;X6R5W5;Q5VZ89-4;A0A0A0MRX3R4GNB2;R4GN35;Q5VZ89-6;Q5VZ89;X6RAE7;Q5VZ89-3;Q VZ89-2;Q5VZ89-5DENN domain-containing protein 4CDENND4C 5 5 1909 0 45.108 0.96894 1.049 3.05E+08
Q9UK61-3;Q9UK61-4;Q9UK61;Q9UK61-2;A0A087X0F1Q9UK61-3;Q9UK61-4;Q9UK61;Q9UK61-2;A0A087X0F1Protein F M208AFAM 08A 12 12 1512 0 40.154 0.9686 0.94078 4.66E+08
P12814;P12814-3P12814;P12814-3Alpha-actinin-1 ACTN1 30 1 892 0 231.85 0.96845 1.3317 2.20E+09
H7BXZ6;Q8IXI2-4;Q8IXI2;Q8IXI2-5;Q8IXI2-2;Q8IXI2-7;Q8IXI2-3;Q8IXI2-6;K7EIQ7H7BXZ6;Q8IXI2-4;Q8IXI2;Q8IXI2-5;Q8IXI2-2;Q8IXI2-7;Q8IX 2-3;Q8IXI2-6Mitochondrial Rho GTPase;Mitochondrial Rho GTPase 1TMEM91;RHOT1 7 6 597 0 60.608 0.96832 1.0732 2.98E+08
A6NJD9;A8MVT4;A8MYK1;Q16540;H7C2P76NJD9;A8MVT4 A8MYK1;Q16540;H7C2P739S ribosomal protein L23, mitochondrialMRP 3 3 163 0 15.422 0.96803 1.3186 4.25E+08
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O60701;O60701-2;O60701-3;E7ER95;E7ER83;E7ETF4;E7EV97;D6RHF4;E9PBD2O60701;O60701-2;O60701-3UDP-glucose 6-dehydrogenaseUGDH 19 19 494 0 219.07 0.96782 0.8789 6.22E+09
Q1KMD3;H3BQZ7Q1KMD3;H3BQZ7Heterogeneous nuclear ribonucleoprotein U-like protein 2HNRNPUL2;HNRNPUL2-BSCL2 10 10 747 0 41.43 0.96778 1.7322 7.34E+08
F6RFD5;P60981;P60981-2F6RFD5;P60981;P60981-2Destrin DSTN 5 4 135 0 24.885 0.96722 0.64999 2.01E+09
Q9NXE4;Q9NXE4-4;B1PBA3;Q9NXE4-3;H7C1Q6;Q9NXE4-9;Q9NXE4-7;H7C0W5;H7C2J2;H7C235;Q9NXE4-5;C9J647;F8WF03;F2Z2I0;F2Z2W5Q9NXE4;Q9NXE4-4;B1PBA3;Q9NXE4-3;H7C1Q6;Q9NXE4-9;Q9NXE4-7; 0W5Sphingomyelin phosphodiesterase 4SMPD4 15 1 827 0 114.34 0.96721 1.1185 1.97E+09
Q14C86-2;Q14C86-6;Q14C86-3;Q14C86-4;Q14C86-5;Q14C86;F8W9S7;C9IZ08;B4DGD8;B0QZ65;H0Y7I9;A0A0A0MQV8;H0Y4E7;C9IZX9Q14C86-2;Q14C86-6;Q14C86-3;Q14C86-4;Q14C86-5 Q14C 6;F8W9S7GTPase-activating protein and VP 9 domain-containing protein 1GAPVD1 25 25 1460 0 215.3 0.967 0.644 1.60E+09
P62487;E9PIU7;H0YEE4;E9PKH3P62487 DNA-directed RNA polymerase II subunit RPB7POLR2G 5 5 172 0 34.911 0.9665 1.3523 3.18E+08
Q86W50;I3L362;Q86W50-2;I3L3W3;I3L4V186 50;I3L362;Q86W50-2Methyltransferase-like protein 16METTL16 3 3 562 0 9.5242 0.96629 NaN 1.04E+08
K7ES31;K7ERF1;Q9UBQ5-2;Q9UBQ5;K7EQM4;A0A087WVB9K7ES31;K7ERF1;Q9UBQ5-2;Q9UBQ5;K7EQM4;A0A087WVB9Eukaryotic translation initiation factor 3 subunit KEIF3K 5 5 137 0 24.418 0.96626 0.75235 2.77E+08
D6R938;E9PBG7;E9PF82;Q13557-8;Q13557-12;Q13557-10;Q13557;Q13557-6;Q13557-11;Q13557-9;Q13557-5;Q13557-3;Q13557-4;H0Y9J2;H0Y9C2D6R938;E9PBG7;E9PF82;Q 3557-8;Q13557-12;Q13557-10;Q13557;Q 3557-6;Q13557-11;Q13557-9;Q13557-5;Q13557-3;Q13557-4;H0Y9J2Calcium/calmodulin-dependent protein kinase type II subunit deltaCAMK2D 1 12 498 0 198.55 0.966 1.0632 2.86E+09
O60256;O60256-3;E7EPA1;O60256-4;O60256-2;C9K0K7;C9JJS3;I3L0S1;C9JDU5;C9JDH0;E7EW35;I3L331;I3L164;I3L4G9O60256;O60256-3;E7EPA1;O60256-4;O60256-2;C9K0K7;C9JJS3;I3L0S1Phosphoribosyl pyrophosphate synthase-associated protein 2PRPSAP2 19 17 369 0 181.84 0.96586 1.0525 8.28E+09
P09960;P09960-4;P09960-2;P09960-3;B4DEH5P09 60;P09960-4;P09960-2;P09960-3Leukotriene A-4 hydrolaseLTA4H 21 21 611 0 215.89 0.96558 NaN 1.75E+09
G5E953;Q13615-3;Q13615-2;Q13615;J3QR65;Q9NYA4G5E953;Q136 5-3;Q1 615-2;Q13615Myotubularin-related protein 3MTMR3 5 5 1062 0 13.152 0.96545 0.73384 1.38E+08
C9J2P0;P51965;H7C061;B7Z306;P51965-2;P51965-3;A0A087X283;C9J180C9J2P0;P51965;H7C061;B7Z30 ;P51965-2;P51965-3;A0A087X283Ubiquitin-conjugating enzyme E2 E1UBE2E1 4 2 147 0 11.214 0.96534 1.0748 8.37E+08
O75191;O75191-2O75191;O75191-2Xylulose kinase XYLB 5 5 536 0 26.787 0.9644 1.1038 2.59E+08
P61011;P61011-2;G3V4F7;G3V480;G3V346;A0A0D9SFN7;G3V3L9P61011;P61011-2; 3 4F7Signal recognition particle 54 kDa proteinRP54 29 29 504 0 323.31 0.96416 1.0279 5.78E+09
Q9BZX2;Q9BZX2-2Q9BZX2 Uridine-cytidine kinase 2UCK2 8 7 261 0 112.59 0.96406 0.67065 3.63E+09
Q86YS7;Q86YS7-2;Q86YS7-3;Q86YS7-4;Q86YS7-5;H0YFC4Q86YS7;Q86YS7-2;Q86YS7-3;Q86YS7-4;Q86YS7-5C2 domain-containing protein 5C2CD5 3 3 1000 0 20.276 0.96385 1.562 1.93E+08
P29372-5;P29372-4;P29372-2;P29372;A2IDA3P29372-5;P 9372-4;P29372-2;P29372;A2IDA3DNA-3-methyladenine glycosylaseMPG 6 6 281 0 51.621 0.9638 1.081 1.40E+09
Q07021;I3L3Q7;I3L3B0Q07021;I3L3Q7;I3L3B0Complement component 1 Q subcomponent-binding protein, mitochondrialC1QBP 10 10 282 0 148.28 0.96373 1.196 9.27E+09
P51809-3;P51809;P51809-2;E5RH06P51809-3;P51809;P51809-2Vesicle-associated membrane protein 7VAMP7 5 5 179 0 21.338 0.96364 0.88142 3.18E+08
A0A0A0MTS7;Q8WZ42-5;Q8WZ42-11;Q8WZ42-4;Q8WZ42-7;Q8WZ42-2;Q8WZ42;Q8WZ42-8;Q8WZ42-13;Q8WZ42-12;A0A0A0MRA3;Q8WZ42-6;Q8WZ42-3;Q8WZ42-10;Q8WZ42-9A0A0A0MTS7;Q8WZ42-5;Q8WZ42-11;Q8WZ42-4;Q8WZ42-7;Q8WZ42-2;Q8WZ42;Q8WZ42-8;Q8WZ42-13;Q8WZ42-12;A0A0A0MRA3;Q8WZ42-6;Q8WZ42-3;Q8WZ42-10;Q8WZ42-9Titin TTN 2 35991 0.0051916 2.3083 0.9634 0.75175 2.35E+09
Q9NSE4 Q9NSE4 Isoleucine--tRNA ligase, mitochondrialIARS2 34 34 1012 0 231.9 0.96317 1.0273 5.56E+09
Q8N142;G3V5D8;Q8N142-2 Adenylosuccinate synthetase isozyme 1ADSSL1 5 2 457 0 8.3254 0.96271 0.94443 2.50E+07
P33176;Q12840;J3KNA1;C9JWB9P33176 Kinesin-1 heavy chainKIF5B 37 30 963 0 323.31 0.96266 0.9037 5.40E+09
P17152 P17152 Transmembrane protein 11, mitochondrialTMEM11 3 3 192 0 15.978 0.9623 0.89068 1.49E+09
B7ZM99;A0A087WVM4;Q6UB35;H0Y327;Q6UB35-2;Q5JYA8;Q5JYA3;Q4VXM0;Q4VXV2;Q4VXM1B7ZM99;A0A087WVM4;Monofunctional C1-tetrahydrofolate synthase, mitochondrialMTHFD1L 36 35 979 0 199.46 0.96227 0.9951 6.92E+09
Q5T4S7-3;Q5T4S7;Q5T4S7-2;Q5T4S7-4;Q5T4S7-5;A0A0A0MSW0;X6R960;X6RE05;Q5TBN9;Q5T4S7-6Q5T4S7-3;Q5T4S7;Q5T4S7-2;Q5T4S7-4E3 ubiquitin-protein ligase UBR4UBR4 88 88 5159 0 323.31 0.96175 1.0438 1.06E+10
B5MC22;Q9UDX5;H7C417;F8WEN7;Q9UDX5-2B5MC22;Q9UDX5;H7C417Mitochondrial fission process protein 1MTFP1 3 3 143 0 16.757 0.96168 1.323 3.59E+08
B8ZZW5;Q8NBF6-2;Q8NBF6;H7C0I1B8ZZW5;Q8NBF6-2;Q8NBF6Late secretory pathway protein AVL9 homologAVL9 4 4 630 0 15.141 0.96162 NaN 1.16E+08
Q15084-3;Q15084;Q15084-4;Q15084-5;Q15084-2Q15084-3;Q15084;Q15084-4;Q15084-5;Q15084-2Protein disulfide-isomerase A6PDIA6 17 17 437 0 219.3 0.96099 1.0217 1.40E+10
P45954;P45954-2P45954;P45954-2Short/branched chain specific acyl-CoA dehydrogenase, mitochondrialACADSB 9 9 432 0 72.771 0.96095 0.80762 1.79E+09
D6RGK9;H0Y9C1;H0Y9Z5;Q96LI5;Q96LI5-2D6RGK9;H0Y9C1;H0Y9Z5;Q96LI5;Q96LI5-2CCR4 NOT transcription complex subunit 6-likeCNOT6L 3 1 163 0 9.2514 0.96074 NaN 9.40E+07
P56537;P56537-2;B7ZBH1;A0A0U1RQV5P56537;P56537-2Eukaryotic translation initiation factor 6EIF6 5 5 245 0 167.52 0.96073 0.93516 2.14E+09
Q9H0A0;Q9H0A0-2;A0A087WV29;E9PMU0;E9PJN6Q9H0A0;Q9H0A0-2;A0A 87WV29N-acetyltransferase 10NAT10 32 32 1025 0 210.74 0.96073 1.3838 3.84E+09
P62851 P62851 40S ribosomal protein S25RPS25 6 6 125 0 36.295 0.96068 1.2576 5.92E+09
P43686;P43686-2P43686;P43686-226S protease regulatory subunit 6BPSMC4 37 37 418 0 323.31 0.96024 0.85529 2.55E+10
P08670;B0YJC4;B0YJC5;Q5JVS8;H7C5W5;P41219;P17661;P41219-2;P14136-3;P14136;P14136-2;K7EKH6;F8W835P08670;B0YJC4 Vimentin VIM 55 51 466 0 323.31 0.96008 2.0121 5.57E+10
Q07666-2;Q07666;Q07666-3;O75525-2;O75525;Q5VWX1;E5RG12;H0YAQ1;H0YAQ3;E5RJZ9Q07666-2;Q07666;Q07666-3KH domain-containing, RNA-binding, signal transduction-associated protein 1KHDRBS1 7 7 418 0 35.272 0.9596 NaN 2.60E+08
P55036;H0Y3Y9 P55036 26S proteasome non-ATPase regulatory subunit 4PSMD4 14 2 377 0 182.42 0.9594 0.8258 4.78E+09
Q8N201;H7C582 Q8N201 Integrator complex subunit 1INTS1 16 16 2190 0 61.14 0.95935 1.1253 9.00E+08
Q8TC12;Q8TC12-2;G3V2G6;H0YIZ8;G3V234;H0YJ46;H0YJ10;Q8TC12-3Q8TC12;Q8TC12-2;G3V2G6;H0YIZ8;G3V234;H0YJ46Retinol dehydrogenase 11RDH 1 11 11 318 0 92.914 0.95931 1.0528 2.97E+09
P31040;P31040-2;D6RFM5;A0A087X1I3;P31040-3;H0Y8X1P31040;P31040-2;D6RFM5;A0A087X1I3;P31040-3Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrialSDHA 17 17 664 0 154.66 0.9593 NaN 1.27E+09
O94906;O94906-2O94906;O94906-2Pre-mRNA-processing factor 6PRPF6 38 38 941 0 221.14 0.95925 0.89814 2.90E+09
O14874-2;O14874-3;O14874;H3BUV3;H3BTL2;H3BS02O1487 -2;O14874- O14874[3-methyl- -oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrialBCKDK 3 3 335 0 11.928 0.95916 1.4106 2.77E+08
P43487-2;P43487;F6WQW2;C9JXG8;C9JJ34;C9JGV6;C9JDM3;C9JIC6P43487-2;P43487;F6WQW2;C9JXG8;C9JJ34;C9JGV6Ran-specific GTPase-activating proteinRANBP1 10 10 200 0 139.17 0.95902 0.89296 1.52E+10
Q9Y230;Q9Y230-2;M0R0Y3;X6R2L4;M0QXI6;M0R0Z0;M0QXZ7Q9Y230;Q9Y230-2; 0R0Y3RuvB-like 2 RUVBL2 35 35 463 0 323.31 0.95836 0.99734 3.18E+10
Q9Y512 Q9Y512 Sorting and assembly machinery component 50 homologSAMM50 16 16 469 0 126.77 0.95732 0.956 1.64E+09
Q96ME1-2;Q96ME1-4;Q96ME1;H0Y6I6;Q96ME1-3Q96ME1-2;Q96ME1-4;Q96 E1;H0Y6I6;Q96ME1-3F-box/LRR-repeat protein 18FBXL18 8 8 668 0 70.457 0.95726 NaN 4.92E+08
J3KS15;Q14197;J3QRF8J3KS15;Q14197 Peptidyl-tRNA hydrolase ICT1, mitochondrialICT1 3 3 192 0 36.658 0.95712 1.2855 3.64E+08
Q6NVU6 Q6NVU6 Inactive Ufm1-specific protease 1UFSP1 2 2 142 0 8.6656 0.95694 0.81182 1.13E+08
P21397-2;P21397;P27338-2;P27338P21397-2;P21397;P27338-2;P27338Amine oxidase [flavin-containing] A;Amine oxidase [flavin-containing] BMAOA;MAOB 2 2 394 0 5.9424 0.95692 NaN 7.79E+06
P84085;C9J1Z8;F5H1V1;F5H6T5;F8WDB3P84085;C9J1Z8 ADP-ribosylation factor 5ARF5 11 7 180 0 64.805 0.95683 0.90919 3.74E+08
Q9NRF8;H0Y5S6 Q9NRF8 CTP synthase 2 CTPS2 22 18 586 0 138.03 0.95654 NaN 2.19E+09
O95573;F5GWH2;C9JC11;F5H062O95573 Long-chain-fatty-acid--CoA ligase 3ACSL3 21 19 720 0 129.82 0.95634 0.98825 4.46E+09
P51587 P51587 Breast cancer type 2 susceptibility proteinBRCA2 6 6 3418 0 27.666 0.9559 0.91399 1.08E+08
Q9UNX3;E5RIT6;E5RHH1Q9UNX3;E5RIT6 60S ribosomal protein L26-like 1RPL26L1 13 2 145 0 4.665 0.95585 NaN 6.50E+06
Q9UJX2;Q9UJX2-3;D6RBY8;D6RCF8;H0Y936;Q9UJX2-2Q9UJX2;Q9UJX2-3Cell division cycle protein 23 homologCDC23 8 8 597 0 38.311 0.95527 NaN 2.65E+08
Q6PML9;D6R9M6Q6PML9 Zinc transporter 9SLC30A9 8 8 568 0 67.167 0.95522 1.0866 6.40E+08
Q12769;G3V198;E9PR16;Q12769-3;Q12769-2;E9PSI3Q12769;G3V198;E9PR16Nuclear pore complex protein Nup160NUP160 38 38 1436 0 323.31 0.95521 0.97743 6.27E+09
A5YKK6-2;A5YKK6;A5YKK6-3;A5YKK6-4;H3BMZ2;B5MDN3;H3BVC9;H3BNB1;H3BR89;H3BT18;H3BU44;H3BMH0A5YKK6-2;A5YKK6;A5YKK6-3CCR4-NOT transcription complex subunit 1C OT1 44 44 2371 0 279.39 0.95518 1.0292 4.95E+09
O43707;O43707-2;F5GXS2;O43707-3;H7C144;K7EJH8;K7EP19;M0QZQ3;C9JY79;Q9H254-2;Q9H254-4;Q9H254O43707;O43707-2Alpha-actinin-4 ACTN4 50 37 911 0 323.31 0.9551 1.4173 1.98E+10
Q99615;Q99615-2;K7ESP1;K7EIH8;K7EPP7;K7EJL5;K7EN19;K7EJV7;K7ER44;K7ELJ8;K7EJ24;K7EJE9;K7EK03Q99615;Q99615-2;K7ESP1;K7EIH8;K7EPP7DnaJ homolog subfamily C member 7D AJC 18 18 494 0 100.42 0.95492 NaN 3.69E+08
P49593;P49593-2;B5MCT7;A8MX49;C9J2F3;C9JL74P49593;P49593-2;B5MCT7;A8MX49Protein phosphatase 1FPPM1F 19 19 454 0 323.31 0.95458 0.90632 7.40E+09
A0A087X0W7;A0A087WT95;Q86TX2;P49753;G3V4F2;P49753-20A087X0W7;A0A087WT95;Q86TX2;P49753;G3V4F2;P49753-2cyl-coenzyme A thioesterase 1;Acyl-coenzyme A thioesterase 2, mitochondrialACOT1;ACOT2 16 16 421 0 127.64 0.95408 0.96032 1.89E+09
Q9H9T3-2;Q9H9T3;B4DKA4;Q9H9T3-4;Q9H9T3-5;E5RHR2;E5RHY2;E5RIC0;E5RIZ7;H0YAP7Q9H9T3-2; ;B4DKA4;Q9H9T3-4;Q9H9T3-5Elongator complex protein 3ELP3 13 13 533 0 54.557 0.95402 NaN 6.12E+08
P54619-2;P54619;P54619-3;F8VYY9;H0YIC9;H0YHF8;F8VZX1;F8VPF5;F8VVA3;F8VSL2;F8VSH3;F8VRY2;E9PGP6;Q9UGJ0-2;Q9UGJ0-3;Q9UGJ0P54619-2;P54619;P5461 -3;F8VYY9;H0YIC9;H0YHF85-AMP-activated protein kinase subunit gamma-1PRKAG 11 11 299 93.222 0.9536 0.98376 8.55E+08
P61009 P61009 Signal peptidase complex subunit 3SPCS3 4 4 180 0 20.712 0.95352 0.93905 8.41E+08
Q14181;Q14181-2;H0YDR7;E9PIQ6Q14181;Q14181-2DNA polymerase alpha subunit BPOLA2 9 9 598 0 43.681 0.95343 NaN 6.42E+08
F5H0C4;Q9BRP4-2;Q9BRP4;F5H103;F5H3I1;Q9BRP4-3;F5H3E9;H0YGB1;F5H0F7F5H0C4;Q9BRP4-2;Q9BRP4;F5H103;F5H3I1;Q9BRP4-3Proteasomal ATPase-associated factor 1PAAF1 5 3 393 0 13.946 0.95328 0.72794 2.40E+08
C9JBG0;A8MYQ9;Q9BZG1-2;Q9BZG1;Q96PJ7;C9JY26;E7ES60;Q9BZG1-4;K7EIF2;J3QLC6;H7C0Y7;V9GY61;K7EJW7C JB 0;A8MYQ9;Q9BZG1-2;Q9BZG1;Q9 PJ7;C9JY26;E7ES60;Q9BZG1-4;K7EIF2;J3QLC6;H7C0Y7Ras-related protein Rab-34RAB34 4 4 211 0 12.139 0.95293 0.91462 2.31E+08
P62875 P62875 DNA-directed RNA polymerases I, II, and III subunit RPABC5POLR2L 2 2 67 0 8.7562 0.95281 0.91764 5.52E+08
P30566;A0A0A6YY92;P30566-2;A0A096LNY6;A0A096LNY5;A0A096LPA2;A0A096LNY4;A0A096LP92;B4DEP1;A0A096LP72;A0A096LNT4;V9GY96P30566;A0A0A6YY92;P30566-2;A0A096LNY6denylosuccinate lyaseDSL 26 23 484 0 323.31 0.95278 0.86776 1.95E+10
P51149;C9J8S3;C9J592;C9IZZ0;C9J4V0;C9J4S4;C9J7D1P51149;C9J8S3;C9J592;C9IZZ0;C9J4V0;C9J4S4Ras-related protein Rab-7aRAB7A 10 10 207 0 107.49 0.95223 1.0171 1.53E+09
Q06587;Q06587-2Q06587;Q06587-2E3 ubiquitin-protein ligase RING1RING1 7 6 406 0 136.46 0.95221 1.0028 9.79E+08
Q9BQA1;Q9BQA1-2;H0Y711Q9BQA1;Q9BQA1-2;H0Y711Methylosome protein 50WDR77 7 7 342 0 41.602 0.95147 1.1784 1.55E+09
Q9HD33-2;Q9HD33;Q9HD33-3Q9HD33-2;Q9HD33;Q9HD33-339S ribosomal protein L47, mitochondrialMRP 6 6 230 0 11.588 0.95138 0.96756 1.55E+08
O96008;O96008-2;K7EJ57;K7EKG4O96008;O96008-2;K7EJ57Mitochondrial import receptor subunit TOM40 homologTOMM40 12 12 361 0 323.31 0.95134 1.1623 4.82E+09
P35606-2;P35606;D6RBT6;H0Y938;D6R997;D6RBZ7;D6RCL6;D6RBG7;H0YAC7P35606-2;P35606Coatomer subunit betaCOPB2 42 42 877 0 323.31 0.95123 0.96389 1.24E+10
P35611;P35611-3;E7EV99;E7ENY0;P35611-2;P35611-6;P35611-4;A0A0A0MSR2;P35611-5;H0Y9H2;D6RF25;D6RJE2;H0YFD8;D6RAH3;H0YG19P35611;P35611-3;E7EV99;E7ENY0;P35611-2;P35611-6;P35611-4;A0A0A0MSR2;P35611-5;H0Y9H2Alpha-adducin ADD1 18 16 737 0 125 0.9511 0.99245 2.45E+09
O00505;H0Y4S9 O00505 Importin subunit alpha-4KPNA3 17 10 521 0 113.99 0.95095 NaN 2.23E+09
G5EA19;U3KQS5;E5RG17;Q6P1N9;E5RH86;E5RI69;E5RID7;E5RJY6;H0YBX2G5EA19;U3KQS5; G17;Q6P1N9;E5RH86;E5RI69;E5RID7;E5RJY6;H0YBX2Putative deoxyribonuclease TATDN1TATDN1 2 2 207 0 3.9711 0.95046 0.58409 6.21E+07
K7EMM8;Q49A26-5;Q49A26-2;Q49A26-3;Q49A26;Q49A26-4;K7EQB2K7EMM8;Q49A26-5;Q49A26-2;Q49A26-3;Q49A26;Q49A26-4Putative oxidoreductase GLYR1GLYR1 9 9 524 0 64.541 0.95036 NaN 4.02E+08
F5H8D7;P18887;M0QYS5;M0QZ96;M0R0D2;M0R1U8F5H8D7;P18887 DNA repair protein XRCC1FOXH1;XRCC1 10 10 602 0 23.846 0.95025 0.6618 6.04E+08
O75691 O75691 Small subunit processome component 20 homologUTP20 30 30 2785 0 197.93 0.94974 1.1505 1.89E+09
Q9Y3D0;J3KS95;H3BNV7;J3QLT9Q9Y3D0;J3KS95 Mitotic spindle-associated MMXD complex subunit MIP18FAM96B 8 8 163 0 129.77 0.94933 0.96906 1.51E+09
Q9P258 Q9P258 Protein RCC2 RCC2 6 6 522 0 35.979 0.9489 NaN 1.19E+08
Q9Y4B6-2;Q9Y4B6;Q9Y4B6-3Q9Y4B6-2;Q9Y4B6;Q9Y4B6-3Protein VPRBP VPRBP 19 19 1506 0 83.358 0.9484 1.0286 6.43E+08
O95433;O95433-2;H0YJG7;G3V438;H0YJU2;G3V3W9;H0YJ63O95433;O9543 -2;H0YJG7;G3V438Activator of 90 kDa heat shock protein ATPase homolog 1A SA1 19 19 338 0 323.31 0.94831 0.85825 1.34E+10
Q8IYU2-2;Q8IYU2-3;Q8IYU2;H0YAU8;Q8IYU2-4Q8IYU2-2;Q8I U2-3;Q8IYU2;H0YAU8;Q8IYU2-4E3 ubiquitin-protein ligase HACE1HACE1 2 2 318 0 4.6238 0.94796 NaN 7.52E+07
Q8N4C6-10;Q8N4C6-7;H0YDJ4;H9KV85;E9PN67;C9J066;Q8N4C6-4;Q8N4C6-9;Q8N4C6-2;Q8N4C6;Q8N4C6-5Q8N4C6-10;Q8N4C6-7;H0YDJ4;H9KV85;E9PN67;C9J066;Q8N4C6-4;Q8N4C6-9;Q8N4C6-2;Q8N4C6;Q8N4C6-5Ninein NIN 2 2 2116 0.0027961 2.6934 0.94792 NaN 3.37E+08
O14980;C9JKM9;C9J673;C9IZS4;C9JQ02;C9JV99;F8WF71;C9IYM2;H7BZC5;C9JF49O14980 Exportin-1 XPO1 36 36 1071 0 323.31 0.94785 1.0979 1.42E+10
P38919;I3L3H2 P38919 Eukaryotic initiation factor 4A-III;Eukaryotic initiation factor 4A-III, N-terminally processedEIF4A3 31 25 411 0 174.46 0.94727 1.1031 2.12E+10
Q96D53-2;Q96D53;M0R001;M0R011Q96D53-2;Q96D53;M0R001;M0R011AarF domain-containing protein kinase 4ADCK4 4 4 503 0 46.373 0.94717 0.87945 4.15E+08
P19388;A0A087WVZ9;A0A0A0MQR7;A0A087WWX0;A0A087WVN5;K7EQN2;K7EJ87P19388;A0A087WVZ9; 0A0A0MQR7; 0A087WWX0DNA-directed RNA polymerases I, II, and III subunit RPABC1POLR2E 8 8 210 0 69.908 0.94661 0.98358 9.91E+08
A0A087WYR0;P09132;D6RBG4;A0A087WWU9;P09132-2A0A087WYR0;P 9132Signal recognition particle 19 kDa proteinSRP19 3 3 120 0 11.609 0.94652 0.77496 2.25E+08
O94763-2;O94763-3;O94763O94763-2;O94763-3;O94763Unconventional prefoldin RPB5 interactor 1URI1 1 1 459 0.001821 3.0489 0.94603 NaN 9.37E+06
P11586;F5H2F4;V9GYY3P11586;F5H2F4 C-1-tetrahydrofolate synthase, cytoplasmic;Methylenetetrahydrofolate dehydrogenase;Methenyltetrahydrofolate cyclohydrolase;Formyltetrahydrofolate synthetase;C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processedMTHFD1 62 61 935 0 323.31 0.9459 1.0422 4.57E+10
F2Z2W7;Q8IZ69-2;Q8IZ69;H7C100F2Z2W7 Q8IZ69-2;Q8IZ69tRNA (uracil-5-)-methyltransferase homolog ATRMT2A 6 6 643 0 23.662 0.94586 NaN 1.34E+08
O94925;B7Z509;C9JIJ6;H7C201O94925 Glutaminase kidney isoform, mitochondrialGLS 19 4 669 0 209.91 0.94557 2.1146 1.74E+09
Q9NU22;Q5T795;M0QXR3;REV__P21359-3;REV__P21359-5;REV__P21359-4;REV__J3KSB5;REV__P21359-2;REV__P21359-6;REV__P21359Q9NU22 Midasin MDN1 90 0 596 0 323.31 0.94521 1.0374 7.75E+09
Q9NWX5;F6TX30;Q9NWX5-2;F6TX30 Ankyrin repeat and SOCS box protein 6A B6 5 5 421 0 18.923 0.94474 0.84573 4.48E+08
Q9UN37;I3L4J1 Q9UN37;I3L4J1 Vacuolar protein sorting-associated protein 4AVPS4A 15 8 437 0 74.496 0.9446 1.0161 2.91E+09
I3L2W9;I3L2N2;O14641;I3L0M7;C9K0P9;I3L0Z8;Q92997-2;Q92997I3L2W9;I3L2N2;O14641;I3L0M7Segment polarity protein dishevelled homolog DVL-2DVL2 3 3 363 0 10.522 0.94455 NaN 2.00E+08
Q6UVY6-2;Q6UVY6Q6UVY6-2;Q6UVY6DBH-like monooxygenase protein 1MOXD1 2 2 545 0.0037936 2.6027 0.94448 NaN 3.34E+07
180
Q92538-3;Q92538-2;Q92538Q92538-3;Q92538-2;Q92538Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1GBF1 27 27 1855 0 201.56 0.94401 1.0861 1.72E+09
Q9Y221;Q9Y221-2;J3QRD6;J3QRR4;J3QLW7Q9Y221;Q9Y221-260S ribosome subunit biogenesis protein NIP7 homologNIP7 5 5 180 0 47.434 0.94368 1.6511 1.07E+09
Q8N2F6-4;Q8N2F6-3;Q8N2F6-2;Q8N2F6;H7BXQ8;Q8N2F6-6;Q8N2F6-5;A0A0J9YWR7;A0A0J9YXE4;C9J5N7Q8N2F6-4;Q8N2F6-3;Q8N2F6-2 ;H7BXQ8;Q8N2F6-6;Q8N2F6-5Armadillo repeat-containing protein 10ARMC10 3 3 249 0 16.724 0.9436 NaN 5.17E+07
H7BZN3;Q5UIP0-2;Q5UIP0H7BZN3;Q5UIP0-2;Q5UIP0Telomere-associated protein RIF1RIF1 2 2 845 0 9.1708 0.94309 0.62166 7.17E+07
Q15054;Q15054-2;Q15054-3;E9PM91;E9PNC0;E9PRK3;H0YEX7Q15054;Q15054-2;Q15054-3DNA polymerase delta subunit 3POLD3 8 8 466 0 75.45 0.9429 NaN 4.47E+08
Q9Y2L5;J3QQJ5;Q9Y2L5-2;J3KSL8;J3QSA1;J3QR00;J3QQS5Q9Y2L5;J3QQJ5 Q9Y2L5-2;J3KSL8;J3 A1Trafficking protein particle complex subunit 8TRAPPC8 37 37 1435 0 323.31 0.94225 0.86801 2.34E+09
H0Y630;B4DR80;Q9Y6E0-2;Q9Y6E0;Q5JV98;Q5JV99H0Y630;B4DR80;Q9Y6E0-2;Q9Y6E0Serine/threonine-protein kinase 24;Serine/threonine-protein kinase 24 36 kDa subunit;Serine/threonine-protein kinase 24 12 kDa subunitSTK24 7 1 369 0 15.256 0.94217 1.8173 1.14E+08
P60604;P60604-2;F8WCB9;F8WDB1P60604;P60604-2Ubiquitin-conjugating enzyme E2 G2UBE2G2 3 3 165 0 70.15 0.94205 0.94125 4.62E+08
Q8IVW6-4;Q8IVW6;H3BQ92;K7EJ04;Q8IVW6-3;Q99856Q8IVW6-4;Q8IVW6;H3BQ92;K7EJ04;Q8IVW6-3;Q99856AT-rich interactive domain-containing protein 3B;AT-rich interactive domain-containing protein 3AARID3B;ARID3A 2 2 560 0 5.3569 0.94186 NaN 5.47E+07
O14976-2;O14976;A0A087X1U9;D6RF16;D6RAQ7;D6RE78;D6RAW3;H0Y8H5O14976-2;O1497 Cyclin-G-associated kinaseGAK 9 9 1232 0 168.89 0.94144 1.6298 5.23E+08
O60264 O60264 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5SMARCA5 50 35 1052 0 310.38 0.94131 1.2191 7.78E+09
Q9H0S4;Q9H0S4-2;F5H1N9Q9H0S4;Q9H0S4-2Probable ATP-dependent RNA helicase DDX47DDX47 17 17 455 0 170.24 0.94129 1.0121 3.33E+09
P10155-3;P10155-5;P10155-4;P10155;P10155-2;H0Y9N5;D6RDN1;D6RE09;G5E9R9P10155-3;P10155- ;P1015 -4;P1 155;P10155-260 kDa SS-A/Ro ribonucleoproteinTROVE2 15 15 518 0 187.31 0.94118 1.8148 2.60E+09
J9JID7;Q03252 J9JID7;Q03252 Lamin-B2 LMNB2 15 11 620 0 33.623 0.94113 1.3585 5.10E+08
H7BXI1;A0FGR8-2;A0A087WXU3;A0FGR8;A0FGR8-6;A0FGR8-4;A0FGR8-5H7BXI1;A0FGR8-2;A0A087WXU3;A0FGR8;A0FGR8-6;A0FGR8-4Extended synaptotagmin-2ESYT2 17 17 884 0 141.61 0.94111 0.93773 2.19E+09
P24390-2;P24390;M0R1Y2;P33947-2;P33947P24390- ; 24390;M0R1Y2;P33947-2;P33947ER lumen protein-retaining receptor 1;ER lumen protein-retaining receptor;ER lumen protein-retaining receptor 2KDELR1;KDELR2 3 3 150 0 12.936 0.94109 0.5281 1.28E+08
O43175;Q5SZU1 O43175;Q5SZU1 D-3-phosphoglycerate dehydrogenasePHGDH 27 27 533 0 323.31 0.9408 1.0734 6.82E+10
O75843;H0YJ08;G3V2V9;G3V3Z2;H0YJ47;G3V532O75843 AP-1 complex subunit gamma-like 2AP1G2 7 7 785 0 21.476 0.94074 0.82062 7.59E+08
O75643;O75643-2;B4E0P5O75643 U5 small nuclear ribonucleoprotein 200 kDa helicaseSNRNP200 104 103 2136 0 323.31 0.9407 1.1291 2.63E+10
Q6SZW1;Q6SZW1-2;J3KSG7;J3QRE0;J3KRZ6Q6SZW1;Q6SZW1-2Sterile alpha and TIR motif-containing protein 1SARM1 12 12 724 0 54.041 0.94007 NaN 5.51E+08
Q16658;C9JFC0;A0A0A0MSB2;C9JPH9Q16658 Fascin FSCN1 22 22 493 0 181.37 0.94002 0.71961 6.20E+09
Q08945;E9PMD4;A0A0U1RRK2;E9PPZ7Q 8945 FACT complex subunit SSRP1SSRP1 33 33 709 0 323.31 0.93992 0.97781 1.94E+10
O00148;O00148-2;K7EQN7;O00148-3;K7EPJ3;K7EN69;K7ENP6;K7EL56;K7EIL8;F6SXL5O00148;O00148-2;K7EQN7;O00148-3ATP-dependent RNA helicase DDX39ADDX39A 25 6 427 0 189.81 0.93984 1.0471 4.45E+09
Q9BQ67;M0QX71Q9BQ67 Glutamate-rich WD repeat-containing protein 1GRWD1 15 15 446 0 158.48 0.93977 0.97553 1.46E+10
D6RH30;P19838;P19838-2;D6RC45D6RH30;P19838;P19838-2Nuclear factor NF-kappa-B p105 subunit;Nuclear factor NF-kappa-B p50 subunitNFKB1 3 3 198 0 21.542 0.93951 1.0628 1.38E+08
Q9BUE0 Q9BUE0 Mediator of RNA polymerase II transcription subunit 18MED18 2 2 208 0 6.2263 0.93932 NaN 5.70E+07
Q8WVC2;P63220;Q9BYK1;Q9BYK28WVC2;P63220;Q9BYK140S ribosomal protein S21RPS21 5 5 81 0 68.346 0.93925 1.1915 8.50E+08
Q01167-2;Q01167;A0A087WXM0;I3L4U8;Q01167-3Q01167-2;Q01167;A0A087WXM0Forkhead box protein K2FOX 3 3 614 0 32.988 0.93917 0.9471 1.52E+08
P68371;M0R2D3;A6NNZ2;M0R2T4;A0A075B724P 8371 Tubulin beta-4B chainTUBB4B 36 1 445 0 323.31 0.93915 1.0972 3.92E+11
Q9UFC0;H7C5S6;F8WDB4;H7C5N7Q9UFC0; S6 Leucine-rich repeat and WD repeat-containing protein 1LRWD1 11 11 647 0 149.62 0.93909 NaN 1.05E+09
P82663;E7EPW2;P82663-2;P82663-3;E7EPW2;P82663-2;P82663-32 S ribosomal protein S25, mitochondrialMRP 9 9 173 0 36.067 0.93903 1.1335 6.79E+08
P17655;P17655-2P17655;P17655-2Calpain-2 catalytic subunitCAPN2 16 16 700 0 122.48 0.93861 0.96021 1.43E+09
O43143 O43143 Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15DHX15 35 34 795 0 219.44 0.93853 1.1743 1.18E+10
P22102;P22102-2;F8WD69;C9JBJ1;C9JTV6;C9JZG2;C9JKQ7;A0A140TA71;H7C366P22102;P22102-2Trifunctional purine biosynthetic protein adenosine-3;Phosphoribosylamine--glycine ligase;Phosphoribosylformylglycinamidine cyclo-ligase;Phosphoribosylglycinamide formyltransferaseGART 54 54 1010 0 323.31 0.93823 0.97018 3.68E+10
P30085;Q5T0D2;P30085-2P30085;Q5T0D2;P30085-2UMP-CMP kinase CMPK1 7 7 196 0 79.475 0.93816 0.96325 5.41E+08
Q96SK2-3;Q96SK2;Q96SK2-2;Q96SK2-4;C9JYX1;C9J5K4Q96SK2-3;Q96SK2;Q96SK2-2Transmembrane protein 209TMEM209 7 7 519 0 62.834 0.93801 NaN 4.56E+08
P56385 P56385 ATP synthase subunit e, mitochondrialATP5I 4 4 69 0 14.231 0.93762 1.9119 7.32E+08
Q00839-2;Q5RI18Q00839-2 Heterogeneous nuclear ribonucleoprotein UHNRNPU 38 1 806 0 323.31 0.93715 1.3922 4.72E+10
Q5JRX3;Q5JRX3-2;Q5JRX3-3;A0A0A0MRX9;H0Y4F7;B1APQ0;H0Y7L7;B1APQ1Q5JRX3;Q5JRX3-2;Q5JRX3-3;A0A0A0MRX9Presequence protease, mitochondrialPIT M1 37 37 1037 0 323.31 0.93709 0.99797 7.24E+09
Q99956;F8VW29;Q16828-2;Q16829-2;Q16828;Q1682999956 Dual specificity protein phosphatase 9DUSP9 7 7 384 0 39.999 0.93691 0.94876 5.18E+08
P08237;P08237-3;P08237-2;F8VNX2;F8VZQ1;F8VX13;F8VP00;F8VSL1;F8VW30;F8VZI0;F8W1J8;F8VSF7;F8VUB8;F8VTQ3;F8VYK8;F8VVE3;H0YHB8;H0YIS9P08237;P08237-3;P0 237-2ATP-dependent 6-phosphofructokinase, muscle typeP KM 30 26 780 0 323.31 0.93619 1.002 1.02E+10
Q13188;Q13188-2;A0A087WZ06;E5RFQ9;E5RIM6;Q8NBU1Q1318 ;Q13188-2;A0A087WZ06;E5RFQ9Serine/threonine-protein kinase 3;Serine/threonine-protein kinase 3 36kDa subunit;Serine/threonine-protein kinase 3 20kDa subunitSTK3 4 3 491 0 18.313 0.93604 NaN 1.21E+08
A0A087WZ13;E9PAU2;Q8IY67-2;Q8IY67;K7EKR9;Q8IY67-3;K7EQG20A087WZ13;E9PAU2 Q8IY67-2;Q8IY67Ribonucleoprotein PTB-binding 1RAVER1 15 15 739 0 163.45 0.93588 0.70076 2.35E+09
Q9NV88-3;Q9NV88-2;Q9NV88;G3XAN1;H0YBK3;E5RK47;E5RG70Q9NV88-3;Q9NV88-2;Q9NV88;G3XAN1Integrator complex subunit 9I TS9 5 5 634 0 20.282 0.93546 NaN 2.89E+08
J3KN66;Q5JTV8-3;Q5JTV8;A0A0A0MSK5;Q5JTV8-2;H0YD16;H0Y4R4J3KN66;Q5JTV8-3;Q5JTV8;A0A0A0MSK5;Q5JTV8-2Torsin-1A-interacting protein 1TOR1AIP1 8 8 599 0 78.242 0.93535 0.87686 5.74E+08
Q96IU4;B4DQI4;F8W9U3;Q96IU4-2Q96I 4 B4DQI ;F8W9U3Alpha/beta hydrolase domain-containing protein 14BABHD14B 9 9 210 0 111.96 0.93535 0.88456 3.77E+09
Q7Z3U7-2;Q7Z3U7-6;Q7Z3U7-5;Q7Z3U7;F8VZV1;Q7Z3U7-3;F8VZV6;F8VQS2Q7Z3U7-2;Q7Z3U7-6;Q7Z3U7-5;Q7Z3U7Protein MON2 homologMON2 12 12 1675 0 39.945 0.93534 0.99394 8.10E+08
Q9Y5Q8;Q9Y5Q8-3;Q5T7U1;Q9Y5Q8-2;Q5T7U0;Q5T7U4;H7BY84;H0Y5D2Q9Y5Q8;Q9Y5Q8-3;Q5T7U1;Q9Y5Q8-2General transcription factor 3C polypeptide 5GTF3C5 13 13 519 0 65.651 0.93505 NaN 1.50E+09
C9JXC3;C9JNE2;Q9Y530;H7C5Q1;C9J5P1;C9JA90;C9IZY1C9JXC3;C9JNE2;Q9Y530;H7C5Q1;C9J5P1O-acetyl-ADP-ribose deacetylase 1OARD1 6 6 113 0 21.594 0.93502 0.99167 3.99E+08
Q9NX46 Q9NX46 Poly(ADP-ribose) glycohydrolase ARH3ADPRHL2 4 4 363 0 15.487 0.93451 0.80496 3.70E+08
Q6NSI4;Q6NSI4-4;B1AQ74;Q6NSI4-3;Q6NSI4-2Q6NSI4;Q6NSI4-4 Uncharacterized protein CXorf57CXorf57 4 4 855 0 24.942 0.93392 1.1982 2.03E+08
Q9UHI6;E9PJ60;Q9UHI6-2Q9UHI6 Probable ATP-dependent RNA helicase DDX20DDX20 23 23 824 0 237.53 0.93374 1.1887 3.54E+09
P16615;P16615-5;P16615-2;P16615-3;P16615-4;H7C5W9;O14983-2;O14983;O14983-3;Q93084-4;Q93084-2;Q93084-3;Q93084-7;Q93084;Q93084-6;Q93084-5;J3QSY6;H3BVB2;A0A0C4DH86;H3BTW4P16 15;P16615-5;P16615-2;P16615-3;P16615-4;H7C5W9Sarcoplasmic/endoplasmic reticulum calcium ATPase 2ATP2A2 41 41 1042 0 323. 1 0.93337 1.049 2.58E+10
Q9UDW1;Q9NZY4;Q9UDW1-2Q9UDW1;Q9NZY4;Q9UDW1-2Cytochrome b-c1 complex subunit 9UQCR10 3 3 63 0 10.717 0.93322 0.89658 6.87E+08
Q6DKI1;R4GMU7;Q6DKI1-2I ;R4GMU7;Q6DKI1-260S ribosomal protein L7-like 1RPL7 1 8 8 246 0 34.303 0.93315 1.5444 2.65E+09
O95671-2;O95671;O95671-3O95671-2;O95671;O95671-3N-acetylserotonin O-methyltransferase-like proteinASMTL 4 4 605 0 28.357 0.93313 NaN 2.07E+08
Q05397-7;Q05397;Q05397-5;H0YBP1;E7ESA6;E9PEI4;H0YB16;H0YBZ1;Q05397-2;E5RHD8;E5RGA6;B4DWJ1;Q05397-6;E5RIK4;E5RG54;E5RH48;E5RH01;E5RG66;E5RI03;E5RI72;E5RFW9;E5RJP0;E5RH08;E5RG86;E5RJI4;H0YB99;Q05397-4;Q05397-3Q05397- ;Q05397;Q05397-5;H0YBP1;E7ESA6;E9PEI4;H0YB16;H0YBZ1;Q0 397-2Focal adhesion kinase 1TK2 9 9 1006 0 72.157 0.93296 0.97019 9.07E+08
I3L2C7;P57678;I3L399;I3L4A4;I3L4M4;E7EN12;I3L1J7I3L2C7;P57678 Gem-associated protein 4GEMIN4 23 23 1047 0 182.07 0.93293 1.0393 3.83E+09
Q13155;A8MU58;F8W950;F8WCL2Q13155;A8MU58;F8W950Aminoacyl tRNA synthase complex-interacting multifunctional protein 2AIMP2 13 13 320 0 267.46 0.93286 0.92125 6.30E+09
Q9NWT1 Q9NWT1 p21-activated protein kinase-interacting protein 1PAK1IP1 4 4 392 0 9.3944 0.93275 1.059 1.98E+08
Q9Y2H2;Q9Y2H2-2;Q9Y2H2-4Q9Y2H2 Phosphatidylinositide phosphatase SAC2INPP5F 3 3 1132 0 7.1 0.93252 0.81349 1.19E+08
O75746;O75746-2;F8W9J0;H0YFB2;B4DGK6O75746;O75746-2Calcium-binding mitochondrial carrier protein Aralar1SLC25A12 22 15 678 0 125.88 0.93228 NaN 2.12E+09
A0A0A6YYL4;P57737-3;P57737-4;P57737;P57737-2;I3L167;E7EP81;I3L1U7;I3L0X9;I3L3T0;I3L212;Q9Y3D7;I3L0X8;I3L442;I3L426A0A0A6YYL4;P57737- ;P57 37-4;P57737;P57737-2Coronin- CORO 15 15 10 8 0 171.26 0.93224 0.85504 1.57E+09
A0A087WVQ6;Q00610-2;Q00610;J3KS13;K7EJJ5;J3KRF5;J3KSQ2;J3QL20;A0A087WV74;A0A087WXH4;F5H5N6A0A 87WVQ6;Q00610-2;Q00610Clathrin heavy chain 1CLTC 10 83 1679 0 323.31 0.93221 1.0388 1.45E+11
Q14974;Q14974-2;J3KTM9;J3QR48;J3QKQ5;J3QRG4Q14974;Q1497 -2;J3KTM9Importin subunit beta-1KPNB1 35 35 876 0 323.31 0.9321 1.1218 2.74E+10
Q9UJX3-2;Q9UJX3;H0YIW2;H0YIX7Q9UJX3-2;Q9UJX3Anaphase-promoting complex subunit 7ANAPC7 8 8 537 0 59.628 0.93191 NaN 3.49E+08
Q5SRN1;O60508 Q5SRN1;O60508 Pre-mRNA-processing factor 17CDC40 4 4 539 0 35.123 0.93184 NaN 1.35E+08
Q7Z4R8 Q7Z4R8 UPF0669 protein C6orf120 2 2 191 0 62.118 0.93175 0.79673 3.77E+08
P55884;P55884-2;C9JZG1;C9JQN7P55884;P55884-2Eukaryotic translation initiation factor 3 subunit BEIF3B 34 34 814 0 323.31 0.93103 1.0347 1.27E+10
Q6PGP7;D6RCE2;H0Y964Q6PGP7 Tetratricopeptide repeat protein 37TTC37 31 31 1564 0 291.47 0.93086 0.9918 2.85E+09
Q9NYY8-2;Q9NYY8Q9NYY8-2;Q9NYY8FAST kinase domain-containing protein 2FASTKD2 12 12 648 0 59.769 0.93064 NaN 9.13E+08
P35998;P35998-2;C9JLS9P35998;P35998-226S protease regulatory subunit 7PSMC2 33 33 433 0 297.51 0.93028 0.89308 1.90E+10
P62266;D6RD47;D6RDJ2;D6RIX0;D6R9I7P 2266; D47;D6RDJ2;D6RIX0;D6R9I740S ribosomal protein S23RPS23 6 6 143 0 19.407 0.92913 1.3668 3.36E+09
A0A087WWS7;Q15833-2;Q15833;Q15833-3;M0R0M7;M0R1A1;M0QZ54;M0R376;M0R118;M0R0D4;A0A087WUN8A0A087WWS7;Q15833-2;Q15833;Q15833-3;M0R0M7Syntaxin-binding protein 2STXBP2;ZNF14 9 9 579 0 85.496 0.92908 NaN 4.68E+08
Q9Y2X0-2;Q9Y2X0-3;Q9Y2X0;K7EKS6;B9TWZ6;U3KQ43;Q9Y2X0-5;Q9Y2X0-4;U3KQB4;B9TX03;A0A0J9YYC6;A0A0J9YXE6;A0A0J9YXA0;A0A0J9YXE7;A0A0J9YY02;A0A0J9YXK9;A0A0J9YXL6;A0A0J9YW49;B9TX12;B9TX11Q9Y2X0-2;Q9Y2X0-3;Q9Y2X0;K7EKS6;B9TWZ6;U3KQ43;Q9Y2X0-5;Q9Y2 -4;U3KQB4;B9TX 3;A0A0J9YYC6;A0A0J9YXE6;A0A0J9YXA0Mediator of RNA polymerase II transcription subunit 16MED16 6 6 841 0 28.026 0. 2905 0.9 272 5.69E+08
A0A0A0MQR1;Q9Y4K4;G3V5C6A0A0A0MQR1;Q9Y4K4Mitogen-activated protein kinase kinase kinase kinase 5MAP4K5 9 9 846 0 69.192 0.92884 0.91486 6.24E+08
Q15738;C9JDR0 Q15738;C9JDR0 Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylatingNSDHL 8 8 373 0 101.69 0.92877 0.89785 1.38E+09
Q96EK4 Q96EK4 THAP domain-containing protein 11THAP11 3 3 314 0 5.7717 0.92796 0.9158 1.97E+08
O60341;O60341-2;R4GMP9;R4GMQ1O60341;O60341-2;R4GMP9Lysine-specific histone demethylase 1AKDM1A 16 16 852 0 81.785 0.92792 1.083 1.89E+09
Q9UJU6;Q9UJU6-2;Q9UJU6-3;H0Y5J4;B4DDD6;Q9UJU6-5;Q9UJU6-6;Q9UJU6-4;F8WBG8;F8WC20;F8WBB2;F8WFE1Q9UJU6;Q9UJU6-2;Q9UJU6-3;H0Y5J4;B4DDD6;Q9UJU6-5;Q9UJU6-6;Q9UJU6-4Drebrin-like proteinDBNL 12 12 430 0 217.22 0.9278 0.57684 1.03E+09
B0QY89;Q9Y262-2;Q9Y262;B0QY90;C9JHP4;C9K0Q7;H7C3A0;H0Y7E6B0Q 89;Q9Y262-2;Q9Y262;B0QY90Eukaryotic translation initiation factor 3 subunit LEIF3L 17 17 607 0 244.83 0.92772 NaN 3.02E+09
Q9NXX6;Q9NXX6-2;Q8N140Q9NXX6;Q9NXX6-2Non-structural maintenance of chromosomes element 4 homolog ANSMCE4A 6 6 385 0 19.795 0.92771 1.0509 2.08E+08
Q9NUQ7;D6RGX2;H0YA18;D6RB53;H0Y9B0;D6R9J7;D6RA67Q9NUQ7; GX2; 0YA18Ufm1-specific protease 2UFSP 16 16 469 0 122.41 0.92721 1.1956 2.99E+09
Q8TED0-3;Q8TED0;H0Y8P4;Q8TED0-2;D6RF65Q8TED0-3;Q8TED0;H0Y8P4;Q8TED0-2U3 small nucleolar RNA-associated protein 15 homologUTP15 10 10 499 0 67.551 0.92692 1.0063 8.74E+08
Q9BZF1-3;Q9BZF1-2;Q9BZF1;F8VQX7;F8VUA7;F8VVD3;F8VVE7;F8VZ43;Q9H0X9-3;Q9H0X9-2;Q9H0X9Q9BZF1-3;Q9BZF1-2;Q9BZF1;F8VQX7;F8VUA7Oxysterol-binding protein-related protein 8;Oxysterol-binding proteinOSBPL8 12 12 847 0 102.19 0.92685 0.9037 7.76E+08
Q6PL18;Q6PL18-2Q6PL18;Q6PL18-2ATPase family AAA domain-containing protein 2ATAD2 2 2 1390 0 10.446 0.92666 NaN 6.79E+07
Q9NVH2-3;Q9NVH2-2;Q9NVH2;Q9NVH2-4;A0A087WYC2;A0A087X1Q0;A0A087WXK3Q9NVH2-3;Q9NVH2-2;Q9NVH2;Q9NVH2-4Integrator complex subunit 7INTS7 20 20 942 0 149.17 0.92646 0.85735 2.29E+09
C9JG97;C9JEH3;Q13685;C9JTS3;H7C0R2C9JG97;C9JEH3;Q13685;C9JTS3Angio-associated migratory cell proteinAAMP 8 8 415 0 112.95 0.92636 1.1743 2.90E+09
A0A087WZ30;O94761;A0A087X072;V9GYB6;V9GZ64A0A087WZ30;O94761;A0A087X072ATP-dependent DNA helicase Q4RECQL4 3 3 1208 0 7.802 0.92635 0.64673 3.81E+07
P30050;P30050-2P30050;P30050-260S ribosomal protein L12RPL12 12 12 165 0 160.64 0.92619 1.2097 1.51E+10
A0A0A0MT33;O95104-2;O95104-3;O95104;Q9UPN6;Q9UPN6-2A0A0A0MT33;O95104-2;O95104-3;O 5104;Q9UPN6;Q9UPN6-2Splicing factor, arginine/serine-rich 15;Protein SCAF8SCAF4;SCAF8 1 1 1349 0 3.6507 0.926 NaN 1.18E+08
P49419-2;P49419;F8VS02;A0A140T9V3;P49419-4;A0A0J9YWF7;F8VVF2;H0YHM6;A0A0J9YWM6;F8WDY6;F8WD33P49419-2;P49 19;F8VS02;A0A140T9V3;P49419-4;A0A0J9YWF7Alpha-aminoadipic semialdehyde dehydrogenaseALDH7A1 21 21 511 0 323.31 0.9256 1.0369 7.40E+09
Q8IWB1 Q8IWB1 Inositol 1,4,5-trisphosphate receptor-interacting proteinITPRIP 3 3 547 0 5.7014 0.92559 NaN 6.68E+07
Q14165;F5H1S8;H0YG07;F5GX14Q14165;F5H1S8;H0YG07;F5GX14Malectin MLEC 4 4 292 0 31.645 0.92548 1.0859 2.80E+08
Q96EN8 Q96EN8 Molybdenum cofactor sulfuraseMOCOS 3 3 888 0 18.24 0.92542 1.1928 1.50E+08
P62191;P62191-2;G3V4X1P62191;P62191-226S protease regulatory subunit 4PSMC1 26 26 440 0 323.31 0.92538 0.95468 1.17E+10
P57088;D6RAA6;H0Y8N0;J3KN43;D6RBY2P57088;D6RAA6 Transmembrane protein 33TMEM33 10 10 247 0 68.793 0.92537 1.0002 7.87E+09
Q5QNZ2;P24539 Q5QNZ2;P24539 ATP synthase F(0) complex subunit B1, mitochondrialATP5F1 10 10 195 0 104.91 0.92465 0.77623 7.90E+08
O43149;O43149-3;I3L141;O43149-2O43149 Zinc finger ZZ-type and EF-hand domain-containing protein 1ZZEF1 12 12 2961 0 79.147 0.92426 1.1269 5.35E+08
Q9NVX2;A0A0A0MRH0;K7EN33;Q9NVX2-2;K7ERN7;K7EK23Q9NVX2;A0A0A0MRH0;K7EN33otchless protein homolog 1NLE1 16 16 485 0 186.21 0.92418 0.95607 3.30E+09
P22307-7;P22307-8;P22307;E9PLD1;P22307-3;P22307-4;H0YCB0;H0YD06;H0YF61;P22307-5;P22307-2P22307-7;P22307-8;P22307;E9PLD1;P22307-3;P22307-4Non-specific lipid-transfer proteinSC 7 7 503 0 36.178 0.92416 0.84687 6.55E+08
O75592-2;O75592;H7C3U4;A0A0C4DGY7O75592-2 O75592E3 ubiquitin-protein ligase MYCBP2MYCBP2 30 30 4637 0 207.88 0.92413 0.9173 1.68E+09
Q8WWC4;H7C0V0Q8WWC4;H7C0V0Uncharacterized protein C2orf47, mitochondrialC2orf47 6 6 291 0 33.464 0.92356 0.78508 1.41E+09
Q6PIW4-2;Q6PIW4Q6PIW4-2;Q6PIW4Fidgetin-like protein 1FIGNL1 3 2 563 0 20.767 0.92335 NaN 8.26E+07
181
Q92900-2;Q92900Q92900-2;Q92900Regulator of nonsense transcripts 1UPF1 52 52 1118 0 323.31 0.92282 1.0916 1.52E+10
Q93100-4;Q93100-3;Q93100-2;Q93100;I3L213;I3L3F2;I3L0Z1;H3BV13;I3NHZ9;H3BQ89Q93100-4;Q93100-3;Q93100-2;Q93100Phosphorylase b kinase regulatory subunit betaPHKB 7 7 1086 0 21.809 0.92277 1.0741 4.62E+08
P62244;I3L3P7;I3L246;H3BV27;H3BT37;I3L303;H3BVC7P62244;I3L3P7;I3L24640S ribosomal protein S15aRPS15A 13 7 130 0 123.36 0.92254 1.1001 1.85E+10
Q86WJ1;Q86WJ1-2;Q86WJ1-4;Q86WJ1-3;A0A087WTM4;Q86WJ1-5;A0A087WWW4Q86WJ1;Q86WJ1-2;Q86WJ1-4;Q86WJ1-3;A0A087WTM4;Q86 J1-5Chromodomain-helicase-DN -binding protein 1-likeCHD1L 14 2 897 0 122.46 0.92196 1.0543 9.70E+08
Q10567-3;Q10567-2;Q10567;Q10567-4;C9J1E7;H7C034Q10567-3;Q10567-2;Q10567;Q10567-4;C9J1E7AP 1 complex subunit beta-1AP1B1 20 9 939 0 50.19 0.92182 1.2712 7.92E+08
P52907 P52907 F-actin-capping protein subunit alpha-1CAPZA1 12 10 286 0 145.9 0.92175 0.70347 3.92E+09
E9PER6;O15530-2;O15530-3;O15530;O15530-4;Q6A1A2;O15530-5;H3BPW1;H3BQ10E9PER6;O15530-2;O15530-3;O15530;O15530-4;Q6A1A2;O15530-53-phosphoinositide-dependent protein kinase 1;Putative 3-phosphoinositide-dependent protein kinase 2PDPK1;PDPK2 5 5 529 0 31.752 0.92174 NaN 3.63E+08
Q96RF0-2;Q96RF0-3;Q96RF0Q96RF0-2;Q96RF0-3;Q96RF0Sorting nexin-18 SNX18 6 6 624 0 19.526 0.9217 NaN 2.15E+08
Q32P28-4;Q32P28;Q32P28-3;E2QRI1;Q32P28-2;H7C2W6Q32P28-4;Q3 P28;Q32P28-3;E2QRI1;Q32P28-2Prolyl 3-hydroxylase 1LEPRE1 3 3 697 0 15.672 0.92155 1.4782 2.53E+08
P63010;P63010-2;A0A087X253;P63010-3;A0A087WU93;A0A087WZQ6;A0A087WYD1;K7EJ01;K7EN71;K7ERB2;K7EJX1;A0A087WXS3;K7EKZ5P63010;P63010-2;A0A087X253;P63010-3; A087WU93; 0A087WZQ6;A A087WYD1AP-2 complex subunit betaAP2B1 27 16 937 0 234.48 0.92154 0.97683 5.07E+09
O15397;O15397-2;F5H2I3;F5H244;F5H292;F5GXT5;H0YH64O1 397;O15397-2Importin-8 IPO8 14 13 1037 0 65.656 0.92131 0.96981 1.10E+09
C9J0J7;G5E9Q6;P35080-2;C9JQ45;C9J2N0C9J0J7;G5E9 6;P35080-2;C9JQ45Profilin;Profilin-2 PFN2 7 2 91 0 36.731 0.92119 0.78863 6.09E+08
A6NJA2;P54578-2;P54578-3;P54578;J3QQT6;J3KS55;H0YA47A6NJA2;P54578-2;P54578-3;P54 78Ubiquitin carboxyl-terminal hydrolase;Ubiquitin carboxyl-terminal hydrolase 14USP14 16 16 448 0 132.5 0.92118 0.80275 2.39E+09
Q7L5D6;Q7L5D6-2;C9JPA8;C9JHN8;C9JY46Q7L5D6;Q7L5D6-2Golgi to ER traffic protein 4 homologGET4 9 9 327 0 66.429 0.92115 1.0483 1.87E+09
P10398;Q96II5;P10398-2P10398;Q96II5 Serine/threonine-protein kinase A-RafARAF 8 7 606 0 19.479 0.92111 5.2201 6.67E+08
C9J3L8;C9J5W0;E9PAL7;C9IZQ1;P43307-2;P43307C9J3L8;C9J5W0;E9PAL7;C9IZQ1;P43307-2;P43307Translocon-associated protein subunit alphaSSR1 2 2 265 0 25.042 0.9211 1.3303 9.85E+08
Q96J02-2;Q96J02;Q96J02-3;H0YBA4;Q9H0M0-6;Q9H0M0-3;Q9H0M0Q96J02-2;Q96J02;Q96J02-3E3 ubiquitin-protein ligase Itchy homologITCH 13 13 862 0 80.46 0.92095 0.82292 1.17E+09
Q8IYQ7 Q8IYQ7 Threonine synthase-like 1THNSL1 5 5 743 0 47.913 0.9204 NaN 1.54E+08
O43156 O43156 TELO2-interacting protein 1 homologTTI1 4 4 1089 0 33.313 0.92038 1.0967 3.15E+08
Q9Y295;F8WEE0 Q9Y295 Developmentally-regulated GTP-binding protein 1DRG1 11 11 367 0 83.293 0.92036 1.1885 1.48E+09
A0A0A0MSH8;E9PAZ4;A0A0A0MSW9;D3DQ30;Q5SRH9-5;Q5SRH9-6;Q5SRH9-4;A0A0A0MRQ0;Q5SRH9-3;Q5SRH90A0 0MSH8;E9PAZ4;A0A0A0MSW ;D3DQ30;Q5SRH9-5;Q5SRH9-6;Q5SRH9-4;A0A0A0MRQ0;Q5SRH9-3;Q5SRH9Tetratricopeptide repeat protein 39ATTC 9A 3 3 227 0 6.5771 0.92018 NaN 3.40E+07
Q9BW27-3;Q9BW27;J3KT10;J3QL54;Q9BW27-2;F5H0W7;J3QLH0;J3QLD4;J3KSH3;J3KRC0;J3KS87;J3QLV0;J3QL91;J3QS63Q9BW27-3;Q9BW27;J3KT10;J3QL54;Q9BW27-2Nuclear pore complex protein Nup85NUP85 15 15 610 0 147.9 0.92008 NaN 1.88E+09
Q9BVS4-2;Q9BVS4Q9BVS4-2;Q9BVS4Serine/threonine-protein kinase RIO2RIOK2 2 2 474 0 23.92 0.92004 NaN 6.04E+07
Q96HR8-2;Q96HR8;D6RIB3Q96HR8-2;Q96HR8;D6RIB3H/ACA ribonucleoprotein complex non-core subunit NAF1NAF1;TMX1 2 2 389 0 21.064 0.92003 NaN 1.23E+08
Q9HC35;B5MBZ0;Q9HC35-2;B5MBZ0;Q9HC35-2Echinoderm microtubule-associated protein-like 4EML4 30 30 981 0 241.39 0.91994 1.1081 1.77E+09
O94808;E5RJP4 O94808 Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2GFPT2 12 7 682 0 25.217 0.91947 NaN 2.19E+08
O95373;E9PLJ0;E9PLB2O95373 Importin-7 IPO7 25 24 1038 0 323.31 0.91946 1.0961 7.80E+09
O75607 O75607 Nucleoplasmin-3 NPM3 6 6 178 0 143.1 0.91944 0.95247 7.75E+09
Q12904;Q12904-2;D6R937Q12904;Q12904-2Aminoacyl tRNA synthase complex-interacting multifunctional protein 1;Endothelial monocyte-activating polypeptide 2AIMP1 20 20 312 0 263.58 0.919 1.0764 7.88E+09
K7EIG1 K7EIG1 CLUH 44 0 1251 0 323.31 0.91876 0.93328 6.97E+09
Q8TEQ6 Q8TEQ6 Gem-associated protein 5GEMIN5 34 34 1508 0 323.31 0.91826 1.0752 4.79E+09
O43379-4;O43379;H7C3R4;O43379-3;O43379-2O43379- ; WD repeat-containing protein 62WDR62 8 8 1523 0 39.949 0.91824 0.91629 1.84E+08
P48651;J3KNR6;P48651-3;P48651-2P48651 Phosphatidylserine synthase 1PTDSS1 3 3 473 0 6.93 0.91824 0.63091 3.34E+08
B1AMS2;Q14141-2;Q14141-4;Q14141;Q14141-3B1AMS2;Q14141-2;Q14141-4;Q14141;Q14141-3Septin-6 06-Sep 5 2 431 0 85.512 0.91822 1.064 5.11E+08
Q8NBY1;B4E0Y9;Q9P289-2;Q9P289;Q9P289-3;C9JJV0Q8NBY1;B4E0Y9;Q9P289-2;Q9P289;Q9P289-3Serine/threonine-protein kinase MST4RBM4B;MST4 10 4 392 0 39.802 0.91821 1.1723 1.28E+09
F5H5V6;F5H6S1;F8W8R6;A0A087X0R0;O15550;H0Y6I7;H0Y5J3;A0A087X248;A0A096LPD8;F5H3N7;A0A087X2I9;F5GWV3;A0A087X0Y2;F5H8B4;O14607-5;O14607-3;O14607;O14607-4;O14607-2F5H5V ;F5H6S1;F8W8R6;A0A087X0R0;O1 550;H0Y6I7;H0Y5J3;A0A087X248;A0A096LPD8;F5H3N7;A0A087X2I9;F5GWV3;A0A087X0Y2;F5H8B4;O14607-5;O14607-3;O14607;O14607-4Lysine-specific demethylase 6 istone demethylase UTYKDM6A;UTY 4 4 1269 0 33.2 9 0.91798 0.94 91 5.24E+07
Q9BVJ6-3;Q9BVJ6;Q9BVJ6-2;X6RJY0;Q5TAP6Q9BVJ6-3;Q9BVJ6; 9BVJ6-2U3 small nucleolar RNA-associated protein 14 homolog AUTP14A 10 10 719 0 100 0.9172 0.79381 8.02E+08
Q13564-3;Q13564-2;Q13564;Q13564-4;J3QRA5;J3KRK3Q13564-3;Q13564-2;Q1 564;Q13564-4NEDD8-activating enzyme E1 regulatory subunitNAE1 3 3 445 0 32.831 0.91715 NaN 1.13E+08
Q16512;Q16512-2;Q16512-3;K7EL10;K7EN76;K7EM57;K7EKY9Q16512;Q16512-2;Q16512-3Serine/threonine-protein kinase N1PKN1 12 11 942 0 63.431 0.91715 0.89412 9.78E+08
Q15046;Q15046-2;H3BVA8;J3KRL2;H3BPV7;H3BRC9Q15046;Q15046-2Lysine--tRNA ligaseKARS 32 32 597 0 323.31 0.91712 0.97507 7.06E+09
Q9P0M9;D6RAN8;H7C5U8;D6RE11;B3KN43Q9P0M9; AN8;H7C5U839S ribosomal protein L27, mitochondrialMRP 5 5 148 0 18.369 0.91706 0.385 2.10E+08
Q9UQ13-2;Q9UQ13;X6RI37Q9UQ1 -2;Q9UQ13;X6RI37Leucine-rich repeat protein SHOC-2SHOC2 4 4 536 0 35.799 0.91697 NaN 2.86E+08
A2IDC6;Q13084;A2IDC7;Q4TT37A2IDC6;Q13084;A2IDC7;Q4TT3739S ribosomal protein L28, mitochondrialMRP 4 4 240 0 9.6021 0.91696 1.1425 8.60E+07
E7ES33;E7EPK1;Q16181-2;Q16181;G3V1Q4;Q5JXL7;A0A0U1RRM2;A0A0U1RRH9;A0A0U1RRE1;A0A0U1RQK0;A0A0U1RRD1;Q6ZU15E7ES33;E7EPK1;Q16181-2 16181;G3V1Q4Septin 7 07-Sep 12 12 417 0 83.471 0.91686 1.1792 1.88E+09
Q9UPN7;K7EM28 Q9UPN7 Serine/threonine-protein phosphatase 6 regulatory subunit 1PPP6R1 7 7 881 0 61.714 0.91643 1.0562 2.63E+08
Q8N3U4;Q8N3U4-2;B1AMT4;Q68DW7;Q8WVM7-2;Q8WVM7;B1AMT1;B1AMT2;B1AMT3Q8N3U4;Q8N3U4-2Cohesin subunit SA-2STAG2 11 11 1231 0 30.912 0.91636 0.91671 2.50E+08
O75131;A0A087WYQ3;H0YB26;E5RHZ0;A0A087WXR6;A0A087WUS8;E5RFT7;E7ENV7;Q86YQ8-2;Q9HCH3-2;Q8IYJ1;Q96A23;O95741;Q9UBL6-2;Q86YQ8;Q96A23-2;Q9HCH3;O95741-2;Q9UBL6O75131;A0A087WYQ3;H0YB26Copine-3 CPNE3 20 19 537 0 193.84 0.91619 1.0482 5.05E+09
Q9P0J0;Q9P0J0-2;B4DEZ3;K7EJE1;E7ENQ6;U3KQP3Q9P0J0;Q9P0J0-2;B4DEZ3;K7EJE1;E7ENQ6NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13NDUFA13 9 8 144 0 57.262 0.91589 0.6982 1.95E+09
P68104;Q5VTE0;A0A087WV01;A0A087WVQ9;P68104-2;Q5JR01;A6PW80P68104;Q5VTE ; 0A087WV01;A0A087WVQ9;P68104-2Elongation factor 1 alpha 1;Putative elongation factor 1-alpha-like 3EEF1A1;EEF1 1P5 32 16 462 0 323.31 0.91584 1.1002 1.32E+11
Q06210-2;Q06210Q06210-2;Q06210Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1GFPT1 30 25 681 0 260.32 0.91525 0.84748 6.51E+09
Q13637;O14966;P57729Q13637 Ras-related protein Rab-32RAB32 5 5 225 0 29.167 0.91522 0.93082 2.38E+08
P31689;P31689-2P31689;P31689-2DnaJ homolog subfamily A member 1DNAJA1 16 16 397 0 182.39 0.91495 1.0106 4.83E+09
Q8N8L6 Q8N8L6 ADP-ribosylation factor-like protein 10ARL10 2 2 244 0.00078989 3.2586 0.91495 0.7217 9.81E+07
P51648;P51648-2;J3QRD1;I3L1M4;J3QS00;J3QKK9;J3KTD9;I3L2W1;J3KTG1;C9JGJ2;I3L0X1P51648;P51648-2;J3QRD1;I3L1M4Fatty aldehyde dehydrogenaseALDH3A2 11 10 485 0 31.541 0.91488 0.87031 6.26E+08
Q13257;Q13257-2;D6RJE3Q13257 Mitotic spindle assembly checkpoint protein MAD2AMAD2L1 7 7 205 0 74.072 0.91474 0.99512 2.05E+09
Q9Y2Z4;H0YHS6 Q9Y2Z4;H0YHS6 Tyrosine--tRNA ligase, mitochondrialYARS2 12 12 477 0 146.56 0.91468 1.032 9.45E+08
Q9BTT6;Q5T0G3;Q9BTT6-2Q9BTT6;Q5T0G3;Q9BTT6-2Leucine-rich repeat-containing protein 1LRRC1 4 3 524 0 24.36 0.91456 NaN 4.36E+08
Q96NB2;R4GMR9;R4GN74;R4GNC2;R4GN63;R4GMW0;A0A0C4DGR6;R4GMS6Q96NB2;R4GMR9; 74; NC2;R4GN63;R4GMW0;A0A0C4DGR6Sideroflexin-2 SFXN2 8 8 322 0 23.486 0.91455 1.7619 4.83E+08
Q8NB90;Q8NB90-2;Q8NB90-3Q8NB90;Q8NB90-2;Q8NB90-3Spermatogenesis-associated protein 5SPATA5 14 13 893 0 238 0.91451 0.90548 8.31E+08
P61962;A0A087WWI6;P61962-2P61962;A0A087WWI6DDB1- and CUL4-associated factor 7DCAF7 8 8 342 0 71.59 0.91437 0.98341 2.06E+09
Q9NVC6;E9PJZ4;E9PKQ4;E9PM72Q9NVC6 Mediator of RNA polymerase II transcription subunit 17MED17 3 3 651 0 15.161 0.91403 1.3685 1.87E+08
J3QRU1;P07947;P06241-3;P06241-2;P12931;P06241;P12931-2;Q573B4;P06239;P06239-3J3QRU1;P07947;P06241- ;P06241-2;P12931;P06241;P12931-2Tyrosine-protein kinase Yes;Tyrosine-protein kinase Fyn;Proto-oncogene tyrosine-protein kinase SrcYES ;FYN;SRC 4 3 548 0 11.395 0.91358 1.1417 2.72E+08
Q09161;X6R941;F2Z2T1Q09161 Nuclear cap-binding protein subunit 1NCBP1 23 23 790 0 193.57 0.91352 0.95976 4.99E+09
E9PLL6;P46776;E9PJD9;E9PLX7E9PLL6;P467 6;E9PJD960S ribosomal protein L27aRPL27A 5 5 108 0 22.558 0.91315 1.7399 5.37E+09
P18085;C9JAK5;C9JPM4;U3KQF2P18085;C9JAK5;C9JPM4;U3KQF2ADP-ribosylation factor 4ARF4 11 8 180 0 35.904 0.91286 2.7106 1.30E+09
Q6DD88;F5H6I7;F5GWF8Q6DD88;F5H6I7;F5GWF8Atlastin-3 ATL3 8 8 541 0 69.984 0.91275 1.0193 1.16E+09
Q5TH30;Q9UGV2-2;Q9UGV2;Q9UGV2-3;F8WBF9;Q5TH29Q5TH30;Q9UGV2-2;Q9UGV2;Q9UGV2-3;F8WBF9Protein NDRG3 NDRG3 6 6 388 0 76.811 0.91257 0.65499 8.15E+08
P09110;C9JDE9;P09110-2;B4DVF4;H7C131;H0Y4D4;F2Z2Q6;F2Z3P7P09 10;C9J E9;P091 0-2;B4DVF ;H7C1313-ketoacyl-CoA thiolase, peroxisomalACAA1 6 6 424 0 34.037 0.91203 0.81478 4.18E+08
F8WCF6;P59998;P59998-3;F8WDD7;A0A0A6YYG9;P59998-2;H7C0A3;R4GN08;P59998-4;F8WE39;F8WDW3F8WCF6;P59998;P59998-3;F8WDD7;A0A0A6YYG9;P59998-2 H7C0A3Actin-related protein 2/3 complex subunit 4ARPC4-TTLL3; RPC 7 7 181 0 21.994 0.91167 1.0155 2.86E+09
Q86X55-1;Q86X55;Q86X55-2;K7EQA8;K7EK20;K7EPK1;K7EQB9Q86X55-1;Q86X55;Q86X55-2;K7EQA8Histone-arginine methyltransferase CARM1CARM1 16 16 585 0 113.52 0.91159 1.031 2.06E+09
Q9NPQ8-4;Q9NPQ8;Q9NPQ8-3;Q9NPQ8-2;H0YEN0;E9PSI0;H0YE35;E9PI04;E9PLE5;H0YC88Q9NPQ8-4;Q9NPQ8;Q9NPQ8-3;Q9N Q8-2Synembryn A RIC A 13 12 530 0 117.59 0.9109 NaN 1.49E+09
P46940;H0YLE8;A0A0J9YXZ5;A0A087WWP1;H0YKA5;A0A087X225;F2Z2E2;Q86VI3P46940;H0YLE8;A0A0J9YXZ5Ras GT ase-activating-like protein IQGAP1IQGAP1 49 47 1657 0 323.31 0.91067 1.4184 1.07E+10
Q9Y696;A6PVS0;Q9NZA1-3;O15247;Q9NZA1-2;Q9NZA1;Q96NY7-2;Q96NY7Q9Y696 Chloride intracellular channel protein 4CLIC4 17 17 253 0 258.15 0.91053 0.89217 4.50E+09
I3L2B0 I3L2B0 CLUH 38 2 1236 0 4.3349 0.91051 NaN 9.34E+06
Q9BXW7-2;Q9BXW7;A8MYZ9Q9BXW7-2;Q9BXW7Cat eye syndrome critical region protein 5CECR5 13 13 393 0 199.38 0.91037 0.99205 4.40E+09
Q92769-3;Q92769;H3BM24;E5RFI6;E5RJ04;E5RGV4;E5RHE7;E5RH52;E5RG37;E5RFP9;E5RK19Q92769-3;Q92769Histone deacetylase 2HDAC2 11 7 458 0 93.638 0.91024 NaN 5.88E+08
B1AH87;P30536 B1AH87;P30536 Translocator proteinTSPO 2 2 107 0 3.8388 0.90981 0.97641 1.02E+08
Q8N8A6 Q8N8A6 ATP-dependent RNA helicase DDX51DDX51 7 7 666 0 29.579 0.90926 1.0296 4.28E+08
F8W930;Q9Y6M1-1;Q9Y6M1;Q9Y6M1-5;Q9Y6M1-6;Q9Y6M1-3;Q9Y6M1-4F8W930;Q9Y6M1-1;Q9Y6M1;Q9Y6M1-5;Q9Y6M1-6;Q9Y6M1-3;Q9Y6M1-4Insulin-like growth factor 2 mRNA-binding protein 2IGF2BP2 10 8 605 0 64.113 0.90921 NaN 5.00E+08
O76003 O76003 Glutaredoxin-3 GLRX3 11 11 335 0 92.771 0.90888 0.81783 5.12E+09
Q8NFH4;F8VTY2 Q8NFH4;F8VTY2 Nucleoporin Nup37NUP37 8 8 326 0 66.304 0.90886 1.3591 1.65E+09
I3L4X2;P33527-6;P33527-4;P33527-2;P33527;P33527-9;A0A0A0MS99;P33527-8;P33527-7;P33527-5;P33527-3I3L4X ;P33527-6;P33527-4;P3 527-2;P33527;P33527-9;A0A0A0MS99;P33527-8;P33527-7;P 3527-5;P33527-3Multidrug resistance associated protein 1ABCC1 14 14 1440 0 82.676 0.90847 1.3108 8.49E+08
P17812;P17812-2P17812;P17812-2CTP synthase 1 CTPS1 26 22 591 0 254.51 0.90816 0.89109 9.14E+09
Q9NZL4;Q9NZL4-3;K7EN20;K7EMM7;K7EL16;Q9NZL4-2Q9NZL4;Q9NZL4-3;K7EN20Hsp70-binding protein 1HSPBP1 4 4 362 0 14.198 0.90813 1.3883 6.10E+08
P51153;A0A087WWB9P51153 Ras-related protein Rab-13RAB13 10 7 203 0 51.91 0.90777 0.98066 1.54E+09
P11387;Q969P6-2;Q969P6;E5RIC7;E5RJ95;E5RFS0;E5RJ33;H0YBR3;H0YAR3;H0YC03;E5RGE7;E5RGR4;E5RFE3;E5RGR2P11387 DNA topoisomerase 1TOP1 30 30 765 0 224.65 0.90748 1.3514 7.79E+09
J3KPT4;Q9H4I3-2;Q9H4I3J3KPT4;Q9H4I3-2;Q9H4I3TraB domain-containing proteinTRABD 3 3 379 0 9.7607 0.90719 1.0461 2.99E+08
Q13547;Q5TEE2;E7ESJ6Q13547;Q5TEE2 Histone deacetylase 1HDAC1 12 8 482 0 119.13 0.90702 NaN 2.95E+09
Q14697;Q14697-2;F5H6X6;E9PKU7;E9PNH1Q14697;Q14697-2;F5H6X6;E9PKU7Neutral alpha-glucosidase ABGANAB 31 31 944 0 297.93 0.90647 1.0668 5.18E+09
A0A087WY61;Q14980-2;Q14980;Q14980-4;Q14980-3;H0YFY6;K4DIE0;Q14980-5;F5H4J1;F5H6Y5A0A087WY61;Q14980-2;Q14980;Q14980-4;Q1498 -3;H0YFY6Nuclear mitotic apparatus protein 1NUMA1 8 8 2099 0 65.838 0.90595 1.1684 2.59E+08
Q6YHU6;Q6YHU6-3;Q6YHU6-2;H0Y3V5;Q6YHU6-6;Q6YHU6-5;B5MC89;Q6YHU6-4;F5H3M9;H7BYZ4;B6ZDE5Q6YHU6;Q6Y U6-3;Q6YHU6-2;H0Y3V5Thyroid adenoma-associated proteinT ADA 19 19 1953 0 97.84 0.90589 1.1307 9.24E+08
J3QSE8;Q9BX63-2;Q9BX63;J3QKX0J3QSE8;Q9BX63-2;Q9BX63Fanconi anemia group J proteinBRIP1 3 3 994 0 10.208 0.90581 NaN 3.86E+07
O00442;O00442-2;A6NIC1O00442;O00442-2RNA 3-terminal phosphate cyclaseRTCA 15 15 366 0 155.2 0.90566 1.0924 4.44E+09
Q9NZ01;Q9NZ01-2;M0R3C3;M0QXM3;M0R329;B4DR74Q9NZ01 Very-long-chain enoyl-CoA reductaseTECR 17 17 308 0 89.148 0.90553 0.75701 5.48E+09
Q9H583;Q5T3Q7;Q6P6649H583;Q5T3Q7 HEAT repeat-containing protein 1;HEAT repeat-containing protein 1, N-terminally processedHEATR1 57 57 2144 0 323.31 0.9054 1.2719 9.84E+09
Q86YV9 Q86YV9 Hermansky-Pudlak syndrome 6 proteinHPS6 4 4 775 0 12.03 0.90537 0.99706 2.94E+08
Q5JP53;P07437;Q5ST81Q5JP53;P07437;Q5ST81Tubulin beta chainTUBB 34 5 426 0 323.31 0.90521 1.1635 1.53E+11
J3KN10;P42356;P42356-2;A4QPH2-4;A4QPH2;A8MTF1;Q8N8J0;A4QPH2-2;C9JLI1J3KN10;P42356 Phosphatidylinositol 4-kinase alphaPI4KA 30 30 2102 0 163.74 0.9051 1.018 1.70E+09
P20290-2;P20290;H0Y9Y1;D6RDG3P2 2 0-2;P20290Transcription factor BTF3BTF3 5 5 162 0 90.747 0.90501 1.8296 8.47E+08
Q9H300;F8WCQ4;C9JNP8;Q9H300-2;H7C0U0Q9H300 F8WCQ4;C9JNP8;Q9H300-2;H7C0U0Presenilins-associated rhomboid-like protein, mitochondrial;P-betaPARL 4 4 379 0 13.586 0.90469 0.76029 2.21E+08
Q96GM8;Q96GM8-2Q96GM8;Q96GM8-2Target of EGR1 protein 1TOE1 6 6 510 0 25.663 0.90409 NaN 3.08E+08
Q9ULC4-2;Q9ULC4;Q9ULC4-3Q9ULC4-2;Q9ULC4;Q9ULC4-3Malignant T-cell-amplified sequence 1MCTS1 8 8 169 0 105.7 0.90406 0.78871 2.90E+09
Q9H845;H0Y8Z9 Q9H845;H0Y8Z9 Acyl-CoA dehydrogenase family member 9, mitochondrialACAD9 13 13 621 0 46.063 0.90346 NaN 1.40E+09
P34896-2;P34896;P34896-3;P34896-4;J3KRZ5;J3KRK5P34896-2;P34896;P34896-3;P 4896-4Serine hydroxymethyltransferase, cytosolicSHMT1 13 12 444 0 105.22 0.90342 0.73904 1.69E+09
182
P26640;A0A140T936;A0A140T954;P26640-2;H0Y426;A2ABF4;A0A0G2JJT9;A0A140T904P2 640;A0A140T936Valine--tRNA ligaseV RS 5 50 1264 0 323.31 0.90332 0.96256 1.75E+10
Q8N163-2;Q8N163;G3V119;H0YB24;E5RHJ4;E5RFJ3;H0YC69;E5RGU7;H0YC58;A0A087X2B6;E5RHH8Q8N163-2 Q8N163;G3V119;H0YB24Cell cycle and apoptosis regulator protein 2CCAR2 21 21 923 0 202.31 0.9033 1.0684 4.95E+09
H0Y4B0;O43414-3;O43414-2;O43414;F6QUN3;F6UGJ8H0Y4B0;O43414-3;O43414-2 O43414ERI1 exoribonuclease 3ERI3 4 4 204 0 11.177 0.90326 NaN 3.11E+07
P13861-2;P13861;H7C330;H7C1L0;H7C4A9;C9J830P13861-2;P13861cAMP-dependent protein kinase type II-alpha regulatory subunitPRKAR2A 16 13 382 0 102.46 0.90253 0.97764 1.69E+09
Q96T76;Q96T76-8;Q96T76-9;Q96T76-5;Q5T454;Q96T76-7;H0Y746;B0QZ77;H7C1W5;F8WCH8;H0Y7V3;H7C0A9Q96T76;Q 6T76-8;Q96T76-9;Q96T76-5MMS19 nucleotide excision repair protein homologMMS19 31 31 1030 0 323.31 0.90249 1.2062 9.44E+09
Q9H061;E9PI90;Q9H061-2;E9PIH8Q9H061;E9PI90;Q9H061-2Transmembrane protein 126ATMEM126 4 4 195 0 14.76 0.90225 1.7341 4.75E+08
Q9UIV1-2;Q9UIV1;H0YAV9;H0YBT3;E5RGH2Q9UIV1-2;Q9UIV1;H0YAV9CC 4-NOT transcription complex subunit 7CNOT7 4 4 244 0 45.202 0.90107 0.95463 4.73E+08
Q7L523;Q5VZM2-2;Q5VZM0;Q5VZM2Q7L523;Q5VZM2-2;Q5VZM0;Q5VZM2Ras-related GTP-binding protein A;Ras-related GTP-binding protein BRRAGA;RRAGB 6 6 313 0 27.512 0.90096 2.1119 7.38E+08
O95758-1;O95758-6;O95758-2;O95758;O95758-5;O95758-4;O95758-7;X6R242O95758-1;O95758-6;O95758-2;O95758;O95758-5;O95758- ;O95758-7Polypyrimidine tract-binding protein 3PTBP3 6 3 521 0 31.134 0.90084 1.121 1.30E+08
P49736;H0Y8E6;F8WDM3P49736;H0Y8E6 DNA replication licensing factor MCM2MCM2 36 36 904 0 323.31 0.90079 1.1777 9.86E+09
P19367;P19367-4;P19367-2;P19367-3;B1AR63;B1AR62;B1AR61;Q2TB90;Q2TB90-3;Q2TB90-2P19367;P19367-4;P19367-2;P19367-3Hexokinase-1 HK1 54 50 917 0 323.31 0.90025 1.0767 1.80E+10
O43447;C9JQD4;O43447-2;H0YEL5;A6NM3243447;C9JQD4;O43447- ;H0YEL5Peptidyl-prolyl cis-trans isomerase H;Peptidyl-prolyl cis-trans isomerasePPIH 12 12 177 0 105.52 0.90009 1.2096 5.25E+09
Q9BUK6-3;Q9BUK6-2;Q9BUK6;Q9BUK6-7;Q9BUK6-4;Q9BUK6-5;Q9BUK6-6Q9BUK6-3;Q9BUK6-2;Q9BUK6;Q9BUK6-7Protein misato homolog 1MSTO1 7 6 558 0 20.773 0.90008 NaN 5.30E+08
E9PGW7;Q5T8T7;E7EN96;Q5T8T8;Q15528-2;Q155289PGW7;Q5T8T7;E7EN96;Q5T8T8;Q15528-2;Q15528Mediator of RNA polymerase II transcription subunit 22MED 2 2 2 111 0 4.7881 0.89922 NaN 3.55E+07
P0DN79;P35520;P35520-2;C9JMA6;H7C2H4;H7C1W6;H7C2W00DN79;P35520;P35520-2Cystathionine beta-synthaseCBS 25 25 551 0 169.38 0.89886 0.79834 3.06E+09
O95251-4;O95251;E7EUP3;O95251-2;O95251-3;O95251-5O95251-4;O95251;E7EUP3;O95251-2;O95251-3;O95251-5Histone acetyltransferase KAT7KAT7 7 7 581 0 50.185 0.89868 1.0085 3.63E+08
P60866;P60866-2;E5RJX2;E5RIP1;G3XAN0P60866;P60866-2;E5RJX240S ribosomal protein S20RPS20 11 11 119 0 72.458 0.89825 1.0092 2.21E+10
J3KPS3;P04075;P04075-2;H3BQN4;H3BPS8;H3BUH7;H3BR04;H3BMQ8;H3BU78;H3BR68;A0A087WXX2;P05062J3KPS3;P04075;P04075-2 QN4 PS8; UH7;H3BR04Fructose-bisphosphate aldolase AALDOA 26 3 368 0 323.31 0.89824 1.1614 8.15E+09
A0A0C4DFR8;Q9UBK9;S4R2Z4A0A0C4DFR8;Q9UBK9Protein UXT UXT 3 3 169 0 12.422 0.89814 1.4681 1.47E+08
O75794;X6RKY7;X6RF82;X6RA30;H7BZW7O75794;X6RKY7;X6RF82;X6RA30Cell division cycle protein 123 homologCDC123 5 5 336 0 15.863 0.89787 1.0599 4.20E+08
F5GYQ1;P61421;J3QL14;R4GN72;H3BQB4;H3BSG7;H3BQJ1F5GYQ1;P61421;J QL1 ;R4GN72V-type proton ATPase subunit d 1ATP6V0D1 3 3 392 0 16.399 0.89782 4.4514 7.24E+08
Q8TCX1-3;Q8TCX1;Q8TCX1-2;E5RJK4;E5RFM8;H7BYC8;Q8TCX1-5;Q8TCX1-4Q8TCX1-3;Q8TCX1;Q8TCX1-2;E5RJK4;E5RFM8;H7BY 8;Q8TCX1-5;Q8TCX1-4Cytoplasmic dynein 2 light intermediate chain 1DYNC2LI1 3 3 334 0 9.5106 0.89777 1.4933 1.43E+08
K7ESP4;Q8WVC6;Q8WVC6-2K7ESP4;Q8WVC6 Dephospho-CoA kinase domain-containing proteinDCAKD 10 10 209 0 46.953 0.89752 0.67846 5.94E+08
A0A0U1RRH6;O94880-2;O94880A0A0U1RRH6;O94880-2;O94880PHD finger protein 14PHF14 3 3 948 0 5.525 0.8973 0.99908 5.28E+07
Q8IYB7;H7C440;Q8IYB7-3;Q8IYB7-2;C9JGP4;H7C036;Q8IYB7-4;Q8IYB7-5Q8IYB7;H7C440;Q8IYB7-3;Q8IYB7-2DIS3-like exonuclease 2DIS3L2 8 8 885 0 32.863 0.89693 1.0631 5.30E+08
B7WPG3;C9IYN3;D6W592;Q8WVV9-5;Q8WVV9-4;Q8WVV9;Q8WVV9-3;Q8WVV9-2;H7C464;H7BXH8;C9JJZ7B7 PG3;C9IYN3;D6W592;Q8WVV9-5;Q8WVV9-4;Q8WVV9Heterogeneous nuclear ribonucleoprotein L-likeHNRPLL;HNRNPLL 13 12 508 0 96.557 0.89673 NaN 1.35E+09
Q15437;Q5QPE1;Q5QPE215437 Protein transport protein Sec23BSEC23B 18 15 767 0 244.76 0.89673 0.97305 2.19E+09
Q13885 Q13885 Tubulin beta-2A chainTUBB2A 34 2 445 0 229.97 0.89672 1.075 1.53E+10
O60884;A0A087WT48;I3L320O60884 DnaJ homolog subfamily A member 2DNAJA2 19 19 412 0 279.48 0.89601 1.1816 5.04E+09
Q9BZE9;Q9BZE9-2;Q9BZE9-3;J3QL04;J3QR12;Q9BZE9-4;J3KRY8;C9JAL9;J3QR50;J3KRF7;J3QRW3;J3KRG1Q9BZE9;Q9BZE9-2;Q9BZE9-3;J3QL04;J3QR12;Q BZE -4Tether containing UBX domain for GLUT4ASPSC 1 5 5 553 0 45.96 0.89538 NaN 1.78E+08
Q15459;Q15459-2;H7C1L2Q15459;Q15459-2Splicing factor 3A subunit 1SF3A1 6 6 793 0 28.031 0.89483 1.5057 2.17E+08
Q9UN86-2;Q9UN86;D6RAC7;D6RB17;D6RGJ4;D6RBM9;D6REX8;D6RBR0;D6RE13;D6RBW8;D6R9X5;D6R9A4Q9UN86-2;Q9UN86Ras GTPase-activating protein-binding protein 2G3BP2 12 10 449 0 107.42 0.89467 0.22331 1.23E+09
Q96T58;H0Y5U7;F6WRY4Q96T58;H0Y5U7;F6WRY4Msx2-interacting proteinSPEN 2 2 3664 0 5.8419 0.89453 1.0443 9.81E+06
C9J2Y9;P30876;C9J4M6;C9JMN3;C9JZW8C9J2Y9;P30876 4M6DNA-directed RNA polymerase;DNA-directed RNA polymerase II subunit RPB2POLR2B 41 41 1167 0 323.31 0.89436 1.2828 8.73E+09
Q9NYH9;J3KRR8 Q9NYH9 U3 small nucleolar RNA-associated protein 6 homologUTP6 11 11 597 0 108.5 0.89417 NaN 7.59E+08
Q9BU02;G3V5Q5;G3V5B9;Q9BU02-2;H0YJU8Q9BU02 G3V5Q5;G3V5B9;Q9BU02-2Thiamine-triphosphataseTHTPA 6 6 230 0 14.972 0.8941 0.98361 2.93E+08
A0A0C4DGS1;P39656-3;P39656;P39656-2;U3KQ84A0A0C4DGS1;P39656-3;P39656;P39656-2;U3KQ84Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunitDDOST 13 13 439 0 210.02 0.89396 1.3471 6.81E+09
Q14558-2;Q14558;C9JNQ3Q14558-2;Q14558Phosphoribosyl pyrophosphate synthase-associated protein 1PRPSAP1 11 4 385 0 109.21 0.89336 1.0039 2.91E+09
Q96RG2;Q96RG2-2;Q96RG2-4Q96RG2;Q96RG2-2;Q96RG2-4PAS domain-containing serine/threonine-protein kinasePASK 7 7 1323 0 46.143 0.89334 0.88331 4.09E+08
A0A0A0MTR7;A0A0A0MTC1;Q63HN8;Q63HN8-4;Q63HN8-6A0A0A0MTR7;A0A0A0MTC1;Q63HN8;Q63HN8-4E3 ubiquitin-protein ligase RNF213R F213 38 37 5207 0 197.26 0.89314 0.86386 1.82E+09
P56282-3;P56282;P56282-2;U3KQ22P56282-3;P56282;P56282-2DNA polymerase epsilon subunit 2POLE2 5 5 502 0 37.89 0.89301 1.0974 2.29E+08
Q5VV89;O14880;Q5VV879;O14880 Microsomal glutathione S-transferase 3MGST3 4 4 166 0 42.515 0.89291 1.1699 8.12E+08
P23743;G3V4E1;H0YJH4P23743;G3V4E1 Diacylglycerol kinase alpha;Diacylglycerol kinaseDGKA 3 3 735 0 14.317 0.8929 NaN 1.26E+08
O60333-3 O60333-3 Kinesin-like protein KIF1BKIF1B 16 4 1153 0 72.622 0.89268 1.3203 2.54E+08
Q99504-5;Q99504-3;Q99504;B1APR7;Q99504-2;Q99504-4Q99504-5;Q99504-3; 99504;B1APR7;Q99504-2;Q99504-4Eyes absent homolog 3EYA 2 2 527 0 24.118 0.89258 NaN 1.15E+08
E9PKL7;Q5HYI5;P61019;Q8WUD1;P61019-2;E9PE37;Q6PIK3;H0YD31;Q8WUD1-2E9PKL7;Q5HYI5;P61019;Q8WUD1;P61019-2Ras-related protein Rab-2A;Ras-related protein Rab-2BRAB2A;DKFZp 3C1541;RAB2B 3 3 181 0 6.8899 0.89245 NaN 1.06E+08
J3KQ61;O95696;O95696-2J3KQ61;O95696;O95696-2Bromodomain-containing protein 1BRD1 1 1 509 0.0047346 2.402 0.89228 NaN 2.23E+07
P60983;G3V4P8;G3V3X4;M0QYG8;M0R1D2;M0R0C1;M0QYJ8;O60234P60983;G3V4P8 Glia maturation factor betaG FB 7 7 142 0 62.479 0.892 0.99933 1.03E+09
P16435;H0Y4R2;E7EMD0;C9JU80P16435;H0Y4R2;E7EMD0NADPH--cytochrome P450 reductasePOR 5 5 677 0 21.19 0.8919 NaN 2.57E+08
M0R0Y2;P54920;M0R2M1;M0R027;M0R058;M0R213;A0A087WZQ7;Q9H115-3;Q9H115-2;Q9H115;M0R0I40Y2;P54920;M0R2M1; 0R027;M R 58Alpha-soluble NSF attachment proteinN P 6 6 256 0 56.176 0.89126 0.68214 3.73E+08
Q9H9A5-4;Q9H9A5-3;Q9H9A5-2;Q9H9A5;Q9H9A5-6;E9PCN5;H7C1X9;Q9H9A5-5;H7BZZ7;H7C0K1Q9H9A5-4;Q9H9A5-3;Q9H9A5-2;Q9H9A5;Q9H9A5-6;E PCN ;H7C1X9CCR4-NOT transcription complex subunit 10CNOT10 12 12 695 0 65.433 0.89122 0.80699 1.03E+09
Q14146;Q5VYD0 Q14146 Unhealthy ribosome biogenesis protein 2 homologURB2 29 29 1524 0 122.05 0.89023 1.0652 2.36E+09
D6RIY6;Q06265;Q06265-2;D6R905;Q06265-3;Q06265-4;H0Y9L5;D6RA17;D6RAP4D RIY6;Q06265;Q06265-2;D6R905;Q06265-3;Q0 265-4;H0Y9L5;D6RA17Exosome complex component RRP45EXOSC9 4 4 423 0 14.955 0.89006 NaN 7.63E+08
P49903;P49903-4;P49903-2;Q5T5U6;P49903-3;Q5T5U7P49 03;P49903-4;P49 03-2;Q5T5U6;P49903-3Selenide, water dikinase 1SEPHS 7 7 392 0 129.74 0.89003 1.1802 1.09E+09
Q00013-2;Q00013-3;Q00013;C9J9J4;C9JB34;A8MTH1Q00013-2;Q00013-3;Q00013;C9J9J455 kDa erythrocyte membrane proteinMPP1 4 4 436 0 17.62 0.88978 1.0785 2.36E+08
Q13472-3;Q13472-2;Q13472;K7ELI7;K7EMT6Q13472-3;Q13472-2;Q13472DNA topoisomerase 3-alphaTOP3A 4 4 906 0 7.622 0.88978 NaN 3.48E+08
F8VVA0;F8VQD9;Q9BSB4F8VVA0;F8VQD9;Q9BSB4Autophagy-related protein 101ATG101 1 1 141 0 4.2762 0.88933 0.87893 3.50E+07
P28072;A0A087X2I4;I3L3X7P28072;A0A087X2I4;I3L3X7Proteasome subunit beta type-6PSMB6 6 6 239 0 19.826 0.88903 0.68105 2.32E+08
Q13015 Q13015 Protein AF1q MLLT11 4 4 90 0 128.74 0.88884 0.97043 2.02E+08
Q96A33;Q96A33-2;A0A087WYW6;J3QR89Q96 33;Q96A33-2Coiled-coil domain-containing protein 47CCDC47 10 10 483 0 81.808 0.88882 NaN 3.72E+08
Q96BY7 Q96BY7 Autophagy-related protein 2 homolog BATG2B 6 6 2078 0 65.253 0.88841 1.1392 1.67E+08
V9GYX7;Q9NZ32;G3V2Q5;G3V5Y4;F6S9Y6;G3V524V9GYX7 Q9NZ32;G3V2Q5;G3V5Y4;F6S9Y6Actin-related protein 10ACTR10 5 5 302 0 42.417 0.88816 1.1626 5.99E+08
P31483-2;C9JTN7;H7BY49P31483-2;C9JTN7;H7BY49Nucleolysin TIA-1 isoform p40TIA1 7 0 375 0 26.701 0.88779 1.8973 3.00E+08
Q86V85 Q86V85 Integral membrane protein GPR180GPR180 2 2 440 0 11.542 0.88779 0.77165 7.32E+07
A3KFL1;A3KFL5;A3KFL2;Q13868-3;Q13868-2;Q13868A3KFL1;A KFL5;A3KFL2;Q13868-3;Q13868-2;Q13868Exosome complex component RRP4EXOSC2 2 2 200 0 6.7518 0.88744 NaN 1.37E+08
P61978-3;Q5T6W2;S4R457;S4R359P61978-3 Q5T6W2Heterogeneous nuclear ribonucleoprotein KHNRNPK 34 2 440 0 9.8937 0.88711 1.7273 1.16E+09
Q09028-3;Q09028;Q09028-2;Q09028-4;H0YF10;H0YCT5;H0YDK2;H0YEU5;E9PNS6;E9PNS2;C9JPP3;E9PIC4;C9JAJ9;E9PND5;Q5JNZ6Q09028-3;Q09028;Q09028-2;Q09028-4;H0YF10Histone-binding protein RBBP4RBBP4 14 7 410 0 257.49 0.88708 1.2422 7.61E+09
Q709F0;Q709F0-3;Q709F0-2;D6RDI8;F8WEV0Q709F0;Q709F0-3;Q709F0-2;D6RDI8;F8WEV0Acyl-CoA dehydrogenase family member 11ACAD11 13 13 780 0 104.28 0.88668 0.78425 1.31E+09
P51398-2;P51398-3;P51398;V9GZ03;V9GYL9;V9GYJ9;V9GYA7;V9GZ61;V9GYC9;V9GYW1;V9GY11;V9GYF7;V9GYJ3P51398-2;P51398-3;P51398;V9GZ03;V9GYL9;V9GYJ928S ribosomal protein S29, mitochondrialDAP3 9 9 357 0 64.648 0.88666 1.3855 1.66E+09
P14868;P14868-2;H7BZ35;C9J7S3;C9JLC1;H7C278;C9JQM9P14868;P14868-2Aspartate--tRNA ligase, cytoplasmicDARS 29 29 501 0 228.98 0.88611 0.96973 5.98E+09
Q8N6R0;Q8N6R0-3;Q8N6R0-4;Q8N6R0-1;Q8N6R0-2Q8N6R0;Q8N6R0-3;Q8N6R0-4;Q8N6R0-1;Q8N6R0-2Methyltransferase-like protein 13METTL13 18 18 699 0 98.904 0.88606 0.92495 1.34E+09
Q92995-2;Q92995;H7C5J3Q92995-2;Q92995;H7C5J3Ubiquitin carboxyl-terminal hydrolase 13USP13 5 3 798 0 30.314 0.88564 1.0647 2.73E+08
Q9ULX3;H3BUR4 Q9ULX3 RNA-binding protein NOB1NOB1 17 17 412 0 99.418 0.8855 1.0044 2.51E+09
G5E9W7;G5E9V5;P82650;H7C5L9;H7C5F2;H7C5H3;P82650-2;C9J5D8G5E9W7;G5E9V5;P82650;H7C5L92 S ribosomal protein S22, mitochondrialMRP 13 13 319 0 86.119 0.88396 0.90325 3.42E+09
P86791;P86790;F8WD66P86791;P86790 Vacuolar fusion protein CCZ1 homolog;Vacuolar fusion protein CCZ1 homolog BCCZ1; B 5 5 482 0 28.55 0.88359 0.87148 2.64E+08
Q14676-3;Q14676-2;Q14676;Q14676-4;A2AB05Q14676-3;Q14676-2;Q14676;Q14676-4Mediator of DNA damage checkpoint protein 1MDC1 10 10 1802 0 82.739 0.88337 1.0717 4.99E+08
Q8TCE6-2;Q8TCE6;Q6NSW5;F6TM29Q8TCE6-2;Q8 CE6;Q6NSW5;F6TM29Protein FAM45A;Protein FAM45BFAM45A;FAM45B 6 6 349 0 24.923 0.88335 1.0075 4.71E+08
Q9H2C0 Q9H2C0 Gigaxonin GAN 9 9 597 0 40.052 0.88335 NaN 5.02E+08
Q9UDY8;Q9UDY8-2Q9UDY8;Q9UDY8-2Mucosa-associated lymphoid tissue lymphoma translocation protein 1MALT1 3 3 824 0 58.554 0.88315 1.0892 2.50E+08
P61313;E7EQV9;E7ENU7;E7EX53;P61313-2;E7ERA2P61313;E7EQV9;E7ENU7;E7EX5360S ribosomal protein L15;Ribosomal protein L15RPL15 14 14 204 0 79.4 0.88297 1.2494 3.93E+09
Q13838;Q13838-2;Q5STU3;A0A0G2JJZ9;F6WLT2;A0A140T9X3;A0A140T9X9;A0A140T996;F6UJC5;A0A140TA18;A0A0A0MT12;F6TRA5;F6S4E6;A0A140T973;A0A140T9K1;A0A140T9L4;F6QYI9;A0A0G2JJL7;H0YCC6;H0Y400;A0A140T9K2;A0A0G2JHN7;F6U6E2;F6S2B7Q13838;Q13838-2;Q5STU3;A0A0G2JJZ9;F6WLT2;A0A140T9X3;A0A140T9X9;A0A140T996;F6UJC5;A0A140TA18;A0A0A0MT12;F6TRA5;F6S4E6Spliceosome RNA helicase DDX39BDDX3 B 28 9 428 0 282.17 0.8829 1.1765 3.02E+10
Q96EL3 Q96EL3 39S ribosomal protein L53, mitochondrialMRP 1 1 112 0 19.807 0.8828 1.0428 1.01E+08
Q9NRX4;Q9NRX4-2Q9NRX4 14 kDa phosphohistidine phosphatasePHPT1 5 5 125 0 59.684 0.88268 0.78926 4.63E+08
P60510;H3BTA2;I3L4X0;H3BV22;H3BPN5;H3BVE3P60510;H3BTA2;I3L4X0 22Serine/threonine-protein phosphatase 4 catalytic subunit;Serine/threonine-protein phosphatasePPP4C 7 6 307 0 26.317 0.88252 0.87879 2.14E+08
Q9H0U4;E9PLD0;Q92928;A0A087WTI1H0U4;E9PLD0;Q92928Ras-related protein Rab-1B;Putative Ras-related protein Rab-1CRAB1B;RAB1C 9 4 201 0 119.02 0.88239 1.1202 7.82E+08
P57772;P57772-2;C9J8T0P57772;P57772-2;C9J8T0Selenocysteine-specific elongation factorEEFSEC 14 14 596 0 48.789 0.88235 NaN 4.87E+08
Q96CX2;Q68DU8 Q96CX2 BTB/POZ domain-containing protein KCTD12KCTD12 10 10 325 0 63.699 0.88205 0.6738 1.64E+09
Q08209-2;Q08209;E7ETC2;Q08209-5;Q08209-3;E9PPC8;E9PK68;Q5F2F8;Q08209-4;P16298-2;P16298-3;P16298;P16298-4;P48454-2;P48454;P48454-3;H0YB02;H0YC26;G3V111Q08209-2;Q08209;E7ETC2;Q08209-5;Q08209-3;E9PPC8;E9PK68;Q5F2F8;Q08209-4;P16298-2;P16298-3;P16298;P16298-4Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform;Serine/threonine-protein phosphatase;Serine/threonine-protein phosphatase 2B catalytic subunit beta isoformPPP3CA;PPP3CB 6 6 511 0 15.576 0.88172 NaN 3.38E+08
A1L0T0;M0R026;E9PL44;E9PJS0;M0R1B5;M0QZX5A1L0T0;M0R026 Acetolactate synthase-like proteinILVBL 9 9 632 0 83.361 0.88119 NaN 5.53E+08
Q16576;E9PC52;Q16576-2;Q5JP01;Q5JP02;C9J7L0Q16576;E9PC52;Q16576-2;Q5JP 1Histone binding protein RBBP7RBBP7 16 9 425 0 323.31 0.88077 1.1176 1.19E+10
Q5T8U5;O15260-2;O15260;O15260-3;B7Z1G8Q5T8U5;O15260-2;O15260;O15260-3;B7Z1G8Surfeit locus protein 4SURF4 4 4 186 0 24.198 0.88062 1.1565 1.53E+08
P35270 P35270 Sepiapterin reductaseSPR 8 8 261 0 122.67 0.88049 1.1625 2.92E+09
F8VVA7;P61923;P61923-4;F8VXB1;F8W156;F8W651;F8VYZ4;P61923-5;F8VUC5;F8VXR1;P61923-3;F8VYK5;P61923-2;F8VYE0F8VVA7;P61923;P61923-4; VXB1;F8W156;F8W651;F8VYZ4;P61923-5;F8VUC5;F8VXR1;P61923-3Coatomer subunit zeta-1COPZ 6 6 198 0 76.799 0.88003 0.95066 2.95E+09
H0YGV7;H0YG20;Q9UKM7H0YGV7;H0YG20;Q9UKM7Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidaseMAN1B1 2 2 550 0 6.7358 0.87934 NaN 6.90E+07
Q9BST9;Q9BST9-3;Q9BST9-2Q9BST9;Q9BST9-3;Q9BST9-2Rhotekin RTKN 2 2 563 0 9.8263 0.87917 NaN 1.19E+08
P25490;H0YJV7;H0YJU4;Q96MM3;O15391P25490;H0YJV7 Transcriptional repressor protein YY1YY1 7 7 414 0 26.148 0.87904 0.41018 1.38E+08
Q7Z392;Q7Z392-4;Q7Z392-3;D6RHE5;Q7Z392-2Q7Z392;Q7Z392-4;Q7Z392-3;D6RHE5Trafficking protein particle complex subunit 11TRAPPC11 10 10 1133 0 48.512 0.87876 0.98179 4.29E+08
A0A0C4DG33;O43933;O43933-2;H7BZH3A0A0C DG ;O43933;O43933-2Peroxisome biogenesis factor 1PEX1 9 9 1226 0 28.379 0.87854 0.85579 2.39E+08
Q14739;C9JXK0;C9JES9Q14739;C9JXK0 Lamin-B receptor LBR 17 17 615 0 165.04 0.87833 1.2421 6.07E+09
P47897;P47897-2;B4DDN1;A0A0U1RQT0;C9J165;H7C0R3;A0A0U1RQE9;A0A0U1RRI9;A0A0U1RQL2;A0A0U1RQM8;A0A0U1RQU2;A0A0U1RR66;A0A0U1RQQ5;A0A0U1RQX5;A0A0U1RRJ7;A0A0U1RQJ6;A0A0U1RRC8;F2Z2V6;A0A0U1RQX9;A0A0U1RQC3;A0A0U1RR79P47897;P47897-2;B4DDN1Glutamine--tRNA ligaseQA S 43 43 775 0 323.31 0.87791 1.0264 1.43E+10
Q15021;E7EN77;F5GZK7;F5H431;REV__Q02790Q15021;E7EN77 Condensin complex subunit 1NCAPD2 36 36 1401 0 223.7 0.87763 1.1129 4.71E+09
Q8IU81 Q8IU81 Interferon regulatory factor 2-binding protein 1IRF2BP1 5 5 584 0 10.375 0.87713 NaN 1.56E+08
Q5VW36 Q5VW36 Focadhesin FOCAD 16 5 1801 0 50.82 0.87712 1.1583 9.71E+08
Q05639 Q05639 Elongation factor 1-alpha 2EEF1A2 20 4 463 0 71.454 0.87691 1.0824 1.10E+09
183
Q6L8Q7-2;Q6L8Q7;F6T1Q0Q6L8Q7-2;Q6L8Q7;F6T1Q02,5-phosphodiesterase 12PDE12 17 17 535 0 160.11 0.87691 3.8514 2.26E+09
E7EQY4;E7EV10;Q9BTC8-2;Q9BTC8;E9PCS8;D6W5A2;H0YIT0;E9PF88E7EQY4;E7EV10;Q9BT 8-2;Q9BTC8 E9PCS8;D6W5A2Metastasis-associated protein MTA3MTA3 8 2 514 0 8.9506 0.87668 NaN 6.86E+07
Q9BTE3-2;Q9BTE3;Q9BTE3-3Q9BTE3-2;Q9BTE3;Q9BTE3-3Mini-chromosome maintenance complex-binding proteinMCMBP 10 10 640 0 32.396 0.87624 NaN 5.62E+08
Q16531;F5GY55;Q16531-2;F5GWI0;F5GZY8;F5H2L3;F5GYG8;F5H198Q16531;F5GY55;Q16531-2DNA damage-binding protein 1DDB1 23 23 1140 0 155.26 0.8762 0.93149 2.84E+09
O95816;O95816-2O95816;O95816-2BAG family molecular chaperone regulator 2BAG2 8 8 211 0 30.514 0.87605 0.8975 4.92E+08
Q6YP21-3;Q6YP21;A0A0A0MRN7;A0A0A0MRN6;Q6YP21-2Q6YP21-3;Q6YP21; 0 0A0MRN7;A0A0A0MRN6Kynurenine--oxoglutarate transaminase 3CCBL2 9 9 420 0 59.275 0.87567 0.76116 2.38E+09
Q92734-2;Q92734;C9JTY3;C9JUE0;C9JJP5;Q05BK6;Q92734-4;Q92734-3Q92734-2;Q92734;C9JTY3;C9JUE0;C9JJP5;Q05BK6;Q92734-4;Q92734-3Protein TFG TFG 2 2 396 0 8.6998 0.87563 NaN 5.95E+07
Q8TEA1;U3KQU2 Q8TEA1;U3KQU2 Putative methyltransferase NSUN6NSUN6 5 5 469 0 9.5669 0.87554 0.6276 2.33E+08
Q7Z3T8 Q7Z3T8 Zinc finger FYVE domain-containing protein 16ZFYVE16 5 5 1539 0 25.457 0.87511 0.86356 1.94E+08
P42858;H0YA07 P42858 Huntingtin HTT 32 32 3142 0 311.99 0.87503 1.1044 2.67E+09
P13807-2;P13807;M0QYU1P13807-2;P13807Glycogen [starch] synthase, muscleGYS1 18 18 673 0 170.09 0.87462 0.95948 5.85E+09
Q9UIC8-3;Q9UIC8;Q9UIC8-2;I3L2Q8;H3BUP7;I3L4A2;I3L2E3;I3L537Q9UIC8-3;Q9UIC8;Q9UIC8-2;I3L2Q8Leucine carboxyl methyltransferase 1LCMT1 7 7 279 0 30.014 0.87461 1.1724 9.54E+08
E7EN32;O00255-3;O00255-2;O00255;E7ENS2;E7EPR4;E7ET29;Q9GZQ5E7EN32;O00255-3;O00255-2;O00255Menin MEN1 5 5 555 0 41.709 0.87423 NaN 1.28E+08
H0Y9G6;E7ETU7;P09001;D6RC14;E9PF06H0Y9G6;E7ETU7;P09001;D6RC14;E9PF0639S ribosomal protein L3, mitochondrialMRP 3 3 363 0 9.9789 0.87386 1.3223 7.40E+07
Q16698-2;Q16698;E5RJD2;E5RJG7;E5RFV2;H0YAW3;E5RID6Q16698-2;Q16698;E5RJD2;E5RJG7; FV22,4-dienoyl-CoA reductase, mitochondrialDECR1 6 6 326 0 36.067 0.87337 1.2167 5.70E+08
Q9H2W6;A0A087WT51;A0A087WT90Q9H2W6 39S ribosomal protein L46, mitochondrialMRP 5 5 279 0 18.88 0.87283 1.2137 2.16E+08
Q8IUR0 Q8IUR0 Trafficking protein particle complex subunit 5TRAPPC5 2 2 188 0 4.0625 0.87229 NaN 1.28E+08
P07900;P07900-2;G3V2J8;Q14568;Q58FG0;Q58FG1P07900;P07900-2Heat shock protein HSP 90-alphaHSP90AA1 57 36 732 0 323.31 0.87226 1.133 4.71E+10
Q99714;Q5H928;Q99714-2;Q5H928;Q99714-23-hydroxyacyl-CoA dehydrogenase type-2HSD17B10 4 4 261 0 87.962 0.87216 0.91399 3.27E+08
A0A087WT20;Q9NV06;B3KME9;A0A087X1F8;E5RHM4;Q9NV06-2A0A087WT20;Q9NV06;B3KME9DDB1- and CUL4-associated factor 13DCAF13 10 10 597 0 35.631 0.87178 1.6345 6.58E+08
E9PN17;O75964 E9PN17;O75964 ATP synthase subunit g, mitochondrialATP5L 5 5 76 0 41.246 0.87117 0.9305 1.98E+09
P35232;C9JW96;C9JZ20;E7ESE2;E9PCW0;P35232-2;D6RBK0P35232;C9JW96;C9JZ20;E7ESE ;E9PCW0rohibitin HB 17 17 272 0 210.71 0.87111 1.117 1.87E+10
Q14669-4;Q14669-2;Q14669;Q14669-3;H7C2Y1Q14669-4;Q14669-2;Q14669;Q14669-3E3 ubiquitin-protein ligase TRIP12TRIP12 21 21 1722 0 92.778 0.87103 0.94588 1.54E+09
Q9BQ69 Q9BQ69 O-acetyl-ADP-ribose deacetylase MACROD1MACROD1 6 6 325 0 36.922 0.87052 1.4147 1.12E+09
O00425;O00425-2;F8WD15O00425 Insulin-like growth factor 2 mRNA-binding protein 3IGF2BP3 22 19 579 0 194.23 0.87043 NaN 2.07E+09
Q99707;Q99707-2;B1ANE3Q99707;Q99707-2Methionine synthaseMTR 21 21 1265 0 154.23 0.87042 1.1154 1.97E+09
E9PN81;Q8TDP1-2;Q8TDP1;H0YEF3;E9PKP0;H0YE52;H0YCP5E9PN81;Q8TDP1-2;Q8TDP1;H0YEF3Ribonuclease H  subunit CRNASEH2C 5 5 247 0 26.097 0.87023 1.0376 3.47E+08
J3QS39;J3QTR3;F5H6Q2;F5GYU3;F5H2Z3;F5H265;B4DV12;F5H388;F5H747;F5GXK7;J3QKN0;Q5PY61;Q96C32;P62987;P62979;P0CG47;P0CG48;M0R1V7;F5GZ39;M0R1M6;J3QSA3J3QS39;J3QTR3;F5 6Q2;F5GYU3;F5H2Z3;F5 265;B4DV12;F5H388;F5H747;F GXK7;J3QKN0;Q5PY61;Q96C32;P62987;P62979 P0CG4 ;P0CG48 V7;F5GZ39;M0R1M6;J3QSA3Ubiquitin-60S ribosomal protein L 0;Ubiquitin;60S ribosomal protein L40;Ubiquitin-40S ribosomal protein S27a;Ubiquitin;40S ribosomal protein S27a;Polyubiquitin-B;Ubiquitin;Polyubiquitin-C;UbiquitinUBB;RPS27A;U C;UBA52 11 4 93 0 224.6 0.8 999 1.525 1.39E+11
Q7Z7K6;Q7Z7K6-2Q7Z7K6 Centromere protein VCENPV 5 1 275 0 52.796 0.86948 2.5436 6.54E+08
P62330 P62330 ADP-ribosylation factor 6ARF6 5 5 175 0 34.941 0.86903 1.2066 1.06E+09
A0A0C4DGY8;D6RA00;A0A087WTH0;Q9UHY7;Q9UHY7-20A0C4DGY8;D6RA00;A0A087WTH0;Q9UHY7;Q9UHY7-2Enolase-phosphatase E1ENOPH1 3 3 149 0 16.044 0.86896 0.94156 1.38E+08
O60318;O60318-2O60318 Germinal-center associated nuclear proteinMCM3AP 16 16 1980 0 164.11 0.8685 0.5475 9.45E+08
P51991 P51991 Heterogeneous nuclear ribonucleoprotein A3HNRNPA3 23 4 378 0 233.29 0.86849 0.99804 8.10E+09
Q96GA3;A0A075B6Q4Q96GA3 Protein LTV1 homologLTV1 7 7 475 0 127.18 0.86844 NaN 3.92E+08
R4GNB1;Q4L235-3;Q4L235-4;Q4L235-2;Q4L235R4GNB1;Q L235- ;Q4L235-4;Q4L235-2;Q4L235Acyl-CoA synthetase family member 4AASDH 3 3 945 0 4.6174 0.86802 1.2332 4.96E+07
Q9BZE4;Q9BZE4-2;Q9BZE4-3;Q5T3R7Q9BZE4;Q9BZE4-2;Q9BZE4-3Nucleolar GTP-binding protein 1GTPBP4 19 19 634 0 100.17 0.86801 2.6359 1.30E+09
Q96EM0;D6RC46;E9PKK7Q 6EM0;D6RC46;E9PKK7Trans-L-3-hydroxyproline dehydrataseL3HYPDH 5 5 354 0 12.992 0.86761 0.8615 2.09E+08
C9J6D1;C9JZI7;Q99733;Q99733-2;E9PNW0;E9PJJ2;E9PS34;E9PNJ7;E9PKT8;A8MXH2;C9J1B1;E9PKI2;E9PP22;H0YCI4C9J6D1;C JZI7;Q9 733;Q99733-2;E9PNW0;E9PJJ2;E9PS34;E9PNJ7;E PKT8;A8MXH2;C9J1B1Nucleosome assembly protein 1-like 4NAP1L4 7 5 178 0 68.776 0.86689 1.2676 3.93E+08
K7EP06;O43148;O43148-2K7EP06;O43148;O43148-2mRNA cap guanine-N7 methyltransferaseR MT 2 2 298 0 10.62 0.8667 NaN 1.45E+08
Q969X5-2;Q969X5Q969X5-2;Q969X5Endoplasmic reticulum-Golgi intermediate compartment protein 1ERGIC1 4 4 198 0 11.333 0.86669 1.2115 5.02E+08
A0A0A0MT60;Q5T1M5-2;Q5T1M5;X6RKW4;Q5T1M5-3A0A0A0MT60;Q5T1M5-2;Q5T1M5FK506-binding protein 15FKBP 5 5 1244 0 22.579 0.86665 0.48446 1.83E+08
D6R9P3;D6RD18;D6RBZ0;A0A087WZV1;Q99729-3;Q99729-2;Q99729-4;Q997299P3;D6RD18;D6RBZ0;A0A087WZV1;Q9972 -3;Q9972 -2;Q99729-4;Q99729Heterogeneous nuclear ribonucleoprotein A/BHNRNPAB 16 15 280 0 107.67 0.86662 1.4597 6.40E+09
Q9HAD4;H0YAA3;Q9HAD4-2;D6RE66;A0A0C4DG28;D6RJA5;D6RH33;D6R9E7;D6RB94;B4DK73;H0Y9Z3;B4DHS8;D6RBY6;H0YAI6;D6RA22;D6R9M1;D6RIX6;H0YAA3;Q9H D4-2;D6RE6 ;A0A0C4DG28WD repeat-containing protein 41WDR41 10 10 459 0 182.74 0.86613 1.0648 1.41E+09
Q676U5;E7EVC7;Q676U5-4;Q676U5-5;Q676U5-3;Q676U5-2Q676U5;E7EVC7;Q676U5-4;Q676U5-5;Q676U5-3;Q676U5-2Autophagy-related protein 16 1ATG1 L1 3 3 607 0 56.097 0.86609 NaN 1.61E+08
Q9P2D3-3;Q9P2D3;Q9P2D3-2;H7C2X3Q9P2D3- ;Q9P2D3;Q9P2D3-2HEAT repeat-containing protein 5BHEATR5B 16 16 1982 0 98.049 0.86533 0.91138 4.86E+08
A6NMN0;P46020-2;P46020;A6NIT2;P46020-3A6NMN0;P4 020-2;P46020;A6NIT2;P46020-3Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoformPHKA1 10 9 1240 0 55.266 0.86517 1.0674 4.35E+08
Q9BVI4;F5H303 Q9BVI4 Nucleolar complex protein 4 homologNOC4L 6 6 516 0 23.19 0.86492 1.0991 4.09E+08
P42025 P42025 Beta-centractin ACTR1B 9 3 376 0 21.678 0.86486 0.80559 1.56E+09
A0A087X295;Q9NNW5;E9PDU5;E9PBK6;C9K020;V9GZ65;C9JFP6;V9GYU1;Q6PKC6A0A087X295;Q9NNW5;E9PDU5WD repeat-containing protein 6WDR6 13 13 1151 0 121.23 0.86455 1.1442 2.24E+09
Q9BUQ8;H0YI52;F8VVA2Q9BUQ8 Probable ATP-dependent RNA helicase DDX23DDX23 18 18 820 0 77.088 0.86392 1.0957 2.18E+09
P54646;A0A087WXX9P54646;A0A087WXX95-AMP-activated protein kinase catalytic subunit alpha-2PRKAA2 3 2 552 0 6.1431 0.86388 NaN 5.41E+07
Q8WVD3;Q8WVD3-2;J3QLQ3;J3KRU4;J3KSI2;J3QKM8Q8WVD3;Q8WVD3-2E3 ubiquitin-protein ligase RNF138RNF138 4 4 245 0 46.202 0.86376 0.90854 2.24E+08
Q5T2E6;Q5T2E6-2;Q5T2E8;Q5T2E7Q5T2E6;Q5T2E6-2UPF0668 protein C10orf76 5 5 689 0 50.149 0.8631 NaN 1.63E+08
H0YNG3;P67812-4;P67812;P67812-3;P67812-2;H0YNX5;H0YKT4;H0YNA5;P0C7V7H0YNG3;P67812-4;P67812;P67812-3;P67812-2;H0YNX5;H0YKT4;H0YNA5Signal peptidase complex catalytic subunit SEC11ASEC11A 8 8 163 0 35.05 0.86251 1.012 3.32E+09
O75396;A0A087X1A9O75396 Vesicle-trafficking protein SEC22bSEC22B 7 7 215 0 51.016 0.86225 1.2898 1.36E+09
Q9Y676;A0A0G2JIC6Q9Y676;A0A0G2JIC628S ribosomal protein S18b, mitochondrialMRP B 4 4 258 0 53.92 0.86204 1.2078 3.14E+08
I6L894;Q01484;Q01484-5;Q01484-2;E9PCH6;A0A0U1RQN6;E9PHW9;B7Z651;D6RHE1;H0Y931;H0YAG3;H0Y8Y2;Q01484-7I6L89 ;Q01484;Q01484-5;Q01484-2;E9PCH6;A0A0U1RQN6 E9P W9;B7Z651;D6RHE1Ankyrin-2 ANK2 6 4 3924 0 22.213 0.86198 1.1929 1.42E+08
O00330-3;O00330;H0YD97;O00330-2;E9PLU0;E9PRI6O00330-3; ;H0YD97Pyruvate dehydrogenase protein X component, mitochondrialPDHX 11 11 486 0 32.683 0.86161 0.93598 6.78E+08
Q5QPM7;Q92530;Q5QPM9;H0Y555;F5H4Z3Q5QP 7;Q92530;Q QPM9Proteasome inhibitor PI31 subunitPSMF1 5 5 263 0 42.533 0.86142 0.67304 8.79E+08
P38606-2;P38606;C9JA17;C9JVW8P38606-2;P38606V-type proton ATPase catalytic subunit AATP6V1A 3 3 584 0 10.867 0.86136 NaN 7.47E+07
P41240;H3BUM9;H3BN15;H3BU69;K7ENL8;K7ES68;K7EQY5;A0A087WUR1;P42679-3;P42679;P42679-2P41240 Tyrosine-protein kinase CSKCSK 21 21 450 0 162.87 0.86135 1.0275 4.60E+09
Q13085;Q13085-4;Q13085-3;Q13085-2;Q59FY4;A0A0C4DGT1;A0A087X2F8;A0A087X0W4;A0A087X126;S4R3S7;A0A087WVR6;A0A087WWN5;A0A087WYK6Q13085;Q13085-4;Q13085-3;Q13085-2;Q59FY4Acetyl-CoA carboxylase 1;Biotin carboxylaseA ACA 54 47 2346 0 323.31 0.86132 1.1618 5.28E+09
Q6P1M0;Q6P1M0-2Q6P1M0 Long-chain fatty acid transport protein 4SLC27A4 14 12 643 0 75.071 0.86094 NaN 7.61E+08
R4GNH3;E9PKD5;E9PN50;E9PMD8;E9PLG2R4G H3;E9PK 5 N50;E9PMD8 PSMC3 29 1 423 0 323.31 0.86046 0.95747 1.48E+10
B4E1G1;Q9BUN8-2;Q9BUN8;E5RGY0B4E1G1;Q9BUN8-2;Q9BUN8;E5RGY0Derlin-1 DERL1 4 4 151 0 15.662 0.86035 0.97666 6.43E+08
Q8NEZ5;Q8NEZ5-3;H3BTH6;H3BTR7;H3BRE0;H3BVA4;H3BUC1;Q8NEZ5-2Q8NEZ5;Q8NEZ5-3; 3BTH6F-box only protein 22FBXO22 7 7 403 0 38.56 0.8603 1.0649 7.17E+08
Q10570;A0A087X101;E9PIM1;A0A087WTV4Q10570 Cleavage and polyadenylation specificity factor subunit 1CPSF1 38 38 1443 0 253.76 0.86025 1.1449 4.85E+09
Q9H1A4;H0Y564;F8WAS1Q9H1A4;H0Y564 Anaphase-promoting complex subunit 1ANAPC1 24 24 1944 0 202.14 0.85975 1.0297 1.63E+09
Q9NS69 Q9NS69 Mitochondrial import receptor subunit TOM22 homologTOMM22 5 5 142 0 156.34 0.85971 1.0281 3.53E+09
Q6PCE3 Q6PCE3 Glucose 1,6-bisphosphate synthasePGM2L1 5 5 622 0 20.669 0.85954 NaN 3.02E+08
Q86XI2;Q86XI2-2;H0Y6U5;F8WE06Q86XI2;Q86XI2-2;H0Y6U5Condensin-2 complex subunit G2NCAPG2 26 26 1143 0 130.42 0.8595 1.038 1.34E+09
Q8WZ82 Q8WZ82 Ovarian cancer-associated gene 2 proteinOVCA2 2 2 227 0 12.531 0.85938 0.90191 1.40E+08
Q15424-2;Q15424;Q15424-4;Q15424-3;K7ES42Q15424-2;Q15424;Q15424- ;Q15424-3;K7ES42Scaffold attachment factor B1SAFB 2 2 848 0 11.32 0.85937 NaN 3.86E+07
P14866;M0QXS5;P14866-2;M0R1W6;B4DVF8;M0QYL7;M0QXS5;P14866-2Heterogeneous nuclear ribonucleoprotein LHNRNPL 35 22 589 0 323.31 0.85921 0.86802 2.30E+10
P49005;F8W8R3;A0A087WWF6;C9JLE1;C9J8Z7;C9IZD2;C9JHC7;H7C1B3P49 05;F8W8R3;A0A087WWF6;C9JLE1;C9J8Z7;C9IZD2DN  polymerase delta subunit 2POLD2 16 16 469 0 152.14 0.85903 0.99525 3.87E+09
O15042-3;O15042-2;O15042;E7ET15O15042-3;O15042-2;O15042;E7ET15U  snRNP-associated SURP motif-containing proteinU2S P 6 6 620 0 19.464 0.85828 1.0192 5.26E+08
F8W1B9;O95619;F8VTR4;F8W0J4W1B9;O95619;F8VTR4;F8W0J4YEATS domain-containing protein 4YEATS4 4 4 211 0 12.175 0.85807 0.64046 1.07E+08
A0A0C4DFL7;Q16850;Q16850-2;H7C0D0;C9IYR8A0A0C4DFL7;Q16850;Q16850-2Lanosterol 14-alpha demethylaseCYP51A1 8 8 509 0 34.153 0.85797 0.9373 4.87E+08
J9JIE6;Q9UM00-2;Q9UM00;J3KS45;J3QQY2;J3KTQ7J9JIE6;Q9UM00-2 Q9UM00;J3KS45;J3QQY2;J3KTQ7Transmembrane and coiled-coil domain-containing protein 1TMCO1 4 4 239 0 31.933 0.85796 0.64849 5.79E+08
Q7LGA3-3;Q7LGA3-2;Q7LGA3;K7EP71Q7LGA3-3;Q7LGA3-2;Q7LGA3;K7EP71Heparan sulfate 2-O-sulfotransferase 1HS2ST1 2 2 229 0 3.7472 0.85787 NaN 3.20E+08
F8VZJ2;F8W0W4;H0YHX9;Q13765;E9PAV3-2;E9PAV3;F8W1N5;F8VNW4;F8VZ58;Q9BZK3F8VZJ2;F8W0W4;H0YHX9;Q13765;E9PAV3-2 E9PAV3;F8W1N5;F8VNW4;F8VZ58Nascent polypeptide-associated complex subunit alpha Nascent polypeptide-associated complex subunit alpha, muscle-specific formNACA 6 6 136 0 106.51 0.85777 0.85434 5.18E+09
A0A0A0MQW0;A0A0A0MR39;Q9P2K5-2;Q9P2K5;A0A087WUT0;A0A087WWC8;H0YKS1;A0A0C4DGV1;H0YN19;Q9P2K5-4;Q9P2K5-30 0A0MQW0;A0A0A0MR39;Q9P2K5-2;Q9P2K5; 0A087WUT0Myelin expression factor 2MYEF2 5 5 576 0 25.105 0.85669 NaN 1.84E+08
Q9Y679-2;Q9Y679;Q9Y679-3Q9Y679-2;Q9Y679;Q9Y679-3Ancient ubiquitous protein 1AUP1 10 10 410 0 48.52 0.85646 0.97294 7.96E+08
H0Y6T7;Q92542-2;Q92542H0Y6T7;Q92542-2;Q92542Nicastrin NCSTN 2 2 275 0.0018182 3.0355 0.85567 NaN 5.75E+07
P51659;E7EWE5;P51659-3;P51659-2;E7ER27;G5E9S2;E7ET17;E7EPL9P51659;E7EWE ;P51659-3;P51659-2;E7ER27;G5E9S2;E7ET17Peroxisomal multifunctional enzyme type 2;(3R)-hydroxyacyl-CoA dehydrogenase;Enoyl-CoA hydratase 2HSD17B4 21 21 736 0 250.44 0.85539 1.074 4.91E+09
Q6P2Q9;I3L0J9;I3L3Z8;I3L1T8Q6P2Q9 Pre-mRNA-processing-splicing factor 8PRPF8 112 112 2335 0 323.31 0.8553 1.2348 2.42E+10
Q96DB5-2;Q96DB5;H0YC27;H0YC67;H0YBD9;H0YB03;E5RH53;Q96DB5-3;H0YAP5;H0YB83Q96DB5-2;Q96DB5;H0YC27; 0YC67;H0YBD9;H0YB03;E5RH53;Q96D 5-3Regulator of microtubule dynamics protein 1RMDN1 4 4 284 0 7.8141 0.85424 0.43389 2.39E+08
P07199 P07199 Major centromere autoantigen BCENPB 2 2 599 0 13.229 0.85415 1.0332 8.65E+07
Q8NB37;Q8NB37-2;E9PQD8;H0YE25;H0YF25;E9PLI5;Q8NB37-3;H0YER3;Q8NB37-4Q8NB37;Q8NB37-2;E9PQD8;H0YE25;H0YF25;E9PLI5;Q8NB37-3Parkinson disease 7 domain-containing protein 1PDDC1 3 3 220 0 17.713 0.85407 0.93573 4.89E+08
Q92973-2;Q92973;Q92973-3;S4R398;E7EW37Q92973-2;Q92973;Q9297 -3Transportin-1 TNPO1 7 4 890 0 22.508 0.85397 1.1192 8.97E+08
Q9UJA5;Q9UJA5-4;Q9UJA5-2;Q9UJA5-3Q9UJA5;Q9UJA5-4;Q9UJA5-2tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6TRMT6 7 7 497 0 13.593 0.85373 NaN 5.39E+07
P61163;R4GMT0 P61163;R4GMT0 Alpha-centractin ACTR1A 18 12 376 0 323.31 0.8537 1.0804 1.59E+10
P35813-2;P35813;P35813-3;E9PKB5;B8ZZF0;C9JIR6;O75688-5;O75688-4;O75688-2;O75688P35813-2;P35813;P35813-3;E9PKB5Protein phosphatase 1APPM1A 4 4 324 0 31.993 0.85369 0.91127 2.89E+08
P50583 P50583 Bis(5-nucleosyl)-tetraphosphatase [asymmetrical]NUDT2 2 2 147 0 19.46 0.8536 1.0798 2.88E+08
P50416-2;P50416;H3BUJ0;H3BP22;H3BUV7;H3BMD2P50416-2;P50416Carnitine O-palmitoyltransferase 1, liver isoformCPT1A 10 10 756 0 41.288 0.85288 1.0833 1.24E+09
Q8WYP5;Q8WYP5-3;Q8WYP5-2Q8WYP5;Q8WYP5-3;Q8WYP5-2Protein ELYS AHCTF1 11 11 2266 0 68.394 0.85281 1.5091 5.82E+08
Q3ZCQ8;Q3ZCQ8-2;Q3ZCQ8-3;M0R0C3;M0R2F8;M0R003;M0R047;M0R1Y4;M0QXC3;M0R2Z3;M0R303;M0R2D2;M0R2Q2Q3ZCQ8;Q ZCQ8-2;Q3ZCQ8-3; 0 0C3; 0 2F8Mitochondrial import inner membrane translocase subunit TIM50TIM 50 10 10 353 0 133.78 0.85257 0.93522 4.44E+09
O15270;H0YJV2 O15270;H0YJV2 Serine palmitoyltransferase 2SPTLC2 5 5 562 0 26.637 0.85227 NaN 2.47E+08
Q9BT22;Q9BT22-2;K7EID2;K7EPU3;K7EQK1;A0A087WZJ8;Q6GMV1;C9J202Q9BT22;Q9BT22-2;K7EID2Chitobiosyldiphosphodolichol beta-mannosyltransferaseALG1 6 6 464 0 26.616 0.85219 1.2208 9.46E+08
Q8N335;C9K0P5;C9JFA7;C9JM46Q8N335 Glycerol-3-phosphate dehydrogenase 1-like proteinGPD1L 5 5 351 0 18.49 0.85179 1.1144 2.18E+08
E7ET49;Q8NCG7-2;Q8NCG7-4;Q8NCG7E7ET49;Q8NCG7-2;Q8NCG7-4;Q8NCG7Sn1-specific diacylglycerol lipase betaDAGLB 2 2 631 0 6.0528 0.85165 NaN 1.07E+07
Q9NRK6;A0A0G2JLV0;A0A087WYD6;X5CMH5;Q9NUT2-5;Q9NUT2-4;Q03519;Q9NUT2-2;Q9NUT2Q9NRK6 ATP-binding cassette sub-family B member 10, mitochondrialABCB10 3 3 738 0 20.206 0.85163 NaN 9.84E+07
Q9UNX4;Q6PDA5 Q9UNX4 WD repeat-containing protein 3WDR3 31 31 943 0 236.66 0.85157 1.5039 3.86E+09
Q9P0J7;C9J3I2 Q9P0J7 E3 ubiquitin-protein ligase KCMF1KCMF1 5 5 381 0 98.328 0.85152 1.3037 1.16E+09
184
O60244;H7C3E5;H7C017O60244 Mediator of RNA polymerase II transcription subunit 14MED14 16 16 1454 0 90.762 0.85145 1.0787 8.18E+08
O00264;O00264-2O00264;O00264-2Membrane-associated progesterone receptor component 1PGRMC1 8 8 195 0 35.165 0.85131 0.82996 6.25E+08
O95831-3;O95831;O95831-2;E9PMA0;O95831-6;O95831-5;O95831-4O95831-3;O95831;O95831-2;E9PMA0poptosis inducing factor 1, mitochondrialIFM1 30 30 609 0 207.46 0.85103 0.75128 6.95E+09
Q9NZQ3-4;Q9NZQ3-3;Q9NZQ3-2;Q9NZQ3;H7C2K2;C9JSC3;H7C0T9Q9NZQ3-4;Q9NZQ3-3;Q9NZQ3- Q NZQ3;H7C2K2;C9JSC3CK-interacting protein with SH3 domainCKIPSD 3 1 651 0 6.9653 0.85053 1.1518 9.03E+07
Q53GT1-3;Q53GT1Q53GT1-3;Q53GT1Kelch-like protein 22KLHL22 1 1 491 0 13.414 0.85049 NaN 1.09E+07
Q00796;H0YLA4;H0YKB3;Q00796-2Q00796;H0YLA4 Sorbitol dehydrogenaseSORD 10 10 357 0 60.131 0.85012 1.064 2.84E+09
Q7KZF4;H7C597 Q7KZF4 Staphylococcal nuclease domain-containing protein 1SND1 53 53 910 0 323.31 0.84992 1.1252 2.65E+10
P46778;G3V1B3;M0R181;M0R3I5P46778;G3V1B3;M0R1816 S ribosomal protein L21RPL21 12 12 160 0 75.044 0.84987 1.2656 7.16E+09
P10586-2;P10586;H0Y4H1;H0Y7Z9;H0Y6Z7;H0Y380;Q3KPI9;F5GWR7;P23468-3;P23468-7;P23468-5;P23468-4;P23468-6;P23468-2;P23468;A2A437P1 586-2;P10586;H0Y4H1;H0Y7Z9;H0Y6Z7;H0Y380Receptor-type tyrosine-protein phosphatase FPTPRF 12 10 1 98 0 92.912 0.84922 0.85635 4.82E+08
Q14126;J3KSI6 Q14126 Desmoglein-2 DSG2 12 12 1118 0 62.765 0.84869 1.0676 3.43E+08
P30101 P30101 Protein disulfide-isomerase A3PDIA3 3 2 505 0 5.4847 0.84854 NaN 5.86E+06
A0A0A0MTR2;Q8N543;Q8N543-2;H3BUA6;H3BR79A0A0A0MTR2;Q8N543;Q8N543-2;H3BUA6Prolyl 3-hydroxylase OGFOD1OGFOD1 4 4 499 0 27.371 0.84835 NaN 1.27E+08
Q9NZD8;Q9NZD8-2;H0YMB7;H0YKB0;H0YML6;H0YLD7;H0YLW1;H0YLT5;H0YKM6;H3BRR0Q9NZD8;Q9NZD8-2 B7; KB0Maspardin SPG21 5 5 308 0 22.204 0.84815 1.1165 4.11E+08
A0A087WTA5;E7ERK9;Q9UI10-3;Q9UI10;Q9UI10-2;A0A087WW69;H7C2L8;F8W8L6A0A087WTA5;E7ERK9;Q9UI10-3;Q9UI10;Q9UI10-2Translation initiation factor eIF-2B subunit deltaEIF2B4 13 13 520 0 68.745 0.84796 NaN 6.01E+08
Q9UKF6;G5E9W3;C9JZH6Q UKF ;G5E9W3 Cleavage and polyadenylation specificity factor subunit 3CPSF3 12 12 684 0 46.655 0.84785 1.0176 1.36E+09
P21912;A0A087WWT1;A0A087WXX8P21912; A087WWT1;A0A087WXX8Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrialSDHB 6 6 280 0 27.244 0.84782 1.0127 6.13E+08
Q96GA7;F8VYZ3;H0YID3;H0YIA2Q96GA7;F8VYZ3;H0YID3Serine dehydratase-likeSDSL 5 5 329 0 58.397 0.84713 1.1767 4.16E+08
I3L496;I3L2P4;Q8IYR2I3L496;I3L2P4;Q8IYR2SET and MYND domain-containing protein 4SMYD4 1 1 177 0 12.214 0.8471 NaN 1.36E+08
P10606 P10606 Cytochrome c oxidase subunit 5B, mitochondrialCOX5B 5 5 129 0 12.02 0.84653 0.49494 2.71E+08
A0A087WXP7;Q9H2P9-3;Q9H2P9-2;Q9H2P9-6;Q9H2P9-4;Q9H2P9;Q9H2P9-5A0A087WXP7;Q9H2P9-3;Q9H2P9-2;Q9H2P9-6;Q9H2P9-4;Q9H2P9;Q9H2P9-5Diphthine synthaseDPH5 9 9 243 0 59.327 0.84638 1.1293 1.19E+09
Q14139;Q14139-2;B7Z7P0Q14139;Q14139-2Ubiquitin conjugation factor E4 AUBE4A 4 4 1066 0 23.686 0.84603 1.1903 3.77E+08
B1AHR1;Q9UH03-2;Q9UH03;B1AHR2B1AHR1;Q9UH03- ;Q9UH03;B1AHR2Neuronal-specific septin-3 03-Sep 6 6 294 0 20.068 0.84591 0.80877 2.88E+08
O95486;O95486-2O95486 Protein transport protein Sec24ASEC24A 9 9 1093 0 58.852 0.8454 1.2348 7.67E+08
P22234;E9PBS1;P22234-2;D6RF62P 234;E9PBS1;P22234-2;D6RF62Multifunctional protein ADE2;Phosphoribosylaminoimidazole-succinocarboxamide synthase;Phosphoribosylaminoimidazole carboxylasePAICS 24 24 425 0 323.31 0.84515 1.2458 1.56E+10
P52294;C9JYI4;C9J352;C9JWD9;F2Z3G4;C9J4U1P52 94;C9JYI4 Importin subunit alpha-5;Importin subunit alpha-5, N-terminally processedKPNA1 14 6 538 0 77.739 0.84461 NaN 5.49E+08
B4DGL8;O75027;O75027-2;A0A087WW65;O75027-3;E9PJR8;E9PNQ5B4DGL8;O75027;O75027-2;A0A087WW65;O75027-3ATP-binding cassette sub-family B member 7, mitochondrialABCB7 9 9 702 0 72.474 0.8443 NaN 2.81E+08
P62314;J3QLI9;J3QLR7P62314;J3QLI9 Small nuclear ribonucleoprotein Sm D1SNRPD1 5 5 119 0 81.644 0.84358 1.3965 5.07E+09
Q5SWX8-4;Q5SWX8;Q5SWX8-3;Q5SWX8-2Q5SWX8-4;Q5SWX8;Q5SWX8-3;Q5SWX8-2Protein odr-4 homologODR4 8 8 422 0 34.832 0.84355 0.45436 1.16E+09
P62820;E7END7;P62820-2;P62820-3P62820;E7END7;P62820-2;P62820-3Ras-related protein Rab-1ARAB1A 8 3 205 0 25.702 0.84333 1.3051 1.55E+08
Q9UBM7;E9PM00;E9PJ54;E9PRL8;E9PQ71;E9PIP9;H0YE57;E9PLZ2Q9UBM7;E9PM00;E9PJ547-dehydrocholesterol reductaseDHCR7 8 8 475 0 52.974 0.84323 1.0169 2.36E+09
A0A0A0MS52;Q13555-4;Q5SWX3;A0A0A0MT11;Q13555-10;Q13555-5;Q13555-2;Q13555-8;Q13555;Q13555-6;Q8WU40;Q13555-3;Q13555-7;Q13555-9;H0Y6G2;H7BXS4;E9PBE8;E7EQE4;D6RHX9;D6RFJ0;E7ERS6;E7ETC9;H7C394A0A0A0M 52;Q13555-4;Q5SWX3;A0A0A MT11;Q13555-10;Q13555-5;Q13555-2;Q13555-8;Q13555;Q1355 -6;Q8WU40;Q13555-3;Q13555-7;Q13555-9;H0Y6G2Calcium/calmodulin-dependent protein kinase type II subunit gammaC MK2G 13 7 539 0 8 .382 0.843 2 1.0207 8.27E+08
P51114-2;P51114;B4DXZ6;E9PFF5;E7EU85;P51114-3;C9JZE0;C9JY20;C9JAJ4;C9IZ22;C9JYQ6;C9J5B4P51114-2;P51114;B4DXZ6;E9PFF5;E7EU85;P51114-3Fragile X mental retardation syndrome-related protein 1FXR1 15 13 539 0 84.671 0.84264 0.89349 1.79E+09
Q9BUR4;E9PMG4;E9PMR3Q BU 4;E9PMG4;E9PMR3Telomerase Cajal body protein 1WRAP53 4 4 548 0 59.047 0.84249 NaN 1.29E+08
A0A096LP25;Q6ZSR9A0A096LP25;Q6ZSR9Uncharacterized protein FLJ45252 2 2 511 0 12.005 0.84238 NaN 6.81E+07
E9PCY5;Q02880-2;Q02880;H7BZ82E9PCY5;Q02880-2;Q02880DNA topoisomerase 2;DNA topoisomerase 2-betaTOP2B 27 14 1150 0 66.874 0.84232 1.7124 1.14E+09
B4DKY1;P49589-2;P49589;P49589-3;C9JLN0;E9PRS8;E9PLP0B4DKY1;P49589-2;P4 589;P49589-3Cysteine--tRNA ligase, cytoplasmicCARS 10 10 739 0 30.862 0.84219 0.89599 9.38E+08
P30520;G3V232 P30520 Adenylosuccinate synthetase isozyme 2ADSS 25 22 456 0 295.91 0.84189 1.0865 2.20E+10
O43819;C9JBU1 O43819 Protein SCO2 homolog, mitochondrialSCO2 3 3 266 0 11.038 0.84188 NaN 1.08E+08
Q96EY7;B8ZZQ4;F8WE76;Q96EY7-2Q96EY7 Pentatricopeptide repeat domain-containing protein 3, mitochondrialPTCD3 7 7 689 0 59.511 0.84185 NaN 5.10E+08
H0YK95;H0YL95;Q9UPM8H0YK95;H0YL95;Q9UPM8AP-4 complex subunit epsilon-1AP4E1 2 2 321 0 5.6972 0.84164 NaN 3.80E+07
O75083;O75083-3;D6RD66O75083;O75083-3;D6RD66W  repeat-containing protein 1WDR1 22 22 606 0 323.31 0.84136 0.88353 8.45E+09
Q96F86;H3BSQ0;H3BPN4;H3BPW9;H3BQ37;H3BQP5;H3BU87;H3BNJ7;H3BTD6;H3BMB8;H3BTH0Q96F86 Enhancer of mRNA-decapping protein EDC3 15 15 508 0 65.098 0.84105 NaN 1.02E+09
Q8WWL2-3;Q8WWL2-2;Q8WWL2Q8WWL2-3;Q8WWL2-2;Q8WWL2Protein spire homolog 2SPIRE2 1 1 666 0.0030434 2.6393 0.84061 NaN 2.45E+08
O75530-3;O75530;O75530-2;E9PJK2O75530-3;O75530;O75530-2Polycomb protein EEDEED 4 4 400 0 9.0758 0.8405 1.1388 1.97E+08
Q8TED1;J3KNB5;E7ETY7Q8 ED1;J3KNB5;E7ETY7Probable glutathione peroxidase 8;Glutathione peroxidaseGPX8 3 3 209 0 10.042 0.83965 NaN 2.00E+08
Q12906-5;Q12906-4;Q12906-2;Q12906-6;Q12906-3;Q12906;Q12906-7;K7EKJ9;K7EQR9;K7EKY0;K7ER69;K7EPG3;K7ERM6;K7ENK6;K7EM82;K7EJ09;K7EQ75Q12906-5;Q12906-4;Q12906-2;Q12906-6;Q12906-3;Q12906;Q12906-7Interleukin enhancer-binding factor 3ILF3 34 30 690 0 323.31 0.83945 1.2575 1.26E+10
Q9BYC8 Q9BYC8 39S ribosomal protein L32, mitochondrialMRP 1 1 188 0 76.791 0.83911 NaN 2.74E+08
Q9UDR5;F8WAH1;F8WE53Q9UDR5;F8WAH1;F8WE53Alpha-aminoadipic semialdehyde synthase, mitochondrial;Lysine ketoglutarate reductase;Saccharopine dehydrogenaseAASS 11 11 926 0 70.458 0.83903 0.82412 6.19E+08
Q8NEM2 Q8NEM2 SHC SH2 domain-binding protein 1SHCBP1 3 3 672 0 10.121 0.83896 1.5266 1.11E+08
Q9UJT0;S4R3K3;A0A0B4J2B9;S4R424Q9UJT0;S4R3K3 Tubulin epsilon chainTUBE1 6 6 475 0 38.402 0.83885 1.0026 4.18E+08
Q9HD20-2;Q9HD20;H7C3H2Q9 D20-2;Q9HD20Manganese-transporting ATPase 13A1ATP13 1 5 5 1086 0 14.904 0.83861 1.0515 2.52E+08
A0A087X0Q9;Q9BVL4A0A087X0Q9;Q9BVL4Selenoprotein O SELO 6 6 668 0 19.855 0.83804 NaN 3.69E+08
A0A0A0MRK6;Q13505-3;Q13505;A0A0C4DFQ1;Q13505-2;H0Y6Y5A0A0A0MRK6;Q135 5-3;Q13505;A0A0C4DFQ1;Q13505-2Metaxin- MTX1 5 5 466 0 28.745 0.83788 1.0142 3.67E+08
Q9NY61;A0A087WWS8;A0A087WW41Q9NY61 Protein AATF AATF 6 6 560 0 50.399 0.83736 0.99885 6.80E+08
O95239-2;O95239;Q2VIQ3O95239-2;O95239Chromosome-associated kinesin KIF4AKIF4A 9 9 1127 0 48.795 0.83706 1.0686 3.61E+08
Q05823;Q05823-2Q05823;Q05823-2 -5A-dependent ribonucleaseRNASEL 4 3 741 0 5.3252 0.83695 NaN 9.40E+07
Q8NFF5-3;Q8NFF5-2;Q8NFF5;Q5T196;Q8NFF5-4;Q8NFF5-5;Q5T190;Q5T191Q8NFF5-3;Q8NFF5-2;Q8NFF5;Q5T196FAD synthase;Molybdenum cofactor biosynthesis protein-like region;FAD synthase regionLAD1 12 12 446 0 98.739 0.83679 0.96515 1.57E+09
Q8N0X7 Q8N0X7 Spartin SPG20 13 13 666 0 160.37 0.8367 1.3048 1.83E+09
Q9UGP8;A6PVC9 Q9UGP8 Translocation protein SEC63 homologSEC63 8 8 760 0 30.388 0.83654 1.0871 9.44E+08
P63151;P63151-2;E5RFR9;Q66LE6;E5RIY1;Q00005-6;Q00005;Q00005-2;Q00005-3;Q00005-4;Q00005-5;Q00005-7P63151;P63151-2Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoformPPP2R2A 5 5 447 0 32.538 0.83637 1.1124 2.53E+08
P84077;P61204;P61204-2;F5H423;F5H0C7;H0YGG7P84077;P61204;P612 4-2;F5H423ADP-ribosylation factor 1;ADP-ribosylation factor 3ARF1;ARF3 12 8 181 0 205.56 0.83613 1.3705 1.23E+10
P62495;B7Z7P8;P62495-2;D6RCB3;I3L492;D6RJE8P62495;B7Z7P8;P62495-2Eukaryotic peptide chain release factor subunit 1ETF1 7 7 437 0 38.09 0.83601 1.3081 8.09E+08
Q9BV44;H7C3J3;H7C0R6Q9BV44;H7C3J3;H7C0R6THUMP domain-containing protein 3THUMPD3 8 8 507 0 30.964 0.83595 NaN 4.75E+08
O43542;G3V3H9;G3V399;G3V3C8;G3V3Q2O43542 H9; 99DNA repair protein XRCC3XRC 3 5 5 346 0 9.0886 0.83579 1.5937 2.63E+08
Q3SXM5;Q3SXM5-2;H3BT52;H3BQI7;H3BNH5Q3SXM5;Q3SXM5-2Inactive hydroxysteroid dehydrogenase-like protein 1HSDL1 10 10 330 0 36.814 0.83534 1.1222 1.11E+09
Q13347;Q5TFK1 Q13347 Eukaryotic translation initiation factor 3 subunit IEIF3I 15 15 325 0 172.68 0.83507 1.1472 7.05E+09
Q5R3B4;O95563 Q5R3B4;O95563 Mitochondrial pyruvate carrier 2MPC2 4 4 105 0 9.3841 0.83495 0.5824 1.33E+08
Q147X3;Q147X3-2;J3KNC2;B4DK34Q147X3;Q1 7X -2;J3KNC2N-alpha-acetyltransferase 30NAA30 5 5 362 0 40.873 0.83494 1.2443 2.51E+08
A0A0C4DGA6;Q14527;Q14527-2;H7C5K0A0A0C4DGA6;Q14527;Q14527-2Helicase-like transcription factorHLTF 10 10 1008 0 75.484 0.83474 0.9622 5.44E+08
P84090;G3V279 P84090;G3V279 Enhancer of rudimentary homologERH 2 2 104 0 18.122 0.8342 0.78704 1.02E+09
O00483 O00483 Cytochrome c oxidase subunit NDUFA4NDUFA4 3 3 81 0 10.821 0.83378 1.1233 1.62E+09
Q5R3I4;H7C089;A9UJP8;H7C2L7Q5R3I4 Tetratricopeptide repeat protein 38TTC38 5 5 469 0 18.548 0.83376 0.91433 4.93E+08
Q99717;D6RIZ9;D6RBB4;Q15797;D6R9D4;H0YAK7Q99717 Mothers against decapentaplegic homolog 5SMAD5 6 6 465 0 31.222 0.83355 0.60102 2.66E+08
Q5T760;Q05519-2;Q05519;B4DWT1;S4R3C4;Q5T757Q5T760;Q05519-2;Q05519 B4DWT1Serine/arginine-rich splicing factor 11SRSF11 4 4 389 0 20.774 0.83347 1.0943 4.91E+08
Q9BQ39;A0A087WVC1Q9BQ39;A0A087WVC1ATP-dependent RNA helicase DDX50DDX50 9 7 737 0 44.574 0.83321 0.99971 1.11E+09
P11388;P11388-2;P11388-3;P11388-4;J3KTB7P1 38 ;P11388-2;P11 88-3;P11388-4DNA topoisomerase 2-alphaTOP2A 60 47 1531 0 323.31 0.83288 1.5014 8.72E+09
G3V529;Q9GZR7;Q9GZR7-2;A0A087WXU8;F5GYL3G3V529;Q9GZR7;Q9GZR7-2;A0A087WXU8;F5GYL3ATP-dependent RNA helicase DDX24DD 24 10 10 816 0 93.007 0.83245 1.7248 6.11E+08
Q6KC79-2;Q6KC79Q6KC79-2;Q6KC79Nipped-B-like proteinNIPBL 8 8 2697 0 46.103 0.8324 1.144 2.16E+08
Q9UJZ1;A0A087WYB4;Q9UJZ1-2;F2Z2I8Q9UJZ1;A0A087WYB4;Q9UJZ1-2Stomatin-like protein 2, mitochondrialSTOML2 20 20 356 0 323.31 0.83137 1.0599 1.07E+10
Q96LJ7;H0YNC2 Q96LJ7;H0YNC2 Dehydrogenase/reductase SDR family member 1DHRS1 2 2 313 0 5.6878 0.83114 NaN 2.44E+07
Q9BU61;Q9BU61-2Q9BU61 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3NDUFAF3 3 3 184 0 14.907 0.8305 NaN 8.89E+07
P00387-2;P00387;P00387-3;B1AHF3P0 387-2;P00387;P00387-3;B1AHF3NADH-cytochrome b5 reductase 3;NADH-cytochrome b5 reductase 3 membrane-bound form;NADH-cytochrome b5 reductase 3 soluble formCYB5R3 11 11 278 0 161.48 0.83033 1.0779 2.39E+09
F5H442;Q99816;Q99816-2;J3QRU6;J3QKS4F5H442;Q99816;Q99816-2Tumor susceptibility gene 101 proteinTSG101 6 6 365 0 27.498 0.83011 0.28233 2.03E+08
Q9HD45;Q5TB53 Q9HD45;Q5TB53 Transmembrane 9 superfamily member 3TM9SF3 8 8 589 0 55.799 0.83 0.99433 1.55E+09
C9J266;Q5XPI4;Q5XPI4-2;C9JS59C9J266;Q5XPI4;Q5XPI4-2;C9JS59E3 ubiquitin-protein ligase RNF123RNF123 5 5 762 0 15.839 0.82958 0.704 1.36E+08
E9PFN5;Q9Y2Q3-4;Q9Y2Q3;Q9Y2Q3-3;Q9Y2Q3-2;C9JNT3E9PFN5;Q9Y2Q3-4;Q9Y2Q3;Q9Y2Q3-3;Q9Y2Q3-2Glutathione S-transferase kappa 1GSTK1 3 3 190 0 26.349 0.82925 0.92468 4.01E+08
H0Y8C4;E9PFR3;Q14738;Q14738-3;Q14738-2H0Y8C4;E9PFR3;Q14738;Q14738-3;Q14738-2Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoformPPP2R5D 2 2 504 0 5.1909 0.82899 NaN 4.95E+07
Q9Y232-3;Q9Y232-4;Q9Y232-2;Q9Y232Q9Y232- ;Q9Y232-4;Q9Y232-2;Q9Y232Chromodomain Y-like proteinCDYL 1 1 309 0 3.6714 0.82872 NaN 3.90E+07
O14929;O14929-2;F8W9G7O14929;O14929-2Histone acetyltransferase type B catalytic subunitHAT1 8 8 419 0 151.31 0.82829 1.0507 3.03E+09
Q00653-4;Q00653;A0A087WWG7;Q00653-3;M0R119Q0 653-4;Q00653Nuclear factor NF-kappa-B p100 subunit;Nuclear factor NF-kappa-B p52 subunitNFKB2 5 5 899 0 23.585 0.82817 0.96073 2.32E+08
Q9HA77;H0YFF0;A0A087WWV1;H0YFV1;F5H623;F5H579Q9HA 7 Probable cysteine--tRNA ligase, mitochondrialCARS2 8 8 564 0 27.523 0.82812 0.9077 5.51E+08
F6SL11;O95258-2;O95258;O95258-3;A0A087WWR9;E5RIW6;Q5JY88F6SL11;O95258-2;O9525 ;O95258-3Brain mitochondrial carrier protein 1SLC25A14 5 3 290 0 10.272 0.82799 0.3705 1.86E+08
Q8WU90;H7C466;F8WB26Q8 U90;H7C466;F8WB26Zinc finger CCCH domain-containing protein 15ZC3H15 2 2 426 0 14.931 0.82754 NaN 1.37E+08
P28066;P28066-2P28066;P28066-2Proteasome subunit alpha type-5PSMA5 7 7 241 0 82.046 0.82738 1.3993 1.64E+09
Q9Y6G9;E9PHI6;C9JGM7;C9JLW1Q9Y6G9;E9PHI6 Cytoplasmic dynein 1 light intermediate chain 1DYNC1LI1 10 10 523 0 103.06 0.82695 NaN 3.77E+08
Q13595-4;Q13595-3;Q13595;Q13595-2Q13595-4;Q13595-3;Q13595;Q13595-2Transformer-2 protein homolog alphaTRA A 4 4 180 0 16.104 0.82649 2.4649 4.75E+08
O00410;H0Y8C6;O00410-3;O00410-2;E7ETV3;C9JZD8;E7EQT5;C9JMV5;C9J875;C9JQT6;E7ESA1;E7ESZ1;E7EWK4;E7EX05;E7ETV8;E7EV12;H0Y3V400410;H0Y8C6;O00410-3;O00410-2Importin-5 IPO5 11 10 109 0 76.147 0.82617 1.0033 1.08E+09
Q8IZ73;Q8IZ73-2;A0A087WXE2Q8IZ73;Q8IZ73-2;A0A087WXE2RN  pseudouridylate synthase domain-containing protein 2RPUSD2 4 4 545 0 6.3831 0.82518 NaN 1.03E+08
Q06203;D6RCC8;D6RE15Q06203;D6RCC8 AmidophosphoribosyltransferasePPAT 4 4 517 0 34.297 0.82469 NaN 1.93E+08
Q9H3P7 Q9H3P7 Golgi resident protein GCP60ACBD3 12 12 528 0 220.28 0.82463 NaN 7.05E+08
O60271-4;A0A087X2D8;O60271-2;O60271;O60271-9;O60271-5;O60271-3;H0YBE9;D6RHI8;E9PFH7;A0A087WYG2;Q9UPT6;H0YBS5;Q9UPT6-2O60271-4;A0A087X2D8;O60271-2;O60271;O60271-9;O60271-5;O60271-3C-Jun-amino-terminal kinase-interacting protein 4SPAG9 24 24 1307 0 140.65 0.82422 1.1183 7.89E+08
O60763;O60763-2;REV__R4GMN2;REV__Q5VZ89-5;REV__Q5VZ89-6;REV__Q5VZ89;REV__R4GNB2;REV__R4GN35O60763;O60763-2General vesicular transport factor p115USO1 27 27 962 0 323.31 0.82394 1.1599 4.25E+09
J3KMZ7;Q9H0H0;J3KRH0MZ7;Q9H0H0 Integrator complex subunit 2INTS2 5 5 1196 0 41.397 0.82333 1.4743 5.46E+08
Q9BRR6-2;Q9BRR6;Q9BRR6-4;Q9BRR6-3;H3BRS6Q9BR 6-2;Q9BR 6;Q9BRR6-4;Q9BRR6-3ADP-dependent glucokinaseADPGK 3 3 496 0 13.593 0.82323 1.1179 7.69E+07
185
Q9BY44;Q9BY44-3;F8WAE5;Q9BY44-4;Q9BY44-2;C9IZE1;H7C5R5;H7C5Q3;F8WF18;F8WAT3Q9BY44;Q9BY44-3;F8WAE5;Q9BY44-4 Q9BY44-2Eukaryotic translation initiation factor 2A;Eukaryotic translation initiation factor 2A, N-terminally processedIF2A 18 18 585 0 211.62 0.8231 NaN 2.47E+09
Q5XUX1-3;Q5XUX1-2;Q5XUX1;K7EL01Q5XUX1-3;Q5XUX1-2;Q5XUX1;K7EL01F-box/WD repeat-containing protein 9FBXW9 3 3 458 0 31.282 0.82299 1.3258 1.22E+08
E7ETK0;A0A087WUS0;P62847-2;P62847-3;P62847;P62847-4E7ETK0;A0A087WUS0;P62847-2;P62847-3;P62847;P62847-440S ribosomal protein S2RPS24 7 7 131 0 29.07 0.82297 1.1467 3.33E+09
Q96FX7;H0Y2Q1 Q96FX7;H0Y2Q1 tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61ATRMT61A 5 5 289 0 57.244 0.82272 1.2276 4.02E+08
A0A140TA86;Q5XKP0;K7EIR2;A0A140TA84A0A140TA86;Q5XKP0;K7EIR2;A0A140TA84Protein QIL1 QIL1;C19orf70 4 4 140 0 67.587 0.82264 1.3881 3.61E+08
P46977;P46977-2;A0A0C4DH80;E9PN73;E9PI32;H0YET6P46977;P46977-2Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3AS T3A 12 12 705 0 65.747 0.82259 1.0673 3.29E+09
C9JA28;Q9UNL2;Q9UNL2-2;C9J365C9JA28;Q9UNL2;Q9UNL2-2;C9J365Translocon-associated protein subunit gammaSSR3 2 2 174 0 28.74 0.82233 1.182 1.23E+09
P10809;E7ESH4;E7EXB4;P10809-2;C9JL25;C9JL19;C9JCQ4;C9J0S9P10809 60 kDa heat shock protein, mitochondrialHSPD1 41 41 573 0 323.31 0.82221 1.0604 1.37E+10
P31939;P31939-2;C9JLK0;H7C1S2;F8WEF0P31939;P31939-2Bifunctional purine biosynthesis protein PURH;Phosphoribosylaminoimidazolecarboxamide formyltransferase;IMP cyclohydrolaseATIC 13 13 592 0 143.87 0.82198 NaN 8.75E+08
A0A0C4DGZ0;P24928;A0A087WWE2;P24928-2A0A0C4DGZ0;P24928;A0A087WWE2DNA-directed RNA polymerase II subunit RPB1POLR2A 54 54 1970 0 323.31 0.82192 1.2369 4.17E+09
J3KPP4;O95232;D6RDI2;E7EN55;C9JL41;O95232-2J3KPP4;O95232;D6RDI2Luc7-like protein 3LUC7L3 4 4 489 0 29.809 0.82071 1.0622 2.48E+08
P17858;P17858-2P17858;P17858-2ATP-dependent 6-phosphofructokinase, liver typePFKL 30 25 780 0 323.31 0.82038 1.1991 8.50E+09
P36957;P36957-2;Q86SW4;H0YJF9;G3V3F0;G3V5M3P36957;P36957-2;Q86SW4Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrialDLST 9 9 453 0 50.245 0.82004 1.5782 1.23E+09
P54136;P54136-2;E5RJM9;E5RH09;E5RI24P54136;P54136-2Arginine--tRNA ligase, cytoplasmicRARS 43 43 660 0 310.06 0.81926 1.6576 9.77E+09
Q6P158;H7C109;Q6P158-2;A0A087WZ11;Q6P158-3;H7C1 9 Putative ATP-dependent RNA helicase DHX57DHX57 19 18 1386 0 117.13 0.81915 1.3531 6.81E+08
C9JYM0;O75817 C9JYM0;O75817 Ribonuclease P protein subunit p20POP7 4 4 137 0 12.68 0.81907 3.5549 4.33E+08
F5H619;Q86XA9;Q86XA9-2;H0YIW3;H7C5W6F5H61 ;Q86XA9;Q86XA9-2HEAT repeat-containing protein 5AHEATR5A 6 6 2046 0 22.564 0.81902 1.2677 2.57E+08
Q96T21-2;Q96T21-3;Q96T21;Q5HYY5Q96T21- ;Q96T21-3;Q96T21Selenocysteine insertion sequence-binding protein 2SECISBP2 3 3 781 0 13.104 0.81868 NaN 1.07E+08
A0A087WZT2;Q6UX53A0A087WZT2;Q6UX53Methyltransferase-like protein 7BMETTL7B 2 2 276 0.0037869 2.5752 0.81867 NaN 7.49E+07
O14744;O14744-5;O14744-2;O14744-3;G3V5L5;G3V580;H0YJX6;G3V2X6;C9JSX3;O14744-4;G3V2L6;G3V507;G3V2F5;G3V5T6;H0YJ77;H0YJD3O14744;O1474 -5;O14744-2;O14744-3;G3V5L5;G3V580;H0YJX6Protein arginine N-methyltransferase 5;Protein arginine N-methyltransferase 5, N-terminally processedPRMT5 13 1 637 0 92.422 0.81831 NaN 1.11E+09
G3V1C3;Q9BZZ5-1;Q9BZZ5-3;Q9BZZ5-5;Q9BZZ5-2;Q9BZZ5-6;Q9BZZ5;H0YER7G3V1C3;Q9BZZ5-1;Q9BZZ5-3;Q9BZZ5-5;Q9BZZ5-2;Q9BZZ5-6;Q9BZZ5;H0YER7Apoptosis inhibitor API 2 2 510 0 63.072 0.81732 NaN 8.60E+07
Q9Y291;C9JBY7 Q9Y291;C9JBY7 28S ribosomal protein S33, mitochondrialMRP 3 3 106 0 8.3013 0.81678 1.3782 1.80E+08
U3KPU7;U3KQS2;O43826;O43826-2U3KPU7;U3KQS2;O43826;O43826-2Glucose-6-phosphate translocaseSLC37A4 1 1 429 0 4.6554 0.81677 1.4818 3.21E+08
Q53GS9;B9A018;A0A087X1B2;Q53GS9-2;Q53GS9-3;F8WC91;A0A087WW31;C9JIU2Q53GS9;B9A018;A0A087X1B2;Q53GS9-2;Q53GS9-3U4/U6.U5 tri-snRNP-associated protein 2U P3 13 13 565 0 114.6 0.8167 NaN 1.31E+09
Q969V3-2;Q969V3;K7EMW4;A0A0C4DGP7;K7ELZ9;K7ENM2;K7EQ66;K7EN96Q969V3-2;Q969V3;K7EMW4;A0A0C4DGP7;K7ELZ9 M2Nicalin NCLN 22 22 562 0 281.17 0.8162 1.1629 3.50E+09
Q00577 Q00577 Transcriptional activator protein Pur-alphaPURA 2 2 322 0 107.19 0.81594 1.3565 5.39E+08
Q86U42-2;Q86U42;H0YJH9;B4DEH8;G3V4T2;Q92843-2Q86U42-2;Q86U42;H0YJH9;B4DEH8;G3V4T2;Q92843-2Polyadenylate-binding protein PABPN1 2 2 296 0 11.282 0.81521 NaN 1.60E+08
Q9BVQ7-2;Q9BVQ7;H0YCA5;Q9BVQ7-3Q9BVQ7-2; ;H0YCA5Spermatogenesis-associated protein 5-like protein 1SPATA5L1 3 3 620 0 26.041 0.81517 1.1789 3.31E+08
P11172;P11172-3;P11172-2;E9PFD2;P11172-4;F2Z3P2;F2Z303;F8WDG4P1 72;P11172-3;P1 72-2;E9PFD2;P11172-4Uridine 5 monophosphate synthase;Orotate phosphoribosyltransferase;Orotidine 5-phosphate decarboxylaseUMPS 24 24 480 0 146.91 0.81516 1.1558 5.54E+09
P82673;H0YG82;P82673-2P82673;H0YG82;P82673-228S ribosomal protein S35, mitochondrialMRP 5 5 323 0 63.567 0.81488 0.18951 7.20E+08
A0A087X2H1;Q9ULT8;H0YJP0;G3V4V5;H0YJD4;A0A087WVU6;H0YJ72;H0YJV8A0A087X2H1;Q9ULT8;H0YJP0E3 ubiquitin-protein ligase ECTD1HECTD1 36 36 2614 0 278.17 0.81469 1.2016 2.16E+09
O94829;Q5T4X2 O94829 Importin-13 IPO13 6 6 963 0 19.507 0.81461 1.2688 2.65E+08
P49642;H0YIP2;F8VSB2;F8VNY2P49642 DNA primase small subunitPRIM1 7 7 420 0 46.04 0.81417 1.2813 4.03E+08
Q8N1B4;Q8N1B4-2;A0A0G2JIG2;E9PI03Q8N1B4;Q8N1B4-2Vacuolar protein sorting-associated protein 52 homologVPS52 14 14 723 0 115.7 0.81372 0.74434 6.87E+08
F5H039;Q9NQX3;Q9NQX3-2;G3V582;H0YJ30;G3V4D2;G3V4R0;G3V355;H0YJR5F5H039;Q9NQX3;Q9NQX -2;G3V582;H0YJ3Gephyrin;Molybdopterin adenylyltransferase;Molybdopterin molybdenumtransferaseGPHN 8 8 782 0 32.253 0.81362 1.3998 6.90E+08
P56589;Q7Z6V3 P56589;Q7Z6V3 Peroxisomal biogenesis factor 3PEX3 6 6 373 0 40.878 0.81356 0.77498 7.01E+07
Q9Y478;F5H2X8;F5H610;O43741-2;O43741Q9Y478;F5H2X8 5-AMP-activated protein kinase subunit beta-1PRKAB1 3 3 270 0 43.598 0.81348 0.93657 2.23E+08
Q8IZ83-3;Q8IZ83;F5H4B6;M0QY06;Q8IZ83-2Q8IZ83-3;Q8IZ83 F5H4B6Aldehyde dehydrogenase family 16 member A1ALDH16A1 9 9 751 0 71.562 0.81342 1.0543 1.09E+09
Q92572;F5H459 Q92572 AP-3 complex subunit sigma-1AP3S1 7 7 193 0 25.683 0.81237 0.77746 1.21E+09
P15121;E9PCX2;E9PEF9;C9JRZ8;C9JRZ8-2P15121;E9PCX2;E9PEF9Aldose reductase AKR1B1 5 5 316 0 75.969 0.81214 0.99823 4.35E+08
Q9BTX1-3;Q9BTX1-6;Q9BTX1-5;Q9BTX1-2;Q9BTX1Q9BTX1-3;Q9BTX1-6;Q9BTX1-5;Q9BTX1-2;Q9BTX1Nucleoporin NDC1NDC1 2 2 557 0 21.727 0.8121 NaN 1.55E+08
Q13112 Q13112 Chromatin assembly factor 1 subunit BCHAF1B 8 8 559 0 20.583 0.81151 NaN 2.53E+08
Q86Y07-4;Q86Y07-5;Q86Y07-2;Q86Y07-3;Q86Y07Q86Y07-4;Q86Y07-5;Q86Y07-2;Q86Y07-3;Q86Y07Serine/threonine-protein kinase VRK2VRK2 2 2 390 0 5.4196 0.8107 NaN 3.77E+07
Q9P2K8-2;Q9P2K8;H0YME5;Q9P2K8-3;H0YND8Q9P2K8-2 ;H0YME5Eukaryotic translation initiation factor 2-alpha kinase 4EIF2AK4 10 10 1621 0 49.225 0.81067 1.2988 6.04E+08
B1AHD1;P55769 B1AHD1;P55769 NHP2-like protein 1;NHP2-like protein 1, N-terminally processedNHP2L1 3 3 132 0 16.047 0.81062 NaN 5.70E+08
P46019 P46019 Phosphorylase b kinase regulatory subunit alpha, liver isoformPHKA2 4 3 1235 0 5.7305 0.81051 NaN 1.41E+08
A0A0G2JNZ2;A0A0G2JPP5;Q14160;Q14160-3;A0A0G2JMS7;Q14160-2;H0YCG0;H0YDF9A0A0G2JNZ2;A0A0G2JPP5;Q14160;Q14160-3;A0A0G2JMS7;Q14160-2Protein scribble homologSCRIB 11 10 1630 0 77.369 0.80988 0.85187 8.20E+08
Q6PI78 Q6PI78 Transmembrane protein 65TMEM65 2 2 240 0 8.1667 0.80988 NaN 1.05E+08
Q9HCS7 Q9HCS7 Pre-mRNA-splicing factor SYF1XAB2 10 10 855 0 54.457 0.80979 0.94508 4.82E+08
Q7Z2Z2-2;Q7Z2Z2;H0YKY7;H0YNW8;H0YK75Q7Z2Z2-2;Q7Z2Z2Elongation factor Tu GTP-binding domain-containing protein 1EFTUD1 23 23 1069 0 235.78 0.80973 1.1232 1.25E+09
Q9Y3T9 Q9Y3T9 Nucleolar complex protein 2 homologNOC2L 22 22 749 0 91.058 0.80909 1.2425 4.20E+09
Q05DH4 Q05DH4 Protein FAM160A1FAM160A1 1 1 1040 0.008037 2.0723 0.80882 NaN 9.16E+07
A0A087WVR3;A0A087WTW0;Q96T88;Q96T88-2;A0A087WWG90A087 VR3;A0A087W W0;Q96T8 ;Q96T88-2;A0A087WWG9E3 ubiquitin-protein ligase UHRF1UHRF1 10 10 806 0 31.362 0.80876 1.31 5.73E+08
F5H0F9;Q9UJX4;Q9UJX4-3;F5GY68;H0YFB5;F5H0N1;Q9UJX4-2;F5GZ05;F5H3S5F5H0F9;Q9UJX4;Q9UJX4-3Anaphase-promoting complex subunit 5ANAPC5 10 10 742 0 46.999 0.8085 0.81476 4.80E+08
P0DMV9;P0DMV8;A0A0G2JIW1;P0DMV8-2;V9GZ37P0DMV9;P0DMV8;A0A0G2JIW1;P0DMV8-2;V9GZ37HSPA1A 50 26 641 0 323.31 0.80843 1.4583 1.39E+11
P35219 P35219 Carbonic anhydrase-related proteinCA8 3 3 290 0 20.227 0.8084 1.0199 3.20E+08
O75351;K7EL71;K7EKZ3O75351 Vacuolar protein sorting-associated protein 4BVPS4B 12 5 444 0 88.499 0.80836 1.3773 8.32E+08
P50453 P50453 Serpin B9 SERPINB9 5 5 376 0 15.511 0.80787 0.72496 3.01E+08
Q69YN4;Q69YN4-3;Q69YN4-2;Q69YN4-4;H0YBN5;H0YB68Q69YN4;Q69YN4-3;Q69YN4-2;Q69YN4-4Protein virilizer homologKIAA1429 16 16 1812 0 74.785 0.80761 1.5012 6.09E+08
Q92604 Q92604 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1LPGAT1 2 2 370 0 3.7654 0.80668 1.0999 2.33E+08
Q9BSC4-2;Q9BSC4-4;Q9BSC4Q9BSC4-2;Q9BSC4-4;Q9BSC4Nucleolar protein 10NOL10 2 2 638 0 7.3611 0.80624 0.98571 1.82E+08
P15374;A0A087WTB8;Q5TBK7P15374;A0A087WTB8;Q5TBK7Ubiquitin carboxyl-terminal hydrolase isozyme L3UCHL3 8 8 230 0 37.598 0.80613 1.0635 8.30E+08
Q9UHD8-7;Q9UHD8-2;Q9UHD8-5;Q9UHD8;Q9UHD8-3;Q9UHD8-4;Q9UHD8-9;Q9UHD8-8;K7EL40;K7ENL0;K7EK18;K7ER52;K7EIE4;K7EQD7;K7EPY1;K7EJV0;K7ELJ9;K7EJ51;K7EJZ2;K7EIR4;K7EKN4;K7EN52;K7ENQ5;K7ER14;K7ER34;K7EJL9;K7ERG1;K7EQ08Q9UHD8-7;Q9UHD8-2;Q9UHD8-5;Q9UHD8;Q9UHD8-3;Q9UHD8-4;Q9UHD8-9;Q9UHD8-8Septin-9 09-Sep 27 27 67 0 236.8 0.80595 1.0803 3.31E+09
O00258;B7Z1T1;O00258-2;H7BYE5;A0A096LNT6;H7C384O00258;B7Z1T1;O0 258-2;H7BYE5Tail-anchored protein insertion receptor WRBWRB 4 4 174 0 8.7221 0.80592 NaN 1.21E+08
J3KQS6;Q9NWV8;M0R0I0;Q9NWV8-3;M0QXG9;M0R3F4;M0R2A4;M0R2K3;M0R193;M0R2I2;M0R3H9;Q9NWV8-2J3KQS6;Q9N V8;M0R I0;Q NWV8-3;M0QXG9; 0R3F4; 0R2A4; 0R2K3 193BRISC and BRCA1-A complex member 1BABAM1 5 5 254 0 149.5 0.80579 1.1347 3.96E+08
F8WBW1;Q86X83-2;Q86X83;F8WC41F8WBW1;Q86X83-2;Q86X83;F8WC41COMM domain-containing protein 2COMMD2 2 2 135 0 9.4244 0.80568 NaN 2.09E+08
P61160;P61160-2;F5H6T1P611 0;P61160-2;F5H6T1Actin-related protein 2ACTR2 11 11 394 0 116.11 0.80552 1.0439 2.93E+09
Q14012;C9JES6;H7C071Q140 2;C9JES6;H7C071Calcium/calmodulin-dependent protein kinase type 1CAMK1 2 2 370 0 4.1925 0.80537 0.8125 6.75E+07
Q12788;J3KNP2;A0A087WYP7;H3BN88Q12788;J3KNP2 Transducin beta-like protein 3TBL3 23 23 808 0 213.03 0.80506 1.3427 4.09E+09
Q8TBQ9 Q8TBQ9 Protein kish-A TMEM167A 2 2 72 0 4.3149 0.80421 1.1424 5.97E+08
O15294;O15294-3;O15294-2;O15294-4;C9JZL3O15294;O15294-3;O15294-2;O15294-4UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunitOGT 10 0 1046 0 64.815 0.80369 1.1252 8.73E+08
Q9BWH6-2;Q9BWH6;H3BRE8;Q9BWH6-3;H3BPM3;H3BPY8Q9BWH6-2;Q9B H6;H3BRE8RNA polymerase II-associated protein 1RPAP1 16 16 1315 0 146.06 0.80351 1.225 1.05E+09
Q9GZT4;V9GYE8;I3L4L3;I3L3N0;I3L4B4Q9GZT4;V9GYE8 Serine racemase SRR 7 7 340 0 76.264 0.80337 1.274 4.54E+08
Q9H7D7-2;Q9H7D7;H0Y9R3;C9JCS7Q9 7D7-2 Q H7D7;H0Y9R3WD repeat-containing protein 26WDR26 3 3 645 0 10.534 0.80311 NaN 2.05E+08
Q9ULE6 Q9ULE6 Paladin PALD1 8 8 856 0 62.96 0.8027 1.0537 8.67E+08
P30041 P30041 Peroxiredoxin-6 PRDX6 9 9 224 0 46.867 0.80169 1.1151 1.04E+09
O14735;B3KY94;O14735-3;H3BUR9;O14735-2O14735;B3KY94;O14735-3;H3BUR9CDP-diacylglycerol--inositol 3-phosphatidyltransferaseCDIPT 6 6 213 0 28.894 0.80141 1.1409 2.12E+09
P49327;A0A0U1RQF0;A0A0U1RRG3;J3KTF0P49327;A0A0U1RQF0Fatty acid synthase;[Acyl-carrier-protein] S-acetyltransferase;[Acyl-carrier-protein] S-malonyltransferase;3-oxoacyl-[acyl-carrier-protein] synthase;3-oxoacyl-[acyl-carrier-protein] reductase;3-hydroxyacyl-[acyl-carrier-protein] dehydratase;Enoyl-[acyl-carrier-protein] reductase;Oleoyl-[acyl-carrier-protein] hydrolaseFASN 138 138 2511 0 323.31 0.80139 1.1938 1.88E+11
H3BRE4;H3BNQ5;P49761-3;P49761-1;P49761H3BRE4;H3BNQ5;P49761-3;P49761-1;P49761Dual specificity protein kinase CLK3CLK3 1 1 190 0 9.806 0.80133 NaN 5.85E+07
P13639 P13639 Elongation factor 2EEF2 60 59 858 0 323.31 0.80123 1.2933 5.82E+10
Q8IXB1;Q8IXB1-2;A0A087WXH7;E7EP04;Q8IXB1-3Q8IXB1;Q8IXB1-2 DnaJ homolog subfamily C member 10DNAJC10 3 3 793 0 11.666 0.80074 1.7581 1.13E+08
Q6PI48 Q6PI48 Aspartate--tRNA ligase, mitochondrialDARS2 25 25 645 0 304.43 0.80073 0.8692 5.56E+09
H3BMQ0;P49815-5;P49815-3;P49815-2;P49815-4;P49815;P49815-7;P49815-6;H3BQK4;P49815-8;I3L3B1;Q5HYF7H3BMQ0;P49815-5;P49815-3;P 9815-2;P49815-4;P49815;P49815-7;P49815-6Tuberin TSC 18 18 1751 0 129.5 0.80009 1.122 1.14E+09
Q9BX10-2;Q9BX10-4;Q9BX10;X6RJ09;H0Y7A5;Q9BX10-3Q9BX10-2;Q9BX1 -4;Q9BX10;X6RJ09;H0Y7A5GTP-binding protein 2GTPBP2 3 3 514 0 5.9485 0.80009 NaN 3.14E+07
Q9H936;E9PJH7;A0A0D9SFE1;A0A0D9SEI9;K4DIA8;K4DIB8;E9PS95;K4DIB6;K4DIB3;A0A0D9SFA8;K4DIB0;K4DIA2;A0A0D9SG84;E9PI74;E9PQ36;Q9H1K4;E9PJY0;A0A0A6YYN8;K4DIB4Q9H936;E9PJH7;A0A0D SFE1; 0A0D9SEI9;K4DIA8;K4DIB8;E9PS95Mitochondrial glutamate carrier 1SLC25A22 13 13 323 0 170 0.80006 1.2625 2.73E+09
P09972;K7EKH5;C9J8F3;J3KSV6;J3QKP5;A8MVZ9P09972;K7EKH5;C9J8F3;J3KSV6;J3QKP5;A8MVZ9Fructose-bisphosphate aldolase CALDOC 5 2 364 0 85.15 0.79976 1.0686 2.01E+09
C9JLU1;P52434;P52434-3;P52434-4;P52434-2;P52434-5C9JLU1;P52434;P52434- ;P52434-4DNA-directed RNA polymerases I, II, and III subunit RPABC3POLR2H 8 8 149 0 111.53 0.7995 1.1033 1.35E+09
P34897-3;P34897;P34897-2;H0YIZ0;G3V2Y4;G3V5L0;G3V4W5;G3V2D2;G3V540P34897-3;P34897;P34897-2;H0YIZ0;G3V2Y4Serine hydroxymethyltransferase, mitochondrial;Serine hydroxymethyltransferaseSHMT 14 13 483 0 80.473 0.79905 1.3063 1.91E+09
Q9UPY3-2;Q9UPY3;Q9UPY3-3Q9UPY3-2;Q9UPY3Endoribonuclease DicerICER1 13 13 1829 0 122.87 0.79884 1.1966 3.32E+08
E9PEB5;Q96AE4;Q96AE4-2;C9JSZ1E9PEB5;Q96AE4;Q96AE4-2Far upstream element-binding protein 1FUBP1 10 6 655 0 85.114 0.79874 NaN 2.80E+08
A0A0G2JIS2;Q96KQ7-2;Q96KQ7;A2ABF8;A0A0G2JIR1;A2ABF9;A0A0G2JK64;A0A0G2JRR0;A0A0G2JRN8;H0Y4K5;Q96KQ7-3A0A0G2JIS2;Q96KQ7-2;Q96KQ7;A2ABF8;A0A0G2JIR1;A2ABF9;A0A0G2JK64;A0A0G2JRR0;A0A0G2JRN8Histone-lysine N-methyltransferase EHMT2EHMT2 8 8 1176 0 22.858 0.79846 1.3491 1.58E+08
Q13033-2;Q13033Q13033-2;Q13033Striatin-3 STRN3 4 4 713 0 15.611 0.79845 0.59114 3.47E+08
P39019;M0R2L9;M0QXK4;M0QYF7;M0R140;A0A075B6E2P39019; 0R2L9; 0QXK4;M QYF7;M0R14040S ribosomal protein S19RPS19 14 14 145 0 58.543 0.79843 1.491 3.13E+09
Q68E01-2;Q68E01;Q68E01-3;Q68E01-4;A0A096LNW8Q68E01-2;Q68E01;Q68E01-3Integrator complex subunit 3INTS3 14 14 1042 0 130.38 0.79792 1.0214 9.41E+08
P49755;G3V2K7 P49755;G3V2K7 Transmembrane emp24 domain-containing protein 10TMED10 6 6 219 0 31.832 0.7978 1.1137 1.63E+09
Q13546-2;Q13546Q13546-2;Q13546Receptor-interacting serine/threonine-protein kinase 1RIPK1 6 6 625 0 22.118 0.79775 NaN 2.08E+08
O15504;C9JYA1;O15504-3;O15504-2O1 504;C9JYA1;O15504-3;O15504-2Nucleoporin-like protein 2NUPL2 2 2 423 0 21.887 0.79767 0.78752 2.97E+08
O15355 O15355 Protein phosphatase 1GPPM1G 10 10 546 0 59.888 0.79764 NaN 8.35E+08
F8WJN3;Q16630-3;Q16630;Q16630-2F8WJN3;Q16630-3;Q16630;Q16630-2Cleavage and polyadenylation specificity factor subunit 6CPSF6 3 3 478 0 73.741 0.7968 NaN 9.50E+07
A0A087WW77;Q15334A0A087WW77;Q15334Lethal(2) giant larvae protein homolog 1LLGL1 12 12 1056 0 55.34 0.79631 1.243 1.15E+09
Q96DI7;Q9NSS8;Q96DI7-2Q96DI7;Q9NSS8;Q96DI7-2U5 small nuclear ribonucleoprotein 40 kDa proteinSNRNP40;DKFZp434D199 5 5 357 0 103.68 0.79625 1.2156 2.29E+09
P78406;E9PPG9;E9PQ57;B0QZ37;B0QZ36P78406 mRNA export factorRAE1 5 5 368 0 14.415 0.79595 0.93862 1.72E+08
Q9BQS8;Q9BQS8-4;Q9BQS8-3;Q9BQS8-2Q9BQS8;Q9B S8-4;Q9BQS8-3;Q9BQS8-2FYVE and coiled-coil domain-containing protein 1FYCO1 2 2 1478 0 23.013 0.79588 1.6039 1.35E+08
Q8IZL8;I3L445;C9JFV4;I3L4P1;I3L1P4;I3L4M7;E7EV54Q8IZL8;I3L445;C9JFV4roline-, glutamic acid- and leucine-rich protein 1PELP1 3 3 1130 0 28.876 0.79535 1.1039 2.53E+08
186
Q5TA45-2;Q5TA45-3;Q5TA45;C9IYS7;A0A087WYI0;Q5TA45-4;Q5TA45-5;J3QRY6;Q96HV7;C9J979;E9PNS4;E9PMA2;A0A0D9SGA8;H0YE15;E9PJG0;E9PKA4;E9PNH9;E9PI75;E9PIG1;A0A087WXT8Q5TA45-2;Q5TA45-3;Q5TA45;C9IYS7; 0A087WYI0;Q TA45-4;Q5TA45-5;J3QRY6Integrator complex subunit 11CPSF3L 9 9 499 0 51.128 0.79524 NaN 3.41E+08
Q6P9B9 Q6P9B9 Integrator complex subunit 5INTS5 5 5 1019 0 20.292 0.79492 1.5459 3.91E+08
I1E4Y6;Q6Y7W6-4;Q6Y7W6-5;Q6Y7W6;Q6Y7W6-3;C9JHW1;E7ESB6I1E4Y6;Q6Y7W6-4;Q6Y7W6-5;Q6Y7W6;Q6Y W6-3;C9JHW1;E7ESB6PER  amino acid-rich with GYF domain-containing protein 2GIGYF2 2 2 1321 0 4.9959 0.7949 NaN 2.35E+07
P28074;P28074-2;H0YJM8;G8JLC2;G3V3K3;P28074-3P28074;P28074-2Proteasome subunit beta type-5PSMB5 7 7 263 0 43.904 0.79489 1.2073 4.05E+08
O75529;O75529-2O75529;O75529-2TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5LTAF5L 3 3 589 0 7.8436 0.79474 NaN 4.42E+07
O75955;A0A140T9R1;O75955-2;A0A140T9X0;A2AB12;A2AB09;A2AB10;A0A140T9C3;A0A140T959;A2AB13;A2AB11;A0A0G2JJQ6;A0A140T9W4;A0A140T9B1;A0A140T957;A0A140T910;A0A140T907;A0A140T905;A2ABJ5;A0A140T974O75955;A0A140T9R1;O75955-2;A0A140T9X0;A2AB12;A2AB09;A2AB10Flotillin-1 FLOT1 11 11 427 0 93.374 0. 9442 1.2723 .00E+ 9
Q96CS3;D6RBG6 Q96CS3 FAS-associated factor 2FAF 21 21 445 0 323.31 0.79418 1.2767 1.23E+10
J3QQW9;Q15022 J3QQW9;Q15022 Polycomb protein SUZ12SUZ12 5 5 716 0 80.533 0.79406 1.4543 4.25E+08
P05455;E9PGX9;E9PFL9;E7ERC4P05455 Lupus La protein SSB 8 8 408 0 19.599 0.79397 0.89587 4.29E+08
Q9H6R4-4;Q9H6R4;A0A0A0MRW6;Q9H6R4-2;Q9H6R4-3;A0A0C4DFX0Q9H6R4-4;Q9H R4;A0A0A0MRW6;Q9H6R4-2;Q9H6R4-3Nucleolar protein 6NOL 13 13 1143 0 90.508 0.79371 1.5709 1.14E+09
P62304;A6NHK2 P62304 Small nuclear ribonucleoprotein ESNRPE 3 3 92 0 28.318 0.79362 1.4856 4.50E+09
Q8WU76-2;Q8WU76;A0A087WUD7Q8WU76-2;Q8WU76;A0A087WUD7Sec1 family domain-containing protein 2SCFD2 3 3 639 0 14.291 0.7932 NaN 1.22E+08
O75533;H7C341;B4DGZ4;O75533-2;F8WC19O75533 Splicing factor 3B subunit 1SF3B1 37 36 1304 0 276.47 0.79262 1.1025 5.59E+09
A0A087WUZ3;Q01082;Q01082-3;Q01082-2;F8W6C1A A087WUZ3;Q01082;Q01082-3;Q01082-2Spectrin beta chain, non-erythrocytic 1SPTBN1 12 11 2366 0 43.504 0.79252 1.0609 4.34E+08
Q9Y5J1;J3KSR7;J3QR85;J3QLD6;J3QRG09Y5J1 U3 small nucleolar RNA-associated protein 18 homologUTP18 7 7 556 0 18.946 0.79231 NaN 5.07E+08
Q9UKZ1;H7C0C7 Q9UKZ1;H7C0C7 CCR4-NOT transcription complex subunit 11CNOT11 4 4 510 0 44.881 0.79175 1.3807 4.91E+08
P06576;H0YH81;F8W079;F8W0P7;H0YI37P065 6;H0YH81;F8W079ATP synthase subunit beta, mitochondrial;ATP synthase subunit betaATP5B 24 24 529 0 323.31 0.79122 1.1663 1.91E+10
Q8TEX9;Q8TEX9-2;H0YN14;H0YN07;H0YMR4;H0YLV0;H0YL92;H0YKG5;H0YK93Q8TEX9;Q8TEX9-2; N1Importin-4 IPO4 23 23 1081 0 323.31 0.7912 1.3872 5.69E+09
P19387;H3BRR2 P19387 DNA-directed RNA polymerase II subunit RPB3POLR2C 7 7 275 0 37.911 0.791 1.5561 7.75E+08
Q3LIE7;Q15392-2;Q15392;H7C4B7Q3LIE7;Q15392-2;Q15392;H7C4B7Delta(24)-sterol reductaseNbla03646;DHCR24 13 13 427 0 58.715 0.79075 1.2122 1.03E+09
Q9Y6C9 Q9Y6C9 Mitochondrial carrier homolog 2MTCH2 9 2 303 0 128.01 0.79045 1.465 4.69E+09
O75489;E9PS48;O75489-2;G3V194;E9PKL8;E9PJE7O75489 NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrialNDUFS3 15 15 264 0 88.884 0.78988 0.96029 2.21E+09
P35269;M0R0Z3;M0QXD6;M0R0R9P35269;M0R0Z3;M0QXD6General transcription factor IIF subunit 1GTF2F1 3 3 517 0 38.402 0.78955 NaN 9.79E+07
Q9H223;A0A087WUA5;Q9NZN3-2;Q9NZN4-2;Q9NZN4Q9H223;A0A087WUA5EH domain-containing protein 4EHD4 14 10 541 0 55.16 0.78955 NaN 8.62E+08
Q9BSJ8;Q9BSJ8-2;F8VZB1Q9BSJ8;Q9BSJ8-2 Extended synaptotagmin-1ESYT1 15 15 1104 0 111.58 0.78858 1.4868 2.05E+09
Q9BPU6;E7EWB4;E9PHT0;E7ESV0Q BPU6 Dihydropyrimidinase-related protein 5DPYSL5 17 17 564 0 156.48 0.78815 NaN 1.38E+09
M0R0F9;Q15642-2;Q15642;W4VSQ9;Q15642-4;Q15642-3M0R0F9;Q15642-2; 15642;W4VSQ9;Q15642-4;Q15642-3Cdc42-interacting protein 4TRIP10 2 2 437 0 4.9818 0.78766 NaN 4.22E+07
B7Z7F3;Q9H6Z4-3;Q9H6Z4-2;Q9H6Z4;K7EMH9;K7ENJ2;K7EID7;K7ENB9;K7EPW1;K7ESQ0;K7EIJ4;K7EN31B7Z7F3;Q9H6Z4-3;Q9H6Z4-2;Q9H6Z4Ran-binding protein 3NF8;RANBP3 4 4 494 0 33.799 0.78664 NaN 8.47E+07
Q15029-2;Q15029-3;Q15029;K7EJ74;K7EIT3;K7EIV5Q15029-2;Q15029-3;Q15029116 kDa U5 small nuclear ribonucleoprotein componentEFTUD2 45 30 937 0 323.31 0.7854 1.1734 1.29E+10
P51665;H3BNT7;H3BTM8;H3BQV2P51665; NT7;H3BTM826S proteasome non-ATPase regulatory subunit 7PSMD7 5 5 324 0 38.012 0.78488 1.1193 6.84E+08
J3KQN4;P83881;H0Y5B4;H7BZ11;H7BY91;H0Y3V9J3KQN4;P83881;H0Y5B4;H7BZ1160S ribosomal protein L36aRPL36A;RPL36A-HNRNPH2 10 2 142 0 22.058 0.78442 0.60217 3.64E+08
P52209-2;P52209;K7EPF6;K7EM49;K7EMN2;K7ELN9P52209-2;P522096-phosphogluconate dehydrogenase, decarboxylatingPGD 27 27 470 0 323.31 0.78397 1.154 1.62E+10
O60287 O60287 Nucleolar pre-ribosomal-associated protein 1URB1 24 24 2271 0 211.28 0.78336 1.1487 2.43E+09
Q9Y3U8;J3QSB5;J3KTD3Q9Y3U8;J3QSB5 60S ribosomal protein L36RPL36 6 6 105 0 21.072 0.78329 1.1912 1.31E+09
P04843;B7Z4L4;F8WF32P04843;B7Z4L4 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1RPN1 30 30 607 0 313.98 0.78246 1.0475 7.10E+09
A0A087WY88;Q8N5M9A0A087WY88;Q8N5M9Protein jagunal homolog 1JAGN1 3 3 181 0 8.956 0.78242 1.4522 1.61E+08
Q9H9B4;D6RFI0;S4R2X2;D6RDG7;D6RAE9;H0Y9J5Q9H9B4;D6RFI0;S4 2X2Sideroflexin-1 SFXN1 16 15 322 0 323.31 0.78069 1.054 1.62E+10
O60506-3;O60506;O60506-4;O60506-2;B7Z645;O60506-5;F6UXX1O60506-3;O60506;O60506- ;O60506-2;B7Z645;O60506-5Heterogeneous nuclear ribonucleoprotein QSYNCRIP 18 13 562 0 197.21 0.77981 1.6842 4.31E+09
P56192;P56192-2;H0YHV5;H0YIP0;F5H2V6;F8VS26;F8W0M7;F8W0S4;F8VZZ9;H0YI94;H0YIC2;F8VPL7;H0YHL6;H0YI27P56192;P56192-2Methionine--tRNA ligase, cytoplasmicMARS 2 42 900 0 323.31 0.77933 1.2215 2.31E+10
P52292;J3QLL0;J3KS65;J3QL07P52292;J3QLL0;J3KS65Importin subunit alpha-1KPNA2;POU2F2 14 14 529 0 185 0.77923 0.96736 3.32E+09
A0A087WTP3;Q92945;M0R0I5;M0QYH3;M0QXW7;M0R3J3A0A087WTP3;Q92945; R0I5Far upstream element-binding protein 2KHSRP 8 6 711 0 21.244 0.77879 1.1689 2.04E+08
H0Y8R1;F5H5I6;H0YAK1;Q12849;Q12849-5;H0YAM1H0Y8R1;F5H5I6;H0YAK1;Q12849;Q12849-5G-rich sequence factor 1GRSF 15 15 417 0 149.78 0.77868 1.0523 3.38E+09
Q8IX12-2;Q8IX12;A0A0C4DGG8;F5H2E6;F5H1H2;F5H3E1;H0YFJ7;F5H7M9Q8IX12-2;Q8IX12;A0A0C4DGG8;F5H2E6Cell division cycle and apoptosis regulator protein 1CCAR1 9 19 1135 0 139.97 0.77838 1.1399 2.38E+09
Q86X76-2;Q86X76-4;Q86X76;Q86X76-3;Q86X76-5Q86X7 -2;Q86X76-4;Q86X76;Q86X76-3Nitrilase homolog 1NIT1 4 4 291 0 8.4012 0.77833 0.52879 1.98E+08
F8VPD4;P27708;H7C2E4;H7C3Z5;H7BZB3F8VPD4;P27708 CAD protein;Glutamine-dependent carbamoyl-phosphate synthase;Aspartate carbamoyltransferase;DihydroorotaseCAD 103 99 2162 0 323.31 0.77816 1.3363 4.22E+10
Q13200;Q13200-3;Q13200-2;H7C1H2;C9JPC0;H7C2Q3;F8WBS8Q13200;Q13200-3;Q13200-226S proteasome non-ATPase regulatory subunit 2PSMD2 42 42 908 0 323.31 0.7775 1.1663 1.64E+10
Q8NF37;A0A0G2JQ62;A0A0G2JRI78NF37;A0A0G2JQ62Lysophosphatidylcholine acyltransferase 1LPCAT1 11 11 534 0 42.432 0.77745 1.1524 5.01E+08
P51790-4;P51790;P51790-2;D6RIX3;D6RDZ6;E9PE15;G3XAG5;A0A087WU31;A0A0A0MTB7;P51793-2;P51795;P51793;P51790-5;P51795-2P51790-4;P51790;P51790-2;D6RIX3;D6RDZ6;E9PE15;G3XAG5; 87WU31;A0A0A0MTB7;P51793-2;P51795;P51793;P51790-5;P51795-2H(+)/Cl(-) exchange transporter 3;H(+)/Cl(-) exchange transporter 4;H(+)/Cl(-) exchange transporter 5CLCN3;CLCN4;CLCN5 2 2 791 0.00026709 3.5394 0.77741 NaN 6.47E+07
S4R400;S4R3N8;S4R450S4R400 FOCAD 12 1 1237 0 5.6076 0.77681 NaN 1.83E+08
Q96IJ6;Q96IJ6-2;A0A087WUI8;F8WD54;C9JAH0;C9J255;A0A0U1RRC2Q96IJ6;Q96IJ6-2;A0A087WUI8 F8WD 4Mannose-1-phosphate guanyltransferase alphaGMPPA 9 9 420 0 103.96 0.77675 1.372 9.30E+08
Q9BYJ9 Q9BYJ9 YTH domain-containing family protein 1YTHDF1 8 3 559 0 31.016 0.77544 NaN 1.05E+08
Q9NZ08;Q9NZ08-2;H0Y9X5Q9NZ08;Q9NZ08-2;H0Y9X5Endoplasmic reticulum aminopeptidase 1ERAP1 2 2 941 0.00079072 3.2785 0.77523 NaN 4.87E+07
S4R3D6;Q96GX9-3;Q96GX9S4R3D6;Q96GX9-3;Q96GX9Methylthioribulose-1-phosphate dehydrataseAPIP 2 2 195 0.0020576 2.8789 0.77476 NaN 1.13E+07
Q9BYC9;I3L2X1;Q9BYC9-2Q9BYC9;I3L2X1;Q9BYC9-239S ribosomal protein L20, mitochondrialMRP 2 2 149 0 4.9359 0.77454 1.1257 1.03E+08
Q9NS86 Q9NS86 LanC-like protein 2LANCL2 5 5 450 0 35.267 0.77443 1.429 3.01E+08
P21281;H0YC04;C9JL73;P15313;E5RGH6;C9J5E3;C9JNS9P21281;H0YC04 V-type proton ATPase subunit B, brain isoformATP6V1B2 5 5 511 0 17.763 0.7744 1.5199 3.30E+08
Q6SPF0;E9PIW9;F8WDT5Q6SPF0;E9PIW9 Atherin SAMD1 6 6 538 0 15.221 0.77349 NaN 2.57E+08
E9PLK3;P55786;P55786-2;A6NEC2;E9PP11;H0YDG0;A6NEC2-2;E9PJY4;E9PPD4;A6NEC2-3;H0YCQ5;E9PJ74;E9PRQ5;E9PJF9;E9PPZ2E9PLK3;P55786;P55786-2Puromycin-sensitive aminopeptidaseNPEPPS 27 27 915 0 196.99 0.77264 1.2851 6.73E+09
E9PIR7;F8W809;A0A087WSW9;A0A087WSY9;Q16881-5;Q16881-2;Q16881-4;Q16881-3;Q16881-6;Q16881;E2QRB9;Q16881-7;E9PKD3;A0A0B4J225;E9PIZ5;E9PQI3;E9PLT3;E9PKI4E9PIR ;F8 809; A087WSW9;A0A087WSY9;Q16881-5;Q16881-2;Q16881-4;Q16881-3;Q16881-6; 16881;E2QRB9;Q16881-7;E9PKD3Thioredoxin reductase 1, cytoplasmicGML;TXNRD1 8 482 0 49.2 0.77248 1.2936 1.48E+09
P53396;P53396-2;P53396-3;K7ESG8;K7EIE7P53 96;P53396-2;P53396-3ATP-citrate synthaseACLY 64 64 1101 0 323.31 0.77148 1.1353 5.87E+10
Q96TC7;H0YMB1;Q96TC7-2;H0YLG5;H0YNE5;H0YLV7;H0YMB1;Q96TC7-2;H0YLG5Regulator of microtubule dynamics protein 3RMDN3 6 6 470 0 69.063 0.77056 NaN 2.96E+08
P32189-1;P32189-4;Q14409;P32189-2;P32189;F8WDA9;F8WBI8;F8WC39;A6NP46P32189-1;P32189-4;Q14409;P32189-2;P32189; DA F8WBI8;F8WC39;A6NP46Glycerol kinase;Putative glycerol kinase 3GK;GK P 2 2 524 0 10.771 0.77017 NaN 2.38E+07
P00492 P00492 Hypoxanthine-guanine phosphoribosyltransferaseHPRT1 7 7 218 0 26.344 0.7699 1.4304 2.96E+09
P14735;P14735-2P14735;P14735-2Insulin-degrading enzymeIDE 14 14 1019 0 61.602 0.76884 0.95679 1.28E+09
Q8TCS8;H7C3C5 Q8TCS8 Polyribonucleotide nucleotidyltransferase 1, mitochondrialPNPT1 3 3 783 0 14.374 0.76847 0.81853 1.41E+08
B5MCF9;O00541;O00541-2;B3KXD6;H7C267;H7BYY8B5MCF9;O00541;O00541-2;B3KXD6Pescadillo homologPES1 17 17 571 0 66.908 0.7682 3.4744 9.19E+08
J3QR09;J3KTE4;P84098;J3QL15J3QR09;J3KTE4;P84098Ribosomal protein L19;60S ribosomal protein L19RPL19 14 14 193 0 61.63 0.76817 2.0125 2.45E+09
Q5VTU3;P63172 Q5VTU3;P63172 Dynein light chain Tctex-type 1DYNLT1 3 3 92 0 167.9 0.76811 1.1183 1.24E+09
O00299 O00299 Chloride intracellular channel protein 1CLIC1 17 17 241 0 319.37 0.76766 1.0395 6.91E+09
Q15751;H0YNB1 Q15751 Probable E3 ubiquitin-protein ligase HERC1HERC1 4 4 4861 0 9.6125 0.76715 NaN 3.15E+07
P51148;P51148-2;K7ERI8;K7ERQ8;F8VVK3;K7ENY4;F8VWU4;F8VVZ0;F8VUA5;P61020-2;P20339-2;P61020;P20339;K7EIP6;F8WCY6;F8WD79;F8VPW9;F8VSF8;F8VWZ7P51148;P51148-2;K7ERI8;K7ERQ8;F8VVK3 K7ENY4Ras-related protein Rab-5CRAB5C 6 6 21 0 44.633 0.76714 1.0357 6.34E+08
P49406;S4R3W9;S4R455;A0A0A0MRF4P 9 06;S4R3W9;S4R455;A0A0A0MRF439S ribosomal protein L19, mitochondrialMRP 4 4 292 0 10.916 0.76693 1.2607 2.51E+08
Q14657 Q14657 EKC/KEOPS complex subunit LAGE3LAGE3 3 3 143 0 20.695 0.7669 0.45515 5.99E+07
O95336;M0R261;M0R0U3;M0R1L2O95336;M0R261;M0R0U36-phosphogluconolactonasePGLS 11 11 258 0 142.72 0.76689 0.81786 5.15E+09
Q8IXI1;H3BST5;I3L2C6;H3BUX4;Q8IXI1-2;H3BMP9;H3BVI5;H3BU27Q8IXI1;H3BST5;I3L2C6Mitochondrial Rho GTPase 2RHOT2 9 8 618 0 145.19 0.76655 NaN 9.79E+08
Q7Z494;Q7Z494-2;Q7Z494-3;Q7Z494-6;A0A0J9YXS1;F2Z3A8;H0YAM4;Q7Z494-7;Q7Z494-4;Q7Z494-5Q7Z494;Q7Z494-2Nephrocystin-3 NPHP3 10 10 1330 0 40.564 0.7665 2.317 3.90E+08
Q8TCJ2 Q8TCJ2 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3BSTT3B 5 5 826 0 13.756 0.76589 NaN 3.55E+08
J3QLK5;Q86UE8-3;Q86UE8-2;Q86UE8;J3KRK0;Q9UKI8-3;Q9UKI8-4;Q9UKI8-5;Q9UKI8;Q9UKI8-2;J3QS44J3QLK5;Q86UE8-3;Q86UE8-2;Q86UE8;J3KR 0;Q9UKI8-3;Q9UKI8-4;Q9UKI8-5;Q9UKI8;Q9UKI8-2Serine/threonine-protein kinase tousled like 2;Serine/threonine-protein kinase tousled-like 1TLK2;TL 1 3 3 601 0 9.9461 0.76488 0.72529 1.38E+08
P00338;P00338-3;P00338-5;P00338-2;P00338-4;F5GXY2;F5GYU2;F5GXH2;F5H5J4;F5H6W8;F5GZQ4;F5H8H6;F5GXC7;F5GWW2;F5GXU1P0 3 8;P00338- ;P00338-5;P00338-2;P00338-4;F5GXY2;F5GYU2;F5GXH2L-lactate dehydrogenase A chainLDHA 20 20 332 0 202.47 0.76483 1.0153 5.23E+09
P36871;P36871-2;P36871-3P36871;P 6871-2;P36871-3Phosphoglucomutase-1PGM1 17 17 562 0 106.69 0.76375 1.0382 1.50E+09
P10515;H0YDD4;E9PEJ4P10515;H0YDD4;E9PEJ4Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial;Acetyltransferase component of pyruvate dehydrogenase complexDLAT 13 13 647 0 77.727 0.76318 1.2183 1.97E+09
Q9BWD1;Q9BWD1-2Q9BWD1;Q9BWD1-2Acetyl-CoA acetyltransferase, cytosolicACAT2 14 14 397 0 194.43 0.7624 1.11 6.38E+09
Q8TDZ2-2;Q8TDZ2;Q8TDZ2-4;Q5TED7Q8TDZ2-2;Q8TDZ2;Q8TDZ2-4Protein-methionine sulfoxide oxidase MICAL1MICAL1 3 3 981 0 16.095 0.76184 NaN 1.17E+08
H0Y6Y8;B1AL05;Q8N983-4;Q8N983-3;Q8N983-2;Q8N983;Q8N983-6;Q8N983-7;M0R051;H0YBU8H0Y6Y8;B1AL05;Q8N9 3-4;Q8N9 3-3;Q8N983-2;Q8N983;Q8N983-6;Q8N983-7;M0R05139S ribosomal protein L43, mitochondrialMRP 4 4 169 0 9.4073 0.76147 1.5401 1.82E+08
O75947;O75947-2;F5H608O7 947;O75947-2;F5H608ATP synthase subunit d, mitochondrialATP5H 4 4 161 0 16.892 0.76058 0.69325 1.64E+08
X6RGJ2;Q5SSJ5;Q5SSJ5-2;Q5SWC8;Q5SSJ5-3;B0QZK4;B0QZK9;B0QZK8;Q5SSJ5-5X6RGJ SJ5;Q5SSJ5-2;Q5SWC8;Q5SSJ5-3Heterochromatin protein 1-binding protein 3HP1BP3 7 7 327 0 25.088 0.76038 2.9008 3.74E+08
Q9BQG0;Q9BQG0-2;I3L1L3;I3L2H8;I3L311Q9BQG0;Q9BQG0-2;I L L3Myb-binding protein 1AMYBBP1A 37 37 1328 0 231.04 0.76028 1.5007 3.69E+09
Q9P0I2;Q9P0I2-2;S4R3U9;C9JLM9Q9P0I2;Q9P0I2-2 ER membrane protein complex subunit 3EMC3 4 4 261 0 28.628 0.75997 0.88503 2.71E+08
G5E9S8;G3V2E7;F8W6L3;G3V3H3;G3V5R9;E7EVH7;Q07866-8;Q07866-2;Q07866-3;Q07866;Q07866-7;Q07866-5;Q07866-10;Q07866-6;Q07866-4;Q07866-9;H0YJU9;H0YJL0;H0YJT3;H0YG16;H0YGB8G5E9S8; 2E7;F8W6L3 G3V3H3;G3V5R9;E7EVH7;Q07866-8;Q07866-2;Q07866-3;Q07866;Q07866-7;Q07866-5;Q07866-10;Q07866-6;Q07866-4;Q07866-9;H0YJU9;H0YJL0;H0YJT3;H0YG16Kinesin light chain 1KLC1 4 4 549 0 18.117 0.75962 NaN 1.17E+08
Q99808;Q99808-2Q99808;Q99808-2Equilibrative nucleoside transporter 1SLC29A1 2 2 456 0 5.8282 0.75932 0.65364 1.42E+07
J3KNN3;P15735-2;P15735;H3BP07;H3BTW6;H3BTI9;H3BN16J3KNN ;P15735-2;P15735; 3BP07; 3 TW6Phosphorylase b kinase gamma catalytic chain, liver/testis isoformPHKG2 4 4 410 0 21.878 0.75922 1.1241 2.48E+08
Q13283;E5RIZ6;E5RI46;E5RIF8;E5RH42;E5RJU8;Q13283-2;E5RH00Q13283 Ras GTPase-activating protein-binding protein 1G BP1 13 11 466 0 166.02 0.75904 0.96326 2.38E+09
Q9Y3B7;Q9Y3B7-2;Q9Y3B7-3;H0YCD5;E9PQB6Q9Y3B7;Q9Y3B7-2;Q9Y3B7-339S ribosomal protein L11, mitochondrialMRP 5 5 192 0 41.481 0.75848 1.2831 3.48E+08
B1ANR0;Q13310-2;Q13310;Q13310-3;H0Y5F5;B1ANR1;H0YEU6;H0YER0;H0YEQ8;H0Y6X6;H0YCC8B1ANR0;Q13310-2;Q13310;Q13310-3;H0Y5F5Polyadenylate-binding protein 4PABPC4 10 4 615 0 9.4531 0.75782 NaN 3.06E+08
Q15008;Q15008-4;Q15008-3;Q15008-2;C9J0E9;H7C531;C9J7B7Q15008;Q15008-4;Q15008-3;Q15008-226S proteasome non ATPase regulatory subunit 6PSMD6 13 13 389 0 79.183 0.75732 1.2235 2.63E+09
E7EPT4;P19404 E7EPT4;P19404 NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrialNDUFV2 3 3 252 0 11.76 0.75718 1.0846 2.17E+08
Q5SRE5;Q5SRE5-2;H7C4K7Q5SRE5;Q5SRE5-2Nucleoporin NUP188 homologNUP188 36 36 1749 0 255.01 0.75587 1.1786 3.70E+09
Q9UBQ7;U3KQ56;Q9UBQ7-29 7;U3KQ56 Glyoxylate reductase/hydroxypyruvate reductaseGRHPR 14 14 328 0 209.71 0.75579 1.0984 7.33E+09
Q13724-2;Q13724;C9J8D4;C9JDQ1Q13724-2;Q13724;C9J8D4Mannosyl-oligosaccharide glucosidaseMOGS 4 4 731 0 27.464 0.75544 3.5786 2.11E+08
A0A087X0S7;A0A087WTU1;A0A0B4J2G4;Q15345-3;Q15345;A0A0C4DH00A0A087X0S7; 0A087WTU1;A0A0B4J2G4;Q15345-3;Q15345;A0A0C4DH00Leucine-rich repeat-containing protein 41LRRC 1 4 4 521 0 18.634 0.75371 1.0959 2.04E+08
Q8N2G8-3;Q8N2G8;K7ESN3;Q8N2G8-2;K7EJT7;K7EQ41;K7EL54Q8N2G8- ; ;K7ESN3;Q8N2G8-2GH3 domain-containing proteinGHDC 3 3 491 0 8.6059 0.75271 NaN 4.80E+07
Q6P996-4;Q6P996-5;Q6P996;H3BND4;Q6P996-3;Q86XE2;Q6P996-2;J3KNK7;Q6P474;H3BNL6;Q6XYB5;H3BPV5;H3BM88;A0A0J9YXH6;H3BU11;H3BQ54Q6P996-4;Q6P996-5; ;H3BND4;Q6P9 6-3Pyridoxal-dependent decarboxylase domain-containing protein 1PDXDC1 17 17 760 0 161.12 0.7523 1.2344 1.61E+09
P48553 P48553 Trafficking protein particle complex subunit 10TRAPPC10 1 1 1259 0.00079239 3.306 0.75221 NaN 5.02E+07
Q9NY12-2;Q9NY12Q9NY12-2;Q9NY12H/ACA ribonucleoprotein complex subunit 1GAR1 3 3 199 0 4.103 0.75214 2.0913 1.47E+08
187
P42575;A0A087WYM1;C9JRR9;P42575-2P42575;A0A087WYM1;C9JRR9;P42575-2Caspase-2;Caspase-2 subunit p18;Caspase-2 subunit p13;Caspase-2 subunit p12CASP 2 2 452 0 9.6788 0.75188 NaN 1.60E+08
Q15397;S4R3K8 Q15397 Pumilio domain-containing protein KIAA0020KIAA0020 6 6 648 0 27.535 0.7515 NaN 1.05E+08
Q15048;E9PP40;E9PNL0;E9PRP5Q15048;E9P 40 Leucine-rich repeat-containing protein 14LRRC14 6 6 493 0 45.71 0.75146 1.1576 3.14E+08
Q5QJE6;J3KP30;E9PRB3Q5QJE6;J3KP30 Deoxynucleotidyltransferase terminal-interacting protein 2DNTTIP2 4 4 756 0 25.691 0.75131 1.2515 2.44E+08
P46777;Q5T7N0 P46777 60S ribosomal protein L5RPL5 16 16 297 0 78.685 0.75106 1.7135 1.69E+09
Q92922;F8WE13;F8VXC8;Q8TAQ2-2;Q8TAQ2-3;Q8TAQ2Q92922 SWI/SNF complex subunit SMARCC1SMARCC1 10 10 1105 0 56.048 0.75021 1.0803 2.83E+08
Q15428;K7EMT0 Q15428;K7EMT0 Splicing factor 3A subunit 2SF3A2 5 5 464 0 16.784 0.74837 NaN 4.53E+07
O43396;K7ER96;K7EML9;K7EPB7;K7EKG2;K7EME7O43396;K7ER96;K7EML9Thioredoxin-like protein 1TXNL1 10 10 289 0 108.24 0.74825 1.0762 2.75E+09
Q96DV4;Q96DV4-2Q96DV4 39S ribosomal protein L38, mitochondrialMRP 4 4 380 0 16.594 0.74806 1.4819 1.26E+09
Q96C19;H0Y4Y4 Q96C19 EF-hand domain-containing protein D2EFHD2 3 3 240 0 12.258 0.74804 0.92272 7.26E+07
P62917;E9PKZ0;E9PKU4;E9PP36;G3V1A1P62917;E9 KZ0;E9PKU4;E9PP36;G3V1A160S ribosomal protein L8RPL8 17 17 257 0 146.07 0.74778 1.652 5.15E+09
P22570-5;P22570;P22570-2;P22570-7;A0A0A0MTR6;A0A0C4DFN8;A0A0C4DGN7;A0A0A0MSZ4;P22570-4;P22570-3;A0A0A0MTN9;J3QQX3;A0A0A0MT64;P22570-6;J3QKZ8;J3QQW7P2 570-5;P2 570;P22570-2;P22570-7;A0A0A0MTR6;A0A0C4DFN8;A0A0C4DGN7;A0A0A0MSZ4;P22570-4;P22570-3;A0A0 MTN9;J3QQX3;A0A0A0MT64;P22570-6NADPH:adrenodoxin oxidoreductase, mitochondrialFDXR 4 4 483 15.098 0.7 723 0.76395 8.10E+07
P52306-4;P52306;P52306-5;P52306-6;P52306-2;P52306-3;D6REZ0;H0Y8M2;D6RBC6;D6RHH8;D6RB97P52306-4;P52306;P52306-5;P52306-6;P52306-2;P52306-3Rap1 GTPase GDP dissociation stimulator 1RAP1GDS1 7 7 607 0 43.415 0.74723 NaN 4.26E+08
Q68CQ4 Q68CQ4 Digestive organ expansion factor homologDIEXF 3 3 756 0 8.2522 0.74719 1.5013 1.11E+08
Q02543;M0R3D6;M0R1A7;M0R117;M0R0P7Q02543;M0R3D6; 0R1A7;M0R117;M0R0P760S ribosomal protein L18aRPL18A 13 13 176 0 67.734 0.74717 1.9141 2.51E+09
A0A024R4M0;P46781;B5MCT8;C9JM19;F2Z3C0;A8MXK4A0A024R4M0;P46781 B5M T8;C9JM1940S ribosomal protein S9RPS9 21 21 194 0 61.452 0.74689 1.7169 1.46E+10
Q96P48-3;Q96P48;E7EU13;Q96P48-7;Q96P48-2;Q96P48-4;Q96P48-1;A0A0A0MSJ2;Q96P48-5;F5GWQ2;F5GWN4;F8WBT0;H0YGD1Q96P48-3;Q96P48;E7EU13;Q96P48-7;Q96P48-2;Q96P48-4;Q96P48-1;A0A0A0MSJ2;Q96P48-5Arf-GAP with Rho-GAP domain, ANK repeat and H domain-containing protein 1ARAP1 1 11 1439 0 55.029 0.7468 0.81393 7.42E+08
Q9Y4E6-2;Q9Y4E6;A2RRE0Q9Y4E6-2;Q9Y4E6;A2RRE0WD repeat-containing protein 7WDR7 4 4 1457 0 15.11 0.74656 1.2128 1.49E+08
Q9Y2R0;K7EPV0 Q9Y2R0;K7EPV0 Cytochrome c oxidase assembly factor 3 homolog, mitochondrialCOA3 2 2 106 0.0010485 3.1683 0.74638 NaN 4.86E+07
Q9NRP0;A0A087WUD3;Q9NRP0-2Q9NRP0;A0A087WUD3;Q9NRP0-2Oligosaccharyltransferase complex subunit OSTCOSTC 2 2 149 0 16.39 0.74474 1.5173 2.33E+08
Q86UT6;Q86UT6-2;C9JLK8;C9JQE9;C9J0R6Q86UT6;Q86UT6-2NLR family member X1NLRX1 6 6 975 0 15.608 0.74451 1.0769 4.16E+08
Q9BQC6 Q9BQC6 Ribosomal protein 63, mitochondrialMRPL57 1 1 102 0 13.249 0.74366 NaN 1.62E+08
B0QXZ6;O95503 B0QXZ6;O95503 Chromobox protein homolog 6CBX6 2 2 394 0 10.765 0.74363 NaN 2.36E+07
P09496-2;P09496-4;P09496-3;P09496;F8WF69;P09496-5;C9J8P9P09496-2;P09496-4;P09496-3; ;F8WF69;P09496-5Clathrin light chain ACLTA 5 5 218 0 97.081 0.74231 0.72805 1.25E+08
P14174 P14174 Macrophage migration inhibitory factorMIF 4 4 115 0 25.747 0.74212 2.3623 2.55E+09
J3KN36;A0A0G2JN29;A0A087X117;Q5JPE7-2;Q15155;P69849;Q5JPE7;A0A0G2JP90;A0A087WW46;Q5JPE7-3;I3L0Q6;H3BTW1;A0A087WTD5J3KN36;A0A0G2JN29;A0A087X1 7;Q5JPE7-2; 15155;P69849;Q5JPE7;A0A0G2JP90;A0A087WW4 ;Q5JPE7-3odal modulator 2 Nodal modulator 1;Nodal modulator 3NOMO3;NOMO2;NOMO1 8 8 1267 0 39.075 0.74164 1.4263 4.83E+08
Q04760-2;Q04760Q04760-2;Q04760Lactoylglutathione lyaseGLO1 5 5 169 0 14.525 0.74142 1.0136 5.23E+08
E9PNK6;E9PPQ1;J3KNE7;Q16890-4;Q16890-3;Q16890-2;Q16890-5;Q16890E9PNK6;E9PPQ1;J3KNE7;Q16890-4;Q16890-3;Q16890-2;Q16890-5;Q16890Tumor protein D53TPD52L1 2 2 166 0 4.9894 0.74088 NaN 6.18E+07
H0YLI7;P59780;Q7Z6K5-2;A0A0A6YYH1;H0YLX6;H0YN38;P59780-2H0YLI7;P59780;Q7Z6K5-2;A0A0A6YYH1AP-3 complex subunit sigma-2AP3S2 3 3 205 0 4.9765 0.74026 0.94196 1.38E+08
E9PC44;E9PDM8;O94855;O94855-2E PC44;E9PDM8;O94855;O94855-2Protein transport protein Sec24DSEC24D 6 6 393 0 25.825 0.73977 1.069 8.73E+08
O76094;O76094-2;D6RDY6;R4GNC1O76094;O76094-2;D6RDY6Signal recognition particle subunit SRP72SRP72 12 12 671 0 110.57 0.7396 2.0573 9.25E+08
E9PL17;Q92989;Q92989-2;E9PKV5;E9PJM4E9PL17;Q92989;Q92989-2Polyribonucleotide 5-hydroxyl-kinase Clp1CLP1 4 4 436 0 6.692 0.73953 2.2838 3.75E+08
P49257 P49257 Protein ERGIC-53 LMAN1 10 10 510 0 52.166 0.73888 0.61051 1.17E+09
F5H269;Q9Y485 F5H269;Q9Y485 DmX-like protein 1DMXL1 2 2 3048 0 9.2225 0.73861 0.93 5.27E+07
H3BMH2;H3BSC1;P62491-2;Q15907-2;P62491;Q15907;B4DQU5H3BMH2;H3BSC1;P62491-2;Q15907-2;P62491;Q15907Ras-related protein Rab-11A;Ras-related protein Rab-11BRAB11A;RAB1 B 6 6 155 0 19.214 0.73849 1.3055 6.79E+08
S4R3Q9;J3KNA0;Q15070-2;Q15070;C9JC63;E7EVY0;Q15070-3S4R3Q9;J3KNA0;Q15070-2;Q15070;C9JC63;E7EVY0;Q15070-3Mitochondrial inner membrane protein OXA1LOXA1L 3 3 435 0 10.295 0.73772 1.5537 3.79E+07
A0A0G2JQK5;Q6DKJ4A0A0G2JQK5;Q6DKJ4Nucleoredoxin NXN 3 3 120 0 29.912 0.73752 0.93829 1.09E+08
Q96CU9-3;Q96CU9;Q96CU9-2Q96CU9-3;Q96CU9;Q96CU9-2FAD-dependent oxidoreductase domain-containing protein 1FOXRED1 4 4 472 0 19.977 0.73732 1.2249 5.85E+08
Q15036;Q15036-2;F8WAZ0;F8WFA0;F8WEG6Q15036;Q15036-2Sorting nexin-17 SNX17 9 9 470 0 83.758 0.73701 1.2507 9.53E+08
E7EPF2;E7ETU5;F6Y5H0;P29558-2;P29558;C9J9B2;F8W1T6;C9JIJ9;Q15434;Q6XE24-3;Q6XE24-4;Q6XE24-5;Q6XE24-2;Q6XE24E7EPF2;E7ETU5;F6Y5H0;P2 558-2;P29558;C9J9B2;F8W1T6;C9JIJ9;Q15434;Q6XE24-3;Q6XE24-4;Q6XE24-5;Q6XE24-2;Q6XE24RNA-binding motif, single-stranded-interacting protein 1;RNA-binding motif, single-stranded-interacting protein 2;RNA-binding motif, single-stranded-interacting protein 3RBMS1;RBMS3;RBMS2 2 2 1 8 0 6.6895 0.73674 NaN 1.46E+08
Q9H3K6;A0A087WZT3;Q9H3K6-2;H3BV85;H3BTW0;A0A0B4J295;H3BVE0Q9H3K6;A0A087WZT3;Q9H3K6-2BolA-like protein 2BOLA2 3 3 86 0 47.009 0.7365 1.4405 1.04E+09
P43007;P43007-2P43007;P43007-2Neutral amino acid transporter ASLC1A4 4 4 532 0 33.844 0.73649 NaN 1.50E+08
A0A088AWN3;A0A0A0MSY4;A0A0A0MRA7;Q9BZ29-3;Q9BZ29-5;Q9BZ29;Q9BZ29-4;A0A0A0MT38;Q9BZ29-6;Q5JUD8;H0Y3S1;Q5JUD3;H7BZ79;A0A0D9SFH588AWN3;A0A0A0MSY4;A0A0A0MRA7;Q9BZ29-3;Q9BZ29-5;Q9BZ29;Q9BZ29-4;A0A0A0MT38;Q9BZ29-6Dedicator of cytokinesis protein DOCK9 6 5 207 0 20.112 0.73648 0.9183 1.90E+08
Q8N138-4;Q8N138;J3KTF9;J3QRM9Q8N138-4;Q8N138;J3KTF9ORM1-like protein 3ORMDL3 3 2 137 0 5.1653 0.73609 NaN 1.06E+08
Q9NPE3;H0YM60 Q9NPE3 H/ACA ribonucleoprotein complex subunit 3NOP10 4 4 64 0 16.402 0.73487 2.322 1.70E+08
P62854;Q5JNZ5 P62854;Q5JNZ5 40S ribosomal protein S26;Putative 40S ribosomal protein S26-like 1RPS26;RPS26P11 4 4 115 0 13.018 0.7338 1.6705 2.90E+09
Q5T6H7;Q9NQW7-2;Q9NQW7;Q9NQW7-4;Q9NQW7-3;Q5T6H3;Q5T6H2Q5T6H7;Q9N W7-2;Q9N W7;Q9NQW7-4;Q9NQW7-3;Q5T6H3;Q5T6H2Xaa-Pro aminopeptidase 1XPNPEP1 2 2 552 0 12.404 0.73303 NaN 3.29E+08
Q9Y3B4 Q9Y3B4 Splicing factor 3B subunit 6SF3B6 4 4 125 0 17.768 0.73237 1.2024 1.11E+09
O43809;H3BND3;H3BV41O43809;H3BND3 Cleavage and polyadenylation specificity factor subunit 5NUDT21 7 7 227 0 28.101 0.73235 4.4929 5.17E+08
Q9H8Y5;B8ZZS4;C9JS61Q9H8Y5;B8ZZS4 Ankyrin repeat and zinc finger domain-containing protein 1ANKZF1 3 3 726 0 30.118 0.73193 3.115 3.86E+08
Q9BR76;F5H0D2;A0A087WW53;F5H390;A9Z1Z3-3;A9Z1Z3Q9BR76 Coronin-1B CORO1B 5 5 489 0 56.414 0.73043 1.3173 6.80E+08
A6NNK5;Q12888;Q12888-3;Q12888-2;M0R142;H7BZY0;C9JXV0A6NNK5;Q12888;Q12888-3;Q12888-2Tumor suppressor p53-binding protein 1TP53BP1 3 3 1927 0 10.259 0.72984 1.1937 2.77E+08
P52788-2;P52788;H7C2R7P52788-2;P52788Spermine synthaseSMS 5 5 313 0 112.95 0.72984 1.3703 1.32E+09
A6NEM2;P51610-2;P51610;P51610-4;P51610-3;H7C1C4A6NEM2;P51610-2;P51610;P51610-4Host cell factor 1;HCF N-terminal chain 1;HCF N-terminal chain 2;HCF N-terminal chain 3;HCF N-terminal chain 4;HCF N-terminal chain 5;HCF N-terminal chain 6;HCF C-terminal chain 1;HCF C-terminal chain 2;HCF C-terminal chain 3;HCF C-terminal chain 4;HCF C-terminal chain 5;HCF C-terminal chain 6FC1 17 17 2080 0 79.35 0.72931 1.2734 1.63E+09
P62277;J3KMX5;E9PS50P62277;J3KMX5 40S ribosomal protein S13RPS13 15 15 151 0 99.211 0.72885 1.4767 1.50E+10
O95396 O95396 Adenylyltransferase and sulfurtransferase MOCS3;Molybdopterin-synthase adenylyltransferase;Molybdopterin-synthase sulfurtransferaseMOCS3 12 12 460 0 111.91 0.72881 1.2369 1.02E+09
J3KPG2;E9PJF7;Q5W0H4;A0A0B4J2C3;P13693-2;Q56UQ5;P13693;H0YCX0J3KPG2;E9PJF7;Q5W0H4;A0A0B4J2C3;P13693-2 Q56UQ5;P13693;H0YCX0Translationally-controlled tumor protein TPT1-like proteinTPT1 2 2 160 0.0010493 3.1848 0.72808 NaN 2.52E+07
P68133;P68032;A6NL76;P63267-2;F8WB63;B8ZZJ2P68133;P68032;A6NL76;P63267-2;F8WB63;B8ZZJ2Actin, alpha skeletal muscle Actin, alpha cardiac muscle 1;Actin, gamma-enteric smooth muscleACTA1;ACTC1;ACTG2 16 1 377 0 69.288 0.728 1.4021 1.67E+10
P27105;F8VSL7;P27105-2P27105;F8VSL7;P27105-2Erythrocyte band 7 integral membrane proteinSTOM 2 2 288 0 40.587 0.72698 0.95179 8.04E+07
P60763;J3KSC4;J3QLK0;P63000;P63000-2;F8WET9;B1AH79;G3V4H1;B1AH78;G3V476;A0A0C4DH03;Q9H4E5-2;P17081;Q9H4E5P60763;J KSC4;J3QLK0;P63000;P63000-2Ras-related C3 botulinum toxin substrate 3;Ras-related C3 botulinum toxin substrate R C3;RAC1 3 2 92 0 4.1956 0.72528 NaN 5.27E+07
P62753;A2A3R5;A2A3R7P62753;A2A3R5 40S ribosomal protein S6RPS6 13 13 249 0 120.99 0.72485 2.128 4.53E+09
G3XAN4;Q15629-2;Q15629G3XAN4;Q15629-2;Q15629Translocating chain-associated membrane protein 1TRAM1 2 2 288 0 4.5626 0.72456 0.95908 2.34E+08
Q8N5N7;Q8N5N7-2Q8N5N7;Q8N5N7-239S ribosomal protein L50, mitochondrialMRP 2 2 158 0 23.941 0.72435 1.4743 1.87E+08
P11413;P11413-3;P11413-2;E7EM57;E7EUI8;E9PD92P1 413;P11413-3;P11413-2;E7EM57;E7EUI8;E9PD92Glucose-6-phosphate 1-dehydrogenaseG6PD 10 10 515 0 56.839 0.72432 1.3968 7.87E+08
O75616;J3QSB2;J3QRV9;O75616-2;K7EQJ8;J3QT61O75616;J3QSB2;J3QRV9;O75616-2GTPase Era, mitochondrialERAL1 5 5 437 0 25.393 0.72306 0.89943 5.68E+08
Q12768;E7EQI7;E5RFU6Q12768;E7EQI7 WASH complex subunit strumpellinKIAA0196 12 12 1159 0 57.889 0.72225 1.2618 8.70E+08
E9PEC3;E7EUY3;E7ETT1;E9PDR0;C9JQS9;E7EX59;P05166;P05166-2;F8WBI9;E7ETT4;C9JVW9;H7C5C9;E7ENC1E9PEC3;E7EUY3;E7ETT1;E9PDR0;C9JQS9;E7EX59;P05166;P05166-2;F8WBI9;E7ETT4Propionyl-CoA carboxylase beta chain, mitochondrialPCCB 4 4 423 0 14.173 0.7216 NaN 1.57E+08
O96007 O96007 Molybdopterin synthase catalytic subunitMOCS2 5 5 188 0 28.388 0.72126 0.91631 3.14E+08
P60953;P60953-1;Q5JYX0P60953;P60953-1;Q5JYX0Cell division control protein 42 homologCDC42 6 5 191 0 92.254 0.72072 0.90374 6.57E+08
E9PMY3;E9PML8;E9PJC0;E9PRR9;Q12974-2;Q12974-4;Q12974;A0A0D9SGK2;Q12974-3;Q93096MY3;E9PML8;E9PJC0;E9PRR9;Q12974-2;Q12974-4;Q1 974;A0A0D9SGK2;Q12974-3;Q93096Protein tyrosine phosphatase type IVA 2;Protein tyrosine phosphatase type IVA 1PTP4A2;PTP4 1 2 2 63 0.0047417 2.4134 0.72052 NaN 8.72E+07
Q9H8M7;X6R9S5;X6RC97;X6RC30;Q9H8M7-2Q9H8M7 Protein FAM188AFAM188A 4 4 445 0 9.222 0.71828 1.0401 2.72E+08
O43913;O43913-2;G3V0H0O43913;O43913-2Origin recognition complex subunit 5ORC5 6 6 435 0 35.105 0.71761 1.6022 1.06E+09
Q9BVP2-2;Q9BVP2;C9JYH9;C9JZT7;B4DMU5Q9BVP2-2;Q9BVP2Guanine nucleotide-binding protein-like 3GNL3 8 8 537 0 41.987 0.71617 NaN 8.58E+08
J3KR97;Q9BTW9;Q9BTW9-4;Q9BTW9-5;I3L439;I3L0V3;I3L163;I3L500;I3L143;A0A0J9YWI5;A0A0J9YVR1;I3L4D2;I3L3H4;I3L131;Q9BTW9-3;A0A0J9YVU1;I3L1S3;I3L120;A0A0J9YXU4;A0A0J9YY08;A0A0J9YYG2J3KR97;Q9BTW9;Q9BTW9-4;Q9BTW9-5Tubulin-specific chaperone DTBCD 22 22 1230 0 20 .79 0.71601 1.2643 3.43E+09
Q9UKE5-8;Q9UKE5-5;Q9UKE5-7;Q9UKE5-3;Q9UKE5-6;Q9UKE5-2;Q9UKE5-4;Q9UKE5;Q8N4C8-5;Q8N4C8-2;Q8N4C8-3;Q8N4C8-4;Q8N4C8;C9J338;I3L2I2;E7ETN6;I3L203Q9UKE5-8;Q9UKE5-5;Q9UKE5-7;Q9UKE5-3;Q9UKE5-6;Q9UKE5-2;Q9UKE5-4;Q9UKE5;Q8N4C8-5;Q8N4C8-2;Q8N4C8-3;Q8N4C8-4;Q8N4C8;C9J338TRAF2 and NCK-interacting protein kinase;Misshapen-like kinase 1TNIK;MINK1 9 1268 0 8.2789 0.71561 NaN 3.10E+07
Q8N766-4;Q8N766-3;Q8N766-2;Q8N766;H7C4E3Q8N766-4;Q8N766-3;Q8N766-2;Q8N766ER membrane protein complex subunit 1EMC1 7 7 971 0 38.491 0.71524 1.3333 5.29E+08
Q969S3 Q969S3 Zinc finger protein 622ZNF622 2 2 477 0 7.6961 0.71395 NaN 1.03E+08
Q8N442 Q8N442 Translation factor GUF1, mitochondrial 4 4 669 0 9.1355 0.71391 NaN 4.17E+08
O95197-3;O95197-4;O95197-7;O95197-2;O95197O951 7-3;O951 7-4;O951 7-7;O95197-2;O95197Reticulon-3 RTN3 1 1 236 0 4.4684 0.71359 NaN 6.94E+07
F8VPF2;Q96K12-2;Q96K12F8VPF2;Q96K12-2;Q96K12Fatty acyl-CoA reductase 2FAR2 1 1 44 0.0020672 2.9422 0.71305 1.164 1.89E+07
P31942-2;P31942;P31942-3;P31942-6;P31942-5;P31942-4P31942-2;P31942;P31942-3;P31942-6;P31942-5;P31942-4Heterogeneous nuclear ribonucleoprotein H3HNRNPH3 7 6 331 0 33.999 0.71305 1.4773 9.56E+08
Q9UKD2 Q9UKD2 mRNA turnover protein 4 homologMRTO 15 15 239 0 118.91 0.71162 0.8855 1.55E+09
Q9UBW8;F5H7C6;F5GYF7;F5H248;F5H4U8;F5H4Z0;F5H3M6;G3XAP1;F5GXT7Q9UBW8;F5H7C6;F5GYF7;F5 248;F5H4U8COP9 signalosome complex subunit 7aCOPS7A 4 4 275 0 47.06 0.71055 1.0491 3.10E+08
P06748;P06748-3;P06748-2;E5RI98;E5RGW4P06748;P06748-3;P06748-2Nucleophosmin NPM1 18 18 294 0 323.31 0.71048 1.2615 2.62E+10
B7Z683;A0A0G2JQ41;Q12979-4;Q12979-2;Q12979;I3L1U8;A0A0G2JSE0;A0A0D9SGD7;I3L0R7B7Z683;A0A0G2JQ41;Q12979-4;Q12979-2;Q12979;I3L1U8Active breakpoint cluster region-related proteinABR 3 2 641 0 11.033 0.71026 NaN 7.75E+07
P00403 P00403 Cytochrome c oxidase subunit 2MT-CO2 6 6 227 0 51.516 0.70975 1.1079 1.34E+09
Q9NRG9;Q9NRG9-2;F8VZ44;H3BU82;F8VUB6Q9NRG9;Q9NRG9-2;F8VZ44;H3BU82Aladin AAAS 11 11 546 0 65.909 0.70915 1.4198 1.62E+09
Q5TDH0;Q5TDH0-3;Q5TDH0-2;H0YII4;H0YI90Q5TDH0;Q5TDH0-3;Q5TDH0-2;H0YII4;H0YI90Protein DDI1 homolog 2DDI2 8 8 399 0 67.424 0.70895 1.356 2.83E+09
Q9NYJ8;Q9NYJ8-2;U3KQ62;U3KQR0Q9NYJ8;Q9NYJ8-2TGF-beta-activated kinase 1 and MAP3K7-binding protein 2TAB2 5 5 693 0 49.473 0.70803 1.6854 1.82E+08
Q14674;Q14674-2;H3BRX7Q14674;Q14674-2Separin ESPL1 9 9 2120 0 28.757 0.70795 1.1531 1.44E+08
A6NLH6;Q9P003 A6NLH6;Q9P003 Protein cornichon homolog 4CNIH4 1 1 137 0 47.73 0.7076 1.3597 4.52E+09
Q96K37;H7C1I0;Q96K37-2Q96K37;H7C1I0 Solute carrier family 35 member E1SLC35E1 4 4 410 0 37.357 0.70676 0.95115 1.52E+08
K7ELQ0;K7ES61;X6RAY8;Q9BYD3-2;Q9BYD3;K7EKI4;K7ELF1;K7EJ73K7ELQ0;K7ES61;X6RA 8;Q9BYD3-2;Q9BYD3;K7EKI4;K7ELF13 S ribosomal protein L4, mitochondrialMRP 4 4 220 0 26.235 0.70606 NaN 3.16E+08
Q7KZN9-2;Q7KZN9Q7KZN9-2;Q7KZN9Cytochrome c oxidase assembly protein COX15 homologCOX15 7 7 388 0 24.207 0.70592 1.4215 6.82E+08
B4DR61;P61619;P61619-3;F8W776;Q8TC24;Q9H9S3-2;Q9H9S3-3;Q9H9S3;H7C1Q9;C9JXC6;H7C069;A6NK38;F2Z2C7;A6NIF9;C9JJV4;H7C1S8B4DR61;P61619;P61619-3 F8W776;Q8TC24;Q9H9S3-2;Q9H9S3-3 Q H9S3Protein transport protein Sec61 subunit alpha isoform 1;Protein transport protein Sec61 subunit alpha isoform 2SEC61A1;SEC61A2 14 14 482 0 115.66 0.70518 1.4272 1.28E+09
Q13561;Q13561-3;Q13561-2;H0YHL1;F8VX93;F8VRV7;H0YI98;F8VW18;F8W1I6Q13561;Q13561-3;Q13561-2;H0YHL1;F8VX93;F8VRV7;H0YI98;F8VW18;F8W1I6Dynactin subunit 2DCTN2 2 2 401 0 7.6391 0.70455 NaN 1.14E+08
Q8WTT2 Q8WTT2 Nucleolar complex protein 3 homologNOC3L 8 8 800 0 90.874 0.70409 0.81146 1.59E+09
B1AKV4;F6UTR7;Q9NVA1-4;Q9NVA1-2;Q9NVA1;F8WCR2;B1AKV2;B1AKV6;B1AKV3;Q9NVA1-3;Q9NVA1-5B1AKV4;F6UTR7;Q9NVA1-4;Q9NVA1-2;Q9NVA1 F8WCR2;B1AKV2;B1AKV6;B1AKV3;Q9NVA1-3;Q9NVA1-5Ubiquinol-cytochrome-c reductase complex assembly factor 1UQCC1 2 2 219 0 56.846 0.70334 4.5327 2.62E+08
H0YI50;A0A087WU02;Q96RQ1;F8VPA6;H0YI58;F8W0R1H YI50;A0A087WU02;Q96RQ1;F8VPA6Endoplasmic reticulum-Golgi intermediate compartment protein 2RLN3;ERGIC2 3 3 209 0 10.54 0.70319 0.97136 3.75E+07
Q10469 Q10469 Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferaseMGAT2 4 4 447 0 7.1922 0.70287 NaN 7.32E+08
Q969M3;Q969M3-3;E5RGR9;E5RHH4;Q969M3-2Q969M3;Q969M3-3;E5RGR9;E5RHH4;Q969M3-2Protein YIPF5 YIPF5 2 2 257 0 5.64 0.70274 0.79906 7.52E+08
Q9BYD1;E5RJI7;H0YAX3;E5RFI2Q9BYD1;E5RJI7 39S ribosomal protein L13, mitochondrialMRP 9 9 178 0 35.754 0.70218 1.2911 4.40E+08
P39023;G5E9G0;H7C422;H7C3M2;B5MCW2;F8WCR1;Q92901P390 3;G5E9G0;H7C422;H7C3M2;B5MCW260S ribosomal protein L3RPL3 27 27 403 0 203.07 0.70197 1.8443 8.09E+09
Q8WV93;H0Y5F4;H7C448;A6ZJA2Q8WV93;H0Y5F4 Lactation elevated protein 1LACE1 3 3 481 0 4.7015 0.7012 NaN 7.68E+07
188
P38646;D6RJI2;D6RA73;H0Y8S0;H0YBG6P38646 Stress-70 protein, mitochondrialHSPA9 37 36 679 0 323.31 0.70093 1.7906 9.64E+09
P04844-2;P04844;Q5JYR7;Q5JYR4;F2Z3K5;Q5JYR3;H0Y5M1P04844-2;P048 4Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2RPN2 17 17 615 0 300.23 0.69958 1.138 3.54E+09
O43251-6;O43251-8;B0QYV1;A0A0G2JRA5;O43251-5;O43251-10;O43251-2;O43251;S4R469;F8VR27;F8VZY7;B0QYY4;A0A087X2B1;J3KNW3;B7Z1U7;F8VZG9;O43251-9;Q9NWB1-3;O43251-4;Q9NWB1-4;Q9NWB1-5;Q9NWB1;O43251-7;Q9NWB1-2;I3L1D4;O43251-3;F8VRS4;A0A0G2JSB3;B0QYY7;A0A0G2JRD1;S4R3K7;J3QRF4;A6NFN3;A6NFN3-2;B0QYY6;J3QQZ2;F5H0M1O43251-6;O43251-8;B0QYV1;A0A0G2JRA5;O43251-5;O43251-10;O43251-2;O43 51;S4R469;F8VR27;F8VZY7;B0QYY4;A0A08 X2B1 J3KNW3;B7Z1U7;F8VZG9;O4 251-9;Q9NWB1-3;O43251-4;Q9NWB1-4;Q9NWB1-5;Q9NWB1;O43251-7;Q9NWB1-2;I3L1D4;O43251-3;F8VRS4RNA binding protein fox-1 homolog 2;RNA binding protein fox-1 homolog;RNA binding protein fox-1 homolog 1RBFOX2;RBFOX 11 11 450 0 65.674 0.6 813 0.92973 5.18E+08
P13797;P13797-3;A0A0A0MSQ0;P13797-2;H7C4N2;U3KQI3;P13796;Q14651;Q5TBN3;C9JAM8;F2Z2Z9P13797;P13797-3;A0A0A0MSQ0;P13797-2Plastin-3 PLS3 17 17 630 0 115.16 0.69813 NaN 1.40E+09
Q9UKM9-2;Q9UKM9;Q5QPL9;Q5QPM0;Q5QPM1;Q5QPM2Q UKM9-2;Q9UK 9;Q5QPL9;Q5QPM0;Q5QPM1RNA-binding protein RalyRALY 11 11 290 0 64.88 0.69806 1.477 1.79E+09
P51572;P51572-2;C9JSP1;C9JQ75;C9J0M4;C9JM14;C9JMD7P51572;P51572-2B-cell receptor-associated protein 31BCAP31 5 5 246 0 32.482 0.69783 1.0989 3.93E+08
H0YK01;P49770 H0YK01;P49770 Translation initiation factor eIF-2B subunit betaEIF2B2 1 1 71 0 4.0342 0.6977 1.6581 1.56E+07
Q10713;Q10713-2;Q5SXN9Q10713 Mitochondrial-processing peptidase subunit alphaPMPCA 8 8 525 0 70.934 0.69655 0.99715 5.22E+08
Q92889;Q92889-2Q92889 DNA repair endonuclease XPFERCC4 5 5 916 0 24.762 0.69653 1.488 2.01E+08
Q6AI08;K7EIX2;A0A087WXZ7;K7ELR8;K7ESP5;K7EKW7Q6AI08;K7EIX2;A0A087WXZ7HEAT repeat-containing protein 6HEATR6 11 11 1181 0 98.57 0.69651 1.7089 7.71E+08
Q13416 Q13416 Origin recognition complex subunit 2ORC2 2 2 577 0 6.9376 0.69638 NaN 5.04E+07
P06733;P06733-2;K7EM90;F5H1C3;E5RI09;E5RG95;K7EPM1;K7EKN2;E5RGZ4;F5H0C8;P13929-3;P09104-2;P13929-2;P13929;P09104P06733;P06733-2;K7EM 0Alpha-enolase;EnolaseENO1 19 19 434 0 197.48 0.69592 1.5313 3.06E+09
Q7Z417;Q7Z417-2Q7Z417 Nuclear fragile X mental retardation-interacting protein 2NUFIP2 5 5 695 0 74.257 0.69526 0.83621 1.58E+08
Q9Y276;C9J8G3;C9JAS4;H7C492;H7BZF6;C9J1S9Q9Y276;C9J8G3 Mitochondrial chaperone BCS1BCS1L 5 5 419 0 28.939 0.69453 1.5463 2.88E+08
P16403 P16403 Histone H1.2 HIST1H1C 16 5 213 0 60.122 0.69449 0.60699 2.92E+09
Q7Z2W9-2;Q7Z2W9;H3BUY0;F5H7V8Q7Z2W9-2;Q7Z2W9;H3BUY03 S ribosomal protein L21, mitochondrialMRP 4 4 120 0 14.266 0.6944 1.1846 2.85E+08
O95352;O95352-3;O95352-2;C9JFF4;H7C369;H7C2R3;H7BZ92;H7C059;H7C2J8;C9J415O95352;O95352-3;O95352-2Ubiquitin like modifier-activating enzyme ATG7ATG 5 5 703 0 18.535 0.69431 NaN 1.47E+08
P00367;P00367-3;P49448;P00367-2P00367;P0 367-3;P49448;P00367-2Glutamate dehydrogenase 1, mitochondrial;Glutamate dehydrogenase 2, mitochondrialGLUD1;GLUD2 14 14 558 0 47.877 0.69429 1.3859 1.32E+09
P08240-2;P08240P08240-2;P08240Signal recognition particle receptor subunit alphaSRPR 12 12 610 0 58.177 0.69272 NaN 6.88E+08
B7Z6R6;A0AVF1-2;A0AVF1-3;A0AVF1;B7Z2T3;Q96CU4B7Z6R6;A0 VF1-2;A0AVF1-3;A0AVF1;B7Z2T3Tetratricopeptide repeat protein 26TTC26 5 5 447 0 84.982 0.6908 NaN 2.44E+08
Q14498-3;Q14498-2;Q14498;G3XAC6;A0A0U1RQH7;H0Y4X3;A0A0U1RQW2;Q5QP23;Q5QP22;F8WF24;F2Z2Z5;A8MYG5;F2Z3E6;F8WF73;G3V5Z6;H0YJJ3;A0A087X122Q14498-3;Q14498-2;Q14498;G3XAC6;A0A0U1RQH7;H0Y4X3RNA-binding protein 39RBM39 19 16 08 0 157.31 0.69047 2.191 4.18E+09
J3QLD9;E7EMK3;Q14254;K7EKW9J3QLD9 E MK3;Q14254;K7EKW9Flotillin-2 FLOT2 10 10 428 0 42.026 0.69041 1.709 5.11E+08
G3V5Z7;P60900;G3V295;G3V3U4;G3V3I1;P60900-2;G3V4S5;G3V2S7;P60900-3;H0YJC4G3V5Z7;P60900 295;G3V3U4;G3V3I1;P60900-2Proteasome subunit alpha type;Proteasome subunit alpha type-6PSMA6 7 7 252 0 29.058 0.69039 1.2582 1.05E+09
Q15813;Q15813-2Q15813;Q15813-2Tubulin-specific chaperone ETBCE 14 13 527 0 66.644 0.69016 NaN 9.02E+08
E9PH70;Q9ULH0-4;Q9ULH0;Q9ULH0-3;Q9ULH0-2;H0Y8E4;F8WAY8;H7C584E9PH70;Q9ULH0-4;Q9ULH0;Q9ULH0-3;Q9ULH0-2; 0Y8EKinase D-interacting substrate of 220 kDaKIDINS220 7 7 1305 0 20.854 0.69002 2.2994 2.23E+08
Q00403;B1APE1;B1APE2Q00403 Transcription initiation factor IIBGTF2B 7 7 316 0 45.527 0.69 0.97179 1.71E+08
P52789;E9PB90;P52790P52789;E9PB90 Hexokinase-2 HK2 31 27 917 0 162.4 0.68893 1.3924 3.15E+09
P10412;Q02539;P22492;P16401P10412;Q02539 Histone H1.4;Histone H1.1HIST1H E;HIST1H1A 13 2 219 0.0023036 2.795 0.68849 0.68233 1.05E+07
E9PIF2;Q13206 E9PIF2;Q13206 Probable ATP-dependent RNA helicase DDX10DDX10 4 4 835 0 29.182 0.68803 1.2504 1.20E+08
Q9BWJ5 Q9BWJ5 Splicing factor 3B subunit 5SF3B5 4 4 86 0 39.19 0.68792 0.91811 2.75E+08
A0A0B4J2A0;Q9UHJ6A0A0B4J2A0;Q9UHJ6SedoheptulokinaseSHPK 6 6 478 0 31.252 0.68787 1.4805 4.66E+08
Q9UBB4-2;Q9UBB4;B1AHE3;B1AHE4Q9UBB4-2;Q9UBB4Ataxin-10 ATXN10 16 16 411 0 110.51 0.68752 1.3029 2.05E+09
B4DWR3;P61758 B4DWR3;P61758 Prefoldin subunit 3VBP1 5 5 192 0 10.911 0.68716 1.0862 1.73E+08
Q13405;H0YDP7;E9PI78;E9PNF1Q13405;H0YDP7 39S ribosomal protein L49, mitochondrialMRP 3 3 166 0 29.021 0.68554 1.9738 4.50E+08
Q12874 Q12874 Splicing factor 3A subunit 3SF3A3 3 3 501 0 6.1122 0.68544 NaN 2.98E+07
Q8NFJ9;Q8NFJ9-2;E9PMB7;E7EQH1;Q8NFJ9-3Q8NFJ9;Q8NFJ9-2;E9PMB7;E7EQH1;Q8NFJ9-3Bardet-Biedl syndrome 1 proteinBBS1 2 2 593 0 10.58 0.68507 NaN 4.44E+07
F2Z2Y8;Q9H0E2;E9PNS3;E9PP67;E9PQ25;E7EN89;Q9H0E2-2F2Z2Y8;Q9H0E2;E9PNS3;E9PP67;E9PQ25;E7EN89;Q9H0E2-2Toll-interacting proteinTOLLIP 2 2 213 0 8.7719 0.68433 1.2 2.42E+08
E7EN86;P52747-2;P52747-3;P52747;E9PPB0;C9JRS3;E9PLN4;E9PS81;E9PMY8;E9PJF2;C9JTC5;C9J2G7;C9JCG1;E9PLS7E7EN86;P52747-2;P52747-3;P52747;E9PPB0;C9JRS3;E9PLN4;E9PS81;E9PMY8;E9PJF2;C9JTC5Zinc finger protein 143ZNF143 3 3 610 0 18.668 0.68401 NaN 4.24E+07
Q9Y3P9;Q9Y3P9-3;Q9Y3P9-2;A0A0U1RQV7;E9PS63;F5H8L0;B7ZAP0;Q5R372-7;Q5R372-8;Q5R372-6;Q5R372-5Q9Y3P9;Q9Y3P9-3;Q9Y3P9-2Rab GT ase-activating protein 1RABGAP1 4 4 1069 0 15.43 0.68367 2.7503 1.30E+08
H0Y5D5;Q9BTG3;Q5SYW2;F5H2X7;Q9ULV3-5;Q9ULV3-3;Q9ULV3-4;Q9ULV3-2;Q9ULV3H0Y5D5;Q9BTG3 5SYW2;F5H2X7;Q9ULV3-5;Q9ULV3-3;Q9ULV3-4;Q9ULV3-2;Q9ULV3Cip1-interacting zinc finger proteinCIZ1 1 1 820 0 15.505 0.68344 NaN 2.15E+07
Q96JJ7;B4DIE3;Q96JJ7-2Q96JJ7;B4DIE3;Q96JJ7-2Protein disulfide-isomerase TMX3TMX3 2 2 454 0 5.1156 0.68234 NaN 7.07E+07
Q99536;K7ER81;K7ERT7;K7ENX2;K7EM19;Q99536-2;Q99536-3Q99536;K7ER81;K7ERT7;K7ENX2;K7EM19;Q99536-2;Q99536-3Synaptic vesicle membrane protein VAT-1 homologVAT 2 2 393 0 8.6955 0.68052 NaN 1.45E+08
Q9BZE1;S4R369;A6NHR2;H0Y4J2Q9BZE1;S4R369;A6NHR239S ribosomal protein L37, mitochondrialMRP 4 4 423 0 8.6704 0.68019 0.95789 2.23E+08
M0R3A4;M0QYA2;Q9NWS0;M0R028;M0R1R3;M0R2P8;M0R3A8;M0QZM3;M0QYF4M0R3A4;M0QYA ;Q9NWS0; 0R028; 0R1R3; 0R2P8;M0R3A8;M0QZM3;M0QYF4PIH1 domain-containing protein 1PIH1D 2 2 183 0 9.4537 0.67985 2.3161 2.73E+08
Q15125;C9J719;C9JJ78Q15125;C9J719;C9JJ783-beta-hydroxysteroid-Delta(8),Delta(7)-isomeraseEBP 2 2 230 0 10.789 0.67945 1.1029 3.43E+08
A0A0J9YYL3;A0A0J9YVP6;Q9UHX1-4;Q9UHX1-6;Q9UHX1-2;A0A0J9YXJ8;A0A0J9YXX5;Q9UHX1-3;Q9UHX1-5;Q9UHX1;A0A0J9YVR6;E9PQ56;A0A0J9YWM1;H0YEM1;E9PN18;E9PMU7;H0YCP8;E9PL19A0A0J9YYL3;A0A0J9YVP6;Q9UHX1-4;Q9UHX1-6;Q9UHX1-2;A0A0J9YXJ8;A0A0J9YXX5;Q9UHX1-3;Q9UHX1-5;Q9UHX1;A0A0J9YVR6;E9PQ56;A0A0J9YWM1;H0YEM1Poly(U)-binding-splicing factor PUF60PUF60 16 16 5 5 8.51 0.67848 0.90497 1.25E+09
Q6ZXV5-2;Q6ZXV5Q6ZXV5-2;Q6ZXV5Transmembrane and TPR repeat-containing protein 3TM C3 2 2 914 0 15.076 0.67838 NaN 1.09E+08
O14828-2;O14828O14828-2;O14828Secretory carrier-associated membrane protein 3SCAMP3 3 3 321 0 22.924 0.67768 1.9617 1.07E+08
Q5JTH9-2;Q5JTH9-3;Q5JTH9;A0A087X0G0;A0A087X1U8Q5JTH9-2;Q5JTH9-3;Q5JTH9RRP12-like proteinRRP12 11 11 1197 0 67.838 0.67694 1.7857 3.87E+08
Q9Y333 Q9Y333 U6 snRNA-associated Sm-like protein LSm2LSM2 1 1 95 0 17.461 0.67615 NaN 1.04E+08
B0QYW5;F6RTR7;O43808;F8WE74B0QYW5;F6RTR7;O43808;F8WE74Peroxisomal membrane protein PMP34SLC25A17 3 3 225 0 16.798 0.67608 0.90283 7.12E+08
Q9Y3I1;Q9Y3I1-3;Q9Y3I1-2;F8WBR0;F8WDR9;Q9Y3I1-3;Q9Y3I1-2F-box only protein 7FBXO7 4 4 522 0 21.398 0.67591 NaN 2.14E+08
Q9H6U6-2;Q9H6U6-7;Q9H6U6;Q9H6U6-3;Q9H6U6-8;A0A087X207;A0A087X2J1;K7ESE9;Q9H6U6-6;K7EJU7;K7EKB0;K7EJH7;K7EML5Q9H6U6-2;Q9H6U -7;Q9H6U ;Q9H6U6-3;Q9H6U6-8;A0A087X207;A0A087X2J1;K7ESE9;Q9H6U6-6Breast carcinoma-amplified sequence 3BCAS 7 7 913 0 88.009 0.67478 1.6154 5.50E+08
P22314-2;P22314;Q5JRR6;Q5JRR9;Q5JRS0;Q5JRS1;Q5JRS3;Q5JRS2P22314-2;P22314Ubiquitin-like modifier-activating enzyme 1UBA1 25 25 1018 0 323.31 0.67442 1.3543 5.49E+09
A0A0U1RRM4;P26599;P26599-2;P26599-3;A6NLN1;A0A0D9SF20;K7EKJ7;K7EK45;A0A087WUW5;K7ELW5;K7ES59;A0A087WU68A0A0U1RRM4;P2659 ;P26599-2;P26599-3;A6NLN1;A0A0D9SF20;K7EKJ7Polypyrimidine tract-binding protein 1PTBP1 14 11 588 0 147.04 0.67428 1.3107 4.61E+09
Q8TB37;H0YHR7;F8W061;F8W0A2;Q8TB37-2Q8TB37;H0YHR7;F8W061;F8W0A2;Q8TB37-2Iron-sulfur protein NU PLNUBPL 2 2 319 0 64.26 0.67246 0.80929 1.55E+08
Q9Y4J8-13;Q9Y4J8-2;Q9Y4J8-14;Q9Y4J8-15;Q9Y4J8;M0QZ28;Q9Y4J8-6;Q9Y4J8-10;Q9Y4J8-11;Q9Y4J8-12;Q9Y4J8-16;Q9Y4J8-5;Q9Y4J8-4;Q9Y4J8-3;M0R0C4;M0R021;Q9Y4J8-8;Q9Y4J8-9;Q9Y4J8-7;K7ERH7Q9Y4J8-13;Q9Y4J8-2;Q9Y4J8-14;Q9Y4J8-15; 9Y4J8;M0QZ28;Q9Y4J8-6;Q9Y4J8-10;Q9Y4J8-11;Q9Y4J8-12;Q9Y4J8-16;Q9Y4J8-5;Q9Y4J8-4;Q9Y4J8-3Dystrobrevin alphaDTNA 7 4 683 0 1 8.21 0.67139 0.62784 5.20E+08
O43301;K7ELE6 O43301 Heat shock 70 kDa protein 12AHSPA12A 4 4 675 0 22.024 0.67119 NaN 1.71E+08
Q6IA86-4;Q6IA86-2;Q6IA86-3;Q6IA86-5;Q6IA86;Q6IA86-6;Q6IA86-7;F5GWY6;F5GX79;K7ER35;F5GYE9Q6IA86-4;Q6IA86-2;Q6IA86-3; 6I 86-5; 6I 86;Q6IA86-6;Q6IA86-7Elongator complex protein 2ELP2 7 7 705 0 70.73 0.66985 1.1175 7.32E+08
A2A2V2;P42696;Q5TCT4;P42696-2A2A2V2;P42696 RNA-binding protein 34RBM34 3 3 408 0 8.4888 0.66938 NaN 4.75E+07
Q96GK7;Q6P2I3;C9JGM0;C9J5B6Q96GK7;Q6P2I3;C9JGM0Fumarylacetoacetate hydrolase domain-containing protein 2A;Fumarylacetoacetate hydrolase domain-containing protein 2BFAHD2A;FAHD2B 5 5 314 0 66.516 0.66933 0.7815 4.48E+08
E5RHW4;O94905;E5RJ09;O94905-2;O94905-3E5RHW4;O94905;E5RJ09Erlin-2 ERLIN2 14 11 338 0 98.489 0.66909 1.606 4.11E+09
Q8TDD1;Q8TDD1-2;F8VRX4;H0YHH7Q8TDD1;Q8TDD1-2ATP-dependent RNA helicase DDX54DDX54 8 8 881 0 24.394 0.66871 1.5192 4.91E+08
P09211;A8MX94;A0A087X2E9;A0A087X243P 9211;A8MX94 Glutathione S-transferase PGSTP1 7 7 210 0 190.99 0.66844 1.1261 3.31E+09
P30419-2;P30419;K7EN82;B7Z8J4;Q5VUC6;O60551P30419-2;P30419;K7EN82;B7Z8J4;Q5VUC6;O60551Glycylpeptide N-tetradecanoyltransferase 1;Glycylpeptide N-tetradecanoyltransferase;Glycylpeptide N-tetradecanoyltransferase 2NMT1;NMT2 2 2 416 0 4.933 0.66765 NaN 1.63E+08
P52739-2;P52739;D6RFI6;D6RAT8;D6RBK1;D6RJH2;D6R9I2P52739-2;P52739Zinc finger protein 131ZNF 31 3 3 589 0 37.701 0.66544 0.68594 1.58E+08
Q9H3G5;H7C0X5;A0A087WVP6;A0A087WXJ9;C9JLV0;H7C218;C9J6L4;C9JI22Q9H3G5;H7C0X5; 0A087WVP6Probable serine carboxypeptidase CPVLCPVL 7 7 476 0 20.526 0.66429 2.7352 6.91E+08
K7EM09;K7EPR0;K7ELQ9;Q6UW68K7EM09;K7EPR0;K7ELQ9;Q6UW68Transmembrane protein 205TMEM205 2 2 120 0 14.217 0.66366 1.0853 3.16E+08
Q14137-2;Q14137;A0A075B729Q1413 -2;Q14137Ribosome biogenesis protein BOP1BOP1 13 13 634 0 107.3 0.66361 1.3081 1.19E+09
P61353;K7ELC7;K7EQQ9;K7ERY7P61353;K7ELC7;K7EQQ960S ribosomal protein L27RPL27 10 10 136 0 49.757 0.66293 0.62897 9.74E+09
A0A024RA52;P25787;C9JCK5;H7C402;H3BT36A0A024RA 2;P25787Proteasome subunit alpha type;Proteasome subunit alpha type-2PSMA2 5 5 234 0 23.201 0.66259 1.4012 2.16E+08
Q9NQT8;E7ERX9 Q9NQT8;E7ERX9 Kinesin-like protein KIF13BKIF13B 2 2 1826 0 4.875 0.66232 NaN 1.94E+08
A8MSZ8;A6NN50;O75147-2;O75147-1;O75147-4;O75147A8MSZ8;A6NN50;O75147-2;O75147-1;O75147-4;O75147bscurin-like protein 1OBSL1 1 1 612 0 3.8103 0.66124 1.1021 3.49E+07
P61956-2;P61956;A8MUA9;A8MU27;Q6EEV6;P55854;P55854-2P61956-2;P61956Small ubiquitin-related modifier 2SUMO2 3 3 71 0 40.783 0.66111 1.2511 3.96E+08
Q13423;E9PCX7;D6RAI5;D6RHU2;H0Y8P5;D6RCR6Q13423;E9PCX7 NAD(P) transhydrogenase, mitochondrialNNT 13 13 1086 0 90.191 0.66097 1.49 1.10E+09
Q8TAE8 Q8TAE8 Growth arrest and DNA damage-inducible proteins-interacting protein 1GADD45GIP1 3 3 222 0 6.9471 0.66054 NaN 6.65E+07
A0A0D9SF54;A0A0D9SGF6;Q13813-3;Q13813;Q13813-2A0A0D9SF54;A0A0D9SGF6;Q13813- ;Q13813;Q13813-2Spectrin alpha chain, non-erythrocytic 1SPTAN1 6 6 2457 0 34.958 0.65997 1.3301 2.97E+08
Q9NR30;Q9NR30-2Q9NR30;Q9NR30-2Nucleolar RNA helicase 2DDX21 52 50 783 0 323.31 0.65901 1.5909 3.16E+10
O14818;O14818-2;H0Y586;O14818-4;Q8TAA3-2;Q8TAA3-5;Q8TAA3;A0A087WYS6;F5GY34O1481 ;O14818-2;H0Y586;O14818-4Proteasome subunit alpha type-7PSMA7 12 12 248 0 126.83 0.65781 1.1902 4.17E+09
P24386 P24386 Rab proteins geranylgeranyltransferase component A 1CHM 4 4 653 0 13.857 0.65778 1.103 1.91E+08
S4R3G0;Q13242;H0YIB4S4R3G0;Q13242;H0YIB4Serine/arginine-rich splicing factor 9SRSF9 4 3 119 0 12.068 0.65737 1.9581 3.29E+08
A0A087WUV8;A0A087X2B5;P35613-3;P35613-4;P35613-2;P35613;R4GMX5;I3L192;R4GN83A087WUV8;A0A087X2B5;P35613-3;P35613-4;P35613-2;P35613;R4GMX5;I3L192Basigin BSG 4 4 189 0 12.888 0.65649 2.4809 3.93E+08
P05023-4;P05023;P05023-3;P05023-2;B1AKY9;P50993;H0Y7C1;Q5TC01;P20648;Q5TC02;Q5TC05;M0QXF2P05023-4;P05023;P05023-3;P0 23-2Sodium/potassium-transporting ATPase subunit alpha-1ATP1A1 49 31 1023 0 323.31 0.65503 1.4648 2.26E+10
E5RJR5;P63208;E7ERH2;F8W8N3;P63208-2;E5RGM3E5 JR5;P63208 E7ERH2;F8W8N3;P63208-2S-phase kinase-associated protein 1SKP1 4 4 163 0 24.549 0.65499 2.0552 1.47E+08
Q9GZN8;Q9GZN8-2;H7BYU9Q9GZN8;Q9GZN8-2;H7BYU9UPF0687 protein C20orf27 3 3 174 0 10.892 0.65451 1.5512 1.65E+08
Q9Y4C2;Q9Y4C2-2Q9Y4C2;Q9Y4C2-2Protein FAM115AFAM115A 11 11 921 0 38.824 0.65239 1.3574 8.49E+08
P18077;C9K025;F8WBS5;F8WB72P18077;C9K025;F8WBS5;F8WB7260S ribosomal protein L35aRPL35A 12 12 110 0 31.311 0.6522 1.6206 4.06E+09
P27824;P27824-2;P27824-3;H0Y9Q7;D6RGY2;D6RAU8;D6RB85;D6RDP7;D6RFL1;D6RAQ8;H0Y9H1;D6RHJ3;D6RD16P27824;P27824-2;P27824-3Calnexin CANX 14 14 592 0 69.943 0.65148 1.3348 4.94E+09
Q9UEW8-2;Q9UEW8Q9UEW8-2;Q9UEW8STE20/SPS1-related proline-alanine-rich protein kinaseSTK39 8 6 526 0 20.956 0.65135 NaN 4.76E+08
A0A0B4J220;E9PLD3;E9PRG8A0A0B4J220;E9PLD3;E9PRG8 LOC102288414 2 2 123 0 8.9966 0.65087 NaN 1.87E+08
H0Y2Y8;Q15942;Q15942-2;H7C3D3;C9IZ41;C9JJK5H0Y2Y8;Q15942;Q15942-2;H7C3D3Zyxin ZYX 6 6 540 0 11.586 0.64984 0.48585 1.40E+08
P28070 P28070 Proteasome subunit beta type-4PSMB4 3 3 264 0 19.391 0.64974 1.1214 2.41E+08
Q16643;Q16643-3;D6RFI1;D6R9W4;Q16643-2;D6RCR4Q16643;Q16643-3;D6RFI1;D6R9W4;Q16643-2Drebrin DBN1 4 4 649 0 33.762 0.64807 1.3906 4.84E+08
Q15750;Q15750-2Q15750;Q15750-2TGF-beta-activated kinase 1 and MAP3K7-binding protein 1TAB1 9 9 504 0 54.874 0.64744 NaN 6.16E+08
Q9UNF1;Q5H909;Q9UNF1-2;Q5H907;Q5H909;Q9UNF1-2;Q5H907Melanoma-associated antigen D2MAGED2 17 15 606 0 250.33 0.64727 1.1333 1.92E+09
J3QQ67;Q07020;G3V203;H0YHA7;Q07020-2;F8VYV2;A0A075B7A0;F8VUA6;F8VXR6J QQ67 Q 7020 G3V203;H0YHA7;Q07020-2;F8VYV2;A0A075B7A0;F8VUA660S ribosomal protein L18RPL18 11 11 190 0 86.939 0.64612 1.8543 8.09E+09
Q6UWP7-3;Q6UWP7;C9K0C3;Q6UWP7-2;C9J5S5;C9JA02;C9JMW2;C9JUV9;C9JXY8;C9J6F4Q6UWP7-3;Q6U P7;C9K0C3;Q6UWP7-2Lysocardiolipin acyltransferase 1LCLAT1 3 3 376 0 7.1474 0.64543 1.2992 9.90E+07
Q05209;H0YC15;Q05209-2;Q05209-305209;H0YC15;Q05209-2;Q05209-3Tyrosine-protein phosphatase non-receptor type 12PTPN12 2 2 780 0 7.0448 0.6453 NaN 3.95E+07
Q9HCC0-2;Q9HCC0;D6RD67Q9HCC0-2;Q9HCC0;D6RD67Methylcrotonoyl-CoA carboxylase beta chain, mitochondrialMCCC2 4 4 525 0 18.051 0.64377 NaN 8.92E+07
A0A0U1RR27;Q7Z401;Q7Z401-2;H3BTW5A A0U1RR27;Q7Z401;Q7Z401-2;H3BTW5C-myc promoter-binding proteinDENND4A 4 4 1916 0 18.018 0.64373 2.9762 2.10E+08
Q9Y2S7;B4DEM9 Q9Y2S7;B4DEM9 Polymerase delta-interacting protein 2POLDIP2 3 3 368 0 9.1433 0.64356 NaN 1.72E+08
Q9BYG3;C9J6C5;C9J808Q9BYG3;C9J6C5;C9J808MKI67 FHA domain-interacting nucleolar phosphoproteinNIFK 6 6 293 0 60.69 0.64226 2.2244 7.89E+08
Q92522 Q92522 Histone H1x H1FX 5 5 213 0 21.614 0.64104 2.3067 8.96E+08
Q9Y3A4 Q9Y3A4 Ribosomal RNA-processing protein 7 homolog ARRP7A 3 3 280 0 7.1722 0.64098 0.94107 1.37E+08
189
P49711;P49711-2;V9GY73;Q8NI51-11;Q8NI51-6;Q8NI51-5;Q8NI51-10;Q8NI51-2;Q8NI51-8;Q8NI51;Q8NI51-3;Q8NI51-7P4 711 Transcriptional repressor CTCFCTCF 5 5 27 0 101.28 0.64079 1.6502 3.63E+08
P51812;B1AXG1;E9PMM7;D6R910;B1AXG2;B7Z3B5;F2Z2J1;Q15349;Q15349-3;Q9UK32-2;Q9UK32;Q15349-2P51812;B1AXG1 Ribosomal protein S6 kinase alpha-3RPS6KA3 3 2 740 0 10.338 0.63971 1.6096 2.78E+08
Q9NW13;Q9NW13-2;C9JE21;C9JAA9;H7C5G8Q9NW13;Q9NW13-2RNA-binding protein 28RBM28 10 10 759 0 38.172 0.63966 1.7276 6.35E+08
Q5QPR4;J3QR29;A0A0D9SEI3;Q5QPR3;B7ZVY7;A0A0D9SER5;A0A0D9SEN2;J3QR44;Q9UQ88-5;Q9UQ88-10;P21127-12;P21127-4;P21127-5;P21127-10;P21127-6;P21127-9;Q9UQ88-4;P21127-8;Q9UQ88-3;Q9UQ88-2;P21127-3;P21127-2;Q9UQ88;P21127;Q9UQ88-9Q5QPR4;J3QR29;A0A0D9SEI3;Q5QPR3;B7ZVY7;A0A0D9SER5;A0A0D9SEN2;J3 R44;Q9UQ88-5;Q9UQ88- 0;P21127- ;P21127-4;P21127-5;P21127- 0;P21127-6;P211 7-9;Q9U 88-4;P21127-8;Q9UQ88-3;Q9UQ88- ;P 1127-3;P21127-2 ;P21127;Q9UQ88-9Cyclin-dependent kinase 11A;Cyclin-dependent kinase 11BCDK11A;CDK11B;CDC2L1 5 3 746 0 8.0441 0.63955 1.343 1.17E+08
O43390;O43390-3;B4DT28;O43390-2;O43390-4O43390;O43 90-3;B4DT28;O 3390-2;O43390-4Heterogeneous nuclear ribonucleoprotein RHNRNPR 18 13 633 0 117.96 0.6392 1.7358 3.17E+09
O60294 O60294 tRNA wybutosine-synthesizing protein 4LCMT2 4 4 686 0 20.716 0.63919 NaN 2.76E+08
E9PPY3;O43159 E9PPY3;O43159 Ribosomal RNA-processing protein 8RRP8 3 3 306 0 5.4833 0.63787 NaN 3.48E+07
A0A087X0U3;A0A087WT87;P43003-2;P43003A0A087X0U3;A0A087WT87;P43003-2;P43003Excitatory amino acid transporter 1SLC1A 2 2 430 0 16.038 0.63726 NaN 2.18E+08
Q9Y2P8;Q5VZU3;Q9Y2P8-2;Q5VYW8;Q5VZU29Y2P8;Q5VZU3 RNA 3-terminal phosphate cyclase-like proteinRCL1 11 11 373 0 75.359 0.63684 1.6117 1.41E+09
F8W726;Q14157-4;Q14157-1;Q14157-3;Q14157;Q14157-5;Q5VU77;Q5VU81;Q5VU80;Q5VU79;Q5VU78;H0Y5H6;H7C2T8F8W726;Q 4157-4;Q14157-1;Q14157-3;Q14157;Q14157-5; 77Ubiquitin-associated protein 2-likeUBAP2L 6 6 1079 0 29.696 0.63586 1.3779 3.64E+08
P40926;P40926-2;G3XAL0P40926;P40926-2;G3XAL0Malate dehydrogenase, mitochondrial;Malate dehydrogenaseMDH2 6 6 338 0 40.729 0.63534 1.5717 4.91E+08
Q9NP92;A0A087WV52Q9NP92;A0A087WV5228S ribosomal protein S30, mitochondrialMRP 6 6 439 0 21.633 0.63456 1.5352 2.85E+08
B9A062;P13995;B8ZZU9;P13995-2B9A062;P13995;B8ZZU9;P13995-2Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial;NAD-dependent methylenetetrahydrofolate dehydrogenase;Methenyltetrahydrofolate cyclohydrolaseMTHFD2 2 2 222 0 13.333 0.6335 2.1094 6.20E+08
Q14694;Q14694-3;Q14694-2;H3BQP1;J3KT19;H3BNS8;H3BNA1Q14694;Q14694-3;Q14694-2Ubiquitin carboxyl-terminal hydrolase 10USP10 10 10 798 0 48.918 0.63316 1.1064 9.80E+08
A0A0A0MRP2;O14772;E9PK10;E9PMK0;E9PMM4;A6NHC7;E9PKE1;H0YDF0;Q59H18-3;Q59H18-4;Q59H18-1;V9GXZ4;O14772-3;O14772-2A0A0A0MRP2;O14772;E9PK10;E9PMK0;E9PMM4;A6NHC7;E9PKE1;H0YDF0;Q59H18-3;Q59H18-4;Q59H18-1;V9GXZ4;O14772-3;O14772-2Fucose-1-phosphate guanylyltransferaseFPGT;FPGT-TNNI3K 2 2 607 0 6.7 73 0.63239 NaN 6.98E+07
B4DJV5;Q13610 B4DJV5;Q13610 Periodic tryptophan protein 1 homologPWP1 2 2 439 0 21.337 0.63232 NaN 1.51E+08
P51692;K7EIF9;C9J4I3;K7EK35;P42229-2;P42229P51692;K7EIF9;C9J4I3;K7EK35;P42229-2;P42229Signal transducer and activator of transcription 5B;Signal transducer and activator of transcription;Signal transducer and activator of transcription 5ASTAT5B;STAT5A 2 2 787 0 23.182 0.63219 NaN 6.98E+07
Q9NP97;B1AKR6;Q8TF09;H3BNG9;H3BPA0;Q7Z4M1;H3BQI1;Q9NP97-29NP97;B1AKR6;Q8TF09Dynein light chain roadblock-type 1;Dynein light chain roadblock-type 2DYNLRB1;DYNLRB2 4 4 96 0 32.738 0.63183 1.2737 6.17E+08
F8W6I7;P09651-3;P09651-2;P09651;F8VZ49;Q32P51;F8VTQ5;F8VYN5;F8W646;H0YH80F8W6I7;P09651-3;P09651-2;P09651;F8VZ49;Q32P 1;F8VTQ5Heterogeneous nuclear ribonucleoprotein A1 eterogeneous nuclear ribonucleoprotein A1, N-terminally processed;Heterogeneous nuclear ribonucleoprotein A1-like 2HNRNPA1;HNR PA1L2 22 20 307 0 323.31 0.63166 1.6768 1.81E+10
A1L020 A1L020 RNA-binding protein MEX3AMEX3A 1 1 520 0.0015649 3.0861 0.63082 NaN 1.55E+07
P50454;E9PR70;E9PPV6;E9PKH2;E9PK86;E9PMI5;E9PNX1;E9PJH8;E9PIG2;E9PRS3;H0YEP8;E9PLA6;E9PQ34P50454;E9PR70;E9PPV6;E9PKH2Serpin H1 SERPINH1 15 15 418 0 201.85 0.63063 1.5622 7.91E+09
P62241;Q5JR95 P62241;Q5JR95 40S ribosomal protein S8RPS8 14 14 208 0 160.39 0.62785 2.0073 1.20E+10
Q9NPI6-2;Q9NPI6;A0A087WT55;A0A087WVE6Q9NPI6-2;Q9NPI6mRNA-decapping enzyme 1ADCP1A 6 6 544 0 190.01 0.62646 NaN 6.07E+08
P11940;P11940-2;A0A087WTT1;E7EQV3;E7ERJ7;H0YAR2;Q9H361;H0YBN4;E5RJB9;H0YAP2;E5RGH3;E5RH24;H0YB86;Q4VXU2;H0YAS6;H0YB75;Q4VXU2-2;E5RHG7;H0YAS7;E5RGC4;E5RFD8;E5RJM8;H0YC10;Q5JQF8;Q96DU9-2;Q96DU9P11940;P11940-2;A0A087WTT1;E7EQV3;E7ERJ7; AR2Polyadenylate-binding protein 1PABPC1 23 17 636 0 2 7. 5 0.62608 1.0758 3.77E+09
B5MDF5;P62826;J3KQE5;F5H018;H0YFC6;B4DV51;A0A087X0W0B5MDF5;P62826;J3KQE5;F5H018;H0YFC6GTP-binding nuclear protein RanR N 11 11 233 0 124.22 0.6258 1.3759 4.89E+09
P22626;P22626-2;A0A087WUI2P22626;P226 6-2;A0A087WUI2Heterogeneous nuclear ribonucleoproteins A2/B1HNRNPA2B1 25 24 353 0 323.31 0.62567 1.4933 1.15E+10
E9PHS0;O43813;F8WDS9E9PH 0;O43813;F8WDS9LanC-like protein 1LANCL1 6 6 196 0 28.492 0.62515 1.6301 5.71E+08
C9JQV3;Q8N1F8;H7C2J7;H7C236;Q8N1F8-2C9JQV3;Q8N1F8 Serine/threonine-protein kinase 11-interacting proteinSTK11IP 3 3 1088 0 5.8005 0.62474 1.6606 2.67E+07
R9WNI0;A8MQB8;G3V0J0;Q06787-8;Q06787-6;Q06787-2;Q06787-4;Q06787-5;Q06787-9;Q06787-7;Q06787-3;Q06787;Q8IXW7;A0A087WXI3;G8JLE9;Q06787-11;Q06787-10;A0A087WWR6;A0A087WY29R9WNI A8MQB8;G3V0J0;Q06787-8;Q06787-6;Q06787-2;Q06787-4;Q06787-5;Q06787-9;Q06787-7;Q06787-3 Q 67 ;Q8IXW7;A0A087WXI3;G8JLE9;Q06787-11;Q06787-10Fragile X mental retardation protein 1FMR1 3 2 544 0 14.247 0.62394 NaN 2.50E+07
P04406;P04406-2;E7EUT5;O14556P04406;P04 06-2;E7EUT5Glyceraldehyde-3-phosphate dehydrogenaseGAPDH 20 20 335 0 273.45 0.62359 1.6522 1.39E+10
P10644;K7EPB2;P10644-2;K7EIE5;K7EID3;K7EJ40;K7EK41;K7EPR5;K7EQK3;K7EMU2;X6RAV4;K7EMZ6;K7EM13P10644;K7EPB2;P10644-2;K7EIE5;K7EID3;K7EJ40;K7EK41cAMP-dependent protein kinase type I-alpha regulatory subunit;cAMP-dependent protein kinase type I-alpha regulatory subunit, N-terminally processedPRKAR1A 6 381 0 38.605 0.62359 1.1313 2.57E+08
G5E9V4;Q969F9-2;Q969F9;H7C5G2G5E9V4;Q969F9- ;Q969F9Hermansky-Pudlak syndrome 3 proteinHPS3 3 3 839 0 7.6572 0.6234 1.7497 1.55E+08
Q8IWF6 Q8IWF6 Protein DENND6ADENND6A 2 2 608 0 7.9039 0.6232 NaN 5.24E+07
A0A0A0MRK1;E9PAV9;Q5T3I0;Q5T3I0-3;E9PPY4;F2Z3C6;F8W895;Q5T3I0-20A0A0MRK1;E9PAV9 Q5T3I0;Q5T I0-3;E9PPY4;F2Z C6;F8W895;Q5T3I0-2G patch domain-containing protein 4GPATCH4 2 2 370 0 18.241 0.62298 NaN 7.73E+07
O75369-2;O75369-9;O75369;O75369-8;O75369-6;O75369-3;O75369-5;O75369-4;E7EN95;O75369-7;A0A0A0MT44;H7C5L4;A0A0C4DGA1O75369-2;O75369- ;O75369;O75369-8;O75369-6;O75369-3;O75369-5;O75369-4;E7EN95;O75369-Filamin-B FLNB 56 48 2578 0 323.31 0.62218 1.4843 4.96E+09
O00151 O00151 PDZ and LIM domain protein 1PDLIM1 3 3 329 0 19.681 0.6211 0.7027 1.30E+08
B8ZZJ0;B9A032;B8ZZN6;P63165B8ZZJ0;B9A032;B8ZZN6;P63165Small ubiquitin-related modifier 1SUMO1 1 1 58 0 3.7341 0.6198 1.26 1.17E+08
P18124;A8MUD9;C9JIJ5;C9JZ88P18124;A8MUD9 60S ribosomal protein L7RPL7 18 18 248 0 103.62 0.6191 1.8472 1.25E+10
A0A0B4J203;Q6UN15-4;Q6UN15-3;Q6UN15-5;Q6UN15A0A0B4J203;Q6UN15-4;Q6UN15-3;Q6UN15-5;Q6UN15Pre-mRNA 3-end-processing factor FIP1FIP1L1 4 4 849 0 55.831 0.61852 NaN 2.10E+08
Q8IWA0 Q8IWA0 WD repeat-containing protein 75WDR75 12 12 830 0 128.61 0.61842 1.5685 2.51E+09
Q5MNZ6;I3L4L8;I3L3A5;I3L4S6Q5MNZ6 WD repeat domain phosphoinositide-interacting protein 3WDR45B 3 3 344 0 7.3 0.61816 NaN 2.15E+08
P07195;C9J7H8;A8MW50;F5H793P07195;C9J7H8;A8MW50L-lactate dehydrogenase B chain;L-lactate dehydrogenaseLDHB 10 10 334 0 85.398 0.61812 0.87835 4.99E+09
P62899;H7C2W9;C9JU56;B7Z4E3;B7Z4C8;P62899-3;P62899-2;B8ZZK4P62899;H C2W9;C9JU56;B7Z4E3;B7Z4C8;P62899-3;P62899-2;B8ZZK460S ribosomal protein L31RPL31 11 11 125 0 57.999 0.61777 2.0015 2.25E+09
J3QS48;I3L295;J3KTK8;J3QQZ4;J3KT75;J3QW43;J3QRD5;Q9H3L2;Q1HDL3;A0A087WV81;O75352-2;O75352;J3KSI4;I3L405;I3L261;I3L1D2;I3L4E0J3QS48;I3L295;J3KTK8;J3QQZ4;J3KT7 J3QW43;J3QRD5 Q9H3L2;Q1HDL3;A0A087WV81;O75352-2;O75352;J3KSI4;I3L405;I3L261;I3L1D2;I3L4E0Mannose-P-dolichol utilization defect 1 proteinMPDU1;HBEBP2BPA 2 2 101 0 4.9211 0.61751 1.0932 1.03E+08
P25789;H0YN18;H0YMZ1;H0YL69;P25789-2;H0YMI6;H0YMA1;H0YLS6;H0YLC2;H0YKT8;H0YKS0P25789 N18;H0YMZ1;H0YL69;P25789-2Proteasome subunit alpha type-4;Proteasome subunit alpha typePSMA4 7 7 261 0 24.352 0.61705 1.0293 1.91E+09
Q9HCN8 Q9HCN8 Stromal cell-derived factor 2-like protein 1SDF2L1 3 3 221 0 23.196 0.61692 1.4231 4.99E+08
Q9UII4;E9PBL0 Q9UII4 E3 ISG15--protein ligase HERC5HERC5 5 5 1024 0 18.211 0.61668 0.90439 1.68E+08
F5GZ90;Q9NZJ0-2;Q9NZJ0F5GZ90;Q9NZJ0-2;Q9NZJ0Denticleless protein homologDTL 2 2 688 0 5.0652 0.61663 NaN 4.36E+06
Q9UBS4;H7C2Y5 Q9UBS4 DnaJ homolog subfamily B member 11DNAJB11 5 5 358 0 24.934 0.61627 1.9804 9.78E+08
K7EJU3;K7EN86;C9JSK0;Q13432-2;Q13432;A6NIH7K7EJU3;K7EN86;C9JSK0;Q13432-2;Q13432;A6NIH7Protein unc-119 homolog ;Protein unc-119 homolog BUNC119;UNC119B 1 1 125 0.0051954 2.3158 0.61609 0.90377 1.03E+08
F5H5U2;Q8NHQ9;F5H2I2;F5H735;E7EX41F5 5U2;Q8NHQ9;F5H2I2;F5H735;E7EX41ATP-dependent RNA helicase DDX55DDX55 2 2 569 0 54.093 0.61538 NaN 8.34E+07
Q7Z7F7;Q7Z7F7-2;X6R631;X6RIW1Q7Z7F7;Q7Z7F7-2;X6R631;X6RIW139S ribosomal protein L55, mitochondrialMRP 2 2 128 0 4.5797 0.61298 NaN 6.96E+07
K7ENI6;K7ERE1;Q8N2U0K7ENI6;K7ERE1;Q8N2U0Transmembrane protein 256TMEM256 3 3 41 0 7.7385 0.61179 1.2725 4.44E+08
P61513;C9J4Z3;G5E9R3;Q6P4E4;E9PEL3;M0R0A1;M0R2L6;A6NKH3P61513;C9J4Z3;G5 9R3;Q6P4E4;E9PEL3;M0R0A1;M0R2L660S ribosomal protein L37aRP 7 6 6 92 0 60.243 0.6102 0.50088 3.77E+09
J3KNN7;Q7Z569;Q7Z569-2J3KNN7;Q7Z569;Q7Z569-2BRCA1-associated proteinBRAP 2 2 562 0.00026695 3.5184 0.61 NaN 3.52E+07
Q5JR04;Q9HCE1;Q9HCE1-2Q5JR04;Q9HCE1;Q9HCE1-2Putative helicase MOV-10OV 10 10 947 0 82.183 0.6086 1.8331 5.87E+08
P63092-3;P63092-2;P63092;P63092-4;Q5JWF2-2;Q5JWF2;A0A0A0MR13;S4R3E3;Q5JWE9;H0Y7F4;S4R3V9P63092-3;P63092-2;P63092;P63092-4;Q5JWF2-2;Q5JWF2;A0A0A0MR13Guanine nucleotide binding protein G(s) subunit alpha isoforms short;Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLasGNAS 10 9 379 0 37.773 0.60681 1.4846 1.17E+09
Q9NYP9 Q9NYP9 Protein Mis18-alphaMIS18A 2 2 233 0 25.912 0.60619 0.37567 3.50E+08
Q9NZJ9-2;Q9NZJ9-3;Q9NZJ9;F8VRL4;F8VRR0;A0A0C4DGJ4Q9NZJ9-2;Q9NZJ9-3;Q9NZJ9Diphosphoinositol polyphosphate phosphohydrolase 2NUDT4 3 2 181 0 12.677 0.60614 1.7481 2.16E+10
P47914;F8WF43;C9IYI4P47914 60S ribosomal protein L29RPL29 4 4 159 0 9.2263 0.60608 1.998 8.90E+07
Q8WVX9;E9PNW8;E9PPB8Q8WVX9;E9PNW8Fatty acyl-CoA reductase 1FAR1 14 14 515 0 56.629 0.60469 1.3772 1.53E+09
R4GMR5;P48556;K7EJC1;K7EJR3;K7ERW6R4GMR5;P48556;K7EJC1;K7EJR326S proteasome non-ATPase regulatory subunit 8PSMD8 5 5 287 0 21.344 0.60409 1.1343 2.40E+08
A2AE48;Q12899;A0A0G2JIW2A2AE48;Q1 899;A0A0G2JIW2Tripartite motif-containing protein 26TRIM26 2 2 248 0 5.445 0.60393 NaN 3.67E+07
O00567;H0YDU4;Q5JXT2;H0Y653O00567 Nucleolar protein 56NOP56 25 25 594 0 213.44 0.60204 2.2633 4.56E+09
Q8TEM1;Q8TEM1-2Q8TEM1;Q8TEM1-2Nuclear pore membrane glycoprotein 210NUP210 30 30 1887 0 238.58 0.60193 1.5591 2.86E+09
P07305;P07305-2P07305;P07305-2Histone H1.0;Histone H1.0, N-terminally processedH1F0 4 4 194 0 14.323 0.60084 1.9388 1.17E+08
Q9NQ50 Q9NQ50 39S ribosomal protein L40, mitochondrialMRP 2 2 206 0 5.654 0.60076 1.7597 1.73E+08
P30480;P30460;P01889;A0A140T951;A0A140T962;A0A140T9J9;A0A140T9B3;Q95365;Q29836;Q29718;P30475;P30462;P18463;Q04826;P30479;Q29963;Q29865;Q6DU44;P13747;Q31610;P30486;P01893P30480;P30460;P0 889;A0A140T951;A0A140T962;A0A140T9J9;A0A140T9B3; 95365;Q29836;Q29718;P30475;P30462;P18463; 04826;P30479; 29963;Q29865 6DU44;P13747;Q31610;P30486;P01893HLA class I histocompatibility antigen, B- 2 alpha chain;HLA class I histocompatibility antigen, B-8 alpha chain;HLA class I histocompatibility antigen, B-7 alpha chain;HLA class I histocompatibility antigen, B-38 alpha chain;HLA class I histocompatibility antigen, B-67 alpha chain;HLA class I histocompatibility antigen, B-82 alpha chain;HLA class I histocompatibility antigen, B-39 alpha chain;HLA class I histocompatibility antigen, B-14 alpha chain;HLA class I histocompatibility antigen, B-37 alpha chain;HLA class I histocompatibility antigen, B-40 alpha chain;HLA class I histocompatibility antigen, B-41 alpha chain;HLA class I histocompatibility antigen, Cw-6 alpha chain;HLA class I histocompatibility antigen, Cw-18 alpha chain;HLA class I histocompatibility antigen, alpha chain E;HLA class I histocompatibility antigen, B-81 alpha chain;HLA class I histocompatibility antigen, B-48 alpha chain;Putative HLA class I histocompatibility antigen, alpha chain HHL -B;HLA-C;HL -E;HLA-H 4 0 362 0 27.23 0.60067 0.88666 3.48E+08
Q8NBF2;Q8NBF2-2Q8NBF2;Q8NBF2-2NHL repeat-containing protein 2NHLRC2 4 4 726 0 19.332 0.59921 1.0342 1.76E+08
F5GZS6;J3KPF3;P08195-2;P08195-3;P08195;P08195-4;F5H0E2;H0YFS2;F5H867;F5GZI0;F5GZR9;H0YFX4F5GZS6;J3KPF3;P08195-2;P08195-3;P08195;P08195-44F2 cell-surface antigen heavy chainSLC3A2 22 22 599 0 308.14 0.59838 1.8208 1.17E+10
Q96H55;Q96H55-3;Q96H55-4;A0A087WZQ9;A0A087WU55;A0A087WY49;Q96H55-2Q96H55;Q96H55-3;Q96H55-4Unconventional myosin-XIXMYO19 4 4 970 0 10.913 0.5978 2.5895 1.75E+08
A0A087WV73;P46087;P46087-4;P46087-2;P46087-3;F5GWB7;F5H709;F5H5X6;F5H359;F5GYR3;F5H8G6A0A087WV73;P46087;P46087-4;P46087-2;P46087-3Probable 2 S rRNA (cytosine(444 ) C(5))-methyltransferaseNOP2 21 21 855 0 95.683 0.59668 1.6943 3.74E+09
Q9Y3D6 Q9Y3D6 Mitochondrial fission 1 proteinFIS1 3 3 152 0 16.275 0.59483 1.5824 1.12E+08
C9J7X6;A4D1U4 C9J7X6;A4D1U4 Protein LCHN KIAA1147;LCHN 2 2 351 0 6.4511 0.59475 NaN 3.81E+07
Q8IY81 Q8IY81 pre-rRNA processing protein FTSJ3FTSJ3 2 2 847 0 6.3885 0.59468 2.7209 1.83E+08
Q969Z0;C9J7P5;C9IZN7;Q969Z0-2;C9J5A2;C9J347;H7C4R5Q969Z0;C9J7P5;C9IZN7;Q969Z0-2Protein TBRG4 TBRG4 7 7 631 0 30.901 0.5943 NaN 3.41E+08
Q6P1L8 Q6P1L8 39S ribosomal protein L14, mitochondrialMRP 3 3 145 0 21.16 0.59366 1.1685 2.35E+08
Q96KP4;Q96KP4-2;A0A087WVS2;J3KSV5;A0A087WYZ1;J3QKT2;J3KRD5;J3QQN6;J3QR27;J3QLU1;J3QKQ0;J3QRD0;J3QL02;J3KSS4;J3QRA8Q96KP4;Q96KP4-2Cytosolic non-specific dipeptidaseCNDP2 9 8 475 0 33.157 0.58982 2.7823 7.70E+08
D6RD24;Q7Z6J8;D6RHY9D6RD24;Q7Z6J8;D6RHY9E3 ubiquitin-protein ligase E3DUBE3D 2 2 284 0 15.537 0.5898 0.79481 1.05E+08
P36578;H3BM89;H3BTP7;H3BU31P36578; M89 60S ribosomal protein L4RPL4 25 25 427 0 234.93 0.58787 2.5945 2.02E+10
Q04637-5;Q04637-4;Q04637-3;Q04637;Q04637-9;E7EX73;E9PGM1;E7EUU4;Q04637-6;Q04637-8;Q04637-7;A0A0A0MR52;C9JF13;C9J6B6;C9K073;C9J2Z7;H7C044;H7C0V6;A0A0A0MSA7;A0A0U1RQK7;O43432-4;O43432;O43432-3;F8WCF2;REV__Q8NEG2-2;REV__F5H7J8;C9JHW9;REV__Q8NEG2;REV__C9JQZ6;REV__J3KQX6Q04637-5;Q04637-4;Q04637-3;Q0463 ;Q04637-9;E7EX73 E9PGM1;E7EUU4;Q04637-6;Q04637-8;Q04637-7;A0A0A0MR52;C9JF13Eukaryotic translation initiation factor 4 gamma 1EIF4G1 23 23 1435 0 113.84 0.58722 1.3526 1.50E+09
Q15393;Q15393-3;Q15393-2;I3L4G7;J3QL37;H3BMB0;J3QRB2;J3QKV4Q15393 Splicing factor 3B subunit 3SF3B3 35 35 1217 0 323.31 0.5856 1.6718 1.09E+10
P51571;A6NLM8 P51571;A6NLM8 Translocon-associated protein subunit deltaSSR4 7 7 173 0 50.023 0.58509 1.6016 2.84E+09
A0A087WT84;Q9H9V9-2;Q9H9V9A0A087WT84;Q9H9V9-2;Q9H9V9JmjC domain-containing protein 4JMJD4 3 3 417 0 15.102 0.58366 1.5917 1.71E+08
Q96ER9;C9JSW8;Q96ER9-2;C9JPZ896ER9;C9JSW8;Q96ER9-2Coiled-coil domain-containing protein 51CCDC51 4 4 411 0 13.809 0.58237 0.63573 2.69E+07
A0A024R4E5;Q00341;Q00341-2;H0Y394;H7C0A4;C9JIZ1;C9J5E5;H7BZC3;H7C2D1;C9JZI8;C9JHZ8;C9JES8;C9JHS7;C9JT62;C9JK79;C9JMQ6;C9JQ82;C9JBS3;C9JEJ8;A0A0U1RVI6;C9JHN6;C9JHS9;C9J739A0A024R4E5;Q00341;Q00341-2;H0Y394Vigilin HDLBP 31 31 1268 0 253.46 0.58111 2.07 2.95E+09
Q9BX68 Q9BX68 Histidine triad nucleotide-binding protein 2, mitochondrialHINT2 3 3 163 0 28.296 0.58078 1.7442 1.93E+08
P11802-2;P11802;F8VXD2;F8VYH9;F8VZZ0;F8VTV8;F8VWX7;F8VZ51;F8VZ13P11802-2;P11802;F8VXD2;F8VYH9;F8VZZ0;F8 TV8;F8 WX7;F8VZ51Cyclin-dependent kinase 4CDK4 3 2 183 0.00401 2.4572 0.58063 1.018 6.68E+07
P40429;M0QYS1;Q8J015;Q6NVV1;M0QZU1;A0A096LPE0P40429;M0QYS1;Q8J0156 S ribosomal protein L13aRPL13A;RPL13a 10 10 203 0 37.143 0.58026 2.132 3.68E+09
Q9HCU5;B5MC98;H7C2N7;H7C0W3Q9HCU5;B5MC98Prolactin regulatory element-binding proteinPREB 4 4 417 0 31.933 0.58025 1.0931 1.76E+08
Q8NFQ8 Q8NFQ8 Torsin-1A-interacting protein 2TOR1AIP2 2 2 470 0 7.5339 0.57922 NaN 5.59E+07
Q9H8H0;J3QR28;J3QLQ6;Q9H8H0-2;J3QKV1Q9H8H0;J3QR28 Nucleolar protein 11NOL11 15 15 719 0 68.94 0.57726 2.0154 1.81E+09
Q9NR31;Q9NR31-2;H0Y5E8;Q9Y6B6;X1WI22;D6RAA2;Q5SQT8;D6RDB2;D6RD69;Q9H029Q9NR31;Q9NR31-2;H0Y5E8;Q9Y6B6GTP-binding protein SAR1a GTP-binding protein SAR1bSAR1A;SAR1B 8 8 198 0 24.531 0.57723 2.3458 1.17E+09
Q9NVP1;H7C452 Q9NVP1 ATP-dependent RNA helicase DDX18DDX18 14 14 670 0 48.286 0.5769 2.2431 1.06E+09
Q9H2Y7;U3KQH7;H3BNX5;H3BS99;A0A0C4DGM5;Q9H2Y7-2Q9H2Y7;U3KQH7;H3BNX5;H3BS99;A0A0C4DGM5;Q9H2Y7-2Zinc finger protein 106ZNF106 2 2 1883 0 9.3048 0.57634 NaN 3.10E+07
H0YNU5;P54132 H0YNU5;P54132 Bloom syndrome proteinBLM 3 3 1286 0 6.2066 0.57631 NaN 9.68E+07
A0A0A0MTB8;Q8NI36A0A0A0MTB8;Q8NI36WD repeat-containing protein 36WDR36 12 12 895 0 117.02 0.57588 2.0571 1.24E+09
A0A0U1RQT9;C9JYN0;Q16563-2;Q16563A0A0U1RQT9;C9JYN0;Q16563-2;Q16563Synaptophysin-like protein 1SYPL1 1 1 135 0.0037927 2.6006 0.57587 NaN 1.84E+08
P28838-2;P28838;H0Y9Q1P28838-2;P28838Cytosol aminopeptidaseLAP3 8 8 488 0 32.442 0.5738 1.3595 4.09E+08
Q9NX58 Q9NX58 Cell growth-regulating nucleolar proteinLYAR 6 6 379 0 34 0.57324 2.3155 2.97E+08
Q8IZD4;F5H4R4;B4DVJ6;F5GZK9;Q8IZD4-2Q8IZD4;F5H4R4;B4DVJ6mRNA-decapping enzyme 1BDCP1B 3 3 617 0 9.1251 0.57234 NaN 1.70E+08
Q00059;H7BYN3;Q00059-2;H7BYN3;Q00059-2Transcription factor A, mitochondrialTF M 2 2 246 0 5.9237 0.57199 NaN 8.76E+07
Q08380 Q08380 Galectin-3-binding proteinLGALS3BP 2 2 585 0 18.064 0.57041 NaN 5.75E+07
P07237;H7BZ94;I3L398;I3L312;H0Y3Z3;I3L4M2;I3NI03;I3L3U6;I3L0S0;I3L3P5P07237;H7BZ94;I3L398;I3L312;H0Y3Z3Protein disulfide-isomeraseP4HB 16 16 508 0 145.04 0.56864 0.62438 1.53E+09
190
A0A087WUL2;P49720;A0A087WXQ8;A0A087WY10A0A087WUL2;P49720; A087WXQ8;A0A087WY10Proteasome subunit beta type-3PSMB3 3 3 145 0 18.122 0.56822 1.164 4.29E+08
Q9UBQ0;F8VXU5;Q9UBQ0-2;F8VXU5;Q9UBQ0-2Vacuolar protein sorting-associated protein 29VPS29 6 6 182 0 61.095 0.56799 1.5785 1.78E+09
Q8NFH3;B4E301;F5H0E3;B4DVD1;Q8NFH3-2Q8NFH3 Nucleoporin Nup43NUP43 3 3 380 0 23.628 0.56569 1.7198 4.74E+08
P62937;F8WE65;C9J5S7;P62937-2;E5RIZ5;P0DN26;A0A0H2UH34;A0A0B4J2A2;A0A075B767;A0A075B759;Q9Y536;F5H284;P0DN37P62937;F8WE65;C9J5S7; 62937-2Peptidyl-prolyl cis-trans isomerase ;Peptidyl-prolyl cis-trans isomerase A, N-terminally processed;Peptidyl-prolyl cis-trans isomerasePPIA 14 14 165 0 163.62 0.56545 1.343 1.18E+10
O15511;O15511-2;B1ALC0O15511;O15511-2;B1ALC0Actin-related protein 2/3 complex subunit 5ARPC5 3 3 151 0 11.768 0.56396 1.8711 4.38E+08
O60493-2;O60493;O60493-4;O60493-3O60493-2;O60493;O60493-4;O60493-3Sorting nexin-3 SNX3 4 4 130 0 8.2737 0.5635 1.1479 1.31E+08
P08621;P08621-2;P08621-3;P08621-4;M0QYR1P08621;P08621- U1 small nuclear ribonucleoprotein 70 kDaSNRNP70 11 11 437 0 32.142 0.56337 NaN 6.73E+08
Q96GM5-2;Q96GM5;F8VUB0;F8VZ70;F8VRQ4Q96GM5-2;Q96GM5;F8VUB0;F8VZ70SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1SMARCD1 5 3 474 0 17.034 0.56332 NaN 7.10E+07
Q9Y2X3;H7BZ72;F8WED0Q9Y2X3 Nucleolar protein 58NOP58 21 21 529 0 287.45 0.56256 2.264 7.57E+09
O95747;C9JIG9;F8WBK9O95747;C9JIG9 Serine/threonine-protein kinase OSR1OXSR1 13 11 527 0 82.379 0.56136 NaN 1.24E+09
P50914;E7EPB3 P50914;E7EPB3 60S ribosomal protein L14RPL14 9 9 215 0 35.108 0.56088 2.1281 4.42E+09
P84103-2;P84103;A0A087X2D0P841 3-2;P84103;A0A087X2D0Serine/arginine-rich splicing factor 3SRSF3 5 4 124 0 36.737 0.55747 1.2692 1.86E+09
P05387;H0YDD8 P05387 60S acidic ribosomal protein P2RPLP2 8 8 115 0 172.25 0.55726 0.77795 8.66E+09
D6RC52;D6RCB9;Q9NX24;H0YC83;J3QSY4D6RC52 D6R B9;Q9NX24;H0YC83;J3QSY4H/ACA ribonucleoprotein complex subunit 2NHP2 2 2 132 0 59.524 0.5571 1.6238 2.62E+08
Q15031;E9PHM2;C9JYR8Q15031;E9PHM2 Probable leucine--tRNA ligase, mitochondrialLARS2 5 5 903 0 24.412 0.55622 1.4159 9.61E+08
B7Z879;A0A087WXL6;A0A0G2JS92;Q9H270B7Z879;A0A087WXL6;A0A0G2JS92;Q9H270Vacuolar protein sorting-associated protein 11 homologVPS11 6 6 931 0 15.389 0.55587 0.97545 1.93E+08
P62995-3;P62995;H7C2L4;H7BXF3P62995-3;P62995;H7C2L4;H7BXF3Transformer-2 protein homolog betaTRA2B 3 3 188 0 17.511 0.55578 2.2415 3.13E+08
Q9NR09;H7C094;H7C3P0;REV__Q96C03;REV__Q96C03-3Q9NR09 Baculoviral IAP repeat-containing protein 6BIRC6 33 32 4857 0 294.47 0.55524 1.5953 2.22E+09
E9PR30;P62861 E9PR30;P62861 40S ribosomal protein S30FAU 3 3 98 0 10.178 0.55474 2.142 1.64E+09
A0A087WVD4;Q9HBK9;Q9HBK9-2A0A087WVD4;Q9HBK9;Q9HBK9-2Arsenite methyltransferaseAS3MT 6 6 338 0 37.76 0.5541 1.405 8.92E+08
P22087;M0QXL5;M0R0P1;M0R299;M0R2Q4;M0R2U2;M0R1H0;M0R2B0;A0A0D9SFM2;M0QXC9P22087; 0QXL5; 0R0P1;M0R299;M0R2Q4;M0R2U2;M R1H0;M0R2B0rRNA -O-methyltransferase fibrillarinFBL 12 11 321 0 99.764 0.55398 1.6267 7.61E+09
Q13247-3;Q13247;A0A0D9SEM4;Q13247-2;Q08170;B4DJK0;B4DUA4;Q13243-3;Q13243Q13247-3;Q13247Serine/arginine-rich splicing factor 6SRSF6 5 5 335 0 7.9122 0.55378 1.9407 8.59E+07
H3BT71;P38159;H0Y6E7;P38159-2;Q96E39;H3BR27;P38159-3;H3BNC1;H3BUY5;O75526;Q8N7X1H3BT71;P38159;H0Y 7;P38159-2;Q96E39RNA-binding motif protein, X chromosome;RNA-binding motif protein, X chromosome, N-terminally processed;RNA binding motif protein, X-linked-like-1RBMX;RBMXL1 11 11 296 0 39.773 0.55118 1.8217 1.29E+09
Q9H9J2 Q9H9J2 39S ribosomal protein L44, mitochondrialMRP 3 3 332 0 8.3403 0.55117 NaN 9.78E+07
O60832;O60832-2;C9IYT0;H7C0M1;H7C2Q9;H7BZF2;H7C2Q2O60832;O60832-2;C9IYT0;H7C0M1H/A A ribonucleoprotein complex subunit 4DKC1 14 14 514 0 122.25 0.551 3.5834 1.11E+09
F8VX04;Q9H2H9 F8VX04;Q9H2H9 Sodium-coupled neutral amino acid transporter 1SLC38A1 2 2 503 0.00078802 3.2108 0.55054 NaN 5.06E+07
P19338;H7BY16;C9JYW2;C9JLB1;C9J1H7;C9JWL1P19338;H7BY 6 Nucleolin NCL 40 40 710 0 323.31 0.55052 2.3569 3.13E+10
H3BPE7;P35637-2;P35637H3BPE7;P35637-2;P35637RNA-binding protein FUSFUS 2 2 527 0 5.5338 0.54896 NaN 8.81E+07
O96013-2;O96013-4;O96013;O96013-3;M0R2X4O96013-2;O96013-4;O96013;O96013-3Serine/threonine-protein kinase PAK 4PAK4 3 3 426 0 30.234 0.54871 NaN 1.27E+08
E9PF16;Q96CM8-4;Q96CM8-3;Q96CM8;Q96CM8-2E9PF16;Q96CM8-4;Q96CM8-3;Q96CM8;Q96CM8-2Acyl-CoA synthetase family member 2, mitochondrialACSF2 3 3 572 0 23.537 0.54773 NaN 1.33E+08
P63261;I3L3I0;I3L1U9;I3L4N8;K7EM38;I3L3R2;J3KT65P63261;I3L3I0;I3L1U9;I3L4N8Actin, cytoplasmic 2;Actin, cytoplasmic 2, N-terminally processedACTG1 22 1 375 0 323.31 0.54637 1.636 5.71E+10
Q16763;K7EPJ1;K7EM75Q16763;K7EPJ1 Ubiquitin-conjugating enzyme E2 SUBE2S 5 5 222 0 24.192 0.54621 1.2182 7.60E+07
H3BSH7;Q969X6;Q969X6-3;A0A0J9YWM9;Q969X6-2;H3BRM8;A0A0J9YWK2;H3BPD7;I3L4T9;J3KSI1;A0A0J9YXV4;J3KSE6;J3KTR0H3BSH7;Q969X6;Q969X6-3;A0A0J9YWM9;Q969X6-2Cirhin CIRH1A 9 9 700 0 85.766 0.54596 NaN 9.09E+08
Q12834 Q12834 Cell division cycle protein 20 homologCDC20 7 7 499 0 57.392 0.54504 1.124 2.48E+08
P20618 P20618 Proteasome subunit beta type-1PSMB1 6 6 241 0 36.24 0.54368 1.3385 5.73E+08
P31948;P31948-3;P31948-2;F5H783;F5GXD8;H0YGI8P31948;P31948-3;P31948-2;F5H783Stress-induced-phosphoprotein 1STIP1 15 15 543 0 43.721 0.53925 NaN 4.68E+08
P55011-3;P55011;G3XAL9P55011-3;P55011;G3XAL9Solute carrier family 12 member 2SLC12A2 2 2 1196 0 3.8669 0.53924 NaN 8.03E+07
Q13232;H3BPR2;H3BPD9;H3BMQ7;H3BRA8Q13232 Nucleoside diphosphate kinase 3NME3 8 8 169 0 37.711 0.53831 1.4089 9.74E+08
Q9UMY1;H7C2B1;Q9UMY1-29 Y1;H7C2B1;Q9UMY1-2Nucleolar protein 7NOL7 4 4 257 0 9.5681 0.53569 0.57202 3.49E+07
Q15181;Q5SQT6 Q15181;Q5SQT6 Inorganic pyrophosphatasePPA1 10 10 289 0 173 0.53533 2.0605 4.68E+09
Q9NY93-2;Q9NY93;G3V0G3;H7C3E9;F8WDT8Q9NY93-2 Q9NY93;G3V0G3;H7C3E9Probable ATP-dependent RNA helicase DDX56DDX56 3 3 507 0 4.8078 0.53533 NaN 2.99E+07
Q99460-2;Q99460;A0A087WW66;H7C378;C9J9M4;H7BZR6;F8WCE3Q99460-2;Q99460;A0A087WW6626S proteasome non-ATPase regulatory subunit 1PSMD1 39 39 922 0 323.31 0.53406 1.7493 1.33E+10
P54577;A0A0C4DGZ5P54577;A0A0C4DGZ5Tyrosine--tRNA ligase, cytoplasmic;Tyrosine--tRNA ligase, cytoplasmic, N-terminally processedYARS 5 5 528 0 15.666 0.53363 NaN 1.99E+08
A8MV53;A0A0A6YYI3;A0A0B4J1V8;Q9NQ55-2;Q9NQ55;Q9NQ55-3;C9JHF7;H7C446;C9J3W3A8MV53;A0A0A6YYI3;A0A0B4J1V8;Q9NQ55-2;Q9NQ55;Q9NQ55-3;C9JHF7;H7C446;C9J3W3Suppressor of SWI4 1 homologPPAN 2 2 420 0 3.9078 0.53345 NaN 2.82E+07
Q13823;H0YG10 Q13823 Nucleolar GTP-binding protein 2GNL2 3 3 731 0 12.74 0.53291 2.0665 2.03E+08
P21333-2;P21333;Q5HY54;Q60FE5;A0A087WWY3;F8WE98;H0Y5F3;H0Y5C6P21333-2;P21333;Q5HY54;Q60FE5;A0A087WWY3Filamin-A FLN 63 55 2639 0 323.31 0.53201 1.909 5.31E+09
A0A0B4J2E5;Q15269;A0A0J9YX21;C9J544A0A0B4J2E5;Q15269Periodic tryptophan protein 2 homologPWP2 22 18 919 0 168.4 0.53057 1.6815 4.53E+09
A0A024R571;Q9H4M9;C9J2Z4;C9JC03;C9JDQ8;C9JIJ3;C9IZH1A0A024R571;Q9H4M9;C9J2Z4;C9JC03EH domain-containing protein 1EHD1 15 8 548 0 95.364 0.52825 NaN 8.21E+08
H3BUV4;Q9NWW5;H3BNF1;H3BUT1;H3BRN7;H3BTY4;Q9NWW5-2H3BUV4;Q9NWW5; NF1 UT1;H3BRN7;H3BTY4;Q9NWW5-2Ceroid-lipofuscinosis neuronal protein 6CLN6 4 4 213 0 22.688 0.52716 1.0793 1.38E+09
P53999 P53999 Activated RNA polymerase II transcriptional coactivator p15SUB1 2 2 127 0 7.2306 0.5253 1.1468 1.96E+08
Q96A35;X6RJ73;X6RHI2Q96A35 39S ribosomal protein L24, mitochondrialMRP 5 5 216 0 15.453 0.52501 1.8002 2.75E+08
Q14680-3;Q14680-4;Q14680-5;Q14680-2;Q14680-8;Q14680-7;Q14680-6;Q14680Q14680-3;Q14680-4;Q14680-5;Q14680-2;Q14680-8;Q14680-7;Q14680-6;Q14680Maternal embryonic leucine zipper kinaseMELK 2 2 457 0 4.9051 0.52278 NaN 1.66E+07
Q8IUI8;Q8IUI8-2;J3KST8Q8IUI8;Q8IUI8-2 Cytokine receptor-like factor 3CRLF3 5 5 442 0 33.121 0.52268 2.0847 2.38E+08
Q15758;M0QXM4;Q15758-3;Q15758-2;M0QX44;M0R144Q15758;M0 XM4;Q15758-3;Q15758-2Neutral amino acid transporter B(0)SLC1A5 12 12 541 0 75.775 0.52202 1.2513 2.38E+09
P11021 P11021 78 kDa glucose-regulated proteinHSPA5 44 42 654 0 323.31 0.5216 1.739 1.17E+10
Q8NAT1 Q8NAT1 Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2POMGNT2 2 2 580 0 8.0538 0.51963 NaN 6.46E+07
Q9UHV9 Q9UHV9 Prefoldin subunit 2PFDN2 3 3 154 0 20.712 0.51941 1.875 3.80E+08
Q9H307-2;Q9H307Q9H307-2;Q9H307Pinin PNN 3 3 584 0 6.9502 0.51767 1.6451 9.33E+07
Q13601;Q13601-2;A0A087WZC7Q136 1;Q13601-2KRR1 small subunit processome component homologKRR1 5 5 381 0 17.824 0.51724 1.6351 2.93E+08
Q02878;F8VZ45;U3KQR5;F8VR69;F8VZA3;F8VWR1;F8VU16Q02878 60S ribosomal protein L6RPL6 16 16 288 0 203.79 0.51551 2.4759 5.88E+09
F2Z2V0;B0QZ18;Q99829;A6PVH9;E7ENH5;Q5JX56;Q5JX58;Q5JX59;Q5JX60;Q5JX44;Q5JX55;Q5JX45;Q5JX54;H0Y524;Q5JX61;Q5JX52;Q5JX57;E7EV27;Q5JX53F2Z2V0;B0QZ18;Q99829;A6PVH9;E7ENH5;Q5JX56;Q5JX58;Q5JX59;Q5JX60;Q5JX44;Q5JX55Copine-1 CP E1 10 10 33 0 79.012 0.51395 NaN 1.01E+09
X6R700;Q9Y3Y2-4;Q9Y3Y2;Q9Y3Y2-3;A0A087X1B7;Q5T7Y7X6R700;Q9Y3Y2-4;Q9Y3Y2;Q9Y3Y2-3;A0A087X1B7Chromatin target of PRMT1 proteinCHTOP 3 3 223 0 15.365 0.51365 1.2437 9.22E+07
Q96BN8;H0Y9T0 Q96BN8 Ubiquitin thioesterase otulinOTULIN 3 3 352 0 9.5717 0.51332 0.57678 1.98E+08
F5H6N1;Q96A72;F5H1246N1;Q96A72 Protein mago nashi homolog 2MAGOHB 4 1 90 0 21.156 0.51324 1.4025 4.07E+08
B2R4S9;U3KQK0;Q99879;Q99877;Q93079;Q5QNW6;P62807;P58876;O60814;Q5QNW6-2;Q99880;Q96A08B2R4S U3KQK0; 98 ; 99877;Q93079;Q5QNW6;P62807;P 8876;O60814;Q5 NW6-2;Q99880Histone H2B;Histone H2B type 1-M;Histone H2B type 1-N;Histone H2B type 1-H;Histone H2B type 2-F;Histone H2B type 1-C/E/F/G/I;Histone H2B type 1-D;Histone H2B type 1-K;Histone H2B type 1-LHIST1H2BC;HIST1 2BN;HIST1H2BM;HIST H2BH;HIST2H2BF;HIST1H2BD;HIST1H2BK;HIST1 2 L10 0 1 6 0.0037812 2.563 0.51 6 1.7307 1.74E+08
Q71UI9;P0C0S5;C9J0D1;Q71UI9-3;Q71UI9-4;Q71UI9-2;C9J386Q71UI9;P0C0S5;C9J0D1;Q71UI9-3;Q71UI9-4;Q71UI9-2;C9J386Histone H2A.V;Histone H2A.Z;Histone H2AH2AFV;H2AFZ 5 3 128 0 27.273 0.51257 1.4215 1.73E+09
K7ER15;Q9H0R4;Q9H0R4-2;K7EMY7;K7EQD2;K7EJQ8K7ER15;Q9H0R4;Q9H0R4- ; MY7Haloacid dehalogenase-like hydrolase domain-containing protein 2HDHD2 5 5 204 0 23.51 0.5109 0.78532 4.00E+08
A0A140T9L0;A0A0G2JJL1;H0Y6G3;O15213A0A140T9L0;A0A0G2JJL1;H0Y6G3;O15213WD repeat-containing protein 46WDR46 6 6 322 0 80.618 0.5098 NaN 3.06E+08
K7EN97;Q96S52 K7EN97;Q96S52 GPI transamidase component PIG-SPIGS 1 1 116 0 3.8005 0.50883 NaN 4.81E+06
P30048-2;P30048P30048-2;P30048Thioredoxin-dependent peroxide reductase, mitochondrialPRDX3 4 4 238 0 11.467 0.50806 2.6507 3.63E+08
Q02809;Q02809-2;Q5JXB8;Q5JXB7Q02809;Q02809-2Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1PLOD1 3 3 727 0 13.474 0.5054 1.6047 2.40E+08
Q01650;A0A0C4DGL4;H0YJ95;G3V4Z6;Q9UM01;Q92536Q0165 Large neutral amino acids transporter small subunit 1SLC7A5 5 5 507 0 16.251 0.50289 1.5976 6.25E+08
Q9Y5S9-2;Q9Y5S9;A0A0J9YW13Q9Y5S9-2;Q9Y5S9;A0A0J9YW13RNA-binding protein 8ARBM8A 2 2 173 0 13.394 0.50165 NaN 5.60E+07
Q14684;Q14684-2Q14684;Q14684-2Ribosomal RNA processing protein 1 homolog BRRP1B 5 5 758 0 14.918 0.49955 4.6649 2.64E+08
Q14692 Q14692 Ribosome biogenesis protein BMS1 homologBMS1 9 9 1282 0 54.373 0.49909 2.5234 4.90E+08
D6RGE2;Q96CN7 D6RGE2;Q96CN7 Isochorismatase domain-containing protein 1ISOC1 2 2 188 0 7.3003 0.49733 2.1113 1.73E+08
Q14964;C9JB90;Q96DA2Q14964 Ras-related protein Rab-39ARAB39A 5 4 217 0 25.957 0.49373 1.401 1.04E+09
Q13162;H7C3T4;A6NG45Q13162;H7C3T4 Peroxiredoxin-4 PRDX4 8 5 271 0 23.646 0.49199 1.9381 4.55E+08
Q12986-2;Q12986;Q12986-3Q12986-2;Q12986;Q12986-3Transcriptional repressor NF-X1NFX1 4 4 1024 0 70.5 0.49082 NaN 5.55E+07
Q32Q12;P22392-2;J3KPD9;P22392;E7ERL0;O60361;E5RHP0;F6XY72;C9K028Q32Q12;P2 392-2;J3KPD9;P22392;E7ERL0Nucleoside diphosphate kinase;Nucleoside diphosphate kinase BNM 1-NME2 ME2;NME1 13 5 292 0 71.824 0.48783 1.4241 2.85E+09
Q92759 Q92759 General transcription factor IIH subunit 4GTF2H4 2 2 462 0 7.4428 0.48535 NaN 1.48E+08
A0A0B4J1R6;P29401;P29401-2;E9PFF2A0A0B4J1R6;P2 401;P29401-2Transketolase TKT 5 5 457 0 44.605 0.485 NaN 3.39E+08
P03886 P03886 NADH-ubiquinone oxidoreductase chain 1MT-ND1 3 3 318 0 25.723 0.48371 NaN 1.75E+08
Q8TDN6 Q8TDN6 Ribosome biogenesis protein BRX1 homologBRIX1 6 6 353 0 38.7 0.48277 2.6365 7.66E+08
K7EK07;Q71DI3;Q16695;P84243;P68431;K7EMV3;B4DEB1;K7ES00;Q6NXT2;K7EP01K7EK07;Q71DI3;Q16695;P8424 ;P6843 ; MV3;B4DEB1;K7ES00;Q6NXT2;K7EP01Histone H3;Histone H .2;Histone H3.1t;Histone H3.3;Histone H3.1;Histone H3.3CH3F B IST2H3A;HIST3H3;H3F3A;HIST1H3A;H3F3C6 2 132 0 23.265 0.48196 2.118 1.05E+10
E9PMR6;Q9NZN5-2;Q9NZN5E9PMR6;Q9NZN5-2;Q9NZN5Rho guanine nucleotide exchange factor 12ARHGEF12 7 7 1441 0 18.33 0.47854 0.64158 2.43E+08
Q9Y366 Q9Y366 Intraflagellar transport protein 52 homologIFT52 4 4 437 0 14.318 0.47546 0.69319 1.37E+08
A0A087WUT6;O60841A0A087WUT6;O60841Eukaryotic translation initiation factor 5BEIF5B 7 7 1220 0 61.689 0.47276 1.6642 1.06E+09
P08579 P08579 U2 small nuclear ribonucleoprotein BSNRPB2 4 3 225 0 6.417 0.47275 1.3429 2.93E+08
Q8NC51-4;Q8NC51-3;Q8NC51-2;Q8NC51Q8NC51-4;Q8NC51-3;Q8NC51-2;Q8NC51Plasminogen activator inhibitor 1 RNA-binding proteinSERBP1 4 4 387 0 31.56 0.47251 2.7766 5.28E+07
Q06830;A0A0A0MSI0;A0A0A0MRQ5Q06830;A0A0A0MSI0;A0A0A0MRQ5Peroxiredoxin-1 PRDX1 12 8 199 0 35.638 0.47224 2.3395 4.59E+09
Q92598-2;Q92598;Q92598-3;Q92598-4;A0A0A0MSM0;R4GN69;Q5TBM3Q92598-2;Q92598;Q92598-3;Q92598-4;A0A0A0MS 0Heat shock protein 105 kDaHSPH1 32 29 814 0 287.37 0.47175 2.1273 6.03E+09
Q9Y3B9 Q9Y3B9 RRP15-like proteinRRP15 2 2 282 0 4.6848 0.46954 1.9611 1.69E+08
P17066;P48741 P17066 Heat shock 70 kDa protein 6HSPA6 26 13 643 0 50.116 0.46915 1.2571 2.17E+09
Q5TEC6 Q5TEC6 Histone H3 HIST2H3PS2 5 1 136 0.00026759 3.5832 0.46845 2.1454 1.84E+09
Q9H6R0;I3L1L6;Q9H6R0-2Q9H6R0 Putative ATP-dependent RNA helicase DHX33DHX33 3 3 707 0 7.0445 0.46578 2.0793 2.10E+08
Q9Y3D3;A6ND22;Q9Y3D3-2;A6ND22;Q9Y3D3-228S ribosomal protein S16, mitochondrialMRP 3 3 137 0 9.6555 0.46282 0.97227 7.40E+08
B7Z6D5;Q96GQ7;A0A087X059;A0A087WYH5B7Z6D5;Q96GQ7 Probable ATP-dependent RNA helicase DDX27DDX27 8 8 765 0 27.995 0.46046 2.3707 7.84E+08
O76021;J3QSV6;O76021-2;I3L3U9;I3L3C4;I3L234O76021;J3QSV6;O76021-2Ribosomal L1 domain-containing protein 1RSL1D1 15 15 490 0 54.018 0.46039 NaN 1.14E+09
F6S8N6;A0A0A0MRJ6;H7BY58;P22061;P22061-2;F8WDT3;F8WAV5;F8WAX2;H7C4X2;C9J0F2F6S8N6;A0A0A0MRJ6;H7BY58;P22061;P22061-2Protein-L-isoaspartate O-methyltransferase;Protein-L-isoaspartate(D-aspartate) O-methyltransferasePCMT1 7 7 250 0 43.514 0.45993 0.84006 8.51E+08
Q92793-2;Q92793;I3L466Q92793-2;Q92793;I3L466CREB-binding proteinCREBBP 14 6 2404 0 134.27 0.45789 0.59051 6.96E+08
P55072;C9JUP7;C9IZA5P55072 Transitional endoplasmic reticulum ATPaseVCP 41 41 806 0 323.31 0.45412 2.1296 1.63E+10
Q04323;E9PJ81;E9PRQ7;Q04323-2;A0A087WTZ5;E9PS08Q04323;E9PJ81;E9PRQ7;Q04323-2;A A087WTZ5UBX domain-containing protein 1UBXN1 9 9 297 0 148.11 0.4499 1.9049 2.42E+09
Q96E14;I3L2E0 Q96E14;I3L2E0 RecQ-mediated genome instability protein 2RMI2 2 2 147 0 6.4373 0.44771 NaN 2.36E+08
191
O75477;B0QZ43 O75477;B0QZ43 Erlin-1 ERLIN1 9 6 346 0 23.355 0.44524 1.8751 3.61E+08
P00374-2;P00374P00374-2;P00374Dihydrofolate reductaseDHFR 2 2 135 0 24.03 0.44406 2.7654 2.37E+08
M0QXH0;Q99757M0QXH0;Q99757Thioredoxin, mitochondrialTXN2 2 2 64 0 9.0202 0.44387 0.76682 2.62E+08
Q15061;C9JEE7;C9IZK7Q15061 WD repeat-containing protein 43WDR43 13 13 677 0 78.219 0.43936 1.951 9.55E+08
Q9H7B2;Q5VXN0 Q9H7B2;Q5VXN0 Ribosome production factor 2 homologRPF2 4 4 306 0 14.652 0.43861 2.7166 2.07E+08
Q13895;F8WBL2 Q13895;F8WBL2 Bystin BYSL 5 5 437 0 34.013 0.43852 1.6912 1.70E+08
P12277;H0YJG0;G3V461;G3V4N7;H0YJK0P12277;H0YJG0 Creatine kinase B-typeCKB 5 5 381 0 31.69 0.43837 1.6131 5.01E+08
E9PHY5;O43491-4;E9PK52;O43491-3;E9PII3;O43491-2;I6L9B1;E9PQD2;E9PRG1;E9PIG0;E9PJP4;E9PQN0E9PHY ;O43491-4;E9PK52 3 E9PII3;O43491-2;I6L9B1Band 4.1-like protein 2EPB41L2 37 0 935 0.001049 3.1803 0.43744 NaN 7.61E+06
A0A0A6YYA0;Q86XR7-2;Q9Y3B3-2;Q9Y3B3A0A0A6Y A0;Q86XR7-2;Q9Y3B3-2;Q9Y3B3Transmembrane emp24 domain-containing protein 7TMED7 1 1 188 0.0020645 2.9301 0.43742 NaN 1.39E+08
P38432 P38432 Coilin COIL 5 5 576 0 15.029 0.43405 NaN 3.06E+08
O43237-2;O43237;J3KRZ2;J3KRI4;B4E2E0O4 237-2;O43237;J3KRZ2;J3KRI4;B4E2E0Cytoplasmic dynein 1 light intermediate chain 2DYNC1LI2 2 2 415 0 35.059 0.42459 NaN 1.52E+08
Q7Z628-2;Q7Z628Q7Z628-2;Q7Z628Neuroepithelial cell-transforming gene 1 proteinNET1 2 2 542 0 12.008 0.4218 NaN 3.19E+07
Q9Y281;Q9Y281-3;G3V2U0;F8WDN3Q9Y281;Q9Y281-3Cofilin-2 CFL2 7 3 166 0 102.37 0.41935 0.6615 2.50E+08
P02786;G3V0E5;H7C3V5;F8WBE5P02786;G3V0 Transferrin receptor protein 1;Transferrin receptor protein 1, serum formTFRC 17 17 760 0 85.634 0.4189 2.5975 2.18E+09
G3V4W0;B4DY08;B2R5W2;G3V4C1;P07910-2;P07910-4;P07910-3;G3V2D6;G3V251;G3V5V7;G3V5X6;G3V3K6;P0DMR1;B7ZW38;A0A0G2JPF8;A0A0G2JNQ3;O60812;B2RXH8;B4DSU6;G3V4M8;G3V2H6;E5RG71;B3KT61;Q86SE5;Q86SE5-3G3V4 0;B4DY08;B2R5W2;G3V4C ;P07910-2;P07910-4;P07910-3 2D6; 251; 5V7Heterogeneous nuclear ribonucleoproteins C1/C2HNRNPC 22 2 262 0 174.82 0.41737 1.0097 2.08E+ 0
P57053 P57053 Histone H2B type F-SH2BFS 10 1 126 0 65.942 0.41483 1.9694 1.91E+10
P62805 P62805 Histone H4 HIST1H4A 14 14 103 0 106.98 0.41173 2.0334 4.42E+10
Q9P0M6;Q5SQT3 Q9P0M6 Core histone macro-H2A.2H2AFY2 8 7 372 0 57.323 0.41164 2.2301 1.05E+09
O75367-2;O75367-3;O75367;B4DJC3;D6RCF2O75367-2;O75367-3;O75367;B4DJC3ore histone macro-H2A.1;Histone H2AH2AFY 7 6 369 0 118.23 0.40802 2.2277 2.78E+09
H0Y307;Q9H1H9-3;Q9H1H9-4;Q9H1H9-2;Q9H1H9H0Y307;Q9H1H9-3;Q9H1H9-4;Q9H1H9-2;Q9H1H9Kinesin-like protein KIF13AKIF13A 2 2 889 0.0030418 2.6341 0.40575 NaN 7.21E+07
Q93077;Q7L7L0;P04908Q93077;Q7L7L0;P04908Histone H2A type 1-C;Histone H2A type 3;Histone H2A type 1-B/EHIST1H2AC; IST3H2A;HIST1H2AB7 2 130 0 146.35 0.40472 2.1258 3.22E+10
P23284 P23284 Peptidyl-prolyl cis-trans isomerase BPPIB 2 2 216 0 5.3938 0.40097 2.2106 2.81E+08
A0A087X1A5;O95793-2;O95793;Q5JW30;O95793-3;Q5JW28;G5EA18;E5RJN7;E7EVI1;A0A0A0MTC4;A0A0A0MTD1;F8VPI7;E7EPX0;A0A0A0MTC6;E7EVJ4;E9PH62;A0A0A0MTC5;Q9NUL3-4;Q9NUL3-6;Q9NUL3-8;Q9NUL3-3;Q9NUL3-7;Q9NUL3-2;Q9NUL3A0A087X1A5;O95793-2; ;Q5JW30;O95793-3Double-stranded RNA-binding protein Staufen homolog 1ST U1 7 7 493 0 35.361 .39461 NaN 4.78E+08
Q8WXX5 Q8WXX5 DnaJ homolog subfamily C member 9DNAJC9 2 2 260 0 30.751 0.39267 1.4129 2.56E+08
P49773;D6RC06;D6REP8;D6RE99;D6RD60P49773; 6RC06;D6REP8;D6RE99;D6RD60Histidine triad nucleotide-binding protein 1HINT1 2 2 126 0 31.141 0.38997 2.6223 6.17E+08
Q9UNS1-2;Q9UNS1Q9UNS1-2;Q9UNS1Protein timeless homologTIMELESS 3 3 1207 0 6.6335 0.38905 NaN 6.94E+07
P09382 P09382 Galectin-1 LGALS1 3 3 135 0 11.429 0.38837 3.2174 3.40E+08
H0Y4R1;P12268;E7ETK5;C9K0R9H0Y4R1;P12268 Inosine-5-monophosphate dehydrogenase 2IMPDH2 10 9 470 0 43.772 0.38812 2.5699 6.93E+08
Q9HCJ3-2;Q9HCJ3Q9HCJ3-2;Q9HCJ3Ribonucleoprotein PTB-binding 2RAVER2 2 2 678 0 12.236 0.3864 NaN 1.04E+08
P62879;C9JXA5;E7EP32;C9JIS1;C9JZN1;Q9HAV0;P62879-2;C9JD14P62879;C9JXA5;E7EP32;C9JIS1;C9JZN1;Q9HAV0Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2;Guanine nucleotide-binding protein subunit beta-4G B GNB4 10 4 340 0 15.788 0.38404 0.90754 1.75E+09
Q86TB9-4;Q86TB9;Q86TB9-2;Q86TB9-3Q86TB9-4;Q86TB9;Q86TB9-2Protein PAT1 homolog 1PATL 8 8 703 0 49.37 0.37322 0.82526 3.45E+08
P00505;P00505-2P00505;P00505-2Aspartate aminotransferase, mitochondrialGOT2 3 3 430 0 11.46 0.3708 3.8837 3.20E+08
A0A087WYS3;H7C4X9;Q9ULU4-6;Q9ULU4-23;Q9ULU4-8;Q9ULU4-16;Q9ULU4-9;Q9ULU4-13;Q9ULU4-11;Q9ULU4-7;Q9ULU4-19;A0A0A0MTK7;Q9ULU4-2;Q9ULU4-4;Q9ULU4-3;Q9ULU4-17;Q9ULU4-15;Q9ULU4-21;Q9ULU4-18;Q9ULU4-14;Q9ULU4-12;Q9ULU4-5;Q9ULU4-20;Q9ULU4;Q9ULU4-10;A0A087WVZ6;Q9ULU4-22A0A087WYS3;H7C4X9;Q9ULU4-6;Q9ULU4-23;Q9ULU4-8;Q9ULU4-16;Q9ULU4-9;Q9ULU4-13;Q9ULU4-11;Q9ULU4-7;Q9ULU4-1 ;A0A0A0MTK7;Q9ULU4-2;Q9ULU4-4;Q9ULU4-3;Q9ULU4-17;Q9ULU4-15;Q9ULU4-21;Q9ULU4-18;Q9ULU4-14;Q9ULU4-12;Q9ULU4-5;Q9ULU4-20;Q9ULU4;Q9ULU4-10Protein kinase C-binding protein 1ZMYND8 3 3 1087 0 8.6363 0.36771 NaN 5.81E+07
Q69YN2;Q69YN2-3;X6R7M0;Q69YN2-2Q69YN2;Q69YN2-3CWF19-like protein 1CWF19L1 12 12 538 0 83.734 0.36562 NaN 6.62E+08
G3V393;G3V5M2;P00491G3V3 3;G3V5M2;P00491Purine nucleoside phosphorylasePNP 2 2 61 0 8.4682 0.36406 2.2774 7.05E+07
P60174-1;P60174;P60174-4;U3KPZ0;U3KQF3;U3KPS5P60174-1;P60174;P60174-4Triosephosphate isomeraseTPI1 12 12 249 0 99.071 0.36 2.7076 1.02E+09
P18669;P15259;Q8N0Y7P18669;P15259;Q8N0Y7Phosphoglycerate mutase 1;Phosphoglycerate mutase 2;Probable phosphoglycerate mutase 4PGAM1;PGAM2;PGAM4 4 4 254 0 20.07 0.35288 1.8898 1.70E+08
P11166 P11166 Solute carrier family 2, facilitated glucose transporter member 1SLC2A1 1 1 492 0.004008 2.4512 0.35175 1.4654 4.78E+07
Q04656-5;Q04656;Q04656-2;Q04656-3Q04656-5;Q04656;Q04656-2;Q04656-3Copper-transporting ATPase 1ATP7A 3 3 1422 0 8.0315 0.3461 1.4106 1.06E+08
J3QRG6;P42771;P42771-4;K7ES20;G3XAG3;K7ENC6;A0A0A0MRI0;P42771-2;P42771-3;P42772J3QRG6;P42771;P42771-4;K7ES20 G3XAG3;K7ENC6;A0A0A0MRI0;P42771-2;P42771-3Cyclin-dependent kinase inhibitor , isoforms 1/2/3CDKN2A 4 138 0 28.755 0.34238 3.8365 9.97E+08
G3V2Q1;P07910;G3V576;G3V555;G3V5752Q1;P07910; 6;G3V555;G3V575Heterogeneous nuclear ribonucleoproteins C1/C2HNRNPC 21 1 305 0 134.09 0.34166 1.6683 7.00E+08
P27797;K7EJB9 P27797;K7EJB9 Calreticulin CALR 6 6 417 0 22.931 0.3325 1.6712 9.10E+07
Q04864-2;Q04864Q04864-2;Q04864Proto-oncogene c-RelEL 2 2 587 0 7.0672 0.32509 NaN 3.72E+07
F8VYE8;P36873;P36873-2;F8W0W8;F8VR82;A0A087WYY5;H0Y3Y6;F8WE71;F8W0V8;F8W1A0F8VYE8;P36873;P36 73-2;F8W W8;F8VR82;A0A087 YY5Serine/threonine-protein phosphatase;Serine/threonine-protein phosphatase PP1-gamma catalytic subunitPPP1CC 21 3 304 0 64.566 0.32257 0.79792 2.54E+09
P07355;H0YKS4;H0YMD0;H0YMU9;H0YN42;P07355-2;H0YKL9;H0YKZ7;H0YLV6;H0YMT9;H0YKX9;H0YMM1;A6NMY6;H0YKV8;H0YMW4;H0YNP5;H0YM50;H0YMD9;H0YNB8;H0YN52;H0YKN4;H0YNA0;H0YN28;H0YL33P07355 KS4;H0YMD0;H YMU9;H0YN42;P07355-2;H0YKL9;H0YKZ7; 0YLV6; T9;H0YKX9;H0YMM1 A6N Y6;H0YKV8;H0YMW4; NP5;H0YM50Annexin A2;Annexin;Putative annexin A2-like proteinANXA2;ANXA2P2 6 6 339 0 37.998 0.31706 3.2557 6.93E+08
M0R0X9;M0QXC8;M0QYT9;M0R205;M0QZB8;M0QZB7;Q14653;Q14653-4;M0R0R8;M0QX56;M0R3C2;Q14653-3;Q14653-2M0R0X9; 0QXC8; 0 YT9; 0R205;M0QZB8 M0QZB7;Q14653;Q14653-4;M0R0R8;M0QX 6;M0R3C2;Q14653-3;Q14653-2Interferon regulatory factor 3IRF3 2 2 106 0 20.994 0.31516 NaN 2.22E+08
A0A0J9YXP8;A0A0J9YX90;A0A0J9YYH3;K7EQ48;A0A0A0MTS2;P06744;P06744-2A0A0J9YXP8;A0A0J9YX90;A0A0J9YYH3;K7EQ48;A0A0A0MTS2;P06744;P06744-2Glucose-6-phosphate isomeraseGPI 2 2 268 0 5.9754 0.31354 NaN 5.94E+07
Q9UJC3-2;Q9UJC3Q9UJC3-2;Q9UJC3Protein Hook homolog 1HOOK1 5 5 686 0 34.047 0.31127 0.93112 1.24E+08
P11717 P11717 Cation-independent mannose-6-phosphate receptorIGF2R 2 2 2491 0 3.8964 0.30142 6.3148 6.25E+08
P09661;H0YMA0;H0YLR3;H0YKK0P 9661; MA0 U2 small nuclear ribonucleoprotein ASNRPA1 25 25 255 0 323.31 0.29551 3.7613 1.87E+10
Q92625;Q92625-2;J3QSU0;F8VVQ4;Q7Z6G8Q92625;Q92625-2Ankyrin repeat and SAM domain-containing protein 1AANKS1A 6 6 1134 0 18.269 0.29444 0.75749 9.01E+07
Q8IZV5;E5RK48 Q8IZV5;E5RK48 Retinol dehydrogenase 10RDH10 3 3 341 0 4.7014 0.27577 NaN 2.86E+08
A0A024RCR6;A0A0G2JK23;P46379-2;P46379;P46379-3;A0A0G2JL47;P46379-4;P46379-5;F6S6P2;X6REW1;A0A0G2JJM1;F6UR09;F6U1F2;F6XTU0;A0A0G2JJR8;F6WML8;F6VEM6;F6X9W3;F6U341;F6TC96;H0Y4L1;H0Y710A0A024RCR6;A0A0G2JK23;P46379-2;P46379;P46379-3;A0A0G2JL4 ;P46379-4;P46379-5;F6S6P ;X6REW1;A A0G2JJM1Large proline-rich protein BAG6BAT3;BAG6 11 11 1126 0 55.42 0.26208 5.3189 9.70E+08
P32119;A6NIW5;P32119-2;A6NIW5 Peroxiredoxin-2 PRDX2 15 14 198 0 75.421 0.26034 3.5967 5.86E+09
O95372;Q5QPQ1;Q5QPQ0;Q5QPQ3;Q5QPQ2;Q5QPN9;Q5QPN5O95372;Q5QPQ1;Q5QPQ0;Q5QPQ3;Q5QPQ2;Q5QPN9Acyl-protein thioesterase 2LYPLA2 6 6 231 0 40.192 0.25039 0.67836 2.52E+08
M0R116;A0A0A0MT26;P13637;P13637-2;P13637-30R116;A0A0A0MT26;P13637;P13637-2;P13637-3Sodium/potassium-transporting ATPase subunit alpha-3ATP1A3 20 2 983 0 7.7882 0.24613 NaN 7.24E+07
A0A087WYB2;A0A087WX95;A0A087WW20;Q9BVN2-2;Q9BVN2-3;Q9BVN2-4;Q9BVN2;Q68CX2;A0A087WVK5A0A087WYB2; 0A087WX95;A0A087WW20;Q9BVN2-2;Q9BVN2-3;Q9BVN2-4 Q9BVN2;Q68CX2;A0A087WVK5RUN and SH3 domain-containing protein 1RUSC1;DKFZp761A1822 2 2 225 0 6.5812 0.23448 NaN 1.37E+08
P00918;E5RID5;E5RK37P00918;E5RID5;E5RK37Carbonic anhydrase 2CA2 2 2 260 0 16.315 0.23144 2.6344 3.05E+08
F2Z2K0;Q9UNZ2-6;Q9UNZ2;Q9UNZ2-5F2Z2K0;Q9UNZ2-6;Q9UNZ2;Q9UNZ2-5NSFL1 cofactor p47NSFL1C 2 2 274 0 4.6805 0.2022 4.3483 3.17E+07
P63173;J3KT73;J3QL01;J3KSP2P63173;J3KT73;J3QL0160S ribosomal protein L38RPL38 8 8 70 0 65.954 0.18922 0.15476 2.37E+10
Q13255-2;Q13255-3;Q13255Q13255-2;Q13255-3;Q13255Metabotropic glutamate receptor 1GRM1 2 2 906 0.0020581 2.8827 0.1045 NaN 1.21E+08
Q8N5U6;Q8N5U6-2;F5H5P6;H0YF69Q8N5U6;Q8N5U -2RING finger protein 10RNF10 3 3 811 0 30.562 0.095838 0.88191 4.61E+09
K7ELU5;Q7Z3V5 K7ELU5;Q7Z3V5 Zinc finger protein 571ZNF571 1 1 84 0.0047076 2.3321 0.094262 NaN 8.04E+09
M0QY31;M0R2A2;M0R0B3;A0A096LNM5;M0R235;G5E9F7;A0A087WU99;A0A087WSZ1;A0A087WWQ7;A0A087WT09;M0QX68;Q00888-3;P11464-3;Q13046;Q00888;P11464;P11464-4;Q16557;P11464-20QY31;M R2A2;M0R0B3;A0A096LNM5;M0R235;G5E9F7; A087WU99;A0A087WSZ1;A0A087WWQ7;A0A087WT09;M0QX68;Q00888-3;P11464-3;Q13046;Q00888;P1 464;P1 464-4;Q16557;P11464-2Pregnancy-specific beta-1-glycoprotein 4;Pregnancy-specific beta-1-glycoprotein 1;Putative pregnancy specific beta-1-glycoprotein 7 regnancy-specific beta-1-glycoprotein 3PSG4;PSG1;PSG3;PSG7 1 1 244 .0023095 2.8 39 0.0089702 NaN 1.96E+08
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DNA double-strand breaks (DSBs) are highly cytotoxic cellu-lar lesions that must be effectively and accurately repaired to maintain genome stability and prevent premature aging, neu-
rodegeneration, immunodeficiency, cancer and other diseases1–3. 
In response to DSB detection, the apical kinases ATM, ATR and 
PRKDC (DNA-dependent protein kinase catalytic subunit) become 
activated and phosphorylate numerous substrates to initiate the 
cellular DNA damage response (DDR)4. The ensuing cascade of 
molecular DDR events, which are promoted by various post-trans-
lational modifications including protein phosphorylation, ubiqui-
tylation, sumoylation and poly (ADP-ribosyl)ation, impacts on a 
myriad of cellular components, among other things leading to the 
assembly of DDR factors at DNA-damage sites, arrest or slowing of 
cell-cycle progression, and activation of DNA repair mechanisms4,5. 
The two main types of DSB-repair pathway are non-homologous 
end-joining (NHEJ), which is active throughout the cell cycle, and 
homologous recombination (HR), which normally requires a sis-
ter chromatid as a template and hence only operates in the S and 
G2 phases of the cell cycle. DSB-repair pathway choice is partly 
 determined by functional antagonism between the HR-promoting 
factor BRCA1 and NHEJ-promoting proteins such as TP53BP1 
(53BP1), RIF1 and MAD2L2 (REV7)6–13.
Inherited or acquired mutations in the BRCA1 or BRCA2 genes 
that result in protein loss or a mutant BRCA1/2 protein cause 
breast, ovarian, prostate and other cancers, and render tumours 
hypersensitive to poly(ADP-ribose) polymerase (PARP)-inhibitor 
drugs such as olaparib14–17. Unfortunately, intrinsic or acquired 
PARP-inhibitor resistance frequently leads to a lack of response or 
to patient relapse and tumour regrowth15,18. In the clinic, the most 
common PARP-inhibitor resistance mechanisms reported to date 
are restoration of BRCA1/2 expression or function. Notably, 53BP1 
expression is lost in various triple-negative breast cancers7, which 
may account for certain clinically relevant examples of PARP-
inhibitor resistance. Nevertheless, the mechanisms driving PARP-
inhibitor resistance in a large proportion of BRCA1/2-deficient 
tumours remain unexplained18,19.
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BRCA1 deficiencies cause breast, ovarian, prostate and other cancers, and render tumours hypersensitive to poly(ADP-
ribose) polymerase (PARP) inhibitors. To understand the resistance mechanisms, we conducted whole-genome CRISPR–Cas9 
synthetic-viability/resistance screens in BRCA1-deficient breast cancer cells treated with PARP inhibitors. We identified 
two previously uncharacterized proteins, C20orf196 and FAM35A, whose inactivation confers strong PARP-inhibitor resis-
tance. Mechanistically, we show that C20orf196 and FAM35A form a complex, ‘Shieldin’ (SHLD1/2), with FAM35A inter-
acting with single-stranded DNA through its C-terminal oligonucleotide/oligosaccharide-binding fold region. We establish 
that Shieldin acts as the downstream effector of 53BP1/RIF1/MAD2L2 to promote DNA double-strand break (DSB) end-
joining by restricting DSB resection and to counteract homologous recombination by antagonizing BRCA2/RAD51 loading 
in BRCA1-deficient cells. Notably, Shieldin inactivation further sensitizes BRCA1-deficient cells to cisplatin, suggesting how 
defining the SHLD1/2 status of BRCA1-deficient tumours might aid patient stratification and yield new treatment opportuni-
ties. Highlighting this potential, we document reduced SHLD1/2 expression in human breast cancers displaying intrinsic or 
acquired PARP-inhibitor resistance.
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To systematically survey for genetic mechanisms of PARP-
inhibitor resistance, we conducted whole-genome CRISPR–Cas9 syn-
thetic-viability/resistance screens in human BRCA1-deficient breast 
cancer cells treated with PARP inhibitors. In addition to identifying 
known resistance factors such as 53BP1, RIF1 and MAD2L2 loss6–13, 
we identified two previously uncharacterized proteins, C20orf196 
and FAM35A, whose inactivation confers PARP-inhibitor resistance 
to BRCA1-deficient cells. Our ensuing work led us to define the 
‘Shieldin’ (SHLD1C20orf196/SHLD2FAM35A) complex, which promotes 
NHEJ by serving as the downstream effector of 53BP1, RIF1 and 
MAD2L2, restricts DSB resection, and counteracts HR in BRCA1-
deficient cells by antagonizing replacement of replication protein A 
(RPA) with BRCA2 and RAD51 on resected single-stranded DNA 
(ssDNA). Finally, we report that SHLD1C20orf196/SHLD2FAM35A loss 
confers hypersensitivity to the DNA-crosslinking agent cisplatin, 
and that reduced SHLD1C20orf196 or SHLD2FAM35A expression is associ-
ated with evolution of PARP-inhibitor resistance in a patient-derived 
BRCA1-deficient breast cancer xenograft model and in BRCA1-
mutant cancers displaying intrinsic PARP-inhibitor resistance.
Results
FAM35A or C20orf196 loss suppresses PARP-inhibitor sensi-
tivity of BRCA1-mutant cells. To systematically explore genetic 
mechanisms imparting PARP-inhibitor resistance, we carried 
out genome-wide CRISPR–Cas9 gene-inactivation screens with 
the GeCKO library20 in the BRCA1-mutant breast cancer cell line 
SUM149PT treated in parallel with the PARP inhibitors olaparib, 
talazoparib (BMN673) or AZD2461 (Fig. 1a,b and Supplementary 
Fig. 1a–c). In addition to identifying the known resistance genes 
TP53BP1, RIF1 and MAD2L2, whose products form a complex21, 
we identified several new suppressor candidates (Supplementary 
Table 1 and Supplementary Fig. 1d,e). These included DYNLL1, 
a known 53BP1 interaction partner22, and TEN1, a component 
of the CST telomere-capping complex (CTC1/STN1/TEN1) 
that also promotes telomere DNA replication23. In our ensuing 
studies, however, we focused on the uncharacterized proteins 
FAM35A and C20orf196, which collectively received the high-
est scores from our screens (Fig. 1b and Supplementary Table 1). 
Thus, by carrying out short-interfering RNA (siRNA) mediated 
mRNA silencing in non-transformed, human telomerase reverse 
transcriptase-immortalized retinal pigment epithelial 1 (RPE1) 
cells (Supplementary Fig. 1f), we established that, as for 53BP1 
loss7, depletion of FAM35A or C20orf196 markedly suppressed 
PARP-inhibitor sensitivity caused by BRCA1 inactivation while 
having no discernible effect in BRCA1-proficient cells (Fig. 1c 
and Supplementary Fig. 1g). This conclusion was independently 
confirmed by de novo CRISPR–Cas9 gene editing, with FAM35A 
or C20orf196 inactivation alleviating the olaparib hypersensitiv-
ity of BRCA1-deficient cells in a manner counteracted by the re-
introduction of wild-type FAM35A or C20orf196 (Fig. 1d,e and 
Supplementary Fig. 1h; as shown in Supplementary Fig. 1i, these 
effects did not reflect altered cell-cycle profiles).
FAM35A/C20orf196 complex interacts with and acts down-
stream of 53BP1/RIF1/MAD2L2. Sequence analyses indicated 
that FAM35A and C20orf196 are well conserved in vertebrates. 
Moreover, structure prediction modelling (RaptorX; http://rap-
torx.uchicago.edu/) revealed that FAM35A harbours a disordered 
N terminus and an ordered C-terminal region containing three 
oligonucleotide/oligosaccharide-binding (OB) folds, with the last 
C-terminal OB fold/FAM domain containing a CXXC-type zinc 
finger motif (Fig. 2a). Notably, this organization is highly similar 
to those of the RPA1 subunit of ssDNA binding protein RPA and 
the CTC1 subunit of the CST complex that also binds ssDNA23. In 
this regard, we noted that while the C20orf196 N terminus (resi-
dues 1–70) is predicted to be intrinsically disordered, its C-terminal 
part is more structured and may harbour one- or two-winged helix 
(WH) domains (Fig. 2a) similar to those in the yeast CST subunit 
Stn123,24, suggesting that C20orf196 and Stn1 might play analogous 
or complementary roles.
By combining cellular co-localization and co-immunoprecip-
itation experiments, we established that FAM35A and C20orf196 
directly interact in a manner that is mainly, but not exclusively, 
mediated by the FAM35A OB3/FAM domain (Fig. 2b,c and 
Supplementary Fig. 2a,b). Because loss of FAM35A or C20orf196 
had similar effects to loss of 53BP1/RIF1/MAD2L2 in BRCA1-
deficient cells, we tested for possible interactions between these 
factors. Thus, via co-immunoprecipitation and mass spectrometry 
(MS) studies, we found that both C20orf196 and FAM35A interact 
with MAD2L2, the most distal factor of the 53BP1/RIF1/MAD2L2 
axis mediating PARP-inhibitor sensitivity in BRCA1-deficient 
cells6–13 (Fig. 2d and Supplementary Fig. 2c).
Many DDR proteins accumulate at DSB sites within ioniz-
ing radiation (IR)-induced nuclear foci (IRIF)5. We established 
that both FAM35A and C20orf196 formed IRIF, and by live-cell 
imaging studies found that the proteins were also recruited to 
localized DNA-damage sites induced by laser micro-irradiation 
(Supplementary Fig. 2d). Furthermore, we determined by confo-
cal and super-resolution microscopy that FAM35A co-localized 
with the established DSB markers phosphorylated histone H2AFX25  
(γ H2AX) and 53BP126 (Fig. 2e,f and Supplementary Fig. 2e). Notably, 
siRNA/shRNA-depletion experiments established that while 53BP1 
IRIF and MAD2L2 levels and IRIF were not significantly impaired 
by FAM35A or C20orf196 depletion (Supplementary Fig. 2f–h), 
IRIF formation by FAM35A and C20orf196 required 53BP1, RIF1 
and MAD2L2 but not PTIP (Fig. 2e and Supplementary Fig. 3a–c; 
note that the total levels of green fluorescent protein (GFP)-
tagged FAM35A/C20orf196 were minimally affected by 53BP1/
RIF1/MAD2L2 depletion). We also established that C20orf196 
IRIF were almost totally abrogated by FAM35A depletion, while 
C20orf196 depletion reduced but did not abolish FAM35A IRIF 
(Fig. 2e). In addition, FAM35A formed nuclear foci when cells 
were treated with the DNA topoisomerase I inhibitor camptoth-
ecin (CPT; Supplementary Fig. 3d). Significantly, the FAM35A N 
terminus was necessary and sufficient for its IRIF formation; these 
IRIF depended on 53BP1, RIF1, MAD2L2 and C20orf196, and this 
region could be co-immunoprecipitated with MAD2L2 (Fig. 2f,g 
and Supplementary Fig. 3e,f). Collectively, these findings indicated 
that FAM35A and C20orf196 act as downstream components of 
53BP1/RIF1/MAD2L2 molecular assembly21 at DSB sites.
FAM35A and C20orf196 promote NHEJ. As 53BP1, RIF1 and 
MAD2L2 promote NHEJ6–13, we tested whether FAM35A and 
C20orf196 fulfil a similar role. Indeed, as for depletion of the NHEJ 
factor XRCC4, siRNA depletion of 53BP1, FAM35A or C20orf196 
impaired NHEJ, as measured by random integration of plas-
mid DNA into chromosomes27 (Fig. 3a). In addition, FAM35A or 
C20orf196 depletion conferred IR hypersensitivity to both human 
and mouse cells (Fig. 3b and Supplementary Fig. 4a). 53BP1 and 
associated factors promote NHEJ-mediated class-switch recombi-
nation (CSR) at the immunoglobulin heavy-chain locus, a process 
that allows B lymphocytes to change antibody production from one 
type to another28. By CRISPR–Cas9 gene editing in mouse CH12F3 
(CH12) B lymphocytes29, we established that, as for 53BP1/RIF1/
MAD2L2 inactivation6,8,10–12,30,31, loss of FAM35A or C20orf196 
markedly reduced CSR (Fig. 3c,d and Supplementary Fig. 4b–d). 
Furthermore, analysis of metaphase chromosomal spreads of such 
cells revealed that FAM35A or C20orf196 inactivation led to chro-
mosomal breaks and translocations symptomatic of aberrant CSR32 
(Fig. 3e,f; note from Supplementary Fig. 4e,f that CSR effects were 
not associated with defects in cell proliferation, or in Aid or germ-
line Sα switch region transcription).
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Fig. 1 | CRISPR–Cas9 screens identify suppressors of PARP-inhibitor sensitivity in BRCA1-mutant cells. a, Schematic of screen procedure. MOI, 
multiplicity of infection; PARPi, PARP-inhibitor. b, MAGeCK analysis of guide enrichments following specified drug treatments; false discovery rate (FDR) 
of 0.1 indicated by dotted line; n =  3 technical replicates per drug treatment. c, siRNA-mediated verification of hits in clonogenic survival assays; lower 
panels show area under the curve (AUC); n =  3 independent experiments. d, De novo Cas9-mediated knockout (ko) verification and complementation 
for FAM35A in clonogenic survival assays (multiple ko clones are shown in AUC); n =  4 independent experiments except FAM35Ako(#14) (n =  2), 
FAM35Ako(#40) (n =  3), BRCA1ko/FAM35Ako(#34) (n =  2) and BRCA1ko/FAM35Ako(#2) +  FAM35A (n =  3). e, As in d but for C20orf196; n =  3 
independent experiments except BRCA1ko/C20orf196ko +  C20orf196 (n =  2). In c–e, bars represent mean ±  s.e.m., one-way analysis of variance 
(ANOVA); *P <  0.05, **P <  0.01, ***P <  0.001, ****P <  0.0001, NS, not significant (P ≥  0.05). Individual data points are plotted over bars, and statistical 
source data including the precise P values are provided in Supplementary Table 5.
NATuRe CeLL BIOLOGY | VOL 20 | AUGUST 2018 | 954–965 | www.nature.com/naturecellbiology956 196
ArticlesNATuRe CeLL BIoLogy
FAM35A and C20orf196 antagonize DNA-end resection. To 
explore FAM35A and C20orf196 function further, we carried out 
assays in mouse cells harbouring a temperature-sensitive allele of 
the telomere-associated factor TRF2 (TRF2ts). TRF2ts inactivation 
at higher temperatures results in deprotected chromosome ends 
and causes NHEJ-mediated telomere fusions (Fig. 4a)6,33. Strikingly, 
through the use of short-hairpin RNA (shRNA) mediated mRNA 
silencing, we found that such chromosome fusions were diminished 
by FAM35A or C20orf196 depletion, like that elicited by MAD2L2 
depletion (Fig. 4b and Supplementary Fig. 5a,b).
The impacts of 53BP1, RIF1 or MAD2L2 depletion in the 
TRF2ts system are connected to these factors counteracting 
DSB resection6–13,34. We thus explored whether FAM35A and 
C20orf196 might also have this function. Indeed, as for 53BP1/
RIF1/MAD2L2 inactivation6–13,35, loss of FAM35A or C20orf196 
in human cells enhanced DSB-resection, as measured by RPA 
and ssDNA staining intensity in pre-extracted nuclei after treat-
ment with CPT (Fig. 4c–e; RPA1 kinetics at DNA damage sites 
induced by laser micro-irradiation were not altered by FAM35A 
or C20orf196 depletion, Supplementary Fig. 5c). In line with this 
resection being mediated by canonical pathways, it was dimin-
ished by depletion of the resection promoting factors RBBP8 
(CtIP) or BLM (bloom syndrome RecQ-like helicase, Fig. 4f). 
Furthermore, we established that recruitment of BLM to sites of 
laser micro-irradiation was enhanced by FAM35A or C20orf196 
depletion (Fig. 4g). Similarly, as shown for 53BP1 depletion in 
mouse cells6, FAM35A or C20orf196 depletion in such cells led to 
higher levels of the DNA-end resection marker, Ser4/8 phosphor-
ylated RPA2, after IR treatment (Fig. 4d). Together with our other 
findings, these data established FAM35A and C20orf196 as crucial 
components of 53BP1/RIF1/MAD2L2-mediated chromosomal 
NHEJ, and suggested that their pro-NHEJ function is  connected 
to limiting DSB resection.
FAM35A OB fold region interacts with ssDNA and promotes IR 
survival. Consistent with our prediction of structural similarity 
between FAM35A and RPA1, the FAM35A C terminus could be 
retrieved from cell extracts via interaction with a ssDNA oligonu-
cleotide (Fig. 5a). Sequence alignment to RPA1 and structural mod-
elling of FAM35A identified two Trp (W) residues predicted to be 
at the protein–ssDNA interface, based on analogous residues criti-
cal for RPA binding to ssDNA (Fig. 5b and Supplementary Fig. 5d). 
In accord with this prediction, we found, via electrophoretic gel-
mobility shift assays (EMSAs), that the bacterially expressed, puri-
fied FAM35A C-terminal region bound preferentially to ssDNA 
rather than double-stranded DNA (Fig. 5c and Supplementary 
Fig. 5e), and ssDNA binding was reduced when the two Trp residues 
were mutated to Ala (W489/W640A; Fig. 5c). Furthermore, while 
full-length FAM35A bearing these mutations (FAM35AW489/W640A) 
still interacted with C20orf196 (Supplementary Fig. 5f) and 
formed IRIF in cells, these IRIF were consistently less pronounced 
than those of the wild-type FAM35A protein (Fig. 5d). This sug-
gested that, following IRIF recruitment via its N-terminal region, 
the FAM35A C-terminal ssDNA binding region may allow further 
FAM35A recruitment, retention and/or stabilization. In addition, 
unlike the wild-type protein, FAM35AW489/W640A did not confer 
significant IR resistance when reintroduced into FAM35A null 
cells (Fig. 5e). In parallel studies, expression of the FAM35A C 
terminus did not complement the IR hypersensitivity of FAM35A 
null cells. Moreover, expression of the FAM35A N terminus 
rendered cells IR-hypersensitive, irrespective of whether they 
expressed endogenous FAM35A, implying that the N-terminal 
IRIF-forming domain of FAM35A may have a dominant-negative 
effect on NHEJ (Fig. 5f; overexpression of these FAM35A deriva-
tives did not affect olaparib sensitivity in a wild-type background, 
Supplementary Fig. 5g).
FAM35A and C20orf196 antagonize HR in BRCA1-deficient 
cells. PARP inhibitors generate replication-associated DNA lesions 
that require BRCA1-mediated HR for their effective repair19, 
and loss of 53BP1/RIF1/MAD2L2 partly restores the ability of 
 BRCA1-deficient cells to repair such lesions6–13. This has led to a 
model in which BRCA1 and 53BP1/RIF1/MAD2L2 play antago-
nistic roles in channelling DSBs towards HR or NHEJ, respec-
tively. We thus speculated that BRCA1 might antagonize FAM35A/
C20orf196 action. Accordingly, both FAM35A and C20orf196 IRIF, 
but not 53BP1 IRIF, were significantly enhanced in number and 
intensity following BRCA1 but not BRCA2 depletion (Fig. 6a,b and 
Supplementary Fig. 6a,b).
Collectively, our results suggested that FAM35A/C20orf196 
act at the interface between the opposing functions of BRCA1 and 
53BP1/RIF1/MAD2L2 to regulate DSB-repair pathway choice. 
Although this action could operate at least in part through control 
of DSB resection, which is misregulated and of slower kinetics in 
BRCA1-deficient cells11,36, we reasoned that FAM35A/C20orf196 
might also contribute to the severe defect in BRCA2-mediated 
RAD51 loading at DNA-damage sites in BRCA1-deficient 
cells11,35,37. Indeed, as for 53BP1 inactivation, loss of FAM35A or 
C20orf196 restored RAD51 IRIF formation in BRCA1-null cells 
(Fig. 6c). While exploring the mechanism for this effect, we found 
that elevated resection levels in FAM35A and C20orf196 knock-
out cells, as measured by RPA recruitment at DNA-damage sites, 
were still maintained in the absence of BRCA1 (Supplementary 
Fig. 6c,d). Furthermore, FAM35A/C20orf196 depletion also 
alleviated the impaired recruitment of BRCA2 to DNA-damage 
sites in BRCA1-deficient cells (Fig. 6d and Supplementary Fig. 
6e). Accordingly, studies with a cell-based chromosomal traffic 
light reporter (TLR) HR system38,39 established that FAM35A or 
C20orf196 depletion in BRCA1-deficient cells restored HR to lev-
els similar to those acquired following 53BP1 depletion in this 
setting (Fig. 6e and Supplementary 6f). In addition, removing 
FAM35A or C20orf196 rescued the spontaneous genomic insta-
bility phenotype of BRCA1 knockout cells (Fig. 6f). Building on 
our findings that the FAM35A N-terminal region largely medi-
ates its localization to IRIF (Fig. 2f and Supplementary Fig. 3e,f), 
introducing the FAM35A N terminus, but not the C terminus, 
enhanced PARP-inhibitor sensitivity of BRCA1/FAM35A null 
cells (Fig. 6g and Supplementary Fig. 6g). Furthermore, FAM35A 
inactivation was epistatic to 53BP1 inactivation in relation to 
conferring PARP-inhibitor resistance in BRCA1 knockout cells 
(Supplementary Fig. 6h). Considering our findings together, we 
propose that C20orf196 and FAM35A be named SHLD1 and 
SHLD2, respectively, or collectively as the ‘Shieldin complex’ 
because it shields DSBs from inappropriate activities and pro-
motes appropriate modes of DSB repair.
FAM35A/C20orf196 loss correlates with PARP-inhibitor resis-
tance in cancers. Having identified SHLD1C20orf196 and SHLD2FAM35A 
as mediating the PARP-inhibitor sensitivity of a BRCA1-deficient 
breast cancer cell line, we speculated that this might also apply 
in more physiological settings. Consequently, we employed a 
patient-derived xenograft (PDX) model of BRCA1-deficient breast 
cancer propagated in mice in the presence (cohort 2) or absence 
(cohort 1) of olaparib (Fig. 7a). The resistant tumour was further 
serially passaged into new hosts that were treated in the presence 
(cohort 4) or absence (cohort 3) of olaparib to confirm and sus-
tain drug resistance (Fig. 7a; see also Supplementary Fig. 7a). The 
tumours were then harvested and subjected to whole-genome 
RNA-sequencing. Notably, our analyses revealed that in contrast to 
the other cohorts, nearly all resistant tumours after chronic olapa-
rib treatment (cohort 4) correlated with reduced mRNA expres-
sion of SHLD1C20orf196, SHLD2FAM35A, 53BP1 and/or PARP1 (Fig. 7a; 
each heatmap column represents one tumour/mouse sample). 
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Because this tumour model is  polyclonal40, our data suggested 
that olaparib resistance mechanisms might arise through paral-
lel evolutionary  trajectories  converging on loss of Shieldin activ-
ity. Furthermore, when we stratified a cohort of BRCA1-deficient 
PDX tumours by SHLD1/2 expression, ensuing analyses indicated 
that low SHLD1C20orf196 transcript levels correlated with intrinsic 
olaparib resistance (Fig. 7b). One of the  olaparib-resistant models 
(PDX127) demonstrated concomitant loss of both SHLD1C20orf196 
and SHLD2FAM35A, while two other resistant models exhibiting nor-
mal SHLD1/2 transcript levels harboured  deleterious 53BP1 muta-
tions. Notably, several of these resistant PDX models also display 
BRCA1 nuclear foci41, suggesting the presence of multiple mecha-
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Fig. 2 | FAM35A and C20orf196 domains, interactions and IRIF formation. a, FAM35A and C20orf196 predicted domains and variants used, OB fold (OB) and 
FAM domain (OB3/FD). b, Recruitment of FAM35A/derivatives GFP-fusions to a chromosomal Lac-operator array via mCherry-LacR-C20orf196. Data represent 
three experiments, with quantifications as shown in Supplementary Fig. 2a. Scale bar, 10 µ m. c, Left and middle, Purified recombinant GST-FAM35A directly 
interacts with recombinant His-C20orf196. Right, Cell extracts expressing GFP-FAM35A/derivatives and HA-C20orf196 analysed by co-immunoprecipitation 
and immunoblotting. d, V5-FAM35A co-immunoprecipitates with GFP-MAD2L2; the interaction with C20orf196 is shown in Supplementary Fig. 2c. e, 
Quantification of inducible GFP-FAM35A (left) and GFP-C20orf196 (right) IRIF in γ H2AX-positive cells 5 h after IR (5 Gy) treated with indicated siRNAs. n =  4 
independent experiments except (left) si53BP1 (n =  3), siRIF1 and siMAD2L2 (n =  2) and (right) siCTRL (n =  5), siRIF1(n =  3) and siFAM35A (n =  3). f, As in e 
but for inducible GFP-FAM35A N terminus; n =  4 independent experiments except siRIF1 (n =  3). g, Endogenous MAD2L2 co-immunoprecipitates with GFP-
FAM35A N terminus. In e,f, bars represent mean ±  s.e.m. (relative to wild type), one-way ANOVA; *P <  0.05, **P <  0.01, ****P <  0.0001; NS, not significant 
(P ≥  0.05); individual data points plotted over bars. Statistical source data including precise P values are shown in Supplementary Table 5. All immunoblots are 
representative of two independent experiments; unprocessed scans of immunoblots are shown in Supplementary Fig. 8.
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Finally, we found that in contrast to 53BP1 deficiency42, 
SHLD1C20orf196 or SHLD2FAM35A loss increased the sensitivity of BRCA1-
proficient and BRCA1-null cells to IR, and even more  markedly 
enhanced their sensitivity to the DNA crosslinking agent cisplatin 
(Fig. 7c,d and Supplementary Fig. 7b,c). Furthermore, enhanced 
cisplatin sensitivity following SHLD1C20orf196 or SHLD2FAM35A 
 inactivation was associated with increased DNA-damage focus 
 formation by the FANCD2 protein that is involved in the detection 
and repair of DNA crosslinks (Fig. 7e and Supplementary Fig. 7d). 
These findings therefore suggested that, if loss/reduced expression 
of SHLD1/2 occurs in patients, it may provide collateral therapeutic 
vulnerabilities that could be exploited clinically.
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Fig. 3 | FAM35A and C20orf196 promote NHeJ and immunoglobulin CSR. a, Random plasmid integration assay. b, FAM35Ako and C20orf196ko 
cells were treated with IR and analysed for clonogenic survival. Right, AUC. In a,b, Bars represent mean ±  s.e.m., one-way ANOVA; n =  3 independent 
experiments, except C20orf196ko in b (n =  4), with individual data points plotted over bars; statistical source data are provided in Supplementary 
Table 5. c, Schematic representation of CSR and chromosomal instability in murine IgM+ B cells (germline configuration with Cμ transcription) induced 
to express AID and undergo CSR to IgA (switch configuration with Cα transcription) on addition of anti-CD40, interleukin-4 (IL-4) and transforming 
growth factor beta (TGF-β ). CSR levels were measured as percent of IgA-positive cells after 72 h cytokine stimulation, and DNA fluorescence in situ 
hybridization (FISH) was performed using a chromosome 12-specific paint (grey chromosome) and Igh locus-specific probes (red and green spots) 
for the measurement of chromosomal instability at the Igh locus on induction of CSR. d, CSR levels in Fam35Ako and C20orf196ko CH12-Cas9 cells 
are reduced compared with wild-type (WT) CH12-Cas9 cells. Bars represent mean ±  s.e.m., one-way ANOVA. n =  4 independent experiments of 
three clones except 53bp1ko +  cytokine where n =  3 of two clones, and 53bp1ko-cytokine where n =  2 of two clones; individual data points are plotted 
over bars. e, Representative images of Igh translocation and breaks in aberrant metaphases, as quantified in f. f, Quantification of Igh breaks and 
translocations in metaphases of the indicated CH12-Cas9 cells. Horizontal bars represent means, Fisher’s exact test; n =  2 independent experiments 
except Fam35ako and C20orf196ko where n =  3. For a, b, d and f, *P <  0.05, **P <  0.01, ****P <  0.0001; NS, not significant (P ≥  0.05); statistical source 
data including precise P values are provided in Supplementary Table 5.
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Discussion
Over the past two decades, it has become evident that eukaryotic 
cells have evolved multiple mechanisms of DNA DSB repair that are 
regulated in complex and sophisticated ways to optimize genome 
stability. In particular, much attention has focused on how cells 
strategically employ the two prime modes of DSB repair—NHEJ 
and HR—which antagonize one another, operate optimally in dif-
ferent contexts and whose relative usage is regulated by factors such 
as chromatin structure and cell-cycle stage. In addition to being of 
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Fig. 4 | FAM35A and C20orf196 promote telomere-mediated fusions and limit DNA-end resection. a, Schematic of TRF2ts experimental set-up.  
b, shRNA depletion of FAM35A (left) or C20orf196 (right) reduces uncapped telomere-mediated chromosome fusions. Bars represent means. 
Experiments were performed twice with ≥ 1,300 chromosomes counted per condition, and individual data points are plotted over bars; source data are 
provided in Supplementary Table 5. c, FAM35Ako and C20orf196ko RPE1 cells labelled with BrdU (10 μ M) for 48 h then treated with 1 µ M camptothecin 
(CPT) for 1 h, pre-extracted, fixed and stained for BrdU under non-denaturing conditions to visualize ssDNA. Box and whisker plot with centre line at 
median, box limits at 25th/75th centiles and whiskers ± 1.5× interquartile range (IQR); one-way ANOVA; n =  3 independent experiments. d, IR-induced 
pRPA(S4/8) is enhanced in MEFs due to Fam35a or C20orf196 silencing. Bars represent means. Experiments were performed twice. Individual data points 
are plotted over bars; source data are provided in Supplementary Table 5. e, RPE1-FAM35Ako or -C20orf196ko cells display hyper DNA-end resection 
(cells treated with 1 μ M CPT for 1 h). Representative images from three independent experiments. Scale bar, 10 µ m. f, RPE1-FAM35Ako or -C20orf196ko 
cells display BLM- and CtIP-dependent markers of excessive DNA-end resection. Box and whisker plot with centre line at median, box limits at 25th/75th 
centiles and whiskers ± 1.5× IQR; one-way ANOVA; n =  3 independent experiments. g, Enhanced BLM accrual in FAM35Ako and C20orf196ko compared 
with wild-type (WT) RPE1 cells fixed and stained 2 h after laser micro-irradiation. Left, Representative images. Right, Quantification. Scale bar, 10 µ m.  
Box and whisker plot with centre line at median, box limits at 25th/75th centiles and whiskers ± 1.5× IQR; one-way ANOVA; n =  3 independent 
experiments. a.u., arbitrary units. For c, f and g, *P <  0.05, **P <  0.01, ***P <  0.001, ****P <  0.0001; NS, not significant (P ≥  0.05); statistical source data 
including precise P values are provided in Supplementary Table 5.
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particularly in cancer therapy where DSB-inducing chemothera-
peutic agents are frequently used, and molecularly targeted drugs 
such as PARP inhibitors are being increasingly employed in specific 
settings. Intrinsic or arising PARP-inhibitor resistance in patients 
with BRCA1/2 mutations is nevertheless an increasing clinical 
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Fig. 5 | FAM35A OB folds mediate ssDNA interaction and are required for IR resistance. a, Schematic of FAM35A with residues W489/W640 mutated 
to A (top). Predicted 3D structure of wild-type FAM35A with W489 and W640 positions (lower left). FAM35A W489/W640 promote efficient 
ssDNA binding in cellular extracts (lower right). b, Alignment of yRPA1 with FAM35A C terminus; amino acids critical for yRPA1 ssDNA binding and the 
corresponding amino acid residues in FAM35A are boxed. c, EMSAs on native (non-denaturing) gels with 10 nM ssDNA or dsDNA, and the indicated 
purified, bacterially expressed FAM35A C terminus or W489/W640A mutant (in µ M). d, Inducible GFP-FAM35A W489/W640A fails to efficiently form 
IRIF (12 h after 5 Gy of IR). Scale bar, 10 µ m. Representative images from three independent experiments. e, FAM35Ako RPE1 cells complemented with 
FAM35A derivatives in clonogenic survival assays. Right, AUC. f, Overexpression of FAM35A N terminus but not the C terminus or full-length FAM35A 
sensitizes wild-type cells to IR in clonogenic assays. Right, AUC. In e,f, bars represent mean ±  s.e.m., one-way ANOVA; *P <  0.05, **P <  0.01, ***P <  0.001; 
NS, not significant (P ≥  0.05); n =  3 independent experiments except Groups 2 and 4 in e (n =  2). Individual data points are plotted over bars; statistical 
source data including precise P values are provided in Supplementary Table 5. All immunoblots are representative of two independent experiments; 
unprocessed scans of immunoblots are shown in Supplementary Fig. 8.
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3. BRCA1ko/FAM35Ako + C terminus
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Fig. 6 | FAM35A or C20orf196 loss restores HR in BRCA1-deficient cells. a, Quantification of GFP-FAM35A (left) and GFP-C20orf196 (right) IRIF in U2OS 
cells after BRCA1 or BRCA2 depletion (5 h after 5 Gy). Bars represent mean ±  s.e.m., one-way ANOVA; n =  3 independent experiments, except FAM35A 
siCTRL (n =  4), FAM35A siBRCA2 (n =  2) and C20orf196 siCTRL (n =  5). Individual data points are plotted over bars. b, Quantification of 53BP1 and inducible 
GFP-FAM35A IRIF in U2OS cells with or without BRCA1 depletion (5 Gy, indicated time points). Bars represent mean ±  s.e.m., one-way ANOVA; n =  4 
independent experiments, except 53BP1, 1.5 h siCTRL (n =  2); 53BP1, 1.5 h siBRCA1 and 53BP1, 16 h siCTRL (n =  3); FAM35A, 1.5 h siCTRL (n =  5). Individual 
data points are plotted over bars. c, Representative images (left) and quantification (right) of RAD51 IRIF (5.5 h after 5 Gy) in Cyclin A (CycA) positive 
RPE1ko cell lines as indicated. Bars represent mean ±  s.e.m., one-way ANOVA; n =  3 independent experiments. Individual data points are plotted over bars. 
Scale bar, 10 µ m. d, FAM35A/C20orf196 loss restore BRCA2 recruitment 2 h after laser-induced DNA-damage sites in BRCA1-null cells (for quantification 
see Supplementary Fig. 6e). Scale bar, 10 µ m. e, HR assay in U2OS-TLR cells treated with indicated siRNAs (for gating strategy see Supplementary Fig. 6f). 
Bars represent mean ±  s.e.m., one-way ANOVA; n =  4 independent experiments. Individual data points are plotted over bars. f, Formation of spontaneous 
chromosomal aberrations in BRCA1ko cells is alleviated by FAM35A/C20orf196 inactivation. Representative images of metaphase spreads are shown and 
quantified; bars represent means, n =  2 independent experiments except FAM35Ako and C20orf196ko (n =  1). Individual data points are plotted over bars.  
g, Olaparib clonogenic survival assay with indicated RPE1ko and complemented cell lines. Bars represent mean ±  s.e.m., one-way ANOVA; n =  4 independent 
experiments, except Groups 4 and 5 (n =  3) and Group 3 (n =  2); AUC is shown in Supplementary Fig. 6g. For a–c,e, *P <  0.05, **P <  0.01, ***P <  0.001, 
****P <  0.0001; NS, not significant (P ≥  0.05); statistical source data including precise P values are provided in Supplementary Table 5.
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Fig. 7 | FAM35A or C20orf196 loss correlates with PARP-inhibitor resistance in cancers. a, Top, Schematic of in vivo PDX study. Bottom, Heatmap 
generated from mRNA sequencing showing scaled expression levels of indicated genes from corresponding PDX samples; n =  6, 5, 7, 8 mice for cohorts 
1–4, respectively. b, Expression of C20orf196/FAM35A in breast and ovarian cancer PDXs derived from BRCA1-deficient tumours. y axis: log2 transcript 
per million (tpm). Lines represent mean ±  s.e.m.; n =  12, 4, 15, 1 for SHLD1-high, SHLD1-low, SHLD2-high, SHLD2-low groups, respectively; two-tailed 
unpaired Student’s t-test; ***P =  0.0003. Statistical source data for PDXs are provided in Supplementary Table 5 and the Methods. c,d, Clonogenic survival 
assay after IR (c) or cisplatin treatment (d) in the indicated RPE1ko cell lines (AUC shown in Supplementary Fig. 7b,c, respectively). Data shown represent 
mean ±  s.e.m. (n =  3 independent experiments except for Group 7 in c and Group 7 in d where n =  2). e, Loss of FAM35A/C20orf196 leads to increased 
cisplatin-induced FANCD2 foci. Bars represent mean ±  s.e.m., one-way ANOVA; ***P <  0.001, ****P <  0.0001; NS, not significant (P ≥  0.05); n =  4 
independent experiments, with individual data points plotted over bars; statistical source data are provided in Supplementary Table 5. Scale bar, 10 µ m.  
f, Proposed model for the action of SHLD1/2 in DSB repair in the presence or absence of functional BRCA1.
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resistance screens, we have uncovered two, previously uncharacter-
ized proteins—SHLD1C20orf196 and SHLD2FAM35A—whose loss medi-
ates PARP-inhibitor resistance and which we have shown act as the 
most distal factors of the 53BP1/RIF1/MAD2L2 molecular axis to 
promote NHEJ and restrict HR in BRCA1-deficient settings. Our 
screens have also identified additional candidate PARP-inhibitor 
resistance factors that await validation in future studies.
Mechanistically, we have shown that SHLD1C20orf196 and 
SHLD2FAM35A form a complex, termed ‘Shieldin’, with SHLD1C20orf196 
recruitment to DNA-damage sites via its interactions with 
SHLD2FAM35A and other factors, and SHLD2FAM35A interacting with 
single-stranded DNA via its C-terminal OB fold region. Moreover, 
we have established that SHLD1C20orf196 and SHLD2FAM35A promote 
NHEJ in a manner that may be mediated via their effects on restrict-
ing DNA-end resection, and serve as a barrier to HR by antago-
nizing the replacement of RPA with BRCA2/RAD51 on resected 
ssDNA in a manner counteracted by BRCA1. Our work is in line 
with a recent report43 that independently identified SHLD1C20orf196 
and SHLD2FAM35A as NHEJ-promoting factors and antagonists of 
HR in BRCA1-defective cells. This study also identified a third 
component, RINN1/SHLD3CTC-534A2.2, which is proposed to serve as 
a molecular bridge from RIF1 to MAD2L2 and SHLD1/2.
Although it seems possible that Shieldin loss contributes to HR 
restoration in BRCA1-deficient cells through effects on both resec-
tion and BRCA2/RAD51 loading, the relative importance of these 
mechanisms needs further investigation. We note that more exten-
sive and possibly faster resection in the absence of Shieldin might 
enhance BRCA2/RAD51 loading. Alternatively, or in addition, 
Shieldin might serve as a physical barrier to BRCA2/RAD51 load-
ing at dsDNA/ssDNA junctions in BRCA1-deficient cells—perhaps 
through it being tethered to DSB-flanking chromatin via the 53BP1/
RIF1/MAD2L2 complex allowing interactions between the C termi-
nus of distal SHLD2FAM35A and ssDNA (see Fig. 7f for a model and 
Supplementary Fig. 7e for SHLD2FAM35A domain function summary). 
Nevertheless, we found that overexpression of the SHLD2FAM35A N 
terminus but not the C terminus confers olaparib hypersensitivity 
to BRCA1/FAM35A double knockout cells, suggesting that at least 
in this context, chromatin binding by SHLD2FAM35A plays a domi-
nant role in restricting HR. By contrast, we found that both the 
SHLD2FAM35A N and C termini are important for IR resistance (in 
BRCA1-proficient cells). As IR sensitivity in Shieldin-deficient cells 
probably reflects impaired NHEJ, we speculate that Shieldin poten-
tiates NHEJ by restricting DSB resection as well as by assembling 
with other NHEJ-promoting factors to tether DSB ends together to 
facilitate their juxtaposition and repair.
Notably, we have found that SHLD1C20orf196 or SHLD2FAM35A inac-
tivation confers enhanced cisplatin sensitivity to BRCA1-null or 
BRCA1-proficient cells. Such sensitivity probably does not reflect 
the roles for Shieldin in promoting NHEJ, restricting DNA-end 
resection or antagonizing BRCA1-mediated BRCA2/RAD51 load-
ing because, in our hands, 53BP1 loss does not have pronounced 
effects on cisplatin sensitivity. Intra-strand DNA crosslinks (ICLs) 
generated by cisplatin and other compounds are detected and 
repaired by the Fanconi anaemia (FA) pathway, with a key FA pro-
tein being FANCD2, which forms foci at sites of these lesions44. 
We have observed that, following cisplatin treatment, FANCD2 
foci were more pronounced in cells in which SHLD1C20orf196 or 
SHLD2FAM35A was inactivated. It will thus be of interest to deter-
mine if Shieldin—like MAD2L2, which (with REV3L) functions as 
a regulatory subunit of the trans-lesion DNA synthesis (TLS) poly-
merase Pol zeta, and whose biallelic inactivation has been associated 
with FA45–47—might also promote ICL repair via TLS mechanisms.
Finally, based on our findings, it will be interesting to evalu-
ate SHLD1/2 expression in tumour biopsies from patients, estab-
lish whether this information can be used in patient stratification 
for PARP-inhibitor therapies, and determine whether SHLD1/2 
 expression changes arise in patients whose BRCA1-deficient can-
cers develop resistance after PARP-inhibitor treatment. In this 
regard, we note that if downregulation of Shieldin components 
in BRCA1-deficient cancers does confer clinical resistance, this 
might allow alternative treatments, such as ones based on plati-
num compounds.
Methods
Methods, including statements of data availability and any asso-
ciated accession codes and references, are available at https://doi.
org/10.1038/s41556-018-0140-1.
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Methods
CRISPR–Cas9 screen. CRISPR–Cas9 was performed using genome-scale 
(GeCKO) v2.020. SUM149PT cells were transduced at a multiplicity of infection of 
0.3 and 250-fold coverage of the library. Cells were then selected with puromycin 
for 7 days before treatment with three different PARPi (PARP inhibitor) for 
a further 14 days. ICs used were Olaparib IC95–2 μ M, BMN673 IC95–5 nM, 
AZD2461 IC70–4 µ M. Surviving clones from each condition were collected, and 
genomic DNA (gDNA) was isolated (Blood & Cell Culture DNA Midi Kit, Qiagen) 
and subjected to PCR with Illumina-compatible primers, followed by Illumina 
sequencing. Genes enriched or depleted in the inhibitor-treated samples were 
determined with software package MAGeCK version 0.5.5 (see commands in the 
Code availability section).
Cell culture. U2OS, U2OS-derived, HEK293 and HEK293T-LentiX cells were 
cultured as in ref. 39. RPE1 p53 null FRT48 and RPE1 p53 null FRT-derived cells were 
cultured in F12 (Ham’s F12; Sigma-Aldrich) supplemented with 17 ml NaHCO3 
7.5% per 500 ml (Sigma-Aldrich). All media were supplemented with 10% (vol/vol) 
fetal bovine serum (FBS; BioSera), 100 U ml−1 penicillin, 100 µ g ml−1 streptomycin 
(Sigma-Aldrich) and 2 mM l -glutamine. SUM149PT cells were cultured in Ham’s 
F12 Nutrient Mixture (ThermoFisher) supplemented with 5% (vol/vol) FBS 
(BioSera), 10 mM HEPES, 1 μ g ml−1 hydrocortisone, 5 μ g ml−1 insulin, and antibiotic 
as described above. For maintenance and selection of RPE1 FRT p53 null or U20S 
Trex cells stably expressing GFP or GFP-tagged constructs, 2 μ g ml−1 blasticidin 
(Sigma-Aldrich) and 0.5 mg ml−1 G418 (Invitrogen) were used. U2OS-TLR were 
cultured as in ref. 39. In addition to RPE1 p53 null FRT-derived cells, U20S Trex 
cells stably expressing inducible constructs were cultured with 1 µ g ml−1 doxycycline 
(Sigma-Aldrich) for 24–48 h to induce expression of GFP constructs. All cells 
were originally obtained from the ATCC cell repository and routinely tested to be 
mycoplasma free. The U2OS and RPE1 cell lines were recently authenticated using 
Affymetrix SNP6 copy number analysis. Trf2−/−;p53−/−;TRF2(Ile468Ala) MEFs 
(TRF2ts MEFs) were as described previously33,49. CH12F3 (CH12)29 and CH12-Cas9 
cell lines were cultured in RPMI 1640 supplemented with 10% FBS, 100 U ml−1 
penicillin, 100 μ g ml−1 streptomycin, 50 µ M 2-mercaptoethanol, 1× MEM non-
essential amino acids, 1 mM sodium pyruvate and 10 mM HEPES.
Generation of human stable cell lines and knockouts. U2OS Trex or RPE1 
p53 null FRT-derived cells stably expressing inducible GFP-tagged constructs 
were generated by transfection of pcDNA5/FRT/TO-neo containing the GFP-
tagged construct and pOG44 (1:4, respectively). Selection began at 48 h using 
0.5 mg ml−1 G418 (Invitrogen). Knockouts were generated in RPE1 p53 null cells 
by transfecting an ‘All-in-one’ plasmid48. Single-cell sorting by GFP expression 
was done using MoFlo (Beckman Coulter). Single clones were expanded, genomic 
DNA extracted and screened by PCR, TOPO-cloning and sequencing. Validated 
mouse embryonic stem cell (mESC) knockouts of Fam35a and C20orf196 were 
obtained from Haplobank (www.haplobank.at).
Plasmids and cloning. See Supplementary Table 3.
siRNA and plasmid transfection. siRNAs were obtained from MWG or IDT 
and transfected using Lipofectamine RNAiMAX (Invitrogen) according to the 
manufacturer’s protocol. Plasmid transfections were carried out using TransIT-
LT1 (Mirus Bio) according to the manufacturer’s protocol. For siRNA and DNA 
co-transfections, plasmids were transfected 8 h after siRNA treatment. See 
Supplementary Table 4.
Random plasmid integration assay. The assay was performed as described in ref. 27.
DNA-damage induction using chemical agents, ionizing radiation and laser 
micro-irradiation. These processes were performed as described in ref. 39.
FRAP and association kinetics. FRAP (fluorescence recovery after 
photobleaching) and association kinetics were performed as described in ref. 50.
TLR assays. The TLR assay and the constructs used herein are described in detail 
in refs 38,39.
Cell cycle profiling. Cell cycle profiling was performed as described in ref. 39.
Clonogenic survival assays. Survival assays were performed as described in refs 27,39.
Whole cell extracts and immunoblotting. Whole cell extracts and 
immunoblotting were performed as described in ref. 39. For detection of 
phospho-RPA (pS4/S8-RPA2), lysates were prepared by scraping cells in 2× 
SDS buffer followed by SDS–PAGE using 4–12% Bis-Tris gel (Invitrogen), and 
immunoblotting was carried out using SuperSignal West Pico PLUS (Thermo 
Scientific). IRDye800CW- and IRDye680-labelled secondary antibody were used 
for detection on an Odyssey infrared imager (LI-COR). Quantification of blots was 
performed using ImageJ. All protein concentrations were determined using a BCA 
assay (Pierce). All antibodies are listed in Supplementary Table 2.
Immunoprecipitation. All immunoprecipitation procedures were performed 
twice as described in ref. 39. For the co-immunoprecipitation shown in Fig. 2d 
(FAM35A), 293T cells were co-transfected with pMSCV-blas-eGFP-MAD2L2 and 
either pLX304-blast-V5-Empty or pLX304-V5-FAM35A. At 72 h post-transfection, 
cells were exposed to 25 Gy IR followed by 3 h recovery. GFP-Trap_MA beads 
(ChromoTek) were used, and immunoprecipitation was performed according to 
the manufacturer’s protocol. For C20orf196 (Supplementary Fig. 2c), 293T cells 
were co-transfected with pMSCV-blas-3xFlag-hMAD2L2 and either pcDNA5.1-
GFP or pcDNA5.1-GFP-C20orf196. At 72 h post-transfection, cells were exposed 
to 25 Gy IR followed by 3 h recovery. After washing with cold PBS, cells were lysed 
in 1 ml lysis buffer (50 mM Tris HCl pH 7.4; 150 mM NaCl; 1 mM EDTA; 1% Triton 
X-100) supplemented with the same inhibitors as above. After 30 min incubation 
on ice followed by centrifugation (16,000g), anti-Flag M2 Magnetic Beads (M8823, 
Sigma-Aldrich) pre-washed with TBS (50 mM Tris HCl, 150 mM NaCl pH 7.4), 
were added to the lysate and rotated overnight at 4 °C. Immune complexes were 
eluted by 5 min boiling.
DNA pulldown experiments. Procedures are described in detail in ref. 39, using 
oligos with the sequence:
5′ B io sG /A TC GC AT TG GC AT TG GC AA TG CG AT AC GA CT GA TC GA GG-
GT AC TC AG CT AG CT GA TT CC GATCGGCTTATTCCGTGTACATACATCG
GAT-3′ ( ID T).
In vitro GST pulldown. Gluathione sepharose beads (GE Healthcare) were 
washed with ice-cold PBS and blocked for 30 min with PBS supplemented with 
10% bacterial lysate (non-induced BL21 cells, lysed using PBS/lysozyme) then 
resuspended in binding buffer (10 mM Tris pH 7.5, 150 mM NaCl, 0.5% NP40, 
0.5 mM EDTA, 0.5% BSA). Purified GST (glutathione-S-transferase, bacterial 
expression), GST-FAM35A (Novus Biologicals) and His-C20orf196 (Creative 
BioMart) were added to the beads at 2 pmol and incubated for 30 min at 4 °C. 
Beads were washed five times with 10 mM Tris, pH 7.5, 250 mM NaCl, 0.5% NP40, 
0.5 mM EDTA and eluted with 100 mM Tris pH 8, 20 mM reduced glutathione, 
120 mM NaCl for 15 min rotating at 4 °C. The eluates were boiled for 5 min, loaded 
on 4–12% Bis-Tris gel (Invitrogen) and subjected to western blotting. The blots 
were probed with the indicated antibodies.
Recombinant protein purifications and electrophoretic mobility shift assays. 
Wild-type and mutant FAM35A C-terminal domains were purified using the 
same method. Harvested cells were lysed by sonication in 50 mM Tris pH 8.0, 
5% glycerol, 150 mM NaCl, 2 mM β -mercaptoethanol, 10 mM imidazole, 
protease inhibitor (Roche) and 40 g ml−1 deoxyribonuclease I (Sigma). After 
centrifugation at 30,000g for 30 min, supernatant was loaded onto a gravity 
column containing Ni-NTA affinity resin (Qiagen) pre-equilibrated with 50 mM 
Tris pH 8.0, 5% glycerol, 150 mM NaCl, 2 mM β -mercaptoethanol and 10 mM 
imidazole. After washing beads with the same buffer for 10× column volume, 
protein was eluted using 50 mM Tris pH 8.0, 5% glycerol, 150 mM NaCl, 2 mM 
β -mercaptoethanol and 100 mM imidazole. The eluate was dialysed with Q 
column (GE healthcare) buffer A (20 mM Tris pH 8.0, 50 mM NaCl, 5% glycerol 
and 2 mM β -mercaptoethanol) and loaded onto a 5 ml Q column. Protein was 
eluted in a gradient against buffer B (20 mM Tris pH 8.0, 1 M NaCl, 5% glycerol 
and 2 mM β -mercaptoethanol). Fractions containing FAM35A protein were 
collected and further purified by running through a Superdex 200 10/300 column 
(GE Healthcare) equilibrated in buffer GF (gel-filtration, 20 mM Tris pH 8, 
150 mM NaCl, 5% glycerol and 5 mM dithiothreitol). Protein samples during 
each step of purification were analysed on 4–12% Bis-Tris gels (Invitrogen). Final 
purified samples were concentrated and stored at − 80 °C. Both forward and 





were dissolved in annealing buffer (10 mM Tris pH 8.0, 50 mM NaCl and 1 mM 
EDTA) to a final concentration of 100 μ M. DNA oligo F was used as ssDNA for 
electrophoretic mobility shift assay (EMSA). Equal volumes of DNA oligo F and 
R were mixed and annealed (heated to 95 °C for 2 min and cooled to 25 °C over 
45 min) to generate dsDNA. Each 20 μ l of EMSA reaction contained 10 nM of 
ssDNA/dsDNA incubated with different concentrations of proteins in 20 mM 
Tris HCl pH 7.5, 50 mM KCl, 5% (vol/vol) glycerol, 100 μ M dithiothreitol, 10 μ 
g ml−1 BSA. Samples were incubated at 37 °C for 15 min and applied onto a 5% 
polyacrylamide native gel in 0.5× TBE buffer for electrophoresis at 4 °C. DNA was 
visualized by Typhoon 9000 (GE Healthcare).
GFP-Trap pulldown for mass spectrometry. HEK293T cells were cultured in 
SILAC medium containing either l -arginine and l -lysine, or l -arginine [13C6, 
15N4] and l -lysine [13C6, 15N2] (Cambridge Isotope Laboratories) as described 
previously51. Cells were lysed 48 h post-transfection in modified RIPA buffer 
(50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% sodium 
deoxycholate) supplemented with protease, phosphatase inhibitors and N-
ethylmaleimide. Lysates were cleared by centrifugation at 16,000g for 15 min at 
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4 °C and protein concentrations were estimated using QuickStart Bradford Protein 
assay (BioRad). Per SILAC condition, 20 µ l of pre-equilibrated GFP-Trap-A 
beads (ChromoTek) were added to 2 mg of lysate and incubated 1 h at 4 °C while 
rotating, followed by three washes with modified RIPA buffer. Bound proteins 
were eluted in NuPAGE LDS Sample Buffer (Life Technologies) supplemented 
with 1 mM dithiothreitol, heated at 70 °C for 10 min and alkylated with 5.5 mM 
chloroacetamide at RT. Samples were loaded onto 4–12% gradient SDS–PAGE gels, 
and proteins were stained using a Colloidal Blue Staining Kit (Life Technologies) 
and digested in gel using trypsin. Peptides were extracted from the gel and desalted 
on reversed-phase C18 StageTips52.
Mass spectrometry analysis. Peptide fractions were analysed on a quadrupole 
Orbitrap mass spectrometer (Q Exactive Plus, Thermo Scientific) equipped with an 
EASY-nLC 1000 (Thermo Scientific) as described in ref. 53. Peptide samples were 
loaded onto C18 reversed-phase columns and eluted with a linear gradient from 
8 to 40% acetonitrile containing 0.1% formic acid for 2 h. The mass spectrometer 
was operated in data-dependent mode, automatically switching between MS and 
MS2 acquisition. Survey full-scan MS spectra (m/z 300–1,650) were acquired in 
the Orbitrap. The ten most intense ions were sequentially isolated and fragmented 
using HCD (higher-energy C-trap dissociation)54. Fragment spectra were acquired 
in the Orbitrap mass analyser. Raw data files were analysed using MaxQuant 
(development version 1.5.2.8)55. Parent ion and MS2 spectra were searched against 
a database containing 92,578 human protein sequences obtained from UniProtKB, 
released in December 2016, using the Andromeda search engine56. Spectra were 
searched with a mass tolerance of 6 ppm in the MS mode, 20 ppm in HCD MS2 
mode, strict trypsin specificity and allowing up to three miscleavages. Cysteine 
carbamidomethylation was searched as a fixed modification, whereas protein 
N-terminal acetylation, methionine oxidation, N-ethylmaleimide modification of 
cysteines were searched as variable modifications. The data set was filtered based 
on posterior error probability to arrive at a false discovery rate below 1% estimated 
using a target-decoy approach57.
Immunofluorescence and microscopy imaging. Confocal imaging for γ H2AX, 
RAD51, RPA, ssDNA (BrdU), BLM, BRCA2, FANCD2, Cyclin A and GFP 
(FAM35A and C20orf196) was performed as described in ref. 39; for RAD51 and 
Cyclin A the pre-extraction step was omitted and cells were permeabilized for 
15 min in 0.2% Triton X-100 (Sigma) in PBS after fixation. Super-resolution images 
were acquired using a Deltavision OMX 3D-SIM System V3 BLAZE (Applied 
Precision, a GE Healthcare company) equipped with three sCMOS (scientific 
complementary metal-oxide semiconductor) cameras, 405, 488 and 592.5 nm 
diode laser illumination, an Olympus Plan Apo N × 60, 1.42 NA oil objective, and 
standard excitation and emission filter sets. Imaging of each channel was done 
sequentially using three angles and five phase shifts of the illumination pattern, as 
described in ref. 58. Sections were acquired at 0.125 μ m z steps. Raw OMX data were 
reconstructed and channel registered in SoftWoRx software version 6.5.2 (Applied 
Precision, a GE Healthcare company). Voxelwise nearest-neighbour distances 
were measured for the GFP-FAM35A signal relative to the 53BP1 signal using 
a custom script (Butler R) for Fiji (https://github.com/gurdon-institute/OMX-
Spatial-Analysis). The script maps signal volumes using Kapur’s maximum entropy 
thresholding method59 and measures distances using the exact signed 3D Euclidean 
distance transform with internal distances set to zero for display on the histogram. 
For all images, scale bars represent 10 μ m.
Multiplex fluorescence in situ hybridization. Human 24-colour multiplex 
fluorescence in situ hybridization (M-FISH) probe preparation and slide treatment 
was carried out as in ref. 60. For each human cell sample, 10–30 metaphases were 
karyotyped based on the M-FISH classification and DAPI-banding pattern. FISH 
on metaphase spreads using BAC probes was performed as previously described61 
and counted manually. For CSR assays, DNA FISH on metaphase spreads 
was performed as previously described61 and counted manually. At least 470 
metaphases were evaluated per genotype, using at least two independent clones for 
each condition. For telomere uncapping, cell harvesting, preparation of metaphase 
spreads and telomere FISH with an Alexa488-(CCCTAA repeat) peptide 
nucleic acid custom probe (PN-TC060-005, Panagene/Eurogentec), metaphase 
chromosome analysis was done as described previously6. The data represent two 
independent experiments, with ≥ 1,300 chromosomes for each condition, counted 
manually after blinding the genotypes.
Telomere fusion assays and MEFs viral transduction. Cells were transduced as 
in ref. 49 with pLKO-puro shRNA lentiviruses obtained from the MISSION shRNA 
library (Sigma), against mouse genes as described or left untransduced (‘empty’). 
For assessment of telomere NHEJ, TRF2ts MEFs were grown for 24 h at the non-
permissive temperature of 39 °C to inactivate TRF2 and induce NHEJ-dependent 
chromosome end-to-end fusions because of telomere uncapping.
CSR assays for CH12 and CH12-Cas9 cell lines. The CH12-Cas9 cell line was 
generated by transducing CH12-Cas9 cells made using spin-infect with lentivirus 
particles packaged in HEK293T. Plasmids: pKLV2-EF1aBsd2Acas9-W, pxPAX2 
(Addgene #12260), VSV-G and pMD2.G (Addgene #12259). Blasticidin selection 
(10 μ g ml−1) started 48 h after transduction for one week. In sgRNA expression 
plasmids for CSR assays, sgRNAs were used to target Fam35a, C20orf196 and 
Mad2l2/Rev7 mouse genes (two sgRNAs per target gene; sequences listed in 
Supplementary Table 4). sgRNAs were cloned into pKLV-flipped U6gRNA_
CCDB_PB_BbsI_PGKpuro2ABFP vector62. For the generation of wild-type and 
knockout CH12-Cas9 cell clones, 53bp1 null CH12 cell clones (gift from F. Alt) 
were as previously described63. 12 million CH12-Cas9 cells were nucleofected 
with 2.2 μ g each of sgRNA-1 and sgRNA-2 and 0.6 μ g of piggyBac transposase 
expression vector64, using an Amaxa Nucleofector, Nucleofector Kit V solution 
(Lonza) and program X-001. Two days later, BFP-positive/puromycin-resistant 
CH12-Cas9 cells were selected with 3 μ g ml−1 puromycin for one week. Cells were 
then single cell diluted into 96-well plates, further cultured and screened by PCR, 
and Sanger sequenced using PCR primers (listed in Supplementary Table 4). For 
CSR and cell proliferation assays, CH12 cells were plated at 50,000 cells per ml in 
complete RPMI supplemented with anti-CD40 antibody (1 μ g ml−1, Miltenyi), IL-4 
(20 ng ml−1, Miltenyi) and TGF-β (1 ng ml−1, R&D Biotech) to induce IgM to IgA 
switching. After 3 days, cells were assayed for class-switching by flow cytometry 
using an IgA-PE antibody (eBiosciences) and a Canto II analyser (BD Biosciences). 
Viable cells were counted using a Casy cell counter (Roche). CSR and proliferation 
assays were done on 3× wild-type (WT), 3× Fam35a knockout (Fam35a), 3× 
C20orf196 knockout (C20orf196), 2× 53bp1 knockout (53bp1) and 3× Mad2l2 
knockout (Mad2l2) cell lines in three independent experiments. For RT–PCR 
analysis, Igh, α germ-line transcripts (αGLT) and Aid mRNA were quantified as 
previously described12. Primers are listed in Supplementary Table 4.
Patient-derived tumour xenografts. PDXs were generated and established 
from breast or ovarian cancer patients’ samples (with consent) as previously 
described40. The research was done with appropriate approval by the National 
Research Ethics Service, Cambridgeshire 2 REC (REC reference number: 08/
H0308/178), and by the Vall d’Hebron Hospital Clinical Investigation Ethical 
Committee (PR(AG)183/2012). STG201, the PDX model used in this study, is 
a BRCA-null model featuring BRCA1 promoter methylation, loss of BRCA1 
mRNA and protein expression. We have previously shown its sensitivity in vivo 
and in PDX-derived cells to PARP inhibitors, including olaparib. STG201 is also 
linked to deep molecular and drug sensitivity annotation40 (http://caldaslab.cruk.
cam.ac.uk/bcape/). All other PDXs were derived from breast or ovarian tumours 
from BRCA1-mutation carriers or BRCA1 epigenetic silencing due to promoter 
hypermethylation41. PDX127 did not show any co-expression of BRCA1 but it 
was low in both FAM35A and C20orf196 expression. None of the five PARPi-
sensitive PDXs exhibited low levels of C20orf196, FAM35A or 53BP1 loss nor 
BRCA1 hypomorphs. The study was compliant with all relevant ethical regulations 
regarding research involving animal use and human participants.
Generation of acquired drug resistance in vivo. AZD2281 (Olaparib/Lynparza) 
as a PARP inhibitor was administered to immunocompromised tumour-bearing 
mice following randomization, as previously described (50 mg kg−1, 5 days per 
week)40. To classify the response of the subcutaneous implants we modified the 
RECIST (response evaluation criteria in solid tumours) criteria to be based  
on the percent tumour volume change following continuous olaparib treatment: 
complete response (CR); best response, ≤ − 95%; partial response (PR), − 95% <  
best response ≤ − 30%; stable disease (SD), − 30% < best response ≤ + 20%; 
progressive disease (PD), % tumour volume change at day 21 of treatment > + 
20%. PARPi-resistant PDXs exhibited PD while PARPi-sensitive models exhibited 
SD, PR or CR. For STG201, time-matched vehicle- and olaparib-treated samples 
were collected 25 days after treatment (PARPi naive PDX) and processed for RNA 
extractions and sequencing. A couple of mice in the study were left with continued 
exposure to olaparib until tumour regrowth. One of these resistant tumours was 
serially passaged 126 days after treatment into new host mice (PARPi-resistant 
PDX) and treated with further vehicle or olaparib. At 58 days after treatment, the 
resistance phenotype was confirmed and samples were collected and processed for 
RNA-sequencing. Growth curves show average and standard deviation of at least 
five independent tumour volumes per trial arm. All experimental procedures were 
approved by the University of Cambridge Animal Welfare and Ethical Review 
Committee and by the Vall d’Hebron Hospital Clinical Investigation Ethical 
Committee and Animal Use Committee. For RNA-sequencing, RNA was extracted 
from all samples using the Qiagen miRNeasy or RNeasy Mini kit (cat. ID 217004 
or 74104) according to the manufacturer’s instructions. Libraries for Illumina 
sequencing were prepared using a TruSeq Stranded mRNA HT kit or Total RNA 
Library Prep kit with Ribo-Zero Gold (cat. ID, RS-122-2103 or RS-122-2301, 
Illumina). 500 ng of total RNA with RNA integrity numbers (RINs) above 8 was 
used for library preparation. Samples were processed following the manufacturer’s 
HS (High-Sample) instructions (part no. 15031048 Rev. E, Illumina) with 12 or 
15 cycles of PCR used at the Enrichment of DNA Fragments step. All libraries 
were quantified using KAPA Library Quantification Kit Illumina ROX Low 
(Cat ID, KK4873, KAPA Biosystems) and normalized. Libraries were pooled in 
equal volumes and pools were used for clustering on a HiSeq4000 sequencing 
flow cell following the manufacturer’s instructions. Sequencing was performed 
using 150 bp or 100 bp paired-end run types for dual-indexed libraries. Before 
alignment, the sequencing quality of the reads was enforced using Trim Galore! 
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(v0.4.2; http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/). Then, 
as described in refs 65,66, reads were aligned to a combined human (hg19) and 
mouse (mm10) reference genome using STAR (v2.5.2b)66,67. Counts were assigned 
to genome features using featureCounts (v1.5.2), whereby the alignment score 
is used to discern accurately between reads sourced from human and mouse68. 
Counts from multiple sequencing runs were merged and then normalized using 
the edgeR package69,70.
Statistics and reproducibility. Unless stated otherwise, Prism v7.0b (GraphPad 
Software) was used to generate graphs, perform statistical tests and calculate P 
values. Error bars, statistical tests and number of independent repeats (n) are 
indicated in the figure legends, and statistical source data including precise P 
values are provided in Supplementary Table 5. Statistical tests included two-tailed 
Student’s t-tests, Fisher’s exact test, and one-way analysis of variance (ANOVA), 
the latter all being corrected as recommended for multiple comparisons. 
Microscopy image analyses were performed using ImageJ/FIJI or Volocity 
6.3 (Perkin-Elmer). CRISPR screens were performed with three clones per 
drug treatment. Mass spectrometry of GFP-FAM35A and GFP-C20orf196 was 
performed in two independent experiments. RNA-sequencing was performed 
as three replicates for each trial arm, due to sequencing across multiple lanes 
(which were merged before any further analysis). This was performed for the 
following number of independent biological samples: six PDXs in cohort 1, 
five PDXs in cohort 2, seven PDXs in cohort 3 and eight PDXs in cohort 4. 
For the SHLD1 high and low expression cohorts, 12 and 4 independent PDXs 
were evaluated, respectively. All immunofluorescence assay quantification data 
represent mean ± s.e.m. of three independent biological repeats and n ≥ 30 cells 
per condition unless otherwise specified. All immunoblots are representative of 
two independent experiments, with unprocessed scans of immunoblots shown in 
Supplementary Fig. 8.
Reporting summary. Further information on experimental design is available in 
the Nature Research Reporting Summary linked to this article.
Code availability. A custom FIJI script used in OMX analysis is available at https://
github.com/gurdon-institute/OMX-Spatial-Analysis.
The MAGeCK commands used for CRISPR–Cas9 screens were mageck test -k 
counts.csv -c DMSO -t WC_2461 -n WC_2461 mageck test -k counts.csv -c DMSO -t 
WC-673 -n WC-673 mageck test -k counts.csv -c DMSO -t WC-2281 -n WC-2281
Data availability. The raw data files for the whole-genome CRISPR–Cas9 screen 
in SUM149 cells are available from the NIH Sequence Read Archive (SRA) via 
accession no. PRJNA471892. Raw data files for the PDX RNA sequencing are 
available from the NIH SRA via accession no. PRJNA473981. Raw data files 
for mass spectrometry are available via the ProteomeXchange Consortium on 
the PRIDE partner repository with data set identifier PXD009830. Source data 
for figures are provided in Supplementary Table 5. All other data supporting 
the findings of this study are available from the corresponding authors on 
reasonable request.
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Supplementary Figure 1 
Whole Genome CRISPR screen data and validation studies 
a, Schematic of the one vector lentiviral GeCKOv2 system. b, Histograms of sgRNA representation of 
GeCKOv2 (GKv2) library A (left panel) and B (right panel). Inset: cumulative distribution of sequencing 
reads. The number of sequencing reads for the 10th and 90th sgRNA percentiles are indicated by the 
dashed vertical blue lines and text labels. The representation of sgRNAs is indicated by the fold-difference 
between the 10th and 90th percentile. c, Representative surviving clones after treatment with PARP 
inhibitors, representative of 2 independent experiments. Top panel: naïve, un-transduced SUM149PT 
cells; bottom panel: GeCKOv2 library-transduced cells. d, Distributions of sgRNA frequencies arising in 
different conditions; Box and whisker plot with centre line at median, box limits at 25th/75th centiles and 
whiskers 1.5xIQR; n=3 technical replicates. e, sgRNA enrichments after treatments with the indicated 
drugs; each dot represents one sgRNA, with coloured dots representing the indicated target genes. f, 
Verification of BRCA1 mutant SUM149PT, BRCA1ko RPE1 and siRNAs and shRNAs used in this paper, by 
immunoblot or RT-qPCR (bars represent means; one experiment performed in triplicates). g, Clonogenic 
survival assay using the indicated siRNAs in BRCA1-proficient cells (WT); lower panel shows AUC. Bars 
represent mean  SEM, one-way Anova; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, ns=not significant 
(p≥0.05); n=3 independent experiments, with individual data points plotted over bars; statistical source 
data including the precise p values can be found in Supplementary Table 5. h, Genotypes of human 
knockout clones used in this work confirmed by Topo-cloning and Sanger sequencing. i, Cell cycle profiles 
of cells transfected with the indicated siRNAs used in this work (bars represent means derived from two 
independent experiments). All immunoblots are representative of two independent experiments; 






Supplementary Figure 2 
C20orf196/FAM35A interactions and localisation to DNA damage sites 
a, Co-localisation quantification of FAM35A/derivatives GFP-fusions with mCherry-LacR-C20orf196. 
Horizontal bars represent means, one-way Anova; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, ns=not 
significant (p≥0.05); n=3 independent experiments; statistical source data including the precise p values 
can be found in Supplementary Table 5. b, C-terminus of FAM35A interacts with C20orf196 in cells 
(without normalisation). c, Immunoprecipitation-mass spectrometric analysis of protein interactors of 
GFP-C20orf196 or GFP-FAM35A (MAD2L2 is detected in both; far left and middle left panels). GFP-
C20orf196 co-immunoprecipitates with Flag-MAD2L2 in HEK293 cells (middle right IB panel). 
Endogenous MAD2L2 co-immunoprecipitates with GFP-FAM35A and GFP-C20orf196 (far right IB panel) 
in HEK293 cells. d, Live-cell imaging of GFP-FAM35A or GFP-C20orf196 transiently expressed in U2OS 
cells stably expressing RFP-53BP1. Recruitment of GFP-FAM35A and GFP-C20orf196 to laser tracks was 
visible 30 min after laser micro-irradiation; representative image from 3 independent experiments. e, 
GFP-FAM35A and GFP-FAM35A N-terminus co-localise with 53BP1 in IRIF by super-resolution 
microscopy; histogram of n=11 cells per condition. f, Depletion of FAM35A or C20orf196 does not affect 
53BP1 IRIF (U2OS cells). g, as in f but for MAD2L2 IRIF. Bars represent means derived from 2 
independent experiments, with individual data points plotted over bars. h, Depletion of FAM35A or 
C20orf196 does not affect MAD2L2 protein levels. All immunoblots are representative of two 





Supplementary Figure 3 
DNA damage response and IRIF factor dependencies of FAM35A and C20orf196 
a, Minimal variation of doxycycline induced GFP-FAM35A (U2OS) and GFP-C20orf196 (RPE1) in cells 
treated with the indicated siRNAs. Immunoblots shown are representative of two independent 
experiments with unprocessed scans of immunoblots in Supplementary Fig 8. b, Representative images 
of GFP-FAM35A (left panel) and GFP-C20orf196 (right panel) IRIF in H2AX positive cells quantified in 
Fig 2e. Scale bar 10µm. c, Depletion of PTIP does not affect GFP-C20orf196 or GFP-FAM35A IRIF. Bars 
represent mean  SEM, one-way Anova; ns=not significant (p≥0.05); n=3 independent experiments, with 
individual data points plotted over bars; statistical source data can be found in Supplementary Table 5. 
Scale bar 10µm. d, Camptothecin induced GFP-FAM35A foci. Scale bar 10µm. e, Representative images of 
GFP-FAM35A derivatives with/without pre-extraction IR; d-e representative of 2 independent 
experiments. Scale bar 10µm. f, Representative images of GFP-FAM35A N-terminus IRIF dependencies 





Supplementary Figure 4 




a, Clonogenic survival assay following IR treatment using wild-type, Fam35ako or C20orf196ko mouse ES 
cells (right panel shows AUC). Bars represent means  SEM, one-way Anova; n=3 independent 
experiments, with individual data points plotted over bars. b, Genotypes of CH12-Cas9 cell knockout 
clones used CSR assays confirmed by Topo-cloning and Sanger sequencing. c, Flow cytometry profiles 
showing the percentage of IgA+ cells for indicated CH12-Cas9 cell clones (genotypes) after 3 days 
stimulation with anti-CD40, IL-4 and TGF-β. Cell clone numbers are indicated; representative of 3 
independent experiments. d, CSR assay in C20orf196ko cells complemented with C20orf196. Bars 
represent means  SEM, one-way Anova; n=3 independent experiments, with individual data points 
plotted over bars. e, CH12-Cas9 clones were plated at 50,000 cells/ml and counted after 3 days 
stimulation with anti-CD40, IL4, and TGF-β. Bars represent means  SEM, one-way Anova; n=3 
independent experiments, with individual data points plotted over bars. For a, d and e, *p<0.05, 
***p<0.001, ****p<0.0001, ns=not significant (p≥0.05); statistical source data including the precise p 
values can be found in Supplementary Table 5. f, Igh, α germ-line transcripts (αGLT) and Aid mRNA were 
quantified by semi-quantitative RT–PCR using 2.5-fold serial dilutions of cDNA made from CH12-Cas9 
cells and indicated CH12-Cas9 knockout cell clones after 2 days stimulation with anti-CD40, IL4, and TGF-
β. Hprt was used as a control for transcript expression. Immunoblots are representative of two 






Supplementary Figure 5 
Effects of FAM35A and C20orf196 on telomere fusions, DNA binding and DNA-end resection  
a, Telomere fusion assay as shown in Fig 4b but complemented with shRNA resistant human C20orf196. 
Bars represent means derived from 2 independent experiments with ≥1300 chromosomes counted per 
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condition, and individual data points plotted over bars; source data can be found in Supplementary Table 
5. b, qRT-PCR of mouse (left) and human (right) transcripts in MEFs. Bars represent means from one
experiment performed in triplicates. c, FRAP of GFP-RPA1 in stably expressing U2OS cells, depleted of 
FAM35A or C20orf196. Points represent mean  95% confidence intervals; residence time calculated as 
previously described50; n=28 independent experiments (siCTRL), n=22 (siFAM35A) and n=30 
(siC20orf196). d, Structure of yeast RPA1 (yRPA1) with ssDNA. e, Coomassie stained SDS-PAGE gel 
showing the bacterial purified FAM35A variants used in EMSAs. Immunoblots are representative of two 
independent experiments with unprocessed scans of immunoblots in Supplementary Fig 8. f, GFP-
FAM35A W489/W640A is able to interact with mCherry-LacR-C20orf196 in cells; representative of two 
independent experiments, scale bar 10µm. g, Overexpression of FAM35A or derivatives does not sensitise 
wild-type cells to olaparib, adjacent panel shows AUC. Bars represent means from one experiment 








Supplementary Figure 6 
FAM35A and C20orf196 functions relating to homologous recombination 
a, Representative images for quantifications of GFP-FAM35A presented in Fig 6a; scale bar 10µm. b, 
Representative images for quantifications presented in Fig 6b; scale bar 10µm. c, Representative images 
of FAM35A and C20orf196 effects on DNA-end resection in wild-type and BRCA1ko cells as measured by 
RPA nuclear intensity (after pre-extraction) following camptothecin treatment in the indicated 
genotypes, quantified in Supplementary Fig 6d; scale bar 10µm. d, Quantification of nuclear RPA 
intensity; n=5 independent experiments, except WT siAbraxas and BRCA1ko siCtIP (n=2) and 
BRCA1ko/FAM35Ako (n=4), with individual data points plotted over bars. e, Quantification of BRCA2 
accrual at laser micro-irradiated RPE1 cells with the indicated genotypes for the representative images 
presented in Fig 6d. n=3 independent experiments, with individual data points plotted over bars. f, Gating 
strategy employed for TLR assay. g, AUC for clonogenic survival assay presented in Fig 6g. N=4 
independent experiments, except BRCA1ko/FAM35Ako +FAM35A and +N-terminus where n=3, and +C-
terminus where n=2; with individual data points plotted over bars. h, FAM35A and 53BP1 effects on 
olaparib resistance in BRCA1ko cells are not additive as measured by clonogenic survival assay (left 
panel), AUC (right panel). N=4 independent experiments, except BRCA1ko/53BP1ko/FAM35Ako where 
n=2; with individual data points plotted over bars. In d, e, g and h, bars represent mean  SEM, one-way 
Anova; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, ns=not significant (p≥0.05); statistical source data 






Supplementary Figure 7 
Tumour growth curves in mice and cell sensitivities of SHLD mutant cells to DNA damaging agents 
a, Tumour growth curves of PDX mice cohorts treated with vehicle or olaparib in Fig 7a; points are 
means, with lines representing s.d. for each of cohorts 1-4. b, AUC for clonogenic survival assay presented 
in Fig 7c. N=3 independent experiments except BRCA1ko and C20orf196ko where n=4, and 
BRCA1ko/FAM35Ako where n=2. c, AUC for clonogenic survival assay presented in Fig 7d. N=3 
independent experiments except WT where n=6 and BRCA1ko/FAM35Ako where n=2. b-c Bars 
represent mean  SEM, one-way Anova; *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, ns=not significant 
(p≥0.05). Individual data points plotted over bars; statistical source data including the precise p values 
can be found in Supplementary Table 5. d, GFP-FAM35A foci are not affected by depletion of FANCD2; 
representative images (left panel) and quantification (right panel). Bars represent means from 2 
independent experiments, with individual data points plotted over bars. Scale bar 10µm. e, Graphical 















Supplementary Figure 8  








Supplementary Figure 8 continued 
Uncropped blots  
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